Citrus Sinensis ID: 010401
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 511 | 2.2.26 [Sep-21-2011] | |||||||
| Q55EC7 | 960 | RasGEF domain-containing | yes | no | 0.332 | 0.177 | 0.291 | 2e-15 | |
| Q7TQP6 | 835 | Serine/threonine-protein | yes | no | 0.430 | 0.263 | 0.297 | 4e-15 | |
| Q5GIG6 | 834 | Serine/threonine-protein | yes | no | 0.328 | 0.201 | 0.329 | 7e-15 | |
| Q54TH6 | 597 | Probable serine/threonine | no | no | 0.334 | 0.286 | 0.301 | 2e-14 | |
| Q55GU0 | 916 | Probable serine/threonine | no | no | 0.297 | 0.165 | 0.320 | 5e-14 | |
| Q59H18 | 835 | Serine/threonine-protein | no | no | 0.328 | 0.201 | 0.318 | 5e-14 | |
| P18161 | 1155 | Dual specificity protein | no | no | 0.324 | 0.143 | 0.275 | 6e-14 | |
| P05625 | 647 | RAF proto-oncogene serine | no | no | 0.330 | 0.261 | 0.310 | 8e-13 | |
| P11345 | 648 | RAF proto-oncogene serine | no | no | 0.330 | 0.260 | 0.310 | 1e-12 | |
| Q99N57 | 648 | RAF proto-oncogene serine | no | no | 0.330 | 0.260 | 0.310 | 1e-12 |
| >sp|Q55EC7|GEFX_DICDI RasGEF domain-containing serine/threonine-protein kinase X OS=Dictyostelium discoideum GN=gefX PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 84.3 bits (207), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 51/175 (29%), Positives = 95/175 (54%), Gaps = 5/175 (2%)
Query: 335 WLLNSDNLEFIDQIGPNSFKGVYKGKRVGIE-KLKGCDKGNAYEF--ELRKDLLELMTCG 391
W + ++LEF ++IG SF V++G +G++ +K +K + E+ + +++ L +
Sbjct: 14 WDIPFESLEFNEKIGKGSFGSVFRGCYLGLDVAIKKIEKADDPEYLKYIDREVSMLQSLR 73
Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN 451
H I+ F +CV + GL +VT+ + GG V L+ K+ + + + IA+D+A+ + FL+
Sbjct: 74 HPFIVNFSGICV-HSSGLYIVTEFVSGGDVRQLLKKTPPIGWDKRVSIAVDLAKAMVFLH 132
Query: 452 DHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR-WLAPEV 505
+ +RDL S+ ILLD + L D G + ++ G W+APE+
Sbjct: 133 AKKIIHRDLKSKNILLDEFQRIRLCDFGFARMSEQTKKSRHMTMCGTEGWVAPEI 187
|
Promotes the exchange of Ras-bound GDP by GTP. Dictyostelium discoideum (taxid: 44689) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q7TQP6|TNI3K_RAT Serine/threonine-protein kinase TNNI3K OS=Rattus norvegicus GN=Tnni3k PE=2 SV=3 | Back alignment and function description |
|---|
Score = 83.6 bits (205), Expect = 4e-15, Method: Compositional matrix adjust.
Identities = 72/242 (29%), Positives = 118/242 (48%), Gaps = 22/242 (9%)
Query: 278 RDFGEIEEEEACDESFRNGVENSNLKIQLQMPLPSSSFVVSVDEWQTVQSGGEEI-GRWL 336
+ + +EE C+E + G + S + + P P E V E+ R+
Sbjct: 402 KHYKRPQEELPCNEYSQPGGDGSYVSV----PSPLGKIKSMTKEKADVLLLRAELPSRFH 457
Query: 337 LNSDNLEFIDQIGPNSFKGVYKG----KRVGIEKLKG---CDKGNAYEFELRKDLLELMT 389
L +EF + IG SF VYKG K V I++ + C K + F +++ L
Sbjct: 458 LQLSEIEFHEIIGSGSFGKVYKGRCRNKIVAIKRYRANTYCSKSDVDMF--CREVSILCQ 515
Query: 390 CGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK---LQTKEIIRIAIDVAEG 446
H ++QF C+D+ +VT+ + GGS+ L+ + ++ LQ+K I IA+DVA+G
Sbjct: 516 LNHPCVVQFVGACLDDPSQFAIVTQYISGGSLFSLLHEQKRILDLQSKLI--IAVDVAKG 573
Query: 447 IKFLND--HGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG-YRWLAP 503
+++L+ + +RDLNS ILL G+ + D G +S+ E + G RW+AP
Sbjct: 574 MEYLHSLTQPIIHRDLNSHNILLYEDGHAVVADFGESRFLQSLDEDNMTKQPGNLRWMAP 633
Query: 504 EV 505
EV
Sbjct: 634 EV 635
|
May play a role in cardiac physiology. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q5GIG6|TNI3K_MOUSE Serine/threonine-protein kinase TNNI3K OS=Mus musculus GN=Tnni3k PE=2 SV=4 | Back alignment and function description |
|---|
Score = 82.8 bits (203), Expect = 7e-15, Method: Compositional matrix adjust.
Identities = 61/185 (32%), Positives = 98/185 (52%), Gaps = 17/185 (9%)
Query: 334 RWLLNSDNLEFIDQIGPNSFKGVYKG----KRVGIEKLKG---CDKGNAYEFELRKDLLE 386
R+ L +EF + IG SF VYKG K V I++ + C K + F +++
Sbjct: 454 RFHLQLSEIEFHEIIGSGSFGKVYKGRCRNKIVAIKRYRANTYCSKSDVDMF--CREVSI 511
Query: 387 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK---LQTKEIIRIAIDV 443
L H ++QF C+D+ +VT+ + GGS+ L+ + ++ LQ+K I IA+DV
Sbjct: 512 LCQLNHPCVVQFVGACLDDPSQFAIVTQYISGGSLFSLLHEQKRILDLQSKLI--IAVDV 569
Query: 444 AEGIKFLND--HGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG-YRW 500
A+G+++L+ + +RDLNS ILL G+ + D G +S+ E + G RW
Sbjct: 570 AKGMEYLHSLTQPIIHRDLNSHNILLYEDGHAVVADFGESRFLQSLDEDNMTKQPGNLRW 629
Query: 501 LAPEV 505
+APEV
Sbjct: 630 MAPEV 634
|
May play a role in cardiac physiology. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54TH6|Y9863_DICDI Probable serine/threonine-protein kinase DDB_G0281745 OS=Dictyostelium discoideum GN=DDB_G0281745 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 80.9 bits (198), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 54/179 (30%), Positives = 90/179 (50%), Gaps = 8/179 (4%)
Query: 335 WLLNSDNLEFI-DQIGPNSFK----GVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMT 389
W ++ L+F+ ++IG + G + G V I+KL + E ++++L L
Sbjct: 326 WNIDYKELKFVGNEIGSGKYGSVSLGYWLGTPVAIKKLH--ENNEETEILVQRELQILKE 383
Query: 390 CGHKNILQFYCVCVDENHGLCVVTKLMEGGSVND-LILKSRKLQTKEIIRIAIDVAEGIK 448
H I+QF V +E + ++T+ M+GG + D LI L KE +RI++D+A+ +
Sbjct: 384 IRHPQIVQFLGVSRNEKDEIHIITEFMDGGDLFDALIFGDIPLTWKEKLRISLDIAQSCR 443
Query: 449 FLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEVCF 507
FL+ G+ +RDL SQ ILL + L D+G+ + W+APEVC
Sbjct: 444 FLHARGILHRDLKSQNILLSTNRRAKLCDLGLARMFEERINKRYTCVGTEIWMAPEVCL 502
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q55GU0|Y9955_DICDI Probable serine/threonine-protein kinase DDB_G0267514 OS=Dictyostelium discoideum GN=DDB_G0267514 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 79.7 bits (195), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 50/156 (32%), Positives = 82/156 (52%), Gaps = 4/156 (2%)
Query: 353 FKGVYKGKRVGIEKLK-GCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCV 411
+KG+++G V I+++K D N E RK+L L H NI+ C + LC
Sbjct: 677 YKGLWRGSSVAIKQIKINEDVNNQVLEEFRKELTILSRLRHPNIVLLMAACTAPPN-LCF 735
Query: 412 VTKLMEGGSVND-LILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRH 470
+T+ + GGS+ D L K K+ + ++AI +A+G+ +L+ GV +RD+ S +LLD H
Sbjct: 736 ITEYLPGGSLYDALHSKKIKMNMQLYKKLAIQIAQGMNYLHLSGVIHRDIKSLNLLLDEH 795
Query: 471 GNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEVC 506
NV + D G+ + KS W++PE+
Sbjct: 796 MNVKICDFGL-SKLKSKSTEMTKSIGSPIWMSPELL 830
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q59H18|TNI3K_HUMAN Serine/threonine-protein kinase TNNI3K OS=Homo sapiens GN=TNNI3K PE=1 SV=3 | Back alignment and function description |
|---|
Score = 79.7 bits (195), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 59/185 (31%), Positives = 98/185 (52%), Gaps = 17/185 (9%)
Query: 334 RWLLNSDNLEFIDQIGPNSFKGVYKG----KRVGIEKLKG---CDKGNAYEFELRKDLLE 386
+ L +EF + IG SF VYKG K V I++ + C K + F +++
Sbjct: 455 HFHLQLSEIEFHEIIGSGSFGKVYKGRCRNKIVAIKRYRANTYCSKSDVDMF--CREVSI 512
Query: 387 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK---LQTKEIIRIAIDV 443
L H ++QF C+++ +VT+ + GGS+ L+ + ++ LQ+K I IA+DV
Sbjct: 513 LCQLNHPCVIQFVGACLNDPSQFAIVTQYISGGSLFSLLHEQKRILDLQSKLI--IAVDV 570
Query: 444 AEGIKFLND--HGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG-YRW 500
A+G+++L++ + +RDLNS ILL G+ + D G +S+ E + G RW
Sbjct: 571 AKGMEYLHNLTQPIIHRDLNSHNILLYEDGHAVVADFGESRFLQSLDEDNMTKQPGNLRW 630
Query: 501 LAPEV 505
+APEV
Sbjct: 631 MAPEV 635
|
May play a role in cardiac physiology. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P18161|SPLB_DICDI Dual specificity protein kinase splB OS=Dictyostelium discoideum GN=splB PE=2 SV=2 | Back alignment and function description |
|---|
Score = 79.7 bits (195), Expect = 6e-14, Method: Compositional matrix adjust.
Identities = 51/185 (27%), Positives = 93/185 (50%), Gaps = 19/185 (10%)
Query: 335 WLLNSDNLEFIDQIGPNSF----KGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTC 390
++++ ++++FI ++G +F +G +KG V I+KLK ++ +++ L
Sbjct: 846 YIIDINDIQFIQKVGEGAFSEVWEGWWKGIHVAIKKLKIIGDEEQFKERFIREVQNLKKG 905
Query: 391 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR------KLQTKEIIRIAIDVA 444
H+NI+ F C C++T+ M GGS+ +++ K ++++A D+A
Sbjct: 906 NHQNIVMFIGACYKP---ACIITEYMAGGSLYNILHNPNSSTPKVKYSFPLVLKMATDMA 962
Query: 445 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRW 500
G+ L+ + +RDL SQ ILLD GN+ + D G+ G T T+G RW
Sbjct: 963 LGLLHLHSITIVHRDLTSQNILLDELGNIKISDFGLSREKSREGSMT--MTNGGICNPRW 1020
Query: 501 LAPEV 505
PE+
Sbjct: 1021 RPPEL 1025
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 0 EC: . EC: 2 |
| >sp|P05625|RAF1_CHICK RAF proto-oncogene serine/threonine-protein kinase OS=Gallus gallus GN=RAF1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 75.5 bits (184), Expect = 8e-13, Method: Compositional matrix adjust.
Identities = 55/177 (31%), Positives = 82/177 (46%), Gaps = 8/177 (4%)
Query: 335 WLLNSDNLEFIDQIGPNSFKGVYKGK---RVGIEKLKGCDKGNAYEFELRKDLLELMTCG 391
W + + + +IG SF VYKGK V ++ LK D R ++ L
Sbjct: 342 WEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTR 401
Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSV-NDLILKSRKLQTKEIIRIAIDVAEGIKFL 450
H NIL F +N L +VT+ EG S+ L ++ K Q ++I IA A+G+ +L
Sbjct: 402 HVNILLFMGYMTKDN--LAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYL 459
Query: 451 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK--SVGEATEYETDGYRWLAPEV 505
+ + +RD+ S I L V +GD G+ T S + E T W+APEV
Sbjct: 460 HAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSILWMAPEV 516
|
Serine/threonine-protein kinase that acts as a regulatory link between the membrane-associated Ras GTPases and the MAPK/ERK cascade, and this critical regulatory link functions as a switch determining cell fate decisions. RAF1 activation initiates a mitogen-activated protein kinase (MAPK) cascade that comprises a sequential phosphorylation of the dual-specific MAPK kinases (MAP2K1/MEK1 and MAP2K2/MEK2) and the extracellular signal-regulated kinases (MAPK3/ERK1 and MAPK1/ERK2). Gallus gallus (taxid: 9031) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P11345|RAF1_RAT RAF proto-oncogene serine/threonine-protein kinase OS=Rattus norvegicus GN=Raf1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 75.5 bits (184), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 55/177 (31%), Positives = 82/177 (46%), Gaps = 8/177 (4%)
Query: 335 WLLNSDNLEFIDQIGPNSFKGVYKGK---RVGIEKLKGCDKGNAYEFELRKDLLELMTCG 391
W + + + +IG SF VYKGK V ++ LK D R ++ L
Sbjct: 342 WEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQLQAFRNEVAVLRKTR 401
Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSV-NDLILKSRKLQTKEIIRIAIDVAEGIKFL 450
H NIL F +N L +VT+ EG S+ L ++ K Q ++I IA A+G+ +L
Sbjct: 402 HVNILLFMGYMTKDN--LAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYL 459
Query: 451 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK--SVGEATEYETDGYRWLAPEV 505
+ + +RD+ S I L V +GD G+ T S + E T W+APEV
Sbjct: 460 HAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEV 516
|
Serine/threonine-protein kinase that acts as a regulatory link between the membrane-associated Ras GTPases and the MAPK/ERK cascade, and this critical regulatory link functions as a switch determining cell fate decisions including proliferation, differentiation, apoptosis, survival and oncogenic transformation. RAF1 activation initiates a mitogen-activated protein kinase (MAPK) cascade that comprises a sequential phosphorylation of the dual-specific MAPK kinases (MAP2K1/MEK1 and MAP2K2/MEK2) and the extracellular signal-regulated kinases (MAPK3/ERK1 and MAPK1/ERK2). The phosphorylated form of RAF1 (on residues Ser-338 and Ser-339, by PAK1) phosphorylates BAD/Bcl2-antagonist of cell death at 'Ser-75'. Phosphorylates adenylyl cyclases: ADCY2, ADCY5 and ADCY6, resulting in their activation. Phosphorylates PPP1R12A resulting in inhibition of the phosphatase activity. Can promote NF-kB activation and inhibit signal transducers involved in motility (ROCK2), apoptosis (MAP3K5/ASK1 and STK3/MST2), proliferation and angiogenesis (RB1). Can protect cells from apoptosis also by translocating to the mitochondria where it binds BCL2 and displaces BAD/Bcl2-antagonist of cell death. Regulates Rho signaling and migration, and is required for normal wound healing. Plays a role in the oncogenic transformation of epithelial cells via repression of the TJ protein, occludin (OCLN) by inducing the up-regulation of a transcriptional repressor SNAI2/SLUG, which induces down-regulation of OCLN. Restricts caspase activation in response to selected stimuli, notably Fas stimulation, pathogen-mediated macrophage apoptosis, and erythroid differentiation (By similarity). Phosphorylates TNNT2/cardiac muscle troponin T. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q99N57|RAF1_MOUSE RAF proto-oncogene serine/threonine-protein kinase OS=Mus musculus GN=Raf1 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 75.5 bits (184), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 55/177 (31%), Positives = 82/177 (46%), Gaps = 8/177 (4%)
Query: 335 WLLNSDNLEFIDQIGPNSFKGVYKGK---RVGIEKLKGCDKGNAYEFELRKDLLELMTCG 391
W + + + +IG SF VYKGK V ++ LK D R ++ L
Sbjct: 342 WEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQLQAFRNEVAVLRKTR 401
Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSV-NDLILKSRKLQTKEIIRIAIDVAEGIKFL 450
H NIL F +N L +VT+ EG S+ L ++ K Q ++I IA A+G+ +L
Sbjct: 402 HVNILLFMGYMTKDN--LAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYL 459
Query: 451 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK--SVGEATEYETDGYRWLAPEV 505
+ + +RD+ S I L V +GD G+ T S + E T W+APEV
Sbjct: 460 HAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEV 516
|
Serine/threonine-protein kinase that acts as a regulatory link between the membrane-associated Ras GTPases and the MAPK/ERK cascade, and this critical regulatory link functions as a switch determining cell fate decisions including proliferation, differentiation, apoptosis, survival and oncogenic transformation. RAF1 activation initiates a mitogen-activated protein kinase (MAPK) cascade that comprises a sequential phosphorylation of the dual-specific MAPK kinases (MAP2K1/MEK1 and MAP2K2/MEK2) and the extracellular signal-regulated kinases (MAPK3/ERK1 and MAPK1/ERK2). The phosphorylated form of RAF1 (on residues Ser-338 and Ser-339, by PAK1) phosphorylates BAD/Bcl2-antagonist of cell death at 'Ser-75'. Phosphorylates adenylyl cyclases: ADCY2, ADCY5 and ADCY6, resulting in their activation. Phosphorylates PPP1R12A resulting in inhibition of the phosphatase activity. Phosphorylates TNNT2/cardiac muscle troponin T. Can promote NF-kB activation and inhibit signal transducers involved in motility (ROCK2), apoptosis (MAP3K5/ASK1 and STK3/MST2), proliferation and angiogenesis (RB1). Can protect cells from apoptosis also by translocating to the mitochondria where it binds BCL2 and displaces BAD/Bcl2-antagonist of cell death. Plays a role in the oncogenic transformation of epithelial cells via repression of the TJ protein, occludin (OCLN) by inducing the up-regulation of a transcriptional repressor SNAI2/SLUG, which induces down-regulation of OCLN. Restricts caspase activation in response to selected stimuli, notably Fas stimulation, pathogen-mediated macrophage apoptosis, and erythroid differentiation (By similarity). Regulates Rho signaling and migration, and is required for normal wound healing. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 511 | ||||||
| 255571340 | 609 | protein kinase, putative [Ricinus commun | 0.986 | 0.827 | 0.792 | 0.0 | |
| 225434500 | 592 | PREDICTED: cell surface receptor daf-1 [ | 0.951 | 0.820 | 0.815 | 0.0 | |
| 449450836 | 585 | PREDICTED: probable LIM domain-containin | 0.953 | 0.832 | 0.700 | 0.0 | |
| 297793387 | 604 | kinase family protein [Arabidopsis lyrat | 0.982 | 0.831 | 0.708 | 0.0 | |
| 356553098 | 590 | PREDICTED: mitogen-activated protein kin | 0.954 | 0.827 | 0.687 | 0.0 | |
| 15237684 | 604 | protein kinase family protein [Arabidops | 0.982 | 0.831 | 0.692 | 0.0 | |
| 10177030 | 591 | unnamed protein product [Arabidopsis tha | 0.982 | 0.849 | 0.692 | 0.0 | |
| 356500890 | 588 | PREDICTED: focal adhesion kinase 1-like | 0.949 | 0.824 | 0.692 | 0.0 | |
| 297806737 | 583 | kinase family protein [Arabidopsis lyrat | 0.947 | 0.830 | 0.657 | 0.0 | |
| 356537583 | 582 | PREDICTED: uncharacterized protein LOC10 | 0.945 | 0.829 | 0.652 | 0.0 |
| >gi|255571340|ref|XP_002526619.1| protein kinase, putative [Ricinus communis] gi|223534059|gb|EEF35778.1| protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 844 bits (2181), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 408/515 (79%), Positives = 458/515 (88%), Gaps = 11/515 (2%)
Query: 1 MAAALECWSSRASTDEDMVEQVLMRTNDRSEAVSAAAETSSASAT------GKEYSSVVQ 54
MAAALECWSSRASTDEDMVEQVLMRT DRSE+ +T+S+ ++ SS +Q
Sbjct: 1 MAAALECWSSRASTDEDMVEQVLMRTQDRSESTLLHQDTTSSLSSLNPVIKDPPSSSNMQ 60
Query: 55 KRFQRLSRNVSEAIASLKNTLNLDSAPTGGVGVGARDQPT----ASSNSKIETSRKVVWG 110
KR QRLSRNVSEAIASLKN+LNLDS V + Q + ++K+E+ RKVVW
Sbjct: 61 KRLQRLSRNVSEAIASLKNSLNLDSPRGDSVLQLQQQQQQLPLQVNGSTKVESCRKVVWA 120
Query: 111 SVVRNLTQLYPGSQLPERLVSNMRKHYDSLPLSYAQAGFDMKEVFLHIKLIEQASGDDRP 170
VVRNLTQLYPGSQLPE+LVSN+RKHYDSLPLSYAQAGFDMK+VFLHIKLIEQAS D++P
Sbjct: 121 GVVRNLTQLYPGSQLPEKLVSNIRKHYDSLPLSYAQAGFDMKDVFLHIKLIEQASVDEQP 180
Query: 171 AIMIQEVSDDEAQGSVYKLTFACNSSISWPAMSGALDTASICCKKIQIFEKKGFTLGVVI 230
AIMIQEVSDDE QGSV+KLTFACNS ISWPAMSGALD ASICCKKIQIFEKKGFTL V++
Sbjct: 181 AIMIQEVSDDEVQGSVFKLTFACNSLISWPAMSGALDNASICCKKIQIFEKKGFTLAVIL 240
Query: 231 LAVQAGQEKSFKSQIENALKSAIKKPKPTSVKLPFGLCGCQEENTKGRDFGEIEEEEACD 290
L VQAG EKSFK++IENALK+AIKKPK T+VKLPFGLCGCQEENT+GRDFGEIEE+ +
Sbjct: 241 LLVQAGHEKSFKNRIENALKNAIKKPKQTTVKLPFGLCGCQEENTRGRDFGEIEEDPN-E 299
Query: 291 ESFRNGVENSNLKIQLQMPLPSSSFVVSVDEWQTVQSGGEEIGRWLLNSDNLEFIDQIGP 350
S+RNG EN N+KIQL+MPLP+SSFVVS+DEWQT+QSGG+EIG+WLLNSDNLEF+DQIGP
Sbjct: 300 LSYRNGTENLNVKIQLEMPLPTSSFVVSIDEWQTMQSGGDEIGKWLLNSDNLEFVDQIGP 359
Query: 351 NSFKGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLC 410
NSFKGVYKGKRVGIEKLKGCDKGNAY+FELRKDLLELMTCGHKN+LQFY VCVDENHGLC
Sbjct: 360 NSFKGVYKGKRVGIEKLKGCDKGNAYDFELRKDLLELMTCGHKNVLQFYGVCVDENHGLC 419
Query: 411 VVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRH 470
VVTKLMEGGSV+DL+LK++KLQTKEIIRIA+D+AEGIKF+NDHGVAYRDLN+QRILLDRH
Sbjct: 420 VVTKLMEGGSVSDLMLKNKKLQTKEIIRIAVDIAEGIKFMNDHGVAYRDLNTQRILLDRH 479
Query: 471 GNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEV 505
GN CLGDMGIVTACKS+GEA EYETDGYRWLAPE+
Sbjct: 480 GNACLGDMGIVTACKSMGEAMEYETDGYRWLAPEI 514
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225434500|ref|XP_002275567.1| PREDICTED: cell surface receptor daf-1 [Vitis vinifera] gi|297745851|emb|CBI15907.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 831 bits (2147), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 412/505 (81%), Positives = 453/505 (89%), Gaps = 19/505 (3%)
Query: 1 MAAALECWSSRASTDEDMVEQVLMRTNDRSEAVSAAAETSSASATGKEYSSVVQKRFQRL 60
MAAALECWSSRASTDEDMVEQVLMRT DRSE + ++S G + SS +QKR QRL
Sbjct: 1 MAAALECWSSRASTDEDMVEQVLMRTQDRSEGLP-----ENSSGAGVKESSAMQKRLQRL 55
Query: 61 SRNVSEAIASLKNTLNLDSAPTGGVGVGARDQPTASSNSKIETSRKVVWGSVVRNLTQLY 120
SRNVSEAIASLKN+LNLDS RD P SKIE+ RK+VWG VVRNLTQLY
Sbjct: 56 SRNVSEAIASLKNSLNLDSP---------RDPPA----SKIESCRKLVWGGVVRNLTQLY 102
Query: 121 PGSQLPERLVSNMRKHYDSLPLSYAQAGFDMKEVFLHIKLIEQASGDDRPAIMIQEVSDD 180
PGSQLPE+LVSN+RKHYDSLPLSYAQAGFDMK+VFLHI++IEQAS DD PAI+IQEVSDD
Sbjct: 103 PGSQLPEKLVSNIRKHYDSLPLSYAQAGFDMKDVFLHIRMIEQASVDDHPAILIQEVSDD 162
Query: 181 EAQGSVYKLTFACNSSISWPAMSGALDTASICCKKIQIFEKKGFTLGVVILAVQAGQEKS 240
E QGSV+KLTFACNSSISWPAMSGALD+ASICCKKIQIFEKKGFTLG+++L VQAGQEKS
Sbjct: 163 EIQGSVFKLTFACNSSISWPAMSGALDSASICCKKIQIFEKKGFTLGIILLLVQAGQEKS 222
Query: 241 FKSQIENALKSAIKKPKPTSVKLPFGLCGCQEENTKGRDFGEIEEEEACDESFRNGVENS 300
F+++IENALK AIKK KPT+VKLPFGLCGCQEENTKGR+ GEIEEE + RNG++NS
Sbjct: 223 FQNRIENALKFAIKKSKPTTVKLPFGLCGCQEENTKGREVGEIEEEGG-EPHHRNGIDNS 281
Query: 301 NLKIQLQMPLPSSSFVVSVDEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGK 360
N K+QLQMPLP+SSFVVSVDEWQTVQSGGEEIG+WLLNSDNLEF+DQIGPNSFKGVYKGK
Sbjct: 282 NTKVQLQMPLPTSSFVVSVDEWQTVQSGGEEIGKWLLNSDNLEFVDQIGPNSFKGVYKGK 341
Query: 361 RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGS 420
RVGIEKLKGCDKGN+YEFELRKDLLELMTCGHKNILQF+ VCVDENHGLCVVTKLMEGGS
Sbjct: 342 RVGIEKLKGCDKGNSYEFELRKDLLELMTCGHKNILQFFGVCVDENHGLCVVTKLMEGGS 401
Query: 421 VNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGI 480
V+D+ILK++K Q KEIIRIAIDVAEGIKF+NDHGVAYRDLN+QR+LLDRHGN CLGDMGI
Sbjct: 402 VHDVILKNKKFQNKEIIRIAIDVAEGIKFMNDHGVAYRDLNTQRVLLDRHGNACLGDMGI 461
Query: 481 VTACKSVGEATEYETDGYRWLAPEV 505
VTACKSVGEA EYETDGYRWLAPE+
Sbjct: 462 VTACKSVGEAMEYETDGYRWLAPEI 486
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449450836|ref|XP_004143168.1| PREDICTED: probable LIM domain-containing serine/threonine-protein kinase DDB_G0287001-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 734 bits (1894), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 355/507 (70%), Positives = 423/507 (83%), Gaps = 20/507 (3%)
Query: 1 MAAALECWSSRASTDEDMVEQVLMRTNDRSEAVSAAAETSSASATGKEYSSVVQKRFQRL 60
MA ALECWSSRASTDEDMVEQVLMRT DRSE ++ S+ A G++ SS + +R QR
Sbjct: 1 MATALECWSSRASTDEDMVEQVLMRTQDRSEG----SKPDSSFAVGEKESSAMHRRLQRF 56
Query: 61 SRNVSEAIASLKNTLNLDSAPTGGVGVGARDQPTASSNSKIETSRKVVWGSVVRNLTQLY 120
SRNVSEA+ASLKN+LNLDS RD S ++ E S+K VWG+VVRNLTQLY
Sbjct: 57 SRNVSEAVASLKNSLNLDSI---------RD----PSPTRTEGSKKAVWGTVVRNLTQLY 103
Query: 121 PGSQLPERLVSNMRKHYDSLPLSYAQAGFDMKEVFLHIKLIEQASGDDRPAIMIQEVSDD 180
PGSQLPE+LVSN+RKHYDSLPLSYA AGFDMK+VFLHIKL+EQAS D PAI+ QEV++
Sbjct: 104 PGSQLPEKLVSNIRKHYDSLPLSYALAGFDMKDVFLHIKLMEQASVYDHPAILFQEVTNR 163
Query: 181 EAQGSVYKLTFACNSSISWPAMSGALDTASICCKKIQIFEKKGFTLGVVILAVQAGQEKS 240
+ Q + K TFACNSS+SW AMSGAL+TA+I C+KIQIFEKK FTLGV++ QEK
Sbjct: 164 DVQKPIIKFTFACNSSVSWSAMSGALETAAIRCEKIQIFEKKKFTLGVILFVNLDLQEKL 223
Query: 241 FKSQIENALKSAIKKPKPTSVKLPFGLCGCQEENTKGRDFGEIEEEEACDESFRNGVENS 300
FKS++ENALK AIKKPK T+VKLPFG CGCQE NT G+D E EE+ + + R+G ENS
Sbjct: 224 FKSKVENALKLAIKKPKTTAVKLPFGFCGCQEGNTGGKDLRETEED-GVEPNCRSGFENS 282
Query: 301 NL--KIQLQMPLPSSSFVVSVDEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYK 358
NL +Q++MPL +SSF V+VDEWQT+QSGG E+G+WLL+S+NLEF+DQ+GPNSFKGVYK
Sbjct: 283 NLSENLQIEMPLCTSSFAVTVDEWQTIQSGGNELGKWLLSSENLEFVDQMGPNSFKGVYK 342
Query: 359 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEG 418
G+RV IEK+KGC+KG +Y+FELRKDLLELMTCGHKNIL FY VC+DENHGLCVVTKLMEG
Sbjct: 343 GRRVAIEKIKGCEKGVSYKFELRKDLLELMTCGHKNILMFYGVCIDENHGLCVVTKLMEG 402
Query: 419 GSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDM 478
GSV++L+LK++KLQTKEI RIAID+ EGIKF+NDHGVAYRDLN+QRILLD++GN CLGDM
Sbjct: 403 GSVHELMLKNKKLQTKEITRIAIDIVEGIKFMNDHGVAYRDLNTQRILLDKNGNACLGDM 462
Query: 479 GIVTACKSVGEATEYETDGYRWLAPEV 505
GI+TACK++GEA EYETDGYRWLAPE+
Sbjct: 463 GILTACKNLGEAMEYETDGYRWLAPEI 489
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297793387|ref|XP_002864578.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] gi|297310413|gb|EFH40837.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 722 bits (1863), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 364/514 (70%), Positives = 424/514 (82%), Gaps = 12/514 (2%)
Query: 1 MAAALECWSSRAST----DEDMVEQVLMRTNDRSEA-VSAAAETS----SASATGKEYSS 51
MAAALECWSSRA D+D+V+QVLMRT+DRSE+ +++ ETS ++A + SS
Sbjct: 1 MAAALECWSSRAGGGGGPDDDLVDQVLMRTHDRSESLITSLPETSLEVEGSTAGFDQSSS 60
Query: 52 VVQKRFQRLSRNVSEAIASLKNTLNLDSAPTGGVGVGARDQPTASSNSKIETSRKVVWGS 111
+QKRFQRLSRNVSEAIASLKN+LNLDSA VG P A RK+VW +
Sbjct: 61 AMQKRFQRLSRNVSEAIASLKNSLNLDSARDNQT-VGGATTPKAEVGGG-GGGRKLVWAT 118
Query: 112 VVRNLTQLYPGSQLPERLVSNMRKHYDSLPLSYAQAGFDMKEVFLHIKLIEQASGDDRPA 171
VVRNL ++YPGSQLPE+LVSN++KHYDSLP SY+QA DMKEVFLH+KLIEQASGDD P
Sbjct: 119 VVRNLARMYPGSQLPEKLVSNLKKHYDSLPFSYSQADLDMKEVFLHVKLIEQASGDDNPV 178
Query: 172 IMIQEVSDDEAQGSVYKLTFACNSSISWPAMSGALDTASICCKKIQIFEKKGFTLGVVIL 231
MIQEVS +E +GSV +LTFACNSS+SW MSGALD+ASICCKKIQIFEKKG TLGVV+L
Sbjct: 179 FMIQEVSAEEPRGSVLRLTFACNSSLSWSTMSGALDSASICCKKIQIFEKKGLTLGVVLL 238
Query: 232 AVQAGQEKSFKSQIENALKSAIKKPKPTSVKLPFGLCGCQEENTKGRDFGEIEEEEACDE 291
Q+GQ FK+++ENALK A KKPKPTSVKLPFGLCGCQE+N + EEE+
Sbjct: 239 LDQSGQHNFFKTRVENALKVATKKPKPTSVKLPFGLCGCQEQNGGVGE-LGGVEEESIQH 297
Query: 292 SFRNGVENSNLKIQLQMPLPSSSFVVSVDEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPN 351
S R G+EN N IQL +PL SSSF VSVDEWQT+QSGG EIG+WLLNSD+ EF DQIGP
Sbjct: 298 SNRLGIENLNSTIQLHIPLLSSSFAVSVDEWQTIQSGGSEIGKWLLNSDSFEFGDQIGPT 357
Query: 352 SFKGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCV 411
SFKG+++GKRVGIEKLKGCDKGN+YEFELRKD LELM CGHK+ILQFY VC+DENHGLCV
Sbjct: 358 SFKGIFRGKRVGIEKLKGCDKGNSYEFELRKDYLELMACGHKSILQFYGVCIDENHGLCV 417
Query: 412 VTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG 471
VTKLMEGGS+++L+LKS+KLQTK+I+RIAID+AEG+KF+NDHGVAYRDLN+QRILLD+HG
Sbjct: 418 VTKLMEGGSLHELMLKSKKLQTKQILRIAIDIAEGLKFVNDHGVAYRDLNTQRILLDKHG 477
Query: 472 NVCLGDMGIVTACKSVGEATEYETDGYRWLAPEV 505
N CLGD+GIVTACKS GEA EYETDGYRWLAPE+
Sbjct: 478 NACLGDIGIVTACKSFGEAVEYETDGYRWLAPEI 511
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356553098|ref|XP_003544895.1| PREDICTED: mitogen-activated protein kinase kinase kinase 10-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 719 bits (1857), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 352/512 (68%), Positives = 419/512 (81%), Gaps = 24/512 (4%)
Query: 1 MAAALECWSSRASTDEDM------VEQVLMRTNDRSEAVSAAAETSSASATGKEYSSVVQ 54
MAAALECWSSR + VEQVLMRT+ RSE + + ++ + + V
Sbjct: 1 MAAALECWSSRTTAAAATSTDDDTVEQVLMRTHHRSEGTTTTSTPNNNNNKDPSSAIPVH 60
Query: 55 KRFQRLSRNVSEAIASLKNTLNLDSAPTGGVGVGARDQPTASSNSKIETSRKVVWGSVVR 114
K+ Q+L+RNVSEAIAS +N+LNLDS P S+ +SRK+ WGSVVR
Sbjct: 61 KKLQKLTRNVSEAIASFRNSLNLDSPP---------------SSKADASSRKLAWGSVVR 105
Query: 115 NLTQLYPGSQLPERLVSNMRKHYDSLPLSYAQAGFDMKEVFLHIKLIEQASGDDRPAIMI 174
NLTQLYPGSQLPE+L+SN+RKHYDSLPLSYAQA FDMK+VFLHIKL+EQAS D+PAI+I
Sbjct: 106 NLTQLYPGSQLPEKLMSNIRKHYDSLPLSYAQAEFDMKDVFLHIKLMEQASESDQPAILI 165
Query: 175 QEVSDDEAQGSVYKLTFACNSSISWPAMSGALDTASICCKKIQIFEKKGFTLGVVILAVQ 234
QE D E QGS +LTFACNS ISWPAMSGALD++SICCK++QIFEKKGFTLGVV+L VQ
Sbjct: 166 QEECDYEVQGSALRLTFACNSPISWPAMSGALDSSSICCKRMQIFEKKGFTLGVVLLVVQ 225
Query: 235 AGQEKSFKSQIENALKSAIKKPKPTSVKLPFGLCGCQEENTKGRDFGEIEEEEACDESFR 294
+G +K ++++E+ALK A+K+PK +VKLPFGLCGCQEEN+KG D EIEEE + +R
Sbjct: 226 SGHDKLVRTRVESALKFAMKRPKTGAVKLPFGLCGCQEENSKGGDLVEIEEE--ISDGYR 283
Query: 295 NG-VENSNLKIQLQMPLPSSSFVVSVDEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSF 353
ENS +IQLQ+PLPSSSFVVSVDEWQT++SGG+EI +WLLNSD++EF++QIGPNSF
Sbjct: 284 GKEFENSGQRIQLQVPLPSSSFVVSVDEWQTIKSGGDEIEKWLLNSDSVEFVEQIGPNSF 343
Query: 354 KGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT 413
KGVY GKRV IEKLKGCDKGN+YEFEL KDLLELMTCGH+NILQF +CVD+NHGLCVVT
Sbjct: 344 KGVYLGKRVKIEKLKGCDKGNSYEFELHKDLLELMTCGHRNILQFCGICVDDNHGLCVVT 403
Query: 414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 473
K MEGGSV+DL++K++KLQTK+I+RIA+DVAEGIKF+NDHGVAYRDLN+ RILLDRHGN
Sbjct: 404 KFMEGGSVHDLMMKNKKLQTKDIVRIAVDVAEGIKFMNDHGVAYRDLNTPRILLDRHGNA 463
Query: 474 CLGDMGIVTACKSVGEATEYETDGYRWLAPEV 505
CLGDMGIVTACKSVGEA EYETDGYRWLAPE+
Sbjct: 464 CLGDMGIVTACKSVGEAMEYETDGYRWLAPEI 495
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15237684|ref|NP_200660.1| protein kinase family protein [Arabidopsis thaliana] gi|110738981|dbj|BAF01411.1| protein kinase like protein [Arabidopsis thaliana] gi|332009679|gb|AED97062.1| protein kinase family protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 710 bits (1832), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 356/514 (69%), Positives = 416/514 (80%), Gaps = 12/514 (2%)
Query: 1 MAAALECWSSRAS----TDEDMVEQVLMRTNDRSEAVSAAAETSSASATGK-----EYSS 51
MAAALECWSSRA D D+V+QVLMRT+DRSE+V + +S G + SS
Sbjct: 1 MAAALECWSSRAGDGGDPDNDLVDQVLMRTHDRSESVITSLPETSLEVEGSTTVFDQSSS 60
Query: 52 VVQKRFQRLSRNVSEAIASLKNTLNLDSAPTGGVGVGARDQPTASSNSKIETSRKVVWGS 111
+QKRFQRLSRNVSEAI SLKNTLNLDSA GA S RK+VW +
Sbjct: 61 AMQKRFQRLSRNVSEAIVSLKNTLNLDSARDNQSFGGAMTPKAEVSGGG--GGRKLVWAT 118
Query: 112 VVRNLTQLYPGSQLPERLVSNMRKHYDSLPLSYAQAGFDMKEVFLHIKLIEQASGDDRPA 171
VV+NL ++YPGSQLPE+LVSN++KHYDSLP SY+QA FDMKEVFLH+KLIEQA+GDD P
Sbjct: 119 VVKNLAKMYPGSQLPEKLVSNLKKHYDSLPFSYSQADFDMKEVFLHVKLIEQAAGDDNPV 178
Query: 172 IMIQEVSDDEAQGSVYKLTFACNSSISWPAMSGALDTASICCKKIQIFEKKGFTLGVVIL 231
MIQEVS +E +GSV +LTFACNS +SW MSG LD+ASICCKKIQIFEKKG TLGVV+L
Sbjct: 179 FMIQEVSTEEPRGSVLRLTFACNSFLSWSTMSGVLDSASICCKKIQIFEKKGLTLGVVLL 238
Query: 232 AVQAGQEKSFKSQIENALKSAIKKPKPTSVKLPFGLCGCQEENTKGRDFGEIEEEEACDE 291
Q+GQ FK+++EN LK A KKPKPTSVKLPFGLCGCQE+N + EEE+
Sbjct: 239 LDQSGQHSLFKTRVENTLKVATKKPKPTSVKLPFGLCGCQEQNGGVGEL-GGVEEESIQH 297
Query: 292 SFRNGVENSNLKIQLQMPLPSSSFVVSVDEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPN 351
S R G+EN N IQ+Q+PLPSSSF VSVDEWQT+QSGG EIG+WLLNSD+ EF DQIGP
Sbjct: 298 SSRLGIENLNSTIQIQVPLPSSSFAVSVDEWQTIQSGGNEIGKWLLNSDSFEFGDQIGPT 357
Query: 352 SFKGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCV 411
S KG+++GKRVGIEKLKGCDKGN+YEFELRKD LELM CGHK+ILQFY VC+DENHGLCV
Sbjct: 358 SLKGIFRGKRVGIEKLKGCDKGNSYEFELRKDYLELMACGHKSILQFYGVCIDENHGLCV 417
Query: 412 VTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG 471
VTKLMEGGS+++L+LK++KLQTK+I+RIAID+AEG+KF+NDHGVAYRDLN+QRILLD+HG
Sbjct: 418 VTKLMEGGSLHELMLKNKKLQTKQILRIAIDIAEGLKFVNDHGVAYRDLNTQRILLDKHG 477
Query: 472 NVCLGDMGIVTACKSVGEATEYETDGYRWLAPEV 505
N CLG++GIVTACKS GEA EYETDGYRWLAPE+
Sbjct: 478 NACLGNIGIVTACKSFGEAVEYETDGYRWLAPEI 511
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|10177030|dbj|BAB10268.1| unnamed protein product [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 709 bits (1830), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 356/514 (69%), Positives = 416/514 (80%), Gaps = 12/514 (2%)
Query: 1 MAAALECWSSRAS----TDEDMVEQVLMRTNDRSEAVSAAAETSSASATGK-----EYSS 51
MAAALECWSSRA D D+V+QVLMRT+DRSE+V + +S G + SS
Sbjct: 1 MAAALECWSSRAGDGGDPDNDLVDQVLMRTHDRSESVITSLPETSLEVEGSTTVFDQSSS 60
Query: 52 VVQKRFQRLSRNVSEAIASLKNTLNLDSAPTGGVGVGARDQPTASSNSKIETSRKVVWGS 111
+QKRFQRLSRNVSEAI SLKNTLNLDSA GA S RK+VW +
Sbjct: 61 AMQKRFQRLSRNVSEAIVSLKNTLNLDSARDNQSFGGAMTPKAEVSGGG--GGRKLVWAT 118
Query: 112 VVRNLTQLYPGSQLPERLVSNMRKHYDSLPLSYAQAGFDMKEVFLHIKLIEQASGDDRPA 171
VV+NL ++YPGSQLPE+LVSN++KHYDSLP SY+QA FDMKEVFLH+KLIEQA+GDD P
Sbjct: 119 VVKNLAKMYPGSQLPEKLVSNLKKHYDSLPFSYSQADFDMKEVFLHVKLIEQAAGDDNPV 178
Query: 172 IMIQEVSDDEAQGSVYKLTFACNSSISWPAMSGALDTASICCKKIQIFEKKGFTLGVVIL 231
MIQEVS +E +GSV +LTFACNS +SW MSG LD+ASICCKKIQIFEKKG TLGVV+L
Sbjct: 179 FMIQEVSTEEPRGSVLRLTFACNSFLSWSTMSGVLDSASICCKKIQIFEKKGLTLGVVLL 238
Query: 232 AVQAGQEKSFKSQIENALKSAIKKPKPTSVKLPFGLCGCQEENTKGRDFGEIEEEEACDE 291
Q+GQ FK+++EN LK A KKPKPTSVKLPFGLCGCQE+N + EEE+
Sbjct: 239 LDQSGQHSLFKTRVENTLKVATKKPKPTSVKLPFGLCGCQEQNGGVGEL-GGVEEESIQH 297
Query: 292 SFRNGVENSNLKIQLQMPLPSSSFVVSVDEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPN 351
S R G+EN N IQ+Q+PLPSSSF VSVDEWQT+QSGG EIG+WLLNSD+ EF DQIGP
Sbjct: 298 SSRLGIENLNSTIQIQVPLPSSSFAVSVDEWQTIQSGGNEIGKWLLNSDSFEFGDQIGPT 357
Query: 352 SFKGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCV 411
S KG+++GKRVGIEKLKGCDKGN+YEFELRKD LELM CGHK+ILQFY VC+DENHGLCV
Sbjct: 358 SLKGIFRGKRVGIEKLKGCDKGNSYEFELRKDYLELMACGHKSILQFYGVCIDENHGLCV 417
Query: 412 VTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG 471
VTKLMEGGS+++L+LK++KLQTK+I+RIAID+AEG+KF+NDHGVAYRDLN+QRILLD+HG
Sbjct: 418 VTKLMEGGSLHELMLKNKKLQTKQILRIAIDIAEGLKFVNDHGVAYRDLNTQRILLDKHG 477
Query: 472 NVCLGDMGIVTACKSVGEATEYETDGYRWLAPEV 505
N CLG++GIVTACKS GEA EYETDGYRWLAPE+
Sbjct: 478 NACLGNIGIVTACKSFGEAVEYETDGYRWLAPEM 511
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356500890|ref|XP_003519263.1| PREDICTED: focal adhesion kinase 1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 704 bits (1816), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 355/513 (69%), Positives = 423/513 (82%), Gaps = 28/513 (5%)
Query: 1 MAAALECWSSRASTDEDM------VEQVLMRTNDRSEAVSAAAETSSASATGKEYSSV-V 53
MAAALECWSSR +T VEQVLMRT+ RSE + TS+ + S++ V
Sbjct: 1 MAAALECWSSRTTTSAAAATDDDTVEQVLMRTHHRSEGTTT---TSTHNNKDNLPSAIPV 57
Query: 54 QKRFQRLSRNVSEAIASLKNTLNLDSAPTGGVGVGARDQPTASSNSKIETSRKVVWGSVV 113
K+ Q+L+RNVSEAIAS +N+LNLDS P SSN+ +SRK+ WGSVV
Sbjct: 58 HKKLQKLTRNVSEAIASFRNSLNLDSPP--------------SSNADA-SSRKLAWGSVV 102
Query: 114 RNLTQLYPGSQLPERLVSNMRKHYDSLPLSYAQAGFDMKEVFLHIKLIEQASGDDRPAIM 173
RNLTQLYPGSQLPE+L+SN+RKHYDSLPLSYAQA FDMK VFLHIKL+EQAS D+PAI+
Sbjct: 103 RNLTQLYPGSQLPEKLMSNIRKHYDSLPLSYAQAEFDMKNVFLHIKLMEQASESDQPAIL 162
Query: 174 IQEVSDDEAQGSVYKLTFACNSSISWPAMSGALDTASICCKKIQIFEKKGFTLGVVILAV 233
IQE D E QGS +LTFACNS ISWPAMSGALD++SICCK++QIFEKKGFTLGVV+L V
Sbjct: 163 IQEECDGEIQGSALRLTFACNSPISWPAMSGALDSSSICCKRMQIFEKKGFTLGVVLLVV 222
Query: 234 QAGQEKSFKSQIENALKSAIKKPKPTSVKLPFGLCGCQEENTKGRDFGEIEEEEACDESF 293
G +K ++++ENALK A+KKPK +VKLPFGLCGCQEEN+KGR+ EIEEE + +
Sbjct: 223 LPGHDKLVRTRVENALKFAMKKPKTGAVKLPFGLCGCQEENSKGRELVEIEEETG--DGY 280
Query: 294 RNG-VENSNLKIQLQMPLPSSSFVVSVDEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNS 352
R ENS+ +IQLQ+PLPSSSFVVSVDEWQT++SGG EI +WLLNSD++EF++QIGPNS
Sbjct: 281 RGKEFENSSQRIQLQVPLPSSSFVVSVDEWQTIKSGGNEIEKWLLNSDSVEFVEQIGPNS 340
Query: 353 FKGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV 412
++GVY GKRVGIEKLKGCDKGN+YEFEL KDLLELMTCGH+NILQF +CVD+NHGLCVV
Sbjct: 341 YRGVYMGKRVGIEKLKGCDKGNSYEFELHKDLLELMTCGHRNILQFCGICVDDNHGLCVV 400
Query: 413 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGN 472
TK MEGGSV+DL++K++KLQTK+++RIA+DVAEGIKF+NDHGVAYRDLN++ ILLD+HGN
Sbjct: 401 TKFMEGGSVHDLMMKNKKLQTKDVVRIAVDVAEGIKFMNDHGVAYRDLNTRGILLDKHGN 460
Query: 473 VCLGDMGIVTACKSVGEATEYETDGYRWLAPEV 505
CLGDMGIVTACKSVGEA EYETDGYRWLAPE+
Sbjct: 461 ACLGDMGIVTACKSVGEAMEYETDGYRWLAPEI 493
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297806737|ref|XP_002871252.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] gi|297317089|gb|EFH47511.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 682 bits (1761), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 336/511 (65%), Positives = 419/511 (81%), Gaps = 27/511 (5%)
Query: 1 MAAALECWSSRAS----TDEDMVEQVLMRTNDRSEAVSAAAETSSASATGKEYSSVVQKR 56
MA+ALECW++R + D+D V+QVLM ++DRSE+++AA + + SS +QKR
Sbjct: 1 MASALECWTTRNADGGCADDDFVDQVLMCSDDRSESLTAAPPSD-------QTSSAMQKR 53
Query: 57 FQRLSRNVSEAIASLKNTLNLDSAPTGGVGVGARDQPTASSNSKIETSRKVVWGSVVRNL 116
FQRL RNVS+AIASLKN+LNLDS RD A++ RK+VW +VVRNL
Sbjct: 54 FQRLGRNVSDAIASLKNSLNLDSG---------RDNQNAATGG----GRKLVWATVVRNL 100
Query: 117 TQLYPGSQLPERLVSNMRKHYDSLPLSYAQAGFDMKEVFLHIKLIEQASGDDRPAIMIQE 176
++YPGSQLP+ LVSN+RKHYDSLPLSY+Q GFDMK+VF+HIKLIEQASGDD P +IQE
Sbjct: 101 AKMYPGSQLPDNLVSNLRKHYDSLPLSYSQTGFDMKDVFVHIKLIEQASGDDNPVFVIQE 160
Query: 177 VSDDEA--QGSVYKLTFACNSSISWPAMSGALDTASICCKKIQIFEKKGFTLGVVILAVQ 234
V D+EA QGSV+KLTFA SS+ W +SG+LD ASICCKK+QIFEKKG TLGV +L V+
Sbjct: 161 VCDEEADEQGSVFKLTFASTSSLPWSTISGSLDCASICCKKVQIFEKKGLTLGVALLLVE 220
Query: 235 AGQEKSFKSQIENALKSAIKKPKPTSVKLPFGLCGCQEENTKGRDFGEIEEEEACDESFR 294
+GQEK FK ++ENAL+SA++KPK TSVKLPFGLCGCQE+N +FG+++ E + D+ +R
Sbjct: 221 SGQEKLFKIKVENALRSAVRKPKSTSVKLPFGLCGCQEQNAGVGEFGDVDVE-SIDQCYR 279
Query: 295 NGVENSNLKIQLQMPLPSSSFVVSVDEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFK 354
+ +++ N +IQLQMP PSSSF VSVDEWQT+QSGG++IG+WLLNSD+LEF Q+GPNSFK
Sbjct: 280 HELDDLNTRIQLQMPPPSSSFSVSVDEWQTIQSGGDDIGKWLLNSDDLEFGGQLGPNSFK 339
Query: 355 GVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTK 414
GVY+G +V IEKLKGC+KGN+YEFE+RKD LELMTCGHK+ILQFY VC+DENHGLCVVTK
Sbjct: 340 GVYRGIKVAIEKLKGCEKGNSYEFEIRKDFLELMTCGHKSILQFYGVCIDENHGLCVVTK 399
Query: 415 LMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVC 474
LM+GGS+ +L+LK +KLQTK I +IA+D+AE +KF+NDHGVAYRDLN+QRILLD+ N C
Sbjct: 400 LMQGGSLRELVLKKKKLQTKVIFQIAVDIAEAMKFINDHGVAYRDLNTQRILLDKQCNAC 459
Query: 475 LGDMGIVTACKSVGEATEYETDGYRWLAPEV 505
LGD+G+VTACKSV EA EYETDGYRWLAPE+
Sbjct: 460 LGDLGVVTACKSVSEAMEYETDGYRWLAPEI 490
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356537583|ref|XP_003537306.1| PREDICTED: uncharacterized protein LOC100819097 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 661 bits (1705), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 332/509 (65%), Positives = 407/509 (79%), Gaps = 26/509 (5%)
Query: 1 MAAALECWSSRASTDEDMVEQVLMRTNDRSEAVSAAAETSSASATGKEYSSVVQKRFQRL 60
MAAALECWS RA+T D VLM+ ++ + ++SS SS+V K+ Q+L
Sbjct: 1 MAAALECWSRRATTTVDEDHAVLMQPPEQDPTIPQPRDSSS--------SSIVHKKLQKL 52
Query: 61 SRNVSEAIASLKNTLNLDSAPTGGVGVGARDQPTASSNSKIETSRKVVWGSVVRNLTQLY 120
+RNVSEAIASLKN+LN S + +SK + R +VW +V+R+L LY
Sbjct: 53 TRNVSEAIASLKNSLNSSST-------------VSVESSKPDAPRSLVWTTVLRHLIHLY 99
Query: 121 PGSQLPERLVSNMRKHYDSLPLSYAQAGFDMKEVFLHIKLIEQASGDDRPAIMIQEVSDD 180
PGSQLPE+LV N+RKHYDSLPLSY++AGF++K+VFLH+KL+EQA D++ AI+IQE DD
Sbjct: 100 PGSQLPEKLVCNIRKHYDSLPLSYSKAGFEVKDVFLHMKLMEQALEDEQAAILIQEECDD 159
Query: 181 EAQ--GSVYKLTFACNSSISWPAMSGALDTASICCKKIQIFEKKGFTLGVVILAVQAG-- 236
E Q GSV+KLTFACNS ISWPAMSGALD SICCKKIQIFEKK FTLG+V+L V +G
Sbjct: 160 EIQLQGSVFKLTFACNSPISWPAMSGALDAYSICCKKIQIFEKKCFTLGIVLLLVLSGGG 219
Query: 237 QEKSFKSQIENALKSAIKKPKPTSVKLPFGLCGCQEENTKGRDFGEIEEEEACDESFRNG 296
Q+K ++++E+ALK A+K+PK VKLPFGLCGCQEEN+KGR GEIEE+ D NG
Sbjct: 220 QDKLVRTRVESALKIAMKRPKAGGVKLPFGLCGCQEENSKGRRLGEIEED-GWDAYCGNG 278
Query: 297 VENSNLKIQLQMPLPSSSFVVSVDEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGV 356
EN + KI+LQ+PLPSSSF+V VDEWQT+QSGG EI +WLLNSD+LEF++QI PNS+KG
Sbjct: 279 FENLSQKIELQVPLPSSSFLVVVDEWQTIQSGGAEIEKWLLNSDSLEFVEQIAPNSYKGT 338
Query: 357 YKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLM 416
Y GK+VGIEKL+GC+KGN+YEFELRKDLL LMTCGH+NI+QF VCVD+NHGLCVVTK +
Sbjct: 339 YMGKKVGIEKLRGCEKGNSYEFELRKDLLALMTCGHRNIMQFCGVCVDDNHGLCVVTKFV 398
Query: 417 EGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLG 476
EGGSV+DL+LK++KL +K+I+RIA DVAEGIKF NDHGVAYRDLN+QRILLD+HGN CLG
Sbjct: 399 EGGSVHDLMLKNKKLPSKDIVRIAADVAEGIKFKNDHGVAYRDLNTQRILLDKHGNACLG 458
Query: 477 DMGIVTACKSVGEATEYETDGYRWLAPEV 505
DMGIVTACK+VGEA +YETDGYRWLAPE+
Sbjct: 459 DMGIVTACKNVGEAMDYETDGYRWLAPEI 487
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 511 | ||||||
| TAIR|locus:2171213 | 604 | AT5G58520 [Arabidopsis thalian | 0.982 | 0.831 | 0.686 | 8.8e-189 | |
| TAIR|locus:2182905 | 583 | AT5G07140 [Arabidopsis thalian | 0.954 | 0.837 | 0.631 | 8.9e-173 | |
| TAIR|locus:2121154 | 575 | STY46 "serine/threonine/tyrosi | 0.407 | 0.361 | 0.314 | 9e-20 | |
| TAIR|locus:2827943 | 546 | STY8 "serine/threonine/tyrosin | 0.326 | 0.305 | 0.320 | 1.1e-17 | |
| TAIR|locus:2128043 | 570 | STY17 "serine/threonine/tyrosi | 0.293 | 0.263 | 0.322 | 1.5e-15 | |
| RGD|727908 | 835 | Tnni3k "TNNI3 interacting kina | 0.418 | 0.256 | 0.305 | 2.4e-14 | |
| MGI|MGI:2443276 | 834 | Tnni3k "TNNI3 interacting kina | 0.418 | 0.256 | 0.300 | 5.2e-14 | |
| TAIR|locus:2157717 | 346 | AT5G50180 [Arabidopsis thalian | 0.330 | 0.488 | 0.302 | 6.2e-14 | |
| TAIR|locus:2101689 | 377 | AT3G50720 [Arabidopsis thalian | 0.326 | 0.442 | 0.313 | 9e-14 | |
| DICTYBASE|DDB_G0269298 | 960 | gefX "protein kinase, TKL grou | 0.332 | 0.177 | 0.291 | 1.1e-13 |
| TAIR|locus:2171213 AT5G58520 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1830 (649.3 bits), Expect = 8.8e-189, P = 8.8e-189
Identities = 353/514 (68%), Positives = 412/514 (80%)
Query: 1 MAAALECWSSRAST----DEDMVEQVLMRTNDRXXXXXXXXXXXXXXXXGK-----EYSS 51
MAAALECWSSRA D D+V+QVLMRT+DR G + SS
Sbjct: 1 MAAALECWSSRAGDGGDPDNDLVDQVLMRTHDRSESVITSLPETSLEVEGSTTVFDQSSS 60
Query: 52 VVQKRFQRLSRNVSEAIASLKNTLNLDSAPTGGVGVGARDQPTASSNSKIETSRKVVWGS 111
+QKRFQRLSRNVSEAI SLKNTLNLDSA G P A + RK+VW +
Sbjct: 61 AMQKRFQRLSRNVSEAIVSLKNTLNLDSA-RDNQSFGGAMTPKAEVSGG-GGGRKLVWAT 118
Query: 112 VVRNLTQLYPGSQLPERLVSNMRKHYDSLPLSYAQAGFDMKEVFLHIKLIEQASGDDRPA 171
VV+NL ++YPGSQLPE+LVSN++KHYDSLP SY+QA FDMKEVFLH+KLIEQA+GDD P
Sbjct: 119 VVKNLAKMYPGSQLPEKLVSNLKKHYDSLPFSYSQADFDMKEVFLHVKLIEQAAGDDNPV 178
Query: 172 IMIQEVSDDEAQGSVYKLTFACNSSISWPAMSGALDTASICCKKIQIFEKKGFTLGVVIL 231
MIQEVS +E +GSV +LTFACNS +SW MSG LD+ASICCKKIQIFEKKG TLGVV+L
Sbjct: 179 FMIQEVSTEEPRGSVLRLTFACNSFLSWSTMSGVLDSASICCKKIQIFEKKGLTLGVVLL 238
Query: 232 AVQAGQEKSFKSQIENALKSAIKKPKPTSVKLPFGLCGCQEENTKGRDFGEIEEEEACDE 291
Q+GQ FK+++EN LK A KKPKPTSVKLPFGLCGCQE+N + G +EEE +
Sbjct: 239 LDQSGQHSLFKTRVENTLKVATKKPKPTSVKLPFGLCGCQEQNGGVGELGGVEEE-SIQH 297
Query: 292 SFRNGVENSNLKIQLQMPLPSSSFVVSVDEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPN 351
S R G+EN N IQ+Q+PLPSSSF VSVDEWQT+QSGG EIG+WLLNSD+ EF DQIGP
Sbjct: 298 SSRLGIENLNSTIQIQVPLPSSSFAVSVDEWQTIQSGGNEIGKWLLNSDSFEFGDQIGPT 357
Query: 352 SFKGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCV 411
S KG+++GKRVGIEKLKGCDKGN+YEFELRKD LELM CGHK+ILQFY VC+DENHGLCV
Sbjct: 358 SLKGIFRGKRVGIEKLKGCDKGNSYEFELRKDYLELMACGHKSILQFYGVCIDENHGLCV 417
Query: 412 VTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG 471
VTKLMEGGS+++L+LK++KLQTK+I+RIAID+AEG+KF+NDHGVAYRDLN+QRILLD+HG
Sbjct: 418 VTKLMEGGSLHELMLKNKKLQTKQILRIAIDIAEGLKFVNDHGVAYRDLNTQRILLDKHG 477
Query: 472 NVCLGDMGIVTACKSVGEATEYETDGYRWLAPEV 505
N CLG++GIVTACKS GEA EYETDGYRWLAPE+
Sbjct: 478 NACLGNIGIVTACKSFGEAVEYETDGYRWLAPEI 511
|
|
| TAIR|locus:2182905 AT5G07140 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1679 (596.1 bits), Expect = 8.9e-173, P = 8.9e-173
Identities = 320/507 (63%), Positives = 400/507 (78%)
Query: 1 MAAALECWSSRASTDEDMVEQVLMRTNDRXXXXXXXXXXXXXXXXGKEYSSVVQKRFQRL 60
MA+ALECW++R + + + + + SS +QKRFQRL
Sbjct: 1 MASALECWTTRNAAGGCADDDFVDQV---LMSSEDRSESLTAPPPSDQTSSAMQKRFQRL 57
Query: 61 SRNVSEAIASLKNTLNLDSAPTGGVGVGARDQPTASSNSKIETSRKVVWGSVVRNLTQLY 120
RNVS+AIASLKN+LNLDS+ RD A++ RK+VW +VVRNL ++Y
Sbjct: 58 GRNVSDAIASLKNSLNLDSS---------RDNQNAATGG----GRKLVWATVVRNLAKMY 104
Query: 121 PGSQLPERLVSNMRKHYDSLPLSYAQAGFDMKEVFLHIKLIEQASGDDRPAIMIQEVSDD 180
PGSQLP++LVSN+RKHYDSLPLSY+Q GFDMK+VF+HIKLIEQA GDD P +IQEV D+
Sbjct: 105 PGSQLPDKLVSNLRKHYDSLPLSYSQTGFDMKDVFVHIKLIEQAFGDDNPVFVIQEVCDE 164
Query: 181 EA--QGSVYKLTFACNSSISWPAMSGALDTASICCKKIQIFEKKGFTLGVVILAVQAGQE 238
EA QGSV+KLTFAC S+ W +SG+LD A ICCKK+QIFEKKG TLGVV+L V++GQE
Sbjct: 165 EADDQGSVFKLTFACTCSLPWSTISGSLDGALICCKKVQIFEKKGLTLGVVLLLVESGQE 224
Query: 239 KSFKSQIENALKSAIKKPKPTSVKLPFGLCGCQEENTKGRDFGEIEEEEACDESFRNGVE 298
K FK ++ NAL+SA++KPK TSVKLPFGLCGC+E+N +FG+++ E + D+ +R+ ++
Sbjct: 225 KMFKVKVVNALRSAVRKPKSTSVKLPFGLCGCEEQNAGVGEFGDVDVE-SIDQCYRHELD 283
Query: 299 NSNLKIQLQMPLPSSSFVVSVDEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYK 358
+ N +IQLQMP PSSSF VSVDEWQT+QSGG++I +WLLNSD+LEF Q+GPNSFKGVY+
Sbjct: 284 DLNTRIQLQMPPPSSSFSVSVDEWQTIQSGGDDIRKWLLNSDDLEFSGQLGPNSFKGVYR 343
Query: 359 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEG 418
G +V IEKLKGC+KGN+YEF +RKD LELMTCGHK+ILQFY VC+DENHGLCVVTKLM+G
Sbjct: 344 GTKVAIEKLKGCEKGNSYEFAIRKDFLELMTCGHKSILQFYGVCIDENHGLCVVTKLMQG 403
Query: 419 GSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDM 478
GS+ +L+LK +KLQTK I +IA+D+AEG+KF+NDHGVAYRDLN+QRILLD+ N CLGD+
Sbjct: 404 GSLRELVLKKKKLQTKLIFQIAVDIAEGMKFINDHGVAYRDLNTQRILLDKQCNACLGDL 463
Query: 479 GIVTACKSVGEATEYETDGYRWLAPEV 505
GIVTACKSV EA EYETDGYRWLAPE+
Sbjct: 464 GIVTACKSVNEAMEYETDGYRWLAPEI 490
|
|
| TAIR|locus:2121154 STY46 "serine/threonine/tyrosine kinase 46" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 263 (97.6 bits), Expect = 9.0e-20, P = 9.0e-20
Identities = 73/232 (31%), Positives = 118/232 (50%)
Query: 291 ESFRNGVENSNLKIQLQM---PLPSSSFVVSVDEWQT-------VQSGGEEIGRWLLNSD 340
E R +E KI+LQ P+ SF + QT + + G ++ W +N
Sbjct: 232 ERLRISLEKEAAKIELQSQSWPM-QQSFSPEKENGQTGARTHVPIPNDGTDV--WEINLK 288
Query: 341 NLEFIDQIGPNSFKGVYKG----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNIL 396
+L+F +I S+ +YKG + V I+ LK + E E +++ + HKN++
Sbjct: 289 HLKFGHKIASGSYGDLYKGTYCSQEVAIKVLKPERLDSDLEKEFAQEVFIMRKVRHKNVV 348
Query: 397 QFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR---KLQTKEIIRIAIDVAEGIKFLNDH 453
QF C H LC+VT+ M GGSV D + K + KL T + ++AID+ +G+ +L+ +
Sbjct: 349 QFIGACTKPPH-LCIVTEFMPGGSVYDYLHKQKGVFKLPT--LFKVAIDICKGMSYLHQN 405
Query: 454 GVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEV 505
+ +RDL + +L+D + V + D G+ G T ET YRW+APEV
Sbjct: 406 NIIHRDLKAANLLMDENEVVKVADFGVARVKAQTGVMTA-ETGTYRWMAPEV 456
|
|
| TAIR|locus:2827943 STY8 "serine/threonine/tyrosine kinase 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 244 (91.0 bits), Expect = 1.1e-17, P = 1.1e-17
Identities = 57/178 (32%), Positives = 96/178 (53%)
Query: 335 WLLNSDNLEFIDQIGPNSF----KGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTC 390
W ++ L+ ++ S+ +G Y + V I+ LK N E +++ +
Sbjct: 279 WEIDVTQLKIEKKVASGSYGDLHRGTYCSQEVAIKFLKPDRVNNEMLREFSQEVFIMRKV 338
Query: 391 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR---KLQTKEIIRIAIDVAEGI 447
HKN++QF C + LC+VT+ M GS+ D + K + KLQT ++++A+DVA+G+
Sbjct: 339 RHKNVVQFLGACT-RSPTLCIVTEFMARGSIYDFLHKQKCAFKLQT--LLKVALDVAKGM 395
Query: 448 KFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEV 505
+L+ + + +RDL + +L+D HG V + D G+ G T ET YRW+APEV
Sbjct: 396 SYLHQNNIIHRDLKTANLLMDEHGLVKVADFGVARVQIESGVMTA-ETGTYRWMAPEV 452
|
|
| TAIR|locus:2128043 STY17 "serine/threonine/tyrosine kinase 17" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 231 (86.4 bits), Expect = 1.5e-15, Sum P(2) = 1.5e-15
Identities = 50/155 (32%), Positives = 89/155 (57%)
Query: 353 FKGVYKGKRVGIEKLKGCDKGNAYEF-ELRKDLLELMTCGHKNILQFYCVCVDENHGLCV 411
F+G Y + V I+ LK ++ NA E +++ + HKN++QF C + LC+
Sbjct: 307 FRGTYCSQEVAIKILKP-ERVNAEMLREFSQEVYIMRKVRHKNVVQFIGACT-RSPNLCI 364
Query: 412 VTKLMEGGSVNDLILKSRKL-QTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRH 470
VT+ M GS+ D + K + + + + ++++A+DV++G+ +L+ + + +RDL + +L+D H
Sbjct: 365 VTEFMTRGSIYDFLHKHKGVFKIQSLLKVALDVSKGMNYLHQNNIIHRDLKTANLLMDEH 424
Query: 471 GNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEV 505
V + D G+ G T ET YRW+APEV
Sbjct: 425 EVVKVADFGVARVQTESGVMTA-ETGTYRWMAPEV 458
|
|
| RGD|727908 Tnni3k "TNNI3 interacting kinase" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 217 (81.4 bits), Expect = 2.4e-14, P = 2.4e-14
Identities = 72/236 (30%), Positives = 116/236 (49%)
Query: 284 EEEEACDESFRNGVENSNLKIQLQMPLPSSSFVVSVDEWQTVQSGGEEI-GRWLLNSDNL 342
+EE C+E + G + S + + P P E V E+ R+ L +
Sbjct: 408 QEELPCNEYSQPGGDGSYVSV----PSPLGKIKSMTKEKADVLLLRAELPSRFHLQLSEI 463
Query: 343 EFIDQIGPNSFKGVYKG----KRVGIEKLKG---CDKGNAYEFELRKDLLELMTCGHKNI 395
EF + IG SF VYKG K V I++ + C K + F +++ L H +
Sbjct: 464 EFHEIIGSGSFGKVYKGRCRNKIVAIKRYRANTYCSKSDVDMF--CREVSILCQLNHPCV 521
Query: 396 LQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK---LQTKEIIRIAIDVAEGIKFLND 452
+QF C+D+ +VT+ + GGS+ L+ + ++ LQ+K II A+DVA+G+++L+
Sbjct: 522 VQFVGACLDDPSQFAIVTQYISGGSLFSLLHEQKRILDLQSKLII--AVDVAKGMEYLHS 579
Query: 453 --HGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG-YRWLAPEV 505
+ +RDLNS ILL G+ + D G +S+ E + G RW+APEV
Sbjct: 580 LTQPIIHRDLNSHNILLYEDGHAVVADFGESRFLQSLDEDNMTKQPGNLRWMAPEV 635
|
|
| MGI|MGI:2443276 Tnni3k "TNNI3 interacting kinase" [Mus musculus (taxid:10090)] | Back alignment and assigned GO terms |
|---|
Score = 214 (80.4 bits), Expect = 5.2e-14, P = 5.2e-14
Identities = 71/236 (30%), Positives = 116/236 (49%)
Query: 284 EEEEACDESFRNGVENSNLKIQLQMPLPSSSFVVSVDEWQTVQSGGEEI-GRWLLNSDNL 342
++E C+E + G + S + + P P E V E+ R+ L +
Sbjct: 407 QDELPCNEYSQPGGDGSYVSV----PSPLGKIKSMTKEKADVLLLRAELPSRFHLQLSEI 462
Query: 343 EFIDQIGPNSFKGVYKG----KRVGIEKLKG---CDKGNAYEFELRKDLLELMTCGHKNI 395
EF + IG SF VYKG K V I++ + C K + F +++ L H +
Sbjct: 463 EFHEIIGSGSFGKVYKGRCRNKIVAIKRYRANTYCSKSDVDMF--CREVSILCQLNHPCV 520
Query: 396 LQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK---LQTKEIIRIAIDVAEGIKFLND 452
+QF C+D+ +VT+ + GGS+ L+ + ++ LQ+K II A+DVA+G+++L+
Sbjct: 521 VQFVGACLDDPSQFAIVTQYISGGSLFSLLHEQKRILDLQSKLII--AVDVAKGMEYLHS 578
Query: 453 --HGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG-YRWLAPEV 505
+ +RDLNS ILL G+ + D G +S+ E + G RW+APEV
Sbjct: 579 LTQPIIHRDLNSHNILLYEDGHAVVADFGESRFLQSLDEDNMTKQPGNLRWMAPEV 634
|
|
| TAIR|locus:2157717 AT5G50180 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 205 (77.2 bits), Expect = 6.2e-14, P = 6.2e-14
Identities = 55/182 (30%), Positives = 98/182 (53%)
Query: 334 RWLLNSDNLEFIDQIGPNSFKGVYKGK-RVGIEKLKGCDKGNAYEFELRKDL-----LEL 387
+W ++ L +IG + VY+GK + +K +G E ++D +E+
Sbjct: 12 KWQIDPQLLFVGPKIGEGAHAKVYEGKYKNQTVAIKIVHRGETPEEIAKRDSRFLREVEM 71
Query: 388 MT-CGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK--LQTKEIIRIAIDVA 444
++ HKN+++F C + + +VT+L++GG++ +L R L+T+ I A+D+A
Sbjct: 72 LSRVQHKNLVKFIGACKEPV--MVIVTELLQGGTLRKYLLNLRPACLETRVAIGFALDIA 129
Query: 445 EGIKFLNDHGVAYRDLNSQRILLDR-HGNVCLGDMGIVTACKSVGEATEYETDGYRWLAP 503
G++ L+ HG+ +RDL + +LL H V L D G+ +S+ E ET YRW+AP
Sbjct: 130 RGMECLHSHGIIHRDLKPENLLLTADHKTVKLADFGLARE-ESLTEMMTAETGTYRWMAP 188
Query: 504 EV 505
E+
Sbjct: 189 EL 190
|
|
| TAIR|locus:2101689 AT3G50720 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 205 (77.2 bits), Expect = 9.0e-14, P = 9.0e-14
Identities = 57/182 (31%), Positives = 97/182 (53%)
Query: 336 LLNSDNLEFIDQIGPNSFKGVYKGKRVGIE----KLKGCDKGNAYEFE----LRKDLLEL 387
LLN ++ + IG VYKG+ I K+ K +A + +K++L L
Sbjct: 42 LLNPKDIMRGEMIGEGGNSIVYKGRLKNIVPVAVKIVQPGKTSAVSIQDKQQFQKEVLVL 101
Query: 388 MTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK--LQTKEIIRIAIDVAE 445
+ H+NI++F C++ L +VT+L+ GG++ +L SR L K + A+D++
Sbjct: 102 SSMKHENIVRFVGACIEPQ--LMIVTELVRGGTLQRFMLNSRPSPLDLKVSLSFALDISR 159
Query: 446 GIKFLNDHGVAYRDLNSQRILLDRH-GNVCLGDMGIVTACKSVGEATEYETDGYRWLAPE 504
+++L+ G+ +RDLN + +L+ +V L D G+ K++G T E YRW+APE
Sbjct: 160 AMEYLHSKGIIHRDLNPRNVLVTGDMKHVKLADFGLARE-KTLGGMT-CEAGTYRWMAPE 217
Query: 505 VC 506
VC
Sbjct: 218 VC 219
|
|
| DICTYBASE|DDB_G0269298 gefX "protein kinase, TKL group" [Dictyostelium discoideum (taxid:44689)] | Back alignment and assigned GO terms |
|---|
Score = 212 (79.7 bits), Expect = 1.1e-13, P = 1.1e-13
Identities = 51/175 (29%), Positives = 95/175 (54%)
Query: 335 WLLNSDNLEFIDQIGPNSFKGVYKGKRVGIE-KLKGCDKGNAYEF--ELRKDLLELMTCG 391
W + ++LEF ++IG SF V++G +G++ +K +K + E+ + +++ L +
Sbjct: 14 WDIPFESLEFNEKIGKGSFGSVFRGCYLGLDVAIKKIEKADDPEYLKYIDREVSMLQSLR 73
Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN 451
H I+ F +CV + GL +VT+ + GG V L+ K+ + + + IA+D+A+ + FL+
Sbjct: 74 HPFIVNFSGICVHSS-GLYIVTEFVSGGDVRQLLKKTPPIGWDKRVSIAVDLAKAMVFLH 132
Query: 452 DHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR-WLAPEV 505
+ +RDL S+ ILLD + L D G + ++ G W+APE+
Sbjct: 133 AKKIIHRDLKSKNILLDEFQRIRLCDFGFARMSEQTKKSRHMTMCGTEGWVAPEI 187
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | LOW CONFIDENCE prediction! |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 511 | |||
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-27 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-24 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-23 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 7e-23 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-22 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-22 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 9e-20 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 5e-17 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-16 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-16 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 5e-16 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-15 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 5e-15 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 8e-14 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 9e-14 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 6e-13 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 7e-13 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 7e-13 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 8e-12 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 8e-12 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-11 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-11 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-11 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-11 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-11 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-11 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-11 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-11 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 4e-11 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-10 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-10 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-10 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-10 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-10 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-10 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-10 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-10 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 4e-10 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 6e-10 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 7e-10 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-09 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-09 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-09 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-09 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-09 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 3e-09 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 4e-09 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 4e-09 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 4e-09 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 5e-09 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 5e-09 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 5e-09 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 6e-09 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 7e-09 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 8e-09 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 8e-09 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 9e-09 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 9e-09 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-08 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-08 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-08 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-08 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-08 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-08 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 3e-08 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 3e-08 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 5e-08 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 6e-08 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 7e-08 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 9e-08 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-07 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-07 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-07 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-07 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-07 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-07 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-07 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-07 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-07 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 3e-07 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-07 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-07 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 4e-07 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 4e-07 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 5e-07 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 5e-07 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 6e-07 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 7e-07 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 8e-07 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 8e-07 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 9e-07 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 9e-07 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-06 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-06 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-06 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-06 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-06 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-06 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-06 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-06 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-06 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 3e-06 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 5e-06 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 6e-06 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 7e-06 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 7e-06 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 8e-06 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 8e-06 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 8e-06 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 9e-06 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-05 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-05 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-05 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-05 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-05 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-05 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-05 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-05 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-05 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-05 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-05 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-05 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-05 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 3e-05 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-05 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-05 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-05 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 4e-05 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 4e-05 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 4e-05 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 4e-05 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 5e-05 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 5e-05 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 5e-05 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 5e-05 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 6e-05 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 9e-05 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-04 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-04 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-04 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-04 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-04 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-04 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-04 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-04 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-04 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-04 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-04 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-04 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-04 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-04 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-04 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 3e-04 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-04 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 3e-04 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-04 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-04 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 4e-04 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 4e-04 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 4e-04 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 4e-04 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 4e-04 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 4e-04 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 4e-04 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 4e-04 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 5e-04 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 5e-04 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 5e-04 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 5e-04 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 6e-04 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 6e-04 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 6e-04 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 6e-04 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 6e-04 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 6e-04 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 7e-04 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 7e-04 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 8e-04 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 0.001 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 0.001 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 0.001 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 0.001 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 0.002 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 0.002 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 0.002 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 0.002 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 0.002 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 0.002 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 0.002 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 0.002 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 0.002 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 0.002 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 0.002 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 0.003 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 0.003 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 0.003 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 0.003 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 0.003 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 0.004 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 2e-27
Identities = 50/173 (28%), Positives = 86/173 (49%), Gaps = 11/173 (6%)
Query: 342 LEFIDQIGPNSFKGVYKGKRVGIEKL---KGCDKGNAYEFELRKDLLELM---TCGHKNI 395
E + ++G SF VYK K G K+ K K + + + E+ H NI
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 396 LQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGV 455
++ D++H L +V + EGG + D + + L E +IA+ + G+++L+ +G+
Sbjct: 61 VRLIDAFEDKDH-LYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGI 119
Query: 456 AYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYET-DG-YRWLAPEVC 506
+RDL + ILLD +G V + D G+ A K + ++ T G ++APEV
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGL--AKKLLKSSSSLTTFVGTPWYMAPEVL 170
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-24
Identities = 58/171 (33%), Positives = 89/171 (52%), Gaps = 16/171 (9%)
Query: 348 IGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV 401
+G F VY GK+V I+ +K D + E EL +++ L H NI++ Y V
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLE-ELLREIEILKKLNHPNIVKLYGV 59
Query: 402 CVDENHGLCVVTKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDL 460
DENH L +V + EGGS+ DL+ + KL EI+RI + + EG+++L+ +G+ +RDL
Sbjct: 60 FEDENH-LYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDL 118
Query: 461 NSQRILLD-RHGNVCLGDMGIVTACKSVGEATEYETDG---YRWLAPEVCF 507
+ ILLD +G V L D G+ K + ++APEV
Sbjct: 119 KPENILLDSDNGKVKLADFGL---SKLLTSDKSLLKTIVGTPAYMAPEVLL 166
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 99.5 bits (249), Expect = 1e-23
Identities = 48/180 (26%), Positives = 79/180 (43%), Gaps = 27/180 (15%)
Query: 343 EFIDQIGPNSFKGVYKGKRVGIEK---LKGCDKGNAYEFELRKDLLE----LMTCGHKNI 395
E ++++G SF VY + K +K K + R+ +L L H NI
Sbjct: 2 EILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKD--RERILREIKILKKLKHPNI 59
Query: 396 LQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGV 455
++ Y V DE+ L +V + EGG + DL+ K +L E + +++L+ G+
Sbjct: 60 VRLYDVFEDEDK-LYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGI 118
Query: 456 AYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR--------WLAPEVCF 507
+RDL + ILLD G+V L D G+ A + + ++APEV
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGL---------ARQLDPGEKLTTFVGTPEYMAPEVLL 169
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 97.6 bits (244), Expect = 7e-23
Identities = 50/180 (27%), Positives = 84/180 (46%), Gaps = 21/180 (11%)
Query: 342 LEFIDQIGPNSFKGVYKGKRVGIEKLKGCD------KGNAYEFELRKDLLE----LMTCG 391
LE ++G +F VYKG G + K A E E R++ LE +
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASE-EEREEFLEEASIMKKLS 59
Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVND-LILKSRKLQTKEIIRIAIDVAEGIKFL 450
H NI++ VC L +VT+ M GG + D L KL K+++++A+ +A+G+++L
Sbjct: 60 HPNIVRLLGVCTQGEP-LYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYL 118
Query: 451 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG-----YRWLAPEV 505
+RDL ++ L+ + V + D G+ + + E Y G +W+APE
Sbjct: 119 ESKNFVHRDLAARNCLVTENLVVKISDFGL---SRDIYEDDYYRKRGGGKLPIKWMAPES 175
|
Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 97.2 bits (243), Expect = 1e-22
Identities = 45/183 (24%), Positives = 82/183 (44%), Gaps = 28/183 (15%)
Query: 342 LEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLLE----L 387
L ++G +F VYKGK V ++ LK + ++ L +
Sbjct: 1 LTLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKED-----ASEQQIEEFLREARIM 55
Query: 388 MTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEG 446
H N+++ VC +E L +V + MEGG + + K+R KL +++ A+ +A G
Sbjct: 56 RKLDHPNVVKLLGVCTEE-EPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARG 114
Query: 447 IKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRWLA 502
+++L +RDL ++ L+ + V + D G+ + + + Y G RW+A
Sbjct: 115 MEYLESKNFIHRDLAARNCLVGENLVVKISDFGL---SRDLYDDDYYRKRGGKLPIRWMA 171
Query: 503 PEV 505
PE
Sbjct: 172 PES 174
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 95.7 bits (239), Expect = 3e-22
Identities = 44/184 (23%), Positives = 81/184 (44%), Gaps = 29/184 (15%)
Query: 342 LEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLLE----L 387
L ++G +F VYKG V ++ LK + ++ L +
Sbjct: 1 LTLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLK-----EDASEQQIEEFLREARIM 55
Query: 388 MTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK--LQTKEIIRIAIDVAE 445
H NI++ VC +E L +V + M GG + D + K+R L +++ A+ +A
Sbjct: 56 RKLDHPNIVKLLGVCTEE-EPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIAR 114
Query: 446 GIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRWL 501
G+++L +RDL ++ L+ + V + D G+ + + + Y+ G RW+
Sbjct: 115 GMEYLESKNFIHRDLAARNCLVGENLVVKISDFGL---SRDLYDDDYYKVKGGKLPIRWM 171
Query: 502 APEV 505
APE
Sbjct: 172 APES 175
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.7 bits (221), Expect = 9e-20
Identities = 50/176 (28%), Positives = 80/176 (45%), Gaps = 32/176 (18%)
Query: 353 FKGVYKGK-----RVGIEKLKGCDKGNAYEFELRKDLLE----LMTCGHKNILQFYCVCV 403
+KG KGK V ++ LK E RKD L+ + GH N+++ VC
Sbjct: 12 YKGKLKGKDGKTTEVAVKTLKEDA-----SEEERKDFLKEARVMKKLGHPNVVRLLGVCT 66
Query: 404 DENHGLCVVTKLMEGGSVNDLILKSRK---------LQTKEIIRIAIDVAEGIKFLNDHG 454
+E L +V + MEGG + D + KSR L K+++ AI +A+G+++L
Sbjct: 67 EEEP-LYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK 125
Query: 455 VAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG-----YRWLAPEV 505
+RDL ++ L+ V + D G+ + V + Y RW+APE
Sbjct: 126 FVHRDLAARNCLVGEDLVVKISDFGL---SRDVYDDDYYRKKTGGKLPIRWMAPES 178
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 80.3 bits (199), Expect = 5e-17
Identities = 51/179 (28%), Positives = 87/179 (48%), Gaps = 29/179 (16%)
Query: 343 EFIDQIGPNSFKGVYK------GKRVGIEKLK--GCDKGNAYEFELRKDLLELMTCGHKN 394
E +++IG F VYK GK V I+ +K +K E++ +L+ C H N
Sbjct: 3 EILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQ--ILK--KCKHPN 58
Query: 395 ILQFYCVCVDENHGLCVVTKLMEGGSVNDLI-LKSRKLQTKEIIRIAIDVAEGIKFLNDH 453
I+++Y + L +V + GGS+ DL+ ++ L +I + ++ +G+++L+ +
Sbjct: 59 IVKYYG-SYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN 117
Query: 454 GVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS-------VGEATEYETDGYRWLAPEV 505
G+ +RD+ + ILL G V L D G+ VG T Y W+APEV
Sbjct: 118 GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVG--TPY------WMAPEV 168
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 3e-16
Identities = 51/184 (27%), Positives = 83/184 (45%), Gaps = 29/184 (15%)
Query: 335 WLLNSDNLEFIDQIGPNSF----KGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLE---L 387
W +NS L+ IG F G Y+G++V ++ LK D A F L E +
Sbjct: 1 WAINSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLK-DDSTAAQAF-----LAEASVM 54
Query: 388 MTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK---LQTKEIIRIAIDVA 444
T H N++Q V + N L +VT+ M GS+ D L+SR + + + A+DV
Sbjct: 55 TTLRHPNLVQLLGVVLQGNP-LYIVTEYMAKGSLVDY-LRSRGRAVITLAQQLGFALDVC 112
Query: 445 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR----W 500
EG+++L + +RDL ++ +L+ + D G+ + D + W
Sbjct: 113 EGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGL-------AKEASQGQDSGKLPVKW 165
Query: 501 LAPE 504
APE
Sbjct: 166 TAPE 169
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 78.4 bits (194), Expect = 3e-16
Identities = 37/121 (30%), Positives = 61/121 (50%), Gaps = 9/121 (7%)
Query: 392 HKNILQFY-CVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFL 450
H NI+++Y +E + L + + + GGS++ L+ K KL I + + EG+ +L
Sbjct: 58 HPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYL 117
Query: 451 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY-----RWLAPEV 505
+ +G+ +RD+ IL+D G V L D G K +G+ E G W+APEV
Sbjct: 118 HSNGIVHRDIKGANILVDSDGVVKLADFG---CAKRLGDIETGEGTGSVRGTPYWMAPEV 174
Query: 506 C 506
Sbjct: 175 I 175
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 78.0 bits (193), Expect = 5e-16
Identities = 58/191 (30%), Positives = 91/191 (47%), Gaps = 45/191 (23%)
Query: 339 SDNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELM---- 388
+ + +++IG + VYK GK V I+K++ LRK EL+
Sbjct: 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMR-----------LRKQNKELIINEI 66
Query: 389 ----TCGHKNILQFY-CVCVDENHGLCVVTKLMEGGSVNDLI-LKSRKLQTKEIIRIAID 442
C H NI+ +Y V + L VV + M+GGS+ D+I ++ +I + +
Sbjct: 67 LIMKDCKHPNIVDYYDSYLVGDE--LWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCRE 124
Query: 443 VAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGI---VTACKS-----VGEATEYE 494
V +G+++L+ V +RD+ S ILL + G+V L D G +T KS VG T Y
Sbjct: 125 VLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVG--TPY- 181
Query: 495 TDGYRWLAPEV 505
W+APEV
Sbjct: 182 -----WMAPEV 187
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 1e-15
Identities = 50/188 (26%), Positives = 86/188 (45%), Gaps = 33/188 (17%)
Query: 340 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHK 393
D+ E I+ IG + VY ++V I+++ +K ELRK++ + C H
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRID-LEKCQTSVDELRKEVQAMSQCNHP 59
Query: 394 NILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK---LQTKEIIRIAIDVAEGIKFL 450
N++++Y V L +V + GGS+ D++ S L I + +V +G+++L
Sbjct: 60 NVVKYYTSFV-VGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYL 118
Query: 451 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR----------- 499
+ +G +RD+ + ILL G+V + D G V+A G R
Sbjct: 119 HSNGQIHRDIKAGNILLGEDGSVKIADFG-VSAS--------LADGGDRTRKVRKTFVGT 169
Query: 500 --WLAPEV 505
W+APEV
Sbjct: 170 PCWMAPEV 177
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 5e-15
Identities = 53/179 (29%), Positives = 83/179 (46%), Gaps = 22/179 (12%)
Query: 340 DNLEFIDQIGPNSFKGVYKGKRVGIEKL---KGCDKGNAYEFELRKDLLE---LMTCGHK 393
D E I ++G +F VYK + K + E EL ++E L C H
Sbjct: 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIES--EEELEDFMVEIDILSECKHP 62
Query: 394 NILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIR-IAIDVAEGIKFLND 452
NI+ Y EN L ++ + +GG+++ ++L+ + T+ IR + + E + FL+
Sbjct: 63 NIVGLYEAYFYENK-LWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHS 121
Query: 453 HGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE------ATEYETDGYRWLAPEV 505
H V +RDL + ILL G+V L D G+ KS + T Y W+APEV
Sbjct: 122 HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPY------WMAPEV 174
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 8e-14
Identities = 47/178 (26%), Positives = 82/178 (46%), Gaps = 12/178 (6%)
Query: 335 WLLNSDNLEFIDQIGPNSFKGVYKGK-----RVGIEKLKGCDKGNAYEFELRKDLLELMT 389
W + ++G F V++G RV I+ LK D +F+ K++ L
Sbjct: 1 WERPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQ--KEVQALKR 58
Query: 390 CGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGI 447
HK+++ + VC + ++T+LME GS+ + + L +I +A VAEG+
Sbjct: 59 LRHKHLISLFAVC-SVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGM 117
Query: 448 KFLNDHGVAYRDLNSQRILLDRHGNVC-LGDMGIVTACKSVGEATEYETDGYRWLAPE 504
+L + +RDL ++ IL+ VC + D G+ K + + Y+W APE
Sbjct: 118 AYLEEQNSIHRDLAARNILVG-EDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPE 174
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 9e-14
Identities = 53/175 (30%), Positives = 87/175 (49%), Gaps = 13/175 (7%)
Query: 341 NLEFIDQIGPNSFKGVYKGKRVGIEK---LKGCDKGNAYEFELRKDLLE---LMTCGHKN 394
+ + + ++G S+ VYK KR+ + LK D G+ + E + E L + H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 395 ILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK----LQTKEIIRIAIDVAEGIKFL 450
I+ + +D N LC+V + G ++ I K +K + +EI RI I + G++ L
Sbjct: 61 IISYKEAFLDGNK-LCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQAL 119
Query: 451 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEV 505
++ + +RDL S ILL + V +GD+GI K T+ T Y +APEV
Sbjct: 120 HEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQIGTPHY--MAPEV 172
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 6e-13
Identities = 47/177 (26%), Positives = 82/177 (46%), Gaps = 15/177 (8%)
Query: 335 WLLNSDNLEFIDQIGPNSFKGV----YKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTC 390
W LN L+ + IG F V Y+G +V ++ C K +A + +
Sbjct: 1 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVK----CIKNDATAQAFLAEASVMTQL 56
Query: 391 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK---LQTKEIIRIAIDVAEGI 447
H N++Q V V+E GL +VT+ M GS+ D L+SR L +++ ++DV E +
Sbjct: 57 RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDY-LRSRGRSVLGGDCLLKFSLDVCEAM 115
Query: 448 KFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPE 504
++L + +RDL ++ +L+ + D G+ S + + +W APE
Sbjct: 116 EYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV---KWTAPE 169
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 7e-13
Identities = 42/184 (22%), Positives = 85/184 (46%), Gaps = 24/184 (13%)
Query: 340 DNLEFIDQIGPNSFKGVYK----------GKRVGIEKLKGCDKGNAYEFELRKDLLELMT 389
+L+FI Q+G F V G++V ++ L + + +++ L T
Sbjct: 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLN-HSGEEQHRSDFEREIEILRT 62
Query: 390 CGHKNILQFYCVCVDENHG--LCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEG 446
H+NI+++ VC ++ G L ++ + + GS+ D + + R ++ K ++ + + +G
Sbjct: 63 LDHENIVKYKGVC-EKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKG 121
Query: 447 IKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYET---DG---YRW 500
+ +L +RDL ++ IL++ V + D G+ K + E +Y G W
Sbjct: 122 MDYLGSQRYIHRDLAARNILVESEDLVKISDFGLA---KVLPEDKDYYYVKEPGESPIFW 178
Query: 501 LAPE 504
APE
Sbjct: 179 YAPE 182
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 68.3 bits (168), Expect = 7e-13
Identities = 57/180 (31%), Positives = 84/180 (46%), Gaps = 27/180 (15%)
Query: 345 IDQIGPNSFKGVYKGKRVGIEKL---KGCDKGNAYEFELRKDLLE---LMTCGHKNILQF 398
I QIG SF VY +R KL K D N E E L E L H NI+++
Sbjct: 5 IKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKY 64
Query: 399 YCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQT----KEIIRIAIDVAEGIKFLNDHG 454
Y ++ LC+V + +GG ++ I K +K ++I+ + + +K+L+
Sbjct: 65 YESFEEKGK-LCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK 123
Query: 455 VAYRDLNSQRILLDRHGNVCLGDMGI-------VTACKS-VGEATEYETDGYRWLAPEVC 506
+ +RD+ Q I L +G V LGD GI V K+ VG T Y Y L+PE+C
Sbjct: 124 ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVG--TPY----Y--LSPELC 175
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.0 bits (159), Expect = 8e-12
Identities = 50/179 (27%), Positives = 81/179 (45%), Gaps = 23/179 (12%)
Query: 341 NLEFIDQIGPNSFKGVYKG-----------KRVGIEKLKGCD-KGNAYEFELRKDLLELM 388
N + D IG +F VYKG K++ +EK+K K E +L K+L
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNL---- 56
Query: 389 TCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIK 448
H NI+++ + L ++ + E GS+ +I K + V +G+
Sbjct: 57 --KHPNIVKYIGSIETSDS-LYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLA 113
Query: 449 FLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG--YRWLAPEV 505
+L++ GV +RD+ + IL + G V L D G+ T V + + G Y W+APEV
Sbjct: 114 YLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK-DDASVVGTPY-WMAPEV 170
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 8e-12
Identities = 43/178 (24%), Positives = 83/178 (46%), Gaps = 12/178 (6%)
Query: 335 WLLNSDNLEFIDQIGPNSFKGVYKG-----KRVGIEKLKGCDKGNAYEFELRKDLLELMT 389
W ++ +++ + ++G F V++G V ++ LK G + + +
Sbjct: 1 WEIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLK---PGTMDPKDFLAEAQIMKK 57
Query: 390 CGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGI 447
H ++Q Y VC E + +VT+LM+ GS+ + + R L+ ++I +A VA G+
Sbjct: 58 LRHPKLIQLYAVCTLEE-PIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGM 116
Query: 448 KFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK-SVGEATEYETDGYRWLAPE 504
+L +RDL ++ +L+ + + D G+ K + EA E +W APE
Sbjct: 117 AYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPE 174
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 1e-11
Identities = 43/165 (26%), Positives = 75/165 (45%), Gaps = 18/165 (10%)
Query: 354 KGVY---KGKR--VGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHG 408
KGVY GK V ++ LK + A + E ++ + H I++ VC E
Sbjct: 13 KGVYLMKSGKEVEVAVKTLKQ-EHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKGE--P 69
Query: 409 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLD 468
L +V +L G + + K R++ ++ +A VA G+ +L +RDL ++ +LL
Sbjct: 70 LMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLV 129
Query: 469 RHGNVCLGDMGIVTACKSVGEATEY---ETDG---YRWLAPEVCF 507
+ D G+ +++G ++Y T G +W APE C
Sbjct: 130 NRHQAKISDFGM---SRALGAGSDYYRATTAGRWPLKWYAPE-CI 170
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.5 bits (158), Expect = 1e-11
Identities = 32/124 (25%), Positives = 53/124 (42%), Gaps = 11/124 (8%)
Query: 387 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEG 446
L H I++ + E L +V + GG + + K + + A ++
Sbjct: 47 LSRINHPFIVKLHYAFQTEEK-LYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLA 105
Query: 447 IKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYE-----TDGYRWL 501
+++L+ G+ YRDL + ILLD G++ L D G+ K + T Y L
Sbjct: 106 LEYLHSLGIIYRDLKPENILLDADGHIKLTDFGL---AKELSSEGSRTNTFCGTPEY--L 160
Query: 502 APEV 505
APEV
Sbjct: 161 APEV 164
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 1e-11
Identities = 50/176 (28%), Positives = 90/176 (51%), Gaps = 15/176 (8%)
Query: 335 WLLNSDNLEFIDQIGPNSF----KGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTC 390
WLLN L + IG F +G Y G++V ++ +K CD A F ++ +
Sbjct: 1 WLLNLQKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIK-CDV-TAQAFLEETAVMTKLH- 57
Query: 391 GHKNILQFYCVCVDENHGLCVVTKLMEGGS-VNDLILKSRKL-QTKEIIRIAIDVAEGIK 448
HKN+++ V + ++GL +V +LM G+ VN L + R L ++++ ++DVAEG++
Sbjct: 58 -HKNLVRLLGVIL--HNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGME 114
Query: 449 FLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPE 504
+L + +RDL ++ IL+ G + D G+ + ++ +W APE
Sbjct: 115 YLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPV---KWTAPE 167
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 2e-11
Identities = 38/178 (21%), Positives = 82/178 (46%), Gaps = 20/178 (11%)
Query: 342 LEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLLELMTCG 391
LE I +G +F VYKG V I+ L+ + E+ + + +
Sbjct: 9 LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLRE-ETSPKANKEILDEAYVMASVD 67
Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFL 450
H ++++ +C+ ++T+LM G + D + + + ++ ++ + +A+G+ +L
Sbjct: 68 HPHVVRLLGICLSSQV--QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYL 125
Query: 451 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRWLAPE 504
+ + +RDL ++ +L+ +V + D G + V E EY +G +W+A E
Sbjct: 126 EEKRLVHRDLAARNVLVKTPQHVKITDFG-LAKLLDVDE-KEYHAEGGKVPIKWMALE 181
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 64.0 bits (155), Expect = 2e-11
Identities = 51/176 (28%), Positives = 84/176 (47%), Gaps = 13/176 (7%)
Query: 342 LEFIDQIGPNSFKGVYKGKRVGIEKL---KGCDKGNAYEFELRKDLLELMTCGH-KNILQ 397
E ++ +G ++ VYKG+ V +L K D E E+++++ L H +NI
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 67
Query: 398 FYCVCVDEN-----HGLCVVTKLMEGGSVNDLI--LKSRKLQTKEIIRIAIDVAEGIKFL 450
+Y + +N L +V + GSV DLI K L+ + I I ++ G+ L
Sbjct: 68 YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHL 127
Query: 451 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC-KSVGEATEYETDGYRWLAPEV 505
+ H V +RD+ Q +LL + V L D G+ ++VG + Y W+APEV
Sbjct: 128 HQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPY-WMAPEV 182
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 2e-11
Identities = 44/176 (25%), Positives = 83/176 (47%), Gaps = 11/176 (6%)
Query: 337 LNSDNLEFIDQIGPNSFKGVYKGKRVGIEK--LKGCDKGNAYEFELRKDLLELMTCGHKN 394
++ L + +IG F V+ G + K +K +G E + ++ +M H
Sbjct: 1 IHPSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPK 60
Query: 395 ILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLNDH 453
++Q Y VC E +C+V + ME G ++D + R K + ++ + +DV EG+ +L
Sbjct: 61 LVQLYGVCT-ERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESS 119
Query: 454 GVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRWLAPEV 505
V +RDL ++ L+ + V + D G+ + V + + G +W +PEV
Sbjct: 120 NVIHRDLAARNCLVGENQVVKVSDFGMT---RFVLDDQYTSSTGTKFPVKWSSPEV 172
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 64.8 bits (156), Expect = 3e-11
Identities = 46/182 (25%), Positives = 80/182 (43%), Gaps = 20/182 (10%)
Query: 341 NLEFIDQIGPNSFKGVYKGKR---VGIEKLKGCDKGNAYEFELRKDLLELMT--CGHKNI 395
+ + ++G SF VY + V ++ L + + E E ++++ NI
Sbjct: 1 SYRILRKLGEGSFGEVYLARDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNI 60
Query: 396 LQFYCVCVDENHGLCVVTKLMEGGSVNDLI---LKSRKLQTKEIIRIAIDVAEGIKFLND 452
++ Y DE L +V + ++GGS+ DL+ + L E + I + +++L+
Sbjct: 61 VKLYDFFQDEGS-LYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS 119
Query: 453 HGVAYRDLNSQRILLDRHGN-VCLGDMGIVTACKSVGEATEYE--------TDGYRWLAP 503
G+ +RD+ + ILLDR G V L D G+ G + T GY AP
Sbjct: 120 KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM--AP 177
Query: 504 EV 505
EV
Sbjct: 178 EV 179
|
Length = 384 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 3e-11
Identities = 48/181 (26%), Positives = 86/181 (47%), Gaps = 21/181 (11%)
Query: 337 LNSDNLEFIDQIGPNSFKGVYKGK-----RVGIEKLKGCDKGNAYEFELRKDLLELMTCG 391
++ +L F+ ++G F V GK V I+ +K +G+ E E ++ +M
Sbjct: 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIK---EGSMSEDEFIEEAKVMMKLS 57
Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGS-VNDLILKSRKLQTKEIIRIAIDVAEGIKFL 450
H+ ++Q Y VC + + +VT+ M G +N L ++ Q +++ + DV EG+ +L
Sbjct: 58 HEKLVQLYGVCTKQ-RPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYL 116
Query: 451 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIV------TACKSVGEATEYETDGYRWLAPE 504
+RDL ++ L+D G V + D G+ SVG +++ RW PE
Sbjct: 117 ESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVG--SKFPV---RWSPPE 171
Query: 505 V 505
V
Sbjct: 172 V 172
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 4e-11
Identities = 50/178 (28%), Positives = 89/178 (50%), Gaps = 26/178 (14%)
Query: 343 EFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNIL 396
E I +IG ++ VYK G+ V I+ +K + G+ +E +++++ L C H NI+
Sbjct: 6 ELIQRIGSGTYGDVYKARDIATGELVAIKVIK-LEPGDDFE-IIQQEISMLKECRHPNIV 63
Query: 397 QFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK-LQTKEIIRIAIDVAEGIKFLNDHGV 455
++ + L +V + GGS+ D+ +R L +I + + +G+ +L++ G
Sbjct: 64 AYFGSYL-RRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGK 122
Query: 456 AYRDLNSQRILLDRHGNVCLGDMGI---VTACKS-----VGEATEYETDGYRWLAPEV 505
+RD+ ILL G+V L D G+ +TA + +G T Y W+APEV
Sbjct: 123 IHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIG--TPY------WMAPEV 172
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 1e-10
Identities = 40/133 (30%), Positives = 64/133 (48%), Gaps = 12/133 (9%)
Query: 377 EFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEI 436
E +L K+L H+ I+Q+Y C+ ++ L + + M GGSV D + L
Sbjct: 54 EIQLLKNLQ------HERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVT 106
Query: 437 IRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMG----IVTACKSVGEATE 492
+ + EG+++L+ + + +RD+ IL D GNV LGD G + T C S
Sbjct: 107 RKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKS 166
Query: 493 YETDGYRWLAPEV 505
Y W++PEV
Sbjct: 167 VTGTPY-WMSPEV 178
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 2e-10
Identities = 39/124 (31%), Positives = 61/124 (49%), Gaps = 22/124 (17%)
Query: 392 HKNILQFY-CVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFL 450
H NI++ Y V + L VV + +EGG++ D++ +R + ++I + + V + + FL
Sbjct: 75 HPNIVEMYSSYLVGDE--LWVVMEFLEGGALTDIVTHTR-MNEEQIATVCLAVLKALSFL 131
Query: 451 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE---------ATEYETDGYRWL 501
+ GV +RD+ S ILL G V L D G C V + T Y W+
Sbjct: 132 HAQGVIHRDIKSDSILLTSDGRVKLSDFGF---CAQVSKEVPRRKSLVGTPY------WM 182
Query: 502 APEV 505
APEV
Sbjct: 183 APEV 186
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 2e-10
Identities = 47/170 (27%), Positives = 75/170 (44%), Gaps = 9/170 (5%)
Query: 345 IDQIGPNSF------KGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQF 398
+ +IG SF K GK+ I+++ E RK++ L H NI+Q
Sbjct: 5 VKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQ- 63
Query: 399 YCVCVDENHGLCVVTKLMEGGSVNDLILKSRKL--QTKEIIRIAIDVAEGIKFLNDHGVA 456
Y +EN L +V EGG + I R + +I+ + + +K ++D +
Sbjct: 64 YQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKIL 123
Query: 457 YRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEVC 506
+RD+ SQ I L + G + LGD GI S E +L+PE+C
Sbjct: 124 HRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEIC 173
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 2e-10
Identities = 48/203 (23%), Positives = 83/203 (40%), Gaps = 45/203 (22%)
Query: 335 WLLNSDNLEFIDQIGPNSFKGVYKG-----------KRVGIEKLKGCDK-GNAYEFELRK 382
W L + + I ++G SF VY+G RV I+ + EF
Sbjct: 1 WELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEA 60
Query: 383 DLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQ---------- 432
+++ C H +++ V L VV +LM G + L+SR+ +
Sbjct: 61 SVMKEFNCHH--VVRLLGVVSTGQPTL-VVMELMAKGDLKSY-LRSRRPEAENNPGLGPP 116
Query: 433 -TKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT 491
++ I++A ++A+G+ +L +RDL ++ ++ V +GD G+
Sbjct: 117 TLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDI------- 169
Query: 492 EYETDGY----------RWLAPE 504
YETD Y RW+APE
Sbjct: 170 -YETDYYRKGGKGLLPVRWMAPE 191
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 2e-10
Identities = 44/137 (32%), Positives = 67/137 (48%), Gaps = 10/137 (7%)
Query: 374 NAYEFELRKDLLELMTCGHKNILQFY-CVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQ 432
NA E E++ LL+ + H I+Q+Y C+ E L + + M GGS+ D + L
Sbjct: 49 NALECEIQ--LLKNLR--HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALT 104
Query: 433 TKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMG----IVTACKSVG 488
R + +G+ +L+ + + +RD+ IL D GNV LGD G I T C S G
Sbjct: 105 ENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMS-G 163
Query: 489 EATEYETDGYRWLAPEV 505
+ T W++PEV
Sbjct: 164 TGIKSVTGTPYWMSPEV 180
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 3e-10
Identities = 48/176 (27%), Positives = 81/176 (46%), Gaps = 13/176 (7%)
Query: 342 LEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTCG----HKNILQ 397
E ++ +G ++ VYKG+ V +L + E E + LE+ H+NI
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIAT 77
Query: 398 FYCVCVDE-----NHGLCVVTKLMEGGSVNDLILKSRKLQTKE--IIRIAIDVAEGIKFL 450
+Y + + + L +V + GSV DL+ ++ KE I I ++ G+ L
Sbjct: 78 YYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHL 137
Query: 451 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC-KSVGEATEYETDGYRWLAPEV 505
+ H V +RD+ Q +LL + V L D G+ ++VG + Y W+APEV
Sbjct: 138 HAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPY-WMAPEV 192
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.7 bits (148), Expect = 3e-10
Identities = 50/172 (29%), Positives = 79/172 (45%), Gaps = 25/172 (14%)
Query: 348 IGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV 401
IG SF VYK + V I K+ ++ ++++++ L C I ++Y
Sbjct: 9 IGKGSFGEVYKAIDKRTNQVVAI-KVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYG- 66
Query: 402 CVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLN 461
+ L ++ + GGS DL LK KL I I +V G+++L++ G +RD+
Sbjct: 67 SFLKGSKLWIIMEYCGGGSCLDL-LKPGKLDETYIAFILREVLLGLEYLHEEGKIHRDIK 125
Query: 462 SQRILLDRHGNVCLGDMGIV-----TACKS---VGEATEYETDGYRWLAPEV 505
+ ILL G+V L D G+ T K VG T + W+APEV
Sbjct: 126 AANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVG--TPF------WMAPEV 169
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 3e-10
Identities = 44/177 (24%), Positives = 79/177 (44%), Gaps = 19/177 (10%)
Query: 343 EFIDQIGPNSFKGVYKGKRVG---IEKLKGCDKGNAYEFELRKDLLE---LMTCGHKNIL 396
E +++IG SF V+K R + +K D E + + E L I+
Sbjct: 3 EILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYII 62
Query: 397 QFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK--LQTKEIIRIAIDVAEGIKFLNDHG 454
++Y + L +V + E G ++ L+ R L ++ R I + G+ L+
Sbjct: 63 RYY-ESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK 121
Query: 455 VAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYE-----TDGYRWLAPEVC 506
+ +RD+ S + LD + NV +GD+G+ K + + T + T Y L+PE+C
Sbjct: 122 ILHRDIKSLNLFLDAYDNVKIGDLGVA---KLLSDNTNFANTIVGTPYY--LSPELC 173
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 4e-10
Identities = 37/142 (26%), Positives = 72/142 (50%), Gaps = 4/142 (2%)
Query: 342 LEFIDQIGPNSFKGVYKGKRVGIEK--LKGCDKGNAYEFELRKDLLELMTCGHKNILQFY 399
L F+ ++G F V+ GK G +K +G E + ++ +M H N++Q Y
Sbjct: 6 LTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLY 65
Query: 400 CVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLNDHGVAYR 458
VC + + +VT+ M G + + + + + KL T+ ++ + DV E +++L +G +R
Sbjct: 66 GVCT-KQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHR 124
Query: 459 DLNSQRILLDRHGNVCLGDMGI 480
DL ++ L+ V + D G+
Sbjct: 125 DLAARNCLVGEDNVVKVSDFGL 146
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 6e-10
Identities = 42/174 (24%), Positives = 87/174 (50%), Gaps = 13/174 (7%)
Query: 340 DNLEFIDQIGPNSFKGVYKGKRVGIEKLKGC-----DKGNAYEFELRKDLLELMTCGHKN 394
++ E I +IG ++ VYK + V +L + G + ++++++ + C H N
Sbjct: 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAV-VQQEIIMMKDCKHSN 67
Query: 395 ILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHG 454
I+ ++ + + L + + GGS+ D+ + L +I ++ + +G+ +L+ G
Sbjct: 68 IVAYFGSYLRRDK-LWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKG 126
Query: 455 VAYRDLNSQRILLDRHGNVCLGDMGI---VTACKSVGEATEYETDGYRWLAPEV 505
+RD+ ILL +G+V L D G+ +TA ++ + + Y W+APEV
Sbjct: 127 KMHRDIKGANILLTDNGHVKLADFGVSAQITA--TIAKRKSFIGTPY-WMAPEV 177
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.6 bits (145), Expect = 7e-10
Identities = 49/189 (25%), Positives = 82/189 (43%), Gaps = 31/189 (16%)
Query: 339 SDNLEFIDQIGPNSFKGVYKGKR--------VGIEKLKGCDKGN-AYEFELRKDLLELMT 389
+ E ++ IG ++ VYK + + I + ++ E+ + +
Sbjct: 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKY----- 59
Query: 390 CGHKNILQFYCVCVDENHG-----LCVVTKLMEGGSVNDLILKSRKL--QTKE--IIRIA 440
H NI FY + +N L +V +L GGSV DL+ RK + KE I I
Sbjct: 60 SNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYIL 119
Query: 441 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY-- 498
+ G+ +L+++ V +RD+ Q ILL ++ V L D G+ S T + +
Sbjct: 120 RETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDS----TLGRRNTFIG 175
Query: 499 --RWLAPEV 505
W+APEV
Sbjct: 176 TPYWMAPEV 184
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 58.8 bits (143), Expect = 1e-09
Identities = 42/177 (23%), Positives = 83/177 (46%), Gaps = 26/177 (14%)
Query: 343 EFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNIL 396
+ ++++G S+ VYK G+ V I+ + E+ K++ L C I+
Sbjct: 6 DILEKLGEGSYGSVYKAIHKETGQVVAIKVVPV----EEDLQEIIKEISILKQCDSPYIV 61
Query: 397 QFY-CVCVDENHGLCVVTKLMEGGSVNDLI-LKSRKLQTKEIIRIAIDVAEGIKFLNDHG 454
++Y + + L +V + GSV+D++ + ++ L +EI I +G+++L+ +
Sbjct: 62 KYYGSYFKNTD--LWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNK 119
Query: 455 VAYRDLNSQRILLDRHGNVCLGDMGIVT------ACKSVGEATEYETDGYRWLAPEV 505
+RD+ + ILL+ G L D G+ A ++ T + W+APEV
Sbjct: 120 KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPF------WMAPEV 170
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 1e-09
Identities = 45/135 (33%), Positives = 68/135 (50%), Gaps = 14/135 (10%)
Query: 377 EFELRKDLLELMTCGHKNILQFY-CVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKE 435
E +L K+LL H+ I+Q+Y C+ L + + M GGS+ D LKS T+
Sbjct: 54 EIQLLKNLL------HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQ-LKSYGALTEN 106
Query: 436 IIR-IAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMG----IVTACKSVGEA 490
+ R + EG+ +L+ + + +RD+ IL D GNV LGD G + T C S G
Sbjct: 107 VTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLS-GTG 165
Query: 491 TEYETDGYRWLAPEV 505
+ T W++PEV
Sbjct: 166 MKSVTGTPYWMSPEV 180
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 2e-09
Identities = 38/149 (25%), Positives = 71/149 (47%), Gaps = 10/149 (6%)
Query: 340 DNLEFIDQIGPNSFKGVYKGKRVGIE-----KLKGCDKGNAYEFELRKDLLELMTCGHKN 394
D+LE++ ++G + V K K + A + ++ ++L L C
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPY 60
Query: 395 ILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEII--RIAIDVAEGIKFL-N 451
I+ FY + + + + M+GGS+ D ILK + + E I +IA+ V +G+ +L
Sbjct: 61 IVGFYGAFYNNGD-ISICMEYMDGGSL-DKILKEVQGRIPERILGKIAVAVLKGLTYLHE 118
Query: 452 DHGVAYRDLNSQRILLDRHGNVCLGDMGI 480
H + +RD+ IL++ G + L D G+
Sbjct: 119 KHKIIHRDVKPSNILVNSRGQIKLCDFGV 147
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 2e-09
Identities = 53/173 (30%), Positives = 81/173 (46%), Gaps = 26/173 (15%)
Query: 347 QIGPNSFKGVY------KGKRVGIEKLKGCDKGNAYEFE-LRKDLLELMTCGHKNILQFY 399
+IG SF VY + V I+K+ K + +++ + K++ L H N ++ Y
Sbjct: 22 EIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIE-Y 80
Query: 400 CVCVDENHGLCVVTKLMEG--GSVNDLILKSRK-LQTKEIIRIAIDVAEGIKFLNDHGVA 456
C H +V ME GS +D++ +K LQ EI I +G+ +L+ H
Sbjct: 81 KGCYLREHTAWLV---MEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERI 137
Query: 457 YRDLNSQRILLDRHGNVCLGDMG---IVTACKS-VGEATEYETDGYRWLAPEV 505
+RD+ + ILL G V L D G +V+ S VG T Y W+APEV
Sbjct: 138 HRDIKAGNILLTEPGTVKLADFGSASLVSPANSFVG--TPY------WMAPEV 182
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 3e-09
Identities = 40/173 (23%), Positives = 84/173 (48%), Gaps = 13/173 (7%)
Query: 341 NLEFIDQIGPNSFKGVYKGKRVGIEKLKGC-----DKGNAYEFELRKDLLELMTCGHKNI 395
+ E I ++G ++ VYK + + +L + G+ + +++++ + C H NI
Sbjct: 10 DYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSL-IQQEIFMVKECKHCNI 68
Query: 396 LQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGV 455
+ ++ + L + + GGS+ D+ + L +I + + +G+ +L+ G
Sbjct: 69 VAYFGSYLSREK-LWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGK 127
Query: 456 AYRDLNSQRILLDRHGNVCLGDMGI---VTACKSVGEATEYETDGYRWLAPEV 505
+RD+ ILL +G+V L D G+ +TA ++ + + Y W+APEV
Sbjct: 128 MHRDIKGANILLTDNGDVKLADFGVAAKITA--TIAKRKSFIGTPY-WMAPEV 177
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 3e-09
Identities = 42/147 (28%), Positives = 75/147 (51%), Gaps = 4/147 (2%)
Query: 337 LNSDNLEFIDQIGPNSFKGVYKGK-RVGIE-KLKGCDKGNAYEFELRKDLLELMTCGHKN 394
+N L F+ ++G F V+ GK R I+ +K ++G E + ++ +M H
Sbjct: 1 INPSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPK 60
Query: 395 ILQFYCVCVDENHGLCVVTKLMEGGS-VNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDH 453
++Q Y VC + L +VT+ ME G +N L + KL ++ + DV EG+++L +
Sbjct: 61 LVQLYGVCT-QQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERN 119
Query: 454 GVAYRDLNSQRILLDRHGNVCLGDMGI 480
+RDL ++ L+ G V + D G+
Sbjct: 120 SFIHRDLAARNCLVSSTGVVKVSDFGM 146
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.6 bits (140), Expect = 4e-09
Identities = 37/158 (23%), Positives = 65/158 (41%), Gaps = 35/158 (22%)
Query: 343 EFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTCG----------- 391
E I QIG ++ VYK + +L L+K +E G
Sbjct: 2 EKIAQIGEGTYGQVYKARNKKTGEL----------VALKKIRMENEKEGFPITAIREIKL 51
Query: 392 -----HKNILQFYCVCVDENHGLC-VVTKLMEGGSVNDL--ILKSR--KLQTKEIIRIAI 441
H NI++ + + G +V + M+ +DL +L S K +I
Sbjct: 52 LQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMD----HDLTGLLDSPEVKFTESQIKCYMK 107
Query: 442 DVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMG 479
+ EG+++L+ +G+ +RD+ IL++ G + L D G
Sbjct: 108 QLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFG 145
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 4e-09
Identities = 31/127 (24%), Positives = 61/127 (48%), Gaps = 5/127 (3%)
Query: 359 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHG-LCVVTKLME 417
+ K D + ++ ++L +C I+++Y +DE+ + + + E
Sbjct: 25 TGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCE 84
Query: 418 GGSVNDLI--LKSRKLQTKE--IIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 473
GGS++ + +K R + E + +IA V +G+ +L+ + +RD+ ILL R G V
Sbjct: 85 GGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQV 144
Query: 474 CLGDMGI 480
L D G+
Sbjct: 145 KLCDFGV 151
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 4e-09
Identities = 52/189 (27%), Positives = 88/189 (46%), Gaps = 40/189 (21%)
Query: 348 IGPNSFKGVYKGK------------RVGIEKLKGCDKGNAYEFELRKDLLE--LMT-CGH 392
+G +F VY+G RV ++ L+ KG A + E ++ L E LM+ H
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLR---KG-ATDQEKKEFLKEAHLMSNFNH 58
Query: 393 KNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK-------LQTKEIIRIAIDVAE 445
NI++ VC+ N ++ +LMEGG + + +R L KE++ I +DVA+
Sbjct: 59 PNIVKLLGVCLL-NEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAK 117
Query: 446 GIKFLNDHGVAYRDLNSQRILLDRHGNVC-----LGDMGIVTACKSVGEATEYETDG--- 497
G +L +RDL ++ L+ G +GD G+ + + ++ Y +G
Sbjct: 118 GCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA---RDIYKSDYYRKEGEGL 174
Query: 498 --YRWLAPE 504
RW+APE
Sbjct: 175 LPVRWMAPE 183
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 5e-09
Identities = 48/173 (27%), Positives = 81/173 (46%), Gaps = 24/173 (13%)
Query: 348 IGPNSFKGVYKGK-----RVGIEKLKGCDKGNAYEFELRKD---LLELMTCGHKNILQFY 399
IG ++ VY+GK RV K+ D + +++++ L +L NI ++Y
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 400 -CVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYR 458
L ++ + EGGSV L +K+ + K I I +V +K+++ GV +R
Sbjct: 69 GSYLKGPR--LWIIMEYAEGGSVRTL-MKAGPIAEKYISVIIREVLVALKYIHKVGVIHR 125
Query: 459 DLNSQRILLDRHGNVCLGDMGI------VTACKSVGEATEYETDGYRWLAPEV 505
D+ + IL+ GNV L D G+ ++ +S T Y W+APEV
Sbjct: 126 DIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPY------WMAPEV 172
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 5e-09
Identities = 38/160 (23%), Positives = 88/160 (55%), Gaps = 7/160 (4%)
Query: 354 KGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDE-NHGLCVV 412
+G G++V ++ LK GN + +L+K++ L H+NI+++ +C ++ +G+ ++
Sbjct: 28 EGDNTGEQVAVKSLKPESGGN-HIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLI 86
Query: 413 TKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG 471
+ + GS+ + + +++ K+ K+ ++ A+ + +G+ +L +RDL ++ +L++
Sbjct: 87 MEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEH 146
Query: 472 NVCLGDMGIVTACKSVGEATEYETD---GYRWLAPEVCFL 508
V +GD G+ A ++ E + D W APE C +
Sbjct: 147 QVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPE-CLI 185
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 5e-09
Identities = 47/184 (25%), Positives = 82/184 (44%), Gaps = 22/184 (11%)
Query: 339 SDNLEFIDQIGPNSFKGVYK--GKRVG-------IEKLKGCDKGNAYEFELRKDLLELMT 389
+D E I+ IG ++ VYK K+ G ++ + D+ E E ++L+ +
Sbjct: 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDE----EIEAEYNILQSLP 76
Query: 390 CGHKNILQFYCVCVDENH----GLCVVTKLMEGGSVNDLI----LKSRKLQTKEIIRIAI 441
H N+++FY + + L +V +L GGSV +L+ + ++L I I
Sbjct: 77 -NHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILY 135
Query: 442 DVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWL 501
G++ L+++ + +RD+ ILL G V L D G+ S W+
Sbjct: 136 GALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWM 195
Query: 502 APEV 505
APEV
Sbjct: 196 APEV 199
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 6e-09
Identities = 48/180 (26%), Positives = 82/180 (45%), Gaps = 20/180 (11%)
Query: 341 NLEFIDQIGPNSFKGVY--KGK---------RVGIEKLKGCDKGNAYEFELRKDLLELMT 389
E I +IG SF +Y K K + + K+ +K + +K+++ L
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEAS-----KKEVILLAK 55
Query: 390 CGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKE--IIRIAIDVAEGI 447
H NI+ F+ EN L +V + +GG + I + R + E I+ + ++ G+
Sbjct: 56 MKHPNIVTFFA-SFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGL 114
Query: 448 KFLNDHGVAYRDLNSQRILLDRHGNVC-LGDMGIVTACKSVGEATEYETDGYRWLAPEVC 506
K ++D + +RD+ SQ I L ++G V LGD GI E +L+PE+C
Sbjct: 115 KHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEIC 174
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 7e-09
Identities = 50/181 (27%), Positives = 86/181 (47%), Gaps = 29/181 (16%)
Query: 344 FIDQ-IGPNSFKGVYKG---------KRVGIEKLK-GCDKGNAYEFELRKDLLELMTCG- 391
I++ IG F V +G V I+ LK G +F L E G
Sbjct: 7 TIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDF-----LTEASIMGQ 61
Query: 392 --HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIK 448
H NI++ V V ++ + ++T+ ME GS++ + ++ K +++ + +A G+K
Sbjct: 62 FDHPNIIRLEGV-VTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMK 120
Query: 449 FLNDHGVAYRDLNSQRILLDRHGNVC-LGDMGIVTACKSVGEATEYETDG----YRWLAP 503
+L++ +RDL ++ IL++ + VC + D G+ + EAT Y T G RW AP
Sbjct: 121 YLSEMNYVHRDLAARNILVNSN-LVCKVSDFGLSRRLEDS-EAT-YTTKGGKIPIRWTAP 177
Query: 504 E 504
E
Sbjct: 178 E 178
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 56.4 bits (137), Expect = 8e-09
Identities = 36/148 (24%), Positives = 70/148 (47%), Gaps = 9/148 (6%)
Query: 340 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHK 393
+LE + +G S VYK GK ++K+ + +L ++L L +C
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEE-FRKQLLRELKTLRSCESP 59
Query: 394 NILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFL-ND 452
+++ Y + + +V + M+GGS+ DL+ K K+ + IA + +G+ +L
Sbjct: 60 YVVKCYGA-FYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTK 118
Query: 453 HGVAYRDLNSQRILLDRHGNVCLGDMGI 480
+ +RD+ +L++ G V + D GI
Sbjct: 119 RHIIHRDIKPSNLLINSKGEVKIADFGI 146
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 8e-09
Identities = 35/120 (29%), Positives = 52/120 (43%), Gaps = 5/120 (4%)
Query: 388 MTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGI 447
+ H + Q YC C L V + + GG + I KSR+ A ++ +
Sbjct: 51 LARNHPFLTQLYC-CFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSAL 109
Query: 448 KFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTA--CKSVGEATEYETDGYRWLAPEV 505
FL+D G+ YRDL +LLD G+ L D G+ +T T Y +APE+
Sbjct: 110 MFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDY--IAPEI 167
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 9e-09
Identities = 51/201 (25%), Positives = 86/201 (42%), Gaps = 47/201 (23%)
Query: 340 DNLEFIDQIGPNSFKGVYKGK-----------RVGIEKLKGCDKGNAYE-FELRKDLLEL 387
D + ++G +F V+ G+ V ++ LK +A + FE +LL
Sbjct: 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTN 64
Query: 388 MTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDL---------ILKSRK-----LQT 433
H+NI++FY VC + + +V + ME G +N LKS L
Sbjct: 65 F--QHENIVKFYGVCTEGD-PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTL 121
Query: 434 KEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY 493
++++IA+ +A G+ +L +RDL ++ L+ V +GD G+ + V Y
Sbjct: 122 SQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGM---SRDV-----Y 173
Query: 494 ETDGY----------RWLAPE 504
TD Y RW+ PE
Sbjct: 174 TTDYYRVGGHTMLPIRWMPPE 194
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 9e-09
Identities = 43/152 (28%), Positives = 77/152 (50%), Gaps = 10/152 (6%)
Query: 357 YKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYC--VCVDENHGLCVVTK 414
+ GK+V ++K+ K E L +++ + H+N++ Y + DE L VV +
Sbjct: 45 HTGKQVAVKKMD-LRKQQRREL-LFNEVVIMRDYHHENVVDMYNSYLVGDE---LWVVME 99
Query: 415 LMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVC 474
+EGG++ D++ +R + ++I + + V + +L++ GV +RD+ S ILL G +
Sbjct: 100 FLEGGALTDIVTHTR-MNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIK 158
Query: 475 LGDMGIVT-ACKSVGEATEYETDGYRWLAPEV 505
L D G K V + Y W+APEV
Sbjct: 159 LSDFGFCAQVSKEVPKRKSLVGTPY-WMAPEV 189
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 1e-08
Identities = 44/189 (23%), Positives = 82/189 (43%), Gaps = 35/189 (18%)
Query: 342 LEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLE----LMTCGHKNILQ 397
EF+ G F G + V ++ L+ A R D L+ + + NI++
Sbjct: 30 AEFL-GEGAPEFDG--QPVLVAVKMLRADVTKTA-----RNDFLKEIKIMSRLKNPNIIR 81
Query: 398 FYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTK-------------EIIRIAIDVA 444
VCV ++ LC++T+ ME G +N L R++++ ++ +A+ +A
Sbjct: 82 LLGVCVSDD-PLCMITEYMENGDLN-QFLSQREIESTFTHANNIPSVSIANLLYMAVQIA 139
Query: 445 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG-----YR 499
G+K+L +RDL ++ L+ H + + D G+ +++ Y G R
Sbjct: 140 SGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGM---SRNLYSGDYYRIQGRAVLPIR 196
Query: 500 WLAPEVCFL 508
W+A E L
Sbjct: 197 WMAWESILL 205
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 2e-08
Identities = 47/169 (27%), Positives = 71/169 (42%), Gaps = 15/169 (8%)
Query: 348 IGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQF----YCVCV 403
+G F V + K+ C K + + RK E M K IL+ + V +
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKG--EQMALNEKKILEKVSSRFIVSL 58
Query: 404 ----DENHGLCVVTKLMEGGSVNDLI--LKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAY 457
+ LC+V LM GG + I + I A + G++ L+ + Y
Sbjct: 59 AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVY 118
Query: 458 RDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYE-TDGYRWLAPEV 505
RDL + +LLD HGNV + D+G+ K + T GY +APEV
Sbjct: 119 RDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGY--MAPEV 165
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 2e-08
Identities = 33/120 (27%), Positives = 56/120 (46%), Gaps = 9/120 (7%)
Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN 451
H N++++Y V V + + + GG++ +L+ R L I + + EG+ +L+
Sbjct: 58 HPNLVKYYGVEVHREK-VYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLH 116
Query: 452 DHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRW------LAPEV 505
HG+ +RD+ I LD +G + LGD G A K T + +APEV
Sbjct: 117 SHGIVHRDIKPANIFLDHNGVIKLGDFG--CAVKLKNNTTTMGEEVQSLAGTPAYMAPEV 174
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 2e-08
Identities = 44/170 (25%), Positives = 73/170 (42%), Gaps = 15/170 (8%)
Query: 348 IGPNSFKGVYKG-----------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNIL 396
+G SF VY+G K V + + + E LL + H NI+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ--HPNIV 65
Query: 397 QFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVA 456
Q+ +E++ L + +L+ GGS+ L+ K I + G+++L+D
Sbjct: 66 QYLGTEREEDN-LYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTV 124
Query: 457 YRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEVC 506
+RD+ IL+D +G V L D G+ A ++ Y W+APEV
Sbjct: 125 HRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPY-WMAPEVI 173
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 2e-08
Identities = 44/135 (32%), Positives = 66/135 (48%), Gaps = 14/135 (10%)
Query: 377 EFELRKDLLELMTCGHKNILQFY-CVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKE 435
E +L K+L H+ I+Q+Y C+ L + + M GGSV D LK+ T+
Sbjct: 54 EIQLLKNL------QHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQ-LKAYGALTES 106
Query: 436 IIR-IAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMG----IVTACKSVGEA 490
+ R + EG+ +L+ + + +RD+ IL D GNV LGD G + T C S G
Sbjct: 107 VTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMS-GTG 165
Query: 491 TEYETDGYRWLAPEV 505
T W++PEV
Sbjct: 166 IRSVTGTPYWMSPEV 180
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.8 bits (133), Expect = 2e-08
Identities = 52/177 (29%), Positives = 87/177 (49%), Gaps = 23/177 (12%)
Query: 343 EFIDQIGPNSFKGVYKGKR------VGIEKLKGCDKGNAYE--FELR--KDLLELMTCGH 392
+ I Q+G +F VY + V I+K+K K ++E LR K L +L H
Sbjct: 2 KVIKQLGDGTFGSVYLARNKETGELVAIKKMKK--KFYSWEECMNLREVKSLRKLN--EH 57
Query: 393 KNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQ--TKEIIR-IAIDVAEGIKF 449
NI++ V + + L V + MEG ++ L+ K RK + ++ +IR I + +G+
Sbjct: 58 PNIVKLKEVFRENDE-LYFVFEYMEG-NLYQLM-KDRKGKPFSESVIRSIIYQILQGLAH 114
Query: 450 LNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY-ETDGYRWLAPEV 505
++ HG +RDL + +L+ V + D G+ +S T+Y T YR APE+
Sbjct: 115 IHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTRWYR--APEI 169
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.6 bits (132), Expect = 3e-08
Identities = 47/179 (26%), Positives = 81/179 (45%), Gaps = 27/179 (15%)
Query: 345 IDQIGPNSFKGVYK------GKRVGIEKLK-----GCDKGNAYEFELRKDLLELMTCGHK 393
+ +IG ++ VYK G+ V I+K+K A E+ K L EL H
Sbjct: 4 LGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALR-EI-KLLKEL---NHP 58
Query: 394 NILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIR-IAIDVAEGIKFLND 452
NI++ V + L +V + M+ + LI ++ + +I+ + +G+ F +
Sbjct: 59 NIIKLLDVFRHKGD-LYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHS 116
Query: 453 HGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY---RWL-APEVCF 507
HG+ +RDL + +L++ G + L D G+ +S G T Y RW APE+
Sbjct: 117 HGILHRDLKPENLLINTEGVLKLADFGL---ARSFGSPVRPYTH-YVVTRWYRAPELLL 171
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 54.6 bits (132), Expect = 3e-08
Identities = 50/178 (28%), Positives = 79/178 (44%), Gaps = 22/178 (12%)
Query: 344 FIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQ 397
+ +IG +F V K GK I+ +K K LR+ H NIL+
Sbjct: 3 ILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILR 62
Query: 398 FYCVCVDENHG-LCVVTKLMEGGSVNDLILKSRK--LQTKEIIRIAIDVAEGIKFLNDHG 454
V D G L +V +LM+ ++ +LI K RK L K + + + + ++ +G
Sbjct: 63 LIEVLFDRKTGRLALVFELMDM-NLYELI-KGRKRPLPEKRVKSYMYQLLKSLDHMHRNG 120
Query: 455 VAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV---GEATEY-ETDGYRWLAPEVCFL 508
+ +RD+ + IL+ + L D G +C+ + TEY T YR APE C L
Sbjct: 121 IFHRDIKPENILIKD-DILKLADFG---SCRGIYSKPPYTEYISTRWYR--APE-CLL 171
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 5e-08
Identities = 33/100 (33%), Positives = 52/100 (52%), Gaps = 5/100 (5%)
Query: 409 LCVVTKLMEGGSVNDLI--LKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRIL 466
LC+V LM GG + I + R L+ + +I + + GI L+ + YRD+ + +L
Sbjct: 68 LCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVL 127
Query: 467 LDRHGNVCLGDMGIVTACKSVGEATEYE-TDGYRWLAPEV 505
LD GN L D+G+ K T+ T+GY +APE+
Sbjct: 128 LDDQGNCRLSDLGLAVELKDGKTITQRAGTNGY--MAPEI 165
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 6e-08
Identities = 49/184 (26%), Positives = 87/184 (47%), Gaps = 12/184 (6%)
Query: 330 EEIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKL---KGCDKGNAYEFELRKDLLE 386
E + R L ++ E I ++G +F VYK K L K + + E EL ++E
Sbjct: 2 EHVRRDLDPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS--EEELEDYMVE 59
Query: 387 ---LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILK-SRKLQTKEIIRIAID 442
L TC H I++ + L ++ + GG+V+ ++L+ R L +I I
Sbjct: 60 IEILATCNHPYIVKLLGAFYWDGK-LWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQ 118
Query: 443 VAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGI-VTACKSVGEATEYETDGYRWL 501
+ E +++L+ + +RDL + +LL G++ L D G+ K++ + Y W+
Sbjct: 119 MLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPY-WM 177
Query: 502 APEV 505
APEV
Sbjct: 178 APEV 181
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 7e-08
Identities = 36/117 (30%), Positives = 60/117 (51%), Gaps = 8/117 (6%)
Query: 392 HKNILQFY--CVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKF 449
H+N+++ Y + DE L VV + +EGG++ D++ +R + ++I + + V + +
Sbjct: 76 HENVVEMYNSYLVGDE---LWVVMEFLEGGALTDIVTHTR-MNEEQIAAVCLAVLKALSV 131
Query: 450 LNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVT-ACKSVGEATEYETDGYRWLAPEV 505
L+ GV +RD+ S ILL G V L D G K V Y W+APE+
Sbjct: 132 LHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPY-WMAPEL 187
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 9e-08
Identities = 34/105 (32%), Positives = 52/105 (49%), Gaps = 18/105 (17%)
Query: 409 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLD 468
L + LM GG ++ + + E+ A ++ G++ +++ V YRDL ILLD
Sbjct: 72 LSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLD 131
Query: 469 RHGNVCLGDMGIVTACK--------SVGEATEYETDGYRWLAPEV 505
HG+V + D+G+ AC SVG T GY +APEV
Sbjct: 132 EHGHVRISDLGL--ACDFSKKKPHASVG------THGY--MAPEV 166
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 1e-07
Identities = 45/179 (25%), Positives = 81/179 (45%), Gaps = 24/179 (13%)
Query: 348 IGPNSFKGVYKG-----------KRVGIEKL--KGCDKGNAYEFELRKDLLELMTCGHKN 394
IG SF VY G K+V + + D+ + L +++ L H+N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 395 ILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHG 454
I+Q+ +D +H L + + + GGSV L+ + + + +G+ +L++ G
Sbjct: 68 IVQYLGSSLDADH-LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRG 126
Query: 455 VAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR--------WLAPEV 505
+ +RD+ IL+D G + + D GI + K + +T+G R W+APEV
Sbjct: 127 IIHRDIKGANILVDNKGGIKISDFGI--SKKLEANSLSTKTNGARPSLQGSVFWMAPEV 183
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 46/166 (27%), Positives = 77/166 (46%), Gaps = 12/166 (7%)
Query: 347 QIGPNSFKGVY------KGKRVGIEKLKGCDKGNAYEFE-LRKDLLELMTCGHKNILQFY 399
+IG SF VY + V I+K+ K + +++ + K++ L H N +Q Y
Sbjct: 22 EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ-Y 80
Query: 400 CVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRD 459
C H +V + G + + L + + LQ EI + +G+ +L+ H + +RD
Sbjct: 81 RGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRD 140
Query: 460 LNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEV 505
+ + ILL G V LGD G + + A + Y W+APEV
Sbjct: 141 VKAGNILLSEPGLVKLGDFG---SASIMAPANXFVGTPY-WMAPEV 182
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 52.7 bits (127), Expect = 1e-07
Identities = 50/185 (27%), Positives = 89/185 (48%), Gaps = 26/185 (14%)
Query: 335 WLLNSDNLEFIDQIGPNSFKGVYKGK-----RVGIEKLK-GCDKGNAYEFELRKDLLELM 388
W + ++L+ ++G F V+ G +V ++ LK G A+ E + +M
Sbjct: 1 WEIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQ-----IM 55
Query: 389 -TCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKS---RKLQTKEIIRIAIDVA 444
H ++Q Y VC +E + +VT+ M GS+ D LKS +KL+ +++ +A +A
Sbjct: 56 KKLRHDKLVQLYAVCSEEE-PIYIVTEYMSKGSLLDF-LKSGEGKKLRLPQLVDMAAQIA 113
Query: 445 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYET-DGYR---- 499
EG+ +L +RDL ++ IL+ + + D G+ + E EY +G +
Sbjct: 114 EGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLA----RLIEDDEYTAREGAKFPIK 169
Query: 500 WLAPE 504
W APE
Sbjct: 170 WTAPE 174
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 1e-07
Identities = 30/97 (30%), Positives = 51/97 (52%), Gaps = 2/97 (2%)
Query: 409 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLD 468
LC + LM GG ++ + + KE+ A ++ G++ +++ V YRDL ILLD
Sbjct: 72 LCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLD 131
Query: 469 RHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEV 505
HG+V + D+G+ AC + + ++APEV
Sbjct: 132 EHGHVRISDLGL--ACDFSKKKPHASVGTHGYMAPEV 166
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 1e-07
Identities = 34/119 (28%), Positives = 60/119 (50%), Gaps = 7/119 (5%)
Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK--LQTKEIIRIAIDVAEGIKF 449
H NI+++Y +++ L +V + GG++ + I K L I+ + + +
Sbjct: 58 HPNIIEYYENFLEDK-ALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHH 116
Query: 450 LNDHGVAYRDLNSQRILLDRHGNVC-LGDMGIVTACKSVGEA-TEYETDGYRWLAPEVC 506
++ + +RDL +Q ILLD+H V +GD GI S +A T T Y ++PE+C
Sbjct: 117 VHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCY--ISPELC 173
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 1e-07
Identities = 44/169 (26%), Positives = 80/169 (47%), Gaps = 8/169 (4%)
Query: 343 EFIDQIGPNSFKGVYKGKRVGIEKLKGCDK-GNAYEFELRKDLLE---LMTCGHKNILQF 398
E I ++G +F VYK + L E EL ++E L +C H NI++
Sbjct: 8 EIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKL 67
Query: 399 YCVCVDENHGLCVVTKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAY 457
EN+ L ++ + GG+V+ ++L+ R L +I + E + +L+++ + +
Sbjct: 68 LDAFYYENN-LWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIH 126
Query: 458 RDLNSQRILLDRHGNVCLGDMGI-VTACKSVGEATEYETDGYRWLAPEV 505
RDL + IL G++ L D G+ +++ + Y W+APEV
Sbjct: 127 RDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPY-WMAPEV 174
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 1e-07
Identities = 44/157 (28%), Positives = 77/157 (49%), Gaps = 20/157 (12%)
Query: 359 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDE-NHGLCVVTKLME 417
G+ V ++ LK + G +K++ L T H+NI+++ C ++ GL ++ + +
Sbjct: 33 GEMVAVKTLKR-ECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVP 91
Query: 418 GGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGD 477
GS+ D + K KL +++ A + EG+ +L+ +RDL ++ +LLD V +GD
Sbjct: 92 LGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGD 150
Query: 478 MGIVTACKSVGEATEYETDGYR----------WLAPE 504
G+ K+V E EY YR W A E
Sbjct: 151 FGLA---KAVPEGHEY----YRVREDGDSPVFWYAVE 180
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 40/158 (25%), Positives = 76/158 (48%), Gaps = 9/158 (5%)
Query: 354 KGVYKGKR----VGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGL 409
KG+YK K+ V ++ LK + A + EL ++ + + I++ +C E+
Sbjct: 13 KGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEAES--W 70
Query: 410 CVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDR 469
+V +L E G +N + K++ + K I + V+ G+K+L + +RDL ++ +LL
Sbjct: 71 MLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVT 130
Query: 470 HGNVCLGDMGIVTACKSVGEATEYETDG---YRWLAPE 504
+ D G+ A + + +T G +W APE
Sbjct: 131 QHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPE 168
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 51/181 (28%), Positives = 83/181 (45%), Gaps = 16/181 (8%)
Query: 339 SDNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGH 392
SD E I+ IG ++ V+K G + ++ L + E E ++L+ ++ H
Sbjct: 17 SDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDE-EIEAEYNILKALS-DH 74
Query: 393 KNILQFYCVCV--DENHG--LCVVTKLMEGGSVNDLI---LKSRKLQTKEIIRIAIDVA- 444
N+++FY + D +G L +V +L GGSV DL+ LK + + II + A
Sbjct: 75 PNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEAL 134
Query: 445 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPE 504
G++ L+ + +RD+ ILL G V L D G+ S W+APE
Sbjct: 135 MGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPE 194
Query: 505 V 505
V
Sbjct: 195 V 195
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 3e-07
Identities = 48/199 (24%), Positives = 87/199 (43%), Gaps = 35/199 (17%)
Query: 337 LNSDNLEFIDQIGPNSFKGVYKG-----------KRVGIEKLKGCDKGNAYEFELRKDLL 385
+N + F++++G + F VYKG + V I+ LK +G E E + + +
Sbjct: 2 INLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLRE-EFKHEAM 60
Query: 386 ELMTCGHKNILQF---------------YCVCVDENHGLCVVTKLMEGGSVNDLILKSRK 430
H NI+ YC D + L + + + GS +D
Sbjct: 61 MRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKST 120
Query: 431 LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA 490
L+ + + I +A G++FL+ H V ++DL ++ +L+ NV + D+G+ + V A
Sbjct: 121 LEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLF---REVYAA 177
Query: 491 TEYETDG-----YRWLAPE 504
Y+ G RW++PE
Sbjct: 178 DYYKLMGNSLLPIRWMSPE 196
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.7 bits (125), Expect = 3e-07
Identities = 35/120 (29%), Positives = 51/120 (42%), Gaps = 13/120 (10%)
Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDL--ILKSR--KLQTKEIIRIAIDVAEGI 447
H NI++ V E L +V + + DL L R L I I + G+
Sbjct: 57 HPNIVKLLDVIHTERK-LYLVFEYCD----MDLKKYLDKRPGPLSPNLIKSIMYQLLRGL 111
Query: 448 KFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA--TEYETDGYRWLAPEV 505
+ + H + +RDL Q IL++R G + L D G+ A E T YR APE+
Sbjct: 112 AYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYR--APEI 169
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 3e-07
Identities = 39/166 (23%), Positives = 77/166 (46%), Gaps = 7/166 (4%)
Query: 345 IDQIGPNSFKGVYKG-----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFY 399
+++IG SF V+KG ++V K+ ++ ++++++ L C + ++Y
Sbjct: 9 LEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYY 68
Query: 400 CVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRD 459
+ + L ++ + + GGS DL L+ L +I I ++ +G+ +L+ +RD
Sbjct: 69 GSYLKDTK-LWIIMEYLGGGSALDL-LEPGPLDETQIATILREILKGLDYLHSEKKIHRD 126
Query: 460 LNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEV 505
+ + +LL HG V L D G+ W+APEV
Sbjct: 127 IKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEV 172
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 4e-07
Identities = 47/201 (23%), Positives = 84/201 (41%), Gaps = 47/201 (23%)
Query: 341 NLEFIDQIGPNSFKGVYKGKRVGIEKLKGCD-------KGNAYEFELRKDL---LELMT- 389
+ F++++G +F VYKG+ G + K NA E +++++ ELM+
Sbjct: 6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA-EPKVQQEFRQEAELMSD 64
Query: 390 CGHKNILQFYCVCVDENHGLCVVTKLMEGGSVND-LILKS---------------RKLQT 433
H NI+ VC E C++ + + G +++ L+ S L
Sbjct: 65 LQHPNIVCLLGVCTKE-QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDC 123
Query: 434 KEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY 493
+ + IAI +A G+++L+ H +RDL ++ L+ V + D G+ Y
Sbjct: 124 SDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDI--------Y 175
Query: 494 ETDGY----------RWLAPE 504
D Y RW+ PE
Sbjct: 176 SADYYRVQSKSLLPVRWMPPE 196
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 4e-07
Identities = 42/166 (25%), Positives = 76/166 (45%), Gaps = 7/166 (4%)
Query: 345 IDQIGPNSFKGVYKG-----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFY 399
+++IG SF VYKG K V K+ ++ ++++++ L C I ++Y
Sbjct: 9 LERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYY 68
Query: 400 CVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRD 459
+ + L ++ + + GGS DL LK L+ I I ++ +G+ +L+ +RD
Sbjct: 69 GSYL-KGTKLWIIMEYLGGGSALDL-LKPGPLEETYIATILREILKGLDYLHSERKIHRD 126
Query: 460 LNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEV 505
+ + +LL G+V L D G+ W+APEV
Sbjct: 127 IKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEV 172
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 50.7 bits (122), Expect = 5e-07
Identities = 38/125 (30%), Positives = 61/125 (48%), Gaps = 12/125 (9%)
Query: 387 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAID-VAE 445
L C H I++ Y D+ + + ++ + GG + IL+ R L + R I V
Sbjct: 47 LEECNHPFIVKLYRTFKDKKY-IYMLMEYCLGGELWT-ILRDRGLFDEYTARFYIACVVL 104
Query: 446 GIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK-SVGEATEYE---TDGYRWL 501
++L++ G+ YRDL + +LLD +G V L D G A K G+ T + T Y +
Sbjct: 105 AFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFG--FAKKLKSGQKT-WTFCGTPEY--V 159
Query: 502 APEVC 506
APE+
Sbjct: 160 APEII 164
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 5e-07
Identities = 35/119 (29%), Positives = 62/119 (52%), Gaps = 7/119 (5%)
Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR--KLQTKE--IIRIAIDVAEGI 447
H+NI+Q Y EN + + + GGS++ L L+S+ L+ E II + EG+
Sbjct: 64 HRNIVQ-YLGSDSENGFFKIFMEQVPGGSLSAL-LRSKWGPLKDNEQTIIFYTKQILEGL 121
Query: 448 KFLNDHGVAYRDLNSQRILLDRHGNVC-LGDMGIVTACKSVGEATEYETDGYRWLAPEV 505
K+L+D+ + +RD+ +L++ + V + D G + TE T +++APEV
Sbjct: 122 KYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEV 180
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 6e-07
Identities = 51/183 (27%), Positives = 83/183 (45%), Gaps = 23/183 (12%)
Query: 335 WLLNSDNLEFIDQIGPNSF----KGVYKG-KRVGIEKLK-GCDKGNAY--EFELRKDLLE 386
W + + L+ + ++G F G Y G +V I+ LK G A+ E L K L
Sbjct: 1 WEVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQL-- 58
Query: 387 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKS---RKLQTKEIIRIAIDV 443
H +++ Y V E + ++T+ ME GS+ D LK+ KL ++I +A +
Sbjct: 59 ----QHPRLVRLYAVVTQEP--IYIITEYMENGSLVDF-LKTPEGIKLTINKLIDMAAQI 111
Query: 444 AEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY--RWL 501
AEG+ F+ +RDL + IL+ + D G+ + E T E + +W
Sbjct: 112 AEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIED-NEYTAREGAKFPIKWT 170
Query: 502 APE 504
APE
Sbjct: 171 APE 173
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 7e-07
Identities = 26/94 (27%), Positives = 45/94 (47%), Gaps = 4/94 (4%)
Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN 451
H + Q + C L V + + GG + I +S + A ++ G++FL+
Sbjct: 55 HPFLTQLHS-CFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLH 113
Query: 452 DHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK 485
+ G+ YRDL +LLD G++ + D G+ CK
Sbjct: 114 ERGIIYRDLKLDNVLLDSEGHIKIADFGM---CK 144
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 50.3 bits (121), Expect = 8e-07
Identities = 39/149 (26%), Positives = 65/149 (43%), Gaps = 11/149 (7%)
Query: 340 DNLEFIDQIGPNSFKGVYKGKRVGIEK---LKGCDK------GNAYEFELRKDLLELMTC 390
D+ +F IG SF V K K +K DK ++ K++L +
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLN- 59
Query: 391 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFL 450
GH I++ Y DE + L V + G + I K L K A ++ +++L
Sbjct: 60 GHPGIIKLYYTFQDEEN-LYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYL 118
Query: 451 NDHGVAYRDLNSQRILLDRHGNVCLGDMG 479
+ G+ +RDL + ILLD+ ++ + D G
Sbjct: 119 HSKGIIHRDLKPENILLDKDMHIKITDFG 147
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 8e-07
Identities = 45/171 (26%), Positives = 77/171 (45%), Gaps = 14/171 (8%)
Query: 344 FID--QIGPNSFKGVY------KGKRVGIEKLKGCDKGNAYEFE-LRKDLLELMTCGHKN 394
F+ +IG SF VY + V ++K+ K +++ + K++ L H N
Sbjct: 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82
Query: 395 ILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHG 454
++ Y C + H +V + G + + L + + LQ EI I +G+ +L+ H
Sbjct: 83 TIE-YKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN 141
Query: 455 VAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEV 505
+ +RD+ + ILL G V L D G + A + Y W+APEV
Sbjct: 142 MIHRDIKAGNILLTEPGQVKLADFG---SASKSSPANSFVGTPY-WMAPEV 188
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 50.5 bits (120), Expect = 9e-07
Identities = 45/166 (27%), Positives = 75/166 (45%), Gaps = 12/166 (7%)
Query: 347 QIGPNSFKGVY------KGKRVGIEKLKGCDKGNAYEFE-LRKDLLELMTCGHKNILQFY 399
+IG SF VY + V I+K+ K + +++ + K++ L H N ++ Y
Sbjct: 32 EIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIE-Y 90
Query: 400 CVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRD 459
C H +V + G + + L + + LQ EI I +G+ +L+ H + +RD
Sbjct: 91 KGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRD 150
Query: 460 LNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEV 505
+ + ILL G V L D G + A + Y W+APEV
Sbjct: 151 IKAGNILLTEPGQVKLADFG---SASIASPANSFVGTPY-WMAPEV 192
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 9e-07
Identities = 36/116 (31%), Positives = 61/116 (52%), Gaps = 6/116 (5%)
Query: 392 HKNILQFY-CVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFL 450
H+N+++ Y V E L V+ + ++GG++ D++ ++R L ++I + V + + +L
Sbjct: 77 HQNVVEMYKSYLVGEE--LWVLMEFLQGGALTDIVSQTR-LNEEQIATVCESVLQALCYL 133
Query: 451 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTA-CKSVGEATEYETDGYRWLAPEV 505
+ GV +RD+ S ILL G V L D G K V + Y W+APEV
Sbjct: 134 HSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPY-WMAPEV 188
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 1e-06
Identities = 54/207 (26%), Positives = 84/207 (40%), Gaps = 38/207 (18%)
Query: 334 RWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCD-------KGNAYEFELRKDL-- 384
W L D L +G +F V K + VG++ K +A E +L DL
Sbjct: 6 EWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDL-SDLVS 64
Query: 385 -LELM-TCG-HKNILQFYCVCVDENHGLCVVTKL----------------MEGGSVNDLI 425
+E+M G HKNI+ VC E L VV + E S +D
Sbjct: 65 EMEMMKMIGKHKNIINLLGVCTQEGP-LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPR 123
Query: 426 LKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK 485
L K+++ A VA G++FL +RDL ++ +L+ + + D G+ +
Sbjct: 124 PPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLA---R 180
Query: 486 SVGEATEYE--TDG---YRWLAPEVCF 507
+ Y T+G +W+APE F
Sbjct: 181 DIHHIDYYRKTTNGRLPVKWMAPEALF 207
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 1e-06
Identities = 42/161 (26%), Positives = 74/161 (45%), Gaps = 24/161 (14%)
Query: 362 VGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSV 421
V ++ LK +F +LL + H++I++FY VCV E L +V + M+ G +
Sbjct: 38 VAVKTLKDASDNARKDFHREAELLTNLQ--HEHIVKFYGVCV-EGDPLIMVFEYMKHGDL 94
Query: 422 N--------DLILKSR-----KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLD 468
N D +L + +L +++ IA +A G+ +L +RDL ++ L+
Sbjct: 95 NKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVG 154
Query: 469 RHGNVCLGDMGIVTACKSVGEATEYETDGY-----RWLAPE 504
+ V +GD G+ + V Y G+ RW+ PE
Sbjct: 155 ENLLVKIGDFGM---SRDVYSTDYYRVGGHTMLPIRWMPPE 192
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 1e-06
Identities = 42/196 (21%), Positives = 78/196 (39%), Gaps = 41/196 (20%)
Query: 340 DNLEFIDQIGPNSFKGVYKGKRVGIE----------KLKGCDKGNAYEFELRKDLLELMT 389
D++ + +G +F VY+G G + K E + + L +
Sbjct: 6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSK 65
Query: 390 CGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-------KLQTKEIIRIAID 442
H+NI++ V + ++ +LM GG + + ++R L K+++ A D
Sbjct: 66 FNHQNIVRLIGVSFERLPRF-ILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARD 124
Query: 443 VAEGIKFLNDHGVAYRDLNSQRILLDRHGN---VCLGDMGIVTACKSVGEATE-YETDGY 498
VA+G K+L ++ +RD+ ++ LL G + D G+ A + Y Y
Sbjct: 125 VAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGM---------ARDIYRASYY 175
Query: 499 R----------WLAPE 504
R W+ PE
Sbjct: 176 RKGGRAMLPIKWMPPE 191
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 2e-06
Identities = 47/176 (26%), Positives = 80/176 (45%), Gaps = 27/176 (15%)
Query: 348 IGPNSFKGVYKG---------KRVGIEKLKGCDKGNAYEFELRKDLL-ELMTCG---HKN 394
IG F V++G V I+ LK Y + R+D L E G H N
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKP-----GYTEKQRQDFLSEASIMGQFSHHN 67
Query: 395 ILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR--KLQTKEIIRIAIDVAEGIKFLND 452
I++ V + ++T+ ME G++ D L+ + + +++ + +A G+K+L+D
Sbjct: 68 IIRLEGVVTKFKPAM-IITEYMENGAL-DKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSD 125
Query: 453 HGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRWLAPE 504
+RDL ++ IL++ + + D G+ + E T Y T G RW APE
Sbjct: 126 MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGT-YTTSGGKIPIRWTAPE 180
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 2e-06
Identities = 35/118 (29%), Positives = 50/118 (42%), Gaps = 1/118 (0%)
Query: 388 MTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGI 447
+ H + +C C L V + + GG + I +SRK A +V +
Sbjct: 51 LAAKHPFLTALHC-CFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLAL 109
Query: 448 KFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEV 505
FL+ HGV YRDL ILLD G+ L D G+ G T ++APE+
Sbjct: 110 MFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEI 167
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 31/110 (28%), Positives = 55/110 (50%), Gaps = 7/110 (6%)
Query: 398 FYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAI-DVAEGIKFLNDHGVA 456
+Y +EN + +V L+ GG + + + K ++E ++ I ++ +++L+ G+
Sbjct: 66 WYSFQDEEN--MYLVVDLLLGGDLRYHLSQKVKF-SEEQVKFWICEIVLALEYLHSKGII 122
Query: 457 YRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYE-TDGYRWLAPEV 505
+RD+ ILLD G+V + D I T T T GY +APEV
Sbjct: 123 HRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSGTPGY--MAPEV 170
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 2e-06
Identities = 37/123 (30%), Positives = 60/123 (48%), Gaps = 20/123 (16%)
Query: 392 HKNILQF---YCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIK 448
H NI+ + Y V DE L VV + + GGS+ D++ ++ + +I + + + ++
Sbjct: 75 HPNIVNYLDSYLVG-DE---LWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALE 129
Query: 449 FLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC------KSVGEATEYETDGYRWLA 502
FL+ + V +RD+ S ILL G+V L D G +S T Y W+A
Sbjct: 130 FLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPY------WMA 183
Query: 503 PEV 505
PEV
Sbjct: 184 PEV 186
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 2e-06
Identities = 37/166 (22%), Positives = 77/166 (46%), Gaps = 7/166 (4%)
Query: 345 IDQIGPNSFKGVYKG---KRVGIEKLKGCDKGNAYEF--ELRKDLLELMTCGHKNILQFY 399
+++IG SF V+KG + + +K D A + ++++++ L C + ++Y
Sbjct: 9 LERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYY 68
Query: 400 CVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRD 459
+ + L ++ + + GGS DL L++ +I + ++ +G+ +L+ +RD
Sbjct: 69 GSYL-KGTKLWIIMEYLGGGSALDL-LRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRD 126
Query: 460 LNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEV 505
+ + +LL G+V L D G+ W+APEV
Sbjct: 127 IKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEV 172
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 3e-06
Identities = 43/169 (25%), Positives = 80/169 (47%), Gaps = 12/169 (7%)
Query: 341 NLEFIDQIGPNSFKGVYK-----GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNI 395
++++ + +G + VYK +R+ K+ D + ++ +L L C I
Sbjct: 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYI 61
Query: 396 LQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGV 455
+ FY EN + + T+ M+GGS++ RK+ + RIA+ V +G+ +L +
Sbjct: 62 IGFYGAFFVENR-ISICTEFMDGGSLD----VYRKIPEHVLGRIAVAVVKGLTYLWSLKI 116
Query: 456 AYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPE 504
+RD+ +L++ G V L D G+ T + T T+ Y +APE
Sbjct: 117 LHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYVGTNAY--MAPE 163
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 3e-06
Identities = 48/158 (30%), Positives = 78/158 (49%), Gaps = 19/158 (12%)
Query: 359 GKR---VGIEKLKGCDKGNAYEFELRKDLL-ELMTCG---HKNILQFYCVCVDENHGLCV 411
GKR V I+ LK Y + R+D L E G H NI+ V V ++ + +
Sbjct: 29 GKREIPVAIKTLKA-----GYTEKQRRDFLSEASIMGQFDHPNIIHLEGV-VTKSKPVMI 82
Query: 412 VTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRH 470
VT+ ME GS++ + K + +++ + +A G+K+L+D G +RDL ++ IL++ +
Sbjct: 83 VTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSN 142
Query: 471 GNVCLGDMGIVTACKSVGEATEYETDG----YRWLAPE 504
+ D G+ + EA Y T G RW APE
Sbjct: 143 LVCKVSDFGLSRVLEDDPEAA-YTTRGGKIPIRWTAPE 179
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 5e-06
Identities = 27/100 (27%), Positives = 54/100 (54%), Gaps = 11/100 (11%)
Query: 392 HKNILQFYCVCVD--ENHGL---CVVTKLMEGGSVNDLILKSR------KLQTKEIIRIA 440
H N+++ VC+ E+ G V+ M+ G ++ +L SR L T+ +++
Sbjct: 59 HPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFM 118
Query: 441 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGI 480
D+A G+++L+ +RDL ++ +L+ + NVC+ D G+
Sbjct: 119 TDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGL 158
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 6e-06
Identities = 40/164 (24%), Positives = 75/164 (45%), Gaps = 27/164 (16%)
Query: 362 VGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSV 421
V ++ LK +F+ +LL + H++I++FY VC D + L +V + M+ G +
Sbjct: 38 VAVKALKDPTLAARKDFQREAELLTNLQ--HEHIVKFYGVCGDGD-PLIMVFEYMKHGDL 94
Query: 422 ND----------LILKSRKLQTK------EIIRIAIDVAEGIKFLNDHGVAYRDLNSQRI 465
N +++ + Q K +++ IA +A G+ +L +RDL ++
Sbjct: 95 NKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNC 154
Query: 466 LLDRHGNVCLGDMGIVTACKSVGEATEYETDGY-----RWLAPE 504
L+ + V +GD G+ + V Y G+ RW+ PE
Sbjct: 155 LVGANLLVKIGDFGM---SRDVYSTDYYRVGGHTMLPIRWMPPE 195
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 7e-06
Identities = 36/146 (24%), Positives = 67/146 (45%), Gaps = 22/146 (15%)
Query: 375 AYEFELRK-----DLLELMTCGHKNILQFYCVCVDENHGLCVVTKLME---GGSVNDLIL 426
A E E K DLL+ + H NI+Q+ C+D+ ++ ME GGS++ ++
Sbjct: 41 AAEKEYEKLQEEVDLLK--SLKHVNIVQYLGTCLDD----NTISIFMEFVPGGSISSILN 94
Query: 427 KSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS 486
+ L + + +G+ +L+++ V +RD+ ++L +G + L D G
Sbjct: 95 RFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154
Query: 487 VGEATEYETDGYR-------WLAPEV 505
VG ++ + W+APEV
Sbjct: 155 VG-LHGTHSNMLKSMHGTPYWMAPEV 179
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 7e-06
Identities = 48/183 (26%), Positives = 86/183 (46%), Gaps = 23/183 (12%)
Query: 335 WLLNSDNLEFIDQIGPNSFKGVYKG-----KRVGIEKLK-GCDKGNAY--EFELRKDLLE 386
W + ++L+ I ++G F V+ G +V ++ LK G ++ E ++ K L
Sbjct: 1 WEIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKL-- 58
Query: 387 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL--KSRKLQTKEIIRIAIDVA 444
H ++Q Y V +E + +VT+ M GS+ D + + R L+ ++ +A VA
Sbjct: 59 ----RHDKLVQLYAVVSEEP--IYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVA 112
Query: 445 EGIKFLNDHGVAYRDLNSQRILLDRHGNVC-LGDMGIVTACKSVGEATEYETDGY--RWL 501
G+ ++ +RDL S IL+ G VC + D G+ + E T + + +W
Sbjct: 113 AGMAYIERMNYIHRDLRSANILVG-DGLVCKIADFGLARLIED-NEYTARQGAKFPIKWT 170
Query: 502 APE 504
APE
Sbjct: 171 APE 173
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 8e-06
Identities = 45/189 (23%), Positives = 78/189 (41%), Gaps = 25/189 (13%)
Query: 330 EEIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLE--- 386
+ W L+ + E + +G SF RV I K KG + A + ++++L+
Sbjct: 10 PDTSSWKLS--DFEMGETLGTGSFG------RVRIAKHKGTGEYYAIKCLKKREILKMKQ 61
Query: 387 ----------LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEI 436
LM H I+ C DEN + + + + GG + + K+ +
Sbjct: 62 VQHVAQEKSILMELSHPFIVNMMCSFQDENR-VYFLLEFVVGGELFTHLRKAGRFPNDVA 120
Query: 437 IRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETD 496
++ ++L+ + YRDL + +LLD G+V + D G K V + T
Sbjct: 121 KFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFA---KKVPDRTFTLCG 177
Query: 497 GYRWLAPEV 505
+LAPEV
Sbjct: 178 TPEYLAPEV 186
|
Length = 329 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 8e-06
Identities = 28/104 (26%), Positives = 49/104 (47%)
Query: 402 CVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLN 461
C L +V + + GG + + + RKL + A ++ + FL++ G+ YRDL
Sbjct: 64 CFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLK 123
Query: 462 SQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEV 505
+LLD G++ L D G+ G+ T ++APE+
Sbjct: 124 LDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEI 167
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 8e-06
Identities = 48/171 (28%), Positives = 83/171 (48%), Gaps = 18/171 (10%)
Query: 346 DQIGPNSFKGVYKGK-RVGIE-KLKGCDKGNAYEFELRKDLLE---LMTCGHKNILQFYC 400
++IG +F VYKG + E +K C + RK L E L H NI++
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTEVAVKTC-RSTLPPDLKRKFLQEAEILKQYDHPNIVKLIG 59
Query: 401 VCVDENHGLCVVTKLMEGGS-VNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRD 459
VCV + + +V +L+ GGS + L K +L K+++++++D A G+++L +RD
Sbjct: 60 VCVQK-QPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRD 118
Query: 460 LNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYE-TDGYR-----WLAPE 504
L ++ L+ + + + D G+ E Y +DG + W APE
Sbjct: 119 LAARNCLVGENNVLKISDFGM----SREEEGGIYTVSDGLKQIPIKWTAPE 165
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 9e-06
Identities = 33/155 (21%), Positives = 74/155 (47%), Gaps = 18/155 (11%)
Query: 340 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLE----LMT 389
N + +IG F VYK G+ V ++K++ + +A + R+D L+ L
Sbjct: 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDA---KARQDCLKEIDLLKQ 58
Query: 390 CGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK----LQTKEIIRIAIDVAE 445
H N++++ ++ N L +V +L + G ++ +I +K + + I + + +
Sbjct: 59 LDHPNVIKYLASFIENNE-LNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCS 117
Query: 446 GIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGI 480
++ ++ + +RD+ + + G V LGD+G+
Sbjct: 118 ALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGL 152
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 1e-05
Identities = 41/183 (22%), Positives = 87/183 (47%), Gaps = 18/183 (9%)
Query: 336 LLNSDNLEFIDQIGPNSFKGVYKG------KRVGIE---KLKGCDKGNAYEFELRKDLLE 386
+L L+ + +G +F VYKG + V I K+ G E + L
Sbjct: 3 ILKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALI 62
Query: 387 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAE 445
+ + H ++++ VC+ + +VT+LM G + D + + + + ++ ++ + +A+
Sbjct: 63 MASMDHPHLVRLLGVCLSPT--IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAK 120
Query: 446 GIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRWL 501
G+ +L + + +RDL ++ +L+ +V + D G+ + G+ EY DG +W+
Sbjct: 121 GMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLE--GDEKEYNADGGKMPIKWM 178
Query: 502 APE 504
A E
Sbjct: 179 ALE 181
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 1e-05
Identities = 35/136 (25%), Positives = 57/136 (41%), Gaps = 19/136 (13%)
Query: 377 EFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEI 436
E E KDL H NI+Q Y L + + + GGS+ + + + + +
Sbjct: 58 EIETLKDL------DHLNIVQ-YLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLV 110
Query: 437 IRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETD 496
V EG+ +L+ G+ +RDL + +L+D G + D GI + Y+ D
Sbjct: 111 RFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDI-----YDND 165
Query: 497 GYR-------WLAPEV 505
W+APEV
Sbjct: 166 QNMSMQGSVFWMAPEV 181
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 41/168 (24%), Positives = 71/168 (42%), Gaps = 36/168 (21%)
Query: 362 VGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSV 421
V ++ LK + +F+ +LL ++ H++I++FY VC E L +V + M G +
Sbjct: 38 VAVKALKEASESARQDFQREAELLTVLQ--HQHIVRFYGVCT-EGRPLLMVFEYMRHGDL 94
Query: 422 NDL---------ILKSRKLQT------KEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRIL 466
N IL + +++ IA +A G+ +L +RDL ++ L
Sbjct: 95 NRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCL 154
Query: 467 LDRHGNVCLGDMGIVTACKSVGEATEYETDGY----------RWLAPE 504
+ + V +GD G+ Y TD Y RW+ PE
Sbjct: 155 VGQGLVVKIGDFGMSRDI--------YSTDYYRVGGRTMLPIRWMPPE 194
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 1e-05
Identities = 28/105 (26%), Positives = 47/105 (44%), Gaps = 12/105 (11%)
Query: 409 LCVVTKLMEGGSVNDLILKSRK----LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQR 464
LC+V +M GG + I + + G++ L+ + YRDL +
Sbjct: 68 LCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPEN 127
Query: 465 ILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR----WLAPEV 505
+LLD GNV + D+G+ K + +T GY ++APE+
Sbjct: 128 VLLDNDGNVRISDLGLAVELK----DGQSKTKGYAGTPGFMAPEL 168
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 46.5 bits (111), Expect = 1e-05
Identities = 50/158 (31%), Positives = 70/158 (44%), Gaps = 26/158 (16%)
Query: 343 EFIDQIGPNSFKGVYKGKRVGIEKL---KGCDKGNAYEFELRKDLL--------ELMTCG 391
E ++ IG SF V K +R K+ K D GN E E K L EL
Sbjct: 3 EVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKE--KQQLVSEVNILRELK--- 57
Query: 392 HKNILQFYCVCVD-ENHGLCVVTKLMEGGSVNDLILKSRK----LQTKEIIRIAIDVAEG 446
H NI+++Y +D N L +V + EGG + LI K +K ++ + I RI +
Sbjct: 58 HPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLA 117
Query: 447 IK-----FLNDHGVAYRDLNSQRILLDRHGNVCLGDMG 479
+ + V +RDL I LD + NV LGD G
Sbjct: 118 LYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFG 155
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 2e-05
Identities = 32/117 (27%), Positives = 54/117 (46%), Gaps = 7/117 (5%)
Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN 451
H + +C + H L V + + GG + I S + A ++ G++FL+
Sbjct: 55 HPFLTHLFCTFQTKEH-LFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLH 113
Query: 452 DHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS--VGEATEYETDGY-RWLAPEV 505
G+ YRDL +LLD+ G++ + D G+ CK GE G ++APE+
Sbjct: 114 KKGIIYRDLKLDNVLLDKDGHIKIADFGM---CKENMNGEGKASTFCGTPDYIAPEI 167
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 2e-05
Identities = 44/196 (22%), Positives = 90/196 (45%), Gaps = 39/196 (19%)
Query: 342 LEFIDQIGPNSFKGVYKG----------KRVGIEKLKGCDKGNAYEF-ELRKDLLELMTC 390
+ F++++G +F +YKG + V I+ LK D N ++ E +++ +
Sbjct: 7 VRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLK--DINNPQQWGEFQQEASLMAEL 64
Query: 391 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVND-LILKS----------------RKLQT 433
H NI+ V V + +C++ + + G +++ LI++S L
Sbjct: 65 HHPNIVCLLGV-VTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDH 123
Query: 434 KEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY 493
+ + IAI +A G+++L+ H ++DL ++ IL+ +V + D+G+ + + A Y
Sbjct: 124 GDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGL---SREIYSADYY 180
Query: 494 ETDG-----YRWLAPE 504
RW+ PE
Sbjct: 181 RVQPKSLLPIRWMPPE 196
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 2e-05
Identities = 38/141 (26%), Positives = 66/141 (46%), Gaps = 31/141 (21%)
Query: 394 NILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKE------------------ 435
NI++ VCVDE+ LC++T+ ME G +N L S L KE
Sbjct: 80 NIIRLLGVCVDED-PLCMITEYMENGDLNQF-LSSHHLDDKEENGNDAVPPAHCLPAISY 137
Query: 436 --IIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY 493
++ +A+ +A G+K+L+ +RDL ++ L+ + + + D G+ +++ Y
Sbjct: 138 SSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGM---SRNLYAGDYY 194
Query: 494 ETDG-----YRWLAPEVCFLL 509
G RW+A E C L+
Sbjct: 195 RIQGRAVLPIRWMAWE-CILM 214
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 2e-05
Identities = 33/117 (28%), Positives = 54/117 (46%), Gaps = 7/117 (5%)
Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN 451
H + YC + + L V + + GG + I K A ++ G++FL+
Sbjct: 55 HPFLTHLYCTFQTKEN-LFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLH 113
Query: 452 DHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS--VGEATEYETDGY-RWLAPEV 505
G+ YRDL ILLD G++ + D G+ CK +G+A G ++APE+
Sbjct: 114 SKGIVYRDLKLDNILLDTDGHIKIADFGM---CKENMLGDAKTCTFCGTPDYIAPEI 167
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 2e-05
Identities = 44/174 (25%), Positives = 74/174 (42%), Gaps = 23/174 (13%)
Query: 348 IGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN- 406
IG +F VY+ ++ ++ + E +K++ T G +NIL +DE+
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAH--TIGERNILV--RTLLDESP 56
Query: 407 ------------HGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAE---GIKFLN 451
L +VT M GG + + K + R +AE ++ L+
Sbjct: 57 FIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSED---RAKFYIAELVLALEHLH 113
Query: 452 DHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEV 505
+ + YRDL + ILLD G++ L D G+ A + + T +LAPEV
Sbjct: 114 KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEV 167
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 2e-05
Identities = 41/173 (23%), Positives = 78/173 (45%), Gaps = 27/173 (15%)
Query: 348 IGPNSFKGVYKG--KRVGIEKLKGCDKGNAYEFELR--KDLLELMTCGHKNILQFYCVCV 403
+G +F V+KG K +K C + E +++ + L H NI++ VC
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 404 DENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNS 462
+ + +V +L+ GG + K + +L+TK++++ A+D A G+ +L +RDL +
Sbjct: 63 -QRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAA 121
Query: 463 QRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY-----------RWLAPE 504
+ L+ + + + D G+ + E DG +W APE
Sbjct: 122 RNCLVGENNVLKISDFGM----------SRQEDDGIYSSSGLKQIPIKWTAPE 164
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 33/120 (27%), Positives = 55/120 (45%), Gaps = 12/120 (10%)
Query: 391 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL--KSRKLQTKEIIRIAIDVAEGIK 448
H ++ + E+H +C V + GG DL++ + + A V G++
Sbjct: 60 RHPFLVNLFACFQTEDH-VCFVMEYAAGG---DLMMHIHTDVFSEPRAVFYAACVVLGLQ 115
Query: 449 FLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS---VGEATEYETDGYRWLAPEV 505
+L+++ + YRDL +LLD G V + D G+ CK G+ T +LAPEV
Sbjct: 116 YLHENKIVYRDLKLDNLLLDTEGFVKIADFGL---CKEGMGFGDRTSTFCGTPEFLAPEV 172
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 2e-05
Identities = 26/104 (25%), Positives = 49/104 (47%)
Query: 402 CVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLN 461
C L V + + GG + + + RKL + + +++ + +L++ G+ YRDL
Sbjct: 64 CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLK 123
Query: 462 SQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEV 505
+LLD G++ L D G+ G+ T ++APE+
Sbjct: 124 LDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEI 167
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 3e-05
Identities = 34/150 (22%), Positives = 74/150 (49%), Gaps = 7/150 (4%)
Query: 337 LNSDNLEFIDQIGPNSFKGVYK-----GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCG 391
L D+ E I ++G + V+K + KL + A ++ ++L L C
Sbjct: 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECN 61
Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN 451
I+ FY + + + + M+GGS++ ++ K+ ++ + + +++I V +G+ +L
Sbjct: 62 SPYIVGFYGAFYSDGE-ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR 120
Query: 452 D-HGVAYRDLNSQRILLDRHGNVCLGDMGI 480
+ H + +RD+ IL++ G + L D G+
Sbjct: 121 EKHKIMHRDVKPSNILVNSRGEIKLCDFGV 150
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 3e-05
Identities = 27/100 (27%), Positives = 50/100 (50%), Gaps = 3/100 (3%)
Query: 408 GLCVVTKLMEGGSVNDLI--LKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRI 465
LC+V +M GG + I + + + + + A ++ G++ L+ YRDL + I
Sbjct: 74 ALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENI 133
Query: 466 LLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEV 505
LLD +G++ + D+G+ GE+ ++APEV
Sbjct: 134 LLDDYGHIRISDLGLAVKIPE-GESIRGRVGTVGYMAPEV 172
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 3e-05
Identities = 31/175 (17%), Positives = 72/175 (41%), Gaps = 14/175 (8%)
Query: 343 EFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNIL 396
+ + +IG + V+K G+ V ++K+ + +++ L C H ++
Sbjct: 3 KILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVV 62
Query: 397 QFYCVCVDENHGLCVVTKLME--GGSVNDLILKSRK-LQTKEIIRIAIDVAEGIKFLNDH 453
+ V HG V +ME +++++ + L ++ + +G+ +++ +
Sbjct: 63 KLLDV---FPHGSGFVL-VMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHAN 118
Query: 454 GVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWL-APEVCF 507
G+ +RDL +L+ G + + D G+ RW APE+ +
Sbjct: 119 GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLY 173
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 3e-05
Identities = 38/150 (25%), Positives = 63/150 (42%), Gaps = 13/150 (8%)
Query: 366 KLKGCDKGNAYEFELRKDLLELMTCGHKNILQ--------FYCVCVDENHGLCVVTKLME 417
K+ C K + RK E M K IL+ + LC+V LM
Sbjct: 26 KMYACKKLEKKRIKKRKG--ESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMN 83
Query: 418 GGSVNDLI--LKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCL 475
GG + I + + + A ++ G++ L+ + YRDL + ILLD HG++ +
Sbjct: 84 GGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRI 143
Query: 476 GDMGIVTACKSVGEATEYETDGYRWLAPEV 505
D+G+ G+ + ++APEV
Sbjct: 144 SDLGLAVHVPE-GQTIKGRVGTVGYMAPEV 172
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 4e-05
Identities = 29/119 (24%), Positives = 55/119 (46%), Gaps = 4/119 (3%)
Query: 387 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEG 446
L H I++ + D+ L ++ + + GG + + S + + A ++
Sbjct: 55 LKEVSHPFIIRLFWTEHDQRF-LYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCA 113
Query: 447 IKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEV 505
+++L+ + YRDL + ILLD+ G++ L D G K + + T +LAPEV
Sbjct: 114 LEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFA---KKLRDRTWTLCGTPEYLAPEV 169
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 4e-05
Identities = 36/165 (21%), Positives = 70/165 (42%), Gaps = 24/165 (14%)
Query: 362 VGIEKLK-GCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGS 420
V ++ L+ +F K++ L NI + VC + LC++ + ME G
Sbjct: 49 VAVKVLRPDASDNAREDFL--KEVKILSRLSDPNIARLLGVCTVDPP-LCMIMEYMENGD 105
Query: 421 VN-----------DLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDR 469
+N L S+ L ++ +A +A G+++L +RDL ++ L+ +
Sbjct: 106 LNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGK 165
Query: 470 HGNVCLGDMGIVTACKSVGEATEYETDG-----YRWLAPEVCFLL 509
+ + + D G+ +++ + Y G RW+A E LL
Sbjct: 166 NYTIKIADFGM---SRNLYSSDYYRVQGRAPLPIRWMAWE-SVLL 206
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 45.3 bits (108), Expect = 4e-05
Identities = 47/187 (25%), Positives = 83/187 (44%), Gaps = 36/187 (19%)
Query: 343 EFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYE----FELR--KDLLELMTC 390
E ++G ++ VYK G+ V I+K+K ++ A + LR K L EL
Sbjct: 3 EKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK-- 60
Query: 391 GHKNILQFYCV-CVDENHGLCVVTKLMEGGSVNDL--ILKSRKL-----QTKEIIRIAID 442
H NI+ V N + +V + ME DL ++K + + K + + +
Sbjct: 61 -HPNIIGLLDVFGHKSN--INLVFEFMET----DLEKVIKDKSIVLTPADIKSYMLMTL- 112
Query: 443 VAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYE--TDGYRW 500
G+++L+ + + +RDL +L+ G + L D G+ + S ++ T YR
Sbjct: 113 --RGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYR- 169
Query: 501 LAPEVCF 507
APE+ F
Sbjct: 170 -APELLF 175
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 4e-05
Identities = 30/107 (28%), Positives = 58/107 (54%), Gaps = 6/107 (5%)
Query: 379 ELRKDLLE----LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTK 434
+RK +L + C I+ FY ++EN+ +C+ + M+ GS++ + K + +
Sbjct: 45 SVRKQILRELQIMHECRSPYIVSFYGAFLNENN-ICMCMEFMDCGSLDRIYKKGGPIPVE 103
Query: 435 EIIRIAIDVAEGIKFL-NDHGVAYRDLNSQRILLDRHGNVCLGDMGI 480
+ +IA+ V EG+ +L N H + +RD+ IL++ G + L D G+
Sbjct: 104 ILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGV 150
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 5e-05
Identities = 28/70 (40%), Positives = 37/70 (52%), Gaps = 8/70 (11%)
Query: 440 AIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY- 498
A +VA I +L+ + YRDL + ILLD G+V L D G+ CK G E T +
Sbjct: 102 AAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGL---CKE-GVEPEETTSTFC 157
Query: 499 ---RWLAPEV 505
+LAPEV
Sbjct: 158 GTPEYLAPEV 167
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 5e-05
Identities = 39/151 (25%), Positives = 77/151 (50%), Gaps = 14/151 (9%)
Query: 342 LEFIDQIGPNSFKGVYK----------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCG 391
L+FI Q+G +F V G+ V ++KL+ + +FE +++ L +
Sbjct: 6 LKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFE--REIEILKSLQ 63
Query: 392 HKNILQFYCVCVDENH-GLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKF 449
H NI+++ VC L +V + + GS+ D + K R +L ++++ A + +G+++
Sbjct: 64 HDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEY 123
Query: 450 LNDHGVAYRDLNSQRILLDRHGNVCLGDMGI 480
L +RDL ++ IL++ V +GD G+
Sbjct: 124 LGSKRYVHRDLATRNILVESENRVKIGDFGL 154
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 5e-05
Identities = 33/150 (22%), Positives = 73/150 (48%), Gaps = 7/150 (4%)
Query: 337 LNSDNLEFIDQIGPNSFKGVYK-----GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCG 391
L D+ E I ++G + V K + KL + A ++ ++L L C
Sbjct: 2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECN 61
Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN 451
I+ FY + + + + M+GGS++ ++ +++++ + + +++I V G+ +L
Sbjct: 62 SPYIVGFYGAFYSDGE-ISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLR 120
Query: 452 D-HGVAYRDLNSQRILLDRHGNVCLGDMGI 480
+ H + +RD+ IL++ G + L D G+
Sbjct: 121 EKHQIMHRDVKPSNILVNSRGEIKLCDFGV 150
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 5e-05
Identities = 28/99 (28%), Positives = 49/99 (49%), Gaps = 3/99 (3%)
Query: 409 LCVVTKLMEGGSVNDLI--LKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRIL 466
LC+V LM GG + I + + + + A ++ G++ L+ + YRDL + IL
Sbjct: 75 LCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENIL 134
Query: 467 LDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEV 505
LD +G++ + D+G+ GE ++APEV
Sbjct: 135 LDDYGHIRISDLGLAVEIPE-GETIRGRVGTVGYMAPEV 172
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 6e-05
Identities = 30/110 (27%), Positives = 52/110 (47%), Gaps = 24/110 (21%)
Query: 411 VVTKLMEGGSVNDLILKSR------KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQR 464
V+ M+ G ++ +L SR L + ++R ID+A G+++L+ +RDL ++
Sbjct: 84 VILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARN 143
Query: 465 ILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR----------WLAPE 504
+L+ + VC+ D G+ K + Y D YR WLA E
Sbjct: 144 CMLNENMTVCVADFGL---SKKI-----YSGDYYRQGCASKLPVKWLALE 185
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 9e-05
Identities = 30/145 (20%), Positives = 67/145 (46%), Gaps = 14/145 (9%)
Query: 347 QIGPNSFKGVYKGKRVG------IEKLKGC-----DKGNAYEFELRKDLLELMTCGHKNI 395
Q+G +F Y+ + V ++++ ++ E LRK++ + H +I
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVE-ALRKEIRLMARLNHPHI 65
Query: 396 LQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGV 455
++ +++H + + M GGSV+ L+ K + II + G+ +L+++ +
Sbjct: 66 IRMLGATCEDSH-FNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQI 124
Query: 456 AYRDLNSQRILLDRHGN-VCLGDMG 479
+RD+ +L+D G + + D G
Sbjct: 125 IHRDVKGANLLIDSTGQRLRIADFG 149
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 1e-04
Identities = 49/186 (26%), Positives = 81/186 (43%), Gaps = 48/186 (25%)
Query: 348 IGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFE-LRKDLLE----LMTCGHKNILQFYCVC 402
+G SF GK + K+ G D G Y + L+K L+ + T ++IL
Sbjct: 4 LGQGSF-----GKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDIL------ 52
Query: 403 VDENHGLCV--------------VTKLMEGGSVNDLILKSRK--LQTKEIIRIAI-DVAE 445
+ NH V + + GG DL + K + T+E ++ + ++A
Sbjct: 53 AEVNHPFIVKLHYAFQTEGKLYLILDFLRGG---DLFTRLSKEVMFTEEDVKFYLAELAL 109
Query: 446 GIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY------R 499
+ L+ G+ YRDL + ILLD G++ L D G+ K E+ ++E Y
Sbjct: 110 ALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGL---SK---ESIDHEKKAYSFCGTVE 163
Query: 500 WLAPEV 505
++APEV
Sbjct: 164 YMAPEV 169
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 1e-04
Identities = 48/202 (23%), Positives = 88/202 (43%), Gaps = 43/202 (21%)
Query: 335 WLLNSDNLEFIDQIGPNSFKGVYKG-----------KRVGIEKL-KGCDKGNAYEFELRK 382
W ++ + + + ++G SF VY+G RV ++ + + EF
Sbjct: 1 WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEA 60
Query: 383 DLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLI--LKS-------RKLQT 433
+++ TC H +++ V V + VV +LM G + + L+ R T
Sbjct: 61 SVMKGFTCHH--VVRLLGV-VSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPT 117
Query: 434 -KEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE 492
+E+I++A ++A+G+ +LN +RDL ++ ++ V +GD G+
Sbjct: 118 LQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDI-------- 169
Query: 493 YETDGYR----------WLAPE 504
YETD YR W+APE
Sbjct: 170 YETDYYRKGGKGLLPVRWMAPE 191
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 1e-04
Identities = 23/98 (23%), Positives = 49/98 (50%), Gaps = 12/98 (12%)
Query: 394 NILQFYCVCVDENHGLCVVTKLMEGGSVNDLILK-----------SRKLQTKEIIRIAID 442
NI++ VC+ + LC++T+ ME G +N + + + +I +A
Sbjct: 80 NIIRLLAVCITSD-PLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQ 138
Query: 443 VAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGI 480
+A G+K+L+ +RDL ++ L+ ++ + + D G+
Sbjct: 139 IASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGM 176
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 46/176 (26%), Positives = 81/176 (46%), Gaps = 23/176 (13%)
Query: 346 DQIGPNSFKGVYKGK---------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNIL 396
++G SF V +G+ V ++ LK DK + + K+ + + H+N++
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKS-DKLSDIMDDFLKEAAIMHSLDHENLI 59
Query: 397 QFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRI---AIDVAEGIKFLNDH 453
+ Y V + H L +VT+L GS+ D L+ L I + A+ +A G+++L
Sbjct: 60 RLYGVVLT--HPLMMVTELAPLGSLLDR-LRKDALGHFLISTLCDYAVQIANGMRYLESK 116
Query: 454 GVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR-----WLAPE 504
+RDL ++ ILL V +GD G++ A + Y + + W APE
Sbjct: 117 RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNED--HYVMEEHLKVPFAWCAPE 170
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 1e-04
Identities = 44/206 (21%), Positives = 87/206 (42%), Gaps = 34/206 (16%)
Query: 334 RWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCD---------KGNAYEFELRKDL 384
RW + D L +G F V + +GI+K K + K +A E +L +
Sbjct: 9 RWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLV 68
Query: 385 LEL----MTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR----------- 429
E+ M HKNI+ C ++ L V+ + G++ + + R
Sbjct: 69 SEMEMMKMIGKHKNIINLLGACT-QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIA 127
Query: 430 -----KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC 484
++ K+++ VA G+++L +RDL ++ +L+ + + + D G+
Sbjct: 128 RVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDV 187
Query: 485 KSVGEATEYETDG---YRWLAPEVCF 507
++ + + T+G +W+APE F
Sbjct: 188 NNI-DYYKKTTNGRLPVKWMAPEALF 212
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 1e-04
Identities = 44/183 (24%), Positives = 83/183 (45%), Gaps = 22/183 (12%)
Query: 335 WLLNSDNLEFIDQIGPNSFKGVYKG-----KRVGIEKLK-GCDKGNAY--EFELRKDLLE 386
W + ++++ + ++G F V+ G +V ++ LK G A+ E L K
Sbjct: 1 WEIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMK---- 56
Query: 387 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR---KLQTKEIIRIAIDV 443
T H +++ Y V V + + ++T+ M GS+ D LKS K+ ++I + +
Sbjct: 57 --TLQHDKLVRLYAV-VTKEEPIYIITEYMAKGSLLDF-LKSDEGGKVLLPKLIDFSAQI 112
Query: 444 AEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY--RWL 501
AEG+ ++ +RDL + +L+ + D G+ + E T E + +W
Sbjct: 113 AEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIED-NEYTAREGAKFPIKWT 171
Query: 502 APE 504
APE
Sbjct: 172 APE 174
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 2e-04
Identities = 46/194 (23%), Positives = 80/194 (41%), Gaps = 26/194 (13%)
Query: 334 RWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEK-----------LKGCDKGNAYEFELRK 382
+W +NL F +G +F V + G+ K LK ++ E E
Sbjct: 29 KWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLK--PTAHSSEREALM 86
Query: 383 DLLELMT--CGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK-LQTKEIIRI 439
L++M+ H+NI+ C L + G +N L K L ++++
Sbjct: 87 SELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSF 146
Query: 440 AIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVC-LGDMGIVTACKSVGEATEYETDG- 497
+ VA+G+ FL +RDL ++ +LL HG + + D G+ + + + Y G
Sbjct: 147 SYQVAKGMAFLASKNCIHRDLAARNVLLT-HGKIVKICDFGLA---RDIMNDSNYVVKGN 202
Query: 498 ----YRWLAPEVCF 507
+W+APE F
Sbjct: 203 ARLPVKWMAPESIF 216
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 45/206 (21%), Positives = 85/206 (41%), Gaps = 34/206 (16%)
Query: 334 RWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCD---------KGNAYEFELRKDL 384
RW + D L +G F V + +G++K K K +A E +L +
Sbjct: 12 RWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLI 71
Query: 385 LEL----MTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR----------- 429
E+ M HKNI+ C ++ L V+ + G++ + + R
Sbjct: 72 SEMEMMKMIGKHKNIINLLGACT-QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPT 130
Query: 430 -----KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC 484
+L K+++ A VA G+++L +RDL ++ +L+ + + D G+
Sbjct: 131 QVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI 190
Query: 485 KSVGEATEYETDG---YRWLAPEVCF 507
+ + + T+G +W+APE F
Sbjct: 191 HHI-DYYKKTTNGRLPVKWMAPEALF 215
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 2e-04
Identities = 39/162 (24%), Positives = 70/162 (43%), Gaps = 32/162 (19%)
Query: 341 NLEFIDQIGPNSFKGVYK------GKRVGIEKLK------GCDKGNAYEFELRKDLLELM 388
N + +++IG ++ VYK G+ V ++K++ G E L K+L
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL---- 56
Query: 389 TCGHKNILQFYCVCVDENHGLCV-------VTKLMEGGSVNDLILKSRKLQTKEIIRIAI 441
H NI++ V EN V + K M+ ++ + L K +++
Sbjct: 57 --NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLL---- 110
Query: 442 DVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTA 483
+G+ F + H V +RDL Q +L++ G + L D G+ A
Sbjct: 111 ---QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARA 149
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 27/97 (27%), Positives = 43/97 (44%)
Query: 409 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLD 468
L V + GG + + + R A ++A + +L+ + YRDL + ILLD
Sbjct: 71 LYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLD 130
Query: 469 RHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEV 505
G+V L D G+ + + T +LAPEV
Sbjct: 131 SQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEV 167
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 2e-04
Identities = 41/164 (25%), Positives = 74/164 (45%), Gaps = 36/164 (21%)
Query: 341 NLEFIDQIGPNSFKGVYKG-----------KRVGIEKLKGCDKGNAYEFELRKDLLELMT 389
N + ++++G ++ VYKG K + ++ +G E L K+L
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKEL----- 55
Query: 390 CGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVA----- 444
H+NI++ + V EN L +V + M+ DL +K +R A+D
Sbjct: 56 -KHENIVRLHDVIHTENK-LMLVFEYMD----KDL----KKYMDTHGVRGALDPNTVKSF 105
Query: 445 -----EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTA 483
+GI F +++ V +RDL Q +L+++ G + L D G+ A
Sbjct: 106 TYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARA 149
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 32/125 (25%), Positives = 49/125 (39%), Gaps = 14/125 (11%)
Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKE--IIRIAIDVAEGIKF 449
H NIL + + + L VV+ LM GS DL+ E I I DV + +
Sbjct: 58 HPNILPYVTSFIV-DSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDY 116
Query: 450 LNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA---------TEYETDGYRW 500
++ G +R + + ILL G V L G+ + + + W
Sbjct: 117 IHSKGFIHRSVKASHILLSGDGKVVLS--GLRYSVSMIKHGKRQRVVHDFPKSSVKNLPW 174
Query: 501 LAPEV 505
L+PEV
Sbjct: 175 LSPEV 179
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 42.9 bits (102), Expect = 2e-04
Identities = 49/187 (26%), Positives = 75/187 (40%), Gaps = 39/187 (20%)
Query: 340 DNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFE-LRK-DLLELM----TCGHK 393
D+ EFI +G SF G RV + + K G Y + L K +++L K
Sbjct: 1 DDFEFIKTLGTGSF-----G-RVMLVRHK--GSGKYYALKILSKAKIVKLKQVEHVLNEK 52
Query: 394 NILQ-----FYCVCVD---ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAE 445
ILQ F ++ L +V + + GG + + KS + A V
Sbjct: 53 RILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVL 112
Query: 446 GIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT-------EYETDGY 498
+++L+ + YRDL + +LLD G + + D G K V T EY
Sbjct: 113 ALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGF---AKRVKGRTYTLCGTPEY----- 164
Query: 499 RWLAPEV 505
LAPE+
Sbjct: 165 --LAPEI 169
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 2e-04
Identities = 22/70 (31%), Positives = 34/70 (48%), Gaps = 4/70 (5%)
Query: 431 LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA 490
L ++ I I + E + +L+ G+ +RD+ ++ I LD N LGD G ACK +A
Sbjct: 182 LPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFG--AACKL--DA 237
Query: 491 TEYETDGYRW 500
Y W
Sbjct: 238 HPDTPQCYGW 247
|
Length = 392 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 3e-04
Identities = 31/134 (23%), Positives = 59/134 (44%), Gaps = 29/134 (21%)
Query: 392 HKNILQFYCVCVD--ENHGL---CVVTKLMEGGSVNDLILKSR------KLQTKEIIRIA 440
H N+++ VC + + V+ M+ G ++ +L SR KL + +++
Sbjct: 60 HPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFM 119
Query: 441 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR- 499
+D+A G+++L++ +RDL ++ +L VC+ D G+ Y D YR
Sbjct: 120 VDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGL--------SKKIYSGDYYRQ 171
Query: 500 ---------WLAPE 504
W+A E
Sbjct: 172 GRIAKMPVKWIAIE 185
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 3e-04
Identities = 31/123 (25%), Positives = 51/123 (41%), Gaps = 10/123 (8%)
Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILK--SRKLQTKEIIRIAIDVAEGIKF 449
H NI+ + + +N L VVT M GS DLI + I I V + + +
Sbjct: 58 HPNIVPYRATFIADNE-LWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDY 116
Query: 450 LNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTA-------CKSVGEATEYETDGYRWLA 502
++ G +R + + IL+ G V L + + + V + +Y WL+
Sbjct: 117 IHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLS 176
Query: 503 PEV 505
PEV
Sbjct: 177 PEV 179
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 3e-04
Identities = 43/197 (21%), Positives = 78/197 (39%), Gaps = 39/197 (19%)
Query: 337 LNSDNLEFIDQIGPNSFKGVYKGKRVGIE----------KLKGCDKGNAYEFELRKDLLE 386
NL+ I +G F V+ K GIE K K + E R++L
Sbjct: 2 FPRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDM 61
Query: 387 LMTCGHKNILQFYCVCVD-ENHGLCVVTKLMEGGSVNDLILKSRK---------LQTKEI 436
HKN+++ +C + E H ++ + + G + + ++ L TK+
Sbjct: 62 FRKLSHKNVVRLLGLCREAEPH--YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQK 119
Query: 437 IRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETD 496
+ + +A G+ L++ +RDL ++ L+ V + + + K V Y ++
Sbjct: 120 VALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSL---SKDV-----YNSE 171
Query: 497 GY---------RWLAPE 504
Y RWLAPE
Sbjct: 172 YYKLRNALIPLRWLAPE 188
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 3e-04
Identities = 27/97 (27%), Positives = 47/97 (48%), Gaps = 1/97 (1%)
Query: 409 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLD 468
L VV + + GGS+ D++ ++ + +I + + + ++FL+ + V +RD+ S ILL
Sbjct: 92 LWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG 150
Query: 469 RHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEV 505
G+V L D G W+APEV
Sbjct: 151 MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEV 187
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 3e-04
Identities = 26/97 (26%), Positives = 47/97 (48%), Gaps = 1/97 (1%)
Query: 409 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLD 468
L VV + + GGS+ D++ ++ + +I + + + ++FL+ + V +RD+ S +LL
Sbjct: 91 LFVVMEYLAGGSLTDVVTET-CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLG 149
Query: 469 RHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEV 505
G+V L D G W+APEV
Sbjct: 150 MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEV 186
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 3e-04
Identities = 25/97 (25%), Positives = 47/97 (48%)
Query: 409 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLD 468
L V + + GG + I + K + + + A +++ G+ FL+ G+ YRDL ++LD
Sbjct: 76 LYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLD 135
Query: 469 RHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEV 505
G++ + D G+ G T ++APE+
Sbjct: 136 SEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEI 172
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 4e-04
Identities = 50/184 (27%), Positives = 81/184 (44%), Gaps = 20/184 (10%)
Query: 340 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLK-GCDKGNAYEFELRKDLLELMTCGH 392
D E +++IG ++ VYK GK V ++K + D+ LR+ L M
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES 60
Query: 393 KNILQFYCV-CVDENHG---LCVVTKLMEGGSVNDLIL----KSRKLQTKEIIRIAIDVA 444
I++ V V+E +G L +V + ++ + R L K I +
Sbjct: 61 IYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLL 120
Query: 445 EGIKFLNDHGVAYRDLNSQRILLDRHGNVC-LGDMGIVTACK-SVGEAT-EYETDGYRWL 501
+G+ + HGV +RDL Q +L+D+ + + D+G+ A V T E T YR
Sbjct: 121 KGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYR-- 178
Query: 502 APEV 505
APEV
Sbjct: 179 APEV 182
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 4e-04
Identities = 27/97 (27%), Positives = 46/97 (47%), Gaps = 1/97 (1%)
Query: 409 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLD 468
L VV + + GGS+ D++ ++ + +I + + + + FL+ + V +RD+ S ILL
Sbjct: 91 LWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLG 149
Query: 469 RHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEV 505
G+V L D G W+APEV
Sbjct: 150 MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEV 186
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 4e-04
Identities = 26/86 (30%), Positives = 45/86 (52%), Gaps = 9/86 (10%)
Query: 424 LILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGI--- 480
L +SR L + + I + EG+++L+ + +RD+ ++ I ++ VC+GD+G
Sbjct: 147 LTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQF 206
Query: 481 -VTACKSVGEATEYETDGYRWLAPEV 505
V A +G A ET+ APEV
Sbjct: 207 PVVAPAFLGLAGTVETN-----APEV 227
|
Length = 357 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 4e-04
Identities = 27/101 (26%), Positives = 52/101 (51%), Gaps = 4/101 (3%)
Query: 382 KDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKS-RKLQTKEIIRIA 440
++L L C I+ FY + + + + M+GGS+ D +LK ++ + +I+
Sbjct: 48 RELKVLHECNSPYIVGFYGAFYSDGE-ISICMEHMDGGSL-DQVLKKAGRIPENILGKIS 105
Query: 441 IDVAEGIKFLND-HGVAYRDLNSQRILLDRHGNVCLGDMGI 480
I V G+ +L + H + +RD+ IL++ G + L D G+
Sbjct: 106 IAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGV 146
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 41.8 bits (99), Expect = 4e-04
Identities = 26/100 (26%), Positives = 52/100 (52%), Gaps = 18/100 (18%)
Query: 393 KNILQ----------FYCVCVDENHGLCVVTKLMEGGSVNDL--ILKSRKLQTKEIIRIA 440
++IL +Y +N L +V + + GG DL +L++ +++ RI
Sbjct: 44 RDILSQAQSPYVVKLYYSFQGKKN--LYLVMEYLPGG---DLASLLENVGSLDEDVARIY 98
Query: 441 I-DVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMG 479
I ++ +++L+ +G+ +RDL IL+D +G++ L D G
Sbjct: 99 IAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFG 138
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 4e-04
Identities = 44/182 (24%), Positives = 83/182 (45%), Gaps = 21/182 (11%)
Query: 335 WLLNSDNLEFIDQIGPNSFKGVYKGK-----RVGIEKLK-GCDKGNAY--EFELRKDLLE 386
W + ++L ++G F V+ G RV I+ LK G A+ E ++ K L
Sbjct: 1 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLR- 59
Query: 387 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL--KSRKLQTKEIIRIAIDVA 444
H+ ++Q Y V +E + +VT+ M GS+ D + + L+ +++ +A +A
Sbjct: 60 -----HEKLVQLYAVVSEEP--IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIA 112
Query: 445 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY--RWLA 502
G+ ++ +RDL + IL+ + + D G+ + E T + + +W A
Sbjct: 113 SGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKWTA 171
Query: 503 PE 504
PE
Sbjct: 172 PE 173
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 4e-04
Identities = 34/118 (28%), Positives = 58/118 (49%), Gaps = 11/118 (9%)
Query: 381 RKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKE-IIR 438
RK+ + L H NI+ F + H L +V + +GG + I R KL ++ I++
Sbjct: 46 RKEAVLLAKMKHPNIVAFKESFEADGH-LYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQ 104
Query: 439 IAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMG--------IVTACKSVG 488
+ + G++ +++ V +RD+ S+ I L ++G V LGD G AC VG
Sbjct: 105 WFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVG 162
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 4e-04
Identities = 26/103 (25%), Positives = 54/103 (52%), Gaps = 3/103 (2%)
Query: 379 ELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEII 437
E+ +L + + H I++ +C L +VT+L GS+ D + + R L + ++
Sbjct: 55 EITDHMLAMGSLDHAYIVRLLGIC--PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLL 112
Query: 438 RIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGI 480
+ +A+G+ +L +H + +R+L ++ ILL V + D G+
Sbjct: 113 NWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGV 155
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 5e-04
Identities = 34/154 (22%), Positives = 73/154 (47%), Gaps = 18/154 (11%)
Query: 341 NLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLE----LMTC 390
N +IG F VY+ G V ++K++ D +A + R D ++ L
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDA---KARADCIKEIDLLKQL 59
Query: 391 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL----KSRKLQTKEIIRIAIDVAEG 446
H N++++Y +++N L +V +L + G ++ +I + R + K + + + +
Sbjct: 60 NHPNVIKYYASFIEDNE-LNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSA 118
Query: 447 IKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGI 480
++ ++ V +RD+ + + G V LGD+G+
Sbjct: 119 LEHMHSRRVMHRDIKPANVFITATGVVKLGDLGL 152
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 5e-04
Identities = 28/99 (28%), Positives = 47/99 (47%), Gaps = 3/99 (3%)
Query: 409 LCVVTKLMEGGSVNDLI--LKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRIL 466
LC+V +M GG + I + + + I A ++ G++ L + YRDL + IL
Sbjct: 75 LCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENIL 134
Query: 467 LDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEV 505
LD G++ + D+G+ GE ++APEV
Sbjct: 135 LDDRGHIRISDLGLAVQIPE-GETVRGRVGTVGYMAPEV 172
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 5e-04
Identities = 28/119 (23%), Positives = 57/119 (47%), Gaps = 10/119 (8%)
Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL-KSRKLQTKEIIRIAIDVAEGIKFL 450
H NI++ VC + + +V +L++GG + + +L+ KE+I++ + A G+++L
Sbjct: 52 HPNIVRLIGVCT-QKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYL 110
Query: 451 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR-----WLAPE 504
+RDL ++ L+ + + D G+ + + T G + W APE
Sbjct: 111 ESKHCIHRDLAARNCLVTEKNVLKISDFGM---SREEEDGVYASTGGMKQIPVKWTAPE 166
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 5e-04
Identities = 49/196 (25%), Positives = 88/196 (44%), Gaps = 40/196 (20%)
Query: 340 DNLEFIDQIGPNSFKGVYKG--KRVG------IEKLKGCDKGNAYEFELRKDLLELMTCG 391
++++F D IG +F V + K+ G I+ LK N + + +L L G
Sbjct: 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHR-DFAGELEVLCKLG 60
Query: 392 -HKNILQFYCVCVDENHG-LCVVTKLMEGGSVNDLILKSRKLQT---------------- 433
H NI+ C EN G L + + G++ D + KSR L+T
Sbjct: 61 HHPNIINLLGAC--ENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTS 118
Query: 434 KEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGI-----VTACKSVG 488
+++++ A DVA G+++L++ +RDL ++ +L+ + + D G+ V K++G
Sbjct: 119 QQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMG 178
Query: 489 EATEYETDGYRWLAPE 504
RW+A E
Sbjct: 179 RLP------VRWMAIE 188
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 6e-04
Identities = 35/117 (29%), Positives = 56/117 (47%), Gaps = 17/117 (14%)
Query: 397 QFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAE---GIKFLNDH 453
YC + H L V + + GG DL+ + ++ R AE G++FL+
Sbjct: 60 HLYCTFQTKEH-LFFVMEFLNGG---DLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSK 115
Query: 454 GVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS--VGE---ATEYETDGYRWLAPEV 505
G+ YRDL ++LDR G++ + D G+ CK G+ +T T Y +APE+
Sbjct: 116 GIIYRDLKLDNVMLDRDGHIKIADFGM---CKENVFGDNRASTFCGTPDY--IAPEI 167
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 6e-04
Identities = 25/70 (35%), Positives = 36/70 (51%), Gaps = 8/70 (11%)
Query: 440 AIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY- 498
A ++A + +L+ + YRDL + ILLD G+V L D G+ CK G T +
Sbjct: 102 AAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGL---CKE-GIEHSKTTSTFC 157
Query: 499 ---RWLAPEV 505
+LAPEV
Sbjct: 158 GTPEYLAPEV 167
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 6e-04
Identities = 26/108 (24%), Positives = 59/108 (54%), Gaps = 13/108 (12%)
Query: 408 GLCV------VTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDL 460
G+C+ VT+LM G + D + +++ ++ +++++ + +A+G+ +L + + +RDL
Sbjct: 76 GICLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDL 135
Query: 461 NSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRWLAPE 504
++ +L+ +V + D G+ + TEY DG +W+A E
Sbjct: 136 AARNVLVKSPNHVKITDFGLARLLDI--DETEYHADGGKVPIKWMALE 181
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 6e-04
Identities = 19/59 (32%), Positives = 35/59 (59%), Gaps = 2/59 (3%)
Query: 429 RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV 487
R + +I+ I V I++L+++ + +RD+ ++ I ++ G+VCLGD G AC V
Sbjct: 177 RNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFG--AACFPV 233
|
Length = 391 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 6e-04
Identities = 43/166 (25%), Positives = 72/166 (43%), Gaps = 23/166 (13%)
Query: 352 SFKGVYKGKRVGIEKLKGCDKGNAYEFE-LRK-DLLELMTCGH----KNIL--------- 396
S K + +G + ++ D G+ Y + LRK D+LE GH ++IL
Sbjct: 5 SLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVV 64
Query: 397 -QFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGV 455
FY + L ++ + + GG + L++K L +E + I ++ G
Sbjct: 65 KMFYSF--QDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGF 122
Query: 456 AYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWL 501
+RD+ +LLD G+V L D G+ T K + T+ YR L
Sbjct: 123 IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA-----HRTEFYRNL 163
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 6e-04
Identities = 45/206 (21%), Positives = 84/206 (40%), Gaps = 34/206 (16%)
Query: 334 RWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFELR-----KDLLEL- 387
+W L+ L +G F V + +GI+K K L+ KDL +L
Sbjct: 6 KWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLV 65
Query: 388 -------MTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLI--------------- 425
M HKNI+ C ++ L V+ + G++ + +
Sbjct: 66 SEMEMMKMIGKHKNIINLLGACT-QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTC 124
Query: 426 -LKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC 484
L +L K+++ A VA G+++L +RDL ++ +L+ + + D G+
Sbjct: 125 KLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDV 184
Query: 485 KSVGEATEYETDG---YRWLAPEVCF 507
++ + + T+G +W+APE F
Sbjct: 185 HNI-DYYKKTTNGRLPVKWMAPEALF 209
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 7e-04
Identities = 42/176 (23%), Positives = 79/176 (44%), Gaps = 25/176 (14%)
Query: 348 IGPNSFKGVYKGK---------RVGIEKLKGCDKGNAYEFELRKDLL-ELMTCG---HKN 394
IG F V +G+ V I+ LK Y + R+D L E G H N
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKS-----GYTEKQRRDFLSEASIMGQFDHPN 66
Query: 395 ILQFYCVCVDENHGLCVVTKLMEGGSVNDLI-LKSRKLQTKEIIRIAIDVAEGIKFLNDH 453
I+ V V ++ + ++T+ ME G+++ + + +++ + +A G+K+L++
Sbjct: 67 IIHLEGV-VTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEM 125
Query: 454 GVAYRDLNSQRILLDRHGNVCLGDMGIVTACK-SVGEATEYETDG----YRWLAPE 504
+RDL ++ IL++ + + D G+ + + T + G RW APE
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPE 181
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 7e-04
Identities = 43/198 (21%), Positives = 88/198 (44%), Gaps = 35/198 (17%)
Query: 335 WLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEK--------LKGCDKGNAY----EFELRK 382
W + + + ++G SF VY+G G+ K +K ++ + EF
Sbjct: 1 WEVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEA 60
Query: 383 DLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQT--------- 433
+++ C H +++ V V + V+ +LM G + L+S + +
Sbjct: 61 SVMKEFNCHH--VVRLLGV-VSQGQPTLVIMELMTRGDLKSY-LRSLRPEMENNPVQAPP 116
Query: 434 --KEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT 491
K++I++A ++A+G+ +LN + +RDL ++ ++ V +GD G+ + + E
Sbjct: 117 SLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMT---RDIYETD 173
Query: 492 EYETDG-----YRWLAPE 504
Y G RW++PE
Sbjct: 174 YYRKGGKGLLPVRWMSPE 191
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 8e-04
Identities = 33/120 (27%), Positives = 58/120 (48%), Gaps = 19/120 (15%)
Query: 395 ILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL------KSRKLQTKEIIRIAIDVAEGIK 448
++Q +C D+ + L +V + M GG + +L+ K K T E++ +A+D
Sbjct: 105 VVQLFCAFQDDKY-LYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVV-LALDA----- 157
Query: 449 FLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA---TEYETDGYRWLAPEV 505
++ G+ +RD+ +LLD+HG++ L D G G T T Y ++PEV
Sbjct: 158 -IHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDY--ISPEV 214
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.001
Identities = 26/104 (25%), Positives = 48/104 (46%)
Query: 402 CVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLN 461
C L V + + GG + I + + + + A ++A G+ FL+ G+ YRDL
Sbjct: 69 CFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLK 128
Query: 462 SQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEV 505
++LD G++ + D G+ G T+ ++APE+
Sbjct: 129 LDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEI 172
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.001
Identities = 38/159 (23%), Positives = 74/159 (46%), Gaps = 11/159 (6%)
Query: 354 KGVYKGKR----VGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGL 409
KGVYK ++ V I+ LK ++ + + E+ ++ + + I++ VC E L
Sbjct: 13 KGVYKMRKKQIDVAIKVLKNENEKSVRD-EMMREAEIMHQLDNPYIVRMIGVCEAEA--L 69
Query: 410 CVVTKLMEGGSVND-LILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLD 468
+V ++ GG +N L K ++ ++ + V+ G+K+L +RDL ++ +LL
Sbjct: 70 MLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLV 129
Query: 469 RHGNVCLGDMGIVTACKSVGEATEYETDG---YRWLAPE 504
+ D G+ A + + + G +W APE
Sbjct: 130 NQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPE 168
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.001
Identities = 51/210 (24%), Positives = 90/210 (42%), Gaps = 42/210 (20%)
Query: 334 RWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCD---------KGNAYEFELRKDL 384
+W D L +G F V + + GI+K + K NA + +L DL
Sbjct: 6 KWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDL-ADL 64
Query: 385 ---LELMTC--GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK--------- 430
+ELM HKNI+ VC E L V+ + G++ + L++R+
Sbjct: 65 ISEMELMKLIGKHKNIINLLGVCTQEG-PLYVIVEYAAKGNLREF-LRARRPPGPDYTFD 122
Query: 431 --------LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVT 482
L K+++ A VA G+++L +RDL ++ +L+ + + D G+
Sbjct: 123 ITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLA- 181
Query: 483 ACKSVGEATEYE--TDG---YRWLAPEVCF 507
+ V + Y+ ++G +W+APE F
Sbjct: 182 --RGVHDIDYYKKTSNGRLPVKWMAPEALF 209
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.001
Identities = 21/66 (31%), Positives = 32/66 (48%)
Query: 440 AIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR 499
A ++A + +L+ + YRDL + ILLD G++ L D G+ T
Sbjct: 102 AAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPE 161
Query: 500 WLAPEV 505
+LAPEV
Sbjct: 162 YLAPEV 167
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.002
Identities = 40/158 (25%), Positives = 70/158 (44%), Gaps = 28/158 (17%)
Query: 344 FIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFE-LRKDLL---ELMTCG--HKNIL- 396
F+ +G SF V +R G ++L Y + L+KD++ + + C K +L
Sbjct: 4 FLMVLGKGSFGKVMLAERKGTDEL--------YAIKILKKDVIIQDDDVECTMVEKRVLA 55
Query: 397 ---------QFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGI 447
Q + C L V + + GG + I + K + + A ++A G+
Sbjct: 56 LPGKPPFLTQLHS-CFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGL 114
Query: 448 KFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK 485
FL+ G+ YRDL ++LD G++ + D G+ CK
Sbjct: 115 FFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGM---CK 149
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.002
Identities = 45/204 (22%), Positives = 84/204 (41%), Gaps = 39/204 (19%)
Query: 340 DNLEFIDQIGPNSFKGVYKGKR-----------VGIEKLK-GCDKGNAYEFELRKDLLEL 387
+N+E++ IG +F V++ + V ++ LK +F+ L+
Sbjct: 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 64
Query: 388 MTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLI---------------LKSRK-- 430
H NI++ VC +C++ + M G +N+ + +RK
Sbjct: 65 FD--HPNIVKLLGVCA-VGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCG 121
Query: 431 -----LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK 485
L E + IA VA G+ +L++ +RDL ++ L+ + V + D G+
Sbjct: 122 LNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIY 181
Query: 486 SVG--EATEYETDGYRWLAPEVCF 507
S +A+E + RW+ PE F
Sbjct: 182 SADYYKASENDAIPIRWMPPESIF 205
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.002
Identities = 44/183 (24%), Positives = 80/183 (43%), Gaps = 23/183 (12%)
Query: 335 WLLNSDNLEFIDQIGPNSFKGVY-----KGKRVGIEKLK-GCDKGNAY--EFELRKDLLE 386
W + ++L+ ++G F V+ K +V ++ +K G A+ E + K L
Sbjct: 1 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTL-- 58
Query: 387 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKS---RKLQTKEIIRIAIDV 443
H +++ + V E + ++T+ M GS+ D LKS K ++I + +
Sbjct: 59 ----QHDKLVKLHAVVTKEP--IYIITEFMAKGSLLDF-LKSDEGSKQPLPKLIDFSAQI 111
Query: 444 AEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY--RWL 501
AEG+ F+ +RDL + IL+ + D G+ + E T E + +W
Sbjct: 112 AEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIED-NEYTAREGAKFPIKWT 170
Query: 502 APE 504
APE
Sbjct: 171 APE 173
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.002
Identities = 40/164 (24%), Positives = 71/164 (43%), Gaps = 37/164 (22%)
Query: 341 NLEFIDQIGPNSFKGVYKG-----------KRVGIEKLKGCDKGNAYEFELRKDLLELMT 389
E +++IG ++ V+K KRV ++ D LR+ L L
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD----DDEGVPSSALREICL-LKE 55
Query: 390 CGHKNILQFYCVCVDENHGLCVVTKLME----------GGSVNDLILKSRKLQTKEIIRI 439
HKNI++ Y V + + L +V + + G ++ I+KS Q
Sbjct: 56 LKHKNIVRLYDV-LHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQ------- 107
Query: 440 AIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTA 483
+ +G+ F + H V +RDL Q +L++++G + L D G+ A
Sbjct: 108 ---LLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARA 148
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.002
Identities = 24/101 (23%), Positives = 44/101 (43%)
Query: 405 ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQR 464
+ LC V + GG + + + R ++ + +L+ V YRDL +
Sbjct: 66 THDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLEN 125
Query: 465 ILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEV 505
++LD+ G++ + D G+ S G + +LAPEV
Sbjct: 126 LMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEV 166
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.002
Identities = 23/90 (25%), Positives = 43/90 (47%), Gaps = 1/90 (1%)
Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFL 450
H N+L +C+ VV M+ G + + I + K++I + VA+G+++L
Sbjct: 55 HPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYL 114
Query: 451 NDHGVAYRDLNSQRILLDRHGNVCLGDMGI 480
+RDL ++ +LD V + D G+
Sbjct: 115 ASKKFVHRDLAARNCMLDESFTVKVADFGL 144
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.002
Identities = 32/117 (27%), Positives = 57/117 (48%), Gaps = 11/117 (9%)
Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDL--ILKSRKLQTKEIIRIAIDVAEGIKF 449
H+NI+ + + + VT+L+ DL +L SR L+ + I + G+K+
Sbjct: 68 HENIISLSDIFISPLEDIYFVTELLG----TDLHRLLTSRPLEKQFIQYFLYQILRGLKY 123
Query: 450 LNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY-ETDGYRWLAPEV 505
++ GV +RDL IL++ + ++ + D G+ + T Y T YR APE+
Sbjct: 124 VHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDP--QMTGYVSTRYYR--APEI 176
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.002
Identities = 29/119 (24%), Positives = 59/119 (49%), Gaps = 7/119 (5%)
Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKE--IIRIAIDVAEGIKF 449
H NI+ +Y +D+N L + + GG++ D I++ + +E ++ + + +
Sbjct: 58 HPNIIAYYNHFMDDN-TLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSY 116
Query: 450 LNDHGVAYRDLNSQRILLDRHGNVCLGDMGI--VTACKSVGEATEYETDGYRWLAPEVC 506
++ G+ +RD+ + I L + G + LGD GI + + T T Y ++PE+C
Sbjct: 117 IHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYY--MSPELC 173
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 39.7 bits (92), Expect = 0.002
Identities = 42/182 (23%), Positives = 83/182 (45%), Gaps = 21/182 (11%)
Query: 335 WLLNSDNLEFIDQIGPNSFKGVYKGK-----RVGIEKLK-GCDKGNAY--EFELRKDLLE 386
W + ++L ++G F V+ G +V I+ LK G A+ E ++ K L
Sbjct: 1 WEIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLR- 59
Query: 387 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKS--RKLQTKEIIRIAIDVA 444
H ++ Y V +E + +VT+ M GS+ D + + + L+ +++ +A +A
Sbjct: 60 -----HDKLVPLYAVVSEEP--IYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIA 112
Query: 445 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY--RWLA 502
+G+ ++ +RDL + IL+ + + D G+ + E T + + +W A
Sbjct: 113 DGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIED-NEYTARQGAKFPIKWTA 171
Query: 503 PE 504
PE
Sbjct: 172 PE 173
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.002
Identities = 38/152 (25%), Positives = 66/152 (43%), Gaps = 19/152 (12%)
Query: 345 IDQIGPNSFKGVYKGKR------VGIEKLK------GCDKGNAYEFELRKDLLELMTCGH 392
I++IG ++ VYKG+ V ++K++ G E L K+L H
Sbjct: 5 IEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKEL------QH 58
Query: 393 KNILQFYCVCVDENHGLCVVTKL-MEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN 451
NI+ V + E+ + L M+ D + K + + + + + +GI F +
Sbjct: 59 PNIVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH 118
Query: 452 DHGVAYRDLNSQRILLDRHGNVCLGDMGIVTA 483
V +RDL Q +L+D G + L D G+ A
Sbjct: 119 SRRVLHRDLKPQNLLIDNKGVIKLADFGLARA 150
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.002
Identities = 34/151 (22%), Positives = 71/151 (47%), Gaps = 12/151 (7%)
Query: 340 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHK 393
D +E +D++G ++ VYK G + +++++ + + ++ +L L
Sbjct: 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIR-LELDESKFNQIIMELDILHKAVSP 59
Query: 394 NILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKE---IIRIAIDVAEGIKFL 450
I+ FY E + + + M+ GS++ L + + RI V +G+KFL
Sbjct: 60 YIVDFYGAFFIEG-AVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFL 118
Query: 451 -NDHGVAYRDLNSQRILLDRHGNVCLGDMGI 480
+H + +RD+ +L++ +G V L D G+
Sbjct: 119 KEEHNIIHRDVKPTNVLVNGNGQVKLCDFGV 149
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.003
Identities = 46/178 (25%), Positives = 75/178 (42%), Gaps = 31/178 (17%)
Query: 340 DNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFE-LRK-DLLELMTCGH----K 393
D+ E + IG +F V R+ +K D G+ Y + LRK D+LE H +
Sbjct: 1 DDFESLKVIGRGAFGEV----RLVQKK----DTGHIYAMKILRKADMLEKEQVAHIRAER 52
Query: 394 NIL----------QFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDV 443
+IL FY + L ++ + + GG + L++K L + +
Sbjct: 53 DILVEADGAWVVKMFYSF--QDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAET 110
Query: 444 AEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWL 501
I ++ G +RD+ +LLD G+V L D G+ T K + T+ YR L
Sbjct: 111 VLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA-----HRTEFYRNL 163
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.003
Identities = 27/104 (25%), Positives = 49/104 (47%)
Query: 402 CVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLN 461
C L V + + GG + + + RKL + + +++ + FL++ G+ YRDL
Sbjct: 64 CFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLK 123
Query: 462 SQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEV 505
+LLD G++ L D G+ G+ T ++APE+
Sbjct: 124 LDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEI 167
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 39.4 bits (93), Expect = 0.003
Identities = 35/127 (27%), Positives = 61/127 (48%), Gaps = 18/127 (14%)
Query: 392 HKNILQ----FYCVCVDENHGLCVVTKLMEGGSVNDL--ILKSRKLQTKEIIR-IAIDVA 444
H+NI+ ++ + + +VT+LME DL ++KS + T + I+ +
Sbjct: 58 HENIIGLLDILRPPSPEDFNDVYIVTELME----TDLHKVIKSPQPLTDDHIQYFLYQIL 113
Query: 445 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMG----IVTACKSVGEATEY-ETDGYR 499
G+K+L+ V +RDL IL++ + ++ + D G + G TEY T YR
Sbjct: 114 RGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYR 173
Query: 500 WLAPEVC 506
APE+
Sbjct: 174 --APELL 178
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.003
Identities = 27/94 (28%), Positives = 49/94 (52%), Gaps = 8/94 (8%)
Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLI--LKSRK---LQTKEIIRIAIDVAEG 446
H NI+ + E+ L +V EGG DL LK +K L +++ + +A
Sbjct: 58 HPNIVAYRESWEGEDGLLYIVMGFCEGG---DLYHKLKEQKGKLLPENQVVEWFVQIAMA 114
Query: 447 IKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGI 480
+++L++ + +RDL +Q + L R + +GD+GI
Sbjct: 115 LQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGI 148
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 38.9 bits (90), Expect = 0.003
Identities = 34/135 (25%), Positives = 59/135 (43%), Gaps = 30/135 (22%)
Query: 392 HKNILQFYCVCVDENHG-LCVVTKLMEGGSVNDLILKSRKLQT----------------K 434
H NI+ C E+ G L + + G++ D + KSR L+T +
Sbjct: 55 HPNIINLLGAC--EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 112
Query: 435 EIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGI-----VTACKSVGE 489
+++ A DVA G+ +L+ +RDL ++ IL+ + + D G+ V K++G
Sbjct: 113 QLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGR 172
Query: 490 ATEYETDGYRWLAPE 504
RW+A E
Sbjct: 173 LP------VRWMAIE 181
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 39.0 bits (91), Expect = 0.004
Identities = 20/59 (33%), Positives = 30/59 (50%)
Query: 447 IKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEV 505
++ L+ G+ YRDL + ILLD G+V L D G+ G T ++APE+
Sbjct: 113 LEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEI 171
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 511 | |||
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 99.98 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 99.97 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 99.97 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 99.97 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 99.97 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 99.97 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 99.97 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 99.97 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 99.97 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 99.97 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 99.96 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 99.96 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 99.96 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 99.96 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 99.96 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 99.96 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 99.96 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 99.96 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 99.96 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 99.96 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 99.96 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 99.96 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 99.96 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 99.96 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 99.96 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 99.96 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 99.96 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 99.96 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 99.96 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 99.96 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 99.96 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 99.96 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 99.96 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 99.95 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 99.95 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 99.95 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 99.95 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.95 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 99.95 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 99.95 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 99.95 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 99.95 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 99.95 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 99.95 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 99.95 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 99.95 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 99.95 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 99.95 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 99.95 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 99.95 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 99.95 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 99.95 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 99.95 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.95 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 99.95 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.95 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 99.95 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 99.95 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 99.95 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 99.95 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 99.95 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 99.95 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 99.95 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 99.95 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 99.95 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 99.95 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.95 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.95 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.95 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.95 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.95 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.95 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 99.95 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 99.95 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.95 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.94 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 99.94 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 99.94 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 99.94 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.94 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.94 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 99.94 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.94 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.94 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.94 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.94 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.94 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 99.94 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.94 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.94 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.94 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 99.94 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.94 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.94 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.94 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.94 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.94 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.94 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.94 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.94 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 99.94 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.94 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.94 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.94 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.94 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.94 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.94 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.94 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.94 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.94 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 99.94 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.94 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.94 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.94 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.94 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.94 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.93 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.93 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.93 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.93 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.93 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.93 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.93 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.93 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.93 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 99.93 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.93 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.93 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.93 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.93 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.93 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.93 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.93 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 99.93 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.93 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.93 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.93 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.93 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.93 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.93 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.93 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.93 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.93 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.93 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.93 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.93 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.93 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.93 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.93 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.93 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.93 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.93 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.93 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.93 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.93 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.93 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.93 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.93 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.93 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.93 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.93 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.93 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.93 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.93 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.93 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.93 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.93 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.93 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.93 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.93 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.93 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.93 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.93 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.93 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.93 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.93 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.93 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.93 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.93 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.93 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.93 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.93 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.93 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.93 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.93 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.93 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.93 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.93 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.92 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.92 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.92 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.92 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.92 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.92 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.92 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.92 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.92 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.92 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.92 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.92 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.92 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.92 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.92 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.92 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.92 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.92 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.92 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.92 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.92 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.92 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.92 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.92 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 99.92 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.92 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.92 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.92 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.92 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 99.92 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.92 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.92 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.92 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.92 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 99.92 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.92 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.92 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.92 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.92 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.92 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.92 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.92 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.92 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.92 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.92 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.92 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.92 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.92 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.92 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.92 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.92 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.92 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.92 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.92 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.92 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.92 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.92 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.92 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.92 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.92 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.92 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.92 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.91 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.91 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.91 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.91 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.91 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.91 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.91 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.91 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.91 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.91 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.91 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.91 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.91 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.91 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.91 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.91 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.91 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.91 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.91 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.91 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.91 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.91 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.91 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.91 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.91 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.91 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.91 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.91 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.91 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.91 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.91 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.91 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.91 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.91 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.91 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.91 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.9 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.9 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.9 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.9 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.9 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.9 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.9 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.9 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.9 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.9 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.9 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.9 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.9 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.9 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.9 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.9 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.9 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.9 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.9 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.9 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.9 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.9 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.9 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.9 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.89 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.89 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.89 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.89 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.89 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.89 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.89 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.88 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.88 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.88 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.88 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.88 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.88 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.88 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.88 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.87 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.87 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.86 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.86 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.86 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.85 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.84 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.84 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.84 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.84 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.82 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.82 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.81 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.8 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.8 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.8 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.79 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.78 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.78 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.76 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.75 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.75 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.74 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.74 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.73 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.72 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.71 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.71 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.7 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.7 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.69 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.68 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.64 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.63 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.61 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.61 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.6 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.59 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.58 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.55 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.55 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.34 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.32 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.25 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.24 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.23 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.2 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.15 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.11 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.1 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.07 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.06 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.03 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.01 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.94 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.86 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.81 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.77 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 98.77 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.64 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.59 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.57 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.51 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.3 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.23 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.2 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.19 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.11 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 98.1 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.06 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.93 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.92 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 97.91 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.87 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.84 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.84 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.75 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.73 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.59 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.57 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.41 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.26 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 96.9 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 96.49 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 96.31 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 96.14 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 96.1 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 95.92 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 95.88 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 95.82 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 95.8 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 95.01 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 94.48 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 94.36 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 94.17 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 93.89 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 93.67 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 93.29 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 92.81 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 92.72 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 92.56 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 92.19 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 91.74 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 91.0 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 90.73 | |
| PTZ00384 | 383 | choline kinase; Provisional | 88.95 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 87.51 | |
| smart00587 | 196 | CHK ZnF_C4 abd HLH domain containing kinases domai | 86.5 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 86.28 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 85.51 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 85.11 | |
| PLN02236 | 344 | choline kinase | 85.1 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 84.83 | |
| PF05445 | 434 | Pox_ser-thr_kin: Poxvirus serine/threonine protein | 84.71 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 84.07 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 83.39 |
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=304.65 Aligned_cols=168 Identities=24% Similarity=0.380 Sum_probs=149.7
Q ss_pred CCCeEEEeeeecccceEEEEeE------EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEE
Q 010401 339 SDNLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV 412 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkgk------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LV 412 (511)
..+|.+.++||.|+||.||+|+ .||||.+..........+-+..||.+|+.++|||||.+++++.+++. +|+|
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~-i~lV 87 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDF-IYLV 87 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCe-EEEE
Confidence 4577888999999999999985 69999997543344445557999999999999999999999998886 9999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCC------CcEEEEecCCceeccc
Q 010401 413 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRH------GNVCLGDMGIVTACKS 486 (511)
Q Consensus 413 mEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~------g~vKL~DFGlS~~l~~ 486 (511)
||||.||+|.++|+..+.+++..++.++.||+.||++||+++||||||||+||||+.. -.+||+|||+|+.+..
T Consensus 88 MEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~ 167 (429)
T KOG0595|consen 88 MEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQP 167 (429)
T ss_pred EEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCc
Confidence 9999999999999999999999999999999999999999999999999999999865 4589999999998864
Q ss_pred CCCccccccCCCccccHHhhcc
Q 010401 487 VGEATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 487 ~~~~~~~~~Gt~~YmAPEvl~g 508 (511)
+......||++.|||||+++.
T Consensus 168 -~~~a~tlcGSplYMAPEV~~~ 188 (429)
T KOG0595|consen 168 -GSMAETLCGSPLYMAPEVIMS 188 (429)
T ss_pred -hhHHHHhhCCccccCHHHHHh
Confidence 455678899999999999863
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=302.43 Aligned_cols=172 Identities=22% Similarity=0.335 Sum_probs=155.5
Q ss_pred ecCCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCch-HHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcE
Q 010401 337 LNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNA-YEFELRKDLLELMTCGHKNILQFYCVCVDENHGL 409 (511)
Q Consensus 337 l~~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~-~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l 409 (511)
+..++|++++.||+|+||+||.. +.+|+|++++...... .......|..+|..++||+||+++..|++.+. +
T Consensus 22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~k-L 100 (357)
T KOG0598|consen 22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEK-L 100 (357)
T ss_pred CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCe-E
Confidence 45678999999999999999985 5688998876443333 34457899999999999999999999999887 9
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCC
Q 010401 410 CVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE 489 (511)
Q Consensus 410 ~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~ 489 (511)
|+|+||+.||.|..+|.+++.+++..++.|+.+|+.||.|||++|||||||||+|||+|.+|+++|+|||+++.....+.
T Consensus 101 ylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~ 180 (357)
T KOG0598|consen 101 YLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGD 180 (357)
T ss_pred EEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999998777777
Q ss_pred ccccccCCCccccHHhhccc
Q 010401 490 ATEYETDGYRWLAPEVCFLL 509 (511)
Q Consensus 490 ~~~~~~Gt~~YmAPEvl~gl 509 (511)
.+...|||+.|||||++++.
T Consensus 181 ~t~tfcGT~eYmAPEil~~~ 200 (357)
T KOG0598|consen 181 ATRTFCGTPEYMAPEILLGK 200 (357)
T ss_pred ccccccCCccccChHHHhcC
Confidence 78889999999999999763
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=296.21 Aligned_cols=176 Identities=34% Similarity=0.554 Sum_probs=156.1
Q ss_pred cceEecCCCeEEEeeeecccceEEEEe----EE-EEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCC
Q 010401 333 GRWLLNSDNLEFIDQIGPNSFKGVYKG----KR-VGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENH 407 (511)
Q Consensus 333 ~~~~l~~~~y~l~~~LG~GsFG~VYkg----k~-VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~ 407 (511)
..|.++.+++.+.+.||.|+||+||+| .. ||+|++............+.+|+.+|.+++|||||+|+|+|.+...
T Consensus 34 ~~~~i~~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~ 113 (362)
T KOG0192|consen 34 PEEEIDPDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPG 113 (362)
T ss_pred cceecChHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 467778888888899999999999996 45 9999998766555556789999999999999999999999998763
Q ss_pred cEEEEEeccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC-ccccCCCCCceEEcCCC-cEEEEecCCcee
Q 010401 408 GLCVVTKLMEGGSVNDLILK--SRKLQTKEIIRIAIDVAEGIKFLNDHG-VAYRDLNSQRILLDRHG-NVCLGDMGIVTA 483 (511)
Q Consensus 408 ~l~LVmEy~~gGsL~~lL~~--~~~L~e~~~~~ia~qIa~gL~yLH~~g-IIHRDLKp~NILld~~g-~vKL~DFGlS~~ 483 (511)
.++|||||+++|+|.+++.+ ...++...+..++.||++||+|||+++ ||||||||+|||++.++ ++||+|||+++.
T Consensus 114 ~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~ 193 (362)
T KOG0192|consen 114 SLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSRE 193 (362)
T ss_pred ceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCcccee
Confidence 48999999999999999977 578999999999999999999999999 99999999999999998 999999999987
Q ss_pred cccCCCccccccCCCccccHHhhcc
Q 010401 484 CKSVGEATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 484 l~~~~~~~~~~~Gt~~YmAPEvl~g 508 (511)
............||+.|||||++.+
T Consensus 194 ~~~~~~~~~~~~GT~~wMAPEv~~~ 218 (362)
T KOG0192|consen 194 KVISKTSMTSVAGTYRWMAPEVLRG 218 (362)
T ss_pred eccccccccCCCCCccccChhhhcC
Confidence 7654344555799999999999984
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=291.95 Aligned_cols=169 Identities=20% Similarity=0.278 Sum_probs=150.1
Q ss_pred cCCCeEEEeeeecccceEEEE------eEEEEEEEEecCCCCc-----hHHHHHHHHHHHHHhCCCCceeeEeeeEeeCC
Q 010401 338 NSDNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGN-----AYEFELRKDLLELMTCGHKNILQFYCVCVDEN 406 (511)
Q Consensus 338 ~~~~y~l~~~LG~GsFG~VYk------gk~VAVKkL~~~~~~~-----~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~ 406 (511)
..+.|.+.+.||+|+||.|-+ |+.||||++.+..... .....+++|+++|++++|||||+++++|...+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 356688899999999999988 5789999998654332 12344789999999999999999999999888
Q ss_pred CcEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCC---CcEEEEecCCcee
Q 010401 407 HGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRH---GNVCLGDMGIVTA 483 (511)
Q Consensus 407 ~~l~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~---g~vKL~DFGlS~~ 483 (511)
. .||||||+.||+|.+.+-.++.+.+..-..++.|++.|+.|||++||+||||||+|||+..+ ..+||+|||+|+.
T Consensus 250 s-~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~ 328 (475)
T KOG0615|consen 250 S-SYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKV 328 (475)
T ss_pred c-eEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhc
Confidence 6 89999999999999999999999999999999999999999999999999999999999866 7899999999998
Q ss_pred cccCCCccccccCCCccccHHhhcc
Q 010401 484 CKSVGEATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 484 l~~~~~~~~~~~Gt~~YmAPEvl~g 508 (511)
.. ........|||+.|.|||++..
T Consensus 329 ~g-~~sfm~TlCGTpsYvAPEVl~~ 352 (475)
T KOG0615|consen 329 SG-EGSFMKTLCGTPSYVAPEVLAS 352 (475)
T ss_pred cc-cceehhhhcCCccccChhheec
Confidence 76 3456788999999999999864
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=285.32 Aligned_cols=170 Identities=19% Similarity=0.344 Sum_probs=153.1
Q ss_pred ecCCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEE
Q 010401 337 LNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLC 410 (511)
Q Consensus 337 l~~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~ 410 (511)
+..++++.++.||+|..|+||++ +.+|+|++.. ........++.+|+.+++.++|||||++||+|......++
T Consensus 76 i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~-~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~is 154 (364)
T KOG0581|consen 76 ISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILL-NIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEIS 154 (364)
T ss_pred cCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecc-cCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEE
Confidence 45668889999999999999995 5789999953 4566677889999999999999999999999998773399
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCceEEcCCCcEEEEecCCceecccCCC
Q 010401 411 VVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLND-HGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE 489 (511)
Q Consensus 411 LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~-~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~ 489 (511)
|+||||++|+|.+++...+++++..+..++.+|++||.|||. ++||||||||+|||++..|.|||||||.|+.+...
T Consensus 155 I~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-- 232 (364)
T KOG0581|consen 155 ICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-- 232 (364)
T ss_pred eehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh--
Confidence 999999999999999888899999999999999999999995 99999999999999999999999999999988664
Q ss_pred ccccccCCCccccHHhhccc
Q 010401 490 ATEYETDGYRWLAPEVCFLL 509 (511)
Q Consensus 490 ~~~~~~Gt~~YmAPEvl~gl 509 (511)
.-....||..|||||.+.|.
T Consensus 233 ~a~tfvGT~~YMsPERi~g~ 252 (364)
T KOG0581|consen 233 IANTFVGTSAYMSPERISGE 252 (364)
T ss_pred hcccccccccccChhhhcCC
Confidence 34567899999999999874
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=298.85 Aligned_cols=167 Identities=25% Similarity=0.361 Sum_probs=154.4
Q ss_pred CCeEEEeeeecccceEEEEe------EEEEEEEEecCC-CCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEE
Q 010401 340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCD-KGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV 412 (511)
Q Consensus 340 ~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~-~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LV 412 (511)
.+|+..+.||+|||++||++ ..||+|++.+.. ........+.+||.+-+.++|||||++|++|+|.++ +|||
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~n-VYiv 96 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNN-VYIV 96 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCc-eEEE
Confidence 56899999999999999995 579999996422 234456678999999999999999999999999887 9999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCccc
Q 010401 413 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE 492 (511)
Q Consensus 413 mEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~~ 492 (511)
+|+|..++|..+++..+.++|.+++.++.||+.||.|||+++|||||||..||+++++.+|||+|||+|..+..+++...
T Consensus 97 LELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Erk~ 176 (592)
T KOG0575|consen 97 LELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGERKK 176 (592)
T ss_pred EEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcccccc
Confidence 99999999999999889999999999999999999999999999999999999999999999999999999998888889
Q ss_pred cccCCCccccHHhhc
Q 010401 493 YETDGYRWLAPEVCF 507 (511)
Q Consensus 493 ~~~Gt~~YmAPEvl~ 507 (511)
..||||.|+|||++.
T Consensus 177 TlCGTPNYIAPEVl~ 191 (592)
T KOG0575|consen 177 TLCGTPNYIAPEVLN 191 (592)
T ss_pred eecCCCcccChhHhc
Confidence 999999999999986
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-32 Score=273.99 Aligned_cols=167 Identities=20% Similarity=0.304 Sum_probs=149.7
Q ss_pred cCCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCch-HHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEE
Q 010401 338 NSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNA-YEFELRKDLLELMTCGHKNILQFYCVCVDENHGLC 410 (511)
Q Consensus 338 ~~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~-~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~ 410 (511)
..++|++++.||.|+||.|.+. ..+|+|++...+.... ......+|..+|+.+.||+++++++.|.+.+. +|
T Consensus 42 ~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~-ly 120 (355)
T KOG0616|consen 42 SLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSN-LY 120 (355)
T ss_pred chhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCe-EE
Confidence 4568899999999999999984 4789999975433322 33447889999999999999999999998887 99
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCc
Q 010401 411 VVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA 490 (511)
Q Consensus 411 LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~ 490 (511)
|||||++||.|..++++.+++++..++.|+.||+.||+|||+++|+||||||+|||+|.+|.+||.|||+|+.... .
T Consensus 121 mvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~---r 197 (355)
T KOG0616|consen 121 MVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG---R 197 (355)
T ss_pred EEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecC---c
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999988754 3
Q ss_pred cccccCCCccccHHhhcc
Q 010401 491 TEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 491 ~~~~~Gt~~YmAPEvl~g 508 (511)
+...||||.|+|||++..
T Consensus 198 T~TlCGTPeYLAPEii~s 215 (355)
T KOG0616|consen 198 TWTLCGTPEYLAPEIIQS 215 (355)
T ss_pred EEEecCCccccChHHhhc
Confidence 678899999999999875
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=279.40 Aligned_cols=172 Identities=22% Similarity=0.331 Sum_probs=151.7
Q ss_pred ecCCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCC---chHHHHHHHHHHHHHhCC-CCceeeEeeeEeeCC
Q 010401 337 LNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKG---NAYEFELRKDLLELMTCG-HKNILQFYCVCVDEN 406 (511)
Q Consensus 337 l~~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~---~~~~~~~~~Ei~iL~~l~-HpNIV~l~g~~~~~~ 406 (511)
...+.|++.+.||+|+||+|+.| ..||+|.+...... ......+.+|+.+++.++ ||||++++.++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 34568899999999999999996 47999976543111 123455778999999998 999999999999988
Q ss_pred CcEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCC-CcEEEEecCCceecc
Q 010401 407 HGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRH-GNVCLGDMGIVTACK 485 (511)
Q Consensus 407 ~~l~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~-g~vKL~DFGlS~~l~ 485 (511)
. +|+||||+.||+|.+++...+++.+..++.++.|++.|++|+|++||+||||||+|||++.+ +++||+|||++....
T Consensus 94 ~-~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~ 172 (370)
T KOG0583|consen 94 K-IYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP 172 (370)
T ss_pred e-EEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccC
Confidence 7 99999999999999999888899999999999999999999999999999999999999999 999999999998875
Q ss_pred cCCCccccccCCCccccHHhhccc
Q 010401 486 SVGEATEYETDGYRWLAPEVCFLL 509 (511)
Q Consensus 486 ~~~~~~~~~~Gt~~YmAPEvl~gl 509 (511)
..+......+||+.|+|||++.+-
T Consensus 173 ~~~~~l~t~cGsp~Y~aPEvl~~~ 196 (370)
T KOG0583|consen 173 GEDGLLKTFCGSPAYAAPEVLSGK 196 (370)
T ss_pred CCCCcccCCCCCcccCCHHHhCCC
Confidence 445567888999999999999874
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=279.29 Aligned_cols=179 Identities=21% Similarity=0.380 Sum_probs=153.1
Q ss_pred ccccceE-ecCCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeE
Q 010401 330 EEIGRWL-LNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVC 402 (511)
Q Consensus 330 ~~i~~~~-l~~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~ 402 (511)
+.+..|. ...+.|+.++.||+|.||.||++ +.||+|++.........-.-..+||.+|++++||||++|.+..
T Consensus 106 e~~~~w~~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eiv 185 (560)
T KOG0600|consen 106 EALHGWGPRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIV 185 (560)
T ss_pred cccccccccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEE
Confidence 3333443 44567999999999999999995 5799999986555555566689999999999999999999999
Q ss_pred eeC-CCcEEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCC
Q 010401 403 VDE-NHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGI 480 (511)
Q Consensus 403 ~~~-~~~l~LVmEy~~gGsL~~lL~~~~-~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGl 480 (511)
.+. ...+|||+|||++ +|..++...+ .|++.++..|+.|++.||+|+|.+||+|||||.+|||||++|.+||+|||+
T Consensus 186 t~~~~~siYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGL 264 (560)
T KOG0600|consen 186 TSKLSGSIYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGL 264 (560)
T ss_pred EecCCceEEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccc
Confidence 877 3459999999998 9999986643 899999999999999999999999999999999999999999999999999
Q ss_pred ceecccCCC-ccccccCCCccccHHhhccc
Q 010401 481 VTACKSVGE-ATEYETDGYRWLAPEVCFLL 509 (511)
Q Consensus 481 S~~l~~~~~-~~~~~~Gt~~YmAPEvl~gl 509 (511)
|+.+..... ..+..+-|..|.|||+++|-
T Consensus 265 Ar~y~~~~~~~~T~rVvTLWYRpPELLLG~ 294 (560)
T KOG0600|consen 265 ARFYTPSGSAPYTSRVVTLWYRPPELLLGA 294 (560)
T ss_pred eeeccCCCCcccccceEEeeccChHHhcCC
Confidence 997755443 35556678999999999874
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-31 Score=278.65 Aligned_cols=149 Identities=19% Similarity=0.306 Sum_probs=133.0
Q ss_pred eEecCCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCch-HHHHHHHHHHHHHhCCCCceeeEeeeEeeCCC
Q 010401 335 WLLNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNA-YEFELRKDLLELMTCGHKNILQFYCVCVDENH 407 (511)
Q Consensus 335 ~~l~~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~-~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~ 407 (511)
..+..++|+++++||+|+||.||++ ..+|+|+|++...... ...-++.|-.+|...++|+||+||..|.+.+.
T Consensus 136 ~r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~ 215 (550)
T KOG0605|consen 136 TRLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEY 215 (550)
T ss_pred ccCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCe
Confidence 3567889999999999999999995 4799999986443222 23347788888888999999999999998887
Q ss_pred cEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceec
Q 010401 408 GLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC 484 (511)
Q Consensus 408 ~l~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l 484 (511)
+||||||++||++..+|...+.|++..+++|+.+++.|++-||+.|+|||||||+|+|||..|++||+|||++.-+
T Consensus 216 -LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl 291 (550)
T KOG0605|consen 216 -LYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGL 291 (550)
T ss_pred -eEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchh
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999998543
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=281.91 Aligned_cols=168 Identities=25% Similarity=0.377 Sum_probs=155.9
Q ss_pred CCeEEEeeeecccceEEEEeE------EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEE
Q 010401 340 DNLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT 413 (511)
Q Consensus 340 ~~y~l~~~LG~GsFG~VYkgk------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVm 413 (511)
++|.+.+.||+|+||.||||+ .||+|.+.+....+.....+++|+.+++.++|||||.++++|++..+ +|+|+
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~-~~vVt 80 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAH-LWVVT 80 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccce-EEEEe
Confidence 578889999999999999974 69999998877777777779999999999999999999999999887 99999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCcccc
Q 010401 414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY 493 (511)
Q Consensus 414 Ey~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~~~ 493 (511)
||+.| +|..+|...+.++++.+..++.+++.||.|||+++|+|||+||.|||++..|++|+||||+|+.+..+....+.
T Consensus 81 e~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vlts 159 (808)
T KOG0597|consen 81 EYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVLTS 159 (808)
T ss_pred hhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCceeeee
Confidence 99988 99999998999999999999999999999999999999999999999999999999999999988776666777
Q ss_pred ccCCCccccHHhhccc
Q 010401 494 ETDGYRWLAPEVCFLL 509 (511)
Q Consensus 494 ~~Gt~~YmAPEvl~gl 509 (511)
..|||-|||||++.+.
T Consensus 160 ikGtPlYmAPElv~e~ 175 (808)
T KOG0597|consen 160 IKGTPLYMAPELVEEQ 175 (808)
T ss_pred ccCcccccCHHHHcCC
Confidence 8999999999998764
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.6e-31 Score=283.19 Aligned_cols=173 Identities=24% Similarity=0.335 Sum_probs=149.3
Q ss_pred eEecCCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCch-HHHHHHHHHHHHHhC-CCCceeeEeeeEeeCC
Q 010401 335 WLLNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNA-YEFELRKDLLELMTC-GHKNILQFYCVCVDEN 406 (511)
Q Consensus 335 ~~l~~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~-~~~~~~~Ei~iL~~l-~HpNIV~l~g~~~~~~ 406 (511)
..+..++|.++++||+|+||+|+++ +.+|||++++...-.. .......|..++... +||++++++..|++.+
T Consensus 363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~ 442 (694)
T KOG0694|consen 363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE 442 (694)
T ss_pred CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCC
Confidence 3577889999999999999999995 4799999987554332 233355565555544 7999999999999988
Q ss_pred CcEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceeccc
Q 010401 407 HGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS 486 (511)
Q Consensus 407 ~~l~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~ 486 (511)
+ +|+||||+.||++.. +...+.+++..++.|+.+|+.||+|||++||||||||.+|||+|.+|++||+|||+++....
T Consensus 443 ~-l~fvmey~~Ggdm~~-~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~ 520 (694)
T KOG0694|consen 443 H-LFFVMEYVAGGDLMH-HIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMG 520 (694)
T ss_pred e-EEEEEEecCCCcEEE-EEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCC
Confidence 7 999999999999443 34557899999999999999999999999999999999999999999999999999998887
Q ss_pred CCCccccccCCCccccHHhhccc
Q 010401 487 VGEATEYETDGYRWLAPEVCFLL 509 (511)
Q Consensus 487 ~~~~~~~~~Gt~~YmAPEvl~gl 509 (511)
.+..+.+.||||.|||||++.+.
T Consensus 521 ~g~~TsTfCGTpey~aPEil~e~ 543 (694)
T KOG0694|consen 521 QGDRTSTFCGTPEFLAPEVLTEQ 543 (694)
T ss_pred CCCccccccCChhhcChhhhccC
Confidence 77788999999999999999764
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=273.53 Aligned_cols=173 Identities=24% Similarity=0.383 Sum_probs=145.5
Q ss_pred ceEecCCCeEEEeeeecccceEEEEe-----EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCc
Q 010401 334 RWLLNSDNLEFIDQIGPNSFKGVYKG-----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHG 408 (511)
Q Consensus 334 ~~~l~~~~y~l~~~LG~GsFG~VYkg-----k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~ 408 (511)
+....+++|.-...||+|+||.||+| +.||||++....... ..+|..|+.++.+++|||||+|+|+|.+.+..
T Consensus 69 el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~ 146 (361)
T KOG1187|consen 69 ELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLGYCLEGGEH 146 (361)
T ss_pred HHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEEEEecCCce
Confidence 34456678888899999999999996 479999887543332 45599999999999999999999999987733
Q ss_pred EEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCCCceEEcCCCcEEEEecCCcee
Q 010401 409 LCVVTKLMEGGSVNDLILKSR--KLQTKEIIRIAIDVAEGIKFLNDHG---VAYRDLNSQRILLDRHGNVCLGDMGIVTA 483 (511)
Q Consensus 409 l~LVmEy~~gGsL~~lL~~~~--~L~e~~~~~ia~qIa~gL~yLH~~g---IIHRDLKp~NILld~~g~vKL~DFGlS~~ 483 (511)
.+||+|||++|+|.++|.... .++|..+..|+.++|+||+|||... |||||||++|||+|.+++.||+|||+|+.
T Consensus 147 ~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~ 226 (361)
T KOG1187|consen 147 RLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKL 226 (361)
T ss_pred EEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCccc
Confidence 789999999999999997654 8999999999999999999999843 99999999999999999999999999966
Q ss_pred cccCCCccccc-cCCCccccHHhhcc
Q 010401 484 CKSVGEATEYE-TDGYRWLAPEVCFL 508 (511)
Q Consensus 484 l~~~~~~~~~~-~Gt~~YmAPEvl~g 508 (511)
........... .||+.|+|||++..
T Consensus 227 ~~~~~~~~~~~~~gt~gY~~PEy~~~ 252 (361)
T KOG1187|consen 227 GPEGDTSVSTTVMGTFGYLAPEYAST 252 (361)
T ss_pred CCccccceeeecCCCCccCChhhhcc
Confidence 54311112222 89999999999863
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=273.79 Aligned_cols=169 Identities=19% Similarity=0.344 Sum_probs=153.0
Q ss_pred CCeEEEeeeecccceEEEE------eEEEEEEEEecCCCCc-hHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEE
Q 010401 340 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGN-AYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV 412 (511)
Q Consensus 340 ~~y~l~~~LG~GsFG~VYk------gk~VAVKkL~~~~~~~-~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LV 412 (511)
.+|++.+.||+|.||+|-+ |+.||||.|++....+ .....+++||.+|..++||||+++|.+|...+. +.||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdK-Iviv 131 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDK-IVIV 131 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCce-EEEE
Confidence 4689999999999999987 6789999998654433 345668999999999999999999999998887 9999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCccc
Q 010401 413 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE 492 (511)
Q Consensus 413 mEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~~ 492 (511)
|||..+|.|++++...+.|++.+++.+++||+.|+.|+|+++++|||||.+|||+|.++++||+|||++..+.. .+...
T Consensus 132 MEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~-~kfLq 210 (668)
T KOG0611|consen 132 MEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYAD-KKFLQ 210 (668)
T ss_pred EEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhcc-ccHHH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999876643 45678
Q ss_pred cccCCCccccHHhhcccC
Q 010401 493 YETDGYRWLAPEVCFLLL 510 (511)
Q Consensus 493 ~~~Gt~~YmAPEvl~gl~ 510 (511)
.+||++-|.+||++.|.+
T Consensus 211 TFCGSPLYASPEIvNG~P 228 (668)
T KOG0611|consen 211 TFCGSPLYASPEIVNGTP 228 (668)
T ss_pred HhcCCcccCCccccCCCC
Confidence 899999999999998754
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-32 Score=269.84 Aligned_cols=171 Identities=23% Similarity=0.343 Sum_probs=149.0
Q ss_pred cCCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEee-eEeeCCCcEE
Q 010401 338 NSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYC-VCVDENHGLC 410 (511)
Q Consensus 338 ~~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g-~~~~~~~~l~ 410 (511)
...+|+++++||+|+||.||++ +.+|.|+++-.............|+.+|+.++|||||++|+ .|.+++..++
T Consensus 17 ~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evln 96 (375)
T KOG0591|consen 17 TLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLN 96 (375)
T ss_pred cHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhH
Confidence 3457899999999999999994 57899999854455556677899999999999999999999 4555555589
Q ss_pred EEEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH--CC--ccccCCCCCceEEcCCCcEEEEecCCce
Q 010401 411 VVTKLMEGGSVNDLILK----SRKLQTKEIIRIAIDVAEGIKFLND--HG--VAYRDLNSQRILLDRHGNVCLGDMGIVT 482 (511)
Q Consensus 411 LVmEy~~gGsL~~lL~~----~~~L~e~~~~~ia~qIa~gL~yLH~--~g--IIHRDLKp~NILld~~g~vKL~DFGlS~ 482 (511)
||||||.+|+|..+|+. .+.+++..+|.++.|++.||.++|. .. |+||||||.||+++.+|.|||+|||+++
T Consensus 97 ivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r 176 (375)
T KOG0591|consen 97 IVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGR 176 (375)
T ss_pred HHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHh
Confidence 99999999999999952 3579999999999999999999998 44 9999999999999999999999999999
Q ss_pred ecccCCCccccccCCCccccHHhhcc
Q 010401 483 ACKSVGEATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 483 ~l~~~~~~~~~~~Gt~~YmAPEvl~g 508 (511)
.+...........|||.||+||++..
T Consensus 177 ~l~s~~tfA~S~VGTPyYMSPE~i~~ 202 (375)
T KOG0591|consen 177 FLSSKTTFAHSLVGTPYYMSPERIHE 202 (375)
T ss_pred HhcchhHHHHhhcCCCcccCHHHHhc
Confidence 98776666677899999999999874
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-30 Score=265.74 Aligned_cols=173 Identities=29% Similarity=0.436 Sum_probs=152.7
Q ss_pred ceEecCCCeEEEeeeecccceEEEEeE------EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCC
Q 010401 334 RWLLNSDNLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENH 407 (511)
Q Consensus 334 ~~~l~~~~y~l~~~LG~GsFG~VYkgk------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~ 407 (511)
+|.++.++|++.++||.|.-+.||+++ .||||++.-. +.+.....+++|+..|+.++||||++++..|..++.
T Consensus 20 ~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLE-kc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~ 98 (516)
T KOG0582|consen 20 EFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLE-KCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSE 98 (516)
T ss_pred cCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehh-hhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecce
Confidence 677889999999999999999999964 7999999753 344446779999999999999999999999998886
Q ss_pred cEEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecc
Q 010401 408 GLCVVTKLMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK 485 (511)
Q Consensus 408 ~l~LVmEy~~gGsL~~lL~~~--~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~ 485 (511)
+|+||.||.+|++.+++... ..++|..+..|+.++++||.|||++|.||||||+.||||+.+|.|||+|||.+..+.
T Consensus 99 -LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~ 177 (516)
T KOG0582|consen 99 -LWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLF 177 (516)
T ss_pred -eEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeec
Confidence 99999999999999999653 459999999999999999999999999999999999999999999999999987776
Q ss_pred cCCCcc----ccccCCCccccHHhhcc
Q 010401 486 SVGEAT----EYETDGYRWLAPEVCFL 508 (511)
Q Consensus 486 ~~~~~~----~~~~Gt~~YmAPEvl~g 508 (511)
..+... ....||++|||||+++.
T Consensus 178 ~~G~R~~~rf~tfvgtp~wmAPEvl~q 204 (516)
T KOG0582|consen 178 DSGDRQVTRFNTFVGTPCWMAPEVLMQ 204 (516)
T ss_pred ccCceeeEeeccccCcccccChHHhhh
Confidence 555322 44589999999999653
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=263.85 Aligned_cols=167 Identities=19% Similarity=0.273 Sum_probs=147.4
Q ss_pred CCeEEEeeeecccceEEEE------eEEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEE
Q 010401 340 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT 413 (511)
Q Consensus 340 ~~y~l~~~LG~GsFG~VYk------gk~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVm 413 (511)
+.|+.+.++|+|+||.||+ |+.||||++..........+-.++||..|+.++|+|+|.++.+|..... +++|+
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrk-lhLVF 80 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRK-LHLVF 80 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcce-eEEEe
Confidence 4678889999999999999 4689999998655545555567999999999999999999999998776 99999
Q ss_pred eccCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCccc
Q 010401 414 KLMEGGSVNDLIL-KSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE 492 (511)
Q Consensus 414 Ey~~gGsL~~lL~-~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~~ 492 (511)
|||+. ++.+.|. -...++...+..|+.|++.|+.|+|++++|||||||+||||+.+|.+||||||+|+.+..+++..+
T Consensus 81 E~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~YT 159 (396)
T KOG0593|consen 81 EYCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNYT 159 (396)
T ss_pred eecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcchhh
Confidence 99988 5555554 345799999999999999999999999999999999999999999999999999999987777777
Q ss_pred cccCCCccccHHhhcc
Q 010401 493 YETDGYRWLAPEVCFL 508 (511)
Q Consensus 493 ~~~Gt~~YmAPEvl~g 508 (511)
.-..|..|.|||++.|
T Consensus 160 DYVATRWYRaPELLvG 175 (396)
T KOG0593|consen 160 DYVATRWYRAPELLVG 175 (396)
T ss_pred hhhhhhhccChhhhcc
Confidence 7788999999999987
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=275.10 Aligned_cols=171 Identities=21% Similarity=0.314 Sum_probs=145.5
Q ss_pred ecCCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCC-chHHHHHHHHHHHHHhC-CCCceeeEeeeEeeCCCc
Q 010401 337 LNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKG-NAYEFELRKDLLELMTC-GHKNILQFYCVCVDENHG 408 (511)
Q Consensus 337 l~~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~-~~~~~~~~~Ei~iL~~l-~HpNIV~l~g~~~~~~~~ 408 (511)
....||.+++.||.|+|.+||++ +.+|||++.+.... +...+.+..|-.+|..| +||.|++||..|+|+..
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s- 148 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES- 148 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc-
Confidence 34678999999999999999996 47889888542211 11233466677778887 99999999999999887
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCC
Q 010401 409 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG 488 (511)
Q Consensus 409 l~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~ 488 (511)
+|+|+||+++|+|.++|.+.+.|++..++.|+.||+.||+|||++|||||||||+|||+|.+|++||.|||.|+.+....
T Consensus 149 LYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~ 228 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQ 228 (604)
T ss_pred eEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999998875322
Q ss_pred Cc-----------c--ccccCCCccccHHhhcc
Q 010401 489 EA-----------T--EYETDGYRWLAPEVCFL 508 (511)
Q Consensus 489 ~~-----------~--~~~~Gt~~YmAPEvl~g 508 (511)
.. . ...+||-.|.+||+|..
T Consensus 229 ~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~ 261 (604)
T KOG0592|consen 229 KSQENPVDPNQASSRRSSFVGTAEYVSPELLND 261 (604)
T ss_pred ccccCccCcccccCcccceeeeecccCHHHhcC
Confidence 11 1 34689999999999864
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=274.16 Aligned_cols=170 Identities=24% Similarity=0.451 Sum_probs=147.7
Q ss_pred ccceEecCCCeEEEeeeecccceEEEEeE-----EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCC
Q 010401 332 IGRWLLNSDNLEFIDQIGPNSFKGVYKGK-----RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN 406 (511)
Q Consensus 332 i~~~~l~~~~y~l~~~LG~GsFG~VYkgk-----~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~ 406 (511)
.+.|.++.+.+++++.||+|-||.||.|+ .||+|.++.. ......+.+|+.+|++++|+|||+++|+|..++
T Consensus 198 ~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~---~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~ 274 (468)
T KOG0197|consen 198 RDPWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG---SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQE 274 (468)
T ss_pred cCCeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEecc---ccChhHHHHHHHHHHhCcccCeEEEEEEEecCC
Confidence 34899999999999999999999999985 6999999753 223456789999999999999999999999877
Q ss_pred CcEEEEEeccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceec
Q 010401 407 HGLCVVTKLMEGGSVNDLILK--SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC 484 (511)
Q Consensus 407 ~~l~LVmEy~~gGsL~~lL~~--~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l 484 (511)
. +|||||||+.|+|.++|+. .+.+...+.+.++.|||.||+||+++++|||||.++||||+++..+||+|||+|+..
T Consensus 275 p-iyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~ 353 (468)
T KOG0197|consen 275 P-IYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLI 353 (468)
T ss_pred c-eEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEccccccccc
Confidence 4 9999999999999999976 457999999999999999999999999999999999999999999999999999944
Q ss_pred ccCCCccccccC---CCccccHHhhc
Q 010401 485 KSVGEATEYETD---GYRWLAPEVCF 507 (511)
Q Consensus 485 ~~~~~~~~~~~G---t~~YmAPEvl~ 507 (511)
.+ +. .....| .+.|.|||.+.
T Consensus 354 ~d-~~-Y~~~~~~kfPIkWtAPEa~~ 377 (468)
T KOG0197|consen 354 GD-DE-YTASEGGKFPIKWTAPEALN 377 (468)
T ss_pred CC-Cc-eeecCCCCCCceecCHHHHh
Confidence 33 22 222222 37899999986
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-31 Score=275.71 Aligned_cols=168 Identities=24% Similarity=0.340 Sum_probs=145.6
Q ss_pred cCCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCC-CCceeeEeeeEeeCCCcEE
Q 010401 338 NSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCG-HKNILQFYCVCVDENHGLC 410 (511)
Q Consensus 338 ~~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~-HpNIV~l~g~~~~~~~~l~ 410 (511)
..++|.++++||.|+||.||+| ..||||+++. +.....+---++|+..|++++ |||||++++++.+.+..+|
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~-Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKK-KFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHh-hhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 3467899999999999999996 4799999985 233344444689999999998 9999999999998885599
Q ss_pred EEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCC
Q 010401 411 VVTKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE 489 (511)
Q Consensus 411 LVmEy~~gGsL~~lL~~-~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~ 489 (511)
+|||||+. +|+.+++. ++.+++..++.|+.||+.||+|+|++|+.|||+||+|||+..+..+||+|||+||...+...
T Consensus 87 fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~SkpP 165 (538)
T KOG0661|consen 87 FVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRSKPP 165 (538)
T ss_pred eeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccccCCC
Confidence 99999977 99999965 46899999999999999999999999999999999999999999999999999998876544
Q ss_pred ccccccCCCccccHHhhcc
Q 010401 490 ATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 490 ~~~~~~Gt~~YmAPEvl~g 508 (511)
.+ .-..|..|.|||+++.
T Consensus 166 YT-eYVSTRWYRAPEvLLr 183 (538)
T KOG0661|consen 166 YT-EYVSTRWYRAPEVLLR 183 (538)
T ss_pred cc-hhhhcccccchHHhhh
Confidence 34 4466888999999863
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=258.01 Aligned_cols=173 Identities=23% Similarity=0.391 Sum_probs=143.0
Q ss_pred eEecCCCeEEEeeeecccceEEEEeE-----------EEEEEEEecCCCCchHHHHHHHHHHHHHhC-CCCceeeEeeeE
Q 010401 335 WLLNSDNLEFIDQIGPNSFKGVYKGK-----------RVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCVC 402 (511)
Q Consensus 335 ~~l~~~~y~l~~~LG~GsFG~VYkgk-----------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l-~HpNIV~l~g~~ 402 (511)
|.+..++|++.+.||+|+||.||++. .||+|++... ........+.+|+.++..+ +||||++++++|
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~ 80 (338)
T cd05102 2 WEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEG-ATASEHKALMSELKILIHIGNHLNVVNLLGAC 80 (338)
T ss_pred cccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccc-cchHHHHHHHHHHHHHHHhccCcceeeEEeEe
Confidence 66788899999999999999999973 5899998632 2233345688999999999 899999999999
Q ss_pred eeCCCcEEEEEeccCCCCHHHHHHhc------------------------------------------------------
Q 010401 403 VDENHGLCVVTKLMEGGSVNDLILKS------------------------------------------------------ 428 (511)
Q Consensus 403 ~~~~~~l~LVmEy~~gGsL~~lL~~~------------------------------------------------------ 428 (511)
...+..+|++|||+++|+|.+++...
T Consensus 81 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (338)
T cd05102 81 TKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPP 160 (338)
T ss_pred cCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccc
Confidence 87665689999999999999998642
Q ss_pred --------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCc--cccccCCC
Q 010401 429 --------RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA--TEYETDGY 498 (511)
Q Consensus 429 --------~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~--~~~~~Gt~ 498 (511)
..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++........ .....+++
T Consensus 161 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~ 240 (338)
T cd05102 161 QETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL 240 (338)
T ss_pred hhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCc
Confidence 23778888999999999999999999999999999999999999999999999865332211 12234567
Q ss_pred ccccHHhhcc
Q 010401 499 RWLAPEVCFL 508 (511)
Q Consensus 499 ~YmAPEvl~g 508 (511)
.|+|||++.+
T Consensus 241 ~y~aPE~~~~ 250 (338)
T cd05102 241 KWMAPESIFD 250 (338)
T ss_pred cccCcHHhhc
Confidence 8999999864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-30 Score=252.44 Aligned_cols=169 Identities=21% Similarity=0.323 Sum_probs=151.2
Q ss_pred CCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEE
Q 010401 340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT 413 (511)
Q Consensus 340 ~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVm 413 (511)
++|..++.||+|.||.||+| +.||||+++.....+.......+||..|+.++|+||+.++++|...+. +-||+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~-l~lVf 80 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSN-LSLVF 80 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCc-eEEEE
Confidence 46778899999999999995 589999998765555556678999999999999999999999998886 99999
Q ss_pred eccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCccc
Q 010401 414 KLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE 492 (511)
Q Consensus 414 Ey~~gGsL~~lL~~~-~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~~ 492 (511)
|||+. +|...|+.+ -.++...+..|+.++++|++|||++.|+||||||.|+|++.+|.+||+|||+++.+.......+
T Consensus 81 Efm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~ 159 (318)
T KOG0659|consen 81 EFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQT 159 (318)
T ss_pred Eeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcccc
Confidence 99987 999999754 4799999999999999999999999999999999999999999999999999999887766666
Q ss_pred cccCCCccccHHhhcccC
Q 010401 493 YETDGYRWLAPEVCFLLL 510 (511)
Q Consensus 493 ~~~Gt~~YmAPEvl~gl~ 510 (511)
...-|..|.|||+++|-+
T Consensus 160 ~~V~TRWYRAPELLfGsr 177 (318)
T KOG0659|consen 160 HQVVTRWYRAPELLFGSR 177 (318)
T ss_pred cceeeeeccChHHhccch
Confidence 667888999999998753
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=269.77 Aligned_cols=174 Identities=29% Similarity=0.493 Sum_probs=148.8
Q ss_pred ceEecCCCeEEEeeeecccceEEEEeE---------E-EEEEEEecC-CCCchHHHHHHHHHHHHHhCCCCceeeEeeeE
Q 010401 334 RWLLNSDNLEFIDQIGPNSFKGVYKGK---------R-VGIEKLKGC-DKGNAYEFELRKDLLELMTCGHKNILQFYCVC 402 (511)
Q Consensus 334 ~~~l~~~~y~l~~~LG~GsFG~VYkgk---------~-VAVKkL~~~-~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~ 402 (511)
.|++..++..+.++||+|+||.||+|+ . ||+|..+.. ........++.+|+.+|+.++|||||++||++
T Consensus 151 ~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa 230 (474)
T KOG0194|consen 151 KWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVA 230 (474)
T ss_pred ccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 799999999999999999999999974 2 789988752 24455677899999999999999999999999
Q ss_pred eeCCCcEEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCc
Q 010401 403 VDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIV 481 (511)
Q Consensus 403 ~~~~~~l~LVmEy~~gGsL~~lL~~~~-~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS 481 (511)
.++.. +++|||+|.||+|.++|++.+ .++..+...++.+.+.||+|||++++|||||..+|+|++.++.+||+|||++
T Consensus 231 ~~~~P-l~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs 309 (474)
T KOG0194|consen 231 VLEEP-LMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLS 309 (474)
T ss_pred cCCCc-cEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccc
Confidence 98775 999999999999999998776 5999999999999999999999999999999999999999999999999998
Q ss_pred eecccCCCccccccCCCccccHHhhcc
Q 010401 482 TACKSVGEATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 482 ~~l~~~~~~~~~~~Gt~~YmAPEvl~g 508 (511)
+.............-..+|+|||.+..
T Consensus 310 ~~~~~~~~~~~~~klPirWLAPEtl~~ 336 (474)
T KOG0194|consen 310 RAGSQYVMKKFLKKLPIRWLAPETLNT 336 (474)
T ss_pred cCCcceeeccccccCcceecChhhhcc
Confidence 765311111111123478999999864
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-29 Score=259.76 Aligned_cols=168 Identities=21% Similarity=0.314 Sum_probs=142.9
Q ss_pred CCeEEEeeeecccceEEEEe------EEEEEEEEecCCCC-chHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEE
Q 010401 340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKG-NAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV 412 (511)
Q Consensus 340 ~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~-~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LV 412 (511)
++|++++.||+|+||.||++ +.+|+|++...... ......+.+|+.++..++|+||+++++.+.+.+. +|+|
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~-~~lv 79 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLN-LYLI 79 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCe-EEEE
Confidence 47899999999999999985 47999999743221 2233457889999999999999999999988776 9999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCC---
Q 010401 413 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE--- 489 (511)
Q Consensus 413 mEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~--- 489 (511)
|||+++|+|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+.....
T Consensus 80 ~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~ 159 (363)
T cd05628 80 MEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEF 159 (363)
T ss_pred EcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCcccccccccccc
Confidence 99999999999998888999999999999999999999999999999999999999999999999999875432110
Q ss_pred --------------------------------ccccccCCCccccHHhhcc
Q 010401 490 --------------------------------ATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 490 --------------------------------~~~~~~Gt~~YmAPEvl~g 508 (511)
.....+||+.|+|||++.+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~ 210 (363)
T cd05628 160 YRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQ 210 (363)
T ss_pred cccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcC
Confidence 0123479999999999865
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.4e-30 Score=266.41 Aligned_cols=172 Identities=21% Similarity=0.301 Sum_probs=142.6
Q ss_pred ecCCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCC------------chHHHHHHHHHHHHHhCCCCceeeE
Q 010401 337 LNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKG------------NAYEFELRKDLLELMTCGHKNILQF 398 (511)
Q Consensus 337 l~~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~------------~~~~~~~~~Ei~iL~~l~HpNIV~l 398 (511)
...+.|++++.||+|.||+|-++ +.||||++.+.... .....++++||.+|++|+|||||+|
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 34678999999999999999985 58999999652211 1123468999999999999999999
Q ss_pred eeeEeeCC-CcEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEe
Q 010401 399 YCVCVDEN-HGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGD 477 (511)
Q Consensus 399 ~g~~~~~~-~~l~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~D 477 (511)
+.+..+.+ ..+|||+|||..|.+...-.....+.+.+++.|+.+++.||+|||.+|||||||||+|+||+++|+|||+|
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIsD 253 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKISD 253 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEeec
Confidence 99987754 34999999999998876532222399999999999999999999999999999999999999999999999
Q ss_pred cCCceeccc-----CCCccccccCCCccccHHhhcc
Q 010401 478 MGIVTACKS-----VGEATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 478 FGlS~~l~~-----~~~~~~~~~Gt~~YmAPEvl~g 508 (511)
||.+..+.. .........|||.|||||.+.+
T Consensus 254 FGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~ 289 (576)
T KOG0585|consen 254 FGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSG 289 (576)
T ss_pred cceeeecccCCccccHHHHhhcCCCccccchHhhcC
Confidence 999887622 2223445789999999999876
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=258.11 Aligned_cols=166 Identities=26% Similarity=0.406 Sum_probs=141.1
Q ss_pred CCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCC-cEEEE
Q 010401 340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENH-GLCVV 412 (511)
Q Consensus 340 ~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~-~l~LV 412 (511)
.++...+.||+|+||.||++ ...|||.+...... ....+.+|+.+|.+++|||||+++|....... .+++.
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~--~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~ 94 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSP--TSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIF 94 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccch--hHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEee
Confidence 45678899999999999995 46899998753211 14558999999999999999999997443332 48999
Q ss_pred EeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcC-CCcEEEEecCCceecccCC--
Q 010401 413 TKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDR-HGNVCLGDMGIVTACKSVG-- 488 (511)
Q Consensus 413 mEy~~gGsL~~lL~~~~-~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~-~g~vKL~DFGlS~~l~~~~-- 488 (511)
|||+++|+|.+++.+.+ .|++..++.+..||+.||+|||++|||||||||+|||++. ++.+||+|||+++......
T Consensus 95 mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~ 174 (313)
T KOG0198|consen 95 MEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTK 174 (313)
T ss_pred eeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccccccc
Confidence 99999999999998766 8999999999999999999999999999999999999999 7999999999988776311
Q ss_pred -CccccccCCCccccHHhhc
Q 010401 489 -EATEYETDGYRWLAPEVCF 507 (511)
Q Consensus 489 -~~~~~~~Gt~~YmAPEvl~ 507 (511)
.......||+.|||||++.
T Consensus 175 ~~~~~~~~Gtp~~maPEvi~ 194 (313)
T KOG0198|consen 175 SDSELSVQGTPNYMAPEVIR 194 (313)
T ss_pred ccccccccCCccccCchhhc
Confidence 2244568999999999998
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.3e-29 Score=256.45 Aligned_cols=171 Identities=19% Similarity=0.308 Sum_probs=147.7
Q ss_pred ceEecCCCeEEEeeeecccceEEEEeE-------EEEEEEEecCCC-CchHHHHHHHHHHHHHhCCCCceeeEeeeEeeC
Q 010401 334 RWLLNSDNLEFIDQIGPNSFKGVYKGK-------RVGIEKLKGCDK-GNAYEFELRKDLLELMTCGHKNILQFYCVCVDE 405 (511)
Q Consensus 334 ~~~l~~~~y~l~~~LG~GsFG~VYkgk-------~VAVKkL~~~~~-~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~ 405 (511)
...+..++|++.+.||+|+||.||+++ .||+|++..... .......+.+|+.++..++||||+++++++.+.
T Consensus 24 ~~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~ 103 (340)
T PTZ00426 24 KNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDE 103 (340)
T ss_pred CCCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeC
Confidence 344567889999999999999999963 589998864322 122344578899999999999999999999887
Q ss_pred CCcEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecc
Q 010401 406 NHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK 485 (511)
Q Consensus 406 ~~~l~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~ 485 (511)
+. +|+||||+.+|+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 104 ~~-~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~ 182 (340)
T PTZ00426 104 SY-LYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD 182 (340)
T ss_pred CE-EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence 76 99999999999999999888889999999999999999999999999999999999999999999999999998754
Q ss_pred cCCCccccccCCCccccHHhhcc
Q 010401 486 SVGEATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 486 ~~~~~~~~~~Gt~~YmAPEvl~g 508 (511)
.. .....||+.|+|||++.+
T Consensus 183 ~~---~~~~~gt~~y~aPE~~~~ 202 (340)
T PTZ00426 183 TR---TYTLCGTPEYIAPEILLN 202 (340)
T ss_pred CC---cceecCChhhcCHHHHhC
Confidence 32 345678999999999865
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.4e-29 Score=256.32 Aligned_cols=144 Identities=23% Similarity=0.353 Sum_probs=128.4
Q ss_pred CCeEEEeeeecccceEEEEe------EEEEEEEEecCCCC-chHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEE
Q 010401 340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKG-NAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV 412 (511)
Q Consensus 340 ~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~-~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LV 412 (511)
++|++++.||+|+||.||++ +.||+|++...... ......+.+|+.++..++||||+++++++.+++. +|+|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~-~~lv 79 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENY-LYLI 79 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCe-EEEE
Confidence 47899999999999999985 47999999743221 2233457789999999999999999999998776 9999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceec
Q 010401 413 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC 484 (511)
Q Consensus 413 mEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l 484 (511)
|||+++|+|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+
T Consensus 80 ~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~ 151 (364)
T cd05599 80 MEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGL 151 (364)
T ss_pred ECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceec
Confidence 999999999999988788999999999999999999999999999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.9e-30 Score=256.43 Aligned_cols=171 Identities=20% Similarity=0.333 Sum_probs=151.3
Q ss_pred CCCeEEEeeeecccceEEEEeE------EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCC-CcEEE
Q 010401 339 SDNLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN-HGLCV 411 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkgk------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~-~~l~L 411 (511)
.++|+.+..|++|+||.||+|+ .||+|+++.......+-.--++||.+|.+++|||||.+..+.+..+ +.+||
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 4567889999999999999974 7999999865544444455689999999999999999998887554 34999
Q ss_pred EEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCc
Q 010401 412 VTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA 490 (511)
Q Consensus 412 VmEy~~gGsL~~lL~~~-~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~ 490 (511)
|||||.. +|..++..- .++...++..+..|+++|++|||.+.|+|||||++|+|+++.|.+||+|||+||.+.++.+.
T Consensus 155 VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k~ 233 (419)
T KOG0663|consen 155 VMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLKP 233 (419)
T ss_pred eHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCCccc
Confidence 9999988 999999764 48999999999999999999999999999999999999999999999999999999888777
Q ss_pred cccccCCCccccHHhhcccC
Q 010401 491 TEYETDGYRWLAPEVCFLLL 510 (511)
Q Consensus 491 ~~~~~Gt~~YmAPEvl~gl~ 510 (511)
.+...-|..|.|||+++|-.
T Consensus 234 ~T~lVVTLWYRaPELLLG~~ 253 (419)
T KOG0663|consen 234 YTPLVVTLWYRAPELLLGAK 253 (419)
T ss_pred CcceEEEeeecCHHHhcCCc
Confidence 77888899999999998753
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.4e-29 Score=257.52 Aligned_cols=143 Identities=18% Similarity=0.309 Sum_probs=127.1
Q ss_pred CCeEEEeeeecccceEEEEe------EEEEEEEEecCCC-CchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEE
Q 010401 340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDK-GNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV 412 (511)
Q Consensus 340 ~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~-~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LV 412 (511)
++|++++.||+|+||.||++ +.||+|++..... .......+.+|+.+++.++||||+++++++.+.+. +|+|
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~-~~lv 79 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQY-LYLI 79 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCe-eEEE
Confidence 47899999999999999985 4799999864322 12233457889999999999999999999998776 9999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCcee
Q 010401 413 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTA 483 (511)
Q Consensus 413 mEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~ 483 (511)
|||+++|+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 80 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~ 150 (377)
T cd05629 80 MEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTG 150 (377)
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccc
Confidence 99999999999998878899999999999999999999999999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.9e-29 Score=252.68 Aligned_cols=168 Identities=22% Similarity=0.307 Sum_probs=145.6
Q ss_pred cCCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCC-chHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEE
Q 010401 338 NSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKG-NAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLC 410 (511)
Q Consensus 338 ~~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~-~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~ 410 (511)
..++|++.+.||+|+||.||++ +.+|+|++...... ......+.+|+.+++.++||||+++++++.+++. +|
T Consensus 16 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~-~~ 94 (329)
T PTZ00263 16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENR-VY 94 (329)
T ss_pred CchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCE-EE
Confidence 3578999999999999999996 46999999743221 1233457899999999999999999999988776 99
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCc
Q 010401 411 VVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA 490 (511)
Q Consensus 411 LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~ 490 (511)
+||||+.+|+|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 95 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--- 171 (329)
T PTZ00263 95 FLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR--- 171 (329)
T ss_pred EEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC---
Confidence 99999999999999988888999999999999999999999999999999999999999999999999999876432
Q ss_pred cccccCCCccccHHhhccc
Q 010401 491 TEYETDGYRWLAPEVCFLL 509 (511)
Q Consensus 491 ~~~~~Gt~~YmAPEvl~gl 509 (511)
.....|++.|+|||++.+.
T Consensus 172 ~~~~~gt~~y~aPE~~~~~ 190 (329)
T PTZ00263 172 TFTLCGTPEYLAPEVIQSK 190 (329)
T ss_pred cceecCChhhcCHHHHcCC
Confidence 2345789999999998653
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.8e-29 Score=251.84 Aligned_cols=162 Identities=20% Similarity=0.264 Sum_probs=139.4
Q ss_pred eeeecccceEEEEe------EEEEEEEEecCCC-CchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEEeccCC
Q 010401 346 DQIGPNSFKGVYKG------KRVGIEKLKGCDK-GNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEG 418 (511)
Q Consensus 346 ~~LG~GsFG~VYkg------k~VAVKkL~~~~~-~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVmEy~~g 418 (511)
+.||+|+||.||++ +.+|+|+++.... .......+.+|+.++..++||||+++++++...+. +|+||||+.+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~-~~lv~e~~~~ 79 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDR-LCFVMEYANG 79 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCE-EEEEEeCCCC
Confidence 46999999999985 4699999974322 12233457789999999999999999999988775 9999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCccccccCCC
Q 010401 419 GSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY 498 (511)
Q Consensus 419 GsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~~~~~Gt~ 498 (511)
|+|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++............+||+
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~ 159 (323)
T cd05571 80 GELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTP 159 (323)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceecCc
Confidence 99999998888899999999999999999999999999999999999999999999999999876544334445567999
Q ss_pred ccccHHhhcc
Q 010401 499 RWLAPEVCFL 508 (511)
Q Consensus 499 ~YmAPEvl~g 508 (511)
.|+|||++.+
T Consensus 160 ~y~aPE~~~~ 169 (323)
T cd05571 160 EYLAPEVLED 169 (323)
T ss_pred cccChhhhcC
Confidence 9999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-29 Score=269.31 Aligned_cols=166 Identities=20% Similarity=0.364 Sum_probs=150.2
Q ss_pred eEEEeeeecccceEEEE------eEEEEEEEEecC-CCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEEe
Q 010401 342 LEFIDQIGPNSFKGVYK------GKRVGIEKLKGC-DKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTK 414 (511)
Q Consensus 342 y~l~~~LG~GsFG~VYk------gk~VAVKkL~~~-~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVmE 414 (511)
|++++.||.|+-|.|-+ |+.+|||.+.+. .........+++||.+|+.+.||||+.+|++|.+..+ +|+|.|
T Consensus 14 wkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~-lylvlE 92 (786)
T KOG0588|consen 14 WKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQH-LYLVLE 92 (786)
T ss_pred eeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCce-EEEEEE
Confidence 38889999999999988 568999999765 3344455668999999999999999999999998887 999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCccccc
Q 010401 415 LMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYE 494 (511)
Q Consensus 415 y~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~~~~ 494 (511)
|+++|.|++++...+++++.++..++.||+.|+.|+|..+|+||||||+|+|+|.++++||+|||+|.. ...+......
T Consensus 93 yv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsL-e~~gklLeTS 171 (786)
T KOG0588|consen 93 YVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASL-EVPGKLLETS 171 (786)
T ss_pred ecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeec-ccCCcccccc
Confidence 999999999999999999999999999999999999999999999999999999999999999999864 3445667888
Q ss_pred cCCCccccHHhhccc
Q 010401 495 TDGYRWLAPEVCFLL 509 (511)
Q Consensus 495 ~Gt~~YmAPEvl~gl 509 (511)
||.+.|.|||+++|-
T Consensus 172 CGSPHYA~PEIV~G~ 186 (786)
T KOG0588|consen 172 CGSPHYAAPEIVSGR 186 (786)
T ss_pred CCCcccCCchhhcCC
Confidence 999999999999974
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-28 Score=251.89 Aligned_cols=165 Identities=18% Similarity=0.318 Sum_probs=139.5
Q ss_pred ecCCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEE
Q 010401 337 LNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLC 410 (511)
Q Consensus 337 l~~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~ 410 (511)
...++|++++.||+|+||.||++ +.||+|++... ........+.+|+.+++.++|+||+++++++.+.+. +|
T Consensus 71 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~ 148 (353)
T PLN00034 71 KSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGN-HEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGE-IQ 148 (353)
T ss_pred CCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecC-CcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCe-EE
Confidence 34567889999999999999996 46999998642 233345568899999999999999999999987776 99
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCc
Q 010401 411 VVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA 490 (511)
Q Consensus 411 LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~ 490 (511)
+||||+.+|+|.+. ..+.+..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+......
T Consensus 149 lv~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~ 224 (353)
T PLN00034 149 VLLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP 224 (353)
T ss_pred EEEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceeccccccc
Confidence 99999999998643 34567888899999999999999999999999999999999999999999999876543333
Q ss_pred cccccCCCccccHHhhc
Q 010401 491 TEYETDGYRWLAPEVCF 507 (511)
Q Consensus 491 ~~~~~Gt~~YmAPEvl~ 507 (511)
.....|+..|+|||++.
T Consensus 225 ~~~~~gt~~y~aPE~~~ 241 (353)
T PLN00034 225 CNSSVGTIAYMSPERIN 241 (353)
T ss_pred ccccccCccccCccccc
Confidence 34567899999999874
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-28 Score=255.58 Aligned_cols=142 Identities=18% Similarity=0.288 Sum_probs=127.2
Q ss_pred CeEEEeeeecccceEEEEe------EEEEEEEEecCCCC-chHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEE
Q 010401 341 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKG-NAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT 413 (511)
Q Consensus 341 ~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~-~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVm 413 (511)
.|++++.||+|+||.||++ +.+|+|++...... ......+.+|+.+++.++||||+++++++.+.+. +|+||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~-~~lv~ 80 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDN-LYFVM 80 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCE-EEEEE
Confidence 5889999999999999996 47999999743222 2234557889999999999999999999998776 99999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCcee
Q 010401 414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTA 483 (511)
Q Consensus 414 Ey~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~ 483 (511)
||+++|+|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++++||+|||+++.
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~ 150 (381)
T cd05626 81 DYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTG 150 (381)
T ss_pred ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcc
Confidence 9999999999998878899999999999999999999999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.4e-29 Score=248.19 Aligned_cols=165 Identities=22% Similarity=0.324 Sum_probs=143.0
Q ss_pred CCeEEEeeeecccceEEEEe------EEEEEEEEecCCCC-chHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEE
Q 010401 340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKG-NAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV 412 (511)
Q Consensus 340 ~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~-~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LV 412 (511)
++|++.+.||+|+||.||++ +.+|+|++...... ......+.+|+.+++.++||||+++++++.+++. +|+|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~-~~lv 79 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRF-LYML 79 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCe-EEEE
Confidence 46899999999999999995 46999998643221 1234457889999999999999999999987775 9999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCccc
Q 010401 413 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE 492 (511)
Q Consensus 413 mEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~~ 492 (511)
|||+++|+|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..... ..
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~---~~ 156 (291)
T cd05612 80 MEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR---TW 156 (291)
T ss_pred EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC---cc
Confidence 999999999999988888999999999999999999999999999999999999999999999999998765432 23
Q ss_pred cccCCCccccHHhhcc
Q 010401 493 YETDGYRWLAPEVCFL 508 (511)
Q Consensus 493 ~~~Gt~~YmAPEvl~g 508 (511)
...|++.|+|||++.+
T Consensus 157 ~~~gt~~y~aPE~~~~ 172 (291)
T cd05612 157 TLCGTPEYLAPEVIQS 172 (291)
T ss_pred cccCChhhcCHHHHcC
Confidence 4578999999999865
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=254.81 Aligned_cols=142 Identities=20% Similarity=0.316 Sum_probs=126.2
Q ss_pred CCeEEEeeeecccceEEEEe------EEEEEEEEecCCC-CchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEE
Q 010401 340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDK-GNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV 412 (511)
Q Consensus 340 ~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~-~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LV 412 (511)
.+|++++.||+|+||.||++ +.+|+|++..... .......+.+|+.+++.++||||+++++.+.+++. +|+|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~-~~lv 79 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDN-LYFV 79 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCE-EEEE
Confidence 36899999999999999996 4799999864221 11223457789999999999999999999988775 9999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCce
Q 010401 413 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVT 482 (511)
Q Consensus 413 mEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~ 482 (511)
|||+++|+|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus 80 ~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~ 149 (376)
T cd05598 80 MDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCT 149 (376)
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCc
Confidence 9999999999999887889999999999999999999999999999999999999999999999999975
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-28 Score=254.96 Aligned_cols=142 Identities=18% Similarity=0.310 Sum_probs=126.3
Q ss_pred CeEEEeeeecccceEEEEeE------EEEEEEEecCCCC-chHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEE
Q 010401 341 NLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDKG-NAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT 413 (511)
Q Consensus 341 ~y~l~~~LG~GsFG~VYkgk------~VAVKkL~~~~~~-~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVm 413 (511)
+|++++.||+|+||.||+++ .+|+|++...... ......+.+|+.+++.++||||+++++.+.+++. +|+||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~-~~lv~ 80 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDN-LYFVM 80 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCE-EEEEE
Confidence 58999999999999999964 6899998643221 2233457889999999999999999999998776 99999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCcee
Q 010401 414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTA 483 (511)
Q Consensus 414 Ey~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~ 483 (511)
||+++|+|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~ 150 (382)
T cd05625 81 DYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTG 150 (382)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcc
Confidence 9999999999998778899999999999999999999999999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.9e-30 Score=247.35 Aligned_cols=169 Identities=18% Similarity=0.296 Sum_probs=150.7
Q ss_pred cCCCeEEEeeeecccceEEEEeE------EEEEEEEecCCC-CchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEE
Q 010401 338 NSDNLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDK-GNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLC 410 (511)
Q Consensus 338 ~~~~y~l~~~LG~GsFG~VYkgk------~VAVKkL~~~~~-~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~ 410 (511)
..++|++++.||+|-||.||.|+ .||+|++.+... ......++.+|+++...++||||+++|++|.+... +|
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~r-iy 98 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKR-IY 98 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccce-eE
Confidence 46799999999999999999986 599999975332 22245678999999999999999999999999886 99
Q ss_pred EEEeccCCCCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCC
Q 010401 411 VVTKLMEGGSVNDLIL--KSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG 488 (511)
Q Consensus 411 LVmEy~~gGsL~~lL~--~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~ 488 (511)
+++||.+.|++...|. ..+++++.....|+.|++.||.|+|.++||||||||+|+|++..|.+||+|||.+.... .
T Consensus 99 LilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p--~ 176 (281)
T KOG0580|consen 99 LILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP--S 176 (281)
T ss_pred EEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecC--C
Confidence 9999999999999997 55689999999999999999999999999999999999999999999999999987654 3
Q ss_pred CccccccCCCccccHHhhccc
Q 010401 489 EATEYETDGYRWLAPEVCFLL 509 (511)
Q Consensus 489 ~~~~~~~Gt~~YmAPEvl~gl 509 (511)
......|||..|++||++.+.
T Consensus 177 ~kR~tlcgt~dyl~pEmv~~~ 197 (281)
T KOG0580|consen 177 NKRKTLCGTLDYLPPEMVEGR 197 (281)
T ss_pred CCceeeecccccCCHhhcCCC
Confidence 447788999999999998864
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-28 Score=255.76 Aligned_cols=173 Identities=18% Similarity=0.306 Sum_probs=146.0
Q ss_pred ceEecCCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCC-chHHHHHHHHHHHHHhCCCCceeeEeeeEeeCC
Q 010401 334 RWLLNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKG-NAYEFELRKDLLELMTCGHKNILQFYCVCVDEN 406 (511)
Q Consensus 334 ~~~l~~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~-~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~ 406 (511)
+..+..++|++.+.||+|+||.||++ +.+|+|.+...... ......+.+|+.++..++||||+++++++.+++
T Consensus 37 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (370)
T cd05621 37 KLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDK 116 (370)
T ss_pred hcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence 45566789999999999999999985 46899998642221 223345778999999999999999999998877
Q ss_pred CcEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceeccc
Q 010401 407 HGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS 486 (511)
Q Consensus 407 ~~l~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~ 486 (511)
. +|+||||+++|+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 117 ~-~~lv~Ey~~gg~L~~~l~~-~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~ 194 (370)
T cd05621 117 Y-LYMVMEYMPGGDLVNLMSN-YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE 194 (370)
T ss_pred E-EEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceeccc
Confidence 6 9999999999999999854 4689999999999999999999999999999999999999999999999999987643
Q ss_pred CCC-ccccccCCCccccHHhhcc
Q 010401 487 VGE-ATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 487 ~~~-~~~~~~Gt~~YmAPEvl~g 508 (511)
... ......||+.|+|||++.+
T Consensus 195 ~~~~~~~~~~gt~~Y~aPE~~~~ 217 (370)
T cd05621 195 TGMVRCDTAVGTPDYISPEVLKS 217 (370)
T ss_pred CCceecccCCCCcccCCHHHHhc
Confidence 322 2235579999999999864
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=264.00 Aligned_cols=177 Identities=27% Similarity=0.474 Sum_probs=156.2
Q ss_pred cccceEecCCCeEEEeeeecccceEEEEeE---EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCC
Q 010401 331 EIGRWLLNSDNLEFIDQIGPNSFKGVYKGK---RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENH 407 (511)
Q Consensus 331 ~i~~~~l~~~~y~l~~~LG~GsFG~VYkgk---~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~ 407 (511)
....|++..+++.+...||+|+||+||+|+ .||||++............|.+|+.++++-+|.||+-|.|+|....
T Consensus 383 s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whGdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~- 461 (678)
T KOG0193|consen 383 SLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHGDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP- 461 (678)
T ss_pred cccccccCHHHhhccceeccccccceeecccccceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc-
Confidence 336899999999999999999999999998 5999999987777777788999999999999999999999998765
Q ss_pred cEEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecc-
Q 010401 408 GLCVVTKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK- 485 (511)
Q Consensus 408 ~l~LVmEy~~gGsL~~lL~~-~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~- 485 (511)
+.||+.+|.|.+|+.+|+- +.+|+....+.|+.||+.||.|||.++|||||||..||++.++++|||+|||++....
T Consensus 462 -~AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~ 540 (678)
T KOG0193|consen 462 -LAIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTR 540 (678)
T ss_pred -eeeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeee
Confidence 5899999999999999964 4579999999999999999999999999999999999999999999999999975432
Q ss_pred -cCCCccccccCCCccccHHhhccc
Q 010401 486 -SVGEATEYETDGYRWLAPEVCFLL 509 (511)
Q Consensus 486 -~~~~~~~~~~Gt~~YmAPEvl~gl 509 (511)
..........|...|||||+++..
T Consensus 541 w~g~~q~~qp~gsilwmAPEvIRmq 565 (678)
T KOG0193|consen 541 WSGEQQLEQPHGSLLWMAPEVIRMQ 565 (678)
T ss_pred eccccccCCCccchhhhcHHHHhhc
Confidence 233344556678899999999853
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-28 Score=252.19 Aligned_cols=144 Identities=21% Similarity=0.352 Sum_probs=127.9
Q ss_pred CCeEEEeeeecccceEEEEe------EEEEEEEEecCCC-CchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEE
Q 010401 340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDK-GNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV 412 (511)
Q Consensus 340 ~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~-~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LV 412 (511)
++|++.+.||+|+||.||++ +.+|+|++..... .......+.+|+.++..++||||+++++.+.+.+. +|+|
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~-~~lv 79 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRN-LYLI 79 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE-EEEE
Confidence 47899999999999999985 4799999974322 12234457889999999999999999999988776 9999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceec
Q 010401 413 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC 484 (511)
Q Consensus 413 mEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l 484 (511)
|||+++|+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+
T Consensus 80 ~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~ 151 (360)
T cd05627 80 MEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGL 151 (360)
T ss_pred EeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCccc
Confidence 999999999999988788999999999999999999999999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-28 Score=249.43 Aligned_cols=165 Identities=18% Similarity=0.257 Sum_probs=143.6
Q ss_pred CCeEEEeeeecccceEEEEe------EEEEEEEEecCCCC-chHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEE
Q 010401 340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKG-NAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV 412 (511)
Q Consensus 340 ~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~-~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LV 412 (511)
++|++.+.||+|+||.||++ +.||+|++...... ......+.+|+.++..++||||+++++++.+.+. +|+|
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~-~~lv 79 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEY-LYLA 79 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCE-EEEE
Confidence 46899999999999999996 46999999743221 1233457889999999999999999999988776 9999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCccc
Q 010401 413 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE 492 (511)
Q Consensus 413 mEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~~ 492 (511)
|||+++|+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... ...
T Consensus 80 ~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~---~~~ 156 (333)
T cd05600 80 MEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT---YAN 156 (333)
T ss_pred EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc---ccC
Confidence 99999999999998878899999999999999999999999999999999999999999999999999876543 234
Q ss_pred cccCCCccccHHhhcc
Q 010401 493 YETDGYRWLAPEVCFL 508 (511)
Q Consensus 493 ~~~Gt~~YmAPEvl~g 508 (511)
...|++.|+|||++.+
T Consensus 157 ~~~gt~~y~aPE~~~~ 172 (333)
T cd05600 157 SVVGSPDYMAPEVLRG 172 (333)
T ss_pred CcccCccccChhHhcC
Confidence 5678999999999865
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-28 Score=243.16 Aligned_cols=169 Identities=22% Similarity=0.402 Sum_probs=140.2
Q ss_pred cCCCeEEEeeeecccceEEEEeE----------------------EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCce
Q 010401 338 NSDNLEFIDQIGPNSFKGVYKGK----------------------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNI 395 (511)
Q Consensus 338 ~~~~y~l~~~LG~GsFG~VYkgk----------------------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNI 395 (511)
..++|++.++||+|+||.||++. .||+|.+... .......++.+|+.++.+++||||
T Consensus 3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~ni 81 (304)
T cd05096 3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPD-ANKNARNDFLKEVKILSRLKDPNI 81 (304)
T ss_pred chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCC-CCHHHHHHHHHHHHHHhhcCCCCe
Confidence 45688999999999999999874 5899988642 233345568899999999999999
Q ss_pred eeEeeeEeeCCCcEEEEEeccCCCCHHHHHHhc-------------------CCCCHHHHHHHHHHHHHHHHHHHHCCcc
Q 010401 396 LQFYCVCVDENHGLCVVTKLMEGGSVNDLILKS-------------------RKLQTKEIIRIAIDVAEGIKFLNDHGVA 456 (511)
Q Consensus 396 V~l~g~~~~~~~~l~LVmEy~~gGsL~~lL~~~-------------------~~L~e~~~~~ia~qIa~gL~yLH~~gII 456 (511)
+++++++.+.+. +|+||||+.+|+|.+++... ..+++..+..++.||+.||.|||++||+
T Consensus 82 v~~~~~~~~~~~-~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~iv 160 (304)
T cd05096 82 IRLLGVCVDEDP-LCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFV 160 (304)
T ss_pred eEEEEEEecCCc-eEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 999999988776 99999999999999998542 1367788899999999999999999999
Q ss_pred ccCCCCCceEEcCCCcEEEEecCCceecccCCC--ccccccCCCccccHHhhcc
Q 010401 457 YRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE--ATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 457 HRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~--~~~~~~Gt~~YmAPEvl~g 508 (511)
||||||+|||++.++.+||+|||+++....... ......+++.|+|||++.+
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 214 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILM 214 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhc
Confidence 999999999999999999999999876543221 1122345678999998754
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=250.94 Aligned_cols=169 Identities=21% Similarity=0.328 Sum_probs=145.0
Q ss_pred CCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCc-hHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEE
Q 010401 340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGN-AYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV 412 (511)
Q Consensus 340 ~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~-~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LV 412 (511)
++|++.+.||+|+||.||++ +.||+|++....... .....+.+|+.++..++||||+++++++.+++. +|+|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~-~~lv 79 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEH-LYLV 79 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCe-EEEE
Confidence 46899999999999999985 479999997432222 234557889999999999999999999988776 9999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCC----
Q 010401 413 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG---- 488 (511)
Q Consensus 413 mEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~---- 488 (511)
|||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 80 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~ 159 (350)
T cd05573 80 MEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREY 159 (350)
T ss_pred EcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcccc
Confidence 9999999999999877889999999999999999999999999999999999999999999999999987665432
Q ss_pred -------------------------CccccccCCCccccHHhhccc
Q 010401 489 -------------------------EATEYETDGYRWLAPEVCFLL 509 (511)
Q Consensus 489 -------------------------~~~~~~~Gt~~YmAPEvl~gl 509 (511)
.......||+.|+|||++.+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 205 (350)
T cd05573 160 YLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGT 205 (350)
T ss_pred cccccccccccccccccccccccccccccccccCccccCHHHHcCC
Confidence 122345689999999998653
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.2e-28 Score=245.99 Aligned_cols=167 Identities=19% Similarity=0.284 Sum_probs=141.4
Q ss_pred CeEEEeeeecccceEEEEe---------EEEEEEEEecCCC--CchHHHHHHHHHHHHHhC-CCCceeeEeeeEeeCCCc
Q 010401 341 NLEFIDQIGPNSFKGVYKG---------KRVGIEKLKGCDK--GNAYEFELRKDLLELMTC-GHKNILQFYCVCVDENHG 408 (511)
Q Consensus 341 ~y~l~~~LG~GsFG~VYkg---------k~VAVKkL~~~~~--~~~~~~~~~~Ei~iL~~l-~HpNIV~l~g~~~~~~~~ 408 (511)
+|++.+.||+|+||.||++ +.+|+|++..... .......+.+|+.++..+ +|+||+++++++...+.
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~- 79 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAK- 79 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCE-
Confidence 5889999999999999974 4689999864221 122234577889999998 59999999999987775
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCC
Q 010401 409 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG 488 (511)
Q Consensus 409 l~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~ 488 (511)
+|+||||+.+|+|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 80 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~ 159 (332)
T cd05614 80 LHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE 159 (332)
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccC
Confidence 99999999999999999887889999999999999999999999999999999999999999999999999987653322
Q ss_pred C-ccccccCCCccccHHhhcc
Q 010401 489 E-ATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 489 ~-~~~~~~Gt~~YmAPEvl~g 508 (511)
. ......||+.|+|||++.+
T Consensus 160 ~~~~~~~~gt~~y~aPE~~~~ 180 (332)
T cd05614 160 KERTYSFCGTIEYMAPEIIRG 180 (332)
T ss_pred CCccccccCCccccCHHHhcC
Confidence 2 2334578999999999865
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-28 Score=246.24 Aligned_cols=160 Identities=19% Similarity=0.268 Sum_probs=137.7
Q ss_pred eecccceEEEEe------EEEEEEEEecCCC-CchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEEeccCCCC
Q 010401 348 IGPNSFKGVYKG------KRVGIEKLKGCDK-GNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGS 420 (511)
Q Consensus 348 LG~GsFG~VYkg------k~VAVKkL~~~~~-~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVmEy~~gGs 420 (511)
||+|+||.||++ +.+|+|++..... .......+.+|+.++..++||||+++++++.+.+. +|+||||+++|+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~lv~e~~~~g~ 79 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEK-LYLVLAFINGGE 79 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCe-EEEEEcCCCCCc
Confidence 699999999986 4699999864321 22234557889999999999999999999987775 999999999999
Q ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCccccccCCCcc
Q 010401 421 VNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRW 500 (511)
Q Consensus 421 L~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~~~~~Gt~~Y 500 (511)
|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.............||+.|
T Consensus 80 L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y 159 (312)
T cd05585 80 LFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEY 159 (312)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCccc
Confidence 99999888889999999999999999999999999999999999999999999999999987654333334456799999
Q ss_pred ccHHhhcc
Q 010401 501 LAPEVCFL 508 (511)
Q Consensus 501 mAPEvl~g 508 (511)
+|||++.+
T Consensus 160 ~aPE~~~~ 167 (312)
T cd05585 160 LAPELLLG 167 (312)
T ss_pred CCHHHHcC
Confidence 99999865
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.6e-28 Score=242.97 Aligned_cols=167 Identities=20% Similarity=0.333 Sum_probs=140.7
Q ss_pred CCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEE
Q 010401 339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV 412 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LV 412 (511)
.++|++.+.||+|+||.||++ +.+|+|++..... ......+.+|+.+++.++||||+++++++.+++. +|+|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~lv 81 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE-EGTPFTAIREASLLKGLKHANIVLLHDIIHTKET-LTLV 81 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc-cccchhHHHHHHHHhhCCCCCcCeEEEEEecCCe-EEEE
Confidence 478999999999999999996 4689999874332 2223456789999999999999999999988775 9999
Q ss_pred EeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCcc
Q 010401 413 TKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT 491 (511)
Q Consensus 413 mEy~~gGsL~~lL~~-~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~ 491 (511)
|||+. ++|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.........
T Consensus 82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 160 (303)
T cd07869 82 FEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTY 160 (303)
T ss_pred EECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCccC
Confidence 99996 588887754 3578999999999999999999999999999999999999999999999999987654333333
Q ss_pred ccccCCCccccHHhhcc
Q 010401 492 EYETDGYRWLAPEVCFL 508 (511)
Q Consensus 492 ~~~~Gt~~YmAPEvl~g 508 (511)
....|++.|+|||++.+
T Consensus 161 ~~~~~~~~y~aPE~~~~ 177 (303)
T cd07869 161 SNEVVTLWYRPPDVLLG 177 (303)
T ss_pred CCCcccCCCCChHHHcC
Confidence 44578899999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-28 Score=248.82 Aligned_cols=162 Identities=18% Similarity=0.272 Sum_probs=138.2
Q ss_pred eeeecccceEEEEe------EEEEEEEEecCCC-CchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEEeccCC
Q 010401 346 DQIGPNSFKGVYKG------KRVGIEKLKGCDK-GNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEG 418 (511)
Q Consensus 346 ~~LG~GsFG~VYkg------k~VAVKkL~~~~~-~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVmEy~~g 418 (511)
+.||+|+||.||++ +.||+|++..... .......+.+|+.++..++||||+++++++...+. +|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~-~~lv~E~~~~ 79 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDR-LCFVMEYANG 79 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCE-EEEEEeCCCC
Confidence 46999999999985 4699999974322 12233456789999999999999999999987775 9999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCccccccCCC
Q 010401 419 GSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY 498 (511)
Q Consensus 419 GsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~~~~~Gt~ 498 (511)
|+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.............|++
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~ 159 (323)
T cd05595 80 GELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTP 159 (323)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccCCc
Confidence 99999998778899999999999999999999999999999999999999999999999999876443333344567899
Q ss_pred ccccHHhhcc
Q 010401 499 RWLAPEVCFL 508 (511)
Q Consensus 499 ~YmAPEvl~g 508 (511)
.|+|||++.+
T Consensus 160 ~y~aPE~~~~ 169 (323)
T cd05595 160 EYLAPEVLED 169 (323)
T ss_pred CcCCcccccC
Confidence 9999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.3e-28 Score=248.17 Aligned_cols=162 Identities=18% Similarity=0.257 Sum_probs=138.8
Q ss_pred eeeecccceEEEEe------EEEEEEEEecCCC-CchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEEeccCC
Q 010401 346 DQIGPNSFKGVYKG------KRVGIEKLKGCDK-GNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEG 418 (511)
Q Consensus 346 ~~LG~GsFG~VYkg------k~VAVKkL~~~~~-~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVmEy~~g 418 (511)
+.||+|+||.||++ +.+|+|++..... .......+.+|+.+++.++||||+++++++...+. +|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~-~~lv~Ey~~~ 79 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDR-LCFVMEYVNG 79 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCE-EEEEEeCCCC
Confidence 46999999999985 4799999974322 12234557889999999999999999999987776 9999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCccccccCCC
Q 010401 419 GSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY 498 (511)
Q Consensus 419 GsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~~~~~Gt~ 498 (511)
|+|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.............||+
T Consensus 80 g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~ 159 (328)
T cd05593 80 GELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTP 159 (328)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccCCc
Confidence 99999998778899999999999999999999999999999999999999999999999999876443333344567999
Q ss_pred ccccHHhhcc
Q 010401 499 RWLAPEVCFL 508 (511)
Q Consensus 499 ~YmAPEvl~g 508 (511)
.|+|||++.+
T Consensus 160 ~y~aPE~~~~ 169 (328)
T cd05593 160 EYLAPEVLED 169 (328)
T ss_pred CccChhhhcC
Confidence 9999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.6e-28 Score=246.60 Aligned_cols=162 Identities=20% Similarity=0.299 Sum_probs=139.7
Q ss_pred eeeecccceEEEEe---------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEEecc
Q 010401 346 DQIGPNSFKGVYKG---------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLM 416 (511)
Q Consensus 346 ~~LG~GsFG~VYkg---------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVmEy~ 416 (511)
+.||+|+||.||++ +.+|+|++............+.+|+.++++++||||+++++++.+.+. +|+||||+
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~lv~e~~ 80 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGK-LYLILDFL 80 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCE-EEEEEcCC
Confidence 67999999999974 468999997533333334456789999999999999999999988775 99999999
Q ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCccccccC
Q 010401 417 EGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETD 496 (511)
Q Consensus 417 ~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~~~~~G 496 (511)
.+|+|.+++.+...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.............|
T Consensus 81 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g 160 (318)
T cd05582 81 RGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCG 160 (318)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceecccC
Confidence 99999999987778999999999999999999999999999999999999999999999999998866544333445678
Q ss_pred CCccccHHhhcc
Q 010401 497 GYRWLAPEVCFL 508 (511)
Q Consensus 497 t~~YmAPEvl~g 508 (511)
++.|+|||++.+
T Consensus 161 ~~~y~aPE~~~~ 172 (318)
T cd05582 161 TVEYMAPEVVNR 172 (318)
T ss_pred ChhhcCHHHHcC
Confidence 999999999864
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.6e-28 Score=246.37 Aligned_cols=168 Identities=21% Similarity=0.267 Sum_probs=142.2
Q ss_pred CCeEEEeeeecccceEEEEeE------EEEEEEEecCCCC-chHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEE
Q 010401 340 DNLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDKG-NAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV 412 (511)
Q Consensus 340 ~~y~l~~~LG~GsFG~VYkgk------~VAVKkL~~~~~~-~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LV 412 (511)
++|++.+.||+|+||.||+++ .+|+|.+...... ......+.+|+.++..++|+||+++++++.+.+. +|+|
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~-~~lv 79 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENY-LYLV 79 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE-EEEE
Confidence 478999999999999999964 6899998642211 2223346788888999999999999999988775 9999
Q ss_pred EeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCC-c
Q 010401 413 TKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE-A 490 (511)
Q Consensus 413 mEy~~gGsL~~lL~~-~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~-~ 490 (511)
|||+++|+|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....... .
T Consensus 80 ~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 159 (331)
T cd05624 80 MDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQ 159 (331)
T ss_pred EeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCcee
Confidence 999999999999976 46799999999999999999999999999999999999999999999999999887654332 1
Q ss_pred cccccCCCccccHHhhcc
Q 010401 491 TEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 491 ~~~~~Gt~~YmAPEvl~g 508 (511)
.....|++.|+|||++.+
T Consensus 160 ~~~~~gt~~y~aPE~~~~ 177 (331)
T cd05624 160 SSVAVGTPDYISPEILQA 177 (331)
T ss_pred eccccCCcccCCHHHHhc
Confidence 234578999999999864
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-28 Score=251.37 Aligned_cols=161 Identities=23% Similarity=0.356 Sum_probs=136.8
Q ss_pred CeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCC----cEE
Q 010401 341 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENH----GLC 410 (511)
Q Consensus 341 ~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~----~l~ 410 (511)
.|+-.+++|.|+||.||+| +.||||++...... --+|+.+|+.++|||||++.-+|..... .+.
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~------knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln 98 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY------KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN 98 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc------CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence 4677899999999999997 47999999653332 2467888889999999999877754332 367
Q ss_pred EEEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCC-CcEEEEecCCceecc
Q 010401 411 VVTKLMEGGSVNDLILK----SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRH-GNVCLGDMGIVTACK 485 (511)
Q Consensus 411 LVmEy~~gGsL~~lL~~----~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~-g~vKL~DFGlS~~l~ 485 (511)
+|||||+. +|.++++. +..++...+.-|..||++||.|||+.||+||||||.|||+|.+ |.+||||||.|+.+.
T Consensus 99 lVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~ 177 (364)
T KOG0658|consen 99 LVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLV 177 (364)
T ss_pred HHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeec
Confidence 89999998 99999963 5678999999999999999999999999999999999999965 999999999999998
Q ss_pred cCCCccccccCCCccccHHhhccc
Q 010401 486 SVGEATEYETDGYRWLAPEVCFLL 509 (511)
Q Consensus 486 ~~~~~~~~~~Gt~~YmAPEvl~gl 509 (511)
.+..+.++.|. ..|.|||+++|-
T Consensus 178 ~~epniSYicS-RyYRaPELifga 200 (364)
T KOG0658|consen 178 KGEPNISYICS-RYYRAPELIFGA 200 (364)
T ss_pred cCCCceeEEEe-ccccCHHHHcCc
Confidence 87777777775 459999999873
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.3e-28 Score=244.84 Aligned_cols=168 Identities=22% Similarity=0.291 Sum_probs=140.7
Q ss_pred CeEEEeeeecccceEEEEeE------EEEEEEEecCCC-CchHHHHHHHHHHHHHhCCC-CceeeEeeeEeeCCCcEEEE
Q 010401 341 NLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDK-GNAYEFELRKDLLELMTCGH-KNILQFYCVCVDENHGLCVV 412 (511)
Q Consensus 341 ~y~l~~~LG~GsFG~VYkgk------~VAVKkL~~~~~-~~~~~~~~~~Ei~iL~~l~H-pNIV~l~g~~~~~~~~l~LV 412 (511)
+|++++.||+|+||.||+++ .||+|++..... .......+..|+.++..++| ++|+++++++.+.+. +|+|
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~-~~lv 79 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR-LYFV 79 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCE-EEEE
Confidence 58899999999999999963 699999974322 12233456778888888866 568888888887765 9999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCccc
Q 010401 413 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE 492 (511)
Q Consensus 413 mEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~~ 492 (511)
|||+++|+|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..........
T Consensus 80 ~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~ 159 (324)
T cd05587 80 MEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTR 159 (324)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCcee
Confidence 99999999999998878899999999999999999999999999999999999999999999999999875433333345
Q ss_pred cccCCCccccHHhhccc
Q 010401 493 YETDGYRWLAPEVCFLL 509 (511)
Q Consensus 493 ~~~Gt~~YmAPEvl~gl 509 (511)
...||+.|+|||++.+.
T Consensus 160 ~~~gt~~y~aPE~~~~~ 176 (324)
T cd05587 160 TFCGTPDYIAPEIIAYQ 176 (324)
T ss_pred eecCCccccChhhhcCC
Confidence 56799999999998753
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-28 Score=250.82 Aligned_cols=170 Identities=22% Similarity=0.305 Sum_probs=145.3
Q ss_pred CCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCc-eeeEeeeEeeCCC----
Q 010401 339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKN-ILQFYCVCVDENH---- 407 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpN-IV~l~g~~~~~~~---- 407 (511)
...|+.+++||+|+||+||+| +.||+|++.-....+.......+|+.+++.++|+| |+.+++++.+.+.
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 345677788999999999996 47999999754332222334689999999999999 9999999998773
Q ss_pred -cEEEEEeccCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCce
Q 010401 408 -GLCVVTKLMEGGSVNDLILKSR----KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVT 482 (511)
Q Consensus 408 -~l~LVmEy~~gGsL~~lL~~~~----~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~ 482 (511)
.+++|+||+.. +|..++.... .++...+..++.||+.||.|||+++|+||||||.||||+++|.+||+|||+|+
T Consensus 90 ~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAr 168 (323)
T KOG0594|consen 90 GKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLAR 168 (323)
T ss_pred ceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHH
Confidence 49999999977 9999997543 57888999999999999999999999999999999999999999999999999
Q ss_pred ecccCCCccccccCCCccccHHhhccc
Q 010401 483 ACKSVGEATEYETDGYRWLAPEVCFLL 509 (511)
Q Consensus 483 ~l~~~~~~~~~~~Gt~~YmAPEvl~gl 509 (511)
...-+....+...+|..|.|||+++|-
T Consensus 169 a~~ip~~~yt~evvTlWYRaPEvLlGs 195 (323)
T KOG0594|consen 169 AFSIPMRTYTPEVVTLWYRAPEVLLGS 195 (323)
T ss_pred HhcCCcccccccEEEeeccCHHHhcCC
Confidence 776555556677889899999999874
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.4e-28 Score=245.77 Aligned_cols=162 Identities=19% Similarity=0.258 Sum_probs=137.8
Q ss_pred eeeecccceEEEEe------EEEEEEEEecCCCC-chHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEEeccCC
Q 010401 346 DQIGPNSFKGVYKG------KRVGIEKLKGCDKG-NAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEG 418 (511)
Q Consensus 346 ~~LG~GsFG~VYkg------k~VAVKkL~~~~~~-~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVmEy~~g 418 (511)
+.||+|+||.||++ +.+|+|.+...... .....++.+|+.++..++||||+++++++...+. +|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~-~~lv~E~~~~ 79 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDR-LCFVMEYANG 79 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCE-EEEEEeCCCC
Confidence 46999999999985 47999999743221 2233456788899999999999999999987775 9999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCceEEcCCCcEEEEecCCceecccCCCccccccCC
Q 010401 419 GSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLND-HGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG 497 (511)
Q Consensus 419 GsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~-~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~~~~~Gt 497 (511)
|+|.+++...+.+++..+..++.||+.||.|||+ +||+||||||+|||++.++.+||+|||+++.............||
T Consensus 80 ~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt 159 (325)
T cd05594 80 GELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGT 159 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccccccCC
Confidence 9999999877889999999999999999999997 799999999999999999999999999987654333334456799
Q ss_pred CccccHHhhcc
Q 010401 498 YRWLAPEVCFL 508 (511)
Q Consensus 498 ~~YmAPEvl~g 508 (511)
+.|+|||++.+
T Consensus 160 ~~y~aPE~~~~ 170 (325)
T cd05594 160 PEYLAPEVLED 170 (325)
T ss_pred cccCCHHHHcc
Confidence 99999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.3e-28 Score=246.43 Aligned_cols=162 Identities=19% Similarity=0.312 Sum_probs=138.8
Q ss_pred eeeecccceEEEEe---------EEEEEEEEecCCC--CchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEEe
Q 010401 346 DQIGPNSFKGVYKG---------KRVGIEKLKGCDK--GNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTK 414 (511)
Q Consensus 346 ~~LG~GsFG~VYkg---------k~VAVKkL~~~~~--~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVmE 414 (511)
+.||+|+||.||++ +.+|+|.++.... .......+.+|+.++..++||||+++++++..++. +|+|||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~-~~lv~e 80 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGK-LYLILE 80 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCe-EEEEEe
Confidence 67999999999985 3599999974321 12233456789999999999999999999988775 999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCccccc
Q 010401 415 LMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYE 494 (511)
Q Consensus 415 y~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~~~~ 494 (511)
|+.+|+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++............
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 160 (323)
T cd05584 81 YLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTF 160 (323)
T ss_pred CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCccccc
Confidence 99999999999888889999999999999999999999999999999999999999999999999987654433334456
Q ss_pred cCCCccccHHhhcc
Q 010401 495 TDGYRWLAPEVCFL 508 (511)
Q Consensus 495 ~Gt~~YmAPEvl~g 508 (511)
.|++.|+|||++.+
T Consensus 161 ~gt~~y~aPE~~~~ 174 (323)
T cd05584 161 CGTIEYMAPEILMR 174 (323)
T ss_pred CCCccccChhhccC
Confidence 79999999999864
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.4e-28 Score=252.69 Aligned_cols=174 Identities=18% Similarity=0.260 Sum_probs=146.0
Q ss_pred cceEecCCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCc-hHHHHHHHHHHHHHhCCCCceeeEeeeEeeC
Q 010401 333 GRWLLNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGN-AYEFELRKDLLELMTCGHKNILQFYCVCVDE 405 (511)
Q Consensus 333 ~~~~l~~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~-~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~ 405 (511)
..+.+..++|++.+.||+|+||.||++ +.+|+|.+....... .....+.+|+.+++.++||||+++++++.++
T Consensus 36 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~ 115 (370)
T cd05596 36 TKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDD 115 (370)
T ss_pred ccCCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 345567789999999999999999985 479999996422211 2233467899999999999999999999887
Q ss_pred CCcEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecc
Q 010401 406 NHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK 485 (511)
Q Consensus 406 ~~~l~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~ 485 (511)
+. +|+||||+++|+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 116 ~~-~~lv~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~ 193 (370)
T cd05596 116 KY-LYMVMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMD 193 (370)
T ss_pred CE-EEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence 76 9999999999999999854 468999999999999999999999999999999999999999999999999988764
Q ss_pred cCCC-ccccccCCCccccHHhhcc
Q 010401 486 SVGE-ATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 486 ~~~~-~~~~~~Gt~~YmAPEvl~g 508 (511)
.... ......||+.|+|||++.+
T Consensus 194 ~~~~~~~~~~~gt~~y~aPE~~~~ 217 (370)
T cd05596 194 ANGMVRCDTAVGTPDYISPEVLKS 217 (370)
T ss_pred CCCcccCCCCCCCcCeECHHHhcc
Confidence 3322 2234579999999999864
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.7e-29 Score=263.55 Aligned_cols=165 Identities=27% Similarity=0.441 Sum_probs=146.2
Q ss_pred CCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEE
Q 010401 340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT 413 (511)
Q Consensus 340 ~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVm 413 (511)
..|....+||+|+-|.||.+ +.||||++.... .....-+.+|+.+|+..+|+|||.+++.|..++. +|+||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~--Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~de-LWVVM 349 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRK--QPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDE-LWVVM 349 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEecc--CCchhhhHHHHHHHHhccchHHHHHHHHhcccce-eEEEE
Confidence 45788899999999999985 479999997432 2234558999999999999999999999887776 99999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCcccc
Q 010401 414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY 493 (511)
Q Consensus 414 Ey~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~~~ 493 (511)
|||+||+|.+++. .-.++|.++..++.+++.||+|||.+||||||||.+|||++.+|.+||+|||++..+.........
T Consensus 350 Eym~ggsLTDvVt-~~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR~T 428 (550)
T KOG0578|consen 350 EYMEGGSLTDVVT-KTRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKRST 428 (550)
T ss_pred eecCCCchhhhhh-cccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccCcccc
Confidence 9999999999984 345999999999999999999999999999999999999999999999999999988776666778
Q ss_pred ccCCCccccHHhhcc
Q 010401 494 ETDGYRWLAPEVCFL 508 (511)
Q Consensus 494 ~~Gt~~YmAPEvl~g 508 (511)
..|||.|||||++..
T Consensus 429 mVGTPYWMAPEVvtr 443 (550)
T KOG0578|consen 429 MVGTPYWMAPEVVTR 443 (550)
T ss_pred ccCCCCccchhhhhh
Confidence 899999999999754
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.5e-28 Score=246.42 Aligned_cols=168 Identities=21% Similarity=0.298 Sum_probs=142.1
Q ss_pred CCeEEEeeeecccceEEEEe------EEEEEEEEecCCC-CchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEE
Q 010401 340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDK-GNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV 412 (511)
Q Consensus 340 ~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~-~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LV 412 (511)
++|++.+.||+|+||.||++ +.+|+|++..... .......+.+|+.++..++|+||+++++++.+++. +|+|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~-~~lv 79 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENN-LYLV 79 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCe-EEEE
Confidence 47899999999999999985 4799999964221 12233447788899999999999999999988776 9999
Q ss_pred EeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCC-c
Q 010401 413 TKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE-A 490 (511)
Q Consensus 413 mEy~~gGsL~~lL~~-~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~-~ 490 (511)
|||+++|+|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++........ .
T Consensus 80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 159 (331)
T cd05597 80 MDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQ 159 (331)
T ss_pred EecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCcc
Confidence 999999999999965 45799999999999999999999999999999999999999999999999999876644322 2
Q ss_pred cccccCCCccccHHhhcc
Q 010401 491 TEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 491 ~~~~~Gt~~YmAPEvl~g 508 (511)
.....||+.|||||++.+
T Consensus 160 ~~~~~gt~~y~aPE~~~~ 177 (331)
T cd05597 160 SNVAVGTPDYISPEILQA 177 (331)
T ss_pred ccceeccccccCHHHHhh
Confidence 233568999999999863
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-27 Score=239.74 Aligned_cols=167 Identities=16% Similarity=0.307 Sum_probs=141.1
Q ss_pred CCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEE
Q 010401 339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV 412 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LV 412 (511)
.++|++.+.||.|+||.||+| +.||+|+++.... ......+.+|+.+++.++||||+++++++.+++. +|+|
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~lv 81 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKNLKHANIVTLHDIIHTERC-LTLV 81 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc-CCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCe-EEEE
Confidence 467899999999999999996 4799999864322 2223456789999999999999999999987765 9999
Q ss_pred EeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCcc
Q 010401 413 TKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT 491 (511)
Q Consensus 413 mEy~~gGsL~~lL~~~-~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~ 491 (511)
|||+.+ +|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.........
T Consensus 82 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~~ 160 (288)
T cd07871 82 FEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTY 160 (288)
T ss_pred EeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCccc
Confidence 999975 999988654 457899999999999999999999999999999999999999999999999987654433334
Q ss_pred ccccCCCccccHHhhcc
Q 010401 492 EYETDGYRWLAPEVCFL 508 (511)
Q Consensus 492 ~~~~Gt~~YmAPEvl~g 508 (511)
....+++.|+|||++.+
T Consensus 161 ~~~~~~~~y~aPE~~~~ 177 (288)
T cd07871 161 SNEVVTLWYRPPDVLLG 177 (288)
T ss_pred cCceecccccChHHhcC
Confidence 45577899999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.3e-28 Score=251.35 Aligned_cols=175 Identities=18% Similarity=0.260 Sum_probs=146.8
Q ss_pred ccceEecCCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCC-chHHHHHHHHHHHHHhCCCCceeeEeeeEee
Q 010401 332 IGRWLLNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKG-NAYEFELRKDLLELMTCGHKNILQFYCVCVD 404 (511)
Q Consensus 332 i~~~~l~~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~-~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~ 404 (511)
+....+..++|++.+.||+|+||.||++ +.+|+|.+...... ......+.+|+.+++.++||||+++++++.+
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 3456677889999999999999999986 46899998642221 2223446788999999999999999999987
Q ss_pred CCCcEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceec
Q 010401 405 ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC 484 (511)
Q Consensus 405 ~~~~l~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l 484 (511)
++. +|+||||+++|+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 115 ~~~-~~lv~Ey~~gg~L~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~ 192 (371)
T cd05622 115 DRY-LYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM 192 (371)
T ss_pred CCE-EEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEc
Confidence 765 9999999999999999854 46899999999999999999999999999999999999999999999999999876
Q ss_pred ccCCC-ccccccCCCccccHHhhcc
Q 010401 485 KSVGE-ATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 485 ~~~~~-~~~~~~Gt~~YmAPEvl~g 508 (511)
..... ......||+.|+|||++.+
T Consensus 193 ~~~~~~~~~~~~gt~~y~aPE~l~~ 217 (371)
T cd05622 193 NKEGMVRCDTAVGTPDYISPEVLKS 217 (371)
T ss_pred CcCCcccccCcccCccccCHHHHhc
Confidence 43322 2235679999999999864
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.9e-28 Score=244.62 Aligned_cols=168 Identities=17% Similarity=0.222 Sum_probs=143.2
Q ss_pred CCeEEEeeeecccceEEEEe------EEEEEEEEecCCC-CchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEE
Q 010401 340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDK-GNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV 412 (511)
Q Consensus 340 ~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~-~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LV 412 (511)
++|++.+.||+|+||.||++ +.+|+|+++.... .......+.+|+.+++.++|+||+++++++.+.+. +|+|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~-~~lv 79 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDN-LYLV 79 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCe-EEEE
Confidence 46899999999999999985 4799999975322 12234457888999999999999999999987775 9999
Q ss_pred EeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCc-
Q 010401 413 TKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA- 490 (511)
Q Consensus 413 mEy~~gGsL~~lL~~~-~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~- 490 (511)
|||+++|+|.+++... ..+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||++..+......
T Consensus 80 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~ 159 (330)
T cd05601 80 MEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVN 159 (330)
T ss_pred ECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCcee
Confidence 9999999999999765 68999999999999999999999999999999999999999999999999999876543322
Q ss_pred cccccCCCccccHHhhcc
Q 010401 491 TEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 491 ~~~~~Gt~~YmAPEvl~g 508 (511)
.....||+.|+|||++..
T Consensus 160 ~~~~~gt~~y~aPE~~~~ 177 (330)
T cd05601 160 SKLPVGTPDYIAPEVLTT 177 (330)
T ss_pred eecccCCccccCHHHhcc
Confidence 233478999999999863
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=243.69 Aligned_cols=168 Identities=21% Similarity=0.270 Sum_probs=140.7
Q ss_pred CeEEEeeeecccceEEEEe------EEEEEEEEecCCCC-chHHHHHHHHHHHHHhC-CCCceeeEeeeEeeCCCcEEEE
Q 010401 341 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKG-NAYEFELRKDLLELMTC-GHKNILQFYCVCVDENHGLCVV 412 (511)
Q Consensus 341 ~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~-~~~~~~~~~Ei~iL~~l-~HpNIV~l~g~~~~~~~~l~LV 412 (511)
+|++.+.||+|+||.||++ +.+|+|.+...... ......+..|..++..+ +|++|+++++++.+.+. +|+|
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~-~~lv 79 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDR-LYFV 79 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCE-EEEE
Confidence 5789999999999999996 37999998753221 22233456677777666 68999999999987775 9999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCccc
Q 010401 413 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE 492 (511)
Q Consensus 413 mEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~~ 492 (511)
|||+++|+|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..........
T Consensus 80 ~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~~~ 159 (323)
T cd05616 80 MEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTK 159 (323)
T ss_pred EcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCccc
Confidence 99999999999998878899999999999999999999999999999999999999999999999999876543333445
Q ss_pred cccCCCccccHHhhccc
Q 010401 493 YETDGYRWLAPEVCFLL 509 (511)
Q Consensus 493 ~~~Gt~~YmAPEvl~gl 509 (511)
...||+.|+|||++.+.
T Consensus 160 ~~~gt~~y~aPE~~~~~ 176 (323)
T cd05616 160 TFCGTPDYIAPEIIAYQ 176 (323)
T ss_pred cCCCChhhcCHHHhcCC
Confidence 56799999999998753
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.2e-28 Score=245.54 Aligned_cols=162 Identities=21% Similarity=0.297 Sum_probs=138.3
Q ss_pred eeeecccceEEEEe------EEEEEEEEecCCCCc-hHHHHHHHHHHHHHhC-CCCceeeEeeeEeeCCCcEEEEEeccC
Q 010401 346 DQIGPNSFKGVYKG------KRVGIEKLKGCDKGN-AYEFELRKDLLELMTC-GHKNILQFYCVCVDENHGLCVVTKLME 417 (511)
Q Consensus 346 ~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~-~~~~~~~~Ei~iL~~l-~HpNIV~l~g~~~~~~~~l~LVmEy~~ 417 (511)
+.||+|+||.||++ +.||+|+++...... .....+.+|+.++..+ +||||+++++++.+.+. +|+||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~-~~lv~e~~~ 79 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESR-LFFVIEFVS 79 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCE-EEEEEeCCC
Confidence 46999999999986 469999997532222 2334577888888887 79999999999988776 999999999
Q ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCccccccCC
Q 010401 418 GGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG 497 (511)
Q Consensus 418 gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~~~~~Gt 497 (511)
+|+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++............+||
T Consensus 80 ~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt 159 (329)
T cd05588 80 GGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGT 159 (329)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCccccccCC
Confidence 99999999877889999999999999999999999999999999999999999999999999987543333344556899
Q ss_pred CccccHHhhcc
Q 010401 498 YRWLAPEVCFL 508 (511)
Q Consensus 498 ~~YmAPEvl~g 508 (511)
+.|+|||++.+
T Consensus 160 ~~y~aPE~~~~ 170 (329)
T cd05588 160 PNYIAPEILRG 170 (329)
T ss_pred ccccCHHHHcC
Confidence 99999999865
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-27 Score=241.18 Aligned_cols=167 Identities=18% Similarity=0.259 Sum_probs=140.0
Q ss_pred CeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCC----CcEE
Q 010401 341 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN----HGLC 410 (511)
Q Consensus 341 ~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~----~~l~ 410 (511)
+|++.+.||+|+||.||+| +.||+|++...........++.+|+.+++.++||||+++++++...+ ..+|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4889999999999999996 47999998743333334456889999999999999999999886443 2379
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCC-
Q 010401 411 VVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE- 489 (511)
Q Consensus 411 LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~- 489 (511)
+||||+. ++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 81 lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~ 159 (338)
T cd07859 81 VVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 159 (338)
T ss_pred EEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccCc
Confidence 9999995 59999998777899999999999999999999999999999999999999999999999999876533221
Q ss_pred --ccccccCCCccccHHhhcc
Q 010401 490 --ATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 490 --~~~~~~Gt~~YmAPEvl~g 508 (511)
......|++.|+|||++.+
T Consensus 160 ~~~~~~~~~t~~y~aPE~~~~ 180 (338)
T cd07859 160 AIFWTDYVATRWYRAPELCGS 180 (338)
T ss_pred cccccCCCCCCCcCCHHHHhc
Confidence 1234578999999999864
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.2e-27 Score=236.95 Aligned_cols=166 Identities=21% Similarity=0.311 Sum_probs=140.0
Q ss_pred CeEEEeeeecccceEEEEe------EEEEEEEEecCCCC-chHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEE
Q 010401 341 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKG-NAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT 413 (511)
Q Consensus 341 ~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~-~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVm 413 (511)
.|+..+.||+|+||.||++ +.||+|++...... ......+.+|+.++..++|+||+++++++.+.+. +++||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~-~~lv~ 79 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDA-LCLVL 79 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCe-EEEEE
Confidence 3788899999999999995 46999998643222 2223457789999999999999999999988775 99999
Q ss_pred eccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCcc
Q 010401 414 KLMEGGSVNDLILK--SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT 491 (511)
Q Consensus 414 Ey~~gGsL~~lL~~--~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~ 491 (511)
||+++|+|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++...... ...
T Consensus 80 e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~-~~~ 158 (285)
T cd05631 80 TIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG-ETV 158 (285)
T ss_pred EecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC-Cee
Confidence 99999999988754 246899999999999999999999999999999999999999999999999998875432 223
Q ss_pred ccccCCCccccHHhhcc
Q 010401 492 EYETDGYRWLAPEVCFL 508 (511)
Q Consensus 492 ~~~~Gt~~YmAPEvl~g 508 (511)
....|++.|+|||++.+
T Consensus 159 ~~~~g~~~y~aPE~~~~ 175 (285)
T cd05631 159 RGRVGTVGYMAPEVINN 175 (285)
T ss_pred cCCCCCCCccCHhhhcC
Confidence 44578999999999865
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.1e-29 Score=262.31 Aligned_cols=169 Identities=21% Similarity=0.390 Sum_probs=150.1
Q ss_pred cccceEecCCCeEEEeeeecccceEEEEeE----EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCC
Q 010401 331 EIGRWLLNSDNLEFIDQIGPNSFKGVYKGK----RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN 406 (511)
Q Consensus 331 ~i~~~~l~~~~y~l~~~LG~GsFG~VYkgk----~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~ 406 (511)
.-+.|+++.+.+.-++.||.|+.|.||+|+ .||||+++. .-+.+|.-|++|+||||+.|.|+|....
T Consensus 115 q~e~WeiPFe~IsELeWlGSGaQGAVF~Grl~netVAVKKV~e---------lkETdIKHLRkLkH~NII~FkGVCtqsP 185 (904)
T KOG4721|consen 115 QEELWEIPFEEISELEWLGSGAQGAVFLGRLHNETVAVKKVRE---------LKETDIKHLRKLKHPNIITFKGVCTQSP 185 (904)
T ss_pred hhhhccCCHHHhhhhhhhccCcccceeeeeccCceehhHHHhh---------hhhhhHHHHHhccCcceeeEeeeecCCc
Confidence 345788888888899999999999999985 799999862 1245677789999999999999998665
Q ss_pred CcEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceeccc
Q 010401 407 HGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS 486 (511)
Q Consensus 407 ~~l~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~ 486 (511)
++|||||||..|-|..+|+...++....+..|..+|+.||.|||.+.|||||||.-||||..+..|||+|||.++....
T Consensus 186 -cyCIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~ 264 (904)
T KOG4721|consen 186 -CYCIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSD 264 (904)
T ss_pred -eeEEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhh
Confidence 5999999999999999999989999999999999999999999999999999999999999999999999999988765
Q ss_pred CCCccccccCCCccccHHhhcccC
Q 010401 487 VGEATEYETDGYRWLAPEVCFLLL 510 (511)
Q Consensus 487 ~~~~~~~~~Gt~~YmAPEvl~gl~ 510 (511)
. ...-.++||..|||||+|+..+
T Consensus 265 ~-STkMSFaGTVaWMAPEvIrneP 287 (904)
T KOG4721|consen 265 K-STKMSFAGTVAWMAPEVIRNEP 287 (904)
T ss_pred h-hhhhhhhhhHhhhCHHHhhcCC
Confidence 4 3345678999999999998754
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-27 Score=243.68 Aligned_cols=168 Identities=20% Similarity=0.271 Sum_probs=141.4
Q ss_pred CCeEEEeeeecccceEEEEeE------EEEEEEEecCCC-CchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEE
Q 010401 340 DNLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDK-GNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV 412 (511)
Q Consensus 340 ~~y~l~~~LG~GsFG~VYkgk------~VAVKkL~~~~~-~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LV 412 (511)
++|++.+.||+|+||.||+++ .+|+|.+..... .......+.+|+.++..++|+||+++++++.+.+. +|+|
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~-~~lv 79 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENN-LYLV 79 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCE-EEEE
Confidence 478999999999999999964 589999863221 11223346788888999999999999999988776 9999
Q ss_pred EeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCC-c
Q 010401 413 TKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE-A 490 (511)
Q Consensus 413 mEy~~gGsL~~lL~~-~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~-~ 490 (511)
|||+++|+|.+++.+ ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ .
T Consensus 80 ~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~ 159 (332)
T cd05623 80 MDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ 159 (332)
T ss_pred EeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCcce
Confidence 999999999999976 46799999999999999999999999999999999999999999999999999876543322 2
Q ss_pred cccccCCCccccHHhhcc
Q 010401 491 TEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 491 ~~~~~Gt~~YmAPEvl~g 508 (511)
.....||+.|+|||++.+
T Consensus 160 ~~~~~gt~~y~aPE~~~~ 177 (332)
T cd05623 160 SSVAVGTPDYISPEILQA 177 (332)
T ss_pred ecccccCccccCHHHHhc
Confidence 234579999999999863
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-27 Score=243.89 Aligned_cols=163 Identities=20% Similarity=0.277 Sum_probs=138.2
Q ss_pred eeeecccceEEEEe------EEEEEEEEecCCCCc-hHHHHHHHHHHHHHhC-CCCceeeEeeeEeeCCCcEEEEEeccC
Q 010401 346 DQIGPNSFKGVYKG------KRVGIEKLKGCDKGN-AYEFELRKDLLELMTC-GHKNILQFYCVCVDENHGLCVVTKLME 417 (511)
Q Consensus 346 ~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~-~~~~~~~~Ei~iL~~l-~HpNIV~l~g~~~~~~~~l~LVmEy~~ 417 (511)
+.||+|+||.||++ +.+|+|+++...... .....+..|+.++..+ +||||+++++++.+.+. +|+||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~-~~lv~E~~~ 79 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR-LFFVIEYVN 79 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCE-EEEEEeCCC
Confidence 46999999999986 469999997533222 2334567788887765 89999999999988776 999999999
Q ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCccccccCC
Q 010401 418 GGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG 497 (511)
Q Consensus 418 gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~~~~~Gt 497 (511)
+|+|..++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.............||
T Consensus 80 ~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt 159 (329)
T cd05618 80 GGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGT 159 (329)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccccccCC
Confidence 99999998877889999999999999999999999999999999999999999999999999987644333344556799
Q ss_pred CccccHHhhccc
Q 010401 498 YRWLAPEVCFLL 509 (511)
Q Consensus 498 ~~YmAPEvl~gl 509 (511)
+.|+|||++.+.
T Consensus 160 ~~y~aPE~~~~~ 171 (329)
T cd05618 160 PNYIAPEILRGE 171 (329)
T ss_pred ccccCHHHHcCC
Confidence 999999998653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-27 Score=243.23 Aligned_cols=167 Identities=21% Similarity=0.284 Sum_probs=139.5
Q ss_pred CeEEEeeeecccceEEEEe------EEEEEEEEecCCC-CchHHHHHHHHHHHHHhCC-CCceeeEeeeEeeCCCcEEEE
Q 010401 341 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDK-GNAYEFELRKDLLELMTCG-HKNILQFYCVCVDENHGLCVV 412 (511)
Q Consensus 341 ~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~-~~~~~~~~~~Ei~iL~~l~-HpNIV~l~g~~~~~~~~l~LV 412 (511)
+|++.+.||+|+||.||++ +.||+|++..... .......+..|+.++..+. |++|+++++++.+.+. +|+|
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~-~~lv 79 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDR-LYFV 79 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCE-EEEE
Confidence 4788899999999999985 4799999974321 1222344667777887774 5778889988887765 9999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCccc
Q 010401 413 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE 492 (511)
Q Consensus 413 mEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~~ 492 (511)
|||+++|+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..........
T Consensus 80 ~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~~~ 159 (323)
T cd05615 80 MEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTR 159 (323)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCcccc
Confidence 99999999999998878899999999999999999999999999999999999999999999999999876543333344
Q ss_pred cccCCCccccHHhhcc
Q 010401 493 YETDGYRWLAPEVCFL 508 (511)
Q Consensus 493 ~~~Gt~~YmAPEvl~g 508 (511)
...||+.|+|||++.+
T Consensus 160 ~~~gt~~y~aPE~~~~ 175 (323)
T cd05615 160 TFCGTPDYIAPEIIAY 175 (323)
T ss_pred CccCCccccCHHHHcC
Confidence 5678999999999865
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-27 Score=236.28 Aligned_cols=168 Identities=15% Similarity=0.232 Sum_probs=141.9
Q ss_pred CCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEE
Q 010401 340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT 413 (511)
Q Consensus 340 ~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVm 413 (511)
++|++.+.||+|+||.||++ +.+|+|+++...........+.+|+.++..++||||+++++++..++. +|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~lv~ 79 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGK-LYLVF 79 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCE-EEEEE
Confidence 46899999999999999996 468999997544444445567889999999999999999999987775 99999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCC-ccc
Q 010401 414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE-ATE 492 (511)
Q Consensus 414 Ey~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~-~~~ 492 (511)
||++++.+..+......+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++....... ...
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 159 (287)
T cd07848 80 EYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYT 159 (287)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccccccc
Confidence 9999877766555556799999999999999999999999999999999999999999999999999987643222 223
Q ss_pred cccCCCccccHHhhcc
Q 010401 493 YETDGYRWLAPEVCFL 508 (511)
Q Consensus 493 ~~~Gt~~YmAPEvl~g 508 (511)
...|++.|+|||++.+
T Consensus 160 ~~~~~~~y~aPE~~~~ 175 (287)
T cd07848 160 EYVATRWYRSPELLLG 175 (287)
T ss_pred ccccccccCCcHHHcC
Confidence 4568899999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=249.19 Aligned_cols=173 Identities=23% Similarity=0.379 Sum_probs=143.6
Q ss_pred ceEecCCCeEEEeeeecccceEEEEeE-----------EEEEEEEecCCCCchHHHHHHHHHHHHHhC-CCCceeeEeee
Q 010401 334 RWLLNSDNLEFIDQIGPNSFKGVYKGK-----------RVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCV 401 (511)
Q Consensus 334 ~~~l~~~~y~l~~~LG~GsFG~VYkgk-----------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l-~HpNIV~l~g~ 401 (511)
.|.++.++|++.+.||+|+||.||+++ .||+|+++... .......+.+|+.++..+ +||||++++++
T Consensus 29 ~~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~ 107 (375)
T cd05104 29 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHINIVNLLGA 107 (375)
T ss_pred ccccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc-CcHHHHHHHHHHHHHHHhcCCcceeeeeee
Confidence 677778899999999999999999864 68999986432 233345688999999999 89999999999
Q ss_pred EeeCCCcEEEEEeccCCCCHHHHHHhcC----------------------------------------------------
Q 010401 402 CVDENHGLCVVTKLMEGGSVNDLILKSR---------------------------------------------------- 429 (511)
Q Consensus 402 ~~~~~~~l~LVmEy~~gGsL~~lL~~~~---------------------------------------------------- 429 (511)
|.+.+. .++||||+++|+|.+++....
T Consensus 108 ~~~~~~-~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 186 (375)
T cd05104 108 CTVGGP-TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKR 186 (375)
T ss_pred eccCCc-ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccc
Confidence 988876 899999999999999985421
Q ss_pred -----------------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceeccc
Q 010401 430 -----------------------KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS 486 (511)
Q Consensus 430 -----------------------~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~ 486 (511)
.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~ 266 (375)
T cd05104 187 RSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRN 266 (375)
T ss_pred cccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccC
Confidence 467888999999999999999999999999999999999999999999999987644
Q ss_pred CCCcc--ccccCCCccccHHhhcc
Q 010401 487 VGEAT--EYETDGYRWLAPEVCFL 508 (511)
Q Consensus 487 ~~~~~--~~~~Gt~~YmAPEvl~g 508 (511)
..... ....+++.|+|||++.+
T Consensus 267 ~~~~~~~~~~~~~~~y~aPE~~~~ 290 (375)
T cd05104 267 DSNYVVKGNARLPVKWMAPESIFN 290 (375)
T ss_pred cccccccCCCCCCcceeChhHhcC
Confidence 32211 11234567999999865
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.5e-28 Score=268.37 Aligned_cols=172 Identities=24% Similarity=0.481 Sum_probs=148.0
Q ss_pred cccceEecCCCeEEEeeeecccceEEEEeE-----------EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEe
Q 010401 331 EIGRWLLNSDNLEFIDQIGPNSFKGVYKGK-----------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFY 399 (511)
Q Consensus 331 ~i~~~~l~~~~y~l~~~LG~GsFG~VYkgk-----------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~ 399 (511)
......+...+.++.++||+|+||+||+|+ .||||.++. ........+|++|++++..++|||||+|+
T Consensus 477 ~~~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd-~a~~~~~~dF~REaeLla~l~H~nIVrLl 555 (774)
T KOG1026|consen 477 DLKVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKD-KAENQARQDFRREAELLAELQHPNIVRLL 555 (774)
T ss_pred ccceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcc-cccHHHHHHHHHHHHHHHhccCCCeEEEE
Confidence 344567888999999999999999999963 699999984 33333677899999999999999999999
Q ss_pred eeEeeCCCcEEEEEeccCCCCHHHHHHhc----------C----CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCce
Q 010401 400 CVCVDENHGLCVVTKLMEGGSVNDLILKS----------R----KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRI 465 (511)
Q Consensus 400 g~~~~~~~~l~LVmEy~~gGsL~~lL~~~----------~----~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NI 465 (511)
|+|..++. +|||+|||..|||.++|+.. . +|+..+.+.|+.|||.||+||-++.+|||||..+|+
T Consensus 556 GVC~~~~P-~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNC 634 (774)
T KOG1026|consen 556 GVCREGDP-LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNC 634 (774)
T ss_pred EEEccCCe-eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhc
Confidence 99998875 99999999999999999632 1 278889999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCceecccCCCccccccC-----CCccccHHhhc
Q 010401 466 LLDRHGNVCLGDMGIVTACKSVGEATEYETD-----GYRWLAPEVCF 507 (511)
Q Consensus 466 Lld~~g~vKL~DFGlS~~l~~~~~~~~~~~G-----t~~YmAPEvl~ 507 (511)
||.++..|||+|||+++..-+.+ .|..+ .++||+||.|+
T Consensus 635 LVge~l~VKIsDfGLsRdiYssD---YYk~~~~t~lPIRWMppEsIl 678 (774)
T KOG1026|consen 635 LVGENLVVKISDFGLSRDIYSSD---YYKVRGNTLLPIRWMPPESIL 678 (774)
T ss_pred eeccceEEEecccccchhhhhhh---hhcccCCceeeeecCCHHHhh
Confidence 99999999999999998764432 23333 37999999986
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=242.79 Aligned_cols=162 Identities=22% Similarity=0.278 Sum_probs=134.6
Q ss_pred eeeecccceEEEEe------EEEEEEEEecCCCC-chHHHHHHHHHH-HHHhCCCCceeeEeeeEeeCCCcEEEEEeccC
Q 010401 346 DQIGPNSFKGVYKG------KRVGIEKLKGCDKG-NAYEFELRKDLL-ELMTCGHKNILQFYCVCVDENHGLCVVTKLME 417 (511)
Q Consensus 346 ~~LG~GsFG~VYkg------k~VAVKkL~~~~~~-~~~~~~~~~Ei~-iL~~l~HpNIV~l~g~~~~~~~~l~LVmEy~~ 417 (511)
+.||+|+||.||++ +.||+|++...... .....++..|.. +++.++||||+++++++.+.+. +|+||||+.
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~-~~lv~e~~~ 79 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADK-LYFVLDYVN 79 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCE-EEEEEcCCC
Confidence 46999999999986 46999999643211 112233445544 4567899999999999987775 999999999
Q ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCccccccCC
Q 010401 418 GGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG 497 (511)
Q Consensus 418 gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~~~~~Gt 497 (511)
+|+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.............||
T Consensus 80 ~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt 159 (323)
T cd05575 80 GGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGT 159 (323)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccccccCC
Confidence 99999999888889999999999999999999999999999999999999999999999999987654433344556799
Q ss_pred CccccHHhhcc
Q 010401 498 YRWLAPEVCFL 508 (511)
Q Consensus 498 ~~YmAPEvl~g 508 (511)
+.|+|||++.+
T Consensus 160 ~~y~aPE~~~~ 170 (323)
T cd05575 160 PEYLAPEVLRK 170 (323)
T ss_pred hhhcChhhhcC
Confidence 99999999865
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-27 Score=242.59 Aligned_cols=165 Identities=23% Similarity=0.329 Sum_probs=136.7
Q ss_pred eEEEeeeecccceEEEEe------EEEEEEEEecCCCC-chHHHHHHHHHHHH---HhCCCCceeeEeeeEeeCCCcEEE
Q 010401 342 LEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKG-NAYEFELRKDLLEL---MTCGHKNILQFYCVCVDENHGLCV 411 (511)
Q Consensus 342 y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~-~~~~~~~~~Ei~iL---~~l~HpNIV~l~g~~~~~~~~l~L 411 (511)
|++.+.||+|+||.||++ +.||+|+++..... ......+.+|+.++ ..++||||+++++++.+.+. +|+
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~-~~l 79 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDH-VCF 79 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCE-EEE
Confidence 678999999999999986 46999999743211 12233455565544 46789999999999988776 999
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCcc
Q 010401 412 VTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT 491 (511)
Q Consensus 412 VmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~ 491 (511)
||||+.+|+|..++. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.........
T Consensus 80 v~E~~~~~~L~~~~~-~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~ 158 (324)
T cd05589 80 VMEYAAGGDLMMHIH-TDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRT 158 (324)
T ss_pred EEcCCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCCcc
Confidence 999999999998874 4579999999999999999999999999999999999999999999999999987654433344
Q ss_pred ccccCCCccccHHhhcc
Q 010401 492 EYETDGYRWLAPEVCFL 508 (511)
Q Consensus 492 ~~~~Gt~~YmAPEvl~g 508 (511)
....|++.|||||++.+
T Consensus 159 ~~~~g~~~y~aPE~~~~ 175 (324)
T cd05589 159 STFCGTPEFLAPEVLTE 175 (324)
T ss_pred cccccCccccCHhHhcC
Confidence 55679999999999865
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-27 Score=248.44 Aligned_cols=174 Identities=24% Similarity=0.402 Sum_probs=143.6
Q ss_pred cceEecCCCeEEEeeeecccceEEEEeE-----------EEEEEEEecCCCCchHHHHHHHHHHHHHhC-CCCceeeEee
Q 010401 333 GRWLLNSDNLEFIDQIGPNSFKGVYKGK-----------RVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYC 400 (511)
Q Consensus 333 ~~~~l~~~~y~l~~~LG~GsFG~VYkgk-----------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l-~HpNIV~l~g 400 (511)
+.|.+..++|++.+.||+|+||.||+++ .||+|+++... .......+.+|+.+++.+ +|+||+++++
T Consensus 31 ~~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~~h~nIv~~~~ 109 (374)
T cd05106 31 EKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA-HTDEREALMSELKILSHLGQHKNIVNLLG 109 (374)
T ss_pred ccccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC-CHHHHHHHHHHHHHHHhhccCCceeeEee
Confidence 4677788899999999999999999864 69999997432 222345578999999998 8999999999
Q ss_pred eEeeCCCcEEEEEeccCCCCHHHHHHhc----------------------------------------------------
Q 010401 401 VCVDENHGLCVVTKLMEGGSVNDLILKS---------------------------------------------------- 428 (511)
Q Consensus 401 ~~~~~~~~l~LVmEy~~gGsL~~lL~~~---------------------------------------------------- 428 (511)
+|...+. +|+||||+++|+|.+++...
T Consensus 110 ~~~~~~~-~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (374)
T cd05106 110 ACTHGGP-VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVS 188 (374)
T ss_pred EecCCCC-eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcc
Confidence 9988776 99999999999999998532
Q ss_pred ------------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCc
Q 010401 429 ------------------RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA 490 (511)
Q Consensus 429 ------------------~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~ 490 (511)
.++++..++.++.||+.||.|||++||+||||||+|||+++++.+||+|||+++........
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~ 268 (374)
T cd05106 189 SSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY 268 (374)
T ss_pred ccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcce
Confidence 14678889999999999999999999999999999999999999999999998765433221
Q ss_pred --cccccCCCccccHHhhcc
Q 010401 491 --TEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 491 --~~~~~Gt~~YmAPEvl~g 508 (511)
.....+++.|||||++.+
T Consensus 269 ~~~~~~~~~~~y~aPE~~~~ 288 (374)
T cd05106 269 VVKGNARLPVKWMAPESIFD 288 (374)
T ss_pred eeccCCCCccceeCHHHhcC
Confidence 112234567999998754
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.6e-27 Score=240.35 Aligned_cols=169 Identities=19% Similarity=0.334 Sum_probs=145.8
Q ss_pred ecCCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEE
Q 010401 337 LNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLC 410 (511)
Q Consensus 337 l~~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~ 410 (511)
+..++|++.+.||+|+||.||++ ..+|+|.+... .......++.+|+.+++.++||||+++++++.+++. ++
T Consensus 2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~ 79 (331)
T cd06649 2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLE-IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGE-IS 79 (331)
T ss_pred CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecc-cCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCE-EE
Confidence 45688999999999999999995 46888888642 233345668999999999999999999999988775 99
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCceEEcCCCcEEEEecCCceecccCCC
Q 010401 411 VVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDH-GVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE 489 (511)
Q Consensus 411 LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~-gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~ 489 (511)
+||||+++|+|.+++.....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 157 (331)
T cd06649 80 ICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 157 (331)
T ss_pred EEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc--
Confidence 9999999999999998778899999999999999999999985 6999999999999999999999999998765432
Q ss_pred ccccccCCCccccHHhhccc
Q 010401 490 ATEYETDGYRWLAPEVCFLL 509 (511)
Q Consensus 490 ~~~~~~Gt~~YmAPEvl~gl 509 (511)
......|++.|+|||++.+.
T Consensus 158 ~~~~~~g~~~y~aPE~~~~~ 177 (331)
T cd06649 158 MANSFVGTRSYMSPERLQGT 177 (331)
T ss_pred ccccCCCCcCcCCHhHhcCC
Confidence 23345789999999998753
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-27 Score=241.80 Aligned_cols=162 Identities=22% Similarity=0.302 Sum_probs=134.9
Q ss_pred eeeecccceEEEEeE------EEEEEEEecCCCC-chHHHHHHHHHHHHHh-CCCCceeeEeeeEeeCCCcEEEEEeccC
Q 010401 346 DQIGPNSFKGVYKGK------RVGIEKLKGCDKG-NAYEFELRKDLLELMT-CGHKNILQFYCVCVDENHGLCVVTKLME 417 (511)
Q Consensus 346 ~~LG~GsFG~VYkgk------~VAVKkL~~~~~~-~~~~~~~~~Ei~iL~~-l~HpNIV~l~g~~~~~~~~l~LVmEy~~ 417 (511)
+.||+|+||.||+++ .||+|.++..... ......+..|..++.. .+||||+++++++..++. +|+||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~-~~lv~e~~~ 79 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEH-LFFVMEYLN 79 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCE-EEEEEcCCC
Confidence 469999999999964 6999999753211 1122334555556654 489999999999987775 999999999
Q ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCccccccCC
Q 010401 418 GGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG 497 (511)
Q Consensus 418 gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~~~~~Gt 497 (511)
+|+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++............+||
T Consensus 80 gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt 159 (316)
T cd05592 80 GGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGT 159 (316)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccccccCC
Confidence 99999999877889999999999999999999999999999999999999999999999999998654433444566799
Q ss_pred CccccHHhhcc
Q 010401 498 YRWLAPEVCFL 508 (511)
Q Consensus 498 ~~YmAPEvl~g 508 (511)
+.|+|||++.+
T Consensus 160 ~~y~aPE~~~~ 170 (316)
T cd05592 160 PDYIAPEILKG 170 (316)
T ss_pred ccccCHHHHcC
Confidence 99999999865
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-27 Score=242.16 Aligned_cols=162 Identities=22% Similarity=0.291 Sum_probs=134.9
Q ss_pred eeeecccceEEEEe------EEEEEEEEecCCC-CchHHHHHHHHHH-HHHhCCCCceeeEeeeEeeCCCcEEEEEeccC
Q 010401 346 DQIGPNSFKGVYKG------KRVGIEKLKGCDK-GNAYEFELRKDLL-ELMTCGHKNILQFYCVCVDENHGLCVVTKLME 417 (511)
Q Consensus 346 ~~LG~GsFG~VYkg------k~VAVKkL~~~~~-~~~~~~~~~~Ei~-iL~~l~HpNIV~l~g~~~~~~~~l~LVmEy~~ 417 (511)
+.||+|+||.||++ +.+|+|++..... .......+..|.. +++.++||||+++++++...+. +|+||||+.
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~-~~lv~e~~~ 79 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEK-LYFVLDFVN 79 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCE-EEEEEcCCC
Confidence 46999999999985 4699999864322 1222334455554 4567899999999999988776 999999999
Q ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCccccccCC
Q 010401 418 GGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG 497 (511)
Q Consensus 418 gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~~~~~Gt 497 (511)
+|+|..++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.............|+
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt 159 (325)
T cd05604 80 GGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGT 159 (325)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcccccCC
Confidence 99999999888889999999999999999999999999999999999999999999999999987644333344556799
Q ss_pred CccccHHhhcc
Q 010401 498 YRWLAPEVCFL 508 (511)
Q Consensus 498 ~~YmAPEvl~g 508 (511)
+.|+|||++.+
T Consensus 160 ~~y~aPE~~~~ 170 (325)
T cd05604 160 PEYLAPEVIRK 170 (325)
T ss_pred hhhCCHHHHcC
Confidence 99999999865
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-27 Score=241.57 Aligned_cols=162 Identities=26% Similarity=0.301 Sum_probs=136.5
Q ss_pred eeeecccceEEEEeE------EEEEEEEecCCC-CchHHHHHHHHHHHHHhC-CCCceeeEeeeEeeCCCcEEEEEeccC
Q 010401 346 DQIGPNSFKGVYKGK------RVGIEKLKGCDK-GNAYEFELRKDLLELMTC-GHKNILQFYCVCVDENHGLCVVTKLME 417 (511)
Q Consensus 346 ~~LG~GsFG~VYkgk------~VAVKkL~~~~~-~~~~~~~~~~Ei~iL~~l-~HpNIV~l~g~~~~~~~~l~LVmEy~~ 417 (511)
+.||+|+||.||+|+ .+|+|++..... .......+..|+.++..+ +||||+++++++.+.+. +|+||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~-~~lv~E~~~ 79 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDR-LFFVMEYVN 79 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCe-EEEEEeCCC
Confidence 469999999999963 699999874321 122233456777777755 89999999999998776 999999999
Q ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCccccccCC
Q 010401 418 GGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG 497 (511)
Q Consensus 418 gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~~~~~Gt 497 (511)
+|+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.............|+
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt 159 (321)
T cd05591 80 GGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGT 159 (321)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCccccccccC
Confidence 99999999888889999999999999999999999999999999999999999999999999987654444444556789
Q ss_pred CccccHHhhcc
Q 010401 498 YRWLAPEVCFL 508 (511)
Q Consensus 498 ~~YmAPEvl~g 508 (511)
+.|+|||++.+
T Consensus 160 ~~y~aPE~~~~ 170 (321)
T cd05591 160 PDYIAPEILQE 170 (321)
T ss_pred ccccCHHHHcC
Confidence 99999999865
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-27 Score=241.44 Aligned_cols=162 Identities=22% Similarity=0.282 Sum_probs=134.2
Q ss_pred eeeecccceEEEEeE------EEEEEEEecCCCC-chHHHHHHHHHH-HHHhCCCCceeeEeeeEeeCCCcEEEEEeccC
Q 010401 346 DQIGPNSFKGVYKGK------RVGIEKLKGCDKG-NAYEFELRKDLL-ELMTCGHKNILQFYCVCVDENHGLCVVTKLME 417 (511)
Q Consensus 346 ~~LG~GsFG~VYkgk------~VAVKkL~~~~~~-~~~~~~~~~Ei~-iL~~l~HpNIV~l~g~~~~~~~~l~LVmEy~~ 417 (511)
+.||+|+||.||+++ .+|+|.+...... ......+..|.. +++.++||||+++++++.+.+. +|+||||+.
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~-~~lv~e~~~ 79 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADK-LYFVLDYIN 79 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCe-EEEEEeCCC
Confidence 469999999999964 6999998642211 112233444443 4567899999999999988776 999999999
Q ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCccccccCC
Q 010401 418 GGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG 497 (511)
Q Consensus 418 gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~~~~~Gt 497 (511)
+|+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.............||
T Consensus 80 ~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt 159 (325)
T cd05602 80 GGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGT 159 (325)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcccccCC
Confidence 99999999887889999999999999999999999999999999999999999999999999987654433344556799
Q ss_pred CccccHHhhcc
Q 010401 498 YRWLAPEVCFL 508 (511)
Q Consensus 498 ~~YmAPEvl~g 508 (511)
+.|+|||++.+
T Consensus 160 ~~y~aPE~~~~ 170 (325)
T cd05602 160 PEYLAPEVLHK 170 (325)
T ss_pred ccccCHHHHcC
Confidence 99999999865
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-27 Score=241.68 Aligned_cols=162 Identities=25% Similarity=0.342 Sum_probs=136.2
Q ss_pred eeeecccceEEEEe------EEEEEEEEecCCC-CchHHHHHHHHHHHHHhC-CCCceeeEeeeEeeCCCcEEEEEeccC
Q 010401 346 DQIGPNSFKGVYKG------KRVGIEKLKGCDK-GNAYEFELRKDLLELMTC-GHKNILQFYCVCVDENHGLCVVTKLME 417 (511)
Q Consensus 346 ~~LG~GsFG~VYkg------k~VAVKkL~~~~~-~~~~~~~~~~Ei~iL~~l-~HpNIV~l~g~~~~~~~~l~LVmEy~~ 417 (511)
+.||+|+||.||++ +.||+|++..... .......+..|+.++..+ +||||+++++++.+.+. +|+||||++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~-~~iv~Ey~~ 79 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDR-LFFVMEFVN 79 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCE-EEEEEcCCC
Confidence 46999999999986 3699999874221 122233456777777765 79999999999987776 999999999
Q ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCccccccCC
Q 010401 418 GGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG 497 (511)
Q Consensus 418 gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~~~~~Gt 497 (511)
+|+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.............||
T Consensus 80 ~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt 159 (320)
T cd05590 80 GGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGT 159 (320)
T ss_pred CchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccccccC
Confidence 99999999888889999999999999999999999999999999999999999999999999987654333444556799
Q ss_pred CccccHHhhcc
Q 010401 498 YRWLAPEVCFL 508 (511)
Q Consensus 498 ~~YmAPEvl~g 508 (511)
+.|+|||++.+
T Consensus 160 ~~y~aPE~~~~ 170 (320)
T cd05590 160 PDYIAPEILQE 170 (320)
T ss_pred ccccCHHHHcC
Confidence 99999999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-27 Score=240.62 Aligned_cols=162 Identities=24% Similarity=0.278 Sum_probs=134.1
Q ss_pred eeeecccceEEEEeE------EEEEEEEecCCC-CchHHHHHHHHHH-HHHhCCCCceeeEeeeEeeCCCcEEEEEeccC
Q 010401 346 DQIGPNSFKGVYKGK------RVGIEKLKGCDK-GNAYEFELRKDLL-ELMTCGHKNILQFYCVCVDENHGLCVVTKLME 417 (511)
Q Consensus 346 ~~LG~GsFG~VYkgk------~VAVKkL~~~~~-~~~~~~~~~~Ei~-iL~~l~HpNIV~l~g~~~~~~~~l~LVmEy~~ 417 (511)
+.||+|+||.||+++ .+|+|.+..... .......+.+|+. +++.++||||+++++++.+.+. +|+||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~-~~lv~e~~~ 79 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEK-LYFVLDYVN 79 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCE-EEEEEcCCC
Confidence 469999999999964 699999864221 1122333455544 5677899999999999987775 999999999
Q ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCccccccCC
Q 010401 418 GGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG 497 (511)
Q Consensus 418 gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~~~~~Gt 497 (511)
+|+|...+.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.............|+
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt 159 (321)
T cd05603 80 GGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGT 159 (321)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccccccCC
Confidence 99999998777889999999999999999999999999999999999999999999999999987643333334556789
Q ss_pred CccccHHhhcc
Q 010401 498 YRWLAPEVCFL 508 (511)
Q Consensus 498 ~~YmAPEvl~g 508 (511)
+.|+|||++.+
T Consensus 160 ~~y~aPE~~~~ 170 (321)
T cd05603 160 PEYLAPEVLRK 170 (321)
T ss_pred cccCCHHHhcC
Confidence 99999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.6e-27 Score=240.99 Aligned_cols=162 Identities=20% Similarity=0.270 Sum_probs=138.1
Q ss_pred eeeecccceEEEEe------EEEEEEEEecCCCCc-hHHHHHHHHHHHHHhC-CCCceeeEeeeEeeCCCcEEEEEeccC
Q 010401 346 DQIGPNSFKGVYKG------KRVGIEKLKGCDKGN-AYEFELRKDLLELMTC-GHKNILQFYCVCVDENHGLCVVTKLME 417 (511)
Q Consensus 346 ~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~-~~~~~~~~Ei~iL~~l-~HpNIV~l~g~~~~~~~~l~LVmEy~~ 417 (511)
+.||+|+||.||++ +.+|+|++....... .....+.+|+.++..+ +||||+++++++.+.+. +|+||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~-~~lv~e~~~ 79 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSR-LFLVIEYVN 79 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCE-EEEEEeCCC
Confidence 46999999999986 469999997532222 2334477888888877 79999999999987776 999999999
Q ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCccccccCC
Q 010401 418 GGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG 497 (511)
Q Consensus 418 gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~~~~~Gt 497 (511)
+|+|..++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++............+||
T Consensus 80 ~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt 159 (327)
T cd05617 80 GGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGT 159 (327)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceecccCC
Confidence 99999999877889999999999999999999999999999999999999999999999999987644333444566899
Q ss_pred CccccHHhhcc
Q 010401 498 YRWLAPEVCFL 508 (511)
Q Consensus 498 ~~YmAPEvl~g 508 (511)
+.|+|||++.+
T Consensus 160 ~~y~aPE~~~~ 170 (327)
T cd05617 160 PNYIAPEILRG 170 (327)
T ss_pred cccCCHHHHCC
Confidence 99999999865
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.4e-27 Score=247.11 Aligned_cols=174 Identities=24% Similarity=0.405 Sum_probs=145.2
Q ss_pred cceEecCCCeEEEeeeecccceEEEEeE-----------EEEEEEEecCCCCchHHHHHHHHHHHHHhCC-CCceeeEee
Q 010401 333 GRWLLNSDNLEFIDQIGPNSFKGVYKGK-----------RVGIEKLKGCDKGNAYEFELRKDLLELMTCG-HKNILQFYC 400 (511)
Q Consensus 333 ~~~~l~~~~y~l~~~LG~GsFG~VYkgk-----------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~-HpNIV~l~g 400 (511)
++|.++.++|++.+.||+|+||.||+|+ .||+|++... ........+.+|+.++.+++ ||||+++++
T Consensus 30 ~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~-~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~ 108 (400)
T cd05105 30 SRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPT-ARSSEKQALMSELKIMTHLGPHLNIVNLLG 108 (400)
T ss_pred CceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCC-CChHHHHHHHHHHHHHHhcCCCCCeeeEEE
Confidence 4888999999999999999999999974 4899998642 22333456889999999996 999999999
Q ss_pred eEeeCCCcEEEEEeccCCCCHHHHHHhc----------------------------------------------------
Q 010401 401 VCVDENHGLCVVTKLMEGGSVNDLILKS---------------------------------------------------- 428 (511)
Q Consensus 401 ~~~~~~~~l~LVmEy~~gGsL~~lL~~~---------------------------------------------------- 428 (511)
+|.+.+. +||||||+++|+|.+++...
T Consensus 109 ~~~~~~~-~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 187 (400)
T cd05105 109 ACTKSGP-IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQ 187 (400)
T ss_pred EEccCCc-eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccc
Confidence 9987775 99999999999999988532
Q ss_pred --------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCc
Q 010401 429 --------------------------------------------RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQR 464 (511)
Q Consensus 429 --------------------------------------------~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~N 464 (511)
..+++..+..++.||+.||.|||+++|+||||||+|
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~N 267 (400)
T cd05105 188 YVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARN 267 (400)
T ss_pred cchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHh
Confidence 136778889999999999999999999999999999
Q ss_pred eEEcCCCcEEEEecCCceecccCCC--ccccccCCCccccHHhhcc
Q 010401 465 ILLDRHGNVCLGDMGIVTACKSVGE--ATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 465 ILld~~g~vKL~DFGlS~~l~~~~~--~~~~~~Gt~~YmAPEvl~g 508 (511)
||++.++.+||+|||+++....... ......+++.|+|||++.+
T Consensus 268 ill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 313 (400)
T cd05105 268 VLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFD 313 (400)
T ss_pred EEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcC
Confidence 9999999999999999886543222 1222346678999998865
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.4e-27 Score=239.99 Aligned_cols=168 Identities=20% Similarity=0.363 Sum_probs=144.7
Q ss_pred ecCCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEE
Q 010401 337 LNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLC 410 (511)
Q Consensus 337 l~~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~ 410 (511)
+..++|++.+.||+|+||.||++ +.+++|.+... ........+.+|+.+++.++||||++++++|.+++. +|
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~ 79 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLE-IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGE-IS 79 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecc-cCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCE-EE
Confidence 45688999999999999999995 46788887642 233345568899999999999999999999998776 99
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCceEEcCCCcEEEEecCCceecccCCC
Q 010401 411 VVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLND-HGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE 489 (511)
Q Consensus 411 LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~-~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~ 489 (511)
+||||+++|+|.+++...+.+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||++......
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-- 157 (333)
T cd06650 80 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 157 (333)
T ss_pred EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh--
Confidence 999999999999999877889999999999999999999997 47999999999999999999999999998765332
Q ss_pred ccccccCCCccccHHhhcc
Q 010401 490 ATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 490 ~~~~~~Gt~~YmAPEvl~g 508 (511)
......|++.|+|||++.+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~ 176 (333)
T cd06650 158 MANSFVGTRSYMSPERLQG 176 (333)
T ss_pred ccccCCCCccccCHHHhcC
Confidence 2334578899999999865
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.1e-27 Score=239.47 Aligned_cols=162 Identities=20% Similarity=0.299 Sum_probs=135.2
Q ss_pred eeeecccceEEEEe------EEEEEEEEecCCC-CchHHHHHHHHHHHHHh-CCCCceeeEeeeEeeCCCcEEEEEeccC
Q 010401 346 DQIGPNSFKGVYKG------KRVGIEKLKGCDK-GNAYEFELRKDLLELMT-CGHKNILQFYCVCVDENHGLCVVTKLME 417 (511)
Q Consensus 346 ~~LG~GsFG~VYkg------k~VAVKkL~~~~~-~~~~~~~~~~Ei~iL~~-l~HpNIV~l~g~~~~~~~~l~LVmEy~~ 417 (511)
+.||+|+||.||++ +.||+|.++.... ..........|..++.. .+||||+++++++.+.+. +|+||||+.
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~-~~lv~E~~~ 79 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEH-LFFVMEFLN 79 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCE-EEEEECCCC
Confidence 46999999999986 4699999974321 11223345666666664 589999999999988776 999999999
Q ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCccccccCC
Q 010401 418 GGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG 497 (511)
Q Consensus 418 gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~~~~~Gt 497 (511)
+|+|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.............||
T Consensus 80 ~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt 159 (316)
T cd05620 80 GGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGT 159 (316)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccCCC
Confidence 99999999877889999999999999999999999999999999999999999999999999987543333334556789
Q ss_pred CccccHHhhcc
Q 010401 498 YRWLAPEVCFL 508 (511)
Q Consensus 498 ~~YmAPEvl~g 508 (511)
+.|+|||++.+
T Consensus 160 ~~y~aPE~~~~ 170 (316)
T cd05620 160 PDYIAPEILQG 170 (316)
T ss_pred cCccCHHHHcC
Confidence 99999999865
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.5e-27 Score=252.82 Aligned_cols=169 Identities=21% Similarity=0.313 Sum_probs=153.1
Q ss_pred CCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEE
Q 010401 339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV 412 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LV 412 (511)
...|.+.+.||+|.|++|.++ ..||+|.+.+..........+.+|+.+|+.++|||||+++.+...+.. +|+|
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~-lylV 133 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEAT-LYLV 133 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecce-eEEE
Confidence 456899999999999999996 479999997644444444558999999999999999999999998887 9999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCccc
Q 010401 413 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE 492 (511)
Q Consensus 413 mEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~~ 492 (511)
|||+.+|.+++++.+.+.+.+..+..++.|++.|++|||+++|||||||++||||+.+.++||+|||++..+.. +....
T Consensus 134 ~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~-~~~lq 212 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDY-GLMLQ 212 (596)
T ss_pred EEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeecc-ccccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999998874 45577
Q ss_pred cccCCCccccHHhhccc
Q 010401 493 YETDGYRWLAPEVCFLL 509 (511)
Q Consensus 493 ~~~Gt~~YmAPEvl~gl 509 (511)
..+|++.|.|||++.|.
T Consensus 213 t~cgsppyAaPEl~~g~ 229 (596)
T KOG0586|consen 213 TFCGSPPYAAPELFNGK 229 (596)
T ss_pred ccCCCCCccChHhhcCc
Confidence 88999999999999885
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.7e-27 Score=226.88 Aligned_cols=165 Identities=28% Similarity=0.450 Sum_probs=143.6
Q ss_pred eEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEEec
Q 010401 342 LEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKL 415 (511)
Q Consensus 342 y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVmEy 415 (511)
|++++.||+|+||.||++ +.+|+|.+..............+|+.++..++||||+++++++.+.+. ++++|||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~-~~~v~~~ 79 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNY-LYIVMEY 79 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSE-EEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccc-ccccccc
Confidence 789999999999999996 479999998544333333344569999999999999999999998775 8999999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCcccccc
Q 010401 416 MEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYET 495 (511)
Q Consensus 416 ~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~~~~~ 495 (511)
+.+++|.+++.....+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||.+..............
T Consensus 80 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~ 159 (260)
T PF00069_consen 80 CPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFNPFV 159 (260)
T ss_dssp ETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBSSSS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 99999999998778899999999999999999999999999999999999999999999999999876533334455667
Q ss_pred CCCccccHHhhc
Q 010401 496 DGYRWLAPEVCF 507 (511)
Q Consensus 496 Gt~~YmAPEvl~ 507 (511)
+++.|+|||++.
T Consensus 160 ~~~~y~aPE~~~ 171 (260)
T PF00069_consen 160 GTPEYMAPEVLQ 171 (260)
T ss_dssp SSGGGSCHHHHT
T ss_pred cccccccccccc
Confidence 889999999986
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.1e-27 Score=247.11 Aligned_cols=167 Identities=26% Similarity=0.376 Sum_probs=147.9
Q ss_pred CCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCch-HHHHHHHHHHHHHhCC-CCceeeEeeeEeeCCCcEE
Q 010401 339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNA-YEFELRKDLLELMTCG-HKNILQFYCVCVDENHGLC 410 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~-~~~~~~~Ei~iL~~l~-HpNIV~l~g~~~~~~~~l~ 410 (511)
.+.|++.+.||.|.||.||++ +.+|+|.+.+...... ....+.+|+.+|..+. |||||+++++|.+... ++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~-~~ 112 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDS-VY 112 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCe-EE
Confidence 456899999999999999994 5799999976444332 3456899999999998 9999999999998886 99
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCC----CcEEEEecCCceeccc
Q 010401 411 VVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRH----GNVCLGDMGIVTACKS 486 (511)
Q Consensus 411 LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~----g~vKL~DFGlS~~l~~ 486 (511)
+|||++.||.|.+.+... .+++..+..++.||+.+++|||+.||+||||||+|+|+... +.+|++|||++.....
T Consensus 113 lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~ 191 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP 191 (382)
T ss_pred EEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC
Confidence 999999999999999665 49999999999999999999999999999999999999743 4799999999998876
Q ss_pred CCCccccccCCCccccHHhhcc
Q 010401 487 VGEATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 487 ~~~~~~~~~Gt~~YmAPEvl~g 508 (511)
+......+||+.|+|||++.+
T Consensus 192 -~~~~~~~~Gtp~y~APEvl~~ 212 (382)
T KOG0032|consen 192 -GERLHTIVGTPEYVAPEVLGG 212 (382)
T ss_pred -CceEeeecCCccccCchhhcC
Confidence 667888999999999999874
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.3e-27 Score=229.53 Aligned_cols=170 Identities=20% Similarity=0.324 Sum_probs=140.6
Q ss_pred ecCCCeEEEeeeecccceEEEEeE---------EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCC
Q 010401 337 LNSDNLEFIDQIGPNSFKGVYKGK---------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENH 407 (511)
Q Consensus 337 l~~~~y~l~~~LG~GsFG~VYkgk---------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~ 407 (511)
++.++|++.+.||+|+||.||+|. .||+|.++.. ........+.+|+..+..++||||+++++++..++.
T Consensus 2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 80 (266)
T cd05064 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAG-CSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNT 80 (266)
T ss_pred CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCC-CCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCC
Confidence 345689999999999999999863 6889988743 223334568899999999999999999999987776
Q ss_pred cEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceeccc
Q 010401 408 GLCVVTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS 486 (511)
Q Consensus 408 ~l~LVmEy~~gGsL~~lL~~~-~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~ 486 (511)
+++||||+++|+|.+++... ..+++..++.++.||+.||+|||++|++||||||+|||++.++.++++|||.+.....
T Consensus 81 -~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~ 159 (266)
T cd05064 81 -MMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS 159 (266)
T ss_pred -cEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence 99999999999999999764 5789999999999999999999999999999999999999999999999998765322
Q ss_pred CCCc-cccccCCCccccHHhhcc
Q 010401 487 VGEA-TEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 487 ~~~~-~~~~~Gt~~YmAPEvl~g 508 (511)
.... .....++..|+|||++.+
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~ 182 (266)
T cd05064 160 EAIYTTMSGKSPVLWAAPEAIQY 182 (266)
T ss_pred cchhcccCCCCceeecCHHHHhh
Confidence 1111 112334578999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.4e-27 Score=239.85 Aligned_cols=160 Identities=22% Similarity=0.279 Sum_probs=132.4
Q ss_pred eecccceEEEEe------EEEEEEEEecCCCC-chHHHHHHHHHHHHHhC---CCCceeeEeeeEeeCCCcEEEEEeccC
Q 010401 348 IGPNSFKGVYKG------KRVGIEKLKGCDKG-NAYEFELRKDLLELMTC---GHKNILQFYCVCVDENHGLCVVTKLME 417 (511)
Q Consensus 348 LG~GsFG~VYkg------k~VAVKkL~~~~~~-~~~~~~~~~Ei~iL~~l---~HpNIV~l~g~~~~~~~~l~LVmEy~~ 417 (511)
||+|+||.||++ +.||+|++...... .........|..++... +||||+++++++.+.+. +|+||||+.
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~-~~lv~e~~~ 79 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSD-LYLVTDYMS 79 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCe-EEEEEcCCC
Confidence 799999999985 47999998642211 11222344555555544 79999999999988776 999999999
Q ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCccccccCC
Q 010401 418 GGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG 497 (511)
Q Consensus 418 gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~~~~~Gt 497 (511)
+|+|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.............||
T Consensus 80 ~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt 159 (330)
T cd05586 80 GGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGT 159 (330)
T ss_pred CChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCccCC
Confidence 99999999888889999999999999999999999999999999999999999999999999987654433444556799
Q ss_pred CccccHHhhcc
Q 010401 498 YRWLAPEVCFL 508 (511)
Q Consensus 498 ~~YmAPEvl~g 508 (511)
+.|+|||++.+
T Consensus 160 ~~y~aPE~~~~ 170 (330)
T cd05586 160 TEYLAPEVLLD 170 (330)
T ss_pred ccccCHHHHcC
Confidence 99999999864
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.7e-27 Score=237.69 Aligned_cols=162 Identities=23% Similarity=0.315 Sum_probs=135.0
Q ss_pred eeeecccceEEEEeE------EEEEEEEecCCC-CchHHHHHHHHHHHHHh-CCCCceeeEeeeEeeCCCcEEEEEeccC
Q 010401 346 DQIGPNSFKGVYKGK------RVGIEKLKGCDK-GNAYEFELRKDLLELMT-CGHKNILQFYCVCVDENHGLCVVTKLME 417 (511)
Q Consensus 346 ~~LG~GsFG~VYkgk------~VAVKkL~~~~~-~~~~~~~~~~Ei~iL~~-l~HpNIV~l~g~~~~~~~~l~LVmEy~~ 417 (511)
+.||+|+||.||+|+ .||+|.++.... ..........|..++.. ++||||+++++++.+.+. +|+||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~-~~lv~ey~~ 79 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKEN-LFFVMEYLN 79 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCE-EEEEEeCCC
Confidence 469999999999964 699999975321 11222335566666765 599999999999988776 999999999
Q ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCccccccCC
Q 010401 418 GGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG 497 (511)
Q Consensus 418 gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~~~~~Gt 497 (511)
+|+|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.............||
T Consensus 80 ~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt 159 (316)
T cd05619 80 GGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGT 159 (316)
T ss_pred CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeecCC
Confidence 99999999877789999999999999999999999999999999999999999999999999987643333334456789
Q ss_pred CccccHHhhcc
Q 010401 498 YRWLAPEVCFL 508 (511)
Q Consensus 498 ~~YmAPEvl~g 508 (511)
+.|+|||++.+
T Consensus 160 ~~y~aPE~~~~ 170 (316)
T cd05619 160 PDYIAPEILLG 170 (316)
T ss_pred ccccCHHHHcC
Confidence 99999999865
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.1e-28 Score=246.03 Aligned_cols=173 Identities=21% Similarity=0.331 Sum_probs=152.7
Q ss_pred ceEecCCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHH-HHHHHHHHHHHhCCCCceeeEeeeEeeCC
Q 010401 334 RWLLNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYE-FELRKDLLELMTCGHKNILQFYCVCVDEN 406 (511)
Q Consensus 334 ~~~l~~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~-~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~ 406 (511)
+-.+..++|.++++||+|.||+|.++ +.+|+|++++...-...+ ...+.|-.+|..++||++..+...|+..+
T Consensus 162 ~~kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~d 241 (516)
T KOG0690|consen 162 KNKVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQD 241 (516)
T ss_pred cceeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCc
Confidence 34466789999999999999999984 578899887543322222 22567888999999999999998888877
Q ss_pred CcEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceeccc
Q 010401 407 HGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS 486 (511)
Q Consensus 407 ~~l~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~ 486 (511)
. +|+||||+.||.|..+|.+.+.+++...+.|-.+|+.||.|||+++||+||||.+|+|+|.+|++||.|||+++.-..
T Consensus 242 r-lCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~ 320 (516)
T KOG0690|consen 242 R-LCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIK 320 (516)
T ss_pred e-EEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhccc
Confidence 6 999999999999999998888999999999999999999999999999999999999999999999999999988777
Q ss_pred CCCccccccCCCccccHHhhc
Q 010401 487 VGEATEYETDGYRWLAPEVCF 507 (511)
Q Consensus 487 ~~~~~~~~~Gt~~YmAPEvl~ 507 (511)
.+......||||.|+|||++.
T Consensus 321 ~g~t~kTFCGTPEYLAPEVle 341 (516)
T KOG0690|consen 321 YGDTTKTFCGTPEYLAPEVLE 341 (516)
T ss_pred ccceeccccCChhhcCchhhc
Confidence 777888999999999999985
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-27 Score=251.36 Aligned_cols=172 Identities=20% Similarity=0.309 Sum_probs=154.5
Q ss_pred CCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEE
Q 010401 339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV 412 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LV 412 (511)
.++|+.++.+|+|+||.++.. +.+++|++..............+|+.+++++.|||||.+++.|..++..++||
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 467899999999999999983 57999999876666655567899999999999999999999999888668999
Q ss_pred EeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCc
Q 010401 413 TKLMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA 490 (511)
Q Consensus 413 mEy~~gGsL~~lL~~~--~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~ 490 (511)
|+|++||++.+.|... ..++++.+..|+.||+.|+.|||+++|+|||||+.||+++.++.|||.|||+|+.+......
T Consensus 83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~~ 162 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDSL 162 (426)
T ss_pred EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCchhh
Confidence 9999999999999643 47999999999999999999999999999999999999999999999999999998876656
Q ss_pred cccccCCCccccHHhhcccC
Q 010401 491 TEYETDGYRWLAPEVCFLLL 510 (511)
Q Consensus 491 ~~~~~Gt~~YmAPEvl~gl~ 510 (511)
.....||+.||.||++.+.+
T Consensus 163 a~tvvGTp~YmcPEil~d~p 182 (426)
T KOG0589|consen 163 ASTVVGTPYYMCPEILSDIP 182 (426)
T ss_pred hheecCCCcccCHHHhCCCC
Confidence 77789999999999998764
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.5e-28 Score=257.54 Aligned_cols=163 Identities=26% Similarity=0.376 Sum_probs=141.7
Q ss_pred eEEEeeeecccceEEEEeE------EEEEEEEecCCCCc-hHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEEe
Q 010401 342 LEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDKGN-AYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTK 414 (511)
Q Consensus 342 y~l~~~LG~GsFG~VYkgk------~VAVKkL~~~~~~~-~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVmE 414 (511)
|.-++.||.|+||.||-++ .||||++....+.. ..-..+.+|+..|..++|||++.+.|+|..+.. .|+|||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~T-aWLVME 106 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHT-AWLVME 106 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccch-HHHHHH
Confidence 5667899999999999964 79999997544443 344569999999999999999999999987776 899999
Q ss_pred ccCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCcccc
Q 010401 415 LMEGGSVNDLIL-KSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY 493 (511)
Q Consensus 415 y~~gGsL~~lL~-~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~~~ 493 (511)
||-| +-.|++. ..+++.+.++..|+.+.+.||.|||+++.||||||..|||+++.|.|||+|||.+..... -..
T Consensus 107 YClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P----Ans 181 (948)
T KOG0577|consen 107 YCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP----ANS 181 (948)
T ss_pred HHhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCc----hhc
Confidence 9955 8888885 346899999999999999999999999999999999999999999999999999876543 456
Q ss_pred ccCCCccccHHhhcccC
Q 010401 494 ETDGYRWLAPEVCFLLL 510 (511)
Q Consensus 494 ~~Gt~~YmAPEvl~gl~ 510 (511)
+.|||.|||||+|+-..
T Consensus 182 FvGTPywMAPEVILAMD 198 (948)
T KOG0577|consen 182 FVGTPYWMAPEVILAMD 198 (948)
T ss_pred ccCCccccchhHheecc
Confidence 79999999999998654
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.3e-27 Score=231.84 Aligned_cols=160 Identities=21% Similarity=0.289 Sum_probs=134.6
Q ss_pred eecccceEEEEe------EEEEEEEEecCCCCc-hHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEEeccCCCC
Q 010401 348 IGPNSFKGVYKG------KRVGIEKLKGCDKGN-AYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGS 420 (511)
Q Consensus 348 LG~GsFG~VYkg------k~VAVKkL~~~~~~~-~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVmEy~~gGs 420 (511)
||+|+||.||++ +.+|+|++....... .....+..|+.+++.++|+||+++++++...+. +|+||||+++|+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~-~~lv~e~~~~g~ 79 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTD-LCLVMTIMNGGD 79 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCe-EEEEEeCCCCCC
Confidence 699999999985 479999986432222 122456789999999999999999999887775 999999999999
Q ss_pred HHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCccccccC
Q 010401 421 VNDLILK----SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETD 496 (511)
Q Consensus 421 L~~lL~~----~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~~~~~G 496 (511)
|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++..+...........|
T Consensus 80 L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~g 159 (280)
T cd05608 80 LRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAG 159 (280)
T ss_pred HHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccCC
Confidence 9988742 346899999999999999999999999999999999999999999999999999876544333445578
Q ss_pred CCccccHHhhcc
Q 010401 497 GYRWLAPEVCFL 508 (511)
Q Consensus 497 t~~YmAPEvl~g 508 (511)
++.|+|||++.+
T Consensus 160 ~~~y~aPE~~~~ 171 (280)
T cd05608 160 TPGFMAPELLQG 171 (280)
T ss_pred CcCccCHHHhcC
Confidence 999999999865
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.8e-28 Score=252.88 Aligned_cols=168 Identities=26% Similarity=0.388 Sum_probs=150.4
Q ss_pred CCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEE
Q 010401 339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV 412 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LV 412 (511)
...|..+++||+|+||.||+| +.||+|++... ........+.+|+.+|..++++||.++||.+..+.. +|++
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le-~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~-Lwii 89 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLE-EAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTK-LWII 89 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEechh-hcchhhHHHHHHHHHHHhcCcchHHhhhhheeeccc-HHHH
Confidence 345777799999999999997 57999999753 333344568999999999999999999999998886 9999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCccc
Q 010401 413 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE 492 (511)
Q Consensus 413 mEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~~ 492 (511)
||||.||++.+++.....+.+..+..++++++.||.|||.++.+|||||+.|||+..+|.+||+|||++..+........
T Consensus 90 Mey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr~ 169 (467)
T KOG0201|consen 90 MEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRRK 169 (467)
T ss_pred HHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhccc
Confidence 99999999999997777779999999999999999999999999999999999999999999999999998877776678
Q ss_pred cccCCCccccHHhhcc
Q 010401 493 YETDGYRWLAPEVCFL 508 (511)
Q Consensus 493 ~~~Gt~~YmAPEvl~g 508 (511)
...|||.|||||++.+
T Consensus 170 tfvGTPfwMAPEVI~~ 185 (467)
T KOG0201|consen 170 TFVGTPFWMAPEVIKQ 185 (467)
T ss_pred cccccccccchhhhcc
Confidence 8899999999999974
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-26 Score=229.22 Aligned_cols=167 Identities=22% Similarity=0.370 Sum_probs=134.3
Q ss_pred CCeEEEeeeecccceEEEEe-------EEEEEEEEecCCCCchHHHHHHHHHHHHHhC---CCCceeeEeeeEee----C
Q 010401 340 DNLEFIDQIGPNSFKGVYKG-------KRVGIEKLKGCDKGNAYEFELRKDLLELMTC---GHKNILQFYCVCVD----E 405 (511)
Q Consensus 340 ~~y~l~~~LG~GsFG~VYkg-------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l---~HpNIV~l~g~~~~----~ 405 (511)
++|++.+.||+|+||.||++ +.||+|++............+.+|+.++..+ +||||++++++|.. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36889999999999999986 3589998875433333333455666666554 79999999999852 2
Q ss_pred CCcEEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCcee
Q 010401 406 NHGLCVVTKLMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTA 483 (511)
Q Consensus 406 ~~~l~LVmEy~~gGsL~~lL~~~--~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~ 483 (511)
...+++||||+. ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 159 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI 159 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEe
Confidence 234899999997 4999998643 4589999999999999999999999999999999999999999999999999886
Q ss_pred cccCCCccccccCCCccccHHhhcc
Q 010401 484 CKSVGEATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 484 l~~~~~~~~~~~Gt~~YmAPEvl~g 508 (511)
.... .......|++.|+|||++.+
T Consensus 160 ~~~~-~~~~~~~~~~~y~aPE~~~~ 183 (290)
T cd07862 160 YSFQ-MALTSVVVTLWYRAPEVLLQ 183 (290)
T ss_pred ccCC-cccccccccccccChHHHhC
Confidence 5432 23445578999999999854
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.4e-27 Score=240.80 Aligned_cols=174 Identities=22% Similarity=0.382 Sum_probs=143.8
Q ss_pred ceEecCCCeEEEeeeecccceEEEEe-----------EEEEEEEEecCCCCchHHHHHHHHHHHHHhC-CCCceeeEeee
Q 010401 334 RWLLNSDNLEFIDQIGPNSFKGVYKG-----------KRVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCV 401 (511)
Q Consensus 334 ~~~l~~~~y~l~~~LG~GsFG~VYkg-----------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l-~HpNIV~l~g~ 401 (511)
+|.++.++|++.+.||+|+||.||++ +.||+|++... ........+.+|+.++.++ +|+||++++++
T Consensus 1 ~~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~ 79 (337)
T cd05054 1 KWEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEG-ATASEYKALMTELKILIHIGHHLNVVNLLGA 79 (337)
T ss_pred CcccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCC-CCHHHHHHHHHHHHHHHhhccCcchhheeee
Confidence 37778889999999999999999986 46999988632 2233345578899999998 89999999999
Q ss_pred EeeCCCcEEEEEeccCCCCHHHHHHhc-----------------------------------------------------
Q 010401 402 CVDENHGLCVVTKLMEGGSVNDLILKS----------------------------------------------------- 428 (511)
Q Consensus 402 ~~~~~~~l~LVmEy~~gGsL~~lL~~~----------------------------------------------------- 428 (511)
|...+..++++|||+++++|.+++...
T Consensus 80 ~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (337)
T cd05054 80 CTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEED 159 (337)
T ss_pred EecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccc
Confidence 987666689999999999999998532
Q ss_pred --------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCc--cccccCCC
Q 010401 429 --------RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA--TEYETDGY 498 (511)
Q Consensus 429 --------~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~--~~~~~Gt~ 498 (511)
..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+...... .....++.
T Consensus 160 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~ 239 (337)
T cd05054 160 EEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 239 (337)
T ss_pred hhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCc
Confidence 25788999999999999999999999999999999999999999999999999876432221 12234567
Q ss_pred ccccHHhhcc
Q 010401 499 RWLAPEVCFL 508 (511)
Q Consensus 499 ~YmAPEvl~g 508 (511)
.|+|||++.+
T Consensus 240 ~y~aPE~~~~ 249 (337)
T cd05054 240 KWMAPESIFD 249 (337)
T ss_pred cccCcHHhcC
Confidence 8999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-26 Score=234.18 Aligned_cols=169 Identities=19% Similarity=0.389 Sum_probs=140.3
Q ss_pred ecCCCeEEEeeeecccceEEEEeE----------EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCC
Q 010401 337 LNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN 406 (511)
Q Consensus 337 l~~~~y~l~~~LG~GsFG~VYkgk----------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~ 406 (511)
+...+|++.+.||+|+||.||+|+ .||+|+++. ........++.+|+.+++.++||||++++|+|....
T Consensus 4 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~~ 82 (316)
T cd05108 4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE-ATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST 82 (316)
T ss_pred cchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccc-cCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCCC
Confidence 346689999999999999999975 288998864 223334556889999999999999999999998653
Q ss_pred CcEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecc
Q 010401 407 HGLCVVTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK 485 (511)
Q Consensus 407 ~~l~LVmEy~~gGsL~~lL~~~-~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~ 485 (511)
.++++||+++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 83 --~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 83 --VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred --ceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEcccccccccc
Confidence 67999999999999999764 468899999999999999999999999999999999999999999999999998765
Q ss_pred cCCCcc--ccccCCCccccHHhhcc
Q 010401 486 SVGEAT--EYETDGYRWLAPEVCFL 508 (511)
Q Consensus 486 ~~~~~~--~~~~Gt~~YmAPEvl~g 508 (511)
...... ....++..|+|||++.+
T Consensus 161 ~~~~~~~~~~~~~~~~y~apE~~~~ 185 (316)
T cd05108 161 ADEKEYHAEGGKVPIKWMALESILH 185 (316)
T ss_pred CCCcceeccCCccceeecChHHhcc
Confidence 432211 12233568999999754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-26 Score=243.99 Aligned_cols=162 Identities=17% Similarity=0.261 Sum_probs=138.8
Q ss_pred ecCCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEE
Q 010401 337 LNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLC 410 (511)
Q Consensus 337 l~~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~ 410 (511)
+...+|++++.||+|+||.||++ +.||+|+... ..+.+|+.+++.++||||+++++++...+. .+
T Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~--------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~-~~ 159 (391)
T PHA03212 89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR--------GGTATEAHILRAINHPSIIQLKGTFTYNKF-TC 159 (391)
T ss_pred cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh--------hhhHHHHHHHHhCCCCCCCCEeEEEEECCe-eE
Confidence 44567999999999999999995 4688986531 246789999999999999999999987775 89
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCC-C
Q 010401 411 VVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG-E 489 (511)
Q Consensus 411 LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~-~ 489 (511)
+|||++. ++|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... .
T Consensus 160 lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~ 238 (391)
T PHA03212 160 LILPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN 238 (391)
T ss_pred EEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccccccccc
Confidence 9999995 5999998777789999999999999999999999999999999999999999999999999987543222 2
Q ss_pred ccccccCCCccccHHhhcc
Q 010401 490 ATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 490 ~~~~~~Gt~~YmAPEvl~g 508 (511)
......||+.|+|||++.+
T Consensus 239 ~~~~~~gt~~y~aPE~~~~ 257 (391)
T PHA03212 239 KYYGWAGTIATNAPELLAR 257 (391)
T ss_pred ccccccCccCCCChhhhcC
Confidence 2334579999999999865
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-26 Score=239.15 Aligned_cols=174 Identities=22% Similarity=0.396 Sum_probs=142.2
Q ss_pred ceEecCCCeEEEeeeecccceEEEEe-----------EEEEEEEEecCCCCchHHHHHHHHHHHHHhC-CCCceeeEeee
Q 010401 334 RWLLNSDNLEFIDQIGPNSFKGVYKG-----------KRVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCV 401 (511)
Q Consensus 334 ~~~l~~~~y~l~~~LG~GsFG~VYkg-----------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l-~HpNIV~l~g~ 401 (511)
+|.++.++|++.+.||+|+||.||+| +.||+|+++.. ........+.+|+.++.++ +||||++++++
T Consensus 1 ~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~ 79 (343)
T cd05103 1 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVVNLLGA 79 (343)
T ss_pred CcccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccC-CChHHHHHHHHHHHHHHhccCCccHhhhcce
Confidence 36778889999999999999999986 36899999642 2233345578899999999 78999999999
Q ss_pred EeeCCCcEEEEEeccCCCCHHHHHHhc-----------------------------------------------------
Q 010401 402 CVDENHGLCVVTKLMEGGSVNDLILKS----------------------------------------------------- 428 (511)
Q Consensus 402 ~~~~~~~l~LVmEy~~gGsL~~lL~~~----------------------------------------------------- 428 (511)
+...+..++++|||+++|+|.+++...
T Consensus 80 ~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (343)
T cd05103 80 CTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLS 159 (343)
T ss_pred eecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccc
Confidence 887666689999999999999998542
Q ss_pred --------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCc--cc
Q 010401 429 --------------RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA--TE 492 (511)
Q Consensus 429 --------------~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~--~~ 492 (511)
..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++........ ..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 239 (343)
T cd05103 160 DVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKG 239 (343)
T ss_pred cchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcC
Confidence 13677888899999999999999999999999999999999999999999998765332221 11
Q ss_pred cccCCCccccHHhhcc
Q 010401 493 YETDGYRWLAPEVCFL 508 (511)
Q Consensus 493 ~~~Gt~~YmAPEvl~g 508 (511)
...+++.|+|||++.+
T Consensus 240 ~~~~~~~y~aPE~~~~ 255 (343)
T cd05103 240 DARLPLKWMAPETIFD 255 (343)
T ss_pred CCCCCcceECcHHhcC
Confidence 2234567999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-28 Score=243.99 Aligned_cols=161 Identities=24% Similarity=0.431 Sum_probs=145.6
Q ss_pred eEEEeeeecccceEEEE------eEEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEEec
Q 010401 342 LEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKL 415 (511)
Q Consensus 342 y~l~~~LG~GsFG~VYk------gk~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVmEy 415 (511)
|.++.+||+|+||.||+ |..+|||++.. +....++.+||.+|.+|..|++|++||.+..... +||||||
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV----~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sD-LWIVMEY 109 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV----DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSD-LWIVMEY 109 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc----cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCc-eEeehhh
Confidence 57789999999999998 67899999853 2335678999999999999999999999987776 9999999
Q ss_pred cCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCccccc
Q 010401 416 MEGGSVNDLIL-KSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYE 494 (511)
Q Consensus 416 ~~gGsL~~lL~-~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~~~~ 494 (511)
|..|++.++++ ++++|.+.++..++...++||+|||...-||||||..|||++.+|..||+|||.+..+.+.-......
T Consensus 110 CGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKRNTV 189 (502)
T KOG0574|consen 110 CGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKRNTV 189 (502)
T ss_pred cCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHHhhCcc
Confidence 99999999996 45789999999999999999999999999999999999999999999999999998877655567788
Q ss_pred cCCCccccHHhhc
Q 010401 495 TDGYRWLAPEVCF 507 (511)
Q Consensus 495 ~Gt~~YmAPEvl~ 507 (511)
.||+.|||||++.
T Consensus 190 IGTPFWMAPEVI~ 202 (502)
T KOG0574|consen 190 IGTPFWMAPEVIE 202 (502)
T ss_pred ccCcccccHHHHH
Confidence 9999999999986
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-26 Score=227.91 Aligned_cols=172 Identities=20% Similarity=0.356 Sum_probs=140.7
Q ss_pred eEecCCCeEEEeeeecccceEEEEeE-----------EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEe
Q 010401 335 WLLNSDNLEFIDQIGPNSFKGVYKGK-----------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCV 403 (511)
Q Consensus 335 ~~l~~~~y~l~~~LG~GsFG~VYkgk-----------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~ 403 (511)
|.+..++|++.+.||+|+||.||+|. .+|+|++.... ......++.+|+.+++.++||||+++++++.
T Consensus 1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~ 79 (277)
T cd05062 1 WEVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVS 79 (277)
T ss_pred CcccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 45677889999999999999999853 58999885422 2234456889999999999999999999998
Q ss_pred eCCCcEEEEEeccCCCCHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcE
Q 010401 404 DENHGLCVVTKLMEGGSVNDLILKSR----------KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 473 (511)
Q Consensus 404 ~~~~~l~LVmEy~~gGsL~~lL~~~~----------~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~v 473 (511)
+.+. .++||||+++|+|.+++.... .+++..+..++.|++.||.|||+.|++||||||+||+++.++.+
T Consensus 80 ~~~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~ 158 (277)
T cd05062 80 QGQP-TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTV 158 (277)
T ss_pred CCCC-eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCE
Confidence 7775 899999999999999986422 35678889999999999999999999999999999999999999
Q ss_pred EEEecCCceecccCCCc--cccccCCCccccHHhhcc
Q 010401 474 CLGDMGIVTACKSVGEA--TEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 474 KL~DFGlS~~l~~~~~~--~~~~~Gt~~YmAPEvl~g 508 (511)
+|+|||+++........ .....+++.|+|||++.+
T Consensus 159 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 195 (277)
T cd05062 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD 195 (277)
T ss_pred EECCCCCccccCCcceeecCCCCccCHhhcChhHhhc
Confidence 99999998765332211 112344678999999764
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-26 Score=225.88 Aligned_cols=166 Identities=22% Similarity=0.425 Sum_probs=143.2
Q ss_pred CCCeEEEeeeecccceEEEEeE------EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEE
Q 010401 339 SDNLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV 412 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkgk------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LV 412 (511)
.++|++.+.||+|+||.||+|+ .+++|++.... ......+.+|+.++..++||||+++++++..++. +|+|
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~-~~iv 84 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP--GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREK-LWIC 84 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc--cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCE-EEEE
Confidence 4578999999999999999964 58999886422 2223457889999999999999999999988775 9999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCccc
Q 010401 413 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE 492 (511)
Q Consensus 413 mEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~~ 492 (511)
|||+++++|.+++...+.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++..........
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~ 164 (267)
T cd06646 85 MEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRK 164 (267)
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecccccccC
Confidence 99999999999997777899999999999999999999999999999999999999999999999999987644333334
Q ss_pred cccCCCccccHHhhc
Q 010401 493 YETDGYRWLAPEVCF 507 (511)
Q Consensus 493 ~~~Gt~~YmAPEvl~ 507 (511)
...|++.|+|||.+.
T Consensus 165 ~~~~~~~y~~PE~~~ 179 (267)
T cd06646 165 SFIGTPYWMAPEVAA 179 (267)
T ss_pred ccccCccccCHhHcc
Confidence 557888999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.3e-26 Score=229.61 Aligned_cols=166 Identities=21% Similarity=0.308 Sum_probs=140.1
Q ss_pred CeEEEeeeecccceEEEEe------EEEEEEEEecCCCCc-hHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEE
Q 010401 341 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGN-AYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT 413 (511)
Q Consensus 341 ~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~-~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVm 413 (511)
.|++.+.||+|+||.||++ +.||+|++....... .....+.+|+.+++.++||||+++++.+.+++. +|+||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~lv~ 79 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDA-LCLVL 79 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCe-EEEEE
Confidence 4788999999999999995 479999996432222 223446789999999999999999999988775 99999
Q ss_pred eccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCcc
Q 010401 414 KLMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT 491 (511)
Q Consensus 414 Ey~~gGsL~~lL~~~--~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~ 491 (511)
||+.+|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+||++++++.++|+|||+++..... ...
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~-~~~ 158 (285)
T cd05605 80 TLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG-ETI 158 (285)
T ss_pred eccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCC-Ccc
Confidence 999999999888543 46899999999999999999999999999999999999999999999999998875432 223
Q ss_pred ccccCCCccccHHhhcc
Q 010401 492 EYETDGYRWLAPEVCFL 508 (511)
Q Consensus 492 ~~~~Gt~~YmAPEvl~g 508 (511)
....|++.|+|||++.+
T Consensus 159 ~~~~~~~~y~aPE~~~~ 175 (285)
T cd05605 159 RGRVGTVGYMAPEVVKN 175 (285)
T ss_pred ccccCCCCccCcHHhcC
Confidence 34578899999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.9e-26 Score=247.42 Aligned_cols=165 Identities=19% Similarity=0.236 Sum_probs=139.1
Q ss_pred CeEEEeeeecccceEEEEe-------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEE
Q 010401 341 NLEFIDQIGPNSFKGVYKG-------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT 413 (511)
Q Consensus 341 ~y~l~~~LG~GsFG~VYkg-------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVm 413 (511)
.|.+.+.||+|+||.||++ +.|++|++.. ........+.+|+.+++.++||||++++++|..++. +||||
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~--~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~-~~lv~ 144 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVML--NDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDK-LLLIM 144 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEccc--CCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCE-EEEEE
Confidence 4899999999999999985 3577776642 223334457889999999999999999999998876 99999
Q ss_pred eccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCC
Q 010401 414 KLMEGGSVNDLILK----SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE 489 (511)
Q Consensus 414 Ey~~gGsL~~lL~~----~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~ 489 (511)
||+++|+|.+++.. ...+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++.......
T Consensus 145 E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 145 EYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred ECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 99999999988753 34689999999999999999999999999999999999999999999999999987643221
Q ss_pred --ccccccCCCccccHHhhcc
Q 010401 490 --ATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 490 --~~~~~~Gt~~YmAPEvl~g 508 (511)
.....+||+.|+|||++.+
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~ 245 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWER 245 (478)
T ss_pred cccccccCCCccccCHhHhCC
Confidence 2344578999999999865
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=236.21 Aligned_cols=163 Identities=21% Similarity=0.286 Sum_probs=137.0
Q ss_pred eeeecccceEEEEe------EEEEEEEEecCCC-CchHHHHHHHHHHHHHhC-CCCceeeEeeeEeeCCCcEEEEEeccC
Q 010401 346 DQIGPNSFKGVYKG------KRVGIEKLKGCDK-GNAYEFELRKDLLELMTC-GHKNILQFYCVCVDENHGLCVVTKLME 417 (511)
Q Consensus 346 ~~LG~GsFG~VYkg------k~VAVKkL~~~~~-~~~~~~~~~~Ei~iL~~l-~HpNIV~l~g~~~~~~~~l~LVmEy~~ 417 (511)
+.||+|+||.||++ +.+|+|.++.... .......+..|+.++..+ +||||+++++++.+.+. +|+||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~-~~lv~e~~~ 79 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDR-LFFVMEYVN 79 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCE-EEEEEcCCC
Confidence 46999999999996 3699999974321 122234466777888776 79999999999988776 999999999
Q ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCccccccCC
Q 010401 418 GGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG 497 (511)
Q Consensus 418 gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~~~~~Gt 497 (511)
+|+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++............+|+
T Consensus 80 ~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~ 159 (318)
T cd05570 80 GGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGT 159 (318)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccceecC
Confidence 99999999877789999999999999999999999999999999999999999999999999987643333334455789
Q ss_pred CccccHHhhccc
Q 010401 498 YRWLAPEVCFLL 509 (511)
Q Consensus 498 ~~YmAPEvl~gl 509 (511)
+.|+|||++.+.
T Consensus 160 ~~y~aPE~~~~~ 171 (318)
T cd05570 160 PDYIAPEILSYQ 171 (318)
T ss_pred ccccCHHHhcCC
Confidence 999999998753
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.9e-26 Score=230.93 Aligned_cols=174 Identities=22% Similarity=0.401 Sum_probs=143.8
Q ss_pred cceEecCCCeEEEeeeecccceEEEEeE-------------EEEEEEEecCCCCchHHHHHHHHHHHHHhC-CCCceeeE
Q 010401 333 GRWLLNSDNLEFIDQIGPNSFKGVYKGK-------------RVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQF 398 (511)
Q Consensus 333 ~~~~l~~~~y~l~~~LG~GsFG~VYkgk-------------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l-~HpNIV~l 398 (511)
.+|.+..++|.+.+.||+|+||.||+++ .+|+|.+... .......++.+|+.++..+ +||||+++
T Consensus 11 ~~~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~e~~~l~~l~~h~~i~~~ 89 (307)
T cd05098 11 PRWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIINL 89 (307)
T ss_pred CcceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCC-CChHHHHHHHHHHHHHHHhcCCCCEeeE
Confidence 4678888999999999999999999874 4888888643 2233345678899999998 89999999
Q ss_pred eeeEeeCCCcEEEEEeccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCC
Q 010401 399 YCVCVDENHGLCVVTKLMEGGSVNDLILKS----------------RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNS 462 (511)
Q Consensus 399 ~g~~~~~~~~l~LVmEy~~gGsL~~lL~~~----------------~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp 462 (511)
++++...+. +|+||||+++|+|.+++... ..+++..++.++.||+.||+|||++|++||||||
T Consensus 90 ~~~~~~~~~-~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp 168 (307)
T cd05098 90 LGACTQDGP-LYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAA 168 (307)
T ss_pred EEEEecCCc-eEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccH
Confidence 999987775 99999999999999999653 2478899999999999999999999999999999
Q ss_pred CceEEcCCCcEEEEecCCceecccCCCc--cccccCCCccccHHhhcc
Q 010401 463 QRILLDRHGNVCLGDMGIVTACKSVGEA--TEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 463 ~NILld~~g~vKL~DFGlS~~l~~~~~~--~~~~~Gt~~YmAPEvl~g 508 (511)
+||+++.++.+||+|||+++........ .....+++.|+|||++.+
T Consensus 169 ~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 216 (307)
T cd05098 169 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD 216 (307)
T ss_pred HheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhcc
Confidence 9999999999999999998765432211 112233468999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-26 Score=240.58 Aligned_cols=167 Identities=20% Similarity=0.304 Sum_probs=140.5
Q ss_pred CeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCC----CcEE
Q 010401 341 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN----HGLC 410 (511)
Q Consensus 341 ~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~----~~l~ 410 (511)
+|++++.||+|+||.||++ +.||+|++...........++.+|+.+++.++|+||+++++++.+.+ ..+|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4788899999999999985 47999998643333334456889999999999999999999998765 1389
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCC-C
Q 010401 411 VVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG-E 489 (511)
Q Consensus 411 LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~-~ 489 (511)
+||||+. ++|.+.+.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... .
T Consensus 81 lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~~ 159 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESK 159 (372)
T ss_pred EEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCccc
Confidence 9999996 4899888777889999999999999999999999999999999999999999999999999988654322 1
Q ss_pred ccccccCCCccccHHhhcc
Q 010401 490 ATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 490 ~~~~~~Gt~~YmAPEvl~g 508 (511)
......+++.|+|||++.+
T Consensus 160 ~~~~~~~~~~y~aPE~~~~ 178 (372)
T cd07853 160 HMTQEVVTQYYRAPEILMG 178 (372)
T ss_pred cCCCCCcCCCcCCHHHHcC
Confidence 2233467889999999875
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.9e-27 Score=244.01 Aligned_cols=150 Identities=18% Similarity=0.305 Sum_probs=131.5
Q ss_pred ceEecCCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCC-chHHHHHHHHHHHHHhCCCCceeeEeeeEeeCC
Q 010401 334 RWLLNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKG-NAYEFELRKDLLELMTCGHKNILQFYCVCVDEN 406 (511)
Q Consensus 334 ~~~l~~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~-~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~ 406 (511)
.-.+..++|++++.||.|.-|+||++ ..+|+|++.+.... .....+.+.|-.+|..++||+++.||..|..++
T Consensus 71 ~~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~ 150 (459)
T KOG0610|consen 71 DGSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDK 150 (459)
T ss_pred CCccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccc
Confidence 44567888999999999999999996 47899999754332 223455777888899999999999999999887
Q ss_pred CcEEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceec
Q 010401 407 HGLCVVTKLMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC 484 (511)
Q Consensus 407 ~~l~LVmEy~~gGsL~~lL~~~--~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l 484 (511)
- .|++||||+||+|+.+++++ +.+++..+++|+.+|+.||+|||-.|||+|||||+||||-++|++.|+||.++..+
T Consensus 151 ~-~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~ 229 (459)
T KOG0610|consen 151 Y-SCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRC 229 (459)
T ss_pred e-eEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccC
Confidence 6 99999999999999998654 58999999999999999999999999999999999999999999999999997443
|
|
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.5e-26 Score=228.03 Aligned_cols=172 Identities=20% Similarity=0.364 Sum_probs=140.7
Q ss_pred eEecCCCeEEEeeeecccceEEEEeE-----------EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEe
Q 010401 335 WLLNSDNLEFIDQIGPNSFKGVYKGK-----------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCV 403 (511)
Q Consensus 335 ~~l~~~~y~l~~~LG~GsFG~VYkgk-----------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~ 403 (511)
|+++.++|++.+.||+|+||.||+|. .||+|.+... ........+.+|+.+++.++||||+++++++.
T Consensus 1 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 79 (288)
T cd05061 1 WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNES-ASLRERIEFLNEASVMKGFTCHHVVRLLGVVS 79 (288)
T ss_pred CcccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCc-CCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 56778899999999999999999863 5888887632 22333445788999999999999999999988
Q ss_pred eCCCcEEEEEeccCCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcE
Q 010401 404 DENHGLCVVTKLMEGGSVNDLILKS----------RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 473 (511)
Q Consensus 404 ~~~~~l~LVmEy~~gGsL~~lL~~~----------~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~v 473 (511)
+.+. .|+||||+++|+|.+++... ..++...+..++.|++.||.|||+++|+||||||+|||++.++.+
T Consensus 80 ~~~~-~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~ 158 (288)
T cd05061 80 KGQP-TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTV 158 (288)
T ss_pred CCCC-cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcE
Confidence 7775 89999999999999999642 234567889999999999999999999999999999999999999
Q ss_pred EEEecCCceecccCCCcc--ccccCCCccccHHhhcc
Q 010401 474 CLGDMGIVTACKSVGEAT--EYETDGYRWLAPEVCFL 508 (511)
Q Consensus 474 KL~DFGlS~~l~~~~~~~--~~~~Gt~~YmAPEvl~g 508 (511)
+|+|||+++......... ....++..|+|||.+.+
T Consensus 159 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~ 195 (288)
T cd05061 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD 195 (288)
T ss_pred EECcCCccccccccccccccCCCcccccccCHHHhcc
Confidence 999999987654322211 12234677999999764
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.8e-26 Score=231.28 Aligned_cols=167 Identities=16% Similarity=0.301 Sum_probs=140.4
Q ss_pred CCCeEEEeeeecccceEEEEeE------EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEE
Q 010401 339 SDNLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV 412 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkgk------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LV 412 (511)
.++|++.+.||+|+||.||+|+ .+|+|.+..... ......+.+|+.++..++||||+++++++..++. +|+|
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~lv 82 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKS-LTLV 82 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc-CCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCe-EEEE
Confidence 4678999999999999999963 689999874332 2223446789999999999999999999988776 9999
Q ss_pred EeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCcc
Q 010401 413 TKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT 491 (511)
Q Consensus 413 mEy~~gGsL~~lL~~~-~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~ 491 (511)
|||+.+ +|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.........
T Consensus 83 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 161 (309)
T cd07872 83 FEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTY 161 (309)
T ss_pred EeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCcccc
Confidence 999976 888887554 458899999999999999999999999999999999999999999999999987654433333
Q ss_pred ccccCCCccccHHhhcc
Q 010401 492 EYETDGYRWLAPEVCFL 508 (511)
Q Consensus 492 ~~~~Gt~~YmAPEvl~g 508 (511)
....+++.|+|||++.+
T Consensus 162 ~~~~~~~~y~aPE~~~~ 178 (309)
T cd07872 162 SNEVVTLWYRPPDVLLG 178 (309)
T ss_pred ccccccccccCCHHHhC
Confidence 44567899999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.2e-26 Score=226.18 Aligned_cols=169 Identities=22% Similarity=0.438 Sum_probs=139.6
Q ss_pred cCCCeEEEeeeecccceEEEEeE----------EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCC
Q 010401 338 NSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENH 407 (511)
Q Consensus 338 ~~~~y~l~~~LG~GsFG~VYkgk----------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~ 407 (511)
..++|++.+.||+|+||.||+|+ .+++|.+... ........+.+|+.+++.++||||+++++++..++.
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 81 (283)
T cd05090 3 PLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDI-NNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQP 81 (283)
T ss_pred ChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCC-CCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCc
Confidence 45678999999999999999974 5788888642 223334568889999999999999999999987776
Q ss_pred cEEEEEeccCCCCHHHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCC
Q 010401 408 GLCVVTKLMEGGSVNDLILKS-----------------RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRH 470 (511)
Q Consensus 408 ~l~LVmEy~~gGsL~~lL~~~-----------------~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~ 470 (511)
.|++|||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 82 -~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~ 160 (283)
T cd05090 82 -VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQ 160 (283)
T ss_pred -eEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCC
Confidence 99999999999999998532 247888999999999999999999999999999999999999
Q ss_pred CcEEEEecCCceecccCCC--ccccccCCCccccHHhhcc
Q 010401 471 GNVCLGDMGIVTACKSVGE--ATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 471 g~vKL~DFGlS~~l~~~~~--~~~~~~Gt~~YmAPEvl~g 508 (511)
+.+||+|||+++....... ......++..|+|||++.+
T Consensus 161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 200 (283)
T cd05090 161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMY 200 (283)
T ss_pred CcEEeccccccccccCCcceecccCCCccceecChHHhcc
Confidence 9999999999876543221 1223345678999998854
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.7e-26 Score=235.91 Aligned_cols=166 Identities=20% Similarity=0.258 Sum_probs=138.0
Q ss_pred CCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCC-----C
Q 010401 339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN-----H 407 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~-----~ 407 (511)
.++|++.+.||+|+||.||++ +.+|+|++............+.+|+.+++.++||||+++++++...+ .
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 468899999999999999996 47999999754334444566789999999999999999999986543 2
Q ss_pred cEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccC
Q 010401 408 GLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV 487 (511)
Q Consensus 408 ~l~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~ 487 (511)
.+|+||||+.+ +|...+. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 100 ~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~ 176 (359)
T cd07876 100 DVYLVMELMDA-NLCQVIH--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTN 176 (359)
T ss_pred eeEEEEeCCCc-CHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCccccccC
Confidence 37999999976 6766653 35889999999999999999999999999999999999999999999999998764332
Q ss_pred CCccccccCCCccccHHhhcc
Q 010401 488 GEATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 488 ~~~~~~~~Gt~~YmAPEvl~g 508 (511)
.......||+.|+|||++.+
T Consensus 177 -~~~~~~~~t~~y~aPE~~~~ 196 (359)
T cd07876 177 -FMMTPYVVTRYYRAPEVILG 196 (359)
T ss_pred -ccCCCCcccCCCCCchhccC
Confidence 22334578899999999865
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.3e-26 Score=219.49 Aligned_cols=167 Identities=22% Similarity=0.370 Sum_probs=145.3
Q ss_pred CeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEEe
Q 010401 341 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTK 414 (511)
Q Consensus 341 ~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVmE 414 (511)
+|++.+.||+|+||.||++ +.+++|.+............+.+|+.+++.++||||+++++++.+.+. .|+|||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~lv~e 79 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGK-LNIVME 79 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCE-EEEEEE
Confidence 5788999999999999996 468999887544445556678899999999999999999999987765 999999
Q ss_pred ccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCccc
Q 010401 415 LMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE 492 (511)
Q Consensus 415 y~~gGsL~~lL~~~--~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~~ 492 (511)
|+++++|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||+++..........
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~~ 159 (256)
T cd08529 80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFAN 159 (256)
T ss_pred eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccchhh
Confidence 99999999999653 5789999999999999999999999999999999999999999999999999887665444444
Q ss_pred cccCCCccccHHhhcc
Q 010401 493 YETDGYRWLAPEVCFL 508 (511)
Q Consensus 493 ~~~Gt~~YmAPEvl~g 508 (511)
...|++.|+|||++.+
T Consensus 160 ~~~~~~~y~aPE~~~~ 175 (256)
T cd08529 160 TIVGTPYYLSPELCED 175 (256)
T ss_pred ccccCccccCHHHhcC
Confidence 5578899999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.2e-26 Score=246.95 Aligned_cols=171 Identities=16% Similarity=0.204 Sum_probs=143.5
Q ss_pred cCCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCC----
Q 010401 338 NSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENH---- 407 (511)
Q Consensus 338 ~~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~---- 407 (511)
..++|++.+.||+|+||.||++ +.||+|++............+.+|+..+..++|+||+++++.+...+.
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~ 109 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE 109 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence 4578999999999999999986 479999997544444455668899999999999999999887754321
Q ss_pred ---cEEEEEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCC
Q 010401 408 ---GLCVVTKLMEGGSVNDLILK----SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGI 480 (511)
Q Consensus 408 ---~l~LVmEy~~gGsL~~lL~~----~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGl 480 (511)
.+++||||+++|+|.+++.. ...+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+
T Consensus 110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFGl 189 (496)
T PTZ00283 110 NVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGF 189 (496)
T ss_pred cceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEeccc
Confidence 26899999999999999854 24689999999999999999999999999999999999999999999999999
Q ss_pred ceecccCC--CccccccCCCccccHHhhcc
Q 010401 481 VTACKSVG--EATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 481 S~~l~~~~--~~~~~~~Gt~~YmAPEvl~g 508 (511)
++...... .......||+.|+|||++.+
T Consensus 190 s~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~ 219 (496)
T PTZ00283 190 SKMYAATVSDDVGRTFCGTPYYVAPEIWRR 219 (496)
T ss_pred CeeccccccccccccccCCcceeCHHHhCC
Confidence 98754321 22345679999999999875
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.5e-26 Score=226.12 Aligned_cols=169 Identities=24% Similarity=0.477 Sum_probs=140.4
Q ss_pred cCCCeEEEeeeecccceEEEEeE-----------EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCC
Q 010401 338 NSDNLEFIDQIGPNSFKGVYKGK-----------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN 406 (511)
Q Consensus 338 ~~~~y~l~~~LG~GsFG~VYkgk-----------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~ 406 (511)
..++|++.+.||+|+||.||+|. .+++|.+... ........+.+|+.++..++||||+++++++.+.+
T Consensus 3 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~-~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~ 81 (283)
T cd05048 3 PLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKEN-AEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQ 81 (283)
T ss_pred ChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccC-CCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCC
Confidence 34578999999999999999863 5888888642 22334456889999999999999999999998776
Q ss_pred CcEEEEEeccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCC
Q 010401 407 HGLCVVTKLMEGGSVNDLILKS----------------RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRH 470 (511)
Q Consensus 407 ~~l~LVmEy~~gGsL~~lL~~~----------------~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~ 470 (511)
. .|++|||+++++|.+++... ..+++..++.++.|++.||.|||++|++||||||+||+++++
T Consensus 82 ~-~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~ 160 (283)
T cd05048 82 P-TCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEG 160 (283)
T ss_pred c-eEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCC
Confidence 5 89999999999999999653 457888999999999999999999999999999999999999
Q ss_pred CcEEEEecCCceecccCCC--ccccccCCCccccHHhhcc
Q 010401 471 GNVCLGDMGIVTACKSVGE--ATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 471 g~vKL~DFGlS~~l~~~~~--~~~~~~Gt~~YmAPEvl~g 508 (511)
+.+||+|||+++....... ......+++.|+|||++.+
T Consensus 161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 200 (283)
T cd05048 161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILY 200 (283)
T ss_pred CcEEECCCcceeeccccccccccCCCcccccccCHHHhcc
Confidence 9999999999876533221 1223355788999998754
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.3e-28 Score=258.79 Aligned_cols=166 Identities=25% Similarity=0.454 Sum_probs=144.6
Q ss_pred CCeEEEeeeecccceEEEEeEE------EEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEE
Q 010401 340 DNLEFIDQIGPNSFKGVYKGKR------VGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT 413 (511)
Q Consensus 340 ~~y~l~~~LG~GsFG~VYkgk~------VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVm 413 (511)
+-|+++..||.|+||+||++.. .|.|+|. .+.......+.-||.+|..|+||+||+|++.|+-++. +||+.
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIe--tkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enk-Lwili 108 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIE--TKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENK-LWILI 108 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhc--ccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCc-eEEEE
Confidence 3468889999999999999753 4556664 3444445568899999999999999999998887776 99999
Q ss_pred eccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCccc
Q 010401 414 KLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE 492 (511)
Q Consensus 414 Ey~~gGsL~~lL~~-~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~~ 492 (511)
|||.||.+..++.. ...|.+.++..++.|++.||.|||+++|||||||..|||+.-+|.++|+|||.+...........
T Consensus 109 EFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkRD 188 (1187)
T KOG0579|consen 109 EFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKRD 188 (1187)
T ss_pred eecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhHHhhhc
Confidence 99999999988754 46899999999999999999999999999999999999999999999999999877666666677
Q ss_pred cccCCCccccHHhhcc
Q 010401 493 YETDGYRWLAPEVCFL 508 (511)
Q Consensus 493 ~~~Gt~~YmAPEvl~g 508 (511)
.+.|||.|||||++++
T Consensus 189 sFIGTPYWMAPEVvmC 204 (1187)
T KOG0579|consen 189 SFIGTPYWMAPEVVMC 204 (1187)
T ss_pred cccCCcccccchheee
Confidence 8899999999999876
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=8e-26 Score=223.12 Aligned_cols=168 Identities=20% Similarity=0.303 Sum_probs=143.7
Q ss_pred CCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEE
Q 010401 340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT 413 (511)
Q Consensus 340 ~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVm 413 (511)
++|++.+.||+|+||.||++ +.+++|++............+.+|+.+++.++|+||+++++++...+. +++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~-~~~v~ 79 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRK-LHLVF 79 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCE-EEEEE
Confidence 46899999999999999995 479999886543333334557889999999999999999999988775 89999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCcccc
Q 010401 414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY 493 (511)
Q Consensus 414 Ey~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~~~ 493 (511)
||++++.|..++.....+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||++............
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 159 (286)
T cd07847 80 EYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTD 159 (286)
T ss_pred eccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcccccC
Confidence 99999888888766667999999999999999999999999999999999999999999999999999877554433344
Q ss_pred ccCCCccccHHhhcc
Q 010401 494 ETDGYRWLAPEVCFL 508 (511)
Q Consensus 494 ~~Gt~~YmAPEvl~g 508 (511)
..++..|+|||++.+
T Consensus 160 ~~~~~~~~aPE~~~~ 174 (286)
T cd07847 160 YVATRWYRAPELLVG 174 (286)
T ss_pred cccccccCCHHHHhC
Confidence 567788999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=6e-26 Score=221.54 Aligned_cols=167 Identities=25% Similarity=0.452 Sum_probs=138.8
Q ss_pred cCCCeEEEeeeecccceEEEEeE-----EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEE
Q 010401 338 NSDNLEFIDQIGPNSFKGVYKGK-----RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV 412 (511)
Q Consensus 338 ~~~~y~l~~~LG~GsFG~VYkgk-----~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LV 412 (511)
+.++|++.+.||+|+||.||+++ .+++|.+.... .....+.+|+.+++.++||||+++++++...+. +|+|
T Consensus 2 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~iv 77 (256)
T cd05114 2 NPSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA---MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKP-LYIV 77 (256)
T ss_pred CHHHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC---ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCC-EEEE
Confidence 34678999999999999999963 57888775322 223567889999999999999999999987776 9999
Q ss_pred EeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCc-
Q 010401 413 TKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA- 490 (511)
Q Consensus 413 mEy~~gGsL~~lL~~-~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~- 490 (511)
|||+++|+|.+++.. .+.+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++........
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05114 78 TEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS 157 (256)
T ss_pred EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence 999999999999864 356899999999999999999999999999999999999999999999999998765432221
Q ss_pred cccccCCCccccHHhhcc
Q 010401 491 TEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 491 ~~~~~Gt~~YmAPEvl~g 508 (511)
.....++..|+|||++.+
T Consensus 158 ~~~~~~~~~y~aPE~~~~ 175 (256)
T cd05114 158 SSGAKFPVKWSPPEVFNF 175 (256)
T ss_pred cCCCCCchhhCChhhccc
Confidence 112234568999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.3e-27 Score=237.44 Aligned_cols=169 Identities=19% Similarity=0.280 Sum_probs=144.7
Q ss_pred CCCeEEEeeeecccceEEEE------eEEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEee----CCCc
Q 010401 339 SDNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVD----ENHG 408 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYk------gk~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~----~~~~ 408 (511)
...|..++.||.|+||.|.. |+.||||++...-......++..+|+.+|+.++|+||+.+++++.. .-+.
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D 100 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND 100 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence 45566689999999999998 4689999998655566677889999999999999999999999875 1233
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccC-
Q 010401 409 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV- 487 (511)
Q Consensus 409 l~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~- 487 (511)
+|+|+|+|.. +|...++.+..|++..+..++.||++||+|+|+.+|+||||||+|+|++.+..+||||||+|+.....
T Consensus 101 vYiV~elMet-DL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~ 179 (359)
T KOG0660|consen 101 VYLVFELMET-DLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFF 179 (359)
T ss_pred eEEehhHHhh-HHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccccC
Confidence 9999999954 99999988878999999999999999999999999999999999999999999999999999988542
Q ss_pred -CCccccccCCCccccHHhhcc
Q 010401 488 -GEATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 488 -~~~~~~~~Gt~~YmAPEvl~g 508 (511)
....+.-.-|..|.|||+++.
T Consensus 180 ~~~~mTeYVaTRWYRAPElll~ 201 (359)
T KOG0660|consen 180 EDGFMTEYVATRWYRAPELLLN 201 (359)
T ss_pred cccchhcceeeeeecCHHHHhc
Confidence 122334455788999999864
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.8e-26 Score=225.46 Aligned_cols=169 Identities=22% Similarity=0.388 Sum_probs=141.8
Q ss_pred cCCCeEEEeeeecccceEEEEeE----------------------EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCce
Q 010401 338 NSDNLEFIDQIGPNSFKGVYKGK----------------------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNI 395 (511)
Q Consensus 338 ~~~~y~l~~~LG~GsFG~VYkgk----------------------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNI 395 (511)
..++|++.+.||+|+||.||+++ .+++|++... ........+.+|+.++..++||||
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i 81 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPD-ASDNAREDFLKEVKILSRLSDPNI 81 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCc-cCHHHHHHHHHHHHHHHhcCCCCE
Confidence 45678999999999999999853 3788988642 223345568899999999999999
Q ss_pred eeEeeeEeeCCCcEEEEEeccCCCCHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCc
Q 010401 396 LQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-----------KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQR 464 (511)
Q Consensus 396 V~l~g~~~~~~~~l~LVmEy~~gGsL~~lL~~~~-----------~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~N 464 (511)
+++++++..++. ++++|||+.+++|.+++.... .+++..++.++.|++.||.|||++||+||||||+|
T Consensus 82 ~~~~~~~~~~~~-~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~N 160 (296)
T cd05051 82 ARLLGVCTVDPP-LCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRN 160 (296)
T ss_pred eEEEEEEecCCC-cEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhc
Confidence 999999987765 899999999999999997654 68999999999999999999999999999999999
Q ss_pred eEEcCCCcEEEEecCCceecccCCC--ccccccCCCccccHHhhcc
Q 010401 465 ILLDRHGNVCLGDMGIVTACKSVGE--ATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 465 ILld~~g~vKL~DFGlS~~l~~~~~--~~~~~~Gt~~YmAPEvl~g 508 (511)
|+++.++.++|+|||+++....... ......+++.|+|||++.+
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 206 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLL 206 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhc
Confidence 9999999999999999876543321 1223345678999998764
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.1e-26 Score=234.27 Aligned_cols=167 Identities=20% Similarity=0.277 Sum_probs=138.6
Q ss_pred CCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCC-----C
Q 010401 339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN-----H 407 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~-----~ 407 (511)
.++|++.+.||+|+||.||++ +.+|+|++............+.+|+.+++.++||||+++++++.... .
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 95 (355)
T cd07874 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQ 95 (355)
T ss_pred hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccc
Confidence 568999999999999999985 57999999754444444566788999999999999999999886443 2
Q ss_pred cEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccC
Q 010401 408 GLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV 487 (511)
Q Consensus 408 ~l~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~ 487 (511)
.+|+||||+.+ +|.+.+.. .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 96 ~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~ 172 (355)
T cd07874 96 DVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 172 (355)
T ss_pred eeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCCCc
Confidence 37999999976 77776643 5889999999999999999999999999999999999999999999999999765432
Q ss_pred CCccccccCCCccccHHhhccc
Q 010401 488 GEATEYETDGYRWLAPEVCFLL 509 (511)
Q Consensus 488 ~~~~~~~~Gt~~YmAPEvl~gl 509 (511)
.......||..|+|||++.+.
T Consensus 173 -~~~~~~~~t~~y~aPE~~~~~ 193 (355)
T cd07874 173 -FMMTPYVVTRYYRAPEVILGM 193 (355)
T ss_pred -cccCCccccCCccCHHHHcCC
Confidence 223345788999999998653
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=8e-27 Score=242.59 Aligned_cols=173 Identities=21% Similarity=0.310 Sum_probs=144.8
Q ss_pred eEecCCCeEEEeeeecccceEEEEeEEEEEEEEecCCCC-------chHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCC
Q 010401 335 WLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKG-------NAYEFELRKDLLELMTCGHKNILQFYCVCVDENH 407 (511)
Q Consensus 335 ~~l~~~~y~l~~~LG~GsFG~VYkgk~VAVKkL~~~~~~-------~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~ 407 (511)
+.+..+.|...++||+|+||.||-++..+.-+++.++.- ...+...++|-.+|.+++.++||.+-.+|++.+.
T Consensus 180 qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~ 259 (591)
T KOG0986|consen 180 QPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDA 259 (591)
T ss_pred hhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCc
Confidence 346667889999999999999998655444333332211 1223346788899999999999999999998887
Q ss_pred cEEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecc
Q 010401 408 GLCVVTKLMEGGSVNDLILKSR--KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK 485 (511)
Q Consensus 408 ~l~LVmEy~~gGsL~~lL~~~~--~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~ 485 (511)
+|+||..|.||+|.-+|...+ .+++..+++|+.+|+.||++||+.+||+|||||+|||+|+.|+++|+|.|+|..+.
T Consensus 260 -LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~ 338 (591)
T KOG0986|consen 260 -LCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIP 338 (591)
T ss_pred -eEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecC
Confidence 999999999999999996544 79999999999999999999999999999999999999999999999999998876
Q ss_pred cCCCccccccCCCccccHHhhccc
Q 010401 486 SVGEATEYETDGYRWLAPEVCFLL 509 (511)
Q Consensus 486 ~~~~~~~~~~Gt~~YmAPEvl~gl 509 (511)
.. +......||.+|||||++.+.
T Consensus 339 ~g-~~~~~rvGT~GYMAPEvl~ne 361 (591)
T KOG0986|consen 339 EG-KPIRGRVGTVGYMAPEVLQNE 361 (591)
T ss_pred CC-CccccccCcccccCHHHHcCC
Confidence 53 334555999999999998753
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.4e-26 Score=225.36 Aligned_cols=167 Identities=23% Similarity=0.445 Sum_probs=143.4
Q ss_pred cCCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEE
Q 010401 338 NSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCV 411 (511)
Q Consensus 338 ~~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~L 411 (511)
..++|++.+.||+|+||.||++ +.+++|.++... ......+.+|+.++..++||||+++++++...+. +|+
T Consensus 7 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~-~~l 83 (267)
T cd06645 7 PQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP--GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDK-LWI 83 (267)
T ss_pred cHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc--hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCE-EEE
Confidence 3457888999999999999985 478999886432 2223446789999999999999999999988776 999
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCcc
Q 010401 412 VTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT 491 (511)
Q Consensus 412 VmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~ 491 (511)
+|||+++++|.+++...+.+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++..........
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~ 163 (267)
T cd06645 84 CMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKR 163 (267)
T ss_pred EEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCccccc
Confidence 99999999999999888889999999999999999999999999999999999999999999999999987664433334
Q ss_pred ccccCCCccccHHhhc
Q 010401 492 EYETDGYRWLAPEVCF 507 (511)
Q Consensus 492 ~~~~Gt~~YmAPEvl~ 507 (511)
....|++.|+|||++.
T Consensus 164 ~~~~~~~~y~aPE~~~ 179 (267)
T cd06645 164 KSFIGTPYWMAPEVAA 179 (267)
T ss_pred ccccCcccccChhhhc
Confidence 4557899999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.6e-28 Score=270.90 Aligned_cols=175 Identities=21% Similarity=0.275 Sum_probs=151.7
Q ss_pred cceEecCCCeEEEeeeecccceEEEEeE------EEEEEEEecCCCC-chHHHHHHHHHHHHHhCCCCceeeEeeeEeeC
Q 010401 333 GRWLLNSDNLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDKG-NAYEFELRKDLLELMTCGHKNILQFYCVCVDE 405 (511)
Q Consensus 333 ~~~~l~~~~y~l~~~LG~GsFG~VYkgk------~VAVKkL~~~~~~-~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~ 405 (511)
....+..++|+++++||+|+||.|...+ .+|+|++.+.... .....-|+.|-.+|...+.+-|++++-+|.|+
T Consensus 68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~ 147 (1317)
T KOG0612|consen 68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDE 147 (1317)
T ss_pred HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence 3556889999999999999999999854 5788888653322 11233477888888888999999999999998
Q ss_pred CCcEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecc
Q 010401 406 NHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK 485 (511)
Q Consensus 406 ~~~l~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~ 485 (511)
++ +|+|||||+||+|..++.+..+++++.+++|+.+|+.||.-||+.|+|||||||+|||+|..|++||+|||.+..+.
T Consensus 148 ~~-LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~ 226 (1317)
T KOG0612|consen 148 RY-LYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMD 226 (1317)
T ss_pred cc-eEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcC
Confidence 87 99999999999999999887799999999999999999999999999999999999999999999999999998887
Q ss_pred cCCC-ccccccCCCccccHHhhcc
Q 010401 486 SVGE-ATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 486 ~~~~-~~~~~~Gt~~YmAPEvl~g 508 (511)
.++. ......|||.|++||++..
T Consensus 227 ~dG~V~s~~aVGTPDYISPEvLqs 250 (1317)
T KOG0612|consen 227 ADGTVRSSVAVGTPDYISPEVLQS 250 (1317)
T ss_pred CCCcEEeccccCCCCccCHHHHHh
Confidence 5554 4556689999999999863
|
|
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.8e-26 Score=222.19 Aligned_cols=172 Identities=21% Similarity=0.357 Sum_probs=142.1
Q ss_pred eEecCCCeEEEeeeecccceEEEEeE-----------EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEe
Q 010401 335 WLLNSDNLEFIDQIGPNSFKGVYKGK-----------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCV 403 (511)
Q Consensus 335 ~~l~~~~y~l~~~LG~GsFG~VYkgk-----------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~ 403 (511)
|.+..++|++.+.||+|+||.||+|. .+++|.+.... .......+.+|+.++..++||||+++++++.
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 79 (277)
T cd05032 1 WELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVS 79 (277)
T ss_pred CccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEc
Confidence 45678899999999999999999853 58889886322 2233456788999999999999999999998
Q ss_pred eCCCcEEEEEeccCCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcE
Q 010401 404 DENHGLCVVTKLMEGGSVNDLILKS----------RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 473 (511)
Q Consensus 404 ~~~~~l~LVmEy~~gGsL~~lL~~~----------~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~v 473 (511)
..+. .|+||||+++|+|.+++... ..+++..+..++.||+.||.|||+++|+||||||+||+++.++.+
T Consensus 80 ~~~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~ 158 (277)
T cd05032 80 TGQP-TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTV 158 (277)
T ss_pred CCCC-cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCE
Confidence 8775 99999999999999998642 236788999999999999999999999999999999999999999
Q ss_pred EEEecCCceecccCCC--ccccccCCCccccHHhhcc
Q 010401 474 CLGDMGIVTACKSVGE--ATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 474 KL~DFGlS~~l~~~~~--~~~~~~Gt~~YmAPEvl~g 508 (511)
||+|||+++....... ......++..|+|||.+.+
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 195 (277)
T cd05032 159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD 195 (277)
T ss_pred EECCcccchhhccCcccccCCCCCccccccCHHHHhc
Confidence 9999999876543221 1223456788999998753
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3e-26 Score=243.75 Aligned_cols=171 Identities=24% Similarity=0.377 Sum_probs=143.8
Q ss_pred EecCCCeEEEeeeecccceEEEEe-----EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEE
Q 010401 336 LLNSDNLEFIDQIGPNSFKGVYKG-----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLC 410 (511)
Q Consensus 336 ~l~~~~y~l~~~LG~GsFG~VYkg-----k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~ 410 (511)
+++.+.+.+.++||+|-||.|.++ ..||||+++.. ......+.|.+|+.+|.+|+||||+.++|+|..++. ++
T Consensus 534 EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~-a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DeP-ic 611 (807)
T KOG1094|consen 534 EFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPD-ATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDP-LC 611 (807)
T ss_pred hcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcc-cchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCc-hH
Confidence 356778899999999999999995 57999999863 333346789999999999999999999999998886 99
Q ss_pred EEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCC
Q 010401 411 VVTKLMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG 488 (511)
Q Consensus 411 LVmEy~~gGsL~~lL~~~--~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~ 488 (511)
++||||.+|+|..+|... ..+.......|+.||+.||+||.+.++|||||.++|||++.++++||+|||+++.+-+..
T Consensus 612 mI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~ 691 (807)
T KOG1094|consen 612 MITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGD 691 (807)
T ss_pred HHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCC
Confidence 999999999999999765 334556667899999999999999999999999999999999999999999999775433
Q ss_pred Ccccc--ccCCCccccHHhhcc
Q 010401 489 EATEY--ETDGYRWLAPEVCFL 508 (511)
Q Consensus 489 ~~~~~--~~Gt~~YmAPEvl~g 508 (511)
..... ..-.++|||||.++.
T Consensus 692 yy~vqgr~vlpiRwmawEsill 713 (807)
T KOG1094|consen 692 YYRVQGRAVLPIRWMAWESILL 713 (807)
T ss_pred ceeeecceeeeeeehhHHHHHh
Confidence 21111 122479999998763
|
|
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=6e-26 Score=228.00 Aligned_cols=173 Identities=21% Similarity=0.410 Sum_probs=143.4
Q ss_pred ceEecCCCeEEEeeeecccceEEEEeE-------------EEEEEEEecCCCCchHHHHHHHHHHHHHhC-CCCceeeEe
Q 010401 334 RWLLNSDNLEFIDQIGPNSFKGVYKGK-------------RVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFY 399 (511)
Q Consensus 334 ~~~l~~~~y~l~~~LG~GsFG~VYkgk-------------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l-~HpNIV~l~ 399 (511)
+|.+..++|++.+.||+|+||.||+++ .+++|.+... ........+.+|+.++..+ +||||++++
T Consensus 9 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~i~~~~ 87 (304)
T cd05101 9 RWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLL 87 (304)
T ss_pred cccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccc-cchHHHHHHHHHHHHHHhhccCCCchhee
Confidence 567788899999999999999999874 4788877632 2233445688999999998 899999999
Q ss_pred eeEeeCCCcEEEEEeccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCC
Q 010401 400 CVCVDENHGLCVVTKLMEGGSVNDLILKS----------------RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQ 463 (511)
Q Consensus 400 g~~~~~~~~l~LVmEy~~gGsL~~lL~~~----------------~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~ 463 (511)
+++..... +|++|||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+
T Consensus 88 ~~~~~~~~-~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~ 166 (304)
T cd05101 88 GACTQDGP-LYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAAR 166 (304)
T ss_pred EEEecCCc-eEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccc
Confidence 99987765 89999999999999999653 24678889999999999999999999999999999
Q ss_pred ceEEcCCCcEEEEecCCceecccCCCc--cccccCCCccccHHhhcc
Q 010401 464 RILLDRHGNVCLGDMGIVTACKSVGEA--TEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 464 NILld~~g~vKL~DFGlS~~l~~~~~~--~~~~~Gt~~YmAPEvl~g 508 (511)
||+++.++.+||+|||+++........ .....+++.|+|||++.+
T Consensus 167 Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 213 (304)
T cd05101 167 NVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFD 213 (304)
T ss_pred eEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhcc
Confidence 999999999999999999876443221 222345678999998864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-25 Score=222.90 Aligned_cols=169 Identities=20% Similarity=0.389 Sum_probs=140.5
Q ss_pred ecCCCeEEEeeeecccceEEEEeE----------EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCC
Q 010401 337 LNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN 406 (511)
Q Consensus 337 l~~~~y~l~~~LG~GsFG~VYkgk----------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~ 406 (511)
+..++|++++.||+|+||.||+|+ .||+|.+... .......++.+|+.++..++||||+++++++....
T Consensus 4 l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~ 82 (279)
T cd05109 4 LKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLREN-TSPKANKEILDEAYVMAGVGSPYVCRLLGICLTST 82 (279)
T ss_pred cchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCC-CCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCCC
Confidence 456789999999999999999975 3789988642 23334566889999999999999999999997543
Q ss_pred CcEEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecc
Q 010401 407 HGLCVVTKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK 485 (511)
Q Consensus 407 ~~l~LVmEy~~gGsL~~lL~~-~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~ 485 (511)
.+++|||+++|+|.+++.. .+.+++..+..++.||+.||.|||+++|+||||||+|||+++++.+||+|||+++...
T Consensus 83 --~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~ 160 (279)
T cd05109 83 --VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLD 160 (279)
T ss_pred --cEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeecc
Confidence 6899999999999999966 3578999999999999999999999999999999999999999999999999998765
Q ss_pred cCCCcc--ccccCCCccccHHhhcc
Q 010401 486 SVGEAT--EYETDGYRWLAPEVCFL 508 (511)
Q Consensus 486 ~~~~~~--~~~~Gt~~YmAPEvl~g 508 (511)
...... ....+++.|+|||.+.+
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~ 185 (279)
T cd05109 161 IDETEYHADGGKVPIKWMALESILH 185 (279)
T ss_pred cccceeecCCCccchhhCCHHHhcc
Confidence 332211 12234568999999854
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-25 Score=217.67 Aligned_cols=168 Identities=20% Similarity=0.298 Sum_probs=142.8
Q ss_pred CeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEEe
Q 010401 341 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTK 414 (511)
Q Consensus 341 ~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVmE 414 (511)
.|++.+.||.|+||.||++ +.+++|++............+.+|+.+++.++|+||+++++.+...+..+|++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4789999999999999985 4699999875333344455678899999999999999999988755544899999
Q ss_pred ccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCccc
Q 010401 415 LMEGGSVNDLILK--SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE 492 (511)
Q Consensus 415 y~~gGsL~~lL~~--~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~~ 492 (511)
|+++++|.+++.. ...+++.++..++.|++.||.|||++|++||||||+||+++.++.++|+|||++...........
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~ 160 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAS 160 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccCCccc
Confidence 9999999999865 34689999999999999999999999999999999999999999999999999887654443344
Q ss_pred cccCCCccccHHhhcc
Q 010401 493 YETDGYRWLAPEVCFL 508 (511)
Q Consensus 493 ~~~Gt~~YmAPEvl~g 508 (511)
...+++.|+|||++.+
T Consensus 161 ~~~~~~~y~aPE~~~~ 176 (257)
T cd08223 161 TLIGTPYYMSPELFSN 176 (257)
T ss_pred cccCCcCccChhHhcC
Confidence 5678899999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.4e-26 Score=220.45 Aligned_cols=170 Identities=20% Similarity=0.403 Sum_probs=142.7
Q ss_pred eEecCCCeEEEeeeecccceEEEEeE-----EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcE
Q 010401 335 WLLNSDNLEFIDQIGPNSFKGVYKGK-----RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGL 409 (511)
Q Consensus 335 ~~l~~~~y~l~~~LG~GsFG~VYkgk-----~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l 409 (511)
|.+..++|++.++||+|+||.||+|. .+++|.+... ......+.+|+.+++.++|+||+++++.+.+.+. .
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~ 76 (261)
T cd05072 1 WEIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPG---TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEP-I 76 (261)
T ss_pred CcCchHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCC---chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC-c
Confidence 45677899999999999999999974 5889987632 2234568899999999999999999999987776 8
Q ss_pred EEEEeccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccC
Q 010401 410 CVVTKLMEGGSVNDLILK--SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV 487 (511)
Q Consensus 410 ~LVmEy~~gGsL~~lL~~--~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~ 487 (511)
+++|||+++++|.+++.. ...+++..+..++.|++.||+|||+++++||||||+||+++.++.++|+|||+++.....
T Consensus 77 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05072 77 YIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDN 156 (261)
T ss_pred EEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCC
Confidence 999999999999999864 346888999999999999999999999999999999999999999999999999876442
Q ss_pred CCc-cccccCCCccccHHhhcc
Q 010401 488 GEA-TEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 488 ~~~-~~~~~Gt~~YmAPEvl~g 508 (511)
... .....++..|+|||++.+
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~ 178 (261)
T cd05072 157 EYTAREGAKFPIKWTAPEAINF 178 (261)
T ss_pred ceeccCCCccceecCCHHHhcc
Confidence 211 122334668999998754
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.2e-26 Score=220.89 Aligned_cols=168 Identities=20% Similarity=0.357 Sum_probs=142.2
Q ss_pred CCeEEEeeeecccceEEEEe------EEEEEEEEecCCCC-chHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEE
Q 010401 340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKG-NAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV 412 (511)
Q Consensus 340 ~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~-~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LV 412 (511)
++|++.+.||+|+||.||+| +.+++|.+...... ......+.+|+.+++.++||||+++++++.+.+. .+++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~~v 80 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNE-LNIV 80 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCe-EEEE
Confidence 57899999999999999986 46899988643332 2334557889999999999999999999988775 8999
Q ss_pred EeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCC
Q 010401 413 TKLMEGGSVNDLILK----SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG 488 (511)
Q Consensus 413 mEy~~gGsL~~lL~~----~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~ 488 (511)
|||+++|+|.+++.. ...+++..+..++.||+.||.|||+++++||||||+||+++.++.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~ 160 (267)
T cd08228 81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchh
Confidence 999999999998852 3458899999999999999999999999999999999999999999999999988765433
Q ss_pred CccccccCCCccccHHhhcc
Q 010401 489 EATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 489 ~~~~~~~Gt~~YmAPEvl~g 508 (511)
.......|++.|+|||.+.+
T Consensus 161 ~~~~~~~~~~~~~aPE~~~~ 180 (267)
T cd08228 161 TAAHSLVGTPYYMSPERIHE 180 (267)
T ss_pred HHHhcCCCCccccChhhhcc
Confidence 33334568889999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-25 Score=221.20 Aligned_cols=169 Identities=21% Similarity=0.380 Sum_probs=140.9
Q ss_pred cCCCeEEEeeeecccceEEEEeE---------EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCc
Q 010401 338 NSDNLEFIDQIGPNSFKGVYKGK---------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHG 408 (511)
Q Consensus 338 ~~~~y~l~~~LG~GsFG~VYkgk---------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~ 408 (511)
..++|++.+.||+|+||.||+|+ .|++|.++.. ........+.+|+.++..++||||+++++++...+.
T Consensus 2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~- 79 (266)
T cd05033 2 DPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAG-SSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRP- 79 (266)
T ss_pred ChHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCC-CChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCc-
Confidence 35678999999999999999974 5788988642 233344567889999999999999999999987765
Q ss_pred EEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccC
Q 010401 409 LCVVTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV 487 (511)
Q Consensus 409 l~LVmEy~~gGsL~~lL~~~-~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~ 487 (511)
.|++|||+++++|.+++... +.+++..+..++.|++.||.|||+++|+||||||+||+++.++.++|+|||+++.....
T Consensus 80 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd05033 80 VMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS 159 (266)
T ss_pred eEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence 99999999999999999653 47899999999999999999999999999999999999999999999999999877522
Q ss_pred CCc--cccccCCCccccHHhhcc
Q 010401 488 GEA--TEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 488 ~~~--~~~~~Gt~~YmAPEvl~g 508 (511)
... .....+++.|+|||.+.+
T Consensus 160 ~~~~~~~~~~~~~~y~~Pe~~~~ 182 (266)
T cd05033 160 EATYTTKGGKIPIRWTAPEAIAY 182 (266)
T ss_pred ccceeccCCCCCccccChhhhcc
Confidence 211 112234578999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.4e-26 Score=222.87 Aligned_cols=166 Identities=22% Similarity=0.316 Sum_probs=139.7
Q ss_pred CeEEEeeeecccceEEEEeE------EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEEe
Q 010401 341 NLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTK 414 (511)
Q Consensus 341 ~y~l~~~LG~GsFG~VYkgk------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVmE 414 (511)
+|++.+.||+|+||.||+|+ .|++|++............+.+|+.++..++||||+++++++.+++. +|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~~v~e 79 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESR-LYLIFE 79 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCe-EEEEEe
Confidence 57899999999999999964 69999986533333334567889999999999999999999998776 999999
Q ss_pred ccCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCcc
Q 010401 415 LMEGGSVNDLILKS---RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT 491 (511)
Q Consensus 415 y~~gGsL~~lL~~~---~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~ 491 (511)
|+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++..........
T Consensus 80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 158 (285)
T cd07861 80 FLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVY 158 (285)
T ss_pred cCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcccc
Confidence 997 5898887532 568999999999999999999999999999999999999999999999999987654333323
Q ss_pred ccccCCCccccHHhhcc
Q 010401 492 EYETDGYRWLAPEVCFL 508 (511)
Q Consensus 492 ~~~~Gt~~YmAPEvl~g 508 (511)
....+++.|+|||++.+
T Consensus 159 ~~~~~~~~y~aPE~~~~ 175 (285)
T cd07861 159 THEVVTLWYRAPEVLLG 175 (285)
T ss_pred cCCcccccccChHHhcC
Confidence 34467889999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.6e-26 Score=261.04 Aligned_cols=169 Identities=24% Similarity=0.456 Sum_probs=143.5
Q ss_pred ecCCCeEEEeeeecccceEEEEeE-----------EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeC
Q 010401 337 LNSDNLEFIDQIGPNSFKGVYKGK-----------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDE 405 (511)
Q Consensus 337 l~~~~y~l~~~LG~GsFG~VYkgk-----------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~ 405 (511)
++.+..++.+.||+|.||.||.|. .||+|.+.+. .......+|.+|..+|++++|||||+++|+|.+.
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~-~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~ 767 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL-SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDS 767 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc-CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCC
Confidence 557788999999999999999974 4899999753 3445567799999999999999999999999996
Q ss_pred CCcEEEEEeccCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEec
Q 010401 406 NHGLCVVTKLMEGGSVNDLILKS-------RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDM 478 (511)
Q Consensus 406 ~~~l~LVmEy~~gGsL~~lL~~~-------~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DF 478 (511)
.. .+|++|||.+|+|..+|++. ..++..+++.++.|||+|+.||+++++|||||.++|+||+....|||+||
T Consensus 768 ~~-~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDF 846 (1025)
T KOG1095|consen 768 GP-PLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADF 846 (1025)
T ss_pred CC-cEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEccc
Confidence 55 88999999999999999764 35889999999999999999999999999999999999999999999999
Q ss_pred CCceecccCCCccccccC--CCccccHHhhc
Q 010401 479 GIVTACKSVGEATEYETD--GYRWLAPEVCF 507 (511)
Q Consensus 479 GlS~~l~~~~~~~~~~~G--t~~YmAPEvl~ 507 (511)
|+|+.+...........+ ..+|||||.++
T Consensus 847 GlArDiy~~~yyr~~~~a~lPvkWm~PEsl~ 877 (1025)
T KOG1095|consen 847 GLARDIYDKDYYRKHGEAMLPVKWMPPESLK 877 (1025)
T ss_pred chhHhhhhchheeccCccccceecCCHHHHh
Confidence 999954332221111112 36899999987
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-25 Score=224.63 Aligned_cols=168 Identities=23% Similarity=0.433 Sum_probs=140.3
Q ss_pred cCCCeEEEeeeecccceEEEEeE-----------EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCC
Q 010401 338 NSDNLEFIDQIGPNSFKGVYKGK-----------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN 406 (511)
Q Consensus 338 ~~~~y~l~~~LG~GsFG~VYkgk-----------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~ 406 (511)
+.++|.+.+.||+|+||.||+++ .+++|.+.. ........+.+|+.++.+++||||+++++++...+
T Consensus 3 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (288)
T cd05093 3 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKD--ASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGD 80 (288)
T ss_pred chHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCC--cCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence 45789999999999999999864 377887753 23334556889999999999999999999998777
Q ss_pred CcEEEEEeccCCCCHHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcE
Q 010401 407 HGLCVVTKLMEGGSVNDLILKSR-------------KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 473 (511)
Q Consensus 407 ~~l~LVmEy~~gGsL~~lL~~~~-------------~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~v 473 (511)
. +|++|||+++++|.+++...+ .+++..+..++.|++.||+|||++|++||||||+|||+++++.+
T Consensus 81 ~-~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~ 159 (288)
T cd05093 81 P-LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLV 159 (288)
T ss_pred c-cEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcE
Confidence 5 999999999999999996433 48999999999999999999999999999999999999999999
Q ss_pred EEEecCCceecccCCC--ccccccCCCccccHHhhcc
Q 010401 474 CLGDMGIVTACKSVGE--ATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 474 KL~DFGlS~~l~~~~~--~~~~~~Gt~~YmAPEvl~g 508 (511)
||+|||+++....... ......+++.|+|||++.+
T Consensus 160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 196 (288)
T cd05093 160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY 196 (288)
T ss_pred EeccCCccccccCCceeecCCCCCccccccCHHHhcc
Confidence 9999999876543221 1122334678999999864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-25 Score=220.51 Aligned_cols=170 Identities=23% Similarity=0.437 Sum_probs=141.9
Q ss_pred eEecCCCeEEEeeeecccceEEEEe-----EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcE
Q 010401 335 WLLNSDNLEFIDQIGPNSFKGVYKG-----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGL 409 (511)
Q Consensus 335 ~~l~~~~y~l~~~LG~GsFG~VYkg-----k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l 409 (511)
|++..++|++.+.||+|+||.||+| +.|++|.++... ....++.+|+.++.+++||||+++++++...+. +
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~ 76 (261)
T cd05068 1 WEIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT---MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEP-I 76 (261)
T ss_pred CccchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc---ccHHHHHHHHHHHHHCCCCCccceeEEEecCCC-e
Confidence 4567788999999999999999996 468999886422 224567889999999999999999999887776 8
Q ss_pred EEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccC
Q 010401 410 CVVTKLMEGGSVNDLILKSR--KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV 487 (511)
Q Consensus 410 ~LVmEy~~gGsL~~lL~~~~--~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~ 487 (511)
|++|||+++++|.+++.... .+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++.....
T Consensus 77 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05068 77 YIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKED 156 (261)
T ss_pred eeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCC
Confidence 99999999999999996543 6899999999999999999999999999999999999999999999999999876532
Q ss_pred CCc-cccccCCCccccHHhhcc
Q 010401 488 GEA-TEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 488 ~~~-~~~~~Gt~~YmAPEvl~g 508 (511)
... ......+..|+|||++.+
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~ 178 (261)
T cd05068 157 IYEAREGAKFPIKWTAPEAALY 178 (261)
T ss_pred cccccCCCcCceeccCcccccc
Confidence 211 111122357999998754
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-25 Score=224.57 Aligned_cols=165 Identities=24% Similarity=0.340 Sum_probs=143.9
Q ss_pred CCeEEEeeeecccceEEEEe------EEEEEEEEecCCCC-chHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEE
Q 010401 340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKG-NAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV 412 (511)
Q Consensus 340 ~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~-~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LV 412 (511)
++|++.+.||+|+||.||++ +.+++|++...... ......+.+|+.++++++||||+++++++.+++. +|+|
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~~v 79 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSN-LYLV 79 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCe-EEEE
Confidence 47899999999999999985 57999998643222 2234567889999999999999999999988776 9999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCccc
Q 010401 413 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE 492 (511)
Q Consensus 413 mEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~~ 492 (511)
|||+++++|.+++...+.+++..+..++.||+.||.|||++||+||||+|+||+++.++.+||+|||+++..... ..
T Consensus 80 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~---~~ 156 (290)
T cd05580 80 MEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR---TY 156 (290)
T ss_pred EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC---CC
Confidence 999999999999988888999999999999999999999999999999999999999999999999998876443 34
Q ss_pred cccCCCccccHHhhcc
Q 010401 493 YETDGYRWLAPEVCFL 508 (511)
Q Consensus 493 ~~~Gt~~YmAPEvl~g 508 (511)
...|++.|+|||.+.+
T Consensus 157 ~~~~~~~y~aPE~~~~ 172 (290)
T cd05580 157 TLCGTPEYLAPEIILS 172 (290)
T ss_pred CCCCCccccChhhhcC
Confidence 4578899999998864
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.4e-25 Score=216.83 Aligned_cols=166 Identities=20% Similarity=0.325 Sum_probs=142.2
Q ss_pred CeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEEe
Q 010401 341 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTK 414 (511)
Q Consensus 341 ~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVmE 414 (511)
+|++.+.||.|+||.||++ +.+++|.++... .......+.+|+.+++.++|+||+++++.+.+++. +|++||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~lv~e 78 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK-SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGH-LYIVME 78 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc-chHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCE-EEEEEe
Confidence 5789999999999999985 468999886432 23344567889999999999999999999988776 999999
Q ss_pred ccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCccc
Q 010401 415 LMEGGSVNDLILK--SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE 492 (511)
Q Consensus 415 y~~gGsL~~lL~~--~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~~ 492 (511)
|+++++|.+++.. ...+++..+..++.||+.||.|||++||+|+||||+||+++.++.++|+|||+++..........
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~ 158 (255)
T cd08219 79 YCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYAC 158 (255)
T ss_pred eCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecccccccc
Confidence 9999999998864 24689999999999999999999999999999999999999999999999999987755444344
Q ss_pred cccCCCccccHHhhcc
Q 010401 493 YETDGYRWLAPEVCFL 508 (511)
Q Consensus 493 ~~~Gt~~YmAPEvl~g 508 (511)
...|++.|+|||++.+
T Consensus 159 ~~~~~~~~~aPE~~~~ 174 (255)
T cd08219 159 TYVGTPYYVPPEIWEN 174 (255)
T ss_pred cccCCccccCHHHHcc
Confidence 5678889999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-25 Score=223.74 Aligned_cols=173 Identities=25% Similarity=0.432 Sum_probs=143.5
Q ss_pred ceEecCCCeEEEeeeecccceEEEEeE-----------EEEEEEEecCCCCchHHHHHHHHHHHHHhC-CCCceeeEeee
Q 010401 334 RWLLNSDNLEFIDQIGPNSFKGVYKGK-----------RVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCV 401 (511)
Q Consensus 334 ~~~l~~~~y~l~~~LG~GsFG~VYkgk-----------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l-~HpNIV~l~g~ 401 (511)
.|.+..++|++.+.||+|+||.||+++ .+++|.+... .......++.+|+.++.++ +|+||++++++
T Consensus 6 ~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 84 (293)
T cd05053 6 EWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLGV 84 (293)
T ss_pred ccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCC-CCHHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 677888999999999999999999974 5788888642 2333345678899999999 89999999999
Q ss_pred EeeCCCcEEEEEeccCCCCHHHHHHh----------------cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCce
Q 010401 402 CVDENHGLCVVTKLMEGGSVNDLILK----------------SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRI 465 (511)
Q Consensus 402 ~~~~~~~l~LVmEy~~gGsL~~lL~~----------------~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NI 465 (511)
+..++. +|++|||+++|+|..++.. ...+++..+..++.||+.||.|||+++|+||||||+||
T Consensus 85 ~~~~~~-~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Ni 163 (293)
T cd05053 85 CTQEGP-LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNV 163 (293)
T ss_pred EcCCCC-eEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeE
Confidence 987775 9999999999999999853 24688999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCceecccCCCc--cccccCCCccccHHhhcc
Q 010401 466 LLDRHGNVCLGDMGIVTACKSVGEA--TEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 466 Lld~~g~vKL~DFGlS~~l~~~~~~--~~~~~Gt~~YmAPEvl~g 508 (511)
+++.++.+||+|||+++.+...... .....+++.|+|||++.+
T Consensus 164 l~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 208 (293)
T cd05053 164 LVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFD 208 (293)
T ss_pred EEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhcc
Confidence 9999999999999998876442211 112234567999998754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-26 Score=220.65 Aligned_cols=196 Identities=21% Similarity=0.346 Sum_probs=155.8
Q ss_pred ccCCCCCCCccccccccchhcCCCccccceEecCCCeEEEeeeecccceEEEE------eEEEEEEEEecCCCCchHHHH
Q 010401 306 LQMPLPSSSFVVSVDEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFE 379 (511)
Q Consensus 306 l~~P~psss~~~s~d~~~~~~s~~~~i~~~~l~~~~y~l~~~LG~GsFG~VYk------gk~VAVKkL~~~~~~~~~~~~ 379 (511)
...|.|...++...+.-.....+.. .+.++.+++.-+..||+|+||.|-+ |+..|+|.+.. ........+
T Consensus 15 ~~~P~~~~tpp~~Ld~~a~i~I~~~---~~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~-tvn~q~q~r 90 (282)
T KOG0984|consen 15 LKLPAPRETPPRNLDSRALIYIGDR---NFEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRA-TVNSQEQKR 90 (282)
T ss_pred ccCCCcCCCCCcccCCCceEEEecC---ccccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehh-hcChHHHHH
Confidence 3344454444444443333222222 3678888999999999999998754 78999999975 344555677
Q ss_pred HHHHHHHHHhC-CCCceeeEeeeEeeCCCcEEEEEeccCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHH-C
Q 010401 380 LRKDLLELMTC-GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL----KSRKLQTKEIIRIAIDVAEGIKFLND-H 453 (511)
Q Consensus 380 ~~~Ei~iL~~l-~HpNIV~l~g~~~~~~~~l~LVmEy~~gGsL~~lL~----~~~~L~e~~~~~ia~qIa~gL~yLH~-~ 453 (511)
.++|+.+.++. .+|++|.|||...++.. +||.||.|.. +|..+.+ ..+.++|..+-+|+..|+.||.|||+ .
T Consensus 91 ~L~dldi~~r~~~CPf~V~FyGa~~regd-vwIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL 168 (282)
T KOG0984|consen 91 LLMDLDIIMRTVDCPFTVHFYGALFREGD-VWICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL 168 (282)
T ss_pred HHHhhhhhccCCCCCeEEEeehhhhcccc-EEEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh
Confidence 89999988775 89999999999998887 9999999976 8877653 45789999999999999999999997 4
Q ss_pred CccccCCCCCceEEcCCCcEEEEecCCceecccCCCccccccCCCccccHHhhcc
Q 010401 454 GVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 454 gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~~~~~Gt~~YmAPEvl~g 508 (511)
.|||||+||+|||++.+|.|||||||++-.+.+ +-..+...|+..|||||.+..
T Consensus 169 ~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~d-SiAkt~daGCkpYmaPEri~~ 222 (282)
T KOG0984|consen 169 SVIHRDVKPSNILINYDGQVKICDFGISGYLVD-SIAKTMDAGCKPYMAPERINP 222 (282)
T ss_pred hhhhccCCcceEEEccCCcEEEcccccceeehh-hhHHHHhcCCCccCChhhcCc
Confidence 899999999999999999999999999987754 334555678889999999864
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-25 Score=217.38 Aligned_cols=168 Identities=24% Similarity=0.437 Sum_probs=145.0
Q ss_pred CCCeEEEeeeecccceEEEEeE------EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEE
Q 010401 339 SDNLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV 412 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkgk------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LV 412 (511)
.++|++.+.||.|+||.||+++ .+++|.+...... ....+.+|+.+++.++||||+++++++.+.+. +|++
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~-~~l~ 78 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD--DFEIIQQEISMLKECRHPNIVAYFGSYLRRDK-LWIV 78 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh--hHHHHHHHHHHHHhCCCCChhceEEEEEeCCE-EEEE
Confidence 4678999999999999999974 5889988743222 34568899999999999999999999988775 9999
Q ss_pred EeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCcc
Q 010401 413 TKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT 491 (511)
Q Consensus 413 mEy~~gGsL~~lL~~~-~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~ 491 (511)
|||+.+++|.+++... ..+++..+..++.|++.||.|||+++|+|+||+|+||+++.++.+||+|||++..........
T Consensus 79 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 158 (262)
T cd06613 79 MEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKR 158 (262)
T ss_pred EeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhhcc
Confidence 9999999999998765 789999999999999999999999999999999999999999999999999987665433334
Q ss_pred ccccCCCccccHHhhccc
Q 010401 492 EYETDGYRWLAPEVCFLL 509 (511)
Q Consensus 492 ~~~~Gt~~YmAPEvl~gl 509 (511)
....++..|+|||++.+.
T Consensus 159 ~~~~~~~~y~~Pe~~~~~ 176 (262)
T cd06613 159 KSFIGTPYWMAPEVAAVE 176 (262)
T ss_pred ccccCCccccCchhhccc
Confidence 455788899999998653
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.1e-25 Score=216.98 Aligned_cols=168 Identities=19% Similarity=0.325 Sum_probs=144.2
Q ss_pred CeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEEe
Q 010401 341 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTK 414 (511)
Q Consensus 341 ~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVmE 414 (511)
+|++.+.||.|+||.||.+ +.+++|++...........++.+|+.++++++|+||+++++++.+.+. ++++||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~-~~~~~e 79 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNT-LLIEME 79 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCe-EEEEEE
Confidence 4889999999999988874 578999886544444455668899999999999999999999988765 999999
Q ss_pred ccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCccc
Q 010401 415 LMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE 492 (511)
Q Consensus 415 y~~gGsL~~lL~~~--~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~~ 492 (511)
|+++++|.+++... ..+++..+..++.|++.||.|||+.|++||||+|+||+++.++.+||+|||++...........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~ 159 (256)
T cd08221 80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAE 159 (256)
T ss_pred ecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEccccccccc
Confidence 99999999999654 4689999999999999999999999999999999999999999999999999887654433344
Q ss_pred cccCCCccccHHhhccc
Q 010401 493 YETDGYRWLAPEVCFLL 509 (511)
Q Consensus 493 ~~~Gt~~YmAPEvl~gl 509 (511)
...|++.|+|||++.+.
T Consensus 160 ~~~~~~~y~ape~~~~~ 176 (256)
T cd08221 160 TVVGTPYYMSPELCQGV 176 (256)
T ss_pred ccCCCccccCHhhcCCC
Confidence 55788999999997653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.6e-26 Score=225.69 Aligned_cols=173 Identities=23% Similarity=0.390 Sum_probs=146.9
Q ss_pred ccceEecCCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeC
Q 010401 332 IGRWLLNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDE 405 (511)
Q Consensus 332 i~~~~l~~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~ 405 (511)
++++..+.+.|+++++||.|+||.||+| +.+++|.+.. ........+.+|+.+++.++||||+++++.+..+
T Consensus 4 ~~~~~~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 81 (292)
T cd06644 4 VRRDLDPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIET--KSEEELEDYMVEIEILATCNHPYIVKLLGAFYWD 81 (292)
T ss_pred hhcccCcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEecc--CCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeC
Confidence 4566677788999999999999999986 4688888863 2333455678899999999999999999999877
Q ss_pred CCcEEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceec
Q 010401 406 NHGLCVVTKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC 484 (511)
Q Consensus 406 ~~~l~LVmEy~~gGsL~~lL~~-~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l 484 (511)
+. +|+||||+++++|..++.. ...+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++...
T Consensus 82 ~~-~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~ 160 (292)
T cd06644 82 GK-LWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKN 160 (292)
T ss_pred Ce-EEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceec
Confidence 75 9999999999999988754 457899999999999999999999999999999999999999999999999998765
Q ss_pred ccCCCccccccCCCccccHHhhc
Q 010401 485 KSVGEATEYETDGYRWLAPEVCF 507 (511)
Q Consensus 485 ~~~~~~~~~~~Gt~~YmAPEvl~ 507 (511)
...........+++.|+|||++.
T Consensus 161 ~~~~~~~~~~~~~~~y~aPE~~~ 183 (292)
T cd06644 161 VKTLQRRDSFIGTPYWMAPEVVM 183 (292)
T ss_pred cccccccceecCCccccCceeec
Confidence 44333334556888999999874
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-25 Score=221.38 Aligned_cols=168 Identities=24% Similarity=0.424 Sum_probs=138.0
Q ss_pred CCCeEEEeeeecccceEEEEeE----------EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCC-C
Q 010401 339 SDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN-H 407 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkgk----------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~-~ 407 (511)
..+|++.+.||+|+||.||+++ .+++|++.. ........+.+|+.++..++||||+++++++...+ .
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 80 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQH--STAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 80 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEecc--CCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCC
Confidence 4578999999999999999854 689999863 23334456889999999999999999999875433 3
Q ss_pred cEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceeccc
Q 010401 408 GLCVVTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS 486 (511)
Q Consensus 408 ~l~LVmEy~~gGsL~~lL~~~-~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~ 486 (511)
.+++||||+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++....
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 160 (284)
T cd05081 81 NLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ 160 (284)
T ss_pred ceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence 489999999999999999654 4689999999999999999999999999999999999999999999999999987654
Q ss_pred CCCc---cccccCCCccccHHhhcc
Q 010401 487 VGEA---TEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 487 ~~~~---~~~~~Gt~~YmAPEvl~g 508 (511)
.... .....++..|+|||++.+
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~ 185 (284)
T cd05081 161 DKEYYKVREPGESPIFWYAPESLTE 185 (284)
T ss_pred CCcceeecCCCCCceEeeCHHHhcc
Confidence 3221 111223456999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-25 Score=232.61 Aligned_cols=167 Identities=20% Similarity=0.277 Sum_probs=138.7
Q ss_pred CCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCC-----C
Q 010401 339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN-----H 407 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~-----~ 407 (511)
.++|++.+.||+|+||.||++ +.+|+|++............+.+|+.+++.++||||+++++++...+ .
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 568999999999999999985 46999999754434444566788999999999999999999876433 2
Q ss_pred cEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccC
Q 010401 408 GLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV 487 (511)
Q Consensus 408 ~l~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~ 487 (511)
.+|+||||+.+ +|.+.+.. .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 103 ~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~ 179 (364)
T cd07875 103 DVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 179 (364)
T ss_pred eEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccCCC
Confidence 37999999976 78777643 4788999999999999999999999999999999999999999999999999765432
Q ss_pred CCccccccCCCccccHHhhccc
Q 010401 488 GEATEYETDGYRWLAPEVCFLL 509 (511)
Q Consensus 488 ~~~~~~~~Gt~~YmAPEvl~gl 509 (511)
.......|++.|+|||++.+.
T Consensus 180 -~~~~~~~~t~~y~aPE~~~~~ 200 (364)
T cd07875 180 -FMMTPYVVTRYYRAPEVILGM 200 (364)
T ss_pred -CcccCCcccCCcCCHHHHhCC
Confidence 223445788999999998653
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-25 Score=221.36 Aligned_cols=160 Identities=23% Similarity=0.358 Sum_probs=128.9
Q ss_pred eeeecccceEEEEeE--------EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEEeccC
Q 010401 346 DQIGPNSFKGVYKGK--------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLME 417 (511)
Q Consensus 346 ~~LG~GsFG~VYkgk--------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVmEy~~ 417 (511)
++||+|+||.||+|+ .+++|.+.. .........+.+|+..++.++|+||+++++.+.+.+. +|+||||++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~-~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~-~~lv~e~~~ 78 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRA-SATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIP-YLLVLEFCP 78 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCc-cCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCc-eEEEEEeCC
Confidence 368999999999974 456666643 2223334557889999999999999999999987776 999999999
Q ss_pred CCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCC--c
Q 010401 418 GGSVNDLILKSR-----KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE--A 490 (511)
Q Consensus 418 gGsL~~lL~~~~-----~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~--~ 490 (511)
+|+|.+++.... ..++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++....... .
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred CCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 999999996532 346778899999999999999999999999999999999999999999999865432211 1
Q ss_pred cccccCCCccccHHhhc
Q 010401 491 TEYETDGYRWLAPEVCF 507 (511)
Q Consensus 491 ~~~~~Gt~~YmAPEvl~ 507 (511)
.....+++.|+|||++.
T Consensus 159 ~~~~~~~~~y~aPE~~~ 175 (269)
T cd05042 159 KDCHAVPLRWLAPELVE 175 (269)
T ss_pred cCCCCCcccccCHHHHh
Confidence 22334567899999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-25 Score=238.18 Aligned_cols=173 Identities=22% Similarity=0.403 Sum_probs=143.9
Q ss_pred ceEecCCCeEEEeeeecccceEEEEeE-----------EEEEEEEecCCCCchHHHHHHHHHHHHHhCC-CCceeeEeee
Q 010401 334 RWLLNSDNLEFIDQIGPNSFKGVYKGK-----------RVGIEKLKGCDKGNAYEFELRKDLLELMTCG-HKNILQFYCV 401 (511)
Q Consensus 334 ~~~l~~~~y~l~~~LG~GsFG~VYkgk-----------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~-HpNIV~l~g~ 401 (511)
.|.+..++|.+.+.||+|+||.||+++ .||+|+++... .......+.+|+.++..+. ||||++++++
T Consensus 31 ~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~~H~niv~~~~~ 109 (401)
T cd05107 31 AWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA-RSSEKQALMSELKIMSHLGPHLNIVNLLGA 109 (401)
T ss_pred cceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC-ChhHHHHHHHHHHHHHhcCCCCCeEEEEEE
Confidence 588889999999999999999999974 69999997432 2223345789999999997 9999999999
Q ss_pred EeeCCCcEEEEEeccCCCCHHHHHHhcC----------------------------------------------------
Q 010401 402 CVDENHGLCVVTKLMEGGSVNDLILKSR---------------------------------------------------- 429 (511)
Q Consensus 402 ~~~~~~~l~LVmEy~~gGsL~~lL~~~~---------------------------------------------------- 429 (511)
|...+. +++||||+++|+|.+++...+
T Consensus 110 ~~~~~~-~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (401)
T cd05107 110 CTKGGP-IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESAD 188 (401)
T ss_pred EccCCC-cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccC
Confidence 988775 999999999999999985421
Q ss_pred ----------------------------------------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCC
Q 010401 430 ----------------------------------------------KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQ 463 (511)
Q Consensus 430 ----------------------------------------------~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~ 463 (511)
.+++..++.++.||+.||+|||+.+|+||||||+
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~ 268 (401)
T cd05107 189 YVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAAR 268 (401)
T ss_pred ccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcc
Confidence 2566778889999999999999999999999999
Q ss_pred ceEEcCCCcEEEEecCCceecccCCC--ccccccCCCccccHHhhcc
Q 010401 464 RILLDRHGNVCLGDMGIVTACKSVGE--ATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 464 NILld~~g~vKL~DFGlS~~l~~~~~--~~~~~~Gt~~YmAPEvl~g 508 (511)
|||++.++.+||+|||+++....... ......+++.|+|||++.+
T Consensus 269 NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 315 (401)
T cd05107 269 NVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFN 315 (401)
T ss_pred eEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcC
Confidence 99999999999999999986543221 1223356788999998864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-25 Score=226.70 Aligned_cols=173 Identities=23% Similarity=0.427 Sum_probs=142.3
Q ss_pred ceEecCCCeEEEeeeecccceEEEEeE-------------EEEEEEEecCCCCchHHHHHHHHHHHHHhC-CCCceeeEe
Q 010401 334 RWLLNSDNLEFIDQIGPNSFKGVYKGK-------------RVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFY 399 (511)
Q Consensus 334 ~~~l~~~~y~l~~~LG~GsFG~VYkgk-------------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l-~HpNIV~l~ 399 (511)
.|.+..++|.+.+.||+|+||.||+++ .+|+|.++.. ........+.+|+.++..+ +||||++++
T Consensus 6 ~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~ 84 (314)
T cd05099 6 KWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDN-ATDKDLADLISEMELMKLIGKHKNIINLL 84 (314)
T ss_pred cccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCC-CChHHHHHHHHHHHHHHhccCCCCeeeEE
Confidence 567778899999999999999999974 4888887642 2233345678899999988 699999999
Q ss_pred eeEeeCCCcEEEEEeccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCC
Q 010401 400 CVCVDENHGLCVVTKLMEGGSVNDLILKS----------------RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQ 463 (511)
Q Consensus 400 g~~~~~~~~l~LVmEy~~gGsL~~lL~~~----------------~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~ 463 (511)
+++.+.+. +|++|||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+
T Consensus 85 ~~~~~~~~-~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~ 163 (314)
T cd05099 85 GVCTQEGP-LYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAAR 163 (314)
T ss_pred EEEccCCc-eEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccce
Confidence 99987765 99999999999999999642 34788899999999999999999999999999999
Q ss_pred ceEEcCCCcEEEEecCCceecccCCCc--cccccCCCccccHHhhcc
Q 010401 464 RILLDRHGNVCLGDMGIVTACKSVGEA--TEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 464 NILld~~g~vKL~DFGlS~~l~~~~~~--~~~~~Gt~~YmAPEvl~g 508 (511)
|||++.++.+||+|||+++........ .....+++.|+|||++.+
T Consensus 164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 210 (314)
T cd05099 164 NVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFD 210 (314)
T ss_pred eEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHcc
Confidence 999999999999999999765432211 122234467999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.4e-25 Score=240.05 Aligned_cols=161 Identities=18% Similarity=0.220 Sum_probs=136.2
Q ss_pred cCCCeEEEeeeecccceEEEEeE------EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEE
Q 010401 338 NSDNLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCV 411 (511)
Q Consensus 338 ~~~~y~l~~~LG~GsFG~VYkgk------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~L 411 (511)
....|.+.+.||+|+||.||++. .|++|.... ..+.+|+.++++++|+||+++++++..++. .++
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~--------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~-~~l 237 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY--------ASSVHEARLLRRLSHPAVLALLDVRVVGGL-TCL 237 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc--------cCHHHHHHHHHHCCCCCCCcEEEEEEECCE-EEE
Confidence 35579999999999999999964 588885421 235689999999999999999999988775 899
Q ss_pred EEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCC-
Q 010401 412 VTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE- 489 (511)
Q Consensus 412 VmEy~~gGsL~~lL~~~-~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~- 489 (511)
|||++. ++|.+++... ..+++..++.++.||+.||.|||++|||||||||+|||++.++.+||+|||+++.......
T Consensus 238 v~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~ 316 (461)
T PHA03211 238 VLPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST 316 (461)
T ss_pred EEEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceeccccccc
Confidence 999995 5898888653 5799999999999999999999999999999999999999999999999999986543221
Q ss_pred -ccccccCCCccccHHhhcc
Q 010401 490 -ATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 490 -~~~~~~Gt~~YmAPEvl~g 508 (511)
......||+.|+|||++.+
T Consensus 317 ~~~~~~~GT~~Y~APE~~~~ 336 (461)
T PHA03211 317 PFHYGIAGTVDTNAPEVLAG 336 (461)
T ss_pred ccccccCCCcCCcCHHHHcC
Confidence 1234578999999999865
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2e-25 Score=223.14 Aligned_cols=166 Identities=21% Similarity=0.311 Sum_probs=139.4
Q ss_pred CeEEEeeeecccceEEEEe------EEEEEEEEecCCCCc-hHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEE
Q 010401 341 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGN-AYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT 413 (511)
Q Consensus 341 ~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~-~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVm 413 (511)
.|+..+.||+|+||.||++ +.+|+|.+....... .....+.+|+.++..++|+||+.+++.+.+.+. +|+||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~-~~lv~ 79 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDA-LCLVL 79 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCE-EEEEE
Confidence 3678899999999999984 579999986533222 223446789999999999999999999988775 99999
Q ss_pred eccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCcc
Q 010401 414 KLMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT 491 (511)
Q Consensus 414 Ey~~gGsL~~lL~~~--~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~ 491 (511)
||+.+++|.+++... ..+++..+..++.|++.||.|||+++|+||||||+||+++.++.++|+|||++....... ..
T Consensus 80 e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~~ 158 (285)
T cd05630 80 TLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-TI 158 (285)
T ss_pred EecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc-cc
Confidence 999999999988543 368999999999999999999999999999999999999999999999999987654322 22
Q ss_pred ccccCCCccccHHhhcc
Q 010401 492 EYETDGYRWLAPEVCFL 508 (511)
Q Consensus 492 ~~~~Gt~~YmAPEvl~g 508 (511)
....|++.|+|||++.+
T Consensus 159 ~~~~g~~~y~aPE~~~~ 175 (285)
T cd05630 159 KGRVGTVGYMAPEVVKN 175 (285)
T ss_pred cCCCCCccccChHHHcC
Confidence 34578999999999865
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.1e-26 Score=223.18 Aligned_cols=169 Identities=24% Similarity=0.441 Sum_probs=140.8
Q ss_pred cCCCeEEEeeeecccceEEEEeE-----------EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCC
Q 010401 338 NSDNLEFIDQIGPNSFKGVYKGK-----------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN 406 (511)
Q Consensus 338 ~~~~y~l~~~LG~GsFG~VYkgk-----------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~ 406 (511)
..++|.+.+.||+|+||.||+|+ .+++|.++.. ........+.+|+.++..++|+||+++++++...+
T Consensus 3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 81 (280)
T cd05049 3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKET-ASNDARKDFEREAELLTNFQHENIVKFYGVCTEGD 81 (280)
T ss_pred ChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeeccc-CCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCC
Confidence 35678899999999999999963 4889988642 22224567899999999999999999999999887
Q ss_pred CcEEEEEeccCCCCHHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCc
Q 010401 407 HGLCVVTKLMEGGSVNDLILKS--------------RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGN 472 (511)
Q Consensus 407 ~~l~LVmEy~~gGsL~~lL~~~--------------~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~ 472 (511)
. +|++|||+++++|.+++... ..+++..+..++.||+.||.|||++|++||||||+||+++.++.
T Consensus 82 ~-~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 82 P-PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred C-eEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCe
Confidence 6 99999999999999999653 24788899999999999999999999999999999999999999
Q ss_pred EEEEecCCceecccCCC--ccccccCCCccccHHhhcc
Q 010401 473 VCLGDMGIVTACKSVGE--ATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 473 vKL~DFGlS~~l~~~~~--~~~~~~Gt~~YmAPEvl~g 508 (511)
+||+|||+++....... ......+++.|+|||++.+
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 198 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMY 198 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhcc
Confidence 99999999876533221 1223345678999999864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2e-25 Score=222.86 Aligned_cols=165 Identities=19% Similarity=0.280 Sum_probs=138.7
Q ss_pred eEEEeeeecccceEEEEe------EEEEEEEEecCCCCc-hHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEEe
Q 010401 342 LEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGN-AYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTK 414 (511)
Q Consensus 342 y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~-~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVmE 414 (511)
|+..+.||+|+||.||++ +.+|+|.+....... .....+.+|+.+++.++|+||+.+++.+.+++. +|++||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~-~~lv~e 80 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDA-LCLVLT 80 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCE-EEEEEE
Confidence 677899999999999995 479999986432222 223446789999999999999999999987775 999999
Q ss_pred ccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCccc
Q 010401 415 LMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE 492 (511)
Q Consensus 415 y~~gGsL~~lL~~~--~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~~ 492 (511)
|+.+++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++....... ...
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~ 159 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE-SIR 159 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCC-ccc
Confidence 99999999888543 369999999999999999999999999999999999999999999999999987654322 223
Q ss_pred cccCCCccccHHhhcc
Q 010401 493 YETDGYRWLAPEVCFL 508 (511)
Q Consensus 493 ~~~Gt~~YmAPEvl~g 508 (511)
...|+..|+|||++.+
T Consensus 160 ~~~g~~~~~aPE~~~~ 175 (285)
T cd05632 160 GRVGTVGYMAPEVLNN 175 (285)
T ss_pred CCCCCcCccChHHhcC
Confidence 4578999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-25 Score=220.63 Aligned_cols=169 Identities=24% Similarity=0.369 Sum_probs=140.0
Q ss_pred cCCCeEEEeeeecccceEEEEeE---------EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCc
Q 010401 338 NSDNLEFIDQIGPNSFKGVYKGK---------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHG 408 (511)
Q Consensus 338 ~~~~y~l~~~LG~GsFG~VYkgk---------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~ 408 (511)
+.++|++.+.||+|+||.||+|+ .+++|.++.. ........+.+|+.++..++||||+++++++.+++.
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~- 79 (267)
T cd05066 2 DASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAG-YTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKP- 79 (267)
T ss_pred CHHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCC-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCc-
Confidence 35678999999999999999874 4788888642 223344568899999999999999999999987765
Q ss_pred EEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccC
Q 010401 409 LCVVTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV 487 (511)
Q Consensus 409 l~LVmEy~~gGsL~~lL~~~-~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~ 487 (511)
+|+||||+++++|.+++... +.+++..+..++.|++.||.|||+++++||||||+|||++.++.++|+|||+++.....
T Consensus 80 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd05066 80 VMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 159 (267)
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence 99999999999999999654 46899999999999999999999999999999999999999999999999998876443
Q ss_pred CCccc---cccCCCccccHHhhcc
Q 010401 488 GEATE---YETDGYRWLAPEVCFL 508 (511)
Q Consensus 488 ~~~~~---~~~Gt~~YmAPEvl~g 508 (511)
..... ...++..|+|||++.+
T Consensus 160 ~~~~~~~~~~~~~~~y~~pe~~~~ 183 (267)
T cd05066 160 PEAAYTTRGGKIPIRWTAPEAIAY 183 (267)
T ss_pred cceeeecCCCccceeecCHhHhcc
Confidence 22111 1223467999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-25 Score=218.41 Aligned_cols=166 Identities=24% Similarity=0.378 Sum_probs=142.2
Q ss_pred EecCCCeEEEeeeecccceEEEEe----EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEE
Q 010401 336 LLNSDNLEFIDQIGPNSFKGVYKG----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCV 411 (511)
Q Consensus 336 ~l~~~~y~l~~~LG~GsFG~VYkg----k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~L 411 (511)
.+..++|++.+.||.|+||.||++ +.|++|++..... ...++.+|+.++..++|+||+++++++.+.+. .|+
T Consensus 2 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-~~~ 77 (256)
T cd05039 2 AINSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNP-LYI 77 (256)
T ss_pred ccChhhccceeeeecCCCceEEEEEecCcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCC-eEE
Confidence 456778999999999999999985 5799999974322 45668899999999999999999999987665 999
Q ss_pred EEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCC
Q 010401 412 VTKLMEGGSVNDLILKSR--KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE 489 (511)
Q Consensus 412 VmEy~~gGsL~~lL~~~~--~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~ 489 (511)
||||+++++|.+++.... .+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||+++.....
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~-- 155 (256)
T cd05039 78 VTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG-- 155 (256)
T ss_pred EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccccccc--
Confidence 999999999999997654 7899999999999999999999999999999999999999999999999998876322
Q ss_pred ccccccCCCccccHHhhcc
Q 010401 490 ATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 490 ~~~~~~Gt~~YmAPEvl~g 508 (511)
.....++..|+|||.+.+
T Consensus 156 -~~~~~~~~~~~ape~~~~ 173 (256)
T cd05039 156 -QDSGKLPVKWTAPEALRE 173 (256)
T ss_pred -cccCCCcccccCchhhcC
Confidence 123344567999998753
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.9e-27 Score=230.37 Aligned_cols=166 Identities=25% Similarity=0.355 Sum_probs=143.3
Q ss_pred CeEEEeeeecccceEEEE------eEEEEEEEEecCC---CCch---HHHHHHHHHHHHHhC-CCCceeeEeeeEeeCCC
Q 010401 341 NLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCD---KGNA---YEFELRKDLLELMTC-GHKNILQFYCVCVDENH 407 (511)
Q Consensus 341 ~y~l~~~LG~GsFG~VYk------gk~VAVKkL~~~~---~~~~---~~~~~~~Ei~iL~~l-~HpNIV~l~g~~~~~~~ 407 (511)
.|+-.+.||.|..+.|-+ |+..|+|++.... .+.. ......+|+.+|+++ .||+|+++.+++..+.-
T Consensus 18 ~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF 97 (411)
T KOG0599|consen 18 KYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAF 97 (411)
T ss_pred hcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcch
Confidence 456668899999998877 5678899886422 1111 223367899999986 89999999999998775
Q ss_pred cEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccC
Q 010401 408 GLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV 487 (511)
Q Consensus 408 ~l~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~ 487 (511)
+++|+|+|+.|.|.|+|.+.-.++++..+.|+.|+..|++|||.++||||||||+|||++++.++||+|||+|..+..
T Consensus 98 -~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~~- 175 (411)
T KOG0599|consen 98 -VFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLEP- 175 (411)
T ss_pred -hhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccCC-
Confidence 899999999999999998888999999999999999999999999999999999999999999999999999998865
Q ss_pred CCccccccCCCccccHHhhcc
Q 010401 488 GEATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 488 ~~~~~~~~Gt~~YmAPEvl~g 508 (511)
++.....||||+|+|||.+.+
T Consensus 176 GekLrelCGTPgYLAPEtikC 196 (411)
T KOG0599|consen 176 GEKLRELCGTPGYLAPETIKC 196 (411)
T ss_pred chhHHHhcCCCcccChhheee
Confidence 455778899999999999865
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.2e-25 Score=225.22 Aligned_cols=165 Identities=20% Similarity=0.350 Sum_probs=141.7
Q ss_pred CCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEE
Q 010401 340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT 413 (511)
Q Consensus 340 ~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVm 413 (511)
++|++.+.||+|+||.||++ +.+++|.+.. ........++.+|+.++..++||||++++++|.+++. +|+||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~-~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~lv~ 78 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHL-EIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGE-ISICM 78 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecc-ccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCE-EEEEe
Confidence 46899999999999999996 4578887763 2233344568899999999999999999999988776 99999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCceEEcCCCcEEEEecCCceecccCCCccc
Q 010401 414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLND-HGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE 492 (511)
Q Consensus 414 Ey~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~-~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~~ 492 (511)
||+++++|.+++...+.+++..+..++.||+.||.|||+ ++++||||||+|||++.++.+||+|||++...... ...
T Consensus 79 ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--~~~ 156 (308)
T cd06615 79 EHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MAN 156 (308)
T ss_pred eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc--ccc
Confidence 999999999999877889999999999999999999997 69999999999999999999999999998765332 233
Q ss_pred cccCCCccccHHhhcc
Q 010401 493 YETDGYRWLAPEVCFL 508 (511)
Q Consensus 493 ~~~Gt~~YmAPEvl~g 508 (511)
...|+..|+|||.+.+
T Consensus 157 ~~~~~~~~~aPE~~~~ 172 (308)
T cd06615 157 SFVGTRSYMSPERLQG 172 (308)
T ss_pred cCCCCcCccChhHhcC
Confidence 4578899999998764
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.93 E-value=3e-25 Score=216.47 Aligned_cols=168 Identities=20% Similarity=0.362 Sum_probs=143.2
Q ss_pred CCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCc-hHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEE
Q 010401 340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGN-AYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV 412 (511)
Q Consensus 340 ~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~-~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LV 412 (511)
++|++.+.||+|+||.||++ +.+++|.++...... .....+.+|+.++++++|+||+++++++.+.+. .+++
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~-~~lv 80 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNE-LNIV 80 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCe-EEEE
Confidence 57899999999999999985 468999886433332 235568899999999999999999999988765 8999
Q ss_pred EeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCC
Q 010401 413 TKLMEGGSVNDLILK----SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG 488 (511)
Q Consensus 413 mEy~~gGsL~~lL~~----~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~ 488 (511)
|||+++++|.+++.. ...+++..+..++.+++.||.|||+.||+||||+|+||+++.++.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~ 160 (267)
T cd08224 81 LELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred EecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCC
Confidence 999999999999853 2458999999999999999999999999999999999999999999999999987765433
Q ss_pred CccccccCCCccccHHhhcc
Q 010401 489 EATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 489 ~~~~~~~Gt~~YmAPEvl~g 508 (511)
.......+++.|+|||++.+
T Consensus 161 ~~~~~~~~~~~y~apE~~~~ 180 (267)
T cd08224 161 TAAHSLVGTPYYMSPERIHE 180 (267)
T ss_pred cccceecCCccccCHHHhcc
Confidence 33344568889999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-25 Score=229.00 Aligned_cols=174 Identities=22% Similarity=0.414 Sum_probs=143.4
Q ss_pred cceEecCCCeEEEeeeecccceEEEEeE-------------EEEEEEEecCCCCchHHHHHHHHHHHHHhC-CCCceeeE
Q 010401 333 GRWLLNSDNLEFIDQIGPNSFKGVYKGK-------------RVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQF 398 (511)
Q Consensus 333 ~~~~l~~~~y~l~~~LG~GsFG~VYkgk-------------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l-~HpNIV~l 398 (511)
.+|.+...+|++.+.||+|+||.||+++ .+|+|.+.. .........+.+|+.++.++ +||||+++
T Consensus 5 ~~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~~~E~~~l~~l~~h~~iv~~ 83 (334)
T cd05100 5 PKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKD-DATDKDLSDLVSEMEMMKMIGKHKNIINL 83 (334)
T ss_pred cccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccc-ccCHHHHHHHHHHHHHHHhhcCCCCeeee
Confidence 3788888899999999999999999874 478887763 22333345688999999999 89999999
Q ss_pred eeeEeeCCCcEEEEEeccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCC
Q 010401 399 YCVCVDENHGLCVVTKLMEGGSVNDLILKS----------------RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNS 462 (511)
Q Consensus 399 ~g~~~~~~~~l~LVmEy~~gGsL~~lL~~~----------------~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp 462 (511)
+++|..++. +|++|||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||
T Consensus 84 ~~~~~~~~~-~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp 162 (334)
T cd05100 84 LGACTQDGP-LYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAA 162 (334)
T ss_pred eEEEccCCc-eEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeecccccc
Confidence 999987775 99999999999999998642 2477888899999999999999999999999999
Q ss_pred CceEEcCCCcEEEEecCCceecccCCCc--cccccCCCccccHHhhcc
Q 010401 463 QRILLDRHGNVCLGDMGIVTACKSVGEA--TEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 463 ~NILld~~g~vKL~DFGlS~~l~~~~~~--~~~~~Gt~~YmAPEvl~g 508 (511)
+|||++.++.+||+|||+++........ .....+++.|+|||++.+
T Consensus 163 ~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 210 (334)
T cd05100 163 RNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFD 210 (334)
T ss_pred ceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhcc
Confidence 9999999999999999998866432211 122233467999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.4e-25 Score=223.74 Aligned_cols=166 Identities=21% Similarity=0.336 Sum_probs=142.0
Q ss_pred CeEEEeeeecccceEEEEe------EEEEEEEEecCCCC---chHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEE
Q 010401 341 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKG---NAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCV 411 (511)
Q Consensus 341 ~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~---~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~L 411 (511)
+|++.+.||+|+||.||+| +.|++|++...... ......+..|+.+++.++|+||+++++++.+.+. +++
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~-~~l 79 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSN-INL 79 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCE-EEE
Confidence 4788899999999999996 47999999754333 2234557789999999999999999999998665 999
Q ss_pred EEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCc
Q 010401 412 VTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA 490 (511)
Q Consensus 412 VmEy~~gGsL~~lL~~~~-~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~ 490 (511)
||||+ +|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||+++........
T Consensus 80 v~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~ 158 (298)
T cd07841 80 VFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRK 158 (298)
T ss_pred EEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCcc
Confidence 99999 889999997665 7999999999999999999999999999999999999999999999999999877554433
Q ss_pred cccccCCCccccHHhhcc
Q 010401 491 TEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 491 ~~~~~Gt~~YmAPEvl~g 508 (511)
.....+++.|+|||++.+
T Consensus 159 ~~~~~~~~~y~aPE~~~~ 176 (298)
T cd07841 159 MTHQVVTRWYRAPELLFG 176 (298)
T ss_pred ccccccceeeeCHHHHhC
Confidence 444566788999998754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-25 Score=222.64 Aligned_cols=169 Identities=22% Similarity=0.395 Sum_probs=137.4
Q ss_pred ecCCCeEEEeeeecccceEEEEeEE----------EEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCC
Q 010401 337 LNSDNLEFIDQIGPNSFKGVYKGKR----------VGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN 406 (511)
Q Consensus 337 l~~~~y~l~~~LG~GsFG~VYkgk~----------VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~ 406 (511)
+..++|++.+.||+|+||.||+|+. +++|++... .......++..|+..+..++||||+++++++...
T Consensus 4 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~~- 81 (279)
T cd05111 4 LKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR-SGRQTFQEITDHMLAMGSLDHAYIVRLLGICPGA- 81 (279)
T ss_pred CCHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc-cchHHHHHHHHHHHHHhcCCCCCcceEEEEECCC-
Confidence 3456889999999999999999753 677777532 1222334577888888999999999999987643
Q ss_pred CcEEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecc
Q 010401 407 HGLCVVTKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK 485 (511)
Q Consensus 407 ~~l~LVmEy~~gGsL~~lL~~-~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~ 485 (511)
. .++++||+++|+|.+++.. .+.+++..+..++.||+.||.|||+++++||||||+|||++.++.+||+|||+++...
T Consensus 82 ~-~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 82 S-LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred c-cEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 3 7899999999999999965 4578999999999999999999999999999999999999999999999999998664
Q ss_pred cCCC--ccccccCCCccccHHhhcc
Q 010401 486 SVGE--ATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 486 ~~~~--~~~~~~Gt~~YmAPEvl~g 508 (511)
.... ......+++.|+|||++.+
T Consensus 161 ~~~~~~~~~~~~~~~~y~~pE~~~~ 185 (279)
T cd05111 161 PDDKKYFYSEHKTPIKWMALESILF 185 (279)
T ss_pred CCCcccccCCCCCcccccCHHHhcc
Confidence 3222 1223456678999999864
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=2e-25 Score=217.66 Aligned_cols=168 Identities=24% Similarity=0.362 Sum_probs=142.2
Q ss_pred CCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCch---HHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEE
Q 010401 340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNA---YEFELRKDLLELMTCGHKNILQFYCVCVDENHGLC 410 (511)
Q Consensus 340 ~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~---~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~ 410 (511)
++|++.+.||+|+||.||++ +.+++|.+........ ....+.+|+.++++++||||+++++++.+++. ++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-~~ 80 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDET-LS 80 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCe-EE
Confidence 46889999999999999986 5789998864322211 23457889999999999999999999998775 99
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCc
Q 010401 411 VVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA 490 (511)
Q Consensus 411 LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~ 490 (511)
++|||+++++|.+++...+.+++..+..++.|++.||.|||+.||+||||+|+||+++.++.++|+|||+++........
T Consensus 81 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~ 160 (263)
T cd06625 81 IFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSS 160 (263)
T ss_pred EEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceeccccccc
Confidence 99999999999999987788999999999999999999999999999999999999999999999999998765432211
Q ss_pred c---ccccCCCccccHHhhcc
Q 010401 491 T---EYETDGYRWLAPEVCFL 508 (511)
Q Consensus 491 ~---~~~~Gt~~YmAPEvl~g 508 (511)
. ....|+..|+|||++.+
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~ 181 (263)
T cd06625 161 GTGMKSVTGTPYWMSPEVISG 181 (263)
T ss_pred cccccCCCcCccccCcceecc
Confidence 1 23457788999999764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-25 Score=225.03 Aligned_cols=169 Identities=22% Similarity=0.404 Sum_probs=138.8
Q ss_pred cCCCeEEEeeeecccceEEEEeE--------------------EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceee
Q 010401 338 NSDNLEFIDQIGPNSFKGVYKGK--------------------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQ 397 (511)
Q Consensus 338 ~~~~y~l~~~LG~GsFG~VYkgk--------------------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~ 397 (511)
+.++|++.+.||+|+||.||+++ .||+|++... ........+.+|+.++++++|+||++
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~ei~~l~~l~h~~i~~ 81 (295)
T cd05097 3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRAD-VTKTARNDFLKEIKIMSRLKNPNIIR 81 (295)
T ss_pred chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCC-CCHHHHHHHHHHHHHHHhCCCCCcCe
Confidence 45678999999999999999853 3889988642 23334456889999999999999999
Q ss_pred EeeeEeeCCCcEEEEEeccCCCCHHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCce
Q 010401 398 FYCVCVDENHGLCVVTKLMEGGSVNDLILKSR------------KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRI 465 (511)
Q Consensus 398 l~g~~~~~~~~l~LVmEy~~gGsL~~lL~~~~------------~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NI 465 (511)
+++++...+. +|+||||+++++|.+++.... .+++..+..++.|++.||.|||++|++||||||+||
T Consensus 82 ~~~~~~~~~~-~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Ni 160 (295)
T cd05097 82 LLGVCVSDDP-LCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNC 160 (295)
T ss_pred EEEEEcCCCc-cEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhE
Confidence 9999987776 999999999999999985431 367888999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCceecccCCC--ccccccCCCccccHHhhcc
Q 010401 466 LLDRHGNVCLGDMGIVTACKSVGE--ATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 466 Lld~~g~vKL~DFGlS~~l~~~~~--~~~~~~Gt~~YmAPEvl~g 508 (511)
++++++.+||+|||+++....... ......+++.|+|||++.+
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 205 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILL 205 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhcc
Confidence 999999999999999876533221 1122234678999998754
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-25 Score=224.00 Aligned_cols=168 Identities=21% Similarity=0.279 Sum_probs=139.6
Q ss_pred cCCCeEEE--eeeecccceEEEEe----EEEEEEEEecCCCCch-HHHHHHHHHHHHHhCCCCceeeEeeeEee--CC-C
Q 010401 338 NSDNLEFI--DQIGPNSFKGVYKG----KRVGIEKLKGCDKGNA-YEFELRKDLLELMTCGHKNILQFYCVCVD--EN-H 407 (511)
Q Consensus 338 ~~~~y~l~--~~LG~GsFG~VYkg----k~VAVKkL~~~~~~~~-~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~--~~-~ 407 (511)
+.++++.. ..||+|++|.||+| +.||+|++........ ....+.+|+.+|.+++||||++++|++.+ ++ .
T Consensus 16 ~~~~i~~~~~~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~ 95 (283)
T PHA02988 16 ESDDIDKYTSVLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLP 95 (283)
T ss_pred CHHHcCCCCCeEEeeCCceEEEEEEECCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCC
Confidence 33444444 67999999999996 5899999975433322 23557899999999999999999999876 32 2
Q ss_pred cEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCceEEcCCCcEEEEecCCceeccc
Q 010401 408 GLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLND-HGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS 486 (511)
Q Consensus 408 ~l~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~-~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~ 486 (511)
.+++||||+++|+|.+++...+.+++.....++.|++.||.|||+ .+++||||||+|||++.++.+||+|||+++....
T Consensus 96 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~ 175 (283)
T PHA02988 96 RLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSS 175 (283)
T ss_pred ceEEEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcc
Confidence 389999999999999999887889999999999999999999998 5999999999999999999999999999876543
Q ss_pred CCCccccccCCCccccHHhhcc
Q 010401 487 VGEATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 487 ~~~~~~~~~Gt~~YmAPEvl~g 508 (511)
. .....|++.|+|||++.+
T Consensus 176 ~---~~~~~~~~~y~aPE~~~~ 194 (283)
T PHA02988 176 P---PFKNVNFMVYFSYKMLND 194 (283)
T ss_pred c---cccccCcccccCHHHhhh
Confidence 2 234567889999999864
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.2e-25 Score=222.64 Aligned_cols=168 Identities=23% Similarity=0.406 Sum_probs=139.3
Q ss_pred cCCCeEEEeeeecccceEEEEeE-----------EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCC
Q 010401 338 NSDNLEFIDQIGPNSFKGVYKGK-----------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN 406 (511)
Q Consensus 338 ~~~~y~l~~~LG~GsFG~VYkgk-----------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~ 406 (511)
...+|.+.+.||+|+||.||+++ .+++|.+.. ........+.+|+.++.+++|+||+++++++...+
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (291)
T cd05094 3 KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKD--PTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGD 80 (291)
T ss_pred chHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCC--ccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCC
Confidence 34678999999999999999975 377777752 22333456889999999999999999999998777
Q ss_pred CcEEEEEeccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCC
Q 010401 407 HGLCVVTKLMEGGSVNDLILKS----------------RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRH 470 (511)
Q Consensus 407 ~~l~LVmEy~~gGsL~~lL~~~----------------~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~ 470 (511)
. .++||||+++++|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 81 ~-~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~ 159 (291)
T cd05094 81 P-LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGAN 159 (291)
T ss_pred c-eEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccC
Confidence 6 99999999999999999643 237889999999999999999999999999999999999999
Q ss_pred CcEEEEecCCceecccCCC--ccccccCCCccccHHhhcc
Q 010401 471 GNVCLGDMGIVTACKSVGE--ATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 471 g~vKL~DFGlS~~l~~~~~--~~~~~~Gt~~YmAPEvl~g 508 (511)
+.++|+|||++........ ......+++.|+|||++.+
T Consensus 160 ~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 199 (291)
T cd05094 160 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY 199 (291)
T ss_pred CcEEECCCCcccccCCCceeecCCCCCcceeecChHHhcc
Confidence 9999999999876543221 1223345678999998864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.4e-25 Score=219.49 Aligned_cols=164 Identities=29% Similarity=0.496 Sum_probs=134.4
Q ss_pred EEEeeeecccceEEEEe----------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEE
Q 010401 343 EFIDQIGPNSFKGVYKG----------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV 412 (511)
Q Consensus 343 ~l~~~LG~GsFG~VYkg----------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LV 412 (511)
++.+.||.|+||.||+| ..|+||.++. .........+.+|+..+++++||||++++|++...+. +++|
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~-~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~-~~lv 79 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKP-SSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEP-LFLV 79 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEEST-TSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSS-EEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecc-ccccccceeeeeccccccccccccccccccccccccc-cccc
Confidence 67899999999999995 3579999953 3333346778999999999999999999999996665 9999
Q ss_pred EeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCC-
Q 010401 413 TKLMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE- 489 (511)
Q Consensus 413 mEy~~gGsL~~lL~~~--~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~- 489 (511)
|||+++|+|.++|... ..+++..+..|+.||+.||.|||+++++|+||+++||+++.++.+||+|||++........
T Consensus 80 ~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 80 MEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp EE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 9999999999999775 6899999999999999999999999999999999999999999999999999887632221
Q ss_pred -ccccccCCCccccHHhhcc
Q 010401 490 -ATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 490 -~~~~~~Gt~~YmAPEvl~g 508 (511)
........+.|+|||.+.+
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~ 179 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKD 179 (259)
T ss_dssp EESTTSESGGGGS-HHHHHH
T ss_pred cccccccccccccccccccc
Confidence 1223345678999999864
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.1e-25 Score=231.88 Aligned_cols=162 Identities=20% Similarity=0.283 Sum_probs=137.9
Q ss_pred cCCCeEEEeeeecccceEEEEe--------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcE
Q 010401 338 NSDNLEFIDQIGPNSFKGVYKG--------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGL 409 (511)
Q Consensus 338 ~~~~y~l~~~LG~GsFG~VYkg--------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l 409 (511)
...+|++++.||+|+||.||++ +.|++|.+... ....+|+.+++.++||||+++++++...+. +
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~-~ 161 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-------KTPGREIDILKTISHRAIINLIHAYRWKST-V 161 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-------ccHHHHHHHHHhcCCCCccceeeeEeeCCE-E
Confidence 3467999999999999999985 35788877531 234679999999999999999999987775 9
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCC
Q 010401 410 CVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE 489 (511)
Q Consensus 410 ~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~ 489 (511)
|++||++. ++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 162 ~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~ 240 (392)
T PHA03207 162 CMVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD 240 (392)
T ss_pred EEEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCcccc
Confidence 99999996 58999887677899999999999999999999999999999999999999999999999999876543322
Q ss_pred --ccccccCCCccccHHhhcc
Q 010401 490 --ATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 490 --~~~~~~Gt~~YmAPEvl~g 508 (511)
......||+.|+|||++.+
T Consensus 241 ~~~~~~~~gt~~y~aPE~~~~ 261 (392)
T PHA03207 241 TPQCYGWSGTLETNSPELLAL 261 (392)
T ss_pred cccccccccccCccCHhHhcC
Confidence 1234578999999999864
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.7e-26 Score=238.58 Aligned_cols=160 Identities=21% Similarity=0.327 Sum_probs=142.6
Q ss_pred eeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEEeccCCC
Q 010401 346 DQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGG 419 (511)
Q Consensus 346 ~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVmEy~~gG 419 (511)
+.||.|-||+||-| +.||||+|.+.......+.++++|+.+|.+++||.||.+-..|++.+. +++|||-+.|
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~er-vFVVMEKl~G- 647 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPER-VFVVMEKLHG- 647 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCce-EEEEehhhcc-
Confidence 78999999999974 689999998877777778899999999999999999999999998887 9999999965
Q ss_pred CHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCC---CcEEEEecCCceecccCCCccccc
Q 010401 420 SVNDLIL--KSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRH---GNVCLGDMGIVTACKSVGEATEYE 494 (511)
Q Consensus 420 sL~~lL~--~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~---g~vKL~DFGlS~~l~~~~~~~~~~ 494 (511)
+..++|. ..++|++....+++.||+.||.|||-++|+|.||||+|||+.+. -.+||||||+|++++.. ......
T Consensus 648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk-sFRrsV 726 (888)
T KOG4236|consen 648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK-SFRRSV 726 (888)
T ss_pred hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchh-hhhhhh
Confidence 7777764 34689999999999999999999999999999999999999754 47999999999998764 346677
Q ss_pred cCCCccccHHhhcc
Q 010401 495 TDGYRWLAPEVCFL 508 (511)
Q Consensus 495 ~Gt~~YmAPEvl~g 508 (511)
.||+.|+|||+++.
T Consensus 727 VGTPAYLaPEVLrn 740 (888)
T KOG4236|consen 727 VGTPAYLAPEVLRN 740 (888)
T ss_pred cCCccccCHHHHhh
Confidence 99999999999974
|
|
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.9e-25 Score=225.26 Aligned_cols=173 Identities=23% Similarity=0.392 Sum_probs=143.8
Q ss_pred ceEecCCCeEEEeeeecccceEEEEeE-----------EEEEEEEecCCCCchHHHHHHHHHHHHHhC-CCCceeeEeee
Q 010401 334 RWLLNSDNLEFIDQIGPNSFKGVYKGK-----------RVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCV 401 (511)
Q Consensus 334 ~~~l~~~~y~l~~~LG~GsFG~VYkgk-----------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l-~HpNIV~l~g~ 401 (511)
.|.+..++|++.+.||+|+||.||++. .+|+|+++... .......+.+|+.++.++ +||||++++++
T Consensus 29 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 107 (302)
T cd05055 29 KWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA-HSSEREALMSELKIMSHLGNHENIVNLLGA 107 (302)
T ss_pred cccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC-ChHHHHHHHHHHHHHHhccCCCCcceEEEE
Confidence 566777899999999999999999863 58888886432 223345688999999999 89999999999
Q ss_pred EeeCCCcEEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecC
Q 010401 402 CVDENHGLCVVTKLMEGGSVNDLILKSR--KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMG 479 (511)
Q Consensus 402 ~~~~~~~l~LVmEy~~gGsL~~lL~~~~--~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFG 479 (511)
+...+. +|++|||+++|+|.+++.... .+++..+..++.||+.||+|||+++|+|+||||+|||++.++.++|+|||
T Consensus 108 ~~~~~~-~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg 186 (302)
T cd05055 108 CTIGGP-ILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFG 186 (302)
T ss_pred EecCCc-eEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCc
Confidence 987775 999999999999999996533 38999999999999999999999999999999999999999999999999
Q ss_pred CceecccCCCc--cccccCCCccccHHhhcc
Q 010401 480 IVTACKSVGEA--TEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 480 lS~~l~~~~~~--~~~~~Gt~~YmAPEvl~g 508 (511)
+++........ .....+++.|+|||++.+
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 217 (302)
T cd05055 187 LARDIMNDSNYVVKGNARLPVKWMAPESIFN 217 (302)
T ss_pred ccccccCCCceeecCCCCcccccCCHhhhcc
Confidence 98866443221 112345678999998754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.8e-26 Score=232.49 Aligned_cols=165 Identities=18% Similarity=0.330 Sum_probs=138.1
Q ss_pred CCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCC-----C
Q 010401 339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN-----H 407 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~-----~ 407 (511)
.++|++++.||.|+||.||++ +.||+|++............+.+|+.+++.++||||+++++++.... .
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFN 93 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccC
Confidence 467899999999999999996 46999998643333333455778999999999999999999876432 2
Q ss_pred cEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccC
Q 010401 408 GLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV 487 (511)
Q Consensus 408 ~l~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~ 487 (511)
..|++|+++ +++|.+++. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 94 ~~~~~~~~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 171 (343)
T cd07878 94 EVYLVTNLM-GADLNNIVK-CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDE 171 (343)
T ss_pred cEEEEeecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecCCC
Confidence 278999988 679988774 457999999999999999999999999999999999999999999999999998865432
Q ss_pred CCccccccCCCccccHHhhcc
Q 010401 488 GEATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 488 ~~~~~~~~Gt~~YmAPEvl~g 508 (511)
.....|++.|+|||++.+
T Consensus 172 ---~~~~~~t~~y~aPE~~~~ 189 (343)
T cd07878 172 ---MTGYVATRWYRAPEIMLN 189 (343)
T ss_pred ---cCCccccccccCchHhcC
Confidence 334578899999999865
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.5e-25 Score=218.11 Aligned_cols=167 Identities=25% Similarity=0.463 Sum_probs=139.8
Q ss_pred cCCCeEEEeeeecccceEEEEeE-----EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEE
Q 010401 338 NSDNLEFIDQIGPNSFKGVYKGK-----RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV 412 (511)
Q Consensus 338 ~~~~y~l~~~LG~GsFG~VYkgk-----~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LV 412 (511)
+.++|++.+.||+|+||.||+++ .+|+|.+.... .....+.+|+.++.+++||||+++++++...+. +|++
T Consensus 2 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~lv 77 (256)
T cd05113 2 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS---MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRP-IYIV 77 (256)
T ss_pred ChHHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc---ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCC-cEEE
Confidence 35678999999999999999975 48999886322 223567899999999999999999999987765 8999
Q ss_pred EeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCc-
Q 010401 413 TKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA- 490 (511)
Q Consensus 413 mEy~~gGsL~~lL~~~-~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~- 490 (511)
|||+.+|+|.+++... ..+++..++.++.||+.||.|||++|++|+||||+||+++.++.+||+|||+++........
T Consensus 78 ~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05113 78 TEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS 157 (256)
T ss_pred EEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCceee
Confidence 9999999999999653 47899999999999999999999999999999999999999999999999998765432211
Q ss_pred cccccCCCccccHHhhcc
Q 010401 491 TEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 491 ~~~~~Gt~~YmAPEvl~g 508 (511)
.....++..|+|||++.+
T Consensus 158 ~~~~~~~~~y~~pe~~~~ 175 (256)
T cd05113 158 SVGSKFPVRWSPPEVLLY 175 (256)
T ss_pred cCCCccChhhCCHHHHhc
Confidence 112234567999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.9e-26 Score=223.29 Aligned_cols=166 Identities=20% Similarity=0.364 Sum_probs=139.8
Q ss_pred CeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEEe
Q 010401 341 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTK 414 (511)
Q Consensus 341 ~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVmE 414 (511)
+|++.+.||+|+||.||++ +.+++|.+............+.+|+.+++.++||||+++++++.+.+. +|+++|
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~-~~lv~e 79 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKK-LTLVFE 79 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCc-eEEEEe
Confidence 4788999999999999995 468999986533333334457789999999999999999999988776 999999
Q ss_pred ccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCcccc
Q 010401 415 LMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY 493 (511)
Q Consensus 415 y~~gGsL~~lL~~-~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~~~ 493 (511)
|+.+ +|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++...........
T Consensus 80 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 158 (284)
T cd07839 80 YCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSA 158 (284)
T ss_pred cCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCcCC
Confidence 9975 88887754 467999999999999999999999999999999999999999999999999998765443333344
Q ss_pred ccCCCccccHHhhcc
Q 010401 494 ETDGYRWLAPEVCFL 508 (511)
Q Consensus 494 ~~Gt~~YmAPEvl~g 508 (511)
..+++.|+|||++.+
T Consensus 159 ~~~~~~y~aPE~~~~ 173 (284)
T cd07839 159 EVVTLWYRPPDVLFG 173 (284)
T ss_pred CccccCCcChHHHhC
Confidence 567889999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.6e-26 Score=224.46 Aligned_cols=169 Identities=22% Similarity=0.427 Sum_probs=139.0
Q ss_pred cCCCeEEEeeeecccceEEEEe-----------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCC
Q 010401 338 NSDNLEFIDQIGPNSFKGVYKG-----------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN 406 (511)
Q Consensus 338 ~~~~y~l~~~LG~GsFG~VYkg-----------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~ 406 (511)
+..+|++.++||+|+||.||+| +.||+|++.... .......+.+|+.++..++||||+++++++.+..
T Consensus 3 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~ 81 (283)
T cd05091 3 NLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQ 81 (283)
T ss_pred CHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCC
Confidence 4456788899999999999997 358999987422 2233456788999999999999999999998877
Q ss_pred CcEEEEEeccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCC
Q 010401 407 HGLCVVTKLMEGGSVNDLILKS----------------RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRH 470 (511)
Q Consensus 407 ~~l~LVmEy~~gGsL~~lL~~~----------------~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~ 470 (511)
. +++++||+.+++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++++
T Consensus 82 ~-~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~ 160 (283)
T cd05091 82 P-LSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDK 160 (283)
T ss_pred c-eEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCC
Confidence 6 89999999999999998531 247888899999999999999999999999999999999999
Q ss_pred CcEEEEecCCceecccCCCc--cccccCCCccccHHhhcc
Q 010401 471 GNVCLGDMGIVTACKSVGEA--TEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 471 g~vKL~DFGlS~~l~~~~~~--~~~~~Gt~~YmAPEvl~g 508 (511)
+.+||+|||+++........ .....+++.|+|||++.+
T Consensus 161 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 200 (283)
T cd05091 161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMY 200 (283)
T ss_pred CceEecccccccccccchheeeccCccCCccccCHHHHhc
Confidence 99999999998865432211 123345678999999853
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.1e-25 Score=217.78 Aligned_cols=167 Identities=25% Similarity=0.441 Sum_probs=139.4
Q ss_pred eEecCCCeEEEeeeecccceEEEEe----EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEE
Q 010401 335 WLLNSDNLEFIDQIGPNSFKGVYKG----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLC 410 (511)
Q Consensus 335 ~~l~~~~y~l~~~LG~GsFG~VYkg----k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~ 410 (511)
|.++.++|++.+.||+|+||.||++ +.+++|.+... .....+.+|+.+++.++|+||+++++++...+...+
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 76 (256)
T cd05082 1 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY 76 (256)
T ss_pred CCccHHhCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCC----chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceE
Confidence 4566788999999999999999986 46888887532 123467899999999999999999998765554589
Q ss_pred EEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCC
Q 010401 411 VVTKLMEGGSVNDLILKSR--KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG 488 (511)
Q Consensus 411 LVmEy~~gGsL~~lL~~~~--~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~ 488 (511)
++|||+++++|.+++.... .+++..+..++.||+.||+|||++||+||||||+||++++++.+||+|||+++......
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~ 156 (256)
T cd05082 77 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 156 (256)
T ss_pred EEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccccC
Confidence 9999999999999996543 48899999999999999999999999999999999999999999999999987654321
Q ss_pred CccccccCCCccccHHhhcc
Q 010401 489 EATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 489 ~~~~~~~Gt~~YmAPEvl~g 508 (511)
....++..|+|||++.+
T Consensus 157 ---~~~~~~~~y~aPE~~~~ 173 (256)
T cd05082 157 ---DTGKLPVKWTAPEALRE 173 (256)
T ss_pred ---CCCccceeecCHHHHcc
Confidence 22334567999998754
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.4e-25 Score=221.39 Aligned_cols=159 Identities=25% Similarity=0.363 Sum_probs=132.5
Q ss_pred eecccceEEEEe------EEEEEEEEecCCCC-chHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEEeccCCCC
Q 010401 348 IGPNSFKGVYKG------KRVGIEKLKGCDKG-NAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGS 420 (511)
Q Consensus 348 LG~GsFG~VYkg------k~VAVKkL~~~~~~-~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVmEy~~gGs 420 (511)
||+|+||.||++ +.+|+|++...... ......+..|+.++..++||||+++++++.++.. +|+||||+++++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~-~~lv~e~~~g~~ 79 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTH-LCLVMSLMNGGD 79 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCe-EEEEEecCCCCC
Confidence 699999999984 57999998642221 1223345678999999999999999999987776 999999999999
Q ss_pred HHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCccccccCCC
Q 010401 421 VNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY 498 (511)
Q Consensus 421 L~~lL~~~--~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~~~~~Gt~ 498 (511)
|.+++... ..+++..+..++.||+.||+|||+.||+||||||+||+++.++.++|+|||++...... .......|+.
T Consensus 80 L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~-~~~~~~~~~~ 158 (277)
T cd05607 80 LKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG-KTITQRAGTN 158 (277)
T ss_pred HHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCC-ceeeccCCCC
Confidence 99888543 35889999999999999999999999999999999999999999999999998766432 2233457889
Q ss_pred ccccHHhhcc
Q 010401 499 RWLAPEVCFL 508 (511)
Q Consensus 499 ~YmAPEvl~g 508 (511)
.|+|||++.+
T Consensus 159 ~y~aPE~~~~ 168 (277)
T cd05607 159 GYMAPEILKE 168 (277)
T ss_pred CccCHHHHcc
Confidence 9999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.9e-26 Score=233.52 Aligned_cols=161 Identities=20% Similarity=0.263 Sum_probs=135.0
Q ss_pred ecCCCeEEEeeeecccceEEEEeE------EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEE
Q 010401 337 LNSDNLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLC 410 (511)
Q Consensus 337 l~~~~y~l~~~LG~GsFG~VYkgk------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~ 410 (511)
+...+|++++.||+|+||.||+++ .||+|+... .....|+.+++.++||||+++++++...+. .+
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~--------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~ 133 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK--------GTTLIEAMLLQNVNHPSVIRMKDTLVSGAI-TC 133 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc--------cccHHHHHHHHhCCCCCCcChhheEEeCCe-eE
Confidence 344579999999999999999974 578886432 123568889999999999999999998776 89
Q ss_pred EEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCC
Q 010401 411 VVTKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE 489 (511)
Q Consensus 411 LVmEy~~gGsL~~lL~~-~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~ 489 (511)
+||||+.+ +|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... .
T Consensus 134 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-~ 211 (357)
T PHA03209 134 MVLPHYSS-DLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA-P 211 (357)
T ss_pred EEEEccCC-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccC-c
Confidence 99999964 88888754 467999999999999999999999999999999999999999999999999998754322 2
Q ss_pred ccccccCCCccccHHhhcc
Q 010401 490 ATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 490 ~~~~~~Gt~~YmAPEvl~g 508 (511)
......||+.|+|||++.+
T Consensus 212 ~~~~~~gt~~y~aPE~~~~ 230 (357)
T PHA03209 212 AFLGLAGTVETNAPEVLAR 230 (357)
T ss_pred ccccccccccccCCeecCC
Confidence 2344578999999999865
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.5e-25 Score=220.52 Aligned_cols=166 Identities=21% Similarity=0.337 Sum_probs=132.5
Q ss_pred CeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHh---CCCCceeeEeeeEeeC----CC
Q 010401 341 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMT---CGHKNILQFYCVCVDE----NH 407 (511)
Q Consensus 341 ~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~---l~HpNIV~l~g~~~~~----~~ 407 (511)
+|++.+.||+|+||.||++ +.+|+|.+............+.+|+.+++. ++||||+++++++... ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4789999999999999996 468999887533222222334566666655 4799999999988643 22
Q ss_pred cEEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecc
Q 010401 408 GLCVVTKLMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK 485 (511)
Q Consensus 408 ~l~LVmEy~~gGsL~~lL~~~--~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~ 485 (511)
.++++|||+.+ +|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~ 159 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYS 159 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCcccccc
Confidence 37999999975 898888653 358999999999999999999999999999999999999999999999999987664
Q ss_pred cCCCccccccCCCccccHHhhcc
Q 010401 486 SVGEATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 486 ~~~~~~~~~~Gt~~YmAPEvl~g 508 (511)
.. .......|+..|+|||++.+
T Consensus 160 ~~-~~~~~~~~~~~y~aPE~~~~ 181 (288)
T cd07863 160 CQ-MALTPVVVTLWYRAPEVLLQ 181 (288)
T ss_pred Cc-ccCCCccccccccCchHhhC
Confidence 32 22334567889999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.7e-25 Score=224.09 Aligned_cols=169 Identities=24% Similarity=0.393 Sum_probs=136.9
Q ss_pred ecCCCeEEEeeeecccceEEEEeE--------EEEEEEEecCCCCchHHHHHHHHHHHHHhC-CCCceeeEeeeEeeCCC
Q 010401 337 LNSDNLEFIDQIGPNSFKGVYKGK--------RVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCVCVDENH 407 (511)
Q Consensus 337 l~~~~y~l~~~LG~GsFG~VYkgk--------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l-~HpNIV~l~g~~~~~~~ 407 (511)
+..++|++.+.||+|+||.||+++ .+++|.+... ........+.+|+.++.++ +|+||+++++++.+++.
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~ 82 (303)
T cd05088 4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY 82 (303)
T ss_pred cchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc-CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCC
Confidence 345688999999999999999974 3567766532 2233445678899999999 89999999999988776
Q ss_pred cEEEEEeccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCC
Q 010401 408 GLCVVTKLMEGGSVNDLILKSR----------------KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG 471 (511)
Q Consensus 408 ~l~LVmEy~~gGsL~~lL~~~~----------------~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g 471 (511)
+|+||||+++++|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.++
T Consensus 83 -~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~ 161 (303)
T cd05088 83 -LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 161 (303)
T ss_pred -ceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCC
Confidence 999999999999999996432 578899999999999999999999999999999999999999
Q ss_pred cEEEEecCCceecccCCCccccccCCCccccHHhhcc
Q 010401 472 NVCLGDMGIVTACKSVGEATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 472 ~vKL~DFGlS~~l~~~~~~~~~~~Gt~~YmAPEvl~g 508 (511)
.+||+|||+++..... .......++..|+|||++.+
T Consensus 162 ~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~ 197 (303)
T cd05088 162 VAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNY 197 (303)
T ss_pred cEEeCccccCcccchh-hhcccCCCcccccCHHHHhc
Confidence 9999999998643211 11122234567999998754
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.8e-25 Score=217.29 Aligned_cols=160 Identities=24% Similarity=0.389 Sum_probs=134.3
Q ss_pred eeecccceEEEEe--------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEEeccCC
Q 010401 347 QIGPNSFKGVYKG--------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEG 418 (511)
Q Consensus 347 ~LG~GsFG~VYkg--------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVmEy~~g 418 (511)
+||+|+||.||+| +.+|+|++...........++.+|+.+++.++||||+++++++..+ . .++||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~-~~lv~e~~~~ 79 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEAE-S-WMLVMELAEL 79 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-C-cEEEEecCCC
Confidence 6899999999986 4689998875444444556788999999999999999999988643 3 7899999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCc---ccccc
Q 010401 419 GSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA---TEYET 495 (511)
Q Consensus 419 GsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~---~~~~~ 495 (511)
|+|.+++...+.+++..+..++.|++.||+|||++||+||||||.||+++.++.+||+|||+++........ .....
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 159 (257)
T cd05116 80 GPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGK 159 (257)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCC
Confidence 999999987778999999999999999999999999999999999999999999999999998876443221 12223
Q ss_pred CCCccccHHhhcc
Q 010401 496 DGYRWLAPEVCFL 508 (511)
Q Consensus 496 Gt~~YmAPEvl~g 508 (511)
+++.|+|||.+..
T Consensus 160 ~~~~y~aPE~~~~ 172 (257)
T cd05116 160 WPVKWYAPECMNY 172 (257)
T ss_pred CCccccCHhHhcc
Confidence 4578999998753
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.1e-25 Score=218.45 Aligned_cols=161 Identities=20% Similarity=0.283 Sum_probs=131.4
Q ss_pred eeeecccceEEEEeE--------EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEEeccC
Q 010401 346 DQIGPNSFKGVYKGK--------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLME 417 (511)
Q Consensus 346 ~~LG~GsFG~VYkgk--------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVmEy~~ 417 (511)
+.||+|+||.||+|+ .+++|+++... .......+.+|+.+++.++||||+++++++.+... +++||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~lv~e~~~ 78 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSA-SVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTP-YLLVMEFCP 78 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCC-cEEEEECCC
Confidence 368999999999974 47888886432 23334568889999999999999999999987765 899999999
Q ss_pred CCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCC--c
Q 010401 418 GGSVNDLILKS-----RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE--A 490 (511)
Q Consensus 418 gGsL~~lL~~~-----~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~--~ 490 (511)
+|+|.+++... ..+++..+..++.|++.||+|||+.+++||||||+||+++.++++||+|||+++....... .
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~ 158 (269)
T cd05087 79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT 158 (269)
T ss_pred CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence 99999998642 2456778889999999999999999999999999999999999999999999865433221 1
Q ss_pred cccccCCCccccHHhhcc
Q 010401 491 TEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 491 ~~~~~Gt~~YmAPEvl~g 508 (511)
.....+++.|+|||++.+
T Consensus 159 ~~~~~~~~~y~aPE~~~~ 176 (269)
T cd05087 159 PDQLWVPLRWIAPELVDE 176 (269)
T ss_pred CCCcCCcccccCHhHhcc
Confidence 223456788999999853
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.8e-25 Score=218.03 Aligned_cols=170 Identities=19% Similarity=0.372 Sum_probs=141.4
Q ss_pred eEecCCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCc
Q 010401 335 WLLNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHG 408 (511)
Q Consensus 335 ~~l~~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~ 408 (511)
|.+...+|.+.+.||+|+||.||++ +.+++|.+.. ......++.+|+.++..++|+||+++++++..++.
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~- 76 (263)
T cd05052 1 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP- 76 (263)
T ss_pred CCCchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecC---CchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCC-
Confidence 4566778999999999999999995 4689998863 22234567899999999999999999999987776
Q ss_pred EEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceeccc
Q 010401 409 LCVVTKLMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS 486 (511)
Q Consensus 409 l~LVmEy~~gGsL~~lL~~~--~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~ 486 (511)
++++|||+++++|.+++... ..+++..++.++.|++.||.|||++|++||||||+||++++++.+||+|||++.....
T Consensus 77 ~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~ 156 (263)
T cd05052 77 FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 156 (263)
T ss_pred cEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCcccccccc
Confidence 89999999999999998653 3689999999999999999999999999999999999999999999999999877644
Q ss_pred CCCcc-ccccCCCccccHHhhcc
Q 010401 487 VGEAT-EYETDGYRWLAPEVCFL 508 (511)
Q Consensus 487 ~~~~~-~~~~Gt~~YmAPEvl~g 508 (511)
..... ....+++.|+|||++.+
T Consensus 157 ~~~~~~~~~~~~~~y~aPE~~~~ 179 (263)
T cd05052 157 DTYTAHAGAKFPIKWTAPESLAY 179 (263)
T ss_pred ceeeccCCCCCccccCCHHHhcc
Confidence 22111 11223567999998764
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.8e-25 Score=216.27 Aligned_cols=169 Identities=23% Similarity=0.351 Sum_probs=140.7
Q ss_pred CCeEEEeeeecccceEEEEe------EEEEEEEEecCCCC---chHHHHHHHHHHHHHhCCCCceeeEeeeEeeCC-CcE
Q 010401 340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKG---NAYEFELRKDLLELMTCGHKNILQFYCVCVDEN-HGL 409 (511)
Q Consensus 340 ~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~---~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~-~~l 409 (511)
.+|++.+.||+|+||.||++ +.|++|.+...... ......+.+|+.++..++||||+++++++.+.. ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 57899999999999999985 46999988643222 122345788999999999999999999887643 347
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCC-
Q 010401 410 CVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG- 488 (511)
Q Consensus 410 ~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~- 488 (511)
+++|||+++++|.+++.....+++..+..++.|++.||+|||+++|+|+||||+||+++.++.++|+|||+++......
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~ 161 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICL 161 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccccc
Confidence 8999999999999999777788999999999999999999999999999999999999999999999999987653211
Q ss_pred --CccccccCCCccccHHhhcc
Q 010401 489 --EATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 489 --~~~~~~~Gt~~YmAPEvl~g 508 (511)
.......|+..|+|||++.+
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~ 183 (265)
T cd06652 162 SGTGMKSVTGTPYWMSPEVISG 183 (265)
T ss_pred cccccccCCCCccccChhhhcC
Confidence 11234568889999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-25 Score=221.91 Aligned_cols=166 Identities=28% Similarity=0.446 Sum_probs=143.0
Q ss_pred CCCeEEEeeeecccceEEEEeE------EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEE
Q 010401 339 SDNLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV 412 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkgk------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LV 412 (511)
.++|++.+.||.|+||.||+++ .+++|.+... .......+..|+.++++++||||+++++++..+.. +|+|
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~lv 80 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE--SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENK-LWIL 80 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCe-EEEE
Confidence 4678999999999999999963 6889988632 23334567889999999999999999999987775 9999
Q ss_pred EeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCcc
Q 010401 413 TKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT 491 (511)
Q Consensus 413 mEy~~gGsL~~lL~~-~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~ 491 (511)
|||+++++|.+++.. ...+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||++..........
T Consensus 81 ~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~ 160 (280)
T cd06611 81 IEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKR 160 (280)
T ss_pred eeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhccccccc
Confidence 999999999999865 3579999999999999999999999999999999999999999999999999987654444344
Q ss_pred ccccCCCccccHHhhc
Q 010401 492 EYETDGYRWLAPEVCF 507 (511)
Q Consensus 492 ~~~~Gt~~YmAPEvl~ 507 (511)
....+++.|+|||++.
T Consensus 161 ~~~~~~~~y~~PE~~~ 176 (280)
T cd06611 161 DTFIGTPYWMAPEVVA 176 (280)
T ss_pred ceeecchhhcCHHHHh
Confidence 5567889999999975
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.3e-25 Score=215.43 Aligned_cols=170 Identities=24% Similarity=0.454 Sum_probs=142.5
Q ss_pred eEecCCCeEEEeeeecccceEEEEeE-----EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcE
Q 010401 335 WLLNSDNLEFIDQIGPNSFKGVYKGK-----RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGL 409 (511)
Q Consensus 335 ~~l~~~~y~l~~~LG~GsFG~VYkgk-----~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l 409 (511)
|.+..++|++.+.||.|+||.||++. .+++|.+.... ....++.+|+.+++.++|+||+++++++.+... +
T Consensus 1 ~~~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~ 76 (261)
T cd05034 1 WEIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT---MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEP-I 76 (261)
T ss_pred CccchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc---cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCc-e
Confidence 45778899999999999999999963 58999886422 234568899999999999999999999887665 9
Q ss_pred EEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccC
Q 010401 410 CVVTKLMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV 487 (511)
Q Consensus 410 ~LVmEy~~gGsL~~lL~~~--~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~ 487 (511)
+++|||+++++|.+++... ..+++..+..++.||+.||.|||++|++|+||||+||++++++.+||+|||+++.+...
T Consensus 77 ~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~ 156 (261)
T cd05034 77 YIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDD 156 (261)
T ss_pred EEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccch
Confidence 9999999999999999654 36899999999999999999999999999999999999999999999999998876432
Q ss_pred CC-ccccccCCCccccHHhhcc
Q 010401 488 GE-ATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 488 ~~-~~~~~~Gt~~YmAPEvl~g 508 (511)
.. ......++..|+|||.+.+
T Consensus 157 ~~~~~~~~~~~~~y~~PE~~~~ 178 (261)
T cd05034 157 EYTAREGAKFPIKWTAPEAANY 178 (261)
T ss_pred hhhhhhccCCCccccCHHHhcc
Confidence 11 1112234567999998864
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.2e-25 Score=220.20 Aligned_cols=169 Identities=22% Similarity=0.384 Sum_probs=140.0
Q ss_pred cCCCeEEEeeeecccceEEEEeE-----------EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCC
Q 010401 338 NSDNLEFIDQIGPNSFKGVYKGK-----------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN 406 (511)
Q Consensus 338 ~~~~y~l~~~LG~GsFG~VYkgk-----------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~ 406 (511)
+..+|++.++||+|+||.||+++ .+++|.+.. ........+.+|+.++..++|+||+++++++.+.+
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (280)
T cd05092 3 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE--ASESARQDFQREAELLTVLQHQHIVRFYGVCTEGR 80 (280)
T ss_pred ChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCc--CCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCC
Confidence 45688999999999999999863 577887753 33344566899999999999999999999998776
Q ss_pred CcEEEEEeccCCCCHHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCC
Q 010401 407 HGLCVVTKLMEGGSVNDLILKSR---------------KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG 471 (511)
Q Consensus 407 ~~l~LVmEy~~gGsL~~lL~~~~---------------~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g 471 (511)
. .|++|||+++++|.+++...+ .+++..+..++.||+.||+|||++|++||||||+|||+++++
T Consensus 81 ~-~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~ 159 (280)
T cd05092 81 P-LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGL 159 (280)
T ss_pred c-eEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCC
Confidence 5 899999999999999986532 478899999999999999999999999999999999999999
Q ss_pred cEEEEecCCceecccCCC--ccccccCCCccccHHhhccc
Q 010401 472 NVCLGDMGIVTACKSVGE--ATEYETDGYRWLAPEVCFLL 509 (511)
Q Consensus 472 ~vKL~DFGlS~~l~~~~~--~~~~~~Gt~~YmAPEvl~gl 509 (511)
.+||+|||+++....... ......+++.|+|||++.+.
T Consensus 160 ~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 199 (280)
T cd05092 160 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYR 199 (280)
T ss_pred CEEECCCCceeEcCCCceeecCCCccccccccCHHHhccC
Confidence 999999999876543221 11122346789999987653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2e-25 Score=221.85 Aligned_cols=155 Identities=21% Similarity=0.348 Sum_probs=127.9
Q ss_pred eeecccceEEEEeE------------------------------EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCcee
Q 010401 347 QIGPNSFKGVYKGK------------------------------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNIL 396 (511)
Q Consensus 347 ~LG~GsFG~VYkgk------------------------------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV 396 (511)
.||+|+||.||+|. .|++|.+... .......+.+|+.+++.++||||+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~~~~~~~l~h~niv 79 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS--HRDIALAFFETASLMSQVSHIHLA 79 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH--HHHHHHHHHHHHHHHhcCCCCCee
Confidence 58999999999974 3677777532 222344577888899999999999
Q ss_pred eEeeeEeeCCCcEEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCC----
Q 010401 397 QFYCVCVDENHGLCVVTKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG---- 471 (511)
Q Consensus 397 ~l~g~~~~~~~~l~LVmEy~~gGsL~~lL~~-~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g---- 471 (511)
++++++.+... .|+||||+++|+|..++.. .+.+++..+..++.||+.||+|||+++|+||||||+|||++..+
T Consensus 80 ~~~~~~~~~~~-~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 80 FVHGVCVRGSE-NIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred eEEEEEEeCCc-eEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccC
Confidence 99999988776 8999999999999999865 46789999999999999999999999999999999999998654
Q ss_pred ---cEEEEecCCceecccCCCccccccCCCccccHHhhcc
Q 010401 472 ---NVCLGDMGIVTACKSVGEATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 472 ---~vKL~DFGlS~~l~~~~~~~~~~~Gt~~YmAPEvl~g 508 (511)
.+|++|||++..... .....++..|+|||.+.+
T Consensus 159 ~~~~~kl~d~g~~~~~~~----~~~~~~~~~~~aPe~~~~ 194 (274)
T cd05076 159 TSPFIKLSDPGVSFTALS----REERVERIPWIAPECVPG 194 (274)
T ss_pred ccceeeecCCcccccccc----ccccccCCcccCchhhcC
Confidence 489999999765432 223456788999998864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.9e-25 Score=217.12 Aligned_cols=166 Identities=24% Similarity=0.420 Sum_probs=137.4
Q ss_pred CCCeEEEeeeecccceEEEEeE-----EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEE
Q 010401 339 SDNLEFIDQIGPNSFKGVYKGK-----RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT 413 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkgk-----~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVm 413 (511)
..+|++.+.||+|+||.||+++ .+++|.+.... .....+.+|+.+++.++||||+++++++...+. .|+||
T Consensus 3 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-~~lv~ 78 (256)
T cd05059 3 PSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA---MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRP-IFIVT 78 (256)
T ss_pred hHHcchhhhhccCCCceEEEeEecCCccEEEEEeccCC---CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCc-eEEEE
Confidence 4568899999999999999964 58888875322 223457789999999999999999999987765 89999
Q ss_pred eccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCcc-
Q 010401 414 KLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT- 491 (511)
Q Consensus 414 Ey~~gGsL~~lL~~-~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~- 491 (511)
||+++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++.........
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (256)
T cd05059 79 EYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSS 158 (256)
T ss_pred ecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceeccccccccc
Confidence 99999999999965 3478999999999999999999999999999999999999999999999999987654322111
Q ss_pred ccccCCCccccHHhhcc
Q 010401 492 EYETDGYRWLAPEVCFL 508 (511)
Q Consensus 492 ~~~~Gt~~YmAPEvl~g 508 (511)
....++..|+|||++.+
T Consensus 159 ~~~~~~~~y~~Pe~~~~ 175 (256)
T cd05059 159 QGTKFPVKWAPPEVFDY 175 (256)
T ss_pred CCCCCCccccCHHHhcc
Confidence 11123457999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-25 Score=221.48 Aligned_cols=168 Identities=21% Similarity=0.312 Sum_probs=142.8
Q ss_pred CCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEE
Q 010401 340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT 413 (511)
Q Consensus 340 ~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVm 413 (511)
++|++.+.||+|+||.||++ +.+++|++............+.+|+.+++.++||||+++++++.+++. +|+||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~lv~ 79 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKR-LYLVF 79 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCe-EEEEE
Confidence 46899999999999999996 468999886433333344567889999999999999999999987775 99999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCcccc
Q 010401 414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY 493 (511)
Q Consensus 414 Ey~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~~~ 493 (511)
||++++.|..+......+++..+..++.||+.||.|||+.|++||||+|+||++++++.++|+|||++............
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~ 159 (286)
T cd07846 80 EFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTD 159 (286)
T ss_pred ecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccccCc
Confidence 99999999888766667999999999999999999999999999999999999999999999999998876443333334
Q ss_pred ccCCCccccHHhhcc
Q 010401 494 ETDGYRWLAPEVCFL 508 (511)
Q Consensus 494 ~~Gt~~YmAPEvl~g 508 (511)
..++..|+|||++.+
T Consensus 160 ~~~~~~y~aPE~~~~ 174 (286)
T cd07846 160 YVATRWYRAPELLVG 174 (286)
T ss_pred ccceeeccCcHHhcc
Confidence 567889999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.7e-25 Score=220.30 Aligned_cols=167 Identities=18% Similarity=0.306 Sum_probs=138.3
Q ss_pred CCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEE
Q 010401 339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV 412 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LV 412 (511)
.++|++.+.||+|+||.||+| +.+++|.+..... ......+.+|+.+++.++|+||+++++++.+++. .|+|
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~-~~lv 81 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE-EGVPFTAIREASLLKGLKHANIVLLHDIIHTKET-LTFV 81 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc-CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCe-EEEE
Confidence 467899999999999999996 4799999864322 2223456789999999999999999999987765 8999
Q ss_pred EeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCcc
Q 010401 413 TKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT 491 (511)
Q Consensus 413 mEy~~gGsL~~lL~~-~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~ 491 (511)
|||+. ++|.+.+.. ...+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++.........
T Consensus 82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~ 160 (291)
T cd07870 82 FEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTY 160 (291)
T ss_pred Eeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCCC
Confidence 99996 577776643 3567888999999999999999999999999999999999999999999999987654433333
Q ss_pred ccccCCCccccHHhhcc
Q 010401 492 EYETDGYRWLAPEVCFL 508 (511)
Q Consensus 492 ~~~~Gt~~YmAPEvl~g 508 (511)
....+++.|+|||++.+
T Consensus 161 ~~~~~~~~y~aPE~~~~ 177 (291)
T cd07870 161 SSEVVTLWYRPPDVLLG 177 (291)
T ss_pred CCccccccccCCceeec
Confidence 44567889999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.2e-25 Score=237.03 Aligned_cols=163 Identities=20% Similarity=0.229 Sum_probs=132.2
Q ss_pred cCCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCC-----
Q 010401 338 NSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN----- 406 (511)
Q Consensus 338 ~~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~----- 406 (511)
..++|++.+.||+|+||.||+| +.||+|++.... ....+|+.+++.++||||+++++++....
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~ 137 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNE 137 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHhcCCCCCcceeeeEeecccccCC
Confidence 3567999999999999999996 479999885321 12357899999999999999998875321
Q ss_pred --CcEEEEEeccCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCC-cEEEEecC
Q 010401 407 --HGLCVVTKLMEGGSVNDLIL----KSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG-NVCLGDMG 479 (511)
Q Consensus 407 --~~l~LVmEy~~gGsL~~lL~----~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g-~vKL~DFG 479 (511)
..+++||||+++ +|.+++. ....+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||
T Consensus 138 ~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFG 216 (440)
T PTZ00036 138 KNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFG 216 (440)
T ss_pred CceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccc
Confidence 126799999976 7777664 245799999999999999999999999999999999999999654 79999999
Q ss_pred CceecccCCCccccccCCCccccHHhhcc
Q 010401 480 IVTACKSVGEATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 480 lS~~l~~~~~~~~~~~Gt~~YmAPEvl~g 508 (511)
+++.+..... .....||+.|+|||++.+
T Consensus 217 la~~~~~~~~-~~~~~~t~~y~aPE~~~~ 244 (440)
T PTZ00036 217 SAKNLLAGQR-SVSYICSRFYRAPELMLG 244 (440)
T ss_pred cchhccCCCC-cccCCCCcCccCHHHhcC
Confidence 9987644322 334567899999999865
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.7e-25 Score=218.34 Aligned_cols=171 Identities=26% Similarity=0.397 Sum_probs=140.3
Q ss_pred ceEecCCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhC-CCCceeeEeeeEee--
Q 010401 334 RWLLNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCVCVD-- 404 (511)
Q Consensus 334 ~~~l~~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l-~HpNIV~l~g~~~~-- 404 (511)
.+....++|++.+.||+|+||.||++ +.+++|++... ......+.+|+.++..+ +||||+++++++..
T Consensus 12 ~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~---~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 88 (286)
T cd06638 12 SFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI---HDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKD 88 (286)
T ss_pred cCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc---cchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence 34446788999999999999999985 46889987532 22234577888888888 79999999998853
Q ss_pred --CCCcEEEEEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEec
Q 010401 405 --ENHGLCVVTKLMEGGSVNDLILK----SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDM 478 (511)
Q Consensus 405 --~~~~l~LVmEy~~gGsL~~lL~~----~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DF 478 (511)
.+..+++||||+++++|.+++.. ...+++..+..++.|++.||.|||+++|+||||||+||+++.++.+||+||
T Consensus 89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~df 168 (286)
T cd06638 89 VKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDF 168 (286)
T ss_pred cCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccC
Confidence 22338999999999999998752 346889999999999999999999999999999999999999999999999
Q ss_pred CCceecccCCCccccccCCCccccHHhhc
Q 010401 479 GIVTACKSVGEATEYETDGYRWLAPEVCF 507 (511)
Q Consensus 479 GlS~~l~~~~~~~~~~~Gt~~YmAPEvl~ 507 (511)
|+++.............|++.|+|||++.
T Consensus 169 g~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 197 (286)
T cd06638 169 GVSAQLTSTRLRRNTSVGTPFWMAPEVIA 197 (286)
T ss_pred CceeecccCCCccccccCCCcccChhhhc
Confidence 99887654333334456889999999875
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.2e-25 Score=220.13 Aligned_cols=166 Identities=20% Similarity=0.373 Sum_probs=135.9
Q ss_pred CeEEEeeeecccceEEEEeE-----------EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcE
Q 010401 341 NLEFIDQIGPNSFKGVYKGK-----------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGL 409 (511)
Q Consensus 341 ~y~l~~~LG~GsFG~VYkgk-----------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l 409 (511)
+|++.+.||+|+||.||+|. .+++|.+... .......++.+|+.++..++||||+++++.+...+. .
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~ 78 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKEN-ASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGP-L 78 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCC-CCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCC-c
Confidence 47888999999999999974 4777777532 223334568899999999999999999999987776 8
Q ss_pred EEEEeccCCCCHHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCce
Q 010401 410 CVVTKLMEGGSVNDLILKS------------------------RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRI 465 (511)
Q Consensus 410 ~LVmEy~~gGsL~~lL~~~------------------------~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NI 465 (511)
+++|||+.+|+|.+++... ..+++..++.++.|++.||+|||+++|+||||||+||
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~ni 158 (290)
T cd05045 79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNV 158 (290)
T ss_pred EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheE
Confidence 9999999999999998542 2478889999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCceecccCCC--ccccccCCCccccHHhhcc
Q 010401 466 LLDRHGNVCLGDMGIVTACKSVGE--ATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 466 Lld~~g~vKL~DFGlS~~l~~~~~--~~~~~~Gt~~YmAPEvl~g 508 (511)
|+++++.+||+|||+++....... ......++..|+|||++.+
T Consensus 159 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~ 203 (290)
T cd05045 159 LVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFD 203 (290)
T ss_pred EEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHcc
Confidence 999999999999999876533222 1223345678999998753
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.1e-25 Score=220.46 Aligned_cols=169 Identities=21% Similarity=0.395 Sum_probs=138.2
Q ss_pred cCCCeEEEeeeecccceEEEEeE----------------------EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCce
Q 010401 338 NSDNLEFIDQIGPNSFKGVYKGK----------------------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNI 395 (511)
Q Consensus 338 ~~~~y~l~~~LG~GsFG~VYkgk----------------------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNI 395 (511)
..++|++.+.||+|+||.||+++ .+|+|.+... ........+.+|+.+++.++|+||
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~-~~~~~~~~~~~E~~~l~~l~~~~i 81 (296)
T cd05095 3 PRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLRED-ANKNARNDFLKEIKIMSRLKDPNI 81 (296)
T ss_pred ChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCc
Confidence 45678999999999999999852 5888888643 223344568899999999999999
Q ss_pred eeEeeeEeeCCCcEEEEEeccCCCCHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCc
Q 010401 396 LQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-----------KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQR 464 (511)
Q Consensus 396 V~l~g~~~~~~~~l~LVmEy~~gGsL~~lL~~~~-----------~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~N 464 (511)
+++++++...+. .|++|||+++++|.+++.... .+++..+..++.||+.||+|||++|++||||||+|
T Consensus 82 ~~~~~~~~~~~~-~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~N 160 (296)
T cd05095 82 IRLLAVCITSDP-LCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRN 160 (296)
T ss_pred ceEEEEEecCCc-cEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChhe
Confidence 999999988776 899999999999999986532 36678899999999999999999999999999999
Q ss_pred eEEcCCCcEEEEecCCceecccCCCc--cccccCCCccccHHhhcc
Q 010401 465 ILLDRHGNVCLGDMGIVTACKSVGEA--TEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 465 ILld~~g~vKL~DFGlS~~l~~~~~~--~~~~~Gt~~YmAPEvl~g 508 (511)
||++.++.++|+|||+++.+...... .....+++.|+|||++.+
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 206 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILL 206 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhc
Confidence 99999999999999998765432211 112233578999997653
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.5e-25 Score=250.98 Aligned_cols=169 Identities=21% Similarity=0.315 Sum_probs=139.7
Q ss_pred CCeEEEeeeecccceEEEEe------EEEEEEEEecCCCC-chHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEE
Q 010401 340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKG-NAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV 412 (511)
Q Consensus 340 ~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~-~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LV 412 (511)
++|++.++||+|+||.||+| +.||+|++...... .....++.+|+.+++.++||||+++++++.+.+. .|++
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~-lyLV 80 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDP-VYYT 80 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCE-EEEE
Confidence 57899999999999999996 47999999743222 2345568899999999999999999999988775 9999
Q ss_pred EeccCCCCHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCc
Q 010401 413 TKLMEGGSVNDLILKS-----------RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIV 481 (511)
Q Consensus 413 mEy~~gGsL~~lL~~~-----------~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS 481 (511)
|||++||+|.+++... ..++...+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLA 160 (932)
T PRK13184 81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAA 160 (932)
T ss_pred EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcc
Confidence 9999999999998531 23456778899999999999999999999999999999999999999999999
Q ss_pred eecccCCC------------------ccccccCCCccccHHhhccc
Q 010401 482 TACKSVGE------------------ATEYETDGYRWLAPEVCFLL 509 (511)
Q Consensus 482 ~~l~~~~~------------------~~~~~~Gt~~YmAPEvl~gl 509 (511)
+....... ......||+.|||||++.+.
T Consensus 161 k~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~ 206 (932)
T PRK13184 161 IFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGV 206 (932)
T ss_pred eecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCC
Confidence 86621110 01124689999999998753
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.5e-25 Score=215.88 Aligned_cols=169 Identities=24% Similarity=0.422 Sum_probs=140.6
Q ss_pred eEecCCCeEEEeeeecccceEEEEe-----EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcE
Q 010401 335 WLLNSDNLEFIDQIGPNSFKGVYKG-----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGL 409 (511)
Q Consensus 335 ~~l~~~~y~l~~~LG~GsFG~VYkg-----k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l 409 (511)
|.+..++|+++++||+|+||.||++ +.+|+|.+..... ....+.+|+.+++.++|+||+++++++.+ +. .
T Consensus 1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~-~ 75 (260)
T cd05067 1 WEVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM---SPEAFLAEANLMKQLQHPRLVRLYAVVTQ-EP-I 75 (260)
T ss_pred CccchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC---cHHHHHHHHHHHHhcCCcCeeeEEEEEcc-CC-c
Confidence 4567889999999999999999995 5799999864332 23467889999999999999999998753 33 8
Q ss_pred EEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccC
Q 010401 410 CVVTKLMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV 487 (511)
Q Consensus 410 ~LVmEy~~gGsL~~lL~~~--~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~ 487 (511)
|++|||+.+++|.+++... ..+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++......
T Consensus 76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05067 76 YIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDN 155 (260)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCC
Confidence 9999999999999998643 46899999999999999999999999999999999999999999999999998776532
Q ss_pred CC-ccccccCCCccccHHhhcc
Q 010401 488 GE-ATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 488 ~~-~~~~~~Gt~~YmAPEvl~g 508 (511)
.. ......+++.|+|||++.+
T Consensus 156 ~~~~~~~~~~~~~y~~pe~~~~ 177 (260)
T cd05067 156 EYTAREGAKFPIKWTAPEAINY 177 (260)
T ss_pred CcccccCCcccccccCHHHhcc
Confidence 21 1223345678999998753
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-25 Score=219.37 Aligned_cols=169 Identities=25% Similarity=0.431 Sum_probs=141.6
Q ss_pred ecCCCeEEEeeeecccceEEEEeE-----EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEE
Q 010401 337 LNSDNLEFIDQIGPNSFKGVYKGK-----RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCV 411 (511)
Q Consensus 337 l~~~~y~l~~~LG~GsFG~VYkgk-----~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~L 411 (511)
....+|++.+.||.|+||.||+|+ .+++|.+.... ......+.+|+.+++.++|+||+++++++.+.+. +|+
T Consensus 3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-~~l 79 (261)
T cd05148 3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDD--LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEP-VYI 79 (261)
T ss_pred CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccc--hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCC-eEE
Confidence 345678999999999999999964 58899886422 2234567889999999999999999999988776 999
Q ss_pred EEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCC
Q 010401 412 VTKLMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE 489 (511)
Q Consensus 412 VmEy~~gGsL~~lL~~~--~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~ 489 (511)
||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++........
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 80 ITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY 159 (261)
T ss_pred EEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence 99999999999999653 4689999999999999999999999999999999999999999999999999876644322
Q ss_pred ccccccCCCccccHHhhcc
Q 010401 490 ATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 490 ~~~~~~Gt~~YmAPEvl~g 508 (511)
......+++.|+|||++..
T Consensus 160 ~~~~~~~~~~~~~PE~~~~ 178 (261)
T cd05148 160 LSSDKKIPYKWTAPEAASH 178 (261)
T ss_pred cccCCCCceEecCHHHHcc
Confidence 2233345678999998754
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.6e-25 Score=219.43 Aligned_cols=163 Identities=24% Similarity=0.433 Sum_probs=138.4
Q ss_pred eEEEeeeecccceEEEEeE------EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEEec
Q 010401 342 LEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKL 415 (511)
Q Consensus 342 y~l~~~LG~GsFG~VYkgk------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVmEy 415 (511)
|++.+.||+|+||.||+++ .+++|.+.. ........+.+|+.+++.++||||+++++++..++. .|+||||
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~--~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~-~~~v~e~ 83 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDT--KSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENN-LWILIEF 83 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCC--CCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCE-EEEEEEe
Confidence 5778999999999999964 567777753 223344567889999999999999999999988775 9999999
Q ss_pred cCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCccccc
Q 010401 416 MEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYE 494 (511)
Q Consensus 416 ~~gGsL~~lL~~-~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~~~~ 494 (511)
+++++|..++.+ ...+++..+..++.||+.||.|||+.||+||||||+||+++.++.+||+|||++.............
T Consensus 84 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~ 163 (282)
T cd06643 84 CAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSF 163 (282)
T ss_pred cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccccccccccc
Confidence 999999998754 4579999999999999999999999999999999999999999999999999987654433333455
Q ss_pred cCCCccccHHhhc
Q 010401 495 TDGYRWLAPEVCF 507 (511)
Q Consensus 495 ~Gt~~YmAPEvl~ 507 (511)
.+++.|+|||++.
T Consensus 164 ~~~~~y~aPE~~~ 176 (282)
T cd06643 164 IGTPYWMAPEVVM 176 (282)
T ss_pred cccccccCHhhcc
Confidence 7889999999974
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.3e-26 Score=238.29 Aligned_cols=169 Identities=27% Similarity=0.405 Sum_probs=136.9
Q ss_pred ecCCCeEEEeeeecccceEEEEe----EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCC---CcE
Q 010401 337 LNSDNLEFIDQIGPNSFKGVYKG----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN---HGL 409 (511)
Q Consensus 337 l~~~~y~l~~~LG~GsFG~VYkg----k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~---~~l 409 (511)
++...+.+.+.||+|.||.||+| +.||||++....+ ..+..+++|-.+-.+.|+||++|+++-.... ..+
T Consensus 207 ~~l~pl~l~eli~~Grfg~V~KaqL~~~~VAVKifp~~~k---qs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~ey 283 (534)
T KOG3653|consen 207 LELDPLQLLELIGRGRFGCVWKAQLDNRLVAVKIFPEQEK---QSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEY 283 (534)
T ss_pred ccCCchhhHHHhhcCccceeehhhccCceeEEEecCHHHH---HHHHhHHHHHhccCccchhHHHhhchhccCCccccce
Confidence 44567788999999999999997 5899999963222 2233344444444579999999998765443 138
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---------CccccCCCCCceEEcCCCcEEEEecCC
Q 010401 410 CVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDH---------GVAYRDLNSQRILLDRHGNVCLGDMGI 480 (511)
Q Consensus 410 ~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~---------gIIHRDLKp~NILld~~g~vKL~DFGl 480 (511)
|||++|.+.|+|.++|. ...++|....+++..|++||+|||+. .|+|||||.+||||.++++..|+|||+
T Consensus 284 wLVt~fh~kGsL~dyL~-~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGL 362 (534)
T KOG3653|consen 284 WLVTEFHPKGSLCDYLK-ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGL 362 (534)
T ss_pred eEEeeeccCCcHHHHHH-hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccce
Confidence 99999999999999994 46799999999999999999999973 599999999999999999999999999
Q ss_pred ceecccCCC--ccccccCCCccccHHhhccc
Q 010401 481 VTACKSVGE--ATEYETDGYRWLAPEVCFLL 509 (511)
Q Consensus 481 S~~l~~~~~--~~~~~~Gt~~YmAPEvl~gl 509 (511)
|..+..... ......||.+|||||++.|-
T Consensus 363 Al~~~p~~~~~d~~~qVGT~RYMAPEvLEga 393 (534)
T KOG3653|consen 363 ALRLEPGKPQGDTHGQVGTRRYMAPEVLEGA 393 (534)
T ss_pred eEEecCCCCCcchhhhhhhhhhcCHHHHhhh
Confidence 988753222 23447899999999999863
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.5e-25 Score=221.78 Aligned_cols=169 Identities=21% Similarity=0.322 Sum_probs=141.8
Q ss_pred CCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCC-CcEEE
Q 010401 339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN-HGLCV 411 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~-~~l~L 411 (511)
.++|++.+.||.|+||.||+| +.+++|.++...........+.+|+.+++.++||||+++++++...+ ..+|+
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l 83 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM 83 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence 357889999999999999996 46899999754443334445678999999999999999999988762 34999
Q ss_pred EEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCc
Q 010401 412 VTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA 490 (511)
Q Consensus 412 VmEy~~gGsL~~lL~~~-~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~ 490 (511)
||||+.+ +|.+++... ..+++..+..++.||+.||+|||++|++||||||+||+++.++.+||+|||+++........
T Consensus 84 v~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 162 (293)
T cd07843 84 VMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKP 162 (293)
T ss_pred EehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCccc
Confidence 9999975 999988654 46899999999999999999999999999999999999999999999999998877654333
Q ss_pred cccccCCCccccHHhhcc
Q 010401 491 TEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 491 ~~~~~Gt~~YmAPEvl~g 508 (511)
.....+++.|+|||++.+
T Consensus 163 ~~~~~~~~~~~aPE~~~~ 180 (293)
T cd07843 163 YTQLVVTLWYRAPELLLG 180 (293)
T ss_pred cccccccccccCchhhcC
Confidence 344567888999999865
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.6e-25 Score=222.09 Aligned_cols=167 Identities=17% Similarity=0.313 Sum_probs=140.1
Q ss_pred CCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEE
Q 010401 339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV 412 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LV 412 (511)
.++|++.+.||.|+||.||++ +.||+|.+..... ......+.+|+.+++.++||||+++++++..++. +|+|
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~-~~lv 82 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKS-LTLV 82 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc-cCchhHHHHHHHHHHhcCCCCcceEEEEEecCCe-EEEE
Confidence 467899999999999999996 4689998864322 2223456789999999999999999999987775 9999
Q ss_pred EeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCcc
Q 010401 413 TKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT 491 (511)
Q Consensus 413 mEy~~gGsL~~lL~~-~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~ 491 (511)
|||+.+ +|..++.. ...+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++..........
T Consensus 83 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 161 (301)
T cd07873 83 FEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY 161 (301)
T ss_pred Eecccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCcc
Confidence 999975 89888865 3568999999999999999999999999999999999999999999999999987654333333
Q ss_pred ccccCCCccccHHhhcc
Q 010401 492 EYETDGYRWLAPEVCFL 508 (511)
Q Consensus 492 ~~~~Gt~~YmAPEvl~g 508 (511)
....+++.|+|||++.+
T Consensus 162 ~~~~~~~~y~~PE~~~~ 178 (301)
T cd07873 162 SNEVVTLWYRPPDILLG 178 (301)
T ss_pred cccceeecccCcHHHhC
Confidence 34567889999999764
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.3e-26 Score=247.01 Aligned_cols=171 Identities=22% Similarity=0.371 Sum_probs=149.7
Q ss_pred eEecCCCeEEEeeeecccceEEEEeE---------EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeC
Q 010401 335 WLLNSDNLEFIDQIGPNSFKGVYKGK---------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDE 405 (511)
Q Consensus 335 ~~l~~~~y~l~~~LG~GsFG~VYkgk---------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~ 405 (511)
.+++...+++.++||.|.||.|++|+ .||||.|+.. -.+....+|+.|+.+|-+++||||++|.|+....
T Consensus 624 kEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~G-ytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks 702 (996)
T KOG0196|consen 624 KEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAG-YTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKS 702 (996)
T ss_pred hhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccC-ccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecC
Confidence 35677889999999999999999974 6999999863 3344566799999999999999999999999877
Q ss_pred CCcEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceec
Q 010401 406 NHGLCVVTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC 484 (511)
Q Consensus 406 ~~~l~LVmEy~~gGsL~~lL~~~-~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l 484 (511)
+. +.||+|||++|+|+.+|+.+ +.++..++..+++.|+.||+||-+.++|||||..+||||+.+-..|++|||++|.+
T Consensus 703 ~P-vMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvl 781 (996)
T KOG0196|consen 703 KP-VMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL 781 (996)
T ss_pred ce-eEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeec
Confidence 65 99999999999999999754 67999999999999999999999999999999999999999999999999999988
Q ss_pred ccCCCccccccCC---CccccHHhhc
Q 010401 485 KSVGEATEYETDG---YRWLAPEVCF 507 (511)
Q Consensus 485 ~~~~~~~~~~~Gt---~~YmAPEvl~ 507 (511)
.++........|+ ++|.|||.|.
T Consensus 782 edd~~~~ytt~GGKIPiRWTAPEAIa 807 (996)
T KOG0196|consen 782 EDDPEAAYTTLGGKIPIRWTAPEAIA 807 (996)
T ss_pred ccCCCccccccCCccceeecChhHhh
Confidence 7666444444444 7999999874
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=6e-25 Score=217.48 Aligned_cols=169 Identities=20% Similarity=0.395 Sum_probs=139.6
Q ss_pred ecCCCeEEEeeeecccceEEEEeE----------EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCC
Q 010401 337 LNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN 406 (511)
Q Consensus 337 l~~~~y~l~~~LG~GsFG~VYkgk----------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~ 406 (511)
+...+|++.+.||+|+||.||+|. .+++|.+... ........+.+|+..+..++||||+++++++.. .
T Consensus 4 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~ 81 (279)
T cd05057 4 LKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREE-TSPKANKEILDEAYVMASVDHPHVVRLLGICLS-S 81 (279)
T ss_pred cCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCC-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-C
Confidence 345688999999999999999974 4788877643 223345568899999999999999999999987 4
Q ss_pred CcEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecc
Q 010401 407 HGLCVVTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK 485 (511)
Q Consensus 407 ~~l~LVmEy~~gGsL~~lL~~~-~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~ 485 (511)
..+++|||+++|+|.+++... ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++...
T Consensus 82 -~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~ 160 (279)
T cd05057 82 -QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160 (279)
T ss_pred -ceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCccccccc
Confidence 389999999999999999764 478999999999999999999999999999999999999999999999999988765
Q ss_pred cCCCccc--cccCCCccccHHhhcc
Q 010401 486 SVGEATE--YETDGYRWLAPEVCFL 508 (511)
Q Consensus 486 ~~~~~~~--~~~Gt~~YmAPEvl~g 508 (511)
....... ...+++.|+|||.+..
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~ 185 (279)
T cd05057 161 VDEKEYHAEGGKVPIKWMALESILH 185 (279)
T ss_pred CcccceecCCCcccccccCHHHhhc
Confidence 3222111 1223568999998753
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.6e-25 Score=215.76 Aligned_cols=168 Identities=20% Similarity=0.348 Sum_probs=138.8
Q ss_pred CCCeEEEeeeecccceEEEEeE---------EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcE
Q 010401 339 SDNLEFIDQIGPNSFKGVYKGK---------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGL 409 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkgk---------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l 409 (511)
..+|++.+.||+|+||.||+|+ .|++|.+... .......++..|+.+++.++||||+++++++.+++. .
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~-~ 80 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG-YTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRP-V 80 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCc-e
Confidence 4568999999999999999964 4899988642 233345668899999999999999999999987775 8
Q ss_pred EEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCC
Q 010401 410 CVVTKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG 488 (511)
Q Consensus 410 ~LVmEy~~gGsL~~lL~~-~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~ 488 (511)
++||||+++++|.+++.. .+.+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 81 MIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred EEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence 999999999999999865 3568999999999999999999999999999999999999999999999999987654322
Q ss_pred Ccc--ccccC---CCccccHHhhcc
Q 010401 489 EAT--EYETD---GYRWLAPEVCFL 508 (511)
Q Consensus 489 ~~~--~~~~G---t~~YmAPEvl~g 508 (511)
... ....+ +..|+|||++.+
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~ 185 (269)
T cd05065 161 SDPTYTSSLGGKIPIRWTAPEAIAY 185 (269)
T ss_pred cccccccccCCCcceeecCHhHhcc
Confidence 211 11111 357999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.2e-25 Score=216.62 Aligned_cols=169 Identities=21% Similarity=0.400 Sum_probs=139.4
Q ss_pred eEecCCCeEEEeeeecccceEEEEeE-----EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcE
Q 010401 335 WLLNSDNLEFIDQIGPNSFKGVYKGK-----RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGL 409 (511)
Q Consensus 335 ~~l~~~~y~l~~~LG~GsFG~VYkgk-----~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l 409 (511)
|.+..++|++.++||+|+||.||+++ .|++|++..... ...++.+|+.++..++||||+++++.+.+ +. .
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~---~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~-~ 75 (262)
T cd05071 1 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EP-I 75 (262)
T ss_pred CCCChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc---CHHHHHHHHHHHHhCCCCCcceEEEEECC-CC-c
Confidence 34567789999999999999999974 588998864222 23467889999999999999999998753 33 7
Q ss_pred EEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccC
Q 010401 410 CVVTKLMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV 487 (511)
Q Consensus 410 ~LVmEy~~gGsL~~lL~~~--~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~ 487 (511)
|+||||+++|+|.+++... ..+++..+..++.|++.||.|||+.+|+||||||+||+++.++.++|+|||.++.....
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~ 155 (262)
T cd05071 76 YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN 155 (262)
T ss_pred EEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeecccc
Confidence 9999999999999999653 35889999999999999999999999999999999999999999999999999766433
Q ss_pred CCcc-ccccCCCccccHHhhcc
Q 010401 488 GEAT-EYETDGYRWLAPEVCFL 508 (511)
Q Consensus 488 ~~~~-~~~~Gt~~YmAPEvl~g 508 (511)
.... ....++..|+|||++.+
T Consensus 156 ~~~~~~~~~~~~~y~~PE~~~~ 177 (262)
T cd05071 156 EYTARQGAKFPIKWTAPEAALY 177 (262)
T ss_pred ccccccCCcccceecCHhHhcc
Confidence 2211 12345567999998753
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.9e-26 Score=227.70 Aligned_cols=175 Identities=19% Similarity=0.262 Sum_probs=152.3
Q ss_pred ceEecCCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCch-HHHHHHHHHHHHHh-CCCCceeeEeeeEeeC
Q 010401 334 RWLLNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNA-YEFELRKDLLELMT-CGHKNILQFYCVCVDE 405 (511)
Q Consensus 334 ~~~l~~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~-~~~~~~~Ei~iL~~-l~HpNIV~l~g~~~~~ 405 (511)
.|.+..++|.++.+||+|+|++|.+. +.+|+|++++.-..+. ....++.|-.+... .+||++|.++..|.++
T Consensus 244 ~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqte 323 (593)
T KOG0695|consen 244 SQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTE 323 (593)
T ss_pred ccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhccc
Confidence 57788899999999999999999885 4678888875433322 22334555555544 4899999999998888
Q ss_pred CCcEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecc
Q 010401 406 NHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK 485 (511)
Q Consensus 406 ~~~l~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~ 485 (511)
.. +++|.||++||+|.-++++.++++++.++.|..+|+.||.|||+.|||+||||.+|+|+|..|++||.|+|+++.-.
T Consensus 324 sr-lffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l 402 (593)
T KOG0695|consen 324 SR-LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL 402 (593)
T ss_pred ce-EEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCC
Confidence 76 99999999999999999888999999999999999999999999999999999999999999999999999999887
Q ss_pred cCCCccccccCCCccccHHhhccc
Q 010401 486 SVGEATEYETDGYRWLAPEVCFLL 509 (511)
Q Consensus 486 ~~~~~~~~~~Gt~~YmAPEvl~gl 509 (511)
.++..+...||||.|.|||+++|-
T Consensus 403 ~~gd~tstfcgtpnyiapeilrge 426 (593)
T KOG0695|consen 403 GPGDTTSTFCGTPNYIAPEILRGE 426 (593)
T ss_pred CCCcccccccCCCcccchhhhccc
Confidence 888889999999999999999874
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.3e-25 Score=216.70 Aligned_cols=166 Identities=19% Similarity=0.366 Sum_probs=133.8
Q ss_pred EEEeeeecccceEEEEeE--------EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCC-----CcE
Q 010401 343 EFIDQIGPNSFKGVYKGK--------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN-----HGL 409 (511)
Q Consensus 343 ~l~~~LG~GsFG~VYkgk--------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~-----~~l 409 (511)
.+.+.||+|+||.||+|+ .+|+|.++...........+.+|+.+++.++|+||+++++++.... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 467889999999999974 4888888653333444556788999999999999999999875422 136
Q ss_pred EEEEeccCCCCHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCcee
Q 010401 410 CVVTKLMEGGSVNDLILK------SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTA 483 (511)
Q Consensus 410 ~LVmEy~~gGsL~~lL~~------~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~ 483 (511)
+++|||+.+|+|.+++.. ...+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++.
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 161 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKK 161 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcccc
Confidence 899999999999998742 23588999999999999999999999999999999999999999999999999887
Q ss_pred cccCCCc--cccccCCCccccHHhhcc
Q 010401 484 CKSVGEA--TEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 484 l~~~~~~--~~~~~Gt~~YmAPEvl~g 508 (511)
....... .....+++.|+|||++.+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~pe~~~~ 188 (272)
T cd05075 162 IYNGDYYRQGRIAKMPVKWIAIESLAD 188 (272)
T ss_pred cCcccceecCCcccCCcccCCHHHccC
Confidence 6433211 122345678999999754
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.9e-25 Score=218.75 Aligned_cols=161 Identities=23% Similarity=0.388 Sum_probs=137.5
Q ss_pred CCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEE
Q 010401 340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT 413 (511)
Q Consensus 340 ~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVm 413 (511)
++|++++.||+|+||.||++ +.+|+|.+... ........+.+|+.++.+++||||+++++++...+. .++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~lv~ 78 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLD-ITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENR-ISICT 78 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecC-CChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCE-EEEEE
Confidence 46788999999999999996 46899988642 233344568899999999999999999999998876 89999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCcccc
Q 010401 414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY 493 (511)
Q Consensus 414 Ey~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~~~ 493 (511)
||+++++|..+ ..+++..+..++.|++.||.|||++||+|+||||+|||++.++.++|+|||++...... ....
T Consensus 79 e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~--~~~~ 152 (279)
T cd06619 79 EFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS--IAKT 152 (279)
T ss_pred ecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc--cccC
Confidence 99999999654 35788899999999999999999999999999999999999999999999998765432 2344
Q ss_pred ccCCCccccHHhhcc
Q 010401 494 ETDGYRWLAPEVCFL 508 (511)
Q Consensus 494 ~~Gt~~YmAPEvl~g 508 (511)
..|+..|+|||++.+
T Consensus 153 ~~~~~~y~aPE~~~~ 167 (279)
T cd06619 153 YVGTNAYMAPERISG 167 (279)
T ss_pred CCCChhhcCceeecC
Confidence 578899999998764
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.1e-25 Score=214.63 Aligned_cols=171 Identities=22% Similarity=0.377 Sum_probs=141.5
Q ss_pred eEecCCCeEEEeeeecccceEEEEeE------EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCc
Q 010401 335 WLLNSDNLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHG 408 (511)
Q Consensus 335 ~~l~~~~y~l~~~LG~GsFG~VYkgk------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~ 408 (511)
++++.+++.....||+|+||.||+|+ .+++|.+.. ........+.+|+.++..++|+||+++++++..++.
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~- 79 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPE--RDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGF- 79 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecC--CCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCE-
Confidence 34455666666889999999999974 589998863 233344568899999999999999999999988775
Q ss_pred EEEEEeccCCCCHHHHHHhc-CCC--CHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcC-CCcEEEEecCCceec
Q 010401 409 LCVVTKLMEGGSVNDLILKS-RKL--QTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDR-HGNVCLGDMGIVTAC 484 (511)
Q Consensus 409 l~LVmEy~~gGsL~~lL~~~-~~L--~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~-~g~vKL~DFGlS~~l 484 (511)
.+++|||+++++|.+++... ..+ ++..+..++.||+.||.|||++||+||||||+||+++. ++.++|+|||++...
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~ 159 (268)
T cd06624 80 FKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL 159 (268)
T ss_pred EEEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheec
Confidence 99999999999999999654 455 88889999999999999999999999999999999986 679999999998766
Q ss_pred ccCCCccccccCCCccccHHhhcc
Q 010401 485 KSVGEATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 485 ~~~~~~~~~~~Gt~~YmAPEvl~g 508 (511)
...........|++.|+|||++.+
T Consensus 160 ~~~~~~~~~~~~~~~~~aPE~~~~ 183 (268)
T cd06624 160 AGINPCTETFTGTLQYMAPEVIDK 183 (268)
T ss_pred ccCCCccccCCCCccccChhhhcc
Confidence 443333344567889999999754
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.2e-25 Score=220.23 Aligned_cols=166 Identities=22% Similarity=0.358 Sum_probs=141.4
Q ss_pred CCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEE
Q 010401 339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV 412 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LV 412 (511)
..+|++.+.||+|+||.||+| +.+++|.+...... ....+.+|+.+++.++|+||+++++.+.++.. .|+|
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~--~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~-~~lv 95 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGDE-LWVV 95 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc--hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCE-EEEe
Confidence 457899999999999999996 47899988743322 23557889999999999999999999988775 9999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCccc
Q 010401 413 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE 492 (511)
Q Consensus 413 mEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~~ 492 (511)
|||+++++|.+++.. ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.+||+|||++...........
T Consensus 96 ~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 174 (296)
T cd06654 96 MEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS 174 (296)
T ss_pred ecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccccccccC
Confidence 999999999999854 4689999999999999999999999999999999999999999999999999876543332334
Q ss_pred cccCCCccccHHhhcc
Q 010401 493 YETDGYRWLAPEVCFL 508 (511)
Q Consensus 493 ~~~Gt~~YmAPEvl~g 508 (511)
...|++.|+|||++.+
T Consensus 175 ~~~~~~~y~aPE~~~~ 190 (296)
T cd06654 175 TMVGTPYWMAPEVVTR 190 (296)
T ss_pred cccCCccccCHHHHcC
Confidence 4578899999998764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-24 Score=232.39 Aligned_cols=166 Identities=14% Similarity=0.298 Sum_probs=133.2
Q ss_pred ecCCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhC------CCCceeeEeeeEee
Q 010401 337 LNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTC------GHKNILQFYCVCVD 404 (511)
Q Consensus 337 l~~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l------~HpNIV~l~g~~~~ 404 (511)
+..++|++.++||+|+||.||++ +.||||+++... ........|+.++..+ +|.+|+++++++..
T Consensus 126 ~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~ 202 (467)
T PTZ00284 126 VSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP---KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN 202 (467)
T ss_pred cCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch---hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence 44678999999999999999996 469999996421 1223345566555554 45568999999887
Q ss_pred CCCcEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCceEEcCCC------------
Q 010401 405 ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLND-HGVAYRDLNSQRILLDRHG------------ 471 (511)
Q Consensus 405 ~~~~l~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~-~gIIHRDLKp~NILld~~g------------ 471 (511)
+...+|+|||++ +++|.+++.+.+.+++..+..++.||+.||.|||. .|||||||||+|||++.++
T Consensus 203 ~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~ 281 (467)
T PTZ00284 203 ETGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALP 281 (467)
T ss_pred CCceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccC
Confidence 665589999998 66999998877889999999999999999999998 5999999999999998765
Q ss_pred ----cEEEEecCCceecccCCCccccccCCCccccHHhhccc
Q 010401 472 ----NVCLGDMGIVTACKSVGEATEYETDGYRWLAPEVCFLL 509 (511)
Q Consensus 472 ----~vKL~DFGlS~~l~~~~~~~~~~~Gt~~YmAPEvl~gl 509 (511)
.+||+|||++.... .......||+.|+|||++.+.
T Consensus 282 ~~~~~vkl~DfG~~~~~~---~~~~~~~gt~~Y~APE~~~~~ 320 (467)
T PTZ00284 282 PDPCRVRICDLGGCCDER---HSRTAIVSTRHYRSPEVVLGL 320 (467)
T ss_pred CCCceEEECCCCccccCc---cccccccCCccccCcHHhhcC
Confidence 49999999875422 223456889999999998764
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.7e-25 Score=218.61 Aligned_cols=167 Identities=19% Similarity=0.325 Sum_probs=138.8
Q ss_pred CCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEE
Q 010401 339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV 412 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LV 412 (511)
.++|++.+.||+|+||.||+| +.|++|.+..... ......+.+|+.+++.++|+||+++++++.+++. .|+|
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~-~~lv 81 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHE-EGAPFTAIREASLLKDLKHANIVTLHDIIHTKKT-LTLV 81 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccc-cCCchhHHHHHHHHhhCCCcceeeEEEEEecCCe-EEEE
Confidence 468899999999999999996 4699999864322 2223346789999999999999999999987775 9999
Q ss_pred EeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCcc
Q 010401 413 TKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT 491 (511)
Q Consensus 413 mEy~~gGsL~~lL~~~-~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~ 491 (511)
|||+.+ +|.+++... ..+++..+..++.|++.||.|||+++|+||||||+||+++.++.+||+|||+++.........
T Consensus 82 ~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 160 (291)
T cd07844 82 FEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTY 160 (291)
T ss_pred EecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCccc
Confidence 999985 999988653 478999999999999999999999999999999999999999999999999987543322222
Q ss_pred ccccCCCccccHHhhcc
Q 010401 492 EYETDGYRWLAPEVCFL 508 (511)
Q Consensus 492 ~~~~Gt~~YmAPEvl~g 508 (511)
....+++.|+|||++.+
T Consensus 161 ~~~~~~~~~~aPE~~~~ 177 (291)
T cd07844 161 SNEVVTLWYRPPDVLLG 177 (291)
T ss_pred cccccccccCCcHHhhc
Confidence 33456788999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.5e-25 Score=216.67 Aligned_cols=169 Identities=21% Similarity=0.349 Sum_probs=139.7
Q ss_pred cCCCeEEEeeeecccceEEEEeE-----------EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCC
Q 010401 338 NSDNLEFIDQIGPNSFKGVYKGK-----------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN 406 (511)
Q Consensus 338 ~~~~y~l~~~LG~GsFG~VYkgk-----------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~ 406 (511)
+.++|+++..||.|+||.||+++ .+++|.+... ........+.+|+.++.+++|+||+++++++.+.+
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 81 (275)
T cd05046 3 PRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKT-KDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAE 81 (275)
T ss_pred ChHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCc-cchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCC
Confidence 34688999999999999999975 4778877532 22223456889999999999999999999998766
Q ss_pred CcEEEEEeccCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEe
Q 010401 407 HGLCVVTKLMEGGSVNDLILKSR---------KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGD 477 (511)
Q Consensus 407 ~~l~LVmEy~~gGsL~~lL~~~~---------~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~D 477 (511)
. .|+||||+++|+|.+++.... .+++..+..++.|++.||+|||+++|+||||||+||+++.++.++|+|
T Consensus 82 ~-~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~ 160 (275)
T cd05046 82 P-HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSL 160 (275)
T ss_pred c-ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEcc
Confidence 5 899999999999999997544 689999999999999999999999999999999999999999999999
Q ss_pred cCCceecccCC-CccccccCCCccccHHhhcc
Q 010401 478 MGIVTACKSVG-EATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 478 FGlS~~l~~~~-~~~~~~~Gt~~YmAPEvl~g 508 (511)
||+++...... .......++..|+|||.+.+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~ 192 (275)
T cd05046 161 LSLSKDVYNSEYYKLRNALIPLRWLAPEAVQE 192 (275)
T ss_pred cccccccCcccccccCCceeEEeecChhhhcc
Confidence 99986543211 11223345677999998754
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.8e-25 Score=217.47 Aligned_cols=168 Identities=21% Similarity=0.378 Sum_probs=142.0
Q ss_pred CCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCc-hHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEE
Q 010401 340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGN-AYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV 412 (511)
Q Consensus 340 ~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~-~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LV 412 (511)
++|++.+.||+|+||.||++ +.+++|.+....... ....++.+|+.+++.++|+||+++++++.+++. .+++
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~-~~~v 80 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNE-LNIV 80 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCe-EEEE
Confidence 46788999999999999986 478999886433322 234567899999999999999999999988775 8999
Q ss_pred EeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCC
Q 010401 413 TKLMEGGSVNDLILK----SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG 488 (511)
Q Consensus 413 mEy~~gGsL~~lL~~----~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~ 488 (511)
|||+++++|.+++.. ...+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd08229 81 LELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred EEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCC
Confidence 999999999998853 3468999999999999999999999999999999999999999999999999987665433
Q ss_pred CccccccCCCccccHHhhcc
Q 010401 489 EATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 489 ~~~~~~~Gt~~YmAPEvl~g 508 (511)
.......|+..|+|||.+.+
T Consensus 161 ~~~~~~~~~~~~~ape~~~~ 180 (267)
T cd08229 161 TAAHSLVGTPYYMSPERIHE 180 (267)
T ss_pred cccccccCCcCccCHHHhcC
Confidence 33344578889999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.1e-25 Score=212.07 Aligned_cols=168 Identities=25% Similarity=0.324 Sum_probs=143.0
Q ss_pred CeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeC-CCcEEEEE
Q 010401 341 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDE-NHGLCVVT 413 (511)
Q Consensus 341 ~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~-~~~l~LVm 413 (511)
+|++.+.||.|+||.||++ +.+++|.+...........++..|+.+++.++||||+++++++... +..+|++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 5788999999999999985 4689998875444455556788999999999999999999988653 33479999
Q ss_pred eccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-----HCCccccCCCCCceEEcCCCcEEEEecCCceec
Q 010401 414 KLMEGGSVNDLILK----SRKLQTKEIIRIAIDVAEGIKFLN-----DHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC 484 (511)
Q Consensus 414 Ey~~gGsL~~lL~~----~~~L~e~~~~~ia~qIa~gL~yLH-----~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l 484 (511)
||+++++|.+++.. ...+++..++.++.||+.||.||| +.+++|+||||+||+++.++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 99999999999864 357899999999999999999999 899999999999999999999999999998877
Q ss_pred ccCCCccccccCCCccccHHhhcc
Q 010401 485 KSVGEATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 485 ~~~~~~~~~~~Gt~~YmAPEvl~g 508 (511)
...........++..|+|||++.+
T Consensus 161 ~~~~~~~~~~~~~~~~~~pE~~~~ 184 (265)
T cd08217 161 GHDSSFAKTYVGTPYYMSPEQLNH 184 (265)
T ss_pred cCCcccccccccCCCccChhhhcC
Confidence 654432344568899999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.4e-25 Score=219.87 Aligned_cols=166 Identities=22% Similarity=0.362 Sum_probs=141.8
Q ss_pred CCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEE
Q 010401 339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV 412 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LV 412 (511)
..+|++.+.||+|+||.||++ +.|++|.+..... .....+.+|+.+++.++|+||+++++++..++. +|+|
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~-~~lv 94 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSYLVGDE-LWVV 94 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc--chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCE-EEEe
Confidence 357899999999999999986 4799999864222 234557889999999999999999999987775 9999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCccc
Q 010401 413 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE 492 (511)
Q Consensus 413 mEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~~ 492 (511)
|||+++++|.+++.+ ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.++|+|||++...........
T Consensus 95 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~ 173 (297)
T cd06656 95 MEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS 173 (297)
T ss_pred ecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCccCcC
Confidence 999999999999854 5689999999999999999999999999999999999999999999999999876644333334
Q ss_pred cccCCCccccHHhhcc
Q 010401 493 YETDGYRWLAPEVCFL 508 (511)
Q Consensus 493 ~~~Gt~~YmAPEvl~g 508 (511)
...+++.|+|||++.+
T Consensus 174 ~~~~~~~y~aPE~~~~ 189 (297)
T cd06656 174 TMVGTPYWMAPEVVTR 189 (297)
T ss_pred cccCCccccCHHHHcC
Confidence 4578889999999865
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.5e-25 Score=212.97 Aligned_cols=168 Identities=23% Similarity=0.401 Sum_probs=144.2
Q ss_pred CeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEEe
Q 010401 341 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTK 414 (511)
Q Consensus 341 ~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVmE 414 (511)
+|.+.+.||+|+||.||+| +.+++|.++...........+..|+.+++.++|+||+++++.+...+. +++|+|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~-~~lv~e 79 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREK-VYIFME 79 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCE-EEEEEe
Confidence 4788899999999999996 468999987544433456678999999999999999999999887765 999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCcc---
Q 010401 415 LMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT--- 491 (511)
Q Consensus 415 y~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~--- 491 (511)
|+++++|.+++.....+++..+..++.|++.||.|||++||+|+||+|+||+++.++.+||+|||++..........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~ 159 (264)
T cd06626 80 YCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEE 159 (264)
T ss_pred cCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccccc
Confidence 99999999999877778999999999999999999999999999999999999999999999999987765433211
Q ss_pred -ccccCCCccccHHhhccc
Q 010401 492 -EYETDGYRWLAPEVCFLL 509 (511)
Q Consensus 492 -~~~~Gt~~YmAPEvl~gl 509 (511)
....+++.|+|||++.+.
T Consensus 160 ~~~~~~~~~~~~PE~~~~~ 178 (264)
T cd06626 160 VQSLAGTPAYMAPEVITGG 178 (264)
T ss_pred ccCCcCCcCccChhhccCC
Confidence 134678899999998653
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.4e-25 Score=215.30 Aligned_cols=169 Identities=22% Similarity=0.418 Sum_probs=139.8
Q ss_pred eEecCCCeEEEeeeecccceEEEEeE-----EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcE
Q 010401 335 WLLNSDNLEFIDQIGPNSFKGVYKGK-----RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGL 409 (511)
Q Consensus 335 ~~l~~~~y~l~~~LG~GsFG~VYkgk-----~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l 409 (511)
|.+..++|++.++||+|+||.||++. .+++|.+..... ....+.+|+.++++++|+||+++++++.. +. .
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~---~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~-~ 75 (260)
T cd05070 1 WEIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM---SPESFLEEAQIMKKLRHDKLVQLYAVVSE-EP-I 75 (260)
T ss_pred CCCchHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC---CHHHHHHHHHHHHhcCCCceEEEEeEECC-CC-c
Confidence 45677889999999999999999864 588998864322 23457899999999999999999998754 33 7
Q ss_pred EEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccC
Q 010401 410 CVVTKLMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV 487 (511)
Q Consensus 410 ~LVmEy~~gGsL~~lL~~~--~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~ 487 (511)
|++|||+++++|.+++... ..+++..+..++.|++.||.|||+++|+||||||+||++++++.++|+|||++......
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05070 76 YIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDN 155 (260)
T ss_pred EEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCc
Confidence 8999999999999998653 46899999999999999999999999999999999999999999999999999876443
Q ss_pred CCc-cccccCCCccccHHhhcc
Q 010401 488 GEA-TEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 488 ~~~-~~~~~Gt~~YmAPEvl~g 508 (511)
... .....++..|+|||++.+
T Consensus 156 ~~~~~~~~~~~~~y~aPE~~~~ 177 (260)
T cd05070 156 EYTARQGAKFPIKWTAPEAALY 177 (260)
T ss_pred ccccccCCCCCccccChHHHhc
Confidence 211 112234567999998754
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.9e-25 Score=214.37 Aligned_cols=169 Identities=21% Similarity=0.346 Sum_probs=139.8
Q ss_pred cCCCeEEEeeeecccceEEEEeE---------EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCc
Q 010401 338 NSDNLEFIDQIGPNSFKGVYKGK---------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHG 408 (511)
Q Consensus 338 ~~~~y~l~~~LG~GsFG~VYkgk---------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~ 408 (511)
..++|+..+.||+|+||.||+++ .+++|++... ........+..|+.++..++||||+++++++.+.+.
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~- 80 (268)
T cd05063 3 HPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPG-YTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKP- 80 (268)
T ss_pred ChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEecccc-CCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCC-
Confidence 45678999999999999999874 5788888642 223334568899999999999999999999987776
Q ss_pred EEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccC
Q 010401 409 LCVVTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV 487 (511)
Q Consensus 409 l~LVmEy~~gGsL~~lL~~~-~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~ 487 (511)
.|+||||+++++|.+++... +.+++..+..++.|++.||+|||+.|++||||||+||+++.++.+||+|||++......
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 160 (268)
T cd05063 81 AMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD 160 (268)
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence 89999999999999998653 57899999999999999999999999999999999999999999999999998766432
Q ss_pred CCcccc---ccCCCccccHHhhcc
Q 010401 488 GEATEY---ETDGYRWLAPEVCFL 508 (511)
Q Consensus 488 ~~~~~~---~~Gt~~YmAPEvl~g 508 (511)
...... ...++.|+|||++.+
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~ 184 (268)
T cd05063 161 PEGTYTTSGGKIPIRWTAPEAIAY 184 (268)
T ss_pred cccceeccCCCcCceecCHHHhhc
Confidence 221111 122457999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.7e-25 Score=218.02 Aligned_cols=168 Identities=23% Similarity=0.448 Sum_probs=139.1
Q ss_pred CCeEEEeeeecccceEEEEe----------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCC-Cc
Q 010401 340 DNLEFIDQIGPNSFKGVYKG----------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN-HG 408 (511)
Q Consensus 340 ~~y~l~~~LG~GsFG~VYkg----------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~-~~ 408 (511)
.-|++++.||+|+||.||.+ +.+++|.++.. ........+.+|+.+++.++||||+++++++.+.+ ..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPE-SGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 82 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCcc-ccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence 45788999999999999975 35899998643 22334456899999999999999999999987752 34
Q ss_pred EEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccC
Q 010401 409 LCVVTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV 487 (511)
Q Consensus 409 l~LVmEy~~gGsL~~lL~~~-~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~ 487 (511)
+++||||+++++|.+++.+. ..+++..+..++.||+.||+|||++||+||||||+||+++.++.++|+|||+++.+...
T Consensus 83 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~ 162 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD 162 (284)
T ss_pred eEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccccC
Confidence 89999999999999998654 46899999999999999999999999999999999999999999999999998866433
Q ss_pred CCc---cccccCCCccccHHhhcc
Q 010401 488 GEA---TEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 488 ~~~---~~~~~Gt~~YmAPEvl~g 508 (511)
... .....++..|+|||++.+
T Consensus 163 ~~~~~~~~~~~~~~~y~apE~~~~ 186 (284)
T cd05079 163 KEYYTVKDDLDSPVFWYAPECLIQ 186 (284)
T ss_pred ccceeecCCCCCCccccCHHHhcc
Confidence 221 123345667999998764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.7e-25 Score=216.97 Aligned_cols=155 Identities=23% Similarity=0.389 Sum_probs=129.0
Q ss_pred eeeecccceEEEEeE------------------EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCC
Q 010401 346 DQIGPNSFKGVYKGK------------------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENH 407 (511)
Q Consensus 346 ~~LG~GsFG~VYkgk------------------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~ 407 (511)
+.||+|+||.||+|+ .|++|.+... .......+.+|+.++..++||||+++++++.+...
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~ 78 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS--HRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVE 78 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh--hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 368999999999985 3777776532 22233457788889999999999999999987776
Q ss_pred cEEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCc-------EEEEecC
Q 010401 408 GLCVVTKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGN-------VCLGDMG 479 (511)
Q Consensus 408 ~l~LVmEy~~gGsL~~lL~~-~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~-------vKL~DFG 479 (511)
.+++|||+++|+|..++.. ...+++..++.++.||+.||+|||+++|+||||||+|||++.++. ++++|||
T Consensus 79 -~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 79 -NIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred -CEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 8899999999999998865 357899999999999999999999999999999999999987664 8999999
Q ss_pred CceecccCCCccccccCCCccccHHhhc
Q 010401 480 IVTACKSVGEATEYETDGYRWLAPEVCF 507 (511)
Q Consensus 480 lS~~l~~~~~~~~~~~Gt~~YmAPEvl~ 507 (511)
++..... .....++..|+|||.+.
T Consensus 158 ~~~~~~~----~~~~~~~~~y~aPE~~~ 181 (262)
T cd05077 158 IPITVLS----RQECVERIPWIAPECVE 181 (262)
T ss_pred CCccccC----cccccccccccChhhhc
Confidence 9865532 22345778899999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.1e-25 Score=213.17 Aligned_cols=161 Identities=21% Similarity=0.407 Sum_probs=132.1
Q ss_pred eeeecccceEEEEeE------EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEEeccCCC
Q 010401 346 DQIGPNSFKGVYKGK------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGG 419 (511)
Q Consensus 346 ~~LG~GsFG~VYkgk------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVmEy~~gG 419 (511)
+.||+|+||.||+++ .+++|.+... ........+.+|+.+++.++||||+++++++...+. +|+||||++++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~lv~e~~~~~ 78 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQP-IYIVMELVQGG 78 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCcc-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCC-eEEEEeeccCC
Confidence 468999999999864 5899987532 233345568899999999999999999999988776 99999999999
Q ss_pred CHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCcc--ccccC
Q 010401 420 SVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT--EYETD 496 (511)
Q Consensus 420 sL~~lL~~~-~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~--~~~~G 496 (511)
+|.+++... ..+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||+++......... .....
T Consensus 79 ~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 158 (252)
T cd05084 79 DFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQI 158 (252)
T ss_pred cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCC
Confidence 999998654 468999999999999999999999999999999999999999999999999987654321111 11122
Q ss_pred CCccccHHhhcc
Q 010401 497 GYRWLAPEVCFL 508 (511)
Q Consensus 497 t~~YmAPEvl~g 508 (511)
++.|+|||.+.+
T Consensus 159 ~~~y~aPE~~~~ 170 (252)
T cd05084 159 PVKWTAPEALNY 170 (252)
T ss_pred ceeecCchhhcC
Confidence 456999998754
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.1e-25 Score=216.22 Aligned_cols=166 Identities=27% Similarity=0.440 Sum_probs=139.1
Q ss_pred CCCeEEEeeeecccceEEEEeE------EEEEEEEecCCCCchHHHHHHHHHHHHHhC-CCCceeeEeeeEeeCC-----
Q 010401 339 SDNLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCVCVDEN----- 406 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkgk------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l-~HpNIV~l~g~~~~~~----- 406 (511)
.+.|++.+.||+|+||.||+|+ .+|+|.+.... .....+..|+.++.++ +|+||+++++++...+
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC---ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 3567888999999999999964 58999886422 2235578888888888 7999999999987542
Q ss_pred CcEEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceec
Q 010401 407 HGLCVVTKLMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC 484 (511)
Q Consensus 407 ~~l~LVmEy~~gGsL~~lL~~~--~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l 484 (511)
..+|++|||+++++|.+++... ..+++..+..++.|++.||.|||+++|+||||||+||+++.++.++|+|||++...
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~ 161 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 161 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceec
Confidence 2389999999999999998753 46899999999999999999999999999999999999999999999999998866
Q ss_pred ccCCCccccccCCCccccHHhhc
Q 010401 485 KSVGEATEYETDGYRWLAPEVCF 507 (511)
Q Consensus 485 ~~~~~~~~~~~Gt~~YmAPEvl~ 507 (511)
...........|++.|+|||++.
T Consensus 162 ~~~~~~~~~~~g~~~y~aPE~~~ 184 (272)
T cd06637 162 DRTVGRRNTFIGTPYWMAPEVIA 184 (272)
T ss_pred ccccccCCcccccccccCHhHhc
Confidence 44333345567889999999985
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.6e-25 Score=221.95 Aligned_cols=160 Identities=19% Similarity=0.301 Sum_probs=129.0
Q ss_pred EeeeecccceEEEEeE--------EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCC-CcEEEEEec
Q 010401 345 IDQIGPNSFKGVYKGK--------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN-HGLCVVTKL 415 (511)
Q Consensus 345 ~~~LG~GsFG~VYkgk--------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~-~~l~LVmEy 415 (511)
.++||+|+||.||+++ .+|+|.+..... ...+.+|+.+++.++||||+++++++.... ..+|++|||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY 81 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEec
Confidence 3689999999999974 589998864221 234678999999999999999999986533 348999999
Q ss_pred cCCCCHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEE----cCCCcEEEEecCCce
Q 010401 416 MEGGSVNDLILKS---------RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILL----DRHGNVCLGDMGIVT 482 (511)
Q Consensus 416 ~~gGsL~~lL~~~---------~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILl----d~~g~vKL~DFGlS~ 482 (511)
+.+ +|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07868 82 AEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred cCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCcee
Confidence 965 888887421 258999999999999999999999999999999999999 456789999999998
Q ss_pred ecccCCC---ccccccCCCccccHHhhccc
Q 010401 483 ACKSVGE---ATEYETDGYRWLAPEVCFLL 509 (511)
Q Consensus 483 ~l~~~~~---~~~~~~Gt~~YmAPEvl~gl 509 (511)
....... ......||+.|+|||++.+.
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~ 190 (317)
T cd07868 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGA 190 (317)
T ss_pred ccCCCCccccccCCccccccccCCHHHcCC
Confidence 7643321 22345788999999998763
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.5e-25 Score=214.32 Aligned_cols=155 Identities=21% Similarity=0.380 Sum_probs=129.6
Q ss_pred eeeecccceEEEEeEE----------------EEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcE
Q 010401 346 DQIGPNSFKGVYKGKR----------------VGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGL 409 (511)
Q Consensus 346 ~~LG~GsFG~VYkgk~----------------VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l 409 (511)
+.||+|+||.||+|.. +++|.+.... .....+.+|+.+++.++||||+++++++.. .. .
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~-~ 75 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH---RDSLAFFETASLMSQLSHKHLVKLYGVCVR-DE-N 75 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch---hhHHHHHHHHHHHHcCCCcchhheeeEEec-CC-c
Confidence 4689999999999743 5566554221 114667889999999999999999999987 44 7
Q ss_pred EEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCC-------cEEEEecCCc
Q 010401 410 CVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG-------NVCLGDMGIV 481 (511)
Q Consensus 410 ~LVmEy~~gGsL~~lL~~~~-~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g-------~vKL~DFGlS 481 (511)
++||||+++|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 76 IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 89999999999999997655 789999999999999999999999999999999999999888 7999999998
Q ss_pred eecccCCCccccccCCCccccHHhhccc
Q 010401 482 TACKSVGEATEYETDGYRWLAPEVCFLL 509 (511)
Q Consensus 482 ~~l~~~~~~~~~~~Gt~~YmAPEvl~gl 509 (511)
..... .....++..|+|||++.+.
T Consensus 156 ~~~~~----~~~~~~~~~y~aPE~~~~~ 179 (259)
T cd05037 156 ITVLS----REERVERIPWIAPECIRNG 179 (259)
T ss_pred ccccc----ccccccCCCccChhhhcCC
Confidence 76543 2344566789999998654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.5e-25 Score=217.97 Aligned_cols=169 Identities=18% Similarity=0.243 Sum_probs=143.4
Q ss_pred CCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEE
Q 010401 340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT 413 (511)
Q Consensus 340 ~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVm 413 (511)
++|++.+.||+|+||.||++ +.|++|+++...........+.+|+.+++.++|+||+++++++.+++. ++++|
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-~~iv~ 79 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGR-LYLVF 79 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCE-EEEEE
Confidence 36899999999999999996 468999887543334445678899999999999999999999988775 99999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCC-ccc
Q 010401 414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE-ATE 492 (511)
Q Consensus 414 Ey~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~-~~~ 492 (511)
||++++.+..+......+++..+..++.||+.||.|||+++++||||+|+||++++++.+||+|||++........ ...
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~ 159 (288)
T cd07833 80 EYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLT 159 (288)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcccccc
Confidence 9999877777666666799999999999999999999999999999999999999999999999999887654432 223
Q ss_pred cccCCCccccHHhhccc
Q 010401 493 YETDGYRWLAPEVCFLL 509 (511)
Q Consensus 493 ~~~Gt~~YmAPEvl~gl 509 (511)
...++..|+|||++.+.
T Consensus 160 ~~~~~~~~~~PE~~~~~ 176 (288)
T cd07833 160 DYVATRWYRAPELLVGD 176 (288)
T ss_pred CcccccCCcCCchhcCC
Confidence 34677889999998653
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-24 Score=215.81 Aligned_cols=165 Identities=27% Similarity=0.381 Sum_probs=135.5
Q ss_pred eEEEeeeecccceEEEEe----------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCC-CcEE
Q 010401 342 LEFIDQIGPNSFKGVYKG----------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN-HGLC 410 (511)
Q Consensus 342 y~l~~~LG~GsFG~VYkg----------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~-~~l~ 410 (511)
|++++.||+|+||+||++ +.||+|.+... ........+.+|+.+++.++||||+++++++...+ ..+|
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRE-CGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQ 84 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccc-cChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEE
Confidence 488999999999999763 46899988643 22234456788999999999999999999886543 3489
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCc
Q 010401 411 VVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA 490 (511)
Q Consensus 411 LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~ 490 (511)
++|||+.+++|.+++.. ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++........
T Consensus 85 lv~e~~~~~~l~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~ 163 (283)
T cd05080 85 LIMEYVPLGSLRDYLPK-HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEY 163 (283)
T ss_pred EEecCCCCCCHHHHHHH-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCcchh
Confidence 99999999999999855 46999999999999999999999999999999999999999999999999998866432211
Q ss_pred ---cccccCCCccccHHhhcc
Q 010401 491 ---TEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 491 ---~~~~~Gt~~YmAPEvl~g 508 (511)
.....++..|+|||++.+
T Consensus 164 ~~~~~~~~~~~~~~~PE~~~~ 184 (283)
T cd05080 164 YRVREDGDSPVFWYAVECLKE 184 (283)
T ss_pred hccCCCCCCCceeeCHhHhcc
Confidence 122334567999998754
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=6e-26 Score=224.26 Aligned_cols=169 Identities=20% Similarity=0.368 Sum_probs=145.2
Q ss_pred ceEecCCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCC-CCceeeEeeeEeeCC
Q 010401 334 RWLLNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCG-HKNILQFYCVCVDEN 406 (511)
Q Consensus 334 ~~~l~~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~-HpNIV~l~g~~~~~~ 406 (511)
++..+.++++++..||.|+.|.|++. ..+|||.+++. ......+++++++.++.+.+ +|+||+.+|+|..+.
T Consensus 86 r~~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt-~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~ 164 (391)
T KOG0983|consen 86 RYQADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRT-GNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNT 164 (391)
T ss_pred ccccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeeccc-CCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCc
Confidence 56677788999999999999999984 57899999853 33345677899999888774 899999999999877
Q ss_pred CcEEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH-HCCccccCCCCCceEEcCCCcEEEEecCCceec
Q 010401 407 HGLCVVTKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLN-DHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC 484 (511)
Q Consensus 407 ~~l~LVmEy~~gGsL~~lL~~-~~~L~e~~~~~ia~qIa~gL~yLH-~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l 484 (511)
. ++|.||.|.. .+..+++. .++++|..+-.+...+++||.||. .+||||||+||+|||+|+.|++||||||++-.+
T Consensus 165 d-V~IcMelMs~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrl 242 (391)
T KOG0983|consen 165 D-VFICMELMST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRL 242 (391)
T ss_pred h-HHHHHHHHHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeeccccccee
Confidence 6 9999999965 78887754 568999999999999999999997 479999999999999999999999999999887
Q ss_pred ccCCCccccccCCCccccHHhh
Q 010401 485 KSVGEATEYETDGYRWLAPEVC 506 (511)
Q Consensus 485 ~~~~~~~~~~~Gt~~YmAPEvl 506 (511)
.+ +...+...|.+.|||||.+
T Consensus 243 vd-SkAhtrsAGC~~YMaPERi 263 (391)
T KOG0983|consen 243 VD-SKAHTRSAGCAAYMAPERI 263 (391)
T ss_pred ec-ccccccccCCccccCcccc
Confidence 65 3446677899999999976
|
|
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.7e-25 Score=210.76 Aligned_cols=161 Identities=28% Similarity=0.463 Sum_probs=136.9
Q ss_pred eeeecccceEEEEeE---------EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEEecc
Q 010401 346 DQIGPNSFKGVYKGK---------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLM 416 (511)
Q Consensus 346 ~~LG~GsFG~VYkgk---------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVmEy~ 416 (511)
+.||+|+||.||++. .+++|.+....... ....+.+|+..+..++|+||+++++++.+... ++++|||+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~-~~lv~e~~ 78 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEP-LYLVLEYM 78 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecCCCc-eEEEEEec
Confidence 468999999999964 46888886533322 45668899999999999999999999988665 99999999
Q ss_pred CCCCHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccC
Q 010401 417 EGGSVNDLILKS---------RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV 487 (511)
Q Consensus 417 ~gGsL~~lL~~~---------~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~ 487 (511)
++++|.+++... ..+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||.+......
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 158 (262)
T cd00192 79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD 158 (262)
T ss_pred cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccc
Confidence 999999999764 68999999999999999999999999999999999999999999999999999876543
Q ss_pred C--CccccccCCCccccHHhhcc
Q 010401 488 G--EATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 488 ~--~~~~~~~Gt~~YmAPEvl~g 508 (511)
. .......+++.|+|||.+.+
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~ 181 (262)
T cd00192 159 DYYRKKTGGKLPIRWMAPESLKD 181 (262)
T ss_pred cccccccCCCcCccccCHHHhcc
Confidence 2 22334556789999998764
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=7e-25 Score=246.17 Aligned_cols=167 Identities=19% Similarity=0.287 Sum_probs=145.3
Q ss_pred CCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCC-chHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEE
Q 010401 339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKG-NAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCV 411 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~-~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~L 411 (511)
.++|++++.||+|+||.||+| +.||+|+++..... ......+..|+.++..++||||+++++++...+. +||
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~-~~l 81 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANN-VYL 81 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCE-EEE
Confidence 467899999999999999996 47999999753332 2234567889999999999999999999887776 999
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCcc
Q 010401 412 VTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT 491 (511)
Q Consensus 412 VmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~ 491 (511)
||||+.+++|.+++...+.+++..++.|+.||+.||.|||.++||||||||+|||++.++.+||+|||+++.........
T Consensus 82 VmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~~~~~~~~~~ 161 (669)
T cd05610 82 VMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNRELNM 161 (669)
T ss_pred EEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCccccCCcccc
Confidence 99999999999999877789999999999999999999999999999999999999999999999999998776554445
Q ss_pred ccccCCCccccHHhh
Q 010401 492 EYETDGYRWLAPEVC 506 (511)
Q Consensus 492 ~~~~Gt~~YmAPEvl 506 (511)
....+|+.|++||..
T Consensus 162 ~~~~~t~~~~~pe~~ 176 (669)
T cd05610 162 MDILTTPSMAKPKND 176 (669)
T ss_pred cccccCccccCcccc
Confidence 567788999999864
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.8e-24 Score=211.97 Aligned_cols=169 Identities=20% Similarity=0.367 Sum_probs=140.7
Q ss_pred eEecCCCeEEEeeeecccceEEEEeE-----EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcE
Q 010401 335 WLLNSDNLEFIDQIGPNSFKGVYKGK-----RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGL 409 (511)
Q Consensus 335 ~~l~~~~y~l~~~LG~GsFG~VYkgk-----~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l 409 (511)
|.+..++|++.+.||+|+||.||+++ .+++|.+... ......+.+|+.+++.++|+||+++++.+.+ .. .
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~-~ 75 (260)
T cd05073 1 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG---SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EP-I 75 (260)
T ss_pred CcccccceeEEeEecCccceEEEEEEecCCccEEEEecCCC---hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CC-e
Confidence 56778899999999999999999974 4888887632 2234567889999999999999999999876 43 8
Q ss_pred EEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccC
Q 010401 410 CVVTKLMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV 487 (511)
Q Consensus 410 ~LVmEy~~gGsL~~lL~~~--~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~ 487 (511)
|++|||+++++|.+++.+. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++......
T Consensus 76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 155 (260)
T cd05073 76 YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN 155 (260)
T ss_pred EEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCC
Confidence 9999999999999999653 46788899999999999999999999999999999999999999999999998766432
Q ss_pred CC-ccccccCCCccccHHhhcc
Q 010401 488 GE-ATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 488 ~~-~~~~~~Gt~~YmAPEvl~g 508 (511)
.. ......++..|+|||++.+
T Consensus 156 ~~~~~~~~~~~~~y~~PE~~~~ 177 (260)
T cd05073 156 EYTAREGAKFPIKWTAPEAINF 177 (260)
T ss_pred CcccccCCcccccccCHhHhcc
Confidence 21 1122345577999999854
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.9e-26 Score=237.43 Aligned_cols=171 Identities=22% Similarity=0.295 Sum_probs=146.6
Q ss_pred EecCCCeEEEeeeecccceEEEEeE------EEEEEEEecCCCCchHHHH-HHHHHHHHHhC-CCCceeeEeeeEeeCCC
Q 010401 336 LLNSDNLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDKGNAYEFE-LRKDLLELMTC-GHKNILQFYCVCVDENH 407 (511)
Q Consensus 336 ~l~~~~y~l~~~LG~GsFG~VYkgk------~VAVKkL~~~~~~~~~~~~-~~~Ei~iL~~l-~HpNIV~l~g~~~~~~~ 407 (511)
.+...+|.++.+||+|+||+|.+++ .+|||++++...-.....+ ...|-.+|... +-|++++++..|++-+.
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 4567899999999999999999964 5899999764322221111 23444555544 67999999988888776
Q ss_pred cEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccC
Q 010401 408 GLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV 487 (511)
Q Consensus 408 ~l~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~ 487 (511)
+|+||||+.||+|..+|+.-+++.+..+..|+.+|+.||-|||++|||+||||.+|||+|.+|++||.|||+++.-...
T Consensus 425 -LyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~ 503 (683)
T KOG0696|consen 425 -LYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFD 503 (683)
T ss_pred -eeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccccC
Confidence 9999999999999999998899999999999999999999999999999999999999999999999999999887777
Q ss_pred CCccccccCCCccccHHhhc
Q 010401 488 GEATEYETDGYRWLAPEVCF 507 (511)
Q Consensus 488 ~~~~~~~~Gt~~YmAPEvl~ 507 (511)
+..+...+|||.|+|||++.
T Consensus 504 ~~TTkTFCGTPdYiAPEIi~ 523 (683)
T KOG0696|consen 504 GVTTKTFCGTPDYIAPEIIA 523 (683)
T ss_pred CcceeeecCCCcccccceEE
Confidence 77888999999999999985
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-24 Score=211.70 Aligned_cols=167 Identities=25% Similarity=0.345 Sum_probs=142.3
Q ss_pred CeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEEe
Q 010401 341 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTK 414 (511)
Q Consensus 341 ~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVmE 414 (511)
+|++.+.||+|+||.||++ +.+++|.+...........++.+|+.+++.++||||+++++++.+.+. .|+|||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-~~lv~e 79 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGN-LYIVMD 79 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCe-EEEEEe
Confidence 4789999999999999984 579999987543334445578899999999999999999999987775 999999
Q ss_pred ccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCccc
Q 010401 415 LMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE 492 (511)
Q Consensus 415 y~~gGsL~~lL~~~--~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~~ 492 (511)
|+.+++|.+++... ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++...........
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~ 159 (256)
T cd08218 80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELAR 159 (256)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhhh
Confidence 99999999998653 3578999999999999999999999999999999999999999999999999877654333333
Q ss_pred cccCCCccccHHhhcc
Q 010401 493 YETDGYRWLAPEVCFL 508 (511)
Q Consensus 493 ~~~Gt~~YmAPEvl~g 508 (511)
...|++.|+|||++.+
T Consensus 160 ~~~~~~~~~~pe~~~~ 175 (256)
T cd08218 160 TCIGTPYYLSPEICEN 175 (256)
T ss_pred hccCCccccCHHHhCC
Confidence 4467888999999754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1e-24 Score=213.58 Aligned_cols=167 Identities=20% Similarity=0.360 Sum_probs=140.0
Q ss_pred CeEEEeeeecccceEEEEeE-----EEEEEEEecCCCCc----hHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEE
Q 010401 341 NLEFIDQIGPNSFKGVYKGK-----RVGIEKLKGCDKGN----AYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCV 411 (511)
Q Consensus 341 ~y~l~~~LG~GsFG~VYkgk-----~VAVKkL~~~~~~~----~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~L 411 (511)
+|++.+.||.|+||.||+|. .+|+|.+....... .....+.+|+.+++.++|+||+++++++.+.+. +|+
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNT-ISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCe-EEE
Confidence 46788999999999999964 58999886432211 123457889999999999999999999988765 999
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCC---
Q 010401 412 VTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG--- 488 (511)
Q Consensus 412 VmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~--- 488 (511)
+|||+++++|.+++.+...+++..+..++.|++.||+|||+.+|+|+||+|+||+++.++.++|+|||++.......
T Consensus 80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 159 (265)
T cd06631 80 FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHG 159 (265)
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccc
Confidence 99999999999999877789999999999999999999999999999999999999999999999999987643211
Q ss_pred ---CccccccCCCccccHHhhcc
Q 010401 489 ---EATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 489 ---~~~~~~~Gt~~YmAPEvl~g 508 (511)
.......|+..|+|||++.+
T Consensus 160 ~~~~~~~~~~~~~~~~~pe~~~~ 182 (265)
T cd06631 160 THSNMLKSMHGTPYWMAPEVINE 182 (265)
T ss_pred cccccccccCCCccccChhhhcC
Confidence 11223467889999999864
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-24 Score=213.21 Aligned_cols=167 Identities=21% Similarity=0.367 Sum_probs=136.3
Q ss_pred eEEEeeeecccceEEEEeE---------EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCC-----
Q 010401 342 LEFIDQIGPNSFKGVYKGK---------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENH----- 407 (511)
Q Consensus 342 y~l~~~LG~GsFG~VYkgk---------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~----- 407 (511)
|++.+.||+|+||.||+|. .+|+|+++...........+.+|+..+..++||||+++++++...+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 4678999999999999863 48999987544444445568899999999999999999998865442
Q ss_pred cEEEEEeccCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCc
Q 010401 408 GLCVVTKLMEGGSVNDLILKS------RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIV 481 (511)
Q Consensus 408 ~l~LVmEy~~gGsL~~lL~~~------~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS 481 (511)
..+++|||+++|+|..++... ..+++..+..++.|++.||.|||+++|+||||||+||++++++.+||+|||++
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 160 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS 160 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccce
Confidence 268999999999999998432 36899999999999999999999999999999999999999999999999999
Q ss_pred eecccCCCc--cccccCCCccccHHhhcc
Q 010401 482 TACKSVGEA--TEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 482 ~~l~~~~~~--~~~~~Gt~~YmAPEvl~g 508 (511)
+........ .....++..|+|||++.+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 189 (273)
T cd05035 161 KKIYSGDYYRQGRIAKMPVKWIAIESLAD 189 (273)
T ss_pred eeccccccccccccccCCccccCHhhccc
Confidence 876433211 112234578999998753
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.3e-25 Score=223.71 Aligned_cols=164 Identities=23% Similarity=0.329 Sum_probs=134.9
Q ss_pred EEeeeecc--cceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEEec
Q 010401 344 FIDQIGPN--SFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKL 415 (511)
Q Consensus 344 l~~~LG~G--sFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVmEy 415 (511)
++++||+| +||+||++ +.||+|++............+.+|+.+++.++||||++++++|.+++. +|+||||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~-~~lv~e~ 80 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNE-LWVVTSF 80 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCE-EEEEEec
Confidence 56789999 78999995 469999997543334444567889999999999999999999998876 9999999
Q ss_pred cCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCC----
Q 010401 416 MEGGSVNDLILK--SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE---- 489 (511)
Q Consensus 416 ~~gGsL~~lL~~--~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~---- 489 (511)
+++|+|.+++.. ...+++..+..++.||+.||.|||+++|+||||||+|||++.++.++++|||........+.
T Consensus 81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~ 160 (327)
T cd08227 81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRV 160 (327)
T ss_pred cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccccccc
Confidence 999999999964 34689999999999999999999999999999999999999999999999987544322111
Q ss_pred ---ccccccCCCccccHHhhcc
Q 010401 490 ---ATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 490 ---~~~~~~Gt~~YmAPEvl~g 508 (511)
...+..++..|+|||++.+
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~ 182 (327)
T cd08227 161 VHDFPKYSVKVLPWLSPEVLQQ 182 (327)
T ss_pred cccccccccceecccChHHhhc
Confidence 1123356678999999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-24 Score=212.68 Aligned_cols=166 Identities=23% Similarity=0.394 Sum_probs=139.5
Q ss_pred eEEEeeeecccceEEEEe------EEEEEEEEecCCCCch-------HHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCc
Q 010401 342 LEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNA-------YEFELRKDLLELMTCGHKNILQFYCVCVDENHG 408 (511)
Q Consensus 342 y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~-------~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~ 408 (511)
|.+...||.|+||.||+| +.+++|.+........ ....+.+|+.+++.++||||+++++++.+.+.
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~- 80 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH- 80 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc-
Confidence 567789999999999996 4689998864332211 12457889999999999999999999988775
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCC
Q 010401 409 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG 488 (511)
Q Consensus 409 l~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~ 488 (511)
.+++|||+++++|.+++...+.+++..+..++.|++.||+|||++|++||||+|+||++++++.++|+|||+++......
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANS 160 (267)
T ss_pred cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccccc
Confidence 89999999999999999877889999999999999999999999999999999999999999999999999988765321
Q ss_pred C------ccccccCCCccccHHhhcc
Q 010401 489 E------ATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 489 ~------~~~~~~Gt~~YmAPEvl~g 508 (511)
. ......|+..|+|||.+.+
T Consensus 161 ~~~~~~~~~~~~~~~~~y~~pe~~~~ 186 (267)
T cd06628 161 LSTKTNGARPSLQGSVFWMAPEVVKQ 186 (267)
T ss_pred ccCCccccccccCCCcCccChhHhcc
Confidence 1 1123457889999998764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.2e-24 Score=208.18 Aligned_cols=167 Identities=25% Similarity=0.386 Sum_probs=146.2
Q ss_pred CeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEEe
Q 010401 341 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTK 414 (511)
Q Consensus 341 ~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVmE 414 (511)
+|++.+.||+|+||.||++ +.+++|.+............+.+|+.++++++|+||+++++++.+++. .+++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-~~~v~e 79 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDS-LYIILE 79 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCE-EEEEEe
Confidence 4788999999999999996 479999997654443455678999999999999999999999987765 999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCccccc
Q 010401 415 LMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYE 494 (511)
Q Consensus 415 y~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~~~~ 494 (511)
|+.+++|.+++.....+++..+..++.|++.||.|||++||+||||+|+||+++.++.++|+|||++.............
T Consensus 80 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~ 159 (254)
T cd06627 80 YAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASV 159 (254)
T ss_pred cCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccccccc
Confidence 99999999999877889999999999999999999999999999999999999999999999999998776544333455
Q ss_pred cCCCccccHHhhcc
Q 010401 495 TDGYRWLAPEVCFL 508 (511)
Q Consensus 495 ~Gt~~YmAPEvl~g 508 (511)
.++..|+|||.+.+
T Consensus 160 ~~~~~y~~pe~~~~ 173 (254)
T cd06627 160 VGTPYWMAPEVIEM 173 (254)
T ss_pred ccchhhcCHhhhcC
Confidence 78889999998754
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-24 Score=218.51 Aligned_cols=168 Identities=19% Similarity=0.300 Sum_probs=139.5
Q ss_pred CCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCc-hHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEE
Q 010401 340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGN-AYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV 412 (511)
Q Consensus 340 ~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~-~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LV 412 (511)
++|++.+.||+|+||.||++ +.|++|.+....... .....+.+|+.+++.++||||+++++.+..++. +|+|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~-~~lv 79 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRH-LCMV 79 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCE-EEEE
Confidence 46899999999999999986 469999886432211 233457789999999999999999999987765 8999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCC----
Q 010401 413 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG---- 488 (511)
Q Consensus 413 mEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~---- 488 (511)
|||+++++|.+++...+.+++..+..++.|++.||.|||+++++||||||+||+++.++.+||+|||+++......
T Consensus 80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~ 159 (305)
T cd05609 80 MEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNL 159 (305)
T ss_pred EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCccccc
Confidence 9999999999999877889999999999999999999999999999999999999999999999999986421100
Q ss_pred -----------CccccccCCCccccHHhhcc
Q 010401 489 -----------EATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 489 -----------~~~~~~~Gt~~YmAPEvl~g 508 (511)
.......++..|+|||.+.+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 190 (305)
T cd05609 160 YEGHIEKDTREFLDKQVCGTPEYIAPEVILR 190 (305)
T ss_pred cccccccchhhccccCCccCccccCchhccC
Confidence 01112356788999998754
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.5e-25 Score=215.47 Aligned_cols=159 Identities=26% Similarity=0.331 Sum_probs=128.5
Q ss_pred eeecccceEEEEeE--------EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEEeccCC
Q 010401 347 QIGPNSFKGVYKGK--------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEG 418 (511)
Q Consensus 347 ~LG~GsFG~VYkgk--------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVmEy~~g 418 (511)
+||+|+||.||+|+ .+++|.+... ........+.+|+..+..++||||+++++.|.+... .|+||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~-~~lv~e~~~~ 79 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKAN-ASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIP-YLLVFEYCEL 79 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCC-CChHHHHHHHHHHHHHhccCCcchhheEEEecCCCc-cEEEEecCCC
Confidence 69999999999975 2445555432 222345568899999999999999999999987775 8999999999
Q ss_pred CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCC--Cccc
Q 010401 419 GSVNDLILKS----RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG--EATE 492 (511)
Q Consensus 419 GsL~~lL~~~----~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~--~~~~ 492 (511)
|+|.+++... ..+++..+..++.||+.||+|||+++++||||||+|||++.++.+||+|||++....... ....
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~ 159 (268)
T cd05086 80 GDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETED 159 (268)
T ss_pred CcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhccc
Confidence 9999999653 346677888999999999999999999999999999999999999999999976432211 1123
Q ss_pred cccCCCccccHHhhc
Q 010401 493 YETDGYRWLAPEVCF 507 (511)
Q Consensus 493 ~~~Gt~~YmAPEvl~ 507 (511)
...++..|+|||++.
T Consensus 160 ~~~~~~~y~aPE~~~ 174 (268)
T cd05086 160 DKCVPLRWLAPELVG 174 (268)
T ss_pred CCcCcccccCchhcc
Confidence 456788999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-24 Score=218.21 Aligned_cols=166 Identities=22% Similarity=0.374 Sum_probs=134.4
Q ss_pred CCeEEEeeeecccceEEEEeE--------EEEEEEEecCCCCchHHHHHHHHHHHHHhC-CCCceeeEeeeEeeCCCcEE
Q 010401 340 DNLEFIDQIGPNSFKGVYKGK--------RVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCVCVDENHGLC 410 (511)
Q Consensus 340 ~~y~l~~~LG~GsFG~VYkgk--------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l-~HpNIV~l~g~~~~~~~~l~ 410 (511)
++|++.+.||+|+||.||+|. .+++|.++.. ........+.+|+.+++++ +||||+++++++...+. +|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~-~~ 79 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF-ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGY-LY 79 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc-CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCc-ce
Confidence 578999999999999999974 3577777632 2233345678899999998 79999999999987765 99
Q ss_pred EEEeccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEE
Q 010401 411 VVTKLMEGGSVNDLILKS----------------RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVC 474 (511)
Q Consensus 411 LVmEy~~gGsL~~lL~~~----------------~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vK 474 (511)
++|||+++++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+|
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~k 159 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASK 159 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEE
Confidence 999999999999999643 2478899999999999999999999999999999999999999999
Q ss_pred EEecCCceecccCCCccccccCCCccccHHhhcc
Q 010401 475 LGDMGIVTACKSVGEATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 475 L~DFGlS~~l~~~~~~~~~~~Gt~~YmAPEvl~g 508 (511)
|+|||++...... ........+..|+|||++.+
T Consensus 160 l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~ 192 (297)
T cd05089 160 IADFGLSRGEEVY-VKKTMGRLPVRWMAIESLNY 192 (297)
T ss_pred ECCcCCCccccce-eccCCCCcCccccCchhhcc
Confidence 9999998643211 11112223457999998754
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.3e-26 Score=243.14 Aligned_cols=164 Identities=26% Similarity=0.430 Sum_probs=138.6
Q ss_pred eEEEeeeecccceEEEEe------EEEEEEEEecCC--CCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCC-cEEEE
Q 010401 342 LEFIDQIGPNSFKGVYKG------KRVGIEKLKGCD--KGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENH-GLCVV 412 (511)
Q Consensus 342 y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~--~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~-~l~LV 412 (511)
.++..+||+|+|.+||+| ..||...++..+ .......++..|+.+|+.|+||||+++|.+|.+..+ .+.+|
T Consensus 42 ~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~i 121 (632)
T KOG0584|consen 42 LKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFI 121 (632)
T ss_pred eehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeee
Confidence 477789999999999995 456654443222 333344779999999999999999999999987653 47899
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCceEEc-CCCcEEEEecCCceecccCCC
Q 010401 413 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHG--VAYRDLNSQRILLD-RHGNVCLGDMGIVTACKSVGE 489 (511)
Q Consensus 413 mEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~g--IIHRDLKp~NILld-~~g~vKL~DFGlS~~l~~~~~ 489 (511)
+|++..|+|..|+++.+.++...+..|++||++||.|||++. |||||||++||+|+ ..|.|||+|+|+|+.+.....
T Consensus 122 TEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~a 201 (632)
T KOG0584|consen 122 TELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSHA 201 (632)
T ss_pred eecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhcccc
Confidence 999999999999999999999999999999999999999985 99999999999998 569999999999987654332
Q ss_pred ccccccCCCccccHHhhc
Q 010401 490 ATEYETDGYRWLAPEVCF 507 (511)
Q Consensus 490 ~~~~~~Gt~~YmAPEvl~ 507 (511)
....|||.|||||+..
T Consensus 202 --ksvIGTPEFMAPEmYE 217 (632)
T KOG0584|consen 202 --KSVIGTPEFMAPEMYE 217 (632)
T ss_pred --ceeccCccccChHHHh
Confidence 2378999999999974
|
|
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.6e-24 Score=212.96 Aligned_cols=159 Identities=22% Similarity=0.382 Sum_probs=130.6
Q ss_pred eeecccceEEEEeE--------EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEEeccCC
Q 010401 347 QIGPNSFKGVYKGK--------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEG 418 (511)
Q Consensus 347 ~LG~GsFG~VYkgk--------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVmEy~~g 418 (511)
.||+|+||.||+|. .||+|.+... ........+.+|+.++++++||||+++++++... ..++||||+++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~-~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~--~~~lv~e~~~~ 78 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNE-NEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEAE--ALMLVMEMASG 78 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccc-cChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcCC--CeEEEEEeCCC
Confidence 48999999999863 4888888643 2333445688999999999999999999988643 38999999999
Q ss_pred CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCc---cccc
Q 010401 419 GSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA---TEYE 494 (511)
Q Consensus 419 GsL~~lL~~-~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~---~~~~ 494 (511)
++|.+++.. ...+++..++.++.||+.||.|||++|++||||||+|||++.++.+||+|||+++........ ....
T Consensus 79 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 158 (257)
T cd05115 79 GPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAG 158 (257)
T ss_pred CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCC
Confidence 999999864 457899999999999999999999999999999999999999999999999998765433221 1112
Q ss_pred cCCCccccHHhhcc
Q 010401 495 TDGYRWLAPEVCFL 508 (511)
Q Consensus 495 ~Gt~~YmAPEvl~g 508 (511)
.+++.|+|||++.+
T Consensus 159 ~~~~~y~aPE~~~~ 172 (257)
T cd05115 159 KWPLKWYAPECINF 172 (257)
T ss_pred CCCcccCCHHHHcc
Confidence 23578999998754
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.8e-25 Score=213.69 Aligned_cols=167 Identities=20% Similarity=0.354 Sum_probs=140.1
Q ss_pred CeEEEeeeecccceEEEEe------EEEEEEEEecCCCCc----hHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEE
Q 010401 341 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGN----AYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLC 410 (511)
Q Consensus 341 ~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~----~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~ 410 (511)
+|+..+.||+|+||.||++ +.+++|++....... .....+.+|+..+++++|+||+++++++.+.+. ++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~ 79 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSH-FN 79 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCe-EE
Confidence 4677899999999999985 469999986433211 134568899999999999999999999988776 99
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCC-cEEEEecCCceecccCCC
Q 010401 411 VVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG-NVCLGDMGIVTACKSVGE 489 (511)
Q Consensus 411 LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g-~vKL~DFGlS~~l~~~~~ 489 (511)
+||||+.+++|.+++...+.+++..+..++.||+.||.|||++|++||||+|+||+++.++ .+||+|||++........
T Consensus 80 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~ 159 (268)
T cd06630 80 LFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGT 159 (268)
T ss_pred EEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccccccc
Confidence 9999999999999998778899999999999999999999999999999999999998776 699999999876643211
Q ss_pred ----ccccccCCCccccHHhhcc
Q 010401 490 ----ATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 490 ----~~~~~~Gt~~YmAPEvl~g 508 (511)
......|+..|+|||++.+
T Consensus 160 ~~~~~~~~~~~~~~~~~PE~~~~ 182 (268)
T cd06630 160 GAGEFQGQLLGTIAFMAPEVLRG 182 (268)
T ss_pred cCCccccccccccceeCHhHhcc
Confidence 1223467889999999764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-24 Score=214.89 Aligned_cols=166 Identities=16% Similarity=0.311 Sum_probs=142.3
Q ss_pred CeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEEe
Q 010401 341 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTK 414 (511)
Q Consensus 341 ~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVmE 414 (511)
+|++.+.||+|+||.||++ +.+++|++............+.+|+.+++.++||||+++++++.+++. +|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~-~~~v~e 79 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSG-FVLVME 79 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCe-eEEEec
Confidence 4789999999999999996 469999997644434445668899999999999999999999988775 999999
Q ss_pred ccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCC-ccc
Q 010401 415 LMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE-ATE 492 (511)
Q Consensus 415 y~~gGsL~~lL~~-~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~-~~~ 492 (511)
|+ +++|.+++.. ...+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++........ ...
T Consensus 80 ~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~ 158 (286)
T cd07832 80 YM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYS 158 (286)
T ss_pred cc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCccc
Confidence 99 9999999854 45799999999999999999999999999999999999999999999999999887654322 233
Q ss_pred cccCCCccccHHhhcc
Q 010401 493 YETDGYRWLAPEVCFL 508 (511)
Q Consensus 493 ~~~Gt~~YmAPEvl~g 508 (511)
...|+..|+|||++.+
T Consensus 159 ~~~~~~~y~aPE~~~~ 174 (286)
T cd07832 159 HQVATRWYRAPELLYG 174 (286)
T ss_pred cccCcccccCceeeec
Confidence 4568889999998754
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.1e-24 Score=210.24 Aligned_cols=168 Identities=27% Similarity=0.467 Sum_probs=142.9
Q ss_pred CCeEEEeeeecccceEEEEeE------EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEE
Q 010401 340 DNLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT 413 (511)
Q Consensus 340 ~~y~l~~~LG~GsFG~VYkgk------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVm 413 (511)
++|++.+.||.|+||.||++. .+++|++....... ....+.+|+..++.++|+||+++++.+..++. .|++|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-~~iv~ 78 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDE-LWLVM 78 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCE-EEEEE
Confidence 478999999999999999864 68899886433222 45668899999999999999999999988776 99999
Q ss_pred eccCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCc
Q 010401 414 KLMEGGSVNDLILKS---RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA 490 (511)
Q Consensus 414 Ey~~gGsL~~lL~~~---~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~ 490 (511)
||+++++|.+++... ..+++..+..++.|++.||.|||++||+||||+|+||++++++.++|+|||++..+......
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~ 158 (267)
T cd06610 79 PYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDR 158 (267)
T ss_pred eccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccc
Confidence 999999999999653 46899999999999999999999999999999999999999999999999998766543322
Q ss_pred ----cccccCCCccccHHhhccc
Q 010401 491 ----TEYETDGYRWLAPEVCFLL 509 (511)
Q Consensus 491 ----~~~~~Gt~~YmAPEvl~gl 509 (511)
.....|++.|+|||++...
T Consensus 159 ~~~~~~~~~~~~~y~~Pe~~~~~ 181 (267)
T cd06610 159 TRKVRKTFVGTPCWMAPEVMEQV 181 (267)
T ss_pred cccccccccCChhhcChHHHccc
Confidence 2334688899999997653
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.7e-24 Score=217.74 Aligned_cols=166 Identities=21% Similarity=0.355 Sum_probs=142.1
Q ss_pred CCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEE
Q 010401 339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV 412 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LV 412 (511)
..+|++.+.||.|+||.||+| +.|++|.+.... ......+.+|+.+++.++||||+++++++...+. +|+|
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~lv 94 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK--QPKKELIINEILVMKELKNPNIVNFLDSFLVGDE-LFVV 94 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc--CchHHHHHHHHHHHHhcCCCceeeeeeeEecCce-EEEE
Confidence 356899999999999999985 479999986432 2234567889999999999999999999987775 9999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCccc
Q 010401 413 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE 492 (511)
Q Consensus 413 mEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~~ 492 (511)
|||+++++|..++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++...........
T Consensus 95 ~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~ 173 (296)
T cd06655 95 MEYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRS 173 (296)
T ss_pred EEecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccccccCC
Confidence 999999999998854 4689999999999999999999999999999999999999999999999999876644333334
Q ss_pred cccCCCccccHHhhcc
Q 010401 493 YETDGYRWLAPEVCFL 508 (511)
Q Consensus 493 ~~~Gt~~YmAPEvl~g 508 (511)
...+++.|+|||.+.+
T Consensus 174 ~~~~~~~y~aPE~~~~ 189 (296)
T cd06655 174 TMVGTPYWMAPEVVTR 189 (296)
T ss_pred CcCCCccccCcchhcC
Confidence 4568889999998764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-24 Score=219.41 Aligned_cols=169 Identities=21% Similarity=0.435 Sum_probs=138.4
Q ss_pred ecCCCeEEEeeeecccceEEEEeE----------EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCC
Q 010401 337 LNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN 406 (511)
Q Consensus 337 l~~~~y~l~~~LG~GsFG~VYkgk----------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~ 406 (511)
+..++|+..+.||+|+||.||+|+ .+++|.+... .......++.+|+.+++.++||||+++++++....
T Consensus 4 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~ 82 (303)
T cd05110 4 LKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNET-TGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPT 82 (303)
T ss_pred cchhhceeccccccCCCccEEEEEEecCCCcceeeEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCCC
Confidence 345678999999999999999974 3678877632 22333446788999999999999999999987543
Q ss_pred CcEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecc
Q 010401 407 HGLCVVTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK 485 (511)
Q Consensus 407 ~~l~LVmEy~~gGsL~~lL~~~-~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~ 485 (511)
.++++||+++|+|.+++... ..+++..+..++.||+.||.|||+++|+||||||+||+++.++.+||+|||+++...
T Consensus 83 --~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~ 160 (303)
T cd05110 83 --IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLE 160 (303)
T ss_pred --ceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEcccccccccc
Confidence 67999999999999998654 368999999999999999999999999999999999999999999999999998764
Q ss_pred cCCCc--cccccCCCccccHHhhcc
Q 010401 486 SVGEA--TEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 486 ~~~~~--~~~~~Gt~~YmAPEvl~g 508 (511)
..... .....++..|+|||++.+
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~ 185 (303)
T cd05110 161 GDEKEYNADGGKMPIKWMALECIHY 185 (303)
T ss_pred CcccccccCCCccccccCCHHHhcc
Confidence 33221 122334678999998764
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-25 Score=243.40 Aligned_cols=163 Identities=20% Similarity=0.315 Sum_probs=138.2
Q ss_pred EEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCC----C-cEEE
Q 010401 343 EFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN----H-GLCV 411 (511)
Q Consensus 343 ~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~----~-~l~L 411 (511)
...+.||+|+||.||+| +.||||.+.... ........-+|+.+|++++|+|||+++++=.+.. . ...+
T Consensus 16 ~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~-~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 16 EMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES-SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eehhhhcCCccceeeeecccccccchhHHhhhhhc-ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 56688999999999996 479999997532 3334566789999999999999999998865544 1 1479
Q ss_pred EEeccCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcC--CC--cEEEEecCCceec
Q 010401 412 VTKLMEGGSVNDLILKS---RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDR--HG--NVCLGDMGIVTAC 484 (511)
Q Consensus 412 VmEy~~gGsL~~lL~~~---~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~--~g--~vKL~DFGlS~~l 484 (511)
|||||.+|+|...+++. ..|++.+++.++.+++.||.|||++||+||||||.||++-. +| ..||+|||.|+.+
T Consensus 95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel 174 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAREL 174 (732)
T ss_pred EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccccC
Confidence 99999999999999754 36999999999999999999999999999999999999963 23 4699999999998
Q ss_pred ccCCCccccccCCCccccHHhhc
Q 010401 485 KSVGEATEYETDGYRWLAPEVCF 507 (511)
Q Consensus 485 ~~~~~~~~~~~Gt~~YmAPEvl~ 507 (511)
.+++ .-....||..|++||++.
T Consensus 175 ~d~s-~~~S~vGT~~YLhPel~E 196 (732)
T KOG4250|consen 175 DDNS-LFTSLVGTEEYLHPELYE 196 (732)
T ss_pred CCCC-eeeeecCchhhcChHHHh
Confidence 7765 456778999999999986
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.2e-24 Score=212.00 Aligned_cols=169 Identities=24% Similarity=0.338 Sum_probs=140.0
Q ss_pred CCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCc---hHHHHHHHHHHHHHhCCCCceeeEeeeEeeC-CCcE
Q 010401 340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGN---AYEFELRKDLLELMTCGHKNILQFYCVCVDE-NHGL 409 (511)
Q Consensus 340 ~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~---~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~-~~~l 409 (511)
.+|+..+.||+|+||.||++ +.+++|++....... .....+.+|+.+++.++||||+++++++.+. +..+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 36788999999999999996 468999886432221 2334578899999999999999999988754 2347
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCC-
Q 010401 410 CVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG- 488 (511)
Q Consensus 410 ~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~- 488 (511)
+++|||+++++|.+++...+.+++...+.++.||+.||.|||+++|+||||||+||+++.++.+||+|||+++.+....
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 161 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICM 161 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccccccc
Confidence 8999999999999999877789999999999999999999999999999999999999999999999999987653211
Q ss_pred --CccccccCCCccccHHhhcc
Q 010401 489 --EATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 489 --~~~~~~~Gt~~YmAPEvl~g 508 (511)
.......++..|+|||++.+
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~ 183 (266)
T cd06651 162 SGTGIRSVTGTPYWMSPEVISG 183 (266)
T ss_pred cCCccccCCccccccCHHHhCC
Confidence 11233457889999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.8e-24 Score=209.66 Aligned_cols=166 Identities=25% Similarity=0.400 Sum_probs=141.6
Q ss_pred CeEEEeeeecccceEEEEe------EEEEEEEEecCCCC---chHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEE
Q 010401 341 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKG---NAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCV 411 (511)
Q Consensus 341 ~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~---~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~L 411 (511)
+|+..+.||+|+||.||+| +.+++|.+...... ......+.+|+.+++.++|+||+++++++.+++. +|+
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~-~~l 79 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDN-LYI 79 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCe-EEE
Confidence 3567789999999999996 47999988643321 2234568899999999999999999999987775 999
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCcc
Q 010401 412 VTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT 491 (511)
Q Consensus 412 VmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~ 491 (511)
+|||+++++|.+++.+...+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++....... ..
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~-~~ 158 (258)
T cd06632 80 FLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS-FA 158 (258)
T ss_pred EEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccc-cc
Confidence 99999999999999877779999999999999999999999999999999999999999999999999987764433 23
Q ss_pred ccccCCCccccHHhhcc
Q 010401 492 EYETDGYRWLAPEVCFL 508 (511)
Q Consensus 492 ~~~~Gt~~YmAPEvl~g 508 (511)
....|++.|+|||.+..
T Consensus 159 ~~~~~~~~y~~pe~~~~ 175 (258)
T cd06632 159 KSFKGSPYWMAPEVIAQ 175 (258)
T ss_pred cccCCCcceeCHHHhcC
Confidence 45568889999998754
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.6e-25 Score=213.69 Aligned_cols=166 Identities=20% Similarity=0.314 Sum_probs=142.9
Q ss_pred CeEEEeeeecccceEEEEe------EEEEEEEEecCCCCc-hHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEE
Q 010401 341 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGN-AYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT 413 (511)
Q Consensus 341 ~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~-~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVm 413 (511)
+|++.+.||.|+||.||++ +.+++|.+....... .....+.+|+.++++++||||+++++.+.+++. +|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~lv~ 79 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEEN-MYLVV 79 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCe-EEEEE
Confidence 4789999999999999996 468999987433222 345668899999999999999999999987775 99999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCcccc
Q 010401 414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY 493 (511)
Q Consensus 414 Ey~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~~~ 493 (511)
||+.+++|.+++.....+++..+..++.||+.||.|||+++++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 80 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~~ 158 (258)
T cd05578 80 DLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT-LTTS 158 (258)
T ss_pred eCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc-cccc
Confidence 999999999999777789999999999999999999999999999999999999999999999999987654332 2345
Q ss_pred ccCCCccccHHhhcc
Q 010401 494 ETDGYRWLAPEVCFL 508 (511)
Q Consensus 494 ~~Gt~~YmAPEvl~g 508 (511)
..|+..|+|||++.+
T Consensus 159 ~~~~~~y~~PE~~~~ 173 (258)
T cd05578 159 TSGTPGYMAPEVLCR 173 (258)
T ss_pred cCCChhhcCHHHHcc
Confidence 567889999999754
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.6e-25 Score=218.60 Aligned_cols=167 Identities=21% Similarity=0.382 Sum_probs=143.5
Q ss_pred cCCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEE
Q 010401 338 NSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCV 411 (511)
Q Consensus 338 ~~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~L 411 (511)
+.++|++.+.||+|+||.||++ +.+++|++... ........+.+|+.+++.++||||+++++++...+. +|+
T Consensus 3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~-~~l 80 (284)
T cd06620 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIG-AKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENN-ICM 80 (284)
T ss_pred cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEec-CcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCE-EEE
Confidence 4567899999999999999995 46889987642 233445678899999999999999999999998875 999
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCceEEcCCCcEEEEecCCceecccCCCc
Q 010401 412 VTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLND-HGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA 490 (511)
Q Consensus 412 VmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~-~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~ 490 (511)
||||+++++|.+++...+.+++..+..++.+++.||.|||+ ++++||||||+||+++.++.++|+|||++...... .
T Consensus 81 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~--~ 158 (284)
T cd06620 81 CMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS--I 158 (284)
T ss_pred EEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh--c
Confidence 99999999999999877789999999999999999999996 69999999999999999999999999998654322 1
Q ss_pred cccccCCCccccHHhhcc
Q 010401 491 TEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 491 ~~~~~Gt~~YmAPEvl~g 508 (511)
.....|+..|+|||++.+
T Consensus 159 ~~~~~~~~~~~aPE~~~~ 176 (284)
T cd06620 159 ADTFVGTSTYMSPERIQG 176 (284)
T ss_pred cCccccCcccCCHHHHcc
Confidence 234578899999999764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-24 Score=216.55 Aligned_cols=170 Identities=24% Similarity=0.459 Sum_probs=139.5
Q ss_pred ecCCCeEEEeeeecccceEEEEe-----------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeC
Q 010401 337 LNSDNLEFIDQIGPNSFKGVYKG-----------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDE 405 (511)
Q Consensus 337 l~~~~y~l~~~LG~GsFG~VYkg-----------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~ 405 (511)
++.++|++.+.||+|+||.||++ ..+++|.+... .......++.+|+.++..++||||+++++++.++
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~ 80 (288)
T cd05050 2 YPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE-ASADMQADFQREAALMAEFDHPNIVKLLGVCAVG 80 (288)
T ss_pred CChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCC-cCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCC
Confidence 35678999999999999999985 35788888632 2233445688999999999999999999999887
Q ss_pred CCcEEEEEeccCCCCHHHHHHhcC----------------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCC
Q 010401 406 NHGLCVVTKLMEGGSVNDLILKSR----------------------KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQ 463 (511)
Q Consensus 406 ~~~l~LVmEy~~gGsL~~lL~~~~----------------------~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~ 463 (511)
+. +|++|||+++|+|.+++.... .+++..++.++.||+.||.|||+++++||||||+
T Consensus 81 ~~-~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~ 159 (288)
T cd05050 81 KP-MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATR 159 (288)
T ss_pred Cc-cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHh
Confidence 76 899999999999999996421 3678888999999999999999999999999999
Q ss_pred ceEEcCCCcEEEEecCCceecccCCC--ccccccCCCccccHHhhcc
Q 010401 464 RILLDRHGNVCLGDMGIVTACKSVGE--ATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 464 NILld~~g~vKL~DFGlS~~l~~~~~--~~~~~~Gt~~YmAPEvl~g 508 (511)
||+++.++.++|+|||+++....... .......++.|+|||++.+
T Consensus 160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 206 (288)
T cd05050 160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFY 206 (288)
T ss_pred heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhc
Confidence 99999999999999999876543221 1122234567999998764
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.1e-25 Score=218.41 Aligned_cols=165 Identities=22% Similarity=0.370 Sum_probs=139.6
Q ss_pred CCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEE
Q 010401 340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT 413 (511)
Q Consensus 340 ~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVm 413 (511)
++|++++.||+|+||.||++ +.+|+|.+... ........+.+|+.++..++||||+++++.+...+. +|+||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~-~~lv~ 78 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE-LDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGA-VYMCM 78 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecc-cCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCe-EEEEE
Confidence 46889999999999999995 47899988642 233334568899999999999999999999988775 99999
Q ss_pred eccCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCceEEcCCCcEEEEecCCceecccCCC
Q 010401 414 KLMEGGSVNDLILKS---RKLQTKEIIRIAIDVAEGIKFLND-HGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE 489 (511)
Q Consensus 414 Ey~~gGsL~~lL~~~---~~L~e~~~~~ia~qIa~gL~yLH~-~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~ 489 (511)
||+++++|..++... ..+++..+..++.||+.||.|||. ++|+||||||+||+++.++.+||+|||++......
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-- 156 (286)
T cd06622 79 EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS-- 156 (286)
T ss_pred eecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC--
Confidence 999999999988653 378999999999999999999996 69999999999999999999999999998765332
Q ss_pred ccccccCCCccccHHhhcc
Q 010401 490 ATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 490 ~~~~~~Gt~~YmAPEvl~g 508 (511)
......+++.|+|||++.+
T Consensus 157 ~~~~~~~~~~y~aPE~~~~ 175 (286)
T cd06622 157 LAKTNIGCQSYMAPERIKS 175 (286)
T ss_pred ccccCCCccCccCcchhcC
Confidence 2334567889999999754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.3e-24 Score=212.81 Aligned_cols=165 Identities=21% Similarity=0.348 Sum_probs=134.5
Q ss_pred CCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHH-HHhCCCCceeeEeeeEeeCCCcEEEE
Q 010401 340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLE-LMTCGHKNILQFYCVCVDENHGLCVV 412 (511)
Q Consensus 340 ~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~i-L~~l~HpNIV~l~g~~~~~~~~l~LV 412 (511)
++|++.+.||+|+||.||++ +.||+|++..... .....++..|+.. ++..+||||+++++++..++. +|++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~-~~lv 78 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVN-SQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGD-VWIC 78 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCC-cHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCc-EEEE
Confidence 47899999999999999995 5799999875322 2233455566655 555799999999999987776 9999
Q ss_pred EeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCceEEcCCCcEEEEecCCceecccC
Q 010401 413 TKLMEGGSVNDLILK----SRKLQTKEIIRIAIDVAEGIKFLNDH-GVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV 487 (511)
Q Consensus 413 mEy~~gGsL~~lL~~----~~~L~e~~~~~ia~qIa~gL~yLH~~-gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~ 487 (511)
|||++ |+|.+++.. ...+++..++.++.||+.||+|||++ +++||||||+||+++.++.+||+|||+++.....
T Consensus 79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 79 MEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 99997 588888753 24689999999999999999999997 9999999999999999999999999998765432
Q ss_pred CCccccccCCCccccHHhhcc
Q 010401 488 GEATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 488 ~~~~~~~~Gt~~YmAPEvl~g 508 (511)
.......|+..|+|||++.+
T Consensus 158 -~~~~~~~~~~~y~aPE~~~~ 177 (283)
T cd06617 158 -VAKTIDAGCKPYMAPERINP 177 (283)
T ss_pred -cccccccCCccccChhhcCC
Confidence 22234568889999998754
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.5e-24 Score=209.35 Aligned_cols=167 Identities=23% Similarity=0.395 Sum_probs=145.0
Q ss_pred CCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEE
Q 010401 340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT 413 (511)
Q Consensus 340 ~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVm 413 (511)
++|++.+.||.|+||.||++ +.+++|++...... .....+.+|+..+..++|+||+++++++...+. ++++|
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-~~lv~ 78 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGE-ISIVL 78 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCe-EEEEE
Confidence 36889999999999999996 46899988643322 445678999999999999999999999988765 99999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCceEEcCCCcEEEEecCCceecccCCCccc
Q 010401 414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLND-HGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE 492 (511)
Q Consensus 414 Ey~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~-~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~~ 492 (511)
||+++++|.+++.....+++..+..++.|++.||.|||+ .+++||||+|+||+++.++.++|+|||++...........
T Consensus 79 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~ 158 (264)
T cd06623 79 EYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCN 158 (264)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCccc
Confidence 999999999999877889999999999999999999999 9999999999999999999999999999887654443333
Q ss_pred cccCCCccccHHhhcc
Q 010401 493 YETDGYRWLAPEVCFL 508 (511)
Q Consensus 493 ~~~Gt~~YmAPEvl~g 508 (511)
...++..|+|||.+.+
T Consensus 159 ~~~~~~~y~~pE~~~~ 174 (264)
T cd06623 159 TFVGTVTYMSPERIQG 174 (264)
T ss_pred ceeecccccCHhhhCC
Confidence 5567889999998754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.2e-24 Score=211.28 Aligned_cols=169 Identities=20% Similarity=0.401 Sum_probs=138.5
Q ss_pred eEecCCCeEEEeeeecccceEEEEeE-----EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcE
Q 010401 335 WLLNSDNLEFIDQIGPNSFKGVYKGK-----RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGL 409 (511)
Q Consensus 335 ~~l~~~~y~l~~~LG~GsFG~VYkgk-----~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l 409 (511)
|++..++|++...||+|+||.||++. .+++|.+.... .....+.+|+.+++.++|+||+++++++.. +. .
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~-~ 75 (260)
T cd05069 1 WEIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT---MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EP-I 75 (260)
T ss_pred CcCChHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC---ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CC-c
Confidence 44566789999999999999999964 58888875422 233557889999999999999999988753 33 7
Q ss_pred EEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccC
Q 010401 410 CVVTKLMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV 487 (511)
Q Consensus 410 ~LVmEy~~gGsL~~lL~~~--~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~ 487 (511)
|++|||+.+++|.+++... ..+++..+..++.|++.||.|||+.|++||||||+||++++++.++|+|||+++.....
T Consensus 76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05069 76 YIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDN 155 (260)
T ss_pred EEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCC
Confidence 8999999999999999653 35789999999999999999999999999999999999999999999999998766432
Q ss_pred CCc-cccccCCCccccHHhhcc
Q 010401 488 GEA-TEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 488 ~~~-~~~~~Gt~~YmAPEvl~g 508 (511)
... .....++..|+|||++.+
T Consensus 156 ~~~~~~~~~~~~~y~~Pe~~~~ 177 (260)
T cd05069 156 EYTARQGAKFPIKWTAPEAALY 177 (260)
T ss_pred cccccCCCccchhhCCHHHhcc
Confidence 211 112345678999998754
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.2e-25 Score=241.13 Aligned_cols=169 Identities=27% Similarity=0.420 Sum_probs=144.4
Q ss_pred ecCCCeEEEeeeecccceEEEEeE------EEEEEEEecCCCCchHHHHHHHHHHHHHhC-CCCceeeEeeeEeeCC---
Q 010401 337 LNSDNLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCVCVDEN--- 406 (511)
Q Consensus 337 l~~~~y~l~~~LG~GsFG~VYkgk------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l-~HpNIV~l~g~~~~~~--- 406 (511)
...+-|+++++||.|.+|+||+++ ..|+|++.... ..+.+++.|..+++.. +|||++.+||++...+
T Consensus 16 dp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~---d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~ 92 (953)
T KOG0587|consen 16 DPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE---DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGN 92 (953)
T ss_pred CCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc---cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCC
Confidence 345667999999999999999964 56778775422 2334566777777664 8999999999986432
Q ss_pred -CcEEEEEeccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCcee
Q 010401 407 -HGLCVVTKLMEGGSVNDLILK--SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTA 483 (511)
Q Consensus 407 -~~l~LVmEy~~gGsL~~lL~~--~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~ 483 (511)
+.+|||||||.+|++.|+++. ...+.|..+..|+++++.||.+||.+.+||||||-.|||++.++.|||+|||++..
T Consensus 93 ~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQ 172 (953)
T KOG0587|consen 93 GDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 172 (953)
T ss_pred CCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeee
Confidence 239999999999999999964 45799999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCccccccCCCccccHHhhcc
Q 010401 484 CKSVGEATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 484 l~~~~~~~~~~~Gt~~YmAPEvl~g 508 (511)
+...........||+.|||||++.+
T Consensus 173 ldsT~grRnT~iGtP~WMAPEViac 197 (953)
T KOG0587|consen 173 LDSTVGRRNTFIGTPYWMAPEVIAC 197 (953)
T ss_pred eecccccccCcCCCcccccceeeec
Confidence 9887777888899999999999865
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.9e-25 Score=236.84 Aligned_cols=162 Identities=23% Similarity=0.305 Sum_probs=137.4
Q ss_pred CeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCC------CCceeeEeeeEeeCCCc
Q 010401 341 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCG------HKNILQFYCVCVDENHG 408 (511)
Q Consensus 341 ~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~------HpNIV~l~g~~~~~~~~ 408 (511)
+|++++.||+|+||+|.++ +.||||+++. ...+..+...|+.+|..++ .-|||+++++|.-.++
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN---~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~H- 262 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKN---KKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNH- 262 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeecc---ChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccc-
Confidence 6899999999999999995 6899999974 3344556778889988875 3689999999999998
Q ss_pred EEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCC--CcEEEEecCCceec
Q 010401 409 LCVVTKLMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRH--GNVCLGDMGIVTAC 484 (511)
Q Consensus 409 l~LVmEy~~gGsL~~lL~~~--~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~--g~vKL~DFGlS~~l 484 (511)
+|||+|++.. +|+++|+.+ ..++...++.++.||+.||.+||+.||||.||||+||||.+- ..+||+|||.|...
T Consensus 263 lciVfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~ 341 (586)
T KOG0667|consen 263 LCIVFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE 341 (586)
T ss_pred eeeeehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEeccccccc
Confidence 9999999966 999999765 479999999999999999999999999999999999999843 47999999998765
Q ss_pred ccCCCccccccCCCccccHHhhcccC
Q 010401 485 KSVGEATEYETDGYRWLAPEVCFLLL 510 (511)
Q Consensus 485 ~~~~~~~~~~~Gt~~YmAPEvl~gl~ 510 (511)
... ...-..+..|.|||+|+|++
T Consensus 342 ~q~---vytYiQSRfYRAPEVILGlp 364 (586)
T KOG0667|consen 342 SQR---VYTYIQSRFYRAPEVILGLP 364 (586)
T ss_pred CCc---ceeeeeccccccchhhccCC
Confidence 432 22334456799999999975
|
|
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.2e-24 Score=210.65 Aligned_cols=160 Identities=23% Similarity=0.353 Sum_probs=133.2
Q ss_pred eeeecccceEEEEe---------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEEecc
Q 010401 346 DQIGPNSFKGVYKG---------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLM 416 (511)
Q Consensus 346 ~~LG~GsFG~VYkg---------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVmEy~ 416 (511)
++||+|+||.||+| ..+++|.+...... ....++.+|+.+++.++|+||+++++++.. +. .++||||+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~-~~~v~e~~ 77 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCKG-EP-LMLVMELA 77 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-Cc-eEEEEEeC
Confidence 46999999999987 36889988743332 345668899999999999999999998763 33 89999999
Q ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCcc---cc
Q 010401 417 EGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT---EY 493 (511)
Q Consensus 417 ~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~---~~ 493 (511)
.+|+|.+++.....+++..+..++.|++.||+|||.++++||||||+|||++.++.+||+|||+++......... ..
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~ 157 (257)
T cd05060 78 PLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTA 157 (257)
T ss_pred CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccC
Confidence 999999999877789999999999999999999999999999999999999999999999999988664433211 11
Q ss_pred ccCCCccccHHhhcc
Q 010401 494 ETDGYRWLAPEVCFL 508 (511)
Q Consensus 494 ~~Gt~~YmAPEvl~g 508 (511)
..++..|+|||.+.+
T Consensus 158 ~~~~~~y~aPE~~~~ 172 (257)
T cd05060 158 GRWPLKWYAPECINY 172 (257)
T ss_pred ccccccccCHHHhcC
Confidence 223467999998754
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.92 E-value=2e-24 Score=210.81 Aligned_cols=162 Identities=21% Similarity=0.336 Sum_probs=130.3
Q ss_pred eeeecccceEEEEeE---------EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEEecc
Q 010401 346 DQIGPNSFKGVYKGK---------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLM 416 (511)
Q Consensus 346 ~~LG~GsFG~VYkgk---------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVmEy~ 416 (511)
+.||+|+||.||+|+ .+|+|.+... ........+.+|+.+++.++||||+++++++...+...+++|||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 79 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI-TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYM 79 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCcc-CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecC
Confidence 368999999999864 4788887532 222334567889999999999999999998875554589999999
Q ss_pred CCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCC----cc
Q 010401 417 EGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE----AT 491 (511)
Q Consensus 417 ~gGsL~~lL~~~-~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~----~~ 491 (511)
.+|+|.+++.+. ..+++..+..++.||+.||.|||+.+++||||||+|||++.++.+||+|||+++....... ..
T Consensus 80 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 159 (262)
T cd05058 80 KHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNH 159 (262)
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeeccc
Confidence 999999999653 4567788889999999999999999999999999999999999999999999876533211 11
Q ss_pred ccccCCCccccHHhhcc
Q 010401 492 EYETDGYRWLAPEVCFL 508 (511)
Q Consensus 492 ~~~~Gt~~YmAPEvl~g 508 (511)
....+++.|+|||++.+
T Consensus 160 ~~~~~~~~y~aPE~~~~ 176 (262)
T cd05058 160 TGAKLPVKWMALESLQT 176 (262)
T ss_pred ccCcCCccccChhHhcc
Confidence 12345678999998754
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=3e-24 Score=210.88 Aligned_cols=169 Identities=23% Similarity=0.345 Sum_probs=141.0
Q ss_pred CCeEEEeeeecccceEEEEeE------EEEEEEEecCCC---CchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCC-CcE
Q 010401 340 DNLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDK---GNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN-HGL 409 (511)
Q Consensus 340 ~~y~l~~~LG~GsFG~VYkgk------~VAVKkL~~~~~---~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~-~~l 409 (511)
.+|++.+.||+|+||.||+++ .+++|.+..... .......+.+|+.++++++|+||+++++++.+.. ..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 578999999999999999964 699998753221 2233456888999999999999999999987653 348
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCC-
Q 010401 410 CVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG- 488 (511)
Q Consensus 410 ~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~- 488 (511)
+++|||+++++|.+++...+.+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||+++......
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 161 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICM 161 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccccc
Confidence 8999999999999999777789999999999999999999999999999999999999999999999999987653211
Q ss_pred --CccccccCCCccccHHhhcc
Q 010401 489 --EATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 489 --~~~~~~~Gt~~YmAPEvl~g 508 (511)
.......|+..|+|||++.+
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~ 183 (264)
T cd06653 162 SGTGIKSVTGTPYWMSPEVISG 183 (264)
T ss_pred cCccccccCCcccccCHhhhcC
Confidence 11233467889999999865
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.5e-24 Score=213.31 Aligned_cols=168 Identities=26% Similarity=0.412 Sum_probs=140.2
Q ss_pred cCCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhC-CCCceeeEeeeEeeCC----
Q 010401 338 NSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCVCVDEN---- 406 (511)
Q Consensus 338 ~~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l-~HpNIV~l~g~~~~~~---- 406 (511)
..++|++.+.||+|+||.||++ +.+++|.+... ......+.+|+.++.++ +||||+++++++...+
T Consensus 20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~---~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 96 (291)
T cd06639 20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI---SDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVG 96 (291)
T ss_pred CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccc---ccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCC
Confidence 4678999999999999999995 46899988532 22345577888888888 8999999999987543
Q ss_pred CcEEEEEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCce
Q 010401 407 HGLCVVTKLMEGGSVNDLILK----SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVT 482 (511)
Q Consensus 407 ~~l~LVmEy~~gGsL~~lL~~----~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~ 482 (511)
..+|+||||+++++|.+++.. ...+++..++.++.|++.||+|||+++|+||||||+||+++.++.+||+|||++.
T Consensus 97 ~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~ 176 (291)
T cd06639 97 GQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSA 176 (291)
T ss_pred CeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccch
Confidence 238999999999999998853 3578999999999999999999999999999999999999999999999999988
Q ss_pred ecccCCCccccccCCCccccHHhhcc
Q 010401 483 ACKSVGEATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 483 ~l~~~~~~~~~~~Gt~~YmAPEvl~g 508 (511)
.............|+..|+|||++..
T Consensus 177 ~~~~~~~~~~~~~~~~~y~aPE~~~~ 202 (291)
T cd06639 177 QLTSTRLRRNTSVGTPFWMAPEVIAC 202 (291)
T ss_pred hcccccccccCccCCccccChhhhcC
Confidence 76543333344568889999998753
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-26 Score=226.69 Aligned_cols=168 Identities=21% Similarity=0.283 Sum_probs=143.8
Q ss_pred CCCeEEEeeeecccceEEEE------eEEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEE
Q 010401 339 SDNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV 412 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYk------gk~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LV 412 (511)
.+.|++.++||+|.|+.||+ |+.+|+|.+...+.......++.+|+.+-..++||||+.+.+.+..... .|||
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~-~ylv 88 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESF-HYLV 88 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccce-eEEE
Confidence 56788889999999999998 4556666665433333345668999999999999999999998887665 8999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCC---CcEEEEecCCceecccCCC
Q 010401 413 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRH---GNVCLGDMGIVTACKSVGE 489 (511)
Q Consensus 413 mEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~---g~vKL~DFGlS~~l~~~~~ 489 (511)
+|+|.|++|..-|-.+..+++..+..++.||+.+|.|+|.+||||||+||.|+|+... .-+||+|||++..+. .+.
T Consensus 89 Fe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~-~g~ 167 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN-DGE 167 (355)
T ss_pred EecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC-Ccc
Confidence 9999999999888776788999999999999999999999999999999999999743 458999999999887 556
Q ss_pred ccccccCCCccccHHhhcc
Q 010401 490 ATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 490 ~~~~~~Gt~~YmAPEvl~g 508 (511)
......|||.|||||++..
T Consensus 168 ~~~G~~GtP~fmaPEvvrk 186 (355)
T KOG0033|consen 168 AWHGFAGTPGYLSPEVLKK 186 (355)
T ss_pred ccccccCCCcccCHHHhhc
Confidence 6777899999999999874
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.2e-25 Score=233.07 Aligned_cols=168 Identities=20% Similarity=0.297 Sum_probs=148.8
Q ss_pred CCeEEEeeeecccceEEEE------eEEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEE
Q 010401 340 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT 413 (511)
Q Consensus 340 ~~y~l~~~LG~GsFG~VYk------gk~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVm 413 (511)
.=|.+.+.||+|.|+.|-+ |..||||++.+-+........+.+|+..|+.++|||||+||.+..++.. +|+|+
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTK-lyLiL 96 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTK-LYLIL 96 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccce-EEEEE
Confidence 3478889999999997755 6789999998766666666778999999999999999999999988776 99999
Q ss_pred eccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEc-CCCcEEEEecCCceecccCCCcc
Q 010401 414 KLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLD-RHGNVCLGDMGIVTACKSVGEAT 491 (511)
Q Consensus 414 Ey~~gGsL~~lL~~~-~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld-~~g~vKL~DFGlS~~l~~~~~~~ 491 (511)
|+=.+|+|+++|.+. ..+.+..+.+|+.||+.|+.|+|+..+|||||||+|+.+. .-|-|||.|||++..+. +++..
T Consensus 97 ELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~-PG~kL 175 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ-PGKKL 175 (864)
T ss_pred EecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCC-Ccchh
Confidence 999999999999654 5799999999999999999999999999999999999887 56899999999998764 35667
Q ss_pred ccccCCCccccHHhhccc
Q 010401 492 EYETDGYRWLAPEVCFLL 509 (511)
Q Consensus 492 ~~~~Gt~~YmAPEvl~gl 509 (511)
+..||+..|-|||+++|-
T Consensus 176 ~TsCGSLAYSAPEILLGD 193 (864)
T KOG4717|consen 176 TTSCGSLAYSAPEILLGD 193 (864)
T ss_pred hcccchhhccCchhhhcC
Confidence 889999999999999873
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.5e-24 Score=212.89 Aligned_cols=171 Identities=20% Similarity=0.355 Sum_probs=140.1
Q ss_pred ecCCCeEEEeeeecccceEEEEeE----------EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCC
Q 010401 337 LNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN 406 (511)
Q Consensus 337 l~~~~y~l~~~LG~GsFG~VYkgk----------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~ 406 (511)
+..++|++.+.||+|+||.||+|. .|++|++.. .........+.+|+.+++.++|+||+++++++...+
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~-~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~ 81 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKD-HASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDG 81 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccC-CCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence 456789999999999999999863 467777753 223334556789999999999999999999988765
Q ss_pred CcEEEEEeccCCCCHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEec
Q 010401 407 HGLCVVTKLMEGGSVNDLILKS--------RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDM 478 (511)
Q Consensus 407 ~~l~LVmEy~~gGsL~~lL~~~--------~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DF 478 (511)
...++++||+++++|.+++... ..+++..+..++.||+.||+|||+++++||||||+||+++.++.+||+||
T Consensus 82 ~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 82 EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCC
Confidence 5589999999999999998643 35889999999999999999999999999999999999999999999999
Q ss_pred CCceecccCCCc--cccccCCCccccHHhhcc
Q 010401 479 GIVTACKSVGEA--TEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 479 GlS~~l~~~~~~--~~~~~Gt~~YmAPEvl~g 508 (511)
|+++.+...... .....++..|+|||++.+
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~ 193 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVN 193 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhc
Confidence 999765332211 112345677999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.8e-24 Score=209.81 Aligned_cols=165 Identities=24% Similarity=0.408 Sum_probs=142.8
Q ss_pred CCCeEEEeeeecccceEEEEeE------EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEE
Q 010401 339 SDNLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV 412 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkgk------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LV 412 (511)
.++|++.+.||.|+||.||+++ .+++|.+.... ...++.+|+..++.++|+||+++++.+.+... +|++
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~-~~l~ 76 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE----DLQEIIKEISILKQCDSPYIVKYYGSYFKNTD-LWIV 76 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH----HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCc-EEEE
Confidence 4678999999999999999964 68888886321 14578899999999999999999999998765 9999
Q ss_pred EeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCcc
Q 010401 413 TKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT 491 (511)
Q Consensus 413 mEy~~gGsL~~lL~~-~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~ 491 (511)
+||+.+++|.+++.. ...+++..+..++.|++.||.|||+.+++||||+|+||+++.++.++|+|||++..........
T Consensus 77 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 156 (256)
T cd06612 77 MEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKR 156 (256)
T ss_pred EecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCcccc
Confidence 999999999999965 4578999999999999999999999999999999999999999999999999988765443334
Q ss_pred ccccCCCccccHHhhcc
Q 010401 492 EYETDGYRWLAPEVCFL 508 (511)
Q Consensus 492 ~~~~Gt~~YmAPEvl~g 508 (511)
....++..|+|||++.+
T Consensus 157 ~~~~~~~~y~~PE~~~~ 173 (256)
T cd06612 157 NTVIGTPFWMAPEVIQE 173 (256)
T ss_pred ccccCCccccCHHHHhc
Confidence 45567889999999765
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=2e-24 Score=213.88 Aligned_cols=169 Identities=22% Similarity=0.406 Sum_probs=135.8
Q ss_pred cCCCeEEEeeeecccceEEEEeE-----------EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCC
Q 010401 338 NSDNLEFIDQIGPNSFKGVYKGK-----------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN 406 (511)
Q Consensus 338 ~~~~y~l~~~LG~GsFG~VYkgk-----------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~ 406 (511)
..++|.+.+.||+|+||.||++. .|++|.+.. .........+.+|+.+++.++|+||+++++++.+.+
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~-~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPE-SCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERL 82 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCC-CCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence 45678999999999999999864 367776653 222333456888999999999999999999998777
Q ss_pred CcEEEEEeccCCCCHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCC---cEEEE
Q 010401 407 HGLCVVTKLMEGGSVNDLILKSR-------KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG---NVCLG 476 (511)
Q Consensus 407 ~~l~LVmEy~~gGsL~~lL~~~~-------~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g---~vKL~ 476 (511)
. .++||||+.+++|.+++...+ .+++..+..++.||+.||+|||+++++||||||+||+++.++ .+||+
T Consensus 83 ~-~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 83 P-RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred C-cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEec
Confidence 5 899999999999999996542 488999999999999999999999999999999999998665 58999
Q ss_pred ecCCceecccCCCc--cccccCCCccccHHhhcc
Q 010401 477 DMGIVTACKSVGEA--TEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 477 DFGlS~~l~~~~~~--~~~~~Gt~~YmAPEvl~g 508 (511)
|||+++........ ......++.|+|||++.+
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 195 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLD 195 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhc
Confidence 99998866322111 111223467999999854
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1e-24 Score=241.59 Aligned_cols=173 Identities=20% Similarity=0.322 Sum_probs=140.2
Q ss_pred ceEecCCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhC-CCCceeeEeeeE-ee-
Q 010401 334 RWLLNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCVC-VD- 404 (511)
Q Consensus 334 ~~~l~~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l-~HpNIV~l~g~~-~~- 404 (511)
.+.+...++++.+.|.+|||+.||.+ +.+|+|++... .......+.+||.+|++| +|+|||.+++.. ..
T Consensus 31 ~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~ 108 (738)
T KOG1989|consen 31 TFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINR 108 (738)
T ss_pred EEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccc
Confidence 35567778899999999999999994 57999999743 444556689999999999 599999999932 21
Q ss_pred --CC--CcEEEEEeccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCceEEcCCCcEEEE
Q 010401 405 --EN--HGLCVVTKLMEGGSVNDLILK--SRKLQTKEIIRIAIDVAEGIKFLNDHG--VAYRDLNSQRILLDRHGNVCLG 476 (511)
Q Consensus 405 --~~--~~l~LVmEy~~gGsL~~lL~~--~~~L~e~~~~~ia~qIa~gL~yLH~~g--IIHRDLKp~NILld~~g~vKL~ 476 (511)
.+ ..++|+||||.||.|-+++.. ...|++.++++|+.|+++|+.+||... |||||||-+||||+.+|++|||
T Consensus 109 ~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLC 188 (738)
T KOG1989|consen 109 SSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLC 188 (738)
T ss_pred cCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeC
Confidence 11 127899999999999999964 346999999999999999999999988 9999999999999999999999
Q ss_pred ecCCceecccCCCc---------cccccCCCccccHHhhcc
Q 010401 477 DMGIVTACKSVGEA---------TEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 477 DFGlS~~l~~~~~~---------~~~~~Gt~~YmAPEvl~g 508 (511)
|||.+......-.. .....-|+.|.|||+|-.
T Consensus 189 DFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDl 229 (738)
T KOG1989|consen 189 DFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDL 229 (738)
T ss_pred cccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhh
Confidence 99997643221110 112245899999999854
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.2e-24 Score=214.71 Aligned_cols=167 Identities=17% Similarity=0.290 Sum_probs=139.7
Q ss_pred CeEEEeeeecccceEEEEe---------EEEEEEEEecCCCC--chHHHHHHHHHHHHHhC-CCCceeeEeeeEeeCCCc
Q 010401 341 NLEFIDQIGPNSFKGVYKG---------KRVGIEKLKGCDKG--NAYEFELRKDLLELMTC-GHKNILQFYCVCVDENHG 408 (511)
Q Consensus 341 ~y~l~~~LG~GsFG~VYkg---------k~VAVKkL~~~~~~--~~~~~~~~~Ei~iL~~l-~HpNIV~l~g~~~~~~~~ 408 (511)
+|++.+.||.|+||.||++ +.+|+|.+...... ......+.+|+.++..+ +|+||+++++.+..++.
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~- 79 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTK- 79 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCe-
Confidence 4788999999999999974 45899998643221 22345578899999999 69999999999887765
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCC
Q 010401 409 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG 488 (511)
Q Consensus 409 l~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~ 488 (511)
+|+||||+++++|.+++.....+++..+..++.||+.||.|||+.|++||||+|+|||++.++.+||+|||+++......
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 159 (290)
T cd05613 80 LHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDE 159 (290)
T ss_pred EEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceeccccc
Confidence 89999999999999999877889999999999999999999999999999999999999999999999999987654322
Q ss_pred C-ccccccCCCccccHHhhcc
Q 010401 489 E-ATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 489 ~-~~~~~~Gt~~YmAPEvl~g 508 (511)
. ......|+..|+|||++.+
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~ 180 (290)
T cd05613 160 VERAYSFCGTIEYMAPDIVRG 180 (290)
T ss_pred ccccccccCCcccCChhhccC
Confidence 1 1223468889999999853
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.2e-25 Score=238.18 Aligned_cols=168 Identities=17% Similarity=0.255 Sum_probs=131.5
Q ss_pred CCCeEEEeeeecccceEEEEeEE-------EEEEEE---------------ecCCCCchHHHHHHHHHHHHHhCCCCcee
Q 010401 339 SDNLEFIDQIGPNSFKGVYKGKR-------VGIEKL---------------KGCDKGNAYEFELRKDLLELMTCGHKNIL 396 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkgk~-------VAVKkL---------------~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV 396 (511)
.++|++++.||+|+||+||++.. .+.|.+ +...........+.+|+.++..++||||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 46799999999999999998642 111110 10111222344578999999999999999
Q ss_pred eEeeeEeeCCCcEEEEEeccCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCC
Q 010401 397 QFYCVCVDENHGLCVVTKLMEGGSVNDLILKS-----RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG 471 (511)
Q Consensus 397 ~l~g~~~~~~~~l~LVmEy~~gGsL~~lL~~~-----~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g 471 (511)
++++++.+.+. .|++|+++.+ +|.+++... .......++.++.||+.||+|||++|||||||||+|||++.++
T Consensus 227 ~l~~~~~~~~~-~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~ 304 (501)
T PHA03210 227 KIEEILRSEAN-TYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDG 304 (501)
T ss_pred cEeEEEEECCe-eEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC
Confidence 99999998876 8999999965 777776432 2234567788999999999999999999999999999999999
Q ss_pred cEEEEecCCceecccCCC-ccccccCCCccccHHhhcc
Q 010401 472 NVCLGDMGIVTACKSVGE-ATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 472 ~vKL~DFGlS~~l~~~~~-~~~~~~Gt~~YmAPEvl~g 508 (511)
.+||+|||+++.+..... ......||+.|+|||++.+
T Consensus 305 ~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 342 (501)
T PHA03210 305 KIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAG 342 (501)
T ss_pred CEEEEeCCCceecCcccccccccccCCcCCCCchhhcC
Confidence 999999999987654332 2234578999999999865
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.9e-24 Score=211.30 Aligned_cols=170 Identities=18% Similarity=0.337 Sum_probs=139.1
Q ss_pred EecCCCeEEEeeeecccceEEEEeE---------EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCC
Q 010401 336 LLNSDNLEFIDQIGPNSFKGVYKGK---------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN 406 (511)
Q Consensus 336 ~l~~~~y~l~~~LG~GsFG~VYkgk---------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~ 406 (511)
.+..++|.+.+.||+|+||.||+|. .+++|..... ........+.+|+.+++.++||||+++++++.+.
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~-~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~- 79 (270)
T cd05056 2 EIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNC-TSPSVREKFLQEAYIMRQFDHPHIVKLIGVITEN- 79 (270)
T ss_pred eechhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCc-CCHHHHHHHHHHHHHHHhCCCCchhceeEEEcCC-
Confidence 3566789999999999999999974 3677877532 2233455688999999999999999999998754
Q ss_pred CcEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecc
Q 010401 407 HGLCVVTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK 485 (511)
Q Consensus 407 ~~l~LVmEy~~gGsL~~lL~~~-~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~ 485 (511)
. .|+||||+++|+|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||+++...
T Consensus 80 ~-~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 158 (270)
T cd05056 80 P-VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE 158 (270)
T ss_pred C-cEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeecc
Confidence 3 78999999999999999764 368999999999999999999999999999999999999999999999999988764
Q ss_pred cCCCc-cccccCCCccccHHhhcc
Q 010401 486 SVGEA-TEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 486 ~~~~~-~~~~~Gt~~YmAPEvl~g 508 (511)
..... .....+++.|+|||++.+
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~ 182 (270)
T cd05056 159 DESYYKASKGKLPIKWMAPESINF 182 (270)
T ss_pred cccceecCCCCccccccChhhhcc
Confidence 43211 112233467999998753
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.8e-25 Score=236.53 Aligned_cols=173 Identities=18% Similarity=0.330 Sum_probs=147.8
Q ss_pred cccceEecCCCeEEEeeeecccceEEEEeE----------EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEee
Q 010401 331 EIGRWLLNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYC 400 (511)
Q Consensus 331 ~i~~~~l~~~~y~l~~~LG~GsFG~VYkgk----------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g 400 (511)
....|.+.++.+++.+.||.|-||.||+|. -||||+-+... .......|+.|..+|++++||||++++|
T Consensus 380 ~~rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~-t~d~tekflqEa~iMrnfdHphIikLIG 458 (974)
T KOG4257|consen 380 TVRNYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC-TPDDTEKFLQEASIMRNFDHPHIIKLIG 458 (974)
T ss_pred CCCcceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCC-ChhhHHHHHHHHHHHHhCCCcchhheee
Confidence 345788889999999999999999999973 48889887532 2334666999999999999999999999
Q ss_pred eEeeCCCcEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecC
Q 010401 401 VCVDENHGLCVVTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMG 479 (511)
Q Consensus 401 ~~~~~~~~l~LVmEy~~gGsL~~lL~~~-~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFG 479 (511)
+|.+. +.|||||+++.|.|..+|+.+ ..|+...+..|+.||+.||.|||+..+|||||..+|||+.....|||+|||
T Consensus 459 v~~e~--P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFG 536 (974)
T KOG4257|consen 459 VCVEQ--PMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFG 536 (974)
T ss_pred eeecc--ceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccc
Confidence 99865 489999999999999999765 479999999999999999999999999999999999999999999999999
Q ss_pred CceecccCCCccccccC--CCccccHHhhc
Q 010401 480 IVTACKSVGEATEYETD--GYRWLAPEVCF 507 (511)
Q Consensus 480 lS~~l~~~~~~~~~~~G--t~~YmAPEvl~ 507 (511)
+++.+.+.... ....| .+.|||||.+.
T Consensus 537 LSR~~ed~~yY-kaS~~kLPIKWmaPESIN 565 (974)
T KOG4257|consen 537 LSRYLEDDAYY-KASRGKLPIKWMAPESIN 565 (974)
T ss_pred hhhhccccchh-hccccccceeecCccccc
Confidence 99988654322 22233 37899999874
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2e-24 Score=217.47 Aligned_cols=170 Identities=17% Similarity=0.337 Sum_probs=140.5
Q ss_pred cCCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCC-CcEE
Q 010401 338 NSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN-HGLC 410 (511)
Q Consensus 338 ~~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~-~~l~ 410 (511)
..++|++.+.||+|+||.||+| +.||+|+++...........+.+|+.+++.++|+||+++++++.... ..++
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF 84 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence 3568999999999999999996 46999998753333323344678999999999999999999987653 3489
Q ss_pred EEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCC
Q 010401 411 VVTKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE 489 (511)
Q Consensus 411 LVmEy~~gGsL~~lL~~-~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~ 489 (511)
+||||+.+ +|.+++.. ...+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++........
T Consensus 85 lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~ 163 (309)
T cd07845 85 LVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAK 163 (309)
T ss_pred EEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCccC
Confidence 99999975 89888865 36789999999999999999999999999999999999999999999999999987654333
Q ss_pred ccccccCCCccccHHhhcc
Q 010401 490 ATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 490 ~~~~~~Gt~~YmAPEvl~g 508 (511)
......++..|+|||++.+
T Consensus 164 ~~~~~~~~~~y~aPE~~~~ 182 (309)
T cd07845 164 PMTPKVVTLWYRAPELLLG 182 (309)
T ss_pred CCCcccccccccChhhhcC
Confidence 3333455778999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.8e-24 Score=212.23 Aligned_cols=165 Identities=21% Similarity=0.360 Sum_probs=138.4
Q ss_pred CeEEEeeeecccceEEEEeE------EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEEe
Q 010401 341 NLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTK 414 (511)
Q Consensus 341 ~y~l~~~LG~GsFG~VYkgk------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVmE 414 (511)
+|++.+.||.|+||.||+|+ .+++|++..... ......+.+|+.+++.++|+||+++++++.+.+. +++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~-~~lv~e 78 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE-EGTPSTAIREISLMKELKHENIVRLHDVIHTENK-LMLVFE 78 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc-ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCc-EEEEEe
Confidence 57899999999999999964 689999874322 2223456789999999999999999999998876 999999
Q ss_pred ccCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCcc
Q 010401 415 LMEGGSVNDLILKS---RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT 491 (511)
Q Consensus 415 y~~gGsL~~lL~~~---~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~ 491 (511)
|+.+ +|.+++... ..+++..+..++.||+.||.|||+.|++||||||+||++++++.++|+|||+++.........
T Consensus 79 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~ 157 (284)
T cd07836 79 YMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTF 157 (284)
T ss_pred cCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcccc
Confidence 9986 898888543 368999999999999999999999999999999999999999999999999987654333333
Q ss_pred ccccCCCccccHHhhcc
Q 010401 492 EYETDGYRWLAPEVCFL 508 (511)
Q Consensus 492 ~~~~Gt~~YmAPEvl~g 508 (511)
....+++.|+|||++.+
T Consensus 158 ~~~~~~~~y~~PE~~~~ 174 (284)
T cd07836 158 SNEVVTLWYRAPDVLLG 174 (284)
T ss_pred ccccccccccChHHhcC
Confidence 34567888999999864
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=2e-24 Score=212.86 Aligned_cols=167 Identities=26% Similarity=0.403 Sum_probs=143.5
Q ss_pred CCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEE
Q 010401 340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT 413 (511)
Q Consensus 340 ~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVm 413 (511)
++|++.+.||.|+||.||+| +.+++|.+.... .......+.+|+.+++.++|+||+++++++.++.. +|+|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~~v~ 78 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE-AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSK-LWIIM 78 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc-cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCe-EEEEE
Confidence 36788899999999999996 468999886432 23334557889999999999999999999987765 99999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCcccc
Q 010401 414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY 493 (511)
Q Consensus 414 Ey~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~~~ 493 (511)
||+++++|.+++... .+++..+..++.|++.||.|||+++++||||+|+||+++.++.++|+|||+++...........
T Consensus 79 e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~ 157 (274)
T cd06609 79 EYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT 157 (274)
T ss_pred EeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeeccccccccc
Confidence 999999999998654 7899999999999999999999999999999999999999999999999999877654333445
Q ss_pred ccCCCccccHHhhccc
Q 010401 494 ETDGYRWLAPEVCFLL 509 (511)
Q Consensus 494 ~~Gt~~YmAPEvl~gl 509 (511)
..+++.|+|||++.+.
T Consensus 158 ~~~~~~y~~PE~~~~~ 173 (274)
T cd06609 158 FVGTPFWMAPEVIKQS 173 (274)
T ss_pred ccCCccccChhhhccC
Confidence 6788899999998754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.9e-24 Score=210.77 Aligned_cols=165 Identities=24% Similarity=0.450 Sum_probs=137.2
Q ss_pred eEecCCCeEEEeeeecccceEEEEe----EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEE
Q 010401 335 WLLNSDNLEFIDQIGPNSFKGVYKG----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLC 410 (511)
Q Consensus 335 ~~l~~~~y~l~~~LG~GsFG~VYkg----k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~ 410 (511)
|.+..++|++.+.||+|+||.||+| +.+++|++... .....+.+|+.++..++||||+++++++.... .+
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~----~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~--~~ 74 (254)
T cd05083 1 WLLNLQKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCD----VTAQAFLEETAVMTKLHHKNLVRLLGVILHNG--LY 74 (254)
T ss_pred CcccHHHceeeeeeccCCCCceEecccCCCceEEEeecCc----chHHHHHHHHHHHHhCCCCCcCeEEEEEcCCC--cE
Confidence 3455678999999999999999995 47889988532 12346788999999999999999999987543 78
Q ss_pred EEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCC
Q 010401 411 VVTKLMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG 488 (511)
Q Consensus 411 LVmEy~~gGsL~~lL~~~--~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~ 488 (511)
++|||+++++|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||+++.....
T Consensus 75 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~- 153 (254)
T cd05083 75 IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG- 153 (254)
T ss_pred EEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc-
Confidence 999999999999999654 35889999999999999999999999999999999999999999999999998764321
Q ss_pred CccccccCCCccccHHhhcc
Q 010401 489 EATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 489 ~~~~~~~Gt~~YmAPEvl~g 508 (511)
......+..|+|||++.+
T Consensus 154 --~~~~~~~~~y~~pe~~~~ 171 (254)
T cd05083 154 --VDNSKLPVKWTAPEALKH 171 (254)
T ss_pred --CCCCCCCceecCHHHhcc
Confidence 122334567999998754
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.8e-24 Score=246.34 Aligned_cols=171 Identities=18% Similarity=0.251 Sum_probs=141.4
Q ss_pred ecCCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCC-CcE
Q 010401 337 LNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN-HGL 409 (511)
Q Consensus 337 l~~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~-~~l 409 (511)
...++|++++.||.|+||.||++ +.+++|.+............+..|+.++..++||||++++++|.+.. ..+
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 34568999999999999999996 46889988754444445566889999999999999999999986543 348
Q ss_pred EEEEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-------CccccCCCCCceEEcC---------
Q 010401 410 CVVTKLMEGGSVNDLILK----SRKLQTKEIIRIAIDVAEGIKFLNDH-------GVAYRDLNSQRILLDR--------- 469 (511)
Q Consensus 410 ~LVmEy~~gGsL~~lL~~----~~~L~e~~~~~ia~qIa~gL~yLH~~-------gIIHRDLKp~NILld~--------- 469 (511)
||||||+++|+|.++|.. ...+++..++.|+.||+.||.|||+. +||||||||+||||+.
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~ 169 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence 999999999999999864 25799999999999999999999984 4999999999999964
Q ss_pred --------CCcEEEEecCCceecccCCCccccccCCCccccHHhhcc
Q 010401 470 --------HGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 470 --------~g~vKL~DFGlS~~l~~~~~~~~~~~Gt~~YmAPEvl~g 508 (511)
.+.+||+|||+++.+.... ......||+.|+|||++.+
T Consensus 170 ~~~~n~ng~~iVKLsDFGlAr~l~~~s-~~~s~vGTp~YmAPEvL~g 215 (1021)
T PTZ00266 170 AQANNLNGRPIAKIGDFGLSKNIGIES-MAHSCVGTPYYWSPELLLH 215 (1021)
T ss_pred ccccccCCCCceEEccCCccccccccc-cccccCCCccccCHHHHhc
Confidence 3458999999987654322 2334578999999999864
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.4e-24 Score=216.14 Aligned_cols=168 Identities=21% Similarity=0.285 Sum_probs=140.6
Q ss_pred CCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCc-hHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEE
Q 010401 340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGN-AYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV 412 (511)
Q Consensus 340 ~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~-~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LV 412 (511)
++|++.+.||+|+||.||++ +.+++|.+....... .....+.+|+.++..++|+||+++++.+.+.+. .|++
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-~~lv 79 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETY-LCLV 79 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCE-EEEE
Confidence 46899999999999999985 478999997543322 244568889999999999999999999987765 9999
Q ss_pred EeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCC-
Q 010401 413 TKLMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE- 489 (511)
Q Consensus 413 mEy~~gGsL~~lL~~~--~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~- 489 (511)
|||+.+++|.+++... ..+++..+..++.||+.||.|||+.|++||||||+||+++.++.++|+|||++........
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~ 159 (316)
T cd05574 80 MDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPP 159 (316)
T ss_pred EEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhcccccccc
Confidence 9999999999998653 5789999999999999999999999999999999999999999999999999865432211
Q ss_pred ----------------------------ccccccCCCccccHHhhcc
Q 010401 490 ----------------------------ATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 490 ----------------------------~~~~~~Gt~~YmAPEvl~g 508 (511)
......|+..|+|||++.+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 206 (316)
T cd05574 160 VSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISG 206 (316)
T ss_pred cccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcC
Confidence 0112357888999999864
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.2e-24 Score=212.57 Aligned_cols=165 Identities=24% Similarity=0.379 Sum_probs=140.5
Q ss_pred CeEEEeeeecccceEEEEeE------EEEEEEEecCCCCchHHHHHHHHHHHHHhCC---CCceeeEeeeEeeCCCcEEE
Q 010401 341 NLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDKGNAYEFELRKDLLELMTCG---HKNILQFYCVCVDENHGLCV 411 (511)
Q Consensus 341 ~y~l~~~LG~GsFG~VYkgk------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~---HpNIV~l~g~~~~~~~~l~L 411 (511)
.|++.+.||.|+||.||+|. .+++|.+... .......++.+|+.+++.++ ||||+++++++.++.. .|+
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~-~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~-~~l 79 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLD-TPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPR-LWI 79 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCC-CCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCE-EEE
Confidence 46778999999999999964 5899988642 22333456788999888886 9999999999987765 899
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCcc
Q 010401 412 VTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT 491 (511)
Q Consensus 412 VmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~ 491 (511)
||||+++++|.+++.. +.+++..+..++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++..........
T Consensus 80 v~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06917 80 IMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKR 158 (277)
T ss_pred EEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcccc
Confidence 9999999999999855 478999999999999999999999999999999999999999999999999988776544444
Q ss_pred ccccCCCccccHHhhcc
Q 010401 492 EYETDGYRWLAPEVCFL 508 (511)
Q Consensus 492 ~~~~Gt~~YmAPEvl~g 508 (511)
....|+..|+|||++.+
T Consensus 159 ~~~~~~~~y~aPE~~~~ 175 (277)
T cd06917 159 STFVGTPYWMAPEVITE 175 (277)
T ss_pred ccccCCcceeCHHHhcc
Confidence 45578899999998754
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.1e-24 Score=213.38 Aligned_cols=168 Identities=23% Similarity=0.318 Sum_probs=137.0
Q ss_pred CCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhC-CCCceeeEeeeEeeCCC----c
Q 010401 340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCVCVDENH----G 408 (511)
Q Consensus 340 ~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l-~HpNIV~l~g~~~~~~~----~ 408 (511)
++|++.+.||+|+||.||++ +.|++|++............+.+|+.+++.+ +||||+++++++...+. .
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46899999999999999996 4799998865333333345678899999998 56999999998876542 2
Q ss_pred EEEEEeccCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcC-CCcEEEEecCCce
Q 010401 409 LCVVTKLMEGGSVNDLILKS-----RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDR-HGNVCLGDMGIVT 482 (511)
Q Consensus 409 l~LVmEy~~gGsL~~lL~~~-----~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~-~g~vKL~DFGlS~ 482 (511)
+|++|||+++ +|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||+++
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~ 159 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR 159 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccce
Confidence 7999999986 898888542 35799999999999999999999999999999999999998 8999999999988
Q ss_pred ecccCCCccccccCCCccccHHhhcc
Q 010401 483 ACKSVGEATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 483 ~l~~~~~~~~~~~Gt~~YmAPEvl~g 508 (511)
.............+++.|+|||++.+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~aPE~~~~ 185 (295)
T cd07837 160 AFSIPVKSYTHEIVTLWYRAPEVLLG 185 (295)
T ss_pred ecCCCccccCCcccccCCCChHHhhC
Confidence 66443333334466888999998864
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.5e-24 Score=216.53 Aligned_cols=158 Identities=20% Similarity=0.327 Sum_probs=127.4
Q ss_pred eeeecccceEEEEeE--------EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeC-CCcEEEEEecc
Q 010401 346 DQIGPNSFKGVYKGK--------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDE-NHGLCVVTKLM 416 (511)
Q Consensus 346 ~~LG~GsFG~VYkgk--------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~-~~~l~LVmEy~ 416 (511)
.+||+|+||.||+++ .+|+|.+..... ...+.+|+.+++.++||||+++++++... +..+|+||||+
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 82 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYA 82 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeee
Confidence 679999999999974 588898864221 23467899999999999999999998643 33489999999
Q ss_pred CCCCHHHHHHh---------cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEE----cCCCcEEEEecCCcee
Q 010401 417 EGGSVNDLILK---------SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILL----DRHGNVCLGDMGIVTA 483 (511)
Q Consensus 417 ~gGsL~~lL~~---------~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILl----d~~g~vKL~DFGlS~~ 483 (511)
.+ +|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 83 ~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~ 161 (317)
T cd07867 83 EH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161 (317)
T ss_pred CC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceec
Confidence 75 88877742 1248889999999999999999999999999999999999 5667999999999987
Q ss_pred cccCCC---ccccccCCCccccHHhhcc
Q 010401 484 CKSVGE---ATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 484 l~~~~~---~~~~~~Gt~~YmAPEvl~g 508 (511)
...... ......||+.|+|||++.+
T Consensus 162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~ 189 (317)
T cd07867 162 FNSPLKPLADLDPVVVTFWYRAPELLLG 189 (317)
T ss_pred cCCCcccccccCcceecccccCcHHhcC
Confidence 643322 1234467899999999865
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1e-24 Score=215.66 Aligned_cols=166 Identities=22% Similarity=0.332 Sum_probs=139.5
Q ss_pred CeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEEe
Q 010401 341 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTK 414 (511)
Q Consensus 341 ~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVmE 414 (511)
+|+.++.||.|+||.||++ +.+++|++............+.+|+.++++++||||+++++++.+.+. .++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~-~~~v~e 79 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENK-LYLVFE 79 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCc-EEEEee
Confidence 4789999999999999996 468999886433333334568899999999999999999999987775 999999
Q ss_pred ccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCccc
Q 010401 415 LMEGGSVNDLILK--SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE 492 (511)
Q Consensus 415 y~~gGsL~~lL~~--~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~~ 492 (511)
|+. ++|..++.. ...+++..+..++.||+.||+|||+++++||||+|+||+++.++.+||+|||++...........
T Consensus 80 ~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~ 158 (284)
T cd07860 80 FLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT 158 (284)
T ss_pred ccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCccccc
Confidence 996 589888854 35689999999999999999999999999999999999999999999999999876544333334
Q ss_pred cccCCCccccHHhhcc
Q 010401 493 YETDGYRWLAPEVCFL 508 (511)
Q Consensus 493 ~~~Gt~~YmAPEvl~g 508 (511)
...+++.|+|||++.+
T Consensus 159 ~~~~~~~y~aPE~~~~ 174 (284)
T cd07860 159 HEVVTLWYRAPEILLG 174 (284)
T ss_pred cccccccccCCeEEec
Confidence 4456788999998764
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.2e-24 Score=213.05 Aligned_cols=167 Identities=22% Similarity=0.320 Sum_probs=136.5
Q ss_pred CCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEE
Q 010401 340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT 413 (511)
Q Consensus 340 ~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVm 413 (511)
++|++.+.||+|+||.||+| +.+++|++............+.+|+.+++.++||||+++++++.+.+. .|+||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~lv~ 80 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKR-LYLVF 80 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCe-EEEEE
Confidence 57899999999999999996 469999886433333334557889999999999999999999988776 99999
Q ss_pred eccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcC-CCcEEEEecCCceecccCCCc
Q 010401 414 KLMEGGSVNDLILKSR--KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDR-HGNVCLGDMGIVTACKSVGEA 490 (511)
Q Consensus 414 Ey~~gGsL~~lL~~~~--~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~-~g~vKL~DFGlS~~l~~~~~~ 490 (511)
||+++ +|.+++.... .+++..+..++.||+.||+|||+++++||||+|+||+++. ++.+||+|||++.........
T Consensus 81 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~ 159 (294)
T PLN00009 81 EYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT 159 (294)
T ss_pred ecccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCccc
Confidence 99965 8888875433 3578888999999999999999999999999999999985 567999999998765433222
Q ss_pred cccccCCCccccHHhhcc
Q 010401 491 TEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 491 ~~~~~Gt~~YmAPEvl~g 508 (511)
.....+++.|+|||++.+
T Consensus 160 ~~~~~~~~~y~~PE~~~~ 177 (294)
T PLN00009 160 FTHEVVTLWYRAPEILLG 177 (294)
T ss_pred cccCceeecccCHHHHhC
Confidence 333456788999999864
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.92 E-value=3e-24 Score=214.31 Aligned_cols=170 Identities=18% Similarity=0.335 Sum_probs=138.9
Q ss_pred cCCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCC----
Q 010401 338 NSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENH---- 407 (511)
Q Consensus 338 ~~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~---- 407 (511)
..++|++.+.||+|+||.||++ +.+|+|++............+.+|+.+++.++||||+++++++...+.
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence 3567899999999999999996 479999886543333334456789999999999999999999876542
Q ss_pred ---cEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCcee
Q 010401 408 ---GLCVVTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTA 483 (511)
Q Consensus 408 ---~l~LVmEy~~gGsL~~lL~~~-~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~ 483 (511)
..++||||+.+ +|.+++... ..+++..++.++.||+.||.|||++|++|+||||+||+++.++.+||+|||++..
T Consensus 90 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 168 (310)
T cd07865 90 YKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARA 168 (310)
T ss_pred CCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCccc
Confidence 25999999965 888887554 3789999999999999999999999999999999999999999999999999876
Q ss_pred cccCCCc----cccccCCCccccHHhhcc
Q 010401 484 CKSVGEA----TEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 484 l~~~~~~----~~~~~Gt~~YmAPEvl~g 508 (511)
....... .....++..|+|||++.+
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 197 (310)
T cd07865 169 FSLSKNSKPNRYTNRVVTLWYRPPELLLG 197 (310)
T ss_pred ccCCcccCCCCccCcccCccccCcHHhcC
Confidence 6432211 123456788999998865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=3e-24 Score=211.33 Aligned_cols=169 Identities=22% Similarity=0.413 Sum_probs=139.2
Q ss_pred CCCeEEEeeeecccceEEEEeE----------EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCC-C
Q 010401 339 SDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN-H 407 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkgk----------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~-~ 407 (511)
.++|++.+.||+|+||.||+++ .+|+|.+...... .....+.+|+.+++.++|+||+++++++.... .
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~ 81 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGR 81 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCC
Confidence 4567888999999999999864 6899998743332 34567899999999999999999999887622 2
Q ss_pred cEEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceeccc
Q 010401 408 GLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS 486 (511)
Q Consensus 408 ~l~LVmEy~~gGsL~~lL~~~~-~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~ 486 (511)
..+++|||+++++|.+++.... .+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++.....
T Consensus 82 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05038 82 SLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPE 161 (284)
T ss_pred ceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEccccccccccc
Confidence 3899999999999999996543 689999999999999999999999999999999999999999999999999887653
Q ss_pred CCCcc---ccccCCCccccHHhhcc
Q 010401 487 VGEAT---EYETDGYRWLAPEVCFL 508 (511)
Q Consensus 487 ~~~~~---~~~~Gt~~YmAPEvl~g 508 (511)
..... ....++..|+|||.+.+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~Pe~~~~ 186 (284)
T cd05038 162 DKDYYYVKEPGESPIFWYAPECLRT 186 (284)
T ss_pred CCcceeccCCCCCcccccCcHHHcc
Confidence 22211 12234566999998764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=3e-24 Score=211.13 Aligned_cols=167 Identities=21% Similarity=0.344 Sum_probs=139.0
Q ss_pred CeEEEeeeecccceEEEEe------EEEEEEEEecCCCCc--------hHHHHHHHHHHHHHhCCCCceeeEeeeEeeCC
Q 010401 341 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGN--------AYEFELRKDLLELMTCGHKNILQFYCVCVDEN 406 (511)
Q Consensus 341 ~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~--------~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~ 406 (511)
+|.+.+.||.|+||.||+| +.+++|.++...... .....+.+|+.++..++||||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4678899999999999996 468999885321111 11234678999999999999999999998776
Q ss_pred CcEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceeccc
Q 010401 407 HGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS 486 (511)
Q Consensus 407 ~~l~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~ 486 (511)
. +++||||+++++|.+++...+.+++..+..++.||+.||.|||+++++||||+|+||+++.++.++|+|||+++....
T Consensus 82 ~-~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~ 160 (272)
T cd06629 82 Y-LSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDD 160 (272)
T ss_pred c-eEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeeccccccccc
Confidence 5 999999999999999998778899999999999999999999999999999999999999999999999999876543
Q ss_pred CCC--ccccccCCCccccHHhhcc
Q 010401 487 VGE--ATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 487 ~~~--~~~~~~Gt~~YmAPEvl~g 508 (511)
... ......|+..|+|||++..
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~ 184 (272)
T cd06629 161 IYDNDQNMSMQGSVFWMAPEVIHS 184 (272)
T ss_pred cccccccccccCCccccCHHHhcc
Confidence 211 1233467889999999764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.9e-24 Score=207.39 Aligned_cols=166 Identities=23% Similarity=0.339 Sum_probs=140.8
Q ss_pred CeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEEe
Q 010401 341 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTK 414 (511)
Q Consensus 341 ~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVmE 414 (511)
+|++.+.||+|+||.||++ +.+++|.+............+.+|+.+++.++||||+++++.+..++. +++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~-~~lv~e 79 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKA-LMIVME 79 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCE-EEEEEe
Confidence 5789999999999999985 468999987544444456678899999999999999999999887665 999999
Q ss_pred ccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCC-CcEEEEecCCceecccCCCcc
Q 010401 415 LMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRH-GNVCLGDMGIVTACKSVGEAT 491 (511)
Q Consensus 415 y~~gGsL~~lL~~~--~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~-g~vKL~DFGlS~~l~~~~~~~ 491 (511)
|+++++|.+++... ..+++..+..++.|++.||.|||++|++||||+|+||+++.+ +.+||+|||++........ .
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~-~ 158 (256)
T cd08220 80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK-A 158 (256)
T ss_pred cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc-c
Confidence 99999999999653 358999999999999999999999999999999999999855 4679999999887654322 2
Q ss_pred ccccCCCccccHHhhcc
Q 010401 492 EYETDGYRWLAPEVCFL 508 (511)
Q Consensus 492 ~~~~Gt~~YmAPEvl~g 508 (511)
....|+..|+|||.+.+
T Consensus 159 ~~~~~~~~y~aPE~~~~ 175 (256)
T cd08220 159 YTVVGTPCYISPELCEG 175 (256)
T ss_pred cccccCCcccCchhccC
Confidence 34567889999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.9e-24 Score=207.75 Aligned_cols=165 Identities=26% Similarity=0.422 Sum_probs=137.7
Q ss_pred eEEEeeeecccceEEEEe----------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEE
Q 010401 342 LEFIDQIGPNSFKGVYKG----------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCV 411 (511)
Q Consensus 342 y~l~~~LG~GsFG~VYkg----------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~L 411 (511)
+++.+.||.|+||.||++ ..+++|++.... .......+..|+..+..++|+||+++++++.+.+. .|+
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-~~~ 78 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA-DEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEP-LMI 78 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC-ChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCe-eEE
Confidence 356789999999999985 458899986432 22245678899999999999999999999988765 999
Q ss_pred EEeccCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCC
Q 010401 412 VTKLMEGGSVNDLILKSRK--LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE 489 (511)
Q Consensus 412 VmEy~~gGsL~~lL~~~~~--L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~ 489 (511)
+|||+++++|.+++..... +++..+..++.|++.||.|||+.+++||||||+||+++.++.++|+|||+++.......
T Consensus 79 i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (258)
T smart00219 79 VMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY 158 (258)
T ss_pred EEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccccc
Confidence 9999999999999965443 99999999999999999999999999999999999999999999999999877654322
Q ss_pred ccc-cccCCCccccHHhhcc
Q 010401 490 ATE-YETDGYRWLAPEVCFL 508 (511)
Q Consensus 490 ~~~-~~~Gt~~YmAPEvl~g 508 (511)
... ...+++.|+|||.+.+
T Consensus 159 ~~~~~~~~~~~y~~Pe~~~~ 178 (258)
T smart00219 159 YKKKGGKLPIRWMAPESLKD 178 (258)
T ss_pred cccccCCCcccccChHHhcc
Confidence 111 2236788999998743
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.8e-25 Score=215.48 Aligned_cols=156 Identities=22% Similarity=0.377 Sum_probs=129.0
Q ss_pred eeeecccceEEEEeEE-------------EEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEE
Q 010401 346 DQIGPNSFKGVYKGKR-------------VGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV 412 (511)
Q Consensus 346 ~~LG~GsFG~VYkgk~-------------VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LV 412 (511)
+.||.|+||.||+|.. +++|.+.. ........+.+|+.++..++||||+++++++..+.. .++|
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~--~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~-~~lv 77 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDK--SHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDE-SIMV 77 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcc--hhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCC-cEEE
Confidence 3689999999999753 56666642 122234457888999999999999999999998776 8999
Q ss_pred EeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCc--------EEEEecCCcee
Q 010401 413 TKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGN--------VCLGDMGIVTA 483 (511)
Q Consensus 413 mEy~~gGsL~~lL~~~-~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~--------vKL~DFGlS~~ 483 (511)
|||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++.++. ++++|||++..
T Consensus 78 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 78 QEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred EecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 9999999999999754 36899999999999999999999999999999999999987765 69999999765
Q ss_pred cccCCCccccccCCCccccHHhhcc
Q 010401 484 CKSVGEATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 484 l~~~~~~~~~~~Gt~~YmAPEvl~g 508 (511)
... .....+++.|+|||++.+
T Consensus 158 ~~~----~~~~~~~~~y~aPE~~~~ 178 (258)
T cd05078 158 VLP----KEILLERIPWVPPECIEN 178 (258)
T ss_pred cCC----chhccccCCccCchhccC
Confidence 432 234567889999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.5e-24 Score=209.13 Aligned_cols=167 Identities=29% Similarity=0.443 Sum_probs=141.0
Q ss_pred CCCeEEEeeeecccceEEEEeE------EEEEEEEecCCCCchHHHHHHHHHHHHHhC-CCCceeeEeeeEeeCC-----
Q 010401 339 SDNLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCVCVDEN----- 406 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkgk------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l-~HpNIV~l~g~~~~~~----- 406 (511)
.++|++.+.||+|+||.||+++ .+++|.+... ......+.+|+.+++++ +|+||+++++++.+..
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDII---EDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecC---chhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 5788999999999999999964 5888888632 22345688999999998 7999999999997543
Q ss_pred CcEEEEEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCce
Q 010401 407 HGLCVVTKLMEGGSVNDLILK----SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVT 482 (511)
Q Consensus 407 ~~l~LVmEy~~gGsL~~lL~~----~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~ 482 (511)
..+|+||||+++++|.+++.. ...+++..+..++.|++.||.|||+++++|+||+|+||+++.++.+||+|||++.
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~ 161 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSA 161 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccce
Confidence 237999999999999999854 3578999999999999999999999999999999999999999999999999987
Q ss_pred ecccCCCccccccCCCccccHHhhcc
Q 010401 483 ACKSVGEATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 483 ~l~~~~~~~~~~~Gt~~YmAPEvl~g 508 (511)
.............|+..|+|||++.+
T Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~ 187 (275)
T cd06608 162 QLDSTLGRRNTFIGTPYWMAPEVIAC 187 (275)
T ss_pred ecccchhhhcCccccccccCHhHhcc
Confidence 66544333445568889999998753
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.7e-24 Score=206.81 Aligned_cols=161 Identities=22% Similarity=0.417 Sum_probs=132.7
Q ss_pred eeeecccceEEEEeE-----EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEEeccCCCC
Q 010401 346 DQIGPNSFKGVYKGK-----RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGS 420 (511)
Q Consensus 346 ~~LG~GsFG~VYkgk-----~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVmEy~~gGs 420 (511)
+.||+|+||.||+|. .+++|.+... ........+.+|+.++..++||||+++++++...+. .++||||+++++
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~lv~e~~~~~~ 78 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKED-LPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQP-IYIVMELVPGGD 78 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCc-CCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCc-cEEEEECCCCCc
Confidence 368999999999974 5889887642 233344568899999999999999999999987775 899999999999
Q ss_pred HHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCc-cccccCCC
Q 010401 421 VNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA-TEYETDGY 498 (511)
Q Consensus 421 L~~lL~~~-~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~-~~~~~Gt~ 498 (511)
|.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++......... .....+++
T Consensus 79 L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~ 158 (250)
T cd05085 79 FLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPI 158 (250)
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCcc
Confidence 99998653 46899999999999999999999999999999999999999999999999998754332111 11223456
Q ss_pred ccccHHhhcc
Q 010401 499 RWLAPEVCFL 508 (511)
Q Consensus 499 ~YmAPEvl~g 508 (511)
.|+|||++.+
T Consensus 159 ~y~aPE~~~~ 168 (250)
T cd05085 159 KWTAPEALNY 168 (250)
T ss_pred cccCHHHhcc
Confidence 7999998764
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.1e-24 Score=207.27 Aligned_cols=167 Identities=23% Similarity=0.471 Sum_probs=138.7
Q ss_pred cCCCeEEEeeeecccceEEEEe-----EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEE
Q 010401 338 NSDNLEFIDQIGPNSFKGVYKG-----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV 412 (511)
Q Consensus 338 ~~~~y~l~~~LG~GsFG~VYkg-----k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LV 412 (511)
+..+|++.+.||+|+||.||++ +.+++|.+..... ....+.+|+.+++.++||||+++++++..... .|++
T Consensus 2 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-~~~v 77 (256)
T cd05112 2 HPSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM---SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSP-ICLV 77 (256)
T ss_pred ChhHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC---CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCc-eEEE
Confidence 3467899999999999999985 4688898763222 23457889999999999999999999987775 8999
Q ss_pred EeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCc-
Q 010401 413 TKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA- 490 (511)
Q Consensus 413 mEy~~gGsL~~lL~~~-~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~- 490 (511)
|||+.+++|.+++... ..+++..+..++.|++.||.|||+++++||||||+||+++.++.+||+|||+++........
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 157 (256)
T cd05112 78 FEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS 157 (256)
T ss_pred EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCcccc
Confidence 9999999999998653 56899999999999999999999999999999999999999999999999998765432111
Q ss_pred cccccCCCccccHHhhcc
Q 010401 491 TEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 491 ~~~~~Gt~~YmAPEvl~g 508 (511)
.....++..|+|||++.+
T Consensus 158 ~~~~~~~~~~~aPe~~~~ 175 (256)
T cd05112 158 STGTKFPVKWSSPEVFSF 175 (256)
T ss_pred cCCCccchhhcCHhHhcc
Confidence 112234568999998864
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.7e-24 Score=208.39 Aligned_cols=160 Identities=26% Similarity=0.404 Sum_probs=134.7
Q ss_pred eeeecccceEEEEeE---------EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEEecc
Q 010401 346 DQIGPNSFKGVYKGK---------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLM 416 (511)
Q Consensus 346 ~~LG~GsFG~VYkgk---------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVmEy~ 416 (511)
+.||+|+||.||+++ .+|+|.+...... .....+.+|+..+++++||||+++++++.+ + .++++|||+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~-~~~~v~e~~ 77 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-H-PLMMVTELA 77 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC-C-eEEEEEEec
Confidence 468999999999864 4789988653332 455678899999999999999999999987 4 489999999
Q ss_pred CCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCc---c
Q 010401 417 EGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA---T 491 (511)
Q Consensus 417 ~gGsL~~lL~~~--~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~---~ 491 (511)
++++|.+.+... ..+++..++.++.|++.||+|||++|++||||||+||+++.++.+||+|||+++.+...... .
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 157 (257)
T cd05040 78 PLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVME 157 (257)
T ss_pred CCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceecc
Confidence 999999999664 36899999999999999999999999999999999999999999999999999876543221 1
Q ss_pred ccccCCCccccHHhhcc
Q 010401 492 EYETDGYRWLAPEVCFL 508 (511)
Q Consensus 492 ~~~~Gt~~YmAPEvl~g 508 (511)
....++..|+|||++.+
T Consensus 158 ~~~~~~~~y~~pE~~~~ 174 (257)
T cd05040 158 EHLKVPFAWCAPESLRT 174 (257)
T ss_pred cCCCCCceecCHHHhcc
Confidence 22346778999998764
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.6e-26 Score=223.79 Aligned_cols=169 Identities=25% Similarity=0.397 Sum_probs=141.3
Q ss_pred eEecCCCeEEEeeeecccceEEEE------eEEEEEEEEecCCCCchHHHHHHHHHHHHHhC-CCCceeeEeeeEeeCCC
Q 010401 335 WLLNSDNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCVCVDENH 407 (511)
Q Consensus 335 ~~l~~~~y~l~~~LG~GsFG~VYk------gk~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l-~HpNIV~l~g~~~~~~~ 407 (511)
|.+..++++-+..||.|+||+|+| |+..|||++.... .+....+++.|.+..++- +.||||++||++..++.
T Consensus 59 ~~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n-~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGd 137 (361)
T KOG1006|consen 59 HTFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNN-IEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGD 137 (361)
T ss_pred cccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeecc-chHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCc
Confidence 556677888889999999999998 8899999997532 234556788888876664 89999999999998887
Q ss_pred cEEEEEeccCCCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCceEEcCCCcEEEEecCCc
Q 010401 408 GLCVVTKLMEGGSVNDLIL-----KSRKLQTKEIIRIAIDVAEGIKFLND-HGVAYRDLNSQRILLDRHGNVCLGDMGIV 481 (511)
Q Consensus 408 ~l~LVmEy~~gGsL~~lL~-----~~~~L~e~~~~~ia~qIa~gL~yLH~-~gIIHRDLKp~NILld~~g~vKL~DFGlS 481 (511)
.||.||+|.- +|..+.+ ....++|..+..|..-++.||.||.+ ..|||||+||+|||++..|.+||||||++
T Consensus 138 -cWiCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIc 215 (361)
T KOG1006|consen 138 -CWICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGIC 215 (361)
T ss_pred -eeeeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccch
Confidence 8999999966 7766653 34579999999999999999999975 68999999999999999999999999998
Q ss_pred eecccCCCccccccCCCccccHHhhc
Q 010401 482 TACKSVGEATEYETDGYRWLAPEVCF 507 (511)
Q Consensus 482 ~~l~~~~~~~~~~~Gt~~YmAPEvl~ 507 (511)
-.+.. +...+...|...|||||.+.
T Consensus 216 GqLv~-SiAkT~daGCrpYmAPERi~ 240 (361)
T KOG1006|consen 216 GQLVD-SIAKTVDAGCRPYMAPERID 240 (361)
T ss_pred HhHHH-HHHhhhccCCccccChhccC
Confidence 77644 23355668889999999874
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.8e-24 Score=212.49 Aligned_cols=158 Identities=25% Similarity=0.340 Sum_probs=128.5
Q ss_pred eeecccceEEEEe------EEEEEEEEecCCCCch-HHHHHHHHHHHH---HhCCCCceeeEeeeEeeCCCcEEEEEecc
Q 010401 347 QIGPNSFKGVYKG------KRVGIEKLKGCDKGNA-YEFELRKDLLEL---MTCGHKNILQFYCVCVDENHGLCVVTKLM 416 (511)
Q Consensus 347 ~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~-~~~~~~~Ei~iL---~~l~HpNIV~l~g~~~~~~~~l~LVmEy~ 416 (511)
.||+|+||.||++ +.+|+|.+........ ......+|..++ ...+||||+.+++++..++. .++||||+
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~-~~lv~e~~ 79 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDK-LCFILDLM 79 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCe-EEEEEecC
Confidence 4899999999984 4799998865332222 222233443333 33589999999999987775 89999999
Q ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCccccccC
Q 010401 417 EGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETD 496 (511)
Q Consensus 417 ~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~~~~~G 496 (511)
++|+|.+++...+.+++..+..++.|++.||+|||+++|+||||||+|||++.++.++|+|||++...... ......|
T Consensus 80 ~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~--~~~~~~~ 157 (279)
T cd05633 80 NGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPHASVG 157 (279)
T ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceecccc--CccCcCC
Confidence 99999999987788999999999999999999999999999999999999999999999999998765432 2234578
Q ss_pred CCccccHHhhc
Q 010401 497 GYRWLAPEVCF 507 (511)
Q Consensus 497 t~~YmAPEvl~ 507 (511)
+..|+|||++.
T Consensus 158 ~~~y~aPE~~~ 168 (279)
T cd05633 158 THGYMAPEVLQ 168 (279)
T ss_pred CcCccCHHHhc
Confidence 99999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.4e-25 Score=219.26 Aligned_cols=164 Identities=24% Similarity=0.409 Sum_probs=138.1
Q ss_pred CeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEEe
Q 010401 341 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTK 414 (511)
Q Consensus 341 ~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVmE 414 (511)
.|.....||+|+||.||++ +.+++|++.. ........+.+|+..++.++|+||+++++.+..++. .|+|||
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~--~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~-~~lv~e 99 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDL--RKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDE-LWVVME 99 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEec--chHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCe-EEEEEe
Confidence 4455678999999999985 4689998863 223334557899999999999999999999987776 999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCccccc
Q 010401 415 LMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYE 494 (511)
Q Consensus 415 y~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~~~~ 494 (511)
|+++++|.+++. .+.+++..+..++.||+.||.|||+++|+||||||+||+++.++.++|+|||++.............
T Consensus 100 ~~~~~~L~~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~ 178 (292)
T cd06658 100 FLEGGALTDIVT-HTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSL 178 (292)
T ss_pred CCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCcee
Confidence 999999999874 4568999999999999999999999999999999999999999999999999987654333333445
Q ss_pred cCCCccccHHhhcc
Q 010401 495 TDGYRWLAPEVCFL 508 (511)
Q Consensus 495 ~Gt~~YmAPEvl~g 508 (511)
.|+..|+|||++.+
T Consensus 179 ~~~~~y~aPE~~~~ 192 (292)
T cd06658 179 VGTPYWMAPEVISR 192 (292)
T ss_pred ecCccccCHHHHcc
Confidence 68889999999854
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.7e-24 Score=225.07 Aligned_cols=164 Identities=26% Similarity=0.442 Sum_probs=134.8
Q ss_pred CCCeEEEeeeecccceEEEEe----EEEEEEEEecCCCCchHHHHHHHHHHHH--HhCCCCceeeEeeeEeeCCC---cE
Q 010401 339 SDNLEFIDQIGPNSFKGVYKG----KRVGIEKLKGCDKGNAYEFELRKDLLEL--MTCGHKNILQFYCVCVDENH---GL 409 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkg----k~VAVKkL~~~~~~~~~~~~~~~Ei~iL--~~l~HpNIV~l~g~~~~~~~---~l 409 (511)
..++.+++.||+|.||.||+| ..||||++...+ +.-..+|.++. -.++|+||+.|++.-..+++ .+
T Consensus 210 arqI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~srd-----E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQL 284 (513)
T KOG2052|consen 210 ARQIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSRD-----ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQL 284 (513)
T ss_pred hheeEEEEEecCccccceeeccccCCceEEEEecccc-----hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEE
Confidence 456899999999999999996 579999996432 22234444444 45799999999987655543 28
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--------CccccCCCCCceEEcCCCcEEEEecCCc
Q 010401 410 CVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDH--------GVAYRDLNSQRILLDRHGNVCLGDMGIV 481 (511)
Q Consensus 410 ~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~--------gIIHRDLKp~NILld~~g~vKL~DFGlS 481 (511)
|||++|.+.|+|+|+|.. ..++.+..+.++..++.||+|||-. .|.|||||..||||..+|...|+|+|+|
T Consensus 285 wLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLA 363 (513)
T KOG2052|consen 285 WLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 363 (513)
T ss_pred EEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceee
Confidence 999999999999999966 7899999999999999999999962 4999999999999999999999999998
Q ss_pred eecccCC----CccccccCCCccccHHhhcc
Q 010401 482 TACKSVG----EATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 482 ~~l~~~~----~~~~~~~Gt~~YmAPEvl~g 508 (511)
....... ......+||.+|||||++-.
T Consensus 364 v~h~~~t~~idi~~N~rVGTKRYMAPEvLde 394 (513)
T KOG2052|consen 364 VRHDSDTDTIDIPPNPRVGTKRYMAPEVLDE 394 (513)
T ss_pred EEecccCCcccCCCCCccceeeccChHHhhh
Confidence 7665432 23456789999999999853
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.9e-24 Score=211.08 Aligned_cols=166 Identities=21% Similarity=0.390 Sum_probs=141.2
Q ss_pred CeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEEe
Q 010401 341 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTK 414 (511)
Q Consensus 341 ~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVmE 414 (511)
.|+.++.||.|+||.||+| +.+++|.+... ........+.+|+.++..++||||+++++++.+.+. +|+|||
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~lv~e 82 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLE-EAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTK-LWIIME 82 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecc-ccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCE-EEEEEe
Confidence 4677899999999999996 36899988642 223344568889999999999999999999988775 999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCccccc
Q 010401 415 LMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYE 494 (511)
Q Consensus 415 y~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~~~~ 494 (511)
|+++++|.+++.. +.+++..+..++.|++.||+|||+.+++|+||+|+||+++.++.++|+|||++.............
T Consensus 83 ~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 161 (277)
T cd06640 83 YLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTF 161 (277)
T ss_pred cCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCccccccc
Confidence 9999999999854 578999999999999999999999999999999999999999999999999987765443334445
Q ss_pred cCCCccccHHhhccc
Q 010401 495 TDGYRWLAPEVCFLL 509 (511)
Q Consensus 495 ~Gt~~YmAPEvl~gl 509 (511)
.++..|+|||++.+.
T Consensus 162 ~~~~~y~apE~~~~~ 176 (277)
T cd06640 162 VGTPFWMAPEVIQQS 176 (277)
T ss_pred cCcccccCHhHhccC
Confidence 678889999998653
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.6e-24 Score=210.67 Aligned_cols=164 Identities=24% Similarity=0.438 Sum_probs=139.1
Q ss_pred eEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEEec
Q 010401 342 LEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKL 415 (511)
Q Consensus 342 y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVmEy 415 (511)
|++.+.||.|+||.||+| +.+|+|.+.... .......+.+|+.++..++||||+++++++.+++. +|+||||
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~lv~e~ 83 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTK-LWIIMEY 83 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEecccc-chHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCe-EEEEEEe
Confidence 677889999999999986 368999875322 22334568889999999999999999999988776 9999999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCcccccc
Q 010401 416 MEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYET 495 (511)
Q Consensus 416 ~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~~~~~ 495 (511)
+++++|.+++. ...+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++..............
T Consensus 84 ~~~~~l~~~i~-~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 162 (277)
T cd06641 84 LGGGSALDLLE-PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV 162 (277)
T ss_pred CCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchhhhcccc
Confidence 99999999885 35689999999999999999999999999999999999999999999999999876654332334456
Q ss_pred CCCccccHHhhcc
Q 010401 496 DGYRWLAPEVCFL 508 (511)
Q Consensus 496 Gt~~YmAPEvl~g 508 (511)
++..|+|||++.+
T Consensus 163 ~~~~y~~PE~~~~ 175 (277)
T cd06641 163 GTPFWMAPEVIKQ 175 (277)
T ss_pred CCccccChhhhcc
Confidence 7888999999764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.1e-25 Score=233.84 Aligned_cols=148 Identities=19% Similarity=0.318 Sum_probs=126.9
Q ss_pred EecCCCeEEEeeeecccceEEEEeEE------EEEEEEecCCCCch-HHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCc
Q 010401 336 LLNSDNLEFIDQIGPNSFKGVYKGKR------VGIEKLKGCDKGNA-YEFELRKDLLELMTCGHKNILQFYCVCVDENHG 408 (511)
Q Consensus 336 ~l~~~~y~l~~~LG~GsFG~VYkgk~------VAVKkL~~~~~~~~-~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~ 408 (511)
..+...|..++.||-|+||.|-+++. +|+|.|.+.+.... ...-+..|-++|..-+++-||+||..|.|++.
T Consensus 625 KMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdn- 703 (1034)
T KOG0608|consen 625 KMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDN- 703 (1034)
T ss_pred hccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCc-
Confidence 35566789999999999999999865 45666653222111 12225678888998999999999999998886
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceec
Q 010401 409 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC 484 (511)
Q Consensus 409 l~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l 484 (511)
+|+||+|++||++..+|-+.+-|.|..+++|+.++..|+++.|..|+|||||||+|||||.+|++||.|||+++-+
T Consensus 704 LYFVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGf 779 (1034)
T KOG0608|consen 704 LYFVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGF 779 (1034)
T ss_pred eEEEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccc
Confidence 9999999999999999988899999999999999999999999999999999999999999999999999998544
|
|
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.1e-24 Score=210.18 Aligned_cols=160 Identities=24% Similarity=0.384 Sum_probs=128.7
Q ss_pred eeeecccceEEEEeE--------EEEEEEEecCCCCchHHHHHHHHHHHHHhC-CCCceeeEeeeEeeCCCcEEEEEecc
Q 010401 346 DQIGPNSFKGVYKGK--------RVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCVCVDENHGLCVVTKLM 416 (511)
Q Consensus 346 ~~LG~GsFG~VYkgk--------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l-~HpNIV~l~g~~~~~~~~l~LVmEy~ 416 (511)
+.||+|+||.||+|+ .+++|.++.. ........+.+|+.++.++ +||||+++++++...+. +|++|||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~-~~lv~e~~ 78 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY-LYLAIEYA 78 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEcccc-CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCC-ceEEEEeC
Confidence 368999999999974 3577777632 2233345678899999999 89999999999987775 89999999
Q ss_pred CCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCC
Q 010401 417 EGGSVNDLILKSR----------------KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGI 480 (511)
Q Consensus 417 ~gGsL~~lL~~~~----------------~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGl 480 (511)
++|+|.+++.... .+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||+
T Consensus 79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl 158 (270)
T cd05047 79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGL 158 (270)
T ss_pred CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCC
Confidence 9999999996432 478899999999999999999999999999999999999999999999999
Q ss_pred ceecccCCCccccccCCCccccHHhhcc
Q 010401 481 VTACKSVGEATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 481 S~~l~~~~~~~~~~~Gt~~YmAPEvl~g 508 (511)
+...... ........+..|+|||++.+
T Consensus 159 ~~~~~~~-~~~~~~~~~~~y~apE~~~~ 185 (270)
T cd05047 159 SRGQEVY-VKKTMGRLPVRWMAIESLNY 185 (270)
T ss_pred ccccchh-hhccCCCCccccCChHHHcc
Confidence 7633211 11112233567999998754
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.8e-25 Score=236.48 Aligned_cols=160 Identities=21% Similarity=0.392 Sum_probs=140.5
Q ss_pred eeeecccceEEEEeE------EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEEeccCCC
Q 010401 346 DQIGPNSFKGVYKGK------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGG 419 (511)
Q Consensus 346 ~~LG~GsFG~VYkgk------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVmEy~~gG 419 (511)
-+||+|.||+||-|+ .+|||.+. .+......-+.+||.+-+.++|.|||++.|.+..++. +-|.||-++||
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIp--ekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf-~kIFMEqVPGG 657 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIP--EKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGF-FKIFMEQVPGG 657 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecc--cccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCe-EEEEeecCCCC
Confidence 469999999999985 67889886 3334444557888988899999999999999876664 88999999999
Q ss_pred CHHHHHHhc-CCC--CHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEc-CCCcEEEEecCCceecccCCCcccccc
Q 010401 420 SVNDLILKS-RKL--QTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLD-RHGNVCLGDMGIVTACKSVGEATEYET 495 (511)
Q Consensus 420 sL~~lL~~~-~~L--~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld-~~g~vKL~DFGlS~~l~~~~~~~~~~~ 495 (511)
+|..+|+.. +++ .+..+.+|..||+.||.|||++.|||||||-+|+||+ -.|.+||+|||.++.+..-...+....
T Consensus 658 SLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFT 737 (1226)
T KOG4279|consen 658 SLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFT 737 (1226)
T ss_pred cHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCccccccc
Confidence 999999754 677 7899999999999999999999999999999999998 579999999999999887777788999
Q ss_pred CCCccccHHhhcc
Q 010401 496 DGYRWLAPEVCFL 508 (511)
Q Consensus 496 Gt~~YmAPEvl~g 508 (511)
||..|||||++-.
T Consensus 738 GTLQYMAPEvIDq 750 (1226)
T KOG4279|consen 738 GTLQYMAPEVIDQ 750 (1226)
T ss_pred cchhhhChHhhcc
Confidence 9999999999853
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.4e-24 Score=204.13 Aligned_cols=167 Identities=25% Similarity=0.428 Sum_probs=144.1
Q ss_pred CeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEEe
Q 010401 341 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTK 414 (511)
Q Consensus 341 ~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVmE 414 (511)
+|++.+.||.|+||.||++ +.+++|++............+.+|+.+++.++|+|++++++.+..++. .+++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~-~~lv~e 79 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGK-LCIVME 79 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCE-EEEEEE
Confidence 5788999999999999985 468999987544444556678899999999999999999999987765 999999
Q ss_pred ccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCc
Q 010401 415 LMEGGSVNDLILKS----RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA 490 (511)
Q Consensus 415 y~~gGsL~~lL~~~----~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~ 490 (511)
|+++++|.+++... ..+++..+..++.+++.||.|||++|++|+||+|+||+++.++.++|+|||++.........
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~ 159 (258)
T cd08215 80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDL 159 (258)
T ss_pred ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCcce
Confidence 99999999999653 67999999999999999999999999999999999999999999999999998876554333
Q ss_pred cccccCCCccccHHhhcc
Q 010401 491 TEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 491 ~~~~~Gt~~YmAPEvl~g 508 (511)
.....|++.|+|||.+.+
T Consensus 160 ~~~~~~~~~y~~pe~~~~ 177 (258)
T cd08215 160 AKTVVGTPYYLSPELCQN 177 (258)
T ss_pred ecceeeeecccChhHhcc
Confidence 344578889999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.3e-24 Score=214.31 Aligned_cols=166 Identities=22% Similarity=0.368 Sum_probs=141.3
Q ss_pred CCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEE
Q 010401 339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV 412 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LV 412 (511)
.++|++.+.||+|+||.||++ +.+++|.+... .......+.+|+.+++.++||||+++++++...+. .|+|
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~-~~lv 94 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQ--QQPKKELIINEILVMRENKHPNIVNYLDSYLVGDE-LWVV 94 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccc--cchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCc-EEEE
Confidence 357899999999999999996 36899988532 22234557889999999999999999999988776 9999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCccc
Q 010401 413 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE 492 (511)
Q Consensus 413 mEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~~ 492 (511)
+||+++++|.+++.+ ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++...........
T Consensus 95 ~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~~ 173 (293)
T cd06647 95 MEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS 173 (293)
T ss_pred EecCCCCcHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccccccccc
Confidence 999999999999854 4688999999999999999999999999999999999999999999999999876654433344
Q ss_pred cccCCCccccHHhhcc
Q 010401 493 YETDGYRWLAPEVCFL 508 (511)
Q Consensus 493 ~~~Gt~~YmAPEvl~g 508 (511)
...|++.|+|||.+.+
T Consensus 174 ~~~~~~~y~~PE~~~~ 189 (293)
T cd06647 174 TMVGTPYWMAPEVVTR 189 (293)
T ss_pred cccCChhhcCchhhcc
Confidence 5578889999998754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.5e-24 Score=218.27 Aligned_cols=163 Identities=23% Similarity=0.365 Sum_probs=137.6
Q ss_pred eEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEEec
Q 010401 342 LEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKL 415 (511)
Q Consensus 342 y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVmEy 415 (511)
|+....||+|+||.||++ +.+++|.+.... ......+.+|+.++..++||||+++++.+..++. .|++|||
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~-~~iv~e~ 99 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRK--QQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEE-LWVLMEF 99 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecc--cchHHHHHHHHHHHHhCCCCchhhhhhheeeCCe-EEEEEec
Confidence 344567999999999986 469999986422 2234557889999999999999999999988776 9999999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCcccccc
Q 010401 416 MEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYET 495 (511)
Q Consensus 416 ~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~~~~~ 495 (511)
+++++|..++.. ..+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++..............
T Consensus 100 ~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~ 178 (297)
T cd06659 100 LQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV 178 (297)
T ss_pred CCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhccccccccccee
Confidence 999999998743 5689999999999999999999999999999999999999999999999999876544333334567
Q ss_pred CCCccccHHhhcc
Q 010401 496 DGYRWLAPEVCFL 508 (511)
Q Consensus 496 Gt~~YmAPEvl~g 508 (511)
|++.|+|||++.+
T Consensus 179 ~~~~y~aPE~~~~ 191 (297)
T cd06659 179 GTPYWMAPEVISR 191 (297)
T ss_pred cCccccCHHHHcc
Confidence 8899999999865
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.5e-24 Score=211.69 Aligned_cols=166 Identities=21% Similarity=0.389 Sum_probs=142.2
Q ss_pred CCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEE
Q 010401 340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT 413 (511)
Q Consensus 340 ~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVm 413 (511)
++|++.+.||.|+||.||++ +.+++|.+.... ......++.+|+..++.++||||+++++.+..++. ++++|
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~-~~lv~ 78 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEI-NEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGD-ISICM 78 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEeccc-ChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCE-EEEEE
Confidence 36788899999999999995 468999887532 23445668899999999999999999999988865 99999
Q ss_pred eccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCceEEcCCCcEEEEecCCceecccCCCcc
Q 010401 414 KLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLND-HGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT 491 (511)
Q Consensus 414 Ey~~gGsL~~lL~~~-~~L~e~~~~~ia~qIa~gL~yLH~-~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~ 491 (511)
||+.+++|.+++... ..+++..+..++.|++.||.|||+ .|++||||||+||+++.++.++|+|||++....... .
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~--~ 156 (265)
T cd06605 79 EYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL--A 156 (265)
T ss_pred EecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHH--h
Confidence 999999999999765 789999999999999999999999 999999999999999999999999999987654321 1
Q ss_pred ccccCCCccccHHhhccc
Q 010401 492 EYETDGYRWLAPEVCFLL 509 (511)
Q Consensus 492 ~~~~Gt~~YmAPEvl~gl 509 (511)
....++..|+|||++.+.
T Consensus 157 ~~~~~~~~y~~PE~~~~~ 174 (265)
T cd06605 157 KTFVGTSSYMAPERIQGN 174 (265)
T ss_pred hcccCChhccCHHHHcCC
Confidence 226788899999998653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.1e-24 Score=212.55 Aligned_cols=168 Identities=20% Similarity=0.289 Sum_probs=135.8
Q ss_pred CeEEEeeeecccceEEEEeE--------EEEEEEEecCC-CCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCC-CcEE
Q 010401 341 NLEFIDQIGPNSFKGVYKGK--------RVGIEKLKGCD-KGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN-HGLC 410 (511)
Q Consensus 341 ~y~l~~~LG~GsFG~VYkgk--------~VAVKkL~~~~-~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~-~~l~ 410 (511)
.|++.+.||+|+||.||+|. .+|+|.+.... ........+.+|+.++..++||||+++++++.+.+ ..+|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 47889999999999999964 58999987532 11222345678999999999999999999998772 2389
Q ss_pred EEEeccCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcC----CCcEEEEecCCc
Q 010401 411 VVTKLMEGGSVNDLILKS-----RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDR----HGNVCLGDMGIV 481 (511)
Q Consensus 411 LVmEy~~gGsL~~lL~~~-----~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~----~g~vKL~DFGlS 481 (511)
+||||+.+ +|.+++... ..+++..++.++.||+.||.|||+++|+||||||+||+++. ++.+||+|||++
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 99999976 777776421 26899999999999999999999999999999999999999 999999999998
Q ss_pred eecccCCC---ccccccCCCccccHHhhccc
Q 010401 482 TACKSVGE---ATEYETDGYRWLAPEVCFLL 509 (511)
Q Consensus 482 ~~l~~~~~---~~~~~~Gt~~YmAPEvl~gl 509 (511)
+....... ......+++.|+|||++.+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 190 (316)
T cd07842 160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGA 190 (316)
T ss_pred cccCCCcccccccCCccccccccCHHHHhCC
Confidence 86643322 12234678889999988653
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.5e-24 Score=214.41 Aligned_cols=165 Identities=24% Similarity=0.406 Sum_probs=139.3
Q ss_pred CeEEEeeeecccceEEEEeE------EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEEe
Q 010401 341 NLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTK 414 (511)
Q Consensus 341 ~y~l~~~LG~GsFG~VYkgk------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVmE 414 (511)
.|+..+.||+|+||.||+|. .|++|.+.... .......+.+|+.+++.++||||+++++.+..++. +|+|||
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~lv~e 82 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTK-LWIIME 82 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc-chHHHHHHHHHHHHHHcCCCCccHhhhcccccCCc-eEEEEE
Confidence 35667889999999999963 68898876322 22334568899999999999999999999987775 999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCccccc
Q 010401 415 LMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYE 494 (511)
Q Consensus 415 y~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~~~~ 494 (511)
|+++++|.+++. ...+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++.............
T Consensus 83 ~~~~~~L~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~ 161 (277)
T cd06642 83 YLGGGSALDLLK-PGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTF 161 (277)
T ss_pred ccCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcchhhhcc
Confidence 999999999885 4578999999999999999999999999999999999999999999999999987765433333445
Q ss_pred cCCCccccHHhhcc
Q 010401 495 TDGYRWLAPEVCFL 508 (511)
Q Consensus 495 ~Gt~~YmAPEvl~g 508 (511)
.|+..|+|||++.+
T Consensus 162 ~~~~~y~aPE~~~~ 175 (277)
T cd06642 162 VGTPFWMAPEVIKQ 175 (277)
T ss_pred cCcccccCHHHhCc
Confidence 67889999999865
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.3e-24 Score=206.60 Aligned_cols=167 Identities=25% Similarity=0.415 Sum_probs=140.1
Q ss_pred CeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEEe
Q 010401 341 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTK 414 (511)
Q Consensus 341 ~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVmE 414 (511)
+|++.+.||+|+||.||++ ..+++|.+............+.+|+.+++.++|+||+++++.+.+.+. .|+++|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~-~~lv~e 79 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGR-LFIVME 79 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCe-EEEEEe
Confidence 4789999999999999985 468999886543333344567899999999999999999999987765 999999
Q ss_pred ccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCC-cEEEEecCCceecccCCCcc
Q 010401 415 LMEGGSVNDLILKSR--KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG-NVCLGDMGIVTACKSVGEAT 491 (511)
Q Consensus 415 y~~gGsL~~lL~~~~--~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g-~vKL~DFGlS~~l~~~~~~~ 491 (511)
|+++++|.+++.... .+++..+..++.|++.||.|||+++++|+||||+||+++.++ .+||+|||.+..........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~ 159 (257)
T cd08225 80 YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELA 159 (257)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcccc
Confidence 999999999986533 579999999999999999999999999999999999999876 46999999987765433333
Q ss_pred ccccCCCccccHHhhcc
Q 010401 492 EYETDGYRWLAPEVCFL 508 (511)
Q Consensus 492 ~~~~Gt~~YmAPEvl~g 508 (511)
....|++.|+|||++.+
T Consensus 160 ~~~~~~~~~~ape~~~~ 176 (257)
T cd08225 160 YTCVGTPYYLSPEICQN 176 (257)
T ss_pred cccCCCccccCHHHHcC
Confidence 34468889999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.8e-24 Score=218.34 Aligned_cols=169 Identities=18% Similarity=0.283 Sum_probs=141.0
Q ss_pred CCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCC----Cc
Q 010401 339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN----HG 408 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~----~~ 408 (511)
.++|.+.+.||+|+||.||++ +.|++|++...........++.+|+.+++.++|+||+++++++.... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 357899999999999999996 46999998743323333456778999999999999999999886543 23
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCC
Q 010401 409 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG 488 (511)
Q Consensus 409 l~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~ 488 (511)
+|++|||+. ++|.+++...+.+++..+..++.||+.||.|||+++++||||||+||+++.++.+||+|||+++......
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~ 162 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG 162 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCCc
Confidence 799999996 5999998777889999999999999999999999999999999999999999999999999988664433
Q ss_pred CccccccCCCccccHHhhcc
Q 010401 489 EATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 489 ~~~~~~~Gt~~YmAPEvl~g 508 (511)
.......++..|+|||++..
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~ 182 (337)
T cd07858 163 DFMTEYVVTRWYRAPELLLN 182 (337)
T ss_pred ccccccccccCccChHHHhc
Confidence 33344567889999998764
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=8e-24 Score=218.06 Aligned_cols=166 Identities=20% Similarity=0.257 Sum_probs=137.4
Q ss_pred CCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCC-----C
Q 010401 339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN-----H 407 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~-----~ 407 (511)
.++|+..+.||+|+||.||++ +.+|+|.+...........++.+|+.+++.++||||+++++++.... .
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 94 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ 94 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence 467999999999999999996 46999998643333334456778999999999999999999886443 2
Q ss_pred cEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccC
Q 010401 408 GLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV 487 (511)
Q Consensus 408 ~l~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~ 487 (511)
..|+||||+.+ +|.+.+... +++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++.....
T Consensus 95 ~~~lv~e~~~~-~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~ 171 (353)
T cd07850 95 DVYLVMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 171 (353)
T ss_pred cEEEEEeccCC-CHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCCCC
Confidence 37999999965 888887543 899999999999999999999999999999999999999999999999999876432
Q ss_pred CCccccccCCCccccHHhhcc
Q 010401 488 GEATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 488 ~~~~~~~~Gt~~YmAPEvl~g 508 (511)
. ......++..|+|||++.+
T Consensus 172 ~-~~~~~~~~~~y~aPE~~~~ 191 (353)
T cd07850 172 F-MMTPYVVTRYYRAPEVILG 191 (353)
T ss_pred C-CCCCCcccccccCHHHHhC
Confidence 2 2233467889999999865
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.3e-24 Score=206.82 Aligned_cols=159 Identities=21% Similarity=0.280 Sum_probs=136.7
Q ss_pred eecccceEEEEe------EEEEEEEEecCCCC-chHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEEeccCCCC
Q 010401 348 IGPNSFKGVYKG------KRVGIEKLKGCDKG-NAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGS 420 (511)
Q Consensus 348 LG~GsFG~VYkg------k~VAVKkL~~~~~~-~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVmEy~~gGs 420 (511)
||.|+||.||++ +.+++|.+...... ......+.+|+.+++.++||||+++++.+.+++. +|++|||+++++
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~lv~e~~~~~~ 79 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKY-IYMLMEYCLGGE 79 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCc-cEEEEecCCCCc
Confidence 699999999996 46899998643322 2345668899999999999999999999987776 999999999999
Q ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCccccccCCCcc
Q 010401 421 VNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRW 500 (511)
Q Consensus 421 L~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~~~~~Gt~~Y 500 (511)
|.+++.+...+++..+..++.||+.||.|||+++++|+||+|+||+++.++.++|+|||+++...... ......|+..|
T Consensus 80 L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~ 158 (262)
T cd05572 80 LWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-KTWTFCGTPEY 158 (262)
T ss_pred HHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-ccccccCCcCc
Confidence 99999877789999999999999999999999999999999999999999999999999988765432 23344678899
Q ss_pred ccHHhhcc
Q 010401 501 LAPEVCFL 508 (511)
Q Consensus 501 mAPEvl~g 508 (511)
+|||++.+
T Consensus 159 ~~PE~~~~ 166 (262)
T cd05572 159 VAPEIILN 166 (262)
T ss_pred cChhHhcC
Confidence 99999754
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.7e-23 Score=201.12 Aligned_cols=167 Identities=26% Similarity=0.395 Sum_probs=144.4
Q ss_pred CeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeC--CCcEEEE
Q 010401 341 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDE--NHGLCVV 412 (511)
Q Consensus 341 ~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~--~~~l~LV 412 (511)
+|++.+.||+|+||.||+| +.+++|++............+.+|+..+++++|+||+++++.+.+. +. ++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~-~~lv 79 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNT-LNIF 79 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCe-EEEE
Confidence 4788899999999999996 4689998875443334556789999999999999999999999877 44 8999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCC--c
Q 010401 413 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE--A 490 (511)
Q Consensus 413 mEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~--~ 490 (511)
|||+.+++|.+++.....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+........ .
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 159 (260)
T cd06606 80 LEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEG 159 (260)
T ss_pred EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccccc
Confidence 99999999999997777899999999999999999999999999999999999999999999999999887655432 1
Q ss_pred cccccCCCccccHHhhcc
Q 010401 491 TEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 491 ~~~~~Gt~~YmAPEvl~g 508 (511)
.....++..|+|||.+.+
T Consensus 160 ~~~~~~~~~y~~pE~~~~ 177 (260)
T cd06606 160 TGSVRGTPYWMAPEVIRG 177 (260)
T ss_pred ccCCCCCccccCHhhhcC
Confidence 345678889999998764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.7e-24 Score=211.64 Aligned_cols=165 Identities=24% Similarity=0.344 Sum_probs=138.0
Q ss_pred eEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEEec
Q 010401 342 LEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKL 415 (511)
Q Consensus 342 y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVmEy 415 (511)
|++.+.||.|++|.||+| +.+++|++............+.+|+..++.++||||+++++++.+++. .|++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~-~~iv~e~ 79 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENK-LYLVFEF 79 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCe-EEEEEec
Confidence 567899999999999996 468999887543333334557889999999999999999999988765 9999999
Q ss_pred cCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCcccc
Q 010401 416 MEGGSVNDLILKSR--KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY 493 (511)
Q Consensus 416 ~~gGsL~~lL~~~~--~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~~~ 493 (511)
+. ++|.+++.... .+++..+..++.||+.||+|||+++++||||+|+||+++.++.++|+|||+++...........
T Consensus 80 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~ 158 (283)
T cd07835 80 LD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTH 158 (283)
T ss_pred cC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccccCc
Confidence 95 59999986654 7899999999999999999999999999999999999999999999999998765433322333
Q ss_pred ccCCCccccHHhhcc
Q 010401 494 ETDGYRWLAPEVCFL 508 (511)
Q Consensus 494 ~~Gt~~YmAPEvl~g 508 (511)
..+++.|+|||++.+
T Consensus 159 ~~~~~~~~aPE~~~~ 173 (283)
T cd07835 159 EVVTLWYRAPEILLG 173 (283)
T ss_pred cccccCCCCCceeec
Confidence 456788999998754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=7e-24 Score=209.96 Aligned_cols=159 Identities=25% Similarity=0.364 Sum_probs=133.3
Q ss_pred eecccceEEEEe------EEEEEEEEecCCCC-chHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEEeccCCCC
Q 010401 348 IGPNSFKGVYKG------KRVGIEKLKGCDKG-NAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGS 420 (511)
Q Consensus 348 LG~GsFG~VYkg------k~VAVKkL~~~~~~-~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVmEy~~gGs 420 (511)
||+|+||.||++ +.+++|.+...... ......+.+|+.+++.++||||+++++++...+. +|+||||+++++
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-~~lv~e~~~~~~ 79 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDD-LCLVMTLMNGGD 79 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCe-EEEEEecCCCCc
Confidence 699999999985 57999988643221 2233446789999999999999999999987775 999999999999
Q ss_pred HHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCccccccCCC
Q 010401 421 VNDLILKSR--KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY 498 (511)
Q Consensus 421 L~~lL~~~~--~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~~~~~Gt~ 498 (511)
|.+++.+.. .+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++..... ........++.
T Consensus 80 L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~ 158 (277)
T cd05577 80 LKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG-GKKIKGRAGTP 158 (277)
T ss_pred HHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhcc-CCccccccCCC
Confidence 999997654 799999999999999999999999999999999999999999999999999876543 22223345778
Q ss_pred ccccHHhhcc
Q 010401 499 RWLAPEVCFL 508 (511)
Q Consensus 499 ~YmAPEvl~g 508 (511)
.|+|||++.+
T Consensus 159 ~y~~PE~~~~ 168 (277)
T cd05577 159 GYMAPEVLQG 168 (277)
T ss_pred CcCCHHHhcC
Confidence 8999999765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.8e-24 Score=209.08 Aligned_cols=168 Identities=22% Similarity=0.289 Sum_probs=141.8
Q ss_pred CCeEEEeeeecccceEEEEe------EEEEEEEEecCCC-CchHHHHHHHHHHHHHhCC-CCceeeEeeeEeeCCCcEEE
Q 010401 340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDK-GNAYEFELRKDLLELMTCG-HKNILQFYCVCVDENHGLCV 411 (511)
Q Consensus 340 ~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~-~~~~~~~~~~Ei~iL~~l~-HpNIV~l~g~~~~~~~~l~L 411 (511)
++|.+.+.||+|+||.||++ +.+++|.+..... .......+.+|+.++.+++ ||||+++++++.+++. +++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~-~~l 79 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEEN-LYF 79 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCce-EEE
Confidence 47899999999999999986 4689998864222 2233456788899999998 9999999999987765 999
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCC---
Q 010401 412 VTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG--- 488 (511)
Q Consensus 412 VmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~--- 488 (511)
+|||+.+++|.+++.+.+.+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~ 159 (280)
T cd05581 80 VLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPE 159 (280)
T ss_pred EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCccccc
Confidence 99999999999999887789999999999999999999999999999999999999999999999999987654322
Q ss_pred -----------------CccccccCCCccccHHhhcc
Q 010401 489 -----------------EATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 489 -----------------~~~~~~~Gt~~YmAPEvl~g 508 (511)
.......++..|+|||++.+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~ 196 (280)
T cd05581 160 SNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNE 196 (280)
T ss_pred cCCCCCccccccccccccccccccCCccccCHHHhCC
Confidence 11223456788999998754
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2e-25 Score=253.67 Aligned_cols=168 Identities=24% Similarity=0.364 Sum_probs=145.0
Q ss_pred CeEEEeeeecccceEEEE------eEEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEEe
Q 010401 341 NLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTK 414 (511)
Q Consensus 341 ~y~l~~~LG~GsFG~VYk------gk~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVmE 414 (511)
++.....||.|.||.||. |...|+|.++.+.........+.+|..++..++|||+|++||+-...+. ++|.||
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRek-v~IFME 1314 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREK-VYIFME 1314 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHH-HHHHHH
Confidence 356668899999999998 4678999887655544444567899999999999999999999887776 899999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCc----
Q 010401 415 LMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA---- 490 (511)
Q Consensus 415 y~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~---- 490 (511)
||.+|+|.+++...+-.++.....|..|++.|+.|||++|||||||||.||+++.+|.+|+.|||.|..+..+-+.
T Consensus 1315 yC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~e 1394 (1509)
T KOG4645|consen 1315 YCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGE 1394 (1509)
T ss_pred HhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcCCHH
Confidence 9999999999977777888888999999999999999999999999999999999999999999999887654321
Q ss_pred cccccCCCccccHHhhccc
Q 010401 491 TEYETDGYRWLAPEVCFLL 509 (511)
Q Consensus 491 ~~~~~Gt~~YmAPEvl~gl 509 (511)
.....||+.|||||++.|.
T Consensus 1395 l~~~~GT~~YMAPEvit~t 1413 (1509)
T KOG4645|consen 1395 LQSMMGTPMYMAPEVITGT 1413 (1509)
T ss_pred HHhhcCCchhcCchhhccc
Confidence 2345799999999999864
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.7e-24 Score=209.93 Aligned_cols=159 Identities=23% Similarity=0.292 Sum_probs=128.9
Q ss_pred eeecccceEEEEe------EEEEEEEEecCCCC-chHHHHHHHHH---HHHHhCCCCceeeEeeeEeeCCCcEEEEEecc
Q 010401 347 QIGPNSFKGVYKG------KRVGIEKLKGCDKG-NAYEFELRKDL---LELMTCGHKNILQFYCVCVDENHGLCVVTKLM 416 (511)
Q Consensus 347 ~LG~GsFG~VYkg------k~VAVKkL~~~~~~-~~~~~~~~~Ei---~iL~~l~HpNIV~l~g~~~~~~~~l~LVmEy~ 416 (511)
.||+|+||.||++ +.||+|.+...... ......+..|. ..+...+||||+.+++++.+.+. +|+||||+
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~-~~~v~e~~ 79 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK-LSFILDLM 79 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCE-EEEEEecC
Confidence 4899999999985 47999998643222 11122233333 33444689999999999987775 99999999
Q ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCccccccC
Q 010401 417 EGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETD 496 (511)
Q Consensus 417 ~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~~~~~G 496 (511)
.+|+|.+++...+.+++..+..++.|++.||.|||+.+|+||||||+||+++.++.+||+|||++...... ......|
T Consensus 80 ~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~--~~~~~~~ 157 (278)
T cd05606 80 NGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPHASVG 157 (278)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc--CCcCcCC
Confidence 99999999977778999999999999999999999999999999999999999999999999998765432 2234578
Q ss_pred CCccccHHhhcc
Q 010401 497 GYRWLAPEVCFL 508 (511)
Q Consensus 497 t~~YmAPEvl~g 508 (511)
+..|+|||++.+
T Consensus 158 ~~~y~aPE~~~~ 169 (278)
T cd05606 158 THGYMAPEVLQK 169 (278)
T ss_pred CcCCcCcHHhcC
Confidence 999999999863
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.6e-24 Score=212.27 Aligned_cols=170 Identities=19% Similarity=0.359 Sum_probs=139.2
Q ss_pred cCCCeEEEeeeecccceEEEEeE------EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCC-----
Q 010401 338 NSDNLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN----- 406 (511)
Q Consensus 338 ~~~~y~l~~~LG~GsFG~VYkgk------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~----- 406 (511)
..++|++.+.||+|+||.||+|. .|++|+++...........+.+|+.+++.++||||+++++++.+..
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~ 84 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF 84 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence 45688999999999999999964 6899998754333333455778999999999999999999987654
Q ss_pred ----CcEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCc
Q 010401 407 ----HGLCVVTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIV 481 (511)
Q Consensus 407 ----~~l~LVmEy~~gGsL~~lL~~~-~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS 481 (511)
..+|+||||+++ ++..++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++
T Consensus 85 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~~ 163 (302)
T cd07864 85 KKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLA 163 (302)
T ss_pred cccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCccccc
Confidence 238999999986 777777543 47899999999999999999999999999999999999999999999999998
Q ss_pred eecccCCC-ccccccCCCccccHHhhcc
Q 010401 482 TACKSVGE-ATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 482 ~~l~~~~~-~~~~~~Gt~~YmAPEvl~g 508 (511)
........ ......++..|+|||++.+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~ 191 (302)
T cd07864 164 RLYNSEESRPYTNKVITLWYRPPELLLG 191 (302)
T ss_pred ccccCCcccccccceeccCccChHHhcC
Confidence 76644332 1223355778999998754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.6e-24 Score=209.23 Aligned_cols=167 Identities=25% Similarity=0.420 Sum_probs=137.3
Q ss_pred cCCCeEEEeeeecccceEEEEeE------EEEEEEEecCCCCchHHHHHHHHHHHHHhC-CCCceeeEeeeEeeC-----
Q 010401 338 NSDNLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCVCVDE----- 405 (511)
Q Consensus 338 ~~~~y~l~~~LG~GsFG~VYkgk------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l-~HpNIV~l~g~~~~~----- 405 (511)
..+.|++.+.||.|+||.||+|+ .+++|.+... ......+..|+.++.++ +|+||+++++++...
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~---~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 90 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT---EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGH 90 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC---hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCC
Confidence 34678889999999999999964 6888887532 22334577888888887 799999999998632
Q ss_pred CCcEEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCcee
Q 010401 406 NHGLCVVTKLMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTA 483 (511)
Q Consensus 406 ~~~l~LVmEy~~gGsL~~lL~~~--~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~ 483 (511)
...+|++|||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++..
T Consensus 91 ~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~ 170 (282)
T cd06636 91 DDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 170 (282)
T ss_pred CCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhh
Confidence 23489999999999999998643 4588889999999999999999999999999999999999999999999999876
Q ss_pred cccCCCccccccCCCccccHHhhc
Q 010401 484 CKSVGEATEYETDGYRWLAPEVCF 507 (511)
Q Consensus 484 l~~~~~~~~~~~Gt~~YmAPEvl~ 507 (511)
............|++.|+|||++.
T Consensus 171 ~~~~~~~~~~~~~~~~y~aPE~l~ 194 (282)
T cd06636 171 LDRTVGRRNTFIGTPYWMAPEVIA 194 (282)
T ss_pred hhccccCCCcccccccccCHhhcC
Confidence 543322334456889999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.4e-23 Score=199.25 Aligned_cols=164 Identities=27% Similarity=0.502 Sum_probs=142.0
Q ss_pred CeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEEe
Q 010401 341 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTK 414 (511)
Q Consensus 341 ~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVmE 414 (511)
+|++.+.||+|+||.||++ +.+++|++..... .....+.+|+..+..++|+||+++++.+...+. .++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-~~l~~e 77 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDE-LWIVME 77 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCe-EEEEEe
Confidence 4788899999999999996 4688999864322 345668899999999999999999999987765 999999
Q ss_pred ccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCcccc
Q 010401 415 LMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY 493 (511)
Q Consensus 415 y~~gGsL~~lL~~~-~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~~~ 493 (511)
|+++++|.+++... ..+++..+..++.|++.||.|||.+|++||||+|+||+++.++.++|+|||++........ ...
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~~ 156 (253)
T cd05122 78 FCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-RNT 156 (253)
T ss_pred cCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc-ccc
Confidence 99999999999765 5899999999999999999999999999999999999999999999999999877654322 345
Q ss_pred ccCCCccccHHhhcc
Q 010401 494 ETDGYRWLAPEVCFL 508 (511)
Q Consensus 494 ~~Gt~~YmAPEvl~g 508 (511)
..++..|+|||++.+
T Consensus 157 ~~~~~~~~~PE~~~~ 171 (253)
T cd05122 157 MVGTPYWMAPEVING 171 (253)
T ss_pred eecCCcccCHHHHcC
Confidence 577889999999864
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-23 Score=209.52 Aligned_cols=164 Identities=25% Similarity=0.414 Sum_probs=138.7
Q ss_pred CeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEEe
Q 010401 341 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTK 414 (511)
Q Consensus 341 ~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVmE 414 (511)
.|...+.||+|+||.||++ +.+++|++.. ........+.+|+.+++.++||||+++++++...+. .|+++|
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~--~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~-~~~v~e 96 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDL--RKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDE-LWVVME 96 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEec--cchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCe-EEEEEe
Confidence 3455689999999999996 3589998863 222334557889999999999999999999987776 899999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCccccc
Q 010401 415 LMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYE 494 (511)
Q Consensus 415 y~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~~~~ 494 (511)
|+++++|.+++.. .++++..+..++.|++.||+|||++||+||||+|+||+++.++.++|+|||++.............
T Consensus 97 ~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~ 175 (285)
T cd06648 97 FLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSL 175 (285)
T ss_pred ccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCcccccc
Confidence 9999999999866 678999999999999999999999999999999999999999999999999977654333223345
Q ss_pred cCCCccccHHhhcc
Q 010401 495 TDGYRWLAPEVCFL 508 (511)
Q Consensus 495 ~Gt~~YmAPEvl~g 508 (511)
.|++.|+|||++.+
T Consensus 176 ~~~~~y~aPE~~~~ 189 (285)
T cd06648 176 VGTPYWMAPEVISR 189 (285)
T ss_pred cCCccccCHHHhcC
Confidence 68899999999865
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.7e-25 Score=221.76 Aligned_cols=170 Identities=21% Similarity=0.318 Sum_probs=144.3
Q ss_pred CCCeEEEeeeecccceEEEEe----------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCc
Q 010401 339 SDNLEFIDQIGPNSFKGVYKG----------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHG 408 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkg----------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~ 408 (511)
...|+.+..||+|.||.||++ +.+|+|+++..+..+....-.-+|+.+++.++||||+.+..+|...+..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 346899999999999999996 2589999987665555555578999999999999999999999875656
Q ss_pred EEEEEeccCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCC----CcEEEEecC
Q 010401 409 LCVVTKLMEGGSVNDLILK-----SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRH----GNVCLGDMG 479 (511)
Q Consensus 409 l~LVmEy~~gGsL~~lL~~-----~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~----g~vKL~DFG 479 (511)
+|+++||.+. +|..+|+- .+.++...+..|+.||+.|+.|||++=|+||||||.||||..+ |.|||+|||
T Consensus 103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlG 181 (438)
T KOG0666|consen 103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLG 181 (438)
T ss_pred EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeeccc
Confidence 9999999988 99998852 2468999999999999999999999999999999999999877 899999999
Q ss_pred CceecccCCCc---cccccCCCccccHHhhccc
Q 010401 480 IVTACKSVGEA---TEYETDGYRWLAPEVCFLL 509 (511)
Q Consensus 480 lS~~l~~~~~~---~~~~~Gt~~YmAPEvl~gl 509 (511)
+++.+.+.-+. .....-|+.|.|||+++|-
T Consensus 182 laR~~~~plkpl~s~d~VVVTiWYRAPELLLGa 214 (438)
T KOG0666|consen 182 LARLFNNPLKPLASLDPVVVTIWYRAPELLLGA 214 (438)
T ss_pred HHHHhhccccccccCCceEEEEEecChHHhccc
Confidence 99987654432 2334558899999999874
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.9e-24 Score=217.19 Aligned_cols=168 Identities=21% Similarity=0.314 Sum_probs=139.7
Q ss_pred CCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCC---CcEE
Q 010401 340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN---HGLC 410 (511)
Q Consensus 340 ~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~---~~l~ 410 (511)
++|++.+.||.|+||.||++ +.|++|++............+.+|+.++..++||||+++++++.... ..+|
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 67899999999999999985 47999998753333334456778999999999999999998875322 2389
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCc
Q 010401 411 VVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA 490 (511)
Q Consensus 411 LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~ 490 (511)
+||||+. ++|.+++...+.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.........
T Consensus 85 lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 163 (334)
T cd07855 85 VVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTE 163 (334)
T ss_pred EEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCcC
Confidence 9999996 599999877778999999999999999999999999999999999999999999999999998765432211
Q ss_pred ----cccccCCCccccHHhhcc
Q 010401 491 ----TEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 491 ----~~~~~Gt~~YmAPEvl~g 508 (511)
.....|+..|+|||++.+
T Consensus 164 ~~~~~~~~~~~~~y~~PE~~~~ 185 (334)
T cd07855 164 HKYFMTEYVATRWYRAPELLLS 185 (334)
T ss_pred CCcccccccccccccChHHhcC
Confidence 123467889999999754
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.2e-23 Score=205.76 Aligned_cols=166 Identities=21% Similarity=0.325 Sum_probs=138.4
Q ss_pred CCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCC-CcEEEE
Q 010401 340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN-HGLCVV 412 (511)
Q Consensus 340 ~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~-~~l~LV 412 (511)
++|+..+.||.|+||.||++ +.+++|.+.... ......++.+|+.+++.++||||++++++|.+.. ..+|+|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 79 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDP-NPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIA 79 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCC-chHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEE
Confidence 46899999999999999996 468999886432 2244566889999999999999999999986543 248999
Q ss_pred EeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCC
Q 010401 413 TKLMEGGSVNDLILK----SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG 488 (511)
Q Consensus 413 mEy~~gGsL~~lL~~----~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~ 488 (511)
|||+++++|.+++.. ...+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 159 (287)
T cd06621 80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL 159 (287)
T ss_pred EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccccccccc
Confidence 999999999988743 3468999999999999999999999999999999999999999999999999987553321
Q ss_pred CccccccCCCccccHHhhcc
Q 010401 489 EATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 489 ~~~~~~~Gt~~YmAPEvl~g 508 (511)
.....++..|+|||.+.+
T Consensus 160 --~~~~~~~~~y~~pE~~~~ 177 (287)
T cd06621 160 --AGTFTGTSFYMAPERIQG 177 (287)
T ss_pred --cccccCCccccCHHHhcC
Confidence 223456788999998764
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-23 Score=208.60 Aligned_cols=166 Identities=27% Similarity=0.479 Sum_probs=143.2
Q ss_pred CCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEE
Q 010401 339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV 412 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LV 412 (511)
.+.|+..+.||+|+||.||++ +.+++|++..... ....+.+|+..++.++|+||+++++.+...+. .|++
T Consensus 18 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-~~lv 93 (286)
T cd06614 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLVGDE-LWVV 93 (286)
T ss_pred cccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCE-EEEE
Confidence 456788899999999999996 4689999874332 45567899999999999999999999988875 9999
Q ss_pred EeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCcc
Q 010401 413 TKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT 491 (511)
Q Consensus 413 mEy~~gGsL~~lL~~~~-~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~ 491 (511)
+||+++++|.+++.... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++..........
T Consensus 94 ~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~ 173 (286)
T cd06614 94 MEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKR 173 (286)
T ss_pred EeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchhhh
Confidence 99999999999997765 89999999999999999999999999999999999999999999999999987654433333
Q ss_pred ccccCCCccccHHhhcc
Q 010401 492 EYETDGYRWLAPEVCFL 508 (511)
Q Consensus 492 ~~~~Gt~~YmAPEvl~g 508 (511)
....+++.|+|||++.+
T Consensus 174 ~~~~~~~~y~~PE~~~~ 190 (286)
T cd06614 174 NSVVGTPYWMAPEVIKR 190 (286)
T ss_pred ccccCCcccCCHhHhcC
Confidence 44567889999998764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-23 Score=206.45 Aligned_cols=166 Identities=20% Similarity=0.359 Sum_probs=138.5
Q ss_pred eEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeC-CCcEEEEEe
Q 010401 342 LEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDE-NHGLCVVTK 414 (511)
Q Consensus 342 y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~-~~~l~LVmE 414 (511)
|++.+.||.|+||.||++ +.+++|++............+.+|+.+++.++|+||+++++++.+. ...+++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 578899999999999996 5789999975432333445678899999999999999999999877 234999999
Q ss_pred ccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCC-ccc
Q 010401 415 LMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE-ATE 492 (511)
Q Consensus 415 y~~gGsL~~lL~~~-~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~-~~~ 492 (511)
|+++ +|.+++... ..+++..++.++.||+.||+|||+.|++|+||+|+||++++++.+||+|||++........ ...
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~ 159 (287)
T cd07840 81 YMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYT 159 (287)
T ss_pred cccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCccccc
Confidence 9975 899888654 5799999999999999999999999999999999999999999999999999887654321 123
Q ss_pred cccCCCccccHHhhcc
Q 010401 493 YETDGYRWLAPEVCFL 508 (511)
Q Consensus 493 ~~~Gt~~YmAPEvl~g 508 (511)
...++..|+|||.+.+
T Consensus 160 ~~~~~~~y~~PE~~~~ 175 (287)
T cd07840 160 NRVITLWYRPPELLLG 175 (287)
T ss_pred ccccccccCCceeeEc
Confidence 3456788999998654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.5e-23 Score=211.29 Aligned_cols=163 Identities=26% Similarity=0.378 Sum_probs=137.3
Q ss_pred CCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCC-chHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEE
Q 010401 339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKG-NAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCV 411 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~-~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~L 411 (511)
.+.|++.+.||+|+||.||+| +.|++|++...... ......+.+|+.+++.++||||++++++|.+++. .|+
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~-~~l 92 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHT-AWL 92 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCe-EEE
Confidence 345888899999999999996 46899988643322 2334568899999999999999999999998776 899
Q ss_pred EEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCc
Q 010401 412 VTKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA 490 (511)
Q Consensus 412 VmEy~~gGsL~~lL~~-~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~ 490 (511)
||||+.+ ++.+++.. ...+++..+..++.|++.||.|||++||+||||+|+||+++.++.++|+|||++.....
T Consensus 93 v~e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~---- 167 (307)
T cd06607 93 VMEYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSP---- 167 (307)
T ss_pred EHHhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCC----
Confidence 9999975 77777753 45799999999999999999999999999999999999999999999999999876533
Q ss_pred cccccCCCccccHHhhc
Q 010401 491 TEYETDGYRWLAPEVCF 507 (511)
Q Consensus 491 ~~~~~Gt~~YmAPEvl~ 507 (511)
.....+++.|+|||++.
T Consensus 168 ~~~~~~~~~y~aPE~~~ 184 (307)
T cd06607 168 ANSFVGTPYWMAPEVIL 184 (307)
T ss_pred CCCccCCccccCceeee
Confidence 23446788899999875
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.8e-23 Score=215.03 Aligned_cols=165 Identities=20% Similarity=0.311 Sum_probs=138.5
Q ss_pred CCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCC-----
Q 010401 339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENH----- 407 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~----- 407 (511)
.++|++.+.||+|+||.||++ +.||+|++............+.+|+.+++.++||||+++++++.....
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFH 93 (343)
T ss_pred ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccc
Confidence 567999999999999999996 469999986433333344567899999999999999999999876542
Q ss_pred cEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccC
Q 010401 408 GLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV 487 (511)
Q Consensus 408 ~l~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~ 487 (511)
.+++||||+ +++|.+++. ...+++..+..++.||+.||+|||++||+||||||+||+++.++.++|+|||++......
T Consensus 94 ~~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~ 171 (343)
T cd07880 94 DFYLVMPFM-GTDLGKLMK-HEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE 171 (343)
T ss_pred eEEEEEecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccccccccC
Confidence 258999999 679988875 457999999999999999999999999999999999999999999999999998765432
Q ss_pred CCccccccCCCccccHHhhcc
Q 010401 488 GEATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 488 ~~~~~~~~Gt~~YmAPEvl~g 508 (511)
.....+++.|+|||++.+
T Consensus 172 ---~~~~~~~~~y~aPE~~~~ 189 (343)
T cd07880 172 ---MTGYVVTRWYRAPEVILN 189 (343)
T ss_pred ---ccccccCCcccCHHHHhC
Confidence 233466888999999764
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-24 Score=232.33 Aligned_cols=169 Identities=20% Similarity=0.393 Sum_probs=148.1
Q ss_pred cceEecCCCeEEEeeeecccceEEEEeE------EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCC
Q 010401 333 GRWLLNSDNLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN 406 (511)
Q Consensus 333 ~~~~l~~~~y~l~~~LG~GsFG~VYkgk------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~ 406 (511)
++|++...++....+||-|-||.||.|. .||||.|+. ......+|++|..+|+.++|||+|+|+|+|..+.
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKE---DtMeveEFLkEAAvMKeikHpNLVqLLGVCT~Ep 336 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEP 336 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhh---cchhHHHHHHHHHHHHhhcCccHHHHhhhhccCC
Confidence 4899999999999999999999999984 589999963 3334567999999999999999999999999777
Q ss_pred CcEEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceec
Q 010401 407 HGLCVVTKLMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC 484 (511)
Q Consensus 407 ~~l~LVmEy~~gGsL~~lL~~~--~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l 484 (511)
. +|||+|||.+|+|.++|+.. ..++.-.++.++.||..||+||..+++|||||..+|+|+.++..||++|||+++.+
T Consensus 337 P-FYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlM 415 (1157)
T KOG4278|consen 337 P-FYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLM 415 (1157)
T ss_pred C-eEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhh
Confidence 5 99999999999999999753 35777888999999999999999999999999999999999999999999999988
Q ss_pred ccCCCccccccCC---CccccHHhhc
Q 010401 485 KSVGEATEYETDG---YRWLAPEVCF 507 (511)
Q Consensus 485 ~~~~~~~~~~~Gt---~~YmAPEvl~ 507 (511)
..+ ..+...|. +.|.|||-+.
T Consensus 416 tgD--TYTAHAGAKFPIKWTAPEsLA 439 (1157)
T KOG4278|consen 416 TGD--TYTAHAGAKFPIKWTAPESLA 439 (1157)
T ss_pred cCC--ceecccCccCcccccCccccc
Confidence 653 34455553 7899999763
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-23 Score=214.60 Aligned_cols=167 Identities=19% Similarity=0.326 Sum_probs=137.0
Q ss_pred CCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCC----Cc
Q 010401 339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN----HG 408 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~----~~ 408 (511)
.++|++.+.||+|+||.||+| +.||+|++.... .......+.+|+.+++.++|+||+++++++.... ..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE-HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 467999999999999999996 469999986422 2234455788999999999999999998876443 23
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCC
Q 010401 409 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG 488 (511)
Q Consensus 409 l~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~ 488 (511)
+|++|||+.+ +|.+++ ....+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++......
T Consensus 83 ~~lv~e~~~~-~l~~~~-~~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~ 160 (336)
T cd07849 83 VYIVQELMET-DLYKLI-KTQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEH 160 (336)
T ss_pred EEEEehhccc-CHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeeccccc
Confidence 7999999975 888887 44579999999999999999999999999999999999999999999999999987654322
Q ss_pred Cc---cccccCCCccccHHhhcc
Q 010401 489 EA---TEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 489 ~~---~~~~~Gt~~YmAPEvl~g 508 (511)
.. .....|++.|+|||++.+
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~ 183 (336)
T cd07849 161 DHTGFLTEYVATRWYRAPEIMLN 183 (336)
T ss_pred cccCCcCCcCcCCCccChHHhhC
Confidence 21 123467889999998754
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.7e-23 Score=202.54 Aligned_cols=165 Identities=25% Similarity=0.390 Sum_probs=141.6
Q ss_pred CeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEEe
Q 010401 341 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTK 414 (511)
Q Consensus 341 ~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVmE 414 (511)
+|++.+.||.|+||.||++ +.+++|++...........++.+|+.+++.++|+||+++++++.+... .|+|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-~~~v~e 79 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNK-LCIVME 79 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCE-EEEEeh
Confidence 4788999999999999986 468999987543344445567889999999999999999999987765 999999
Q ss_pred ccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCc
Q 010401 415 LMEGGSVNDLILK----SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA 490 (511)
Q Consensus 415 y~~gGsL~~lL~~----~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~ 490 (511)
|+++++|.+++.. ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++...... .
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~--~ 157 (256)
T cd08530 80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN--M 157 (256)
T ss_pred hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC--C
Confidence 9999999999855 356899999999999999999999999999999999999999999999999998776543 2
Q ss_pred cccccCCCccccHHhhcc
Q 010401 491 TEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 491 ~~~~~Gt~~YmAPEvl~g 508 (511)
.....+++.|+|||.+.+
T Consensus 158 ~~~~~~~~~~~~Pe~~~~ 175 (256)
T cd08530 158 AKTQIGTPHYMAPEVWKG 175 (256)
T ss_pred cccccCCccccCHHHHCC
Confidence 334567889999999865
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.91 E-value=2e-23 Score=205.01 Aligned_cols=167 Identities=21% Similarity=0.323 Sum_probs=134.2
Q ss_pred eEEEeeeecccceEEEEe---------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCC-----
Q 010401 342 LEFIDQIGPNSFKGVYKG---------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENH----- 407 (511)
Q Consensus 342 y~l~~~LG~GsFG~VYkg---------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~----- 407 (511)
|++.+.||+|+||.||+| +.+|+|.+...........++.+|+.+++.++||||+++++++.....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 567789999999999986 468999987544344455668899999999999999999998865431
Q ss_pred cEEEEEeccCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCc
Q 010401 408 GLCVVTKLMEGGSVNDLILKS------RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIV 481 (511)
Q Consensus 408 ~l~LVmEy~~gGsL~~lL~~~------~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS 481 (511)
..++++||+.+|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~ 160 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS 160 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECccccc
Confidence 147889999999999887422 24788999999999999999999999999999999999999999999999998
Q ss_pred eecccCCC--ccccccCCCccccHHhhcc
Q 010401 482 TACKSVGE--ATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 482 ~~l~~~~~--~~~~~~Gt~~YmAPEvl~g 508 (511)
+....... ......+++.|++||.+.+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 189 (273)
T cd05074 161 KKIYSGDYYRQGCASKLPVKWLALESLAD 189 (273)
T ss_pred ccccCCcceecCCCccCchhhcCHhHHhc
Confidence 86543221 1122334578999998753
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.1e-23 Score=202.36 Aligned_cols=161 Identities=23% Similarity=0.437 Sum_probs=132.8
Q ss_pred eeeecccceEEEEe-----EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEEeccCCCC
Q 010401 346 DQIGPNSFKGVYKG-----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGS 420 (511)
Q Consensus 346 ~~LG~GsFG~VYkg-----k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVmEy~~gGs 420 (511)
++||+|+||.||++ +.|++|.+...... .....+.+|+.+++.++|+||+++++++.+.+. .|+||||+.+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-~~~v~e~~~~~~ 78 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQP-IYIVMELVPGGS 78 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCC-eEEEEEcCCCCc
Confidence 46899999999985 46899988643322 345668899999999999999999999988776 999999999999
Q ss_pred HHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCc--cccccCC
Q 010401 421 VNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA--TEYETDG 497 (511)
Q Consensus 421 L~~lL~~-~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~--~~~~~Gt 497 (511)
|.+++.. ...+++..+..++.+++.||.|||+++++||||||+||+++.++.+||+|||++......... .....++
T Consensus 79 l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~ 158 (251)
T cd05041 79 LLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIP 158 (251)
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcce
Confidence 9999865 356889999999999999999999999999999999999999999999999998765421111 1112234
Q ss_pred CccccHHhhcc
Q 010401 498 YRWLAPEVCFL 508 (511)
Q Consensus 498 ~~YmAPEvl~g 508 (511)
..|+|||++.+
T Consensus 159 ~~y~~PE~~~~ 169 (251)
T cd05041 159 IKWTAPEALNY 169 (251)
T ss_pred eccCChHhhcc
Confidence 57999998764
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-24 Score=204.48 Aligned_cols=166 Identities=20% Similarity=0.355 Sum_probs=143.8
Q ss_pred CeEEEeeeecccceEEEEeE------EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEEe
Q 010401 341 NLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTK 414 (511)
Q Consensus 341 ~y~l~~~LG~GsFG~VYkgk------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVmE 414 (511)
+|.-.++||+|.||+||+++ .||+|.++-.+..+..-....+||-+++.+.|.|||+++++...++. +-+|+|
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkk-ltlvfe 81 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKK-LTLVFE 81 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCce-eEEeHH
Confidence 35556889999999999974 79999998655544444567899999999999999999999998876 999999
Q ss_pred ccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCcccc
Q 010401 415 LMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY 493 (511)
Q Consensus 415 y~~gGsL~~lL~~-~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~~~ 493 (511)
||.. +|..+..+ ++.++.+.++.++.|+++||.|+|++++.||||||.|+||+.+|++|++|||+++.++-+-.-...
T Consensus 82 ~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvrcysa 160 (292)
T KOG0662|consen 82 FCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSA 160 (292)
T ss_pred HhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEeeec
Confidence 9966 99999865 578999999999999999999999999999999999999999999999999999987654444556
Q ss_pred ccCCCccccHHhhcc
Q 010401 494 ETDGYRWLAPEVCFL 508 (511)
Q Consensus 494 ~~Gt~~YmAPEvl~g 508 (511)
..-|..|.+|.++.|
T Consensus 161 evvtlwyrppdvlfg 175 (292)
T KOG0662|consen 161 EVVTLWYRPPDVLFG 175 (292)
T ss_pred eeeeeeccCcceeee
Confidence 667888999998876
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.91 E-value=1e-23 Score=204.40 Aligned_cols=160 Identities=18% Similarity=0.291 Sum_probs=134.7
Q ss_pred eecccceEEEEe------EEEEEEEEecCCCC-chHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEEeccCCCC
Q 010401 348 IGPNSFKGVYKG------KRVGIEKLKGCDKG-NAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGS 420 (511)
Q Consensus 348 LG~GsFG~VYkg------k~VAVKkL~~~~~~-~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVmEy~~gGs 420 (511)
||.|+||.||++ +.+++|.+...... ......+.+|+.++.+++||||+++++.+..++. .|++|||+++++
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~-~~lv~e~~~~~~ 79 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKN-LYLVMEYLPGGD 79 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcE-EEEEEecCCCCc
Confidence 689999999995 46899988643221 2344568889999999999999999999887665 999999999999
Q ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCC--------ccc
Q 010401 421 VNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE--------ATE 492 (511)
Q Consensus 421 L~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~--------~~~ 492 (511)
|.+++.+.+.+++..+..++.||+.||.|||++|++||||+|+||+++.++.++|+|||++........ ...
T Consensus 80 L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~ 159 (265)
T cd05579 80 LASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDK 159 (265)
T ss_pred HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccccccc
Confidence 999998777899999999999999999999999999999999999999999999999999876543321 223
Q ss_pred cccCCCccccHHhhcc
Q 010401 493 YETDGYRWLAPEVCFL 508 (511)
Q Consensus 493 ~~~Gt~~YmAPEvl~g 508 (511)
...++..|+|||++..
T Consensus 160 ~~~~~~~~~~Pe~~~~ 175 (265)
T cd05579 160 RIVGTPDYIAPEVILG 175 (265)
T ss_pred CcccCccccCHHHhcC
Confidence 4467788999998754
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.1e-23 Score=207.46 Aligned_cols=167 Identities=19% Similarity=0.295 Sum_probs=139.5
Q ss_pred CeEEEeeeecccceEEEEe---------EEEEEEEEecCCCC--chHHHHHHHHHHHHHhC-CCCceeeEeeeEeeCCCc
Q 010401 341 NLEFIDQIGPNSFKGVYKG---------KRVGIEKLKGCDKG--NAYEFELRKDLLELMTC-GHKNILQFYCVCVDENHG 408 (511)
Q Consensus 341 ~y~l~~~LG~GsFG~VYkg---------k~VAVKkL~~~~~~--~~~~~~~~~Ei~iL~~l-~HpNIV~l~g~~~~~~~~ 408 (511)
+|++.+.||+|+||.||++ +.+|+|.++..... ......+.+|+.++..+ +||||+++++.+..++.
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~- 79 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTK- 79 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCE-
Confidence 4788999999999999985 35889988643221 12334577899999999 69999999999887765
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCC
Q 010401 409 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG 488 (511)
Q Consensus 409 l~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~ 488 (511)
+|+||||+.+|+|.+++.....+++..+..++.|++.||.|||+.+++||||+|+||+++.++.++|+|||+++......
T Consensus 80 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 159 (288)
T cd05583 80 LHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEE 159 (288)
T ss_pred EEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECcccccccccc
Confidence 89999999999999999777789999999999999999999999999999999999999999999999999987654332
Q ss_pred Cc-cccccCCCccccHHhhcc
Q 010401 489 EA-TEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 489 ~~-~~~~~Gt~~YmAPEvl~g 508 (511)
.. .....|+..|+|||.+.+
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~ 180 (288)
T cd05583 160 EERAYSFCGTIEYMAPEVIRG 180 (288)
T ss_pred ccccccccCCccccCHHHhcC
Confidence 21 223467889999999764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=2e-23 Score=203.98 Aligned_cols=159 Identities=20% Similarity=0.308 Sum_probs=130.1
Q ss_pred eeeecccceEEEEe------EEEEEEEEecCCCCc-hHHHHHHHHHHHH-HhCCCCceeeEeeeEeeCCCcEEEEEeccC
Q 010401 346 DQIGPNSFKGVYKG------KRVGIEKLKGCDKGN-AYEFELRKDLLEL-MTCGHKNILQFYCVCVDENHGLCVVTKLME 417 (511)
Q Consensus 346 ~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~-~~~~~~~~Ei~iL-~~l~HpNIV~l~g~~~~~~~~l~LVmEy~~ 417 (511)
+.||.|+||.||++ +.+|+|.+....... .....+..|..++ ...+|+||+++++++...+. +|++|||++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~-~~lv~e~~~ 80 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDY-LYLVMEYLN 80 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCe-EEEEEeccC
Confidence 56899999999995 469999886432211 1122234444333 44589999999999987765 999999999
Q ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCccccccCC
Q 010401 418 GGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG 497 (511)
Q Consensus 418 gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~~~~~Gt 497 (511)
+++|.+++...+.+++..+..++.||+.||.|||+++++||||+|+||+++.++.++|+|||+++.... .....++
T Consensus 81 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----~~~~~~~ 156 (260)
T cd05611 81 GGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----NKKFVGT 156 (260)
T ss_pred CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc----cccCCCC
Confidence 999999998778899999999999999999999999999999999999999999999999999876433 2344678
Q ss_pred CccccHHhhccc
Q 010401 498 YRWLAPEVCFLL 509 (511)
Q Consensus 498 ~~YmAPEvl~gl 509 (511)
+.|+|||.+.+.
T Consensus 157 ~~y~~pe~~~~~ 168 (260)
T cd05611 157 PDYLAPETILGV 168 (260)
T ss_pred cCccChhhhcCC
Confidence 899999998653
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2e-24 Score=217.12 Aligned_cols=160 Identities=24% Similarity=0.419 Sum_probs=136.4
Q ss_pred eeeecccceEEEE------eEEEEEEEEecCCCCchHHHHHHHHHHHHHhC-CCCceeeEeeeEeeCCCcEEEEEeccCC
Q 010401 346 DQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCVCVDENHGLCVVTKLMEG 418 (511)
Q Consensus 346 ~~LG~GsFG~VYk------gk~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l-~HpNIV~l~g~~~~~~~~l~LVmEy~~g 418 (511)
+.||+|+|+.|-. |+.+|||++.+. ......++.+|+.++..+ .|+||++|+++|+++.. +|+|||-|.|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq--~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~-FYLVfEKm~G 160 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ--PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTR-FYLVFEKMRG 160 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcC--CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccce-EEEEEecccC
Confidence 5799999999865 568999999743 445677899999999998 79999999999998886 9999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCc---EEEEecCCceecccCCC------
Q 010401 419 GSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGN---VCLGDMGIVTACKSVGE------ 489 (511)
Q Consensus 419 GsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~---vKL~DFGlS~~l~~~~~------ 489 (511)
|.|..+|.+...+++.++.++..+|+.||.|||.+||.||||||+|||-.+.+. ||||||.+...+.....
T Consensus 161 GplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spast 240 (463)
T KOG0607|consen 161 GPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPAST 240 (463)
T ss_pred chHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCC
Confidence 999999999999999999999999999999999999999999999999976554 79999998654432211
Q ss_pred -ccccccCCCccccHHhhcc
Q 010401 490 -ATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 490 -~~~~~~Gt~~YmAPEvl~g 508 (511)
.....+|+-.|||||++..
T Consensus 241 P~L~tPvGSAEfMAPEVVd~ 260 (463)
T KOG0607|consen 241 PELLTPVGSAEFMAPEVVDV 260 (463)
T ss_pred ccccCcccchhhcchhHHhh
Confidence 1234467789999999753
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.2e-23 Score=212.18 Aligned_cols=169 Identities=20% Similarity=0.298 Sum_probs=139.8
Q ss_pred eEecCCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCc
Q 010401 335 WLLNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHG 408 (511)
Q Consensus 335 ~~l~~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~ 408 (511)
.....++|++.+.||.|+||.||++ +.+++|++............+.+|+.++..++||||++++++|...+..
T Consensus 5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 84 (328)
T cd07856 5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED 84 (328)
T ss_pred eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence 3445778999999999999999996 4689998864333333445678899999999999999999998765545
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCC
Q 010401 409 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG 488 (511)
Q Consensus 409 l~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~ 488 (511)
.|++|||+ +++|.+++. ...+++..+..++.||+.||.|||+++|+||||+|+||+++.++.++|+|||+++....
T Consensus 85 ~~lv~e~~-~~~L~~~~~-~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~-- 160 (328)
T cd07856 85 IYFVTELL-GTDLHRLLT-SRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDP-- 160 (328)
T ss_pred EEEEeehh-ccCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCC--
Confidence 89999999 558988874 35688899999999999999999999999999999999999999999999999875432
Q ss_pred CccccccCCCccccHHhhcc
Q 010401 489 EATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 489 ~~~~~~~Gt~~YmAPEvl~g 508 (511)
......++..|+|||++.+
T Consensus 161 -~~~~~~~~~~y~aPE~~~~ 179 (328)
T cd07856 161 -QMTGYVSTRYYRAPEIMLT 179 (328)
T ss_pred -CcCCCcccccccCceeeec
Confidence 1233456788999998754
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.7e-23 Score=211.09 Aligned_cols=167 Identities=20% Similarity=0.295 Sum_probs=136.2
Q ss_pred CeEEEeeeecccceEEEEeE--------EEEEEEEecCCCCchHHHHHHHHHHHHHhC-CCCceeeEeeeEeeC---CCc
Q 010401 341 NLEFIDQIGPNSFKGVYKGK--------RVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCVCVDE---NHG 408 (511)
Q Consensus 341 ~y~l~~~LG~GsFG~VYkgk--------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l-~HpNIV~l~g~~~~~---~~~ 408 (511)
+|++.+.||+|+||.||+++ .+|+|++............+.+|+.+++++ +||||+++++.+... ...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 47889999999999999964 589998864333333445678899999988 699999999875432 123
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCC
Q 010401 409 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG 488 (511)
Q Consensus 409 l~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~ 488 (511)
+|++|+|+. ++|.+.+.....+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||+++.+....
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~ 159 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENP 159 (332)
T ss_pred EEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceeccccc
Confidence 789999986 5999998777889999999999999999999999999999999999999999999999999998664322
Q ss_pred C----ccccccCCCccccHHhhcc
Q 010401 489 E----ATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 489 ~----~~~~~~Gt~~YmAPEvl~g 508 (511)
. ......|+..|+|||++.+
T Consensus 160 ~~~~~~~~~~~g~~~y~aPE~~~~ 183 (332)
T cd07857 160 GENAGFMTEYVATRWYRAPEIMLS 183 (332)
T ss_pred ccccccccCcccCccccCcHHHhC
Confidence 1 1223468889999998754
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.6e-23 Score=209.09 Aligned_cols=169 Identities=20% Similarity=0.369 Sum_probs=136.4
Q ss_pred CCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCC-----
Q 010401 339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENH----- 407 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~----- 407 (511)
.++|++.+.||.|+||.||++ +.+++|++............+.+|+.+++.++||||+++++++.+...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 578999999999999999996 468999886433333233456789999999999999999998765433
Q ss_pred --cEEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceec
Q 010401 408 --GLCVVTKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC 484 (511)
Q Consensus 408 --~l~LVmEy~~gGsL~~lL~~-~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l 484 (511)
.+|+||||+.+ +|...+.. ...+++..+..++.||+.||.|||++||+||||||+||++++++.++|+|||+++..
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 165 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPY 165 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchhc
Confidence 27999999976 77777654 457999999999999999999999999999999999999999999999999998765
Q ss_pred ccCCCc-----------cccccCCCccccHHhhcc
Q 010401 485 KSVGEA-----------TEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 485 ~~~~~~-----------~~~~~Gt~~YmAPEvl~g 508 (511)
...... .....+++.|+|||++.+
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 200 (311)
T cd07866 166 DGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLG 200 (311)
T ss_pred cCCCcccccCCcccccccccceeccCcCChHHhhC
Confidence 432211 122345778999998764
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=9.5e-24 Score=214.17 Aligned_cols=168 Identities=20% Similarity=0.312 Sum_probs=142.2
Q ss_pred CeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCC----CcEE
Q 010401 341 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN----HGLC 410 (511)
Q Consensus 341 ~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~----~~l~ 410 (511)
+|++.+.||.|+||.||++ +.+++|++............+.+|+.+++.++|+||+++++++.... ..+|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4789999999999999996 46899998754332344566889999999999999999999988765 2389
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCC-
Q 010401 411 VVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE- 489 (511)
Q Consensus 411 LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~- 489 (511)
++|||+.+ +|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++........
T Consensus 81 lv~e~~~~-~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~ 159 (330)
T cd07834 81 IVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDE 159 (330)
T ss_pred EEecchhh-hHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeecccccc
Confidence 99999975 8999987777899999999999999999999999999999999999999999999999999887654331
Q ss_pred --ccccccCCCccccHHhhccc
Q 010401 490 --ATEYETDGYRWLAPEVCFLL 509 (511)
Q Consensus 490 --~~~~~~Gt~~YmAPEvl~gl 509 (511)
......++..|+|||++.+.
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~ 181 (330)
T cd07834 160 KGFLTEYVVTRWYRAPELLLSS 181 (330)
T ss_pred cccccccccccCcCCceeeecc
Confidence 23344678889999998654
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.3e-23 Score=204.03 Aligned_cols=161 Identities=23% Similarity=0.312 Sum_probs=131.9
Q ss_pred eEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhC-CCCceeeEeeeEeeC--CCcEEEE
Q 010401 342 LEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCVCVDE--NHGLCVV 412 (511)
Q Consensus 342 y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l-~HpNIV~l~g~~~~~--~~~l~LV 412 (511)
|++.+.||+|+||.||++ +.+|+|+++...... ......+|+..+.++ +|+||+++++++.+. +. +++|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~-~~lv 78 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSL-EQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGR-LALV 78 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCc-hhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCc-EEEE
Confidence 578899999999999996 468999886432222 223345788888887 499999999999876 54 8999
Q ss_pred EeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCcc
Q 010401 413 TKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT 491 (511)
Q Consensus 413 mEy~~gGsL~~lL~~-~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~ 491 (511)
|||+.+ +|.+.+.. ...+++..+..++.||+.||+|||++|++||||||+||+++. +.+||+|||+++....... .
T Consensus 79 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~-~ 155 (282)
T cd07831 79 FELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP-Y 155 (282)
T ss_pred EecCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCCC-c
Confidence 999975 88888765 357899999999999999999999999999999999999999 9999999999886643322 2
Q ss_pred ccccCCCccccHHhhc
Q 010401 492 EYETDGYRWLAPEVCF 507 (511)
Q Consensus 492 ~~~~Gt~~YmAPEvl~ 507 (511)
....++..|+|||++.
T Consensus 156 ~~~~~~~~y~aPE~~~ 171 (282)
T cd07831 156 TEYISTRWYRAPECLL 171 (282)
T ss_pred CCCCCCcccCChhHhh
Confidence 3345788999999864
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2e-25 Score=234.51 Aligned_cols=170 Identities=21% Similarity=0.284 Sum_probs=149.4
Q ss_pred ecCCCeEEEeeeecccceEEEEeE----E--EEEEEEecCCCCc-hHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcE
Q 010401 337 LNSDNLEFIDQIGPNSFKGVYKGK----R--VGIEKLKGCDKGN-AYEFELRKDLLELMTCGHKNILQFYCVCVDENHGL 409 (511)
Q Consensus 337 l~~~~y~l~~~LG~GsFG~VYkgk----~--VAVKkL~~~~~~~-~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l 409 (511)
+...+++.+..||-|+||.|-+.+ . +|+|.+++....+ .....+..|-.+|+.++.|+||++|..|.+.+. +
T Consensus 417 v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~ky-v 495 (732)
T KOG0614|consen 417 VKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKY-V 495 (732)
T ss_pred cchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchh-h
Confidence 456788899999999999998743 2 6777776544333 334457889999999999999999999998876 9
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCC
Q 010401 410 CVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE 489 (511)
Q Consensus 410 ~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~ 489 (511)
||+||-|-||.|...+++++.+++..+++|+..++.|++|||++|||+|||||+|++++.+|.+||.|||+|+.+....+
T Consensus 496 YmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~K 575 (732)
T KOG0614|consen 496 YMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRK 575 (732)
T ss_pred hhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccCCc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999877544
Q ss_pred ccccccCCCccccHHhhcc
Q 010401 490 ATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 490 ~~~~~~Gt~~YmAPEvl~g 508 (511)
+-..|||+.|.|||+++.
T Consensus 576 -TwTFcGTpEYVAPEIILn 593 (732)
T KOG0614|consen 576 -TWTFCGTPEYVAPEIILN 593 (732)
T ss_pred -eeeecCCcccccchhhhc
Confidence 667899999999999874
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.9e-23 Score=212.04 Aligned_cols=166 Identities=17% Similarity=0.303 Sum_probs=137.1
Q ss_pred cCCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCC-----
Q 010401 338 NSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN----- 406 (511)
Q Consensus 338 ~~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~----- 406 (511)
..++|++.+.||+|+||.||++ +.||+|++............+.+|+.++.+++||||+++++++....
T Consensus 15 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (345)
T cd07877 15 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 94 (345)
T ss_pred ccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccc
Confidence 4578999999999999999996 46999998753333333455788999999999999999999886432
Q ss_pred CcEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceeccc
Q 010401 407 HGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS 486 (511)
Q Consensus 407 ~~l~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~ 486 (511)
...|++++++ +++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++....
T Consensus 95 ~~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~ 172 (345)
T cd07877 95 NDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 172 (345)
T ss_pred ccEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccccccc
Confidence 2278888887 6799888754 4689999999999999999999999999999999999999999999999999876532
Q ss_pred CCCccccccCCCccccHHhhcc
Q 010401 487 VGEATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 487 ~~~~~~~~~Gt~~YmAPEvl~g 508 (511)
......++..|+|||++.+
T Consensus 173 ---~~~~~~~~~~y~aPE~~~~ 191 (345)
T cd07877 173 ---EMTGYVATRWYRAPEIMLN 191 (345)
T ss_pred ---cccccccCCCccCHHHHhC
Confidence 2234467888999998754
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.3e-23 Score=204.20 Aligned_cols=161 Identities=27% Similarity=0.451 Sum_probs=130.3
Q ss_pred eeeecccceEEEEeE------------EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEE
Q 010401 346 DQIGPNSFKGVYKGK------------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT 413 (511)
Q Consensus 346 ~~LG~GsFG~VYkgk------------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVm 413 (511)
+.||+|+||.||+|+ .+++|.+... ........+.+|+.+++.++||||+++++++.+.+. .+++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~~v~ 78 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKG-ATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEP-QYIIM 78 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcc-cchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCC-eEEEE
Confidence 368999999999974 4677777532 222334568889999999999999999999987775 99999
Q ss_pred eccCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCC-----cEEEEecCCc
Q 010401 414 KLMEGGSVNDLILKS-------RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG-----NVCLGDMGIV 481 (511)
Q Consensus 414 Ey~~gGsL~~lL~~~-------~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g-----~vKL~DFGlS 481 (511)
||+++++|.+++... ..+++..+..++.|++.||.|||+.+++|+||||+||+++.++ .++|+|||++
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 999999999999642 2478899999999999999999999999999999999999887 8999999998
Q ss_pred eecccCCC--ccccccCCCccccHHhhcc
Q 010401 482 TACKSVGE--ATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 482 ~~l~~~~~--~~~~~~Gt~~YmAPEvl~g 508 (511)
+....... ......++..|+|||++.+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 187 (269)
T cd05044 159 RDIYKSDYYRKEGEGLLPVRWMAPESLLD 187 (269)
T ss_pred cccccccccccCcccCCCccccCHHHHcc
Confidence 76533211 1122344678999998764
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.3e-23 Score=212.41 Aligned_cols=164 Identities=20% Similarity=0.312 Sum_probs=135.1
Q ss_pred EEEeeeecccceEEEEe------EEEEEEEEecCCCCch------------HHHHHHHHHHHHHhCCCCceeeEeeeEee
Q 010401 343 EFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNA------------YEFELRKDLLELMTCGHKNILQFYCVCVD 404 (511)
Q Consensus 343 ~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~------------~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~ 404 (511)
.+.+.||.|+||.||++ +.||+|++........ ....+.+|+.++..++|+||+++++++..
T Consensus 12 ~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 91 (335)
T PTZ00024 12 QKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVE 91 (335)
T ss_pred hhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEec
Confidence 45578999999999996 4689998864322210 12246789999999999999999999987
Q ss_pred CCCcEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceec
Q 010401 405 ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC 484 (511)
Q Consensus 405 ~~~~l~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l 484 (511)
++. +|++|||+. |+|.+++.....+++..+..++.|++.||+|||++||+||||+|+||+++.++.++|+|||+++..
T Consensus 92 ~~~-~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~~~~~ 169 (335)
T PTZ00024 92 GDF-INLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRY 169 (335)
T ss_pred CCc-EEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCccceeec
Confidence 775 999999997 599999977778999999999999999999999999999999999999999999999999998765
Q ss_pred ccC--------------CCccccccCCCccccHHhhcc
Q 010401 485 KSV--------------GEATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 485 ~~~--------------~~~~~~~~Gt~~YmAPEvl~g 508 (511)
... ........++..|+|||++.+
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 207 (335)
T PTZ00024 170 GYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMG 207 (335)
T ss_pred ccccccccccccccccccccccccccccCCCCChhccc
Confidence 411 111223346778999999865
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.1e-23 Score=209.74 Aligned_cols=162 Identities=23% Similarity=0.385 Sum_probs=136.7
Q ss_pred EEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEEecc
Q 010401 343 EFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLM 416 (511)
Q Consensus 343 ~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVmEy~ 416 (511)
.....||+|+||.||++ +.+++|++.. ........+.+|+.+++.++|+||+++++.+...+. .|++|||+
T Consensus 23 ~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~lv~e~~ 99 (292)
T cd06657 23 DNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDL--RKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDE-LWVVMEFL 99 (292)
T ss_pred hhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecc--cchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCE-EEEEEecC
Confidence 33478999999999985 5799998853 223345568899999999999999999999988776 99999999
Q ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCccccccC
Q 010401 417 EGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETD 496 (511)
Q Consensus 417 ~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~~~~~G 496 (511)
++++|.+++. ...+++..+..++.|++.||+|||++|++||||+|+||+++.++.++|+|||++..............|
T Consensus 100 ~~~~L~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 178 (292)
T cd06657 100 EGGALTDIVT-HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVG 178 (292)
T ss_pred CCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccccccccccccc
Confidence 9999999874 456899999999999999999999999999999999999999999999999998765443323344568
Q ss_pred CCccccHHhhcc
Q 010401 497 GYRWLAPEVCFL 508 (511)
Q Consensus 497 t~~YmAPEvl~g 508 (511)
++.|+|||++.+
T Consensus 179 ~~~y~~pE~~~~ 190 (292)
T cd06657 179 TPYWMAPELISR 190 (292)
T ss_pred CccccCHHHhcC
Confidence 889999998754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-23 Score=215.11 Aligned_cols=168 Identities=21% Similarity=0.311 Sum_probs=137.7
Q ss_pred CCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhC-CCCceeeEeeeEeeCC-CcEE
Q 010401 339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCVCVDEN-HGLC 410 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l-~HpNIV~l~g~~~~~~-~~l~ 410 (511)
.++|++.+.||+|+||.||+| +.+++|++............+.+|+.++..+ +||||++++++|...+ ..+|
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 457889999999999999996 4689998864333333344567899999999 9999999999986543 3489
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCC-
Q 010401 411 VVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE- 489 (511)
Q Consensus 411 LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~- 489 (511)
+||||+.+ +|..++... .+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++.......
T Consensus 86 lv~e~~~~-~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~ 163 (337)
T cd07852 86 LVFEYMET-DLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEEN 163 (337)
T ss_pred EEeccccc-CHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhcccccccc
Confidence 99999975 999988654 788999999999999999999999999999999999999999999999999876643221
Q ss_pred ----ccccccCCCccccHHhhcc
Q 010401 490 ----ATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 490 ----~~~~~~Gt~~YmAPEvl~g 508 (511)
......|++.|+|||++.+
T Consensus 164 ~~~~~~~~~~~~~~y~aPE~~~~ 186 (337)
T cd07852 164 PENPVLTDYVATRWYRAPEILLG 186 (337)
T ss_pred ccCcchhcccccccccCceeeec
Confidence 1223467889999998753
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.1e-23 Score=207.13 Aligned_cols=166 Identities=22% Similarity=0.330 Sum_probs=134.7
Q ss_pred CCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCC-CCceeeEeeeEeeCCCcEEE
Q 010401 339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCG-HKNILQFYCVCVDENHGLCV 411 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~-HpNIV~l~g~~~~~~~~l~L 411 (511)
.++|+..+.||+|+||.||++ +.+|+|++...... .....+.+|+.++.++. |+||+++++++..++. .++
T Consensus 3 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~-~~~ 80 (288)
T cd06616 3 AEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGD-CWI 80 (288)
T ss_pred HHHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCc-EEE
Confidence 346777889999999999985 47999998643322 34456788999999985 9999999999988776 899
Q ss_pred EEeccCCCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCceEEcCCCcEEEEecCCceecc
Q 010401 412 VTKLMEGGSVNDLIL-----KSRKLQTKEIIRIAIDVAEGIKFLND-HGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK 485 (511)
Q Consensus 412 VmEy~~gGsL~~lL~-----~~~~L~e~~~~~ia~qIa~gL~yLH~-~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~ 485 (511)
+|||+.. ++.++.. ....+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++...
T Consensus 81 ~~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 159 (288)
T cd06616 81 CMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159 (288)
T ss_pred EEecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence 9999865 6655432 23579999999999999999999997 599999999999999999999999999987654
Q ss_pred cCCCccccccCCCccccHHhhcc
Q 010401 486 SVGEATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 486 ~~~~~~~~~~Gt~~YmAPEvl~g 508 (511)
... ......|++.|+|||++.+
T Consensus 160 ~~~-~~~~~~~~~~y~aPE~~~~ 181 (288)
T cd06616 160 DSI-AKTRDAGCRPYMAPERIDP 181 (288)
T ss_pred cCC-ccccccCccCccCHHHhcc
Confidence 322 2234467889999999864
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.9e-23 Score=205.12 Aligned_cols=172 Identities=13% Similarity=0.177 Sum_probs=125.3
Q ss_pred ecCCCeEEEeeeecccceEEEEeE---------EEEEEEEecCCCCchHHH---------HHHHHHHHHHhCCCCceeeE
Q 010401 337 LNSDNLEFIDQIGPNSFKGVYKGK---------RVGIEKLKGCDKGNAYEF---------ELRKDLLELMTCGHKNILQF 398 (511)
Q Consensus 337 l~~~~y~l~~~LG~GsFG~VYkgk---------~VAVKkL~~~~~~~~~~~---------~~~~Ei~iL~~l~HpNIV~l 398 (511)
+..++|++.+.||+|+||.||+|+ .+++|+..........+. ....+...+..+.|+||+++
T Consensus 9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~ 88 (294)
T PHA02882 9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY 88 (294)
T ss_pred cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence 445789999999999999999974 234443321111111111 11222334456799999999
Q ss_pred eeeEeeCCCc---EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEE
Q 010401 399 YCVCVDENHG---LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCL 475 (511)
Q Consensus 399 ~g~~~~~~~~---l~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL 475 (511)
++.+...... .+++|+++.. ++.+++......++..+..++.|++.||.|||+++|+||||||+|||++.++.++|
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l 167 (294)
T PHA02882 89 YGCGSFKRCRMYYRFILLEKLVE-NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYI 167 (294)
T ss_pred EEeeeEecCCceEEEEEEehhcc-CHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEE
Confidence 9877655421 3678887754 77777765556788899999999999999999999999999999999999999999
Q ss_pred EecCCceecccCCC-------ccccccCCCccccHHhhccc
Q 010401 476 GDMGIVTACKSVGE-------ATEYETDGYRWLAPEVCFLL 509 (511)
Q Consensus 476 ~DFGlS~~l~~~~~-------~~~~~~Gt~~YmAPEvl~gl 509 (511)
+|||+|+.+..... ......||+.|+|||++.+.
T Consensus 168 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~ 208 (294)
T PHA02882 168 IDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGA 208 (294)
T ss_pred EEcCCceeeccCCcccccccccccccCCCccccCHHHhCCC
Confidence 99999987643221 12234689999999987653
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.3e-24 Score=226.00 Aligned_cols=168 Identities=23% Similarity=0.255 Sum_probs=142.5
Q ss_pred CCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCc-hHH-----HHHHHHHHHHHhCC---CCceeeEeeeEe
Q 010401 339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGN-AYE-----FELRKDLLELMTCG---HKNILQFYCVCV 403 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~-~~~-----~~~~~Ei~iL~~l~---HpNIV~l~g~~~ 403 (511)
..+|..++.+|.|+||+|+++ ..|.+|.|.+...-. .+. -.+-.||.+|..++ |+||++++++|+
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE 639 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence 446899999999999999996 368889887533211 111 12567999999997 999999999999
Q ss_pred eCCCcEEEEEecc-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCce
Q 010401 404 DENHGLCVVTKLM-EGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVT 482 (511)
Q Consensus 404 ~~~~~l~LVmEy~-~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~ 482 (511)
+++. +||+||-- ++-+|.++|.....++|.++..|+.||+.|+++||+.||||||||-+|+.++.+|.+||+|||.+.
T Consensus 640 ddd~-yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsaa 718 (772)
T KOG1152|consen 640 DDDY-YYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSAA 718 (772)
T ss_pred cCCe-eEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccchh
Confidence 8886 99999976 466999999888899999999999999999999999999999999999999999999999999987
Q ss_pred ecccCCCccccccCCCccccHHhhccc
Q 010401 483 ACKSVGEATEYETDGYRWLAPEVCFLL 509 (511)
Q Consensus 483 ~l~~~~~~~~~~~Gt~~YmAPEvl~gl 509 (511)
...+. .-....||..|.|||++.|-
T Consensus 719 ~~ksg--pfd~f~gtv~~aapevl~g~ 743 (772)
T KOG1152|consen 719 YTKSG--PFDVFVGTVDYAAPEVLGGE 743 (772)
T ss_pred hhcCC--CcceeeeeccccchhhhCCC
Confidence 65442 24567899999999999863
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=3e-23 Score=204.77 Aligned_cols=163 Identities=23% Similarity=0.330 Sum_probs=135.9
Q ss_pred eEEEeeeecccceEEEEeE------EEEEEEEecCCCCchHHHHHHHHHHHHHhCC-CCceeeEeeeEeeCCCcEEEEEe
Q 010401 342 LEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDKGNAYEFELRKDLLELMTCG-HKNILQFYCVCVDENHGLCVVTK 414 (511)
Q Consensus 342 y~l~~~LG~GsFG~VYkgk------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~-HpNIV~l~g~~~~~~~~l~LVmE 414 (511)
|++.+.||.|+||.||+|+ .+++|++..... ........+|+..+++++ |+||+++++++.+++. .|+|||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~-~~lv~e 78 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFY-SWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDE-LYFVFE 78 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhcc-chhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCc-EEEEEe
Confidence 5788999999999999974 589998864222 223334567888999998 9999999999988766 999999
Q ss_pred ccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCccc
Q 010401 415 LMEGGSVNDLILKSR--KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE 492 (511)
Q Consensus 415 y~~gGsL~~lL~~~~--~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~~ 492 (511)
|+ +|+|.+++.... .+++..+..++.|++.+|.|||++|++|+||+|+||+++.++.++|+|||+++....... ..
T Consensus 79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~ 156 (283)
T cd07830 79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP-YT 156 (283)
T ss_pred cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC-cC
Confidence 99 779999886654 789999999999999999999999999999999999999999999999999876643222 23
Q ss_pred cccCCCccccHHhhcc
Q 010401 493 YETDGYRWLAPEVCFL 508 (511)
Q Consensus 493 ~~~Gt~~YmAPEvl~g 508 (511)
...++..|+|||++..
T Consensus 157 ~~~~~~~~~aPE~~~~ 172 (283)
T cd07830 157 DYVSTRWYRAPEILLR 172 (283)
T ss_pred CCCCcccccCceeeec
Confidence 3467888999998753
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.1e-23 Score=203.86 Aligned_cols=165 Identities=22% Similarity=0.324 Sum_probs=139.3
Q ss_pred eEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEEec
Q 010401 342 LEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKL 415 (511)
Q Consensus 342 y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVmEy 415 (511)
|++.+.||+|+||.||+| +.+++|.+............+..|+.+++.++|+||+++++++.+.+. +++||||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~-~~~v~e~ 79 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERK-LYLVFEY 79 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCc-eEEEecC
Confidence 567789999999999995 578999987543233334557789999999999999999999987765 9999999
Q ss_pred cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCccccc
Q 010401 416 MEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYE 494 (511)
Q Consensus 416 ~~gGsL~~lL~~~-~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~~~~ 494 (511)
+.+ +|.+++... ..+++..+..++.|++.||.|||++||+||||+|+||++++++.++|+|||+++............
T Consensus 80 ~~~-~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~ 158 (282)
T cd07829 80 CDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHE 158 (282)
T ss_pred cCc-CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccccCcc
Confidence 985 999999765 579999999999999999999999999999999999999999999999999988765433333344
Q ss_pred cCCCccccHHhhcc
Q 010401 495 TDGYRWLAPEVCFL 508 (511)
Q Consensus 495 ~Gt~~YmAPEvl~g 508 (511)
.++..|+|||++.+
T Consensus 159 ~~~~~~~aPE~~~~ 172 (282)
T cd07829 159 VVTLWYRAPEILLG 172 (282)
T ss_pred ccCcCcCChHHhcC
Confidence 56778999999754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.4e-24 Score=244.04 Aligned_cols=170 Identities=24% Similarity=0.388 Sum_probs=138.8
Q ss_pred CCCeEEEeeeecccceEEEE------eEEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEee--------
Q 010401 339 SDNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVD-------- 404 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYk------gk~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~-------- 404 (511)
..+|+.++.||+||||.||+ |+.+|||+|.... .......+.+|+..|++++|||||++|..|..
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ 556 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL 556 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence 35788889999999999999 4579999997533 44556678999999999999999998765430
Q ss_pred ----------------------------------------------------------------------C---------
Q 010401 405 ----------------------------------------------------------------------E--------- 405 (511)
Q Consensus 405 ----------------------------------------------------------------------~--------- 405 (511)
+
T Consensus 557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~ 636 (1351)
T KOG1035|consen 557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS 636 (1351)
T ss_pred cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence 0
Q ss_pred -----------------------C--------CcEEEEEeccCCCCHHHHHHhcCCC-CHHHHHHHHHHHHHHHHHHHHC
Q 010401 406 -----------------------N--------HGLCVVTKLMEGGSVNDLILKSRKL-QTKEIIRIAIDVAEGIKFLNDH 453 (511)
Q Consensus 406 -----------------------~--------~~l~LVmEy~~gGsL~~lL~~~~~L-~e~~~~~ia~qIa~gL~yLH~~ 453 (511)
+ ..+||-||||+...+.++++.+... ....+++++++|+.||.|+|+.
T Consensus 637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~ 716 (1351)
T KOG1035|consen 637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQ 716 (1351)
T ss_pred CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhC
Confidence 0 2279999999998888888766554 5788999999999999999999
Q ss_pred CccccCCCCCceEEcCCCcEEEEecCCceecc------------------cCCCccccccCCCccccHHhhccc
Q 010401 454 GVAYRDLNSQRILLDRHGNVCLGDMGIVTACK------------------SVGEATEYETDGYRWLAPEVCFLL 509 (511)
Q Consensus 454 gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~------------------~~~~~~~~~~Gt~~YmAPEvl~gl 509 (511)
|||||||||.||+++.++.|||+|||+++... ......+...||.-|+|||++.+.
T Consensus 717 giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~ 790 (1351)
T KOG1035|consen 717 GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDT 790 (1351)
T ss_pred ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccc
Confidence 99999999999999999999999999987721 111134556789999999998653
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.5e-23 Score=202.16 Aligned_cols=166 Identities=18% Similarity=0.316 Sum_probs=135.8
Q ss_pred CeEEEeeeecccceEEEEeE------EEEEEEEecCC---CCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEE
Q 010401 341 NLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCD---KGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCV 411 (511)
Q Consensus 341 ~y~l~~~LG~GsFG~VYkgk------~VAVKkL~~~~---~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~L 411 (511)
+|.+.+.||+|+||.||+++ .+++|.++... .......++..|+.+++.++||||+++++++.+.+. .++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~l 79 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDA-FCI 79 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCc-eEE
Confidence 47889999999999999864 24455554322 222334456788899999999999999999987776 899
Q ss_pred EEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccC
Q 010401 412 VTKLMEGGSVNDLILK----SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV 487 (511)
Q Consensus 412 VmEy~~gGsL~~lL~~----~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~ 487 (511)
||||+++++|.+++.. ...+++..+..++.|++.||.|||++|++|+||+|+||+++. +.++|+|||+++.....
T Consensus 80 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~ 158 (260)
T cd08222 80 ITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGS 158 (260)
T ss_pred EEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCC
Confidence 9999999999998853 357899999999999999999999999999999999999975 67999999998876544
Q ss_pred CCccccccCCCccccHHhhcc
Q 010401 488 GEATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 488 ~~~~~~~~Gt~~YmAPEvl~g 508 (511)
........|++.|+|||.+.+
T Consensus 159 ~~~~~~~~~~~~~~~pe~~~~ 179 (260)
T cd08222 159 CDLATTFTGTPYYMSPEALKH 179 (260)
T ss_pred cccccCCCCCcCccCHHHHcc
Confidence 444445668889999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.2e-23 Score=207.71 Aligned_cols=165 Identities=22% Similarity=0.285 Sum_probs=136.6
Q ss_pred EEEeeeecccceEEEE----eEEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEEeccCC
Q 010401 343 EFIDQIGPNSFKGVYK----GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEG 418 (511)
Q Consensus 343 ~l~~~LG~GsFG~VYk----gk~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVmEy~~g 418 (511)
.+.+.+|.|+++.||+ ++.+|+|++............+.+|+.+++.++|+||+++++++.+.+. .|++|||+++
T Consensus 5 ~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~-~~~~~e~~~~ 83 (314)
T cd08216 5 LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSE-LYVVSPLMAY 83 (314)
T ss_pred hhhHhhcCCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCe-EEEEEeccCC
Confidence 4456667778888887 4689999997543444455678999999999999999999999988776 8999999999
Q ss_pred CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCC-------
Q 010401 419 GSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE------- 489 (511)
Q Consensus 419 GsL~~lL~~~--~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~------- 489 (511)
|+|.+++... ..+++..+..++.|++.||.|||+++|+||||||+||+++.++.+||+|||.+........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~ 163 (314)
T cd08216 84 GSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHD 163 (314)
T ss_pred CCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecccccccccccc
Confidence 9999999653 4689999999999999999999999999999999999999999999999999876543222
Q ss_pred ccccccCCCccccHHhhcc
Q 010401 490 ATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 490 ~~~~~~Gt~~YmAPEvl~g 508 (511)
......++..|+|||++.+
T Consensus 164 ~~~~~~~~~~y~aPE~~~~ 182 (314)
T cd08216 164 FPKSSVKNLPWLSPEVLQQ 182 (314)
T ss_pred ccccccccccccCHHHhcC
Confidence 1223346678999999854
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.3e-23 Score=203.22 Aligned_cols=157 Identities=19% Similarity=0.272 Sum_probs=126.6
Q ss_pred CeEEEeee--ecccceEEEEeE------EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEE
Q 010401 341 NLEFIDQI--GPNSFKGVYKGK------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV 412 (511)
Q Consensus 341 ~y~l~~~L--G~GsFG~VYkgk------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LV 412 (511)
+|++.+.+ |+|+||.||+++ .+++|.+....... . ..++..+. .+||||+++++.+...+. +|+|
T Consensus 15 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~---~--e~~~~~~~-~~h~~iv~~~~~~~~~~~-~~iv 87 (267)
T PHA03390 15 NCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA---I--EPMVHQLM-KDNPNFIKLYYSVTTLKG-HVLI 87 (267)
T ss_pred hhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch---h--hHHHHHHh-hcCCCEEEEEEEEecCCe-eEEE
Confidence 44555555 999999999953 58888876422111 1 11111111 279999999999988775 9999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCC-cEEEEecCCceecccCCCcc
Q 010401 413 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG-NVCLGDMGIVTACKSVGEAT 491 (511)
Q Consensus 413 mEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g-~vKL~DFGlS~~l~~~~~~~ 491 (511)
|||+++++|.+++.....+++..+..++.||+.||.|||+.|++||||||+||+++.++ .++|+|||+++.....
T Consensus 88 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~---- 163 (267)
T PHA03390 88 MDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP---- 163 (267)
T ss_pred EEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC----
Confidence 99999999999998777899999999999999999999999999999999999999988 9999999998766432
Q ss_pred ccccCCCccccHHhhcc
Q 010401 492 EYETDGYRWLAPEVCFL 508 (511)
Q Consensus 492 ~~~~Gt~~YmAPEvl~g 508 (511)
....++..|+|||++.+
T Consensus 164 ~~~~~~~~y~aPE~~~~ 180 (267)
T PHA03390 164 SCYDGTLDYFSPEKIKG 180 (267)
T ss_pred ccCCCCCcccChhhhcC
Confidence 23467889999999864
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=9.8e-23 Score=206.70 Aligned_cols=161 Identities=27% Similarity=0.400 Sum_probs=135.8
Q ss_pred CeEEEeeeecccceEEEEeE------EEEEEEEecCCC-CchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEE
Q 010401 341 NLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDK-GNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT 413 (511)
Q Consensus 341 ~y~l~~~LG~GsFG~VYkgk------~VAVKkL~~~~~-~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVm 413 (511)
.|+..+.||+|+||.||+++ .+++|++..... .......+.+|+.+++.++|||++++++++.+++. .|+||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~lv~ 104 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHT-AWLVM 104 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCe-EEEEE
Confidence 46788999999999999964 689998864322 22334568889999999999999999999988776 89999
Q ss_pred eccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCccc
Q 010401 414 KLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE 492 (511)
Q Consensus 414 Ey~~gGsL~~lL~~-~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~~ 492 (511)
||+.+ +|.+++.. ...+++..+..++.||+.||.|||++||+||||+|+||+++.++.++|+|||++..... ..
T Consensus 105 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~----~~ 179 (317)
T cd06635 105 EYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP----AN 179 (317)
T ss_pred eCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC----cc
Confidence 99975 78777743 45789999999999999999999999999999999999999999999999999765432 23
Q ss_pred cccCCCccccHHhhc
Q 010401 493 YETDGYRWLAPEVCF 507 (511)
Q Consensus 493 ~~~Gt~~YmAPEvl~ 507 (511)
...|++.|+|||++.
T Consensus 180 ~~~~~~~y~aPE~~~ 194 (317)
T cd06635 180 SFVGTPYWMAPEVIL 194 (317)
T ss_pred cccCCccccChhhhh
Confidence 456888999999974
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.6e-23 Score=205.18 Aligned_cols=172 Identities=20% Similarity=0.359 Sum_probs=139.4
Q ss_pred ceEecCCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhC-CCCceeeEeeeEeeCC
Q 010401 334 RWLLNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCVCVDEN 406 (511)
Q Consensus 334 ~~~l~~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l-~HpNIV~l~g~~~~~~ 406 (511)
.|.++.++|++.+.||+|+||.||++ +.+|+|.+...... ....++.+|+.++.+. +||||+++++++.++.
T Consensus 9 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~ 87 (296)
T cd06618 9 KYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK-EENKRILMDLDVVLKSHDCPYIVKCYGYFITDS 87 (296)
T ss_pred eccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh-HHHHHHHHHHHHHHhccCCCchHhhheeeecCC
Confidence 45667889999999999999999995 46899998743322 2334456677666666 5999999999998877
Q ss_pred CcEEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCceEEcCCCcEEEEecCCceec
Q 010401 407 HGLCVVTKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLND-HGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC 484 (511)
Q Consensus 407 ~~l~LVmEy~~gGsL~~lL~~-~~~L~e~~~~~ia~qIa~gL~yLH~-~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l 484 (511)
. +|++|||+.+ ++.+++.. .+.+++..+..++.||+.||.|||+ +||+||||+|+||+++.++.+||+|||++..+
T Consensus 88 ~-~~~v~e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~ 165 (296)
T cd06618 88 D-VFICMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRL 165 (296)
T ss_pred e-EEEEeeccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhc
Confidence 6 9999999855 88887754 4578999999999999999999997 69999999999999999999999999998765
Q ss_pred ccCCCccccccCCCccccHHhhccc
Q 010401 485 KSVGEATEYETDGYRWLAPEVCFLL 509 (511)
Q Consensus 485 ~~~~~~~~~~~Gt~~YmAPEvl~gl 509 (511)
.... ......+++.|+|||++.+.
T Consensus 166 ~~~~-~~~~~~~~~~y~aPE~~~~~ 189 (296)
T cd06618 166 VDSK-AKTRSAGCAAYMAPERIDPP 189 (296)
T ss_pred cCCC-cccCCCCCccccCHhhcCCC
Confidence 4322 22334577889999998654
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.4e-23 Score=198.16 Aligned_cols=160 Identities=24% Similarity=0.306 Sum_probs=137.5
Q ss_pred eecccceEEEEe------EEEEEEEEecCCCCc-hHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEEeccCCCC
Q 010401 348 IGPNSFKGVYKG------KRVGIEKLKGCDKGN-AYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGS 420 (511)
Q Consensus 348 LG~GsFG~VYkg------k~VAVKkL~~~~~~~-~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVmEy~~gGs 420 (511)
||.|+||.||++ +.+++|.+....... .....+..|+.+++.++|+||+++++.+..++. .|++|||+++++
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~~v~e~~~~~~ 79 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEK-LYLVLEYAPGGE 79 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCe-eEEEEecCCCCc
Confidence 699999999985 578999886543222 244567889999999999999999999987775 999999999999
Q ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCccccccCCCcc
Q 010401 421 VNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRW 500 (511)
Q Consensus 421 L~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~~~~~Gt~~Y 500 (511)
|.+++.....+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++..............++..|
T Consensus 80 L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ 159 (250)
T cd05123 80 LFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEY 159 (250)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCCccc
Confidence 99999877789999999999999999999999999999999999999999999999999987765443334556778899
Q ss_pred ccHHhhcc
Q 010401 501 LAPEVCFL 508 (511)
Q Consensus 501 mAPEvl~g 508 (511)
+|||.+.+
T Consensus 160 ~~Pe~~~~ 167 (250)
T cd05123 160 LAPEVLLG 167 (250)
T ss_pred cChHHhCC
Confidence 99999764
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.5e-23 Score=210.16 Aligned_cols=162 Identities=21% Similarity=0.318 Sum_probs=131.1
Q ss_pred eeeecc--cceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEEeccC
Q 010401 346 DQIGPN--SFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLME 417 (511)
Q Consensus 346 ~~LG~G--sFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVmEy~~ 417 (511)
..||+| +||.||++ +.||+|.+............+.+|+.+++.++||||++++++|..++. +|+||||+.
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~-~~~v~e~~~ 82 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSW-LWVISPFMA 82 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCc-eEEEEeccc
Confidence 456776 89999995 579999987544444444668889998889999999999999998776 899999999
Q ss_pred CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCc-----
Q 010401 418 GGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA----- 490 (511)
Q Consensus 418 gGsL~~lL~~~--~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~----- 490 (511)
+++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.++++||+.+.........
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (328)
T cd08226 83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVY 162 (328)
T ss_pred CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccc
Confidence 99999998653 35899999999999999999999999999999999999999999999999865433221111
Q ss_pred --cccccCCCccccHHhhcc
Q 010401 491 --TEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 491 --~~~~~Gt~~YmAPEvl~g 508 (511)
.....++..|+|||++.+
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~ 182 (328)
T cd08226 163 DFPQFSTSVLPWLSPELLRQ 182 (328)
T ss_pred cccccccCccCccChhhhcC
Confidence 112234567999999865
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-22 Score=199.79 Aligned_cols=166 Identities=16% Similarity=0.359 Sum_probs=135.8
Q ss_pred CeEEEeeeecccceEEEEeE-------EEEEEEEecCCC--------CchHHHHHHHHHHHHHh-CCCCceeeEeeeEee
Q 010401 341 NLEFIDQIGPNSFKGVYKGK-------RVGIEKLKGCDK--------GNAYEFELRKDLLELMT-CGHKNILQFYCVCVD 404 (511)
Q Consensus 341 ~y~l~~~LG~GsFG~VYkgk-------~VAVKkL~~~~~--------~~~~~~~~~~Ei~iL~~-l~HpNIV~l~g~~~~ 404 (511)
+|++.+.||+|+||.||+++ .+++|.+..... ......++..|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47788999999999999853 588898753221 12223446677877764 799999999999988
Q ss_pred CCCcEEEEEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCceEEcCCCcEEEEecC
Q 010401 405 ENHGLCVVTKLMEGGSVNDLILK----SRKLQTKEIIRIAIDVAEGIKFLND-HGVAYRDLNSQRILLDRHGNVCLGDMG 479 (511)
Q Consensus 405 ~~~~l~LVmEy~~gGsL~~lL~~----~~~L~e~~~~~ia~qIa~gL~yLH~-~gIIHRDLKp~NILld~~g~vKL~DFG 479 (511)
++. .|++|||+++++|.+++.. ...+++..++.++.|++.||.|||. .+++||||+|+||+++.++.+||+|||
T Consensus 81 ~~~-~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg 159 (269)
T cd08528 81 NDR-LYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFG 159 (269)
T ss_pred CCe-EEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEeccc
Confidence 775 9999999999999998743 3468999999999999999999996 789999999999999999999999999
Q ss_pred CceecccCCCccccccCCCccccHHhhcc
Q 010401 480 IVTACKSVGEATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 480 lS~~l~~~~~~~~~~~Gt~~YmAPEvl~g 508 (511)
++....... ......|+..|+|||++.+
T Consensus 160 ~~~~~~~~~-~~~~~~~~~~~~~Pe~~~~ 187 (269)
T cd08528 160 LAKQKQPES-KLTSVVGTILYSCPEIVKN 187 (269)
T ss_pred ceeeccccc-ccccccCcccCcChhhhcC
Confidence 987755432 3445678889999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.2e-23 Score=201.85 Aligned_cols=165 Identities=23% Similarity=0.330 Sum_probs=139.4
Q ss_pred eEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEEec
Q 010401 342 LEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKL 415 (511)
Q Consensus 342 y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVmEy 415 (511)
|++.+.||.|++|.||++ +.+++|++............+.+|+.+++.++|+||+++++++.+++. ++++|||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-~~~v~e~ 79 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGD-LYLVFEF 79 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCC-EEEEEec
Confidence 466789999999999996 468999987544443445668889999999999999999999988776 9999999
Q ss_pred cCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCccccc
Q 010401 416 MEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYE 494 (511)
Q Consensus 416 ~~gGsL~~lL~~-~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~~~~ 494 (511)
+++ +|.+++.. ...+++..+..++.||+.||.|||+++|+|+||||+||+++.++.++|+|||.+.............
T Consensus 80 ~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~~~ 158 (283)
T cd05118 80 MDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHY 158 (283)
T ss_pred cCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccccCc
Confidence 976 88888865 3589999999999999999999999999999999999999999999999999988775543223334
Q ss_pred cCCCccccHHhhcc
Q 010401 495 TDGYRWLAPEVCFL 508 (511)
Q Consensus 495 ~Gt~~YmAPEvl~g 508 (511)
.++..|+|||++.+
T Consensus 159 ~~~~~~~~PE~~~~ 172 (283)
T cd05118 159 VVTRWYRAPELLLG 172 (283)
T ss_pred cCcccccCcHHHhc
Confidence 57788999999864
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.6e-24 Score=228.47 Aligned_cols=172 Identities=21% Similarity=0.359 Sum_probs=147.0
Q ss_pred ceEecCCCeEEEeeeecccceEEEEeE---------EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEee
Q 010401 334 RWLLNSDNLEFIDQIGPNSFKGVYKGK---------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVD 404 (511)
Q Consensus 334 ~~~l~~~~y~l~~~LG~GsFG~VYkgk---------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~ 404 (511)
...+..+++.+.++||+|+||.|++|. .||||.++..... .....|++|+.+|.+++|+|+++|||+..+
T Consensus 104 kclIpee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~-~~mddflrEas~M~~L~H~hliRLyGvVl~ 182 (1039)
T KOG0199|consen 104 KCLIPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLN-AIMDDFLREASHMLKLQHPHLIRLYGVVLD 182 (1039)
T ss_pred ceeccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccc-hhHHHHHHHHHHHHhccCcceeEEeeeecc
Confidence 455777888999999999999999973 6999999864433 356679999999999999999999999997
Q ss_pred CCCcEEEEEeccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCce
Q 010401 405 ENHGLCVVTKLMEGGSVNDLILK--SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVT 482 (511)
Q Consensus 405 ~~~~l~LVmEy~~gGsL~~lL~~--~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~ 482 (511)
. .+.||||+++.|+|.+.|++ ...|....+..|+.||+.||.||..+++|||||..+|+|+.....|||+|||+.+
T Consensus 183 q--p~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmR 260 (1039)
T KOG0199|consen 183 Q--PAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMR 260 (1039)
T ss_pred c--hhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeeccccee
Confidence 4 47899999999999999976 3468889999999999999999999999999999999999999999999999999
Q ss_pred ecccCCCccccc---cCCCccccHHhhcc
Q 010401 483 ACKSVGEATEYE---TDGYRWLAPEVCFL 508 (511)
Q Consensus 483 ~l~~~~~~~~~~---~Gt~~YmAPEvl~g 508 (511)
.++.+.+.+... .-.+.|.|||.|+-
T Consensus 261 aLg~ned~Yvm~p~rkvPfAWCaPEsLrh 289 (1039)
T KOG0199|consen 261 ALGENEDMYVMAPQRKVPFAWCAPESLRH 289 (1039)
T ss_pred ccCCCCcceEecCCCcCcccccCHhHhcc
Confidence 987766543211 11367999999864
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.8e-23 Score=214.19 Aligned_cols=157 Identities=13% Similarity=0.100 Sum_probs=122.1
Q ss_pred CCCeEEEeeeecccceEEEEeE-------EEEEEEEecCCC---CchHHHHHHHHHHHHHhCCCCceee-EeeeEeeCCC
Q 010401 339 SDNLEFIDQIGPNSFKGVYKGK-------RVGIEKLKGCDK---GNAYEFELRKDLLELMTCGHKNILQ-FYCVCVDENH 407 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkgk-------~VAVKkL~~~~~---~~~~~~~~~~Ei~iL~~l~HpNIV~-l~g~~~~~~~ 407 (511)
.++|.+.+.||+|+||+||+++ .+|||++..... .......+.+|+.+|..++|+||+. +++. +.
T Consensus 17 ~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----~~ 92 (365)
T PRK09188 17 SARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----GK 92 (365)
T ss_pred cCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----CC
Confidence 5678999999999999999974 468988753211 1223455899999999999999985 4432 33
Q ss_pred cEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCC-CCCceEEcCCCcEEEEecCCceeccc
Q 010401 408 GLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDL-NSQRILLDRHGNVCLGDMGIVTACKS 486 (511)
Q Consensus 408 ~l~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDL-Kp~NILld~~g~vKL~DFGlS~~l~~ 486 (511)
.|+||||++|++|... .. .. ...++.+++.||.|||++||+|||| ||+|||++.++.+||+|||+|+.+..
T Consensus 93 -~~LVmE~~~G~~L~~~-~~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~ 164 (365)
T PRK09188 93 -DGLVRGWTEGVPLHLA-RP---HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRR 164 (365)
T ss_pred -cEEEEEccCCCCHHHh-Cc---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceeccc
Confidence 7999999999999732 11 11 1467889999999999999999999 99999999999999999999987654
Q ss_pred CCCc--------cccccCCCccccHHhhc
Q 010401 487 VGEA--------TEYETDGYRWLAPEVCF 507 (511)
Q Consensus 487 ~~~~--------~~~~~Gt~~YmAPEvl~ 507 (511)
.+.. .....+++.|+|||++.
T Consensus 165 ~~~~~~~~~~~d~~~~~~~~~~~~pe~~~ 193 (365)
T PRK09188 165 RGALYRIAAYEDLRHLLKHKRTYAPDALT 193 (365)
T ss_pred CcchhhhhhhhhhhhhhccCccCCcccCC
Confidence 3321 13456788899999863
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.1e-22 Score=197.28 Aligned_cols=165 Identities=22% Similarity=0.344 Sum_probs=133.2
Q ss_pred eEEEeeeecccceEEEEeE------EEEEEEEecCCCCchHHHHHHHHHHHHHhC---CCCceeeEeeeEeeCCC----c
Q 010401 342 LEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDKGNAYEFELRKDLLELMTC---GHKNILQFYCVCVDENH----G 408 (511)
Q Consensus 342 y~l~~~LG~GsFG~VYkgk------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l---~HpNIV~l~g~~~~~~~----~ 408 (511)
|++.+.||+|+||.||+++ .+++|.+............+.+|+.++..+ +|+||+++++++.+.+. .
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 5788999999999999964 689999874333332334456677666554 69999999999986552 2
Q ss_pred EEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceeccc
Q 010401 409 LCVVTKLMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS 486 (511)
Q Consensus 409 l~LVmEy~~gGsL~~lL~~~--~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~ 486 (511)
++++|||+.+ +|.+++... ..+++..++.++.||+.||.|||+++++|+||+|+||+++.++.+||+|||++.....
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~ 159 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSF 159 (287)
T ss_pred eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceeccC
Confidence 8999999975 899888653 3589999999999999999999999999999999999999999999999999877644
Q ss_pred CCCccccccCCCccccHHhhcc
Q 010401 487 VGEATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 487 ~~~~~~~~~Gt~~YmAPEvl~g 508 (511)
... .....++..|+|||++.+
T Consensus 160 ~~~-~~~~~~~~~~~~PE~~~~ 180 (287)
T cd07838 160 EMA-LTSVVVTLWYRAPEVLLQ 180 (287)
T ss_pred Ccc-cccccccccccChHHhcc
Confidence 322 233457888999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.8e-22 Score=203.25 Aligned_cols=160 Identities=26% Similarity=0.391 Sum_probs=134.3
Q ss_pred eEEEeeeecccceEEEEeE------EEEEEEEecCCCCc-hHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEEe
Q 010401 342 LEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDKGN-AYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTK 414 (511)
Q Consensus 342 y~l~~~LG~GsFG~VYkgk------~VAVKkL~~~~~~~-~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVmE 414 (511)
|...+.||+|+||.||+|+ .+++|++....... .....+.+|+.+++.++||||+++++++.+.+. .|+|||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~lv~e 101 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHT-AWLVME 101 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCE-EEEEEe
Confidence 5667889999999999974 68999986433322 233457889999999999999999999998776 899999
Q ss_pred ccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCcccc
Q 010401 415 LMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY 493 (511)
Q Consensus 415 y~~gGsL~~lL~~-~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~~~ 493 (511)
|+.+ ++.+++.. ...+++..+..++.||+.||.|||++|++||||+|+||+++.++.+||+|||++..... ...
T Consensus 102 ~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~----~~~ 176 (313)
T cd06633 102 YCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP----ANS 176 (313)
T ss_pred cCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCC----CCC
Confidence 9965 78777754 45789999999999999999999999999999999999999999999999999764322 334
Q ss_pred ccCCCccccHHhhc
Q 010401 494 ETDGYRWLAPEVCF 507 (511)
Q Consensus 494 ~~Gt~~YmAPEvl~ 507 (511)
..|+..|+|||++.
T Consensus 177 ~~~~~~y~aPE~~~ 190 (313)
T cd06633 177 FVGTPYWMAPEVIL 190 (313)
T ss_pred ccccccccChhhcc
Confidence 57888999999974
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.3e-22 Score=206.62 Aligned_cols=164 Identities=16% Similarity=0.304 Sum_probs=134.9
Q ss_pred CCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCC-----
Q 010401 339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENH----- 407 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~----- 407 (511)
.++|.+.+.||+|+||.||+| +.+|+|++............+.+|+.+++.++||||+++++++.....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 357999999999999999986 469999987533333334557889999999999999999999875432
Q ss_pred cEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccC
Q 010401 408 GLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV 487 (511)
Q Consensus 408 ~l~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~ 487 (511)
.+|+||||+.. +|..++ ...+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++....
T Consensus 94 ~~~lv~e~~~~-~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~- 169 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADA- 169 (342)
T ss_pred eEEEEeccccc-CHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCC-
Confidence 26899999965 777664 34689999999999999999999999999999999999999999999999999875432
Q ss_pred CCccccccCCCccccHHhhcc
Q 010401 488 GEATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 488 ~~~~~~~~Gt~~YmAPEvl~g 508 (511)
......++..|+|||++.+
T Consensus 170 --~~~~~~~~~~y~aPE~~~~ 188 (342)
T cd07879 170 --EMTGYVVTRWYRAPEVILN 188 (342)
T ss_pred --CCCCceeeecccChhhhcC
Confidence 1234466788999999864
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=9.2e-23 Score=199.48 Aligned_cols=173 Identities=20% Similarity=0.225 Sum_probs=143.6
Q ss_pred ceEecCCCeEEEeeeecccceEEEEeE------EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeC--
Q 010401 334 RWLLNSDNLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDE-- 405 (511)
Q Consensus 334 ~~~l~~~~y~l~~~LG~GsFG~VYkgk------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~-- 405 (511)
...++.++|++.+.||+|||..||.++ .+|+|++.-. ........++|++..++++||||++++++...+
T Consensus 15 tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~--~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~ 92 (302)
T KOG2345|consen 15 TVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCH--SQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEK 92 (302)
T ss_pred cEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeecc--chHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhc
Confidence 566889999999999999999999965 6899998632 244566789999999999999999999877533
Q ss_pred --CCcEEEEEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCceEEcCCCcEEEEe
Q 010401 406 --NHGLCVVTKLMEGGSVNDLILK----SRKLQTKEIIRIAIDVAEGIKFLNDHG--VAYRDLNSQRILLDRHGNVCLGD 477 (511)
Q Consensus 406 --~~~l~LVmEy~~gGsL~~lL~~----~~~L~e~~~~~ia~qIa~gL~yLH~~g--IIHRDLKp~NILld~~g~vKL~D 477 (511)
.+..||+++|...|+|.+.+.. ...+++.+++.|+.+|++||++||+.. +.||||||.|||+.+.+.++|.|
T Consensus 93 D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D 172 (302)
T KOG2345|consen 93 DGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMD 172 (302)
T ss_pred cCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEe
Confidence 3448999999999999999853 237999999999999999999999998 99999999999999999999999
Q ss_pred cCCceeccc---CC-C-----ccccccCCCccccHHhhcc
Q 010401 478 MGIVTACKS---VG-E-----ATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 478 FGlS~~l~~---~~-~-----~~~~~~Gt~~YmAPEvl~g 508 (511)
||.++...- .+ + .......|..|.|||++..
T Consensus 173 ~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~v 212 (302)
T KOG2345|consen 173 LGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNV 212 (302)
T ss_pred ccCccccceEeechHHHHHHHHHHHHhCCCcccCchheec
Confidence 999765421 11 1 1222356888999999864
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.5e-22 Score=206.45 Aligned_cols=165 Identities=20% Similarity=0.340 Sum_probs=137.5
Q ss_pred CCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCC-----
Q 010401 339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENH----- 407 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~----- 407 (511)
.++|++.+.||+|+||.||+| +.+++|++............+.+|+.+++.++||||+++++++...+.
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQ 93 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccc
Confidence 567999999999999999996 468999886433233344557789999999999999999987764432
Q ss_pred cEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccC
Q 010401 408 GLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV 487 (511)
Q Consensus 408 ~l~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~ 487 (511)
.+|+|+||+ +++|.+++.. ..+++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||++......
T Consensus 94 ~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~ 171 (343)
T cd07851 94 DVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE 171 (343)
T ss_pred cEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccccccccc
Confidence 389999999 5699998854 57999999999999999999999999999999999999999999999999998765432
Q ss_pred CCccccccCCCccccHHhhcc
Q 010401 488 GEATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 488 ~~~~~~~~Gt~~YmAPEvl~g 508 (511)
.....++..|+|||++.+
T Consensus 172 ---~~~~~~~~~y~aPE~~~~ 189 (343)
T cd07851 172 ---MTGYVATRWYRAPEIMLN 189 (343)
T ss_pred ---ccCCcccccccCHHHHhC
Confidence 233467888999999754
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.2e-22 Score=201.26 Aligned_cols=162 Identities=28% Similarity=0.406 Sum_probs=135.3
Q ss_pred CCeEEEeeeecccceEEEEeE------EEEEEEEecCCC-CchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEE
Q 010401 340 DNLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDK-GNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV 412 (511)
Q Consensus 340 ~~y~l~~~LG~GsFG~VYkgk------~VAVKkL~~~~~-~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LV 412 (511)
..|...+.||+|+||.||+|+ .+++|.+..... ......++.+|+.+++.++|+|++++++++...+. .|+|
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~lv 93 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHT-AWLV 93 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCe-eEEE
Confidence 346777899999999999864 589998864222 22334457889999999999999999999988765 8999
Q ss_pred EeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCcc
Q 010401 413 TKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT 491 (511)
Q Consensus 413 mEy~~gGsL~~lL~~-~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~ 491 (511)
|||+. |++.+++.. ...+++..+..++.|++.||.|||+++++||||+|+||+++.++.++|+|||++..... .
T Consensus 94 ~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~----~ 168 (308)
T cd06634 94 MEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----A 168 (308)
T ss_pred EEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecC----c
Confidence 99997 588887743 45689999999999999999999999999999999999999999999999999876543 2
Q ss_pred ccccCCCccccHHhhc
Q 010401 492 EYETDGYRWLAPEVCF 507 (511)
Q Consensus 492 ~~~~Gt~~YmAPEvl~ 507 (511)
....+++.|+|||++.
T Consensus 169 ~~~~~~~~y~aPE~~~ 184 (308)
T cd06634 169 NXFVGTPYWMAPEVIL 184 (308)
T ss_pred ccccCCccccCHHHHh
Confidence 3456788999999975
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.3e-22 Score=204.54 Aligned_cols=166 Identities=16% Similarity=0.238 Sum_probs=133.8
Q ss_pred CCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCC------
Q 010401 339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN------ 406 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~------ 406 (511)
..+|++.+.||.|+||.||+| +.|++|++..... .....+.+|+.+++.++||||+++++++....
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~--~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP--QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTED 81 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC--chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccc
Confidence 367899999999999999986 4799999864332 33455788999999999999999998765432
Q ss_pred -------CcEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEc-CCCcEEEEec
Q 010401 407 -------HGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLD-RHGNVCLGDM 478 (511)
Q Consensus 407 -------~~l~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld-~~g~vKL~DF 478 (511)
..+|+||||+.+ +|.+++. ...+++..++.++.||+.||.|||++||+||||||+||+++ .++.+||+||
T Consensus 82 ~~~~~~~~~~~lv~e~~~~-~L~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~df 159 (342)
T cd07854 82 VGSLTELNSVYIVQEYMET-DLANVLE-QGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDF 159 (342)
T ss_pred cccccccceEEEEeecccc-cHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCc
Confidence 137899999974 8988874 35789999999999999999999999999999999999998 4567899999
Q ss_pred CCceecccCCC---ccccccCCCccccHHhhcc
Q 010401 479 GIVTACKSVGE---ATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 479 GlS~~l~~~~~---~~~~~~Gt~~YmAPEvl~g 508 (511)
|+++.+..... ......++..|+|||++.+
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 192 (342)
T cd07854 160 GLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLS 192 (342)
T ss_pred ccceecCCccccccccccccccccccCHHHHhC
Confidence 99876532211 1123457888999998753
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.9e-24 Score=213.47 Aligned_cols=167 Identities=20% Similarity=0.306 Sum_probs=141.6
Q ss_pred EEEeeeecccceEEEE------eEEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCC----cEEEE
Q 010401 343 EFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENH----GLCVV 412 (511)
Q Consensus 343 ~l~~~LG~GsFG~VYk------gk~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~----~l~LV 412 (511)
+-.+.||-|+||.||. |+.|++|++..........+++.+|+..|..++|.|++...++....+- .+|++
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 3447799999999996 7899999997655555567889999999999999999998887654431 27899
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCC-Ccc
Q 010401 413 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG-EAT 491 (511)
Q Consensus 413 mEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~-~~~ 491 (511)
+|+|.. +|+.+|-+...++.+.+.-+..||++||+|||+.+|+||||||.|+|++.+..+||||||+++.-.... ...
T Consensus 136 TELmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~hM 214 (449)
T KOG0664|consen 136 TELMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLNM 214 (449)
T ss_pred HHHHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhhhhhh
Confidence 999976 999999888899999999999999999999999999999999999999999999999999998654322 234
Q ss_pred ccccCCCccccHHhhcccC
Q 010401 492 EYETDGYRWLAPEVCFLLL 510 (511)
Q Consensus 492 ~~~~Gt~~YmAPEvl~gl~ 510 (511)
+...-|..|.|||+++|-+
T Consensus 215 TqEVVTQYYRAPEiLMGaR 233 (449)
T KOG0664|consen 215 THEVVTQYYRAPELLMGAR 233 (449)
T ss_pred HHHHHHHHhccHHHhhcch
Confidence 5556677899999999854
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.7e-22 Score=211.99 Aligned_cols=172 Identities=20% Similarity=0.251 Sum_probs=144.2
Q ss_pred ceEecCCCeEEEeeeecccceEEEEe-----EEEEEEEEecCCCCchHHHHHHHHHHHHHhC-CCCceeeEeeeEeeCCC
Q 010401 334 RWLLNSDNLEFIDQIGPNSFKGVYKG-----KRVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCVCVDENH 407 (511)
Q Consensus 334 ~~~l~~~~y~l~~~LG~GsFG~VYkg-----k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l-~HpNIV~l~g~~~~~~~ 407 (511)
-+.++...|++++.||.||-.+||+. +.+|+|++...........-+.+|+..|.++ +|.+||+||+|-..++.
T Consensus 355 ~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~ 434 (677)
T KOG0596|consen 355 IIKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGY 434 (677)
T ss_pred eEEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCce
Confidence 45678889999999999999999995 4688888765444455556689999999998 79999999999887665
Q ss_pred cEEEEEeccCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceeccc
Q 010401 408 GLCVVTKLMEGGSVNDLILKSRK-LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS 486 (511)
Q Consensus 408 ~l~LVmEy~~gGsL~~lL~~~~~-L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~ 486 (511)
+||||||=+. +|..+|++... ++...++.|..||+.++.++|++||||.||||.|+|+- .|.+||+|||+|..+..
T Consensus 435 -lYmvmE~Gd~-DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~ 511 (677)
T KOG0596|consen 435 -LYMVMECGDI-DLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQP 511 (677)
T ss_pred -EEEEeecccc-cHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-eeeEEeeeechhcccCc
Confidence 9999997755 99999976654 44468889999999999999999999999999999995 78999999999987754
Q ss_pred CCC--ccccccCCCccccHHhhcc
Q 010401 487 VGE--ATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 487 ~~~--~~~~~~Gt~~YmAPEvl~g 508 (511)
+.. .....+||+.||+||.+..
T Consensus 512 DTTsI~kdsQvGT~NYMsPEAl~~ 535 (677)
T KOG0596|consen 512 DTTSIVKDSQVGTVNYMSPEALTD 535 (677)
T ss_pred cccceeeccccCcccccCHHHHhh
Confidence 332 3455689999999999864
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.3e-24 Score=228.48 Aligned_cols=167 Identities=23% Similarity=0.448 Sum_probs=146.4
Q ss_pred cCCCeEEEeeeecccceEEEEeE------EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEE
Q 010401 338 NSDNLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCV 411 (511)
Q Consensus 338 ~~~~y~l~~~LG~GsFG~VYkgk------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~L 411 (511)
+.++|+++..+|.|+||.|||++ ..|+|+++-. ..+ ...-+..|+.+++.++||||+.++|.+..... +|+
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLe-p~d-d~~~iqqei~~~~dc~h~nivay~gsylr~dk-lwi 89 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLE-PGD-DFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDK-LWI 89 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeecc-CCc-cccccccceeeeecCCCcChHHHHhhhhhhcC-cEE
Confidence 46789999999999999999964 6788888742 222 22346889999999999999999999987776 999
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCcc
Q 010401 412 VTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT 491 (511)
Q Consensus 412 VmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~ 491 (511)
+||||.+|+|.+.-...+++++.++...+++.++||+|||+.|-+|||||-.|||+++.|.+|+.|||.+..+...-...
T Consensus 90 cMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~Kr 169 (829)
T KOG0576|consen 90 CMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAKR 169 (829)
T ss_pred EEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhhhhh
Confidence 99999999999988778899999999999999999999999999999999999999999999999999987776555556
Q ss_pred ccccCCCccccHHhhc
Q 010401 492 EYETDGYRWLAPEVCF 507 (511)
Q Consensus 492 ~~~~Gt~~YmAPEvl~ 507 (511)
....||+.|||||+--
T Consensus 170 ksfiGtpywmapEvaa 185 (829)
T KOG0576|consen 170 KSFIGTPYWMAPEVAA 185 (829)
T ss_pred hcccCCccccchhHHH
Confidence 6789999999999853
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.5e-22 Score=215.21 Aligned_cols=171 Identities=18% Similarity=0.227 Sum_probs=126.6
Q ss_pred ecCCCeEEEeeeecccceEEEEeE----------------------EEEEEEEecCCCCchH------------HHHHHH
Q 010401 337 LNSDNLEFIDQIGPNSFKGVYKGK----------------------RVGIEKLKGCDKGNAY------------EFELRK 382 (511)
Q Consensus 337 l~~~~y~l~~~LG~GsFG~VYkgk----------------------~VAVKkL~~~~~~~~~------------~~~~~~ 382 (511)
...++|++.++||+|+||.||+|. .||||++......... ......
T Consensus 142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v 221 (507)
T PLN03224 142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV 221 (507)
T ss_pred ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence 367899999999999999999873 5899998642221110 011234
Q ss_pred HHHHHHhCCCCce-----eeEeeeEeeC-------CCcEEEEEeccCCCCHHHHHHhc----------------------
Q 010401 383 DLLELMTCGHKNI-----LQFYCVCVDE-------NHGLCVVTKLMEGGSVNDLILKS---------------------- 428 (511)
Q Consensus 383 Ei~iL~~l~HpNI-----V~l~g~~~~~-------~~~l~LVmEy~~gGsL~~lL~~~---------------------- 428 (511)
|+..+.+++|.++ +.++++|... ....|+||||+++++|.+++...
T Consensus 222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 5666666666554 6677776431 12389999999999999988532
Q ss_pred --CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCC-ccccccCCCccccHHh
Q 010401 429 --RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE-ATEYETDGYRWLAPEV 505 (511)
Q Consensus 429 --~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~-~~~~~~Gt~~YmAPEv 505 (511)
..+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+++....... ......+++.|+|||+
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~ 381 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEE 381 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhh
Confidence 1235677888999999999999999999999999999999999999999999875533211 1222345789999999
Q ss_pred hc
Q 010401 506 CF 507 (511)
Q Consensus 506 l~ 507 (511)
+.
T Consensus 382 l~ 383 (507)
T PLN03224 382 LV 383 (507)
T ss_pred hc
Confidence 75
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.4e-22 Score=202.54 Aligned_cols=161 Identities=19% Similarity=0.283 Sum_probs=129.0
Q ss_pred CCCeEEE-eeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHH-HhCCCCceeeEeeeEee---CCC
Q 010401 339 SDNLEFI-DQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLEL-MTCGHKNILQFYCVCVD---ENH 407 (511)
Q Consensus 339 ~~~y~l~-~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL-~~l~HpNIV~l~g~~~~---~~~ 407 (511)
.++|.+- ++||-|--|+|..+ +.+|+|+|... ...++|+++- +.-.|||||.+++++.. +..
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rk 132 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-------PKARREVELHWMASGHPHIVSIIDVYENSYQGRK 132 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCce
Confidence 3445443 67999999999874 56788888532 2245666543 33489999999998853 345
Q ss_pred cEEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcC---CCcEEEEecCCce
Q 010401 408 GLCVVTKLMEGGSVNDLILKSR--KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDR---HGNVCLGDMGIVT 482 (511)
Q Consensus 408 ~l~LVmEy~~gGsL~~lL~~~~--~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~---~g~vKL~DFGlS~ 482 (511)
++.+|||.|.||.|...+...+ .+++.++..|+.||+.|+.|||+.+|.||||||+|+|... +..+||+|||+|+
T Consensus 133 cLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK 212 (400)
T KOG0604|consen 133 CLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAK 212 (400)
T ss_pred eeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEeccccccc
Confidence 6899999999999999997665 5999999999999999999999999999999999999974 4578999999998
Q ss_pred ecccCCCccccccCCCccccHHhhc
Q 010401 483 ACKSVGEATEYETDGYRWLAPEVCF 507 (511)
Q Consensus 483 ~l~~~~~~~~~~~Gt~~YmAPEvl~ 507 (511)
..... ......+-|+.|.|||++.
T Consensus 213 ~t~~~-~~L~TPc~TPyYvaPevlg 236 (400)
T KOG0604|consen 213 ETQEP-GDLMTPCFTPYYVAPEVLG 236 (400)
T ss_pred ccCCC-ccccCCcccccccCHHHhC
Confidence 76543 2355667899999999974
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.5e-22 Score=220.64 Aligned_cols=173 Identities=24% Similarity=0.441 Sum_probs=146.8
Q ss_pred ceEecCCCeEEEeeeecccceEEEEeE-------------EEEEEEEecCCCCchHHHHHHHHHHHHHhC-CCCceeeEe
Q 010401 334 RWLLNSDNLEFIDQIGPNSFKGVYKGK-------------RVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFY 399 (511)
Q Consensus 334 ~~~l~~~~y~l~~~LG~GsFG~VYkgk-------------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l-~HpNIV~l~ 399 (511)
.|+++.+++++.+.||+|.||+|++|. .||||.++..... .....+..|+.+|+.+ .|+||+.+.
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~ll 368 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLL 368 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhhe
Confidence 789999999999999999999999963 5899999864443 5566789999999988 699999999
Q ss_pred eeEeeCCCcEEEEEeccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCC
Q 010401 400 CVCVDENHGLCVVTKLMEGGSVNDLILKSR----------------KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQ 463 (511)
Q Consensus 400 g~~~~~~~~l~LVmEy~~gGsL~~lL~~~~----------------~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~ 463 (511)
|+|.+.+. +++|+||+..|+|.++++..+ .++...++.++.||+.||+||++..+|||||..+
T Consensus 369 G~~t~~~~-~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaR 447 (609)
T KOG0200|consen 369 GACTQDGP-LYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAAR 447 (609)
T ss_pred eeeccCCc-eEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhh
Confidence 99998554 999999999999999997544 3888999999999999999999999999999999
Q ss_pred ceEEcCCCcEEEEecCCceecccCCCcc-ccccC--CCccccHHhhcc
Q 010401 464 RILLDRHGNVCLGDMGIVTACKSVGEAT-EYETD--GYRWLAPEVCFL 508 (511)
Q Consensus 464 NILld~~g~vKL~DFGlS~~l~~~~~~~-~~~~G--t~~YmAPEvl~g 508 (511)
|||+..+..+||+|||+++......... ....| ..+|||||.+..
T Consensus 448 NVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~ 495 (609)
T KOG0200|consen 448 NVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD 495 (609)
T ss_pred hEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhcc
Confidence 9999999999999999998655433322 22233 256999999864
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.9e-23 Score=213.09 Aligned_cols=171 Identities=20% Similarity=0.340 Sum_probs=143.1
Q ss_pred ecCCCeEEEeeeecccceEEEEe------EEEEEEEEecCC-----CCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeC
Q 010401 337 LNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCD-----KGNAYEFELRKDLLELMTCGHKNILQFYCVCVDE 405 (511)
Q Consensus 337 l~~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~-----~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~ 405 (511)
.-.++|-++..||+|+|+.||++ +.||+|+-...+ +...+.+..-+|-.+-+.++||.||++|++|.-+
T Consensus 460 tLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD 539 (775)
T KOG1151|consen 460 TLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD 539 (775)
T ss_pred chHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec
Confidence 44567888999999999999995 678888754321 1222333456778888889999999999999877
Q ss_pred CCcEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--CccccCCCCCceEEcC---CCcEEEEecCC
Q 010401 406 NHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDH--GVAYRDLNSQRILLDR---HGNVCLGDMGI 480 (511)
Q Consensus 406 ~~~l~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~--gIIHRDLKp~NILld~---~g~vKL~DFGl 480 (511)
.+.+|-|+|||+|.+|.-+|+..+.+++.+++.|+.||+.||.||.+. -|||=||||.|||+-+ -|.+||.|||+
T Consensus 540 tdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGL 619 (775)
T KOG1151|consen 540 TDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGL 619 (775)
T ss_pred cccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecch
Confidence 777999999999999999999889999999999999999999999976 4999999999999964 47899999999
Q ss_pred ceecccCCCc-------cccccCCCccccHHhhc
Q 010401 481 VTACKSVGEA-------TEYETDGYRWLAPEVCF 507 (511)
Q Consensus 481 S~~l~~~~~~-------~~~~~Gt~~YmAPEvl~ 507 (511)
++++.+.+.. +....|||.|++||-|.
T Consensus 620 SKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFv 653 (775)
T KOG1151|consen 620 SKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFV 653 (775)
T ss_pred hhhccCCccCcccceeeecccCceeeecCcceee
Confidence 9998765532 45568999999999875
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.3e-21 Score=190.31 Aligned_cols=147 Identities=22% Similarity=0.276 Sum_probs=121.8
Q ss_pred ccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEEeccCCCCHHHH
Q 010401 351 NSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDL 424 (511)
Q Consensus 351 GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVmEy~~gGsL~~l 424 (511)
|.||.||++ +.+++|++.... ...+|...+....||||+++++++.+.+. .|++|||+++|+|.++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~-~~lv~e~~~~~~L~~~ 75 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------EYSRERLTIIPHCVPNMVCLHKYIVSEDS-VFLVLQHAEGGKLWSH 75 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-------hhhhHHHHHHhcCCCceeehhhheecCCe-EEEEEecCCCCCHHHH
Confidence 899999985 469999986422 12334444555679999999999987765 9999999999999999
Q ss_pred HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCccccccCCCccccHH
Q 010401 425 ILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPE 504 (511)
Q Consensus 425 L~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~~~~~Gt~~YmAPE 504 (511)
+.+...+++..+..++.|++.||.|||++||+||||||+||+++.++.++++|||++...... .....++..|+|||
T Consensus 76 l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~---~~~~~~~~~y~aPE 152 (237)
T cd05576 76 ISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS---CDGEAVENMYCAPE 152 (237)
T ss_pred HHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc---cccCCcCccccCCc
Confidence 977778999999999999999999999999999999999999999999999999987665432 22334567799999
Q ss_pred hhcc
Q 010401 505 VCFL 508 (511)
Q Consensus 505 vl~g 508 (511)
.+.+
T Consensus 153 ~~~~ 156 (237)
T cd05576 153 VGGI 156 (237)
T ss_pred ccCC
Confidence 8753
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.7e-22 Score=219.94 Aligned_cols=163 Identities=24% Similarity=0.406 Sum_probs=140.4
Q ss_pred eEEEeeeecccceEEEEeE----------EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEE
Q 010401 342 LEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCV 411 (511)
Q Consensus 342 y~l~~~LG~GsFG~VYkgk----------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~L 411 (511)
++..++||+|+||+||+|. +||||++.. ........+++.|+..|.+++||||++|+|+|.... +-|
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~-~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~--~ql 774 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIE-FTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST--LQL 774 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeec-cCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch--HHH
Confidence 4556899999999999973 689999874 334445677999999999999999999999998654 779
Q ss_pred EEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCc
Q 010401 412 VTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA 490 (511)
Q Consensus 412 VmEy~~gGsL~~lL~~~-~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~ 490 (511)
|++||++|+|.++++.. ..+-.+..+.|+.||++||.|||.++++||||..+|+||..-..+||.|||+++.+..+...
T Consensus 775 vtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~e 854 (1177)
T KOG1025|consen 775 VTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKE 854 (1177)
T ss_pred HHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCccccc
Confidence 99999999999999754 58899999999999999999999999999999999999999999999999999988776654
Q ss_pred cccccC--CCccccHHhhc
Q 010401 491 TEYETD--GYRWLAPEVCF 507 (511)
Q Consensus 491 ~~~~~G--t~~YmAPEvl~ 507 (511)
..+..| .+.|||-|.++
T Consensus 855 y~~~~gK~pikwmale~i~ 873 (1177)
T KOG1025|consen 855 YSAPGGKVPIKWMALESIR 873 (1177)
T ss_pred ccccccccCcHHHHHHHhh
Confidence 444444 36899998875
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.5e-23 Score=203.91 Aligned_cols=174 Identities=17% Similarity=0.320 Sum_probs=139.5
Q ss_pred EecCCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCC---
Q 010401 336 LLNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN--- 406 (511)
Q Consensus 336 ~l~~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~--- 406 (511)
......|+-..+||+|.||.||++ +.||+|++--......+-....+|+.+|..+.|+|++.++.+|....
T Consensus 13 ~~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~ 92 (376)
T KOG0669|consen 13 CDEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPT 92 (376)
T ss_pred eecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCc
Confidence 344566777889999999999984 56888765432222233345689999999999999999998875432
Q ss_pred ----CcEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCc
Q 010401 407 ----HGLCVVTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIV 481 (511)
Q Consensus 407 ----~~l~LVmEy~~gGsL~~lL~~~-~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS 481 (511)
..+|+|+++|.. +|..+|... .+++..++..++.++..||.|+|+..|+|||+|++|+||+.+|.+||+|||++
T Consensus 93 ~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGla 171 (376)
T KOG0669|consen 93 NRDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLA 171 (376)
T ss_pred ccccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccc
Confidence 128999999988 999998554 58999999999999999999999999999999999999999999999999999
Q ss_pred eecccCCC----ccccccCCCccccHHhhcccC
Q 010401 482 TACKSVGE----ATEYETDGYRWLAPEVCFLLL 510 (511)
Q Consensus 482 ~~l~~~~~----~~~~~~Gt~~YmAPEvl~gl~ 510 (511)
+.+..... ..+...-|..|.+||.++|-+
T Consensus 172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~r 204 (376)
T KOG0669|consen 172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDR 204 (376)
T ss_pred cceecccccCCCCcccceeeeecCCHHHhhccc
Confidence 76643221 123344588899999999865
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=3e-21 Score=213.08 Aligned_cols=166 Identities=17% Similarity=0.207 Sum_probs=115.1
Q ss_pred EecCCCeEEEeeeecccceEEEEe----------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeE---
Q 010401 336 LLNSDNLEFIDQIGPNSFKGVYKG----------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVC--- 402 (511)
Q Consensus 336 ~l~~~~y~l~~~LG~GsFG~VYkg----------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~--- 402 (511)
.+..++|++.+.||+|+||.||+| +.||+|++..... .+.. ..+ .+....+.++..+...+
T Consensus 128 ~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~---~e~~-~~e--~l~~~~~~~~~~~~~~~~~~ 201 (566)
T PLN03225 128 SFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA---VEIW-MNE--RVRRACPNSCADFVYGFLEP 201 (566)
T ss_pred CCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch---hHHH-HHH--HHHhhchhhHHHHHHhhhcc
Confidence 346789999999999999999996 3588998753211 1111 111 11222222332222111
Q ss_pred -e-eCCCcEEEEEeccCCCCHHHHHHhcC-C-------------------CCHHHHHHHHHHHHHHHHHHHHCCccccCC
Q 010401 403 -V-DENHGLCVVTKLMEGGSVNDLILKSR-K-------------------LQTKEIIRIAIDVAEGIKFLNDHGVAYRDL 460 (511)
Q Consensus 403 -~-~~~~~l~LVmEy~~gGsL~~lL~~~~-~-------------------L~e~~~~~ia~qIa~gL~yLH~~gIIHRDL 460 (511)
. ..+..+++||||+.+++|.+++.... . .....+..++.||+.||+|||+++|+||||
T Consensus 202 ~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDL 281 (566)
T PLN03225 202 VSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDV 281 (566)
T ss_pred cccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcC
Confidence 1 22334899999999999999986432 1 112345679999999999999999999999
Q ss_pred CCCceEEcC-CCcEEEEecCCceecccCC-CccccccCCCccccHHhhc
Q 010401 461 NSQRILLDR-HGNVCLGDMGIVTACKSVG-EATEYETDGYRWLAPEVCF 507 (511)
Q Consensus 461 Kp~NILld~-~g~vKL~DFGlS~~l~~~~-~~~~~~~Gt~~YmAPEvl~ 507 (511)
||+|||++. ++.+||+|||+++.+.... .......+++.|||||.+.
T Consensus 282 KP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~ 330 (566)
T PLN03225 282 KPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYI 330 (566)
T ss_pred CHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhh
Confidence 999999985 6899999999998654322 1234457889999999764
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.1e-20 Score=174.45 Aligned_cols=163 Identities=27% Similarity=0.361 Sum_probs=138.4
Q ss_pred eEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEEec
Q 010401 342 LEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKL 415 (511)
Q Consensus 342 y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVmEy 415 (511)
|.+.+.||.|+||.||++ +.+++|.+...... .....+.+|+..+..++|+|++++++++..... .++++||
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~-~~~v~e~ 78 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFEDPEP-LYLVMEY 78 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeecCCc-eEEEEec
Confidence 467789999999999996 46899988743222 245678899999999999999999999887665 8999999
Q ss_pred cCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCC-Ccccc
Q 010401 416 MEGGSVNDLILKSRK-LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG-EATEY 493 (511)
Q Consensus 416 ~~gGsL~~lL~~~~~-L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~-~~~~~ 493 (511)
+++++|.+++..... +++..+..++.+++.++.|||+++++|+||+|.||+++.++.++|+|||++....... .....
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~ 158 (225)
T smart00221 79 CEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLKT 158 (225)
T ss_pred cCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccccc
Confidence 999999999976665 8999999999999999999999999999999999999999999999999988765432 12234
Q ss_pred ccCCCccccHHhh
Q 010401 494 ETDGYRWLAPEVC 506 (511)
Q Consensus 494 ~~Gt~~YmAPEvl 506 (511)
..++..|++||++
T Consensus 159 ~~~~~~~~~pe~~ 171 (225)
T smart00221 159 VKGTPFYLAPEVL 171 (225)
T ss_pred eeccCCcCCHhHh
Confidence 4677889999987
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=7.2e-21 Score=220.81 Aligned_cols=153 Identities=18% Similarity=0.316 Sum_probs=125.4
Q ss_pred CeEEEeeeecccceEEEEeE------EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEEe
Q 010401 341 NLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTK 414 (511)
Q Consensus 341 ~y~l~~~LG~GsFG~VYkgk------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVmE 414 (511)
.+...+.||+|+||.||+|+ .||+|++...... ...|+..+++++||||++++|+|.+++. .|+|||
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~l~~l~HpnIv~~~~~~~~~~~-~~lv~E 763 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI------PSSEIADMGKLQHPNIVKLIGLCRSEKG-AYLIHE 763 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc------cHHHHHHHhhCCCCCcceEEEEEEcCCC-CEEEEe
Confidence 35566789999999999974 6899988632211 1345778899999999999999988776 899999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCcc
Q 010401 415 LMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN---DHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT 491 (511)
Q Consensus 415 y~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH---~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~ 491 (511)
|+++|+|.++++ .+++..+..++.||+.||+||| +.+|+||||||+||+++.++..++. ||....... .
T Consensus 764 y~~~g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~----~ 835 (968)
T PLN00113 764 YIEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT----D 835 (968)
T ss_pred CCCCCcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc----C
Confidence 999999999985 3889999999999999999999 6699999999999999999888876 666543321 1
Q ss_pred ccccCCCccccHHhhcc
Q 010401 492 EYETDGYRWLAPEVCFL 508 (511)
Q Consensus 492 ~~~~Gt~~YmAPEvl~g 508 (511)
....+++.|||||++.+
T Consensus 836 ~~~~~t~~y~aPE~~~~ 852 (968)
T PLN00113 836 TKCFISSAYVAPETRET 852 (968)
T ss_pred CCccccccccCcccccC
Confidence 23367899999999765
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=6.8e-21 Score=182.29 Aligned_cols=138 Identities=14% Similarity=0.106 Sum_probs=106.1
Q ss_pred EeeeecccceEEEEe-----EEEEEEEEecCCCCchH------------------------HHHHHHHHHHHHhCCCCce
Q 010401 345 IDQIGPNSFKGVYKG-----KRVGIEKLKGCDKGNAY------------------------EFELRKDLLELMTCGHKNI 395 (511)
Q Consensus 345 ~~~LG~GsFG~VYkg-----k~VAVKkL~~~~~~~~~------------------------~~~~~~Ei~iL~~l~HpNI 395 (511)
...||+|+||.||+| +.||+|+++........ .....+|+..+..+.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 367999999999995 57999999753221111 1123458888888887776
Q ss_pred eeEeeeEeeCCCcEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HHCCccccCCCCCceEEcCCCcEE
Q 010401 396 LQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFL-NDHGVAYRDLNSQRILLDRHGNVC 474 (511)
Q Consensus 396 V~l~g~~~~~~~~l~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yL-H~~gIIHRDLKp~NILld~~g~vK 474 (511)
.....+.. .+ .+|||||++++++...+.....+++..+..++.|++.+|.|+ |+.||+||||||+|||++ ++.++
T Consensus 82 ~~p~~~~~-~~--~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~ 157 (190)
T cd05147 82 PCPEPILL-KS--HVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLY 157 (190)
T ss_pred CCCcEEEe-cC--CEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEE
Confidence 44332222 22 479999999987766544556899999999999999999999 799999999999999998 57899
Q ss_pred EEecCCceeccc
Q 010401 475 LGDMGIVTACKS 486 (511)
Q Consensus 475 L~DFGlS~~l~~ 486 (511)
|+|||+|.....
T Consensus 158 LiDFG~a~~~~~ 169 (190)
T cd05147 158 IIDVSQSVEHDH 169 (190)
T ss_pred EEEccccccCCC
Confidence 999999876533
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.84 E-value=8.7e-20 Score=167.66 Aligned_cols=159 Identities=35% Similarity=0.551 Sum_probs=133.7
Q ss_pred eecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEEeccCCCCH
Q 010401 348 IGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSV 421 (511)
Q Consensus 348 LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVmEy~~gGsL 421 (511)
||+|++|.||++ +.+++|++....... ....+.+|+..++.+.|++|+++++++..... .+++|||+.+++|
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~-~~~~~e~~~~~~l 78 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDENH-LYLVMEYCEGGSL 78 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCe-EEEEEecCCCCcH
Confidence 689999999996 458889886432221 34568899999999999999999999987765 8999999999999
Q ss_pred HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcC-CCcEEEEecCCceecccCCCccccccCCCc
Q 010401 422 NDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDR-HGNVCLGDMGIVTACKSVGEATEYETDGYR 499 (511)
Q Consensus 422 ~~lL~~~-~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~-~g~vKL~DFGlS~~l~~~~~~~~~~~Gt~~ 499 (511)
.+++... ..+++..+..++.+++.++.|||+.|++|+||+|.||+++. ++.++|+|||.+..............+...
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~ 158 (215)
T cd00180 79 KDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPA 158 (215)
T ss_pred HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCCCC
Confidence 9999665 47899999999999999999999999999999999999999 899999999998766443222334556788
Q ss_pred cccHHhhcc
Q 010401 500 WLAPEVCFL 508 (511)
Q Consensus 500 YmAPEvl~g 508 (511)
|++||.+..
T Consensus 159 ~~~pe~~~~ 167 (215)
T cd00180 159 YMAPEVLLG 167 (215)
T ss_pred ccChhHhcc
Confidence 999998754
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=8.5e-20 Score=173.85 Aligned_cols=138 Identities=15% Similarity=0.122 Sum_probs=107.8
Q ss_pred EeeeecccceEEEEe-----EEEEEEEEecCCCCch------------------------HHHHHHHHHHHHHhCCCCce
Q 010401 345 IDQIGPNSFKGVYKG-----KRVGIEKLKGCDKGNA------------------------YEFELRKDLLELMTCGHKNI 395 (511)
Q Consensus 345 ~~~LG~GsFG~VYkg-----k~VAVKkL~~~~~~~~------------------------~~~~~~~Ei~iL~~l~HpNI 395 (511)
...||+|+||.||+| +.||+|++........ ....+.+|...+.++.|++|
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 467999999999995 5899999975421100 01224578888999999988
Q ss_pred eeEeeeEeeCCCcEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCceEEcCCCcEE
Q 010401 396 LQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLND-HGVAYRDLNSQRILLDRHGNVC 474 (511)
Q Consensus 396 V~l~g~~~~~~~~l~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~-~gIIHRDLKp~NILld~~g~vK 474 (511)
.....+.... .||||||++|+++.........++...+..++.|++.++.+||. +||+||||||+|||++ ++.++
T Consensus 82 ~~p~~~~~~~---~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~~ 157 (190)
T cd05145 82 PVPEPILLKK---NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKPY 157 (190)
T ss_pred CCceEEEecC---CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCEE
Confidence 5544443322 47999999987654443344568888999999999999999999 9999999999999999 89999
Q ss_pred EEecCCceeccc
Q 010401 475 LGDMGIVTACKS 486 (511)
Q Consensus 475 L~DFGlS~~l~~ 486 (511)
|+|||+++....
T Consensus 158 liDFG~a~~~~~ 169 (190)
T cd05145 158 IIDVSQAVELDH 169 (190)
T ss_pred EEEcccceecCC
Confidence 999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.1e-19 Score=172.14 Aligned_cols=153 Identities=29% Similarity=0.443 Sum_probs=130.2
Q ss_pred cceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEEeccCCCCHHHHH
Q 010401 352 SFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLI 425 (511)
Q Consensus 352 sFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVmEy~~gGsL~~lL 425 (511)
+||.||++ +.+++|++........ ...+.+|+..+++++|+||+++++.+..... .+++|||+.+++|.+++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~-~~l~~e~~~~~~L~~~~ 78 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFEDEDK-LYLVMEYCDGGDLFDLL 78 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheeeCCE-EEEEEeCCCCCCHHHHH
Confidence 58889885 4689999864332221 4678899999999999999999999987765 89999999999999999
Q ss_pred HhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCccccccCCCccccHHh
Q 010401 426 LKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEV 505 (511)
Q Consensus 426 ~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~~~~~Gt~~YmAPEv 505 (511)
.....+++..+..++.+++.++.|||+.+++|+||+|+||+++.++.++|+|||.+....... ......+++.|++||.
T Consensus 79 ~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~pE~ 157 (244)
T smart00220 79 KKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-LLTTFVGTPEYMAPEV 157 (244)
T ss_pred HhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc-ccccccCCcCCCCHHH
Confidence 766668999999999999999999999999999999999999999999999999988765432 2345567889999998
Q ss_pred hc
Q 010401 506 CF 507 (511)
Q Consensus 506 l~ 507 (511)
+.
T Consensus 158 ~~ 159 (244)
T smart00220 158 LL 159 (244)
T ss_pred Hc
Confidence 75
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.6e-20 Score=190.17 Aligned_cols=164 Identities=21% Similarity=0.296 Sum_probs=135.0
Q ss_pred CCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCC--C----ceeeEeeeEeeCC
Q 010401 339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGH--K----NILQFYCVCVDEN 406 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~H--p----NIV~l~g~~~~~~ 406 (511)
..+|++.+.+|+|.||+|-++ ..||+|+++.. ..+....+-|+.+|.++.+ | -++++.++|.-.+
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V---~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrg 164 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV---DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRG 164 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH---HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccC
Confidence 678999999999999999884 58999999742 3344556778888888832 2 2678888887777
Q ss_pred CcEEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcC---------------
Q 010401 407 HGLCVVTKLMEGGSVNDLILKSR--KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDR--------------- 469 (511)
Q Consensus 407 ~~l~LVmEy~~gGsL~~lL~~~~--~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~--------------- 469 (511)
+ .|||+|.+ |-++.+++..+. +++...++.|+.|++.+++|||+.+++|-||||+|||+.+
T Consensus 165 h-iCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~ 242 (415)
T KOG0671|consen 165 H-ICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCF 242 (415)
T ss_pred c-eEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccce
Confidence 6 99999998 559999997654 7899999999999999999999999999999999999942
Q ss_pred -----CCcEEEEecCCceecccCCCccccccCCCccccHHhhcccC
Q 010401 470 -----HGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEVCFLLL 510 (511)
Q Consensus 470 -----~g~vKL~DFGlS~~l~~~~~~~~~~~Gt~~YmAPEvl~gl~ 510 (511)
+..+||+|||.|+.-.. .......|..|.|||+++||-
T Consensus 243 ~r~~ks~~I~vIDFGsAtf~~e---~hs~iVsTRHYRAPEViLgLG 285 (415)
T KOG0671|consen 243 IRPLKSTAIKVIDFGSATFDHE---HHSTIVSTRHYRAPEVILGLG 285 (415)
T ss_pred eccCCCcceEEEecCCcceecc---CcceeeeccccCCchheeccC
Confidence 22589999999876433 346778899999999999873
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=6.4e-20 Score=198.08 Aligned_cols=159 Identities=21% Similarity=0.352 Sum_probs=130.3
Q ss_pred cCCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhC-CCCceeeEeeeEeeCCCcEE
Q 010401 338 NSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCVCVDENHGLC 410 (511)
Q Consensus 338 ~~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l-~HpNIV~l~g~~~~~~~~l~ 410 (511)
..+.|++...+|.|+|+.|-.+ +..++|.+..... +..+|+.++... +||||+++++++.++.+ .|
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~------~~~~e~~~~~~~~~h~niv~~~~v~~~~~~-~~ 392 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD------DNQDEIPISLLVRDHPNIVKSHDVYEDGKE-IY 392 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheecccccc------ccccccchhhhhcCCCcceeecceecCCce-ee
Confidence 3677899999999999999885 4678888864321 234555454443 89999999999998887 99
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEE-cCCCcEEEEecCCceecccCCC
Q 010401 411 VVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILL-DRHGNVCLGDMGIVTACKSVGE 489 (511)
Q Consensus 411 LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILl-d~~g~vKL~DFGlS~~l~~~~~ 489 (511)
+|||++.|+.+.+.+...+.+. .++..|+.+|+.|+.|||++|||||||||+|||+ +..++++|+|||.++.....
T Consensus 393 ~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-- 469 (612)
T KOG0603|consen 393 LVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-- 469 (612)
T ss_pred eeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh--
Confidence 9999999999988886655554 7888999999999999999999999999999999 69999999999998876543
Q ss_pred ccccccCCCccccHHhhc
Q 010401 490 ATEYETDGYRWLAPEVCF 507 (511)
Q Consensus 490 ~~~~~~Gt~~YmAPEvl~ 507 (511)
....+-|..|.|||++.
T Consensus 470 -~~tp~~t~~y~APEvl~ 486 (612)
T KOG0603|consen 470 -CDTPALTLQYVAPEVLA 486 (612)
T ss_pred -hcccchhhcccChhhhc
Confidence 22335567899999986
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.4e-19 Score=199.69 Aligned_cols=159 Identities=22% Similarity=0.317 Sum_probs=124.6
Q ss_pred EeeeecccceE-EEE----eEEEEEEEEecCCCCchHHHHHHHHHHHHHhC-CCCceeeEeeeEeeCCCcEEEEEeccCC
Q 010401 345 IDQIGPNSFKG-VYK----GKRVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCVCVDENHGLCVVTKLMEG 418 (511)
Q Consensus 345 ~~~LG~GsFG~-VYk----gk~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l-~HpNIV~l~g~~~~~~~~l~LVmEy~~g 418 (511)
.+.+|.|+-|+ ||+ |+.||||.+-. .......+|+..|+.. .|||||++|+.-.+... +||+.|+|..
T Consensus 514 ~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~-----e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF-~YIalELC~~ 587 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVYEGREVAVKRLLE-----EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQF-LYIALELCAC 587 (903)
T ss_pred HHHcccCCCCcEEEEEeeCCceehHHHHhh-----HhHHHHHHHHHHHHhccCCCceEEEEeeccCCce-EEEEehHhhh
Confidence 46688888764 455 58999998852 2233468999999877 79999999987665554 9999999966
Q ss_pred CCHHHHHHhc-C---CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcC---C--CcEEEEecCCceecccCCC
Q 010401 419 GSVNDLILKS-R---KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDR---H--GNVCLGDMGIVTACKSVGE 489 (511)
Q Consensus 419 GsL~~lL~~~-~---~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~---~--g~vKL~DFGlS~~l~~~~~ 489 (511)
+|.+++... . .......+....|++.||++||+.+||||||||.||||+. + ..++|+|||+++.+..+..
T Consensus 588 -sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~s 666 (903)
T KOG1027|consen 588 -SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKS 666 (903)
T ss_pred -hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCcc
Confidence 999999653 1 1112455788999999999999999999999999999986 3 4689999999998865432
Q ss_pred ---ccccccCCCccccHHhhcccC
Q 010401 490 ---ATEYETDGYRWLAPEVCFLLL 510 (511)
Q Consensus 490 ---~~~~~~Gt~~YmAPEvl~gl~ 510 (511)
......||.+|+|||+++..+
T Consensus 667 S~~r~s~~sGt~GW~APE~L~~~~ 690 (903)
T KOG1027|consen 667 SFSRLSGGSGTSGWQAPEQLREDR 690 (903)
T ss_pred hhhcccCCCCcccccCHHHHhccc
Confidence 234567899999999998643
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.3e-18 Score=165.05 Aligned_cols=166 Identities=27% Similarity=0.433 Sum_probs=140.4
Q ss_pred eEEEeeeecccceEEEEeEE---EEEEEEecCCCCch-HHHHHHHHHHHHHhCCCC-ceeeEeeeEeeCCCcEEEEEecc
Q 010401 342 LEFIDQIGPNSFKGVYKGKR---VGIEKLKGCDKGNA-YEFELRKDLLELMTCGHK-NILQFYCVCVDENHGLCVVTKLM 416 (511)
Q Consensus 342 y~l~~~LG~GsFG~VYkgk~---VAVKkL~~~~~~~~-~~~~~~~Ei~iL~~l~Hp-NIV~l~g~~~~~~~~l~LVmEy~ 416 (511)
|.+.+.||.|+||.||++.. +++|.+........ ....+.+|+.++..+.|+ +|+++++.+..... .+++++|+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~-~~~~~~~~ 80 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGS-LYLVMEYV 80 (384)
T ss_pred ceeEEeecCCCCeEEEEEEeccEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCE-EEEEEecC
Confidence 67889999999999999864 58888875444432 466688999999999988 79999999965554 79999999
Q ss_pred CCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCC-cEEEEecCCceecccCCC---
Q 010401 417 EGGSVNDLILKSR---KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG-NVCLGDMGIVTACKSVGE--- 489 (511)
Q Consensus 417 ~gGsL~~lL~~~~---~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g-~vKL~DFGlS~~l~~~~~--- 489 (511)
.++++.+++.... .+.......++.|++.++.|+|+.+++|||+||+||+++..+ .++++|||+++.......
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~ 160 (384)
T COG0515 81 DGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSS 160 (384)
T ss_pred CCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcccc
Confidence 9999998776554 799999999999999999999999999999999999999988 799999999886544332
Q ss_pred ---ccccccCCCccccHHhhcc
Q 010401 490 ---ATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 490 ---~~~~~~Gt~~YmAPEvl~g 508 (511)
......|+..|+|||.+.+
T Consensus 161 ~~~~~~~~~~t~~~~~pe~~~~ 182 (384)
T COG0515 161 IPALPSTSVGTPGYMAPEVLLG 182 (384)
T ss_pred ccccccccccccccCCHHHhcC
Confidence 2356688999999999876
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=7.4e-20 Score=184.42 Aligned_cols=167 Identities=22% Similarity=0.283 Sum_probs=135.1
Q ss_pred CCCeEEEeeeecccceEEEE-----eEEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCC-----Cc
Q 010401 339 SDNLEFIDQIGPNSFKGVYK-----GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN-----HG 408 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYk-----gk~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~-----~~ 408 (511)
..+|.-++.+|.|.-..|-- ++.|++|++...........+..+|+.++..+.|+||++++.+|.-.. ..
T Consensus 16 ~~Ry~nL~p~~~g~~~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQIVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeeecccCCCCceEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 34667778888888833332 578999998754333344566789999999999999999999886443 23
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCC
Q 010401 409 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG 488 (511)
Q Consensus 409 l~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~ 488 (511)
+|+|||||.. +|...+. -.++-..+..++.|++.|++|||+.||+||||||+||++..++.+||.|||+++.-...
T Consensus 96 ~y~v~e~m~~-nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~- 171 (369)
T KOG0665|consen 96 VYLVMELMDA-NLCQVIL--MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD- 171 (369)
T ss_pred HHHHHHhhhh-HHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccCcc-
Confidence 8999999976 9998886 34788899999999999999999999999999999999999999999999999865432
Q ss_pred CccccccCCCccccHHhhccc
Q 010401 489 EATEYETDGYRWLAPEVCFLL 509 (511)
Q Consensus 489 ~~~~~~~Gt~~YmAPEvl~gl 509 (511)
-..+....|..|.|||++.++
T Consensus 172 ~~mtpyVvtRyyrapevil~~ 192 (369)
T KOG0665|consen 172 FMMTPYVVTRYYRAPEVILGM 192 (369)
T ss_pred cccCchhheeeccCchheecc
Confidence 234445667789999999874
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.5e-18 Score=169.21 Aligned_cols=133 Identities=14% Similarity=0.220 Sum_probs=102.8
Q ss_pred EeeeecccceEEEEeE---EEEEEEEecCCCCchHHHHHHHHHHHHHhC-----CCCceeeEeeeEeeCCC--cEE-EEE
Q 010401 345 IDQIGPNSFKGVYKGK---RVGIEKLKGCDKGNAYEFELRKDLLELMTC-----GHKNILQFYCVCVDENH--GLC-VVT 413 (511)
Q Consensus 345 ~~~LG~GsFG~VYkgk---~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l-----~HpNIV~l~g~~~~~~~--~l~-LVm 413 (511)
.+.||+|+||.||... ..+||++.... ......+.+|+.++..+ .||||+++||++.++.. .++ +||
T Consensus 7 ~~~LG~G~~~~Vy~hp~~~~k~IKv~~~~~--~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~ 84 (210)
T PRK10345 7 QSPLGTGRHRKCYAHPEDAQRCIKIVYHRG--DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIA 84 (210)
T ss_pred cceecCCCceEEEECCCCcCeEEEEEeccc--cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEe
Confidence 4789999999999832 23577775422 22345689999999998 67999999999988742 233 789
Q ss_pred ec--cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHH-HHHHHCCccccCCCCCceEEcC----CCcEEEEe-cCCce
Q 010401 414 KL--MEGGSVNDLILKSRKLQTKEIIRIAIDVAEGI-KFLNDHGVAYRDLNSQRILLDR----HGNVCLGD-MGIVT 482 (511)
Q Consensus 414 Ey--~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL-~yLH~~gIIHRDLKp~NILld~----~g~vKL~D-FGlS~ 482 (511)
|| +.+|+|.+++.+ ..+++. ..++.+++.++ +|||+++|+||||||+|||++. ++.++|+| ||...
T Consensus 85 e~~G~~~~tL~~~l~~-~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~~~ 158 (210)
T PRK10345 85 DFDGKPSITLTEFAEQ-CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGEST 158 (210)
T ss_pred cCCCCcchhHHHHHHc-ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCCcc
Confidence 99 557999999965 346655 35678888888 9999999999999999999974 34799999 55433
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.4e-19 Score=189.49 Aligned_cols=167 Identities=22% Similarity=0.278 Sum_probs=137.2
Q ss_pred ecCCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCC------CCceeeEeeeEee
Q 010401 337 LNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCG------HKNILQFYCVCVD 404 (511)
Q Consensus 337 l~~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~------HpNIV~l~g~~~~ 404 (511)
+-..+|.+....|+|-|+.|..| ..||||+|..... -.+.=++|+.+|.+|+ .-|++.|+-.|..
T Consensus 429 ~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~---M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~h 505 (752)
T KOG0670|consen 429 LLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV---MHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKH 505 (752)
T ss_pred hhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH---HhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhh
Confidence 34568999999999999999985 5899999975332 2233478899999873 4678999999988
Q ss_pred CCCcEEEEEeccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCC-CcEEEEecCC
Q 010401 405 ENHGLCVVTKLMEGGSVNDLILKSR---KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRH-GNVCLGDMGI 480 (511)
Q Consensus 405 ~~~~l~LVmEy~~gGsL~~lL~~~~---~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~-g~vKL~DFGl 480 (511)
.++ +|||+|.+.. +|.++|++-+ .|....++.|+.|+..||.+|..+||+|.||||+||||+.. ..+||||||.
T Consensus 506 knH-LClVFE~Lsl-NLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGS 583 (752)
T KOG0670|consen 506 KNH-LCLVFEPLSL-NLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGS 583 (752)
T ss_pred cce-eEEEehhhhc-hHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCcc
Confidence 887 9999999966 9999997644 58889999999999999999999999999999999999965 4579999999
Q ss_pred ceecccCCCccccccCCCccccHHhhcccC
Q 010401 481 VTACKSVGEATEYETDGYRWLAPEVCFLLL 510 (511)
Q Consensus 481 S~~l~~~~~~~~~~~Gt~~YmAPEvl~gl~ 510 (511)
|.....+. .+.|.+ +..|.|||+++|++
T Consensus 584 A~~~~ene-itPYLV-SRFYRaPEIiLG~~ 611 (752)
T KOG0670|consen 584 ASFASENE-ITPYLV-SRFYRAPEIILGLP 611 (752)
T ss_pred cccccccc-ccHHHH-HHhccCcceeecCc
Confidence 88765533 233433 34599999999975
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.8e-19 Score=173.65 Aligned_cols=162 Identities=17% Similarity=0.323 Sum_probs=132.2
Q ss_pred cCCCeEEEeeeecccceEEEEeE------EEEEEEEecCCCCchHHHHHHHHHHHHHhC-CCCceeeEeeeEeeCCC-cE
Q 010401 338 NSDNLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCVCVDENH-GL 409 (511)
Q Consensus 338 ~~~~y~l~~~LG~GsFG~VYkgk------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l-~HpNIV~l~g~~~~~~~-~l 409 (511)
..++|++.+++|+|-|+.||.|. .+.||.+++. ..+.+.+|+.+|..+ .||||++++++..+... ..
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV-----kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktp 110 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV-----KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTP 110 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH-----HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCc
Confidence 57789999999999999999985 5778888743 246689999999998 49999999999987653 26
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCC-CcEEEEecCCceecccCC
Q 010401 410 CVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRH-GNVCLGDMGIVTACKSVG 488 (511)
Q Consensus 410 ~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~-g~vKL~DFGlS~~l~~~~ 488 (511)
.+++||+.+.+...+. ..++...++.++.++++||.|+|+.||.|||+||.|++||.. -.++|+|+|+|.+.-...
T Consensus 111 aLiFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~ 187 (338)
T KOG0668|consen 111 SLIFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 187 (338)
T ss_pred hhHhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCCc
Confidence 7999999998877665 458889999999999999999999999999999999999954 578999999998764432
Q ss_pred CccccccCCCccccHHhhcc
Q 010401 489 EATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 489 ~~~~~~~Gt~~YmAPEvl~g 508 (511)
+ ..-...+..|--||++-.
T Consensus 188 e-YnVRVASRyfKGPELLVd 206 (338)
T KOG0668|consen 188 E-YNVRVASRYFKGPELLVD 206 (338)
T ss_pred e-eeeeeehhhcCCchheee
Confidence 2 223334455777887654
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.5e-17 Score=170.96 Aligned_cols=166 Identities=17% Similarity=0.217 Sum_probs=126.2
Q ss_pred CeEEEeeeecccceEEEEeE-------EEEEEEEecCCCCchHHHHHHHHHHHHHhCC----CCceeeEeeeEeeCCCcE
Q 010401 341 NLEFIDQIGPNSFKGVYKGK-------RVGIEKLKGCDKGNAYEFELRKDLLELMTCG----HKNILQFYCVCVDENHGL 409 (511)
Q Consensus 341 ~y~l~~~LG~GsFG~VYkgk-------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~----HpNIV~l~g~~~~~~~~l 409 (511)
+|++.+.||+|+||.||.+. .+|+|.......... . .+..|..++..+. .+++..+++.....+..-
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~-~-~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~ 96 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP-S-VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFN 96 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC-c-cchhHHHHHHHHhhhcCCCCCCEEEEeccCCCcee
Confidence 78999999999999999975 466666654322221 1 4566777777665 368888888774233337
Q ss_pred EEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCC-----CcEEEEecCCce
Q 010401 410 CVVTKLMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRH-----GNVCLGDMGIVT 482 (511)
Q Consensus 410 ~LVmEy~~gGsL~~lL~~~--~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~-----g~vKL~DFGlS~ 482 (511)
||||+.+ |.+|.++.... +.++...+..++.|++.+|++||+.|++||||||.|+++... ..+.|.|||+++
T Consensus 97 ~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar 175 (322)
T KOG1164|consen 97 FIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLAR 175 (322)
T ss_pred EEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCc
Confidence 8999988 66999988533 589999999999999999999999999999999999999865 469999999998
Q ss_pred --ecccCC-C-------ccccccCCCccccHHhhccc
Q 010401 483 --ACKSVG-E-------ATEYETDGYRWLAPEVCFLL 509 (511)
Q Consensus 483 --~l~~~~-~-------~~~~~~Gt~~YmAPEvl~gl 509 (511)
...... . ......||.+|.++....+.
T Consensus 176 ~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~ 212 (322)
T KOG1164|consen 176 RFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGI 212 (322)
T ss_pred cccccCCCCcccccCCCCccCCCCccccccHHHhCCC
Confidence 432211 1 12234599999999876653
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.5e-17 Score=158.93 Aligned_cols=133 Identities=17% Similarity=0.232 Sum_probs=109.1
Q ss_pred eeeecccceEEEEe----EEEEEEEEecCCCCch------HHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEEec
Q 010401 346 DQIGPNSFKGVYKG----KRVGIEKLKGCDKGNA------YEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKL 415 (511)
Q Consensus 346 ~~LG~GsFG~VYkg----k~VAVKkL~~~~~~~~------~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVmEy 415 (511)
+.||+|++|.||+| ..+++|+......... ...++.+|+.++..+.|++|.....++.+.+. .+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~-~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPEN-FIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCC-CEEEEEE
Confidence 57999999999997 4788887654222111 12347789999999999998877777766665 7899999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceec
Q 010401 416 MEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC 484 (511)
Q Consensus 416 ~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l 484 (511)
++|++|.+++..... ....++.+++.+|.+||+.|++|||++|.|||++ ++.++|+|||+++..
T Consensus 81 ~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~ 144 (211)
T PRK14879 81 IEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEFS 144 (211)
T ss_pred eCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccCC
Confidence 999999999854322 7788999999999999999999999999999999 889999999998754
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.74 E-value=2.3e-18 Score=178.64 Aligned_cols=136 Identities=22% Similarity=0.384 Sum_probs=118.7
Q ss_pred CCCeEEEeeeecccceEEEEe---------EEEEEEEEecCCCCchHHHHHHHHHHHHHhC-CCCceeeEeeeEeeCCCc
Q 010401 339 SDNLEFIDQIGPNSFKGVYKG---------KRVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCVCVDENHG 408 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkg---------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l-~HpNIV~l~g~~~~~~~~ 408 (511)
.+.|..+++||.|+|+.||++ +.||+|.+...... .++..|++.|..+ .+.||+++.+.+...++
T Consensus 35 ~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p----~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~- 109 (418)
T KOG1167|consen 35 SNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP----SRILNELEMLYRLGGSDNIIKLNGCFRNNDQ- 109 (418)
T ss_pred hhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc----hHHHHHHHHHHHhccchhhhcchhhhccCCe-
Confidence 456788999999999999985 47999999753332 4578999999887 79999999999887776
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEc-CCCcEEEEecCCce
Q 010401 409 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLD-RHGNVCLGDMGIVT 482 (511)
Q Consensus 409 l~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld-~~g~vKL~DFGlS~ 482 (511)
..+||||++.....+++.. ++...+..|+..++.||.|+|.+|||||||||+|+|.+ ..+.-.|+|||++.
T Consensus 110 v~ivlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~ 181 (418)
T KOG1167|consen 110 VAIVLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQ 181 (418)
T ss_pred eEEEecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHH
Confidence 9999999999999888754 66889999999999999999999999999999999998 56788999999986
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.6e-18 Score=171.81 Aligned_cols=164 Identities=16% Similarity=0.292 Sum_probs=127.3
Q ss_pred CCCeEEEeeeecccceEEEEeE------EEEEEEEecCCCCchHHHHHHHHHHHHHhC-CCCceeeEeeeEeeCCCcEEE
Q 010401 339 SDNLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCVCVDENHGLCV 411 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkgk------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l-~HpNIV~l~g~~~~~~~~l~L 411 (511)
.+.|.+.+.||+|.||++-+++ .+++|.+.+. .....+|.+|...--.| .|.||+.-|++..+..+.+.+
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p---~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF 99 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP---QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVF 99 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc---hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEE
Confidence 4568899999999999999974 5778877632 22345677887654444 699999988765544444789
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEc--CCCcEEEEecCCceecccCCC
Q 010401 412 VTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLD--RHGNVCLGDMGIVTACKSVGE 489 (511)
Q Consensus 412 VmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld--~~g~vKL~DFGlS~~l~~~~~ 489 (511)
+|||++.|+|..-+.. ..+.+.....++.|+++|+.|||++++||||||.+||||- +...+||||||+++..+..
T Consensus 100 ~qE~aP~gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~t-- 176 (378)
T KOG1345|consen 100 VQEFAPRGDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTT-- 176 (378)
T ss_pred eeccCccchhhhhcCc-ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCce--
Confidence 9999999999887643 4577888899999999999999999999999999999996 3458999999998765432
Q ss_pred ccccccCCCccccHHhhccc
Q 010401 490 ATEYETDGYRWLAPEVCFLL 509 (511)
Q Consensus 490 ~~~~~~Gt~~YmAPEvl~gl 509 (511)
..+..-+..|-+||++..+
T Consensus 177 -V~~~~~~~~y~~pe~~~~~ 195 (378)
T KOG1345|consen 177 -VKYLEYVNNYHAPELCDTV 195 (378)
T ss_pred -ehhhhhhcccCCcHHHhhc
Confidence 2333445678999988654
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=3.4e-17 Score=159.57 Aligned_cols=154 Identities=12% Similarity=0.089 Sum_probs=112.2
Q ss_pred EEeeeecccceEEEEeE----EEEEEEEecCCC--CchHHHHHHHHHHHHHhC-CCCceeeEeeeEeeCCCcEEEEEecc
Q 010401 344 FIDQIGPNSFKGVYKGK----RVGIEKLKGCDK--GNAYEFELRKDLLELMTC-GHKNILQFYCVCVDENHGLCVVTKLM 416 (511)
Q Consensus 344 l~~~LG~GsFG~VYkgk----~VAVKkL~~~~~--~~~~~~~~~~Ei~iL~~l-~HpNIV~l~g~~~~~~~~l~LVmEy~ 416 (511)
....|++|+||+||... .++.+.+..... .......+.+|+.+|.++ +|++|++++++ +. .|++|||+
T Consensus 6 ~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~-~~lvmeyI 80 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRGGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DG-RHLDRSYL 80 (218)
T ss_pred cceeecCCCcceEEEeecCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cC-EEEEEeee
Confidence 45789999999999853 444444432111 011122478999999999 45889999886 22 78999999
Q ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCC-CCCceEEcCCCcEEEEecCCceecccCCCc-----
Q 010401 417 EGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDL-NSQRILLDRHGNVCLGDMGIVTACKSVGEA----- 490 (511)
Q Consensus 417 ~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDL-Kp~NILld~~g~vKL~DFGlS~~l~~~~~~----- 490 (511)
.|.+|...+.. . ...++.|++.+|+++|++||+|||| ||+|||++.++.++|+|||++.........
T Consensus 81 ~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~ 153 (218)
T PRK12274 81 AGAAMYQRPPR------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLA 153 (218)
T ss_pred cCccHHhhhhh------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHHH
Confidence 99998755321 1 1357789999999999999999999 799999999999999999999865433310
Q ss_pred --------cccccCCCccccHHhhccc
Q 010401 491 --------TEYETDGYRWLAPEVCFLL 509 (511)
Q Consensus 491 --------~~~~~Gt~~YmAPEvl~gl 509 (511)
......++.|++|+.-..|
T Consensus 154 ~rDl~~llk~~~~y~~~~l~~~~~~~l 180 (218)
T PRK12274 154 REDLRHLLKHKRMYCPAALTPVERRVL 180 (218)
T ss_pred HHHHHHHHHHHHhcCCCCCCHHHHhhh
Confidence 1112357788999876554
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.7e-17 Score=155.01 Aligned_cols=129 Identities=16% Similarity=0.210 Sum_probs=102.5
Q ss_pred eeecccceEEEEeE----EEEEEEEecCCCCc-h-----HHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEEecc
Q 010401 347 QIGPNSFKGVYKGK----RVGIEKLKGCDKGN-A-----YEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLM 416 (511)
Q Consensus 347 ~LG~GsFG~VYkgk----~VAVKkL~~~~~~~-~-----~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVmEy~ 416 (511)
.||+|+||.||+|. .+++|+........ . ...++.+|+.++..+.|+++.....++...+. .+++|||+
T Consensus 1 ~ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~-~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDN-KTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCC-CEEEEEEE
Confidence 48999999999976 78888865322111 1 12456789999999988876555545555554 78999999
Q ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceec
Q 010401 417 EGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC 484 (511)
Q Consensus 417 ~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l 484 (511)
+|++|.+++..... .++.+++.+|.+||+.|++|||++|+||+++ ++.++++|||++...
T Consensus 80 ~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 80 EGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred CCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 99999998754321 7899999999999999999999999999999 899999999998764
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.71 E-value=2.9e-17 Score=162.66 Aligned_cols=140 Identities=15% Similarity=0.144 Sum_probs=108.3
Q ss_pred CeEEEeeeecccceEEEEeE-------EEEEEEEecCCCCc-------------------h---HHHHHHHHHHHHHhCC
Q 010401 341 NLEFIDQIGPNSFKGVYKGK-------RVGIEKLKGCDKGN-------------------A---YEFELRKDLLELMTCG 391 (511)
Q Consensus 341 ~y~l~~~LG~GsFG~VYkgk-------~VAVKkL~~~~~~~-------------------~---~~~~~~~Ei~iL~~l~ 391 (511)
-|.+.+.||+|+||.||+|. .||+|+++...... . ....+.+|+..+.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47888999999999999975 69999987532110 0 1123568899998886
Q ss_pred CCc--eeeEeeeEeeCCCcEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC-ccccCCCCCceEEc
Q 010401 392 HKN--ILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHG-VAYRDLNSQRILLD 468 (511)
Q Consensus 392 HpN--IV~l~g~~~~~~~~l~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~g-IIHRDLKp~NILld 468 (511)
+.+ +.++++. . . .++||||+.+++|.........+....+..++.||+.+|.|||.+| |+||||||+||+++
T Consensus 109 ~~~i~~p~~~~~---~-~-~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~ 183 (237)
T smart00090 109 EAGVPVPKPIAW---R-R-NVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH 183 (237)
T ss_pred hcCCCCCeeeEe---c-C-ceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE
Confidence 533 3344432 2 2 5799999999888766544455667778899999999999999999 99999999999999
Q ss_pred CCCcEEEEecCCceeccc
Q 010401 469 RHGNVCLGDMGIVTACKS 486 (511)
Q Consensus 469 ~~g~vKL~DFGlS~~l~~ 486 (511)
++.++|+|||.+.....
T Consensus 184 -~~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 184 -DGKVVIIDVSQSVELDH 200 (237)
T ss_pred -CCCEEEEEChhhhccCC
Confidence 88999999999876544
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.71 E-value=1e-16 Score=158.23 Aligned_cols=138 Identities=12% Similarity=0.133 Sum_probs=111.2
Q ss_pred CCCeEEEeeeecccceEEEEe----EEEEEEEEecCCCCchH-HHH------HHHHHHHHHhCCCCceeeEeeeEeeCC-
Q 010401 339 SDNLEFIDQIGPNSFKGVYKG----KRVGIEKLKGCDKGNAY-EFE------LRKDLLELMTCGHKNILQFYCVCVDEN- 406 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkg----k~VAVKkL~~~~~~~~~-~~~------~~~Ei~iL~~l~HpNIV~l~g~~~~~~- 406 (511)
.++|+.++.||.|+||.||+. +.+++|.+......... ... +++|+..+.++.|++|..+.+++.+..
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~ 109 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAER 109 (232)
T ss_pred hCceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeeccc
Confidence 678999999999999999994 46999999754333221 111 578888999999999999988866432
Q ss_pred ------CcEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCC
Q 010401 407 ------HGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGI 480 (511)
Q Consensus 407 ------~~l~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGl 480 (511)
...+++|||++|.+|.++. .+++ ....+|+.+|..+|+.|++|||+||+||+++.+| ++|+|||.
T Consensus 110 ~~~~~~~~~~lvmEyi~G~tL~~~~----~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liDfg~ 180 (232)
T PRK10359 110 KTLRYAHTYIMLIEYIEGVELNDMP----EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIIDLSG 180 (232)
T ss_pred ccccccCCeEEEEEEECCccHHHhh----hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEECCC
Confidence 2378999999999998874 2333 2456999999999999999999999999999988 99999999
Q ss_pred ceecc
Q 010401 481 VTACK 485 (511)
Q Consensus 481 S~~l~ 485 (511)
.+...
T Consensus 181 ~~~~~ 185 (232)
T PRK10359 181 KRCTA 185 (232)
T ss_pred ccccc
Confidence 77653
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.70 E-value=9.1e-17 Score=176.31 Aligned_cols=134 Identities=16% Similarity=0.152 Sum_probs=107.7
Q ss_pred eEEEeeeecccceEEEEeE----EEEEEEEecCC-CCc-----hHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEE
Q 010401 342 LEFIDQIGPNSFKGVYKGK----RVGIEKLKGCD-KGN-----AYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCV 411 (511)
Q Consensus 342 y~l~~~LG~GsFG~VYkgk----~VAVKkL~~~~-~~~-----~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~L 411 (511)
|...+.||+|+||.||+|+ .+++|+..... ... ....++.+|+.++..++|++|+..+.++.+.+. .++
T Consensus 335 ~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~-~~l 413 (535)
T PRK09605 335 KIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE-KTI 413 (535)
T ss_pred cCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC-CEE
Confidence 3557899999999999953 45555432211 111 123457899999999999999988777776655 789
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecc
Q 010401 412 VTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK 485 (511)
Q Consensus 412 VmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~ 485 (511)
||||+++++|.+++. ....++.+++.+|.|||++||+||||||+|||+ .++.++|+|||+++...
T Consensus 414 v~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~~~ 478 (535)
T PRK09605 414 VMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYSD 478 (535)
T ss_pred EEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCcccccCC
Confidence 999999999999884 356789999999999999999999999999999 67899999999998654
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.4e-16 Score=155.99 Aligned_cols=161 Identities=19% Similarity=0.270 Sum_probs=122.6
Q ss_pred ecCCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCC-CceeeEeeeEeeCCCcE
Q 010401 337 LNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGH-KNILQFYCVCVDENHGL 409 (511)
Q Consensus 337 l~~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~H-pNIV~l~g~~~~~~~~l 409 (511)
+-..+|+++++||.|+||.+|.| ..||||.-...... -++..|..+...+++ ..|..+..+...... -
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h----pqL~yEskvY~iL~~g~GiP~i~~y~~e~~y-n 86 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH----PQLLYESKVYRILQGGVGIPHIRHYGTEKDY-N 86 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC----cchhHHHHHHHHhccCCCCchhhhhcccccc-c
Confidence 45788999999999999999995 58999977532222 234566666666644 555555555544443 6
Q ss_pred EEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcC---CCcEEEEecCCceecc
Q 010401 410 CVVTKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDR---HGNVCLGDMGIVTACK 485 (511)
Q Consensus 410 ~LVmEy~~gGsL~~lL~~-~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~---~g~vKL~DFGlS~~l~ 485 (511)
.+||+++ |-+|.+++.- .+.++..+++-++.|++.-++|+|.+++|||||||+|+|..- -..+.++|||+|+...
T Consensus 87 vlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~ 165 (341)
T KOG1163|consen 87 VLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR 165 (341)
T ss_pred eeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhc
Confidence 7999998 7799999863 457899999999999999999999999999999999999973 3568999999998875
Q ss_pred cCCCc-------cccccCCCccccH
Q 010401 486 SVGEA-------TEYETDGYRWLAP 503 (511)
Q Consensus 486 ~~~~~-------~~~~~Gt~~YmAP 503 (511)
+.... .....||.+|.+-
T Consensus 166 d~~t~~HIpyre~r~ltGTaRYASi 190 (341)
T KOG1163|consen 166 DIRTRQHIPYREDRNLTGTARYASI 190 (341)
T ss_pred cccccccCccccCCccceeeeehhh
Confidence 43321 2234678888763
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.69 E-value=2.3e-16 Score=160.16 Aligned_cols=161 Identities=20% Similarity=0.332 Sum_probs=124.9
Q ss_pred ecCCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhC-CCCceeeEeeeEeeCCCcE
Q 010401 337 LNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCVCVDENHGL 409 (511)
Q Consensus 337 l~~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l-~HpNIV~l~g~~~~~~~~l 409 (511)
+-.-.|+++++||+|+||.++.| +.||||.-....... ++..|-...+.| ..++|.+.|-+...+.+ -
T Consensus 25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~AP----QLrdEYr~YKlL~g~~GIP~vYYFGqeG~~-N 99 (449)
T KOG1165|consen 25 MVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAP----QLRDEYRTYKLLGGTEGIPQVYYFGQEGKY-N 99 (449)
T ss_pred EecccceeccccccCcceeeecccccccCceEEEEeccccCCcc----hHHHHHHHHHHHcCCCCCCceeeeccccch-h
Confidence 34567999999999999999997 479999765322222 234444444444 67999998855554444 5
Q ss_pred EEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCC-----CcEEEEecCCcee
Q 010401 410 CVVTKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRH-----GNVCLGDMGIVTA 483 (511)
Q Consensus 410 ~LVmEy~~gGsL~~lL~~-~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~-----g~vKL~DFGlS~~ 483 (511)
.||||++ |-+|.|++.- .++++.+.+..++.|++.-++|+|++.+|+|||||+|+||... ..+.|+|||+|+.
T Consensus 100 iLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~ 178 (449)
T KOG1165|consen 100 ILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE 178 (449)
T ss_pred hhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence 6999998 6799999864 4589999999999999999999999999999999999999744 4689999999998
Q ss_pred cccCCCc-------cccccCCCccccH
Q 010401 484 CKSVGEA-------TEYETDGYRWLAP 503 (511)
Q Consensus 484 l~~~~~~-------~~~~~Gt~~YmAP 503 (511)
..++... .....||-+||+=
T Consensus 179 YrDp~TkqHIPYrE~KSLsGTARYMSI 205 (449)
T KOG1165|consen 179 YRDPKTKQHIPYREHKSLSGTARYMSI 205 (449)
T ss_pred hcCccccccCccccccccccceeeeEe
Confidence 7654432 1234689999973
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.2e-16 Score=150.79 Aligned_cols=134 Identities=16% Similarity=0.162 Sum_probs=102.4
Q ss_pred eEEEeeeecccceEEEEe-----EEEEEEEEecCCCCc--------------------hHHHHHHHHHHHHHhCCCCc--
Q 010401 342 LEFIDQIGPNSFKGVYKG-----KRVGIEKLKGCDKGN--------------------AYEFELRKDLLELMTCGHKN-- 394 (511)
Q Consensus 342 y~l~~~LG~GsFG~VYkg-----k~VAVKkL~~~~~~~--------------------~~~~~~~~Ei~iL~~l~HpN-- 394 (511)
|.+.+.||+|+||.||++ +.||||++....... ........|+..+..+.|++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 96 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP 96 (198)
T ss_pred hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence 667789999999999985 579999876422110 01122567888888887774
Q ss_pred eeeEeeeEeeCCCcEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEE
Q 010401 395 ILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVC 474 (511)
Q Consensus 395 IV~l~g~~~~~~~~l~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vK 474 (511)
++..++ ... .++||||++|++|..+... .....++.+|+.++.++|..||+||||||+||+++.++.++
T Consensus 97 v~~~~~----~~~-~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~ 165 (198)
T cd05144 97 VPKPID----WNR-HAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIY 165 (198)
T ss_pred CCceee----cCC-ceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEE
Confidence 444443 222 6899999999998765421 34567889999999999999999999999999999999999
Q ss_pred EEecCCceeccc
Q 010401 475 LGDMGIVTACKS 486 (511)
Q Consensus 475 L~DFGlS~~l~~ 486 (511)
|+|||++.....
T Consensus 166 liDfg~~~~~~~ 177 (198)
T cd05144 166 IIDWPQMVSTDH 177 (198)
T ss_pred EEECCccccCCC
Confidence 999999866543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.64 E-value=4.2e-15 Score=156.82 Aligned_cols=130 Identities=22% Similarity=0.362 Sum_probs=108.8
Q ss_pred ecCCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhC--------CCCceeeEeeeE
Q 010401 337 LNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTC--------GHKNILQFYCVC 402 (511)
Q Consensus 337 l~~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l--------~HpNIV~l~g~~ 402 (511)
+...+|.++++||-|-|++||++ +.||+|+.+. ...+......||.+|+.+ ...+||+|++.|
T Consensus 75 F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS---AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~F 151 (590)
T KOG1290|consen 75 FNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS---AQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHF 151 (590)
T ss_pred ccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh---hhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccc
Confidence 45688999999999999999996 6899999963 344555678899998875 235799999999
Q ss_pred eeCC---CcEEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCceEEcCC
Q 010401 403 VDEN---HGLCVVTKLMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLND-HGVAYRDLNSQRILLDRH 470 (511)
Q Consensus 403 ~~~~---~~l~LVmEy~~gGsL~~lL~~~--~~L~e~~~~~ia~qIa~gL~yLH~-~gIIHRDLKp~NILld~~ 470 (511)
...+ ..+|||+|++ |-+|..+|... +.++...+..|+.||+.||.|||+ +||||-||||+|||+..+
T Consensus 152 khsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~ 224 (590)
T KOG1290|consen 152 KHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCST 224 (590)
T ss_pred eecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeecc
Confidence 6543 2399999999 55999998653 579999999999999999999995 799999999999999754
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.63 E-value=4.2e-16 Score=160.75 Aligned_cols=174 Identities=16% Similarity=0.254 Sum_probs=138.6
Q ss_pred cceEecCCCeEEEeeeecccceEEEEeEE-----------EEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeee
Q 010401 333 GRWLLNSDNLEFIDQIGPNSFKGVYKGKR-----------VGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV 401 (511)
Q Consensus 333 ~~~~l~~~~y~l~~~LG~GsFG~VYkgk~-----------VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~ 401 (511)
.+..+..+++++...+-+|.||.||.|.+ |-+|.++. ..+......++.|...+..+.|||++++.++
T Consensus 277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~-~AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQ-HASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHh-cccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 34556778899999999999999999943 34555543 2333344557888888888999999999999
Q ss_pred EeeCCCcEEEEEeccCCCCHHHHHH-----h---cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcE
Q 010401 402 CVDENHGLCVVTKLMEGGSVNDLIL-----K---SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 473 (511)
Q Consensus 402 ~~~~~~~l~LVmEy~~gGsL~~lL~-----~---~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~v 473 (511)
+..+....++++.++..|+|..+|. + ...+...++..++.|++.||+|||++||||.||..+|++||+.-.|
T Consensus 356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqV 435 (563)
T KOG1024|consen 356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQV 435 (563)
T ss_pred EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeE
Confidence 9776655789999999999999996 2 1357778889999999999999999999999999999999999999
Q ss_pred EEEecCCceecccCCCc--cccccCCCccccHHhhc
Q 010401 474 CLGDMGIVTACKSVGEA--TEYETDGYRWLAPEVCF 507 (511)
Q Consensus 474 KL~DFGlS~~l~~~~~~--~~~~~Gt~~YmAPEvl~ 507 (511)
||+|=.++|.+-..+.. ........+||+||.+.
T Consensus 436 kltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~ 471 (563)
T KOG1024|consen 436 KLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQ 471 (563)
T ss_pred EeccchhccccCcccccccCCCCCCcccccCHHHHh
Confidence 99999999876432211 11222347899999875
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.61 E-value=8.6e-17 Score=174.05 Aligned_cols=156 Identities=17% Similarity=0.277 Sum_probs=129.9
Q ss_pred eeecccceEEEEe---------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCC-CCceeeEeeeEeeCCCcEEEEEecc
Q 010401 347 QIGPNSFKGVYKG---------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCG-HKNILQFYCVCVDENHGLCVVTKLM 416 (511)
Q Consensus 347 ~LG~GsFG~VYkg---------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~-HpNIV~l~g~~~~~~~~l~LVmEy~ 416 (511)
.+|+|+||+|++. +.+|.|.+++.............|..++..++ ||+++.++..++.+.. ++++++|.
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~k-l~l~ld~~ 79 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGK-LYLILDFL 79 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccc-hhHhhhhc
Confidence 3799999999983 35677777643222221123445666677775 9999999999988877 99999999
Q ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCccccccC
Q 010401 417 EGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETD 496 (511)
Q Consensus 417 ~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~~~~~G 496 (511)
.+|+|...+.....+.+.....+..+++.+++++|+.+|+|||+|++||+++.+|++++.|||+++....... .||
T Consensus 80 rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~----~cg 155 (612)
T KOG0603|consen 80 RGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI----ACG 155 (612)
T ss_pred ccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhh----ccc
Confidence 9999999988888899999999999999999999999999999999999999999999999999988765332 299
Q ss_pred CCccccHHhhc
Q 010401 497 GYRWLAPEVCF 507 (511)
Q Consensus 497 t~~YmAPEvl~ 507 (511)
|+.|||||++.
T Consensus 156 t~eymApEI~~ 166 (612)
T KOG0603|consen 156 TYEYRAPEIIN 166 (612)
T ss_pred chhhhhhHhhh
Confidence 99999999987
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.61 E-value=3.1e-15 Score=140.29 Aligned_cols=134 Identities=17% Similarity=0.191 Sum_probs=93.3
Q ss_pred EeeeecccceEEEEe-----EEEEEEEEecCCCCchHHHH----------------------HHHHHHHHHhCCCCc--e
Q 010401 345 IDQIGPNSFKGVYKG-----KRVGIEKLKGCDKGNAYEFE----------------------LRKDLLELMTCGHKN--I 395 (511)
Q Consensus 345 ~~~LG~GsFG~VYkg-----k~VAVKkL~~~~~~~~~~~~----------------------~~~Ei~iL~~l~HpN--I 395 (511)
.+.||+|+||.||++ +.||+|++............ ...|...+..+.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 467999999999995 57999998753221111111 134555555554332 4
Q ss_pred eeEeeeEeeCCCcEEEEEeccCCCCHHH-HHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCceEEcCCCcE
Q 010401 396 LQFYCVCVDENHGLCVVTKLMEGGSVND-LILKSRKLQTKEIIRIAIDVAEGIKFLND-HGVAYRDLNSQRILLDRHGNV 473 (511)
Q Consensus 396 V~l~g~~~~~~~~l~LVmEy~~gGsL~~-lL~~~~~L~e~~~~~ia~qIa~gL~yLH~-~gIIHRDLKp~NILld~~g~v 473 (511)
.+.++. .. .++||||++++.+.. .+.... .. ..+..++.+++.++.++|. ++|+||||||+||+++ ++.+
T Consensus 82 ~~~~~~----~~-~~lv~e~~~g~~~~~~~l~~~~-~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~ 153 (187)
T cd05119 82 PKPIDL----NR-HVLVMEFIGGDGIPAPRLKDVR-LL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKV 153 (187)
T ss_pred CceEec----CC-CEEEEEEeCCCCccChhhhhhh-hc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcE
Confidence 444432 12 689999999854322 111111 11 6678899999999999999 9999999999999999 9999
Q ss_pred EEEecCCceeccc
Q 010401 474 CLGDMGIVTACKS 486 (511)
Q Consensus 474 KL~DFGlS~~l~~ 486 (511)
+|+|||.+.....
T Consensus 154 ~liDfg~a~~~~~ 166 (187)
T cd05119 154 YIIDVPQAVEIDH 166 (187)
T ss_pred EEEECcccccccC
Confidence 9999999876544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.60 E-value=2.5e-15 Score=132.46 Aligned_cols=128 Identities=15% Similarity=0.116 Sum_probs=104.8
Q ss_pred EeeeecccceEEEEeE----EEEEEEEecCCCCchHHHHHHHHHHHHHhCCC--CceeeEeeeEeeCCCcEEEEEeccCC
Q 010401 345 IDQIGPNSFKGVYKGK----RVGIEKLKGCDKGNAYEFELRKDLLELMTCGH--KNILQFYCVCVDENHGLCVVTKLMEG 418 (511)
Q Consensus 345 ~~~LG~GsFG~VYkgk----~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~H--pNIV~l~g~~~~~~~~l~LVmEy~~g 418 (511)
.+.||.|.++.||+++ .+++|....... ...+.+|+..+..+.| .++++++++...++. .+++|||+.+
T Consensus 3 ~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~-~~~v~e~~~g 77 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKDEDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGESDGW-SYLLMEWIEG 77 (155)
T ss_pred ceecccccccceEEEEecCCeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCc-cEEEEEecCC
Confidence 4789999999999964 678887753222 4557888888888876 588899888776654 8999999998
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCCCceEEcCCCcEEEEecCCceec
Q 010401 419 GSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDH---GVAYRDLNSQRILLDRHGNVCLGDMGIVTAC 484 (511)
Q Consensus 419 GsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~---gIIHRDLKp~NILld~~g~vKL~DFGlS~~l 484 (511)
+.+..+ +......++.+++.+|.+||.. +++|+|++|+||+++..+.++++|||.++..
T Consensus 78 ~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 78 ETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred eecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence 777644 4556677899999999999984 7999999999999999899999999997643
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.59 E-value=2e-14 Score=142.56 Aligned_cols=135 Identities=17% Similarity=0.105 Sum_probs=97.7
Q ss_pred eeeecccceEEEE-eEEEEEEEEecCCC-----------CchHHHHHHHHHHHHHhCCCCce--eeEeeeEeeCCCc---
Q 010401 346 DQIGPNSFKGVYK-GKRVGIEKLKGCDK-----------GNAYEFELRKDLLELMTCGHKNI--LQFYCVCVDENHG--- 408 (511)
Q Consensus 346 ~~LG~GsFG~VYk-gk~VAVKkL~~~~~-----------~~~~~~~~~~Ei~iL~~l~HpNI--V~l~g~~~~~~~~--- 408 (511)
+..|.|+...|+. +..+++|.+..... ......++.+|+.++..+.|++| +..+++.......
T Consensus 41 ~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~~~~~ 120 (239)
T PRK01723 41 SAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHGLFYR 120 (239)
T ss_pred cCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecCccee
Confidence 3444444444444 56788887753110 11233457889999999988875 6667665443322
Q ss_pred EEEEEeccCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecc
Q 010401 409 LCVVTKLMEG-GSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK 485 (511)
Q Consensus 409 l~LVmEy~~g-GsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~ 485 (511)
.++||||++| .+|.+++.. ..+++.. +.+|+.+|.+||++||+||||||+|||++.++.++|+|||.+....
T Consensus 121 ~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~~~~~ 193 (239)
T PRK01723 121 ADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRGELRT 193 (239)
T ss_pred eeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCcccCC
Confidence 2599999997 689988754 4555543 5689999999999999999999999999999999999999987643
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.58 E-value=7.4e-16 Score=176.32 Aligned_cols=119 Identities=8% Similarity=0.108 Sum_probs=86.3
Q ss_pred CCC-CceeeEeeeEee------CCCcEEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCC
Q 010401 390 CGH-KNILQFYCVCVD------ENHGLCVVTKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLN 461 (511)
Q Consensus 390 l~H-pNIV~l~g~~~~------~~~~l~LVmEy~~gGsL~~lL~~-~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLK 461 (511)
+.| +||..++++|.. ...+++++|||+ +++|.++|.. ...+++..+..++.||+.||.|||++||+|||||
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlK 107 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVR 107 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCC
Confidence 345 577777777611 112377888988 5599999965 3569999999999999999999999999999999
Q ss_pred CCceEEcCC-------------------CcEEEEecCCceecccCCC----------------ccccccCCCccccHHhh
Q 010401 462 SQRILLDRH-------------------GNVCLGDMGIVTACKSVGE----------------ATEYETDGYRWLAPEVC 506 (511)
Q Consensus 462 p~NILld~~-------------------g~vKL~DFGlS~~l~~~~~----------------~~~~~~Gt~~YmAPEvl 506 (511)
|+||||+.. +.+||+|||+++....... ......||+.|||||++
T Consensus 108 P~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~ 187 (793)
T PLN00181 108 PSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEED 187 (793)
T ss_pred chhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhh
Confidence 999999654 4556666666653211000 01113578889999998
Q ss_pred ccc
Q 010401 507 FLL 509 (511)
Q Consensus 507 ~gl 509 (511)
.+.
T Consensus 188 ~~~ 190 (793)
T PLN00181 188 NGS 190 (793)
T ss_pred ccC
Confidence 753
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.55 E-value=1.2e-14 Score=166.32 Aligned_cols=172 Identities=18% Similarity=0.182 Sum_probs=126.5
Q ss_pred ccceEecCCCeEEEeeeecccceEEEEe-----EEEEEEEEecCCCCchHHHHHHHHHHHHHhCC---CCceeeEeeeEe
Q 010401 332 IGRWLLNSDNLEFIDQIGPNSFKGVYKG-----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCG---HKNILQFYCVCV 403 (511)
Q Consensus 332 i~~~~l~~~~y~l~~~LG~GsFG~VYkg-----k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~---HpNIV~l~g~~~ 403 (511)
...+++..+.|.+.++||+|+||+||+| +.||+|+=+.. ..+++.+-. .++.+|+ -+.|+.+..+..
T Consensus 690 ~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~---~~WEfYI~~--q~~~RLk~~~~~~~~~~~~a~~ 764 (974)
T KOG1166|consen 690 NTEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPP---NPWEFYICL--QVMERLKPQMLPSIMHISSAHV 764 (974)
T ss_pred cceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCC---CceeeeehH--HHHHhhchhhhcchHHHHHHHc
Confidence 3467788899999999999999999995 68999987532 222222222 1222222 233444444433
Q ss_pred eCCCcEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcC-------CCcEEEE
Q 010401 404 DENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDR-------HGNVCLG 476 (511)
Q Consensus 404 ~~~~~l~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~-------~g~vKL~ 476 (511)
-.+. -++|+||.+.|+|.++++..+.+++..+..++.|++.-+++||..+|||+||||+|+||.. ..-++|+
T Consensus 765 ~~~~-S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lI 843 (974)
T KOG1166|consen 765 FQNA-SVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLI 843 (974)
T ss_pred cCCc-ceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEE
Confidence 3443 5699999999999999998889999999999999999999999999999999999999952 3458999
Q ss_pred ecCCceeccc--CCCccccccCCCccccHHhhccc
Q 010401 477 DMGIVTACKS--VGEATEYETDGYRWLAPEVCFLL 509 (511)
Q Consensus 477 DFGlS~~l~~--~~~~~~~~~Gt~~YmAPEvl~gl 509 (511)
|||-+--+.- ++..-...++|-.+-.+|+..|-
T Consensus 844 DfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~gr 878 (974)
T KOG1166|consen 844 DFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGR 878 (974)
T ss_pred ecccceeeeEcCCCcEEeeeeccccchhHHHhcCC
Confidence 9999855432 22233445666667778877653
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.55 E-value=2.3e-15 Score=167.30 Aligned_cols=165 Identities=18% Similarity=0.247 Sum_probs=124.5
Q ss_pred EEEeeeecccceEEEEeEEE------EEEEEe----cCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEE
Q 010401 343 EFIDQIGPNSFKGVYKGKRV------GIEKLK----GCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV 412 (511)
Q Consensus 343 ~l~~~LG~GsFG~VYkgk~V------AVKkL~----~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LV 412 (511)
.....+|.|++|.|+....+ +.|... ...........+..|..+-..+.|+|++.....+.+... .+-.
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~-~~~~ 399 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDG-ILQS 399 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhccc-chhh
Confidence 45678999999977764322 222211 111111112225556666667899999888777766654 4455
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCC---
Q 010401 413 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE--- 489 (511)
Q Consensus 413 mEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~--- 489 (511)
||||++ +|..++...+.+...++..++.|++.|++|||..||.|||+|++|+++..+|.+||+|||.+.......+
T Consensus 400 mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~ 478 (601)
T KOG0590|consen 400 MEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNI 478 (601)
T ss_pred hhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcchhh
Confidence 999999 9999997777899999999999999999999999999999999999999999999999999876543332
Q ss_pred -ccccccCCCccccHHhhccc
Q 010401 490 -ATEYETDGYRWLAPEVCFLL 509 (511)
Q Consensus 490 -~~~~~~Gt~~YmAPEvl~gl 509 (511)
.....+|+-.|+|||++.+.
T Consensus 479 ~~~~g~~gS~pY~apE~~~~~ 499 (601)
T KOG0590|consen 479 HESSGIVGSDPYLAPEVLTGK 499 (601)
T ss_pred hhhcCcccCCcCcCccccccc
Confidence 24456788899999998653
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.34 E-value=4.9e-12 Score=136.04 Aligned_cols=137 Identities=18% Similarity=0.204 Sum_probs=91.8
Q ss_pred eeeecccceEEEEe-----EEEEEEEEecCCCCch--------------------------------------HHHHHHH
Q 010401 346 DQIGPNSFKGVYKG-----KRVGIEKLKGCDKGNA--------------------------------------YEFELRK 382 (511)
Q Consensus 346 ~~LG~GsFG~VYkg-----k~VAVKkL~~~~~~~~--------------------------------------~~~~~~~ 382 (511)
+.||.|++|+||+| +.||||+.++...... .+..+.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 56999999999995 5799999875321100 0011334
Q ss_pred HHHHHHhC----CCCceeeEeeeEeeCCCcEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHH-HHHHHHHCCcc
Q 010401 383 DLLELMTC----GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAE-GIKFLNDHGVA 456 (511)
Q Consensus 383 Ei~iL~~l----~HpNIV~l~g~~~~~~~~l~LVmEy~~gGsL~~lL~~~-~~L~e~~~~~ia~qIa~-gL~yLH~~gII 456 (511)
|...+.++ .|.+-+.+-.++.+.....++||||++|++|.++.... ...+ ...++..++. .+..+|..|++
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g~~ 279 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDGFF 279 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCCce
Confidence 44444433 23333333333332222368999999999998876432 1222 2345555555 46789999999
Q ss_pred ccCCCCCceEEcCCCcEEEEecCCceecc
Q 010401 457 YRDLNSQRILLDRHGNVCLGDMGIVTACK 485 (511)
Q Consensus 457 HRDLKp~NILld~~g~vKL~DFGlS~~l~ 485 (511)
|+|+||.||+++.++.++++|||++..+.
T Consensus 280 H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 280 HADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred eCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 99999999999999999999999987764
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.32 E-value=5e-13 Score=151.74 Aligned_cols=165 Identities=18% Similarity=0.191 Sum_probs=126.5
Q ss_pred CeEEEeeeecccceEEEEeE----EEEEEEEecCCCCch--HHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEEe
Q 010401 341 NLEFIDQIGPNSFKGVYKGK----RVGIEKLKGCDKGNA--YEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTK 414 (511)
Q Consensus 341 ~y~l~~~LG~GsFG~VYkgk----~VAVKkL~~~~~~~~--~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVmE 414 (511)
++...+.||.+.|=+|.+++ .|.||++.+....-. ...+..+|+. ....+|||++++.-+-..+.. .|||-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kA-AylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKA-AYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCceEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHH-HHHHHH
Confidence 67889999999999999975 488998875443322 2233344444 455699999999877666654 789999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceec--ccCC-Ccc
Q 010401 415 LMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC--KSVG-EAT 491 (511)
Q Consensus 415 y~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l--~~~~-~~~ 491 (511)
|..+ +|+|.|..+.-+..-+...|+.|++.||.-+|..||+|+|||.+||||..-+.+.|+||..-+.. ..+. ...
T Consensus 102 yvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPadf 180 (1431)
T KOG1240|consen 102 YVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPADF 180 (1431)
T ss_pred HHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCcccc
Confidence 9977 99999977777888888999999999999999999999999999999999999999999874432 1111 112
Q ss_pred ccccCC----CccccHHhhcc
Q 010401 492 EYETDG----YRWLAPEVCFL 508 (511)
Q Consensus 492 ~~~~Gt----~~YmAPEvl~g 508 (511)
.+...| ..|+|||.|--
T Consensus 181 ~fFFDTSrRRtCYiAPERFv~ 201 (1431)
T KOG1240|consen 181 TFFFDTSRRRTCYIAPERFVS 201 (1431)
T ss_pred eEEEecCCceeeecChHhhhc
Confidence 233333 46999998753
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.25 E-value=2.3e-11 Score=111.76 Aligned_cols=124 Identities=15% Similarity=0.132 Sum_probs=89.3
Q ss_pred EeeeecccceEEEEe----EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCcee-eEeeeEeeCCCcEEEEEeccCCC
Q 010401 345 IDQIGPNSFKGVYKG----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNIL-QFYCVCVDENHGLCVVTKLMEGG 419 (511)
Q Consensus 345 ~~~LG~GsFG~VYkg----k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV-~l~g~~~~~~~~l~LVmEy~~gG 419 (511)
++.|+.|.++.||+. +.+++|....... ....+.+|+..+..+.+.+++ +++... ... -++||||++|.
T Consensus 3 ~~~l~~G~~~~vy~~~~~~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~-~~lv~e~i~G~ 76 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVANKKYVVRIPGNGTE---LLINRENEAENSKLAAEAGIGPKLYYFD--PET-GVLITEFIEGS 76 (170)
T ss_pred eeecCCcccCceEEEEECCeEEEEEeCCCCcc---cccCHHHHHHHHHHHHHhCCCCceEEEe--CCC-CeEEEEecCCC
Confidence 367899999999984 5788887753221 122356777777777554443 444433 222 47999999998
Q ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCc-----cccCCCCCceEEcCCCcEEEEecCCcee
Q 010401 420 SVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGV-----AYRDLNSQRILLDRHGNVCLGDMGIVTA 483 (511)
Q Consensus 420 sL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gI-----IHRDLKp~NILld~~g~vKL~DFGlS~~ 483 (511)
++... . . ....++.+++.+|..||..++ +|+|++|.||+++ ++.++++|||.+..
T Consensus 77 ~l~~~----~-~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 77 ELLTE----D-F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred ccccc----c-c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 87643 0 1 113456789999999999885 9999999999999 67899999999764
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.24 E-value=2.4e-11 Score=112.26 Aligned_cols=78 Identities=24% Similarity=0.259 Sum_probs=67.7
Q ss_pred CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCccccccCC
Q 010401 419 GSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG 497 (511)
Q Consensus 419 GsL~~lL~~-~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~~~~~Gt 497 (511)
|+|.+++.. ...+++..++.++.||+.||.|||+++ ||+|||++.++.+|+ ||+++..... ...||
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~-----~~~g~ 67 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE-----QSRVD 67 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc-----cCCCc
Confidence 689999976 456999999999999999999999998 999999999999999 9998876432 22688
Q ss_pred CccccHHhhccc
Q 010401 498 YRWLAPEVCFLL 509 (511)
Q Consensus 498 ~~YmAPEvl~gl 509 (511)
+.|||||++.+.
T Consensus 68 ~~y~aPE~~~~~ 79 (176)
T smart00750 68 PYFMAPEVIQGQ 79 (176)
T ss_pred ccccChHHhcCC
Confidence 999999998753
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.23 E-value=1.5e-11 Score=134.98 Aligned_cols=139 Identities=17% Similarity=0.157 Sum_probs=89.5
Q ss_pred CCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCc--------------------------------hHHHH--
Q 010401 340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGN--------------------------------AYEFE-- 379 (511)
Q Consensus 340 ~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~--------------------------------~~~~~-- 379 (511)
.+|+. +.||.|++|+||++ +.||||++++..... .....
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 34555 78999999999984 579999997531100 11111
Q ss_pred ----HHHHHHHHHhC----CCCceeeEeeeEeeCCCcEEEEEeccCCCCHHHHH--HhcC----CCCHHHHHHHHHHHHH
Q 010401 380 ----LRKDLLELMTC----GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLI--LKSR----KLQTKEIIRIAIDVAE 445 (511)
Q Consensus 380 ----~~~Ei~iL~~l----~HpNIV~l~g~~~~~~~~l~LVmEy~~gGsL~~lL--~~~~----~L~e~~~~~ia~qIa~ 445 (511)
+.+|+..+.++ .+.+.+.+-.++.+-...-+|||||+.|+.+.++- ...+ .+.+..+..++.||
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-- 276 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-- 276 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH--
Confidence 33343333333 23333443334433222367999999999998753 2222 23333344444444
Q ss_pred HHHHHHHCCccccCCCCCceEEcCCC----cEEEEecCCceeccc
Q 010401 446 GIKFLNDHGVAYRDLNSQRILLDRHG----NVCLGDMGIVTACKS 486 (511)
Q Consensus 446 gL~yLH~~gIIHRDLKp~NILld~~g----~vKL~DFGlS~~l~~ 486 (511)
+..|++|+|+||.||+++.+| .++++|||++..+..
T Consensus 277 -----f~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 277 -----FRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred -----HhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 469999999999999999888 999999999877643
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.20 E-value=4.7e-11 Score=124.21 Aligned_cols=118 Identities=25% Similarity=0.337 Sum_probs=89.3
Q ss_pred CCCceeeEeeeEee--------------------------CCCcEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHH
Q 010401 391 GHKNILQFYCVCVD--------------------------ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVA 444 (511)
Q Consensus 391 ~HpNIV~l~g~~~~--------------------------~~~~l~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa 444 (511)
.|||||.+.++|.+ .+..+|+||.-++. +|..++-.+ ..+....+-++.|++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~-~~s~r~~~~~laQlL 351 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTR-HRSYRTGRVILAQLL 351 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcC-CCchHHHHHHHHHHH
Confidence 69999998887653 12238999999877 999998543 456777888999999
Q ss_pred HHHHHHHHCCccccCCCCCceEEc--CCC--cEEEEecCCceecccCCCcc------ccccCCCccccHHhhcccC
Q 010401 445 EGIKFLNDHGVAYRDLNSQRILLD--RHG--NVCLGDMGIVTACKSVGEAT------EYETDGYRWLAPEVCFLLL 510 (511)
Q Consensus 445 ~gL~yLH~~gIIHRDLKp~NILld--~~g--~vKL~DFGlS~~l~~~~~~~------~~~~Gt~~YmAPEvl~gl~ 510 (511)
+|+.|||++||.|||+|.+|||+. +++ .+.|+|||++-..+..+-.. ....|.-.-||||+....+
T Consensus 352 Eav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P 427 (598)
T KOG4158|consen 352 EAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP 427 (598)
T ss_pred HHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCC
Confidence 999999999999999999999995 343 46899999975544322211 1234556789999986544
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.15 E-value=5e-10 Score=114.14 Aligned_cols=163 Identities=16% Similarity=0.183 Sum_probs=98.3
Q ss_pred CeEEEeeeecccceEEEEe------EEEEEEEEecCCCCch-HHHHHHHHHHHHHhCCC----------CceeeEeeeEe
Q 010401 341 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNA-YEFELRKDLLELMTCGH----------KNILQFYCVCV 403 (511)
Q Consensus 341 ~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~-~~~~~~~Ei~iL~~l~H----------pNIV~l~g~~~ 403 (511)
.+.....||.|+|+.||.+ +.+|+|+......... ..+.+.+|......+.+ -.++.-++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 3577899999999999994 6789998864443322 34445666544444322 11221122111
Q ss_pred ---------eCC---C----cEEEEEeccCCCCHHHHHH---hcCC----CCHHHHHHHHHHHHHHHHHHHHCCccccCC
Q 010401 404 ---------DEN---H----GLCVVTKLMEGGSVNDLIL---KSRK----LQTKEIIRIAIDVAEGIKFLNDHGVAYRDL 460 (511)
Q Consensus 404 ---------~~~---~----~l~LVmEy~~gGsL~~lL~---~~~~----L~e~~~~~ia~qIa~gL~yLH~~gIIHRDL 460 (511)
... . ..+++|+-+.+ +|.+++. .... +.......+..|+++.+++||..|++|+||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~-dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi 171 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQG-DLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI 171 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--SE-EHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred EcCCCcceecCCCCccceeehhhhccchhhh-cHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence 110 0 14678888855 9988864 2221 222333456689999999999999999999
Q ss_pred CCCceEEcCCCcEEEEecCCceecccCCCccccccCCCccccHHhhc
Q 010401 461 NSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEVCF 507 (511)
Q Consensus 461 Kp~NILld~~g~vKL~DFGlS~~l~~~~~~~~~~~Gt~~YmAPEvl~ 507 (511)
+|+|++++.+|.++|+||+.....+.. ......+..|.+||...
T Consensus 172 ~~~nfll~~~G~v~Lg~F~~~~r~g~~---~~~~~~~~~~~PPe~~~ 215 (288)
T PF14531_consen 172 KPENFLLDQDGGVFLGDFSSLVRAGTR---YRCSEFPVAFTPPELES 215 (288)
T ss_dssp SGGGEEE-TTS-EEE--GGGEEETTEE---EEGGGS-TTTS-HHHHH
T ss_pred ceeeEEEcCCCCEEEcChHHHeecCce---eeccCCCcccCChhhhh
Confidence 999999999999999999987655431 22233446789999763
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.11 E-value=7.3e-12 Score=139.47 Aligned_cols=168 Identities=18% Similarity=0.233 Sum_probs=133.8
Q ss_pred CCeEEEeeeecccceEEEEe-------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCC-CCceeeEeeeEeeCCCcEEE
Q 010401 340 DNLEFIDQIGPNSFKGVYKG-------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCG-HKNILQFYCVCVDENHGLCV 411 (511)
Q Consensus 340 ~~y~l~~~LG~GsFG~VYkg-------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~-HpNIV~l~g~~~~~~~~l~L 411 (511)
..|.+.+.||+|+|+.|-.. ..+++|.+............+..|..+-..+. |+|++.+++....... .++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~-~~~ 98 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRS-YLL 98 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcc-ccc
Confidence 34677788999999999874 24566666543333334445566777767776 9999999999887775 889
Q ss_pred EEeccCCCCHHHHH-HhcC-CCCHHHHHHHHHHHHHHHHHHH-HCCccccCCCCCceEEcCCC-cEEEEecCCceeccc-
Q 010401 412 VTKLMEGGSVNDLI-LKSR-KLQTKEIIRIAIDVAEGIKFLN-DHGVAYRDLNSQRILLDRHG-NVCLGDMGIVTACKS- 486 (511)
Q Consensus 412 VmEy~~gGsL~~lL-~~~~-~L~e~~~~~ia~qIa~gL~yLH-~~gIIHRDLKp~NILld~~g-~vKL~DFGlS~~l~~- 486 (511)
+++|..++++.+.+ .... ..+...+-.++.|+..++.|+| ..++.|||+||+|.+++..+ ..++.|||+|.....
T Consensus 99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~ 178 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNK 178 (601)
T ss_pred ccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhcccccc
Confidence 99999999999988 4443 5778888999999999999999 99999999999999999999 999999999987655
Q ss_pred CCC--ccccccC-CCccccHHhhcc
Q 010401 487 VGE--ATEYETD-GYRWLAPEVCFL 508 (511)
Q Consensus 487 ~~~--~~~~~~G-t~~YmAPEvl~g 508 (511)
.+. .....+| ++.|+|||.+.+
T Consensus 179 ~g~~~~~~~~~g~s~~y~a~E~~~~ 203 (601)
T KOG0590|consen 179 NGAERSLKDRCGSSPPYGAPEHLSG 203 (601)
T ss_pred CCcceeeecccCCCCCCCCcccccc
Confidence 222 3445678 999999999865
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.10 E-value=9.1e-10 Score=106.62 Aligned_cols=100 Identities=18% Similarity=0.203 Sum_probs=74.3
Q ss_pred HHHHHHHHhCCC--CceeeEeeeEeeCCCcEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HHCCccc
Q 010401 381 RKDLLELMTCGH--KNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFL-NDHGVAY 457 (511)
Q Consensus 381 ~~Ei~iL~~l~H--pNIV~l~g~~~~~~~~l~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yL-H~~gIIH 457 (511)
++|+..|.++.. -++...+++ .+ -+|||||+.+..+..-..+...++......+..+++.+|.+| |+.||||
T Consensus 74 ~kE~r~L~rl~~~Gv~vP~pi~~---~~--~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVH 148 (197)
T cd05146 74 EKEMHNLKRMQKAGIPCPEVVVL---KK--HVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVH 148 (197)
T ss_pred HHHHHHHHHHHHcCCCCCeEEEe---cC--CEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 478888888743 455566643 22 479999997654432221223455666778889999999998 8999999
Q ss_pred cCCCCCceEEcCCCcEEEEecCCceeccc
Q 010401 458 RDLNSQRILLDRHGNVCLGDMGIVTACKS 486 (511)
Q Consensus 458 RDLKp~NILld~~g~vKL~DFGlS~~l~~ 486 (511)
+||++.|||++ ++.++|+|||-+.....
T Consensus 149 GDLs~~NIL~~-~~~v~iIDF~qav~~~h 176 (197)
T cd05146 149 ADLSEYNMLWH-DGKVWFIDVSQSVEPTH 176 (197)
T ss_pred CCCCHHHEEEE-CCcEEEEECCCceeCCC
Confidence 99999999997 57899999999876543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.07 E-value=4.1e-11 Score=119.49 Aligned_cols=168 Identities=17% Similarity=0.303 Sum_probs=127.8
Q ss_pred ecCCCeEEEeeeecccceEEEEeE----EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEE
Q 010401 337 LNSDNLEFIDQIGPNSFKGVYKGK----RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV 412 (511)
Q Consensus 337 l~~~~y~l~~~LG~GsFG~VYkgk----~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LV 412 (511)
++..++.++.+|.+...|..|+|+ .+.+|++............|..|.-.|+-+.||||+.++|.|....+ +.++
T Consensus 187 id~~~lnl~tkl~e~hsgelwrgrwqgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppn-lv~i 265 (448)
T KOG0195|consen 187 IDVSSLNLITKLAESHSGELWRGRWQGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPN-LVII 265 (448)
T ss_pred cchhhhhhhhhhccCCCcccccccccCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCC-ceEe
Confidence 344566778889999999999986 46677776655555555667888888888899999999999998876 8899
Q ss_pred EeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC-ccc-cCCCCCceEEcCCCcEEEEecCCceecccCC
Q 010401 413 TKLMEGGSVNDLILKSR--KLQTKEIIRIAIDVAEGIKFLNDHG-VAY-RDLNSQRILLDRHGNVCLGDMGIVTACKSVG 488 (511)
Q Consensus 413 mEy~~gGsL~~lL~~~~--~L~e~~~~~ia~qIa~gL~yLH~~g-IIH-RDLKp~NILld~~g~vKL~DFGlS~~l~~~~ 488 (511)
..||+.|+|+.+|.... .++..++.+++.+|++|+.|||+.. ++- --|....+++|++.+.+|+ .+-+++.-
T Consensus 266 sq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltaris-mad~kfsf--- 341 (448)
T KOG0195|consen 266 SQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARIS-MADTKFSF--- 341 (448)
T ss_pred eeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhhee-cccceeee---
Confidence 99999999999997543 5778899999999999999999864 443 3688999999999888775 12111110
Q ss_pred CccccccCCCccccHHhhcccC
Q 010401 489 EATEYETDGYRWLAPEVCFLLL 510 (511)
Q Consensus 489 ~~~~~~~Gt~~YmAPEvl~gl~ 510 (511)
......-.+.||+||.+..-+
T Consensus 342 -qe~gr~y~pawmspealqrkp 362 (448)
T KOG0195|consen 342 -QEVGRAYSPAWMSPEALQRKP 362 (448)
T ss_pred -eccccccCcccCCHHHHhcCc
Confidence 011223357899999987543
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.06 E-value=9.1e-11 Score=133.51 Aligned_cols=130 Identities=20% Similarity=0.332 Sum_probs=89.2
Q ss_pred CCCeEEEeeeecccceEEEEeEE------EEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEE
Q 010401 339 SDNLEFIDQIGPNSFKGVYKGKR------VGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV 412 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkgk~------VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LV 412 (511)
..+|+.++.|..|+||.||..+. +|+ ++.+ ++ .+.+. ++.....|++ |
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~-kiNk---q~----lilRn--ilt~a~npfv----------------v 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAM-KINK---QN----LILRN--ILTFAGNPFV----------------V 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhh-cccc---cc----hhhhc--cccccCCcce----------------e
Confidence 45789999999999999999743 444 2321 11 11111 1222223322 2
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCC----
Q 010401 413 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG---- 488 (511)
Q Consensus 413 mEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~---- 488 (511)
|+-..+++..++++... +.+++|||+.||+|||+||+|.||..-|++|+.|||+++...-..
T Consensus 136 ------gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl 201 (1205)
T KOG0606|consen 136 ------GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNL 201 (1205)
T ss_pred ------chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchh
Confidence 56666666556666433 889999999999999999999999999999999999976431100
Q ss_pred -----------CccccccCCCccccHHhhcc
Q 010401 489 -----------EATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 489 -----------~~~~~~~Gt~~YmAPEvl~g 508 (511)
-.....+||+.|.|||++..
T Consensus 202 ~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilr 232 (1205)
T KOG0606|consen 202 KEGHIEKDTHEFQDKQVCGTPEYIAPEVILR 232 (1205)
T ss_pred hhcchHHHHHHhhhccccCCccccChhhhhh
Confidence 01234589999999999864
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.03 E-value=2.5e-10 Score=123.42 Aligned_cols=120 Identities=23% Similarity=0.320 Sum_probs=98.8
Q ss_pred HhCCCCceeeEeeeEeeCCCcEEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCc-cccCCCCCce
Q 010401 388 MTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGV-AYRDLNSQRI 465 (511)
Q Consensus 388 ~~l~HpNIV~l~g~~~~~~~~l~LVmEy~~gGsL~~lL~~-~~~L~e~~~~~ia~qIa~gL~yLH~~gI-IHRDLKp~NI 465 (511)
+.+.|.|+.+++|.+.++.. .++|.+||..|+|.+.+.. .-.+++.-...++.+|+.||.|||...| .|+.++..|+
T Consensus 2 ~~l~h~n~~~f~g~~~~~~~-~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 2 RQLDHDNLNKFIGASVDGPE-MIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred cccchhhhhhheeeEecCCc-eEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 46789999999999999976 8999999999999999965 3478888888999999999999998665 9999999999
Q ss_pred EEcCCCcEEEEecCCceecccCC--CccccccCCCccccHHhhcc
Q 010401 466 LLDRHGNVCLGDMGIVTACKSVG--EATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 466 Lld~~g~vKL~DFGlS~~l~~~~--~~~~~~~Gt~~YmAPEvl~g 508 (511)
++|..+.+||+|||+........ .......-..-|.|||++++
T Consensus 81 lvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~ 125 (484)
T KOG1023|consen 81 LVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRG 125 (484)
T ss_pred eeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcc
Confidence 99999999999999976653210 11111112356999999986
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.01 E-value=2.1e-09 Score=102.75 Aligned_cols=130 Identities=15% Similarity=0.146 Sum_probs=90.8
Q ss_pred eeeecccceEEEEeE----EEEEEEEe-cCCCCch-----HHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEEec
Q 010401 346 DQIGPNSFKGVYKGK----RVGIEKLK-GCDKGNA-----YEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKL 415 (511)
Q Consensus 346 ~~LG~GsFG~VYkgk----~VAVKkL~-~~~~~~~-----~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVmEy 415 (511)
..+++|+-+.||.+. .+.+|.-. +...... ...+..+|+.++.++.--.|..-+-+..+.+. ..|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~-~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDN-GLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeeccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCC-CEEEEEE
Confidence 357888988888863 33333221 1111111 23346778888888755454444444555554 5699999
Q ss_pred cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceec
Q 010401 416 MEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC 484 (511)
Q Consensus 416 ~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l 484 (511)
++|-.|.+++... ...++..+-.-+.-||..||||+||.++||++..++ +.++|||++...
T Consensus 81 I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~s 141 (204)
T COG3642 81 IEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEFS 141 (204)
T ss_pred eCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCccccc
Confidence 9999999888654 245667777778889999999999999999998655 999999998754
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.94 E-value=3.6e-09 Score=100.74 Aligned_cols=136 Identities=15% Similarity=0.183 Sum_probs=96.9
Q ss_pred eeeecccceEEEEe-----EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCC--CceeeEeeeEeeCC--CcEEEEEecc
Q 010401 346 DQIGPNSFKGVYKG-----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGH--KNILQFYCVCVDEN--HGLCVVTKLM 416 (511)
Q Consensus 346 ~~LG~GsFG~VYkg-----k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~H--pNIV~l~g~~~~~~--~~l~LVmEy~ 416 (511)
+.|+.|.++.||+. +.+++|........ .....+..|..++..+.+ .++.+++.+..... ...++||||+
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 66899999999994 56778876532221 123457888888888765 34566776655432 1368999999
Q ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH--------------------------------------------
Q 010401 417 EGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLND-------------------------------------------- 452 (511)
Q Consensus 417 ~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~-------------------------------------------- 452 (511)
+|.++.+.+.. ..+++.....++.+++.+|.+||+
T Consensus 83 ~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (223)
T cd05154 83 DGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLL 161 (223)
T ss_pred CCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHH
Confidence 99888765421 346666667777777777777773
Q ss_pred ------------CCccccCCCCCceEEcC--CCcEEEEecCCcee
Q 010401 453 ------------HGVAYRDLNSQRILLDR--HGNVCLGDMGIVTA 483 (511)
Q Consensus 453 ------------~gIIHRDLKp~NILld~--~g~vKL~DFGlS~~ 483 (511)
..++|+|+++.||+++. ++.+.|+||+.+..
T Consensus 162 ~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 162 RWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 23699999999999998 66789999998754
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.86 E-value=1.8e-08 Score=96.37 Aligned_cols=140 Identities=19% Similarity=0.247 Sum_probs=97.4
Q ss_pred EEeeeecccceEEEEe----EEEEEEEEec-----CC-CCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEE
Q 010401 344 FIDQIGPNSFKGVYKG----KRVGIEKLKG-----CD-KGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT 413 (511)
Q Consensus 344 l~~~LG~GsFG~VYkg----k~VAVKkL~~-----~~-~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVm 413 (511)
.+..|-+|+-+.|+++ +...||.-.. .. .......+..+|+..|.++.--.|.--.-++.|.+. -.|+|
T Consensus 11 ~l~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~-~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYG-GQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCC-CeEEE
Confidence 4567889999999985 3444443211 11 111234557889999988755455433334555554 57999
Q ss_pred eccCC-CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCC---cEEEEecCCceec
Q 010401 414 KLMEG-GSVNDLILKSR--KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG---NVCLGDMGIVTAC 484 (511)
Q Consensus 414 Ey~~g-GsL~~lL~~~~--~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g---~vKL~DFGlS~~l 484 (511)
||++| .++.+++.... .........++..|-..+.-||.++|||+||..+||++..++ .+.++|||++...
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS 166 (229)
T ss_pred EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence 99977 58888886432 223333378899999999999999999999999999998665 3589999997643
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.81 E-value=5.2e-08 Score=98.64 Aligned_cols=104 Identities=11% Similarity=0.046 Sum_probs=77.5
Q ss_pred HHHHHHHHHhCCCCcee--eEeeeEeeC----CCcEEEEEeccCCC-CHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHH
Q 010401 380 LRKDLLELMTCGHKNIL--QFYCVCVDE----NHGLCVVTKLMEGG-SVNDLILK--SRKLQTKEIIRIAIDVAEGIKFL 450 (511)
Q Consensus 380 ~~~Ei~iL~~l~HpNIV--~l~g~~~~~----~~~l~LVmEy~~gG-sL~~lL~~--~~~L~e~~~~~ia~qIa~gL~yL 450 (511)
+.+|...+.+|...+|. ...++.... ...-+||||++++. +|.+++.. ....+......++.+++..+.-|
T Consensus 75 a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~L 154 (268)
T PRK15123 75 ADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDM 154 (268)
T ss_pred HHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHH
Confidence 56777777666333332 233333321 12268999999886 89998853 34456677789999999999999
Q ss_pred HHCCccccCCCCCceEEcC-------CCcEEEEecCCcee
Q 010401 451 NDHGVAYRDLNSQRILLDR-------HGNVCLGDMGIVTA 483 (511)
Q Consensus 451 H~~gIIHRDLKp~NILld~-------~g~vKL~DFGlS~~ 483 (511)
|..||+|+|+++.|||++. ++.+.|+||+.+..
T Consensus 155 H~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 155 HAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred HHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence 9999999999999999985 46899999998754
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.77 E-value=4.4e-09 Score=114.25 Aligned_cols=169 Identities=15% Similarity=0.134 Sum_probs=131.7
Q ss_pred CCeEEEeeeec--ccceEEEEe--------EEEEEEEEecCCCCchHHHHHHHHHHHHHhC-CCCceeeEeeeEeeCCCc
Q 010401 340 DNLEFIDQIGP--NSFKGVYKG--------KRVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCVCVDENHG 408 (511)
Q Consensus 340 ~~y~l~~~LG~--GsFG~VYkg--------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l-~HpNIV~l~g~~~~~~~~ 408 (511)
..+.+.+.+|. |.+|.||.+ ..+|+|+-+...........-.+|+..-+.+ .|+|.++.+..+...+.
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~- 192 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGI- 192 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCc-
Confidence 34566788999 999999995 3578887554333333333345666555555 69999998988887776
Q ss_pred EEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHH----HHHHHHHCCccccCCCCCceEEcCC-CcEEEEecCCce
Q 010401 409 LCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAE----GIKFLNDHGVAYRDLNSQRILLDRH-GNVCLGDMGIVT 482 (511)
Q Consensus 409 l~LVmEy~~gGsL~~lL~~~~-~L~e~~~~~ia~qIa~----gL~yLH~~gIIHRDLKp~NILld~~-g~vKL~DFGlS~ 482 (511)
+|+-+|++. .+|..+..... -++...++.++.+... ||.++|..+++|-|+||.||....+ ...++.|||+..
T Consensus 193 lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~ 271 (524)
T KOG0601|consen 193 LFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLVS 271 (524)
T ss_pred ceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcceeE
Confidence 889999885 58888876544 3888899999999999 9999999999999999999999998 788999999988
Q ss_pred ecccCCCccccc-----cCCCccccHHhhcccC
Q 010401 483 ACKSVGEATEYE-----TDGYRWLAPEVCFLLL 510 (511)
Q Consensus 483 ~l~~~~~~~~~~-----~Gt~~YmAPEvl~gl~ 510 (511)
.+.......... .|...|++||++.++.
T Consensus 272 ~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~ 304 (524)
T KOG0601|consen 272 KISDGNFSSVFKVSKRPEGDCIYAAKELLNGLA 304 (524)
T ss_pred EccCCccccceeeeecCCCCceEeChhhhcccc
Confidence 876654333333 6677899999998764
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.77 E-value=1.8e-09 Score=115.88 Aligned_cols=97 Identities=20% Similarity=0.360 Sum_probs=84.1
Q ss_pred EEEEEeccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecc
Q 010401 409 LCVVTKLMEGGSVNDLILKSR---KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK 485 (511)
Q Consensus 409 l~LVmEy~~gGsL~~lL~~~~---~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~ 485 (511)
+||.|++|...+|.+.|..+. ..+......++.|++.|++| ++.+|||+||.||....+..+||.|||+.....
T Consensus 331 lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~~ 407 (516)
T KOG1033|consen 331 LYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQD 407 (516)
T ss_pred hhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheeecc
Confidence 889999999999999996443 45677888999999999999 999999999999999999999999999987765
Q ss_pred cCC------CccccccCCCccccHHhhcc
Q 010401 486 SVG------EATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 486 ~~~------~~~~~~~Gt~~YmAPEvl~g 508 (511)
... ...+...||..||+||.|.+
T Consensus 408 ~~~~~~~~~a~~t~~~gt~~YmsPEQi~g 436 (516)
T KOG1033|consen 408 KDETVAPAAASHTQQVGTLLYMSPEQIRG 436 (516)
T ss_pred cCCcccchhhhhhhcccccccCCHHHHhh
Confidence 544 13456689999999999985
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.64 E-value=4.1e-07 Score=88.13 Aligned_cols=107 Identities=19% Similarity=0.214 Sum_probs=81.1
Q ss_pred HHHHHHHHHHhCCCCce--eeEeeeEeeCC---CcEEEEEeccCCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH
Q 010401 379 ELRKDLLELMTCGHKNI--LQFYCVCVDEN---HGLCVVTKLMEGG-SVNDLILKSRKLQTKEIIRIAIDVAEGIKFLND 452 (511)
Q Consensus 379 ~~~~Ei~iL~~l~HpNI--V~l~g~~~~~~---~~l~LVmEy~~gG-sL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~ 452 (511)
+..+|...+..+....| ...+++..... ...++|||++++. +|.+++.....++......++.+++..+.-||.
T Consensus 57 ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH~ 136 (206)
T PF06293_consen 57 RAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLHD 136 (206)
T ss_pred HHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHHH
Confidence 46677766665533222 33344443322 2258999999874 799998764457777888999999999999999
Q ss_pred CCccccCCCCCceEEcCCC---cEEEEecCCceecc
Q 010401 453 HGVAYRDLNSQRILLDRHG---NVCLGDMGIVTACK 485 (511)
Q Consensus 453 ~gIIHRDLKp~NILld~~g---~vKL~DFGlS~~l~ 485 (511)
+||+|+|+++.|||++.++ .+.++||+-++...
T Consensus 137 ~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~ 172 (206)
T PF06293_consen 137 AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP 172 (206)
T ss_pred CcCCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence 9999999999999999887 89999999876543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.59 E-value=3.3e-08 Score=107.49 Aligned_cols=145 Identities=15% Similarity=0.149 Sum_probs=114.6
Q ss_pred cCCCeEEEeeeecccceEEEEe-------EEEEEEEEecCCCCchHHHHHHHHHHHHHhC-CCCceeeEeeeEeeCCCcE
Q 010401 338 NSDNLEFIDQIGPNSFKGVYKG-------KRVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCVCVDENHGL 409 (511)
Q Consensus 338 ~~~~y~l~~~LG~GsFG~VYkg-------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l-~HpNIV~l~g~~~~~~~~l 409 (511)
...+|.++..||.|.|+.||+. ..+++|.+.........+..-..|+.+...+ .|.+++.++..|..-.+ .
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~-~ 341 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ-G 341 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc-c
Confidence 3557899999999999999983 3577776654333333333334555544444 68999998888876665 7
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCC-CcEEEEecCCcee
Q 010401 410 CVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRH-GNVCLGDMGIVTA 483 (511)
Q Consensus 410 ~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~-g~vKL~DFGlS~~ 483 (511)
|+-.||+.++++...+.-...+++...+.+..|++.++.++|+..++|+|+||+||++.++ +..++.|||+.+.
T Consensus 342 ~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~ 416 (524)
T KOG0601|consen 342 YIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTR 416 (524)
T ss_pred cCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccc
Confidence 8999999999988777555578889999999999999999999999999999999999986 7889999999764
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.57 E-value=3.4e-07 Score=88.11 Aligned_cols=99 Identities=20% Similarity=0.226 Sum_probs=66.7
Q ss_pred HHHHHHHHHHhCCCC--ceeeEeeeEeeCCCcEEEEEeccC--CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHH-HHHC
Q 010401 379 ELRKDLLELMTCGHK--NILQFYCVCVDENHGLCVVTKLME--GGSVNDLILKSRKLQTKEIIRIAIDVAEGIKF-LNDH 453 (511)
Q Consensus 379 ~~~~Ei~iL~~l~Hp--NIV~l~g~~~~~~~~l~LVmEy~~--gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~y-LH~~ 453 (511)
...+|...|.++..- ++.+.+++ . + -+|||||+. |..+..+.... ++......++.+++..+.. +|..
T Consensus 54 ~~~~E~~~L~~l~~~Gv~vP~p~~~--~-~--~~ivME~I~~~G~~~~~l~~~~--~~~~~~~~~~~~il~~~~~~~~~~ 126 (188)
T PF01163_consen 54 WAKKEFRNLKRLYEAGVPVPKPYDY--N-R--NVIVMEYIGEDGVPLPRLKDVD--LSPEEPKELLEEILEEIIKMLHKA 126 (188)
T ss_dssp HHHHHHHHHHHCCCTT-SS--EEEE--E-T--TEEEEE--EETTEEGGCHHHCG--GGGSTHHHHHHHHHHHHHHHHHCT
T ss_pred HHHHHHHHHHHHHHCCccCCcEEEE--e-C--CEEEEEecCCCccchhhHHhcc--ccchhHHHHHHHHHHHHHHHHHhc
Confidence 467899999998766 45566543 2 2 359999998 65565543221 2244556677788886665 5799
Q ss_pred CccccCCCCCceEEcCCCcEEEEecCCceecc
Q 010401 454 GVAYRDLNSQRILLDRHGNVCLGDMGIVTACK 485 (511)
Q Consensus 454 gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~ 485 (511)
||+|+||.+.|||++++ .+.|+|||.+....
T Consensus 127 givHGDLs~~NIlv~~~-~~~iIDf~qav~~~ 157 (188)
T PF01163_consen 127 GIVHGDLSEYNILVDDG-KVYIIDFGQAVDSS 157 (188)
T ss_dssp TEEESS-STTSEEEETT-CEEE--GTTEEETT
T ss_pred CceecCCChhhEEeecc-eEEEEecCcceecC
Confidence 99999999999999877 99999999987654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.51 E-value=5e-07 Score=99.84 Aligned_cols=120 Identities=18% Similarity=0.296 Sum_probs=95.7
Q ss_pred eEEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEEeccCCCCHHHHHHhcCCCCHHHHHH
Q 010401 359 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIR 438 (511)
Q Consensus 359 gk~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ 438 (511)
+.+|.|...+.... .......+-+..|+.++||||++++..+..+.. +|||+|-+. -|..++...+ ...+..
T Consensus 37 ~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~-~ylvTErV~--Pl~~~lk~l~---~~~v~~ 108 (690)
T KOG1243|consen 37 GGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGT-LYLVTERVR--PLETVLKELG---KEEVCL 108 (690)
T ss_pred CCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhhcccCc-eEEEeeccc--cHHHHHHHhH---HHHHHH
Confidence 45677877764333 334446777888999999999999999988776 999999873 4666665433 566677
Q ss_pred HHHHHHHHHHHHH-HCCccccCCCCCceEEcCCCcEEEEecCCceeccc
Q 010401 439 IAIDVAEGIKFLN-DHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS 486 (511)
Q Consensus 439 ia~qIa~gL~yLH-~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~ 486 (511)
-+.||+.||.||| +++++|++|.-..|+|+..|..||.+|-++.....
T Consensus 109 Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~ 157 (690)
T KOG1243|consen 109 GLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASG 157 (690)
T ss_pred HHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEecccc
Confidence 7899999999997 67899999999999999999999999998765443
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.30 E-value=1.4e-05 Score=78.50 Aligned_cols=135 Identities=13% Similarity=0.080 Sum_probs=93.8
Q ss_pred ecccceEEEE----eEEEEEEEEecC-CCC---chHHHHHHHHHHHHHhCCCCc--eeeEeeeEe---eC-CCcEEEEEe
Q 010401 349 GPNSFKGVYK----GKRVGIEKLKGC-DKG---NAYEFELRKDLLELMTCGHKN--ILQFYCVCV---DE-NHGLCVVTK 414 (511)
Q Consensus 349 G~GsFG~VYk----gk~VAVKkL~~~-~~~---~~~~~~~~~Ei~iL~~l~HpN--IV~l~g~~~---~~-~~~l~LVmE 414 (511)
|+||-+.|+. |+.+-+|.-... ..+ ......+.+|+..|..+..-+ +.+.. ++. .+ ...-+||+|
T Consensus 27 ~rgG~SgV~r~~~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVTe 105 (216)
T PRK09902 27 RRNGMSGVQCVERNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVTE 105 (216)
T ss_pred CCCCcceEEEEEeCCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEEE
Confidence 5677777776 455667765411 111 223445788888888764322 33433 222 11 122679999
Q ss_pred ccCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCc--EEEEecCCceec
Q 010401 415 LMEG-GSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGN--VCLGDMGIVTAC 484 (511)
Q Consensus 415 y~~g-GsL~~lL~~~--~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~--vKL~DFGlS~~l 484 (511)
-+.+ .+|.+++... .+.+......++.+|+..+.-||+.|+.|+|+.+.||+++.++. ++++||--++..
T Consensus 106 ~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~~ 180 (216)
T PRK09902 106 DMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRRR 180 (216)
T ss_pred eCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccchh
Confidence 7753 4888887542 35577777899999999999999999999999999999987777 999999876653
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.23 E-value=1.5e-05 Score=78.64 Aligned_cols=136 Identities=17% Similarity=0.224 Sum_probs=84.2
Q ss_pred CCCeEEEeeeecccceEEEE----eEEEEEEEEecCCCCchHHHH-------HHHHHH---HHHhCCCCceeeEeeeEee
Q 010401 339 SDNLEFIDQIGPNSFKGVYK----GKRVGIEKLKGCDKGNAYEFE-------LRKDLL---ELMTCGHKNILQFYCVCVD 404 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYk----gk~VAVKkL~~~~~~~~~~~~-------~~~Ei~---iL~~l~HpNIV~l~g~~~~ 404 (511)
..+|+..+.+-......|.+ |+...+|.......-.+.... ..+.+. .+...+-.....++.+...
T Consensus 30 ~~~~~~~kv~k~~~r~~ValIei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ek 109 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALIEIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEK 109 (229)
T ss_pred hCCceEEEeecCCCccEEEEEEECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeee
Confidence 45677888887777777776 556777766532211111110 112222 2222233333333333322
Q ss_pred CC----CcEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCC
Q 010401 405 EN----HGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGI 480 (511)
Q Consensus 405 ~~----~~l~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGl 480 (511)
.. ...+++|||++|..|.++.. +++ .+...|..++.-||+.|++|+|..|.|+++.+++ ++++||+.
T Consensus 110 k~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~-i~iID~~~ 180 (229)
T PF06176_consen 110 KIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG-IRIIDTQG 180 (229)
T ss_pred eeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc-EEEEECcc
Confidence 11 12568999999988876542 333 2445677789999999999999999999998555 99999987
Q ss_pred cee
Q 010401 481 VTA 483 (511)
Q Consensus 481 S~~ 483 (511)
.+.
T Consensus 181 k~~ 183 (229)
T PF06176_consen 181 KRM 183 (229)
T ss_pred ccc
Confidence 554
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.20 E-value=9.6e-06 Score=87.80 Aligned_cols=126 Identities=15% Similarity=0.230 Sum_probs=97.4
Q ss_pred eEEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeC---CCcEEEEEeccCC-CCHHHHHHh-------
Q 010401 359 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDE---NHGLCVVTKLMEG-GSVNDLILK------- 427 (511)
Q Consensus 359 gk~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~---~~~l~LVmEy~~g-GsL~~lL~~------- 427 (511)
|..+..|+++........ ....-++.++++.|+|||+|..+|... +..+++|++|+++ ++|.++.-.
T Consensus 301 G~~YvLkRlhg~r~~~~n--k~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~F~~~~~t~~ 378 (655)
T KOG3741|consen 301 GNAYVLKRLHGDRDQSTN--KDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLYFANPPFTKR 378 (655)
T ss_pred CceeeeeeeccccccCcc--cchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHHccCCccccc
Confidence 678889999643332221 123445678899999999999888732 2238999999985 477776421
Q ss_pred --------cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceeccc
Q 010401 428 --------SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS 486 (511)
Q Consensus 428 --------~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~ 486 (511)
+...++..+|.|+.|+..||.++|+.|+.-+-|.+.+||++.+..++|+..|+.-.+..
T Consensus 379 ~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 379 TNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred cccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 12478899999999999999999999999999999999999998999999888655543
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.19 E-value=4.7e-06 Score=91.58 Aligned_cols=138 Identities=18% Similarity=0.282 Sum_probs=86.1
Q ss_pred eeeecccceEEEE-----eEEEEEEEEecCCCCc--------------------------------hHHH------HHHH
Q 010401 346 DQIGPNSFKGVYK-----GKRVGIEKLKGCDKGN--------------------------------AYEF------ELRK 382 (511)
Q Consensus 346 ~~LG~GsFG~VYk-----gk~VAVKkL~~~~~~~--------------------------------~~~~------~~~~ 382 (511)
..|+.++-|+||+ |+.||||+.++.-... .... .+.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 6789999999998 5689999987621100 0011 1233
Q ss_pred HHHHHHhC-----CCCceeeEeeeEeeCCCcEEEEEeccCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Q 010401 383 DLLELMTC-----GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL-KSRKLQTKEIIRIAIDVAEGIKFLNDHGVA 456 (511)
Q Consensus 383 Ei~iL~~l-----~HpNIV~l~g~~~~~~~~l~LVmEy~~gGsL~~lL~-~~~~L~e~~~~~ia~qIa~gL~yLH~~gII 456 (511)
|...+.++ +.++|. +=.++.+-...-.|+|||+.|-.+.+... +...++...+.....++. ++.+-..|+.
T Consensus 211 EA~n~~~~~~nf~~~~~v~-VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f--~~q~~~dgff 287 (517)
T COG0661 211 EAANAERFRENFKDDPDVY-VPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAF--LRQLLRDGFF 287 (517)
T ss_pred HHHHHHHHHHHcCCCCCeE-eceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHH--HHHHHhcCcc
Confidence 33333332 233332 22233221122469999999998888852 224455444333322221 3334458999
Q ss_pred ccCCCCCceEEcCCCcEEEEecCCceeccc
Q 010401 457 YRDLNSQRILLDRHGNVCLGDMGIVTACKS 486 (511)
Q Consensus 457 HRDLKp~NILld~~g~vKL~DFGlS~~l~~ 486 (511)
|.|.+|.||+++.+|.+.+.|||+...+..
T Consensus 288 HaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 288 HADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred ccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 999999999999999999999999876643
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.11 E-value=3e-05 Score=76.47 Aligned_cols=132 Identities=13% Similarity=0.126 Sum_probs=77.7
Q ss_pred eeeecccceEEEE--eEEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCce--eeEeeeEeeCCCcEEEEEeccCCCC-
Q 010401 346 DQIGPNSFKGVYK--GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNI--LQFYCVCVDENHGLCVVTKLMEGGS- 420 (511)
Q Consensus 346 ~~LG~GsFG~VYk--gk~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNI--V~l~g~~~~~~~~l~LVmEy~~gGs- 420 (511)
..||+|..+.||+ |..+.+|..... . ....+.+|..++..+..-.+ .+.+++..+.+. .++|||++.|..
T Consensus 7 ~~i~~G~t~~~y~~~~~~~VlR~~~~~-~---~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~-~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTHKTGKWMLKLYNPG-F---DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGR-LGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEecCCCEEEEeCCCC-C---CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCe-eeeeeeecCCccc
Confidence 6789999999999 445556665421 1 22346788888877654333 555666655554 789999998863
Q ss_pred HHHHH--------------Hh----cCC-----CCHHHH-HHHHH----------HHHH-HHHHHHH----CCccccCCC
Q 010401 421 VNDLI--------------LK----SRK-----LQTKEI-IRIAI----------DVAE-GIKFLND----HGVAYRDLN 461 (511)
Q Consensus 421 L~~lL--------------~~----~~~-----L~e~~~-~~ia~----------qIa~-gL~yLH~----~gIIHRDLK 461 (511)
+...+ .. -.. ...... ..+.. .+.. ...+|.. ..++|+|+.
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~ 161 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ 161 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence 21111 00 000 111000 01100 0111 1222321 247899999
Q ss_pred CCceEEcCCCcEEEEecCCcee
Q 010401 462 SQRILLDRHGNVCLGDMGIVTA 483 (511)
Q Consensus 462 p~NILld~~g~vKL~DFGlS~~ 483 (511)
|.||++++++ +.|+||+.+..
T Consensus 162 ~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 162 IGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCcEEEcCCC-cEEEechhcCc
Confidence 9999999888 99999998653
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.10 E-value=2.7e-06 Score=87.57 Aligned_cols=94 Identities=17% Similarity=0.357 Sum_probs=79.5
Q ss_pred HHHHHHhCCCCceeeEeeeEeeCCC----cEEEEEeccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC
Q 010401 383 DLLELMTCGHKNILQFYCVCVDENH----GLCVVTKLMEGGSVNDLILKS----RKLQTKEIIRIAIDVAEGIKFLNDHG 454 (511)
Q Consensus 383 Ei~iL~~l~HpNIV~l~g~~~~~~~----~l~LVmEy~~gGsL~~lL~~~----~~L~e~~~~~ia~qIa~gL~yLH~~g 454 (511)
-...|..+-|.|||+++.||.+... ...+++|||..|++..+|++. ..+......+|+.||+.||.|||+..
T Consensus 117 vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~ 196 (458)
T KOG1266|consen 117 VFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC
Confidence 3445556789999999999876442 378999999999999999642 45788888899999999999999875
Q ss_pred --ccccCCCCCceEEcCCCcEEEE
Q 010401 455 --VAYRDLNSQRILLDRHGNVCLG 476 (511)
Q Consensus 455 --IIHRDLKp~NILld~~g~vKL~ 476 (511)
|+|+++..+-|.+..+|-+||.
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig 220 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIG 220 (458)
T ss_pred CccccCCcchhheeecCCceEEec
Confidence 9999999999999999988875
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.06 E-value=2e-05 Score=79.83 Aligned_cols=134 Identities=17% Similarity=0.197 Sum_probs=91.6
Q ss_pred eEEEeeeecccceEEEEe-----EEEEEEEEecCC-----------------CC---chHHHHHHHHHHHHHhCCCC--c
Q 010401 342 LEFIDQIGPNSFKGVYKG-----KRVGIEKLKGCD-----------------KG---NAYEFELRKDLLELMTCGHK--N 394 (511)
Q Consensus 342 y~l~~~LG~GsFG~VYkg-----k~VAVKkL~~~~-----------------~~---~~~~~~~~~Ei~iL~~l~Hp--N 394 (511)
..+...||-|--+.||.| ..+++|.=+... .. .......++|..+|.++... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 356688999999999985 578887533210 00 11122357788888887544 5
Q ss_pred eeeEeeeEeeCCCcEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEE
Q 010401 395 ILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVC 474 (511)
Q Consensus 395 IV~l~g~~~~~~~~l~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vK 474 (511)
|.+.+++ + ...+||||+.|-.|...- ++.+..-.++..|+.-+.-+-..||||+|+.+=||+++++|.+.
T Consensus 173 VP~P~~~----n-RHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~ 242 (304)
T COG0478 173 VPKPIAW----N-RHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIV 242 (304)
T ss_pred CCCcccc----c-cceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEE
Confidence 5555543 2 267999999996665432 23444445555565556555589999999999999999999999
Q ss_pred EEecCCceecc
Q 010401 475 LGDMGIVTACK 485 (511)
Q Consensus 475 L~DFGlS~~l~ 485 (511)
++||--+....
T Consensus 243 vIDwPQ~v~~~ 253 (304)
T COG0478 243 VIDWPQAVPIS 253 (304)
T ss_pred EEeCcccccCC
Confidence 99997655443
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.93 E-value=0.00018 Score=69.95 Aligned_cols=126 Identities=22% Similarity=0.320 Sum_probs=87.7
Q ss_pred eeeecccceEEEE---eEEEEEEEEecCC--------------CCchHHHHHHHHHHHHHhCC------CCceeeEeeeE
Q 010401 346 DQIGPNSFKGVYK---GKRVGIEKLKGCD--------------KGNAYEFELRKDLLELMTCG------HKNILQFYCVC 402 (511)
Q Consensus 346 ~~LG~GsFG~VYk---gk~VAVKkL~~~~--------------~~~~~~~~~~~Ei~iL~~l~------HpNIV~l~g~~ 402 (511)
..||+|+.-.||. -....||+++... .......+.++|+.....+. +.+|.++||+.
T Consensus 7 ~~i~~G~~R~cy~HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G~v 86 (199)
T PF10707_consen 7 DLIAQGGERDCYQHPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYGFV 86 (199)
T ss_pred cccccCCCceEEECCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeEEE
Confidence 5699999999998 2456778776543 01112344566666555544 88999999999
Q ss_pred eeCCCcEEEEEeccCC------CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCC--C--c
Q 010401 403 VDENHGLCVVTKLMEG------GSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRH--G--N 472 (511)
Q Consensus 403 ~~~~~~l~LVmEy~~g------GsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~--g--~ 472 (511)
.++-. +.+|+|.+.. -+|.+++.. +.++. .+...+. .-.+||-+++|+.+|++|.||++... + .
T Consensus 87 eT~~G-~Glv~e~I~d~dG~~s~TL~~~l~~-~~~~~-~~~~~L~---~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~~~ 160 (199)
T PF10707_consen 87 ETNLG-LGLVVELIRDADGNISPTLEDYLKE-GGLTE-ELRQALD---EFKRYLLDHHIVIRDLNPHNIVVQRRDSGEFR 160 (199)
T ss_pred ecCCc-eEEEEEEEECCCCCcCccHHHHHHc-CCccH-HHHHHHH---HHHHHHHHcCCeecCCCcccEEEEecCCCceE
Confidence 98876 8899998742 368888843 44555 3333333 34568889999999999999999733 2 4
Q ss_pred EEEEe
Q 010401 473 VCLGD 477 (511)
Q Consensus 473 vKL~D 477 (511)
+.|+|
T Consensus 161 lvlID 165 (199)
T PF10707_consen 161 LVLID 165 (199)
T ss_pred EEEEe
Confidence 77777
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.92 E-value=0.0001 Score=70.18 Aligned_cols=136 Identities=14% Similarity=0.136 Sum_probs=76.6
Q ss_pred EeeeecccceEEEEeE----EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCC--ceeeEeeeEeeC--CCcEEEEEecc
Q 010401 345 IDQIGPNSFKGVYKGK----RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHK--NILQFYCVCVDE--NHGLCVVTKLM 416 (511)
Q Consensus 345 ~~~LG~GsFG~VYkgk----~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~Hp--NIV~l~g~~~~~--~~~l~LVmEy~ 416 (511)
++.|+.|..+.||+.. .+++|..... .....+.+|..++..+... -+..++...... ....+++|+++
T Consensus 2 i~~l~~G~~n~~~~v~~~~~~~vlK~~~~~----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i 77 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDDGRYVLKFYRPP----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYI 77 (239)
T ss_dssp EEEEEESSSSEEEEEEETTSEEEEEEESSH----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEE
T ss_pred CccCCCCCeeeEEEEEECCcEEEEEEeCCC----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEe
Confidence 4679999999999943 5778876421 3445577887777766332 345666543322 22268999999
Q ss_pred CCCCHHH----------------HHH---hc----CCCCHHH---H---HH---H------------HHHHHH-HHHHHH
Q 010401 417 EGGSVND----------------LIL---KS----RKLQTKE---I---IR---I------------AIDVAE-GIKFLN 451 (511)
Q Consensus 417 ~gGsL~~----------------lL~---~~----~~L~e~~---~---~~---i------------a~qIa~-gL~yLH 451 (511)
+|..+.. .+. .. ..+.... . .. . ...+.. .++.++
T Consensus 78 ~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (239)
T PF01636_consen 78 PGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELE 157 (239)
T ss_dssp SSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHH
Confidence 9987777 111 11 0111100 0 00 0 112222 333333
Q ss_pred H-------CCccccCCCCCceEEc-CCCcEEEEecCCceec
Q 010401 452 D-------HGVAYRDLNSQRILLD-RHGNVCLGDMGIVTAC 484 (511)
Q Consensus 452 ~-------~gIIHRDLKp~NILld-~~g~vKL~DFGlS~~l 484 (511)
+ ..++|+|+.|.|||++ .++.+.|+||+.+...
T Consensus 158 ~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~~ 198 (239)
T PF01636_consen 158 ALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGWG 198 (239)
T ss_dssp HHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EEE
T ss_pred hhhccCCCcEEEEeccccccceeeeccceeEEEecccceEC
Confidence 2 3599999999999999 6677789999987543
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.91 E-value=2.1e-06 Score=98.73 Aligned_cols=175 Identities=15% Similarity=0.134 Sum_probs=121.3
Q ss_pred eEecCCCeEEEeeeecccceEEEEeEE------EEEEEEecCCCCch-HHHHHHHHHHHHHhCCCCceeeEeeeEeeCCC
Q 010401 335 WLLNSDNLEFIDQIGPNSFKGVYKGKR------VGIEKLKGCDKGNA-YEFELRKDLLELMTCGHKNILQFYCVCVDENH 407 (511)
Q Consensus 335 ~~l~~~~y~l~~~LG~GsFG~VYkgk~------VAVKkL~~~~~~~~-~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~ 407 (511)
|....+.+.+++-+-.|+|+.++..+. .++|......+-.. .....+.+-.++-..++|.++...-.+....
T Consensus 799 yrsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rs- 877 (1205)
T KOG0606|consen 799 YRSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRS- 877 (1205)
T ss_pred ccCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCC-
Confidence 444567778888899999999998542 33333321111100 1111222222333345677776665544333
Q ss_pred cEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecc--
Q 010401 408 GLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK-- 485 (511)
Q Consensus 408 ~l~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~-- 485 (511)
+++++|+|+.+++|...++..+..+.+-++.++..+..+++|||...++|||++|.|+|+..+|..++.|||......
T Consensus 878 P~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~ 957 (1205)
T KOG0606|consen 878 PLPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLI 957 (1205)
T ss_pred CcchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccc
Confidence 489999999999999999887888888888999999999999999999999999999999999999999998422110
Q ss_pred ----cC---------------C----------CccccccCCCccccHHhhcccC
Q 010401 486 ----SV---------------G----------EATEYETDGYRWLAPEVCFLLL 510 (511)
Q Consensus 486 ----~~---------------~----------~~~~~~~Gt~~YmAPEvl~gl~ 510 (511)
.. . .......||+.|+|||.+++..
T Consensus 958 ~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~ 1011 (1205)
T KOG0606|consen 958 PPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRR 1011 (1205)
T ss_pred cCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccccc
Confidence 00 0 0022345789999999998764
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.87 E-value=0.00036 Score=68.17 Aligned_cols=135 Identities=16% Similarity=0.233 Sum_probs=92.7
Q ss_pred CccccceEecCCCeEEEeeeecccc-eEEEE----eEEEEEEEEecCC---C------Cc----------hHHHHHHHHH
Q 010401 329 GEEIGRWLLNSDNLEFIDQIGPNSF-KGVYK----GKRVGIEKLKGCD---K------GN----------AYEFELRKDL 384 (511)
Q Consensus 329 ~~~i~~~~l~~~~y~l~~~LG~GsF-G~VYk----gk~VAVKkL~~~~---~------~~----------~~~~~~~~Ei 384 (511)
++.+..+.....++++++.||.|.- |.||+ |+.+|+|..+... . .. ....-|..|.
T Consensus 26 gPKL~~F~~h~~~I~flefLg~g~~~~~V~kv~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~EC 105 (207)
T PF13095_consen 26 GPKLEPFTHHGDDIEFLEFLGHGSHDGYVFKVEIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCEC 105 (207)
T ss_pred CCCcCCcCCCCCcEeeeeecCCCCceeEEEEEEECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHH
Confidence 4445555554589999999999999 99999 5789999933210 0 00 1122366777
Q ss_pred HHHHhC---CCCce--eeEeeeEeeCC-----------------CcEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHH
Q 010401 385 LELMTC---GHKNI--LQFYCVCVDEN-----------------HGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAID 442 (511)
Q Consensus 385 ~iL~~l---~HpNI--V~l~g~~~~~~-----------------~~l~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~q 442 (511)
....++ ++.++ |+++|+..-.. ....||.||++... .+... -+.+
T Consensus 106 RAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~~----~~~~ 172 (207)
T PF13095_consen 106 RAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQIR----DIPQ 172 (207)
T ss_pred HhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccchh----HHHH
Confidence 776655 56667 99999874321 11467888876633 22222 3566
Q ss_pred HHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCc
Q 010401 443 VAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIV 481 (511)
Q Consensus 443 Ia~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS 481 (511)
|.+-|..+|+.||+-+|+++.|.. .-||+|||.+
T Consensus 173 ~~~dl~~~~k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 173 MLRDLKILHKLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHHHHHHHHCCeeeccCcccccc-----CCEEEecccC
Confidence 777789999999999999999975 3589999864
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.84 E-value=2.1e-06 Score=94.71 Aligned_cols=158 Identities=16% Similarity=0.078 Sum_probs=113.5
Q ss_pred eEEEeeeecccceEEEEeEEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCc-eeeEeeeEeeCCCcEEEEEeccCCC-
Q 010401 342 LEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKN-ILQFYCVCVDENHGLCVVTKLMEGG- 419 (511)
Q Consensus 342 y~l~~~LG~GsFG~VYkgk~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpN-IV~l~g~~~~~~~~l~LVmEy~~gG- 419 (511)
+.+...+++|+++++||.+..|-|.|........ ....-++++|.+++||| .+..++-+..+.. .++.|+++.++
T Consensus 244 s~~fh~fvK~altknpKkRptaeklL~h~fvs~~--l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~-~~i~~~i~s~~r 320 (829)
T KOG0576|consen 244 SEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT--LSRRLAIELLDKVNNPNPVVRYLEDYDGEDY-LWIPMRICSTGR 320 (829)
T ss_pred hHHHHHHHHHHhcCCCccCCChhhheeceeeccc--hhhHHHHHHHHHccCCCCcccccccCCcccc-cchhhhhhcCCc
Confidence 4566778999999999999888877753222222 44567788899999999 5565655554443 89999999876
Q ss_pred CHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCccccccCCC
Q 010401 420 SVNDLI-LKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY 498 (511)
Q Consensus 420 sL~~lL-~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~~~~~Gt~ 498 (511)
+..... ...-.+...+...+.+.-.++++|||+.--+||| ||+..+ +..+..||+....+.... ......+++
T Consensus 321 s~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~-~~~t~~~~~ 394 (829)
T KOG0576|consen 321 SSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM-KPRTAIGTP 394 (829)
T ss_pred cccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCccc-ccccCCCCC
Confidence 222221 1222345556667778888999999998778999 777764 789999999977665432 345667899
Q ss_pred ccccHHhhcc
Q 010401 499 RWLAPEVCFL 508 (511)
Q Consensus 499 ~YmAPEvl~g 508 (511)
.|+|||+...
T Consensus 395 ~~~~pev~~~ 404 (829)
T KOG0576|consen 395 EPLAPEVIQE 404 (829)
T ss_pred CCCCchhhcc
Confidence 9999997653
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.84 E-value=0.00015 Score=72.69 Aligned_cols=136 Identities=18% Similarity=0.180 Sum_probs=89.3
Q ss_pred EEeeeecccceEEEE-----eEEEEEEEEecCCCC-------------------ch---HHHHHHHHHHHHHhCC--CCc
Q 010401 344 FIDQIGPNSFKGVYK-----GKRVGIEKLKGCDKG-------------------NA---YEFELRKDLLELMTCG--HKN 394 (511)
Q Consensus 344 l~~~LG~GsFG~VYk-----gk~VAVKkL~~~~~~-------------------~~---~~~~~~~Ei~iL~~l~--HpN 394 (511)
+...|..|--+.||+ +..+|+|+.+..... +. ......+|...|.++. +-.
T Consensus 52 ~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVr 131 (268)
T COG1718 52 LVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVR 131 (268)
T ss_pred eEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence 345788888999999 468999988742111 00 0111455666666652 233
Q ss_pred eeeEeeeEeeCCCcEEEEEeccCCCC-HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCceEEcCCCc
Q 010401 395 ILQFYCVCVDENHGLCVVTKLMEGGS-VNDLILKSRKLQTKEIIRIAIDVAEGIKFLND-HGVAYRDLNSQRILLDRHGN 472 (511)
Q Consensus 395 IV~l~g~~~~~~~~l~LVmEy~~gGs-L~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~-~gIIHRDLKp~NILld~~g~ 472 (511)
+.+-+++.. -.|||||+.... -.-.| +.-.+...++..+..+++..+.-|-. .++||+||..=|||+. ++.
T Consensus 132 vP~Pi~~~~-----nVLvMEfIg~~g~pAP~L-kDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~ 204 (268)
T COG1718 132 VPEPIAFRN-----NVLVMEFIGDDGLPAPRL-KDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGE 204 (268)
T ss_pred CCCceeecC-----CeEEEEeccCCCCCCCCc-ccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCe
Confidence 344443321 359999996531 11111 11123344678888899999988865 9999999999999999 899
Q ss_pred EEEEecCCceeccc
Q 010401 473 VCLGDMGIVTACKS 486 (511)
Q Consensus 473 vKL~DFGlS~~l~~ 486 (511)
+.|+|||-|.....
T Consensus 205 p~iID~~QaV~~~h 218 (268)
T COG1718 205 PYIIDVSQAVTIDH 218 (268)
T ss_pred EEEEECccccccCC
Confidence 99999998876654
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.75 E-value=0.00026 Score=69.50 Aligned_cols=30 Identities=20% Similarity=0.124 Sum_probs=26.8
Q ss_pred CccccCCCCCceEEcCCCcEEEEecCCcee
Q 010401 454 GVAYRDLNSQRILLDRHGNVCLGDMGIVTA 483 (511)
Q Consensus 454 gIIHRDLKp~NILld~~g~vKL~DFGlS~~ 483 (511)
.++|+|+.|.|||++.++.+.|+||+.+..
T Consensus 164 ~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 164 VVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred EEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 489999999999999987789999998754
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.73 E-value=9.9e-05 Score=81.38 Aligned_cols=135 Identities=15% Similarity=0.205 Sum_probs=84.6
Q ss_pred eeeecccceEEEEe-----EEEEEEEEecCCCCc-----------------------------------hHHHHHHHHHH
Q 010401 346 DQIGPNSFKGVYKG-----KRVGIEKLKGCDKGN-----------------------------------AYEFELRKDLL 385 (511)
Q Consensus 346 ~~LG~GsFG~VYkg-----k~VAVKkL~~~~~~~-----------------------------------~~~~~~~~Ei~ 385 (511)
+.||.-+.|+||++ +.||||+-++.-... ..+..+.+|..
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 67999999999995 579999987621111 01112333433
Q ss_pred HHHh----CCCCc------eeeEeeeEeeCCCcEEEEEeccCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 010401 386 ELMT----CGHKN------ILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL-KSRKLQTKEIIRIAIDVAEGIKFLNDHG 454 (511)
Q Consensus 386 iL~~----l~HpN------IV~l~g~~~~~~~~l~LVmEy~~gGsL~~lL~-~~~~L~e~~~~~ia~qIa~gL~yLH~~g 454 (511)
...+ +.|-+ |.++|-.+. ..-.|+||||+|..+.|+-. ....++...+...+.++. ++-|-..|
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~s---t~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~--~~qIf~~G 321 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLS---TKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAY--LEQIFKTG 321 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcC---cceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHH--HHHHHhcC
Confidence 3222 34444 344443222 23579999999987776642 233456554443333322 22334578
Q ss_pred ccccCCCCCceEEcC----CCcEEEEecCCceecc
Q 010401 455 VAYRDLNSQRILLDR----HGNVCLGDMGIVTACK 485 (511)
Q Consensus 455 IIHRDLKp~NILld~----~g~vKL~DFGlS~~l~ 485 (511)
++|.|-.|.||++.. ++.+.+-|||+...+.
T Consensus 322 ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 322 FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred CccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 999999999999993 6789999999976654
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.59 E-value=0.00018 Score=69.25 Aligned_cols=98 Identities=15% Similarity=0.149 Sum_probs=77.4
Q ss_pred HHHHHHHHhCCC-CceeeEeeeEeeCCCcEEEEEeccCCCCHHHH---HHhcCCCCHHHHHHHHHHHHHHHHHHHH---C
Q 010401 381 RKDLLELMTCGH-KNILQFYCVCVDENHGLCVVTKLMEGGSVNDL---ILKSRKLQTKEIIRIAIDVAEGIKFLND---H 453 (511)
Q Consensus 381 ~~Ei~iL~~l~H-pNIV~l~g~~~~~~~~l~LVmEy~~gGsL~~l---L~~~~~L~e~~~~~ia~qIa~gL~yLH~---~ 453 (511)
..|..++..+.+ +++++++|+|. -+++.||...+++... +..--..+|..+..++.+++..+++|+. .
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG-----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~ 81 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG-----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLG 81 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC-----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 356777777765 69999999995 3578999987766421 1111246899999999999999999986 3
Q ss_pred CccccCCCCCceEEcCCCcEEEEecCCcee
Q 010401 454 GVAYRDLNSQRILLDRHGNVCLGDMGIVTA 483 (511)
Q Consensus 454 gIIHRDLKp~NILld~~g~vKL~DFGlS~~ 483 (511)
.+.-.|++++|+-++++|.+|++|...+..
T Consensus 82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred cEEEeecchHHeEEeCCCcEEEEechhcch
Confidence 477789999999999999999999987543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.57 E-value=0.00032 Score=67.29 Aligned_cols=132 Identities=17% Similarity=0.180 Sum_probs=89.4
Q ss_pred CCCeEEEeeeecccceEEEEeE----EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceee-EeeeEeeCCCcEEEEE
Q 010401 339 SDNLEFIDQIGPNSFKGVYKGK----RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQ-FYCVCVDENHGLCVVT 413 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkgk----~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~-l~g~~~~~~~~l~LVm 413 (511)
.......++||+|.+|.||+|. .+|+|+-+... ....++.|..+|..+.-.++.+ +|.+-. .++.|
T Consensus 21 ~~~~~v~~~L~KG~~s~Vyl~~~~~~~~a~Kvrr~ds----~r~~l~kEakiLeil~g~~~~p~vy~yg~-----~~i~m 91 (201)
T COG2112 21 KYELRVEKELAKGTTSVVYLGEWRGGEVALKVRRRDS----PRRNLEKEAKILEILAGEGVTPEVYFYGE-----DFIRM 91 (201)
T ss_pred chhhhhhhhhhcccccEEEEeeccCceEEEEEecCCc----chhhHHHHHHHHHHhhhcCCCceEEEech-----hhhhh
Confidence 3344666889999999999964 67888776432 2345778888888776666643 443322 24669
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCC-CCceEEcCCCcEEEEecCCceeccc
Q 010401 414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLN-SQRILLDRHGNVCLGDMGIVTACKS 486 (511)
Q Consensus 414 Ey~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLK-p~NILld~~g~vKL~DFGlS~~l~~ 486 (511)
||+.|-.|.+..... +... ...++..-.-|-..||-|..|. |..+++..++.+.|+||.-|+....
T Consensus 92 e~i~G~~L~~~~~~~---~rk~----l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k~~ 158 (201)
T COG2112 92 EYIDGRPLGKLEIGG---DRKH----LLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATFKKK 158 (201)
T ss_pred hhhcCcchhhhhhcc---cHHH----HHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhhccC
Confidence 999998888765321 2222 3344455445677899999886 6666666667999999999875443
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.41 E-value=0.0014 Score=76.38 Aligned_cols=75 Identities=19% Similarity=0.322 Sum_probs=48.6
Q ss_pred EeeeecccceEEEEe--------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCC-CCce--eeEeeeEeeCC--CcEEE
Q 010401 345 IDQIGPNSFKGVYKG--------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCG-HKNI--LQFYCVCVDEN--HGLCV 411 (511)
Q Consensus 345 ~~~LG~GsFG~VYkg--------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~-HpNI--V~l~g~~~~~~--~~l~L 411 (511)
++.|+.|.+..+|+- ..+.+|+..... .......+.+|..++..+. |.+| .+++++|.+.. ...|+
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~-~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~fl 121 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGK-LLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFY 121 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCc-cCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceE
Confidence 466788888888862 244555543211 1112345788999998885 6665 77777776542 23689
Q ss_pred EEeccCCCC
Q 010401 412 VTKLMEGGS 420 (511)
Q Consensus 412 VmEy~~gGs 420 (511)
||||++|..
T Consensus 122 VME~v~G~~ 130 (822)
T PLN02876 122 IMEYLEGRI 130 (822)
T ss_pred EEEecCCcc
Confidence 999998754
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.26 E-value=0.0016 Score=63.94 Aligned_cols=31 Identities=16% Similarity=0.097 Sum_probs=26.2
Q ss_pred CCccccCCCCCceEEcCCCcEEEEecCCcee
Q 010401 453 HGVAYRDLNSQRILLDRHGNVCLGDMGIVTA 483 (511)
Q Consensus 453 ~gIIHRDLKp~NILld~~g~vKL~DFGlS~~ 483 (511)
.+++|+|+.+.|||++.++..-|+||+.+..
T Consensus 164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~ 194 (235)
T cd05155 164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV 194 (235)
T ss_pred ceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence 3589999999999998766667999998654
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.90 E-value=0.0057 Score=65.53 Aligned_cols=157 Identities=13% Similarity=0.100 Sum_probs=102.1
Q ss_pred eEEEeeeecccceEEEEeE---EEEEEEEecCCCCchHHHHHHHHHHHHHh-CCCCceee--------EeeeEeeCCCcE
Q 010401 342 LEFIDQIGPNSFKGVYKGK---RVGIEKLKGCDKGNAYEFELRKDLLELMT-CGHKNILQ--------FYCVCVDENHGL 409 (511)
Q Consensus 342 y~l~~~LG~GsFG~VYkgk---~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~-l~HpNIV~--------l~g~~~~~~~~l 409 (511)
+.....||+|+-+.+|.-. .-..|+.+...... ..+.. ..|.+ -.||-+-. ++|- +....+
T Consensus 13 i~~gr~LgqGgea~ly~l~e~~d~VAKIYh~Pppa~--~aqk~---a~la~~p~~p~~~~rvaWPqa~L~G~--~~~~~i 85 (637)
T COG4248 13 IPPGRPLGQGGEADLYTLGEVRDQVAKIYHAPPPAA--QAQKV---AELAATPDAPLLNYRVAWPQATLHGG--RRGKVI 85 (637)
T ss_pred cCCCccccCCccceeeecchhhchhheeecCCCchH--HHHHH---HHhccCCCCcchhhhhcccHHHhhCC--Ccccee
Confidence 3455789999999999832 23345554322221 11111 22232 35654432 1221 112226
Q ss_pred EEEEeccCCC-CHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCce
Q 010401 410 CVVTKLMEGG-SVNDLILK------SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVT 482 (511)
Q Consensus 410 ~LVmEy~~gG-sL~~lL~~------~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~ 482 (511)
.+.|+.+.+. -+..+++. -....|.-+.+.++.++.+..-||.+|.+-+|++++|+|+++++.|.|.|=..-.
T Consensus 86 GflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 86 GFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred EEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEccccee
Confidence 7888888765 23333321 1247889999999999999999999999999999999999999999999854422
Q ss_pred ecccCCCccccccCCCccccHHhh
Q 010401 483 ACKSVGEATEYETDGYRWLAPEVC 506 (511)
Q Consensus 483 ~l~~~~~~~~~~~Gt~~YmAPEvl 506 (511)
+..++....+..|...|.+||.=
T Consensus 166 -i~~ng~~~~cpVg~~eftPPElQ 188 (637)
T COG4248 166 -INANGTLHLCPVGVSEFTPPELQ 188 (637)
T ss_pred -eccCCceEecccCccccCCHHHh
Confidence 22334445566788999999974
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.49 E-value=0.04 Score=56.60 Aligned_cols=76 Identities=12% Similarity=0.076 Sum_probs=48.8
Q ss_pred eEEEeeeecccceEEEEe----EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCC---CceeeEeeeEeeC--CCcEEEE
Q 010401 342 LEFIDQIGPNSFKGVYKG----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGH---KNILQFYCVCVDE--NHGLCVV 412 (511)
Q Consensus 342 y~l~~~LG~GsFG~VYkg----k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~H---pNIV~l~g~~~~~--~~~l~LV 412 (511)
..-.+.||.|..+.||.- ..+.+|..+. ... ...+..|...|+.+.- -.+.++++++.++ ....+||
T Consensus 16 ~~~~~~i~~G~~~~vy~~~~~~~~~~~k~~~~--~~~--~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LV 91 (297)
T PRK10593 16 LSRVECISEQPYAALWALYDSQGNPMPLMARS--FST--PGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLL 91 (297)
T ss_pred hheeeecCCccceeEEEEEcCCCCEEEEEecc--ccc--chHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEE
Confidence 344578999999999982 2344555331 111 1346777777776632 3577788777543 2237999
Q ss_pred EeccCCCCH
Q 010401 413 TKLMEGGSV 421 (511)
Q Consensus 413 mEy~~gGsL 421 (511)
||+++++++
T Consensus 92 mE~i~G~~~ 100 (297)
T PRK10593 92 LERLRGVSV 100 (297)
T ss_pred EeccCCEec
Confidence 999998654
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=96.31 E-value=0.015 Score=57.74 Aligned_cols=29 Identities=14% Similarity=0.189 Sum_probs=25.5
Q ss_pred CccccCCCCCceEEcCCCcEEEEecCCcee
Q 010401 454 GVAYRDLNSQRILLDRHGNVCLGDMGIVTA 483 (511)
Q Consensus 454 gIIHRDLKp~NILld~~g~vKL~DFGlS~~ 483 (511)
.++|+|+.|.||+++.++ +.|+||..+..
T Consensus 147 ~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 147 APLHMDVHAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred eeecCCCCcCcEEEeCCC-CEEEeccccCc
Confidence 489999999999999877 78999998653
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.14 E-value=0.12 Score=55.58 Aligned_cols=72 Identities=15% Similarity=0.081 Sum_probs=44.7
Q ss_pred EeeeecccceEEEEe------EEEEEEEEecCCC---C--chHHHHHHHHHHHHHhC---CCCceeeEeeeEeeCCCcEE
Q 010401 345 IDQIGPNSFKGVYKG------KRVGIEKLKGCDK---G--NAYEFELRKDLLELMTC---GHKNILQFYCVCVDENHGLC 410 (511)
Q Consensus 345 ~~~LG~GsFG~VYkg------k~VAVKkL~~~~~---~--~~~~~~~~~Ei~iL~~l---~HpNIV~l~g~~~~~~~~l~ 410 (511)
.+.||.|.+..||+. +.+.||.-..... . .....+...|...|..+ ...++.+++.+ +.+. .+
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~-~~ 107 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEEL-AV 107 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCC-CE
Confidence 468999999999993 3688887432111 0 11233455666666654 23457777765 3333 57
Q ss_pred EEEeccCCC
Q 010401 411 VVTKLMEGG 419 (511)
Q Consensus 411 LVmEy~~gG 419 (511)
+||||+++.
T Consensus 108 lVME~L~~~ 116 (401)
T PRK09550 108 TVMEDLSDH 116 (401)
T ss_pred EEEecCCCc
Confidence 999998763
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.10 E-value=0.041 Score=53.49 Aligned_cols=30 Identities=20% Similarity=0.133 Sum_probs=26.6
Q ss_pred CccccCCCCCceEEcC-CCcEEEEecCCcee
Q 010401 454 GVAYRDLNSQRILLDR-HGNVCLGDMGIVTA 483 (511)
Q Consensus 454 gIIHRDLKp~NILld~-~g~vKL~DFGlS~~ 483 (511)
+++|+|+.+.|||++. ++.+.|+||..|..
T Consensus 171 ~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~ 201 (235)
T cd05157 171 VFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY 201 (235)
T ss_pred EEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence 5899999999999997 57899999998654
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.92 E-value=0.059 Score=57.40 Aligned_cols=139 Identities=16% Similarity=0.151 Sum_probs=92.1
Q ss_pred EEEeeeecccceEEEE-----eEEEEEEEEecC----------------------CCCchH--HHHHHHHHHHHHhCCCC
Q 010401 343 EFIDQIGPNSFKGVYK-----GKRVGIEKLKGC----------------------DKGNAY--EFELRKDLLELMTCGHK 393 (511)
Q Consensus 343 ~l~~~LG~GsFG~VYk-----gk~VAVKkL~~~----------------------~~~~~~--~~~~~~Ei~iL~~l~Hp 393 (511)
++-..|..|--+.||. |..+|||+.+-. ...... ....++|+..|.+++..
T Consensus 147 ~inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred ecccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 4456788888999998 567899876531 111111 11246677778877655
Q ss_pred ceeeEeeeEeeCCCcEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HHCCccccCCCCCceEEcCCCc
Q 010401 394 NILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFL-NDHGVAYRDLNSQRILLDRHGN 472 (511)
Q Consensus 394 NIV~l~g~~~~~~~~l~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yL-H~~gIIHRDLKp~NILld~~g~ 472 (511)
.|.----+.. .+ ..|||+|+......--..+.-.++...+..+-.+++.-|.-| |.+++||.||.-=|+|+. +|.
T Consensus 227 GIP~PePIlL-k~--hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyh-dG~ 302 (520)
T KOG2270|consen 227 GIPCPEPILL-KN--HVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYH-DGK 302 (520)
T ss_pred CCCCCCceee-ec--ceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEE-CCE
Confidence 5432222222 22 359999995422211111334577778888888888888877 578999999999999995 788
Q ss_pred EEEEecCCceecc
Q 010401 473 VCLGDMGIVTACK 485 (511)
Q Consensus 473 vKL~DFGlS~~l~ 485 (511)
+.|+|-+-|....
T Consensus 303 lyiIDVSQSVE~D 315 (520)
T KOG2270|consen 303 LYIIDVSQSVEHD 315 (520)
T ss_pred EEEEEccccccCC
Confidence 9999988765543
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.88 E-value=0.17 Score=51.77 Aligned_cols=30 Identities=20% Similarity=0.204 Sum_probs=26.0
Q ss_pred CCccccCCCCCceEEcCCCcEEEEecCCce
Q 010401 453 HGVAYRDLNSQRILLDRHGNVCLGDMGIVT 482 (511)
Q Consensus 453 ~gIIHRDLKp~NILld~~g~vKL~DFGlS~ 482 (511)
.++||+|+.|.|||++.+...-|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 479999999999999966656899999864
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=95.82 E-value=0.099 Score=52.72 Aligned_cols=133 Identities=12% Similarity=0.028 Sum_probs=73.5
Q ss_pred EeeeecccceEEEEe----EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCc--eeeEeee------EeeCCCcEEEE
Q 010401 345 IDQIGPNSFKGVYKG----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKN--ILQFYCV------CVDENHGLCVV 412 (511)
Q Consensus 345 ~~~LG~GsFG~VYkg----k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpN--IV~l~g~------~~~~~~~l~LV 412 (511)
++.|..|....+|+. ..+.+|.... . ....+..|+.++..+.+.+ +.+++.. ....+ ..+++
T Consensus 19 i~~i~~G~~n~~y~v~~~~~~~vLr~~~~---~--~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~-~~~~l 92 (296)
T cd05153 19 FEGISAGIENTNYFVTTDSGRYVLTLFEK---V--SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAG-KPAAL 92 (296)
T ss_pred eecccCccccceEEEEeCCCcEEEEEcCC---C--ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCC-ceEEE
Confidence 456777777778872 3566776642 1 1234556666666553222 3444321 11222 36899
Q ss_pred EeccCCCCHHH-----------HHH---h-cCCC----------CHHHH----------HHHHHHHHHHHHHHHH-----
Q 010401 413 TKLMEGGSVND-----------LIL---K-SRKL----------QTKEI----------IRIAIDVAEGIKFLND----- 452 (511)
Q Consensus 413 mEy~~gGsL~~-----------lL~---~-~~~L----------~e~~~----------~~ia~qIa~gL~yLH~----- 452 (511)
++|++|..+.. .+. . ...+ .+... ......+..++.++..
T Consensus 93 ~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~ 172 (296)
T cd05153 93 VEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSD 172 (296)
T ss_pred EEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhc
Confidence 99998865421 110 0 0000 10000 0011123334455543
Q ss_pred --CCccccCCCCCceEEcCCCcEEEEecCCcee
Q 010401 453 --HGVAYRDLNSQRILLDRHGNVCLGDMGIVTA 483 (511)
Q Consensus 453 --~gIIHRDLKp~NILld~~g~vKL~DFGlS~~ 483 (511)
.+++|+|+.|.|||++.++.+.|+||+.+..
T Consensus 173 ~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 173 LPRGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CCCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 4799999999999999887789999988643
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=95.80 E-value=0.006 Score=68.47 Aligned_cols=68 Identities=24% Similarity=0.402 Sum_probs=51.0
Q ss_pred HHHHHHHHHHH-CCccccCCCCCceEEcCCCcEEEEecCCceecccCCCc--ccc-------ccCCCccccHHhhccc
Q 010401 442 DVAEGIKFLND-HGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA--TEY-------ETDGYRWLAPEVCFLL 509 (511)
Q Consensus 442 qIa~gL~yLH~-~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~--~~~-------~~Gt~~YmAPEvl~gl 509 (511)
+++.||.|+|. .++||+.|.|++|.++.++.+||+.|+++.....+... ..+ ......|.|||++.+.
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~ 184 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT 184 (700)
T ss_pred cccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence 44489999996 58999999999999999999999999997665442221 111 1123579999998753
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.01 E-value=0.076 Score=56.47 Aligned_cols=92 Identities=22% Similarity=0.276 Sum_probs=63.8
Q ss_pred HHhCCCCceeeEeeeEeeCCCcEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCce
Q 010401 387 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLND-HGVAYRDLNSQRI 465 (511)
Q Consensus 387 L~~l~HpNIV~l~g~~~~~~~~l~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~-~gIIHRDLKp~NI 465 (511)
...+.-++..+.+-+-.++....|++|++- |+++.-. +.-.+.++..++.+.+.-+.-+.. -.+=|||+.-.||
T Consensus 279 w~~~g~~~~e~~~vv~~de~~y~yl~~kdh-gt~is~i----k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~ni 353 (488)
T COG5072 279 WRECGSVFLETLKVVSLDETLYLYLHFKDH-GTPISII----KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNI 353 (488)
T ss_pred hhhccchhhhcceEEecCCceEEEEEEecC-Cceeeee----ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccce
Confidence 334556666666555445554467888865 5455322 223466777777777666666654 3589999999999
Q ss_pred EEcCCCcEEEEecCCceec
Q 010401 466 LLDRHGNVCLGDMGIVTAC 484 (511)
Q Consensus 466 Lld~~g~vKL~DFGlS~~l 484 (511)
||+ +|+|.|+||-++|.-
T Consensus 354 LId-~GnvtLIDfklsRl~ 371 (488)
T COG5072 354 LID-EGNVTLIDFKLSRLS 371 (488)
T ss_pred eee-cCceEEEEeeeeecc
Confidence 999 999999999999843
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=94.48 E-value=0.027 Score=59.05 Aligned_cols=129 Identities=16% Similarity=0.182 Sum_probs=77.9
Q ss_pred eEEEeeeecccceEEEEe-----EEEEEEEEe-----------------cCCCCch---HHHHHHHHHHHHHhC-CCCc-
Q 010401 342 LEFIDQIGPNSFKGVYKG-----KRVGIEKLK-----------------GCDKGNA---YEFELRKDLLELMTC-GHKN- 394 (511)
Q Consensus 342 y~l~~~LG~GsFG~VYkg-----k~VAVKkL~-----------------~~~~~~~---~~~~~~~Ei~iL~~l-~HpN- 394 (511)
+.++..||-|--+-||.+ +..++|.-. ......+ ......+|...|+.+ .|-+
T Consensus 94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp 173 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP 173 (465)
T ss_pred hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence 355678888888888873 333333210 0111111 112245677777766 3332
Q ss_pred eeeEeeeEeeCCCcEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEE
Q 010401 395 ILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVC 474 (511)
Q Consensus 395 IV~l~g~~~~~~~~l~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vK 474 (511)
+.+.++ .+ +.++|||++.|-.|...- ...+... +...+..-+--|-.+|+||+|..-=||++++++.++
T Consensus 174 VPkpiD----~~-RH~Vvmelv~g~Pl~~v~---~v~d~~~---ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i~ 242 (465)
T KOG2268|consen 174 VPKPID----HN-RHCVVMELVDGYPLRQVR---HVEDPPT---LYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKIV 242 (465)
T ss_pred CCCccc----cc-ceeeHHHhhcccceeeee---ecCChHH---HHHHHHHHHHHHHHcCceecccchheeEEecCCCEE
Confidence 223332 23 378999999887775442 1122222 333333344557789999999999999999999999
Q ss_pred EEecCCc
Q 010401 475 LGDMGIV 481 (511)
Q Consensus 475 L~DFGlS 481 (511)
++||--.
T Consensus 243 vIDFPQm 249 (465)
T KOG2268|consen 243 VIDFPQM 249 (465)
T ss_pred EeechHh
Confidence 9999653
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=94.36 E-value=0.31 Score=51.84 Aligned_cols=29 Identities=21% Similarity=0.190 Sum_probs=24.3
Q ss_pred CCccccCCCCCceEEcCCCcEEEEecCCce
Q 010401 453 HGVAYRDLNSQRILLDRHGNVCLGDMGIVT 482 (511)
Q Consensus 453 ~gIIHRDLKp~NILld~~g~vKL~DFGlS~ 482 (511)
..++|+|+.+.||++++++ ++++||.++.
T Consensus 192 ~~llHGDl~~gNi~~~~~~-~~~iD~e~~~ 220 (370)
T TIGR01767 192 ETLLHGDLHSGSIFVSEHE-TKVIDPEFAF 220 (370)
T ss_pred ceeeeccCCcccEEEcCCC-CEEEcCcccc
Confidence 3589999999999997654 7799998754
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=94.17 E-value=0.3 Score=49.68 Aligned_cols=31 Identities=23% Similarity=0.197 Sum_probs=25.8
Q ss_pred CccccCCCCCceEEcCCCc-EEEEecCCceec
Q 010401 454 GVAYRDLNSQRILLDRHGN-VCLGDMGIVTAC 484 (511)
Q Consensus 454 gIIHRDLKp~NILld~~g~-vKL~DFGlS~~l 484 (511)
.++|+|+++.|||+++++. .-|+||+.+...
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG 217 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVG 217 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence 4899999999999997565 469999987653
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=93.89 E-value=0.4 Score=50.15 Aligned_cols=30 Identities=13% Similarity=0.130 Sum_probs=27.3
Q ss_pred CccccCCCCCceEEcCCCcEEEEecCCcee
Q 010401 454 GVAYRDLNSQRILLDRHGNVCLGDMGIVTA 483 (511)
Q Consensus 454 gIIHRDLKp~NILld~~g~vKL~DFGlS~~ 483 (511)
.++|+|+.+.||+++..+-+=+.||+++..
T Consensus 199 ~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 199 VLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred eeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 489999999999999988899999999764
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=93.67 E-value=0.94 Score=49.06 Aligned_cols=71 Identities=13% Similarity=0.062 Sum_probs=42.5
Q ss_pred EeeeecccceEEEEe----EEEEEEEEecCC--CCc---hHHHHHHHHHHHHHhC---CCCceeeEeeeEeeCCCcEEEE
Q 010401 345 IDQIGPNSFKGVYKG----KRVGIEKLKGCD--KGN---AYEFELRKDLLELMTC---GHKNILQFYCVCVDENHGLCVV 412 (511)
Q Consensus 345 ~~~LG~GsFG~VYkg----k~VAVKkL~~~~--~~~---~~~~~~~~Ei~iL~~l---~HpNIV~l~g~~~~~~~~l~LV 412 (511)
.+.||-|..-.||+- +.+.||.-.... .+. ....+...|...|..+ ...++.+++.++.+. -+++
T Consensus 37 ~~eiggGn~N~VyrV~~~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded~---~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSSSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRTM---ALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEcCCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCCC---CEEE
Confidence 577899999999983 356777543111 111 1122333445555443 235788888887643 4689
Q ss_pred EeccCC
Q 010401 413 TKLMEG 418 (511)
Q Consensus 413 mEy~~g 418 (511)
|||+++
T Consensus 114 ME~L~~ 119 (418)
T PLN02756 114 MRYLEP 119 (418)
T ss_pred EeecCC
Confidence 999976
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=93.29 E-value=0.26 Score=53.24 Aligned_cols=59 Identities=15% Similarity=0.129 Sum_probs=43.0
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HHCCccccCCCCCceEEc
Q 010401 409 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFL-NDHGVAYRDLNSQRILLD 468 (511)
Q Consensus 409 l~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yL-H~~gIIHRDLKp~NILld 468 (511)
..|+-+|..|-++..++.. ...++.....++.-.+.|+--+ --.+++|.|+.|.||++-
T Consensus 320 ~vl~E~~~~Gl~v~~~v~~-~~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlir 379 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVKW-KSQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIR 379 (565)
T ss_pred ceeeeeccccccHHhhhhc-ccChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEE
Confidence 4567788889899988843 3455656666666666665544 346899999999999995
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=92.81 E-value=0.18 Score=51.59 Aligned_cols=30 Identities=23% Similarity=0.247 Sum_probs=27.1
Q ss_pred CCccccCCCCCceEEcCCCcEEEEecCCce
Q 010401 453 HGVAYRDLNSQRILLDRHGNVCLGDMGIVT 482 (511)
Q Consensus 453 ~gIIHRDLKp~NILld~~g~vKL~DFGlS~ 482 (511)
.+++|+|+++.||+++.++.+.|+||+.+.
T Consensus 187 ~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 187 RGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred CccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 589999999999999988877899999864
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=92.72 E-value=0.18 Score=60.15 Aligned_cols=109 Identities=14% Similarity=0.211 Sum_probs=83.2
Q ss_pred HHHHHHHHHhCCCCceeeEeeeEeeCCCc---EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Q 010401 380 LRKDLLELMTCGHKNILQFYCVCVDENHG---LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVA 456 (511)
Q Consensus 380 ~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~---l~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gII 456 (511)
.+.|+..+.++.|+|++.++++-...... +.+..+++..-++...+..-..++...++.+..++.+||.|+|+....
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~l~ 308 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLSLE 308 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhccc
Confidence 45667777888999999999887644321 234457888889999888888899999999999999999999998766
Q ss_pred ccCCCCC---ceEEcCCCcEEEE--ecCCceecccCC
Q 010401 457 YRDLNSQ---RILLDRHGNVCLG--DMGIVTACKSVG 488 (511)
Q Consensus 457 HRDLKp~---NILld~~g~vKL~--DFGlS~~l~~~~ 488 (511)
|.-|..+ +-..+..+.+.++ ||+.++.+....
T Consensus 309 ~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~ 345 (1351)
T KOG1035|consen 309 HVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNE 345 (1351)
T ss_pred eeEEecccccccccCccceeecchhhhcccccCCCcc
Confidence 6655555 4455566777777 998887765433
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=92.56 E-value=0.98 Score=46.50 Aligned_cols=72 Identities=8% Similarity=0.096 Sum_probs=39.3
Q ss_pred eEEEeeeecccceEEEE----eEEEEEEEEecCCCCchHHHHHHHHHHHHHhC---CCCceeeEeeeEeeCCCcEEEEEe
Q 010401 342 LEFIDQIGPNSFKGVYK----GKRVGIEKLKGCDKGNAYEFELRKDLLELMTC---GHKNILQFYCVCVDENHGLCVVTK 414 (511)
Q Consensus 342 y~l~~~LG~GsFG~VYk----gk~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l---~HpNIV~l~g~~~~~~~~l~LVmE 414 (511)
.+-.+.++-|....+|+ ++.+-+|.-.. ... ..+..|..-|+.+ .--.+.+.+++....+. -||+||
T Consensus 19 i~~~~~v~GG~i~~a~~~~~~~~~~FvK~~~~-~~~----~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~-~fLlle 92 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLDTDGGSYFVKVNSE-SGR----DMFEGEAEGLKALAEANPIRVPKVIAWGEYDDD-AFLLLE 92 (288)
T ss_dssp --EEEEE--SSSSEEEEEETTS-EEEEEEEEG-GGC----CHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSC-CEEEEE
T ss_pred eeeeEecCCCChhheEEEECCCccEEEEecCh-hhH----HHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCC-ceEEEE
Confidence 34557788899999997 46788887762 111 2345555555554 45557788887766655 689999
Q ss_pred ccCCC
Q 010401 415 LMEGG 419 (511)
Q Consensus 415 y~~gG 419 (511)
|++.+
T Consensus 93 ~l~~~ 97 (288)
T PF03881_consen 93 FLEMG 97 (288)
T ss_dssp -----
T ss_pred eecCC
Confidence 99765
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=92.19 E-value=0.27 Score=49.79 Aligned_cols=29 Identities=28% Similarity=0.381 Sum_probs=25.4
Q ss_pred CCccccCCCCCceEEcCCCcEEEEecCCce
Q 010401 453 HGVAYRDLNSQRILLDRHGNVCLGDMGIVT 482 (511)
Q Consensus 453 ~gIIHRDLKp~NILld~~g~vKL~DFGlS~ 482 (511)
.+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 47899999999999987 678999999653
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=91.74 E-value=1.3 Score=46.13 Aligned_cols=29 Identities=24% Similarity=0.316 Sum_probs=25.2
Q ss_pred ccccCCCCCceEEcC-CCcEEEEecCCcee
Q 010401 455 VAYRDLNSQRILLDR-HGNVCLGDMGIVTA 483 (511)
Q Consensus 455 IIHRDLKp~NILld~-~g~vKL~DFGlS~~ 483 (511)
++|.|+.+.|||+++ ++.++++||..|..
T Consensus 184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred EEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 799999999999974 57899999998643
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=91.00 E-value=1.7 Score=47.02 Aligned_cols=29 Identities=10% Similarity=0.158 Sum_probs=24.6
Q ss_pred CCccccCCCCCceEEcCCCcEEEEecCCce
Q 010401 453 HGVAYRDLNSQRILLDRHGNVCLGDMGIVT 482 (511)
Q Consensus 453 ~gIIHRDLKp~NILld~~g~vKL~DFGlS~ 482 (511)
..++|+||.|.||+++.+ .+|++|.-++.
T Consensus 227 ~aLlHGDlHtGSI~v~~~-~~kvIDpEFAf 255 (409)
T PRK12396 227 QALIHGDLHTGSVFVKND-STKVIDPEFAF 255 (409)
T ss_pred hhhccCcCCCCCEEecCC-ceEEEcccccc
Confidence 358999999999999865 58999988764
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=90.73 E-value=0.36 Score=48.95 Aligned_cols=30 Identities=23% Similarity=0.187 Sum_probs=26.7
Q ss_pred CccccCCCCCceEEcCC----CcEEEEecCCcee
Q 010401 454 GVAYRDLNSQRILLDRH----GNVCLGDMGIVTA 483 (511)
Q Consensus 454 gIIHRDLKp~NILld~~----g~vKL~DFGlS~~ 483 (511)
.++|+|+.+.|||++.+ +.++++||..|..
T Consensus 180 ~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~ 213 (302)
T cd05156 180 VFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY 213 (302)
T ss_pred eEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence 58999999999999974 8899999998754
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=88.95 E-value=4.8 Score=43.10 Aligned_cols=29 Identities=17% Similarity=0.015 Sum_probs=24.0
Q ss_pred CCccccCCCCCceEEcCCCcEEEEecCCce
Q 010401 453 HGVAYRDLNSQRILLDRHGNVCLGDMGIVT 482 (511)
Q Consensus 453 ~gIIHRDLKp~NILld~~g~vKL~DFGlS~ 482 (511)
..++|.|+-+.|||.++ +.++++||--|.
T Consensus 227 ~VfCHNDL~~gNIL~~~-~~l~lID~EYA~ 255 (383)
T PTZ00384 227 VLFCHNDLFFTNILDFN-QGIYFIDFDFAG 255 (383)
T ss_pred eeeeeccCCcccEEecC-CCEEEEEecccc
Confidence 35799999999999764 569999998764
|
|
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=87.51 E-value=0.46 Score=46.01 Aligned_cols=29 Identities=14% Similarity=0.125 Sum_probs=25.2
Q ss_pred CccccCCCCCceEEcCCCcEEEEecCCcee
Q 010401 454 GVAYRDLNSQRILLDRHGNVCLGDMGIVTA 483 (511)
Q Consensus 454 gIIHRDLKp~NILld~~g~vKL~DFGlS~~ 483 (511)
..+|+|+.|.||++.+++ ++|+||+.+..
T Consensus 78 ~p~H~D~~~~N~~~~~~~-~~lIDwe~a~~ 106 (188)
T PRK10271 78 APLHMDVHAGNLVHSASG-LRLIDWEYAGD 106 (188)
T ss_pred eeecCCCCCccEEEECCC-EEEEeCCcccC
Confidence 369999999999998777 89999998643
|
|
| >smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain | Back alignment and domain information |
|---|
Probab=86.50 E-value=1.2 Score=42.81 Aligned_cols=32 Identities=19% Similarity=0.206 Sum_probs=26.7
Q ss_pred CCccccCCCCCceEEcCCC-----cEEEEecCCceec
Q 010401 453 HGVAYRDLNSQRILLDRHG-----NVCLGDMGIVTAC 484 (511)
Q Consensus 453 ~gIIHRDLKp~NILld~~g-----~vKL~DFGlS~~l 484 (511)
..++|||+.+.||++..++ .+.|+||..++..
T Consensus 120 ~vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~~g 156 (196)
T smart00587 120 NVLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSHYG 156 (196)
T ss_pred eEEeeCCCCccceeeccCCCCCccceEEEecccCCcC
Confidence 4689999999999998544 6899999987653
|
subfamily of choline kinases |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=86.28 E-value=2.3 Score=42.86 Aligned_cols=101 Identities=14% Similarity=0.038 Sum_probs=63.4
Q ss_pred EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHH
Q 010401 361 RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIA 440 (511)
Q Consensus 361 ~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia 440 (511)
...+|++....... ...-+..+..+++++ ..|+++. .+.+..+.++.|+|-.-.. +. .-.+.
T Consensus 87 ~L~lKKi~slp~~~-~~~~y~nky~v~Arm--hGilrL~---NDn~~~yGvIlE~Cy~~~i---------~~---~N~i~ 148 (308)
T PF07387_consen 87 PLFLKKIRSLPCCI-NDALYFNKYRVFARM--HGILRLK---NDNNYKYGVILERCYKIKI---------NF---SNFIT 148 (308)
T ss_pred hhhhhhccCCCccc-chhhhhhhhhHHHHh--hheeEee---cCCCceeEEEEeeccCccc---------ch---hHHHH
Confidence 34567776433321 123346667777653 3566666 3344447899999843111 11 11111
Q ss_pred HHHHHHHHHHHH--CCccccCCCCCceEEcCCCcEEEEecCC
Q 010401 441 IDVAEGIKFLND--HGVAYRDLNSQRILLDRHGNVCLGDMGI 480 (511)
Q Consensus 441 ~qIa~gL~yLH~--~gIIHRDLKp~NILld~~g~vKL~DFGl 480 (511)
.. +++|.-.|+ .+.+|+|..|+||+-|..|.+||.|=+.
T Consensus 149 ag-i~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 149 AG-IKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred Hh-HHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhh
Confidence 11 456777884 4699999999999999999999999875
|
The function of this family is unknown. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=85.51 E-value=0.52 Score=45.35 Aligned_cols=30 Identities=30% Similarity=0.367 Sum_probs=21.5
Q ss_pred CccccCCCCCceEE-cCCCcEEEEecCCcee
Q 010401 454 GVAYRDLNSQRILL-DRHGNVCLGDMGIVTA 483 (511)
Q Consensus 454 gIIHRDLKp~NILl-d~~g~vKL~DFGlS~~ 483 (511)
.++|.|+.+.|||+ +.++.++|+||..|..
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 48999999999999 8899999999998754
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=85.11 E-value=1.2 Score=45.52 Aligned_cols=30 Identities=10% Similarity=0.031 Sum_probs=27.4
Q ss_pred CccccCCCCCceEEcCCCcEEEEecCCcee
Q 010401 454 GVAYRDLNSQRILLDRHGNVCLGDMGIVTA 483 (511)
Q Consensus 454 gIIHRDLKp~NILld~~g~vKL~DFGlS~~ 483 (511)
+++|+|+.+.|+|++.++.+.++||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 799999999999999999999999988654
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=85.10 E-value=0.99 Score=47.37 Aligned_cols=30 Identities=20% Similarity=0.318 Sum_probs=26.3
Q ss_pred CccccCCCCCceEEcC-CCcEEEEecCCcee
Q 010401 454 GVAYRDLNSQRILLDR-HGNVCLGDMGIVTA 483 (511)
Q Consensus 454 gIIHRDLKp~NILld~-~g~vKL~DFGlS~~ 483 (511)
.++|+|+++.|||+++ ++.+.|+||..+..
T Consensus 201 ~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 201 GFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred eEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 5899999999999986 47899999998754
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=84.83 E-value=1.4 Score=46.39 Aligned_cols=29 Identities=17% Similarity=0.226 Sum_probs=25.8
Q ss_pred ccccCCCCCceEEcCCCc-EEEEecCCcee
Q 010401 455 VAYRDLNSQRILLDRHGN-VCLGDMGIVTA 483 (511)
Q Consensus 455 IIHRDLKp~NILld~~g~-vKL~DFGlS~~ 483 (511)
+||.|+.|.||+++.+.. +.++||+-+..
T Consensus 199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~ 228 (331)
T COG2334 199 IIHGDLHPDNVLFDDDTDVSGFIDFDDAGY 228 (331)
T ss_pred eeecCCCccceeEcCCCCeeeEEEcccccc
Confidence 999999999999998875 89999998643
|
|
| >PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly | Back alignment and domain information |
|---|
Probab=84.71 E-value=0.71 Score=48.96 Aligned_cols=51 Identities=18% Similarity=0.171 Sum_probs=34.3
Q ss_pred HHHHHHHHHHHHHHHHHH----HCCccccCCCCCceEEcCCC------------------cEEEEecCCceec
Q 010401 434 KEIIRIAIDVAEGIKFLN----DHGVAYRDLNSQRILLDRHG------------------NVCLGDMGIVTAC 484 (511)
Q Consensus 434 ~~~~~ia~qIa~gL~yLH----~~gIIHRDLKp~NILld~~g------------------~vKL~DFGlS~~l 484 (511)
+-++.++.||+.-.--+- ...++|-||||+|||+-+.. ..+|.||.+|+..
T Consensus 275 ~YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv~ 347 (434)
T PF05445_consen 275 EYVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGNRNYVFKEPIRCCLNDFDFSQVA 347 (434)
T ss_pred HHHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECCeEEEecccceeeecccCHHHhc
Confidence 445667777754331121 24699999999999996433 3688899887654
|
; GO: 0004672 protein kinase activity, 0005524 ATP binding |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=84.07 E-value=0.33 Score=59.69 Aligned_cols=124 Identities=15% Similarity=0.019 Sum_probs=83.1
Q ss_pred HHHHHHhCCCCceeeEeeeEee-CCCcEEEEEeccCCCCHHHHHHhc-C---CCCHHHHHHHHHHH-HHHHHHHHHC---
Q 010401 383 DLLELMTCGHKNILQFYCVCVD-ENHGLCVVTKLMEGGSVNDLILKS-R---KLQTKEIIRIAIDV-AEGIKFLNDH--- 453 (511)
Q Consensus 383 Ei~iL~~l~HpNIV~l~g~~~~-~~~~l~LVmEy~~gGsL~~lL~~~-~---~L~e~~~~~ia~qI-a~gL~yLH~~--- 453 (511)
|...++...|+++...+.-... .+...|..++|+.+|.+.+.|-++ . .+... ......++ +.+..-+|+.
T Consensus 1279 e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~-~v~~~~kvsvl~~~~~ls~tnl 1357 (2724)
T KOG1826|consen 1279 ERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRS-PVHLRHKVSVLNRNVILSLTNL 1357 (2724)
T ss_pred hhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhc-hHHHHHHHHHhccchhhhcccC
Confidence 3334455689888776644332 233368999999999999998543 1 23222 23333444 5556665642
Q ss_pred --CccccCCCCCceEEcCCCcEEEEecCCceecccCCCccccccCCCccccHHhhc
Q 010401 454 --GVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEVCF 507 (511)
Q Consensus 454 --gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~~~~~Gt~~YmAPEvl~ 507 (511)
-.+|++||+-|.+|..+.++|+.++|+.++............+++-|++|++..
T Consensus 1358 g~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N 1413 (2724)
T KOG1826|consen 1358 GNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKN 1413 (2724)
T ss_pred CccchhhhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHH
Confidence 279999999999999999999999999885444333334456667788887753
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=83.39 E-value=0.82 Score=52.23 Aligned_cols=54 Identities=9% Similarity=-0.021 Sum_probs=37.6
Q ss_pred cccCCCCC-ceEEcCCCcEEEEecCCceecccCCC--ccccccCCCccccHHhhccc
Q 010401 456 AYRDLNSQ-RILLDRHGNVCLGDMGIVTACKSVGE--ATEYETDGYRWLAPEVCFLL 509 (511)
Q Consensus 456 IHRDLKp~-NILld~~g~vKL~DFGlS~~l~~~~~--~~~~~~Gt~~YmAPEvl~gl 509 (511)
.+++..|. |++++..+..++.|||.++....... ......||+.|||||++.+.
T Consensus 499 ~~~~~~p~~~~~~~p~~~~~~~~~~~~~~~~~g~~~~~~~~~vGT~~Y~APE~l~~~ 555 (669)
T cd05610 499 PTQKPRPHGNLYQTPKQVKIGTPYRTPKSVRRGAAPVEGERILGTPDYLAPELLLGK 555 (669)
T ss_pred CCCCCCCCCceeECCccccccccCCCchhhhcccccccCCceeeCccccCHHHcCCC
Confidence 44566666 66777777788999999876543221 22345789999999998753
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 511 | ||||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-13 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 7e-13 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-12 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-12 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 3e-12 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 7e-11 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 7e-11 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 8e-11 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-10 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-10 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-10 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-10 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-10 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-10 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-10 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-10 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-10 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-10 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 5e-10 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 5e-10 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 5e-10 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 5e-10 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 6e-10 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 6e-10 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 6e-10 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 6e-10 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 8e-10 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 9e-10 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 9e-10 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-09 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-09 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-09 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-09 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-09 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-09 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-09 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-09 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-09 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-09 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 5e-09 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 5e-09 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 8e-09 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-08 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-08 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-08 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-08 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-08 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-08 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-08 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 3e-08 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 3e-08 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 3e-08 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-08 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-08 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-08 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-08 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-08 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 3e-08 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 3e-08 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-08 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 4e-08 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 4e-08 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 4e-08 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 5e-08 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 5e-08 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 7e-08 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 7e-08 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 7e-08 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 8e-08 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 8e-08 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-07 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-07 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-07 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-07 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-07 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 1e-07 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 1e-07 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 1e-07 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-07 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-07 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-07 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-07 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-07 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-07 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-07 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 3e-07 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-07 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 3e-07 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-07 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-07 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-07 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-07 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 3e-07 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-07 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-07 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-07 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-07 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-07 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-07 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 3e-07 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 4e-07 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 4e-07 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 4e-07 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 4e-07 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-07 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 4e-07 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 4e-07 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 4e-07 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 5e-07 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 5e-07 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-07 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 5e-07 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 5e-07 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 5e-07 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-07 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 6e-07 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 6e-07 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-07 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 7e-07 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 7e-07 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 8e-07 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 8e-07 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-06 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-06 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-06 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-06 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-06 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-06 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-06 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-06 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-06 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-06 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-06 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-06 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-06 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-06 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-06 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-06 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-06 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-06 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-06 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-06 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-06 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-06 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-06 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 3e-06 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 3e-06 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 3e-06 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-06 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 3e-06 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 4e-06 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 4e-06 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 4e-06 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 4e-06 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 4e-06 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 4e-06 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 4e-06 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 4e-06 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 5e-06 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 5e-06 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 5e-06 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 5e-06 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 5e-06 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 5e-06 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 5e-06 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-06 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 5e-06 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 5e-06 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 6e-06 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 6e-06 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 6e-06 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 6e-06 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 6e-06 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 6e-06 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-06 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-06 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 6e-06 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-06 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 6e-06 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 6e-06 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 6e-06 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 6e-06 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 6e-06 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 6e-06 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 6e-06 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 6e-06 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 7e-06 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 7e-06 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 7e-06 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 7e-06 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 7e-06 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 7e-06 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 8e-06 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 8e-06 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 8e-06 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 8e-06 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 8e-06 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 8e-06 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 8e-06 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 8e-06 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 9e-06 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-05 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-05 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-05 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-05 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-05 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-05 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-05 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-05 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-05 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-05 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-05 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-05 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-05 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-05 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-05 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-05 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-05 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-05 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-05 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-05 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-05 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-05 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-05 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-05 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-05 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-05 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-05 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-05 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-05 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-05 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-05 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-05 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-05 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-05 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-05 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-05 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-05 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-05 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-05 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-05 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-05 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-05 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-05 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-05 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-05 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-05 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-05 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-05 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-05 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-05 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-05 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-05 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-05 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-05 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-05 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-05 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-05 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-05 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 3e-05 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 3e-05 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 3e-05 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-05 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-05 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-05 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 3e-05 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 3e-05 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-05 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-05 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 4e-05 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 4e-05 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-05 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-05 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 4e-05 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-05 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-05 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-05 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-05 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-05 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-05 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-05 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-05 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 5e-05 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 5e-05 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 5e-05 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 5e-05 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 5e-05 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-05 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 6e-05 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 6e-05 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-05 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 6e-05 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 6e-05 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-05 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 6e-05 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-05 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 7e-05 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 7e-05 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-05 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 7e-05 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-05 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 7e-05 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 7e-05 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 7e-05 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 7e-05 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-05 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 7e-05 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 7e-05 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 8e-05 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 8e-05 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 8e-05 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 8e-05 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 8e-05 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 8e-05 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 8e-05 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 8e-05 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 8e-05 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 8e-05 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 8e-05 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-05 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 9e-05 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 9e-05 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 9e-05 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-05 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 9e-05 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-04 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-04 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-04 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-04 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-04 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-04 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-04 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-04 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-04 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-04 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-04 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-04 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-04 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-04 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-04 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-04 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-04 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-04 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-04 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-04 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-04 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-04 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-04 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-04 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-04 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-04 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-04 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-04 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-04 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-04 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-04 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-04 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-04 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-04 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-04 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-04 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-04 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-04 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-04 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-04 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-04 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-04 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-04 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-04 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-04 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-04 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-04 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-04 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-04 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-04 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-04 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-04 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-04 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-04 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-04 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-04 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-04 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-04 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-04 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-04 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-04 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-04 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-04 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-04 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-04 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-04 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-04 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-04 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-04 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-04 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-04 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-04 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-04 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-04 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 3e-04 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 3e-04 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-04 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 3e-04 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 3e-04 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-04 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-04 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 3e-04 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 3e-04 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 3e-04 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-04 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 3e-04 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-04 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 3e-04 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 3e-04 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-04 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 3e-04 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-04 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 3e-04 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 3e-04 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-04 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-04 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 3e-04 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-04 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-04 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-04 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-04 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-04 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 3e-04 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-04 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-04 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-04 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 3e-04 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-04 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 4e-04 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 4e-04 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 4e-04 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 4e-04 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 4e-04 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 4e-04 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 4e-04 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 4e-04 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 4e-04 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 4e-04 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 5e-04 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 5e-04 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 5e-04 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 5e-04 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 5e-04 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 5e-04 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 5e-04 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 5e-04 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 5e-04 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 6e-04 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 6e-04 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 6e-04 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 6e-04 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 6e-04 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-04 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 7e-04 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 8e-04 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 8e-04 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 8e-04 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 8e-04 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 8e-04 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 9e-04 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 9e-04 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-04 |
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 2e-29
Identities = 47/215 (21%), Positives = 93/215 (43%), Gaps = 24/215 (11%)
Query: 311 PSSSFVVSVDEWQTVQSG-GEEIGRWLLNSDNLEFIDQIGPNSF----KGVYKGKRVGIE 365
P S +++ Q+ SG G + + ++ + QIG + G ++G++V ++
Sbjct: 7 PGESLRDLIEQSQSSGSGSGLPLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWRGEKVAVK 66
Query: 366 KLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHG---LCVVTKLMEGGSVN 422
++ + ++ + + H+NIL F + L ++T E GS+
Sbjct: 67 VFFTTEEA---SWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLY 123
Query: 423 DLILKSRKLQTKEIIRIAIDVAEGIKFL--------NDHGVAYRDLNSQRILLDRHGNVC 474
D LKS L K ++++A G+ L +A+RDL S+ IL+ ++G C
Sbjct: 124 DY-LKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCC 182
Query: 475 LGDMGIVTACKSVGEATEYETDG----YRWLAPEV 505
+ D+G+ S + + R++ PEV
Sbjct: 183 IADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEV 217
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 3e-28
Identities = 44/187 (23%), Positives = 86/187 (45%), Gaps = 23/187 (12%)
Query: 338 NSDNLEFIDQIGPNSF----KGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHK 393
+ ++ ++ +G + +G ++G+ V ++ D+ ++ E +L + H+
Sbjct: 6 VARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDE-KSWFRE--TELYNTVMLRHE 62
Query: 394 NILQFYCVCVDENHG---LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFL 450
NIL F + H L ++T E GS+ D L+ L T +RI + +A G+ L
Sbjct: 63 NILGFIASDMTSRHSSTQLWLITHYHEMGSLYDY-LQLTTLDTVSCLRIVLSIASGLAHL 121
Query: 451 --------NDHGVAYRDLNSQRILLDRHGNVCLGDMG---IVTACKSVGEATEYETDG-Y 498
+A+RDL S+ IL+ ++G C+ D+G + + + + G
Sbjct: 122 HIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTK 181
Query: 499 RWLAPEV 505
R++APEV
Sbjct: 182 RYMAPEV 188
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 8e-28
Identities = 42/190 (22%), Positives = 86/190 (45%), Gaps = 23/190 (12%)
Query: 335 WLLNSDNLEFIDQIGPNSF----KGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTC 390
+ + + IG F +G ++G+ V ++ ++ ++ E ++ + +
Sbjct: 37 QRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREE-RSWFRE--AEIYQTVML 93
Query: 391 GHKNILQFYCVCVDENHG---LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGI 447
H+NIL F +N L +V+ E GS+ D L + + +I++A+ A G+
Sbjct: 94 RHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDY-LNRYTVTVEGMIKLALSTASGL 152
Query: 448 KFLNDH--------GVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG-- 497
L+ +A+RDL S+ IL+ ++G C+ D+G+ S + + +
Sbjct: 153 AHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV 212
Query: 498 --YRWLAPEV 505
R++APEV
Sbjct: 213 GTKRYMAPEV 222
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 1e-27
Identities = 43/184 (23%), Positives = 83/184 (45%), Gaps = 10/184 (5%)
Query: 331 EIGRWLLNSDNLEFIDQIGPNSF----KGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLE 386
+ + +L ++IG SF + + G V ++ L D E +++
Sbjct: 28 DGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAI 87
Query: 387 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKS---RKLQTKEIIRIAIDV 443
+ H NI+ F + L +VT+ + GS+ L+ KS +L + + +A DV
Sbjct: 88 MKRLRHPNIVLFMGAVTQPPN-LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDV 146
Query: 444 AEGIKFL--NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWL 501
A+G+ +L + + +R+L S +L+D+ V + D G+ S +++ W+
Sbjct: 147 AKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWM 206
Query: 502 APEV 505
APEV
Sbjct: 207 APEV 210
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-27
Identities = 50/186 (26%), Positives = 77/186 (41%), Gaps = 8/186 (4%)
Query: 326 QSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGK---RVGIEKLKGCDKGNAYEFELRK 382
+ W + + +IG SF VYKGK V ++ L +
Sbjct: 10 HGSRDAADDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKN 69
Query: 383 DLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAI 441
++ L H NIL F L +VT+ EG S+ + S K + K++I IA
Sbjct: 70 EVGVLRKTRHVNILLFMGYSTAPQ--LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIAR 127
Query: 442 DVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG--YR 499
A G+ +L+ + +RDL S I L V +GD G+ T + ++E
Sbjct: 128 QTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSIL 187
Query: 500 WLAPEV 505
W+APEV
Sbjct: 188 WMAPEV 193
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-27
Identities = 33/184 (17%), Positives = 74/184 (40%), Gaps = 22/184 (11%)
Query: 335 WLLNSDNLEFIDQIGPNSF----KGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTC 390
++ L F+ ++ N KG ++G + ++ LK D + ++ L
Sbjct: 5 SGIDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIF 64
Query: 391 GHKNILQFYCVCVDENHG-LCVVTKLMEGGSVNDLILK--SRKLQTKEIIRIAIDVAEGI 447
H N+L C ++T M GS+ +++ + + + + ++ A+D+A G+
Sbjct: 65 SHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGM 124
Query: 448 KFL--NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRWL 501
FL + + LNS+ +++D + + +++ G W+
Sbjct: 125 AFLHTLEPLIPRHALNSRSVMIDEDMTARISMADV---------KFSFQSPGRMYAPAWV 175
Query: 502 APEV 505
APE
Sbjct: 176 APEA 179
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 4e-27
Identities = 43/182 (23%), Positives = 82/182 (45%), Gaps = 21/182 (11%)
Query: 335 WLLNSDNLEFIDQIGPNSF----KGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTC 390
+++ +E + +G +F K ++ K V I++++ + A+ ELR+ L
Sbjct: 3 HMIDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESESERKAFIVELRQ----LSRV 58
Query: 391 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR---KLQTKEIIRIAIDVAEGI 447
H NI++ Y C++ +C+V + EGGS+ +++ + + + ++G+
Sbjct: 59 NHPNIVKLYGACLNP---VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGV 115
Query: 448 KFL---NDHGVAYRDLNSQRILLDRHGNVC-LGDMGIVTACKSVGEATEYETDGYRWLAP 503
+L + +RDL +LL G V + D G TAC T W+AP
Sbjct: 116 AYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFG--TACDIQTHMTN-NKGSAAWMAP 172
Query: 504 EV 505
EV
Sbjct: 173 EV 174
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 6e-27
Identities = 50/203 (24%), Positives = 90/203 (44%), Gaps = 29/203 (14%)
Query: 326 QSGGEEIG--RWLLNSDNLEFIDQIGPNSFKGVYK----GKRVGIEKLKGCDKGNAYEFE 379
S G ++G S L+ ++ F V+K + V ++ DK +++ E
Sbjct: 8 HSSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDK-QSWQNE 66
Query: 380 LRKDLLELMTCGHKNILQFYCVCVDENHG---LCVVTKLMEGGSVNDLILKSRKLQTKEI 436
++ L H+NILQF L ++T E GS++D LK+ + E+
Sbjct: 67 --YEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDF-LKANVVSWNEL 123
Query: 437 IRIAIDVAEGIKFLNDH----------GVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS 486
IA +A G+ +L++ +++RD+ S+ +LL + C+ D G+ A K
Sbjct: 124 CHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGL--ALKF 181
Query: 487 VGEATEYETDG----YRWLAPEV 505
+ +T G R++APEV
Sbjct: 182 EAGKSAGDTHGQVGTRRYMAPEV 204
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 2e-26
Identities = 41/196 (20%), Positives = 71/196 (36%), Gaps = 29/196 (14%)
Query: 335 WLLNSDNLEFIDQIGPNSF----KGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTC 390
L+ DNL+ ++ IG + KG + V ++ ++ F K++ +
Sbjct: 8 PSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFANRQ---NFINEKNIYRVPLM 64
Query: 391 GHKNILQFYCVC----VDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEG 446
H NI +F D +V + GS+ L R+A V G
Sbjct: 65 EHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKY-LSLHTSDWVSSCRLAHSVTRG 123
Query: 447 IKFL---------NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG 497
+ +L +++RDLNS+ +L+ G + D G+ E D
Sbjct: 124 LAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDN 183
Query: 498 --------YRWLAPEV 505
R++APEV
Sbjct: 184 AAISEVGTIRYMAPEV 199
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 5e-26
Identities = 45/216 (20%), Positives = 91/216 (42%), Gaps = 24/216 (11%)
Query: 299 NSNLKIQLQMPLPSSSFVVSVDEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYK 358
N +L P +S + + EW +I + LE + IG F VY
Sbjct: 5 NLSLLSARSFPRKASQTSIFLQEW--------DI-----PFEQLEIGELIGKGRFGQVYH 51
Query: 359 GK---RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKL 415
G+ V I + +++++ H+N++ F C+ H L ++T L
Sbjct: 52 GRWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPH-LAIITSL 110
Query: 416 MEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVC 474
+G ++ ++ ++ L + +IA ++ +G+ +L+ G+ ++DL S+ + D +G V
Sbjct: 111 CKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVV 169
Query: 475 LGDMGI-----VTACKSVGEATEYETDGYRWLAPEV 505
+ D G+ V + + LAPE+
Sbjct: 170 ITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEI 205
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 7e-26
Identities = 39/188 (20%), Positives = 75/188 (39%), Gaps = 21/188 (11%)
Query: 335 WLLNSDNLEFIDQIGPNSF----KGVYKGKRVGIEKLKGCDKGNAYEF--ELRKDLLELM 388
++ L + IG F + + G V ++ + + + +R++
Sbjct: 2 LEIDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFA 61
Query: 389 TCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIK 448
H NI+ VC+ E + LC+V + GG +N + L +++ ++ A+ +A G+
Sbjct: 62 MLKHPNIIALRGVCLKEPN-LCLVMEFARGGPLNRV-LSGKRIPPDILVNWAVQIARGMN 119
Query: 449 FL---NDHGVAYRDLNSQRILLDRHGNVCLGDMGIV------TACKSVGEATEYETDG-- 497
+L + +RDL S IL+ + I+ A T +
Sbjct: 120 YLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR--EWHRTTKMSAAGA 177
Query: 498 YRWLAPEV 505
Y W+APEV
Sbjct: 178 YAWMAPEV 185
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 41/196 (20%), Positives = 84/196 (42%), Gaps = 32/196 (16%)
Query: 335 WLLNSDNLEFIDQIGPNSF----KGVYK--GKRVGIEKLKGCDKGNAYEFELRKDLL--- 385
+ +L + +G F K ++ G+ + +++L D+ E ++ L
Sbjct: 5 RIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDE------ETQRTFLKEV 58
Query: 386 ELMTC-GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILK-SRKLQTKEIIRIAIDV 443
++M C H N+L+F V + L +T+ ++GG++ +I + + + A D+
Sbjct: 59 KVMRCLEHPNVLKFIGVLYKDKR-LNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDI 117
Query: 444 AEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGI--------------VTACKSVGE 489
A G+ +L+ + +RDLNS L+ + NV + D G+ + K +
Sbjct: 118 ASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRK 177
Query: 490 ATEYETDGYRWLAPEV 505
W+APE+
Sbjct: 178 KRYTVVGNPYWMAPEM 193
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 4e-24
Identities = 44/190 (23%), Positives = 81/190 (42%), Gaps = 25/190 (13%)
Query: 335 WLLNSDNLEFIDQIGPNSFKGVYKGK------RVGIEKLK-GCDKGNAYEFELRKDLLE- 386
L + +E+ QIG F V+KG+ V I+ L G +G E ++
Sbjct: 14 PTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQRE 73
Query: 387 ---LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL-KSRKLQTKEIIRIAID 442
+ H NI++ Y + + +V + + G + +L K+ ++ +R+ +D
Sbjct: 74 VFIMSNLNHPNIVKLYGLMHN---PPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLD 130
Query: 443 VAEGIKFLNDHGVAY--RDLNSQRILLD---RHGNVCL--GDMGIVTACKSVGEATEYET 495
+A GI+++ + RDL S I L + VC D G + +SV +
Sbjct: 131 IALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFG--LSQQSVHSVSG-LL 187
Query: 496 DGYRWLAPEV 505
++W+APE
Sbjct: 188 GNFQWMAPET 197
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 8e-21
Identities = 31/178 (17%), Positives = 58/178 (32%), Gaps = 23/178 (12%)
Query: 343 EFIDQIGPNSFKGVYKGKRVGIEKLKGC-------DKGNAYEFELRKDLLE----LMTCG 391
+ + ++G S+ V+K + K G + + L E
Sbjct: 60 QRLSRLGHGSYGEVFKVRS----KEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQ 115
Query: 392 HKNILQFYCVCVDENHGLCVVTKLME--GGSVNDLILKSRK-LQTKEIIRIAIDVAEGIK 448
H ++ + L + E G S+ L ++ D +
Sbjct: 116 HPCCVRLEQAWEEGGI-LYLQ---TELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALA 171
Query: 449 FLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEVC 506
L+ G+ + D+ I L G LGD G++ + G E D ++APE+
Sbjct: 172 HLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPR-YMAPELL 228
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 1e-20
Identities = 44/183 (24%), Positives = 72/183 (39%), Gaps = 25/183 (13%)
Query: 340 DNLEFIDQIGPNSFKGVYKGKRVGIEK---LKGCDKGNAYEFELRKDLLE---LMTCGHK 393
+ + +IG SF K + +K + E + E L H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 394 NILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK--LQTKEIIRIAIDVAEGIKFLN 451
NI+Q+ + L +V EGG + I + Q +I+ + + +K ++
Sbjct: 84 NIVQYRESFEENGS-LYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH 142
Query: 452 DHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS--------VGEATEYETDGYRWLAP 503
D + +RD+ SQ I L + G V LGD GI S +G T Y +L+P
Sbjct: 143 DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIG--TPY------YLSP 194
Query: 504 EVC 506
E+C
Sbjct: 195 EIC 197
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 1e-20
Identities = 42/188 (22%), Positives = 82/188 (43%), Gaps = 27/188 (14%)
Query: 335 WLLNSDNLEFIDQIGPNSFKGVYKGK------RVGIEKLK-GCDKGNAYEFELRKDLLE- 386
W+LN ++L +QIG +F V+ G+ V ++ + +F L E
Sbjct: 109 WVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKF-----LQEA 163
Query: 387 --LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK--LQTKEIIRIAID 442
L H NI++ VC + + +V +L++GG L++ L+ K ++++ D
Sbjct: 164 RILKQYSHPNIVRLIGVCTQKQP-IYIVMELVQGGDFLTF-LRTEGARLRVKTLLQMVGD 221
Query: 443 VAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----- 497
A G+++L +RDL ++ L+ + + D G+ + + + G
Sbjct: 222 AAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGM---SREEADGVYAASGGLRQVP 278
Query: 498 YRWLAPEV 505
+W APE
Sbjct: 279 VKWTAPEA 286
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 7e-20
Identities = 46/189 (24%), Positives = 79/189 (41%), Gaps = 35/189 (18%)
Query: 334 RWLLNSDNLEFIDQIGPNSF----KGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLE--- 386
W LN L+ + IG F G Y+G +V ++ +K + L
Sbjct: 15 GWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIK--------NDATAQAFLAEAS 66
Query: 387 -LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK---LQTKEIIRIAID 442
+ H N++Q V V+E GL +VT+ M GS+ D L+SR L +++ ++D
Sbjct: 67 VMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDY-LRSRGRSVLGGDCLLKFSLD 125
Query: 443 VAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA-TEYETDG---- 497
V E +++L + +RDL ++ +L+ + D G+ T
Sbjct: 126 VCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGL---------TKEASSTQDTGKL 176
Query: 498 -YRWLAPEV 505
+W APE
Sbjct: 177 PVKWTAPEA 185
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 9e-20
Identities = 46/188 (24%), Positives = 80/188 (42%), Gaps = 33/188 (17%)
Query: 334 RWLLNSDNLEFIDQIGPNSF----KGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLE--- 386
W LN L+ + IG F G Y+G +V ++ +K + L
Sbjct: 187 GWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIK--------NDATAQAFLAEAS 238
Query: 387 -LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR---KLQTKEIIRIAID 442
+ H N++Q V V+E GL +VT+ M GS+ D L+SR L +++ ++D
Sbjct: 239 VMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDY-LRSRGRSVLGGDCLLKFSLD 297
Query: 443 VAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY---- 498
V E +++L + +RDL ++ +L+ + D G+ + T
Sbjct: 298 VCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGL--TKE------ASSTQDTGKLP 349
Query: 499 -RWLAPEV 505
+W APE
Sbjct: 350 VKWTAPEA 357
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 1e-19
Identities = 40/198 (20%), Positives = 75/198 (37%), Gaps = 36/198 (18%)
Query: 337 LNSDNLEFIDQIGPNSFKGVYKGKRVG---------IEKLKGCDKGNAY-EFELRKDLLE 386
+++ + FI ++G F V + + I + D+ A E ++ +
Sbjct: 26 IDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLF-- 83
Query: 387 LMTCGHKNILQFYCVCVDENHG---LCVVTKLMEGGSVNDLI----LKSRKLQTKEIIRI 439
H NIL+ C+ E ++ + G++ + I K L +I+ +
Sbjct: 84 ----NHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWL 139
Query: 440 AIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV-----------G 488
+ + G++ ++ G A+RDL ILL G L D+G +
Sbjct: 140 LLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQD 199
Query: 489 EATEYETDGYRWLAPEVC 506
A + T YR APE+
Sbjct: 200 WAAQRCTISYR--APELF 215
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 87.7 bits (217), Expect = 6e-19
Identities = 41/201 (20%), Positives = 67/201 (33%), Gaps = 34/201 (16%)
Query: 330 EEIGRWLLNSDNLEFIDQIG--PNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELR 381
+ + +L E + IG V G+ V + ++ N L+
Sbjct: 15 QGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQ 74
Query: 382 KDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLI--LKSRKLQTKEIIRI 439
+L H NI+ + + +N L VVT M GS DLI + I I
Sbjct: 75 GELHVSKLFNHPNIVPYRATFIADNE-LWVVTSFMAYGSAKDLICTHFMDGMNELAIAYI 133
Query: 440 AIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGI---------------VTAC 484
V + + +++ G +R + + IL+ G V L +
Sbjct: 134 LQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPK 193
Query: 485 KSVGEATEYETDGYRWLAPEV 505
SV WL+PEV
Sbjct: 194 YSVK--VLP------WLSPEV 206
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 2e-18
Identities = 55/194 (28%), Positives = 88/194 (45%), Gaps = 27/194 (13%)
Query: 334 RWLLNSDNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLEL 387
W +N D+ E + IG + V ++V I K +K EL K++ +
Sbjct: 9 PWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAI-KRINLEKCQTSMDELLKEIQAM 67
Query: 388 MTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLI--------LKSRKLQTKEIIRI 439
C H NI+ +Y V ++ L +V KL+ GGSV D+I KS L I I
Sbjct: 68 SQCHHPNIVSYYTSFVVKDE-LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATI 126
Query: 440 AIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR 499
+V EG+++L+ +G +RD+ + ILL G+V + D G+ + + + R
Sbjct: 127 LREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGV---SAFLATGGDITRNKVR 183
Query: 500 --------WLAPEV 505
W+APEV
Sbjct: 184 KTFVGTPCWMAPEV 197
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 2e-18
Identities = 45/187 (24%), Positives = 91/187 (48%), Gaps = 25/187 (13%)
Query: 333 GRWLLNSDNLEFIDQIGPNSFKGVYKGK-----RVGIEKLKGCDKGNAYEFELRKDLLE- 386
G+W+++ L F+ +IG F V+ G +V I+ ++ +D +E
Sbjct: 1 GKWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-------EEDFIEE 53
Query: 387 ---LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAID 442
+M H ++Q Y VC+++ +C+VT+ ME G ++D + R + ++ + +D
Sbjct: 54 AEVMMKLSHPKLVQLYGVCLEQAP-ICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLD 112
Query: 443 VAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----Y 498
V EG+ +L + V +RDL ++ L+ + + + D G+ + V + + G
Sbjct: 113 VCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGM---TRFVLDDQYTSSTGTKFPV 169
Query: 499 RWLAPEV 505
+W +PEV
Sbjct: 170 KWASPEV 176
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 2e-18
Identities = 36/198 (18%), Positives = 79/198 (39%), Gaps = 43/198 (21%)
Query: 343 EFIDQIGPNSFKGVYKGKRVGIEKLKGC-------DKGNAYEFELRKDLLE----LMTCG 391
+++IG F V+K + +L GC K A + + L E +
Sbjct: 14 HELEKIGSGEFGSVFKCVK----RLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQT----KEIIRIAIDVAEGI 447
H ++++++ +++H + + + GGS+ D I ++ ++ + E+ + + V G+
Sbjct: 70 HSHVVRYFSAWAEDDH-MLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGL 128
Query: 448 KFLNDHGVAYRDLNSQRILLDRHGNVC-------------------LGDMGIVTACKSVG 488
++++ + + D+ I + R +GD+G VT +
Sbjct: 129 RYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT---RIS 185
Query: 489 EATEYETDGYRWLAPEVC 506
E D +LA EV
Sbjct: 186 SPQVEEGDSR-FLANEVL 202
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 3e-18
Identities = 35/194 (18%), Positives = 77/194 (39%), Gaps = 31/194 (15%)
Query: 335 WLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEK----------LKGCDKGNAYEFELRKDL 384
+ +++L F + +G +F ++KG R + LK DK + +
Sbjct: 3 HKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHR---NYSESF 59
Query: 385 LE----LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVND-LILKSRKLQTKEIIRI 439
E + HK+++ Y VCV + +V + ++ GS++ L + + +
Sbjct: 60 FEAASMMSKLSHKHLVLNYGVCVCGDE-NILVQEFVKFGSLDTYLKKNKNCINILWKLEV 118
Query: 440 AIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG--------EAT 491
A +A + FL ++ + + ++ ++ ILL R + G+ K +
Sbjct: 119 AKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPF---IK-LSDPGISITVLPK 174
Query: 492 EYETDGYRWLAPEV 505
+ + W+ PE
Sbjct: 175 DILQERIPWVPPEC 188
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 3e-18
Identities = 43/188 (22%), Positives = 81/188 (43%), Gaps = 24/188 (12%)
Query: 333 GRWLLNSDNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLE 386
GR+L +F +IG SFK VYK V +L+ + +++
Sbjct: 25 GRFL------KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEM 78
Query: 387 LMTCGHKNILQFY---CVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDV 443
L H NI++FY V + +VT+LM G++ + + + ++ K + +
Sbjct: 79 LKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQI 138
Query: 444 AEGIKFLNDHG--VAYRDLNSQRILLDRH-GNVCLGDMGIVTACKSVGEATEYETDG--Y 498
+G++FL+ + +RDL I + G+V +GD+G+ + G
Sbjct: 139 LKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGL---ATLKRASFAKAVIGTPE 195
Query: 499 RWLAPEVC 506
++APE+
Sbjct: 196 -FMAPEMY 202
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 5e-18
Identities = 37/186 (19%), Positives = 78/186 (41%), Gaps = 28/186 (15%)
Query: 340 DNLEFIDQIGPNSFKGVYKGKRVGIEK---LKGCDKGNAYEFELRKDLLE----LMTCGH 392
N +IG F VY+ + LK + + + R D ++ L H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 393 KNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQT----KEIIRIAIDVAEGIK 448
N++++Y +++N L +V +L + G ++ +I +K + + + + + + ++
Sbjct: 92 PNVIKYYASFIEDNE-LNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALE 150
Query: 449 FLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS--------VGEATEYETDGYRW 500
++ V +RD+ + + G V LGD+G+ S VG T Y +
Sbjct: 151 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVG--TPY------Y 202
Query: 501 LAPEVC 506
++PE
Sbjct: 203 MSPERI 208
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 7e-18
Identities = 43/231 (18%), Positives = 85/231 (36%), Gaps = 60/231 (25%)
Query: 308 MPLPSSSFVVSVDEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKL 367
+P S +++ I R + L +G F V +G +
Sbjct: 15 VPRGSEELQNKLEDV--------VIDR-----NLLILGKILGEGEFGSVMEGNLKQEDGT 61
Query: 368 ------KGCDKGNAYEFELRKDLL---ELM-TCGHKNILQFYCVCVDEN----HGLCVVT 413
K N+ + E ++ L M H N+++ VC++ + V+
Sbjct: 62 SLKVAVKTMKLDNSSQRE-IEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVIL 120
Query: 414 KLMEGGSVNDLILKSR------KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILL 467
M+ G ++ +L SR + + +++ +D+A G+++L++ +RDL ++ +L
Sbjct: 121 PFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCML 180
Query: 468 DRHGNVCLGDMG----IVTACKSVGEATEYETDGY----------RWLAPE 504
VC+ D G I Y D Y +W+A E
Sbjct: 181 RDDMTVCVADFGLSKKI------------YSGDYYRQGRIAKMPVKWIAIE 219
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 8e-18
Identities = 49/228 (21%), Positives = 87/228 (38%), Gaps = 62/228 (27%)
Query: 312 SSSFVVSVDEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCD 371
S++ V DEW E+ R + + ++G SF VY+G G+ K +
Sbjct: 10 SAADVYVPDEW--------EVAR-----EKITMSRELGQGSFGMVYEGVAKGVVKDEPET 56
Query: 372 -------KGNAYEFELRKDLL---ELMT-CGHKNILQFYCVCVDENHGLCVVTKLMEGGS 420
A E R + L +M ++++ V V+ +LM G
Sbjct: 57 RVAIKTVNEAASMRE-RIEFLNEASVMKEFNCHHVVRLLGVVSQGQP-TLVIMELMTRGD 114
Query: 421 VNDLILKSR----------KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRH 470
+ + R ++I++A ++A+G+ +LN + +RDL ++ ++
Sbjct: 115 LKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED 174
Query: 471 GNVCLGDMG----IVTACKSVGEATEYETDGY----------RWLAPE 504
V +GD G I YETD Y RW++PE
Sbjct: 175 FTVKIGDFGMTRDI------------YETDYYRKGGKGLLPVRWMSPE 210
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 9e-18
Identities = 46/233 (19%), Positives = 85/233 (36%), Gaps = 50/233 (21%)
Query: 305 QLQMPLPSSSFVVSVDEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGI 364
+L + +W E R D L+ +G +F V + GI
Sbjct: 5 ELPLDEHCERLPYDASKW--------EFPR-----DRLKLGKPLGRGAFGQVIEADAFGI 51
Query: 365 EKLKGCD-------KGNAYEFELRKDLL---ELMT--CGHKNILQFYCVCVDENHGLCVV 412
+K C K A E + L+ +++ H N++ C L V+
Sbjct: 52 DKTATCRTVAVKMLKEGATHSE-HRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVI 110
Query: 413 TKLMEGGSVNDLILKSR----------------KLQTKEIIRIAIDVAEGIKFLNDHGVA 456
+ + G+++ + R L + +I + VA+G++FL
Sbjct: 111 VEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCI 170
Query: 457 YRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG-----YRWLAPE 504
+RDL ++ ILL V + D G+ + + + +Y G +W+APE
Sbjct: 171 HRDLAARNILLSEKNVVKICDFGL---ARDIYKDPDYVRKGDARLPLKWMAPE 220
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 9e-18
Identities = 39/210 (18%), Positives = 74/210 (35%), Gaps = 48/210 (22%)
Query: 330 EEIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEK------LKGCDKGNAYEFELRKD 383
E++ L+ +G F V + + + +K K + ++
Sbjct: 13 EKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKML-KADIIASSDIEE 71
Query: 384 LL---ELMT-CGHKNILQFYCVCVDE-----NHGLCVVTKLMEGGSVNDLILKSR----- 429
L M H ++ + V + V+ M+ G ++ +L SR
Sbjct: 72 FLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENP 131
Query: 430 -KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMG----IVTAC 484
L + ++R +D+A G+++L+ +RDL ++ +L VC+ D G I
Sbjct: 132 FNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKI---- 187
Query: 485 KSVGEATEYETDGY----------RWLAPE 504
Y D Y +WLA E
Sbjct: 188 --------YSGDYYRQGCASKLPVKWLALE 209
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 1e-17
Identities = 44/187 (23%), Positives = 84/187 (44%), Gaps = 20/187 (10%)
Query: 334 RWLLNSDNLEFIDQ-IGPNSF----KGVYKGKRVGIE-KLKGCDKGNAYEFELRKDLLE- 386
L+ L D+ +G +F KG Y+ K+V +K K A + L+ +LL
Sbjct: 10 EVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKIL-KNEANDPALKDELLAE 68
Query: 387 ---LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDV 443
+ + I++ +C E +V ++ E G +N + ++R ++ K II + V
Sbjct: 69 ANVMQQLDNPYIVRMIGICEAE--SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQV 126
Query: 444 AEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG-----Y 498
+ G+K+L + +RDL ++ +LL + D G+ A ++ + Y+
Sbjct: 127 SMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA--DENYYKAQTHGKWPV 184
Query: 499 RWLAPEV 505
+W APE
Sbjct: 185 KWYAPEC 191
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 1e-17
Identities = 44/187 (23%), Positives = 81/187 (43%), Gaps = 25/187 (13%)
Query: 333 GRWLLNSDNLEFIDQIGPNSFKGVYKGK-----RVGIEKLKGCDKGNAYEFELRKDLLE- 386
G L + + + ++G F V GK V ++ +K + +
Sbjct: 1 GHMELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS-------EDEFFQE 53
Query: 387 ---LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVND-LILKSRKLQTKEIIRIAID 442
+M H +++FY VC E + +VT+ + G + + L + L+ +++ + D
Sbjct: 54 AQTMMKLSHPKLVKFYGVCSKEYP-IYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYD 112
Query: 443 VAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----Y 498
V EG+ FL H +RDL ++ L+DR V + D G+ + V + + G
Sbjct: 113 VCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGM---TRYVLDDQYVSSVGTKFPV 169
Query: 499 RWLAPEV 505
+W APEV
Sbjct: 170 KWSAPEV 176
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 1e-17
Identities = 39/199 (19%), Positives = 78/199 (39%), Gaps = 37/199 (18%)
Query: 328 GGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDKGNAYEFELR 381
G +W + ++ ++G + VY+G V ++ LK D EF
Sbjct: 1 GSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEF--- 56
Query: 382 KDLLE---LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK--LQTKEI 436
L E + H N++Q VC E ++T+ M G++ D + + + + +
Sbjct: 57 --LKEAAVMKEIKHPNLVQLLGVCTREPP-FYIITEFMTYGNLLDYLRECNRQEVSAVVL 113
Query: 437 IRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETD 496
+ +A ++ +++L +RDL ++ L+ + V + D G+ + D
Sbjct: 114 LYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGL---------SRLMTGD 164
Query: 497 GY----------RWLAPEV 505
Y +W APE
Sbjct: 165 TYTAHAGAKFPIKWTAPES 183
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 2e-17
Identities = 43/206 (20%), Positives = 79/206 (38%), Gaps = 36/206 (17%)
Query: 333 GRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEK---LKGCDKGNAYEFELRKDLLE--- 386
GR+L + E I +G F V++ K + +K N E K + E
Sbjct: 1 GRYL---TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNR-ELAREKVMREVKA 56
Query: 387 LMTCGHKNILQFYCVCVDENHG-----------LCVVTKLMEGGSVNDLILKSRKLQTKE 435
L H I++++ +++N L + +L ++ D + ++ +E
Sbjct: 57 LAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERE 116
Query: 436 ---IIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE 492
+ I + +AE ++FL+ G+ +RDL I V +GD G+VTA E
Sbjct: 117 RSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQT 176
Query: 493 YETDGYR------------WLAPEVC 506
T +++PE
Sbjct: 177 VLTPMPAYARHTGQVGTKLYMSPEQI 202
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 2e-17
Identities = 36/188 (19%), Positives = 76/188 (40%), Gaps = 28/188 (14%)
Query: 335 WLLNSDNLEFIDQIGPNSFKGVYKGK---------RVGIEKLK-GCDKGNAYEFELRKDL 384
+ + + +E IG F V++G V I+ K +F L
Sbjct: 10 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKF-----L 64
Query: 385 LE---LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVND-LILKSRKLQTKEIIRIA 440
E + H +I++ V + + ++ +L G + L ++ L +I A
Sbjct: 65 QEALTMRQFDHPHIVKLIGVITENP--VWIIMELCTLGELRSFLQVRKYSLDLASLILYA 122
Query: 441 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG--- 497
++ + +L +RD+ ++ +L+ + V LGD G+ + + ++T Y+
Sbjct: 123 YQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGL---SRYMEDSTYYKASKGKL 179
Query: 498 -YRWLAPE 504
+W+APE
Sbjct: 180 PIKWMAPE 187
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 2e-17
Identities = 34/198 (17%), Positives = 75/198 (37%), Gaps = 30/198 (15%)
Query: 339 SDNLEFIDQIGPNSFKGVYKGKRVGIEKL---KGCDKGNAYEFELRKDLLELMTCGHKNI 395
+ + E I +G +F V K + + K + +++ L + H+ +
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYV 64
Query: 396 LQFYCVCVDENHG------------LCVVTKLMEGGSVNDLILK-SRKLQTKEIIRIAID 442
+++Y ++ + L + + E G++ DLI + Q E R+
Sbjct: 65 VRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQ 124
Query: 443 VAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR--- 499
+ E + +++ G+ +RDL I +D NV +GD G+ + + ++
Sbjct: 125 ILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSS 184
Query: 500 -----------WLAPEVC 506
++A EV
Sbjct: 185 DNLTSAIGTAMYVATEVL 202
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 2e-17
Identities = 45/191 (23%), Positives = 82/191 (42%), Gaps = 26/191 (13%)
Query: 334 RWLLNSDNLEFIDQIGPNSFKGVYKGK---------RVGIEKLKGCDKGNAYEFELRKDL 384
L+ +L ++++G SF V +G+ V ++ LK + E D
Sbjct: 12 TCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLK---PDVLSQPEAMDDF 68
Query: 385 LE----LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRI 439
+ + + H+N+++ Y V + + +VT+L GS+ D + K + + R
Sbjct: 69 IREVNAMHSLDHRNLIRLYGVVLTPP--MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRY 126
Query: 440 AIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG-- 497
A+ VAEG+ +L +RDL ++ +LL V +GD G++ A Y
Sbjct: 127 AVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ--NDDHYVMQEHR 184
Query: 498 ---YRWLAPEV 505
+ W APE
Sbjct: 185 KVPFAWCAPES 195
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 2e-17
Identities = 49/230 (21%), Positives = 88/230 (38%), Gaps = 28/230 (12%)
Query: 294 RNGVENSNLKIQLQMPLPSSSFVVSVDEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSF 353
+ NL Q ++P P + + ++G + + + IG
Sbjct: 6 HHSSGRENLYFQGKLPEPQF-YAEPHTYEEPGRAGRSF--TREIEASRIHIEKIIGSGDS 62
Query: 354 KGVYKGK---------RVGIEKLK-GCDKGNAYEFELRKDLLE---LMTCGHKNILQFYC 400
V G+ V I+ LK G + +F L E + H NI++
Sbjct: 63 GEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDF-----LSEASIMGQFDHPNIIRLEG 117
Query: 401 VCVDENHGLCVVTKLMEGGSVND-LILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRD 459
V +VT+ ME GS++ L + +++ + V G+++L+D G +RD
Sbjct: 118 VVTRGRL-AMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRD 176
Query: 460 LNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRWLAPEV 505
L ++ +L+D + + D G+ + Y T G RW APE
Sbjct: 177 LAARNVLVDSNLVCKVSDFGLSRVLED-DPDAAYTTTGGKIPIRWTAPEA 225
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 3e-17
Identities = 44/178 (24%), Positives = 81/178 (45%), Gaps = 27/178 (15%)
Query: 343 EFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNIL 396
+++IG SF V+K K V I K+ ++ ++++++ L C +
Sbjct: 25 TKLEKIGKGSFGEVFKGIDNRTQKVVAI-KIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 397 QFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVA 456
++Y ++ L ++ + + GGS DL L+ L +I I ++ +G+ +L+
Sbjct: 84 KYYG-SYLKDTKLWIIMEYLGGGSALDL-LEPGPLDETQIATILREILKGLDYLHSEKKI 141
Query: 457 YRDLNSQRILLDRHGNVCLGDMGIVTACKS---------VGEATEYETDGYRWLAPEV 505
+RD+ + +LL HG V L D G V + VG T + W+APEV
Sbjct: 142 HRDIKAANVLLSEHGEVKLADFG-VAGQLTDTQIKRNTFVG--TPF------WMAPEV 190
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 4e-17
Identities = 32/191 (16%), Positives = 75/191 (39%), Gaps = 28/191 (14%)
Query: 333 GRWLLNSDNLEFIDQIGPNSFKGVYKGK---------RVGIEKLK-GCDKGNAYEFELRK 382
++ + +++ +G F VY+G V ++ K C N +F
Sbjct: 5 PQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKF---- 60
Query: 383 DLLE---LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVND-LILKSRKLQTKEIIR 438
+ E + H +I++ + +E ++ +L G + L L+ ++
Sbjct: 61 -MSEAVIMKNLDHPHIVKLIGIIEEEP--TWIIMELYPYGELGHYLERNKNSLKVLTLVL 117
Query: 439 IAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG- 497
++ + + + +L +RD+ + IL+ V LGD G+ + + + Y+
Sbjct: 118 YSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLS---RYIEDEDYYKASVT 174
Query: 498 ---YRWLAPEV 505
+W++PE
Sbjct: 175 RLPIKWMSPES 185
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 4e-17
Identities = 45/190 (23%), Positives = 79/190 (41%), Gaps = 26/190 (13%)
Query: 335 WLLNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLK-GCDKGNAYEFELRKD 383
++ + IG F VYKG V I+ LK G + +F
Sbjct: 39 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDF----- 93
Query: 384 LLE---LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVND-LILKSRKLQTKEIIRI 439
L E + H NI++ V + ++T+ ME G+++ L K + +++ +
Sbjct: 94 LGEAGIMGQFSHHNIIRLEGVISKYKP-MMIITEYMENGALDKFLREKDGEFSVLQLVGM 152
Query: 440 AIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG-- 497
+A G+K+L + +RDL ++ IL++ + + D G+ + E Y T G
Sbjct: 153 LRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE-ATYTTSGGK 211
Query: 498 --YRWLAPEV 505
RW APE
Sbjct: 212 IPIRWTAPEA 221
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 4e-17
Identities = 40/196 (20%), Positives = 82/196 (41%), Gaps = 31/196 (15%)
Query: 335 WLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCD-------KGNAYEFELRKDLL-- 385
+ N+ I +G +F VY+G+ G+ E + D L
Sbjct: 25 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQD-ELDFLME 83
Query: 386 -ELMT-CGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-------KLQTKEI 436
+++ H+NI++ V + ++ +LM GG + + ++R L ++
Sbjct: 84 ALIISKFNHQNIVRCIGVSLQSLP-RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDL 142
Query: 437 IRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGN---VCLGDMGIVTACKSVGEATEY 493
+ +A D+A G ++L ++ +RD+ ++ LL G +GD G+ + + A+ Y
Sbjct: 143 LHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA---RDIYRASYY 199
Query: 494 ETDGY-----RWLAPE 504
G +W+ PE
Sbjct: 200 RKGGCAMLPVKWMPPE 215
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 5e-17
Identities = 50/249 (20%), Positives = 91/249 (36%), Gaps = 63/249 (25%)
Query: 296 GVENSNLKIQLQMPLPSSSFVVSVDEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKG 355
NL Q + S + W E+ R D L +G +F
Sbjct: 38 IPTTENLYFQGMLAGVSEYELPEDPRW--------ELPR-----DRLVLGKPLGEGAFGQ 84
Query: 356 VYKGKRVGIEKLKGCD---------KGNAYEFELRKDLL---ELMT--CGHKNILQFYCV 401
V + +G++K K K +A E + DL+ E+M HKNI+
Sbjct: 85 VVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD-LSDLISEMEMMKMIGKHKNIINLLGA 143
Query: 402 CVDENHGLCVVTKLMEGGSVNDLILKSRK----------------LQTKEIIRIAIDVAE 445
C + L V+ + G++ + + R L +K+++ A VA
Sbjct: 144 CTQDGP-LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVAR 202
Query: 446 GIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY------- 498
G+++L +RDL ++ +L+ + + D G+ + + + D Y
Sbjct: 203 GMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGL---ARDI-----HHIDYYKKTTNGR 254
Query: 499 ---RWLAPE 504
+W+APE
Sbjct: 255 LPVKWMAPE 263
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 5e-17
Identities = 39/185 (21%), Positives = 74/185 (40%), Gaps = 26/185 (14%)
Query: 343 EFIDQIGPNSFKGVYKGKRVGIEK---LKGCDKGNAYEFELRKDLLELMTCGHKNILQFY 399
+ I+ IG F V+K K K +K N + +++ L H NI+ +
Sbjct: 14 KEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE---KAEREVKALAKLDHVNIVHYN 70
Query: 400 CVCVDENHG---------------LCVVTKLMEGGSVNDLILKSRK--LQTKEIIRIAID 442
++ L + + + G++ I K R L + +
Sbjct: 71 GCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQ 130
Query: 443 VAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG-YRWL 501
+ +G+ +++ + RDL I L V +GD G+VT+ K+ G+ T + G R++
Sbjct: 131 ITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRT--RSKGTLRYM 188
Query: 502 APEVC 506
+PE
Sbjct: 189 SPEQI 193
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 6e-17
Identities = 43/179 (24%), Positives = 78/179 (43%), Gaps = 22/179 (12%)
Query: 339 SDNLEFIDQIGPNSFKGVYKGKRVGIEKL---KGCDKGNAYEFEL-RKDLLELMTCGHKN 394
++IG + VY V + + + + EL ++L + + N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 395 ILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHG 454
I+ + + + L VV + + GGS+ D++ + +I + + + ++FL+ +
Sbjct: 79 IVNYLDSYLVGDE-LWVVMEYLAGGSLTDVV-TETCMDEGQIAAVCRECLQALEFLHSNQ 136
Query: 455 VAYRDLNSQRILLDRHGNVCLGDMGI---VTACKS-----VGEATEYETDGYRWLAPEV 505
V +RD+ S ILL G+V L D G +T +S VG T Y W+APEV
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVG--TPY------WMAPEV 187
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 7e-17
Identities = 44/220 (20%), Positives = 84/220 (38%), Gaps = 53/220 (24%)
Query: 320 DEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCD-------- 371
+W E R D L +G +F V + VGI+K K +
Sbjct: 28 PKW--------EFPR-----DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKM 74
Query: 372 -KGNAYEFELRKDLL---ELMT--CGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLI 425
K +A E + DL+ E+M HKNI+ C + L V+ + G++ + +
Sbjct: 75 LKDDATEKD-LSDLVSEMEMMKMIGKHKNIINLLGACTQDGP-LYVIVEYASKGNLREYL 132
Query: 426 LKSRK----------------LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDR 469
R + K+++ +A G+++L +RDL ++ +L+
Sbjct: 133 RARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTE 192
Query: 470 HGNVCLGDMGIVTACKSVGEATEYETDG-----YRWLAPE 504
+ + + D G+ + + Y+ +W+APE
Sbjct: 193 NNVMKIADFGL---ARDINNIDYYKKTTNGRLPVKWMAPE 229
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 8e-17
Identities = 40/196 (20%), Positives = 81/196 (41%), Gaps = 31/196 (15%)
Query: 335 WLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCD-------KGNAYEFELRKDLL-- 385
+ N+ I +G +F VY+G+ G+ E + D L
Sbjct: 66 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQD-ELDFLME 124
Query: 386 -ELMT-CGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-------KLQTKEI 436
+++ H+NI++ V + ++ +LM GG + + ++R L ++
Sbjct: 125 ALIISKFNHQNIVRCIGVSLQSLP-RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL 183
Query: 437 IRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGN---VCLGDMGIVTACKSVGEATEY 493
+ +A D+A G ++L ++ +RD+ ++ LL G +GD G+ + + A Y
Sbjct: 184 LHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA---RDIYRAGYY 240
Query: 494 ETDGY-----RWLAPE 504
G +W+ PE
Sbjct: 241 RKGGCAMLPVKWMPPE 256
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 1e-16
Identities = 35/206 (16%), Positives = 79/206 (38%), Gaps = 41/206 (19%)
Query: 323 QTVQSGGEEIGRWLLNSDNLEFIDQIGPNSF----KGVYKGK--RVGIEKLKGCDKGNAY 376
T+ +W + ++ ++G + +GV+K V ++ LK
Sbjct: 203 PTIYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----- 257
Query: 377 EFELRKDLLE----LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR--- 429
++ L+ + H N++Q VC E ++T+ M G++ D L+
Sbjct: 258 --MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP-FYIITEFMTYGNLLDY-LRECNRQ 313
Query: 430 KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE 489
++ ++ +A ++ +++L +R+L ++ L+ + V + D G+
Sbjct: 314 EVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGL--------- 364
Query: 490 ATEYETDGY----------RWLAPEV 505
+ D Y +W APE
Sbjct: 365 SRLMTGDTYTAHAGAKFPIKWTAPES 390
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 1e-16
Identities = 45/195 (23%), Positives = 87/195 (44%), Gaps = 27/195 (13%)
Query: 326 QSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGK-----RVGIEKLKGCDKGNAYEFEL 380
+ G G W ++ +L F+ ++G F V GK V I+ +K
Sbjct: 10 STAGLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-------MS 62
Query: 381 RKDLLE----LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR--KLQTK 434
+ +E +M H+ ++Q Y VC + + ++T+ M G + + L+ + QT+
Sbjct: 63 EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRP-IFIITEYMANGCLLNY-LREMRHRFQTQ 120
Query: 435 EIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYE 494
+++ + DV E +++L +RDL ++ L++ G V + D G+ + V +
Sbjct: 121 QLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGL---SRYVLDDEYTS 177
Query: 495 TDG----YRWLAPEV 505
+ G RW PEV
Sbjct: 178 SVGSKFPVRWSPPEV 192
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 1e-16
Identities = 44/179 (24%), Positives = 76/179 (42%), Gaps = 22/179 (12%)
Query: 339 SDNLEFIDQIGPNSFKGVYKGKRVGIEKL---KGCDKGNAYEFEL-RKDLLELMTCGHKN 394
L+ +IG S V + + K D EL +++ + H N
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103
Query: 395 ILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHG 454
+++ Y + L V+ + ++GG++ D I+ +L ++I + V + + +L+ G
Sbjct: 104 VVEMYKSYLVGEE-LWVLMEFLQGGALTD-IVSQVRLNEEQIATVCEAVLQALAYLHAQG 161
Query: 455 VAYRDLNSQRILLDRHGNVCLGDMGI---VTACKS-----VGEATEYETDGYRWLAPEV 505
V +RD+ S ILL G V L D G ++ VG T Y W+APEV
Sbjct: 162 VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVG--TPY------WMAPEV 212
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 1e-16
Identities = 42/192 (21%), Positives = 80/192 (41%), Gaps = 37/192 (19%)
Query: 334 RWLLNSDNLEFIDQIGPNSFKGVYKGK-----RVGIEKLKGCDKGNAYEFELRKDLLE-- 386
W + + L+ ++++G F V+ G +V ++ LK L
Sbjct: 7 EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-------MSPDAFLAEA 59
Query: 387 --LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK---LQTKEIIRIAI 441
+ H+ +++ Y V E + ++T+ ME GS+ D LK+ L +++ +A
Sbjct: 60 NLMKQLQHQRLVRLYAVVTQE--PIYIITEYMENGSLVDF-LKTPSGIKLTINKLLDMAA 116
Query: 442 DVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMG---IVTACKSVGEATEYETDG- 497
+AEG+ F+ + +RDL + IL+ + + D G ++ E EY
Sbjct: 117 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLI-------EDNEYTAREG 169
Query: 498 ----YRWLAPEV 505
+W APE
Sbjct: 170 AKFPIKWTAPEA 181
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 2e-16
Identities = 47/188 (25%), Positives = 79/188 (42%), Gaps = 26/188 (13%)
Query: 340 DNLEFIDQIGPNSFKGVYKGKRVGIEK---LKGCDKGNAYEFELRKDLLE---LMTCGHK 393
++ E + IG S+ K +R K K D G+ E E + + E L H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 394 NILQFYCVCVDENHG-LCVVTKLMEGGSVNDLILKSRKLQT----KEIIRIAIDVAEGIK 448
NI+++Y +D + L +V + EGG + +I K K + + ++R+ + +K
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 449 FL-----NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY-----ETDGY 498
H V +RDL + LD NV LGD G+ + + T + T Y
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL---ARILNHDTSFAKTFVGTPYY 182
Query: 499 RWLAPEVC 506
++PE
Sbjct: 183 --MSPEQM 188
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 3e-16
Identities = 38/188 (20%), Positives = 88/188 (46%), Gaps = 28/188 (14%)
Query: 336 LLNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLL 385
+L + I +G +F VYKG V I++L+ A + K++L
Sbjct: 11 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-----EATSPKANKEIL 65
Query: 386 E----LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIA 440
+ + + + ++ + +C+ + ++T+LM G + D + + + + ++ ++
Sbjct: 66 DEAYVMASVDNPHVCRLLGICLTST--VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC 123
Query: 441 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG--- 497
+ +A+G+ +L D + +RDL ++ +L+ +V + D G+ + E EY +G
Sbjct: 124 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA--EEKEYHAEGGKV 181
Query: 498 -YRWLAPE 504
+W+A E
Sbjct: 182 PIKWMALE 189
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 3e-16
Identities = 44/225 (19%), Positives = 83/225 (36%), Gaps = 58/225 (25%)
Query: 320 DEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCD-------K 372
+W E R NL +G F V K ++ G K
Sbjct: 16 PKW--------EFPR-----KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLK 62
Query: 373 GNAYEFELRKDLL---ELM-TCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKS 428
NA E +DLL ++ H ++++ Y C + L ++ + + GS+ + +S
Sbjct: 63 ENASPSE-LRDLLSEFNVLKQVNHPHVIKLYGACSQDGP-LLLIVEYAKYGSLRGFLRES 120
Query: 429 RK------------------------LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQR 464
RK L ++I A +++G+++L + + +RDL ++
Sbjct: 121 RKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARN 180
Query: 465 ILLDRHGNVCLGDMGIVTACKSVGEATEYETDG-----YRWLAPE 504
IL+ + + D G+ + V E Y +W+A E
Sbjct: 181 ILVAEGRKMKISDFGL---SRDVYEEDSYVKRSQGRIPVKWMAIE 222
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 4e-16
Identities = 38/188 (20%), Positives = 71/188 (37%), Gaps = 29/188 (15%)
Query: 338 NSDNLEFIDQIGPNSFKGVYKGK---------RVGIEKLKGCDKGNAYEFELRKDLL--- 385
+S + F + IG F VY G ++ L + L
Sbjct: 23 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-----TDIGEVSQFLTEG 77
Query: 386 ELMT-CGHKNILQFYCVCVDENHGLCVVTKLMEGGSVND-LILKSRKLQTKEIIRIAIDV 443
+M H N+L +C+ VV M+ G + + + ++ K++I + V
Sbjct: 78 IIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV 137
Query: 444 AEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY----- 498
A+G+K+L +RDL ++ +LD V + D G+ + + + Y
Sbjct: 138 AKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLA---RDMYDKEYYSVHNKTGAKL 194
Query: 499 --RWLAPE 504
+W+A E
Sbjct: 195 PVKWMALE 202
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 5e-16
Identities = 44/176 (25%), Positives = 79/176 (44%), Gaps = 22/176 (12%)
Query: 343 EFIDQIGPNSFKGVYKGKRVGIEKL---KGCDKGNAYEFE-LRKDLLELMTCGHKNILQF 398
E + ++G +F VYK K L K + + E E ++ L TC H I++
Sbjct: 22 EIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKL 81
Query: 399 YCVCVDENHGLCVVTKLMEGGSVNDLILKSRK-LQTKEIIRIAIDVAEGIKFLNDHGVAY 457
+ L ++ + GG+V+ ++L+ + L +I + + E + FL+ + +
Sbjct: 82 LGAYYHDGK-LWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIH 140
Query: 458 RDLNSQRILLDRHGNVCLGDMGI-----VTACK---SVGEATEYETDGYRWLAPEV 505
RDL + +L+ G++ L D G+ T K +G T Y W+APEV
Sbjct: 141 RDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIG--TPY------WMAPEV 188
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 6e-16
Identities = 43/211 (20%), Positives = 81/211 (38%), Gaps = 50/211 (23%)
Query: 334 RWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCD---------KGNAYEFELRKDL 384
+W D L +G F V + VGI+K K + K +A E + DL
Sbjct: 75 KWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD-LSDL 133
Query: 385 L---ELMT--CGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK--------- 430
+ E+M HKNI+ C + L V+ + G++ + + R
Sbjct: 134 VSEMEMMKMIGKHKNIINLLGACTQDGP-LYVIVEYASKGNLREYLRARRPPGMEYSYDI 192
Query: 431 -------LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTA 483
+ K+++ +A G+++L +RDL ++ +L+ + + + D G+
Sbjct: 193 NRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGL--- 249
Query: 484 CKSVGEATEYETDGY----------RWLAPE 504
+ + D Y +W+APE
Sbjct: 250 ARDI-----NNIDYYKKTTNGRLPVKWMAPE 275
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 6e-16
Identities = 45/188 (23%), Positives = 80/188 (42%), Gaps = 23/188 (12%)
Query: 335 WLLNSDNLEFIDQIGPNSFKGVYKGK---------RVGIEKLK-GCDKGNAYEFELRKDL 384
L++ N+ +G F V G+ V I+ LK G + +F L
Sbjct: 40 KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF-----L 94
Query: 385 LE---LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVND-LILKSRKLQTKEIIRIA 440
E + H NI++ V + +VT+ ME GS++ L + +++ +
Sbjct: 95 GEASIMGQFDHPNIIRLEGVVTKSKP-VMIVTEYMENGSLDSFLRKHDAQFTVIQLVGML 153
Query: 441 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG--- 497
+A G+K+L+D G +RDL ++ IL++ + + D G+ + EA G
Sbjct: 154 RGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIP 213
Query: 498 YRWLAPEV 505
RW +PE
Sbjct: 214 IRWTSPEA 221
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 8e-16
Identities = 43/191 (22%), Positives = 81/191 (42%), Gaps = 28/191 (14%)
Query: 334 RWLLNSDNLEFID-QIGPNSFKGVYKGK--------RVGIEKLK-GCDKGNAYEFELRKD 383
+ L DNL D ++G +F V +G V I+ LK G +K + E
Sbjct: 3 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEM----- 57
Query: 384 LLE---LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRI 439
+ E + + I++ VC E L +V ++ GG ++ ++ R ++ + +
Sbjct: 58 MREAQIMHQLDNPYIVRLIGVCQAEA--LMLVMEMAGGGPLHKFLVGKREEIPVSNVAEL 115
Query: 440 AIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG-- 497
V+ G+K+L + +RDL ++ +LL + D G+ A + + + Y
Sbjct: 116 LHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA--DDSYYTARSAG 173
Query: 498 ---YRWLAPEV 505
+W APE
Sbjct: 174 KWPLKWYAPEC 184
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 9e-16
Identities = 44/217 (20%), Positives = 90/217 (41%), Gaps = 51/217 (23%)
Query: 320 DEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCD-------K 372
++W E R +NL+F +G +F V + G+ K K
Sbjct: 39 EKW--------EFPR-----NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLK 85
Query: 373 GNAYEFELRKDLL---ELMT--CGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILK 427
A+ E ++ L+ ++M+ H+NI+ C + V+T+ G + + + +
Sbjct: 86 STAHADE-KEALMSELKIMSHLGQHENIVNLLGACTHGGP-VLVITEYCCYGDLLNFLRR 143
Query: 428 SRK--------------LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 473
+ T++++ + VA+G+ FL +RD+ ++ +LL +G+V
Sbjct: 144 KSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT-NGHV 202
Query: 474 C-LGDMGIVTACKSVGEATEYETDG-----YRWLAPE 504
+GD G+ + + + Y G +W+APE
Sbjct: 203 AKIGDFGL---ARDIMNDSNYIVKGNARLPVKWMAPE 236
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 9e-16
Identities = 40/188 (21%), Positives = 75/188 (39%), Gaps = 31/188 (16%)
Query: 335 WLLNSDNLEFIDQIGPNSFKGVYKGK-----RVGIEKLKGCDKGNAYEFELRKDLLE--- 386
W + ++L+ ++G F V+ +V ++ +K + L
Sbjct: 183 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-------VEAFLAEAN 235
Query: 387 -LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK---LQTKEIIRIAID 442
+ T H +++ + V E + ++T+ M GS+ D LKS + ++I +
Sbjct: 236 VMKTLQHDKLVKLHAVVTKE--PIYIITEFMAKGSLLDF-LKSDEGSKQPLPKLIDFSAQ 292
Query: 443 VAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----- 497
+AEG+ F+ +RDL + IL+ + D G+ V E EY
Sbjct: 293 IAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGL----ARVIEDNEYTAREGAKFP 348
Query: 498 YRWLAPEV 505
+W APE
Sbjct: 349 IKWTAPEA 356
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 1e-15
Identities = 46/191 (24%), Positives = 77/191 (40%), Gaps = 30/191 (15%)
Query: 335 WLLNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDL 384
+ + L+ I +G F V V ++ LK R
Sbjct: 26 TVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQH-----RSGW 80
Query: 385 LE----LMTCGHKNILQFYCVCVDEN-HGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRI 439
+ L T H++I+++ C D L +V + + GS+ D L + +++
Sbjct: 81 KQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDY-LPRHSIGLAQLLLF 139
Query: 440 AIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY---ETD 496
A + EG+ +L+ +RDL ++ +LLD V +GD G+ K+V E EY D
Sbjct: 140 AQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLA---KAVPEGHEYYRVRED 196
Query: 497 G---YRWLAPE 504
G W APE
Sbjct: 197 GDSPVFWYAPE 207
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 78.7 bits (194), Expect = 1e-15
Identities = 37/188 (19%), Positives = 78/188 (41%), Gaps = 28/188 (14%)
Query: 335 WLLNSDNLEFIDQIGPNSFKGVYKGK---------RVGIEKLKGCDKGNAYEFELRKDLL 385
+ + + +E IG F V++G V I+ K N +R+ L
Sbjct: 385 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCK-----NCTSDSVREKFL 439
Query: 386 E---LM-TCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVND-LILKSRKLQTKEIIRIA 440
+ M H +I++ V + + ++ +L G + L ++ L +I A
Sbjct: 440 QEALTMRQFDHPHIVKLIGVITENP--VWIIMELCTLGELRSFLQVRKFSLDLASLILYA 497
Query: 441 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG--- 497
++ + +L +RD+ ++ +L+ + V LGD G+ + + ++T Y+
Sbjct: 498 YQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGL---SRYMEDSTYYKASKGKL 554
Query: 498 -YRWLAPE 504
+W+APE
Sbjct: 555 PIKWMAPE 562
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 77.5 bits (191), Expect = 1e-15
Identities = 45/224 (20%), Positives = 77/224 (34%), Gaps = 28/224 (12%)
Query: 299 NSNLKIQLQMPLPSSSFVVSVDEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYK 358
+ NL Q + ++ + Q VQ + F + IG F VY
Sbjct: 53 SENLYFQGANTVHIDLSALNPELVQAVQHVVIGPSS-----LIVHFNEVIGRGHFGCVYH 107
Query: 359 GK---------RVGIEKLKGCDKGNAYEFELRKDLL---ELMT-CGHKNILQFYCVCVDE 405
G ++ L + L +M H N+L +C+
Sbjct: 108 GTLLDNDGKKIHCAVKSLNRI-----TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 162
Query: 406 NHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQR 464
VV M+ G + + I K++I + VA+G+KFL +RDL ++
Sbjct: 163 EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARN 222
Query: 465 ILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRWLAPE 504
+LD V + D G+ + + G +W+A E
Sbjct: 223 CMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 266
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 1e-15
Identities = 45/221 (20%), Positives = 84/221 (38%), Gaps = 55/221 (24%)
Query: 320 DEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCD-------K 372
+W E R + L F +G +F V + G+ K K
Sbjct: 16 HKW--------EFPR-----NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK 62
Query: 373 GNAYEFELRKDLL---ELMT--CGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILK 427
+A+ E R+ L+ ++++ H NI+ C V+T+ G + + + +
Sbjct: 63 PSAHLTE-REALMSELKVLSYLGNHMNIVNLLGACTIGGP-TLVITEYCCYGDLLNFLRR 120
Query: 428 SRK------------------LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDR 469
R L ++++ + VA+G+ FL +RDL ++ ILL
Sbjct: 121 KRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT- 179
Query: 470 HGNVC-LGDMGIVTACKSVGEATEYETDG-----YRWLAPE 504
HG + + D G+ + + + Y G +W+APE
Sbjct: 180 HGRITKICDFGL---ARDIKNDSNYVVKGNARLPVKWMAPE 217
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 2e-15
Identities = 34/190 (17%), Positives = 79/190 (41%), Gaps = 30/190 (15%)
Query: 335 WLLNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDL 384
+ L + +G F V+KG V I+ ++ + + + +
Sbjct: 8 RIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIE-----DKSGRQSFQAV 62
Query: 385 LE----LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRI 439
+ + + H +I++ +C L +VT+ + GS+ D + + R L + ++
Sbjct: 63 TDHMLAIGSLDHAHIVRLLGLCPGS--SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNW 120
Query: 440 AIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG-- 497
+ +A+G+ +L +HG+ +R+L ++ +LL V + D G+ + +
Sbjct: 121 GVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVA---DLLPPDDKQLLYSEA 177
Query: 498 ---YRWLAPE 504
+W+A E
Sbjct: 178 KTPIKWMALE 187
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 2e-15
Identities = 48/273 (17%), Positives = 88/273 (32%), Gaps = 76/273 (27%)
Query: 281 GEIEEEEACDESFRNGVENSNLKIQLQMPLPSSSFVVSVDEWQTVQSGGEEIGRWLLNSD 340
G +E + + + L + E R +
Sbjct: 1 GAMESAAVTLTTLPSELLLDRLHPNPMYQRMPLLLNPKLLSL--------EYPR-----N 47
Query: 341 NLEFIDQIGPNSFKGVYKGKRVGIEKLKGCD-------KGNAYEFELRKDLL---ELMT- 389
N+E++ IG +F V++ + G+ + K A +++ D LM
Sbjct: 48 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA-DMQADFQREAALMAE 106
Query: 390 CGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-------------------- 429
+ NI++ VC +C++ + M G +N+ +
Sbjct: 107 FDNPNIVKLLGVCAVGKP-MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSS 165
Query: 430 ----KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMG----IV 481
L E + IA VA G+ +L++ +RDL ++ L+ + V + D G I
Sbjct: 166 PGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNI- 224
Query: 482 TACKSVGEATEYETDGY----------RWLAPE 504
Y D Y RW+ PE
Sbjct: 225 -----------YSADYYKADGNDAIPIRWMPPE 246
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 76.4 bits (188), Expect = 2e-15
Identities = 42/181 (23%), Positives = 85/181 (46%), Gaps = 21/181 (11%)
Query: 337 LNSDNLEFIDQIGPNSFKGVYKG--KRVGIE---KLKGCDKGNAYEFELRKDLLELMTCG 391
L D+ E I ++G + V+K K G+ KL + A ++ ++L L C
Sbjct: 30 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECN 89
Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFL- 450
I+ FY + + + + M+GGS++ ++ K+ ++ + + +++I V +G+ +L
Sbjct: 90 SPYIVGFYGAFYSDGE-ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR 148
Query: 451 NDHGVAYRDLNSQRILLDRHGNVCLGDMGI-----VTACKS-VGEATEYETDGYRWLAPE 504
H + +RD+ IL++ G + L D G+ + S VG T +++PE
Sbjct: 149 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVG--TRS------YMSPE 200
Query: 505 V 505
Sbjct: 201 R 201
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 2e-15
Identities = 41/205 (20%), Positives = 80/205 (39%), Gaps = 45/205 (21%)
Query: 335 WLLNSDNLEFIDQIGPNSFKGVYKGK-----------RVGIEKLKGCDKGNAYEFELRKD 383
+ ++ ++G +F V+ + V ++ LK + R+D
Sbjct: 36 HHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASE------SARQD 89
Query: 384 LL---ELMT-CGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR---------- 429
EL+T H++I++F+ VC + L +V + M G +N +
Sbjct: 90 FQREAELLTMLQHQHIVRFFGVCTEGRP-LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGE 148
Query: 430 -----KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC 484
L +++ +A VA G+ +L +RDL ++ L+ + V +GD G+
Sbjct: 149 DVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMS--- 205
Query: 485 KSVGEATEYETDGY-----RWLAPE 504
+ + Y G RW+ PE
Sbjct: 206 RDIYSTDYYRVGGRTMLPIRWMPPE 230
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 3e-15
Identities = 41/224 (18%), Positives = 71/224 (31%), Gaps = 58/224 (25%)
Query: 311 PSSSFVVSVDEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGK---------R 361
S+ + V + I IG F VY G+ +
Sbjct: 3 LDSALLAEVKDV--------LIPH---ERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQ 51
Query: 362 VGIEKLKGCDKGNAYEFELRKDLL---ELM-TCGHKNILQFYCVCVDENHGLCVVTKLME 417
I+ L E + + L LM H N+L + + V+ M
Sbjct: 52 CAIKSLS-----RITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMC 106
Query: 418 GGSVNDLILKSRK-LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLG 476
G + I ++ K++I + VA G+++L + +RDL ++ +LD V +
Sbjct: 107 HGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVA 166
Query: 477 DMG----IVTACKSVGEATEYETDGY------------RWLAPE 504
D G I + + Y +W A E
Sbjct: 167 DFGLARDI------------LDREYYSVQQHRHARLPVKWTALE 198
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 4e-15
Identities = 44/205 (21%), Positives = 83/205 (40%), Gaps = 29/205 (14%)
Query: 317 VSVDEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSF----KGVYKGK-RVGIEKLKGCD 371
+V Q+ G W + ++L ++G F G + G RV I+ LK
Sbjct: 161 TTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT 220
Query: 372 KGNAYEFELRKDLLE----LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILK 427
+ L+ + H+ ++Q Y V +E + +VT+ M GS+ D LK
Sbjct: 221 -------MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE--PIYIVTEYMSKGSLLDF-LK 270
Query: 428 SRK---LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC 484
L+ +++ +A +A G+ ++ +RDL + IL+ + + D G+
Sbjct: 271 GETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLA--- 327
Query: 485 KSVGEATEYETDG----YRWLAPEV 505
+ + + G +W APE
Sbjct: 328 RLIEDNEYTARQGAKFPIKWTAPEA 352
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 4e-15
Identities = 51/182 (28%), Positives = 82/182 (45%), Gaps = 27/182 (14%)
Query: 343 EFIDQIGPNSFKGVYKGKRVGIEKL---KGCDKGNAYEFELRKDLLELMT-CGHKNILQF 398
E ++ +G ++ VYKG+ V +L K D E E+++++ L H+NI +
Sbjct: 27 ELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATY 86
Query: 399 Y-----CVCVDENHGLCVVTKLMEGGSVNDLI--LKSRKLQTKEIIRIAIDVAEGIKFLN 451
Y + L +V + GSV DLI K L+ + I I ++ G+ L+
Sbjct: 87 YGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH 146
Query: 452 DHGVAYRDLNSQRILLDRHGNVCLGDMGI-----VTACK---SVGEATEYETDGYRWLAP 503
H V +RD+ Q +LL + V L D G+ T + +G T Y W+AP
Sbjct: 147 QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIG--TPY------WMAP 198
Query: 504 EV 505
EV
Sbjct: 199 EV 200
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 76.9 bits (189), Expect = 5e-15
Identities = 43/221 (19%), Positives = 89/221 (40%), Gaps = 30/221 (13%)
Query: 305 QLQMPLPSSSFVVSVDEWQTVQSGGEEIGR--WLLNSDNLEFID-QIGPNSFKGVYKGK- 360
++ P + +++ S EE+ L DNL D ++G +F V +G
Sbjct: 298 RITSPDKPRPMPMDTSVFESPFSDPEELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVY 357
Query: 361 -------RVGIEKLKGCDKGNAYEFELRKDLLE----LMTCGHKNILQFYCVCVDENHGL 409
V I+ LK E ++++ + + I++ VC E L
Sbjct: 358 RMRKKQIDVAIKVLK-----QGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEA--L 410
Query: 410 CVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLD 468
+V ++ GG ++ ++ R ++ + + V+ G+K+L + +R+L ++ +LL
Sbjct: 411 MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLV 470
Query: 469 RHGNVCLGDMGIVTACKSVGEATEYETDG-----YRWLAPE 504
+ D G+ A + + + Y +W APE
Sbjct: 471 NRHYAKISDFGLSKALGA--DDSYYTARSAGKWPLKWYAPE 509
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 76.5 bits (188), Expect = 5e-15
Identities = 41/187 (21%), Positives = 78/187 (41%), Gaps = 29/187 (15%)
Query: 335 WLLNSDNLEFIDQIGPNSFKGVYKGK-----RVGIEKLKGCDKGNAYEFELRKDLLE--- 386
W + ++L ++G F V+ G RV I+ LK + L+
Sbjct: 262 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-------MSPEAFLQEAQ 314
Query: 387 -LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK---LQTKEIIRIAID 442
+ H+ ++Q Y V +E + +VT+ M GS+ D LK L+ +++ +A
Sbjct: 315 VMKKLRHEKLVQLYAVVSEE--PIYIVTEYMSKGSLLDF-LKGETGKYLRLPQLVDMAAQ 371
Query: 443 VAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----Y 498
+A G+ ++ +RDL + IL+ + + D G+ + + + G
Sbjct: 372 IASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLA---RLIEDNEYTARQGAKFPI 428
Query: 499 RWLAPEV 505
+W APE
Sbjct: 429 KWTAPEA 435
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 7e-15
Identities = 38/196 (19%), Positives = 74/196 (37%), Gaps = 25/196 (12%)
Query: 326 QSGGEEIG--RWLLNSDNLEFIDQIGPNSFKGVYKG-----KRVGIEKLKGCDKGNAYEF 378
Q+G IG R+ ++LE + ++G + V+K V K
Sbjct: 9 QTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENK 68
Query: 379 ELRKDLLELM-TCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEII 437
+ DL ++ + I+Q + + + + +LM + + + +
Sbjct: 69 RILMDLDVVLKSHDCPYIVQCFGTFITNTD-VFIAMELMGTCAEKLKKRMQGPIPERILG 127
Query: 438 RIAIDVAEGIKFL-NDHGVAYRDLNSQRILLDRHGNVCLGDMGI-------VTACKSVGE 489
++ + + + + +L HGV +RD+ ILLD G + L D GI +S G
Sbjct: 128 KMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAG- 186
Query: 490 ATEYETDGYRWLAPEV 505
++APE
Sbjct: 187 -CAA------YMAPER 195
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 75.0 bits (184), Expect = 7e-15
Identities = 43/230 (18%), Positives = 84/230 (36%), Gaps = 35/230 (15%)
Query: 305 QLQMPLPSSSFVVSVDEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGI 364
L P+ S + EWQ + + L S + +G +F VY+ + +
Sbjct: 33 GLSKPVSSYP---NTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDL 89
Query: 365 EK--------LKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCVCVDENHGLCVVTKL 415
LK N +EF + L+E + ++FY + +N +V +L
Sbjct: 90 NDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNG-SVLVGEL 148
Query: 416 MEGGSVNDLILKSRKLQTK-----EIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILL--- 467
G++ + I + K +I A+ + I+ ++D + + D+ +L
Sbjct: 149 YSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNG 208
Query: 468 --------DRHGNVCLGDMGIVTACKSVGEATEY----ETDGYRWLAPEV 505
D + L D+G K + T + ET G++ E+
Sbjct: 209 FLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQ--CVEM 256
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 1e-14
Identities = 42/204 (20%), Positives = 81/204 (39%), Gaps = 46/204 (22%)
Query: 335 WLLNSDNLEFIDQIGPNSFKGVYKGK--------RVGIEKLKGCDKGNAYEFELRKDLL- 385
+L+ ++++F D IG +F V K + I+++K A + + +D
Sbjct: 20 PVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE----YASKDD-HRDFAG 74
Query: 386 --ELMT--CGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR------------ 429
E++ H NI+ C + L + + G++ D + KSR
Sbjct: 75 ELEVLCKLGHHPNIINLLGACEHRGY-LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIAN 133
Query: 430 ----KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK 485
L +++++ A DVA G+ +L+ +RDL ++ IL+ + + D G+
Sbjct: 134 STASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR--- 190
Query: 486 SVGEATEYETDG-----YRWLAPE 504
Y RW+A E
Sbjct: 191 ---GQEVYVKKTMGRLPVRWMAIE 211
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 1e-14
Identities = 44/182 (24%), Positives = 85/182 (46%), Gaps = 28/182 (15%)
Query: 339 SDNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGH 392
+ + ++++G S+ VYK G+ V I+++ E+ K++ + C
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD----LQEIIKEISIMQQCDS 83
Query: 393 KNILQFYCVCVDENHGLCVVTKLMEGGSVNDLI-LKSRKLQTKEIIRIAIDVAEGIKFLN 451
+++++Y L +V + GSV+D+I L+++ L EI I +G+++L+
Sbjct: 84 PHVVKYYGSYFKNTD-LWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLH 142
Query: 452 DHGVAYRDLNSQRILLDRHGNVCLGDMGI-----VTACKS---VGEATEYETDGYRWLAP 503
+RD+ + ILL+ G+ L D G+ T K +G T + W+AP
Sbjct: 143 FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIG--TPF------WMAP 194
Query: 504 EV 505
EV
Sbjct: 195 EV 196
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 1e-14
Identities = 49/252 (19%), Positives = 92/252 (36%), Gaps = 50/252 (19%)
Query: 293 FRNGVENSNLKIQLQMPLPSSSFVVSVDEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNS 352
++ + +Q+ S + VD + E +W +NLEF +G +
Sbjct: 3 YKKQFRYESQLQMVQVTGSSDNEYFYVDFREY-----EYDLKWEFPRENLEFGKVLGSGA 57
Query: 353 FKGVYKGKRVGIEKLKGCD-------KGNAYEFELRKDLL---ELMT--CGHKNILQFYC 400
F V GI K K A E R+ L+ ++MT H+NI+
Sbjct: 58 FGKVMNATAYGISKTGVSIQVAVKMLKEKADSSE-REALMSELKMMTQLGSHENIVNLLG 116
Query: 401 VCVDENHGLCVVTKLMEGGSVNDLILKSR-----------------------KLQTKEII 437
C + ++ + G + + + R L ++++
Sbjct: 117 ACTLSGP-IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLL 175
Query: 438 RIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG 497
A VA+G++FL +RDL ++ +L+ V + D G+ + + + Y G
Sbjct: 176 CFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGL---ARDIMSDSNYVVRG 232
Query: 498 -----YRWLAPE 504
+W+APE
Sbjct: 233 NARLPVKWMAPE 244
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 1e-14
Identities = 38/188 (20%), Positives = 88/188 (46%), Gaps = 28/188 (14%)
Query: 336 LLNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLL 385
+L + I +G +F VYKG V I++L+ A + K++L
Sbjct: 11 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-----EATSPKANKEIL 65
Query: 386 E----LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIA 440
+ + + + ++ + +C+ + ++T+LM G + D + + + + ++ ++
Sbjct: 66 DEAYVMASVDNPHVCRLLGICLTST--VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC 123
Query: 441 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG--- 497
+ +A+G+ +L D + +RDL ++ +L+ +V + D G+ + E EY +G
Sbjct: 124 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA--EEKEYHAEGGKV 181
Query: 498 -YRWLAPE 504
+W+A E
Sbjct: 182 PIKWMALE 189
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 1e-14
Identities = 40/192 (20%), Positives = 82/192 (42%), Gaps = 30/192 (15%)
Query: 335 WLLNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDL 384
L+ I +G F V + +V ++ LK DL
Sbjct: 16 THFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLK-----PESGGNHIADL 70
Query: 385 LE----LMTCGHKNILQFYCVCVDE-NHGLCVVTKLMEGGSVND-LILKSRKLQTKEIIR 438
+ L H+NI+++ +C ++ +G+ ++ + + GS+ + L K+ K+ ++
Sbjct: 71 KKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLK 130
Query: 439 IAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY---ET 495
A+ + +G+ +L +RDL ++ +L++ V +GD G+ K++ EY +
Sbjct: 131 YAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLT---KAIETDKEYYTVKD 187
Query: 496 DG---YRWLAPE 504
D W APE
Sbjct: 188 DRDSPVFWYAPE 199
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 2e-14
Identities = 39/202 (19%), Positives = 81/202 (40%), Gaps = 37/202 (18%)
Query: 335 WLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCD-------KGNAYEFELRKDLL-- 385
++ + F++++G + F VYKG G + K A R++
Sbjct: 4 KEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPL-REEFRHE 62
Query: 386 -ELMTCG-HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-------------- 429
L H N++ V + L ++ G +++ ++
Sbjct: 63 AMLRARLQHPNVVCLLGVVTKDQP-LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTV 121
Query: 430 --KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV 487
L+ + + + +A G+++L+ H V ++DL ++ +L+ NV + D+G+ + V
Sbjct: 122 KSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLF---REV 178
Query: 488 GEATEYETDGY-----RWLAPE 504
A Y+ G RW+APE
Sbjct: 179 YAADYYKLLGNSLLPIRWMAPE 200
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 3e-14
Identities = 35/192 (18%), Positives = 77/192 (40%), Gaps = 31/192 (16%)
Query: 335 WLLNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDL 384
+ +L++I Q+G +F V + V +++L+ + ++D
Sbjct: 18 TIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGP------DQQRDF 71
Query: 385 LE----LMTCGHKNILQFYCVCVD-ENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIR 438
L I+++ V L +V + + G + D + + R +L ++
Sbjct: 72 QREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLL 131
Query: 439 IAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY---ET 495
+ + +G+++L +RDL ++ IL++ +V + D G+ K + +Y
Sbjct: 132 YSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLA---KLLPLDKDYYVVRE 188
Query: 496 DG---YRWLAPE 504
G W APE
Sbjct: 189 PGQSPIFWYAPE 200
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 3e-14
Identities = 47/223 (21%), Positives = 85/223 (38%), Gaps = 59/223 (26%)
Query: 318 SVDEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGK-----------RVGIEK 366
+ I R ++ ++G +F V+ + V ++
Sbjct: 6 GIHVQ--------HIKR-----RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKA 52
Query: 367 LKGCDKGNAYEFELRKDLL---ELMT-CGHKNILQFYCVCVDENHGLCVVTKLMEGGSVN 422
LK RKD EL+T H++I++FY VC D + L +V + M+ G +N
Sbjct: 53 LKDPTL------AARKDFQREAELLTNLQHEHIVKFYGVCGDGDP-LIMVFEYMKHGDLN 105
Query: 423 DLILKSR----------------KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRIL 466
+ +L +++ IA +A G+ +L +RDL ++ L
Sbjct: 106 KFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCL 165
Query: 467 LDRHGNVCLGDMGIVTACKSVGEATEYETDGY-----RWLAPE 504
+ + V +GD G+ + V Y G+ RW+ PE
Sbjct: 166 VGANLLVKIGDFGMS---RDVYSTDYYRVGGHTMLPIRWMPPE 205
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 4e-14
Identities = 42/204 (20%), Positives = 86/204 (42%), Gaps = 33/204 (16%)
Query: 324 TVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLK-GCDK 372
+ S E+ +L+F+ Q+G +F V + V ++KL+ ++
Sbjct: 25 AMGSAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE 84
Query: 373 GNAYEFELRKDLLE----LMTCGHKNILQFYCVCV-DENHGLCVVTKLMEGGSVND-LIL 426
+D L + H NI+++ VC L ++ + + GS+ D L
Sbjct: 85 H-------LRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK 137
Query: 427 KSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS 486
++ ++++ + +G+++L +RDL ++ IL++ V +GD G+ K
Sbjct: 138 HKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT---KV 194
Query: 487 VGEATEY---ETDG---YRWLAPE 504
+ + EY + G W APE
Sbjct: 195 LPQDKEYYKVKEPGESPIFWYAPE 218
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 7e-14
Identities = 39/193 (20%), Positives = 82/193 (42%), Gaps = 33/193 (17%)
Query: 335 WLLNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLK-GCDKGNAYEFELRKD 383
+L+F+ Q+G +F V + V ++KL+ ++ +D
Sbjct: 5 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH-------LRD 57
Query: 384 LLE----LMTCGHKNILQFYCVCV-DENHGLCVVTKLMEGGSVND-LILKSRKLQTKEII 437
L + H NI+++ VC L ++ + + GS+ D L ++ +++
Sbjct: 58 FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLL 117
Query: 438 RIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY---E 494
+ + +G+++L +RDL ++ IL++ V +GD G+ K + + E+ +
Sbjct: 118 QYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT---KVLPQDKEFFKVK 174
Query: 495 TDG---YRWLAPE 504
G W APE
Sbjct: 175 EPGESPIFWYAPE 187
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 8e-14
Identities = 40/235 (17%), Positives = 76/235 (32%), Gaps = 43/235 (18%)
Query: 292 SFRNGVENSNLKIQLQMPLPSSSFVVSVDEWQTVQSG-GEEIGRWLLNSDNLEFIDQIGP 350
S + + K+Q P + V + E E W+ ++G
Sbjct: 15 SLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWM------THQPRVGR 68
Query: 351 NSFKGVYKG-----------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFY 399
SF V++ K+V +E + E I+ Y
Sbjct: 69 GSFGEVHRMKDKQTGFQCAVKKVRLEVFR------VEELVA------CAGLSSPRIVPLY 116
Query: 400 CVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRD 459
+ + + +L+EGGS+ LI + L + EG+++L+ + + D
Sbjct: 117 GAVREGPW-VNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGD 175
Query: 460 LNSQRILLDRHGNVC-LGDMGIVTACKSVGEATEYETDGYR--------WLAPEV 505
+ + +LL G+ L D G + ++ +APEV
Sbjct: 176 VKADNVLLSSDGSRAALCDFGH---ALCLQPDGLGKSLLTGDYIPGTETHMAPEV 227
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 70.6 bits (173), Expect = 2e-13
Identities = 39/200 (19%), Positives = 62/200 (31%), Gaps = 32/200 (16%)
Query: 337 LNSDNLEFIDQIGPNSFKGVYKGKRVGIEK---LKGCDKGNAYEFELRKDLLELMT--CG 391
L L + F VY+ + VG + LK + + M G
Sbjct: 25 LGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSG 84
Query: 392 HKNILQFYCVCVDENHGLCVVTK----LME--GGSVNDLILKSR---KLQTKEIIRIAID 442
H NI+QF L E G + + + K L +++I
Sbjct: 85 HPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQ 144
Query: 443 VAEGIKFLNDHG--VAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG------------ 488
++ ++ + +RDL + +LL G + L D G T
Sbjct: 145 TCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALV 204
Query: 489 --EATEYETDGYRWLAPEVC 506
E T T YR PE+
Sbjct: 205 EEEITRNTTPMYR--TPEII 222
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 4e-13
Identities = 33/183 (18%), Positives = 66/183 (36%), Gaps = 34/183 (18%)
Query: 343 EFIDQIGPNSFKGVYKG----------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGH 392
+ QIG V++ K V +E+ ++Y E+ L +
Sbjct: 31 SILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTL-DSYRNEI--AYLNKLQQHS 87
Query: 393 KNILQFYCVCVDENHGLCVVTKLME--GGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFL 450
I++ Y + + + + +V ME +N + K + + E ++ E + +
Sbjct: 88 DKIIRLYDYEITDQY-IYMV---MECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTI 143
Query: 451 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR--------WLA 502
+ HG+ + DL L+ G + L D GI + T T + ++
Sbjct: 144 HQHGIVHSDLKPANFLIVD-GMLKLIDFGI---ANQMQPDT---TSVVKDSQVGTVNYMP 196
Query: 503 PEV 505
PE
Sbjct: 197 PEA 199
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 4e-13
Identities = 44/209 (21%), Positives = 80/209 (38%), Gaps = 33/209 (15%)
Query: 317 VSVDEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKG--KRVGIE---KLKGCD 371
+S++ ++ E+ W +++L+ + +IG ++ V K K G K
Sbjct: 1 MSIESSGKLKISPEQH--WDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRST 58
Query: 372 KGNAYEFELRKDLLELM-TCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK 430
+ +L DL +M + I+QFY E + +LM D K
Sbjct: 59 VDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGD-CWICMELMSTSF--DKFYKYVY 115
Query: 431 LQTKEII------RIAIDVAEGIKFL-NDHGVAYRDLNSQRILLDRHGNVCLGDMGI--- 480
++I +I + + + L + + +RD+ ILLDR GN+ L D GI
Sbjct: 116 SVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQ 175
Query: 481 ----VTACKSVGEATEYETDGYRWLAPEV 505
+ + G ++APE
Sbjct: 176 LVDSIAKTRDAG--CRP------YMAPER 196
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 8e-13
Identities = 46/175 (26%), Positives = 80/175 (45%), Gaps = 22/175 (12%)
Query: 343 EFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFE-LRKDLLELMTCGHKNI 395
+ +IG SF VY + V I+K+ K + +++ + K++ L H N
Sbjct: 57 SDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNT 116
Query: 396 LQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGV 455
+Q+ + E+ +V + G + + L + + LQ EI + +G+ +L+ H +
Sbjct: 117 IQYRGCYLREHT-AWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNM 175
Query: 456 AYRDLNSQRILLDRHGNVCLGDMGIVTACKS-----VGEATEYETDGYRWLAPEV 505
+RD+ + ILL G V LGD G + + VG T Y W+APEV
Sbjct: 176 IHRDVKAGNILLSEPGLVKLGDFG-SASIMAPANSFVG--TPY------WMAPEV 221
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 1e-12
Identities = 31/123 (25%), Positives = 56/123 (45%), Gaps = 19/123 (15%)
Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN 451
H++++ F+ D + + VV +L S+ +L + + L E + G ++L+
Sbjct: 74 HQHVVGFHGFFEDNDF-VFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLH 132
Query: 452 DHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR---------WLA 502
+ V +RDL + L+ V +GD G+ AT+ E DG R ++A
Sbjct: 133 RNRVIHRDLKLGNLFLNEDLEVKIGDFGL---------ATKVEYDGERKKVLCGTPNYIA 183
Query: 503 PEV 505
PEV
Sbjct: 184 PEV 186
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 1e-12
Identities = 31/123 (25%), Positives = 56/123 (45%), Gaps = 19/123 (15%)
Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN 451
H++++ F+ D + + VV +L S+ +L + + L E + G ++L+
Sbjct: 100 HQHVVGFHGFFEDNDF-VFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLH 158
Query: 452 DHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR---------WLA 502
+ V +RDL + L+ V +GD G+ AT+ E DG R ++A
Sbjct: 159 RNRVIHRDLKLGNLFLNEDLEVKIGDFGL---------ATKVEYDGERKKVLCGTPNYIA 209
Query: 503 PEV 505
PEV
Sbjct: 210 PEV 212
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 1e-12
Identities = 38/202 (18%), Positives = 75/202 (37%), Gaps = 36/202 (17%)
Query: 327 SGGEEIGRWLLNSDNLEFIDQIGPNSF-----KGVYKG-----KRVGIEKLKGCDKGNAY 376
G EE ++ + D +G + +G++ KR+ E D+
Sbjct: 11 DGDEETSVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADR---- 66
Query: 377 EFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQT-KE 435
E +L ++ E H N+++++C D + +L ++ + + + E
Sbjct: 67 EVQLLRESDE-----HPNVIRYFCTEKDRQF-QYIAIELC-AATLQEYVEQKDFAHLGLE 119
Query: 436 IIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGN-----VCLGDMGIVTACK--SVG 488
I + G+ L+ + +RDL IL+ + D G+ CK +VG
Sbjct: 120 PITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGL---CKKLAVG 176
Query: 489 EATEYETDGYR----WLAPEVC 506
+ G W+APE+
Sbjct: 177 RHSFSRRSGVPGTEGWIAPEML 198
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 1e-12
Identities = 32/177 (18%), Positives = 67/177 (37%), Gaps = 22/177 (12%)
Query: 343 EFIDQIGPNSFKGVYKG----------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGH 392
+ QIG V++ K V +E+ ++Y E+ L +
Sbjct: 12 SILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTL-DSYRNEI--AYLNKLQQHS 68
Query: 393 KNILQFYCVCVDENHGLCVVTKLME--GGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFL 450
I++ Y + + + + +V ME +N + K + + E ++ E + +
Sbjct: 69 DKIIRLYDYEITDQY-IYMV---MECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTI 124
Query: 451 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETD-G-YRWLAPEV 505
+ HG+ + DL L+ G + L D GI + + ++ G ++ PE
Sbjct: 125 HQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEA 180
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 3e-12
Identities = 37/228 (16%), Positives = 77/228 (33%), Gaps = 32/228 (14%)
Query: 295 NGVENSNLKIQLQMPLPSSSFVVSVDEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFK 354
+G++ + + + S D+ + S E I + + QIG
Sbjct: 15 SGMKETAAAKFERQHMDSPDLGTDDDDKAS-SSANECIS---VKGRIYSILKQIGSGGSS 70
Query: 355 GVYKGKRVGIEK--LKGCDKGNAYEFELRK-----DLLELMTCGHKNILQFYCVCVDENH 407
V++ + +K + A L L + I++ Y + + +
Sbjct: 71 KVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 130
Query: 408 GLCVVTKLME--GGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRI 465
+ +V ME +N + K + + E ++ E + ++ HG+ + DL
Sbjct: 131 -IYMV---MECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANF 186
Query: 466 LLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR--------WLAPEV 505
L+ G + L D GI + T T + ++ PE
Sbjct: 187 LIVD-GMLKLIDFGI---ANQMQPDT---TSVVKDSQVGAVNYMPPEA 227
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 1e-11
Identities = 25/114 (21%), Positives = 45/114 (39%), Gaps = 3/114 (2%)
Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN 451
H NIL+ Y D + ++ + G+V + K K + ++A + + +
Sbjct: 68 HPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 126
Query: 452 DHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEV 505
V +RD+ + +LL G + + D G S T Y L PE+
Sbjct: 127 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDY--LPPEM 178
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 6e-11
Identities = 39/186 (20%), Positives = 70/186 (37%), Gaps = 26/186 (13%)
Query: 337 LNSDNLEFIDQIGPNSFKGVYKG--KRVGIE---KLKGCDKGNAYEFELRKDLLELM-TC 390
+ +D+LE I ++G ++ V K G K + + L DL M T
Sbjct: 4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTV 63
Query: 391 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQT---KEIIRIAIDVAEGI 447
+ FY E + + +LM+ K QT + +IA+ + + +
Sbjct: 64 DCPFTVTFYGALFREGD-VWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKAL 122
Query: 448 KFL-NDHGVAYRDLNSQRILLDRHGNVCLGDMGI-------VTACKSVGEATEYETDGYR 499
+ L + V +RD+ +L++ G V + D GI V G +
Sbjct: 123 EHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAG--CKP------ 174
Query: 500 WLAPEV 505
++APE
Sbjct: 175 YMAPER 180
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 62.9 bits (153), Expect = 9e-11
Identities = 36/184 (19%), Positives = 70/184 (38%), Gaps = 44/184 (23%)
Query: 353 FKGVYKGKRVGIEK--LKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLC 410
F+G ++G+ V + K L E +L + + H N++++YC + L
Sbjct: 33 FQGSFQGRPVAV-KRMLIDFCDIALMEIKLLTESDD-----HPNVIRYYCSETTDRF-LY 85
Query: 411 VVTKLMEGGSVNDLILK-------SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQ 463
+ +L ++ DL+ + + I + +A G+ L+ + +RDL Q
Sbjct: 86 IALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQ 144
Query: 464 RILLD-------------RHGNVCLGDMGIVTACKSVGEATEYE---------TDGYRWL 501
IL+ + + + D G+ CK + T G+R
Sbjct: 145 NILVSTSSRFTADQQTGAENLRILISDFGL---CKKLDSGQSSFRTNLNNPSGTSGWR-- 199
Query: 502 APEV 505
APE+
Sbjct: 200 APEL 203
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 61.4 bits (149), Expect = 2e-10
Identities = 27/124 (21%), Positives = 47/124 (37%), Gaps = 15/124 (12%)
Query: 398 FYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKE---IIRIAIDVAEGIKFLNDHG 454
L + +L ++ D + + L+ +E + I I +AE ++FL+ G
Sbjct: 125 GQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG 184
Query: 455 VAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR------------WLA 502
+ +RDL I V +GD G+VTA E T +++
Sbjct: 185 LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS 244
Query: 503 PEVC 506
PE
Sbjct: 245 PEQI 248
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 4e-10
Identities = 39/177 (22%), Positives = 77/177 (43%), Gaps = 31/177 (17%)
Query: 348 IGPNSFKGVYKG-----------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNIL 396
+G ++ VY G K + + E+ L + HKNI+
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEI---PERDSRYSQPLHEEI--ALHK--HLKHKNIV 82
Query: 397 QFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR--KLQTKE--IIRIAIDVAEGIKFLND 452
Q+ + + + + + GGS++ L L+S+ L+ E I + EG+K+L+D
Sbjct: 83 QYLGSFSENGF-IKIFMEQVPGGSLSAL-LRSKWGPLKDNEQTIGFYTKQILEGLKYLHD 140
Query: 453 HGVAYRDLNSQRILLDRH-GNVCLGDMGIVTACKSVGEATEYET-DG--YRWLAPEV 505
+ + +RD+ +L++ + G + + D G + + G ET G ++APE+
Sbjct: 141 NQIVHRDIKGDNVLINTYSGVLKISDFGT--SKRLAGINPCTETFTGTLQ-YMAPEI 194
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 61.4 bits (149), Expect = 4e-10
Identities = 48/248 (19%), Positives = 91/248 (36%), Gaps = 43/248 (17%)
Query: 281 GEIEEEEACDESFRNGVE--NSNLKIQLQMPLPSSSFVVSVDEWQTVQSGGEEIGRWLLN 338
G + +++ + F+ +E NL+ + S +W+ V+ L
Sbjct: 134 GHLVKKQVPPDLFQPYIEEICQNLRGDVFQKFIESDKFTRFCQWKNVELNIH------LT 187
Query: 339 SDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFELRKDLL-----ELMTCGHK 393
++ IG F VY ++ K+ L K + E + +
Sbjct: 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKC-------LDKKRIKMKQGETLALNER 240
Query: 394 NILQ-------------FYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIA 440
+L Y + L + LM GG ++ + + ++ A
Sbjct: 241 IMLSLVSTGDCPFIVCMSYAFHTPDK--LSFILDLMNGGDLHYHLSQHGVFSEADMRFYA 298
Query: 441 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYE---TDG 497
++ G++ +++ V YRDL ILLD HG+V + D+G+ + + T G
Sbjct: 299 AEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGL---ACDFSKKKPHASVGTHG 355
Query: 498 YRWLAPEV 505
Y +APEV
Sbjct: 356 Y--MAPEV 361
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 61.0 bits (147), Expect = 6e-10
Identities = 67/477 (14%), Positives = 126/477 (26%), Gaps = 164/477 (34%)
Query: 9 SSRASTDEDMVEQVLMRTNDRSEAVSAAAETSSASATGKEYSSVVQKRF---QRLS-RNV 64
S + + VE+VL R N + E S + Y + + Q + NV
Sbjct: 73 SKQEEMVQKFVEEVL-RINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNV 131
Query: 65 S--EAIASLKNTL-NLDSAPT----GGVGVG----ARDQPTASSNSKIET--SRKVVWGS 111
S + L+ L L A G +G G A D + K++ K+ W +
Sbjct: 132 SRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALD---VCLSYKVQCKMDFKIFWLN 188
Query: 112 VVRNLTQLYPGSQLPERLVSNMRKHYDSLPLSYAQAGFDMKEVFLHIKLIEQASGDDRPA 171
+ + PE ++ ++K + ++ + L I + R
Sbjct: 189 LKNCNS--------PETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRI---HSIQAELRRL 237
Query: 172 IMIQE------VSDDEAQGSVYKLTFACNSSISWPAMSGALDTASICCKKIQIFEKKGFT 225
+ + V + V N+ W A + + CK
Sbjct: 238 LKSKPYENCLLVLLN-----V------QNAKA-WNAFN-------LSCK----------- 267
Query: 226 LGVVILAVQAGQEKSFKSQIENALKSAIKKPKPTSVKLPFGLCGCQEENTKG--RDFGEI 283
IL + Q+ + L +A + L + K + +
Sbjct: 268 ----ILLT------TRFKQVTDFLSAATTT-HISLDHHSMTL---TPDEVKSLLLKYLDC 313
Query: 284 EE----EEACDESFRNGVENSNLKIQLQMPLPSSSFVVSVDE----WQTVQSGGEEIGRW 335
E + P S S+ + W W
Sbjct: 314 RPQDLPREVLTTN----------------PRRLSIIAESIRDGLATWD----------NW 347
Query: 336 L-LNSDNLE-----FIDQIGPNSFKGVYKG-----KRVGI-------------------- 364
+N D L ++ + P ++ ++ I
Sbjct: 348 KHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVV 407
Query: 365 -EKL--KGCDKGNAYE---------FELRKDLLELMTCGHKNILQFYCV--CVDENH 407
KL + E EL+ L H++I+ Y + D +
Sbjct: 408 VNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYAL-HRSIVDHYNIPKTFDSDD 463
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 41.4 bits (96), Expect = 7e-04
Identities = 42/268 (15%), Positives = 82/268 (30%), Gaps = 79/268 (29%)
Query: 271 QEENTKGRDFGEIEEEEACDESFRNGVENSNLKIQLQMPLPSSSFVVSVDEWQTVQSGGE 330
++ D ++++ ++ + + + S + T+ S E
Sbjct: 26 EDAFVDNFDCKDVQDMP------KSILSKEEIDHIIMSKDAVSGTLRLFW---TLLSKQE 76
Query: 331 EIGRWLLNS---DNLEFI------DQIGPNSFKGVYKGKRVGIEKLKG----CDKGNAYE 377
E+ + + N +F+ +Q P+ +Y +R ++L K N
Sbjct: 77 EMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQR---DRLYNDNQVFAKYNVSR 133
Query: 378 FE----LRKDLLEL----------MT-CGHKNIL--QFYCVCVDENHGLCVVTKLMEGG- 419
+ LR+ LLEL + G K + VC+ V M+
Sbjct: 134 LQPYLKLRQALLELRPAKNVLIDGVLGSG-KTWVALD---VCLSYK-----VQCKMDFKI 184
Query: 420 ---------SVNDLILKSRKL--QTKEIIRIAIDVAEGIKF-LNDHGVAYRDLNSQR--- 464
S ++ +KL Q D + IK ++ R L +
Sbjct: 185 FWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYE 244
Query: 465 ---ILLDRHGNVCLGDMGIVTA----CK 485
++L NV + A CK
Sbjct: 245 NCLLVLL---NVQ--NAKAWNAFNLSCK 267
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 8e-10
Identities = 23/114 (20%), Positives = 48/114 (42%), Gaps = 3/114 (2%)
Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN 451
H NIL+ Y D + ++ + G + + K + + ++A+ + + +
Sbjct: 73 HPNILRMYNYFHDRKR-IYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCH 131
Query: 452 DHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEV 505
+ V +RD+ + +L+ G + + D G S+ T T Y L PE+
Sbjct: 132 ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMCGTLDY--LPPEM 183
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 1e-09
Identities = 29/119 (24%), Positives = 56/119 (47%), Gaps = 12/119 (10%)
Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN 451
H+NI+ V +++ +V + +EG ++++ I L I + +GIK +
Sbjct: 70 HQNIVSMIDVDEEDDCYY-LVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAH 128
Query: 452 DHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG------YRWLAPE 504
D + +RD+ Q IL+D + + + D GI A + E + +T+ Y +PE
Sbjct: 129 DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKA---LSETSLTQTNHVLGTVQY--FSPE 182
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 59.5 bits (144), Expect = 1e-09
Identities = 32/183 (17%), Positives = 70/183 (38%), Gaps = 28/183 (15%)
Query: 343 EFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFE--LRKDLLELMTCGHKN 394
D +G + V++ G I K + + ++ L HKN
Sbjct: 12 LLSDILGQGATANVFRGRHKKTGDLFAI---KVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 395 ILQFYCVCVDENHG-LCVVTKLMEGGSVNDLILK---SRKLQTKEIIRIAIDVAEGIKFL 450
I++ + + + ++ + GS+ ++ + + L E + + DV G+ L
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 451 NDHGVAYRDLNSQRILL----DRHGNVCLGDMGIVTACKSVGE----ATEYETDGYRWLA 502
++G+ +R++ I+ D L D G A + + + + Y T+ Y L
Sbjct: 129 RENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFG---AARELEDDEQFVSLYGTEEY--LH 183
Query: 503 PEV 505
P++
Sbjct: 184 PDM 186
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 1e-09
Identities = 37/234 (15%), Positives = 74/234 (31%), Gaps = 49/234 (20%)
Query: 309 PLPSSSFVVSVDEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVY----KGKRVGI 364
PL S ++S + + +N + I + F + K +
Sbjct: 2 PLGSMKDILSNYSNLIYLNKYVKEKDKYIN--DYRIIRTLNQGKFNKIILCEKDNKFYAL 59
Query: 365 --------EKLKGCDKGNAYEFELRKDL------LELMT-CGHKNILQFYCVCVDENHGL 409
EK + K N + ++ L+++T ++ L + + + +
Sbjct: 60 KKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDE-V 118
Query: 410 CVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVA--------EGIKFLNDH-GVAYRDL 460
++ + ME S+ L I I V ++++ + +RD+
Sbjct: 119 YIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDV 178
Query: 461 NSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRW--------LAPEVC 506
IL+D++G V L D G S Y D + PE
Sbjct: 179 KPSNILMDKNGRVKLSDFGE-----SE-----YMVDKKIKGSRGTYEFMPPEFF 222
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 1e-09
Identities = 32/183 (17%), Positives = 70/183 (38%), Gaps = 28/183 (15%)
Query: 343 EFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFE--LRKDLLELMTCGHKN 394
D +G + V++ G I K + + ++ L HKN
Sbjct: 12 LLSDILGQGATANVFRGRHKKTGDLFAI---KVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 395 ILQFYCVCVDEN-HGLCVVTKLMEGGSVNDLILK---SRKLQTKEIIRIAIDVAEGIKFL 450
I++ + + + ++ + GS+ ++ + + L E + + DV G+ L
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 451 NDHGVAYRDLNSQRILL----DRHGNVCLGDMGIVTACKSVGE----ATEYETDGYRWLA 502
++G+ +R++ I+ D L D G A + + + + Y T+ Y L
Sbjct: 129 RENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFG---AARELEDDEQFVSLYGTEEY--LH 183
Query: 503 PEV 505
P++
Sbjct: 184 PDM 186
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 2e-09
Identities = 41/154 (26%), Positives = 60/154 (38%), Gaps = 21/154 (13%)
Query: 364 IEKLKGCDKGNAYEFELRKDLL---ELMT--CGHKNILQFYCVCVDENHGLCVVTKLMEG 418
I+ G ELR+ L +++ GH NI+Q +V LM+
Sbjct: 50 IDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTF-FFLVFDLMKK 108
Query: 419 GSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDM 478
G + D + + L KE +I + E I L+ + +RDL + ILLD N+ L D
Sbjct: 109 GELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDF 168
Query: 479 GIVTACK-------SVGEATEYETDGYRWLAPEV 505
G G T Y LAPE+
Sbjct: 169 GFSCQLDPGEKLREVCG------TPSY--LAPEI 194
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 4e-09
Identities = 20/95 (21%), Positives = 41/95 (43%), Gaps = 3/95 (3%)
Query: 392 HKNILQFYCVCVDENHGLCV---VTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIK 448
H I+ Y E + V + ++G ++ D++ + K I + D + +
Sbjct: 71 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALN 130
Query: 449 FLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTA 483
F + +G+ +RD+ I++ V + D GI A
Sbjct: 131 FSHQNGIIHRDVKPANIMISATNAVKVMDFGIARA 165
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 56.8 bits (138), Expect = 4e-09
Identities = 27/124 (21%), Positives = 56/124 (45%), Gaps = 20/124 (16%)
Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLI-LKSRKLQTKEIIRIAIDVAEGIKFL 450
H +IL+ Y D N+ + +V ++ G +N + + + E + G+ +L
Sbjct: 70 HPSILELYNYFEDSNY-VYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYL 128
Query: 451 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR---------WL 501
+ HG+ +RDL +LL R+ N+ + D G+ AT+ + + ++
Sbjct: 129 HSHGILHRDLTLSNLLLTRNMNIKIADFGL---------ATQLKMPHEKHYTLCGTPNYI 179
Query: 502 APEV 505
+PE+
Sbjct: 180 SPEI 183
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 4e-09
Identities = 33/123 (26%), Positives = 52/123 (42%), Gaps = 16/123 (13%)
Query: 390 CGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKF 449
GH +I+ + + +V LM G + D + + L KE I + E + F
Sbjct: 157 AGHPHIITLIDSYESSSF-MFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSF 215
Query: 450 LNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK-------SVGEATEYETDGYRWLA 502
L+ + + +RDL + ILLD + + L D G + G T GY LA
Sbjct: 216 LHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCG------TPGY--LA 267
Query: 503 PEV 505
PE+
Sbjct: 268 PEI 270
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 57.1 bits (138), Expect = 7e-09
Identities = 55/220 (25%), Positives = 83/220 (37%), Gaps = 45/220 (20%)
Query: 311 PSSSFVVSVDEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGC 370
P + ++ S+ + +Q E + + +G F V + K+ C
Sbjct: 157 PFADYLDSIYFNRFLQWKWLERQP--VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYAC 214
Query: 371 DKGNAYEFELRKDLL-----ELMTCGHKNILQ----------FYCVCVDENHGLCVVTKL 415
K L K + E M K IL+ Y + LC+V L
Sbjct: 215 KK-------LEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDA--LCLVLTL 265
Query: 416 MEGGSVNDL---ILKSRKLQTKEIIRIAIDVAE---GIKFLNDHGVAYRDLNSQRILLDR 469
M GG DL I + E R AE G++ L+ + YRDL + ILLD
Sbjct: 266 MNGG---DLKFHIYHMGQAGFPEA-RAVFYAAEICCGLEDLHRERIVYRDLKPENILLDD 321
Query: 470 HGNVCLGDMGIVTACKSVGEATEYE----TDGYRWLAPEV 505
HG++ + D+G+ V E + T GY +APEV
Sbjct: 322 HGHIRISDLGL---AVHVPEGQTIKGRVGTVGY--MAPEV 356
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 1e-08
Identities = 35/163 (21%), Positives = 62/163 (38%), Gaps = 25/163 (15%)
Query: 338 NSDNLEFIDQIGPNSFKGVYK------GKRVGIEKLK-GCDKGNAYEF---ELR--KDLL 385
+ E + +IG ++ VYK G V ++ ++ G +R L
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 386 ELMTCGHKNILQFYCVCVDENHG----LCVVTKLMEGGSVNDL--ILKSRK---LQTKEI 436
L H N+++ VC + +V + ++ DL L L + I
Sbjct: 67 RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD----QDLRTYLDKAPPPGLPAETI 122
Query: 437 IRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMG 479
+ G+ FL+ + + +RDL + IL+ G V L D G
Sbjct: 123 KDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFG 165
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 55.0 bits (132), Expect = 2e-08
Identities = 21/135 (15%), Positives = 45/135 (33%), Gaps = 13/135 (9%)
Query: 378 FELRKDLLELMTCGHKNILQFYCVCVDENH-GLCVVTKLME------GGSVNDLILKSRK 430
F DL++ K +++ D + M+ G + +
Sbjct: 145 FIFPFDLVKDP--QKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKS 202
Query: 431 LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA 490
L +++ + V + L+ +G+ + L I+LD+ G V L +
Sbjct: 203 LVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEH--LVRDGARV 260
Query: 491 TEYETDGYRWLAPEV 505
+ G+ PE+
Sbjct: 261 VSSVSRGF--EPPEL 273
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 3e-08
Identities = 36/127 (28%), Positives = 59/127 (46%), Gaps = 15/127 (11%)
Query: 391 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFL 450
GH+N+L+ +E+ +V + M GGS+ I K R E + DVA + FL
Sbjct: 69 GHRNVLELIEFFEEEDR-FYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFL 127
Query: 451 NDHGVAYRDLNSQRILL---DRHGNVCLGDMGIVTACKSVGEATEYETD---------GY 498
++ G+A+RDL + IL ++ V + D + + K G+ + T Y
Sbjct: 128 HNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEY 187
Query: 499 RWLAPEV 505
+APEV
Sbjct: 188 --MAPEV 192
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 55.1 bits (132), Expect = 3e-08
Identities = 39/209 (18%), Positives = 75/209 (35%), Gaps = 50/209 (23%)
Query: 326 QSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFE 379
+ G W E +++G F V + G++V I K C + E
Sbjct: 7 SLPTQTCGPW-------EMKERLGTGGFGYVLRWIHQDTGEQVAI---KQCRQ------E 50
Query: 380 LRKDLLE--------LMTCGHKNILQFYCV-----CVDENHGLCVVTKLMEGGSVNDLIL 426
L E + H N++ V + N + + EGG + +
Sbjct: 51 LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLN 110
Query: 427 KSRK---LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVC---LGDMGI 480
+ L+ I + D++ +++L+++ + +RDL + I+L + D+G
Sbjct: 111 QFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLG- 169
Query: 481 VTACKSVGE----ATEYETDGYRWLAPEV 505
K + + T Y LAPE+
Sbjct: 170 --YAKELDQGELCTEFVGTLQY--LAPEL 194
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 3e-08
Identities = 21/88 (23%), Positives = 44/88 (50%), Gaps = 1/88 (1%)
Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN 451
H NI++ + V E L ++ + GG V D ++ +++ KE + +++ +
Sbjct: 73 HPNIVKLFEVIETEKT-LYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCH 131
Query: 452 DHGVAYRDLNSQRILLDRHGNVCLGDMG 479
+ +RDL ++ +LLD N+ + D G
Sbjct: 132 QKRIVHRDLKAENLLLDADMNIKIADFG 159
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 6e-08
Identities = 18/89 (20%), Positives = 31/89 (34%), Gaps = 3/89 (3%)
Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN 451
+ + V V G VV + + GGS+ ++ IR +A +
Sbjct: 90 KPGVARVLDV-VHTRAGGLVVAEWIRGGSLQEVA--DTSPSPVGAIRAMQSLAAAADAAH 146
Query: 452 DHGVAYRDLNSQRILLDRHGNVCLGDMGI 480
GVA + R+ + G+V L
Sbjct: 147 RAGVALSIDHPSRVRVSIDGDVVLAYPAT 175
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 7e-08
Identities = 33/125 (26%), Positives = 57/125 (45%), Gaps = 9/125 (7%)
Query: 387 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEG 446
L H NI+ V D + + VVT+LM+GG + D IL+ + +E + + +
Sbjct: 70 LRYGQHPNIITLKDVYDDGKY-VYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKT 128
Query: 447 IKFLNDHGVAYRDLNSQRILL----DRHGNVCLGDMGIVTACKSVGEA--TEYETDGYRW 500
+++L+ GV +RDL IL ++ + D G ++ T T +
Sbjct: 129 VEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANF-- 186
Query: 501 LAPEV 505
+APEV
Sbjct: 187 VAPEV 191
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 53.0 bits (127), Expect = 9e-08
Identities = 27/151 (17%), Positives = 51/151 (33%), Gaps = 27/151 (17%)
Query: 320 DEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCD-------K 372
+W E R D L+ +G +F V + GI+K C K
Sbjct: 15 SKW--------EFPR-----DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK 61
Query: 373 GNAYEFELRKDL---LELMT--CGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILK 427
A E + L L+++ H N++ C L V+ + + G+++ +
Sbjct: 62 EGATHSE-HRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRS 120
Query: 428 SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYR 458
R + A +G ++ V +
Sbjct: 121 KRNEFVPYKTKGA-RFRQGKDYVGAIPVDLK 150
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 44.9 bits (106), Expect = 4e-05
Identities = 23/88 (26%), Positives = 40/88 (45%), Gaps = 8/88 (9%)
Query: 422 NDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIV 481
L L + +I + VA+G++FL +RDL ++ ILL V + D G+
Sbjct: 181 APEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGL- 239
Query: 482 TACKSVGEATEYETDG-----YRWLAPE 504
+ + + +Y G +W+APE
Sbjct: 240 --ARDIYKDPDYVRKGDARLPLKWMAPE 265
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 53.1 bits (127), Expect = 9e-08
Identities = 19/124 (15%), Positives = 38/124 (30%), Gaps = 14/124 (11%)
Query: 392 HKNILQFYCVCVDENHG----LCVVTKLMEG------GSVNDLILKSRKLQTKEIIRIAI 441
+ V +DE + M+ + + L +++ +
Sbjct: 159 DPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTL 218
Query: 442 DVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWL 501
V + L+ +G+ + L I+LD+ G V L G + G +
Sbjct: 219 QVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEH---LVRDGASAVSPI-GRGFA 274
Query: 502 APEV 505
PE
Sbjct: 275 PPET 278
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 9e-08
Identities = 31/126 (24%), Positives = 60/126 (47%), Gaps = 14/126 (11%)
Query: 387 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEG 446
L H I++ E++ + V +LMEGG + D ++ +++L+ +
Sbjct: 194 LKKLNHPCIIKIKNFFDAEDYYI--VLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLA 251
Query: 447 IKFLNDHGVAYRDLNSQRILL---DRHGNVCLGDMGIVTACKSVGEATEYETD----GYR 499
+++L+++G+ +RDL + +LL + + + D G K +GE + T Y
Sbjct: 252 VQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGH---SKILGETSLMRTLCGTPTY- 307
Query: 500 WLAPEV 505
LAPEV
Sbjct: 308 -LAPEV 312
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 1e-07
Identities = 30/120 (25%), Positives = 53/120 (44%), Gaps = 8/120 (6%)
Query: 391 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFL 450
GH NI++ + V D+ H +V +L+ GG + + I K + E I + + +
Sbjct: 64 GHPNIVKLHEVFHDQLH-TFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHM 122
Query: 451 NDHGVAYRDLNSQRILL---DRHGNVCLGDMGIVTACKSVGEA--TEYETDGYRWLAPEV 505
+D GV +RDL + +L + + + + D G + T T Y APE+
Sbjct: 123 HDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHY--AAPEL 180
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 39/194 (20%), Positives = 78/194 (40%), Gaps = 36/194 (18%)
Query: 339 SDNLEFIDQIGPNSFKGVYKGKRVG---------IEKLKGCDKGNAYEFELRKDLLE--- 386
++ + ++G ++ V K I+K + + + + + E
Sbjct: 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIY 94
Query: 387 -----LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAI 441
L + H NI++ + V D+ + +VT+ EGG + + I+ K + I
Sbjct: 95 NEISLLKSLDHPNIIKLFDVFEDKKY-FYLVTEFYEGGELFEQIINRHKFDECDAANIMK 153
Query: 442 DVAEGIKFLNDHGVAYRDLNSQRILL---DRHGNVCLGDMGIVTACKS-------VGEAT 491
+ GI +L+ H + +RD+ + ILL + N+ + D G+ + +G
Sbjct: 154 QILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLG--- 210
Query: 492 EYETDGYRWLAPEV 505
T Y +APEV
Sbjct: 211 ---TAYY--IAPEV 219
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 52.9 bits (127), Expect = 1e-07
Identities = 49/225 (21%), Positives = 76/225 (33%), Gaps = 52/225 (23%)
Query: 311 PSSSFVVSVDEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGC 370
P F+ S+ + +Q E + D +G F V+ + KL C
Sbjct: 158 PFQEFLDSLYFLRFLQWKWLEAQP--MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYAC 215
Query: 371 DKGNAYEFELRKDLL-----ELMTCGHKNILQ----------FYCVCVDENHGLCVVTKL 415
K L K L K IL Y + LC+V +
Sbjct: 216 KK-------LNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTD--LCLVMTI 266
Query: 416 MEGGSVNDLILKSRKLQTKEII----RIAIDVAE---GIKFLNDHGVAYRDLNSQRILLD 468
M GG D+ + R A+ G++ L+ + YRDL + +LLD
Sbjct: 267 MNGG---DIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLD 323
Query: 469 RHGNVCLGDMGIVTACKSVGEATEYE--------TDGYRWLAPEV 505
GNV + D+G+ E + T G+ +APE+
Sbjct: 324 DDGNVRISDLGL---AV---ELKAGQTKTKGYAGTPGF--MAPEL 360
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 3e-07
Identities = 25/126 (19%), Positives = 49/126 (38%), Gaps = 18/126 (14%)
Query: 387 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEG 446
L +++ D ++ L +V + + GG + + + + A +
Sbjct: 95 LQAVNFPFLVKLEFSFKDNSN-LYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT 153
Query: 447 IKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT-------EYETDGYR 499
++L+ + YRDL + +L+D+ G + + D G K V T E
Sbjct: 154 FEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGF---AKRVKGRTWTLCGTPEA------ 204
Query: 500 WLAPEV 505
LAPE+
Sbjct: 205 -LAPEI 209
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 51.0 bits (123), Expect = 4e-07
Identities = 21/70 (30%), Positives = 35/70 (50%), Gaps = 17/70 (24%)
Query: 443 VAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT-------EYET 495
V +++L+ + YRDL + ILLD++G++ + D G K V + T +Y
Sbjct: 115 VCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGF---AKYVPDVTYTLCGTPDY-- 169
Query: 496 DGYRWLAPEV 505
+APEV
Sbjct: 170 -----IAPEV 174
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 51.4 bits (123), Expect = 4e-07
Identities = 21/118 (17%), Positives = 47/118 (39%), Gaps = 7/118 (5%)
Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQT-KEIIRIAIDVAEGIKFL 450
H ++ + D+N + ++ + M GG + + + + E + V +G+ +
Sbjct: 213 HPTLVNLHDAFEDDNE-MVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHM 271
Query: 451 NDHGVAYRDLNSQRILL-DRHGN-VCLGDMGIVTACKSVGEATE-YETDGYRWLAPEV 505
+++ + DL + I+ + N + L D G+ T + APEV
Sbjct: 272 HENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEF--AAPEV 327
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 4e-07
Identities = 20/119 (16%), Positives = 43/119 (36%), Gaps = 12/119 (10%)
Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN 451
+++ + + L V +L+ G + ++ + L + I + + +
Sbjct: 93 EPHVVPIHDFGEIDGQ-LYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAH 151
Query: 452 DHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG------YRWLAPE 504
G +RD+ + IL+ L D GI +A + + Y +APE
Sbjct: 152 AAGATHRDVKPENILVSADDFAYLVDFGIASA---TTDEKLTQLGNTVGTLYY--MAPE 205
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 5e-07
Identities = 44/178 (24%), Positives = 79/178 (44%), Gaps = 14/178 (7%)
Query: 339 SDNLEFIDQIGPNSFKGVYKG--KRVGIEK-LKGCDKGNAYEFELRKDLLE----LMTCG 391
SD + +G SF V K G E +K K + ++ LL L
Sbjct: 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN 451
H NI++ Y D+ + +V ++ GG + D I+ ++ + RI V GI +++
Sbjct: 85 HPNIMKLYEFFEDKGY-FYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMH 143
Query: 452 DHGVAYRDLNSQRILL---DRHGNVCLGDMGIVTACKSVGEATEY-ETDGYRWLAPEV 505
+ + +RDL + +LL + N+ + D G+ T ++ + + T Y +APEV
Sbjct: 144 KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYY--IAPEV 199
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 5e-07
Identities = 37/166 (22%), Positives = 68/166 (40%), Gaps = 37/166 (22%)
Query: 340 DNLEFIDQIGPNSFKGVYK-------GKRVGIEKLKGCDKGNAYEFE--------LR--K 382
E + +IG ++ V+K G+ V +++++ + +R
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVR-------VQTGEEGMPLSTIREVA 63
Query: 383 DLLELMTCGHKNILQFYCVCV----DENHGLCVVTKLMEGGSVNDL-----ILKSRKLQT 433
L L T H N+++ + VC D L +V + ++ DL + + T
Sbjct: 64 VLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD----QDLTTYLDKVPEPGVPT 119
Query: 434 KEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMG 479
+ I + + G+ FL+ H V +RDL Q IL+ G + L D G
Sbjct: 120 ETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFG 165
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 5e-07
Identities = 27/136 (19%), Positives = 60/136 (44%), Gaps = 7/136 (5%)
Query: 339 SDNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGH 392
S+ + + ++G ++ V I+ ++ + +L +++ L H
Sbjct: 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95
Query: 393 KNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLND 452
NI++ Y D+ + +V + +GG + D I+ K + I V G+ +L+
Sbjct: 96 PNIMKLYDFFEDKRN-YYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHK 154
Query: 453 HGVAYRDLNSQRILLD 468
H + +RDL + +LL+
Sbjct: 155 HNIVHRDLKPENLLLE 170
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 49.9 bits (120), Expect = 6e-07
Identities = 24/88 (27%), Positives = 43/88 (48%), Gaps = 1/88 (1%)
Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN 451
H +I++ Y V +V + + GG + D I K +++ E R+ + + + +
Sbjct: 70 HPHIIKLYQVISTPTD-FFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCH 128
Query: 452 DHGVAYRDLNSQRILLDRHGNVCLGDMG 479
H V +RDL + +LLD H N + D G
Sbjct: 129 RHMVVHRDLKPENVLLDAHMNAKIADFG 156
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 50.4 bits (120), Expect = 7e-07
Identities = 13/138 (9%), Positives = 33/138 (23%), Gaps = 11/138 (7%)
Query: 377 EFELRKDLLELMTCGHKNILQFYCVCVDENHG-LCVVTKLMEG------GSVNDLILKSR 429
L + Q D ++ +++ + +
Sbjct: 130 RRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRG 189
Query: 430 KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE 489
+ + + L G+ + + + G + LGD+ + + G
Sbjct: 190 DEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGP 249
Query: 490 ATEYETDGYRWLAPEVCF 507
A+ AP
Sbjct: 250 ASS----VPVTYAPREFL 263
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 49.9 bits (120), Expect = 7e-07
Identities = 34/129 (26%), Positives = 61/129 (47%), Gaps = 19/129 (14%)
Query: 387 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEG 446
L H NI++ + + D + +V +L GG + D I+K ++ + RI V G
Sbjct: 75 LKKLDHPNIMKLFEILEDSSS-FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSG 133
Query: 447 IKFLNDHGVAYRDLNSQRILL---DRHGNVCLGDMGIVTACKS-------VGEATEYETD 496
I +++ H + +RDL + ILL ++ ++ + D G+ T + +G T
Sbjct: 134 ITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIG------TA 187
Query: 497 GYRWLAPEV 505
Y +APEV
Sbjct: 188 YY--IAPEV 194
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 49.9 bits (120), Expect = 9e-07
Identities = 33/137 (24%), Positives = 53/137 (38%), Gaps = 16/137 (11%)
Query: 353 FKGVYKGKRVGIEKLKGCDKGNAY----EFELRKDLLELMTCG---HKNILQFYCVCVDE 405
+KG V ++KL +F E+ H+N+++ D
Sbjct: 48 YKGYVNNTTVAVKKLAAMVDITTEELKQQF-----DQEIKVMAKCQHENLVELLGFSSDG 102
Query: 406 NHGLCVVTKLMEGGSVNDLILKSRKLQT---KEIIRIAIDVAEGIKFLNDHGVAYRDLNS 462
+ LC+V M GS+ D + +IA A GI FL+++ +RD+ S
Sbjct: 103 DD-LCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKS 161
Query: 463 QRILLDRHGNVCLGDMG 479
ILLD + D G
Sbjct: 162 ANILLDEAFTAKISDFG 178
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 9e-07
Identities = 31/126 (24%), Positives = 59/126 (46%), Gaps = 14/126 (11%)
Query: 387 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEG 446
L H I++ E++ + V +LMEGG + D ++ +++L+ +
Sbjct: 69 LKKLNHPCIIKIKNFFDAEDYYI--VLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLA 126
Query: 447 IKFLNDHGVAYRDLNSQRILLDRHG---NVCLGDMGIVTACKSVGEATEYETD----GYR 499
+++L+++G+ +RDL + +LL + + D G K +GE + T Y
Sbjct: 127 VQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGH---SKILGETSLMRTLCGTPTY- 182
Query: 500 WLAPEV 505
LAPEV
Sbjct: 183 -LAPEV 187
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 1e-06
Identities = 25/105 (23%), Positives = 49/105 (46%), Gaps = 17/105 (16%)
Query: 409 LCVVTKLMEGGSVNDL---ILKSRKLQTKEIIRI-AIDVAEGIKFLNDHGVAYRDLNSQR 464
+ +V L+ GG DL + ++ +E +++ ++ + +L + + +RD+
Sbjct: 90 MFMVVDLLLGG---DLRYHLQQNVHF-KEETVKLFICELVMALDYLQNQRIIHRDMKPDN 145
Query: 465 ILLDRHGNVCLGDMGIVTACKSVGEATEYE----TDGYRWLAPEV 505
ILLD HG+V + D I + T+ T Y +APE+
Sbjct: 146 ILLDEHGHVHITDFNI---AAMLPRETQITTMAGTKPY--MAPEM 185
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 48.7 bits (117), Expect = 1e-06
Identities = 22/108 (20%), Positives = 53/108 (49%), Gaps = 2/108 (1%)
Query: 360 KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGG 419
K + +L +G + E E+ +++ L H NI+ + + ++ + ++ +L+ GG
Sbjct: 36 KFIKKRRLSSSRRGVSRE-EIEREVNILREIRHPNIITLHDIFENKTD-VVLILELVSGG 93
Query: 420 SVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILL 467
+ D + + L E + + +G+ +L+ +A+ DL + I+L
Sbjct: 94 ELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIML 141
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 49.8 bits (119), Expect = 1e-06
Identities = 27/88 (30%), Positives = 47/88 (53%), Gaps = 1/88 (1%)
Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN 451
H +I++ Y V + + +V + + GG + D I K+ +L KE R+ + G+ + +
Sbjct: 75 HPHIIKLYQVISTPSD-IFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCH 133
Query: 452 DHGVAYRDLNSQRILLDRHGNVCLGDMG 479
H V +RDL + +LLD H N + D G
Sbjct: 134 RHMVVHRDLKPENVLLDAHMNAKIADFG 161
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 27/149 (18%), Positives = 54/149 (36%), Gaps = 12/149 (8%)
Query: 343 EFIDQIGPNSFKGVYKGKRVG---------IEKLKGCDKGNAYEFELRKDLLE---LMTC 390
+ +G +F V+ I+K K + + +L K LE L
Sbjct: 27 STMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRV 86
Query: 391 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFL 450
H NI++ + ++ V+ K G + I + +L I + + +L
Sbjct: 87 EHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYL 146
Query: 451 NDHGVAYRDLNSQRILLDRHGNVCLGDMG 479
+ +RD+ + I++ + L D G
Sbjct: 147 RLKDIIHRDIKDENIVIAEDFTIKLIDFG 175
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 49.9 bits (119), Expect = 2e-06
Identities = 27/93 (29%), Positives = 43/93 (46%), Gaps = 10/93 (10%)
Query: 416 ME---GGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGN 472
ME G S+ +KL E I +++ + +L+ G+ Y DL + I+L
Sbjct: 163 MEYVGGQSLKRSK--GQKLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEEQ- 219
Query: 473 VCLGDMGIVTACKSVGEATEYETDGYRWLAPEV 505
+ L D+G V+ S G Y T G+ APE+
Sbjct: 220 LKLIDLGAVSRINSFGYL--YGTPGF--QAPEI 248
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 23/118 (19%), Positives = 50/118 (42%), Gaps = 7/118 (5%)
Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL-KSRKLQTKEIIRIAIDVAEGIKFL 450
H ++ + D+ + ++ + + GG + D I + K+ E+I EG+K +
Sbjct: 107 HPKLINLHDAFEDKYE-MVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHM 165
Query: 451 NDHGVAYRDLNSQRILLDRHGN--VCLGDMGIVTACKSVGEATE-YETDGYRWLAPEV 505
++H + + D+ + I+ + V + D G+ T T + APE+
Sbjct: 166 HEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEF--AAPEI 221
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 2e-06
Identities = 24/119 (20%), Positives = 49/119 (41%), Gaps = 7/119 (5%)
Query: 391 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL-KSRKLQTKEIIRIAIDVAEGIKF 449
H+NIL + L ++ + + G + + I + +L +EI+ V E ++F
Sbjct: 59 RHRNILHLHESFESMEE-LVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQF 117
Query: 450 LNDHGVAYRDLNSQRILLDRHGN--VCLGDMGIVTACKSVGEATE-YETDGYRWLAPEV 505
L+ H + + D+ + I+ + + + + G K + Y APEV
Sbjct: 118 LHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEY--YAPEV 174
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 48.7 bits (117), Expect = 2e-06
Identities = 30/129 (23%), Positives = 53/129 (41%), Gaps = 19/129 (14%)
Query: 387 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEG 446
+ + H NI++ Y D + +V +L GG + + ++ R + + RI DV
Sbjct: 60 MKSLDHPNIIRLYETFEDNTD-IYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSA 118
Query: 447 IKFLNDHGVAYRDLNSQRILL---DRHGNVCLGDMGIVTACKS-------VGEATEYETD 496
+ + + VA+RDL + L + L D G+ K VG T
Sbjct: 119 VAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVG------TP 172
Query: 497 GYRWLAPEV 505
Y ++P+V
Sbjct: 173 YY--VSPQV 179
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 48.7 bits (117), Expect = 2e-06
Identities = 21/88 (23%), Positives = 42/88 (47%), Gaps = 1/88 (1%)
Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN 451
H+N+++FY + N + + GG + D I + + R + G+ +L+
Sbjct: 64 HENVVKFYGHRREGNI-QYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 452 DHGVAYRDLNSQRILLDRHGNVCLGDMG 479
G+ +RD+ + +LLD N+ + D G
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFG 150
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 2e-06
Identities = 28/124 (22%), Positives = 51/124 (41%), Gaps = 8/124 (6%)
Query: 387 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEG 446
H NI++ + +E H ++ L+ GG + + I+ + + E
Sbjct: 64 CRLLKHPNIVRLHDSISEEGH-HYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEA 122
Query: 447 IKFLNDHGVAYRDLNSQRILL---DRHGNVCLGDMGIVTACKSVGEA--TEYETDGYRWL 501
+ + GV +R+L + +LL + V L D G+ + +A T GY L
Sbjct: 123 VLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGY--L 180
Query: 502 APEV 505
+PEV
Sbjct: 181 SPEV 184
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 30/151 (19%), Positives = 67/151 (44%), Gaps = 9/151 (5%)
Query: 360 KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGG 419
K + + + +G E E+ +++ L H NI+ + V + + ++ +L+ GG
Sbjct: 43 KFIKKRQSRASRRGVCRE-EIEREVSILRQVLHPNIITLHDVYENRTD-VVLILELVSGG 100
Query: 420 SVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILL----DRHGNVCL 475
+ D + + L +E + +G+ +L+ +A+ DL + I+L ++ L
Sbjct: 101 ELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKL 160
Query: 476 GDMGIVTACKSVGEATE-YETDGYRWLAPEV 505
D G+ + E + T + +APE+
Sbjct: 161 IDFGLAHEIEDGVEFKNIFGTPEF--VAPEI 189
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 2e-06
Identities = 24/119 (20%), Positives = 54/119 (45%), Gaps = 8/119 (6%)
Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN 451
H N++ + V + + ++ +L+ GG + D + + L +E + +G+ +L+
Sbjct: 74 HHNVITLHDVYENRTD-VVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH 132
Query: 452 DHGVAYRDLNSQRILLDRH----GNVCLGDMGIVTACKSVGEATE-YETDGYRWLAPEV 505
+A+ DL + I+L ++ L D G+ + E + T + +APE+
Sbjct: 133 TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEF--VAPEI 189
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 3e-06
Identities = 40/158 (25%), Positives = 67/158 (42%), Gaps = 27/158 (17%)
Query: 338 NSDNLEFIDQIGPNSFKGVYKG-----KRVGIEKLK-GCDKGNAYEFELRKDLLELMTCG 391
++ N+ +G F VYKG V +++LK +G +F E+
Sbjct: 33 SNKNI-----LGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQF-----QTEVEMIS 82
Query: 392 ---HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTK---EI-IRIAIDVA 444
H+N+L+ C+ +V M GSV + + + Q RIA+ A
Sbjct: 83 MAVHRNLLRLRGFCMTPTE-RLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSA 141
Query: 445 EGIKFLNDHG---VAYRDLNSQRILLDRHGNVCLGDMG 479
G+ +L+DH + +RD+ + ILLD +GD G
Sbjct: 142 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 179
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 3e-06
Identities = 31/110 (28%), Positives = 47/110 (42%), Gaps = 26/110 (23%)
Query: 409 LCVVTKLMEGGSVNDL---ILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRI 465
L V + + GG DL I K A ++ G++FL+ G+ YRDL I
Sbjct: 93 LFFVMEYLNGG---DLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNI 149
Query: 466 LLDRHGNVCLGDMGIVTACK---SVGEAT-------EYETDGYRWLAPEV 505
LLD+ G++ + D G+ CK T +Y +APE+
Sbjct: 150 LLDKDGHIKIADFGM---CKENMLGDAKTNTFCGTPDY-------IAPEI 189
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 3e-06
Identities = 30/136 (22%), Positives = 61/136 (44%), Gaps = 7/136 (5%)
Query: 339 SDNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGH 392
++ + +G SF V K + ++ + N + +++ L H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 393 KNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLND 452
NI++ + + D + +V +L GG + D I+K ++ + RI V GI +++
Sbjct: 81 PNIMKLFEILEDSSS-FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHK 139
Query: 453 HGVAYRDLNSQRILLD 468
H + +RDL + ILL+
Sbjct: 140 HNIVHRDLKPENILLE 155
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 3e-06
Identities = 35/166 (21%), Positives = 67/166 (40%), Gaps = 39/166 (23%)
Query: 340 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKD------LLE- 386
E + +IG +F V+K G++V ++K+ E K+ L E
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL---------MENEKEGFPITALREI 67
Query: 387 --LMTCGHKNILQFYCVCVDENHGLCV-------VTKLMEGGSVNDL--ILKSR--KLQT 433
L H+N++ +C + V E +DL +L + K
Sbjct: 68 KILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCE----HDLAGLLSNVLVKFTL 123
Query: 434 KEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMG 479
EI R+ + G+ +++ + + +RD+ + +L+ R G + L D G
Sbjct: 124 SEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFG 169
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 48.9 bits (116), Expect = 3e-06
Identities = 30/110 (27%), Positives = 49/110 (44%), Gaps = 26/110 (23%)
Query: 409 LCVVTKLMEGGSVNDL---ILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRI 465
L V + + GG DL I + + + + A ++A G+ FL G+ YRDL +
Sbjct: 417 LYFVMEYVNGG---DLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNV 473
Query: 466 LLDRHGNVCLGDMGIVTACK---SVGEAT-------EYETDGYRWLAPEV 505
+LD G++ + D G+ CK G T +Y +APE+
Sbjct: 474 MLDSEGHIKIADFGM---CKENIWDGVTTKTFCGTPDY-------IAPEI 513
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 4e-06
Identities = 21/88 (23%), Positives = 42/88 (47%), Gaps = 1/88 (1%)
Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN 451
H+N+++FY + N + + GG + D I + + R + G+ +L+
Sbjct: 64 HENVVKFYGHRREGNI-QYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 122
Query: 452 DHGVAYRDLNSQRILLDRHGNVCLGDMG 479
G+ +RD+ + +LLD N+ + D G
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFG 150
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 4e-06
Identities = 34/130 (26%), Positives = 56/130 (43%), Gaps = 12/130 (9%)
Query: 385 LELMTCGHKNILQFYCVCVDENHG---LCVVTKLMEGGSVNDLILKSRKLQT---KEIIR 438
G +I+ V + +HG L ++ + MEGG + I + R Q +E
Sbjct: 74 HHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQE-RGDQAFTEREAAE 132
Query: 439 IAIDVAEGIKFLNDHGVAYRDLNSQRILL---DRHGNVCLGDMGIVTACKSVGEATEYET 495
I D+ I+FL+ H +A+RD+ + +L ++ + L D G T T
Sbjct: 133 IMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYT 192
Query: 496 DGYRWLAPEV 505
Y +APEV
Sbjct: 193 PYY--VAPEV 200
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 4e-06
Identities = 29/118 (24%), Positives = 54/118 (45%), Gaps = 7/118 (5%)
Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL-KSRKLQTKEIIRIAIDVAEGIKFL 450
H N++Q Y +N + +V + ++GG + D I+ +S L + I + EGI+ +
Sbjct: 145 HANLIQLYDAFESKND-IVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHM 203
Query: 451 NDHGVAYRDLNSQRILLDRHGN--VCLGDMGIVTACKSVGEATE-YETDGYRWLAPEV 505
+ + + DL + IL + + D G+ K + + T + LAPEV
Sbjct: 204 HQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEF--LAPEV 259
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 4e-06
Identities = 34/110 (30%), Positives = 48/110 (43%), Gaps = 26/110 (23%)
Query: 409 LCVVTKLMEGGSVNDL---ILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRI 465
L V + + GG DL I KSR+ A ++ + FL+D G+ YRDL +
Sbjct: 99 LFFVMEFVNGG---DLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNV 155
Query: 466 LLDRHGNVCLGDMGIVTACK---SVGEAT-------EYETDGYRWLAPEV 505
LLD G+ L D G+ CK G T +Y +APE+
Sbjct: 156 LLDHEGHCKLADFGM---CKEGICNGVTTATFCGTPDY-------IAPEI 195
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 47.6 bits (114), Expect = 5e-06
Identities = 21/89 (23%), Positives = 43/89 (48%), Gaps = 2/89 (2%)
Query: 392 HKNILQFYCVCVDEN-HGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFL 450
H N+++ V D N L +V +L+ G V ++ L + D+ +GI++L
Sbjct: 95 HPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKP-LSEDQARFYFQDLIKGIEYL 153
Query: 451 NDHGVAYRDLNSQRILLDRHGNVCLGDMG 479
+ + +RD+ +L+ G++ + D G
Sbjct: 154 HYQKIIHRDIKPSNLLVGEDGHIKIADFG 182
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 5e-06
Identities = 24/90 (26%), Positives = 46/90 (51%), Gaps = 6/90 (6%)
Query: 392 HKNILQFYCVCVDENHGLCVVTKLME--GGSVNDLILKSRKLQTKEIIRIAIDVAEGIKF 449
H +I++ Y V + +V +E GG + D I++ +++ E R + I++
Sbjct: 68 HPHIIKLYDVITTPTD-IVMV---IEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEY 123
Query: 450 LNDHGVAYRDLNSQRILLDRHGNVCLGDMG 479
+ H + +RDL + +LLD + NV + D G
Sbjct: 124 CHRHKIVHRDLKPENLLLDDNLNVKIADFG 153
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 47.2 bits (113), Expect = 5e-06
Identities = 23/119 (19%), Positives = 52/119 (43%), Gaps = 8/119 (6%)
Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN 451
H N++ + V ++ + ++ +L+ GG + D + + L +E + G+ +L+
Sbjct: 73 HPNVITLHEVYENKTD-VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131
Query: 452 DHGVAYRDLNSQRILL----DRHGNVCLGDMGIVTACKSVGEATE-YETDGYRWLAPEV 505
+A+ DL + I+L + + D G+ E + T + +APE+
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEF--VAPEI 188
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 47.2 bits (113), Expect = 5e-06
Identities = 28/129 (21%), Positives = 51/129 (39%), Gaps = 19/129 (14%)
Query: 387 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEG 446
H NI++ + +E+ +V L+ GG + + I+ + + E
Sbjct: 59 CRKLQHPNIVRLHDSIQEESF-HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILES 117
Query: 447 IKFLNDHGVAYRDLNSQRILL---DRHGNVCLGDMGIVTACKS-------VGEATEYETD 496
I + + +G+ +R+L + +LL + V L D G+ G T
Sbjct: 118 IAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAG------TP 171
Query: 497 GYRWLAPEV 505
GY L+PEV
Sbjct: 172 GY--LSPEV 178
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 5e-06
Identities = 38/177 (21%), Positives = 76/177 (42%), Gaps = 17/177 (9%)
Query: 339 SDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGC---DKGNAYEFELRKDLLELMTCGHKNI 395
SD E ++G + VY+ K+ G +K K + +R ++ L+ H NI
Sbjct: 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKK-IVRTEIGVLLRLSHPNI 110
Query: 396 LQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGV 455
++ + + +V +L+ GG + D I++ ++ + E + +L+++G+
Sbjct: 111 IKLKEIFETPTE-ISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGI 169
Query: 456 AYRDLNSQRILL---DRHGNVCLGDMGIVTACKSVGEATEYE----TDGYRWLAPEV 505
+RDL + +L + + D G+ K V + T GY APE+
Sbjct: 170 VHRDLKPENLLYATPAPDAPLKIADFGL---SKIVEHQVLMKTVCGTPGY--CAPEI 221
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 6e-06
Identities = 24/73 (32%), Positives = 33/73 (45%), Gaps = 20/73 (27%)
Query: 443 VAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK---SVGEAT-------E 492
+A + +L+ + YRDL + ILLD G++ L D G+ CK T E
Sbjct: 148 IASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGL---CKENIEHNSTTSTFCGTPE 204
Query: 493 YETDGYRWLAPEV 505
Y LAPEV
Sbjct: 205 Y-------LAPEV 210
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 47.2 bits (113), Expect = 7e-06
Identities = 44/161 (27%), Positives = 69/161 (42%), Gaps = 30/161 (18%)
Query: 338 NSDNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFE-------LR--K 382
+ E +D +G F VYK + V I+K+K G+ E + LR K
Sbjct: 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIK---LGHRSEAKDGINRTALREIK 64
Query: 383 DLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDL--ILKSRK--LQTKEIIR 438
L EL H NI+ ++ + +V ME DL I+K L I
Sbjct: 65 LLQEL---SHPNIIGLLDAFGHKS-NISLVFDFME----TDLEVIIKDNSLVLTPSHIKA 116
Query: 439 IAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMG 479
+ +G+++L+ H + +RDL +LLD +G + L D G
Sbjct: 117 YMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFG 157
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 47.2 bits (113), Expect = 7e-06
Identities = 21/73 (28%), Positives = 35/73 (47%), Gaps = 20/73 (27%)
Query: 443 VAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK---SVGEAT-------E 492
+ +++L+ V YRD+ + ++LD+ G++ + D G+ CK S G E
Sbjct: 114 IVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGL---CKEGISDGATMKTFCGTPE 170
Query: 493 YETDGYRWLAPEV 505
Y LAPEV
Sbjct: 171 Y-------LAPEV 176
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 46.8 bits (112), Expect = 8e-06
Identities = 33/191 (17%), Positives = 72/191 (37%), Gaps = 42/191 (21%)
Query: 340 DNLEFIDQIGPNSFKGVYKGKRVGIEK---LKGCDKGNAYEFELRKDLLE--------LM 388
++ +F +G SF V + + + +K +K ++++ + +
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEK----RHIIKENKVPYVTRERDVMS 85
Query: 389 TCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKL---QTK----EIIRIAI 441
H ++ Y D+ L + G + I K T+ EI+ A+
Sbjct: 86 RLDHPFFVKLYFTFQDDEK-LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV-SAL 143
Query: 442 DVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYE------- 494
+ +L+ G+ +RDL + ILL+ ++ + D G K + ++
Sbjct: 144 E------YLHGKGIIHRDLKPENILLNEDMHIQITDFGT---AKVLSPESKQARANSFVG 194
Query: 495 TDGYRWLAPEV 505
T Y ++PE+
Sbjct: 195 TAQY--VSPEL 203
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 46.8 bits (112), Expect = 8e-06
Identities = 40/180 (22%), Positives = 75/180 (41%), Gaps = 30/180 (16%)
Query: 343 EFIDQIGPNSFKGVYK------GKRVG---IEKLKGCDKGNAYEFELRKDLLELMTCGHK 393
F++ +G +F V+ GK I+K + L ++ L H+
Sbjct: 12 IFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSS-----LENEIAVLKKIKHE 66
Query: 394 NILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDH 453
NI+ + H +V +L+ GG + D IL+ K+ + V +K+L+++
Sbjct: 67 NIVTLEDIYESTTH-YYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHEN 125
Query: 454 GVAYRDLNSQRILL---DRHGNVCLGDMGIVTACKSVGEATEYETD-----GYRWLAPEV 505
G+ +RDL + +L + + + + D G+ S E + GY +APEV
Sbjct: 126 GIVHRDLKPENLLYLTPEENSKIMITDFGL-----SKMEQNGIMSTACGTPGY--VAPEV 178
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 46.4 bits (111), Expect = 1e-05
Identities = 24/75 (32%), Positives = 34/75 (45%), Gaps = 23/75 (30%)
Query: 444 AE---GIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK---SVGEAT------ 491
AE + L+ G+ YRDL + I+L+ G+V L D G+ CK G T
Sbjct: 128 AEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGL---CKESIHDGTVTHTFCGT 184
Query: 492 -EYETDGYRWLAPEV 505
EY +APE+
Sbjct: 185 IEY-------MAPEI 192
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 1e-05
Identities = 30/110 (27%), Positives = 49/110 (44%), Gaps = 26/110 (23%)
Query: 409 LCVVTKLMEGGSVNDL---ILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRI 465
L V + + GG DL I + + + + A ++A G+ FL G+ YRDL +
Sbjct: 96 LYFVMEYVNGG---DLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNV 152
Query: 466 LLDRHGNVCLGDMGIVTACK---SVGEAT-------EYETDGYRWLAPEV 505
+LD G++ + D G+ CK G T +Y +APE+
Sbjct: 153 MLDSEGHIKIADFGM---CKENIWDGVTTKTFCGTPDY-------IAPEI 192
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 1e-05
Identities = 28/124 (22%), Positives = 51/124 (41%), Gaps = 19/124 (15%)
Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN 451
H NI++ + +E+ +V L+ GG + + I+ + + E I + +
Sbjct: 87 HPNIVRLHDSIQEESF-HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCH 145
Query: 452 DHGVAYRDLNSQRILL---DRHGNVCLGDMGIVTACKS-------VGEATEYETDGYRWL 501
+G+ +R+L + +LL + V L D G+ G T GY L
Sbjct: 146 SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAG------TPGY--L 197
Query: 502 APEV 505
+PEV
Sbjct: 198 SPEV 201
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 46.4 bits (111), Expect = 1e-05
Identities = 35/158 (22%), Positives = 66/158 (41%), Gaps = 32/158 (20%)
Query: 340 DNLEFIDQIGPNSFKGVYK-----GKRVGIEKLKGCDKGNAYEFELRKD------LLE-- 386
+ + ++++G ++ VYK G+ V +++++ + + + E
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIR---------LDAEDEGIPSTAIREIS 71
Query: 387 -LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDL--ILKSRK--LQTKEIIRIAI 441
L H NI+ V E L +V + ME DL +L K LQ +I
Sbjct: 72 LLKELHHPNIVSLIDVIHSERC-LTLVFEFME----KDLKKVLDENKTGLQDSQIKIYLY 126
Query: 442 DVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMG 479
+ G+ + H + +RDL Q +L++ G + L D G
Sbjct: 127 QLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFG 164
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 46.0 bits (110), Expect = 1e-05
Identities = 34/158 (21%), Positives = 68/158 (43%), Gaps = 32/158 (20%)
Query: 340 DNLEFIDQIGPNSFKGVYK-----GKRVGIEKLKGCDKGNAYEFELRKD------LLE-- 386
+ +++IG ++ VYK G+ ++K++ E + + E
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIR---------LEKEDEGIPSTTIREIS 52
Query: 387 -LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDL--ILKSRK--LQTKEIIRIAI 441
L H NI++ Y V + L +V + ++ DL +L + L++ +
Sbjct: 53 ILKELKHSNIVKLYDVIHTKKR-LVLVFEHLD----QDLKKLLDVCEGGLESVTAKSFLL 107
Query: 442 DVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMG 479
+ GI + +D V +RDL Q +L++R G + + D G
Sbjct: 108 QLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFG 145
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 46.0 bits (110), Expect = 1e-05
Identities = 36/163 (22%), Positives = 69/163 (42%), Gaps = 40/163 (24%)
Query: 340 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKD------LLE- 386
+N + +++IG ++ VYK G+ V ++K++ + + + E
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR---------LDTETEGVPSTAIREI 53
Query: 387 --LMTCGHKNILQFYCVCVDENHGLCVV--------TKLMEGGSVNDLILKSRKLQTKEI 436
L H NI++ V EN L +V K M+ ++ + L K ++
Sbjct: 54 SLLKELNHPNIVKLLDVIHTENK-LYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL 112
Query: 437 IRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMG 479
++ G+ F + H V +RDL Q +L++ G + L D G
Sbjct: 113 LQ-------GLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFG 148
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 2e-05
Identities = 28/124 (22%), Positives = 56/124 (45%), Gaps = 15/124 (12%)
Query: 391 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK--LQTKEIIRIAIDVAEGIK 448
++ + V + + + ++ + GG + L L + ++IR+ + EG+
Sbjct: 87 SCPRVINLHEVYENTSE-IILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVY 145
Query: 449 FLNDHGVAYRDLNSQRILL---DRHGNVCLGDMGIVTACKSVGEATEYE----TDGYRWL 501
+L+ + + + DL Q ILL G++ + D G+ + +G A E T Y L
Sbjct: 146 YLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGM---SRKIGHACELREIMGTPEY--L 200
Query: 502 APEV 505
APE+
Sbjct: 201 APEI 204
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 26/151 (17%), Positives = 55/151 (36%), Gaps = 12/151 (7%)
Query: 364 IEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVND 423
++ K +L+++ H +I++ + L +V + M+G +
Sbjct: 57 VDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGM-LYMVFEFMDGADLCF 115
Query: 424 LILKSRKLQT----KEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILL---DRHGNVCLG 476
I+K + E +++ +D+ + +RD+ +LL + V LG
Sbjct: 116 EIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLG 175
Query: 477 DMGIVTACKSVGEA--TEYETDGYRWLAPEV 505
G+ G T + +APEV
Sbjct: 176 GFGVAIQLGESGLVAGGRVGTPHF--MAPEV 204
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 45.6 bits (109), Expect = 2e-05
Identities = 48/219 (21%), Positives = 82/219 (37%), Gaps = 60/219 (27%)
Query: 325 VQSGGEEIGRWLLNSDNLEFIDQIGPNSF-------KGVYKGKRVGIEKLKGCDKGNAYE 377
++ +EI + E ++ P+ F +G + GK ++K+ G D Y
Sbjct: 1 MEGSIKEIA---ITHHVKEGHEKADPSQFELLKVLGQGSF-GKVFLVKKISGSDARQLYA 56
Query: 378 FE-LRKDLL----ELMTCGHKNILQ----------FYCVCVDENHGLCVVTKLMEGGSVN 422
+ L+K L + T ++IL Y + L ++ + GG
Sbjct: 57 MKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGK--LYLILDFLRGG--- 111
Query: 423 DL---ILKSRKLQTKEIIRIAIDVAE---GIKFLNDHGVAYRDLNSQRILLDRHGNVCLG 476
DL + K + + +AE + L+ G+ YRDL + ILLD G++ L
Sbjct: 112 DLFTRLSKEVMFTEE---DVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLT 168
Query: 477 DMGIVTACK---SVGEAT-------EYETDGYRWLAPEV 505
D G+ K + EY +APEV
Sbjct: 169 DFGL---SKESIDHEKKAYSFCGTVEY-------MAPEV 197
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 37/137 (27%), Positives = 65/137 (47%), Gaps = 20/137 (14%)
Query: 379 ELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVTKLMEGGSVNDL--ILKSRKL 431
ELR LL+ M H+N++ V ++E + + +VT LM DL I+K +KL
Sbjct: 78 ELR--LLKHMK--HENVIGLLDVFTPARSLEEFNDVYLVTHLMG----ADLNNIVKCQKL 129
Query: 432 QTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT 491
+ + + G+K+++ + +RDL + ++ + + D G+ A + E T
Sbjct: 130 TDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGL--ARHTADEMT 187
Query: 492 EY-ETDGYRWLAPEVCF 507
Y T YR APE+
Sbjct: 188 GYVATRWYR--APEIML 202
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 2e-05
Identities = 31/159 (19%), Positives = 62/159 (38%), Gaps = 34/159 (21%)
Query: 340 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFE-------LR--KDL 384
+ +D++G ++ VYK V +++++ E E +R L
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIR-------LEHEEGAPCTAIREVSLL 54
Query: 385 LELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDL--ILKSRK--LQTKEIIRIA 440
+L H NI+ + + E L +V + ++ DL L + +
Sbjct: 55 KDL---KHANIVTLHDIIHTEKS-LTLVFEYLD----KDLKQYLDDCGNIINMHNVKLFL 106
Query: 441 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMG 479
+ G+ + + V +RDL Q +L++ G + L D G
Sbjct: 107 FQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFG 145
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 2e-05
Identities = 21/73 (28%), Positives = 35/73 (47%), Gaps = 20/73 (27%)
Query: 443 VAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK---SVGEAT-------E 492
++ + +L++ G+ YRDL +LLD G++ L D G+ CK G+ T
Sbjct: 119 ISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGM---CKEGLRPGDTTSTFCGTPN 175
Query: 493 YETDGYRWLAPEV 505
Y +APE+
Sbjct: 176 Y-------IAPEI 181
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 40/201 (19%), Positives = 64/201 (31%), Gaps = 55/201 (27%)
Query: 343 EFIDQIGPNSFKGVY---------KGKRVGIEKLKGCDKGNAYE--FELRKD-------- 383
I G Y +G V I+++
Sbjct: 25 TVQRFIS----SGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 384 -LLELMTCGHKNILQ----FYCVCVDENHGLCVVTKLMEGGSVNDL--ILKSRKLQTKE- 435
LL H NIL F H L +VT+LM DL ++ +++
Sbjct: 81 RLLNHFH--HPNILGLRDIFVHFEEPAMHKLYLVTELMR----TDLAQVIHDQRIVISPQ 134
Query: 436 --------IIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV 487
I+ G+ L++ GV +RDL+ ILL + ++ + D + +
Sbjct: 135 HIQYFMYHILL-------GLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTAD 187
Query: 488 GEATEY-ETDGYRWLAPEVCF 507
T Y YR APE+
Sbjct: 188 ANKTHYVTHRWYR--APELVM 206
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 3e-05
Identities = 28/127 (22%), Positives = 54/127 (42%), Gaps = 17/127 (13%)
Query: 387 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDL--ILKSRKLQTKEIIRIAIDVA 444
+ ++Q + D+ + L +V + M GG DL ++ + + K +V
Sbjct: 123 MAFANSPWVVQLFYAFQDDRY-LYMVMEYMPGG---DLVNLMSNYDVPEKWARFYTAEVV 178
Query: 445 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETD---G---Y 498
+ ++ G +RD+ +LLD+ G++ L D G C + + D G Y
Sbjct: 179 LALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGT---CMKMNKEGMVRCDTAVGTPDY 235
Query: 499 RWLAPEV 505
++PEV
Sbjct: 236 --ISPEV 240
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 3e-05
Identities = 21/76 (27%), Positives = 33/76 (43%), Gaps = 24/76 (31%)
Query: 444 AE---GIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK----SVGEAT----- 491
E ++ L+ G+ YRD+ + ILLD +G+V L D G+ K E
Sbjct: 166 GEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGL---SKEFVADETERAYDFCG 222
Query: 492 --EYETDGYRWLAPEV 505
EY +AP++
Sbjct: 223 TIEY-------MAPDI 231
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 45.2 bits (108), Expect = 3e-05
Identities = 32/159 (20%), Positives = 66/159 (41%), Gaps = 33/159 (20%)
Query: 340 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKD------LLE- 386
E +++IG ++ V+K + V +++++ + + L E
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR---------LDDDDEGVPSSALREI 52
Query: 387 --LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDL--ILKSRK--LQTKEIIRIA 440
L HKNI++ + V + L +V + + DL S L + +
Sbjct: 53 CLLKELKHKNIVRLHDVLHSDKK-LTLVFEFCD----QDLKKYFDSCNGDLDPEIVKSFL 107
Query: 441 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMG 479
+ +G+ F + V +RDL Q +L++R+G + L + G
Sbjct: 108 FQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFG 146
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 3e-05
Identities = 21/73 (28%), Positives = 35/73 (47%), Gaps = 20/73 (27%)
Query: 443 VAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK---SVGEAT-------E 492
++ + +L++ G+ YRDL +LLD G++ L D G+ CK G+ T
Sbjct: 162 ISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGM---CKEGLRPGDTTSTFCGTPN 218
Query: 493 YETDGYRWLAPEV 505
Y +APE+
Sbjct: 219 Y-------IAPEI 224
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 4e-05
Identities = 24/104 (23%), Positives = 45/104 (43%), Gaps = 12/104 (11%)
Query: 409 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRI-AIDVAEGIKFLNDHGVAYRDLNSQRILL 467
L +V GG + L+ K +E+ R ++ I ++ +RD+ IL+
Sbjct: 149 LYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILM 208
Query: 468 DRHGNVCLGDMGIVTACKSVGEATEYETD---G---YRWLAPEV 505
D +G++ L D G C + E ++ G Y ++PE+
Sbjct: 209 DMNGHIRLADFGS---CLKLMEDGTVQSSVAVGTPDY--ISPEI 247
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 44.5 bits (106), Expect = 4e-05
Identities = 28/133 (21%), Positives = 55/133 (41%), Gaps = 23/133 (17%)
Query: 387 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQT----KEIIRIAID 442
L + H NI++ + V D ++ + +V + EGG + + I+ ++ + +
Sbjct: 74 LKSLDHPNIIKIFEVFEDYHN-MYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQ 132
Query: 443 VAEGIKFLNDHGVAYRDLNSQRILL---DRHGNVCLGDMGIVTACKS-------VGEATE 492
+ + + + V ++DL + IL H + + D G+ KS G
Sbjct: 133 MMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAG---- 188
Query: 493 YETDGYRWLAPEV 505
T Y +APEV
Sbjct: 189 --TALY--MAPEV 197
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 44.5 bits (106), Expect = 4e-05
Identities = 37/186 (19%), Positives = 71/186 (38%), Gaps = 35/186 (18%)
Query: 340 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFE------LR--KDLL 385
+ E I +IG S+ V+K G+ V I+K + + LR + L
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFL-----ESEDDPVIKKIALREIRMLK 57
Query: 386 ELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDL--ILKSRK--LQTKEIIRIAI 441
+L H N++ V + L +V + + + + L + + + I
Sbjct: 58 QL---KHPNLVNLLEVFRRKRR-LHLVFEYCD----HTVLHELDRYQRGVPEHLVKSITW 109
Query: 442 DVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA-TEY-ETDGYR 499
+ + F + H +RD+ + IL+ +H + L D G + + T YR
Sbjct: 110 QTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYR 169
Query: 500 WLAPEV 505
+PE+
Sbjct: 170 --SPEL 173
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 4e-05
Identities = 33/150 (22%), Positives = 58/150 (38%), Gaps = 21/150 (14%)
Query: 345 IDQIGPNSFKGVYKGKRVG--------IEKLKGCDKGNAYEFELRKDLLELMTCGHKNIL 396
+IG +F + GK + +E +K E+ K L I
Sbjct: 14 GKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQL-----GSGDGIP 68
Query: 397 QFYCVCVDENHGLCVVTKLMEGGSVNDLI-LKSRKLQTKEIIRIAIDVAEGIKFLNDHGV 455
Q Y + V+ L G S+ DL L R K ++ IAI + +++++ +
Sbjct: 69 QVYYFGPCGKYNAMVLELL--GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNL 126
Query: 456 AYRDLNSQRILLDRHGN-----VCLGDMGI 480
YRD+ + L+ R GN + + D +
Sbjct: 127 IYRDVKPENFLIGRPGNKTQQVIHIIDFAL 156
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 4e-05
Identities = 54/283 (19%), Positives = 95/283 (33%), Gaps = 57/283 (20%)
Query: 253 IKKPKPTSVKLPFGLCGCQEENTKGRDFG-EIEEEEACDESFRNGVEN--SNLKIQLQMP 309
++P+P F + Q R F E EE E + ++ LK Q
Sbjct: 65 TERPRPN----TFIIRCLQWTTVIERTFHVETPEE---REEWTTAIQTVADGLKKQAAAE 117
Query: 310 LPSSSFVVSVDEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKL-- 367
+ S S + + + + E++ +G +F V K +
Sbjct: 118 MDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYA 177
Query: 368 -KGCDKGNAYEFELRKDLLELMTCGHKNILQ----------FYCVCVDENHGLCVVTKLM 416
K K + ++ +T +LQ Y + LC V +
Sbjct: 178 MKILKKEVIVA---KDEVAHTLT--ENRVLQNSRHPFLTALKYSFQTHDR--LCFVMEYA 230
Query: 417 EGGSVNDL---ILKSRKLQTKEIIRIAIDVAEGIKFL-NDHGVAYRDLNSQRILLDRHGN 472
GG +L + + R ++ + +L ++ V YRDL + ++LD+ G+
Sbjct: 231 NGG---ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGH 287
Query: 473 VCLGDMGIVTACK---SVGEAT-------EYETDGYRWLAPEV 505
+ + D G+ CK G EY LAPEV
Sbjct: 288 IKITDFGL---CKEGIKDGATMKTFCGTPEY-------LAPEV 320
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 44.1 bits (105), Expect = 6e-05
Identities = 36/142 (25%), Positives = 62/142 (43%), Gaps = 12/142 (8%)
Query: 348 IGPNSFKGVYKG-----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVC 402
IG F VYKG +V +++ EFE + L C H +++ C
Sbjct: 47 IGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETL--SFCRHPHLVSLIGFC 104
Query: 403 VDENHGLCVVTKLMEGGSVNDLILKSRKLQT----KEIIRIAIDVAEGIKFLNDHGVAYR 458
+ N + ++ K ME G++ + S ++ + I I A G+ +L+ + +R
Sbjct: 105 DERNE-MILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHR 163
Query: 459 DLNSQRILLDRHGNVCLGDMGI 480
D+ S ILLD + + D GI
Sbjct: 164 DVKSINILLDENFVPKITDFGI 185
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 6e-05
Identities = 29/131 (22%), Positives = 51/131 (38%), Gaps = 25/131 (19%)
Query: 391 GHKNILQFYCVCVDENHG---LCVVTKLMEGGSVNDLILKSRKLQT---KEIIRIAIDVA 444
+I++ V + G L +V + ++GG + I R Q +E I +
Sbjct: 113 QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQD-RGDQAFTEREASEIMKSIG 171
Query: 445 EGIKFLNDHGVAYRDLNSQRILL---DRHGNVCLGDMGIVTACKS-------VGEATEYE 494
E I++L+ +A+RD+ + +L + + L D G S
Sbjct: 172 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY------ 225
Query: 495 TDGYRWLAPEV 505
T Y +APEV
Sbjct: 226 TPYY--VAPEV 234
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 6e-05
Identities = 43/188 (22%), Positives = 78/188 (41%), Gaps = 40/188 (21%)
Query: 343 EFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEF---------ELRKDLLEL 387
+ +G ++ V G +V I+KL ++ ELR LL+
Sbjct: 28 RDLQPVGSGAYGAVCSAVDGRTGAKVAIKKL-----YRPFQSELFAKRAYRELR--LLKH 80
Query: 388 MTCGHKNILQFYCV-----CVDENHGLCVVTKLMEGGSVNDL--ILKSRKLQTKEIIRIA 440
M H+N++ V +D+ +V M DL ++K KL I +
Sbjct: 81 MR--HENVIGLLDVFTPDETLDDFTDFYLVMPFMG----TDLGKLMKHEKLGEDRIQFLV 134
Query: 441 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY-ETDGYR 499
+ +G+++++ G+ +RDL + ++ + + D G+ A ++ E T Y T YR
Sbjct: 135 YQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGL--ARQADSEMTGYVVTRWYR 192
Query: 500 WLAPEVCF 507
APEV
Sbjct: 193 --APEVIL 198
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 7e-05
Identities = 17/91 (18%), Positives = 42/91 (46%), Gaps = 4/91 (4%)
Query: 392 HKNILQFYCVCVDENHG-LCVVTKLMEGGSVN--DLILKSRKLQTKEIIRIAIDVAEGIK 448
HKN++Q V +E + +V + G D + + ++ + + +G++
Sbjct: 65 HKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPE-KRFPVCQAHGYFCQLIDGLE 123
Query: 449 FLNDHGVAYRDLNSQRILLDRHGNVCLGDMG 479
+L+ G+ ++D+ +LL G + + +G
Sbjct: 124 YLHSQGIVHKDIKPGNLLLTTGGTLKISALG 154
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 8e-05
Identities = 30/148 (20%), Positives = 57/148 (38%), Gaps = 19/148 (12%)
Query: 345 IDQIGPNSFKGVYKGKRVG--------IEKLKGCDKGNAYEFELRKDLLELMTCGHKNIL 396
+IG SF +Y G + +E +K E ++ K + G I
Sbjct: 14 GRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQ-----GGVGIP 68
Query: 397 QFYCVCVDENHGLCVVTKLMEGGSVNDLI-LKSRKLQTKEIIRIAIDVAEGIKFLNDHGV 455
+ ++ + V+ L G S+ DL SRK K ++ +A + I++++
Sbjct: 69 TIRWCGAEGDYNVMVMELL--GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNF 126
Query: 456 AYRDLNSQRILLDRHGN---VCLGDMGI 480
+RD+ L+ V + D G+
Sbjct: 127 IHRDVKPDNFLMGLGKKGNLVYIIDFGL 154
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 43.8 bits (103), Expect = 9e-05
Identities = 33/148 (22%), Positives = 60/148 (40%), Gaps = 19/148 (12%)
Query: 345 IDQIGPNSFKGVYKGKRVG--------IEKLKGCDKGNAYEFELRKDLLELMTCGHKNIL 396
+IG SF +Y G + +E +K YE ++ + L G I
Sbjct: 12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQ-----GGTGIP 66
Query: 397 QFYCVCVDENHGLCVVTKLMEGGSVNDLI-LKSRKLQTKEIIRIAIDVAEGIKFLNDHGV 455
V+ ++ + V+ L G S+ DL SRKL K ++ +A + ++F++
Sbjct: 67 NVRWFGVEGDYNVLVMDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 124
Query: 456 AYRDLNSQRILLDRHGN---VCLGDMGI 480
+RD+ L+ V + D G+
Sbjct: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGL 152
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 9e-05
Identities = 30/109 (27%), Positives = 49/109 (44%), Gaps = 13/109 (11%)
Query: 404 DENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRI-AIDVAEGIKFLNDHGVAYRDLNS 462
DEN+ L +V + GG + L+ K + E+ R ++ I ++ G +RD+
Sbjct: 132 DENY-LYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKP 190
Query: 463 QRILLDRHGNVCLGDMGIVTACKSVGEATEYETD---G---YRWLAPEV 505
ILLDR G++ L D G C + + G Y L+PE+
Sbjct: 191 DNILLDRCGHIRLADFGS---CLKLRADGTVRSLVAVGTPDY--LSPEI 234
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 1e-04
Identities = 41/188 (21%), Positives = 77/188 (40%), Gaps = 35/188 (18%)
Query: 340 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFE------LR--KDLL 385
+ E + +G S+ V K G+ V I+K + + + +R K L
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFL-----ESDDDKMVKKIAMREIKLLK 79
Query: 386 ELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDL--ILKSRK--LQTKEIIRIAI 441
+L H+N++ VC + +V + ++ + + L+ L + + +
Sbjct: 80 QL---RHENLVNLLEVCKKKKR-WYLVFEFVD----HTILDDLELFPNGLDYQVVQKYLF 131
Query: 442 DVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA-TEY-ETDGYR 499
+ GI F + H + +RD+ + IL+ + G V L D G + GE + T YR
Sbjct: 132 QIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYR 191
Query: 500 WLAPEVCF 507
APE+
Sbjct: 192 --APELLV 197
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 1e-04
Identities = 31/187 (16%), Positives = 69/187 (36%), Gaps = 34/187 (18%)
Query: 338 NSDNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCG 391
N D+ + + ++G + V++ ++V ++ LK K E++ +LE + G
Sbjct: 34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKR-EIK--ILENL-RG 89
Query: 392 HKNILQFYCVCVDENHGLC--VVTKLMEGGSVNDL-----ILKSRKLQ--TKEIIRIAID 442
NI+ + D V + D L ++ EI++
Sbjct: 90 GPNIITLADIVKDPVSRTPALVFEHVNN----TDFKQLYQTLTDYDIRFYMYEILK---- 141
Query: 443 VAEGIKFLNDHGVAYRDLNSQRILLDR-HGNVCLGDMGIVTACKSVGEATEY-ETDGYRW 500
+ + + G+ +RD+ +++D H + L D G+ E + ++
Sbjct: 142 ---ALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFK- 197
Query: 501 LAPEVCF 507
PE+
Sbjct: 198 -GPELLV 203
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 1e-04
Identities = 20/90 (22%), Positives = 39/90 (43%), Gaps = 3/90 (3%)
Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN 451
H NI++F V + H L ++ + GG + + I + + E + G+ + +
Sbjct: 75 HPNIVRFKEVILTPTH-LAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCH 133
Query: 452 DHGVAYRDLNSQRILLDRH--GNVCLGDMG 479
+ +RDL + LLD + + D G
Sbjct: 134 SMQICHRDLKLENTLLDGSPAPRLKICDFG 163
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 1e-04
Identities = 38/164 (23%), Positives = 74/164 (45%), Gaps = 37/164 (22%)
Query: 339 SDNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFE-------LR--KD 383
S + ++++G ++ VYK G V ++++K + E +R
Sbjct: 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVK-------LDSEEGTPSTAIREISL 56
Query: 384 LLELMTCGHKNILQFYCVCVDENHGLCVV--------TKLMEGGSVNDLILKSRKLQTKE 435
+ EL H+NI++ Y V EN L +V K M+ +V + R L+
Sbjct: 57 MKEL---KHENIVRLYDVIHTENK-LTLVFEFMDNDLKKYMDSRTVGN---TPRGLELNL 109
Query: 436 IIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMG 479
+ + +G+ F +++ + +RDL Q +L+++ G + LGD G
Sbjct: 110 VKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFG 153
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 1e-04
Identities = 43/191 (22%), Positives = 75/191 (39%), Gaps = 42/191 (21%)
Query: 343 EFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEF---------ELRKDLLEL 387
+ IG ++ V RV I+K+ + +E E++ +L
Sbjct: 30 TNLSYIGEGAYGMVCSAYDNLNKVRVAIKKI------SPFEHQTYCQRTLREIK--ILLR 81
Query: 388 MTCGHKNILQ----FYCVCVDENHGLCVVTKLMEGGSVNDL--ILKSRKLQTKEIIRIAI 441
H+NI+ +++ + +V LME DL +LK++ L I
Sbjct: 82 FR--HENIIGINDIIRAPTIEQMKDVYIVQDLME----TDLYKLLKTQHLSNDHICYFLY 135
Query: 442 DVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMG----IVTACKSVGEATEY-ETD 496
+ G+K+++ V +RDL +LL+ ++ + D G G TEY T
Sbjct: 136 QILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 195
Query: 497 GYRWLAPEVCF 507
YR APE+
Sbjct: 196 WYR--APEIML 204
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 2e-04
Identities = 32/164 (19%), Positives = 64/164 (39%), Gaps = 30/164 (18%)
Query: 340 DNLEFID-QIGPNSFKGVYK--------GKRVGIEKLK--GCDKGNAYEFELRKDLLELM 388
D E+ ++G ++ VYK K +++++ G E L L EL
Sbjct: 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIAL---LRELK 76
Query: 389 TCGHKNILQFYCVCVD-ENHGLCVV--------TKLMEGGSVNDLILKSRKLQTKEIIRI 439
H N++ V + + + ++ +++ + K +L + +
Sbjct: 77 ---HPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSL 133
Query: 440 AIDVAEGIKFLNDHGVAYRDLNSQRILL----DRHGNVCLGDMG 479
+ +GI +L+ + V +RDL IL+ G V + DMG
Sbjct: 134 LYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMG 177
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 42.5 bits (100), Expect = 2e-04
Identities = 37/221 (16%), Positives = 67/221 (30%), Gaps = 60/221 (27%)
Query: 343 EFIDQIGPNSFKGVYKGKRVG---------IEKLKGCDKGNAYEFELRKDLLELMTCGHK 393
IG S+ V + K K ++ ++ + H
Sbjct: 29 HLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHP 88
Query: 394 NILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQT-------------------- 433
NI + Y V DE + +C+V +L GG + D + T
Sbjct: 89 NIARLYEVYEDEQY-ICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNE 147
Query: 434 --------------------KEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILL--DRHG 471
K I I + + +L++ G+ +RD+ + L ++
Sbjct: 148 EAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSF 207
Query: 472 NVCLGDMGIVTACKSVGEATEYE------TDGYRWLAPEVC 506
+ L D G+ + Y T + +APEV
Sbjct: 208 EIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYF--VAPEVL 246
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 2e-04
Identities = 31/151 (20%), Positives = 57/151 (37%), Gaps = 21/151 (13%)
Query: 344 FIDQIGPNSFKGVYKGKRVG--------IEKLKGCDKGNAYEFELRKDLLELMTCGHKNI 395
+IG SF +++G + E + E+ K L G I
Sbjct: 14 VGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLL-----AGCTGI 68
Query: 396 LQFYCVCVDENHGLCVVTKLMEGGSVNDLI-LKSRKLQTKEIIRIAIDVAEGIKFLNDHG 454
Y + H + V+ L G S+ DL+ L RK K + A + ++ +++
Sbjct: 69 PNVYYFGQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS 126
Query: 455 VAYRDLNSQRILLDRHGN-----VCLGDMGI 480
+ YRD+ L+ R + + + D G+
Sbjct: 127 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGM 157
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 4e-04
Identities = 22/126 (17%), Positives = 45/126 (35%), Gaps = 35/126 (27%)
Query: 391 GHKNILQFYCVCVDENHG---LCVVTKLMEGGSVNDLILKSRKL-----QTKEIIRIAID 442
+I++ V + G L +V + ++GG + I + EI++
Sbjct: 69 QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMK---S 125
Query: 443 VAEGIKFLNDHGVAYRDLNSQRILL---DRHGNVCLGDMGIVTACKSVGEATEYETDGYR 499
+ E I++L+ +A+RD+ + +L + + L D G
Sbjct: 126 IGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG-------------------- 165
Query: 500 WLAPEV 505
A E
Sbjct: 166 -FAKET 170
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 5e-04
Identities = 41/188 (21%), Positives = 76/188 (40%), Gaps = 39/188 (20%)
Query: 343 EFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEF---------ELRKDLLEL 387
+ + IG + V + V I+KL ++ EL L++
Sbjct: 28 QNLKPIGSGAQGIVCAAYDAILERNVAIKKL-----SRPFQNQTHAKRAYRELV--LMKC 80
Query: 388 MTCGHKNILQFYCV-----CVDENHGLCVVTKLMEGGSVNDL--ILKSRKLQTKEIIRIA 440
+ HKNI+ V ++E + +V +LM+ +L +++ +L + + +
Sbjct: 81 V--NHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD----ANLCQVIQM-ELDHERMSYLL 133
Query: 441 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY-ETDGYR 499
+ GIK L+ G+ +RDL I++ + + D G+ + T Y T YR
Sbjct: 134 YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYR 193
Query: 500 WLAPEVCF 507
APEV
Sbjct: 194 --APEVIL 199
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 5e-04
Identities = 33/163 (20%), Positives = 63/163 (38%), Gaps = 37/163 (22%)
Query: 340 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKD------LLE- 386
D I ++G ++ VYK + V I++++ E ++ + E
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIR---------LEHEEEGVPGTAIREV 84
Query: 387 --LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDL---ILKSRKLQTKEIIRIAI 441
L H+NI++ V + L ++ + E NDL + K+ + + I
Sbjct: 85 SLLKELQHRNIIELKSVIHHNHR-LHLIFEYAE----NDLKKYMDKNPDVSMRVIKSFLY 139
Query: 442 DVAEGIKFLNDHGVAYRDLNSQRILLD-----RHGNVCLGDMG 479
+ G+ F + +RDL Q +LL + +GD G
Sbjct: 140 QLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFG 182
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 6e-04
Identities = 38/184 (20%), Positives = 71/184 (38%), Gaps = 35/184 (19%)
Query: 345 IDQIGPNSFKGVYKGK-----RVGIEKLKGCDKGNAYEFELRK-DLLELMTCGHKNILQF 398
IG SF V++ K V I+K+ DK F+ R+ ++ ++ H N++
Sbjct: 45 CKVIGNGSFGVVFQAKLVESDEVAIKKVLQ-DK----RFKNRELQIMRIVK--HPNVVDL 97
Query: 399 YCV------CVDENHGLCVVTKLMEGGSVNDL--ILKSRKLQTKEIIRIAIDV-----AE 445
DE L +V + + + + + + + I +
Sbjct: 98 KAFFYSNGDKKDEVF-LNLVLEYVP----ETVYRASRHYAKLKQTMPMLLIKLYMYQLLR 152
Query: 446 GIKFLNDHGVAYRDLNSQRILLDRH-GNVCLGDMGIVTACKSVGEATEY-ETDGYRWLAP 503
+ +++ G+ +RD+ Q +LLD G + L D G + Y + YR AP
Sbjct: 153 SLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYR--AP 210
Query: 504 EVCF 507
E+ F
Sbjct: 211 ELIF 214
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 6e-04
Identities = 42/188 (22%), Positives = 76/188 (40%), Gaps = 41/188 (21%)
Query: 343 EFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEF---------ELRKDLLEL 387
+G ++ V G++V I+KL ++ EL LL+
Sbjct: 27 VSPTHVGSGAYGSVCSAIDKRSGEKVAIKKL-----SRPFQSEIFAKRAYRELL--LLKH 79
Query: 388 MTCGHKNILQFYCV-----CVDENHGLCVVTKLMEGGSVNDL--ILKSRKLQTKEIIRIA 440
M H+N++ V + + +V M+ DL I+ K ++I +
Sbjct: 80 MQ--HENVIGLLDVFTPASSLRNFYDFYLVMPFMQ----TDLQKIMGL-KFSEEKIQYLV 132
Query: 441 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY-ETDGYR 499
+ +G+K+++ GV +RDL + ++ + + D G+ A + E T Y T YR
Sbjct: 133 YQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGL--ARHADAEMTGYVVTRWYR 190
Query: 500 WLAPEVCF 507
APEV
Sbjct: 191 --APEVIL 196
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 6e-04
Identities = 32/151 (21%), Positives = 58/151 (38%), Gaps = 15/151 (9%)
Query: 343 EFIDQIGPNSFKGVYKGKRVG---------IEKLKGCDKGNAYEFELRK---DLLELMTC 390
+ +G F VY G RV +EK + D G LL+ ++
Sbjct: 46 QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 105
Query: 391 GHKNILQFYCVCVDENHGLCVVTKLMEG-GSVNDLILKSRKLQTKEIIRIAIDVAEGIKF 449
G +++ + ++ + E + D I + LQ + V E ++
Sbjct: 106 GFSGVIRLLDWFERPDS-FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 164
Query: 450 LNDHGVAYRDLNSQRILLD-RHGNVCLGDMG 479
++ GV +RD+ + IL+D G + L D G
Sbjct: 165 CHNCGVLHRDIKDENILIDLNRGELKLIDFG 195
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 6e-04
Identities = 27/147 (18%), Positives = 51/147 (34%), Gaps = 15/147 (10%)
Query: 348 IGPNSFKGVYKGKRVG---------IEKLKGCDKGNAYEFELRKDLLELM-----TCGHK 393
+G F V+ G R+ I + + + + L+ GH
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 394 NILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDH 453
+++ + + V+ + + + D I + L V I+ +
Sbjct: 99 GVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSR 158
Query: 454 GVAYRDLNSQRILLD-RHGNVCLGDMG 479
GV +RD+ + IL+D R G L D G
Sbjct: 159 GVVHRDIKDENILIDLRRGCAKLIDFG 185
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 511 | |||
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 99.97 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 99.97 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 99.97 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 99.97 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 99.97 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 99.97 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 99.97 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 99.97 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 99.97 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 99.97 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 99.97 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 99.97 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 99.97 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 99.97 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 99.97 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 99.97 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 99.97 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 99.97 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 99.97 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 99.97 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 99.97 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 99.97 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 99.97 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 99.97 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 99.97 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 99.97 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 99.97 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 99.97 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 99.97 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 99.97 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 99.97 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 99.97 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 99.97 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 99.97 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 99.97 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 99.97 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 99.97 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 99.97 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 99.97 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 99.97 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 99.97 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 99.97 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 99.97 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 99.97 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 99.96 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 99.96 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 99.96 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 99.96 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 99.96 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 99.96 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 99.96 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 99.96 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 99.96 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 99.96 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 99.96 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 99.96 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 99.96 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 99.96 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 99.96 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 99.96 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 99.96 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 99.96 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 99.96 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 99.96 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 99.96 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 99.96 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 99.96 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 99.96 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 99.96 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 99.96 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 99.96 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 99.96 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.96 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 99.96 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 99.96 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 99.96 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 99.96 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 99.96 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 99.96 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 99.96 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 99.96 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 99.96 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 99.96 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 99.96 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 99.96 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 99.96 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 99.96 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 99.96 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.96 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 99.96 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 99.96 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 99.96 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 99.96 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 99.96 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 99.96 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 99.96 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 99.96 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 99.96 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 99.96 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 99.96 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 99.96 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 99.96 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 99.96 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 99.96 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 99.96 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 99.96 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 99.96 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.96 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 99.96 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 99.96 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 99.96 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 99.96 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 99.96 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 99.96 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 99.96 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 99.96 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 99.96 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 99.96 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 99.96 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 99.96 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 99.96 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 99.96 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 99.96 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 99.96 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 99.96 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 99.96 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 99.96 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 99.96 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 99.96 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 99.96 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 99.96 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 99.96 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 99.96 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 99.96 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 99.96 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 99.96 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 99.96 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 99.96 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 99.96 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 99.96 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 99.96 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 99.96 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 99.96 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 99.96 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 99.96 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 99.96 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 99.96 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.95 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 99.95 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 99.95 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 99.95 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 99.95 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 99.95 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 99.95 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 99.95 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 99.95 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 99.95 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 99.95 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 99.95 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 99.95 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 99.95 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 99.95 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 99.95 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 99.95 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 99.95 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 99.95 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 99.95 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 99.95 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 99.95 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 99.95 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 99.95 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 99.95 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 99.95 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 99.95 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 99.95 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 99.95 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 99.95 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 99.95 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 99.95 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 99.95 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 99.95 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 99.95 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 99.95 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 99.95 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 99.95 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.95 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 99.95 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 99.95 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 99.95 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 99.95 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.95 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 99.95 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.95 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 99.95 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 99.95 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 99.95 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 99.95 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 99.95 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 99.95 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 99.95 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 99.95 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 99.95 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 99.95 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.95 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 99.95 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.95 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 99.94 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 99.94 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 99.94 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.94 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 99.94 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 99.94 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 99.94 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.94 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 99.94 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.94 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.94 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.94 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.94 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 99.94 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 99.94 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.94 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.93 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.93 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.93 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.93 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 99.93 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.92 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.91 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.91 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.91 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.89 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.87 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.79 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.6 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.22 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.04 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.94 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.53 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.41 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.28 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.03 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 97.96 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.84 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.71 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.64 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.59 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.21 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.98 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 96.75 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 96.41 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.1 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 95.74 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 95.61 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 95.05 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 93.93 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 93.46 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 85.57 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 85.23 |
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-39 Score=326.01 Aligned_cols=173 Identities=30% Similarity=0.465 Sum_probs=149.0
Q ss_pred ceEecCCCeEEEeeeecccceEEEEeE---EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEE
Q 010401 334 RWLLNSDNLEFIDQIGPNSFKGVYKGK---RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLC 410 (511)
Q Consensus 334 ~~~l~~~~y~l~~~LG~GsFG~VYkgk---~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~ 410 (511)
.|+++.++|++.++||+|+||.||+|+ .||||+++...........+.+|+.++++++|||||+++|++.+ +. +|
T Consensus 30 ~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~-~~ 107 (307)
T 3omv_A 30 YWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DN-LA 107 (307)
T ss_dssp CCBCCTTSCCEEEECCCCSSSEEEEEESSSEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SS-CE
T ss_pred CcEEcHHHeEEeeEEeeCCCcEEEEEEECCcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-Ce-EE
Confidence 688999999999999999999999986 69999997655555566779999999999999999999998864 33 89
Q ss_pred EEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCC-
Q 010401 411 VVTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG- 488 (511)
Q Consensus 411 LVmEy~~gGsL~~lL~~~-~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~- 488 (511)
||||||++|+|.++|... ..+++..+..|+.||+.||+|||+++||||||||+||||+.++++||+|||+|+......
T Consensus 108 iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~ 187 (307)
T 3omv_A 108 IVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSG 187 (307)
T ss_dssp EEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC------
T ss_pred EEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCCc
Confidence 999999999999999654 579999999999999999999999999999999999999999999999999998764322
Q ss_pred -CccccccCCCccccHHhhcc
Q 010401 489 -EATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 489 -~~~~~~~Gt~~YmAPEvl~g 508 (511)
......+||+.|||||++.+
T Consensus 188 ~~~~~~~~GT~~ymAPE~l~~ 208 (307)
T 3omv_A 188 SQQVEQPTGSVLWMAPEVIRM 208 (307)
T ss_dssp ------CCCCTTSCCHHHHHC
T ss_pred ceeecccccCCCccCHHHhhc
Confidence 23445689999999999864
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-39 Score=333.23 Aligned_cols=171 Identities=24% Similarity=0.339 Sum_probs=145.7
Q ss_pred cCCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEE
Q 010401 338 NSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCV 411 (511)
Q Consensus 338 ~~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~L 411 (511)
..++|++++.||+|+||.||++ +.||||++...........++.+|+.+|+.++|||||++++++.+++. +||
T Consensus 22 sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~-~yi 100 (350)
T 4b9d_A 22 SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGS-LYI 100 (350)
T ss_dssp CCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE-EEE
T ss_pred cccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCE-EEE
Confidence 3578999999999999999996 479999998655555556778999999999999999999999998876 999
Q ss_pred EEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCC
Q 010401 412 VTKLMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE 489 (511)
Q Consensus 412 VmEy~~gGsL~~lL~~~--~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~ 489 (511)
|||||+||+|.++|... ..+++..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.+.....
T Consensus 101 VmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~ 180 (350)
T 4b9d_A 101 VMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE 180 (350)
T ss_dssp EEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHH
T ss_pred EEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCcc
Confidence 99999999999999654 3579999999999999999999999999999999999999999999999999987754433
Q ss_pred ccccccCCCccccHHhhccc
Q 010401 490 ATEYETDGYRWLAPEVCFLL 509 (511)
Q Consensus 490 ~~~~~~Gt~~YmAPEvl~gl 509 (511)
.....+||+.|||||++.+.
T Consensus 181 ~~~~~~GT~~YmAPE~l~~~ 200 (350)
T 4b9d_A 181 LARACIGTPYYLSPEICENK 200 (350)
T ss_dssp HHHHHHSCCTTCCHHHHTTC
T ss_pred cccccCCCccccCHHHHCCC
Confidence 34556899999999999763
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=328.72 Aligned_cols=172 Identities=20% Similarity=0.310 Sum_probs=143.9
Q ss_pred ecCCCeEEEeeeecccceEEEEeE---------EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCC
Q 010401 337 LNSDNLEFIDQIGPNSFKGVYKGK---------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENH 407 (511)
Q Consensus 337 l~~~~y~l~~~LG~GsFG~VYkgk---------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~ 407 (511)
.+.++|++++.||+|+||+||+++ .||+|++...........++.+|+.+|+.++|||||++++++.+++.
T Consensus 21 ~~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~ 100 (304)
T 3ubd_A 21 ADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGK 100 (304)
T ss_dssp CCGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTE
T ss_pred CCccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCE
Confidence 345789999999999999999864 59999997543322233457889999999999999999999998876
Q ss_pred cEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccC
Q 010401 408 GLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV 487 (511)
Q Consensus 408 ~l~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~ 487 (511)
+|||||||+||+|.+++.+.+.+++..++.|+.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+.....
T Consensus 101 -~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 179 (304)
T 3ubd_A 101 -LYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH 179 (304)
T ss_dssp -EEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC----
T ss_pred -EEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccCC
Confidence 9999999999999999988889999999999999999999999999999999999999999999999999999876655
Q ss_pred CCccccccCCCccccHHhhccc
Q 010401 488 GEATEYETDGYRWLAPEVCFLL 509 (511)
Q Consensus 488 ~~~~~~~~Gt~~YmAPEvl~gl 509 (511)
.......+||+.|||||++.+.
T Consensus 180 ~~~~~~~~GT~~YmAPE~~~~~ 201 (304)
T 3ubd_A 180 EKKAYSFCGTVEYMAPEVVNRR 201 (304)
T ss_dssp -CCCCSCCCCGGGCCHHHHHTS
T ss_pred CccccccccCcccCCHHHhccC
Confidence 5555667899999999998753
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=325.98 Aligned_cols=169 Identities=15% Similarity=0.242 Sum_probs=149.1
Q ss_pred CCCeEEEeeeecccceEEEEe------EEEEEEEEecCCC-CchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEE
Q 010401 339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDK-GNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCV 411 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~-~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~L 411 (511)
.++|++++.||+|+||+||++ +.||+|++..... .......+.+|+.+|+.++|||||+++++|.+++. +||
T Consensus 31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~-~yi 109 (311)
T 4aw0_A 31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEK-LYF 109 (311)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE-EEE
T ss_pred ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCE-EEE
Confidence 457999999999999999996 4799999974321 12234568999999999999999999999998876 999
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCC--C
Q 010401 412 VTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG--E 489 (511)
Q Consensus 412 VmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~--~ 489 (511)
||||++||+|.+++.+.+.+++..++.|+.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+.+.... .
T Consensus 110 vmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~ 189 (311)
T 4aw0_A 110 GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 189 (311)
T ss_dssp EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCC
T ss_pred EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCcc
Confidence 99999999999999888899999999999999999999999999999999999999999999999999999875433 2
Q ss_pred ccccccCCCccccHHhhcc
Q 010401 490 ATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 490 ~~~~~~Gt~~YmAPEvl~g 508 (511)
.....+||+.|||||++.+
T Consensus 190 ~~~~~~GTp~YmAPEvl~~ 208 (311)
T 4aw0_A 190 RANSFVGTAQYVSPELLTE 208 (311)
T ss_dssp CBCCCCSCGGGCCHHHHHH
T ss_pred cccCcccCcccCCHHHHcC
Confidence 3456789999999999875
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=326.91 Aligned_cols=166 Identities=23% Similarity=0.382 Sum_probs=148.3
Q ss_pred CCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEE
Q 010401 339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV 412 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LV 412 (511)
.+.|+++++||+|+||.||++ +.||||++....... ...+.+|+.+|+.++|||||+++++|.+++. +|||
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~--~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~-~~iv 149 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR--RELLFNEVVIMRDYQHENVVEMYNSYLVGDE-LWVV 149 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS--GGGGHHHHHHHHHCCCTTBCCEEEEEEETTE-EEEE
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH--HHHHHHHHHHHHhCCCCCCCcEEEEEEECCE-EEEE
Confidence 356899999999999999996 479999997533222 3457899999999999999999999998886 9999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCccc
Q 010401 413 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE 492 (511)
Q Consensus 413 mEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~~ 492 (511)
||||+||+|.+++.. +.+++..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.+........
T Consensus 150 mEy~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~ 228 (346)
T 4fih_A 150 MEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK 228 (346)
T ss_dssp ECCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBC
T ss_pred EeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCccc
Confidence 999999999999864 5799999999999999999999999999999999999999999999999999998876555566
Q ss_pred cccCCCccccHHhhcc
Q 010401 493 YETDGYRWLAPEVCFL 508 (511)
Q Consensus 493 ~~~Gt~~YmAPEvl~g 508 (511)
..+||+.|||||++.+
T Consensus 229 ~~~GTp~YmAPEvl~~ 244 (346)
T 4fih_A 229 SLVGTPYWMAPELISR 244 (346)
T ss_dssp CCCSCGGGCCHHHHTT
T ss_pred ccccCcCcCCHHHHCC
Confidence 7899999999999875
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=319.87 Aligned_cols=169 Identities=23% Similarity=0.433 Sum_probs=145.7
Q ss_pred ecCCCeEEEeeeecccceEEEEeE-----------EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeC
Q 010401 337 LNSDNLEFIDQIGPNSFKGVYKGK-----------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDE 405 (511)
Q Consensus 337 l~~~~y~l~~~LG~GsFG~VYkgk-----------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~ 405 (511)
+..++|.+.++||+|+||.||+|+ .||||+++. .......++.+|+.+|++++|||||+++|+|.++
T Consensus 10 I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~--~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~ 87 (299)
T 4asz_A 10 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKD--ASDNARKDFHREAELLTNLQHEHIVKFYGVCVEG 87 (299)
T ss_dssp CCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECS--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred cCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCC--CChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC
Confidence 567789999999999999999974 599999974 3444566799999999999999999999999987
Q ss_pred CCcEEEEEeccCCCCHHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCc
Q 010401 406 NHGLCVVTKLMEGGSVNDLILKS-------------RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGN 472 (511)
Q Consensus 406 ~~~l~LVmEy~~gGsL~~lL~~~-------------~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~ 472 (511)
+. +|||||||++|+|.++|... ..+++..+..|+.||+.||.|||+++||||||||+|||++.++.
T Consensus 88 ~~-~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~ 166 (299)
T 4asz_A 88 DP-LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL 166 (299)
T ss_dssp SS-EEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC
T ss_pred CE-EEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCc
Confidence 76 99999999999999999653 36999999999999999999999999999999999999999999
Q ss_pred EEEEecCCceecccCCCc--cccccCCCccccHHhhcc
Q 010401 473 VCLGDMGIVTACKSVGEA--TEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 473 vKL~DFGlS~~l~~~~~~--~~~~~Gt~~YmAPEvl~g 508 (511)
+||+|||+|+........ .....||+.|||||++.+
T Consensus 167 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~ 204 (299)
T 4asz_A 167 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY 204 (299)
T ss_dssp EEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHH
T ss_pred EEECCcccceecCCCCceeecCceecChhhcCHHHHcC
Confidence 999999999876443321 223468999999999875
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=317.43 Aligned_cols=171 Identities=21% Similarity=0.424 Sum_probs=146.9
Q ss_pred EecCCCeEEEeeeecccceEEEEeE-----------EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEee
Q 010401 336 LLNSDNLEFIDQIGPNSFKGVYKGK-----------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVD 404 (511)
Q Consensus 336 ~l~~~~y~l~~~LG~GsFG~VYkgk-----------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~ 404 (511)
+++.+++++.++||+|+||.||+|+ .||||+++... ......+|.+|+.++++++|||||+++|+|.+
T Consensus 22 ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~ 100 (308)
T 4gt4_A 22 EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLREEFRHEAMLRARLQHPNVVCLLGVVTK 100 (308)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C-CC-CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc-ChHHHHHHHHHHHHHHhCCCCCCCCcceEEEE
Confidence 3566788999999999999999975 59999997532 33345678999999999999999999999998
Q ss_pred CCCcEEEEEeccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEc
Q 010401 405 ENHGLCVVTKLMEGGSVNDLILKS----------------RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLD 468 (511)
Q Consensus 405 ~~~~l~LVmEy~~gGsL~~lL~~~----------------~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld 468 (511)
++. +|||||||++|+|.++|... ..+++..+..|+.||+.||+|||+++||||||||+||||+
T Consensus 101 ~~~-~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~ 179 (308)
T 4gt4_A 101 DQP-LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVY 179 (308)
T ss_dssp SSS-CEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred CCE-EEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEEC
Confidence 776 99999999999999999542 3589999999999999999999999999999999999999
Q ss_pred CCCcEEEEecCCceecccCCC--ccccccCCCccccHHhhcc
Q 010401 469 RHGNVCLGDMGIVTACKSVGE--ATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 469 ~~g~vKL~DFGlS~~l~~~~~--~~~~~~Gt~~YmAPEvl~g 508 (511)
+++++||+|||+|+.+..... ......||++|||||++.+
T Consensus 180 ~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~ 221 (308)
T 4gt4_A 180 DKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMY 221 (308)
T ss_dssp GGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHH
T ss_pred CCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhC
Confidence 999999999999987644322 2345678999999999865
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=318.23 Aligned_cols=171 Identities=21% Similarity=0.368 Sum_probs=141.3
Q ss_pred EecCCCeEEEeeeecccceEEEEeE-----------EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEee
Q 010401 336 LLNSDNLEFIDQIGPNSFKGVYKGK-----------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVD 404 (511)
Q Consensus 336 ~l~~~~y~l~~~LG~GsFG~VYkgk-----------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~ 404 (511)
.+..++|.+.++||+|+||.||+|+ .||||+++. .......+|.+|+.+|++++|||||+++|+|.+
T Consensus 37 ~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~--~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~ 114 (329)
T 4aoj_A 37 HIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE--ASESARQDFQREAELLTMLQHQHIVRFFGVCTE 114 (329)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESC--CSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred ccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECc--CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence 4566789999999999999999974 599999973 344455679999999999999999999999998
Q ss_pred CCCcEEEEEeccCCCCHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcC
Q 010401 405 ENHGLCVVTKLMEGGSVNDLILKS---------------RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDR 469 (511)
Q Consensus 405 ~~~~l~LVmEy~~gGsL~~lL~~~---------------~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~ 469 (511)
.+. +|||||||++|+|.+++... +++++.++..|+.||+.||.|||+++||||||||+||||+.
T Consensus 115 ~~~-~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~ 193 (329)
T 4aoj_A 115 GRP-LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQ 193 (329)
T ss_dssp SSS-EEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEET
T ss_pred CCE-EEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECC
Confidence 776 99999999999999999643 35899999999999999999999999999999999999999
Q ss_pred CCcEEEEecCCceecccCCC--ccccccCCCccccHHhhccc
Q 010401 470 HGNVCLGDMGIVTACKSVGE--ATEYETDGYRWLAPEVCFLL 509 (511)
Q Consensus 470 ~g~vKL~DFGlS~~l~~~~~--~~~~~~Gt~~YmAPEvl~gl 509 (511)
++++||+|||+|+....... ......||+.|||||++.+.
T Consensus 194 ~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~ 235 (329)
T 4aoj_A 194 GLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYR 235 (329)
T ss_dssp TTEEEECCCC----------------CCCCGGGCCHHHHTTC
T ss_pred CCcEEEcccccceeccCCCcceecCcccccccccChhhhcCC
Confidence 99999999999987644322 23345789999999998753
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=329.96 Aligned_cols=167 Identities=24% Similarity=0.388 Sum_probs=148.9
Q ss_pred CCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEE
Q 010401 339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV 412 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LV 412 (511)
.+.|+++++||+|+||.||+| +.||||++....... ...+.+|+.+|+.++|||||+++++|.+++. +|||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~--~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~-~~iV 226 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR--RELLFNEVVIMRDYQHENVVEMYNSYLVGDE-LWVV 226 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS--GGGHHHHHHHHHHCCCTTBCCEEEEEEETTE-EEEE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH--HHHHHHHHHHHHhCCCCCCCceEEEEEECCE-EEEE
Confidence 356999999999999999996 479999997543322 3457899999999999999999999998876 9999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCccc
Q 010401 413 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE 492 (511)
Q Consensus 413 mEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~~ 492 (511)
||||+||+|.+++.. +.+++..+..|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.+........
T Consensus 227 mEy~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~ 305 (423)
T 4fie_A 227 MEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK 305 (423)
T ss_dssp EECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCBC
T ss_pred EeCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCcccc
Confidence 999999999999854 5799999999999999999999999999999999999999999999999999998866555566
Q ss_pred cccCCCccccHHhhccc
Q 010401 493 YETDGYRWLAPEVCFLL 509 (511)
Q Consensus 493 ~~~Gt~~YmAPEvl~gl 509 (511)
..+||+.|||||++.+.
T Consensus 306 ~~~GTp~YmAPEvl~~~ 322 (423)
T 4fie_A 306 SLVGTPYWMAPELISRL 322 (423)
T ss_dssp CCEECTTTCCHHHHTTC
T ss_pred ccccCcCcCCHHHHCCC
Confidence 78999999999998753
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=310.64 Aligned_cols=167 Identities=20% Similarity=0.338 Sum_probs=133.3
Q ss_pred CCeEEEeeeecccceEEEEe------EEEEEEEEecCCCC-chHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEE
Q 010401 340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKG-NAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV 412 (511)
Q Consensus 340 ~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~-~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LV 412 (511)
++|++++.||+|+||.||++ +.||+|++...... .....++.+|+.+++.++|||||++++++.+++. +|||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~-~~iv 91 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDE-IIMV 91 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE-EEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCE-EEEE
Confidence 57899999999999999996 58999999754322 2234568999999999999999999999998776 9999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCccc
Q 010401 413 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE 492 (511)
Q Consensus 413 mEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~~ 492 (511)
|||+ +|+|.+++.+.+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+..... ....
T Consensus 92 mEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~-~~~~ 169 (275)
T 3hyh_A 92 IEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG-NFLK 169 (275)
T ss_dssp EECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC-----------
T ss_pred EeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCC-CccC
Confidence 9999 6799999988889999999999999999999999999999999999999999999999999999876543 2345
Q ss_pred cccCCCccccHHhhccc
Q 010401 493 YETDGYRWLAPEVCFLL 509 (511)
Q Consensus 493 ~~~Gt~~YmAPEvl~gl 509 (511)
..+||+.|||||++.+-
T Consensus 170 ~~~GT~~Y~APE~~~~~ 186 (275)
T 3hyh_A 170 TSCGSPNYAAPEVISGK 186 (275)
T ss_dssp -----CTTSCHHHHSSS
T ss_pred CeeECcccCChhhhcCC
Confidence 57899999999999764
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-37 Score=311.21 Aligned_cols=165 Identities=25% Similarity=0.400 Sum_probs=144.4
Q ss_pred eEEEeeeecccceEEEEeE------EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeC---CCcEEEE
Q 010401 342 LEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDE---NHGLCVV 412 (511)
Q Consensus 342 y~l~~~LG~GsFG~VYkgk------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~---~~~l~LV 412 (511)
|++.++||+|+||.||+|+ .||+|++...........++.+|+.+|+.++|||||+++++|.+. +..+|||
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv 107 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 107 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence 4788899999999999964 799999986555555566789999999999999999999998752 2348999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCceEEcC-CCcEEEEecCCceecccCCC
Q 010401 413 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHG--VAYRDLNSQRILLDR-HGNVCLGDMGIVTACKSVGE 489 (511)
Q Consensus 413 mEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~g--IIHRDLKp~NILld~-~g~vKL~DFGlS~~l~~~~~ 489 (511)
||||+||+|.+++.+.+.+++..+..|+.||+.||+|||++| ||||||||+||||+. +|.+||+|||+|+.... .
T Consensus 108 mEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~--~ 185 (290)
T 3fpq_A 108 TELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA--S 185 (290)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT--T
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC--C
Confidence 999999999999988889999999999999999999999998 999999999999984 79999999999975432 2
Q ss_pred ccccccCCCccccHHhhcc
Q 010401 490 ATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 490 ~~~~~~Gt~~YmAPEvl~g 508 (511)
.....+||+.|||||++.+
T Consensus 186 ~~~~~~GTp~YmAPE~~~~ 204 (290)
T 3fpq_A 186 FAKAVIGTPEFMAPEMYEE 204 (290)
T ss_dssp SBEESCSSCCCCCGGGGGT
T ss_pred ccCCcccCccccCHHHcCC
Confidence 3456789999999998864
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=319.09 Aligned_cols=165 Identities=19% Similarity=0.279 Sum_probs=142.3
Q ss_pred ecCCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEE
Q 010401 337 LNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLC 410 (511)
Q Consensus 337 l~~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~ 410 (511)
...+.|++.++||+|+||.||++ +.||||+++.... ..+|+.+++.++|||||+++++|.+++. +|
T Consensus 55 ~~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-------~~~E~~il~~l~HpnIV~l~~~~~~~~~-~~ 126 (336)
T 4g3f_A 55 EEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-------RVEELVACAGLSSPRIVPLYGAVREGPW-VN 126 (336)
T ss_dssp BTTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-------CTHHHHTTTTCCCTTBCCEEEEEEETTE-EE
T ss_pred cchhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-------HHHHHHHHHhCCCCCCCcEEEEEEECCE-EE
Confidence 34567899999999999999996 4799999975322 2468999999999999999999998876 99
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCC-cEEEEecCCceecccCCC
Q 010401 411 VVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG-NVCLGDMGIVTACKSVGE 489 (511)
Q Consensus 411 LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g-~vKL~DFGlS~~l~~~~~ 489 (511)
||||||+||+|.++|...+.+++..++.|+.||+.||+|||++|||||||||+||||+.+| .+||+|||+|+.+.....
T Consensus 127 ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~ 206 (336)
T 4g3f_A 127 IFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL 206 (336)
T ss_dssp EEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred EEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence 9999999999999998888999999999999999999999999999999999999999887 699999999988754332
Q ss_pred -----ccccccCCCccccHHhhccc
Q 010401 490 -----ATEYETDGYRWLAPEVCFLL 509 (511)
Q Consensus 490 -----~~~~~~Gt~~YmAPEvl~gl 509 (511)
.....+||+.|||||++.+.
T Consensus 207 ~~~~~~~~~~~GT~~YmAPE~~~~~ 231 (336)
T 4g3f_A 207 GKSLLTGDYIPGTETHMAPEVVMGK 231 (336)
T ss_dssp -------CCCCCCGGGCCHHHHTTC
T ss_pred ccceecCCccccCccccCHHHHCCC
Confidence 12345799999999999763
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=320.97 Aligned_cols=175 Identities=23% Similarity=0.394 Sum_probs=150.7
Q ss_pred cceEecCCCeEEEeeeecccceEEEEe-----------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCC-CceeeEee
Q 010401 333 GRWLLNSDNLEFIDQIGPNSFKGVYKG-----------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGH-KNILQFYC 400 (511)
Q Consensus 333 ~~~~l~~~~y~l~~~LG~GsFG~VYkg-----------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~H-pNIV~l~g 400 (511)
.+|+++.++|++.+.||+|+||.||+| +.||||++... ........+.+|+.+|.+++| ||||+++|
T Consensus 57 ~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~-~~~~~~~~~~~E~~il~~l~hhpnIV~l~g 135 (353)
T 4ase_A 57 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVVNLLG 135 (353)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccc-cChHHHHHHHHHHHHHHHcCCCCcEEEEEE
Confidence 478999999999999999999999997 36999999742 233345668999999999965 89999999
Q ss_pred eEeeCCCcEEEEEeccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCc
Q 010401 401 VCVDENHGLCVVTKLMEGGSVNDLILKS----------------RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQR 464 (511)
Q Consensus 401 ~~~~~~~~l~LVmEy~~gGsL~~lL~~~----------------~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~N 464 (511)
+|.+.+..+|||||||++|+|.++|+.. ..+++..+..|+.||+.||+|||+++||||||||+|
T Consensus 136 ~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~N 215 (353)
T 4ase_A 136 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN 215 (353)
T ss_dssp EECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred EEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccc
Confidence 9987665589999999999999999642 348999999999999999999999999999999999
Q ss_pred eEEcCCCcEEEEecCCceecccCCC--ccccccCCCccccHHhhcc
Q 010401 465 ILLDRHGNVCLGDMGIVTACKSVGE--ATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 465 ILld~~g~vKL~DFGlS~~l~~~~~--~~~~~~Gt~~YmAPEvl~g 508 (511)
||++.++.+||+|||+|+.+..... ......||+.|||||++.+
T Consensus 216 ILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~ 261 (353)
T 4ase_A 216 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD 261 (353)
T ss_dssp EEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH
T ss_pred eeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhc
Confidence 9999999999999999987654332 2334578999999999875
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-37 Score=309.90 Aligned_cols=169 Identities=20% Similarity=0.322 Sum_probs=134.0
Q ss_pred CCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCC------
Q 010401 340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENH------ 407 (511)
Q Consensus 340 ~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~------ 407 (511)
++|++++.||+|+||.||++ +.||||++.... .......+.+|+.+|+.++|||||+++++|.+.+.
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence 46899999999999999996 479999997532 33345668999999999999999999999976542
Q ss_pred -----cEEEEEeccCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecC
Q 010401 408 -----GLCVVTKLMEGGSVNDLILKSRK---LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMG 479 (511)
Q Consensus 408 -----~l~LVmEy~~gGsL~~lL~~~~~---L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFG 479 (511)
.+|||||||.+|+|.+++..... .++..++.|+.||+.||+|||++|||||||||+|||++.+|.+||+|||
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFG 163 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFG 163 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCC
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCc
Confidence 27999999999999999976544 4556788999999999999999999999999999999999999999999
Q ss_pred CceecccCCCc------------cccccCCCccccHHhhccc
Q 010401 480 IVTACKSVGEA------------TEYETDGYRWLAPEVCFLL 509 (511)
Q Consensus 480 lS~~l~~~~~~------------~~~~~Gt~~YmAPEvl~gl 509 (511)
+|+.+...... ....+||+.|||||++.+.
T Consensus 164 la~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~ 205 (299)
T 4g31_A 164 LVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGN 205 (299)
T ss_dssp CC--------------------------CCCTTSCHHHHTTC
T ss_pred cceecCCCccccccccccccccccCCcccCccccCHHHHcCC
Confidence 99877543221 2335799999999998763
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-36 Score=302.73 Aligned_cols=165 Identities=24% Similarity=0.449 Sum_probs=137.1
Q ss_pred CCeEEEeeeecccceEEEEe----EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCC---cEEEE
Q 010401 340 DNLEFIDQIGPNSFKGVYKG----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENH---GLCVV 412 (511)
Q Consensus 340 ~~y~l~~~LG~GsFG~VYkg----k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~---~l~LV 412 (511)
++|.+.++||+|+||.||+| +.||||++.. .......++.|+..+.+++|||||+++|+|.+++. .+|||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~---~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV 79 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTEEEEEEEECG---GGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECc---cchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence 46899999999999999996 5799999963 22333444567777778999999999999987652 37999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--------CccccCCCCCceEEcCCCcEEEEecCCceec
Q 010401 413 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDH--------GVAYRDLNSQRILLDRHGNVCLGDMGIVTAC 484 (511)
Q Consensus 413 mEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~--------gIIHRDLKp~NILld~~g~vKL~DFGlS~~l 484 (511)
||||++|+|.++|.. ..+++..+..++.|++.||+|||++ +||||||||+||||+.++++||+|||+|+..
T Consensus 80 ~Ey~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~ 158 (303)
T 3hmm_A 80 SDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 158 (303)
T ss_dssp EECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred ecCCCCCcHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccc
Confidence 999999999999965 5699999999999999999999987 9999999999999999999999999999877
Q ss_pred ccCCCc----cccccCCCccccHHhhcc
Q 010401 485 KSVGEA----TEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 485 ~~~~~~----~~~~~Gt~~YmAPEvl~g 508 (511)
...... ....+||+.|||||++.+
T Consensus 159 ~~~~~~~~~~~~~~~GT~~ymAPE~l~~ 186 (303)
T 3hmm_A 159 DSATDTIDIAPNHRVGTKRYMAPEVLDD 186 (303)
T ss_dssp ETTTTEESCC-----CCGGGCCHHHHTT
T ss_pred cCCCCceeeecccccccccccCHHHhcc
Confidence 543322 223579999999999865
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-35 Score=308.99 Aligned_cols=170 Identities=21% Similarity=0.303 Sum_probs=146.2
Q ss_pred CCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeC-----CC
Q 010401 339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDE-----NH 407 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~-----~~ 407 (511)
.++|++++.||+|+||.||++ +.||||++...........++.+|+.+|+.++|||||++++++... ..
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 367999999999999999996 5799999976544455566789999999999999999999987643 23
Q ss_pred cEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccC
Q 010401 408 GLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV 487 (511)
Q Consensus 408 ~l~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~ 487 (511)
.+|||||||. |+|.+++...+.+++..++.|+.||+.||.|||++|||||||||+|||++.+|.+||+|||+|+.+...
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~ 211 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTS 211 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC---
T ss_pred EEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecccC
Confidence 4899999996 589999988889999999999999999999999999999999999999999999999999999876432
Q ss_pred C----CccccccCCCccccHHhhccc
Q 010401 488 G----EATEYETDGYRWLAPEVCFLL 509 (511)
Q Consensus 488 ~----~~~~~~~Gt~~YmAPEvl~gl 509 (511)
. ......+||+.|||||++.+.
T Consensus 212 ~~~~~~~~~~~~GT~~Y~APEv~~~~ 237 (398)
T 4b99_A 212 PAEHQYFMTEYVATRWYRAPELMLSL 237 (398)
T ss_dssp ----CCCCCSSCCCCTTCCHHHHTTC
T ss_pred ccccccccccceeChHhcCHHHhcCC
Confidence 2 234456899999999998764
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-34 Score=319.37 Aligned_cols=169 Identities=22% Similarity=0.333 Sum_probs=143.9
Q ss_pred ecCCCeEEEeeeecccceEEEEe------EEEEEEEEecCC----CCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCC
Q 010401 337 LNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCD----KGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN 406 (511)
Q Consensus 337 l~~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~----~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~ 406 (511)
+..++|++++.||+|+||+||++ +.||+|++.+.. ...........++.++..++|||||+++++|.+.+
T Consensus 186 ~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~ 265 (689)
T 3v5w_A 186 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD 265 (689)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS
T ss_pred CchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECC
Confidence 45678999999999999999995 579999996421 11111122233456667789999999999999888
Q ss_pred CcEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceeccc
Q 010401 407 HGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS 486 (511)
Q Consensus 407 ~~l~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~ 486 (511)
. +||||||++||+|.++|...+.+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.+..
T Consensus 266 ~-lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~ 344 (689)
T 3v5w_A 266 K-LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK 344 (689)
T ss_dssp E-EEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred E-EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecCC
Confidence 6 999999999999999998888999999999999999999999999999999999999999999999999999987654
Q ss_pred CCCccccccCCCccccHHhhcc
Q 010401 487 VGEATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 487 ~~~~~~~~~Gt~~YmAPEvl~g 508 (511)
. .....+||+.|||||++..
T Consensus 345 ~--~~~t~~GTp~YmAPEvl~~ 364 (689)
T 3v5w_A 345 K--KPHASVGTHGYMAPEVLQK 364 (689)
T ss_dssp C--CCCSCCSCGGGCCHHHHST
T ss_pred C--CCCCccCCcCccCHHHHhC
Confidence 3 2456799999999999963
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-33 Score=290.66 Aligned_cols=163 Identities=19% Similarity=0.344 Sum_probs=138.5
Q ss_pred CCCeEEEeeeecccceEEEEe---------EEEEEEEEecCCCCchHHHHHHHHHHHHHhC-CCCceeeEeeeEeeCCCc
Q 010401 339 SDNLEFIDQIGPNSFKGVYKG---------KRVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCVCVDENHG 408 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkg---------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l-~HpNIV~l~g~~~~~~~~ 408 (511)
.++|+++++||+|+||.||++ +.||+|++.... ...++.+|+.+|..+ +||||++++++|.+.+.
T Consensus 20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~- 94 (361)
T 4f9c_A 20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS----HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDH- 94 (361)
T ss_dssp GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTE-
T ss_pred cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc----CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCE-
Confidence 357999999999999999986 369999986421 235678999999988 79999999999998876
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCC-CcEEEEecCCceecccC
Q 010401 409 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRH-GNVCLGDMGIVTACKSV 487 (511)
Q Consensus 409 l~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~-g~vKL~DFGlS~~l~~~ 487 (511)
+||||||+++|+|.+++ +.+++.+++.|+.||+.||+|||++|||||||||+|||++.+ +.+||+|||+|+.....
T Consensus 95 ~~lvmE~~~g~~L~~~~---~~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~ 171 (361)
T 4f9c_A 95 VVIAMPYLEHESFLDIL---NSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDT 171 (361)
T ss_dssp EEEEEECCCCCCHHHHH---TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTC
T ss_pred EEEEEeCCCcccHHHHH---cCCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCc
Confidence 99999999999999998 358999999999999999999999999999999999999876 89999999999865432
Q ss_pred CC----------------------------ccccccCCCccccHHhhccc
Q 010401 488 GE----------------------------ATEYETDGYRWLAPEVCFLL 509 (511)
Q Consensus 488 ~~----------------------------~~~~~~Gt~~YmAPEvl~gl 509 (511)
.. .....+||+.|||||++.+.
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~ 221 (361)
T 4f9c_A 172 KIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKC 221 (361)
T ss_dssp SCGGGGGC--------------------------CCCCGGGCCHHHHTTC
T ss_pred cccccccccccccccccccccccccccccccccccccCccccCHHHHcCC
Confidence 11 12335799999999999764
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-33 Score=305.60 Aligned_cols=167 Identities=16% Similarity=0.290 Sum_probs=146.6
Q ss_pred CCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEE
Q 010401 339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV 412 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LV 412 (511)
.++|++++.||+|+||.||++ +.||+|++.. ........+.+|+.+|+.++|||||+++++|.+.+. +|||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~--~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~-~~iv 232 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMT--PHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNE-MVMI 232 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC--CSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSE-EEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEec--cchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE-EEEE
Confidence 357999999999999999995 5799999974 233345668899999999999999999999998776 9999
Q ss_pred EeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCC--CcEEEEecCCceecccCCC
Q 010401 413 TKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRH--GNVCLGDMGIVTACKSVGE 489 (511)
Q Consensus 413 mEy~~gGsL~~lL~~-~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~--g~vKL~DFGlS~~l~~~~~ 489 (511)
||||.||+|.++|.. .+.+++..+..|+.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+.+... .
T Consensus 233 ~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~-~ 311 (573)
T 3uto_A 233 YEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK-Q 311 (573)
T ss_dssp EECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT-S
T ss_pred EeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCC-C
Confidence 999999999999954 4689999999999999999999999999999999999999854 89999999999987543 3
Q ss_pred ccccccCCCccccHHhhccc
Q 010401 490 ATEYETDGYRWLAPEVCFLL 509 (511)
Q Consensus 490 ~~~~~~Gt~~YmAPEvl~gl 509 (511)
.....+||+.|||||++.+.
T Consensus 312 ~~~~~~GT~~y~APEv~~~~ 331 (573)
T 3uto_A 312 SVKVTTGTAEFAAPEVAEGK 331 (573)
T ss_dssp EEEEECSSGGGCCHHHHTTC
T ss_pred ceeeeEECccccCHHHhCCC
Confidence 34566899999999998763
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2.3e-31 Score=271.07 Aligned_cols=169 Identities=19% Similarity=0.296 Sum_probs=150.5
Q ss_pred CCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEE
Q 010401 339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV 412 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LV 412 (511)
.++|++.+.||+|+||.||++ +.||+|++...........++.+|+.+++.++||||+++++++.+.+. +|+|
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~-~~lv 92 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKT-LYLI 92 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE-EEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCE-EEEE
Confidence 468999999999999999996 479999997654455556678899999999999999999999988776 9999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCccc
Q 010401 413 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE 492 (511)
Q Consensus 413 mEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~~ 492 (511)
|||+++|+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..... ....
T Consensus 93 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~-~~~~ 171 (328)
T 3fe3_A 93 MEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG-GKLD 171 (328)
T ss_dssp ECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS-CGGG
T ss_pred EECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCC-Cccc
Confidence 999999999999988888999999999999999999999999999999999999999999999999999766443 3345
Q ss_pred cccCCCccccHHhhccc
Q 010401 493 YETDGYRWLAPEVCFLL 509 (511)
Q Consensus 493 ~~~Gt~~YmAPEvl~gl 509 (511)
..+||+.|+|||++.+.
T Consensus 172 ~~~gt~~y~aPE~~~~~ 188 (328)
T 3fe3_A 172 AFCGAPPYAAPELFQGK 188 (328)
T ss_dssp TTSSSGGGCCHHHHHTC
T ss_pred cccCCcceeCcccccCC
Confidence 66899999999998753
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-31 Score=273.95 Aligned_cols=170 Identities=17% Similarity=0.290 Sum_probs=148.7
Q ss_pred cCCCeEEEeeeecccceEEEEe------EEEEEEEEecCCC-CchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEE
Q 010401 338 NSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDK-GNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLC 410 (511)
Q Consensus 338 ~~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~-~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~ 410 (511)
..++|++++.||+|+||.||++ +.||+|++..... .......+.+|+.++..++||||+++++++.+.+. +|
T Consensus 3 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~-~~ 81 (337)
T 1o6l_A 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDR-LC 81 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSE-EE
T ss_pred ChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCE-EE
Confidence 4578999999999999999995 5799999974211 11223457889999999999999999999998776 99
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCc
Q 010401 411 VVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA 490 (511)
Q Consensus 411 LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~ 490 (511)
+||||+++|+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++........
T Consensus 82 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~ 161 (337)
T 1o6l_A 82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT 161 (337)
T ss_dssp EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCC
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCCCc
Confidence 99999999999999988888999999999999999999999999999999999999999999999999999875554445
Q ss_pred cccccCCCccccHHhhcc
Q 010401 491 TEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 491 ~~~~~Gt~~YmAPEvl~g 508 (511)
....+||+.|+|||++.+
T Consensus 162 ~~~~~gt~~y~aPE~~~~ 179 (337)
T 1o6l_A 162 MKTFCGTPEYLAPEVLED 179 (337)
T ss_dssp BCCCEECGGGCCGGGGSS
T ss_pred ccccccChhhCChhhhcC
Confidence 566789999999999865
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=8.3e-31 Score=261.38 Aligned_cols=172 Identities=20% Similarity=0.326 Sum_probs=148.2
Q ss_pred ceEecCCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCC
Q 010401 334 RWLLNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENH 407 (511)
Q Consensus 334 ~~~l~~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~ 407 (511)
.+.+..++|++.+.||+|+||.||++ +.||+|++.. ........+.+|+.++..++||||+++++++.+++.
T Consensus 4 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 81 (310)
T 3s95_A 4 HRIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR--FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKR 81 (310)
T ss_dssp CEEECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESC--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTE
T ss_pred ceeeChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEecc--CCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCe
Confidence 45567889999999999999999996 4699999853 344456678999999999999999999999998776
Q ss_pred cEEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceeccc
Q 010401 408 GLCVVTKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS 486 (511)
Q Consensus 408 ~l~LVmEy~~gGsL~~lL~~-~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~ 486 (511)
+++||||+.+|+|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 82 -~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 160 (310)
T 3s95_A 82 -LNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVD 160 (310)
T ss_dssp -EEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC-
T ss_pred -eEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceeccc
Confidence 9999999999999999976 56899999999999999999999999999999999999999999999999999987643
Q ss_pred CCCc--------------cccccCCCccccHHhhcc
Q 010401 487 VGEA--------------TEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 487 ~~~~--------------~~~~~Gt~~YmAPEvl~g 508 (511)
.... .....||+.|+|||++.+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 196 (310)
T 3s95_A 161 EKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMING 196 (310)
T ss_dssp -------------------CCCCSCGGGCCHHHHTT
T ss_pred ccccccccccccccccccccccCCCcceeCHHHhcC
Confidence 3221 114578999999999875
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-31 Score=274.85 Aligned_cols=171 Identities=26% Similarity=0.365 Sum_probs=141.3
Q ss_pred ecCCCeEEEeeeecccceEEEEe------EEEEEEEEecCCC-CchHHHHHHHHHHHHHhC-CCCceeeEeeeEeeCCCc
Q 010401 337 LNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDK-GNAYEFELRKDLLELMTC-GHKNILQFYCVCVDENHG 408 (511)
Q Consensus 337 l~~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~-~~~~~~~~~~Ei~iL~~l-~HpNIV~l~g~~~~~~~~ 408 (511)
+..++|++++.||+|+||.||++ +.||+|++..... .......+.+|+.++..+ +||||+++++++.+.+.
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~- 98 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDR- 98 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE-
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCE-
Confidence 55788999999999999999996 4799999974211 112234567888888887 79999999999998776
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCC
Q 010401 409 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG 488 (511)
Q Consensus 409 l~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~ 488 (511)
+|+||||+.+|+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++......
T Consensus 99 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~ 178 (353)
T 3txo_A 99 LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG 178 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecccCC
Confidence 99999999999999999888899999999999999999999999999999999999999999999999999998655544
Q ss_pred CccccccCCCccccHHhhcc
Q 010401 489 EATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 489 ~~~~~~~Gt~~YmAPEvl~g 508 (511)
......+||+.|+|||++.+
T Consensus 179 ~~~~~~~gt~~y~aPE~~~~ 198 (353)
T 3txo_A 179 VTTATFCGTPDYIAPEILQE 198 (353)
T ss_dssp -------CCGGGCCHHHHHH
T ss_pred ccccccCCCcCeEChhhcCC
Confidence 55666789999999999864
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.5e-31 Score=269.54 Aligned_cols=170 Identities=19% Similarity=0.292 Sum_probs=149.2
Q ss_pred cCCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCc-hHHHHHHHHHHHHHhC-CCCceeeEeeeEeeCCCcE
Q 010401 338 NSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGN-AYEFELRKDLLELMTC-GHKNILQFYCVCVDENHGL 409 (511)
Q Consensus 338 ~~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~-~~~~~~~~Ei~iL~~l-~HpNIV~l~g~~~~~~~~l 409 (511)
..++|++++.||+|+||.||++ +.||+|++....... .....+.+|+.++..+ +||||+++++++.+.+. +
T Consensus 7 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~-~ 85 (345)
T 3a8x_A 7 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR-L 85 (345)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE-E
T ss_pred chhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCE-E
Confidence 4568999999999999999995 579999997543333 3345578899999887 89999999999988775 9
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCC
Q 010401 410 CVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE 489 (511)
Q Consensus 410 ~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~ 489 (511)
|+||||+++|+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.......
T Consensus 86 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~~ 165 (345)
T 3a8x_A 86 FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD 165 (345)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTTC
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCCCC
Confidence 99999999999999998878899999999999999999999999999999999999999999999999999987554444
Q ss_pred ccccccCCCccccHHhhcc
Q 010401 490 ATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 490 ~~~~~~Gt~~YmAPEvl~g 508 (511)
.....+||+.|+|||++.+
T Consensus 166 ~~~~~~gt~~y~aPE~~~~ 184 (345)
T 3a8x_A 166 TTSTFCGTPNYIAPEILRG 184 (345)
T ss_dssp CBCCCCSCGGGCCHHHHTT
T ss_pred cccccCCCccccCccccCC
Confidence 5566789999999999875
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.9e-31 Score=277.62 Aligned_cols=172 Identities=19% Similarity=0.290 Sum_probs=148.6
Q ss_pred ecCCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCc-hHHHHHHHHHHHHHhC-CCCceeeEeeeEeeCCCc
Q 010401 337 LNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGN-AYEFELRKDLLELMTC-GHKNILQFYCVCVDENHG 408 (511)
Q Consensus 337 l~~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~-~~~~~~~~Ei~iL~~l-~HpNIV~l~g~~~~~~~~ 408 (511)
+..++|++++.||+|+||.||++ +.+|+|+++...... .....+.+|..++..+ +||||++++++|.+.+.
T Consensus 49 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~- 127 (396)
T 4dc2_A 49 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR- 127 (396)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSE-
T ss_pred CChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCE-
Confidence 45678999999999999999996 479999997533222 1223467888888776 89999999999998776
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCC
Q 010401 409 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG 488 (511)
Q Consensus 409 l~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~ 488 (511)
+|+||||+++|+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++......
T Consensus 128 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~ 207 (396)
T 4dc2_A 128 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG 207 (396)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred EEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecccCC
Confidence 99999999999999999888899999999999999999999999999999999999999999999999999998755555
Q ss_pred CccccccCCCccccHHhhccc
Q 010401 489 EATEYETDGYRWLAPEVCFLL 509 (511)
Q Consensus 489 ~~~~~~~Gt~~YmAPEvl~gl 509 (511)
......+||+.|+|||++.+.
T Consensus 208 ~~~~~~~gt~~Y~aPE~l~~~ 228 (396)
T 4dc2_A 208 DTTSTFCGTPNYIAPEILRGE 228 (396)
T ss_dssp CCBCCCCBCGGGCCHHHHTTC
T ss_pred CccccccCCcccCCchhhcCC
Confidence 556677899999999998753
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=99.97 E-value=9.6e-31 Score=258.78 Aligned_cols=167 Identities=20% Similarity=0.334 Sum_probs=146.8
Q ss_pred CCeEEEeeeecccceEEEEeE------EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEE
Q 010401 340 DNLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT 413 (511)
Q Consensus 340 ~~y~l~~~LG~GsFG~VYkgk------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVm 413 (511)
++|++.+.||+|+||.||+++ .||+|++............+.+|+.+++.++||||+++++++.+++. +|+||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~lv~ 80 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKK-LTLVF 80 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTE-EEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCE-EEEEE
Confidence 579999999999999999964 69999998655555556678899999999999999999999998776 99999
Q ss_pred eccCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCccc
Q 010401 414 KLMEGGSVNDLIL-KSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE 492 (511)
Q Consensus 414 Ey~~gGsL~~lL~-~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~~ 492 (511)
||+.+ ++.+.+. ..+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..........
T Consensus 81 e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 159 (292)
T 3o0g_A 81 EFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYS 159 (292)
T ss_dssp ECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSCCC
T ss_pred ecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCcccccc
Confidence 99987 6666554 457899999999999999999999999999999999999999999999999999988765555556
Q ss_pred cccCCCccccHHhhcc
Q 010401 493 YETDGYRWLAPEVCFL 508 (511)
Q Consensus 493 ~~~Gt~~YmAPEvl~g 508 (511)
...||+.|+|||++.+
T Consensus 160 ~~~~t~~y~aPE~~~~ 175 (292)
T 3o0g_A 160 AEVVTLWYRPPDVLFG 175 (292)
T ss_dssp SCCSCGGGCCHHHHTT
T ss_pred CCccccCCcChHHHcC
Confidence 6788999999999865
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.5e-31 Score=264.50 Aligned_cols=175 Identities=25% Similarity=0.350 Sum_probs=142.2
Q ss_pred ceEecCCCeEEEeeeecccceEEEEe----EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcE
Q 010401 334 RWLLNSDNLEFIDQIGPNSFKGVYKG----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGL 409 (511)
Q Consensus 334 ~~~l~~~~y~l~~~LG~GsFG~VYkg----k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l 409 (511)
.+.+..++|++.+.||+|+||.||++ +.||+|++...........++.+|+.++++++||||+++++++.+.+. +
T Consensus 31 ~~~i~~~~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~-~ 109 (309)
T 3p86_A 31 DMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPN-L 109 (309)
T ss_dssp -CBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTC-C
T ss_pred cccCChhHceeeeEeecCCCeEEEEEEECCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCc-e
Confidence 56677889999999999999999996 579999997655445555678999999999999999999999988776 8
Q ss_pred EEEEeccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCceEEcCCCcEEEEecCCceec
Q 010401 410 CVVTKLMEGGSVNDLILKSR---KLQTKEIIRIAIDVAEGIKFLNDHG--VAYRDLNSQRILLDRHGNVCLGDMGIVTAC 484 (511)
Q Consensus 410 ~LVmEy~~gGsL~~lL~~~~---~L~e~~~~~ia~qIa~gL~yLH~~g--IIHRDLKp~NILld~~g~vKL~DFGlS~~l 484 (511)
|+||||+.+|+|.+++.... .+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++..
T Consensus 110 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~ 189 (309)
T 3p86_A 110 SIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK 189 (309)
T ss_dssp EEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC-----
T ss_pred EEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCccc
Confidence 99999999999999997644 3999999999999999999999999 999999999999999999999999999865
Q ss_pred ccCCCccccccCCCccccHHhhccc
Q 010401 485 KSVGEATEYETDGYRWLAPEVCFLL 509 (511)
Q Consensus 485 ~~~~~~~~~~~Gt~~YmAPEvl~gl 509 (511)
...........||+.|+|||++.+.
T Consensus 190 ~~~~~~~~~~~gt~~y~aPE~~~~~ 214 (309)
T 3p86_A 190 ASTFLSSKSAAGTPEWMAPEVLRDE 214 (309)
T ss_dssp ------------CCTTSCHHHHTTC
T ss_pred cccccccccCCCCccccChhhhcCC
Confidence 5443344566899999999998753
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7.1e-31 Score=269.96 Aligned_cols=172 Identities=22% Similarity=0.322 Sum_probs=146.5
Q ss_pred EecCCCeEEEeeeecccceEEEEe------EEEEEEEEecCCC-CchHHHHHHHHHHHHHhC-CCCceeeEeeeEeeCCC
Q 010401 336 LLNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDK-GNAYEFELRKDLLELMTC-GHKNILQFYCVCVDENH 407 (511)
Q Consensus 336 ~l~~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~-~~~~~~~~~~Ei~iL~~l-~HpNIV~l~g~~~~~~~ 407 (511)
.+..++|++.+.||+|+||.||++ +.||+|+++.... .......+..|..++..+ +||||+++++++.+.+.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 356789999999999999999996 4799999974211 111234467788888765 99999999999998776
Q ss_pred cEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccC
Q 010401 408 GLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV 487 (511)
Q Consensus 408 ~l~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~ 487 (511)
+|+||||+++|+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 93 -~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 171 (345)
T 1xjd_A 93 -LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 171 (345)
T ss_dssp -EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred -EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccC
Confidence 9999999999999999988888999999999999999999999999999999999999999999999999999865444
Q ss_pred CCccccccCCCccccHHhhcc
Q 010401 488 GEATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 488 ~~~~~~~~Gt~~YmAPEvl~g 508 (511)
.......+||+.|+|||++.+
T Consensus 172 ~~~~~~~~gt~~y~aPE~~~~ 192 (345)
T 1xjd_A 172 DAKTNTFCGTPDYIAPEILLG 192 (345)
T ss_dssp TCCBCCCCSCGGGCCHHHHTT
T ss_pred CCcccCCCCCcccCChhhhcC
Confidence 444566789999999999875
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-30 Score=264.13 Aligned_cols=171 Identities=17% Similarity=0.304 Sum_probs=138.0
Q ss_pred ecCCCeEEEeeeecccceEEEEeE---------EEEEEEEecCCC--CchHHHHHHHHHHHHHhCCCCceeeEeeeEeeC
Q 010401 337 LNSDNLEFIDQIGPNSFKGVYKGK---------RVGIEKLKGCDK--GNAYEFELRKDLLELMTCGHKNILQFYCVCVDE 405 (511)
Q Consensus 337 l~~~~y~l~~~LG~GsFG~VYkgk---------~VAVKkL~~~~~--~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~ 405 (511)
+..++|++.+.||+|+||.||+++ .||+|+++.... .......+.+|+.++..++||||+++++++.+.
T Consensus 14 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 93 (327)
T 3a62_A 14 IRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTG 93 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECS
T ss_pred CCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcC
Confidence 456789999999999999999854 699999975322 122334578899999999999999999999987
Q ss_pred CCcEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecc
Q 010401 406 NHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK 485 (511)
Q Consensus 406 ~~~l~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~ 485 (511)
+. +|+||||+.+|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 94 ~~-~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~ 172 (327)
T 3a62_A 94 GK-LYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESI 172 (327)
T ss_dssp SC-EEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC----
T ss_pred CE-EEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcccccc
Confidence 76 99999999999999999888889999999999999999999999999999999999999999999999999988655
Q ss_pred cCCCccccccCCCccccHHhhcc
Q 010401 486 SVGEATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 486 ~~~~~~~~~~Gt~~YmAPEvl~g 508 (511)
..........||+.|+|||++.+
T Consensus 173 ~~~~~~~~~~gt~~y~aPE~~~~ 195 (327)
T 3a62_A 173 HDGTVTHTFCGTIEYMAPEILMR 195 (327)
T ss_dssp ------CTTSSCCTTSCHHHHTT
T ss_pred cCCccccccCCCcCccCHhhCcC
Confidence 44444556689999999999865
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-30 Score=269.65 Aligned_cols=171 Identities=20% Similarity=0.267 Sum_probs=147.1
Q ss_pred ecCCCeEEEeeeecccceEEEEe------EEEEEEEEecCCC-CchHHHHHHHHHHHHHhC-CCCceeeEeeeEeeCCCc
Q 010401 337 LNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDK-GNAYEFELRKDLLELMTC-GHKNILQFYCVCVDENHG 408 (511)
Q Consensus 337 l~~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~-~~~~~~~~~~Ei~iL~~l-~HpNIV~l~g~~~~~~~~ 408 (511)
+..++|++++.||+|+||.||++ +.||+|++..... .......+..|..++..+ +||||+++++++.+.+.
T Consensus 17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~- 95 (353)
T 2i0e_A 17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR- 95 (353)
T ss_dssp --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSE-
T ss_pred CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCE-
Confidence 55789999999999999999995 5799999974211 112234567888888877 89999999999988775
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCC
Q 010401 409 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG 488 (511)
Q Consensus 409 l~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~ 488 (511)
+|+||||+++|+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++......
T Consensus 96 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~ 175 (353)
T 2i0e_A 96 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG 175 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccCC
Confidence 99999999999999999887889999999999999999999999999999999999999999999999999998755444
Q ss_pred CccccccCCCccccHHhhcc
Q 010401 489 EATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 489 ~~~~~~~Gt~~YmAPEvl~g 508 (511)
......+||+.|+|||++.+
T Consensus 176 ~~~~~~~gt~~y~aPE~~~~ 195 (353)
T 2i0e_A 176 VTTKTFCGTPDYIAPEIIAY 195 (353)
T ss_dssp CCBCCCCSCGGGCCHHHHTT
T ss_pred cccccccCCccccChhhhcC
Confidence 45566789999999999865
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-30 Score=268.41 Aligned_cols=173 Identities=20% Similarity=0.409 Sum_probs=147.7
Q ss_pred ceEecCCCeEEEeeeecccceEEEEeE-------------EEEEEEEecCCCCchHHHHHHHHHHHHHhC-CCCceeeEe
Q 010401 334 RWLLNSDNLEFIDQIGPNSFKGVYKGK-------------RVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFY 399 (511)
Q Consensus 334 ~~~l~~~~y~l~~~LG~GsFG~VYkgk-------------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l-~HpNIV~l~ 399 (511)
.|.+..++|++.+.||+|+||.||+++ .||+|+++.. .......++.+|+.++..+ +||||++++
T Consensus 75 ~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~ 153 (370)
T 2psq_A 75 KWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLL 153 (370)
T ss_dssp TTBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTT-CBHHHHHHHHHHHHHHHHSCCCTTBCCEE
T ss_pred cccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCC-cCHHHHHHHHHHHHHHHHhcCCCCEeeEE
Confidence 456677899999999999999999975 4999999743 2333455689999999999 899999999
Q ss_pred eeEeeCCCcEEEEEeccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCC
Q 010401 400 CVCVDENHGLCVVTKLMEGGSVNDLILKSR----------------KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQ 463 (511)
Q Consensus 400 g~~~~~~~~l~LVmEy~~gGsL~~lL~~~~----------------~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~ 463 (511)
++|.+.+. +|+||||+.+|+|.+++.... .+++..++.++.||+.||+|||++||+||||||+
T Consensus 154 ~~~~~~~~-~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~ 232 (370)
T 2psq_A 154 GACTQDGP-LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAAR 232 (370)
T ss_dssp EEECSSSS-CEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGG
T ss_pred EEEccCCC-EEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchh
Confidence 99988776 999999999999999997542 4789999999999999999999999999999999
Q ss_pred ceEEcCCCcEEEEecCCceecccCCC--ccccccCCCccccHHhhcc
Q 010401 464 RILLDRHGNVCLGDMGIVTACKSVGE--ATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 464 NILld~~g~vKL~DFGlS~~l~~~~~--~~~~~~Gt~~YmAPEvl~g 508 (511)
|||++.++.+||+|||+++....... ......+++.|+|||++.+
T Consensus 233 NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~ 279 (370)
T 2psq_A 233 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD 279 (370)
T ss_dssp GEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHT
T ss_pred hEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcC
Confidence 99999999999999999987654332 2334456789999999865
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-30 Score=260.35 Aligned_cols=166 Identities=22% Similarity=0.358 Sum_probs=146.5
Q ss_pred CCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEE
Q 010401 339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV 412 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LV 412 (511)
.++|++.+.||+|+||.||++ +.||+|++...... ....+.+|+.+++.++||||+++++++.+.+. +|+|
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~-~~lv 95 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGDE-LWVV 95 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE-EEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccccc--HHHHHHHHHHHHhcCCCCCCCeEeEEEEECCE-EEEE
Confidence 457899999999999999996 47999999753332 24557899999999999999999999998876 9999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCccc
Q 010401 413 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE 492 (511)
Q Consensus 413 mEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~~ 492 (511)
|||+.+|+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...........
T Consensus 96 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 174 (297)
T 3fxz_A 96 MEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS 174 (297)
T ss_dssp EECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBC
T ss_pred EECCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccccC
Confidence 999999999999865 4699999999999999999999999999999999999999999999999999988765555556
Q ss_pred cccCCCccccHHhhcc
Q 010401 493 YETDGYRWLAPEVCFL 508 (511)
Q Consensus 493 ~~~Gt~~YmAPEvl~g 508 (511)
...||+.|+|||++.+
T Consensus 175 ~~~gt~~y~aPE~~~~ 190 (297)
T 3fxz_A 175 TMVGTPYWMAPEVVTR 190 (297)
T ss_dssp CCCSCGGGCCHHHHHC
T ss_pred CccCCcCccChhhhcC
Confidence 6789999999999865
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=8.6e-31 Score=265.72 Aligned_cols=175 Identities=23% Similarity=0.396 Sum_probs=148.9
Q ss_pred cceEecCCCeEEEeeeecccceEEEEe-----------EEEEEEEEecCCCCchHHHHHHHHHHHHHhC-CCCceeeEee
Q 010401 333 GRWLLNSDNLEFIDQIGPNSFKGVYKG-----------KRVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYC 400 (511)
Q Consensus 333 ~~~~l~~~~y~l~~~LG~GsFG~VYkg-----------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l-~HpNIV~l~g 400 (511)
..|.+..++|++.+.||+|+||.||++ +.||+|+++.. ........+.+|+.++..+ +||||+++++
T Consensus 15 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpniv~~~~ 93 (359)
T 3vhe_A 15 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVVNLLG 93 (359)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCc-CCHHHHHHHHHHHHHHHhhcCCcceeeeee
Confidence 367788999999999999999999998 47999999742 3333455689999999999 8999999999
Q ss_pred eEeeCCCcEEEEEeccCCCCHHHHHHhcCC--------------------------------------------------
Q 010401 401 VCVDENHGLCVVTKLMEGGSVNDLILKSRK-------------------------------------------------- 430 (511)
Q Consensus 401 ~~~~~~~~l~LVmEy~~gGsL~~lL~~~~~-------------------------------------------------- 430 (511)
++.+.+..+++||||+.+|+|.+++.....
T Consensus 94 ~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (359)
T 3vhe_A 94 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSL 173 (359)
T ss_dssp EECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------------
T ss_pred eeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccccc
Confidence 998876668999999999999999965432
Q ss_pred ----------------CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCC--ccc
Q 010401 431 ----------------LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE--ATE 492 (511)
Q Consensus 431 ----------------L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~--~~~ 492 (511)
+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... ...
T Consensus 174 ~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 253 (359)
T 3vhe_A 174 SDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 253 (359)
T ss_dssp ----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC-
T ss_pred chhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhcc
Confidence 89999999999999999999999999999999999999999999999999986643322 233
Q ss_pred cccCCCccccHHhhcc
Q 010401 493 YETDGYRWLAPEVCFL 508 (511)
Q Consensus 493 ~~~Gt~~YmAPEvl~g 508 (511)
...||+.|+|||++.+
T Consensus 254 ~~~~t~~y~aPE~~~~ 269 (359)
T 3vhe_A 254 DARLPLKWMAPETIFD 269 (359)
T ss_dssp -CEECGGGCCHHHHHH
T ss_pred ccCCCceeEChhhhcC
Confidence 4567889999999864
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.1e-30 Score=262.23 Aligned_cols=171 Identities=22% Similarity=0.330 Sum_probs=144.2
Q ss_pred EecCCCeEEEeeeecccceEEEEeEE---------EEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCC
Q 010401 336 LLNSDNLEFIDQIGPNSFKGVYKGKR---------VGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN 406 (511)
Q Consensus 336 ~l~~~~y~l~~~LG~GsFG~VYkgk~---------VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~ 406 (511)
.+..++|++.+.||+|+||.||+|+. ||+|+++.. ........+.+|+.++..++||||+++++++.+.+
T Consensus 45 ~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 123 (325)
T 3kul_A 45 EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAG-YTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGR 123 (325)
T ss_dssp BCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTT-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGG
T ss_pred ccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCC-CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence 45678899999999999999999753 999999742 23444567899999999999999999999998777
Q ss_pred CcEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecc
Q 010401 407 HGLCVVTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK 485 (511)
Q Consensus 407 ~~l~LVmEy~~gGsL~~lL~~~-~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~ 485 (511)
. +|+||||+.+|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 124 ~-~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 202 (325)
T 3kul_A 124 L-AMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLE 202 (325)
T ss_dssp C-CEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred c-cEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence 6 89999999999999999654 589999999999999999999999999999999999999999999999999998765
Q ss_pred cCCCc---cccccCCCccccHHhhcc
Q 010401 486 SVGEA---TEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 486 ~~~~~---~~~~~Gt~~YmAPEvl~g 508 (511)
..... .....+|+.|+|||++.+
T Consensus 203 ~~~~~~~~~~~~~~t~~y~aPE~~~~ 228 (325)
T 3kul_A 203 DDPDAAYTTTGGKIPIRWTAPEAIAF 228 (325)
T ss_dssp ----CCEECC---CCGGGSCHHHHHH
T ss_pred cCccceeeccCCCCcccccCHhHhcC
Confidence 43322 222345678999999864
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.1e-30 Score=256.81 Aligned_cols=170 Identities=19% Similarity=0.311 Sum_probs=142.7
Q ss_pred CCCeEEEeeeecccceEEEEeE------EEEEEEEecCCCCc-hHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEE
Q 010401 339 SDNLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDKGN-AYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCV 411 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkgk------~VAVKkL~~~~~~~-~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~L 411 (511)
.++|++.+.||+|+||.||+++ .||+|++....... .....+.+|+.++..++||||+++++++.+.+. +|+
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~-~~l 88 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDC-YYL 88 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSE-EEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCe-EEE
Confidence 5689999999999999999964 79999997543333 344668999999999999999999999987765 999
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCC-c
Q 010401 412 VTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE-A 490 (511)
Q Consensus 412 VmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~-~ 490 (511)
||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... .
T Consensus 89 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 168 (294)
T 4eqm_A 89 VMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQ 168 (294)
T ss_dssp EEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-------
T ss_pred EEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccccccccc
Confidence 999999999999998888899999999999999999999999999999999999999999999999999876643322 2
Q ss_pred cccccCCCccccHHhhccc
Q 010401 491 TEYETDGYRWLAPEVCFLL 509 (511)
Q Consensus 491 ~~~~~Gt~~YmAPEvl~gl 509 (511)
.....||+.|+|||++.+.
T Consensus 169 ~~~~~gt~~y~aPE~~~~~ 187 (294)
T 4eqm_A 169 TNHVLGTVQYFSPEQAKGE 187 (294)
T ss_dssp ------CCSSCCHHHHHTC
T ss_pred cCccccCccccCHhHhcCC
Confidence 3345789999999998753
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.5e-30 Score=262.84 Aligned_cols=171 Identities=16% Similarity=0.211 Sum_probs=146.1
Q ss_pred cceEecCCCeEEEeeeecccceEEEEe-----------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCC---CCceeeE
Q 010401 333 GRWLLNSDNLEFIDQIGPNSFKGVYKG-----------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCG---HKNILQF 398 (511)
Q Consensus 333 ~~~~l~~~~y~l~~~LG~GsFG~VYkg-----------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~---HpNIV~l 398 (511)
..+.+..++|++.+.||+|+||.||+| +.||+|++... . ..++.+|+.++..++ |+||+++
T Consensus 58 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~--~~~~~~e~~~~~~l~~~~~~~iv~~ 132 (365)
T 3e7e_A 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---N--PWEFYIGTQLMERLKPSMQHMFMKF 132 (365)
T ss_dssp CEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---C--HHHHHHHHHHHHHSCGGGGGGBCCE
T ss_pred eeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---C--hhHHHHHHHHHHHhhhhhhhhhhhh
Confidence 467788899999999999999999998 25899999632 2 345677777777776 9999999
Q ss_pred eeeEeeCCCcEEEEEeccCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcC----
Q 010401 399 YCVCVDENHGLCVVTKLMEGGSVNDLILK-----SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDR---- 469 (511)
Q Consensus 399 ~g~~~~~~~~l~LVmEy~~gGsL~~lL~~-----~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~---- 469 (511)
++++...+. .|+||||+++|+|.+++.. ...+++..++.++.||+.||+|||++|||||||||+|||++.
T Consensus 133 ~~~~~~~~~-~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~ 211 (365)
T 3e7e_A 133 YSAHLFQNG-SVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLE 211 (365)
T ss_dssp EEEEECSSC-EEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTC
T ss_pred heeeecCCC-cEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccC
Confidence 999998876 9999999999999999963 457999999999999999999999999999999999999998
Q ss_pred -------CCcEEEEecCCceecccC--CCccccccCCCccccHHhhccc
Q 010401 470 -------HGNVCLGDMGIVTACKSV--GEATEYETDGYRWLAPEVCFLL 509 (511)
Q Consensus 470 -------~g~vKL~DFGlS~~l~~~--~~~~~~~~Gt~~YmAPEvl~gl 509 (511)
++.+||+|||+++.+... .......+||+.|+|||++.+.
T Consensus 212 ~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 260 (365)
T 3e7e_A 212 QDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNK 260 (365)
T ss_dssp C------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTC
T ss_pred ccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCC
Confidence 899999999999765422 2234556799999999998763
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-30 Score=264.08 Aligned_cols=167 Identities=22% Similarity=0.328 Sum_probs=145.5
Q ss_pred cCCCeEEEeeeecccceEEEEe------EEEEEEEEecCCC-CchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEE
Q 010401 338 NSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDK-GNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLC 410 (511)
Q Consensus 338 ~~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~-~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~ 410 (511)
..++|++++.||+|+||.||++ +.||+|++..... .......+.+|+.++..++||||+++++++.+.+. +|
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~-~~ 82 (318)
T 1fot_A 4 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQ-IF 82 (318)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSE-EE
T ss_pred ChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCE-EE
Confidence 3568899999999999999985 5799999974211 11123457789999999999999999999988775 99
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCc
Q 010401 411 VVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA 490 (511)
Q Consensus 411 LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~ 490 (511)
+||||+++|+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.... .
T Consensus 83 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~---~ 159 (318)
T 1fot_A 83 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD---V 159 (318)
T ss_dssp EEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS---C
T ss_pred EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCC---c
Confidence 9999999999999998888899999999999999999999999999999999999999999999999999987543 2
Q ss_pred cccccCCCccccHHhhcc
Q 010401 491 TEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 491 ~~~~~Gt~~YmAPEvl~g 508 (511)
....+||+.|+|||++.+
T Consensus 160 ~~~~~gt~~y~aPE~~~~ 177 (318)
T 1fot_A 160 TYTLCGTPDYIAPEVVST 177 (318)
T ss_dssp BCCCCSCTTTCCHHHHTT
T ss_pred cccccCCccccCHhHhcC
Confidence 345689999999999865
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.3e-30 Score=274.02 Aligned_cols=169 Identities=17% Similarity=0.236 Sum_probs=147.7
Q ss_pred CCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEE
Q 010401 339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV 412 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LV 412 (511)
.++|++.+.||+|+||.||++ +.+|+|++............+.+|+.+++.++||||+++++++.+++. +|+|
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~-~~lv 88 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGH-HYLI 88 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSE-EEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCE-EEEE
Confidence 356899999999999999995 579999998644444455668999999999999999999999988776 9999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEc---CCCcEEEEecCCceecccCCC
Q 010401 413 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLD---RHGNVCLGDMGIVTACKSVGE 489 (511)
Q Consensus 413 mEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld---~~g~vKL~DFGlS~~l~~~~~ 489 (511)
|||+.+|+|.+.+...+.+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++.......
T Consensus 89 ~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~ 168 (444)
T 3soa_A 89 FDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ 168 (444)
T ss_dssp ECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCC
T ss_pred EEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCc
Confidence 99999999999998888999999999999999999999999999999999999998 467899999999987765554
Q ss_pred ccccccCCCccccHHhhcc
Q 010401 490 ATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 490 ~~~~~~Gt~~YmAPEvl~g 508 (511)
......||+.|+|||++.+
T Consensus 169 ~~~~~~gt~~Y~APE~l~~ 187 (444)
T 3soa_A 169 AWFGFAGTPGYLSPEVLRK 187 (444)
T ss_dssp BCCCSCSCGGGCCHHHHTT
T ss_pred eeecccCCcccCCHHHhcC
Confidence 4556789999999999865
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-30 Score=270.79 Aligned_cols=170 Identities=21% Similarity=0.304 Sum_probs=140.2
Q ss_pred cCCCeEEEeeeecccceEEEEeE------EEEEEEEecCCCCc-hHHHHHHHHHHH-HHhCCCCceeeEeeeEeeCCCcE
Q 010401 338 NSDNLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDKGN-AYEFELRKDLLE-LMTCGHKNILQFYCVCVDENHGL 409 (511)
Q Consensus 338 ~~~~y~l~~~LG~GsFG~VYkgk------~VAVKkL~~~~~~~-~~~~~~~~Ei~i-L~~l~HpNIV~l~g~~~~~~~~l 409 (511)
..++|++++.||+|+||.||+++ .+|+|++....... .....+.+|..+ ++.++||||+++++++.+.+. +
T Consensus 36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~-~ 114 (373)
T 2r5t_A 36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADK-L 114 (373)
T ss_dssp CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSE-E
T ss_pred ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCE-E
Confidence 45688999999999999999964 69999997543222 223445666665 456899999999999998775 9
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCC
Q 010401 410 CVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE 489 (511)
Q Consensus 410 ~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~ 489 (511)
|+||||+.+|+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.......
T Consensus 115 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~~ 194 (373)
T 2r5t_A 115 YFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNS 194 (373)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCCC
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccCCC
Confidence 99999999999999998888899999999999999999999999999999999999999999999999999987554444
Q ss_pred ccccccCCCccccHHhhcc
Q 010401 490 ATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 490 ~~~~~~Gt~~YmAPEvl~g 508 (511)
.....+||+.|+|||++.+
T Consensus 195 ~~~~~~gt~~y~aPE~~~~ 213 (373)
T 2r5t_A 195 TTSTFCGTPEYLAPEVLHK 213 (373)
T ss_dssp CCCSBSCCCCCCCHHHHTT
T ss_pred ccccccCCccccCHHHhCC
Confidence 5667789999999999875
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=9.6e-31 Score=277.92 Aligned_cols=173 Identities=20% Similarity=0.267 Sum_probs=147.3
Q ss_pred ceEecCCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCc-hHHHHHHHHHHHHHhCCCCceeeEeeeEeeCC
Q 010401 334 RWLLNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGN-AYEFELRKDLLELMTCGHKNILQFYCVCVDEN 406 (511)
Q Consensus 334 ~~~l~~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~-~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~ 406 (511)
.+.+..++|++++.||+|+||.||++ +.||+|++....... .....+.+|+.++..++||||++++++|.+.+
T Consensus 68 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~ 147 (437)
T 4aw2_A 68 QMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDN 147 (437)
T ss_dssp HHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSS
T ss_pred cccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCC
Confidence 34566789999999999999999996 579999996421111 11122678899999999999999999999877
Q ss_pred CcEEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecc
Q 010401 407 HGLCVVTKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK 485 (511)
Q Consensus 407 ~~l~LVmEy~~gGsL~~lL~~-~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~ 485 (511)
. +|+||||+++|+|.+++.. .+.+++..++.++.||+.||.|||++|||||||||+|||++.++.+||+|||+++...
T Consensus 148 ~-~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~ 226 (437)
T 4aw2_A 148 N-LYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLM 226 (437)
T ss_dssp E-EEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred E-EEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcc
Confidence 6 9999999999999999976 4689999999999999999999999999999999999999999999999999998765
Q ss_pred cCCCc-cccccCCCccccHHhhc
Q 010401 486 SVGEA-TEYETDGYRWLAPEVCF 507 (511)
Q Consensus 486 ~~~~~-~~~~~Gt~~YmAPEvl~ 507 (511)
..... ....+||+.|+|||++.
T Consensus 227 ~~~~~~~~~~~GT~~Y~APE~l~ 249 (437)
T 4aw2_A 227 EDGTVQSSVAVGTPDYISPEILQ 249 (437)
T ss_dssp TTSCEECCSCCSCGGGCCHHHHH
T ss_pred cCCCcccccccCCcCeeChHHHh
Confidence 44332 33468999999999986
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-30 Score=272.07 Aligned_cols=171 Identities=19% Similarity=0.300 Sum_probs=149.0
Q ss_pred EecCCCeEEEeeeecccceEEEEe------EEEEEEEEecCCC-CchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCc
Q 010401 336 LLNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDK-GNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHG 408 (511)
Q Consensus 336 ~l~~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~-~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~ 408 (511)
.+..++|++++.||+|+||.||++ +.||+|++..... .......+.+|+.++..++||||++++++|.+.+.
T Consensus 11 ~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~- 89 (384)
T 4fr4_A 11 DVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEED- 89 (384)
T ss_dssp CCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE-
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE-
Confidence 355678999999999999999996 4699999964221 11223557899999999999999999999998776
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCC
Q 010401 409 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG 488 (511)
Q Consensus 409 l~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~ 488 (511)
+|+||||+.+|+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~- 168 (384)
T 4fr4_A 90 MFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE- 168 (384)
T ss_dssp EEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT-
T ss_pred EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCC-
Confidence 9999999999999999988888999999999999999999999999999999999999999999999999999876543
Q ss_pred CccccccCCCccccHHhhcc
Q 010401 489 EATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 489 ~~~~~~~Gt~~YmAPEvl~g 508 (511)
......+||+.|+|||++.+
T Consensus 169 ~~~~~~~gt~~Y~aPE~~~~ 188 (384)
T 4fr4_A 169 TQITTMAGTKPYMAPEMFSS 188 (384)
T ss_dssp CCBCCCCSCGGGCCGGGTCC
T ss_pred CceeccCCCccccCCeeecc
Confidence 33556789999999999864
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.6e-30 Score=258.64 Aligned_cols=169 Identities=21% Similarity=0.309 Sum_probs=142.8
Q ss_pred cCCCeEEEeeeecccceEEEEeE-----EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEE
Q 010401 338 NSDNLEFIDQIGPNSFKGVYKGK-----RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV 412 (511)
Q Consensus 338 ~~~~y~l~~~LG~GsFG~VYkgk-----~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LV 412 (511)
-.++|++++.||+|+||.||+++ .||+|++............+.+|+.+++.++||||+++++++.+++. +|+|
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~-~~lv 97 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERC-LTLV 97 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSC-EEEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCE-EEEE
Confidence 35789999999999999999964 69999997544444445668899999999999999999999988776 9999
Q ss_pred EeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCcc
Q 010401 413 TKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT 491 (511)
Q Consensus 413 mEy~~gGsL~~lL~~~-~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~ 491 (511)
|||+.+ +|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.........
T Consensus 98 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~ 176 (311)
T 3niz_A 98 FEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSY 176 (311)
T ss_dssp EECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC--
T ss_pred EcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCCcccc
Confidence 999986 888888654 469999999999999999999999999999999999999999999999999998876544445
Q ss_pred ccccCCCccccHHhhcc
Q 010401 492 EYETDGYRWLAPEVCFL 508 (511)
Q Consensus 492 ~~~~Gt~~YmAPEvl~g 508 (511)
....||+.|+|||++.+
T Consensus 177 ~~~~~t~~y~aPE~~~~ 193 (311)
T 3niz_A 177 THEVVTLWYRAPDVLMG 193 (311)
T ss_dssp -CCCCCCTTCCHHHHTT
T ss_pred cCCcccCCcCCHHHhcC
Confidence 56688999999999865
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.2e-30 Score=254.45 Aligned_cols=173 Identities=21% Similarity=0.390 Sum_probs=148.3
Q ss_pred ceEecCCCeEEEeeeecccceEEEEe-----------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeE
Q 010401 334 RWLLNSDNLEFIDQIGPNSFKGVYKG-----------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVC 402 (511)
Q Consensus 334 ~~~l~~~~y~l~~~LG~GsFG~VYkg-----------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~ 402 (511)
.|.+..++|++.+.||+|+||.||++ +.||+|++... ........+.+|+.+++.++||||+++++++
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 95 (314)
T 2ivs_A 17 KWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN-ASPSELRDLLSEFNVLKQVNHPHVIKLYGAC 95 (314)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTT-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred ccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCC-CCHHHHHHHHHHHHHHhhCCCCceeeEEEEE
Confidence 56778889999999999999999997 56999999742 2334456688999999999999999999999
Q ss_pred eeCCCcEEEEEeccCCCCHHHHHHhcC------------------------CCCHHHHHHHHHHHHHHHHHHHHCCcccc
Q 010401 403 VDENHGLCVVTKLMEGGSVNDLILKSR------------------------KLQTKEIIRIAIDVAEGIKFLNDHGVAYR 458 (511)
Q Consensus 403 ~~~~~~l~LVmEy~~gGsL~~lL~~~~------------------------~L~e~~~~~ia~qIa~gL~yLH~~gIIHR 458 (511)
.+.+. +|+||||+.+|+|.+++.... .+++..++.++.||+.||.|||++||+||
T Consensus 96 ~~~~~-~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~ 174 (314)
T 2ivs_A 96 SQDGP-LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHR 174 (314)
T ss_dssp CSSSS-CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred ecCCc-eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCccc
Confidence 88776 999999999999999997543 38999999999999999999999999999
Q ss_pred CCCCCceEEcCCCcEEEEecCCceecccCCC--ccccccCCCccccHHhhcc
Q 010401 459 DLNSQRILLDRHGNVCLGDMGIVTACKSVGE--ATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 459 DLKp~NILld~~g~vKL~DFGlS~~l~~~~~--~~~~~~Gt~~YmAPEvl~g 508 (511)
||||+|||++.++.+||+|||+++....... ......+++.|+|||++.+
T Consensus 175 dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 226 (314)
T 2ivs_A 175 DLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFD 226 (314)
T ss_dssp CCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHH
T ss_pred ccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcC
Confidence 9999999999999999999999987654332 2233456788999998864
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.3e-30 Score=258.99 Aligned_cols=173 Identities=23% Similarity=0.362 Sum_probs=148.6
Q ss_pred ccceEecCCCeEEEeeeecccceEEEEe----EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCC
Q 010401 332 IGRWLLNSDNLEFIDQIGPNSFKGVYKG----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENH 407 (511)
Q Consensus 332 i~~~~l~~~~y~l~~~LG~GsFG~VYkg----k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~ 407 (511)
...+.+..++|++.+.||+|+||.||+| +.||+|++.. .........+|+.++..++||||+++++++.+...
T Consensus 16 ~~n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 92 (322)
T 3soc_A 16 TENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPI---QDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTS 92 (322)
T ss_dssp CCCEEETTEEEEEEEEEECSTTCEEEEEEETTEEEEEEEECG---GGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECS
T ss_pred ccccccchhhchhhheecccCceEEEEEEECCCEEEEEEeec---CchHHHHHHHHHHHHhcCCCCCchhhcceeccCCC
Confidence 3478889999999999999999999996 5799999953 23344556778988999999999999999987543
Q ss_pred ---cEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC----------CccccCCCCCceEEcCCCcEE
Q 010401 408 ---GLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDH----------GVAYRDLNSQRILLDRHGNVC 474 (511)
Q Consensus 408 ---~l~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~----------gIIHRDLKp~NILld~~g~vK 474 (511)
.+|+||||+++|+|.+++.. ..+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+|
T Consensus 93 ~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~k 171 (322)
T 3soc_A 93 VDVDLWLITAFHEKGSLSDFLKA-NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTAC 171 (322)
T ss_dssp SSEEEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEE
T ss_pred CCceEEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEE
Confidence 27999999999999999965 4699999999999999999999999 999999999999999999999
Q ss_pred EEecCCceecccCCC--ccccccCCCccccHHhhcc
Q 010401 475 LGDMGIVTACKSVGE--ATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 475 L~DFGlS~~l~~~~~--~~~~~~Gt~~YmAPEvl~g 508 (511)
|+|||+++....... ......||+.|+|||++.+
T Consensus 172 L~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 207 (322)
T 3soc_A 172 IADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEG 207 (322)
T ss_dssp ECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTT
T ss_pred EccCCcccccccccCccccccCccCccccCHhhccc
Confidence 999999987654332 2334578999999999875
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.97 E-value=7.3e-30 Score=254.42 Aligned_cols=168 Identities=20% Similarity=0.325 Sum_probs=139.5
Q ss_pred CCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCC------
Q 010401 340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENH------ 407 (511)
Q Consensus 340 ~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~------ 407 (511)
++|++++.||+|+||.||++ +.||+|++.... .......+.+|+.++++++||||++++++|.+.+.
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC-chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 46899999999999999996 469999997533 33345678999999999999999999999865432
Q ss_pred --------------------------------------------------cEEEEEeccCCCCHHHHHHhcC---CCCHH
Q 010401 408 --------------------------------------------------GLCVVTKLMEGGSVNDLILKSR---KLQTK 434 (511)
Q Consensus 408 --------------------------------------------------~l~LVmEy~~gGsL~~lL~~~~---~L~e~ 434 (511)
.+|+||||+.+|+|.+++.... ..++.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 2799999999999999997643 35666
Q ss_pred HHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCC------------ccccccCCCcccc
Q 010401 435 EIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE------------ATEYETDGYRWLA 502 (511)
Q Consensus 435 ~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~------------~~~~~~Gt~~YmA 502 (511)
.++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... ......||+.|+|
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 244 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS 244 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSC
T ss_pred HHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccC
Confidence 7899999999999999999999999999999999999999999999987754321 2234578999999
Q ss_pred HHhhcc
Q 010401 503 PEVCFL 508 (511)
Q Consensus 503 PEvl~g 508 (511)
||++.+
T Consensus 245 PE~~~~ 250 (332)
T 3qd2_B 245 PEQIHG 250 (332)
T ss_dssp HHHHHC
T ss_pred hHHhcC
Confidence 999865
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.7e-30 Score=254.67 Aligned_cols=168 Identities=19% Similarity=0.277 Sum_probs=141.7
Q ss_pred CCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEE
Q 010401 340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT 413 (511)
Q Consensus 340 ~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVm 413 (511)
++|++++.||+|+||.||++ +.||+|++............+.+|+.++..++||||+++++++.+.+. +++||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~-~~lv~ 81 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRR-LHLVF 81 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE-EEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCe-EEEEE
Confidence 67999999999999999996 469999997654444455668899999999999999999999998776 99999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCcccc
Q 010401 414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY 493 (511)
Q Consensus 414 Ey~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~~~ 493 (511)
||+.+++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...........
T Consensus 82 e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 161 (311)
T 4agu_A 82 EYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDD 161 (311)
T ss_dssp ECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC--------
T ss_pred EeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccccCC
Confidence 99999999999877788999999999999999999999999999999999999999999999999999877655444556
Q ss_pred ccCCCccccHHhhcc
Q 010401 494 ETDGYRWLAPEVCFL 508 (511)
Q Consensus 494 ~~Gt~~YmAPEvl~g 508 (511)
..||+.|+|||++.+
T Consensus 162 ~~~~~~y~aPE~~~~ 176 (311)
T 4agu_A 162 EVATRWYRSPELLVG 176 (311)
T ss_dssp ----GGGCCHHHHHT
T ss_pred CcCCccccChHHHhc
Confidence 688999999999865
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6e-30 Score=264.61 Aligned_cols=168 Identities=18% Similarity=0.286 Sum_probs=146.6
Q ss_pred CCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCc----hHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCc
Q 010401 339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGN----AYEFELRKDLLELMTCGHKNILQFYCVCVDENHG 408 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~----~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~ 408 (511)
.++|++.+.||+|+||.||++ +.||+|++....... .....+.+|+.++..++||||+++++++.+.+.
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~- 89 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD- 89 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE-
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE-
Confidence 457899999999999999995 479999997543221 134568999999999999999999999988775
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCC----cEEEEecCCceec
Q 010401 409 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG----NVCLGDMGIVTAC 484 (511)
Q Consensus 409 l~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g----~vKL~DFGlS~~l 484 (511)
+|+||||+.+|+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++..
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~ 169 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169 (361)
T ss_dssp EEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEEC
T ss_pred EEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEc
Confidence 999999999999999998778899999999999999999999999999999999999998877 7999999999876
Q ss_pred ccCCCccccccCCCccccHHhhcc
Q 010401 485 KSVGEATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 485 ~~~~~~~~~~~Gt~~YmAPEvl~g 508 (511)
... ......+||+.|+|||++.+
T Consensus 170 ~~~-~~~~~~~gt~~y~aPE~~~~ 192 (361)
T 2yab_A 170 EDG-VEFKNIFGTPEFVAPEIVNY 192 (361)
T ss_dssp CTT-CCCCCCCSCGGGCCHHHHTT
T ss_pred CCC-CccccCCCCccEECchHHcC
Confidence 543 23445679999999999865
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-30 Score=275.44 Aligned_cols=173 Identities=22% Similarity=0.283 Sum_probs=147.4
Q ss_pred ceEecCCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCc-hHHHHHHHHHHHHHhCCCCceeeEeeeEeeCC
Q 010401 334 RWLLNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGN-AYEFELRKDLLELMTCGHKNILQFYCVCVDEN 406 (511)
Q Consensus 334 ~~~l~~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~-~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~ 406 (511)
++.+..++|++++.||+|+||.||++ +.||+|++....... .....+.+|..++..++||||++++++|.+.+
T Consensus 55 ~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~ 134 (412)
T 2vd5_A 55 EVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDEN 134 (412)
T ss_dssp HHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSS
T ss_pred hccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCC
Confidence 44567789999999999999999996 479999996421111 11223678899999999999999999999877
Q ss_pred CcEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecc
Q 010401 407 HGLCVVTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK 485 (511)
Q Consensus 407 ~~l~LVmEy~~gGsL~~lL~~~-~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~ 485 (511)
. +|+||||+++|+|.+++.+. ..+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+++...
T Consensus 135 ~-~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~ 213 (412)
T 2vd5_A 135 Y-LYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLR 213 (412)
T ss_dssp E-EEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred E-EEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheecc
Confidence 6 99999999999999999764 479999999999999999999999999999999999999999999999999998765
Q ss_pred cCCC-ccccccCCCccccHHhhc
Q 010401 486 SVGE-ATEYETDGYRWLAPEVCF 507 (511)
Q Consensus 486 ~~~~-~~~~~~Gt~~YmAPEvl~ 507 (511)
.... .....+||+.|+|||++.
T Consensus 214 ~~~~~~~~~~~Gt~~Y~APE~l~ 236 (412)
T 2vd5_A 214 ADGTVRSLVAVGTPDYLSPEILQ 236 (412)
T ss_dssp TTSCEECSSCCSCGGGCCHHHHH
T ss_pred CCCccccceeccccCcCCHHHHh
Confidence 4333 233468999999999986
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=7.9e-30 Score=263.57 Aligned_cols=173 Identities=23% Similarity=0.431 Sum_probs=149.3
Q ss_pred ceEecCCCeEEEeeeecccceEEEEeE-------------EEEEEEEecCCCCchHHHHHHHHHHHHHhC-CCCceeeEe
Q 010401 334 RWLLNSDNLEFIDQIGPNSFKGVYKGK-------------RVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFY 399 (511)
Q Consensus 334 ~~~l~~~~y~l~~~LG~GsFG~VYkgk-------------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l-~HpNIV~l~ 399 (511)
.|.+..++|++.+.||+|+||.||+++ .||+|+++.. .......++.+|+.++..+ +||||++++
T Consensus 63 ~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~~ 141 (382)
T 3tt0_A 63 RWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIINLL 141 (382)
T ss_dssp TTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc-cCHHHHHHHHHHHHHHHHhcCCchhhhhe
Confidence 567788899999999999999999985 5999999753 3334456688999999999 999999999
Q ss_pred eeEeeCCCcEEEEEeccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCC
Q 010401 400 CVCVDENHGLCVVTKLMEGGSVNDLILKSR----------------KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQ 463 (511)
Q Consensus 400 g~~~~~~~~l~LVmEy~~gGsL~~lL~~~~----------------~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~ 463 (511)
+++.+.+. +|+||||+.+|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+
T Consensus 142 ~~~~~~~~-~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~ 220 (382)
T 3tt0_A 142 GACTQDGP-LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAAR 220 (382)
T ss_dssp EEECSSSS-CEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred eeeccCCc-eEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcc
Confidence 99988776 999999999999999997543 4899999999999999999999999999999999
Q ss_pred ceEEcCCCcEEEEecCCceecccCCC--ccccccCCCccccHHhhcc
Q 010401 464 RILLDRHGNVCLGDMGIVTACKSVGE--ATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 464 NILld~~g~vKL~DFGlS~~l~~~~~--~~~~~~Gt~~YmAPEvl~g 508 (511)
|||++.++.+||+|||+++....... ......+|+.|+|||++.+
T Consensus 221 NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~ 267 (382)
T 3tt0_A 221 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD 267 (382)
T ss_dssp GEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHS
T ss_pred eEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcC
Confidence 99999999999999999987654322 2334456789999999865
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=99.97 E-value=6.6e-30 Score=263.44 Aligned_cols=167 Identities=19% Similarity=0.252 Sum_probs=146.5
Q ss_pred CCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEE
Q 010401 340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT 413 (511)
Q Consensus 340 ~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVm 413 (511)
++|++.+.||+|+||.||++ +.||+|++............+.+|+.+++.++||||+++++++.+.+. +|+||
T Consensus 29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~-~~lv~ 107 (362)
T 2bdw_A 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESF-HYLVF 107 (362)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE-EEEEE
T ss_pred cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCE-EEEEE
Confidence 46899999999999999995 479999998655444455668999999999999999999999998775 99999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCC---CcEEEEecCCceecccCCCc
Q 010401 414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRH---GNVCLGDMGIVTACKSVGEA 490 (511)
Q Consensus 414 Ey~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~---g~vKL~DFGlS~~l~~~~~~ 490 (511)
||+.+|+|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+++..... ..
T Consensus 108 e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~-~~ 186 (362)
T 2bdw_A 108 DLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS-EA 186 (362)
T ss_dssp CCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC-CS
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCC-cc
Confidence 999999999999877889999999999999999999999999999999999999865 45999999999876532 23
Q ss_pred cccccCCCccccHHhhcc
Q 010401 491 TEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 491 ~~~~~Gt~~YmAPEvl~g 508 (511)
.....||+.|+|||++.+
T Consensus 187 ~~~~~gt~~y~aPE~~~~ 204 (362)
T 2bdw_A 187 WHGFAGTPGYLSPEVLKK 204 (362)
T ss_dssp CCCSCSCTTTCCHHHHTT
T ss_pred cccCCCCccccCHHHHcc
Confidence 445689999999999865
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=99.97 E-value=8.3e-30 Score=263.08 Aligned_cols=174 Identities=24% Similarity=0.335 Sum_probs=150.7
Q ss_pred ceEecCCCeEEEeeeecc--cceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeC
Q 010401 334 RWLLNSDNLEFIDQIGPN--SFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDE 405 (511)
Q Consensus 334 ~~~l~~~~y~l~~~LG~G--sFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~ 405 (511)
.+....++|++++.||+| +||.||++ +.||+|++............+.+|+.+++.++||||+++++++.+.
T Consensus 19 ~~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 98 (389)
T 3gni_B 19 SFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD 98 (389)
T ss_dssp CCCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred cccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEEC
Confidence 455667889999999999 99999996 4799999986544455556688999999999999999999999988
Q ss_pred CCcEEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCcee
Q 010401 406 NHGLCVVTKLMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTA 483 (511)
Q Consensus 406 ~~~l~LVmEy~~gGsL~~lL~~~--~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~ 483 (511)
+. +|+||||+.+|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 99 ~~-~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~ 177 (389)
T 3gni_B 99 NE-LWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLS 177 (389)
T ss_dssp TE-EEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred CE-EEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEccccccee
Confidence 76 99999999999999999764 6799999999999999999999999999999999999999999999999999876
Q ss_pred cccCCC-------ccccccCCCccccHHhhcc
Q 010401 484 CKSVGE-------ATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 484 l~~~~~-------~~~~~~Gt~~YmAPEvl~g 508 (511)
...... ......||+.|+|||++.+
T Consensus 178 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 209 (389)
T 3gni_B 178 MISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQ 209 (389)
T ss_dssp CEETTEECSCBCCCCTTCTTTGGGSCHHHHST
T ss_pred eccccccccccccccccccccccccCHHHHhc
Confidence 533221 2233478899999999876
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=8.1e-31 Score=276.22 Aligned_cols=173 Identities=18% Similarity=0.257 Sum_probs=146.9
Q ss_pred ceEecCCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCC-chHHHHHHHHHHHHHhCCCCceeeEeeeEeeCC
Q 010401 334 RWLLNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKG-NAYEFELRKDLLELMTCGHKNILQFYCVCVDEN 406 (511)
Q Consensus 334 ~~~l~~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~-~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~ 406 (511)
++.+..++|++++.||+|+||.||++ +.+|+|++...... ......+.+|+.++..++||||++++++|.+.+
T Consensus 63 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 142 (410)
T 3v8s_A 63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 142 (410)
T ss_dssp HHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence 45567889999999999999999996 46999999642110 001123678999999999999999999999877
Q ss_pred CcEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceeccc
Q 010401 407 HGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS 486 (511)
Q Consensus 407 ~~l~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~ 486 (511)
. +|+||||+++|+|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 143 ~-~~lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~ 220 (410)
T 3v8s_A 143 Y-LYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK 220 (410)
T ss_dssp E-EEEEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred E-EEEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeecc
Confidence 6 9999999999999999854 5699999999999999999999999999999999999999999999999999987654
Q ss_pred CCC-ccccccCCCccccHHhhcc
Q 010401 487 VGE-ATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 487 ~~~-~~~~~~Gt~~YmAPEvl~g 508 (511)
... .....+||+.|+|||++.+
T Consensus 221 ~~~~~~~~~~gt~~Y~APE~l~~ 243 (410)
T 3v8s_A 221 EGMVRCDTAVGTPDYISPEVLKS 243 (410)
T ss_dssp TSEEECCSCCSCGGGCCHHHHHT
T ss_pred CCcccccCCcCCccccCHHHhhc
Confidence 332 2345689999999999875
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.7e-30 Score=271.88 Aligned_cols=168 Identities=18% Similarity=0.278 Sum_probs=134.7
Q ss_pred CCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCC----Cc
Q 010401 339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN----HG 408 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~----~~ 408 (511)
.++|++++.||+|+||.||++ +.||+|++...........++.+|+.+|..++||||+++++++.... ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 478999999999999999996 47999999754444555677899999999999999999999985442 24
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCC
Q 010401 409 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG 488 (511)
Q Consensus 409 l~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~ 488 (511)
+|+||||+. ++|.+++.....+++..++.++.||+.||+|||++|||||||||+||||+.++.+||+|||+++......
T Consensus 132 ~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~ 210 (458)
T 3rp9_A 132 LYVVLEIAD-SDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPE 210 (458)
T ss_dssp EEEEECCCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCT
T ss_pred EEEEEeccc-cchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccCcc
Confidence 899999985 6999999887889999999999999999999999999999999999999999999999999998764321
Q ss_pred C---------------------------ccccccCCCccccHHhhc
Q 010401 489 E---------------------------ATEYETDGYRWLAPEVCF 507 (511)
Q Consensus 489 ~---------------------------~~~~~~Gt~~YmAPEvl~ 507 (511)
. .....+||+.|+|||++.
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~ 256 (458)
T 3rp9_A 211 NGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELIL 256 (458)
T ss_dssp TCCCCCC---------------------------CCCTTCCHHHHT
T ss_pred ccccccccCccccccccccccccccccccccCCcccccccChHHhh
Confidence 1 123457899999999874
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=99.97 E-value=3.3e-30 Score=254.77 Aligned_cols=167 Identities=20% Similarity=0.333 Sum_probs=139.9
Q ss_pred CCeEEEeeeecccceEEEEe-----EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEEe
Q 010401 340 DNLEFIDQIGPNSFKGVYKG-----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTK 414 (511)
Q Consensus 340 ~~y~l~~~LG~GsFG~VYkg-----k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVmE 414 (511)
++|++++.||+|+||.||++ +.||+|++............+.+|+.+++.++||||+++++++.+.+. +|+|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~lv~e 80 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKR-LVLVFE 80 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSC-EEEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCe-EEEEEE
Confidence 57899999999999999996 479999997543333334567899999999999999999999998776 999999
Q ss_pred ccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCcccc
Q 010401 415 LMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY 493 (511)
Q Consensus 415 y~~gGsL~~lL~~~-~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~~~ 493 (511)
|+.+ +|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...........
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 159 (288)
T 1ob3_A 81 HLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH 159 (288)
T ss_dssp CCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-------
T ss_pred ecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCcccccccc
Confidence 9986 999998653 67999999999999999999999999999999999999999999999999999876544333455
Q ss_pred ccCCCccccHHhhcc
Q 010401 494 ETDGYRWLAPEVCFL 508 (511)
Q Consensus 494 ~~Gt~~YmAPEvl~g 508 (511)
..||+.|+|||++.+
T Consensus 160 ~~~t~~y~aPE~~~~ 174 (288)
T 1ob3_A 160 EIVTLWYRAPDVLMG 174 (288)
T ss_dssp --CCCTTCCHHHHTT
T ss_pred ccccccccCchheeC
Confidence 678999999999865
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.4e-30 Score=249.55 Aligned_cols=172 Identities=23% Similarity=0.500 Sum_probs=146.6
Q ss_pred cceEecCCCeEEEeeeecccceEEEEeE-----EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCC
Q 010401 333 GRWLLNSDNLEFIDQIGPNSFKGVYKGK-----RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENH 407 (511)
Q Consensus 333 ~~~~l~~~~y~l~~~LG~GsFG~VYkgk-----~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~ 407 (511)
+.|.++.++|++.+.||+|+||.||+++ .||+|++..... ...++.+|+.++.+++||||+++++++.+.+.
T Consensus 3 ~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 79 (269)
T 4hcu_A 3 GKWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM---SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAP 79 (269)
T ss_dssp --CBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB---CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred ccEEeChhhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc---CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCc
Confidence 3688889999999999999999999964 699999974322 23568899999999999999999999988776
Q ss_pred cEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceeccc
Q 010401 408 GLCVVTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS 486 (511)
Q Consensus 408 ~l~LVmEy~~gGsL~~lL~~~-~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~ 486 (511)
+|+||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++....
T Consensus 80 -~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 158 (269)
T 4hcu_A 80 -ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 158 (269)
T ss_dssp -EEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred -eEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccc
Confidence 99999999999999999653 5689999999999999999999999999999999999999999999999999876543
Q ss_pred CC-CccccccCCCccccHHhhcc
Q 010401 487 VG-EATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 487 ~~-~~~~~~~Gt~~YmAPEvl~g 508 (511)
.. .......+++.|+|||++.+
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~ 181 (269)
T 4hcu_A 159 DQYTSSTGTKFPVKWASPEVFSF 181 (269)
T ss_dssp HHHHSTTSTTCCGGGCCHHHHHH
T ss_pred cccccccCcccccccCCHHHhcC
Confidence 22 12233456778999999864
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=5e-30 Score=258.07 Aligned_cols=173 Identities=23% Similarity=0.424 Sum_probs=146.4
Q ss_pred ceEecCCCeEEEeeeecccceEEEEe-----------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeE
Q 010401 334 RWLLNSDNLEFIDQIGPNSFKGVYKG-----------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVC 402 (511)
Q Consensus 334 ~~~l~~~~y~l~~~LG~GsFG~VYkg-----------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~ 402 (511)
.+.+..++|++.+.||+|+||.||++ +.||+|+++.. ........+.+|+.++..++||||+++++++
T Consensus 41 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 119 (343)
T 1luf_A 41 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE-ASADMQADFQREAALMAEFDNPNIVKLLGVC 119 (343)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred eeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 45567789999999999999999996 46899999743 2334456689999999999999999999999
Q ss_pred eeCCCcEEEEEeccCCCCHHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Q 010401 403 VDENHGLCVVTKLMEGGSVNDLILKS------------------------RKLQTKEIIRIAIDVAEGIKFLNDHGVAYR 458 (511)
Q Consensus 403 ~~~~~~l~LVmEy~~gGsL~~lL~~~------------------------~~L~e~~~~~ia~qIa~gL~yLH~~gIIHR 458 (511)
.+.+. +|+||||+++|+|.+++... ..+++..++.++.||+.||.|||++||+||
T Consensus 120 ~~~~~-~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~ 198 (343)
T 1luf_A 120 AVGKP-MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHR 198 (343)
T ss_dssp CSSSS-CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred ccCCc-eEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 88776 99999999999999999653 568999999999999999999999999999
Q ss_pred CCCCCceEEcCCCcEEEEecCCceecccCC--CccccccCCCccccHHhhcc
Q 010401 459 DLNSQRILLDRHGNVCLGDMGIVTACKSVG--EATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 459 DLKp~NILld~~g~vKL~DFGlS~~l~~~~--~~~~~~~Gt~~YmAPEvl~g 508 (511)
||||+|||++.++.+||+|||+++...... .......+++.|+|||++.+
T Consensus 199 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~ 250 (343)
T 1luf_A 199 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY 250 (343)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH
T ss_pred CCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhcc
Confidence 999999999999999999999987654322 12334567889999998764
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=3.1e-30 Score=265.20 Aligned_cols=167 Identities=18% Similarity=0.237 Sum_probs=145.8
Q ss_pred cCCCeEEEeeeecccceEEEEe------EEEEEEEEecCCC-CchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEE
Q 010401 338 NSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDK-GNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLC 410 (511)
Q Consensus 338 ~~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~-~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~ 410 (511)
..++|++++.||+|+||.||++ +.||+|++..... .......+.+|+.++..++||||+++++++.+.+. +|
T Consensus 39 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~-~~ 117 (350)
T 1rdq_E 39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSN-LY 117 (350)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE-EE
T ss_pred CHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE-EE
Confidence 3567899999999999999996 4799999964221 11223457889999999999999999999998775 99
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCc
Q 010401 411 VVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA 490 (511)
Q Consensus 411 LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~ 490 (511)
+||||+++|+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 118 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~--- 194 (350)
T 1rdq_E 118 MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--- 194 (350)
T ss_dssp EEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC---
T ss_pred EEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCC---
Confidence 99999999999999988788999999999999999999999999999999999999999999999999999876432
Q ss_pred cccccCCCccccHHhhcc
Q 010401 491 TEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 491 ~~~~~Gt~~YmAPEvl~g 508 (511)
....+||+.|+|||++.+
T Consensus 195 ~~~~~gt~~y~aPE~~~~ 212 (350)
T 1rdq_E 195 TWTLCGTPEALAPEIILS 212 (350)
T ss_dssp BCCCEECGGGCCHHHHTT
T ss_pred cccccCCccccCHHHhcC
Confidence 345689999999999865
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-30 Score=274.37 Aligned_cols=171 Identities=18% Similarity=0.286 Sum_probs=138.9
Q ss_pred ecCCCeEEEeeeecccceEEEEe------EEEEEEEEecCCC-CchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcE
Q 010401 337 LNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDK-GNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGL 409 (511)
Q Consensus 337 l~~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~-~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l 409 (511)
+..++|++++.||+|+||.||++ +.||+|++..... .......+.+|+.++..++||||+++++++.+.+. +
T Consensus 145 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~-~ 223 (446)
T 4ejn_A 145 VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDR-L 223 (446)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTE-E
T ss_pred CChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCE-E
Confidence 45678999999999999999985 4799999974321 22223456788999999999999999999998876 9
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCceEEcCCCcEEEEecCCceecccCC
Q 010401 410 CVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLND-HGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG 488 (511)
Q Consensus 410 ~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~-~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~ 488 (511)
|+||||+++|+|.+++...+.+++..+..++.||+.||+|||+ +||+||||||+|||++.++.+||+|||+++......
T Consensus 224 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 303 (446)
T 4ejn_A 224 CFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG 303 (446)
T ss_dssp EEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC--
T ss_pred EEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCCC
Confidence 9999999999999999888899999999999999999999998 999999999999999999999999999998755544
Q ss_pred CccccccCCCccccHHhhcc
Q 010401 489 EATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 489 ~~~~~~~Gt~~YmAPEvl~g 508 (511)
......+||+.|+|||++.+
T Consensus 304 ~~~~~~~gt~~y~aPE~~~~ 323 (446)
T 4ejn_A 304 ATMKTFCGTPEYLAPEVLED 323 (446)
T ss_dssp ---CCSSSCGGGCCHHHHHT
T ss_pred cccccccCCccccCHhhcCC
Confidence 45566789999999999865
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.5e-30 Score=255.44 Aligned_cols=171 Identities=18% Similarity=0.256 Sum_probs=141.7
Q ss_pred ecCCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCc------------------------hHHHHHHHHHHH
Q 010401 337 LNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGN------------------------AYEFELRKDLLE 386 (511)
Q Consensus 337 l~~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~------------------------~~~~~~~~Ei~i 386 (511)
+..++|++.+.||+|+||.||++ +.||+|++....... .....+.+|+.+
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 89 (298)
T 2zv2_A 10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI 89 (298)
T ss_dssp CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred eeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence 34578999999999999999996 579999997532211 112457899999
Q ss_pred HHhCCCCceeeEeeeEeeC-CCcEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCce
Q 010401 387 LMTCGHKNILQFYCVCVDE-NHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRI 465 (511)
Q Consensus 387 L~~l~HpNIV~l~g~~~~~-~~~l~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NI 465 (511)
++.++||||+++++++.+. +..+|+||||+++++|.+++ ..+.+++..++.++.||+.||.|||++||+||||||+||
T Consensus 90 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Ni 168 (298)
T 2zv2_A 90 LKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNL 168 (298)
T ss_dssp HHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS-CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred HHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHE
Confidence 9999999999999999863 33489999999999998865 446799999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCceecccCCCccccccCCCccccHHhhcc
Q 010401 466 LLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 466 Lld~~g~vKL~DFGlS~~l~~~~~~~~~~~Gt~~YmAPEvl~g 508 (511)
|++.++.+||+|||+++.............||+.|+|||++.+
T Consensus 169 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 211 (298)
T 2zv2_A 169 LVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSE 211 (298)
T ss_dssp EECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCT
T ss_pred EECCCCCEEEecCCCccccccccccccCCcCCccccChhhhcc
Confidence 9999999999999999877654444456689999999999865
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-29 Score=247.11 Aligned_cols=171 Identities=25% Similarity=0.434 Sum_probs=146.5
Q ss_pred ceEecCCCeEEEeeeecccceEEEEeE-----EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCc
Q 010401 334 RWLLNSDNLEFIDQIGPNSFKGVYKGK-----RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHG 408 (511)
Q Consensus 334 ~~~l~~~~y~l~~~LG~GsFG~VYkgk-----~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~ 408 (511)
.+.+..++|++.+.||+|+||.||+++ .||+|++..... ...++.+|+.++..++||||+++++++.+.+.
T Consensus 2 ~~~l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~- 77 (268)
T 3sxs_A 2 HMELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM---SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYP- 77 (268)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB---CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS-
T ss_pred ceEechhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC---cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCc-
Confidence 456778899999999999999999974 799999974322 23568899999999999999999999987776
Q ss_pred EEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccC
Q 010401 409 LCVVTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV 487 (511)
Q Consensus 409 l~LVmEy~~gGsL~~lL~~~-~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~ 487 (511)
+|+||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 157 (268)
T 3sxs_A 78 IYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD 157 (268)
T ss_dssp EEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTT
T ss_pred eEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchh
Confidence 99999999999999999764 46999999999999999999999999999999999999999999999999999876543
Q ss_pred CC-ccccccCCCccccHHhhcc
Q 010401 488 GE-ATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 488 ~~-~~~~~~Gt~~YmAPEvl~g 508 (511)
.. ......+++.|+|||++.+
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~ 179 (268)
T 3sxs_A 158 QYVSSVGTKFPVKWSAPEVFHY 179 (268)
T ss_dssp CEEECCSCCCCGGGCCHHHHHH
T ss_pred hhhcccCCCcCcccCCHHHHhc
Confidence 22 1223345678999999864
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=99.97 E-value=8.1e-30 Score=250.24 Aligned_cols=173 Identities=24% Similarity=0.471 Sum_probs=145.7
Q ss_pred ccceEecCCCeEEEeeeecccceEEEEeE-----EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCC
Q 010401 332 IGRWLLNSDNLEFIDQIGPNSFKGVYKGK-----RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN 406 (511)
Q Consensus 332 i~~~~l~~~~y~l~~~LG~GsFG~VYkgk-----~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~ 406 (511)
.+.|.+..++|++.+.||+|+||.||+++ .||+|++..... ...++.+|+.++..++||||+++++++.+.+
T Consensus 16 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 92 (283)
T 3gen_A 16 YGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM---SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQR 92 (283)
T ss_dssp CCTTBCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB---CHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred CCCccCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC---CHHHHHHHHHHHhcCCCCCEeeEEEEEecCC
Confidence 34778889999999999999999999974 799999974322 2456889999999999999999999998777
Q ss_pred CcEEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecc
Q 010401 407 HGLCVVTKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK 485 (511)
Q Consensus 407 ~~l~LVmEy~~gGsL~~lL~~-~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~ 485 (511)
. +|+||||+.+++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 93 ~-~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 171 (283)
T 3gen_A 93 P-IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL 171 (283)
T ss_dssp S-EEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBC
T ss_pred C-eEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEcccccccccc
Confidence 6 9999999999999999965 4679999999999999999999999999999999999999999999999999987654
Q ss_pred cCCC-ccccccCCCccccHHhhcc
Q 010401 486 SVGE-ATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 486 ~~~~-~~~~~~Gt~~YmAPEvl~g 508 (511)
.... ......+++.|+|||++.+
T Consensus 172 ~~~~~~~~~~~~~~~y~aPE~~~~ 195 (283)
T 3gen_A 172 DDEYTSSVGSKFPVRWSPPEVLMY 195 (283)
T ss_dssp CHHHHSTTSTTSCGGGCCHHHHHH
T ss_pred ccccccccCCccCcccCCHHHhcc
Confidence 3221 1233456778999999864
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=1.9e-29 Score=255.46 Aligned_cols=165 Identities=19% Similarity=0.261 Sum_probs=144.6
Q ss_pred CCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEE
Q 010401 339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV 412 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LV 412 (511)
.++|++.+.||+|+||.||++ +.+|+|.+.. .......+.+|+.++..++||||+++++++.+.+. +|+|
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~-~~lv 79 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV---KGTDQVLVKKEISILNIARHRNILHLHESFESMEE-LVMI 79 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---CTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTE-EEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEec---CcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCE-EEEE
Confidence 468999999999999999996 5799999863 23344568899999999999999999999998776 9999
Q ss_pred EeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcC--CCcEEEEecCCceecccCCC
Q 010401 413 TKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDR--HGNVCLGDMGIVTACKSVGE 489 (511)
Q Consensus 413 mEy~~gGsL~~lL~~~-~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~--~g~vKL~DFGlS~~l~~~~~ 489 (511)
|||+++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++..... .
T Consensus 80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~-~ 158 (321)
T 1tki_A 80 FEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG-D 158 (321)
T ss_dssp ECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT-C
T ss_pred EEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC-C
Confidence 9999999999999654 47999999999999999999999999999999999999997 789999999999876543 2
Q ss_pred ccccccCCCccccHHhhcc
Q 010401 490 ATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 490 ~~~~~~Gt~~YmAPEvl~g 508 (511)
......||+.|+|||++.+
T Consensus 159 ~~~~~~gt~~y~aPE~~~~ 177 (321)
T 1tki_A 159 NFRLLFTAPEYYAPEVHQH 177 (321)
T ss_dssp EEEEEESCGGGSCHHHHTT
T ss_pred ccccccCChhhcCcHHhcC
Confidence 3455678999999999865
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=7e-30 Score=251.02 Aligned_cols=165 Identities=21% Similarity=0.373 Sum_probs=142.8
Q ss_pred ecCCCeEEEeeeecccceEEEEe-------------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEe
Q 010401 337 LNSDNLEFIDQIGPNSFKGVYKG-------------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCV 403 (511)
Q Consensus 337 l~~~~y~l~~~LG~GsFG~VYkg-------------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~ 403 (511)
+..++|++.+.||+|+||.||++ +.||+|++... .......+.+|+.++..++||||+++++++.
T Consensus 5 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 82 (289)
T 4fvq_A 5 IRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA--HRNYSESFFEAASMMSKLSHKHLVLNYGVCV 82 (289)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGG--GGGGHHHHHHHHHHHHTSCCTTBCCEEEEEC
T ss_pred echhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccc--cHHHHHHHHHHHHHHHhCCCCCEeEEEEEEE
Confidence 45678999999999999999996 35889988642 2334566899999999999999999999999
Q ss_pred eCCCcEEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCc--------EE
Q 010401 404 DENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGN--------VC 474 (511)
Q Consensus 404 ~~~~~l~LVmEy~~gGsL~~lL~~~~-~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~--------vK 474 (511)
+++. .|+||||+.+|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++. +|
T Consensus 83 ~~~~-~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 83 CGDE-NILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp CTTC-CEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred eCCC-CEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceee
Confidence 8776 899999999999999997654 4999999999999999999999999999999999999998887 99
Q ss_pred EEecCCceecccCCCccccccCCCccccHHhhcc
Q 010401 475 LGDMGIVTACKSVGEATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 475 L~DFGlS~~l~~~~~~~~~~~Gt~~YmAPEvl~g 508 (511)
|+|||++..... .....|++.|+|||++.+
T Consensus 162 l~Dfg~~~~~~~----~~~~~~~~~y~aPE~~~~ 191 (289)
T 4fvq_A 162 LSDPGISITVLP----KDILQERIPWVPPECIEN 191 (289)
T ss_dssp ECCCCSCTTTSC----HHHHHHTTTTSCHHHHHC
T ss_pred eccCcccccccC----ccccCCcCcccCHHHhCC
Confidence 999999865432 234567889999999875
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.5e-30 Score=259.95 Aligned_cols=168 Identities=17% Similarity=0.308 Sum_probs=143.4
Q ss_pred CCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEE
Q 010401 339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV 412 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LV 412 (511)
.++|++.+.||+|+||.||++ +.||+|++..... ......+.+|+.+++.++||||+++++++.+++. .|+|
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~-~~lv 83 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNI-QYLF 83 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEECSSE-EEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc-cchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCe-EEEE
Confidence 468899999999999999996 4799999964322 2223457899999999999999999999998775 8999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCC--Cc
Q 010401 413 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG--EA 490 (511)
Q Consensus 413 mEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~--~~ 490 (511)
|||+++|+|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...... ..
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 163 (323)
T 3tki_A 84 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 163 (323)
T ss_dssp EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred EEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcccc
Confidence 9999999999999777789999999999999999999999999999999999999999999999999998664322 22
Q ss_pred cccccCCCccccHHhhcc
Q 010401 491 TEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 491 ~~~~~Gt~~YmAPEvl~g 508 (511)
.....||+.|+|||++.+
T Consensus 164 ~~~~~gt~~y~aPE~~~~ 181 (323)
T 3tki_A 164 LNKMCGTLPYVAPELLKR 181 (323)
T ss_dssp BCSCCSCGGGSCHHHHHC
T ss_pred cCCCccCcCccCcHHhcc
Confidence 345679999999999865
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=9.2e-30 Score=250.38 Aligned_cols=173 Identities=19% Similarity=0.367 Sum_probs=135.4
Q ss_pred cceEecCCCeEEEeeeecccceEEEEeE---------EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEe
Q 010401 333 GRWLLNSDNLEFIDQIGPNSFKGVYKGK---------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCV 403 (511)
Q Consensus 333 ~~~~l~~~~y~l~~~LG~GsFG~VYkgk---------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~ 403 (511)
.+|.+..++|++.+.||+|+||.||+|+ .||+|++... ........+.+|+.++..++||||+++++++.
T Consensus 8 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 86 (281)
T 1mp8_A 8 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT 86 (281)
T ss_dssp -CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred cceEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCccceEEEEEc
Confidence 3567788899999999999999999974 3888888642 23344556889999999999999999999985
Q ss_pred eCCCcEEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCce
Q 010401 404 DENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVT 482 (511)
Q Consensus 404 ~~~~~l~LVmEy~~gGsL~~lL~~~~-~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~ 482 (511)
+ +. .|+||||+.+++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 87 ~-~~-~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 164 (281)
T 1mp8_A 87 E-NP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR 164 (281)
T ss_dssp S-SS-CEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred c-Cc-cEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECcccccc
Confidence 3 33 899999999999999997544 79999999999999999999999999999999999999999999999999998
Q ss_pred ecccCCC-ccccccCCCccccHHhhcc
Q 010401 483 ACKSVGE-ATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 483 ~l~~~~~-~~~~~~Gt~~YmAPEvl~g 508 (511)
....... ......+++.|+|||++.+
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~ 191 (281)
T 1mp8_A 165 YMEDSTYYKASKGKLPIKWMAPESINF 191 (281)
T ss_dssp --------------CCGGGCCHHHHHH
T ss_pred ccCcccccccccCCCcccccChhhccc
Confidence 7644322 1233456788999999864
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-29 Score=260.76 Aligned_cols=167 Identities=19% Similarity=0.319 Sum_probs=137.2
Q ss_pred ecCCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEE
Q 010401 337 LNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLC 410 (511)
Q Consensus 337 l~~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~ 410 (511)
...++|++.+.||+|+||.||++ +.||+|++...... ...+.+|+.+++.++||||+++++++.+.+. +|
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~-~~ 92 (361)
T 3uc3_A 17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI---DENVQREIINHRSLRHPNIVRFKEVILTPTH-LA 92 (361)
T ss_dssp CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS---CHHHHHHHHHHHHCCCTTBCCEEEEEECSSE-EE
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc---cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCE-EE
Confidence 45678999999999999999996 46999999753322 2457899999999999999999999998776 99
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCc--EEEEecCCceecccCC
Q 010401 411 VVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGN--VCLGDMGIVTACKSVG 488 (511)
Q Consensus 411 LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~--vKL~DFGlS~~l~~~~ 488 (511)
+||||+.+|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++.....
T Consensus 93 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~- 171 (361)
T 3uc3_A 93 IIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH- 171 (361)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred EEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcccccccc-
Confidence 99999999999999988888999999999999999999999999999999999999987765 999999998754332
Q ss_pred CccccccCCCccccHHhhcc
Q 010401 489 EATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 489 ~~~~~~~Gt~~YmAPEvl~g 508 (511)
.......||+.|+|||++.+
T Consensus 172 ~~~~~~~gt~~y~aPE~~~~ 191 (361)
T 3uc3_A 172 SQPKSTVGTPAYIAPEVLLR 191 (361)
T ss_dssp ---------CTTSCHHHHHC
T ss_pred CCCCCCcCCCCcCChhhhcC
Confidence 22345579999999999865
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.4e-29 Score=245.00 Aligned_cols=165 Identities=21% Similarity=0.379 Sum_probs=143.5
Q ss_pred CCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhC-CCCceeeEeeeEeeCCCcEEEE
Q 010401 340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCVCVDENHGLCVV 412 (511)
Q Consensus 340 ~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l-~HpNIV~l~g~~~~~~~~l~LV 412 (511)
++|++.+.||+|+||.||++ +.||+|++...........++.+|+..+..+ +||||+++++++.+.+. +|+|
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~-~~lv 89 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDH-MLIQ 89 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTE-EEEE
T ss_pred chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCe-EEEE
Confidence 57899999999999999995 4799999986555556667789999999998 99999999999988776 9999
Q ss_pred EeccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCC------------------
Q 010401 413 TKLMEGGSVNDLILKS----RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRH------------------ 470 (511)
Q Consensus 413 mEy~~gGsL~~lL~~~----~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~------------------ 470 (511)
|||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~ 169 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASN 169 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCC
Confidence 9999999999999654 679999999999999999999999999999999999999844
Q ss_pred -CcEEEEecCCceecccCCCccccccCCCccccHHhhccc
Q 010401 471 -GNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEVCFLL 509 (511)
Q Consensus 471 -g~vKL~DFGlS~~l~~~~~~~~~~~Gt~~YmAPEvl~gl 509 (511)
..+||+|||++...... ....||+.|+|||++.+.
T Consensus 170 ~~~~kl~Dfg~~~~~~~~----~~~~gt~~y~aPE~~~~~ 205 (289)
T 1x8b_A 170 KVMFKIGDLGHVTRISSP----QVEEGDSRFLANEVLQEN 205 (289)
T ss_dssp CCCEEECCCTTCEETTCS----CCCCCCGGGCCHHHHTTC
T ss_pred ceEEEEcccccccccCCc----cccCCCccccChhHhcCC
Confidence 47999999999876542 334689999999998653
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.7e-29 Score=250.67 Aligned_cols=173 Identities=23% Similarity=0.371 Sum_probs=148.2
Q ss_pred ceEecCCCeEEEeeeecccceEEEEeE-----------EEEEEEEecCCCCchHHHHHHHHHHHHHhC-CCCceeeEeee
Q 010401 334 RWLLNSDNLEFIDQIGPNSFKGVYKGK-----------RVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCV 401 (511)
Q Consensus 334 ~~~l~~~~y~l~~~LG~GsFG~VYkgk-----------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l-~HpNIV~l~g~ 401 (511)
.|.+..++|++.+.||+|+||.||+++ .||+|++... ........+.+|+.++..+ +||||++++++
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 95 (313)
T 1t46_A 17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS-AHLTEREALMSELKVLSYLGNHMNIVNLLGA 95 (313)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcc-hhHHHHHHHHHHHHHHhhcccCCCeeeEEEE
Confidence 677888999999999999999999974 6999999743 2333456689999999999 99999999999
Q ss_pred EeeCCCcEEEEEeccCCCCHHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCC
Q 010401 402 CVDENHGLCVVTKLMEGGSVNDLILKSR------------------KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQ 463 (511)
Q Consensus 402 ~~~~~~~l~LVmEy~~gGsL~~lL~~~~------------------~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~ 463 (511)
+.+++. .++||||+++|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+
T Consensus 96 ~~~~~~-~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~ 174 (313)
T 1t46_A 96 CTIGGP-TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAAR 174 (313)
T ss_dssp ECSSSS-CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred EecCCC-cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccc
Confidence 988776 899999999999999996543 4899999999999999999999999999999999
Q ss_pred ceEEcCCCcEEEEecCCceecccCCCc--cccccCCCccccHHhhcc
Q 010401 464 RILLDRHGNVCLGDMGIVTACKSVGEA--TEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 464 NILld~~g~vKL~DFGlS~~l~~~~~~--~~~~~Gt~~YmAPEvl~g 508 (511)
|||++.++.+||+|||+++........ .....|++.|+|||++.+
T Consensus 175 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 221 (313)
T 1t46_A 175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN 221 (313)
T ss_dssp GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH
T ss_pred eEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcC
Confidence 999999999999999999876543321 223456788999998764
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=99.96 E-value=5.2e-30 Score=262.35 Aligned_cols=169 Identities=18% Similarity=0.267 Sum_probs=143.6
Q ss_pred CCCeEEEeeeecccceEEEEe------EEEEEEEEecCC---CCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcE
Q 010401 339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCD---KGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGL 409 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~---~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l 409 (511)
.++|++.+.||+|+||.||++ +.||+|++.... ........+.+|+.+++.++||||+++++++.+.+. +
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~-~ 101 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGM-L 101 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE-E
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE-E
Confidence 356899999999999999996 479999986321 111234568899999999999999999999998776 9
Q ss_pred EEEEeccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCc---EEEEecCCce
Q 010401 410 CVVTKLMEGGSVNDLILKS----RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGN---VCLGDMGIVT 482 (511)
Q Consensus 410 ~LVmEy~~gGsL~~lL~~~----~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~---vKL~DFGlS~ 482 (511)
|+||||+++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++
T Consensus 102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~ 181 (351)
T 3c0i_A 102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAI 181 (351)
T ss_dssp EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCE
T ss_pred EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCccee
Confidence 9999999999999888532 35899999999999999999999999999999999999986654 9999999998
Q ss_pred ecccCCCccccccCCCccccHHhhcc
Q 010401 483 ACKSVGEATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 483 ~l~~~~~~~~~~~Gt~~YmAPEvl~g 508 (511)
.............||+.|+|||++.+
T Consensus 182 ~~~~~~~~~~~~~gt~~y~aPE~~~~ 207 (351)
T 3c0i_A 182 QLGESGLVAGGRVGTPHFMAPEVVKR 207 (351)
T ss_dssp ECCTTSCBCCCCCSCGGGCCHHHHTT
T ss_pred EecCCCeeecCCcCCcCccCHHHHcC
Confidence 87654444556689999999999865
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.96 E-value=9.5e-30 Score=254.75 Aligned_cols=177 Identities=20% Similarity=0.316 Sum_probs=134.8
Q ss_pred ccceEecCCCeEEEeeeecccceEEEEeE---------EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeE
Q 010401 332 IGRWLLNSDNLEFIDQIGPNSFKGVYKGK---------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVC 402 (511)
Q Consensus 332 i~~~~l~~~~y~l~~~LG~GsFG~VYkgk---------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~ 402 (511)
+.++.+..++|++.+.||+|+||.||+++ .||+|++...........++.+|+.+++.++||||+++++++
T Consensus 15 ~~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 94 (323)
T 3qup_A 15 LEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVS 94 (323)
T ss_dssp -CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEE
T ss_pred hhhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhcee
Confidence 34566788899999999999999999974 689999976444455567789999999999999999999999
Q ss_pred eeCCCc-----EEEEEeccCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCC
Q 010401 403 VDENHG-----LCVVTKLMEGGSVNDLILKSR------KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG 471 (511)
Q Consensus 403 ~~~~~~-----l~LVmEy~~gGsL~~lL~~~~------~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g 471 (511)
.+.... .++||||+.+|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 95 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~ 174 (323)
T 3qup_A 95 LRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDM 174 (323)
T ss_dssp ECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTS
T ss_pred eccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCC
Confidence 876541 389999999999999995432 599999999999999999999999999999999999999999
Q ss_pred cEEEEecCCceecccCCC--ccccccCCCccccHHhhcc
Q 010401 472 NVCLGDMGIVTACKSVGE--ATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 472 ~vKL~DFGlS~~l~~~~~--~~~~~~Gt~~YmAPEvl~g 508 (511)
.+||+|||+++....... ......+++.|+|||++.+
T Consensus 175 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 213 (323)
T 3qup_A 175 TVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLAD 213 (323)
T ss_dssp CEEECCCCC-----------------CCGGGCCHHHHHH
T ss_pred CEEEeeccccccccccccccccccccCcccccCchhhcC
Confidence 999999999987644322 1223456778999999864
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=9.5e-30 Score=256.96 Aligned_cols=173 Identities=23% Similarity=0.377 Sum_probs=145.4
Q ss_pred ceEecCCCeEEEeeeecccceEEEEeE-----------EEEEEEEecCCCCchHHHHHHHHHHHHHhC-CCCceeeEeee
Q 010401 334 RWLLNSDNLEFIDQIGPNSFKGVYKGK-----------RVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCV 401 (511)
Q Consensus 334 ~~~l~~~~y~l~~~LG~GsFG~VYkgk-----------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l-~HpNIV~l~g~ 401 (511)
+|.+..++|++.+.||+|+||.||+++ .||+|++.... .......+.+|+.++..+ +||||++++++
T Consensus 39 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 117 (344)
T 1rjb_A 39 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGA 117 (344)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 577888999999999999999999976 49999997422 222345688999999999 99999999999
Q ss_pred EeeCCCcEEEEEeccCCCCHHHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHHCCcccc
Q 010401 402 CVDENHGLCVVTKLMEGGSVNDLILKSR-----------------------KLQTKEIIRIAIDVAEGIKFLNDHGVAYR 458 (511)
Q Consensus 402 ~~~~~~~l~LVmEy~~gGsL~~lL~~~~-----------------------~L~e~~~~~ia~qIa~gL~yLH~~gIIHR 458 (511)
+.+.+. +|+||||+++|+|.+++.... .+++..++.++.||+.||.|||++||+||
T Consensus 118 ~~~~~~-~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~ 196 (344)
T 1rjb_A 118 CTLSGP-IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHR 196 (344)
T ss_dssp ECSSSS-CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEET
T ss_pred EeeCCc-cEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence 988776 999999999999999996542 37899999999999999999999999999
Q ss_pred CCCCCceEEcCCCcEEEEecCCceecccCCCc--cccccCCCccccHHhhcc
Q 010401 459 DLNSQRILLDRHGNVCLGDMGIVTACKSVGEA--TEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 459 DLKp~NILld~~g~vKL~DFGlS~~l~~~~~~--~~~~~Gt~~YmAPEvl~g 508 (511)
||||+|||++.++.+||+|||+++........ .....||+.|+|||++.+
T Consensus 197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~ 248 (344)
T 1rjb_A 197 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE 248 (344)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH
T ss_pred CCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhcc
Confidence 99999999999999999999999876543321 233456788999998864
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.9e-29 Score=265.66 Aligned_cols=169 Identities=21% Similarity=0.311 Sum_probs=143.9
Q ss_pred CCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCC----Cc
Q 010401 339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN----HG 408 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~----~~ 408 (511)
.++|++.+.||+|+||.||++ +.||+|++...........++.+|+.+++.++||||+++++++.... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 578999999999999999996 57999999764444555677899999999999999999999997663 34
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCC
Q 010401 409 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG 488 (511)
Q Consensus 409 l~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~ 488 (511)
+|+||||+.+ +|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 105 ~~lv~e~~~~-~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~ 183 (432)
T 3n9x_A 105 LYIVLEIADS-DLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEK 183 (432)
T ss_dssp EEEEEECCSE-EHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC----
T ss_pred EEEEEecCCc-CHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCcccccccc
Confidence 8999999965 999999887889999999999999999999999999999999999999999999999999998765432
Q ss_pred C----------------------ccccccCCCccccHHhhcc
Q 010401 489 E----------------------ATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 489 ~----------------------~~~~~~Gt~~YmAPEvl~g 508 (511)
. .....+||+.|+|||++..
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~ 225 (432)
T 3n9x_A 184 DTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILL 225 (432)
T ss_dssp ---------------------------CCCCCTTCCHHHHTT
T ss_pred cccccccccccccccccccchhccccCCCCCccccCHHHHhc
Confidence 1 1345678999999998743
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.1e-29 Score=253.75 Aligned_cols=167 Identities=17% Similarity=0.265 Sum_probs=145.5
Q ss_pred CCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCc----hHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcE
Q 010401 340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGN----AYEFELRKDLLELMTCGHKNILQFYCVCVDENHGL 409 (511)
Q Consensus 340 ~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~----~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l 409 (511)
++|++.+.||+|+||.||++ +.||+|++....... .....+.+|+.++..++||||+++++++.+.+. +
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~-~ 89 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD-V 89 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE-E
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE-E
Confidence 45899999999999999995 479999997543221 135668899999999999999999999988775 9
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCC----cEEEEecCCceecc
Q 010401 410 CVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG----NVCLGDMGIVTACK 485 (511)
Q Consensus 410 ~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g----~vKL~DFGlS~~l~ 485 (511)
|+||||+.+|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++...
T Consensus 90 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~ 169 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 169 (326)
T ss_dssp EEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECC
T ss_pred EEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECC
Confidence 99999999999999998778899999999999999999999999999999999999999887 89999999998765
Q ss_pred cCCCccccccCCCccccHHhhcc
Q 010401 486 SVGEATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 486 ~~~~~~~~~~Gt~~YmAPEvl~g 508 (511)
... ......||+.|+|||++.+
T Consensus 170 ~~~-~~~~~~gt~~y~aPE~~~~ 191 (326)
T 2y0a_A 170 FGN-EFKNIFGTPEFVAPEIVNY 191 (326)
T ss_dssp TTS-CCCCCCSCTTTCCHHHHTT
T ss_pred CCC-ccccccCCcCcCCceeecC
Confidence 432 2445679999999999864
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=1.5e-29 Score=250.27 Aligned_cols=170 Identities=22% Similarity=0.420 Sum_probs=139.6
Q ss_pred ecCCCeEEEeeeecccceEEEEeE----------EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCC
Q 010401 337 LNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN 406 (511)
Q Consensus 337 l~~~~y~l~~~LG~GsFG~VYkgk----------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~ 406 (511)
+..++|++++.||+|+||.||+++ .||+|++.. ........+.+|+.++..++||||+++++++...+
T Consensus 7 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 84 (295)
T 3ugc_A 7 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH--STEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG 84 (295)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESC--CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHH
T ss_pred CCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEccc--CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 456789999999999999999864 699999973 33344566899999999999999999999986532
Q ss_pred -CcEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceec
Q 010401 407 -HGLCVVTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC 484 (511)
Q Consensus 407 -~~l~LVmEy~~gGsL~~lL~~~-~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l 484 (511)
..+++||||+++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 85 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~ 164 (295)
T 3ugc_A 85 RRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVL 164 (295)
T ss_dssp HTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC--
T ss_pred CCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccccc
Confidence 2389999999999999999764 45999999999999999999999999999999999999999999999999999876
Q ss_pred ccCCC---ccccccCCCccccHHhhcc
Q 010401 485 KSVGE---ATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 485 ~~~~~---~~~~~~Gt~~YmAPEvl~g 508 (511)
..... ......++..|+|||++.+
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~ 191 (295)
T 3ugc_A 165 PQDKEFFKVKEPGESPIFWYAPESLTE 191 (295)
T ss_dssp -----------CTTCGGGGCCHHHHHH
T ss_pred cCCcceeeeccCCCCccceeCcHHhcC
Confidence 54322 1223456678999999864
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=99.96 E-value=2.1e-29 Score=266.92 Aligned_cols=168 Identities=24% Similarity=0.434 Sum_probs=145.0
Q ss_pred ceEecCCCeEEEeeeecccceEEEEe----EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcE
Q 010401 334 RWLLNSDNLEFIDQIGPNSFKGVYKG----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGL 409 (511)
Q Consensus 334 ~~~l~~~~y~l~~~LG~GsFG~VYkg----k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l 409 (511)
.|.++.++|++.+.||+|+||.||+| +.||||+++... ....+.+|+.++++++||||+++++++.+.+..+
T Consensus 187 ~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 262 (450)
T 1k9a_A 187 GWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL 262 (450)
T ss_dssp TCBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEESSCT----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCE
T ss_pred ccccChHHeEEEeeecCcCCeeEEEEEecCCeEEEEEeCCch----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCce
Confidence 67888999999999999999999996 579999997432 2356889999999999999999999998776559
Q ss_pred EEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccC
Q 010401 410 CVVTKLMEGGSVNDLILKSR--KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV 487 (511)
Q Consensus 410 ~LVmEy~~gGsL~~lL~~~~--~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~ 487 (511)
|+||||+++|+|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 263 ~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 342 (450)
T 1k9a_A 263 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 342 (450)
T ss_dssp EEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc
Confidence 99999999999999997654 3799999999999999999999999999999999999999999999999999865332
Q ss_pred CCccccccCCCccccHHhhcc
Q 010401 488 GEATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 488 ~~~~~~~~Gt~~YmAPEvl~g 508 (511)
.....+++.|+|||++.+
T Consensus 343 ---~~~~~~~~~y~aPE~~~~ 360 (450)
T 1k9a_A 343 ---QDTGKLPVKWTAPEALRE 360 (450)
T ss_dssp -------CCCTTTSCHHHHHS
T ss_pred ---ccCCCCCcceeCHHHhcC
Confidence 223367889999999864
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=6.4e-30 Score=264.12 Aligned_cols=173 Identities=22% Similarity=0.425 Sum_probs=145.8
Q ss_pred ceEecCCCeEEEeeeecccceEEEEeE------EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCC
Q 010401 334 RWLLNSDNLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENH 407 (511)
Q Consensus 334 ~~~l~~~~y~l~~~LG~GsFG~VYkgk------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~ 407 (511)
.|.++.++|++.+.||+|+||.||+|+ .||+|+++.. .......++.+|+.+++.++||||+++++++.+.+.
T Consensus 108 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 186 (377)
T 3cbl_A 108 KWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQP 186 (377)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT-SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred ccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc-CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCC
Confidence 577888999999999999999999964 6999998742 233334468899999999999999999999987775
Q ss_pred cEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceeccc
Q 010401 408 GLCVVTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS 486 (511)
Q Consensus 408 ~l~LVmEy~~gGsL~~lL~~~-~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~ 486 (511)
+|+||||+++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 187 -~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~ 265 (377)
T 3cbl_A 187 -IYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEAD 265 (377)
T ss_dssp -CEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTT
T ss_pred -cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCC
Confidence 99999999999999999754 4699999999999999999999999999999999999999999999999999986543
Q ss_pred CCCcc--ccccCCCccccHHhhcc
Q 010401 487 VGEAT--EYETDGYRWLAPEVCFL 508 (511)
Q Consensus 487 ~~~~~--~~~~Gt~~YmAPEvl~g 508 (511)
..... ....+++.|+|||++.+
T Consensus 266 ~~~~~~~~~~~~~~~y~aPE~~~~ 289 (377)
T 3cbl_A 266 GVYAASGGLRQVPVKWTAPEALNY 289 (377)
T ss_dssp SEEECCSSCCEEEGGGSCHHHHHH
T ss_pred CceeecCCCCCCCcCcCCHhHhcc
Confidence 21111 11234578999999864
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=9.7e-30 Score=254.51 Aligned_cols=170 Identities=19% Similarity=0.330 Sum_probs=138.7
Q ss_pred CCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCc-hHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCc---
Q 010401 339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGN-AYEFELRKDLLELMTCGHKNILQFYCVCVDENHG--- 408 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~-~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~--- 408 (511)
.++|++.+.||+|+||.||++ +.||+|++....... .....+.+|+.++..++||||+++++++......
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 578999999999999999996 479999997543333 3445688999999999999999999998765431
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCC
Q 010401 409 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG 488 (511)
Q Consensus 409 l~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~ 488 (511)
+|+||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 170 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSG 170 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC-------
T ss_pred cEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCcccccccc
Confidence 49999999999999999888889999999999999999999999999999999999999999999999999998764432
Q ss_pred C---ccccccCCCccccHHhhcc
Q 010401 489 E---ATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 489 ~---~~~~~~Gt~~YmAPEvl~g 508 (511)
. ......||+.|+|||++.+
T Consensus 171 ~~~~~~~~~~gt~~y~aPE~~~~ 193 (311)
T 3ork_A 171 NSVTQTAAVIGTAQYLSPEQARG 193 (311)
T ss_dssp -----------CCTTCCHHHHHT
T ss_pred cccccccccCcCcccCCHHHhcC
Confidence 2 2233568999999999875
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.5e-29 Score=254.56 Aligned_cols=167 Identities=22% Similarity=0.383 Sum_probs=130.3
Q ss_pred CCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEE
Q 010401 339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV 412 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LV 412 (511)
.++|++++.||+|+||.||++ +.||+|++..... ......+.+|+.+++.++||||+++++++.+++. +|+|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~-~~lv 81 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE-EGTPSTAIREISLMKELKHENIVRLYDVIHTENK-LTLV 81 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCST-TCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTE-EEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccc-cccHHHHHHHHHHHHhcCCCCcceEEEEEEECCe-EEEE
Confidence 457899999999999999996 4799999975332 2223457899999999999999999999988775 9999
Q ss_pred EeccCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceeccc
Q 010401 413 TKLMEGGSVNDLILKS------RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS 486 (511)
Q Consensus 413 mEy~~gGsL~~lL~~~------~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~ 486 (511)
|||+.+ +|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 82 ~e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 160 (317)
T 2pmi_A 82 FEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGI 160 (317)
T ss_dssp EECCCC-BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTS
T ss_pred EEecCC-CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCC
Confidence 999984 999998643 3589999999999999999999999999999999999999999999999999987754
Q ss_pred CCCccccccCCCccccHHhhcc
Q 010401 487 VGEATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 487 ~~~~~~~~~Gt~~YmAPEvl~g 508 (511)
.........||+.|+|||++.+
T Consensus 161 ~~~~~~~~~~t~~y~aPE~~~~ 182 (317)
T 2pmi_A 161 PVNTFSSEVVTLWYRAPDVLMG 182 (317)
T ss_dssp CCCCCCCCCSCCTTCCHHHHTT
T ss_pred CcccCCCCcccccccCchHhhC
Confidence 4444456688999999999875
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=5.2e-29 Score=244.21 Aligned_cols=169 Identities=20% Similarity=0.248 Sum_probs=147.6
Q ss_pred CCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEE
Q 010401 339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV 412 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LV 412 (511)
.++|++.+.||+|+||.||++ +.||+|++............+.+|+.++..++||||+++++++.+.+. .|+|
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~~v 83 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESF-HYLV 83 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE-EEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCE-EEEE
Confidence 468999999999999999995 479999997655455555668899999999999999999999987775 8999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCc---EEEEecCCceecccCCC
Q 010401 413 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGN---VCLGDMGIVTACKSVGE 489 (511)
Q Consensus 413 mEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~---vKL~DFGlS~~l~~~~~ 489 (511)
|||+.+++|.+.+.....+++..+..++.||+.||.|||++||+||||||+||+++.++. +||+|||++...... .
T Consensus 84 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~-~ 162 (284)
T 3kk8_A 84 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS-E 162 (284)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS-C
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC-c
Confidence 999999999999988888999999999999999999999999999999999999986655 999999999776543 2
Q ss_pred ccccccCCCccccHHhhccc
Q 010401 490 ATEYETDGYRWLAPEVCFLL 509 (511)
Q Consensus 490 ~~~~~~Gt~~YmAPEvl~gl 509 (511)
......|++.|+|||++.+.
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~ 182 (284)
T 3kk8_A 163 AWHGFAGTPGYLSPEVLKKD 182 (284)
T ss_dssp BCCCSCSCGGGCCHHHHTTC
T ss_pred cccCCCCCcCCcCchhhcCC
Confidence 33456789999999998653
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=7.5e-30 Score=262.96 Aligned_cols=171 Identities=22% Similarity=0.419 Sum_probs=144.4
Q ss_pred EecCCCeEEEeeeecccceEEEEeE-----------EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEee
Q 010401 336 LLNSDNLEFIDQIGPNSFKGVYKGK-----------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVD 404 (511)
Q Consensus 336 ~l~~~~y~l~~~LG~GsFG~VYkgk-----------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~ 404 (511)
.+..++|++++.||+|+||.||+|+ .||+|++.. ........++.+|+.++..++||||+++++++.+
T Consensus 67 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~-~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 145 (367)
T 3l9p_A 67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE-VCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ 145 (367)
T ss_dssp BCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCS-SCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred hcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccc-ccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence 3556789999999999999999976 699999964 2334455568899999999999999999999988
Q ss_pred CCCcEEEEEeccCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCC---cEE
Q 010401 405 ENHGLCVVTKLMEGGSVNDLILKS-------RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG---NVC 474 (511)
Q Consensus 405 ~~~~l~LVmEy~~gGsL~~lL~~~-------~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g---~vK 474 (511)
.+. .|+||||+.+|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++ .+|
T Consensus 146 ~~~-~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~k 224 (367)
T 3l9p_A 146 SLP-RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK 224 (367)
T ss_dssp SSS-CEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred CCC-CEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEE
Confidence 776 89999999999999999654 3589999999999999999999999999999999999999555 599
Q ss_pred EEecCCceecccCC--CccccccCCCccccHHhhcc
Q 010401 475 LGDMGIVTACKSVG--EATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 475 L~DFGlS~~l~~~~--~~~~~~~Gt~~YmAPEvl~g 508 (511)
|+|||+++...... .......||+.|+|||++.+
T Consensus 225 L~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~ 260 (367)
T 3l9p_A 225 IGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFME 260 (367)
T ss_dssp ECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHH
T ss_pred ECCCccccccccccccccCCCcCCcccEECHHHhcC
Confidence 99999997653322 22334567899999999864
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=99.96 E-value=3.2e-29 Score=253.15 Aligned_cols=173 Identities=20% Similarity=0.411 Sum_probs=147.8
Q ss_pred ceEecCCCeEEEeeeecccceEEEEeE-------------EEEEEEEecCCCCchHHHHHHHHHHHHHhC-CCCceeeEe
Q 010401 334 RWLLNSDNLEFIDQIGPNSFKGVYKGK-------------RVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFY 399 (511)
Q Consensus 334 ~~~l~~~~y~l~~~LG~GsFG~VYkgk-------------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l-~HpNIV~l~ 399 (511)
.|.+..++|++.+.||+|+||.||+++ .||+|++... ........+.+|+.++..+ +||||++++
T Consensus 29 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 107 (334)
T 2pvf_A 29 KWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLL 107 (334)
T ss_dssp TTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccC-CcHHHHHHHHHHHHHHHHhhcCCCEeeEE
Confidence 567788999999999999999999975 4899999742 2334456688999999999 999999999
Q ss_pred eeEeeCCCcEEEEEeccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCC
Q 010401 400 CVCVDENHGLCVVTKLMEGGSVNDLILKSR----------------KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQ 463 (511)
Q Consensus 400 g~~~~~~~~l~LVmEy~~gGsL~~lL~~~~----------------~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~ 463 (511)
+++.+.+. +|+||||+.+|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+
T Consensus 108 ~~~~~~~~-~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~ 186 (334)
T 2pvf_A 108 GACTQDGP-LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAAR 186 (334)
T ss_dssp EEECSSSC-CEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred EEEccCCc-eEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccc
Confidence 99988776 999999999999999997543 3899999999999999999999999999999999
Q ss_pred ceEEcCCCcEEEEecCCceecccCCC--ccccccCCCccccHHhhcc
Q 010401 464 RILLDRHGNVCLGDMGIVTACKSVGE--ATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 464 NILld~~g~vKL~DFGlS~~l~~~~~--~~~~~~Gt~~YmAPEvl~g 508 (511)
|||++.++.+||+|||+++....... ......+++.|+|||++.+
T Consensus 187 NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 233 (334)
T 2pvf_A 187 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD 233 (334)
T ss_dssp GEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHH
T ss_pred eEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcC
Confidence 99999999999999999987654332 2233456788999998754
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.8e-29 Score=254.78 Aligned_cols=171 Identities=22% Similarity=0.344 Sum_probs=143.9
Q ss_pred ecCCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEE
Q 010401 337 LNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLC 410 (511)
Q Consensus 337 l~~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~ 410 (511)
...++|++.+.||+|+||.||++ +.||+|++............+.+|+.++..++||||+++++++.+.+. +|
T Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~ 100 (331)
T 4aaa_A 22 QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKR-WY 100 (331)
T ss_dssp BCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE-EE
T ss_pred hhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCE-EE
Confidence 34678999999999999999996 479999997655445555668899999999999999999999998776 99
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCc
Q 010401 411 VVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA 490 (511)
Q Consensus 411 LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~ 490 (511)
+||||+.+++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++........
T Consensus 101 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 180 (331)
T 4aaa_A 101 LVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV 180 (331)
T ss_dssp EEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC---------
T ss_pred EEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCccc
Confidence 99999999999988877778999999999999999999999999999999999999999999999999999876654444
Q ss_pred cccccCCCccccHHhhcc
Q 010401 491 TEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 491 ~~~~~Gt~~YmAPEvl~g 508 (511)
.....|++.|+|||++.+
T Consensus 181 ~~~~~~t~~y~aPE~~~~ 198 (331)
T 4aaa_A 181 YDDEVATRWYRAPELLVG 198 (331)
T ss_dssp ---CCCCCTTCCHHHHTT
T ss_pred cCCCcCCccccCcccccC
Confidence 556688999999999865
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.4e-29 Score=252.13 Aligned_cols=164 Identities=23% Similarity=0.344 Sum_probs=143.8
Q ss_pred CeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEEe
Q 010401 341 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTK 414 (511)
Q Consensus 341 ~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVmE 414 (511)
.|+..+.||+|+||.||+| +.||||++..... .....+.+|+.++..++||||+++++++...+. +|+|||
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~lv~e 122 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ--QRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEE-LWVLME 122 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--CSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTE-EEEEEC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccch--hHHHHHHHHHHHHHhCCCCCcceEEEEEEECCE-EEEEEe
Confidence 3678889999999999985 4799999975332 234567899999999999999999999998776 999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCccccc
Q 010401 415 LMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYE 494 (511)
Q Consensus 415 y~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~~~~ 494 (511)
|+++++|.+++. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++............
T Consensus 123 ~~~~~~L~~~l~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 201 (321)
T 2c30_A 123 FLQGGALTDIVS-QVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL 201 (321)
T ss_dssp CCCSCBHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCC
T ss_pred cCCCCCHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCccccccc
Confidence 999999999985 4579999999999999999999999999999999999999999999999999998776544445566
Q ss_pred cCCCccccHHhhcc
Q 010401 495 TDGYRWLAPEVCFL 508 (511)
Q Consensus 495 ~Gt~~YmAPEvl~g 508 (511)
.||+.|+|||++.+
T Consensus 202 ~gt~~y~aPE~~~~ 215 (321)
T 2c30_A 202 VGTPYWMAPEVISR 215 (321)
T ss_dssp CSCGGGCCHHHHTT
T ss_pred cCCccccCHhhhcC
Confidence 89999999999864
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=99.96 E-value=1e-29 Score=260.39 Aligned_cols=168 Identities=20% Similarity=0.295 Sum_probs=144.8
Q ss_pred CCCeEEEeeeecccceEEEEeE------EEEEEEEecCCCC-chHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEE
Q 010401 339 SDNLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDKG-NAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCV 411 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkgk------~VAVKkL~~~~~~-~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~L 411 (511)
.++|++.+.||+|+||.||+++ .||+|++...... ......+.+|+.+++.++||||+++++++.+.+. +|+
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~-~~l 86 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTD-IVM 86 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSE-EEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCE-EEE
Confidence 4678999999999999999964 6999999642111 1123457899999999999999999999998776 999
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCcc
Q 010401 412 VTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT 491 (511)
Q Consensus 412 VmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~ 491 (511)
||||+ +|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ...
T Consensus 87 v~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~-~~~ 164 (336)
T 3h4j_B 87 VIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG-NFL 164 (336)
T ss_dssp EECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS-BTT
T ss_pred EEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCC-ccc
Confidence 99999 6799999988889999999999999999999999999999999999999999999999999999866443 334
Q ss_pred ccccCCCccccHHhhccc
Q 010401 492 EYETDGYRWLAPEVCFLL 509 (511)
Q Consensus 492 ~~~~Gt~~YmAPEvl~gl 509 (511)
...+||+.|+|||++.+.
T Consensus 165 ~~~~gt~~y~aPE~~~~~ 182 (336)
T 3h4j_B 165 KTSCGSPNYAAPEVINGK 182 (336)
T ss_dssp CCCTTSTTTSCGGGSCCS
T ss_pred ccccCCcCcCCHHHHcCC
Confidence 556899999999998753
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=1.6e-29 Score=251.14 Aligned_cols=174 Identities=23% Similarity=0.398 Sum_probs=148.0
Q ss_pred ceEecCCCeEEEeeeecccceEEEEe-----------EEEEEEEEecCCCCchHHHHHHHHHHHHHhC-CCCceeeEeee
Q 010401 334 RWLLNSDNLEFIDQIGPNSFKGVYKG-----------KRVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCV 401 (511)
Q Consensus 334 ~~~l~~~~y~l~~~LG~GsFG~VYkg-----------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l-~HpNIV~l~g~ 401 (511)
.|.+..++|++.+.||+|+||.||++ +.||+|++... ........+.+|+.++..+ +||||++++++
T Consensus 21 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 99 (316)
T 2xir_A 21 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVVNLLGA 99 (316)
T ss_dssp HHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccC-CCcHHHHHHHHHHHHHHhcccCCCeeeEEEE
Confidence 56778889999999999999999997 47999999742 2333445688999999999 79999999999
Q ss_pred EeeCCCcEEEEEeccCCCCHHHHHHhcCC----------------CCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCce
Q 010401 402 CVDENHGLCVVTKLMEGGSVNDLILKSRK----------------LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRI 465 (511)
Q Consensus 402 ~~~~~~~l~LVmEy~~gGsL~~lL~~~~~----------------L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NI 465 (511)
+...+..+|+||||+++|+|.+++..... +++..++.++.||+.||.|||++||+||||||+||
T Consensus 100 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Ni 179 (316)
T 2xir_A 100 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 179 (316)
T ss_dssp ECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred EecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceE
Confidence 98776568999999999999999976443 88999999999999999999999999999999999
Q ss_pred EEcCCCcEEEEecCCceecccCCC--ccccccCCCccccHHhhcc
Q 010401 466 LLDRHGNVCLGDMGIVTACKSVGE--ATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 466 Lld~~g~vKL~DFGlS~~l~~~~~--~~~~~~Gt~~YmAPEvl~g 508 (511)
+++.++.+||+|||+++....... ......||+.|+|||++.+
T Consensus 180 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~ 224 (316)
T 2xir_A 180 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD 224 (316)
T ss_dssp EECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH
T ss_pred EECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhcc
Confidence 999999999999999987644322 1233456789999999864
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-29 Score=256.51 Aligned_cols=168 Identities=19% Similarity=0.291 Sum_probs=135.4
Q ss_pred CCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEE
Q 010401 339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV 412 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LV 412 (511)
.++|++.+.||+|+||.||++ +.||+|++............+.+|+.+++.++||||+++++++.+.+. +|+|
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~lv 111 (329)
T 3gbz_A 33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHR-LHLI 111 (329)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTE-EEEE
T ss_pred hhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCE-EEEE
Confidence 457899999999999999996 479999997544444344567899999999999999999999998776 9999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEc-----CCCcEEEEecCCceecccC
Q 010401 413 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLD-----RHGNVCLGDMGIVTACKSV 487 (511)
Q Consensus 413 mEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld-----~~g~vKL~DFGlS~~l~~~ 487 (511)
|||+.+ +|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++.....
T Consensus 112 ~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~ 190 (329)
T 3gbz_A 112 FEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIP 190 (329)
T ss_dssp EECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC--
T ss_pred EecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCCc
Confidence 999985 9999998888899999999999999999999999999999999999994 4556999999999876544
Q ss_pred CCccccccCCCccccHHhhcc
Q 010401 488 GEATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 488 ~~~~~~~~Gt~~YmAPEvl~g 508 (511)
........||+.|+|||++.+
T Consensus 191 ~~~~~~~~~t~~y~aPE~~~~ 211 (329)
T 3gbz_A 191 IRQFTHEIITLWYRPPEILLG 211 (329)
T ss_dssp ---------CCTTCCHHHHTT
T ss_pred ccccCCCcCCccccCHHHhcC
Confidence 444556678999999999876
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=5.2e-29 Score=246.23 Aligned_cols=173 Identities=24% Similarity=0.376 Sum_probs=144.2
Q ss_pred ceEecCCCeEEEe-eeecccceEEEEe--------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEee
Q 010401 334 RWLLNSDNLEFID-QIGPNSFKGVYKG--------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVD 404 (511)
Q Consensus 334 ~~~l~~~~y~l~~-~LG~GsFG~VYkg--------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~ 404 (511)
++.++.++|++.+ .||+|+||.||+| +.||+|++...........++.+|+.++..++||||+++++++.
T Consensus 10 ~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~- 88 (291)
T 1xbb_A 10 EVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE- 88 (291)
T ss_dssp -CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-
T ss_pred eeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEC-
Confidence 4556778899998 9999999999997 46999999764444445667899999999999999999999994
Q ss_pred CCCcEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceec
Q 010401 405 ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC 484 (511)
Q Consensus 405 ~~~~l~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l 484 (511)
.+. +|+||||+.+++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 89 ~~~-~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 167 (291)
T 1xbb_A 89 AES-WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKAL 167 (291)
T ss_dssp SSS-EEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred CCC-cEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence 444 8999999999999999988888999999999999999999999999999999999999999999999999999876
Q ss_pred ccCCCc---cccccCCCccccHHhhcc
Q 010401 485 KSVGEA---TEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 485 ~~~~~~---~~~~~Gt~~YmAPEvl~g 508 (511)
...... .....+++.|+|||++.+
T Consensus 168 ~~~~~~~~~~~~~~~~~~y~aPE~~~~ 194 (291)
T 1xbb_A 168 RADENYYKAQTHGKWPVKWYAPECINY 194 (291)
T ss_dssp CTTCSEEEC----CCCGGGCCHHHHHH
T ss_pred ccCCCcccccccCCCCceeeChHHhcc
Confidence 543321 222345688999999864
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=6.9e-29 Score=245.28 Aligned_cols=169 Identities=18% Similarity=0.199 Sum_probs=148.4
Q ss_pred CCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCC-chHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEE
Q 010401 339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKG-NAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCV 411 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~-~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~L 411 (511)
.++|++.+.||+|+||.||++ +.+|+|.+...... ......+.+|+.+++.++||||+++++++.+.+. +|+
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~l 92 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDF-VFV 92 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE-EEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCE-EEE
Confidence 456899999999999999996 46899998754322 3345568899999999999999999999987765 999
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCcc
Q 010401 412 VTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT 491 (511)
Q Consensus 412 VmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~ 491 (511)
||||+.+++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.........
T Consensus 93 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 172 (294)
T 2rku_A 93 VLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK 172 (294)
T ss_dssp EEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTCCB
T ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCcccc
Confidence 99999999999999877889999999999999999999999999999999999999999999999999998776544445
Q ss_pred ccccCCCccccHHhhcc
Q 010401 492 EYETDGYRWLAPEVCFL 508 (511)
Q Consensus 492 ~~~~Gt~~YmAPEvl~g 508 (511)
....|++.|+|||++.+
T Consensus 173 ~~~~~~~~y~aPE~~~~ 189 (294)
T 2rku_A 173 KVLCGTPNYIAPEVLSK 189 (294)
T ss_dssp CCCCSCCSSCCHHHHTT
T ss_pred ccccCCCCcCCcchhcc
Confidence 56678999999999865
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=5.7e-29 Score=246.03 Aligned_cols=171 Identities=23% Similarity=0.461 Sum_probs=141.9
Q ss_pred ecCCCeEEEeeeecccceEEEEeE----------EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCC
Q 010401 337 LNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN 406 (511)
Q Consensus 337 l~~~~y~l~~~LG~GsFG~VYkgk----------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~ 406 (511)
+..+.|++.+.||+|+||.||+++ .||+|++.... .......+.+|+.++..++||||+++++++.+.+
T Consensus 18 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 96 (302)
T 4e5w_A 18 FEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDG 96 (302)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--
T ss_pred hhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCC
Confidence 345668999999999999999864 69999997533 2233456889999999999999999999998763
Q ss_pred -CcEEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceec
Q 010401 407 -HGLCVVTKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC 484 (511)
Q Consensus 407 -~~l~LVmEy~~gGsL~~lL~~-~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l 484 (511)
..+++||||+++|+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 97 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 176 (302)
T 4e5w_A 97 GNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI 176 (302)
T ss_dssp -CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred CceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccccccc
Confidence 338999999999999999954 457999999999999999999999999999999999999999999999999999877
Q ss_pred ccCCC---ccccccCCCccccHHhhcc
Q 010401 485 KSVGE---ATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 485 ~~~~~---~~~~~~Gt~~YmAPEvl~g 508 (511)
..... ......||..|+|||++.+
T Consensus 177 ~~~~~~~~~~~~~~~~~~y~aPE~~~~ 203 (302)
T 4e5w_A 177 ETDKEYYTVKDDRDSPVFWYAPECLMQ 203 (302)
T ss_dssp CTTCCEEECCCCTTCCGGGCCHHHHHH
T ss_pred cCCCcceeccCCCCCCccccCCeeecC
Confidence 54432 2334567788999999864
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.6e-29 Score=250.11 Aligned_cols=169 Identities=16% Similarity=0.237 Sum_probs=143.3
Q ss_pred ecCCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCC-cE
Q 010401 337 LNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENH-GL 409 (511)
Q Consensus 337 l~~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~-~l 409 (511)
...++|++.+.||+|+||.||++ +.||+|++..... ......+.+|+.++..++||||+++++++...+. .+
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 84 (319)
T 4euu_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK 84 (319)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceE
Confidence 34567899999999999999996 4799999974322 2224557899999999999999999999986652 38
Q ss_pred EEEEeccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEE----cCCCcEEEEecCCce
Q 010401 410 CVVTKLMEGGSVNDLILKSR---KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILL----DRHGNVCLGDMGIVT 482 (511)
Q Consensus 410 ~LVmEy~~gGsL~~lL~~~~---~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILl----d~~g~vKL~DFGlS~ 482 (511)
|+||||+++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp EEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred EEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 99999999999999997543 39999999999999999999999999999999999999 788889999999998
Q ss_pred ecccCCCccccccCCCccccHHhhc
Q 010401 483 ACKSVGEATEYETDGYRWLAPEVCF 507 (511)
Q Consensus 483 ~l~~~~~~~~~~~Gt~~YmAPEvl~ 507 (511)
...... ......||+.|+|||++.
T Consensus 165 ~~~~~~-~~~~~~gt~~y~aPE~~~ 188 (319)
T 4euu_A 165 ELEDDE-QFVSLYGTEEYLHPDMYE 188 (319)
T ss_dssp ECCTTC-CBCCCCSCGGGCCHHHHH
T ss_pred ecCCCC-ceeecccCCCccCHHHhh
Confidence 765433 234567899999999986
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=2.3e-29 Score=247.19 Aligned_cols=174 Identities=20% Similarity=0.370 Sum_probs=149.6
Q ss_pred cccceEecCCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEee
Q 010401 331 EIGRWLLNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVD 404 (511)
Q Consensus 331 ~i~~~~l~~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~ 404 (511)
.+..|.+..++|++.+.||+|+||.||++ +.||+|++.. .......+.+|+.+++.++||||+++++++.+
T Consensus 4 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 80 (288)
T 3kfa_A 4 NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 80 (288)
T ss_dssp TCCTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECS---CSTHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred chhcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCc---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence 34578888999999999999999999996 4799999963 23345668899999999999999999999988
Q ss_pred CCCcEEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCce
Q 010401 405 ENHGLCVVTKLMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVT 482 (511)
Q Consensus 405 ~~~~l~LVmEy~~gGsL~~lL~~~--~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~ 482 (511)
++. +|+||||+.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.
T Consensus 81 ~~~-~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~ 159 (288)
T 3kfa_A 81 EPP-FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSR 159 (288)
T ss_dssp SSS-EEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGG
T ss_pred CCC-EEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccce
Confidence 776 99999999999999999753 459999999999999999999999999999999999999999999999999998
Q ss_pred ecccCCC-ccccccCCCccccHHhhcc
Q 010401 483 ACKSVGE-ATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 483 ~l~~~~~-~~~~~~Gt~~YmAPEvl~g 508 (511)
....... ......+++.|+|||++.+
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~ 186 (288)
T 3kfa_A 160 LMTGDTYTAHAGAKFPIKWTAPESLAY 186 (288)
T ss_dssp TSCSSSSEEETTEEECGGGCCHHHHHH
T ss_pred eccCCccccccCCccccCcCChhhhcc
Confidence 7654332 2233456788999999864
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.1e-29 Score=251.50 Aligned_cols=166 Identities=17% Similarity=0.235 Sum_probs=138.2
Q ss_pred CCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhC-CCCceeeEeeeEeeCCCcEEEE
Q 010401 340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCVCVDENHGLCVV 412 (511)
Q Consensus 340 ~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l-~HpNIV~l~g~~~~~~~~l~LV 412 (511)
++|++.++||+|+||.||+| +.||||++...........+...|+..+..+ +||||++++++|.+++. +|+|
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~-~~lv 135 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGI-LYLQ 135 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE-EEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCE-EEEE
Confidence 57899999999999999996 4799999875444444455566666666554 99999999999998776 9999
Q ss_pred EeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCcc
Q 010401 413 TKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT 491 (511)
Q Consensus 413 mEy~~gGsL~~lL~~~-~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~ 491 (511)
|||+ +++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... ...
T Consensus 136 ~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~-~~~ 213 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA-GAG 213 (311)
T ss_dssp EECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC------
T ss_pred Eecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccC-CCC
Confidence 9999 66999988654 46999999999999999999999999999999999999999999999999998876443 234
Q ss_pred ccccCCCccccHHhhcc
Q 010401 492 EYETDGYRWLAPEVCFL 508 (511)
Q Consensus 492 ~~~~Gt~~YmAPEvl~g 508 (511)
....||+.|+|||++.+
T Consensus 214 ~~~~gt~~y~aPE~~~~ 230 (311)
T 3p1a_A 214 EVQEGDPRYMAPELLQG 230 (311)
T ss_dssp -CCCCCGGGCCGGGGGT
T ss_pred cccCCCccccCHhHhcC
Confidence 45678999999999865
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.6e-29 Score=281.80 Aligned_cols=173 Identities=20% Similarity=0.250 Sum_probs=147.3
Q ss_pred eEecCCCeEEEeeeecccceEEEEeE------EEEEEEEecCCC-CchHHHHHHHHHHHHHhC-CCCceeeEeeeEeeCC
Q 010401 335 WLLNSDNLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDK-GNAYEFELRKDLLELMTC-GHKNILQFYCVCVDEN 406 (511)
Q Consensus 335 ~~l~~~~y~l~~~LG~GsFG~VYkgk------~VAVKkL~~~~~-~~~~~~~~~~Ei~iL~~l-~HpNIV~l~g~~~~~~ 406 (511)
..+..++|++++.||+|+||.||+++ .||+|+++.... .......+..|..++..+ +||||+++++++.+.+
T Consensus 336 ~~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~ 415 (674)
T 3pfq_A 336 DRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD 415 (674)
T ss_dssp ----CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSS
T ss_pred ccccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCC
Confidence 34567899999999999999999964 699999974211 111234467788888876 7999999999998877
Q ss_pred CcEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceeccc
Q 010401 407 HGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS 486 (511)
Q Consensus 407 ~~l~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~ 486 (511)
. +||||||+.+|+|.+++...+.+++..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+++....
T Consensus 416 ~-~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 494 (674)
T 3pfq_A 416 R-LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW 494 (674)
T ss_dssp E-EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCC
T ss_pred E-EEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeecccc
Confidence 5 999999999999999998888999999999999999999999999999999999999999999999999999987655
Q ss_pred CCCccccccCCCccccHHhhcc
Q 010401 487 VGEATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 487 ~~~~~~~~~Gt~~YmAPEvl~g 508 (511)
........+||+.|+|||++.+
T Consensus 495 ~~~~~~~~~GT~~Y~APE~l~~ 516 (674)
T 3pfq_A 495 DGVTTKTFCGTPDYIAPEIIAY 516 (674)
T ss_dssp TTCCBCCCCSCSSSCCHHHHTC
T ss_pred CCcccccccCCCcccCHhhhcC
Confidence 5555667789999999999865
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=7.1e-29 Score=251.44 Aligned_cols=169 Identities=18% Similarity=0.199 Sum_probs=148.8
Q ss_pred CCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCC-chHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEE
Q 010401 339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKG-NAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCV 411 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~-~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~L 411 (511)
.++|++.+.||+|+||.||++ +.+|+|++...... ......+.+|+.+++.++||||+++++++.+.+. +|+
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~l 118 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDF-VFV 118 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE-EEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCe-EEE
Confidence 456899999999999999996 47999998753322 2345568899999999999999999999998775 999
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCcc
Q 010401 412 VTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT 491 (511)
Q Consensus 412 VmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~ 491 (511)
||||+.+++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.........
T Consensus 119 v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~ 198 (335)
T 2owb_A 119 VLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK 198 (335)
T ss_dssp EECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTCCB
T ss_pred EEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCcccc
Confidence 99999999999999877889999999999999999999999999999999999999999999999999998776544445
Q ss_pred ccccCCCccccHHhhcc
Q 010401 492 EYETDGYRWLAPEVCFL 508 (511)
Q Consensus 492 ~~~~Gt~~YmAPEvl~g 508 (511)
....|++.|+|||++.+
T Consensus 199 ~~~~gt~~y~aPE~~~~ 215 (335)
T 2owb_A 199 KVLCGTPNYIAPEVLSK 215 (335)
T ss_dssp CCCCSCCSSCCHHHHHT
T ss_pred cccCCCccccCHHHhcc
Confidence 56789999999999865
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=6.2e-29 Score=243.16 Aligned_cols=165 Identities=19% Similarity=0.297 Sum_probs=145.0
Q ss_pred CCeEEEeeeecccceEEEEeE------EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEE
Q 010401 340 DNLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT 413 (511)
Q Consensus 340 ~~y~l~~~LG~GsFG~VYkgk------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVm 413 (511)
++|++.+.||+|+||.||+++ .+|+|++....... ...+.+|+.++..++||||+++++++.+.+. +|+||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~-~~lv~ 85 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED--VDRFKQEIEIMKSLDHPNIIRLYETFEDNTD-IYLVM 85 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHTCCCTTBCCEEEEEECSSE-EEEEE
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccch--HHHHHHHHHHHHhCCCCCEeeEEEEEecCCe-EEEEE
Confidence 468999999999999999964 68999997533322 4568899999999999999999999987775 99999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEE---cCCCcEEEEecCCceecccCCCc
Q 010401 414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILL---DRHGNVCLGDMGIVTACKSVGEA 490 (511)
Q Consensus 414 Ey~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILl---d~~g~vKL~DFGlS~~l~~~~~~ 490 (511)
||+.+++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++...... ..
T Consensus 86 e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~-~~ 164 (277)
T 3f3z_A 86 ELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG-KM 164 (277)
T ss_dssp ECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT-SC
T ss_pred eccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc-cc
Confidence 999999999999888889999999999999999999999999999999999999 78899999999999876543 23
Q ss_pred cccccCCCccccHHhhcc
Q 010401 491 TEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 491 ~~~~~Gt~~YmAPEvl~g 508 (511)
.....||+.|+|||++.+
T Consensus 165 ~~~~~~t~~y~aPE~~~~ 182 (277)
T 3f3z_A 165 MRTKVGTPYYVSPQVLEG 182 (277)
T ss_dssp BCCCCSCTTTCCHHHHTT
T ss_pred hhccCCCCCccChHHhcc
Confidence 455678999999999865
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=5.3e-29 Score=253.17 Aligned_cols=171 Identities=16% Similarity=0.221 Sum_probs=143.4
Q ss_pred eEecCCCeEEEeeeecccceEEEEe-----EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCC--CceeeEeeeEeeCCC
Q 010401 335 WLLNSDNLEFIDQIGPNSFKGVYKG-----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGH--KNILQFYCVCVDENH 407 (511)
Q Consensus 335 ~~l~~~~y~l~~~LG~GsFG~VYkg-----k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~H--pNIV~l~g~~~~~~~ 407 (511)
..+..++|++.+.||+|+||.||++ +.||+|++............+.+|+.++..++| |||+++++++.+++.
T Consensus 4 i~~~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~ 83 (343)
T 3dbq_A 4 ISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 83 (343)
T ss_dssp EESSSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred eeeecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCE
Confidence 3456778999999999999999996 479999998655555555678999999999976 999999999998775
Q ss_pred cEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccC
Q 010401 408 GLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV 487 (511)
Q Consensus 408 ~l~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~ 487 (511)
+|+|||+ .+++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++.....
T Consensus 84 -~~lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~ 160 (343)
T 3dbq_A 84 -IYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 160 (343)
T ss_dssp -EEEEECC-CSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC---
T ss_pred -EEEEEeC-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCcc
Confidence 9999995 5779999998888999999999999999999999999999999999999997 688999999999876443
Q ss_pred CC--ccccccCCCccccHHhhcc
Q 010401 488 GE--ATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 488 ~~--~~~~~~Gt~~YmAPEvl~g 508 (511)
.. ......||+.|+|||++.+
T Consensus 161 ~~~~~~~~~~gt~~y~aPE~~~~ 183 (343)
T 3dbq_A 161 TTSVVKDSQVGTVNYMPPEAIKD 183 (343)
T ss_dssp ---------CCCCSSCCHHHHHH
T ss_pred cccccCCCCcCCcCcCCHHHHhh
Confidence 22 2335579999999999864
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.96 E-value=4e-29 Score=258.17 Aligned_cols=168 Identities=19% Similarity=0.302 Sum_probs=133.7
Q ss_pred CCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCC-CCceeeEeeeEeeCC-CcEE
Q 010401 339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCG-HKNILQFYCVCVDEN-HGLC 410 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~-HpNIV~l~g~~~~~~-~~l~ 410 (511)
.++|++++.||+|+||.||++ +.||+|++...........++.+|+.++..+. ||||+++++++...+ ..+|
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 87 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVY 87 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEE
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEE
Confidence 468999999999999999996 47999999754445555667889999999996 999999999997654 2489
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCC--
Q 010401 411 VVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG-- 488 (511)
Q Consensus 411 LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~-- 488 (511)
+||||+.+ +|..++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 88 lv~e~~~~-~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 165 (388)
T 3oz6_A 88 LVFDYMET-DLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRV 165 (388)
T ss_dssp EEEECCSE-EHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCC
T ss_pred EEecccCc-CHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccccccccccc
Confidence 99999974 99999865 579999999999999999999999999999999999999999999999999998753311
Q ss_pred -------------------CccccccCCCccccHHhhcc
Q 010401 489 -------------------EATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 489 -------------------~~~~~~~Gt~~YmAPEvl~g 508 (511)
......+||+.|+|||++.+
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 204 (388)
T 3oz6_A 166 TNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLG 204 (388)
T ss_dssp CCCGGGCCC---------------CCCGGGGCCHHHHTT
T ss_pred cccccccccccccccccccccccCCcccCCcCCHHHhcC
Confidence 11234578999999999875
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.3e-29 Score=251.90 Aligned_cols=173 Identities=21% Similarity=0.400 Sum_probs=147.4
Q ss_pred ceEecCCCeEEEeeeecccceEEEEeE-----------EEEEEEEecCCCCchHHHHHHHHHHHHHhC-CCCceeeEeee
Q 010401 334 RWLLNSDNLEFIDQIGPNSFKGVYKGK-----------RVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCV 401 (511)
Q Consensus 334 ~~~l~~~~y~l~~~LG~GsFG~VYkgk-----------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l-~HpNIV~l~g~ 401 (511)
.|.+..++|++.+.||+|+||.||+++ .||+|.+... ........+.+|+.++..+ +||||++++++
T Consensus 40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 118 (333)
T 2i1m_A 40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKST-AHADEKEALMSELKIMSHLGQHENIVNLLGA 118 (333)
T ss_dssp GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccc-cChHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 577888999999999999999999975 5999999743 2333456688999999999 89999999999
Q ss_pred EeeCCCcEEEEEeccCCCCHHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEE
Q 010401 402 CVDENHGLCVVTKLMEGGSVNDLILKS--------------RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILL 467 (511)
Q Consensus 402 ~~~~~~~l~LVmEy~~gGsL~~lL~~~--------------~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILl 467 (511)
+.+.+. +|+||||+++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 119 ~~~~~~-~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~ 197 (333)
T 2i1m_A 119 CTHGGP-VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLL 197 (333)
T ss_dssp ECSSSS-CEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEE
T ss_pred EecCCc-eEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEE
Confidence 988776 99999999999999999642 357999999999999999999999999999999999999
Q ss_pred cCCCcEEEEecCCceecccCCCc--cccccCCCccccHHhhcc
Q 010401 468 DRHGNVCLGDMGIVTACKSVGEA--TEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 468 d~~g~vKL~DFGlS~~l~~~~~~--~~~~~Gt~~YmAPEvl~g 508 (511)
+.++.+||+|||+++........ .....|++.|+|||++.+
T Consensus 198 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 240 (333)
T 2i1m_A 198 TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFD 240 (333)
T ss_dssp EGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHH
T ss_pred CCCCeEEECccccccccccccceeecCCCCCCccccCHHHhcc
Confidence 99999999999999866443321 223456778999998764
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=5.2e-29 Score=246.31 Aligned_cols=172 Identities=28% Similarity=0.442 Sum_probs=138.4
Q ss_pred ceEecCCCeEEEeeeecccceEEEEeE---EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEE
Q 010401 334 RWLLNSDNLEFIDQIGPNSFKGVYKGK---RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLC 410 (511)
Q Consensus 334 ~~~l~~~~y~l~~~LG~GsFG~VYkgk---~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~ 410 (511)
.+++..++|++.+.||+|+||.||+|+ .+|+|+++...........+.+|+.+++.++||||+++++++.. +. ++
T Consensus 18 ~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~-~~ 95 (289)
T 3og7_A 18 DWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQ-LA 95 (289)
T ss_dssp CCBCCTTSCEEEEEEEECSSEEEEEEESSSEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SS-CE
T ss_pred CCccCccceeeeeEecCCCCeEEEEEEEcCceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeeccC-Cc-cE
Confidence 567788999999999999999999975 69999997655555556678999999999999999999996643 33 89
Q ss_pred EEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCC-
Q 010401 411 VVTKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG- 488 (511)
Q Consensus 411 LVmEy~~gGsL~~lL~~-~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~- 488 (511)
+||||+.+++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 96 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 175 (289)
T 3og7_A 96 IVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG 175 (289)
T ss_dssp EEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC----------
T ss_pred EEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceeccccccccc
Confidence 99999999999999954 4579999999999999999999999999999999999999999999999999987654321
Q ss_pred -CccccccCCCccccHHhhc
Q 010401 489 -EATEYETDGYRWLAPEVCF 507 (511)
Q Consensus 489 -~~~~~~~Gt~~YmAPEvl~ 507 (511)
.......||+.|+|||++.
T Consensus 176 ~~~~~~~~gt~~y~aPE~~~ 195 (289)
T 3og7_A 176 SHQFEQLSGSILWMAPEVIR 195 (289)
T ss_dssp --------CCCTTCCHHHHC
T ss_pred cccccccCCCccccCchhhc
Confidence 2234457899999999986
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=4e-29 Score=252.42 Aligned_cols=169 Identities=20% Similarity=0.402 Sum_probs=139.0
Q ss_pred ecCCCeEEEeeeecccceEEEEeE----------EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCC
Q 010401 337 LNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN 406 (511)
Q Consensus 337 l~~~~y~l~~~LG~GsFG~VYkgk----------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~ 406 (511)
+..++|++.+.||+|+||.||+|+ .||+|.+... .......++.+|+.++..++||||++++++|.+.+
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 90 (327)
T 3poz_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTST 90 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS
T ss_pred cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccc-cCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC
Confidence 566789999999999999999975 3578877532 22334566899999999999999999999998653
Q ss_pred CcEEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecc
Q 010401 407 HGLCVVTKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK 485 (511)
Q Consensus 407 ~~l~LVmEy~~gGsL~~lL~~-~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~ 485 (511)
.+++|||+.+|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 91 --~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 168 (327)
T 3poz_A 91 --VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp --EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred --eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence 7899999999999999976 4579999999999999999999999999999999999999999999999999998765
Q ss_pred cCCCc--cccccCCCccccHHhhcc
Q 010401 486 SVGEA--TEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 486 ~~~~~--~~~~~Gt~~YmAPEvl~g 508 (511)
..... .....+|+.|+|||++.+
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~ 193 (327)
T 3poz_A 169 AEEKEYHAEGGKVPIKWMALESILH 193 (327)
T ss_dssp TTCC-------CCCGGGSCHHHHHH
T ss_pred CCcccccccCCCccccccChHHhcc
Confidence 43322 233456789999999865
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=99.96 E-value=5.8e-29 Score=254.77 Aligned_cols=163 Identities=22% Similarity=0.348 Sum_probs=140.1
Q ss_pred CCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhC-CCCceeeEeeeEeeCCCcEEE
Q 010401 339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCVCVDENHGLCV 411 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l-~HpNIV~l~g~~~~~~~~l~L 411 (511)
.++|++.+.||+|+||.||++ +.||+|++...... ..+|+.++.++ +||||+++++++.+++. +|+
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~------~~~E~~~l~~~~~hp~iv~~~~~~~~~~~-~~l 93 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD------PTEEIEILLRYGQHPNIITLKDVYDDGKY-VYV 93 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC------CHHHHHHHHHHTTSTTBCCEEEEEECSSE-EEE
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC------hHHHHHHHHHhcCCCCcCeEEEEEEcCCE-EEE
Confidence 356899999999999999995 57999999754322 24567777776 89999999999988775 999
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCC----CcEEEEecCCceecccC
Q 010401 412 VTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRH----GNVCLGDMGIVTACKSV 487 (511)
Q Consensus 412 VmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~----g~vKL~DFGlS~~l~~~ 487 (511)
||||+.+|+|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||+.++ +.+||+|||+++.....
T Consensus 94 v~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~ 173 (342)
T 2qr7_A 94 VTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE 173 (342)
T ss_dssp EECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCT
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCC
Confidence 99999999999999888889999999999999999999999999999999999998543 35999999999877655
Q ss_pred CCccccccCCCccccHHhhcc
Q 010401 488 GEATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 488 ~~~~~~~~Gt~~YmAPEvl~g 508 (511)
.......+||+.|+|||++.+
T Consensus 174 ~~~~~~~~gt~~y~aPE~~~~ 194 (342)
T 2qr7_A 174 NGLLMTPCYTANFVAPEVLER 194 (342)
T ss_dssp TCCBCCSSCCSSCCCHHHHHH
T ss_pred CCceeccCCCccccCHHHhcC
Confidence 444556789999999999864
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.3e-29 Score=242.20 Aligned_cols=171 Identities=23% Similarity=0.504 Sum_probs=146.4
Q ss_pred ceEecCCCeEEEeeeecccceEEEEe-----EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCc
Q 010401 334 RWLLNSDNLEFIDQIGPNSFKGVYKG-----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHG 408 (511)
Q Consensus 334 ~~~l~~~~y~l~~~LG~GsFG~VYkg-----k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~ 408 (511)
+|.++.++|++.+.||+|+||.||++ +.||+|++..... ....+.+|+.+++.++||||+++++++.+++.
T Consensus 2 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~- 77 (267)
T 3t9t_A 2 KWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM---SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAP- 77 (267)
T ss_dssp -CBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB---CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS-
T ss_pred ceEEchhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC---CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC-
Confidence 67888899999999999999999996 4699999974332 23568899999999999999999999988776
Q ss_pred EEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccC
Q 010401 409 LCVVTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV 487 (511)
Q Consensus 409 l~LVmEy~~gGsL~~lL~~~-~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~ 487 (511)
+|+||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++.....
T Consensus 78 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 157 (267)
T 3t9t_A 78 ICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 157 (267)
T ss_dssp CEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred eEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccccccccccc
Confidence 99999999999999999764 56899999999999999999999999999999999999999999999999998765332
Q ss_pred C-CccccccCCCccccHHhhcc
Q 010401 488 G-EATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 488 ~-~~~~~~~Gt~~YmAPEvl~g 508 (511)
. .......+++.|+|||++.+
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~ 179 (267)
T 3t9t_A 158 QYTSSTGTKFPVKWASPEVFSF 179 (267)
T ss_dssp HHHSTTSTTCCGGGCCHHHHHH
T ss_pred cccccccccccccccChhhhcC
Confidence 1 11233456778999999864
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=7.1e-29 Score=250.26 Aligned_cols=167 Identities=19% Similarity=0.263 Sum_probs=142.7
Q ss_pred ecCCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhC-CCCceeeEeeeEeeCCCcE
Q 010401 337 LNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCVCVDENHGL 409 (511)
Q Consensus 337 l~~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l-~HpNIV~l~g~~~~~~~~l 409 (511)
+..++|++.+.||+|+||.||+| +.||+|++...... ..+.+|+.+++.+ +||||+++++++.+.+. .
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~-~ 80 (330)
T 2izr_A 6 MVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA----PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKY-N 80 (330)
T ss_dssp EETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS----CCHHHHHHHHHHHCSCTTSCCEEEEEEETTE-E
T ss_pred EEcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch----HHHHHHHHHHHHhhCCCCCCEEEEEEecCCc-c
Confidence 34678999999999999999996 47999999743322 2467899999999 99999999999988775 8
Q ss_pred EEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCc-----EEEEecCCcee
Q 010401 410 CVVTKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGN-----VCLGDMGIVTA 483 (511)
Q Consensus 410 ~LVmEy~~gGsL~~lL~~-~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~-----vKL~DFGlS~~ 483 (511)
|+||||+ +++|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+++.
T Consensus 81 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 81 AMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred EEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 9999999 8899999975 468999999999999999999999999999999999999998887 99999999987
Q ss_pred cccCCCc-------cccccCCCccccHHhhccc
Q 010401 484 CKSVGEA-------TEYETDGYRWLAPEVCFLL 509 (511)
Q Consensus 484 l~~~~~~-------~~~~~Gt~~YmAPEvl~gl 509 (511)
....... .....||+.|+|||++.+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 192 (330)
T 2izr_A 160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGK 192 (330)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC
T ss_pred eecCCCCccccccccCCcCCCccccChHHHcCC
Confidence 6543321 2456799999999998753
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=8.9e-29 Score=247.21 Aligned_cols=174 Identities=19% Similarity=0.343 Sum_probs=146.9
Q ss_pred cceEecCCCeEEEeeeecccceEEEEe-----------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeee
Q 010401 333 GRWLLNSDNLEFIDQIGPNSFKGVYKG-----------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV 401 (511)
Q Consensus 333 ~~~~l~~~~y~l~~~LG~GsFG~VYkg-----------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~ 401 (511)
..|.+..++|++.+.||+|+||.||+| +.||+|++.. .........+.+|+.+++.++||||++++++
T Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 96 (322)
T 1p4o_A 18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNE-AASMRERIEFLNEASVMKEFNCHHVVRLLGV 96 (322)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCT-TSCHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccc-ccCHHHHHHHHHHHHHHHhcCCCCEeeeEEE
Confidence 367788899999999999999999985 3589998864 2333345568899999999999999999999
Q ss_pred EeeCCCcEEEEEeccCCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCC
Q 010401 402 CVDENHGLCVVTKLMEGGSVNDLILKS----------RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG 471 (511)
Q Consensus 402 ~~~~~~~l~LVmEy~~gGsL~~lL~~~----------~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g 471 (511)
+.+.+. .|+||||+.+|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 97 ~~~~~~-~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~ 175 (322)
T 1p4o_A 97 VSQGQP-TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF 175 (322)
T ss_dssp ECSSSS-CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTC
T ss_pred EccCCc-cEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCC
Confidence 987776 89999999999999999642 3568999999999999999999999999999999999999999
Q ss_pred cEEEEecCCceecccCCC--ccccccCCCccccHHhhcc
Q 010401 472 NVCLGDMGIVTACKSVGE--ATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 472 ~vKL~DFGlS~~l~~~~~--~~~~~~Gt~~YmAPEvl~g 508 (511)
.+||+|||+++....... ......+++.|+|||++.+
T Consensus 176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 214 (322)
T 1p4o_A 176 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD 214 (322)
T ss_dssp CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH
T ss_pred eEEECcCccccccccccccccccCCCCCCCccChhhhcc
Confidence 999999999886543322 1223356788999999864
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=99.96 E-value=3.4e-29 Score=273.20 Aligned_cols=171 Identities=22% Similarity=0.309 Sum_probs=146.9
Q ss_pred ecCCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCC-chHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcE
Q 010401 337 LNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKG-NAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGL 409 (511)
Q Consensus 337 l~~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~-~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l 409 (511)
+..++|++.+.||+|+||.||++ +.||+|++...... ......+.+|+.++..++||||+++++++.+.+. +
T Consensus 182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~-l 260 (543)
T 3c4z_A 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTD-L 260 (543)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE-E
T ss_pred CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCE-E
Confidence 34568899999999999999995 47999999642211 1123457889999999999999999999988775 9
Q ss_pred EEEEeccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecc
Q 010401 410 CVVTKLMEGGSVNDLILKS----RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK 485 (511)
Q Consensus 410 ~LVmEy~~gGsL~~lL~~~----~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~ 485 (511)
|+||||++||+|.+++... ..+++..++.|+.||+.||+|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 261 ~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 261 CLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp EEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 9999999999999999653 369999999999999999999999999999999999999999999999999998876
Q ss_pred cCCCccccccCCCccccHHhhcc
Q 010401 486 SVGEATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 486 ~~~~~~~~~~Gt~~YmAPEvl~g 508 (511)
.........+||+.|+|||++.+
T Consensus 341 ~~~~~~~~~~GT~~Y~APE~l~~ 363 (543)
T 3c4z_A 341 AGQTKTKGYAGTPGFMAPELLLG 363 (543)
T ss_dssp TTCCCBCCCCSCTTTSCHHHHTT
T ss_pred CCCcccccccCCccccChhhhcC
Confidence 54444455689999999999875
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.96 E-value=9.2e-31 Score=264.72 Aligned_cols=166 Identities=13% Similarity=0.108 Sum_probs=133.5
Q ss_pred cCCCeEEEeeeecccceEEEEe----EEEEEEEEecCCC------CchHHHHHHHHHHHHHhCC---------CCceeeE
Q 010401 338 NSDNLEFIDQIGPNSFKGVYKG----KRVGIEKLKGCDK------GNAYEFELRKDLLELMTCG---------HKNILQF 398 (511)
Q Consensus 338 ~~~~y~l~~~LG~GsFG~VYkg----k~VAVKkL~~~~~------~~~~~~~~~~Ei~iL~~l~---------HpNIV~l 398 (511)
..++|++.+.||+|+||.||++ +.||+|++..... .......+.+|+.+++.++ ||||+++
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 18 PTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp CHHHHHTCEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred ccccchheeeecccCceEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 3456788999999999999996 5799999975432 1222355788888887775 6666666
Q ss_pred eeeE-----------------ee------------CCCcEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHH
Q 010401 399 YCVC-----------------VD------------ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKF 449 (511)
Q Consensus 399 ~g~~-----------------~~------------~~~~l~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~y 449 (511)
.+++ .+ ....+||||||+.+|++.+.+.+ +.+++..++.++.||+.||.|
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL~~ 176 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLAV 176 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHHHH
Confidence 6654 22 13349999999999977666633 678999999999999999999
Q ss_pred HH-HCCccccCCCCCceEEcCCC--------------------cEEEEecCCceecccCCCccccccCCCccccHHhhcc
Q 010401 450 LN-DHGVAYRDLNSQRILLDRHG--------------------NVCLGDMGIVTACKSVGEATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 450 LH-~~gIIHRDLKp~NILld~~g--------------------~vKL~DFGlS~~l~~~~~~~~~~~Gt~~YmAPEvl~g 508 (511)
|| ++||+||||||+|||++.++ .+||+|||+|+.... ....||+.|+|||++.+
T Consensus 177 lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-----~~~~gt~~y~aPE~~~g 251 (336)
T 2vuw_A 177 AEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-----GIVVFCDVSMDEDLFTG 251 (336)
T ss_dssp HHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-----TEEECCCCTTCSGGGCC
T ss_pred HHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-----CcEEEeecccChhhhcC
Confidence 99 99999999999999999887 899999999987653 24589999999999876
Q ss_pred c
Q 010401 509 L 509 (511)
Q Consensus 509 l 509 (511)
.
T Consensus 252 ~ 252 (336)
T 2vuw_A 252 D 252 (336)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=3e-29 Score=259.49 Aligned_cols=171 Identities=24% Similarity=0.371 Sum_probs=135.2
Q ss_pred EecCCCeEEEeeeecccceEEEEeE---------EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCC
Q 010401 336 LLNSDNLEFIDQIGPNSFKGVYKGK---------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN 406 (511)
Q Consensus 336 ~l~~~~y~l~~~LG~GsFG~VYkgk---------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~ 406 (511)
.+..++|++.+.||+|+||.||+|+ .||+|+++.. ........+.+|+.++..++||||+++++++.+.+
T Consensus 41 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 119 (373)
T 2qol_A 41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG-YTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSK 119 (373)
T ss_dssp BCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTT-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred hcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCc-cCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC
Confidence 3566789999999999999999974 4899999742 23344567899999999999999999999998777
Q ss_pred CcEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecc
Q 010401 407 HGLCVVTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK 485 (511)
Q Consensus 407 ~~l~LVmEy~~gGsL~~lL~~~-~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~ 485 (511)
. +|+||||+++|+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 120 ~-~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 198 (373)
T 2qol_A 120 P-VMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLE 198 (373)
T ss_dssp S-CEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred c-eEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence 6 89999999999999999764 479999999999999999999999999999999999999999999999999998765
Q ss_pred cCCCc---cccccCCCccccHHhhcc
Q 010401 486 SVGEA---TEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 486 ~~~~~---~~~~~Gt~~YmAPEvl~g 508 (511)
..... .....+++.|+|||++.+
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~ 224 (373)
T 2qol_A 199 DDPEAAYTTRGGKIPIRWTSPEAIAY 224 (373)
T ss_dssp ---------------CTTSCHHHHHH
T ss_pred cCCccceeccCCCcCCCccChhhhcc
Confidence 43221 122234678999999864
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=5.8e-29 Score=240.95 Aligned_cols=169 Identities=18% Similarity=0.310 Sum_probs=146.3
Q ss_pred eEecCCCeEEEeeeecccceEEEEe----EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCC-CcE
Q 010401 335 WLLNSDNLEFIDQIGPNSFKGVYKG----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN-HGL 409 (511)
Q Consensus 335 ~~l~~~~y~l~~~LG~GsFG~VYkg----k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~-~~l 409 (511)
+.+..++|++.+.||+|+||.||+| +.+|+|+++...........+.+|+.++..++||||+++++++.+.. ..+
T Consensus 5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 84 (271)
T 3kmu_A 5 SGIDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHP 84 (271)
T ss_dssp CCCCGGGCEEEEEEEEETTEEEEEEEETTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSC
T ss_pred CCCCHHHhHHHHHhcCCCcceEEEEEECCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCe
Confidence 3456778999999999999999996 57999999865555555667899999999999999999999998762 238
Q ss_pred EEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCceEEcCCCcEEEEecCCceecc
Q 010401 410 CVVTKLMEGGSVNDLILKSR--KLQTKEIIRIAIDVAEGIKFLNDHG--VAYRDLNSQRILLDRHGNVCLGDMGIVTACK 485 (511)
Q Consensus 410 ~LVmEy~~gGsL~~lL~~~~--~L~e~~~~~ia~qIa~gL~yLH~~g--IIHRDLKp~NILld~~g~vKL~DFGlS~~l~ 485 (511)
++||||+++|+|.+++.... .+++..++.++.||+.||.|||++| |+||||||+|||++.++.++|+|||++....
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~ 164 (271)
T 3kmu_A 85 TLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ 164 (271)
T ss_dssp EEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred EeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeeec
Confidence 99999999999999997654 5899999999999999999999999 9999999999999999999999999865432
Q ss_pred cCCCccccccCCCccccHHhhcc
Q 010401 486 SVGEATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 486 ~~~~~~~~~~Gt~~YmAPEvl~g 508 (511)
.....||+.|+|||++.+
T Consensus 165 -----~~~~~~t~~y~aPE~~~~ 182 (271)
T 3kmu_A 165 -----SPGRMYAPAWVAPEALQK 182 (271)
T ss_dssp -----CTTCBSCGGGSCHHHHHS
T ss_pred -----ccCccCCccccChhhhcc
Confidence 234578999999999875
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=6.5e-29 Score=245.06 Aligned_cols=165 Identities=24% Similarity=0.431 Sum_probs=136.1
Q ss_pred CCCeEEEeeeecccceEEEEe----EEEEEEEEecCCCCchHHHHHHHHHHHHHh--CCCCceeeEeeeEeeC---CCcE
Q 010401 339 SDNLEFIDQIGPNSFKGVYKG----KRVGIEKLKGCDKGNAYEFELRKDLLELMT--CGHKNILQFYCVCVDE---NHGL 409 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkg----k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~--l~HpNIV~l~g~~~~~---~~~l 409 (511)
.++|++.+.||+|+||.||+| +.||+|++... . ...+.+|..++.. ++||||+++++++.+. ...+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~---~--~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~ 81 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSR---D--EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 81 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEETTEEEEEEEECGG---G--HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEECCEEEEEEEeccc---c--chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence 567899999999999999996 57999998632 2 2334455555554 8999999999987653 2238
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------HCCccccCCCCCceEEcCCCcEEEEecCCc
Q 010401 410 CVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN--------DHGVAYRDLNSQRILLDRHGNVCLGDMGIV 481 (511)
Q Consensus 410 ~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH--------~~gIIHRDLKp~NILld~~g~vKL~DFGlS 481 (511)
|+||||+.+|+|.+++. ...+++..++.++.||+.||.||| ++||+||||||+|||++.++.+||+|||++
T Consensus 82 ~lv~e~~~~g~L~~~l~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a 160 (301)
T 3q4u_A 82 WLITHYHEMGSLYDYLQ-LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA 160 (301)
T ss_dssp EEEECCCTTCBHHHHHT-TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEehhhccCCCHHHHHh-hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCe
Confidence 99999999999999994 457999999999999999999999 999999999999999999999999999999
Q ss_pred eecccCCCc----cccccCCCccccHHhhccc
Q 010401 482 TACKSVGEA----TEYETDGYRWLAPEVCFLL 509 (511)
Q Consensus 482 ~~l~~~~~~----~~~~~Gt~~YmAPEvl~gl 509 (511)
+........ .....||+.|+|||++.+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 192 (301)
T 3q4u_A 161 VMHSQSTNQLDVGNNPRVGTKRYMAPEVLDET 192 (301)
T ss_dssp EEEETTTTEEECCCCCCCCCGGGCCHHHHTTC
T ss_pred eecccccccccccccccccccceeChhhhcCc
Confidence 876543322 2234789999999998753
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.1e-29 Score=251.81 Aligned_cols=169 Identities=20% Similarity=0.366 Sum_probs=139.1
Q ss_pred ecCCCeEEEeeeecccceEEEEeEE----------EEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCC
Q 010401 337 LNSDNLEFIDQIGPNSFKGVYKGKR----------VGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN 406 (511)
Q Consensus 337 l~~~~y~l~~~LG~GsFG~VYkgk~----------VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~ 406 (511)
+..++|++.+.||+|+||.||+|+. |++|.+..... ......+.+|+.++..++||||+++++++.+ +
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~ 87 (325)
T 3kex_A 10 FKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSG-RQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG-S 87 (325)
T ss_dssp CCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTS-CSCBCSCCHHHHHHHTCCCTTBCCEEEEECB-S
T ss_pred cCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEecccccc-HHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-C
Confidence 5678899999999999999999753 78888754321 2222346788999999999999999999864 3
Q ss_pred CcEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecc
Q 010401 407 HGLCVVTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK 485 (511)
Q Consensus 407 ~~l~LVmEy~~gGsL~~lL~~~-~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~ 485 (511)
. .++||||+.+|+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 88 ~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 166 (325)
T 3kex_A 88 S-LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLP 166 (325)
T ss_dssp S-EEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred c-cEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccC
Confidence 3 89999999999999999754 579999999999999999999999999999999999999999999999999998765
Q ss_pred cCCC--ccccccCCCccccHHhhcc
Q 010401 486 SVGE--ATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 486 ~~~~--~~~~~~Gt~~YmAPEvl~g 508 (511)
.... ......|++.|+|||++.+
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~ 191 (325)
T 3kex_A 167 PDDKQLLYSEAKTPIKWMALESIHF 191 (325)
T ss_dssp CCTTCCC-----CCTTTSCHHHHHH
T ss_pred cccccccccCCCCcccccChHHhcc
Confidence 4332 2334567789999999864
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1e-28 Score=248.14 Aligned_cols=168 Identities=18% Similarity=0.281 Sum_probs=145.9
Q ss_pred CCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCc----hHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCc
Q 010401 339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGN----AYEFELRKDLLELMTCGHKNILQFYCVCVDENHG 408 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~----~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~ 408 (511)
.++|++.+.||+|+||.||++ +.||+|++....... .....+.+|+.++..++||||+++++++.+.+.
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~- 89 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD- 89 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE-
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE-
Confidence 346899999999999999996 479999997543221 135668999999999999999999999988775
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCC----cEEEEecCCceec
Q 010401 409 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG----NVCLGDMGIVTAC 484 (511)
Q Consensus 409 l~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g----~vKL~DFGlS~~l 484 (511)
+|+||||+.+++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++..
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~ 169 (321)
T 2a2a_A 90 VVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169 (321)
T ss_dssp EEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEEC
T ss_pred EEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceec
Confidence 999999999999999998878899999999999999999999999999999999999999888 7999999999876
Q ss_pred ccCCCccccccCCCccccHHhhcc
Q 010401 485 KSVGEATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 485 ~~~~~~~~~~~Gt~~YmAPEvl~g 508 (511)
.... ......||+.|+|||++.+
T Consensus 170 ~~~~-~~~~~~gt~~y~aPE~~~~ 192 (321)
T 2a2a_A 170 EDGV-EFKNIFGTPEFVAPEIVNY 192 (321)
T ss_dssp CTTC-CCCCCCSCGGGCCHHHHTT
T ss_pred Cccc-cccccCCCCCccCcccccC
Confidence 5432 2345578999999999865
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=99.96 E-value=4e-29 Score=253.17 Aligned_cols=157 Identities=22% Similarity=0.333 Sum_probs=120.8
Q ss_pred eeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCC-CCceeeEeeeEeeCCCcEEEEEeccCC
Q 010401 346 DQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCG-HKNILQFYCVCVDENHGLCVVTKLMEG 418 (511)
Q Consensus 346 ~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~-HpNIV~l~g~~~~~~~~l~LVmEy~~g 418 (511)
+.||+|+||.||++ +.||+|++... ....+.+|+.++..+. ||||+++++++.+++. +|+||||+.+
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~-~~lv~e~~~~ 90 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKR-----MEANTQKEITALKLCEGHPNIVKLHEVFHDQLH-TFLVMELLNG 90 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEGG-----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE-EEEEECCCCS
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEChh-----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCE-EEEEEEccCC
Confidence 78999999999995 47999999632 2455788999999996 9999999999998776 9999999999
Q ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCC---cEEEEecCCceecccCCCcccccc
Q 010401 419 GSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG---NVCLGDMGIVTACKSVGEATEYET 495 (511)
Q Consensus 419 GsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g---~vKL~DFGlS~~l~~~~~~~~~~~ 495 (511)
|+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.............
T Consensus 91 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 170 (325)
T 3kn6_A 91 GELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC 170 (325)
T ss_dssp CBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC---------
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCcccccC
Confidence 99999998888999999999999999999999999999999999999998766 899999999987665554455667
Q ss_pred CCCccccHHhhcc
Q 010401 496 DGYRWLAPEVCFL 508 (511)
Q Consensus 496 Gt~~YmAPEvl~g 508 (511)
||+.|+|||++.+
T Consensus 171 ~t~~y~aPE~~~~ 183 (325)
T 3kn6_A 171 FTLHYAAPELLNQ 183 (325)
T ss_dssp -------------
T ss_pred CCcCccCHHHhcC
Confidence 8999999999864
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=99.96 E-value=5.7e-29 Score=267.09 Aligned_cols=172 Identities=19% Similarity=0.362 Sum_probs=147.7
Q ss_pred cceEecCCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCC
Q 010401 333 GRWLLNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN 406 (511)
Q Consensus 333 ~~~~l~~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~ 406 (511)
..|.+..++|++.+.||+|+||.||+| +.||||+++... ....++.+|+.+|+.++||||++++++|.+.+
T Consensus 213 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 289 (495)
T 1opk_A 213 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP 289 (495)
T ss_dssp SCCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred cccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc---cchHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 367888899999999999999999996 479999997432 23456899999999999999999999998877
Q ss_pred CcEEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceec
Q 010401 407 HGLCVVTKLMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC 484 (511)
Q Consensus 407 ~~l~LVmEy~~gGsL~~lL~~~--~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l 484 (511)
. +||||||+.+|+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 290 ~-~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 368 (495)
T 1opk_A 290 P-FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLM 368 (495)
T ss_dssp S-CEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECC
T ss_pred c-EEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceec
Confidence 6 99999999999999999753 46899999999999999999999999999999999999999999999999999876
Q ss_pred ccCCC-ccccccCCCccccHHhhcc
Q 010401 485 KSVGE-ATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 485 ~~~~~-~~~~~~Gt~~YmAPEvl~g 508 (511)
..... ......+++.|+|||++.+
T Consensus 369 ~~~~~~~~~~~~~~~~y~aPE~~~~ 393 (495)
T 1opk_A 369 TGDTYTAHAGAKFPIKWTAPESLAY 393 (495)
T ss_dssp TTCCEECCTTCCCCGGGCCHHHHHH
T ss_pred cCCceeecCCCcCCcceeCHhHHhc
Confidence 43221 1223345678999999864
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-28 Score=243.63 Aligned_cols=168 Identities=21% Similarity=0.333 Sum_probs=140.4
Q ss_pred CCeEEEeeeecccceEEEEeE---------EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEE
Q 010401 340 DNLEFIDQIGPNSFKGVYKGK---------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLC 410 (511)
Q Consensus 340 ~~y~l~~~LG~GsFG~VYkgk---------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~ 410 (511)
.+|++.+.||+|+||.||+|+ .+|+|.+.. .........+.+|+.++++++||||+++++++.+.+...|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~-~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR-ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETT-CCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEeccc-CCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 357999999999999999975 478888864 2233345668899999999999999999999876665589
Q ss_pred EEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCC
Q 010401 411 VVTKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE 489 (511)
Q Consensus 411 LVmEy~~gGsL~~lL~~-~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~ 489 (511)
+||||+.+|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 104 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 183 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEY 183 (298)
T ss_dssp EEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGG
T ss_pred EEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccccch
Confidence 99999999999999965 35689999999999999999999999999999999999999999999999999986643221
Q ss_pred ----ccccccCCCccccHHhhcc
Q 010401 490 ----ATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 490 ----~~~~~~Gt~~YmAPEvl~g 508 (511)
......+|+.|+|||++.+
T Consensus 184 ~~~~~~~~~~~~~~y~aPE~~~~ 206 (298)
T 3f66_A 184 YSVHNKTGAKLPVKWMALESLQT 206 (298)
T ss_dssp CBC-----CCBCGGGSCHHHHHH
T ss_pred hccccccCCCCCccccChHHhcC
Confidence 1233456788999999864
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=2.3e-29 Score=257.90 Aligned_cols=171 Identities=18% Similarity=0.294 Sum_probs=144.2
Q ss_pred ecCCCeEEEeeeecccceEEEEeE---------EEEEEEEecCCC--CchHHHHHHHHHHHHHhC-CCCceeeEeeeEee
Q 010401 337 LNSDNLEFIDQIGPNSFKGVYKGK---------RVGIEKLKGCDK--GNAYEFELRKDLLELMTC-GHKNILQFYCVCVD 404 (511)
Q Consensus 337 l~~~~y~l~~~LG~GsFG~VYkgk---------~VAVKkL~~~~~--~~~~~~~~~~Ei~iL~~l-~HpNIV~l~g~~~~ 404 (511)
+..++|++.+.||+|+||.||+++ .||+|+++.... .......+.+|+.++..+ +||||+++++++.+
T Consensus 51 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 130 (355)
T 1vzo_A 51 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT 130 (355)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred ccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEee
Confidence 345789999999999999999864 599999864221 111223456788888888 79999999999988
Q ss_pred CCCcEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceec
Q 010401 405 ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC 484 (511)
Q Consensus 405 ~~~~l~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l 484 (511)
.+. +|+||||+.+|+|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 131 ~~~-~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 209 (355)
T 1vzo_A 131 ETK-LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 209 (355)
T ss_dssp TTE-EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred Cce-EEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeec
Confidence 776 9999999999999999988788999999999999999999999999999999999999999999999999999876
Q ss_pred ccCC-CccccccCCCccccHHhhcc
Q 010401 485 KSVG-EATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 485 ~~~~-~~~~~~~Gt~~YmAPEvl~g 508 (511)
.... .......||+.|+|||++.+
T Consensus 210 ~~~~~~~~~~~~gt~~y~aPE~~~~ 234 (355)
T 1vzo_A 210 VADETERAYDFCGTIEYMAPDIVRG 234 (355)
T ss_dssp CGGGGGGGCGGGSCCTTCCHHHHTT
T ss_pred ccCCCCcccCcccCcCccChhhhcC
Confidence 4322 22334579999999999874
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=99.96 E-value=5.4e-29 Score=263.82 Aligned_cols=170 Identities=20% Similarity=0.364 Sum_probs=144.9
Q ss_pred ceEecCCCeEEEeeeecccceEEEEeE-----EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCc
Q 010401 334 RWLLNSDNLEFIDQIGPNSFKGVYKGK-----RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHG 408 (511)
Q Consensus 334 ~~~l~~~~y~l~~~LG~GsFG~VYkgk-----~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~ 408 (511)
.|.+..++|++.+.||+|+||.||+|+ .||||+++... .....+.+|+.+++.++||||+++++++. .+ .
T Consensus 182 ~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~-~ 256 (454)
T 1qcf_A 182 AWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS---MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KE-P 256 (454)
T ss_dssp CSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS---BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SS-S
T ss_pred ceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC---ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CC-c
Confidence 677888999999999999999999974 69999997432 23566899999999999999999999986 33 3
Q ss_pred EEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceeccc
Q 010401 409 LCVVTKLMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS 486 (511)
Q Consensus 409 l~LVmEy~~gGsL~~lL~~~--~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~ 486 (511)
+|+||||+.+|+|.+++... ..+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++....
T Consensus 257 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~ 336 (454)
T 1qcf_A 257 IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIED 336 (454)
T ss_dssp CEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCC
T ss_pred cEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCC
Confidence 89999999999999999643 3789999999999999999999999999999999999999999999999999987643
Q ss_pred CCC-ccccccCCCccccHHhhcc
Q 010401 487 VGE-ATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 487 ~~~-~~~~~~Gt~~YmAPEvl~g 508 (511)
... ......+++.|+|||++.+
T Consensus 337 ~~~~~~~~~~~~~~y~aPE~~~~ 359 (454)
T 1qcf_A 337 NEYTAREGAKFPIKWTAPEAINF 359 (454)
T ss_dssp HHHHTTCSSSSCGGGSCHHHHHH
T ss_pred CceeccCCCcccccccCHHHhcc
Confidence 211 1223345678999999864
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=3e-29 Score=255.36 Aligned_cols=168 Identities=15% Similarity=0.164 Sum_probs=145.0
Q ss_pred CCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCch------HHHHHHHHHHHHHhCCCCceeeEeeeEeeCCC
Q 010401 340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNA------YEFELRKDLLELMTCGHKNILQFYCVCVDENH 407 (511)
Q Consensus 340 ~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~------~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~ 407 (511)
++|++.+.||+|+||.||++ +.||+|++........ ....+.+|+.++..++||||+++++++.+.+.
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 103 (335)
T 3dls_A 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGF 103 (335)
T ss_dssp HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCE
Confidence 56899999999999999996 4799999986432211 22346789999999999999999999987775
Q ss_pred cEEEEEeccCCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceeccc
Q 010401 408 GLCVVTKLMEGG-SVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS 486 (511)
Q Consensus 408 ~l~LVmEy~~gG-sL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~ 486 (511)
+++||||+.+| +|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 104 -~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~ 182 (335)
T 3dls_A 104 -FQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLER 182 (335)
T ss_dssp -EEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred -EEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceECCC
Confidence 99999999776 9999998888899999999999999999999999999999999999999999999999999987654
Q ss_pred CCCccccccCCCccccHHhhccc
Q 010401 487 VGEATEYETDGYRWLAPEVCFLL 509 (511)
Q Consensus 487 ~~~~~~~~~Gt~~YmAPEvl~gl 509 (511)
.. ......||+.|+|||++.+.
T Consensus 183 ~~-~~~~~~gt~~y~aPE~~~~~ 204 (335)
T 3dls_A 183 GK-LFYTFCGTIEYCAPEVLMGN 204 (335)
T ss_dssp TC-CBCEECSCGGGCCHHHHTTC
T ss_pred CC-ceeccCCCccccChhhhcCC
Confidence 32 34456799999999998753
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-28 Score=257.40 Aligned_cols=166 Identities=16% Similarity=0.298 Sum_probs=143.3
Q ss_pred CCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEE
Q 010401 339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV 412 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LV 412 (511)
.++|++.+.||+|+||.||++ +.+|+|++... .......+.+|+.++..++||||+++++++.+.+. +|+|
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~-~~lv 126 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP--YPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYE-MVLI 126 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSE-EEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEeccc--chhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCE-EEEE
Confidence 357899999999999999996 46899998742 23344568899999999999999999999988775 9999
Q ss_pred EeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcC--CCcEEEEecCCceecccCCC
Q 010401 413 TKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDR--HGNVCLGDMGIVTACKSVGE 489 (511)
Q Consensus 413 mEy~~gGsL~~lL~~~-~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~--~g~vKL~DFGlS~~l~~~~~ 489 (511)
|||+.+|+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++......
T Consensus 127 ~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~- 205 (387)
T 1kob_A 127 LEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE- 205 (387)
T ss_dssp EECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS-
T ss_pred EEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCc-
Confidence 9999999999998654 47999999999999999999999999999999999999974 5789999999998765432
Q ss_pred ccccccCCCccccHHhhcc
Q 010401 490 ATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 490 ~~~~~~Gt~~YmAPEvl~g 508 (511)
......||+.|+|||++.+
T Consensus 206 ~~~~~~gt~~y~aPE~~~~ 224 (387)
T 1kob_A 206 IVKVTTATAEFAAPEIVDR 224 (387)
T ss_dssp CEEEECSSGGGCCHHHHTT
T ss_pred ceeeeccCCCccCchhccC
Confidence 3445679999999999865
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1e-28 Score=273.61 Aligned_cols=173 Identities=24% Similarity=0.384 Sum_probs=143.0
Q ss_pred ceEecCCCeEEEe-eeecccceEEEEe--------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEee
Q 010401 334 RWLLNSDNLEFID-QIGPNSFKGVYKG--------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVD 404 (511)
Q Consensus 334 ~~~l~~~~y~l~~-~LG~GsFG~VYkg--------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~ 404 (511)
.+.++...+.+.. +||+|+||.||+| +.||||+++..........++.+|+.++..++||||+++++++.+
T Consensus 362 ~~~~~~~~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~ 441 (635)
T 4fl3_A 362 EVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA 441 (635)
T ss_dssp SSBCCGGGEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred cccccchhccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 4555666666654 8999999999986 469999997644444456779999999999999999999999864
Q ss_pred CCCcEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceec
Q 010401 405 ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC 484 (511)
Q Consensus 405 ~~~~l~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l 484 (511)
+. +++||||+.+|+|.+++...+.+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+++.+
T Consensus 442 -~~-~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~ 519 (635)
T 4fl3_A 442 -ES-WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKAL 519 (635)
T ss_dssp -SS-EEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHT
T ss_pred -CC-EEEEEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCcccc
Confidence 33 8999999999999999988888999999999999999999999999999999999999999999999999999876
Q ss_pred ccCCC---ccccccCCCccccHHhhcc
Q 010401 485 KSVGE---ATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 485 ~~~~~---~~~~~~Gt~~YmAPEvl~g 508 (511)
..... ......+|+.|+|||++.+
T Consensus 520 ~~~~~~~~~~~~~~~t~~y~APE~~~~ 546 (635)
T 4fl3_A 520 RADENYYKAQTHGKWPVKWYAPECINY 546 (635)
T ss_dssp TC-------------CGGGSCHHHHHH
T ss_pred ccCccccccccCCCCceeeeChhhhcC
Confidence 54322 1223346788999999864
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-28 Score=245.68 Aligned_cols=167 Identities=24% Similarity=0.384 Sum_probs=137.5
Q ss_pred CCCeEEE-eeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhC-CCCceeeEeeeEeeCCCcEE
Q 010401 339 SDNLEFI-DQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCVCVDENHGLC 410 (511)
Q Consensus 339 ~~~y~l~-~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l-~HpNIV~l~g~~~~~~~~l~ 410 (511)
.+.|++. +.||+|+||.||++ +.||+|++.... ......+.+|+.++.++ +||||+++++++.+++. +|
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~-~~ 87 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP--GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDR-FY 87 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS--SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTE-EE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc--chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCE-EE
Confidence 4567885 78999999999996 479999997532 23345688999999884 79999999999998776 99
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCc---EEEEecCCceecccC
Q 010401 411 VVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGN---VCLGDMGIVTACKSV 487 (511)
Q Consensus 411 LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~---vKL~DFGlS~~l~~~ 487 (511)
+||||+.+|+|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++. +||+|||+++.....
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~ 167 (316)
T 2ac3_A 88 LVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLN 167 (316)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-----
T ss_pred EEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccC
Confidence 99999999999999988888999999999999999999999999999999999999998776 999999998765422
Q ss_pred CC-------ccccccCCCccccHHhhcc
Q 010401 488 GE-------ATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 488 ~~-------~~~~~~Gt~~YmAPEvl~g 508 (511)
.. ......||+.|+|||++.+
T Consensus 168 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 195 (316)
T 2ac3_A 168 GDCSPISTPELLTPCGSAEYMAPEVVEA 195 (316)
T ss_dssp --------------CCSGGGCCHHHHHH
T ss_pred CccccccccccccccCCcCccChHHhhc
Confidence 11 1223468999999999864
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=9.4e-29 Score=246.47 Aligned_cols=178 Identities=18% Similarity=0.350 Sum_probs=139.3
Q ss_pred cccceEecCCCeEEEeeeecccceEEEEeE---------EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeee
Q 010401 331 EIGRWLLNSDNLEFIDQIGPNSFKGVYKGK---------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV 401 (511)
Q Consensus 331 ~i~~~~l~~~~y~l~~~LG~GsFG~VYkgk---------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~ 401 (511)
.+..+.+..++|++.+.||+|+||.||+|+ .||+|++............+.+|+.++..++||||++++++
T Consensus 25 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 104 (313)
T 3brb_A 25 KLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGV 104 (313)
T ss_dssp CTTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEE
T ss_pred hHHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEE
Confidence 344677788899999999999999999863 69999997544445555678999999999999999999999
Q ss_pred EeeCCC----cEEEEEeccCCCCHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCC
Q 010401 402 CVDENH----GLCVVTKLMEGGSVNDLILK------SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG 471 (511)
Q Consensus 402 ~~~~~~----~l~LVmEy~~gGsL~~lL~~------~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g 471 (511)
+.+.+. ..++||||+.+|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 105 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~ 184 (313)
T 3brb_A 105 CIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDM 184 (313)
T ss_dssp EEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTS
T ss_pred EeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCC
Confidence 986553 25999999999999999842 35699999999999999999999999999999999999999999
Q ss_pred cEEEEecCCceecccCCC--ccccccCCCccccHHhhcc
Q 010401 472 NVCLGDMGIVTACKSVGE--ATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 472 ~vKL~DFGlS~~l~~~~~--~~~~~~Gt~~YmAPEvl~g 508 (511)
.+||+|||+++....... ......+++.|+|||++.+
T Consensus 185 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 223 (313)
T 3brb_A 185 TVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLAD 223 (313)
T ss_dssp CEEECSCSCC----------------CCGGGSCHHHHHS
T ss_pred cEEEeecCcceecccccccCcccccCCCccccCchhhcC
Confidence 999999999887644321 1233456788999999864
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.5e-29 Score=268.75 Aligned_cols=170 Identities=24% Similarity=0.352 Sum_probs=147.9
Q ss_pred cCCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCC-chHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEE
Q 010401 338 NSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKG-NAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLC 410 (511)
Q Consensus 338 ~~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~-~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~ 410 (511)
..++|.+.+.||+|+||.||+| +.||+|++...... ......+.+|+.+++.++||||+++++++.+.+. +|
T Consensus 14 ~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~-~~ 92 (476)
T 2y94_A 14 KIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSD-IF 92 (476)
T ss_dssp EETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE-EE
T ss_pred eecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE-EE
Confidence 3568899999999999999996 47999999742211 1123568899999999999999999999998776 99
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCc
Q 010401 411 VVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA 490 (511)
Q Consensus 411 LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~ 490 (511)
+||||+++|+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..... ..
T Consensus 93 lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~-~~ 171 (476)
T 2y94_A 93 MVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-EF 171 (476)
T ss_dssp EEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTT-CC
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhcccc-cc
Confidence 99999999999999987788999999999999999999999999999999999999999999999999999876542 33
Q ss_pred cccccCCCccccHHhhccc
Q 010401 491 TEYETDGYRWLAPEVCFLL 509 (511)
Q Consensus 491 ~~~~~Gt~~YmAPEvl~gl 509 (511)
....+||+.|+|||++.+.
T Consensus 172 ~~~~~gt~~y~aPE~~~~~ 190 (476)
T 2y94_A 172 LRTSCGSPNYAAPEVISGR 190 (476)
T ss_dssp BCCCCSCSTTCCHHHHTTC
T ss_pred ccccCCCcCeEChhhccCC
Confidence 4556899999999998753
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.3e-28 Score=248.67 Aligned_cols=165 Identities=19% Similarity=0.321 Sum_probs=141.9
Q ss_pred ecCCCeEEEeeeecccceEEEEeE------EEEEEEEecCCCCchHHHHHHHHHHHHHhCC-----CCceeeEeeeEeeC
Q 010401 337 LNSDNLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDKGNAYEFELRKDLLELMTCG-----HKNILQFYCVCVDE 405 (511)
Q Consensus 337 l~~~~y~l~~~LG~GsFG~VYkgk------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~-----HpNIV~l~g~~~~~ 405 (511)
+-.++|++++.||+|+||.||+++ .||+|++.. .......+..|+.++..+. ||||+++++++...
T Consensus 32 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~ 108 (360)
T 3llt_A 32 LLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN---IKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYY 108 (360)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS---CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEET
T ss_pred EecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc---chhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeEC
Confidence 457899999999999999999964 699999963 3334455778888888885 99999999999988
Q ss_pred CCcEEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcC--------------
Q 010401 406 NHGLCVVTKLMEGGSVNDLILKSR--KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDR-------------- 469 (511)
Q Consensus 406 ~~~l~LVmEy~~gGsL~~lL~~~~--~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~-------------- 469 (511)
+. +|+||||+ +++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 109 ~~-~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~ 186 (360)
T 3llt_A 109 DH-MCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVT 186 (360)
T ss_dssp TE-EEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTT
T ss_pred Ce-eEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhccc
Confidence 76 99999999 889999997543 5999999999999999999999999999999999999975
Q ss_pred -----------CCcEEEEecCCceecccCCCccccccCCCccccHHhhccc
Q 010401 470 -----------HGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEVCFLL 509 (511)
Q Consensus 470 -----------~g~vKL~DFGlS~~l~~~~~~~~~~~Gt~~YmAPEvl~gl 509 (511)
++.+||+|||+++..... .....||+.|+|||++.+.
T Consensus 187 ~~~~~~~~~~~~~~~kl~DFG~a~~~~~~---~~~~~gt~~y~aPE~~~~~ 234 (360)
T 3llt_A 187 DGKKIQIYRTKSTGIKLIDFGCATFKSDY---HGSIINTRQYRAPEVILNL 234 (360)
T ss_dssp TCCEEEEEEESCCCEEECCCTTCEETTSC---CCSCCSCGGGCCHHHHTTC
T ss_pred ccccccccccCCCCEEEEeccCceecCCC---CcCccCcccccCcHHHcCC
Confidence 789999999999865432 3456789999999998753
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=99.96 E-value=2.7e-28 Score=240.58 Aligned_cols=169 Identities=24% Similarity=0.387 Sum_probs=145.6
Q ss_pred cCCCeEEEeeeecccceEEEEeE------EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeC---CCc
Q 010401 338 NSDNLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDE---NHG 408 (511)
Q Consensus 338 ~~~~y~l~~~LG~GsFG~VYkgk------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~---~~~ 408 (511)
....|++.+.||+|+||.||+|. .||+|++............+.+|+.+++.++||||+++++++... ...
T Consensus 24 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 103 (290)
T 1t4h_A 24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 103 (290)
T ss_dssp TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred CceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCce
Confidence 44568999999999999999974 699999986555555566789999999999999999999998652 334
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCceEEc-CCCcEEEEecCCceecc
Q 010401 409 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHG--VAYRDLNSQRILLD-RHGNVCLGDMGIVTACK 485 (511)
Q Consensus 409 l~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~g--IIHRDLKp~NILld-~~g~vKL~DFGlS~~l~ 485 (511)
+|+||||+++++|.+++...+.+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++....
T Consensus 104 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~ 183 (290)
T 1t4h_A 104 IVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccccc
Confidence 8999999999999999988788999999999999999999999999 99999999999998 78999999999986543
Q ss_pred cCCCccccccCCCccccHHhhcc
Q 010401 486 SVGEATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 486 ~~~~~~~~~~Gt~~YmAPEvl~g 508 (511)
.. ......|++.|+|||++.+
T Consensus 184 ~~--~~~~~~~t~~y~aPE~~~~ 204 (290)
T 1t4h_A 184 AS--FAKAVIGTPEFMAPEMYEE 204 (290)
T ss_dssp TT--SBEESCSSCCCCCGGGGGT
T ss_pred cc--ccccccCCcCcCCHHHHhc
Confidence 32 2345678999999998764
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.7e-29 Score=273.81 Aligned_cols=170 Identities=21% Similarity=0.307 Sum_probs=146.2
Q ss_pred ecCCCeEEEeeeecccceEEEEe------EEEEEEEEecCCC-CchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcE
Q 010401 337 LNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDK-GNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGL 409 (511)
Q Consensus 337 l~~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~-~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l 409 (511)
+..++|++.+.||+|+||.||++ +.||+|++..... .......+.+|+.+|..++||||+++++++.+.+. +
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~-l 259 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDA-L 259 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE-E
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCE-E
Confidence 45678999999999999999995 4799999964211 11223457889999999999999999999988775 9
Q ss_pred EEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccC
Q 010401 410 CVVTKLMEGGSVNDLILKSR--KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV 487 (511)
Q Consensus 410 ~LVmEy~~gGsL~~lL~~~~--~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~ 487 (511)
|+||||++||+|.+++...+ .+++..++.++.||+.||+|||++|||||||||+|||++.+|.+||+|||+++.....
T Consensus 260 ~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~ 339 (576)
T 2acx_A 260 CLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 339 (576)
T ss_dssp EEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecccC
Confidence 99999999999999997644 4999999999999999999999999999999999999999999999999999876543
Q ss_pred CCccccccCCCccccHHhhcc
Q 010401 488 GEATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 488 ~~~~~~~~Gt~~YmAPEvl~g 508 (511)
. .....+||+.|+|||++.+
T Consensus 340 ~-~~~~~~GT~~Y~APEvl~~ 359 (576)
T 2acx_A 340 Q-TIKGRVGTVGYMAPEVVKN 359 (576)
T ss_dssp C-CEECCCSCGGGCCHHHHTT
T ss_pred c-cccccCCCccccCHHHHcC
Confidence 2 3445689999999999875
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=7.8e-29 Score=253.72 Aligned_cols=164 Identities=20% Similarity=0.309 Sum_probs=129.1
Q ss_pred CCCeEEEeeeecccceEEEEeE------EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEE
Q 010401 339 SDNLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV 412 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkgk------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LV 412 (511)
.++|++.+.||+|+||.||+++ .||+|++.... ....+.+|+.++..++||||+++++++.+.+. +|+|
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~lv 126 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTE-ISLV 126 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEECSSE-EEEE
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCe-EEEE
Confidence 4679999999999999999964 69999997432 23457889999999999999999999988775 9999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcC---CCcEEEEecCCceecccCCC
Q 010401 413 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDR---HGNVCLGDMGIVTACKSVGE 489 (511)
Q Consensus 413 mEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~---~g~vKL~DFGlS~~l~~~~~ 489 (511)
|||+++|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++..... .
T Consensus 127 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~-~ 205 (349)
T 2w4o_A 127 LELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ-V 205 (349)
T ss_dssp ECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC----------
T ss_pred EEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcc-c
Confidence 999999999999988788999999999999999999999999999999999999975 889999999998866432 2
Q ss_pred ccccccCCCccccHHhhcc
Q 010401 490 ATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 490 ~~~~~~Gt~~YmAPEvl~g 508 (511)
......||+.|+|||++.+
T Consensus 206 ~~~~~~gt~~y~aPE~~~~ 224 (349)
T 2w4o_A 206 LMKTVCGTPGYCAPEILRG 224 (349)
T ss_dssp -------CGGGSCHHHHTT
T ss_pred ccccccCCCCccCHHHhcC
Confidence 2345678999999999875
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=4.5e-29 Score=244.78 Aligned_cols=169 Identities=19% Similarity=0.294 Sum_probs=142.4
Q ss_pred ecCCCeEEEeeeecccceEEEEeE------EEEEEEEecCCCC-chHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcE
Q 010401 337 LNSDNLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDKG-NAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGL 409 (511)
Q Consensus 337 l~~~~y~l~~~LG~GsFG~VYkgk------~VAVKkL~~~~~~-~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l 409 (511)
...++|++.+.||+|+||.||+++ .||+|++...... ......+.+|+.++..++||||+++++++.+.+. .
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~ 84 (279)
T 3fdn_A 6 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATR-V 84 (279)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE-E
T ss_pred eecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCE-E
Confidence 356789999999999999999974 6999998642211 1124558899999999999999999999988775 9
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCC
Q 010401 410 CVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE 489 (511)
Q Consensus 410 ~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~ 489 (511)
++||||+++|+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 85 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~-- 162 (279)
T 3fdn_A 85 YLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-- 162 (279)
T ss_dssp EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC-----
T ss_pred EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCcc--
Confidence 999999999999999988788999999999999999999999999999999999999999999999999998654332
Q ss_pred ccccccCCCccccHHhhcc
Q 010401 490 ATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 490 ~~~~~~Gt~~YmAPEvl~g 508 (511)
......|++.|+|||++.+
T Consensus 163 ~~~~~~~~~~y~aPE~~~~ 181 (279)
T 3fdn_A 163 RRTDLCGTLDYLPPEMIEG 181 (279)
T ss_dssp -----CCCCTTCCHHHHTT
T ss_pred cccccCCCCCccCHhHhcc
Confidence 2345578999999999865
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-28 Score=241.31 Aligned_cols=170 Identities=23% Similarity=0.439 Sum_probs=145.2
Q ss_pred ceEecCCCeEEEeeeecccceEEEEe-----EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCc
Q 010401 334 RWLLNSDNLEFIDQIGPNSFKGVYKG-----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHG 408 (511)
Q Consensus 334 ~~~l~~~~y~l~~~LG~GsFG~VYkg-----k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~ 408 (511)
+|.+..++|++.+.||+|+||.||+| +.||+|++..... ....+.+|+.++..++||||+++++++.++ .
T Consensus 7 ~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~- 81 (279)
T 1qpc_A 7 EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM---SPDAFLAEANLMKQLQHQRLVRLYAVVTQE-P- 81 (279)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECSS-S-
T ss_pred hcccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcc---cHHHHHHHHHHHHhCCCcCcceEEEEEcCC-C-
Confidence 67888899999999999999999996 4799999964322 245688999999999999999999998643 3
Q ss_pred EEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceeccc
Q 010401 409 LCVVTKLMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS 486 (511)
Q Consensus 409 l~LVmEy~~gGsL~~lL~~~--~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~ 486 (511)
.++||||+.+++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++....
T Consensus 82 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 161 (279)
T 1qpc_A 82 IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIED 161 (279)
T ss_dssp CEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred cEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccC
Confidence 89999999999999999643 3799999999999999999999999999999999999999999999999999987654
Q ss_pred CCC-ccccccCCCccccHHhhcc
Q 010401 487 VGE-ATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 487 ~~~-~~~~~~Gt~~YmAPEvl~g 508 (511)
... ......+++.|+|||++.+
T Consensus 162 ~~~~~~~~~~~~~~y~aPE~~~~ 184 (279)
T 1qpc_A 162 NEYTAREGAKFPIKWTAPEAINY 184 (279)
T ss_dssp SCEECCTTCCCCTTTSCHHHHHH
T ss_pred cccccccCCCCccCccChhhhcc
Confidence 322 1233456788999999863
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=2.1e-28 Score=248.06 Aligned_cols=171 Identities=22% Similarity=0.344 Sum_probs=139.9
Q ss_pred EecCCCeEEEeeeecccceEEEEeE----------EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeC
Q 010401 336 LLNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDE 405 (511)
Q Consensus 336 ~l~~~~y~l~~~LG~GsFG~VYkgk----------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~ 405 (511)
.+..++|++.+.||+|+||.||+|+ .||+|+++.. ........+.+|+.++..++||||+++++++.+.
T Consensus 40 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 118 (333)
T 1mqb_A 40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG-YTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY 118 (333)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred cCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecC
Confidence 4667899999999999999999974 3899999742 2334455688999999999999999999999877
Q ss_pred CCcEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceec
Q 010401 406 NHGLCVVTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC 484 (511)
Q Consensus 406 ~~~l~LVmEy~~gGsL~~lL~~~-~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l 484 (511)
+. +|+||||+.+|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 119 ~~-~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 197 (333)
T 1mqb_A 119 KP-MMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL 197 (333)
T ss_dssp SS-EEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred CC-cEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhh
Confidence 76 99999999999999999654 57999999999999999999999999999999999999999999999999999876
Q ss_pred ccCCCc---cccccCCCccccHHhhcc
Q 010401 485 KSVGEA---TEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 485 ~~~~~~---~~~~~Gt~~YmAPEvl~g 508 (511)
...... .....+++.|+|||++.+
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~ 224 (333)
T 1mqb_A 198 EDDPEATYTTSGGKIPIRWTAPEAISY 224 (333)
T ss_dssp -------------CCCGGGSCHHHHHS
T ss_pred ccccccccccCCCCccccccCchhccc
Confidence 543221 222345778999999864
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=9.8e-29 Score=263.59 Aligned_cols=168 Identities=20% Similarity=0.271 Sum_probs=137.7
Q ss_pred cCCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCC-----
Q 010401 338 NSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN----- 406 (511)
Q Consensus 338 ~~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~----- 406 (511)
..++|++++.||+|+||.||++ +.||+|++...........++.+|+.+++.++||||+++++++...+
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 3578999999999999999996 57999999854444455667899999999999999999999997553
Q ss_pred CcEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceeccc
Q 010401 407 HGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS 486 (511)
Q Consensus 407 ~~l~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~ 486 (511)
..+|+||||+.+ +|.+.+. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 140 ~~~~lv~E~~~~-~l~~~~~--~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 216 (464)
T 3ttj_A 140 QDVYLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 216 (464)
T ss_dssp CEEEEEEECCSE-EHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-----
T ss_pred CeEEEEEeCCCC-CHHHHHh--hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCC
Confidence 237999999976 5777663 3489999999999999999999999999999999999999999999999999987654
Q ss_pred CCCccccccCCCccccHHhhccc
Q 010401 487 VGEATEYETDGYRWLAPEVCFLL 509 (511)
Q Consensus 487 ~~~~~~~~~Gt~~YmAPEvl~gl 509 (511)
. .......||+.|+|||++.+.
T Consensus 217 ~-~~~~~~~gt~~y~aPE~~~~~ 238 (464)
T 3ttj_A 217 S-FMMTPYVVTRYYRAPEVILGM 238 (464)
T ss_dssp C-CCC----CCCTTCCHHHHTTC
T ss_pred C-cccCCCcccccccCHHHHcCC
Confidence 2 234556899999999998763
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=5e-29 Score=265.77 Aligned_cols=167 Identities=22% Similarity=0.392 Sum_probs=143.1
Q ss_pred CCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEE
Q 010401 340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT 413 (511)
Q Consensus 340 ~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVm 413 (511)
++|++.+.||+|+||.||++ +.||+|++............+.+|+.+++.++||||+++++++.+.+. +|+||
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~-~~lv~ 100 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSS-FYIVG 100 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE-EEEEE
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCE-EEEEE
Confidence 56899999999999999996 479999996433223335668899999999999999999999998775 99999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEc---CCCcEEEEecCCceecccCCCc
Q 010401 414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLD---RHGNVCLGDMGIVTACKSVGEA 490 (511)
Q Consensus 414 Ey~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld---~~g~vKL~DFGlS~~l~~~~~~ 490 (511)
||+.+|+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++..... ..
T Consensus 101 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~-~~ 179 (486)
T 3mwu_A 101 ELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-TK 179 (486)
T ss_dssp CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC---
T ss_pred EcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC-Cc
Confidence 9999999999998888999999999999999999999999999999999999995 4567999999999866443 22
Q ss_pred cccccCCCccccHHhhcc
Q 010401 491 TEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 491 ~~~~~Gt~~YmAPEvl~g 508 (511)
.....||+.|+|||++.+
T Consensus 180 ~~~~~gt~~y~aPE~~~~ 197 (486)
T 3mwu_A 180 MKDRIGTAYYIAPEVLRG 197 (486)
T ss_dssp --CCTTGGGGCCGGGGGS
T ss_pred cCCCcCCCCCCCHHHhCC
Confidence 445679999999999865
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.3e-29 Score=251.38 Aligned_cols=169 Identities=22% Similarity=0.377 Sum_probs=144.2
Q ss_pred ecCCCeEEEeeeecccceEEEEe-----EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEE
Q 010401 337 LNSDNLEFIDQIGPNSFKGVYKG-----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCV 411 (511)
Q Consensus 337 l~~~~y~l~~~LG~GsFG~VYkg-----k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~L 411 (511)
...++|++.+.||+|+||.||+| +.||+|++... .......+.+|+.++..++||||+++++++.+.+. +|+
T Consensus 36 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~l 112 (321)
T 2qkw_B 36 EATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPE--SSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNE-MIL 112 (321)
T ss_dssp CCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSC--CSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTC-CEE
T ss_pred HHHhccCccceeecCCCeeEEEEEECCCCEEEEEEeccc--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCe-EEE
Confidence 35678999999999999999995 58999988743 23345568899999999999999999999987776 899
Q ss_pred EEeccCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccC
Q 010401 412 VTKLMEGGSVNDLILKSR----KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV 487 (511)
Q Consensus 412 VmEy~~gGsL~~lL~~~~----~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~ 487 (511)
||||+++|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 192 (321)
T 2qkw_B 113 IYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTEL 192 (321)
T ss_dssp EEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSSS
T ss_pred EEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 999999999999985432 5899999999999999999999999999999999999999999999999999865432
Q ss_pred CC--ccccccCCCccccHHhhcc
Q 010401 488 GE--ATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 488 ~~--~~~~~~Gt~~YmAPEvl~g 508 (511)
.. ......||+.|+|||++.+
T Consensus 193 ~~~~~~~~~~gt~~y~aPE~~~~ 215 (321)
T 2qkw_B 193 DQTHLSTVVKGTLGYIDPEYFIK 215 (321)
T ss_dssp SCCCCBCCCEEETTTCCHHHHHH
T ss_pred cccccccccCCCccccCHHHhcC
Confidence 22 2234468899999999854
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.7e-28 Score=255.44 Aligned_cols=171 Identities=16% Similarity=0.223 Sum_probs=144.0
Q ss_pred eEecCCCeEEEeeeecccceEEEEe-----EEEEEEEEecCCCCchHHHHHHHHHHHHHhCC--CCceeeEeeeEeeCCC
Q 010401 335 WLLNSDNLEFIDQIGPNSFKGVYKG-----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCG--HKNILQFYCVCVDENH 407 (511)
Q Consensus 335 ~~l~~~~y~l~~~LG~GsFG~VYkg-----k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~--HpNIV~l~g~~~~~~~ 407 (511)
..+..++|++.+.||+|+||.||++ +.||||++............+.+|+.++..+. ||||+++++++..++.
T Consensus 51 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~ 130 (390)
T 2zmd_A 51 ISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 130 (390)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred ccccCCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCE
Confidence 3455667999999999999999996 47999999765544555667899999999986 5999999999988776
Q ss_pred cEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccC
Q 010401 408 GLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV 487 (511)
Q Consensus 408 ~l~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~ 487 (511)
+|+||| +.+++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++.+...
T Consensus 131 -~~lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~ 207 (390)
T 2zmd_A 131 -IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 207 (390)
T ss_dssp -EEEEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred -EEEEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence 999999 56779999998888899999999999999999999999999999999999995 689999999999876433
Q ss_pred CC--ccccccCCCccccHHhhcc
Q 010401 488 GE--ATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 488 ~~--~~~~~~Gt~~YmAPEvl~g 508 (511)
.. ......||+.|+|||++.+
T Consensus 208 ~~~~~~~~~~gt~~y~aPE~~~~ 230 (390)
T 2zmd_A 208 TTSVVKDSQVGAVNYMPPEAIKD 230 (390)
T ss_dssp ------CCSCCCGGGCCHHHHHC
T ss_pred CccccCCCCCcCCCccChHHhhh
Confidence 22 2345579999999999875
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-28 Score=262.98 Aligned_cols=167 Identities=19% Similarity=0.342 Sum_probs=140.2
Q ss_pred CCeEEEeeeecccceEEEEeE------EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEE
Q 010401 340 DNLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT 413 (511)
Q Consensus 340 ~~y~l~~~LG~GsFG~VYkgk------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVm 413 (511)
++|++++.||+|+||.||+++ .+|+|++............+.+|+.+++.++||||+++++++.+.+. +|+||
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~-~~lv~ 115 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRN-YYLVM 115 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSE-EEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCE-EEEEE
Confidence 468999999999999999964 69999997644333345668899999999999999999999998775 99999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcC---CCcEEEEecCCceecccCCCc
Q 010401 414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDR---HGNVCLGDMGIVTACKSVGEA 490 (511)
Q Consensus 414 Ey~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~---~g~vKL~DFGlS~~l~~~~~~ 490 (511)
||+.+|+|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++..... ..
T Consensus 116 e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~-~~ 194 (494)
T 3lij_A 116 ECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ-KK 194 (494)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT-BC
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC-cc
Confidence 99999999999988888999999999999999999999999999999999999976 455999999999876543 23
Q ss_pred cccccCCCccccHHhhcc
Q 010401 491 TEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 491 ~~~~~Gt~~YmAPEvl~g 508 (511)
.....||+.|+|||++.+
T Consensus 195 ~~~~~gt~~y~aPE~l~~ 212 (494)
T 3lij_A 195 MKERLGTAYYIAPEVLRK 212 (494)
T ss_dssp BCCCCSCTTTCCHHHHTT
T ss_pred ccccCCCcCeeCHHHHcc
Confidence 455679999999999754
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.2e-28 Score=245.98 Aligned_cols=170 Identities=19% Similarity=0.376 Sum_probs=145.0
Q ss_pred ecCCCeEEEeeeecccceEEEEeE----------EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeC-
Q 010401 337 LNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDE- 405 (511)
Q Consensus 337 l~~~~y~l~~~LG~GsFG~VYkgk----------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~- 405 (511)
+..++|++.+.||+|+||.||+++ .||+|++.. ........+.+|+.++..++||||+++++++...
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 97 (327)
T 3lxl_A 20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQH--SGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPG 97 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESS--CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred hchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEecc--CCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCC
Confidence 567889999999999999999865 599999974 2334455689999999999999999999998743
Q ss_pred CCcEEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceec
Q 010401 406 NHGLCVVTKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC 484 (511)
Q Consensus 406 ~~~l~LVmEy~~gGsL~~lL~~-~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l 484 (511)
...+|+||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 177 (327)
T 3lxl_A 98 RQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLL 177 (327)
T ss_dssp SCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred CceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceec
Confidence 3348999999999999999975 457999999999999999999999999999999999999999999999999999876
Q ss_pred ccCCC---ccccccCCCccccHHhhcc
Q 010401 485 KSVGE---ATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 485 ~~~~~---~~~~~~Gt~~YmAPEvl~g 508 (511)
..... ......|++.|+|||++.+
T Consensus 178 ~~~~~~~~~~~~~~~~~~y~aPE~~~~ 204 (327)
T 3lxl_A 178 PLDKDYYVVREPGQSPIFWYAPESLSD 204 (327)
T ss_dssp CTTCSEEECSSCCCSCGGGSCHHHHHH
T ss_pred ccCCccceeeccCCccccccCHHHhcc
Confidence 54332 2233457788999999864
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=2.5e-28 Score=240.59 Aligned_cols=168 Identities=20% Similarity=0.257 Sum_probs=141.7
Q ss_pred CeEEEeeeecccceEEEEeE---------EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEE
Q 010401 341 NLEFIDQIGPNSFKGVYKGK---------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCV 411 (511)
Q Consensus 341 ~y~l~~~LG~GsFG~VYkgk---------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~L 411 (511)
.|++.+.||+|+||.||+|+ .+|+|++.. .........+.+|+.+++.++||||+++++++.+.+...++
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~-~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSR-ITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHV 100 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETT-CCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccc-cccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEE
Confidence 35667999999999999975 689999864 22333456688999999999999999999999877764599
Q ss_pred EEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCC--
Q 010401 412 VTKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG-- 488 (511)
Q Consensus 412 VmEy~~gGsL~~lL~~-~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~-- 488 (511)
||||+.+|+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 101 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 180 (298)
T 3pls_A 101 LLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYY 180 (298)
T ss_dssp EECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGG
T ss_pred EEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCccc
Confidence 9999999999999975 4578999999999999999999999999999999999999999999999999997654322
Q ss_pred --CccccccCCCccccHHhhccc
Q 010401 489 --EATEYETDGYRWLAPEVCFLL 509 (511)
Q Consensus 489 --~~~~~~~Gt~~YmAPEvl~gl 509 (511)
.......+++.|+|||++.+.
T Consensus 181 ~~~~~~~~~~~~~y~aPE~~~~~ 203 (298)
T 3pls_A 181 SVQQHRHARLPVKWTALESLQTY 203 (298)
T ss_dssp CSCCSSCTTCGGGGSCHHHHTTC
T ss_pred ccccCcCCCCCccccChhhhccC
Confidence 123344677899999998753
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.5e-28 Score=242.91 Aligned_cols=166 Identities=20% Similarity=0.311 Sum_probs=137.5
Q ss_pred CCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEE
Q 010401 340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT 413 (511)
Q Consensus 340 ~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVm 413 (511)
++|.+.+.||+|+||.||++ +.+|+|++.... .......+.+|+.+++.++||||+++++++.+.+. +|+||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~-~~lv~ 99 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDR-SQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHN-MYIVM 99 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGG-CCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE-EEEEE
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccc-cchhHHHHHHHHHHHHhCCCchHHhHHHheecCCe-EEEEE
Confidence 46899999999999999985 479999997533 22335668899999999999999999999987765 99999
Q ss_pred eccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEE---cCCCcEEEEecCCceeccc
Q 010401 414 KLMEGGSVNDLILK----SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILL---DRHGNVCLGDMGIVTACKS 486 (511)
Q Consensus 414 Ey~~gGsL~~lL~~----~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILl---d~~g~vKL~DFGlS~~l~~ 486 (511)
||+.+|+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++....
T Consensus 100 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~ 179 (285)
T 3is5_A 100 ETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS 179 (285)
T ss_dssp CCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC---
T ss_pred EeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCC
Confidence 99999999999853 3679999999999999999999999999999999999999 4568899999999976644
Q ss_pred CCCccccccCCCccccHHhhcc
Q 010401 487 VGEATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 487 ~~~~~~~~~Gt~~YmAPEvl~g 508 (511)
. .......|++.|+|||++.+
T Consensus 180 ~-~~~~~~~~t~~y~aPE~~~~ 200 (285)
T 3is5_A 180 D-EHSTNAAGTALYMAPEVFKR 200 (285)
T ss_dssp --------CTTGGGCCHHHHTT
T ss_pred c-ccCcCcccccCcCChHHhcc
Confidence 2 23445678999999998754
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=99.96 E-value=6.1e-29 Score=254.69 Aligned_cols=171 Identities=9% Similarity=0.181 Sum_probs=136.8
Q ss_pred cCCCeEEEeeeecccceEEEEe-----------EEEEEEEEecCCCCchHHHH---------HHHHHHHHHhCCCCceee
Q 010401 338 NSDNLEFIDQIGPNSFKGVYKG-----------KRVGIEKLKGCDKGNAYEFE---------LRKDLLELMTCGHKNILQ 397 (511)
Q Consensus 338 ~~~~y~l~~~LG~GsFG~VYkg-----------k~VAVKkL~~~~~~~~~~~~---------~~~Ei~iL~~l~HpNIV~ 397 (511)
..++|++.+.||+|+||.||+| +.||+|++.........+.+ +..|+..+..++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 4668999999999999999997 45899998753221111111 234455667789999999
Q ss_pred EeeeEeeCC---CcEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEc--CCC
Q 010401 398 FYCVCVDEN---HGLCVVTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLD--RHG 471 (511)
Q Consensus 398 l~g~~~~~~---~~l~LVmEy~~gGsL~~lL~~~-~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld--~~g 471 (511)
+++++.... ..+||||||+ +++|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++ .++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~ 191 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPD 191 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTT
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCC
Confidence 999987642 2379999999 99999999765 6899999999999999999999999999999999999999 889
Q ss_pred cEEEEecCCceecccCCCc-------cccccCCCccccHHhhccc
Q 010401 472 NVCLGDMGIVTACKSVGEA-------TEYETDGYRWLAPEVCFLL 509 (511)
Q Consensus 472 ~vKL~DFGlS~~l~~~~~~-------~~~~~Gt~~YmAPEvl~gl 509 (511)
.+||+|||+++.+...... .....||+.|+|||++.+.
T Consensus 192 ~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 236 (364)
T 3op5_A 192 QVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGV 236 (364)
T ss_dssp CEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTC
T ss_pred eEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCC
Confidence 9999999999876543221 1334599999999998764
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.1e-29 Score=252.65 Aligned_cols=173 Identities=25% Similarity=0.384 Sum_probs=145.5
Q ss_pred ceEecCCCeEEEeeeecccceEEEEe-----EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCc
Q 010401 334 RWLLNSDNLEFIDQIGPNSFKGVYKG-----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHG 408 (511)
Q Consensus 334 ~~~l~~~~y~l~~~LG~GsFG~VYkg-----k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~ 408 (511)
.+.+..++|++.+.||+|+||.||++ +.||+|++...... .....+.+|+.++..++||||+++++++.+.+.
T Consensus 24 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~- 101 (326)
T 3uim_A 24 ELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTE- 101 (326)
T ss_dssp HHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSC-
T ss_pred HHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCc-hHHHHHHHHHHHHHhccCCCccceEEEEecCCc-
Confidence 45567788999999999999999996 46999999753221 122357899999999999999999999988776
Q ss_pred EEEEEeccCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCCCceEEcCCCcEEEEecCCc
Q 010401 409 LCVVTKLMEGGSVNDLILKSR----KLQTKEIIRIAIDVAEGIKFLNDH---GVAYRDLNSQRILLDRHGNVCLGDMGIV 481 (511)
Q Consensus 409 l~LVmEy~~gGsL~~lL~~~~----~L~e~~~~~ia~qIa~gL~yLH~~---gIIHRDLKp~NILld~~g~vKL~DFGlS 481 (511)
.++||||+.+|+|.+++.... .+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~ 181 (326)
T 3uim_A 102 RLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 181 (326)
T ss_dssp CEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSC
T ss_pred eEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccc
Confidence 899999999999999996532 499999999999999999999999 9999999999999999999999999999
Q ss_pred eecccCCC-ccccccCCCccccHHhhcc
Q 010401 482 TACKSVGE-ATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 482 ~~l~~~~~-~~~~~~Gt~~YmAPEvl~g 508 (511)
+....... ......||+.|+|||++.+
T Consensus 182 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 209 (326)
T 3uim_A 182 KLMDYKDTHVTTAVRGTIGHIAPEYLST 209 (326)
T ss_dssp EECCSSSSCEECCCCSCGGGCCHHHHHH
T ss_pred cccCcccccccccccCCcCccCHHHhcc
Confidence 87654332 2334568999999999854
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=99.96 E-value=2.3e-28 Score=239.43 Aligned_cols=167 Identities=20% Similarity=0.315 Sum_probs=141.8
Q ss_pred CCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCc----hHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcE
Q 010401 340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGN----AYEFELRKDLLELMTCGHKNILQFYCVCVDENHGL 409 (511)
Q Consensus 340 ~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~----~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l 409 (511)
++|++.+.||+|+||.||++ +.+|+|+++...... .....+.+|+.+++.++||||+++++++.+.+. +
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~-~ 83 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTD-V 83 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE-E
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCe-E
Confidence 46899999999999999996 479999997543221 135668999999999999999999999988775 9
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCC----cEEEEecCCceecc
Q 010401 410 CVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG----NVCLGDMGIVTACK 485 (511)
Q Consensus 410 ~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g----~vKL~DFGlS~~l~ 485 (511)
|+||||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||++....
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~ 163 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE 163 (283)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC
T ss_pred EEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceecc
Confidence 99999999999999998878899999999999999999999999999999999999999877 89999999998764
Q ss_pred cCCCccccccCCCccccHHhhcc
Q 010401 486 SVGEATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 486 ~~~~~~~~~~Gt~~YmAPEvl~g 508 (511)
... ......|++.|+|||++.+
T Consensus 164 ~~~-~~~~~~~~~~y~aPE~~~~ 185 (283)
T 3bhy_A 164 AGN-EFKNIFGTPEFVAPEIVNY 185 (283)
T ss_dssp ---------CCCGGGCCHHHHTT
T ss_pred CCC-cccccCCCcCccCcceecC
Confidence 432 2344578999999999864
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-28 Score=243.24 Aligned_cols=168 Identities=22% Similarity=0.339 Sum_probs=141.4
Q ss_pred CCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEE
Q 010401 339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV 412 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LV 412 (511)
.++|++.+.||+|+||.||++ +.||+|++............+.+|+.+++.++||||+++++++.+++. +|+|
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~lv 80 (299)
T 2r3i_A 2 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENK-LYLV 80 (299)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTE-EEEE
T ss_pred cchhhhhhhhccCCCeeEEEEEEcCCCceEEEEEeecCccchhhHHHHHHHHHHHHHcCCCCeeeEEEEEecCCc-eEEE
Confidence 468899999999999999996 479999986533333333567899999999999999999999998776 9999
Q ss_pred EeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCc
Q 010401 413 TKLMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA 490 (511)
Q Consensus 413 mEy~~gGsL~~lL~~~--~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~ 490 (511)
|||+. ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.........
T Consensus 81 ~e~~~-~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~ 159 (299)
T 2r3i_A 81 FEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 159 (299)
T ss_dssp EECCS-EEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECSTTHHHHHCCCSBC
T ss_pred EEccc-CCHHHHHHhhhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHeEEcCCCCEEECcchhhhhccCCccc
Confidence 99997 5999998654 46899999999999999999999999999999999999999999999999998876544444
Q ss_pred cccccCCCccccHHhhcc
Q 010401 491 TEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 491 ~~~~~Gt~~YmAPEvl~g 508 (511)
.....|++.|+|||++.+
T Consensus 160 ~~~~~~~~~y~aPE~~~~ 177 (299)
T 2r3i_A 160 YTHEVVTLWYRAPEILLG 177 (299)
T ss_dssp TTSCBCCCTTCCHHHHTT
T ss_pred cCcccccccccCcHHhhc
Confidence 455678999999999875
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.4e-28 Score=261.90 Aligned_cols=168 Identities=21% Similarity=0.357 Sum_probs=142.7
Q ss_pred CCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCc-----------hHHHHHHHHHHHHHhCCCCceeeEeee
Q 010401 339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGN-----------AYEFELRKDLLELMTCGHKNILQFYCV 401 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~-----------~~~~~~~~Ei~iL~~l~HpNIV~l~g~ 401 (511)
.++|++++.||+|+||.||++ +.+|+|++....... .....+.+|+.+++.++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 467899999999999999996 479999997533221 234568899999999999999999999
Q ss_pred EeeCCCcEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCC---cEEEEec
Q 010401 402 CVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG---NVCLGDM 478 (511)
Q Consensus 402 ~~~~~~~l~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g---~vKL~DF 478 (511)
+.+.+. +|+||||+.+|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+||
T Consensus 115 ~~~~~~-~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Df 193 (504)
T 3q5i_A 115 FEDKKY-FYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDF 193 (504)
T ss_dssp EECSSE-EEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCC
T ss_pred EEcCCE-EEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEEC
Confidence 998775 999999999999999998888899999999999999999999999999999999999999776 6999999
Q ss_pred CCceecccCCCccccccCCCccccHHhhcc
Q 010401 479 GIVTACKSVGEATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 479 GlS~~l~~~~~~~~~~~Gt~~YmAPEvl~g 508 (511)
|+++..... .......||+.|+|||++.+
T Consensus 194 g~a~~~~~~-~~~~~~~gt~~y~aPE~~~~ 222 (504)
T 3q5i_A 194 GLSSFFSKD-YKLRDRLGTAYYIAPEVLKK 222 (504)
T ss_dssp TTCEECCTT-SCBCCCCSCTTTCCHHHHTT
T ss_pred CCCEEcCCC-CccccccCCcCCCCHHHhcc
Confidence 999876543 23455679999999999764
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.7e-28 Score=240.88 Aligned_cols=172 Identities=15% Similarity=0.296 Sum_probs=142.6
Q ss_pred ceEecCCCeEEEeeeecccceEEEEeE---------EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEee
Q 010401 334 RWLLNSDNLEFIDQIGPNSFKGVYKGK---------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVD 404 (511)
Q Consensus 334 ~~~l~~~~y~l~~~LG~GsFG~VYkgk---------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~ 404 (511)
.|.+..++|++.+.||+|+||.||+|+ .||+|.+... ........+.+|+.++..++||||+++++++.+
T Consensus 6 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 84 (281)
T 3cc6_A 6 QYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKD-CTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE 84 (281)
T ss_dssp CCSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTT-SCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS
T ss_pred cceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccc-cCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC
Confidence 355677899999999999999999974 4899998743 233445668999999999999999999999875
Q ss_pred CCCcEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCcee
Q 010401 405 ENHGLCVVTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTA 483 (511)
Q Consensus 405 ~~~~l~LVmEy~~gGsL~~lL~~~-~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~ 483 (511)
+. .|+||||+.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 85 ~~--~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 162 (281)
T 3cc6_A 85 EP--TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRY 162 (281)
T ss_dssp SS--CEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred CC--CEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCcc
Confidence 43 68999999999999999654 4699999999999999999999999999999999999999999999999999886
Q ss_pred cccCCC-ccccccCCCccccHHhhcc
Q 010401 484 CKSVGE-ATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 484 l~~~~~-~~~~~~Gt~~YmAPEvl~g 508 (511)
...... ......+++.|+|||++.+
T Consensus 163 ~~~~~~~~~~~~~~~~~y~aPE~~~~ 188 (281)
T 3cc6_A 163 IEDEDYYKASVTRLPIKWMSPESINF 188 (281)
T ss_dssp C---------CCCCCGGGCCHHHHHH
T ss_pred cccccccccccCCCCcceeCchhhcc
Confidence 644322 2233456788999999864
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=9.8e-29 Score=251.79 Aligned_cols=169 Identities=20% Similarity=0.349 Sum_probs=145.8
Q ss_pred ecCCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEE
Q 010401 337 LNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLC 410 (511)
Q Consensus 337 l~~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~ 410 (511)
+..++|++.+.||+|+||.||++ +.||+|++... ........+.+|+.++..++||||+++++++.+++. +|
T Consensus 30 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~ 107 (360)
T 3eqc_A 30 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE-IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGE-IS 107 (360)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECC-CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTE-EE
T ss_pred cccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccc-cCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCE-EE
Confidence 45678999999999999999995 47999999753 334445668999999999999999999999998776 99
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCceEEcCCCcEEEEecCCceecccCCC
Q 010401 411 VVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDH-GVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE 489 (511)
Q Consensus 411 LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~-gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~ 489 (511)
+||||+++++|.+++...+.+++..+..++.||+.||.|||+. ||+||||||+|||++.++.+||+|||++......
T Consensus 108 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 185 (360)
T 3eqc_A 108 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 185 (360)
T ss_dssp EEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--
T ss_pred EEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc--
Confidence 9999999999999998888899999999999999999999985 9999999999999999999999999998765332
Q ss_pred ccccccCCCccccHHhhccc
Q 010401 490 ATEYETDGYRWLAPEVCFLL 509 (511)
Q Consensus 490 ~~~~~~Gt~~YmAPEvl~gl 509 (511)
......||+.|+|||++.+.
T Consensus 186 ~~~~~~gt~~y~aPE~~~~~ 205 (360)
T 3eqc_A 186 MANSFVGTRSYMSPERLQGT 205 (360)
T ss_dssp C----CCCCTTCCHHHHTTC
T ss_pred cccCCCCCCCeECHHHHcCC
Confidence 23445789999999998753
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-28 Score=242.66 Aligned_cols=169 Identities=17% Similarity=0.315 Sum_probs=146.0
Q ss_pred ecCCCeEEEeeeecccceEEEEe------EEEEEEEEecCCC-CchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcE
Q 010401 337 LNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDK-GNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGL 409 (511)
Q Consensus 337 l~~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~-~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l 409 (511)
+..++|++.+.||+|+||.||++ +.||+|++..... .......+.+|+.++..++||||+++++++.+.+. +
T Consensus 11 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~ 89 (284)
T 2vgo_A 11 FTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKR-I 89 (284)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE-E
T ss_pred hhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCE-E
Confidence 45678999999999999999996 4699999864211 11124568899999999999999999999988765 9
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCC
Q 010401 410 CVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE 489 (511)
Q Consensus 410 ~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~ 489 (511)
|+||||+++|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 90 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~-- 167 (284)
T 2vgo_A 90 YLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL-- 167 (284)
T ss_dssp EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS--
T ss_pred EEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCccc--
Confidence 999999999999999988788999999999999999999999999999999999999999999999999998765432
Q ss_pred ccccccCCCccccHHhhcc
Q 010401 490 ATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 490 ~~~~~~Gt~~YmAPEvl~g 508 (511)
......|++.|+|||++.+
T Consensus 168 ~~~~~~~~~~y~aPE~~~~ 186 (284)
T 2vgo_A 168 RRRTMCGTLDYLPPEMIEG 186 (284)
T ss_dssp CBCCCCSCGGGCCHHHHTT
T ss_pred ccccccCCCCcCCHHHhcc
Confidence 2345678999999999865
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.7e-28 Score=241.08 Aligned_cols=167 Identities=23% Similarity=0.428 Sum_probs=146.2
Q ss_pred CCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEE
Q 010401 339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV 412 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LV 412 (511)
.+.|++.+.||+|+||.||+| +.||+|++..... ......+.+|+.++..++||||+++++++.+.+. +|+|
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~lv 98 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTK-LWII 98 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC-STTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE-EEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCe-EEEE
Confidence 456899999999999999996 4799999975432 2345668899999999999999999999998775 9999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCccc
Q 010401 413 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE 492 (511)
Q Consensus 413 mEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~~ 492 (511)
|||+++++|.+++. .+.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++...........
T Consensus 99 ~e~~~~~~L~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 177 (303)
T 3a7i_A 99 MEYLGGGSALDLLE-PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN 177 (303)
T ss_dssp EECCTTEEHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCCBC
T ss_pred EEeCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCccccccC
Confidence 99999999999985 46799999999999999999999999999999999999999999999999999987765444445
Q ss_pred cccCCCccccHHhhcc
Q 010401 493 YETDGYRWLAPEVCFL 508 (511)
Q Consensus 493 ~~~Gt~~YmAPEvl~g 508 (511)
...|++.|+|||++.+
T Consensus 178 ~~~~~~~y~aPE~~~~ 193 (303)
T 3a7i_A 178 TFVGTPFWMAPEVIKQ 193 (303)
T ss_dssp CCCSCGGGCCHHHHTT
T ss_pred ccCCCcCccCHHHHhc
Confidence 6678999999999865
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=6.9e-29 Score=242.99 Aligned_cols=168 Identities=21% Similarity=0.368 Sum_probs=128.0
Q ss_pred CCeEEEeeeecccceEEEEeE------EEEEEEEecCCCC-chHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEE
Q 010401 340 DNLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDKG-NAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV 412 (511)
Q Consensus 340 ~~y~l~~~LG~GsFG~VYkgk------~VAVKkL~~~~~~-~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LV 412 (511)
++|++.+.||+|+||.||+++ .||+|.+...... ......+.+|+.++..++||||+++++++.+.+. +|+|
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~lv 89 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNY-VYLV 89 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSE-EEEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCe-EEEE
Confidence 568999999999999999964 6999999642111 1123567899999999999999999999988775 9999
Q ss_pred EeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCcc
Q 010401 413 TKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT 491 (511)
Q Consensus 413 mEy~~gGsL~~lL~~~-~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~ 491 (511)
|||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++..........
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~ 169 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKH 169 (278)
T ss_dssp EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC------
T ss_pred EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCCcc
Confidence 9999999999999764 579999999999999999999999999999999999999999999999999998765444334
Q ss_pred ccccCCCccccHHhhcc
Q 010401 492 EYETDGYRWLAPEVCFL 508 (511)
Q Consensus 492 ~~~~Gt~~YmAPEvl~g 508 (511)
....|++.|+|||++.+
T Consensus 170 ~~~~~~~~y~aPE~~~~ 186 (278)
T 3cok_A 170 YTLCGTPNYISPEIATR 186 (278)
T ss_dssp -----------------
T ss_pred eeccCCCCcCCcchhcC
Confidence 45678999999998764
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.5e-28 Score=269.28 Aligned_cols=172 Identities=22% Similarity=0.379 Sum_probs=141.0
Q ss_pred ceEecCCCeEEEe-eeecccceEEEEeE--------EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEee
Q 010401 334 RWLLNSDNLEFID-QIGPNSFKGVYKGK--------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVD 404 (511)
Q Consensus 334 ~~~l~~~~y~l~~-~LG~GsFG~VYkgk--------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~ 404 (511)
.+.+..+++.+.+ .||+|+||.||+|. .||||+++.. .......++.+|+.+|+.++||||+++++++.+
T Consensus 329 ~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~ 407 (613)
T 2ozo_A 329 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA 407 (613)
T ss_dssp CSBCCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCC-CSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES
T ss_pred ceeccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCC-CChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc
Confidence 4567778888887 89999999999863 4899999753 223345678999999999999999999999976
Q ss_pred CCCcEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCcee
Q 010401 405 ENHGLCVVTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTA 483 (511)
Q Consensus 405 ~~~~l~LVmEy~~gGsL~~lL~~~-~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~ 483 (511)
+. +|+||||+.+|+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 408 -~~-~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~ 485 (613)
T 2ozo_A 408 -EA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKA 485 (613)
T ss_dssp -SS-EEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTT
T ss_pred -CC-eEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCccc
Confidence 33 89999999999999999654 5699999999999999999999999999999999999999999999999999987
Q ss_pred cccCCCc---cccccCCCccccHHhhcc
Q 010401 484 CKSVGEA---TEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 484 l~~~~~~---~~~~~Gt~~YmAPEvl~g 508 (511)
....... .....+++.|+|||++.+
T Consensus 486 ~~~~~~~~~~~~~~~~~~~y~APE~~~~ 513 (613)
T 2ozo_A 486 LGADDSYYTARSAGKWPLKWYAPECINF 513 (613)
T ss_dssp CC--------------CCTTSCHHHHHH
T ss_pred ccCCCceeeeccCCCCccceeCHhhhcC
Confidence 6433221 122345688999999864
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.3e-28 Score=243.42 Aligned_cols=169 Identities=21% Similarity=0.339 Sum_probs=136.7
Q ss_pred cCCCeEEEeeeecccceEEEEeE------EEEEEEEecCCCC---chHHHHHHHHHHHHHhC---CCCceeeEeeeEeeC
Q 010401 338 NSDNLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDKG---NAYEFELRKDLLELMTC---GHKNILQFYCVCVDE 405 (511)
Q Consensus 338 ~~~~y~l~~~LG~GsFG~VYkgk------~VAVKkL~~~~~~---~~~~~~~~~Ei~iL~~l---~HpNIV~l~g~~~~~ 405 (511)
..++|++.+.||+|+||.||+++ .||+|++...... ......+.+|+.++..+ +||||+++++++.+.
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 36789999999999999999964 7999998743211 11123455666666555 599999999999876
Q ss_pred CC----cEEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecC
Q 010401 406 NH----GLCVVTKLMEGGSVNDLILKSR--KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMG 479 (511)
Q Consensus 406 ~~----~l~LVmEy~~gGsL~~lL~~~~--~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFG 479 (511)
.. .+++||||+.+ +|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus 87 ~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg 165 (308)
T 3g33_A 87 RTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFG 165 (308)
T ss_dssp CSSSEEEEEEEEECCCC-BHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCS
T ss_pred CCCCceeEEEEehhhhc-CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCc
Confidence 53 37999999974 9999997654 39999999999999999999999999999999999999999999999999
Q ss_pred CceecccCCCccccccCCCccccHHhhcc
Q 010401 480 IVTACKSVGEATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 480 lS~~l~~~~~~~~~~~Gt~~YmAPEvl~g 508 (511)
+++..... .......||+.|+|||++.+
T Consensus 166 ~a~~~~~~-~~~~~~~gt~~y~aPE~~~~ 193 (308)
T 3g33_A 166 LARIYSYQ-MALTPVVVTLWYRAPEVLLQ 193 (308)
T ss_dssp CTTTSTTC-CCSGGGGCCCSSCCHHHHHT
T ss_pred cccccCCC-cccCCccccccccCchHHcC
Confidence 99766432 23455688999999999864
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.5e-28 Score=241.21 Aligned_cols=169 Identities=18% Similarity=0.293 Sum_probs=129.4
Q ss_pred EecCCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcE
Q 010401 336 LLNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGL 409 (511)
Q Consensus 336 ~l~~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l 409 (511)
.+..++|++.+.||+|+||.||++ +.||+|++............+.++...++.++||||+++++++.+++. .
T Consensus 3 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~-~ 81 (290)
T 3fme_A 3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGD-V 81 (290)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSS-E
T ss_pred cccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCC-E
Confidence 456788999999999999999996 469999997533222223334444455777899999999999998776 9
Q ss_pred EEEEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCceEEcCCCcEEEEecCCceec
Q 010401 410 CVVTKLMEGGSVNDLILK----SRKLQTKEIIRIAIDVAEGIKFLNDH-GVAYRDLNSQRILLDRHGNVCLGDMGIVTAC 484 (511)
Q Consensus 410 ~LVmEy~~gGsL~~lL~~----~~~L~e~~~~~ia~qIa~gL~yLH~~-gIIHRDLKp~NILld~~g~vKL~DFGlS~~l 484 (511)
|+||||+.+ +|.+++.. ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||+++..
T Consensus 82 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 82 WICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred EEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 999999975 88877743 46899999999999999999999998 9999999999999999999999999999876
Q ss_pred ccCCCccccccCCCccccHHhhc
Q 010401 485 KSVGEATEYETDGYRWLAPEVCF 507 (511)
Q Consensus 485 ~~~~~~~~~~~Gt~~YmAPEvl~ 507 (511)
.... ......||+.|+|||++.
T Consensus 161 ~~~~-~~~~~~~t~~y~aPE~~~ 182 (290)
T 3fme_A 161 VDDV-AKDIDAGCKPYMAPERIN 182 (290)
T ss_dssp ----------CCCCCCSCHHHHS
T ss_pred cccc-cccccCCCccccChhhcC
Confidence 4432 234457899999999973
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-28 Score=253.97 Aligned_cols=165 Identities=18% Similarity=0.301 Sum_probs=137.9
Q ss_pred CCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCC-----
Q 010401 339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENH----- 407 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~----- 407 (511)
.++|++++.||+|+||.||++ +.||+|++...........++.+|+.+++.++||||+++++++...+.
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 578999999999999999996 479999997544444556678999999999999999999999976532
Q ss_pred cEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccC
Q 010401 408 GLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV 487 (511)
Q Consensus 408 ~l~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~ 487 (511)
.+|+||||+ +++|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 181 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE 181 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSS
T ss_pred eEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeecccccccc
Confidence 269999999 7799999865 67999999999999999999999999999999999999999999999999999875432
Q ss_pred CCccccccCCCccccHHhhcc
Q 010401 488 GEATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 488 ~~~~~~~~Gt~~YmAPEvl~g 508 (511)
.....||+.|+|||++.+
T Consensus 182 ---~~~~~~t~~y~aPE~~~~ 199 (367)
T 1cm8_A 182 ---MTGYVVTRWYRAPEVILN 199 (367)
T ss_dssp ---CCSSCSCGGGCCTHHHHT
T ss_pred ---cCcCcCCCCcCCHHHHhC
Confidence 345578999999999875
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-28 Score=262.22 Aligned_cols=168 Identities=21% Similarity=0.348 Sum_probs=146.4
Q ss_pred CCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCC-chHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEE
Q 010401 339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKG-NAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCV 411 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~-~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~L 411 (511)
.++|++.+.||+|+||.||++ +.||+|++...... ......+.+|+.+++.++||||+++++++.+.+. +|+
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~-~~l 103 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGY-FYL 103 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE-EEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE-EEE
Confidence 356899999999999999985 47999999754332 3345668999999999999999999999998775 999
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEE---cCCCcEEEEecCCceecccCC
Q 010401 412 VTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILL---DRHGNVCLGDMGIVTACKSVG 488 (511)
Q Consensus 412 VmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILl---d~~g~vKL~DFGlS~~l~~~~ 488 (511)
||||+.+|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.....
T Consensus 104 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~- 182 (484)
T 3nyv_A 104 VGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS- 182 (484)
T ss_dssp EECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCC-
T ss_pred EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccc-
Confidence 99999999999999888899999999999999999999999999999999999999 46789999999999876543
Q ss_pred CccccccCCCccccHHhhcc
Q 010401 489 EATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 489 ~~~~~~~Gt~~YmAPEvl~g 508 (511)
.......||+.|+|||++.+
T Consensus 183 ~~~~~~~gt~~y~aPE~~~~ 202 (484)
T 3nyv_A 183 KKMKDKIGTAYYIAPEVLHG 202 (484)
T ss_dssp CSHHHHTTGGGTCCHHHHHT
T ss_pred cccccCCCCccccCceeecC
Confidence 23445679999999999865
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=7.5e-29 Score=242.45 Aligned_cols=170 Identities=24% Similarity=0.309 Sum_probs=143.2
Q ss_pred CCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeC-CCcEEE
Q 010401 339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDE-NHGLCV 411 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~-~~~l~L 411 (511)
.++|++.+.||+|+||.||++ +.|++|++............+.+|+.+++.++||||+++++++.+. +..+|+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 467899999999999999996 4699999986554555566789999999999999999999988643 334899
Q ss_pred EEeccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC-----ccccCCCCCceEEcCCCcEEEEecCCce
Q 010401 412 VTKLMEGGSVNDLILKS----RKLQTKEIIRIAIDVAEGIKFLNDHG-----VAYRDLNSQRILLDRHGNVCLGDMGIVT 482 (511)
Q Consensus 412 VmEy~~gGsL~~lL~~~----~~L~e~~~~~ia~qIa~gL~yLH~~g-----IIHRDLKp~NILld~~g~vKL~DFGlS~ 482 (511)
||||+++++|.+++... ..+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 99999999999999643 34999999999999999999999999 9999999999999999999999999987
Q ss_pred ecccCCCccccccCCCccccHHhhcc
Q 010401 483 ACKSVGEATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 483 ~l~~~~~~~~~~~Gt~~YmAPEvl~g 508 (511)
.............|++.|+|||++.+
T Consensus 165 ~~~~~~~~~~~~~~~~~y~aPE~~~~ 190 (279)
T 2w5a_A 165 ILNHDTSFAKTFVGTPYYMSPEQMNR 190 (279)
T ss_dssp HC---CHHHHHHHSCCTTCCHHHHHC
T ss_pred eeccccccccccCCCccccChHHhcc
Confidence 76543333344578999999999865
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.9e-29 Score=251.48 Aligned_cols=166 Identities=17% Similarity=0.323 Sum_probs=133.3
Q ss_pred CCeEEEeeeecccceEEEEeE------EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEE
Q 010401 340 DNLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT 413 (511)
Q Consensus 340 ~~y~l~~~LG~GsFG~VYkgk------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVm 413 (511)
++|++++.||+|+||.||+++ .||+|++..... ......+.+|+.++..++||||+++++++.+.+. +|+||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~lv~ 79 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKS-LTLVF 79 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSC-EEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc-cccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCE-EEEEe
Confidence 579999999999999999964 699999964321 1111234578999999999999999999988776 99999
Q ss_pred eccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCccc
Q 010401 414 KLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE 492 (511)
Q Consensus 414 Ey~~gGsL~~lL~~~-~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~~ 492 (511)
||+.+ +|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..........
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~ 158 (324)
T 3mtl_A 80 EYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYD 158 (324)
T ss_dssp ECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC--------
T ss_pred ccccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCccccc
Confidence 99975 999988654 4699999999999999999999999999999999999999999999999999987654444455
Q ss_pred cccCCCccccHHhhcc
Q 010401 493 YETDGYRWLAPEVCFL 508 (511)
Q Consensus 493 ~~~Gt~~YmAPEvl~g 508 (511)
...||+.|+|||++.+
T Consensus 159 ~~~~t~~y~aPE~~~~ 174 (324)
T 3mtl_A 159 NEVVTLWYRPPDILLG 174 (324)
T ss_dssp ----CGGGCCHHHHTT
T ss_pred cccCcccccChhhhcC
Confidence 5678999999999875
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.2e-28 Score=241.42 Aligned_cols=169 Identities=20% Similarity=0.366 Sum_probs=132.7
Q ss_pred CCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCC-chHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEE
Q 010401 339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKG-NAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCV 411 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~-~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~L 411 (511)
.++|++.+.||+|+||.||++ +.||+|++...... ......+.+|+.++..++||||+++++++.+.+. +++
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~-~~l 109 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNE-LNI 109 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTE-EEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCc-EEE
Confidence 356899999999999999996 47999999753333 3345568899999999999999999999998775 999
Q ss_pred EEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccC
Q 010401 412 VTKLMEGGSVNDLILK----SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV 487 (511)
Q Consensus 412 VmEy~~gGsL~~lL~~----~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~ 487 (511)
||||+.+++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++.....
T Consensus 110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~ 189 (310)
T 2wqm_A 110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 189 (310)
T ss_dssp EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC---------
T ss_pred EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecCC
Confidence 9999999999999853 456899999999999999999999999999999999999999999999999998876554
Q ss_pred CCccccccCCCccccHHhhcc
Q 010401 488 GEATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 488 ~~~~~~~~Gt~~YmAPEvl~g 508 (511)
........|++.|+|||++.+
T Consensus 190 ~~~~~~~~~~~~y~aPE~~~~ 210 (310)
T 2wqm_A 190 TTAAHSLVGTPYYMSPERIHE 210 (310)
T ss_dssp ---------CCSSCCHHHHTT
T ss_pred CccccccCCCeeEeChHHhCC
Confidence 433445678999999999864
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-28 Score=241.96 Aligned_cols=168 Identities=24% Similarity=0.434 Sum_probs=137.2
Q ss_pred ceEecCCCeEEEeeeecccceEEEEe----EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcE
Q 010401 334 RWLLNSDNLEFIDQIGPNSFKGVYKG----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGL 409 (511)
Q Consensus 334 ~~~l~~~~y~l~~~LG~GsFG~VYkg----k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l 409 (511)
.|.+..++|++.+.||+|+||.||++ +.||+|.+.... ....+.+|+.++..++||||+++++++.+.+..+
T Consensus 15 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (278)
T 1byg_A 15 GWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL 90 (278)
T ss_dssp CCBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CC
T ss_pred cccCChhhceEEeEEecCCCceEEEEEEcCCEEEEEEecchh----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCce
Confidence 56778889999999999999999996 579999986422 3456889999999999999999999987665458
Q ss_pred EEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccC
Q 010401 410 CVVTKLMEGGSVNDLILKSR--KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV 487 (511)
Q Consensus 410 ~LVmEy~~gGsL~~lL~~~~--~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~ 487 (511)
|+||||+++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 170 (278)
T 1byg_A 91 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 170 (278)
T ss_dssp EEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred EEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeecccccccccc
Confidence 99999999999999996543 3899999999999999999999999999999999999999999999999998765432
Q ss_pred CCccccccCCCccccHHhhcc
Q 010401 488 GEATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 488 ~~~~~~~~Gt~~YmAPEvl~g 508 (511)
.....+++.|+|||++.+
T Consensus 171 ---~~~~~~~~~y~aPE~~~~ 188 (278)
T 1byg_A 171 ---QDTGKLPVKWTAPEALRE 188 (278)
T ss_dssp --------CCTTTSCHHHHHH
T ss_pred ---ccCCCccccccCHHHhCC
Confidence 233467889999999864
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=5.1e-28 Score=238.61 Aligned_cols=172 Identities=22% Similarity=0.384 Sum_probs=144.9
Q ss_pred ceEecCCCeEEEe-eeecccceEEEEeE--------EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEee
Q 010401 334 RWLLNSDNLEFID-QIGPNSFKGVYKGK--------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVD 404 (511)
Q Consensus 334 ~~~l~~~~y~l~~-~LG~GsFG~VYkgk--------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~ 404 (511)
.+.+..++|.+.+ .||+|+||.||+|. .||+|+++.. ........+.+|+.++..++||||+++++++.
T Consensus 3 ~~~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~- 80 (287)
T 1u59_A 3 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ- 80 (287)
T ss_dssp CCBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-
T ss_pred cccccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCc-cchhHHHHHHHHHHHHHhCCCCCEeEEEEEec-
Confidence 4567778888887 99999999999864 5999999753 23344566899999999999999999999994
Q ss_pred CCCcEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCcee
Q 010401 405 ENHGLCVVTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTA 483 (511)
Q Consensus 405 ~~~~l~LVmEy~~gGsL~~lL~~~-~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~ 483 (511)
.+. +++||||+.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++.
T Consensus 81 ~~~-~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~ 159 (287)
T 1u59_A 81 AEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKA 159 (287)
T ss_dssp SSS-EEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred CCC-cEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceee
Confidence 444 89999999999999999643 5699999999999999999999999999999999999999999999999999987
Q ss_pred cccCCCc---cccccCCCccccHHhhcc
Q 010401 484 CKSVGEA---TEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 484 l~~~~~~---~~~~~Gt~~YmAPEvl~g 508 (511)
....... .....+++.|+|||++.+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 187 (287)
T 1u59_A 160 LGADDSYYTARSAGKWPLKWYAPECINF 187 (287)
T ss_dssp CTTCSCEECCCCSSCCCGGGCCHHHHHH
T ss_pred eccCcceeeccccccccccccCHHHhcc
Confidence 6543321 223356789999999863
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-28 Score=249.95 Aligned_cols=169 Identities=18% Similarity=0.345 Sum_probs=141.9
Q ss_pred CCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCC------
Q 010401 339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN------ 406 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~------ 406 (511)
.++|++++.||+|+||.||++ +.||+|++............+.+|+.++..++||||+++++++.+..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 357899999999999999996 47999999754444444556789999999999999999999998742
Q ss_pred -CcEEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceec
Q 010401 407 -HGLCVVTKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC 484 (511)
Q Consensus 407 -~~l~LVmEy~~gGsL~~lL~~-~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l 484 (511)
..+|+||||+.+ +|.+.+.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~ 174 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAF 174 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred CceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhcccc
Confidence 238999999986 77777754 357999999999999999999999999999999999999999999999999999876
Q ss_pred ccCC----CccccccCCCccccHHhhcc
Q 010401 485 KSVG----EATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 485 ~~~~----~~~~~~~Gt~~YmAPEvl~g 508 (511)
.... .......||+.|+|||++.+
T Consensus 175 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 202 (351)
T 3mi9_A 175 SLAKNSQPNRYTNRVVTLWYRPPELLLG 202 (351)
T ss_dssp CCCSSSSCCCCCSSCSCGGGCCHHHHTT
T ss_pred cccccccccccCCcccccCccCchhhcC
Confidence 4222 22344578999999999875
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=99.96 E-value=2.5e-28 Score=237.72 Aligned_cols=168 Identities=23% Similarity=0.467 Sum_probs=132.8
Q ss_pred ecCCCeEEEeeeecccceEEEEe----EEEEEEEEecCCCCc--hHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEE
Q 010401 337 LNSDNLEFIDQIGPNSFKGVYKG----KRVGIEKLKGCDKGN--AYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLC 410 (511)
Q Consensus 337 l~~~~y~l~~~LG~GsFG~VYkg----k~VAVKkL~~~~~~~--~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~ 410 (511)
++.++|++.+.||+|+||.||++ +.+|+|+++...... .....+.+|+.++..++||||+++++++.+++. +|
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~ 82 (271)
T 3dtc_A 4 IDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPN-LC 82 (271)
T ss_dssp CCTTSEEEEEEEEEETTEEEEEEEETTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC---CE
T ss_pred cchhheeeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCc-eE
Confidence 45788999999999999999996 579999986432221 224568899999999999999999999988776 89
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCCCceEEcC--------CCcEEEEecC
Q 010401 411 VVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHG---VAYRDLNSQRILLDR--------HGNVCLGDMG 479 (511)
Q Consensus 411 LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~g---IIHRDLKp~NILld~--------~g~vKL~DFG 479 (511)
+||||+.+++|.+++. .+.+++..++.++.||+.||.|||++| |+||||||+|||++. ++.+||+|||
T Consensus 83 lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg 161 (271)
T 3dtc_A 83 LVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG 161 (271)
T ss_dssp EEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCC
T ss_pred EEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCC
Confidence 9999999999999984 567999999999999999999999999 899999999999986 7789999999
Q ss_pred CceecccCCCccccccCCCccccHHhhcc
Q 010401 480 IVTACKSVGEATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 480 lS~~l~~~~~~~~~~~Gt~~YmAPEvl~g 508 (511)
+++...... .....|++.|+|||++.+
T Consensus 162 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~ 188 (271)
T 3dtc_A 162 LAREWHRTT--KMSAAGAYAWMAPEVIRA 188 (271)
T ss_dssp C---------------CCGGGSCHHHHHH
T ss_pred ccccccccc--ccCCCCccceeCHHHhcc
Confidence 997654332 234578999999999864
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=1.5e-28 Score=260.61 Aligned_cols=170 Identities=22% Similarity=0.398 Sum_probs=140.3
Q ss_pred ceEecCCCeEEEeeeecccceEEEEeE-----EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCc
Q 010401 334 RWLLNSDNLEFIDQIGPNSFKGVYKGK-----RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHG 408 (511)
Q Consensus 334 ~~~l~~~~y~l~~~LG~GsFG~VYkgk-----~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~ 408 (511)
.|.+..++|++.+.||+|+||.||+|+ .||+|+++.... ....+.+|+.+++.++||||+++++++.+ + .
T Consensus 178 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~-~ 252 (452)
T 1fmk_A 178 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-E-P 252 (452)
T ss_dssp CSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS-S-S
T ss_pred ccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC---CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-C-c
Confidence 577888999999999999999999974 699999975332 24568999999999999999999999876 4 3
Q ss_pred EEEEEeccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceeccc
Q 010401 409 LCVVTKLMEGGSVNDLILK--SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS 486 (511)
Q Consensus 409 l~LVmEy~~gGsL~~lL~~--~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~ 486 (511)
+|+||||+.+|+|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 253 ~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 332 (452)
T 1fmk_A 253 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED 332 (452)
T ss_dssp CEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred eEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCC
Confidence 8999999999999999964 35699999999999999999999999999999999999999999999999999987643
Q ss_pred CCC-ccccccCCCccccHHhhcc
Q 010401 487 VGE-ATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 487 ~~~-~~~~~~Gt~~YmAPEvl~g 508 (511)
... ......+++.|+|||++.+
T Consensus 333 ~~~~~~~~~~~~~~y~aPE~~~~ 355 (452)
T 1fmk_A 333 NEYTARQGAKFPIKWTAPEAALY 355 (452)
T ss_dssp ----------CCGGGSCHHHHHH
T ss_pred CceecccCCcccccccCHhHHhc
Confidence 221 1223456788999998864
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=1.5e-28 Score=239.53 Aligned_cols=167 Identities=17% Similarity=0.313 Sum_probs=144.8
Q ss_pred CCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEE
Q 010401 340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT 413 (511)
Q Consensus 340 ~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVm 413 (511)
++|++.+.||+|+||.||++ +.||+|++.... .......+.+|+.+++.++||||+++++++.+++. .|+||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~lv~ 84 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR-AVDCPENIKKEICINKMLNHENVVKFYGHRREGNI-QYLFL 84 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGG-CTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTE-EEEEE
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeecc-chhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCE-EEEEE
Confidence 46899999999999999996 479999997432 22345668899999999999999999999988775 89999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCC--Ccc
Q 010401 414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG--EAT 491 (511)
Q Consensus 414 Ey~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~--~~~ 491 (511)
||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++....... ...
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 164 (276)
T 2yex_A 85 EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 164 (276)
T ss_dssp ECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCB
T ss_pred EecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhcc
Confidence 999999999998777789999999999999999999999999999999999999999999999999988664322 123
Q ss_pred ccccCCCccccHHhhcc
Q 010401 492 EYETDGYRWLAPEVCFL 508 (511)
Q Consensus 492 ~~~~Gt~~YmAPEvl~g 508 (511)
....|++.|+|||++.+
T Consensus 165 ~~~~~~~~y~aPE~~~~ 181 (276)
T 2yex_A 165 NKMCGTLPYVAPELLKR 181 (276)
T ss_dssp CCCCSCGGGCCGGGGTC
T ss_pred cCCccccCccChHHHhc
Confidence 45578999999999864
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=5.7e-28 Score=242.73 Aligned_cols=170 Identities=24% Similarity=0.365 Sum_probs=142.3
Q ss_pred ecCCCeEEEeeeecccceEEEEe----------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCC
Q 010401 337 LNSDNLEFIDQIGPNSFKGVYKG----------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN 406 (511)
Q Consensus 337 l~~~~y~l~~~LG~GsFG~VYkg----------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~ 406 (511)
+..+.|++++.||+|+||.||++ +.||+|++... ........+.+|+.+++.++||||+++++++.+.+
T Consensus 28 ~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 106 (318)
T 3lxp_A 28 FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD-AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAG 106 (318)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred ecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc-cChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCC
Confidence 33445699999999999999764 56999999753 33344566899999999999999999999998753
Q ss_pred -CcEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecc
Q 010401 407 -HGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK 485 (511)
Q Consensus 407 -~~l~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~ 485 (511)
..+++||||+++|+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 107 ~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 185 (318)
T 3lxp_A 107 AASLQLVMEYVPLGSLRDYLPR-HSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 185 (318)
T ss_dssp TTEEEEEECCCTTCBHHHHGGG-SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred CceEEEEEecccCCcHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCcccccccc
Confidence 348999999999999999854 459999999999999999999999999999999999999999999999999998775
Q ss_pred cCCC---ccccccCCCccccHHhhcc
Q 010401 486 SVGE---ATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 486 ~~~~---~~~~~~Gt~~YmAPEvl~g 508 (511)
.... ......+++.|+|||++.+
T Consensus 186 ~~~~~~~~~~~~~~~~~y~aPE~~~~ 211 (318)
T 3lxp_A 186 EGHEYYRVREDGDSPVFWYAPECLKE 211 (318)
T ss_dssp TTCSEEEC---CCCCGGGCCHHHHHH
T ss_pred ccccccccccCCCCCceeeChHHhcC
Confidence 4332 1234457788999999865
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.7e-28 Score=255.07 Aligned_cols=170 Identities=16% Similarity=0.232 Sum_probs=143.2
Q ss_pred ecCCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCC-cE
Q 010401 337 LNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENH-GL 409 (511)
Q Consensus 337 l~~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~-~l 409 (511)
...++|++.+.||+|+||.||+| +.||+|++..... ......+.+|+.++..++||||+++++++.+.+. .+
T Consensus 6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 84 (396)
T 4eut_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK 84 (396)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred CCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCee
Confidence 34567899999999999999996 4799999974322 2224557899999999999999999999987652 38
Q ss_pred EEEEeccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEE----cCCCcEEEEecCCce
Q 010401 410 CVVTKLMEGGSVNDLILKSR---KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILL----DRHGNVCLGDMGIVT 482 (511)
Q Consensus 410 ~LVmEy~~gGsL~~lL~~~~---~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILl----d~~g~vKL~DFGlS~ 482 (511)
|+||||+.+|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 85 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp EEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 99999999999999996533 39999999999999999999999999999999999999 778889999999998
Q ss_pred ecccCCCccccccCCCccccHHhhcc
Q 010401 483 ACKSVGEATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 483 ~l~~~~~~~~~~~Gt~~YmAPEvl~g 508 (511)
...... ......||+.|+|||++.+
T Consensus 165 ~~~~~~-~~~~~~gt~~y~aPE~~~~ 189 (396)
T 4eut_A 165 ELEDDE-QFVSLYGTEEYLHPDMYER 189 (396)
T ss_dssp ECCCGG-GSSCSSSCCTTCCHHHHHH
T ss_pred EccCCC-ccccccCCccccCHHHhhc
Confidence 765432 2345678999999999864
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=4.3e-28 Score=245.53 Aligned_cols=169 Identities=20% Similarity=0.401 Sum_probs=136.9
Q ss_pred ecCCCeEEEeeeecccceEEEEeE----------EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCC
Q 010401 337 LNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN 406 (511)
Q Consensus 337 l~~~~y~l~~~LG~GsFG~VYkgk----------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~ 406 (511)
+..++|++.+.||+|+||.||+++ .|++|.+... ........+.+|+.++..++||||+++++++.+..
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 90 (327)
T 3lzb_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTST 90 (327)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCC-SSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS
T ss_pred cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccc-cCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC
Confidence 567889999999999999999975 3678887642 23334567899999999999999999999998654
Q ss_pred CcEEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecc
Q 010401 407 HGLCVVTKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK 485 (511)
Q Consensus 407 ~~l~LVmEy~~gGsL~~lL~~-~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~ 485 (511)
.+++|+|+.+|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 91 --~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~ 168 (327)
T 3lzb_A 91 --VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp --EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred --ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence 7899999999999999965 4579999999999999999999999999999999999999999999999999998764
Q ss_pred cCCC--ccccccCCCccccHHhhcc
Q 010401 486 SVGE--ATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 486 ~~~~--~~~~~~Gt~~YmAPEvl~g 508 (511)
.... ......+|+.|+|||++.+
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~ 193 (327)
T 3lzb_A 169 AEEKEYHAEGGKVPIKWMALESILH 193 (327)
T ss_dssp -----------CCCGGGSCHHHHHH
T ss_pred CccccccccCCCccccccCHHHHcC
Confidence 3322 2233456778999999865
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=1.8e-28 Score=245.69 Aligned_cols=165 Identities=24% Similarity=0.425 Sum_probs=134.1
Q ss_pred CCCeEEEeeeecccceEEEEe----EEEEEEEEecCCCCchHHHHHHHHHHHHH--hCCCCceeeEeeeEeeCC---CcE
Q 010401 339 SDNLEFIDQIGPNSFKGVYKG----KRVGIEKLKGCDKGNAYEFELRKDLLELM--TCGHKNILQFYCVCVDEN---HGL 409 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkg----k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~--~l~HpNIV~l~g~~~~~~---~~l 409 (511)
.++|++.+.||+|+||.||+| +.||+|++... . .....+|..++. .++||||+++++++.+.. ..+
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~---~--~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 110 (337)
T 3mdy_A 36 AKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTT---E--EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQL 110 (337)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEETTEEEEEEEEEGG---G--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEE
T ss_pred ccceEEEeEeecCCCeEEEEEEECCceEEEEEEecc---c--cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCce
Confidence 357899999999999999996 57999998632 2 223334444444 459999999999998773 348
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--------CccccCCCCCceEEcCCCcEEEEecCCc
Q 010401 410 CVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDH--------GVAYRDLNSQRILLDRHGNVCLGDMGIV 481 (511)
Q Consensus 410 ~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~--------gIIHRDLKp~NILld~~g~vKL~DFGlS 481 (511)
|+||||+.+|+|.+++.. ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++
T Consensus 111 ~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a 189 (337)
T 3mdy_A 111 YLITDYHENGSLYDYLKS-TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 189 (337)
T ss_dssp EEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEeccCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCc
Confidence 999999999999999954 4799999999999999999999998 9999999999999999999999999999
Q ss_pred eecccCCCc----cccccCCCccccHHhhccc
Q 010401 482 TACKSVGEA----TEYETDGYRWLAPEVCFLL 509 (511)
Q Consensus 482 ~~l~~~~~~----~~~~~Gt~~YmAPEvl~gl 509 (511)
+........ .....||+.|+|||++.+.
T Consensus 190 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 221 (337)
T 3mdy_A 190 VKFISDTNEVDIPPNTRVGTKRYMPPEVLDES 221 (337)
T ss_dssp EECC---------CCSSCSCGGGCCHHHHTTC
T ss_pred eeeccccccccCCCCCCccCcceeChhhcccc
Confidence 876543322 1245789999999998653
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.1e-27 Score=236.44 Aligned_cols=167 Identities=24% Similarity=0.257 Sum_probs=144.7
Q ss_pred CCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCC-------chHHHHHHHHHHHHHhCC-CCceeeEeeeEee
Q 010401 339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKG-------NAYEFELRKDLLELMTCG-HKNILQFYCVCVD 404 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~-------~~~~~~~~~Ei~iL~~l~-HpNIV~l~g~~~~ 404 (511)
.++|++.+.||+|+||.||++ +.||+|++...... ......+.+|+.++.++. ||||+++++++.+
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 578999999999999999996 57999999754321 112345788999999995 9999999999987
Q ss_pred CCCcEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceec
Q 010401 405 ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC 484 (511)
Q Consensus 405 ~~~~l~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l 484 (511)
.+. +|+||||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++...
T Consensus 96 ~~~-~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 174 (298)
T 1phk_A 96 NTF-FFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL 174 (298)
T ss_dssp SSE-EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred CCe-EEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhhc
Confidence 765 9999999999999999988788999999999999999999999999999999999999999999999999999876
Q ss_pred ccCCCccccccCCCccccHHhhc
Q 010401 485 KSVGEATEYETDGYRWLAPEVCF 507 (511)
Q Consensus 485 ~~~~~~~~~~~Gt~~YmAPEvl~ 507 (511)
... .......|++.|+|||++.
T Consensus 175 ~~~-~~~~~~~~~~~y~aPE~~~ 196 (298)
T 1phk_A 175 DPG-EKLREVCGTPSYLAPEIIE 196 (298)
T ss_dssp CTT-CCBCCCCSCGGGCCHHHHH
T ss_pred CCC-cccccccCCccccCHHHhc
Confidence 543 2344567899999999985
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=6.3e-28 Score=247.40 Aligned_cols=163 Identities=27% Similarity=0.389 Sum_probs=140.8
Q ss_pred CCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCch-HHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEE
Q 010401 340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNA-YEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV 412 (511)
Q Consensus 340 ~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~-~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LV 412 (511)
+.|++.+.||+|+||.||++ +.||+|++........ ....+.+|+.++..++||||+++++++.+++. .|+|
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~-~~lv 132 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHT-AWLV 132 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE-EEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCe-EEEE
Confidence 35899999999999999996 4799999975433322 33568899999999999999999999998775 9999
Q ss_pred EeccCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCcc
Q 010401 413 TKLMEGGSVNDLIL-KSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT 491 (511)
Q Consensus 413 mEy~~gGsL~~lL~-~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~ 491 (511)
|||+. |+|.+++. ....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... .
T Consensus 133 ~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~----~ 207 (348)
T 1u5q_A 133 MEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----A 207 (348)
T ss_dssp EECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS----B
T ss_pred EecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC----C
Confidence 99997 58888875 456899999999999999999999999999999999999999999999999999876543 2
Q ss_pred ccccCCCccccHHhhcc
Q 010401 492 EYETDGYRWLAPEVCFL 508 (511)
Q Consensus 492 ~~~~Gt~~YmAPEvl~g 508 (511)
....||+.|+|||++.+
T Consensus 208 ~~~~gt~~y~aPE~~~~ 224 (348)
T 1u5q_A 208 NSFVGTPYWMAPEVILA 224 (348)
T ss_dssp CCCCSCGGGCCHHHHHT
T ss_pred CcccCCcceeCHhhhcc
Confidence 34578999999999864
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=3.8e-28 Score=251.49 Aligned_cols=162 Identities=21% Similarity=0.318 Sum_probs=134.3
Q ss_pred EEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEEecc
Q 010401 343 EFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLM 416 (511)
Q Consensus 343 ~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVmEy~ 416 (511)
...+.||+|+||.||++ +.||+|++... .......+.+|+.++..++||||+++++++.+.+. +|+||||+
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~-~~lv~E~~ 168 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTR--GMKDKEEVKNEISVMNQLDHANLIQLYDAFESKND-IVLVMEYV 168 (373)
T ss_dssp EEEEECC-----CEEEEEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE-EEEEEECC
T ss_pred ecceEEecCcCEEEEEEEEcCCCcEEEEEEEccc--ccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE-EEEEEeCC
Confidence 44678999999999996 47999999742 23345668999999999999999999999998775 99999999
Q ss_pred CCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEE--cCCCcEEEEecCCceecccCCCcccc
Q 010401 417 EGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILL--DRHGNVCLGDMGIVTACKSVGEATEY 493 (511)
Q Consensus 417 ~gGsL~~lL~~~-~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILl--d~~g~vKL~DFGlS~~l~~~~~~~~~ 493 (511)
++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++...... ....
T Consensus 169 ~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~-~~~~ 247 (373)
T 2x4f_A 169 DGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE-KLKV 247 (373)
T ss_dssp TTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC-BCCC
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc-cccc
Confidence 999999988654 479999999999999999999999999999999999999 567899999999998765432 2345
Q ss_pred ccCCCccccHHhhcc
Q 010401 494 ETDGYRWLAPEVCFL 508 (511)
Q Consensus 494 ~~Gt~~YmAPEvl~g 508 (511)
..||+.|+|||++.+
T Consensus 248 ~~gt~~y~aPE~~~~ 262 (373)
T 2x4f_A 248 NFGTPEFLAPEVVNY 262 (373)
T ss_dssp CCSSCTTCCHHHHTT
T ss_pred ccCCCcEeChhhccC
Confidence 579999999999864
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=7.6e-29 Score=244.39 Aligned_cols=173 Identities=30% Similarity=0.487 Sum_probs=128.9
Q ss_pred ceEecCCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCC
Q 010401 334 RWLLNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENH 407 (511)
Q Consensus 334 ~~~l~~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~ 407 (511)
.|.+..++|++.+.||+|+||.||++ +.||+|++.... ......++.+|+.++..++||||+++++++...+.
T Consensus 9 p~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 87 (303)
T 2vwi_A 9 PWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEK-CQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDE 87 (303)
T ss_dssp ----CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEESSSC
T ss_pred ccccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhh-cchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCC
Confidence 56778899999999999999999996 479999886422 12234557889999999999999999999998876
Q ss_pred cEEEEEeccCCCCHHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecC
Q 010401 408 GLCVVTKLMEGGSVNDLILK--------SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMG 479 (511)
Q Consensus 408 ~l~LVmEy~~gGsL~~lL~~--------~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFG 479 (511)
.|+||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||
T Consensus 88 -~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg 166 (303)
T 2vwi_A 88 -LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFG 166 (303)
T ss_dssp -EEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCH
T ss_pred -cEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEecc
Confidence 9999999999999999863 3569999999999999999999999999999999999999999999999999
Q ss_pred CceecccCCC-----ccccccCCCccccHHhhcc
Q 010401 480 IVTACKSVGE-----ATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 480 lS~~l~~~~~-----~~~~~~Gt~~YmAPEvl~g 508 (511)
++........ ......||+.|+|||++.+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 200 (303)
T 2vwi_A 167 VSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQ 200 (303)
T ss_dssp HHHHCC---------------CCCTTCCHHHHHH
T ss_pred chheeccCCCccchhhhcccCCCccccCHHHhcc
Confidence 9876543221 1234578999999999864
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.7e-28 Score=245.11 Aligned_cols=170 Identities=25% Similarity=0.368 Sum_probs=135.4
Q ss_pred eEecCCCeEEEeeeecccceEEEEe----EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEee----CC
Q 010401 335 WLLNSDNLEFIDQIGPNSFKGVYKG----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVD----EN 406 (511)
Q Consensus 335 ~~l~~~~y~l~~~LG~GsFG~VYkg----k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~----~~ 406 (511)
..+..++|++.+.||+|+||.||+| +.||+|++... .......+.++..+..++||||+++++.+.. +.
T Consensus 8 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 84 (336)
T 3g2f_A 8 PSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFA---NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGR 84 (336)
T ss_dssp -CCCTTSEEEEEEEEECSSEEEEEEEETTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSC
T ss_pred CCcChHHhheeeecccCCCeEEEEEEECCeEEEEEEeecc---chhhHHHHHHHHHHHhccCcchhhheecccccccCCC
Confidence 3456789999999999999999996 57999999632 2222333444544556899999999975532 22
Q ss_pred CcEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---------CccccCCCCCceEEcCCCcEEEEe
Q 010401 407 HGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDH---------GVAYRDLNSQRILLDRHGNVCLGD 477 (511)
Q Consensus 407 ~~l~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~---------gIIHRDLKp~NILld~~g~vKL~D 477 (511)
..+|+||||+++|+|.+++.. ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|
T Consensus 85 ~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~D 163 (336)
T 3g2f_A 85 MEYLLVMEYYPNGSLXKYLSL-HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISD 163 (336)
T ss_dssp EEEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECC
T ss_pred ceEEEEEecCCCCcHHHHHhh-cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEee
Confidence 237899999999999999955 4468999999999999999999999 999999999999999999999999
Q ss_pred cCCceecccCC--------CccccccCCCccccHHhhcc
Q 010401 478 MGIVTACKSVG--------EATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 478 FGlS~~l~~~~--------~~~~~~~Gt~~YmAPEvl~g 508 (511)
||+++.+.... .......||+.|+|||++.+
T Consensus 164 FG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 202 (336)
T 3g2f_A 164 FGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEG 202 (336)
T ss_dssp CTTCEECSSSSCC---------CCTTSCGGGCCHHHHTT
T ss_pred ccceeecccccccCccccccccccCCCccceeCchhhcC
Confidence 99998765322 11224468999999999875
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.1e-28 Score=244.87 Aligned_cols=169 Identities=24% Similarity=0.396 Sum_probs=138.4
Q ss_pred ecCCCeEEEeeeecccceEEEEeE--------EEEEEEEecCCCCchHHHHHHHHHHHHHhC-CCCceeeEeeeEeeCCC
Q 010401 337 LNSDNLEFIDQIGPNSFKGVYKGK--------RVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCVCVDENH 407 (511)
Q Consensus 337 l~~~~y~l~~~LG~GsFG~VYkgk--------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l-~HpNIV~l~g~~~~~~~ 407 (511)
+..++|++.+.||+|+||.||+++ .+++|.+... ........+.+|+.++.++ +||||+++++++.+.+.
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 100 (327)
T 1fvr_A 22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY 100 (327)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTE
T ss_pred ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccc-cchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCc
Confidence 445789999999999999999974 3588988742 2223345588999999999 99999999999988776
Q ss_pred cEEEEEeccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCC
Q 010401 408 GLCVVTKLMEGGSVNDLILKSR----------------KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG 471 (511)
Q Consensus 408 ~l~LVmEy~~gGsL~~lL~~~~----------------~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g 471 (511)
+|+||||+++|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 101 -~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~ 179 (327)
T 1fvr_A 101 -LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 179 (327)
T ss_dssp -EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred -eEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCC
Confidence 999999999999999996543 699999999999999999999999999999999999999999
Q ss_pred cEEEEecCCceecccCCCccccccCCCccccHHhhcc
Q 010401 472 NVCLGDMGIVTACKSVGEATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 472 ~vKL~DFGlS~~l~~~~~~~~~~~Gt~~YmAPEvl~g 508 (511)
.+||+|||+++..... .......+++.|+|||++.+
T Consensus 180 ~~kL~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~ 215 (327)
T 1fvr_A 180 VAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNY 215 (327)
T ss_dssp CEEECCTTCEESSCEE-CCC----CCTTTCCHHHHHH
T ss_pred eEEEcccCcCcccccc-ccccCCCCCccccChhhhcc
Confidence 9999999998744321 12334456788999999864
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=1.8e-28 Score=249.56 Aligned_cols=168 Identities=24% Similarity=0.360 Sum_probs=138.4
Q ss_pred CCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCch---HHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcE
Q 010401 339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNA---YEFELRKDLLELMTCGHKNILQFYCVCVDENHGL 409 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~---~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l 409 (511)
.++|++.+.||+|+||.||++ +.||+|++........ ....+.+|+.++..++||||+++++++.+.+. +
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~ 87 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN-I 87 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC-C
T ss_pred hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc-e
Confidence 467899999999999999996 4799999874322211 12357899999999999999999999988776 9
Q ss_pred EEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCC
Q 010401 410 CVVTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG 488 (511)
Q Consensus 410 ~LVmEy~~gGsL~~lL~~~-~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~ 488 (511)
|+||||+.+ +|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 88 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 166 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 166 (346)
T ss_dssp EEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred EEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCCc
Confidence 999999986 898888654 468999999999999999999999999999999999999999999999999998776554
Q ss_pred CccccccCCCccccHHhhcc
Q 010401 489 EATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 489 ~~~~~~~Gt~~YmAPEvl~g 508 (511)
.......||+.|+|||++.+
T Consensus 167 ~~~~~~~~t~~y~aPE~~~~ 186 (346)
T 1ua2_A 167 RAYTHQVVTRWYRAPELLFG 186 (346)
T ss_dssp CCCCCSCCCCTTCCHHHHTT
T ss_pred ccCCcccccccccCchHhhC
Confidence 44556788999999999865
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=2.1e-28 Score=253.70 Aligned_cols=167 Identities=22% Similarity=0.341 Sum_probs=131.9
Q ss_pred CeEEEeeeecccceEEEEeE---------EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEE
Q 010401 341 NLEFIDQIGPNSFKGVYKGK---------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCV 411 (511)
Q Consensus 341 ~y~l~~~LG~GsFG~VYkgk---------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~L 411 (511)
.|++.+.||+|+||.||+|+ .||+|.++. ........++.+|+.+++.++||||+++++++.+.+...|+
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~-~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l 168 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR-ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCS-CSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCC-CCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence 47889999999999999874 478898864 23334456789999999999999999999998765545899
Q ss_pred EEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCC-
Q 010401 412 VTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE- 489 (511)
Q Consensus 412 VmEy~~gGsL~~lL~~~-~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~- 489 (511)
||||+.+|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 169 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~ 248 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 248 (373)
T ss_dssp EEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------------
T ss_pred EEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccccccccc
Confidence 99999999999999754 4688999999999999999999999999999999999999999999999999986543221
Q ss_pred ---ccccccCCCccccHHhhcc
Q 010401 490 ---ATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 490 ---~~~~~~Gt~~YmAPEvl~g 508 (511)
......+++.|+|||++.+
T Consensus 249 ~~~~~~~~~~~~~y~aPE~~~~ 270 (373)
T 3c1x_A 249 SVHNKTGAKLPVKWMALESLQT 270 (373)
T ss_dssp ---------CCGGGSCHHHHHH
T ss_pred cccccCCCCCcccccChHHhcC
Confidence 1233456788999999864
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.2e-28 Score=238.76 Aligned_cols=169 Identities=22% Similarity=0.331 Sum_probs=137.9
Q ss_pred cCCCeEEEeeeecccceEEEEe------EEEEEEEEecCCC-CchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEE
Q 010401 338 NSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDK-GNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLC 410 (511)
Q Consensus 338 ~~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~-~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~ 410 (511)
..++|++.+.||+|+||.||++ +.||+|++..... .......+.+|+.+++.++||||+++++++.+.+. +|
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~ 87 (276)
T 2h6d_A 9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTD-FF 87 (276)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE-EE
T ss_pred eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCe-EE
Confidence 4578999999999999999996 4799999964221 11224467899999999999999999999988775 99
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCc
Q 010401 411 VVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA 490 (511)
Q Consensus 411 LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~ 490 (511)
+||||+.+++|.+++...+.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++...... ..
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~-~~ 166 (276)
T 2h6d_A 88 MVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-EF 166 (276)
T ss_dssp EEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC----
T ss_pred EEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCC-cc
Confidence 99999999999999988788999999999999999999999999999999999999999999999999998766432 22
Q ss_pred cccccCCCccccHHhhcc
Q 010401 491 TEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 491 ~~~~~Gt~~YmAPEvl~g 508 (511)
.....|++.|+|||++.+
T Consensus 167 ~~~~~~~~~y~aPE~~~~ 184 (276)
T 2h6d_A 167 LRTSCGSPNYAAPEVISG 184 (276)
T ss_dssp ----------CCTGGGTT
T ss_pred eecccCCccccCHHHHcC
Confidence 345578899999999865
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=99.95 E-value=3.1e-28 Score=242.10 Aligned_cols=164 Identities=21% Similarity=0.373 Sum_probs=140.8
Q ss_pred CCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEE
Q 010401 340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT 413 (511)
Q Consensus 340 ~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVm 413 (511)
++|++.+.||+|+||.||++ +.||+|++.... ......+.+|+.++..++||||+++++++.+.+. +|+||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~lv~ 85 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSP--AFRDSSLENEIAVLKKIKHENIVTLEDIYESTTH-YYLVM 85 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEECSSE-EEEEE
T ss_pred ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccc--ccchHHHHHHHHHHHhCCCCCeeehhhhcccCCE-EEEEE
Confidence 46899999999999999985 479999997432 2233557899999999999999999999988775 99999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEE---cCCCcEEEEecCCceecccCCCc
Q 010401 414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILL---DRHGNVCLGDMGIVTACKSVGEA 490 (511)
Q Consensus 414 Ey~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILl---d~~g~vKL~DFGlS~~l~~~~~~ 490 (511)
||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||+++.... ..
T Consensus 86 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~--~~ 163 (304)
T 2jam_A 86 QLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN--GI 163 (304)
T ss_dssp CCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC--BT
T ss_pred EcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCC--Cc
Confidence 999999999999887889999999999999999999999999999999999999 7889999999999875432 22
Q ss_pred cccccCCCccccHHhhcc
Q 010401 491 TEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 491 ~~~~~Gt~~YmAPEvl~g 508 (511)
.....|++.|+|||++.+
T Consensus 164 ~~~~~~~~~y~aPE~~~~ 181 (304)
T 2jam_A 164 MSTACGTPGYVAPEVLAQ 181 (304)
T ss_dssp THHHHSCCCBCCTTTBSS
T ss_pred cccccCCCCccChHHhcc
Confidence 344578999999999865
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.95 E-value=4.3e-28 Score=242.69 Aligned_cols=169 Identities=14% Similarity=0.213 Sum_probs=138.7
Q ss_pred CCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCC-chHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEE
Q 010401 339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKG-NAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCV 411 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~-~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~L 411 (511)
.++|++.+.||+|+||.||++ +.||+|++...... ......+.+|+.++..++||||+++++++.+++. +|+
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~-~~l 111 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQ-LYV 111 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTE-EEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCe-EEE
Confidence 468999999999999999996 47999998753322 2234668899999999999999999999998775 999
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCC-Cc
Q 010401 412 VTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG-EA 490 (511)
Q Consensus 412 VmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~-~~ 490 (511)
||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ..
T Consensus 112 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~ 191 (309)
T 2h34_A 112 DMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQ 191 (309)
T ss_dssp EEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC-----------
T ss_pred EEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCcccccccccc
Confidence 99999999999999887889999999999999999999999999999999999999999999999999987654322 12
Q ss_pred cccccCCCccccHHhhcc
Q 010401 491 TEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 491 ~~~~~Gt~~YmAPEvl~g 508 (511)
.....|++.|+|||++.+
T Consensus 192 ~~~~~~~~~y~aPE~~~~ 209 (309)
T 2h34_A 192 LGNTVGTLYYMAPERFSE 209 (309)
T ss_dssp -----CCGGGCCGGGTCC
T ss_pred ccccCCCcCccCHHHHcC
Confidence 234578999999999864
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.8e-28 Score=242.36 Aligned_cols=167 Identities=22% Similarity=0.407 Sum_probs=138.2
Q ss_pred cCCCeEEEeeeecccceEEEEeE------EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEE
Q 010401 338 NSDNLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCV 411 (511)
Q Consensus 338 ~~~~y~l~~~LG~GsFG~VYkgk------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~L 411 (511)
..++|++.+.||+|+||.||+++ .+|+|++.... ......+.+|+.++..++||||+++++++.+.+. +|+
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~l 93 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS--EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGK-LWI 93 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-C-EEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC--HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCe-EEE
Confidence 35678999999999999999964 68999986432 2234567899999999999999999999998776 999
Q ss_pred EEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCc
Q 010401 412 VTKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA 490 (511)
Q Consensus 412 VmEy~~gGsL~~lL~~-~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~ 490 (511)
||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 94 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 173 (302)
T 2j7t_A 94 MIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQK 173 (302)
T ss_dssp EEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHHC
T ss_pred EEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccccccccc
Confidence 9999999999999865 467999999999999999999999999999999999999999999999999997644322222
Q ss_pred cccccCCCccccHHhhc
Q 010401 491 TEYETDGYRWLAPEVCF 507 (511)
Q Consensus 491 ~~~~~Gt~~YmAPEvl~ 507 (511)
.....|++.|+|||++.
T Consensus 174 ~~~~~~~~~y~aPE~~~ 190 (302)
T 2j7t_A 174 RDSFIGTPYWMAPEVVM 190 (302)
T ss_dssp -----CCGGGCCHHHHH
T ss_pred cccccCChhhcCCeeec
Confidence 34457899999999984
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.9e-28 Score=242.99 Aligned_cols=173 Identities=20% Similarity=0.302 Sum_probs=143.0
Q ss_pred ceEecCCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeC--
Q 010401 334 RWLLNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDE-- 405 (511)
Q Consensus 334 ~~~l~~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~-- 405 (511)
-+.+..++|++.+.||+|+||.||++ +.||+|++.. ........+.+|+.+++.++||||+++++++...
T Consensus 23 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 100 (317)
T 2buj_A 23 MVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILC--HEQQDREEAQREADMHRLFNHPNILRLVAYCLRERG 100 (317)
T ss_dssp EEEETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEE--SSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEET
T ss_pred EEEECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEec--CCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccC
Confidence 45677889999999999999999996 4799999864 2334456688999999999999999999998732
Q ss_pred -CCcEEEEEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCC
Q 010401 406 -NHGLCVVTKLMEGGSVNDLILK----SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGI 480 (511)
Q Consensus 406 -~~~l~LVmEy~~gGsL~~lL~~----~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGl 480 (511)
...+|+||||+.+|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 101 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~ 180 (317)
T 2buj_A 101 AKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGS 180 (317)
T ss_dssp TEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSS
T ss_pred CCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCc
Confidence 2248999999999999999964 46799999999999999999999999999999999999999999999999999
Q ss_pred ceecccCCCc---------cccccCCCccccHHhhcc
Q 010401 481 VTACKSVGEA---------TEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 481 S~~l~~~~~~---------~~~~~Gt~~YmAPEvl~g 508 (511)
++........ .....||+.|+|||++.+
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 217 (317)
T 2buj_A 181 MNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSV 217 (317)
T ss_dssp CEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSC
T ss_pred chhcccccccccccccccccccccCCcccCCHhHhcc
Confidence 8765321110 123457899999999864
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=6.9e-28 Score=239.95 Aligned_cols=166 Identities=23% Similarity=0.415 Sum_probs=140.3
Q ss_pred cCCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEE
Q 010401 338 NSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCV 411 (511)
Q Consensus 338 ~~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~L 411 (511)
..++|++.+.||+|+||.||++ +.||+|.+..... ...+.+|+.++..++||||+++++++.+.+. +|+
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~l 101 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD----LQEIIKEISIMQQCDSPHVVKYYGSYFKNTD-LWI 101 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC----CHHHHHHHHHHHTCCCTTBCCEEEEEEETTE-EEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH----HHHHHHHHHHHHhCCCCCCccEEEEEEeCCE-EEE
Confidence 4567999999999999999996 5799999975321 2457899999999999999999999998775 999
Q ss_pred EEeccCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCc
Q 010401 412 VTKLMEGGSVNDLIL-KSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA 490 (511)
Q Consensus 412 VmEy~~gGsL~~lL~-~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~ 490 (511)
||||+.+++|.+++. ....+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.........
T Consensus 102 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 181 (314)
T 3com_A 102 VMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAK 181 (314)
T ss_dssp EEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBSC
T ss_pred EeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhccc
Confidence 999999999999996 4568999999999999999999999999999999999999999999999999999877654444
Q ss_pred cccccCCCccccHHhhcc
Q 010401 491 TEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 491 ~~~~~Gt~~YmAPEvl~g 508 (511)
.....|++.|+|||++.+
T Consensus 182 ~~~~~~~~~y~aPE~~~~ 199 (314)
T 3com_A 182 RNTVIGTPFWMAPEVIQE 199 (314)
T ss_dssp BCCCCSCGGGCCHHHHSS
T ss_pred cCccCCCCCccChhhcCC
Confidence 556678999999999865
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.4e-27 Score=235.19 Aligned_cols=166 Identities=19% Similarity=0.311 Sum_probs=141.5
Q ss_pred ecCCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhC-CCCceeeEeeeEeeCCCcE
Q 010401 337 LNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCVCVDENHGL 409 (511)
Q Consensus 337 l~~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l-~HpNIV~l~g~~~~~~~~l 409 (511)
+..++|++.+.||+|+||.||++ +.||+|++...... ..+.+|+.++..+ +|+||+++++++.+... .
T Consensus 7 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~-~ 81 (298)
T 1csn_A 7 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLH-N 81 (298)
T ss_dssp EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTE-E
T ss_pred ccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCcc----HHHHHHHHHHHHHhcCCCCCeEEeecCCCce-e
Confidence 45678999999999999999996 47999998743222 2467888899988 89999999999987775 8
Q ss_pred EEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCc-----EEEEecCCcee
Q 010401 410 CVVTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGN-----VCLGDMGIVTA 483 (511)
Q Consensus 410 ~LVmEy~~gGsL~~lL~~~-~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~-----vKL~DFGlS~~ 483 (511)
|+||||+ +++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++.
T Consensus 82 ~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~ 160 (298)
T 1csn_A 82 VLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160 (298)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred EEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence 9999999 88999999764 46999999999999999999999999999999999999987776 99999999987
Q ss_pred cccCCC-------ccccccCCCccccHHhhcc
Q 010401 484 CKSVGE-------ATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 484 l~~~~~-------~~~~~~Gt~~YmAPEvl~g 508 (511)
...... ......||+.|+|||++.+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 192 (298)
T 1csn_A 161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLG 192 (298)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT
T ss_pred cccccccccccccCccCCCCCcccCCchhhcC
Confidence 654322 1344578999999999865
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=7.6e-28 Score=247.78 Aligned_cols=167 Identities=20% Similarity=0.277 Sum_probs=134.1
Q ss_pred CCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCC-----C
Q 010401 339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN-----H 407 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~-----~ 407 (511)
.++|++++.||+|+||.||++ +.||+|++............+.+|+.+++.++||||+++++++...+ .
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 578999999999999999996 57999999864444455567889999999999999999999997654 2
Q ss_pred cEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccC
Q 010401 408 GLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV 487 (511)
Q Consensus 408 ~l~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~ 487 (511)
.+|+||||+.+ +|.+++. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 104 ~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~ 180 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 180 (371)
T ss_dssp EEEEEEECCSE-EHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC-------
T ss_pred ceEEEEEcCCC-CHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecccccccc
Confidence 48999999975 7888875 45899999999999999999999999999999999999999999999999999866432
Q ss_pred CCccccccCCCccccHHhhccc
Q 010401 488 GEATEYETDGYRWLAPEVCFLL 509 (511)
Q Consensus 488 ~~~~~~~~Gt~~YmAPEvl~gl 509 (511)
.......||+.|+|||++.+.
T Consensus 181 -~~~~~~~gt~~y~aPE~~~~~ 201 (371)
T 2xrw_A 181 -FMMTPYVVTRYYRAPEVILGM 201 (371)
T ss_dssp ----------CTTCCHHHHTTC
T ss_pred -cccCCceecCCccCHHHhcCC
Confidence 223456789999999998753
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.6e-28 Score=245.44 Aligned_cols=170 Identities=21% Similarity=0.395 Sum_probs=140.7
Q ss_pred ecCCCeEEEeeeecccceEEEEeE-----------EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeC
Q 010401 337 LNSDNLEFIDQIGPNSFKGVYKGK-----------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDE 405 (511)
Q Consensus 337 l~~~~y~l~~~LG~GsFG~VYkgk-----------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~ 405 (511)
+..++|++.+.||+|+||.||+|+ .||+|++.. ........++.+|+.++..++||||+++++++.+.
T Consensus 27 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~-~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 105 (327)
T 2yfx_A 27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPE-VCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS 105 (327)
T ss_dssp CCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCS-SCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecc-ccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCC
Confidence 456789999999999999999986 699999963 23344556788999999999999999999999987
Q ss_pred CCcEEEEEeccCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcC---CCcEEE
Q 010401 406 NHGLCVVTKLMEGGSVNDLILKS-------RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDR---HGNVCL 475 (511)
Q Consensus 406 ~~~l~LVmEy~~gGsL~~lL~~~-------~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~---~g~vKL 475 (511)
+. .|+||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||
T Consensus 106 ~~-~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 106 LP-RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp SS-CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred CC-cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEE
Confidence 76 89999999999999999754 34899999999999999999999999999999999999994 456999
Q ss_pred EecCCceecccCCC--ccccccCCCccccHHhhcc
Q 010401 476 GDMGIVTACKSVGE--ATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 476 ~DFGlS~~l~~~~~--~~~~~~Gt~~YmAPEvl~g 508 (511)
+|||+++....... ......|++.|+|||++.+
T Consensus 185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 219 (327)
T 2yfx_A 185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFME 219 (327)
T ss_dssp CCCHHHHHHHC------CCGGGSCGGGCCHHHHHH
T ss_pred CccccccccccccccccCCCcCCCcceeCHhHhcC
Confidence 99999875533221 2234567889999999854
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=99.95 E-value=4.1e-28 Score=238.31 Aligned_cols=166 Identities=21% Similarity=0.373 Sum_probs=135.6
Q ss_pred CCeEEEeeeecccceEEEEeE------EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeC--------
Q 010401 340 DNLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDE-------- 405 (511)
Q Consensus 340 ~~y~l~~~LG~GsFG~VYkgk------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~-------- 405 (511)
++|++.+.||+|+||.||+++ .||+|++.. .......+.+|+.++..++||||+++++++.+.
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH---TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE---EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec---cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 468999999999999999964 799999963 233445688999999999999999999998653
Q ss_pred ----CCcEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCC
Q 010401 406 ----NHGLCVVTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGI 480 (511)
Q Consensus 406 ----~~~l~LVmEy~~gGsL~~lL~~~-~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGl 480 (511)
...+|+||||+++|+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~ 162 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGL 162 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred ccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCcc
Confidence 23489999999999999999754 4688899999999999999999999999999999999999999999999999
Q ss_pred ceecccC--------------CCccccccCCCccccHHhhcc
Q 010401 481 VTACKSV--------------GEATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 481 S~~l~~~--------------~~~~~~~~Gt~~YmAPEvl~g 508 (511)
++..... ........|++.|+|||++.+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 204 (303)
T 1zy4_A 163 AKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDG 204 (303)
T ss_dssp CSCTTC-------------------------CTTSCHHHHTS
T ss_pred hhhcccccchhccccccccccccccccCCCcccccCcccccC
Confidence 8765421 112234568899999999864
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=99.95 E-value=8.8e-28 Score=247.32 Aligned_cols=167 Identities=22% Similarity=0.271 Sum_probs=144.9
Q ss_pred CCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCc------hHHHHHHHHHHHHHhC-CCCceeeEeeeEeeCC
Q 010401 340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGN------AYEFELRKDLLELMTC-GHKNILQFYCVCVDEN 406 (511)
Q Consensus 340 ~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~------~~~~~~~~Ei~iL~~l-~HpNIV~l~g~~~~~~ 406 (511)
++|++.+.||+|+||.||++ +.||||++....... .....+.+|+.++..+ +||||+++++++...+
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 173 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS 173 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence 56899999999999999995 479999997543221 1234578899999998 8999999999998776
Q ss_pred CcEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceeccc
Q 010401 407 HGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS 486 (511)
Q Consensus 407 ~~l~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~ 486 (511)
. .|+||||+.+++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+..
T Consensus 174 ~-~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~ 252 (365)
T 2y7j_A 174 F-MFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEP 252 (365)
T ss_dssp E-EEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred E-EEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccCC
Confidence 5 999999999999999998778899999999999999999999999999999999999999999999999999987654
Q ss_pred CCCccccccCCCccccHHhhcc
Q 010401 487 VGEATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 487 ~~~~~~~~~Gt~~YmAPEvl~g 508 (511)
. .......||+.|+|||++.+
T Consensus 253 ~-~~~~~~~gt~~y~aPE~~~~ 273 (365)
T 2y7j_A 253 G-EKLRELCGTPGYLAPEILKC 273 (365)
T ss_dssp T-CCBCCCCSCGGGCCHHHHHH
T ss_pred C-cccccCCCCCCccChhhccc
Confidence 3 23445689999999999864
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=5.9e-28 Score=237.53 Aligned_cols=172 Identities=22% Similarity=0.361 Sum_probs=142.2
Q ss_pred ceEecCCCeEEEeeeecccceEEEEeE------EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCC
Q 010401 334 RWLLNSDNLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENH 407 (511)
Q Consensus 334 ~~~l~~~~y~l~~~LG~GsFG~VYkgk------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~ 407 (511)
.+....++|.....||+|+||.||+|+ .||+|.+... .......+.+|+.++..++||||+++++++.+.+.
T Consensus 16 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 93 (295)
T 2clq_A 16 EYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPER--DSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGF 93 (295)
T ss_dssp CEEECBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECC--CC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred cccccccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCC--chHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCc
Confidence 444555666666799999999999974 7999999753 23334568899999999999999999999988775
Q ss_pred cEEEEEeccCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcC-CCcEEEEecCCcee
Q 010401 408 GLCVVTKLMEGGSVNDLILKS---RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDR-HGNVCLGDMGIVTA 483 (511)
Q Consensus 408 ~l~LVmEy~~gGsL~~lL~~~---~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~-~g~vKL~DFGlS~~ 483 (511)
+++||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++. ++.+||+|||+++.
T Consensus 94 -~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~ 172 (295)
T 2clq_A 94 -IKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKR 172 (295)
T ss_dssp -EEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEE
T ss_pred -EEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccc
Confidence 99999999999999999654 25678899999999999999999999999999999999997 89999999999987
Q ss_pred cccCCCccccccCCCccccHHhhcc
Q 010401 484 CKSVGEATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 484 l~~~~~~~~~~~Gt~~YmAPEvl~g 508 (511)
............|++.|+|||++.+
T Consensus 173 ~~~~~~~~~~~~~~~~y~aPE~~~~ 197 (295)
T 2clq_A 173 LAGINPCTETFTGTLQYMAPEIIDK 197 (295)
T ss_dssp SCC-----CCCCCCGGGCCHHHHHH
T ss_pred cCCCCCcccccCCCccccChhhhcC
Confidence 6544333455678999999999864
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=99.95 E-value=2.3e-28 Score=264.91 Aligned_cols=170 Identities=22% Similarity=0.398 Sum_probs=144.8
Q ss_pred ceEecCCCeEEEeeeecccceEEEEeE-----EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCc
Q 010401 334 RWLLNSDNLEFIDQIGPNSFKGVYKGK-----RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHG 408 (511)
Q Consensus 334 ~~~l~~~~y~l~~~LG~GsFG~VYkgk-----~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~ 408 (511)
.|.+..++|++.+.||+|+||.||+|+ .||||+++.... ....+.+|+.+|+.++||||+++++++.+ + .
T Consensus 261 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~-~ 335 (535)
T 2h8h_A 261 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-E-P 335 (535)
T ss_dssp CSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS-S-S
T ss_pred ceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC---CHHHHHHHHHHHHhCCCCCEeeEEEEEee-c-c
Confidence 677888999999999999999999974 699999975332 24568999999999999999999999876 3 3
Q ss_pred EEEEEeccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceeccc
Q 010401 409 LCVVTKLMEGGSVNDLILK--SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS 486 (511)
Q Consensus 409 l~LVmEy~~gGsL~~lL~~--~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~ 486 (511)
+||||||+.+|+|.+++.. ...+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++....
T Consensus 336 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 415 (535)
T 2h8h_A 336 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED 415 (535)
T ss_dssp CEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCC
T ss_pred ceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCC
Confidence 8999999999999999964 35699999999999999999999999999999999999999999999999999976543
Q ss_pred CCC-ccccccCCCccccHHhhcc
Q 010401 487 VGE-ATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 487 ~~~-~~~~~~Gt~~YmAPEvl~g 508 (511)
... ......+++.|+|||++.+
T Consensus 416 ~~~~~~~~~~~~~~y~aPE~~~~ 438 (535)
T 2h8h_A 416 NEYTARQGAKFPIKWTAPEAALY 438 (535)
T ss_dssp HHHHTTCSTTSCGGGSCHHHHHH
T ss_pred CceecccCCcCcccccCHHHhcc
Confidence 211 1223346788999998864
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=9.9e-28 Score=240.01 Aligned_cols=169 Identities=25% Similarity=0.417 Sum_probs=137.9
Q ss_pred EecCCCeEEEeeeecccceEEEEeE------EEEEEEEecCCCCchHHHHHHHHHHHHHhC-CCCceeeEeeeEeeC---
Q 010401 336 LLNSDNLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCVCVDE--- 405 (511)
Q Consensus 336 ~l~~~~y~l~~~LG~GsFG~VYkgk------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l-~HpNIV~l~g~~~~~--- 405 (511)
....++|++.+.||+|+||.||+|+ .||+|++..... ....+.+|+.++..+ +||||+++++++...
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 96 (326)
T 2x7f_A 20 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD---EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP 96 (326)
T ss_dssp CCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS---TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--
T ss_pred cCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc---cHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCc
Confidence 3457789999999999999999964 699999974322 235678999999998 899999999999874
Q ss_pred --CCcEEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCc
Q 010401 406 --NHGLCVVTKLMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIV 481 (511)
Q Consensus 406 --~~~l~LVmEy~~gGsL~~lL~~~--~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS 481 (511)
...+|+||||+.+|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 176 (326)
T 2x7f_A 97 GMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVS 176 (326)
T ss_dssp CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTT
T ss_pred cccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCc
Confidence 23489999999999999999753 57999999999999999999999999999999999999999999999999998
Q ss_pred eecccCCCccccccCCCccccHHhhc
Q 010401 482 TACKSVGEATEYETDGYRWLAPEVCF 507 (511)
Q Consensus 482 ~~l~~~~~~~~~~~Gt~~YmAPEvl~ 507 (511)
..............|++.|+|||++.
T Consensus 177 ~~~~~~~~~~~~~~~~~~y~aPE~~~ 202 (326)
T 2x7f_A 177 AQLDRTVGRRNTFIGTPYWMAPEVIA 202 (326)
T ss_dssp C-------------CCGGGCCHHHHC
T ss_pred eecCcCccccccccCCccccChhhhc
Confidence 87654333344567899999999986
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.4e-28 Score=248.05 Aligned_cols=169 Identities=20% Similarity=0.293 Sum_probs=137.5
Q ss_pred CCCeEEEeeeecccceEEEEeE------EEEEEEEecCC---CCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcE
Q 010401 339 SDNLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCD---KGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGL 409 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkgk------~VAVKkL~~~~---~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l 409 (511)
.++|++.+.||+|+||.||+++ .||+|++.... ........+.+|+.++..++||||+++++++.+.+. +
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~-~ 103 (345)
T 3hko_A 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQY-I 103 (345)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE-E
T ss_pred hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCe-E
Confidence 4678999999999999999974 68999986421 122345668999999999999999999999988775 9
Q ss_pred EEEEeccCCCCHHHHHHh----------------------------------------cCCCCHHHHHHHHHHHHHHHHH
Q 010401 410 CVVTKLMEGGSVNDLILK----------------------------------------SRKLQTKEIIRIAIDVAEGIKF 449 (511)
Q Consensus 410 ~LVmEy~~gGsL~~lL~~----------------------------------------~~~L~e~~~~~ia~qIa~gL~y 449 (511)
|+||||+++|+|.+++.. ...+++..++.++.||+.||.|
T Consensus 104 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~ 183 (345)
T 3hko_A 104 CLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHY 183 (345)
T ss_dssp EEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHH
Confidence 999999999999998841 1124677888999999999999
Q ss_pred HHHCCccccCCCCCceEEcCCC--cEEEEecCCceecccCCC----ccccccCCCccccHHhhcc
Q 010401 450 LNDHGVAYRDLNSQRILLDRHG--NVCLGDMGIVTACKSVGE----ATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 450 LH~~gIIHRDLKp~NILld~~g--~vKL~DFGlS~~l~~~~~----~~~~~~Gt~~YmAPEvl~g 508 (511)
||++||+||||||+|||++.++ .+||+|||+++.+..... ......||+.|+|||++.+
T Consensus 184 LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 248 (345)
T 3hko_A 184 LHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNT 248 (345)
T ss_dssp HHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTC
T ss_pred HHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhcc
Confidence 9999999999999999998766 899999999987643222 2345578999999999864
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=99.95 E-value=2.1e-28 Score=256.96 Aligned_cols=167 Identities=19% Similarity=0.282 Sum_probs=133.7
Q ss_pred CCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCC------chHHHHHHHHHHHHHhCCCCceeeEeeeEeeCC
Q 010401 339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKG------NAYEFELRKDLLELMTCGHKNILQFYCVCVDEN 406 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~------~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~ 406 (511)
.++|++.+.||+|+||.||++ +.||+|++...... ......+.+|+.++++++||||+++++++..+
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~- 212 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE- 212 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEESS-
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEecC-
Confidence 468999999999999999996 57999999753211 11122478999999999999999999998543
Q ss_pred CcEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCC---cEEEEecCCcee
Q 010401 407 HGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG---NVCLGDMGIVTA 483 (511)
Q Consensus 407 ~~l~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g---~vKL~DFGlS~~ 483 (511)
. +|+||||+.+|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.
T Consensus 213 ~-~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~ 291 (419)
T 3i6u_A 213 D-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 291 (419)
T ss_dssp E-EEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTS
T ss_pred c-eEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeeccccee
Confidence 3 899999999999999987778899999999999999999999999999999999999997544 599999999987
Q ss_pred cccCCCccccccCCCccccHHhhcc
Q 010401 484 CKSVGEATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 484 l~~~~~~~~~~~Gt~~YmAPEvl~g 508 (511)
.... ......+||+.|+|||++.+
T Consensus 292 ~~~~-~~~~~~~gt~~y~aPE~~~~ 315 (419)
T 3i6u_A 292 LGET-SLMRTLCGTPTYLAPEVLVS 315 (419)
T ss_dssp CC------------CTTCCTTTTC-
T ss_pred cCCC-ccccccCCCCCccCceeeec
Confidence 6542 23445679999999999854
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=99.95 E-value=7e-28 Score=235.34 Aligned_cols=162 Identities=22% Similarity=0.367 Sum_probs=139.2
Q ss_pred CCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeC--------
Q 010401 340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDE-------- 405 (511)
Q Consensus 340 ~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~-------- 405 (511)
++|++.+.||+|+||.||++ +.||+|++.... ..+.+|+.++..++||||+++++++...
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 46899999999999999996 479999997432 2457899999999999999999988641
Q ss_pred -------CCcEEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEE
Q 010401 406 -------NHGLCVVTKLMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLG 476 (511)
Q Consensus 406 -------~~~l~LVmEy~~gGsL~~lL~~~--~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~ 476 (511)
...+|+||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~ 164 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIG 164 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEEC
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEEC
Confidence 22389999999999999999643 579999999999999999999999999999999999999999999999
Q ss_pred ecCCceecccCCCccccccCCCccccHHhhcc
Q 010401 477 DMGIVTACKSVGEATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 477 DFGlS~~l~~~~~~~~~~~Gt~~YmAPEvl~g 508 (511)
|||++....... ......|++.|+|||++.+
T Consensus 165 Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~ 195 (284)
T 2a19_B 165 DFGLVTSLKNDG-KRTRSKGTLRYMSPEQISS 195 (284)
T ss_dssp CCTTCEESSCCS-CCCCCCSCCTTSCHHHHHC
T ss_pred cchhheeccccc-cccccCCcccccChhhhcc
Confidence 999998765433 2345578999999999865
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=2.4e-27 Score=237.63 Aligned_cols=163 Identities=15% Similarity=0.273 Sum_probs=139.7
Q ss_pred ecCCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCC-CCceeeEeeeEeeC-CCc
Q 010401 337 LNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCG-HKNILQFYCVCVDE-NHG 408 (511)
Q Consensus 337 l~~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~-HpNIV~l~g~~~~~-~~~ 408 (511)
...++|++.+.||+|+||.||++ +.||+|++... ....+.+|+.++..+. ||||+++++++.+. ...
T Consensus 33 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~ 107 (330)
T 3nsz_A 33 GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-----KKKKIKREIKILENLRGGPNIITLADIVKDPVSRT 107 (330)
T ss_dssp EEGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCC
T ss_pred cCCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc-----chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCc
Confidence 34678999999999999999996 47999999632 1356789999999996 99999999999873 233
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCC-cEEEEecCCceecccC
Q 010401 409 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG-NVCLGDMGIVTACKSV 487 (511)
Q Consensus 409 l~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g-~vKL~DFGlS~~l~~~ 487 (511)
.++||||+.+++|.+++. .+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.....
T Consensus 108 ~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~ 184 (330)
T 3nsz_A 108 PALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 184 (330)
T ss_dssp EEEEEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred eEEEEeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC
Confidence 899999999999999874 489999999999999999999999999999999999999776 8999999999876543
Q ss_pred CCccccccCCCccccHHhhcc
Q 010401 488 GEATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 488 ~~~~~~~~Gt~~YmAPEvl~g 508 (511)
. ......|+..|+|||++.+
T Consensus 185 ~-~~~~~~~~~~y~aPE~~~~ 204 (330)
T 3nsz_A 185 Q-EYNVRVASRYFKGPELLVD 204 (330)
T ss_dssp C-CCCSCCSCGGGCCHHHHTT
T ss_pred C-ccccccccccccChhhhcC
Confidence 2 3445678899999999865
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=99.95 E-value=1.1e-28 Score=254.42 Aligned_cols=167 Identities=10% Similarity=0.059 Sum_probs=134.8
Q ss_pred cCCCeEEEeeeecccceEEEEe------EEEEEEEEecCCC-CchHHHHHHHHH---HHHHhCCCCceeeEe-------e
Q 010401 338 NSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDK-GNAYEFELRKDL---LELMTCGHKNILQFY-------C 400 (511)
Q Consensus 338 ~~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~-~~~~~~~~~~Ei---~iL~~l~HpNIV~l~-------g 400 (511)
..++|++.+.||+|+||.||+| +.||||++..... .......+.+|+ ..+..++||||++++ +
T Consensus 71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~ 150 (377)
T 3byv_A 71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 150 (377)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence 3567999999999999999995 4799999975432 233456688999 455566899999998 6
Q ss_pred eEeeCCC----------------cEEEEEeccCCCCHHHHHHhcCCCCH-------HHHHHHHHHHHHHHHHHHHCCccc
Q 010401 401 VCVDENH----------------GLCVVTKLMEGGSVNDLILKSRKLQT-------KEIIRIAIDVAEGIKFLNDHGVAY 457 (511)
Q Consensus 401 ~~~~~~~----------------~l~LVmEy~~gGsL~~lL~~~~~L~e-------~~~~~ia~qIa~gL~yLH~~gIIH 457 (511)
++.+.+. ..|+||||+ +|+|.+++...+.+++ ..++.++.||+.||+|||++||+|
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH 229 (377)
T 3byv_A 151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVH 229 (377)
T ss_dssp EEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred hhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 6554432 278999999 5799999976554555 788889999999999999999999
Q ss_pred cCCCCCceEEcCCCcEEEEecCCceecccCCCccccccCCCccccHHhhccc
Q 010401 458 RDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEVCFLL 509 (511)
Q Consensus 458 RDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~~~~~Gt~~YmAPEvl~gl 509 (511)
|||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+.
T Consensus 230 rDikp~NIll~~~~~~kL~DFG~a~~~~~---~~~~~~g-~~y~aPE~~~~~ 277 (377)
T 3byv_A 230 TYLRPVDIVLDQRGGVFLTGFEHLVRDGA---RVVSSVS-RGFEPPELEARR 277 (377)
T ss_dssp SCCCGGGEEECTTCCEEECCGGGCEETTC---EEECCCC-TTCCCHHHHHHH
T ss_pred CCCCHHHEEEcCCCCEEEEechhheecCC---cccCCCC-cCccChhhhccc
Confidence 99999999999999999999999986432 2445567 999999998753
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.2e-27 Score=235.27 Aligned_cols=165 Identities=24% Similarity=0.427 Sum_probs=140.2
Q ss_pred ecCCCeEEEeeeecccceEEEEeE------EEEEEEEecCCCCchHH-----HHHHHHHHHHHhCCCCceeeEeeeEeeC
Q 010401 337 LNSDNLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDKGNAYE-----FELRKDLLELMTCGHKNILQFYCVCVDE 405 (511)
Q Consensus 337 l~~~~y~l~~~LG~GsFG~VYkgk------~VAVKkL~~~~~~~~~~-----~~~~~Ei~iL~~l~HpNIV~l~g~~~~~ 405 (511)
+..++|++.+.||+|+||.||+++ .||+|++.......... ..+.+|+.++..++||||+++++++.+.
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 95 (287)
T 4f0f_A 16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP 95 (287)
T ss_dssp CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT
T ss_pred hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC
Confidence 456889999999999999999964 69999987543332222 5688999999999999999999998654
Q ss_pred CCcEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCceEEcCCCc-----EEEEe
Q 010401 406 NHGLCVVTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHG--VAYRDLNSQRILLDRHGN-----VCLGD 477 (511)
Q Consensus 406 ~~~l~LVmEy~~gGsL~~lL~~~-~~L~e~~~~~ia~qIa~gL~yLH~~g--IIHRDLKp~NILld~~g~-----vKL~D 477 (511)
.++||||+.+|+|.+++... ..+++..++.++.||+.||.|||++| |+||||||+|||++.++. +||+|
T Consensus 96 ---~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 96 ---PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp ---TEEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred ---CeEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 36999999999999988644 57999999999999999999999999 999999999999988776 99999
Q ss_pred cCCceecccCCCccccccCCCccccHHhhc
Q 010401 478 MGIVTACKSVGEATEYETDGYRWLAPEVCF 507 (511)
Q Consensus 478 FGlS~~l~~~~~~~~~~~Gt~~YmAPEvl~ 507 (511)
||+++.... ......||+.|+|||++.
T Consensus 173 fg~~~~~~~---~~~~~~g~~~y~aPE~~~ 199 (287)
T 4f0f_A 173 FGLSQQSVH---SVSGLLGNFQWMAPETIG 199 (287)
T ss_dssp CTTCBCCSS---CEECCCCCCTTSCGGGSS
T ss_pred CCccccccc---cccccCCCccccCchhhc
Confidence 999875433 244567899999999984
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.2e-27 Score=237.45 Aligned_cols=165 Identities=25% Similarity=0.383 Sum_probs=140.3
Q ss_pred EEEeeeecccceEEEEe----EEEEEEEEecCCC--CchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEEecc
Q 010401 343 EFIDQIGPNSFKGVYKG----KRVGIEKLKGCDK--GNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLM 416 (511)
Q Consensus 343 ~l~~~LG~GsFG~VYkg----k~VAVKkL~~~~~--~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVmEy~ 416 (511)
...+.||+|+||.||+| +.||+|++..... .......+.+|+.++..++||||+++++++.+.+. +|+||||+
T Consensus 34 ~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~-~~lv~e~~ 112 (307)
T 2nru_A 34 VGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDD-LCLVYVYM 112 (307)
T ss_dssp TTCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS-CEEEEECC
T ss_pred ccCCccccCCCeEEEEEEECCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCc-eEEEEEec
Confidence 34588999999999996 4799999975322 23345668999999999999999999999988776 89999999
Q ss_pred CCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCC--cc
Q 010401 417 EGGSVNDLILK---SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE--AT 491 (511)
Q Consensus 417 ~gGsL~~lL~~---~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~--~~ 491 (511)
++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++....... ..
T Consensus 113 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 192 (307)
T 2nru_A 113 PNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMT 192 (307)
T ss_dssp TTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEEC
T ss_pred CCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccccccccccc
Confidence 99999999963 34699999999999999999999999999999999999999999999999999987654322 12
Q ss_pred ccccCCCccccHHhhcc
Q 010401 492 EYETDGYRWLAPEVCFL 508 (511)
Q Consensus 492 ~~~~Gt~~YmAPEvl~g 508 (511)
....|++.|+|||++.+
T Consensus 193 ~~~~g~~~y~aPE~~~~ 209 (307)
T 2nru_A 193 SRIVGTTAYMAPEALRG 209 (307)
T ss_dssp SSCCSCGGGCCHHHHTT
T ss_pred cccCCCcCcCChHHhcC
Confidence 34578999999998764
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=1.4e-27 Score=244.61 Aligned_cols=167 Identities=19% Similarity=0.316 Sum_probs=142.1
Q ss_pred CCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCC----Cc
Q 010401 339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN----HG 408 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~----~~ 408 (511)
.++|++++.||+|+||.||++ +.||+|++... ........+.+|+.++..++||||+++++++.... ..
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF-EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCT-TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccc-cCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 468999999999999999996 47999999742 23344566889999999999999999999997653 34
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCC
Q 010401 409 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG 488 (511)
Q Consensus 409 l~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~ 488 (511)
+|+||||+.+ +|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 105 ~~iv~e~~~~-~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 182 (364)
T 3qyz_A 105 VYIVQDLMET-DLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 182 (364)
T ss_dssp EEEEEECCSE-EHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred EEEEEcccCc-CHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCCC
Confidence 8999999975 99999854 569999999999999999999999999999999999999999999999999998765432
Q ss_pred Cc---cccccCCCccccHHhhcc
Q 010401 489 EA---TEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 489 ~~---~~~~~Gt~~YmAPEvl~g 508 (511)
.. .....||+.|+|||++.+
T Consensus 183 ~~~~~~~~~~gt~~y~aPE~~~~ 205 (364)
T 3qyz_A 183 DHTGFLTEYVATRWYRAPEIMLN 205 (364)
T ss_dssp CBCCTTCCCCSCGGGCCHHHHHT
T ss_pred CccccccccccccCCCCCHHhcC
Confidence 21 234578999999998754
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.8e-27 Score=239.62 Aligned_cols=170 Identities=22% Similarity=0.415 Sum_probs=142.9
Q ss_pred ecCCCeEEEeeeecccceEEEEeE----------EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCC
Q 010401 337 LNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN 406 (511)
Q Consensus 337 l~~~~y~l~~~LG~GsFG~VYkgk----------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~ 406 (511)
+..++|++++.||+|+||.||+++ .||+|++.. ........+.+|+.+++.++||||+++++++...+
T Consensus 38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 115 (326)
T 2w1i_A 38 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH--STEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG 115 (326)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESS--CCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC--
T ss_pred cCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEecc--CCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecC
Confidence 456678999999999999999864 699999974 33444566899999999999999999999987654
Q ss_pred -CcEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceec
Q 010401 407 -HGLCVVTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC 484 (511)
Q Consensus 407 -~~l~LVmEy~~gGsL~~lL~~~-~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l 484 (511)
..+++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 116 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~ 195 (326)
T 2w1i_A 116 RRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVL 195 (326)
T ss_dssp --CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred CCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhhc
Confidence 2389999999999999999765 46999999999999999999999999999999999999999999999999999877
Q ss_pred ccCCCc---cccccCCCccccHHhhcc
Q 010401 485 KSVGEA---TEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 485 ~~~~~~---~~~~~Gt~~YmAPEvl~g 508 (511)
...... .....++..|+|||++.+
T Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~ 222 (326)
T 2w1i_A 196 PQDKEYYKVKEPGESPIFWYAPESLTE 222 (326)
T ss_dssp CSSCSEEECSSCCSCCGGGCCHHHHHH
T ss_pred cccccccccccCCCCceeEECchhhcC
Confidence 543321 223456778999999864
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.2e-27 Score=247.15 Aligned_cols=166 Identities=17% Similarity=0.223 Sum_probs=135.5
Q ss_pred EecCCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCC---
Q 010401 336 LLNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN--- 406 (511)
Q Consensus 336 ~l~~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~--- 406 (511)
....++|++.+.||+|+||.||++ +.||+|++...... ..+|+.+++.++||||++++++|....
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~------~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 76 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY------KNRELDIMKVLDHVNIIKLVDYFYTTGDEE 76 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS------CCHHHHHHTTCCCTTBCCEEEEEEEC----
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch------HHHHHHHHHHcCCCCccchhheeeecCccc
Confidence 345678999999999999999996 47999999743221 236899999999999999999985432
Q ss_pred ----------------------------------CcEEEEEeccCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHH
Q 010401 407 ----------------------------------HGLCVVTKLMEGGSVNDLIL----KSRKLQTKEIIRIAIDVAEGIK 448 (511)
Q Consensus 407 ----------------------------------~~l~LVmEy~~gGsL~~lL~----~~~~L~e~~~~~ia~qIa~gL~ 448 (511)
..+++||||+++ +|.+.+. ....+++..++.++.||+.||.
T Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~ 155 (383)
T 3eb0_A 77 PKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVG 155 (383)
T ss_dssp ---------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence 228899999985 8777764 3468999999999999999999
Q ss_pred HHHHCCccccCCCCCceEEc-CCCcEEEEecCCceecccCCCccccccCCCccccHHhhccc
Q 010401 449 FLNDHGVAYRDLNSQRILLD-RHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEVCFLL 509 (511)
Q Consensus 449 yLH~~gIIHRDLKp~NILld-~~g~vKL~DFGlS~~l~~~~~~~~~~~Gt~~YmAPEvl~gl 509 (511)
|||++||+||||||+|||++ .++.+||+|||+++...... ......||+.|+|||++.+.
T Consensus 156 ~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~ 216 (383)
T 3eb0_A 156 FIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE-PSVAYICSRFYRAPELMLGA 216 (383)
T ss_dssp HHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS-CCCCCCCCSSCCCHHHHTTC
T ss_pred HHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC-CCcCcccCCCccCHHHhcCC
Confidence 99999999999999999998 68999999999998765433 34455789999999998753
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=99.95 E-value=7.8e-28 Score=236.20 Aligned_cols=172 Identities=25% Similarity=0.402 Sum_probs=136.1
Q ss_pred eEecCCCeEEEeeeecccceEEEEeE---------EEEEEEEecCCC-CchHHHHHHHHHHHHHhCCCCceeeEeeeEee
Q 010401 335 WLLNSDNLEFIDQIGPNSFKGVYKGK---------RVGIEKLKGCDK-GNAYEFELRKDLLELMTCGHKNILQFYCVCVD 404 (511)
Q Consensus 335 ~~l~~~~y~l~~~LG~GsFG~VYkgk---------~VAVKkL~~~~~-~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~ 404 (511)
..+..++|++.+.||+|+||.||+++ .||+|+++.... .......+.+|+.++..++||||+++++++.+
T Consensus 13 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 92 (291)
T 1u46_A 13 CLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT 92 (291)
T ss_dssp EECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcc
Confidence 44667889999999999999999975 489998875332 23345668999999999999999999999986
Q ss_pred CCCcEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCcee
Q 010401 405 ENHGLCVVTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTA 483 (511)
Q Consensus 405 ~~~~l~LVmEy~~gGsL~~lL~~~-~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~ 483 (511)
.+ .++||||+.+++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++.
T Consensus 93 ~~--~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 93 PP--MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRA 170 (291)
T ss_dssp SS--CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred CC--ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEcccccccc
Confidence 54 78999999999999999654 5799999999999999999999999999999999999999999999999999987
Q ss_pred cccCCC---ccccccCCCccccHHhhcc
Q 010401 484 CKSVGE---ATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 484 l~~~~~---~~~~~~Gt~~YmAPEvl~g 508 (511)
...... ......+++.|+|||++.+
T Consensus 171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 198 (291)
T 1u46_A 171 LPQNDDHYVMQEHRKVPFAWCAPESLKT 198 (291)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHH
T ss_pred ccccccchhhhccCCCCceeeCchhhcC
Confidence 654332 1233456788999999864
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=99.95 E-value=6.2e-28 Score=252.12 Aligned_cols=162 Identities=19% Similarity=0.276 Sum_probs=128.6
Q ss_pred CCCeEEE-eeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHH-hCCCCceeeEeeeEee---CCC
Q 010401 339 SDNLEFI-DQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELM-TCGHKNILQFYCVCVD---ENH 407 (511)
Q Consensus 339 ~~~y~l~-~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~-~l~HpNIV~l~g~~~~---~~~ 407 (511)
.++|.+. +.||+|+||.||++ +.||+|++... ..+.+|+.++. ..+||||+++++++.. +..
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~ 132 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK 132 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCc
Confidence 3466776 78999999999996 46999999631 34567777764 4589999999998865 233
Q ss_pred cEEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcC---CCcEEEEecCCce
Q 010401 408 GLCVVTKLMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDR---HGNVCLGDMGIVT 482 (511)
Q Consensus 408 ~l~LVmEy~~gGsL~~lL~~~--~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~---~g~vKL~DFGlS~ 482 (511)
.+||||||+.+|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++
T Consensus 133 ~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~ 212 (400)
T 1nxk_A 133 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 212 (400)
T ss_dssp EEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEeccccc
Confidence 489999999999999999754 36999999999999999999999999999999999999997 7899999999998
Q ss_pred ecccCCCccccccCCCccccHHhhcc
Q 010401 483 ACKSVGEATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 483 ~l~~~~~~~~~~~Gt~~YmAPEvl~g 508 (511)
..... ......+||+.|+|||++.+
T Consensus 213 ~~~~~-~~~~~~~gt~~y~aPE~~~~ 237 (400)
T 1nxk_A 213 ETTSH-NSLTTPCYTPYYVAPEVLGP 237 (400)
T ss_dssp ECC------------CTTCCGGGSCC
T ss_pred ccCCC-CccccCCCCCCccCHhhcCC
Confidence 76432 22456688999999999854
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=4.8e-28 Score=243.03 Aligned_cols=165 Identities=19% Similarity=0.304 Sum_probs=137.7
Q ss_pred CCeEEEeeeecccceEEEEe------EEEEEEEEecCCCC------chHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCC
Q 010401 340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKG------NAYEFELRKDLLELMTCGHKNILQFYCVCVDENH 407 (511)
Q Consensus 340 ~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~------~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~ 407 (511)
++|++.+.||+|+||.||++ +.||+|++...... ......+.+|+.++..++||||+++++++..++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 88 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED- 88 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-
Confidence 56899999999999999996 57999999643211 112234789999999999999999999987543
Q ss_pred cEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCc---EEEEecCCceec
Q 010401 408 GLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGN---VCLGDMGIVTAC 484 (511)
Q Consensus 408 ~l~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~---vKL~DFGlS~~l 484 (511)
+|+||||+.+++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++..
T Consensus 89 -~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 167 (322)
T 2ycf_A 89 -YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 167 (322)
T ss_dssp -EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEEC
T ss_pred -eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceec
Confidence 8999999999999999987788999999999999999999999999999999999999987664 999999999876
Q ss_pred ccCCCccccccCCCccccHHhhc
Q 010401 485 KSVGEATEYETDGYRWLAPEVCF 507 (511)
Q Consensus 485 ~~~~~~~~~~~Gt~~YmAPEvl~ 507 (511)
... .......||+.|+|||++.
T Consensus 168 ~~~-~~~~~~~gt~~y~aPE~~~ 189 (322)
T 2ycf_A 168 GET-SLMRTLCGTPTYLAPEVLV 189 (322)
T ss_dssp CCC-HHHHHHHSCCTTCCHHHHH
T ss_pred ccc-cccccccCCcCccCchhhc
Confidence 432 2233457899999999974
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=5.9e-29 Score=247.81 Aligned_cols=175 Identities=22% Similarity=0.458 Sum_probs=144.5
Q ss_pred ccceEecCCCeEEEeeeecccceEEEEeE---EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCc
Q 010401 332 IGRWLLNSDNLEFIDQIGPNSFKGVYKGK---RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHG 408 (511)
Q Consensus 332 i~~~~l~~~~y~l~~~LG~GsFG~VYkgk---~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~ 408 (511)
...|.+..++|++.+.||+|+||.||+|+ .+++|+++...........+.+|+.++..++||||+++++++.+.+.
T Consensus 25 ~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~- 103 (319)
T 2y4i_B 25 LQEWDIPFEQLEIGELIGKGRFGQVYHGRWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPH- 103 (319)
T ss_dssp GGGSSSCCSCEECCCBCCCSSSSEEEEEEESSSEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSC-
T ss_pred cccccCCHHHeEEeeEeccCCceEEEEEEEcCeEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCc-
Confidence 34777889999999999999999999985 58999987543333333456789999999999999999999998776
Q ss_pred EEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccC
Q 010401 409 LCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV 487 (511)
Q Consensus 409 l~LVmEy~~gGsL~~lL~~~~-~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~ 487 (511)
+++||||+.+++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++.....
T Consensus 104 ~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~ 182 (319)
T 2y4i_B 104 LAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVL 182 (319)
T ss_dssp EEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC-----
T ss_pred eEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCccccccc
Confidence 999999999999999996544 799999999999999999999999999999999999998 789999999998754321
Q ss_pred -----CCccccccCCCccccHHhhcc
Q 010401 488 -----GEATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 488 -----~~~~~~~~Gt~~YmAPEvl~g 508 (511)
........|++.|+|||++.+
T Consensus 183 ~~~~~~~~~~~~~g~~~y~aPE~~~~ 208 (319)
T 2y4i_B 183 QAGRREDKLRIQNGWLCHLAPEIIRQ 208 (319)
T ss_dssp -----CCSCBCCSGGGGTSCHHHHSC
T ss_pred cccccccccccCCCcccccChHHhhh
Confidence 122334568899999999875
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=99.95 E-value=5.2e-28 Score=249.98 Aligned_cols=165 Identities=18% Similarity=0.303 Sum_probs=125.5
Q ss_pred CCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCC-----C
Q 010401 339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN-----H 407 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~-----~ 407 (511)
.++|++++.||+|+||.||++ +.||+|++...........++.+|+.+++.++||||+++++++.... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 478999999999999999996 57999999754444445667889999999999999999999987541 2
Q ss_pred cEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccC
Q 010401 408 GLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV 487 (511)
Q Consensus 408 ~l~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~ 487 (511)
.+|+||||+ +++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~ 185 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE 185 (367)
T ss_dssp CCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC----------
T ss_pred eEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeecccccccccc
Confidence 379999999 6799998854 67999999999999999999999999999999999999999999999999999865432
Q ss_pred CCccccccCCCccccHHhhcc
Q 010401 488 GEATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 488 ~~~~~~~~Gt~~YmAPEvl~g 508 (511)
.....||+.|+|||++.+
T Consensus 186 ---~~~~~~t~~y~aPE~~~~ 203 (367)
T 2fst_X 186 ---MTGYVATRWYRAPEIMLN 203 (367)
T ss_dssp --------CCCTTCCHHHHTT
T ss_pred ---CCCcCcCcCccChHHHcC
Confidence 345678999999999875
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.9e-28 Score=268.41 Aligned_cols=159 Identities=11% Similarity=0.076 Sum_probs=125.3
Q ss_pred eeeecccceEEEE------eEEEEEEEEecCCCC--------chHHHHHHHHHHHHHhC-CCCceeeEeeeEeeCCCcEE
Q 010401 346 DQIGPNSFKGVYK------GKRVGIEKLKGCDKG--------NAYEFELRKDLLELMTC-GHKNILQFYCVCVDENHGLC 410 (511)
Q Consensus 346 ~~LG~GsFG~VYk------gk~VAVKkL~~~~~~--------~~~~~~~~~Ei~iL~~l-~HpNIV~l~g~~~~~~~~l~ 410 (511)
..++.|++|.+.. |+.+++|.+...... .....++.+|+.+|+++ .|+||+++++++.+++. +|
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~-~y 318 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQS-GW 318 (569)
T ss_dssp CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSE-EE
T ss_pred hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCE-EE
Confidence 4566666665543 667899999753211 12234589999999999 79999999999998876 99
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCc
Q 010401 411 VVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA 490 (511)
Q Consensus 411 LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~ 490 (511)
|||||++|++|.++|...+++++. .|+.||+.||+|+|++|||||||||+|||++.+|.+||+|||+|+........
T Consensus 319 LVMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~ 395 (569)
T 4azs_A 319 LVMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSW 395 (569)
T ss_dssp EEEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---CC
T ss_pred EEEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCcc
Confidence 999999999999999888888765 47899999999999999999999999999999999999999999987665555
Q ss_pred cccccCCCccccHHhhcc
Q 010401 491 TEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 491 ~~~~~Gt~~YmAPEvl~g 508 (511)
....+||+.|||||++.+
T Consensus 396 ~~t~vGTp~YmAPE~l~g 413 (569)
T 4azs_A 396 PTNLVQSFFVFVNELFAE 413 (569)
T ss_dssp SHHHHHHHHHHHHHHC--
T ss_pred ccCceechhhccHHHhCC
Confidence 666789999999999875
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.2e-27 Score=239.44 Aligned_cols=162 Identities=22% Similarity=0.449 Sum_probs=132.7
Q ss_pred ecCCCeEEEeeeecccceEEEEe----EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEE
Q 010401 337 LNSDNLEFIDQIGPNSFKGVYKG----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV 412 (511)
Q Consensus 337 l~~~~y~l~~~LG~GsFG~VYkg----k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LV 412 (511)
++.++|++.+.||+|+||.||++ +.||+|++.. ......+.+|+.++.+++||||+++++++.+ . .|+|
T Consensus 5 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~----~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~-~~lv 77 (307)
T 2eva_A 5 IDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIES----ESERKAFIVELRQLSRVNHPNIVKLYGACLN--P-VCLV 77 (307)
T ss_dssp CCGGGEEEEEEEECCSSSEEEEEEETTEEEEEEECSS----TTHHHHHHHHHHHHHHCCCTTBCCEEEBCTT--T-TEEE
T ss_pred CCHhHeeeeeEeecCCCceEEEEEECCeeEEEEEecC----hhHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--C-cEEE
Confidence 45678999999999999999996 5799999853 2234568899999999999999999998873 2 7899
Q ss_pred EeccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCCCceEEcCCCc-EEEEecCCceecc
Q 010401 413 TKLMEGGSVNDLILKSR---KLQTKEIIRIAIDVAEGIKFLND---HGVAYRDLNSQRILLDRHGN-VCLGDMGIVTACK 485 (511)
Q Consensus 413 mEy~~gGsL~~lL~~~~---~L~e~~~~~ia~qIa~gL~yLH~---~gIIHRDLKp~NILld~~g~-vKL~DFGlS~~l~ 485 (511)
|||+++|+|.+++.... .+++..++.++.||+.||.|||+ +||+||||||+|||++.++. +||+|||++....
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~ 157 (307)
T 2eva_A 78 MEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ 157 (307)
T ss_dssp EECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-----
T ss_pred EEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccc
Confidence 99999999999997554 47889999999999999999999 89999999999999998886 7999999987654
Q ss_pred cCCCccccccCCCccccHHhhcc
Q 010401 486 SVGEATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 486 ~~~~~~~~~~Gt~~YmAPEvl~g 508 (511)
.. .....||+.|+|||++.+
T Consensus 158 ~~---~~~~~gt~~y~aPE~~~~ 177 (307)
T 2eva_A 158 TH---MTNNKGSAAWMAPEVFEG 177 (307)
T ss_dssp ----------CCTTSSCHHHHTC
T ss_pred cc---cccCCCCCceEChhhhCC
Confidence 32 334568999999999865
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.1e-27 Score=236.32 Aligned_cols=167 Identities=22% Similarity=0.385 Sum_probs=143.8
Q ss_pred CCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEE
Q 010401 340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT 413 (511)
Q Consensus 340 ~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVm 413 (511)
++|++.+.||+|+||.||++ +.||+|++............+.+|+.++++++||||+++++++.+.+. +|+||
T Consensus 22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~lv~ 100 (287)
T 2wei_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSS-FYIVG 100 (287)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE-EEEEE
T ss_pred hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCe-EEEEE
Confidence 56899999999999999996 479999997544444445678899999999999999999999987765 99999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCC---CcEEEEecCCceecccCCCc
Q 010401 414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRH---GNVCLGDMGIVTACKSVGEA 490 (511)
Q Consensus 414 Ey~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~---g~vKL~DFGlS~~l~~~~~~ 490 (511)
||+.+++|.+++.....+++..++.++.||+.||.|||++||+||||||+||+++.+ +.+||+|||++....... .
T Consensus 101 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~-~ 179 (287)
T 2wei_A 101 ELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT-K 179 (287)
T ss_dssp CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCS-S
T ss_pred EccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCC-c
Confidence 999999999999877889999999999999999999999999999999999999754 479999999987654332 2
Q ss_pred cccccCCCccccHHhhcc
Q 010401 491 TEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 491 ~~~~~Gt~~YmAPEvl~g 508 (511)
.....|++.|+|||++.+
T Consensus 180 ~~~~~~~~~y~aPE~~~~ 197 (287)
T 2wei_A 180 MKDRIGTAYYIAPEVLRG 197 (287)
T ss_dssp CSCHHHHHTTCCHHHHTT
T ss_pred cccccCcccccChHHhcC
Confidence 334457889999999865
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=8e-28 Score=244.66 Aligned_cols=171 Identities=13% Similarity=0.173 Sum_probs=134.4
Q ss_pred cCCCeEEEeeeecccceEEEEeE---------EEEEEEEecCCCCchHH---------HHHHHHHHHHHhCCCCceeeEe
Q 010401 338 NSDNLEFIDQIGPNSFKGVYKGK---------RVGIEKLKGCDKGNAYE---------FELRKDLLELMTCGHKNILQFY 399 (511)
Q Consensus 338 ~~~~y~l~~~LG~GsFG~VYkgk---------~VAVKkL~~~~~~~~~~---------~~~~~Ei~iL~~l~HpNIV~l~ 399 (511)
..++|++.+.||+|+||.||+++ .+|+|++.........+ ..+.+|+..+..++||||++++
T Consensus 35 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~ 114 (345)
T 2v62_A 35 EGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFY 114 (345)
T ss_dssp TSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEE
T ss_pred cCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceee
Confidence 45789999999999999999975 48899887532211111 1255677888889999999999
Q ss_pred eeEeeC---CCcEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCC--cEE
Q 010401 400 CVCVDE---NHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG--NVC 474 (511)
Q Consensus 400 g~~~~~---~~~l~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g--~vK 474 (511)
+++.+. +..+|+||||+ +++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+|
T Consensus 115 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~k 193 (345)
T 2v62_A 115 GSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVY 193 (345)
T ss_dssp EEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEE
T ss_pred cccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEE
Confidence 999872 33489999999 899999997777899999999999999999999999999999999999999877 999
Q ss_pred EEecCCceecccCCC-------ccccccCCCccccHHhhccc
Q 010401 475 LGDMGIVTACKSVGE-------ATEYETDGYRWLAPEVCFLL 509 (511)
Q Consensus 475 L~DFGlS~~l~~~~~-------~~~~~~Gt~~YmAPEvl~gl 509 (511)
|+|||+++.+..... ......||+.|+|||++.+.
T Consensus 194 L~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 235 (345)
T 2v62_A 194 LADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGV 235 (345)
T ss_dssp ECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTC
T ss_pred EEeCCCceecccccccccchhccccccCCCccccCHHHhcCC
Confidence 999999987643221 11445789999999998753
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.2e-27 Score=238.90 Aligned_cols=167 Identities=17% Similarity=0.304 Sum_probs=139.1
Q ss_pred CCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCC----Cc
Q 010401 339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN----HG 408 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~----~~ 408 (511)
.++|++.+.||+|+||.||++ +.||+|++... ........+.+|+.++..++||||+++++++.... ..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF-DKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc-ccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 578999999999999999996 47999999642 33334556789999999999999999999887542 34
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCC
Q 010401 409 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG 488 (511)
Q Consensus 409 l~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~ 488 (511)
.|+||||+. ++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 89 ~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 166 (353)
T 2b9h_A 89 VYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESA 166 (353)
T ss_dssp EEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred EEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEeccccccccccc
Confidence 899999997 499999855 579999999999999999999999999999999999999999999999999998764322
Q ss_pred Cc----------cccccCCCccccHHhhcc
Q 010401 489 EA----------TEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 489 ~~----------~~~~~Gt~~YmAPEvl~g 508 (511)
.. .....||+.|+|||++.+
T Consensus 167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 196 (353)
T 2b9h_A 167 ADNSEPTGQQSGMVEFVATRWYRAPEVMLT 196 (353)
T ss_dssp -------------CCCCCCGGGCCHHHHHS
T ss_pred ccccCccccccchhhccccccccCCeeecc
Confidence 11 123468999999998754
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.9e-27 Score=236.03 Aligned_cols=172 Identities=16% Similarity=0.220 Sum_probs=142.6
Q ss_pred ceEecCCCeEEEeeeecccceEEEEe-----EEEEEEEEecCCCCchHHHHHHHHHHHHHhCC--CCceeeEeeeEeeCC
Q 010401 334 RWLLNSDNLEFIDQIGPNSFKGVYKG-----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCG--HKNILQFYCVCVDEN 406 (511)
Q Consensus 334 ~~~l~~~~y~l~~~LG~GsFG~VYkg-----k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~--HpNIV~l~g~~~~~~ 406 (511)
.+.+..++|++.+.||+|+||.||++ +.||+|++............+.+|+.++..++ ||||+++++++.+.+
T Consensus 22 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~ 101 (313)
T 3cek_A 22 SMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ 101 (313)
T ss_dssp EEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSS
T ss_pred eeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCC
Confidence 56677888999999999999999995 57999999765444555667899999999986 599999999998877
Q ss_pred CcEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceeccc
Q 010401 407 HGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS 486 (511)
Q Consensus 407 ~~l~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~ 486 (511)
. +|+||| +.+++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++....
T Consensus 102 ~-~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~~ 178 (313)
T 3cek_A 102 Y-IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 178 (313)
T ss_dssp E-EEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC---
T ss_pred E-EEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeeccccccccC
Confidence 5 999999 55779999998888899999999999999999999999999999999999996 58999999999987643
Q ss_pred CCC--ccccccCCCccccHHhhcc
Q 010401 487 VGE--ATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 487 ~~~--~~~~~~Gt~~YmAPEvl~g 508 (511)
... ......|++.|+|||++.+
T Consensus 179 ~~~~~~~~~~~gt~~y~aPE~~~~ 202 (313)
T 3cek_A 179 DTTSVVKDSQVGTVNYMPPEAIKD 202 (313)
T ss_dssp -----------CCGGGCCHHHHTT
T ss_pred ccccccccCCCCCCCcCCHHHHhh
Confidence 322 1234578999999999875
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=99.95 E-value=2.1e-27 Score=244.44 Aligned_cols=168 Identities=18% Similarity=0.311 Sum_probs=140.2
Q ss_pred ceEecCCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCC
Q 010401 334 RWLLNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENH 407 (511)
Q Consensus 334 ~~~l~~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~ 407 (511)
.|.+ .++|.+.+.||+|+||.||++ +.||+|++...........++.+|+.+++.++||||+++++++...+.
T Consensus 37 ~~~l-~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 115 (371)
T 4exu_A 37 AWEL-PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASS 115 (371)
T ss_dssp EEEE-ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSS
T ss_pred eecc-cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCC
Confidence 4544 478999999999999999996 579999997655555556778999999999999999999999987664
Q ss_pred c-----EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCce
Q 010401 408 G-----LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVT 482 (511)
Q Consensus 408 ~-----l~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~ 482 (511)
. +|+||||+. ++|.+++. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 116 ~~~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~ 192 (371)
T 4exu_A 116 LRNFYDFYLVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLAR 192 (371)
T ss_dssp STTCCCCEEEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC-
T ss_pred cccceeEEEEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCccc
Confidence 1 399999997 48888763 359999999999999999999999999999999999999999999999999988
Q ss_pred ecccCCCccccccCCCccccHHhhcc
Q 010401 483 ACKSVGEATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 483 ~l~~~~~~~~~~~Gt~~YmAPEvl~g 508 (511)
..... .....||+.|+|||++.+
T Consensus 193 ~~~~~---~~~~~~t~~y~aPE~~~~ 215 (371)
T 4exu_A 193 HADAE---MTGYVVTRWYRAPEVILS 215 (371)
T ss_dssp ----------CTTCCCTTSCHHHHSC
T ss_pred ccccC---cCCcccCccccCHHHhcC
Confidence 65432 345678999999999875
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.1e-27 Score=237.17 Aligned_cols=171 Identities=17% Similarity=0.274 Sum_probs=129.4
Q ss_pred ceEecCCCeEEEeeeecccceEEEEeE------EEEEEEEecCCCCchHHHHHHHHHHHHHhCC-CCceeeEeeeEee--
Q 010401 334 RWLLNSDNLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDKGNAYEFELRKDLLELMTCG-HKNILQFYCVCVD-- 404 (511)
Q Consensus 334 ~~~l~~~~y~l~~~LG~GsFG~VYkgk------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~-HpNIV~l~g~~~~-- 404 (511)
.+.+...+|++.+.||+|+||.||+++ .||+|++.. ........+.+|+.++..+. ||||+++++++..
T Consensus 22 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~ 99 (337)
T 3ll6_A 22 TVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLS--NEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGK 99 (337)
T ss_dssp EEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEE--SSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECT
T ss_pred eeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecC--CchHHHHHHHHHHHHHHHhccCCChhhccccccccc
Confidence 556777899999999999999999975 699999864 23344556889999999995 9999999999852
Q ss_pred -----CCCcEEEEEeccCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCceEEcCCCcEE
Q 010401 405 -----ENHGLCVVTKLMEGGSVNDLILK---SRKLQTKEIIRIAIDVAEGIKFLNDHG--VAYRDLNSQRILLDRHGNVC 474 (511)
Q Consensus 405 -----~~~~l~LVmEy~~gGsL~~lL~~---~~~L~e~~~~~ia~qIa~gL~yLH~~g--IIHRDLKp~NILld~~g~vK 474 (511)
....++++|||+. |+|.+++.. .+.+++..++.++.||+.||.|||++| |+||||||+|||++.++.+|
T Consensus 100 ~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~k 178 (337)
T 3ll6_A 100 EESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIK 178 (337)
T ss_dssp TTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEE
T ss_pred cccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEE
Confidence 2233899999996 599998854 457999999999999999999999999 99999999999999999999
Q ss_pred EEecCCceecccCCCc------------cccccCCCccccHHhhc
Q 010401 475 LGDMGIVTACKSVGEA------------TEYETDGYRWLAPEVCF 507 (511)
Q Consensus 475 L~DFGlS~~l~~~~~~------------~~~~~Gt~~YmAPEvl~ 507 (511)
|+|||+++........ .....||+.|+|||++.
T Consensus 179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~ 223 (337)
T 3ll6_A 179 LCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIID 223 (337)
T ss_dssp BCCCTTCBCCSSCC-------------------------------
T ss_pred EecCccceeccccCcccccccccccchhhccccCCCCcCChhhhh
Confidence 9999999876442211 11345889999999984
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=99.95 E-value=6.7e-27 Score=230.13 Aligned_cols=166 Identities=19% Similarity=0.242 Sum_probs=140.1
Q ss_pred CCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEE
Q 010401 339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV 412 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LV 412 (511)
.++|++.+.||+|+||.||++ +.||+|++...... .++.+|+.++..++|++++..++.+...+...++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC----CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch----hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEE
Confidence 578999999999999999996 47999998753322 24788999999999988887777776555558999
Q ss_pred EeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEE---cCCCcEEEEecCCceecccCC
Q 010401 413 TKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILL---DRHGNVCLGDMGIVTACKSVG 488 (511)
Q Consensus 413 mEy~~gGsL~~lL~~-~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILl---d~~g~vKL~DFGlS~~l~~~~ 488 (511)
|||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++......
T Consensus 84 ~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~ 162 (296)
T 3uzp_A 84 MELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 162 (296)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred EEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccc
Confidence 9999 8899999963 4579999999999999999999999999999999999999 488999999999998765433
Q ss_pred C-------ccccccCCCccccHHhhccc
Q 010401 489 E-------ATEYETDGYRWLAPEVCFLL 509 (511)
Q Consensus 489 ~-------~~~~~~Gt~~YmAPEvl~gl 509 (511)
. ......||+.|+|||++.+.
T Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 190 (296)
T 3uzp_A 163 THQHIPYRENKNLTGTARYASINTHLGI 190 (296)
T ss_dssp TCCBCCCCCSCCCCSCTTTCCHHHHTTC
T ss_pred cccccccccccccccccccCChhhhcCC
Confidence 2 12455789999999998753
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.4e-27 Score=237.31 Aligned_cols=164 Identities=26% Similarity=0.440 Sum_probs=139.7
Q ss_pred CCCeEEEeeeecccceEEEEe----EEEEEEEEecCCCCchHHHHHHHHHHHHHh--CCCCceeeEeeeEeeCCC---cE
Q 010401 339 SDNLEFIDQIGPNSFKGVYKG----KRVGIEKLKGCDKGNAYEFELRKDLLELMT--CGHKNILQFYCVCVDENH---GL 409 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkg----k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~--l~HpNIV~l~g~~~~~~~---~l 409 (511)
.++|++.+.||+|+||.||++ +.||+|++... ....+.+|+.++.. ++||||+++++++...+. .+
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~ 115 (342)
T 1b6c_B 41 ARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 115 (342)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEETTEEEEEEEECGG-----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCE
T ss_pred cccEEEEeeecCCCCcEEEEEEEcCccEEEEEeCch-----hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcccee
Confidence 357899999999999999996 57999998532 23456677777776 799999999999987761 48
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------HCCccccCCCCCceEEcCCCcEEEEecCCc
Q 010401 410 CVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN--------DHGVAYRDLNSQRILLDRHGNVCLGDMGIV 481 (511)
Q Consensus 410 ~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH--------~~gIIHRDLKp~NILld~~g~vKL~DFGlS 481 (511)
|+||||+.+|+|.+++.. ..+++..++.++.||+.||.||| ++||+||||||+|||++.++.+||+|||++
T Consensus 116 ~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~ 194 (342)
T 1b6c_B 116 WLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 194 (342)
T ss_dssp EEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred EEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECCCc
Confidence 999999999999999965 56999999999999999999999 899999999999999999999999999999
Q ss_pred eecccCCC----ccccccCCCccccHHhhcc
Q 010401 482 TACKSVGE----ATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 482 ~~l~~~~~----~~~~~~Gt~~YmAPEvl~g 508 (511)
+....... ......||+.|+|||++.+
T Consensus 195 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 225 (342)
T 1b6c_B 195 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDD 225 (342)
T ss_dssp EEEETTTTEEEECCCSCCCCGGGCCHHHHTS
T ss_pred eeccccccccccccccCCcCcccCCHhhhcc
Confidence 87654332 1244578999999999875
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.1e-27 Score=243.95 Aligned_cols=162 Identities=10% Similarity=0.145 Sum_probs=138.7
Q ss_pred CCCeEEEeeeecccceEEEEeE--------------EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceee-------
Q 010401 339 SDNLEFIDQIGPNSFKGVYKGK--------------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQ------- 397 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkgk--------------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~------- 397 (511)
.++|++.+.||+|+||.||+++ .||+|.+... ..+.+|+.++..++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~ 113 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKKLYS 113 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHHHTT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhhhcc
Confidence 4789999999999999999973 5899998742 24678999999999999987
Q ss_pred --------EeeeEeeCCCcEEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEE
Q 010401 398 --------FYCVCVDENHGLCVVTKLMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILL 467 (511)
Q Consensus 398 --------l~g~~~~~~~~l~LVmEy~~gGsL~~lL~~~--~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILl 467 (511)
+++++...+..+|+||||+ +++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 114 ~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~ 192 (352)
T 2jii_A 114 TPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFV 192 (352)
T ss_dssp CTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEE
T ss_pred CCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEE
Confidence 6777776555589999999 99999999765 689999999999999999999999999999999999999
Q ss_pred cCCC--cEEEEecCCceecccCCC-------ccccccCCCccccHHhhcc
Q 010401 468 DRHG--NVCLGDMGIVTACKSVGE-------ATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 468 d~~g--~vKL~DFGlS~~l~~~~~-------~~~~~~Gt~~YmAPEvl~g 508 (511)
+.++ .+||+|||+++.+..... ......||+.|+|||++.+
T Consensus 193 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 242 (352)
T 2jii_A 193 DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKG 242 (352)
T ss_dssp ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTT
T ss_pred cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHcc
Confidence 9998 999999999987653322 1233478999999999875
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.5e-27 Score=240.91 Aligned_cols=168 Identities=18% Similarity=0.306 Sum_probs=139.4
Q ss_pred CCeEEE-eeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhC-CCCceeeEeeeEeeCCCcEEE
Q 010401 340 DNLEFI-DQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCVCVDENHGLCV 411 (511)
Q Consensus 340 ~~y~l~-~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l-~HpNIV~l~g~~~~~~~~l~L 411 (511)
+.|.+. +.||+|+||.||++ +.||+|++............+.+|+.++..+ +||||+++++++.+.+. +|+
T Consensus 28 ~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~-~~l 106 (327)
T 3lm5_A 28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSE-IIL 106 (327)
T ss_dssp HHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE-EEE
T ss_pred hEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCe-EEE
Confidence 346666 89999999999995 5799999986544444566789999999988 56999999999987775 999
Q ss_pred EEeccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcC---CCcEEEEecCCceeccc
Q 010401 412 VTKLMEGGSVNDLILK--SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDR---HGNVCLGDMGIVTACKS 486 (511)
Q Consensus 412 VmEy~~gGsL~~lL~~--~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~---~g~vKL~DFGlS~~l~~ 486 (511)
||||+.+|+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++....
T Consensus 107 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~ 186 (327)
T 3lm5_A 107 ILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGH 186 (327)
T ss_dssp EEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC--
T ss_pred EEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCC
Confidence 9999999999999854 367999999999999999999999999999999999999997 78999999999987654
Q ss_pred CCCccccccCCCccccHHhhccc
Q 010401 487 VGEATEYETDGYRWLAPEVCFLL 509 (511)
Q Consensus 487 ~~~~~~~~~Gt~~YmAPEvl~gl 509 (511)
.. ......||+.|+|||++.+.
T Consensus 187 ~~-~~~~~~gt~~y~aPE~~~~~ 208 (327)
T 3lm5_A 187 AC-ELREIMGTPEYLAPEILNYD 208 (327)
T ss_dssp --------CCCGGGCCHHHHTTC
T ss_pred cc-ccccccCCcCccCCeeecCC
Confidence 32 23456799999999998653
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=5e-27 Score=234.18 Aligned_cols=163 Identities=22% Similarity=0.357 Sum_probs=138.8
Q ss_pred CCCeEEEeeeecccceEEEEe-------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCC------ceeeEeeeEeeC
Q 010401 339 SDNLEFIDQIGPNSFKGVYKG-------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHK------NILQFYCVCVDE 405 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkg-------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~Hp------NIV~l~g~~~~~ 405 (511)
.++|++.+.||+|+||.||++ +.||+|++.. .......+.+|+.++..++|+ +|+++++++.+.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~ 89 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKN---VDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHH 89 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS---SHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEET
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEec---CCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccC
Confidence 578999999999999999986 4699999963 233455678888888887655 599999999887
Q ss_pred CCcEEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcC--------------
Q 010401 406 NHGLCVVTKLMEGGSVNDLILKSR--KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDR-------------- 469 (511)
Q Consensus 406 ~~~l~LVmEy~~gGsL~~lL~~~~--~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~-------------- 469 (511)
+. +|+||||+ +++|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 90 ~~-~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~ 167 (339)
T 1z57_A 90 GH-ICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRD 167 (339)
T ss_dssp TE-EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred Cc-EEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccccc
Confidence 76 99999999 789999997654 6899999999999999999999999999999999999987
Q ss_pred -----CCcEEEEecCCceecccCCCccccccCCCccccHHhhccc
Q 010401 470 -----HGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEVCFLL 509 (511)
Q Consensus 470 -----~g~vKL~DFGlS~~l~~~~~~~~~~~Gt~~YmAPEvl~gl 509 (511)
++.+||+|||+++.... ......||+.|+|||++.+.
T Consensus 168 ~~~~~~~~~kl~Dfg~~~~~~~---~~~~~~gt~~y~aPE~~~~~ 209 (339)
T 1z57_A 168 ERTLINPDIKVVDFGSATYDDE---HHSTLVSTRHYRAPEVILAL 209 (339)
T ss_dssp EEEESCCCEEECCCSSCEETTS---CCCSSCSCGGGCCHHHHTTS
T ss_pred cccccCCCceEeeCcccccCcc---ccccccCCccccChHHhhCC
Confidence 66899999999886543 23456789999999998753
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=99.95 E-value=5.4e-27 Score=230.40 Aligned_cols=166 Identities=19% Similarity=0.240 Sum_probs=136.7
Q ss_pred CCCeEEEeeeecccceEEEEeE------EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEE
Q 010401 339 SDNLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV 412 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkgk------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LV 412 (511)
.++|++.+.||+|+||.||+++ .||+|++...... .++.+|+.++..++|++++..++.+.......++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C----CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc----hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence 4679999999999999999964 7999987643322 23678889999999988888877776655558999
Q ss_pred EeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEE---cCCCcEEEEecCCceecccCC
Q 010401 413 TKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILL---DRHGNVCLGDMGIVTACKSVG 488 (511)
Q Consensus 413 mEy~~gGsL~~lL~~-~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILl---d~~g~vKL~DFGlS~~l~~~~ 488 (511)
|||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++......
T Consensus 84 ~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~ 162 (296)
T 4hgt_A 84 MELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 162 (296)
T ss_dssp EECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred EEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcc
Confidence 9999 8899999964 4679999999999999999999999999999999999999 789999999999998765433
Q ss_pred C-------ccccccCCCccccHHhhccc
Q 010401 489 E-------ATEYETDGYRWLAPEVCFLL 509 (511)
Q Consensus 489 ~-------~~~~~~Gt~~YmAPEvl~gl 509 (511)
. ......||+.|+|||++.+.
T Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 190 (296)
T 4hgt_A 163 THQHIPYRENKNLTGTARYASINTHLGI 190 (296)
T ss_dssp TCCBCCCCCSCCCCSCGGGCCHHHHTTC
T ss_pred cCccCCCCcccccCCCccccchHHhcCC
Confidence 2 12345789999999998753
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=5.1e-27 Score=232.69 Aligned_cols=166 Identities=14% Similarity=0.210 Sum_probs=132.2
Q ss_pred CCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeC-------
Q 010401 339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDE------- 405 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~------- 405 (511)
.++|++++.||+|+||.||++ +.||+|++... ......++.+|+.+++.++||||+++++++...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 87 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT--DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDD 87 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC-
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC--ChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccc
Confidence 578999999999999999996 57999999742 334456688999999999999999999987432
Q ss_pred ------CCcEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEc-CCCcEEEEec
Q 010401 406 ------NHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLD-RHGNVCLGDM 478 (511)
Q Consensus 406 ------~~~l~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld-~~g~vKL~DF 478 (511)
...+|+||||+. |+|.+++. .+.+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+||
T Consensus 88 ~~~~~~~~~~~lv~e~~~-~~L~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~Df 165 (320)
T 2i6l_A 88 VGSLTELNSVYIVQEYME-TDLANVLE-QGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDF 165 (320)
T ss_dssp ---CCSCSEEEEEEECCS-EEHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECCC
T ss_pred cccccccCceeEEeeccC-CCHHHHhh-cCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEccC
Confidence 234899999998 59999984 46799999999999999999999999999999999999997 5679999999
Q ss_pred CCceecccCC---CccccccCCCccccHHhhcc
Q 010401 479 GIVTACKSVG---EATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 479 GlS~~l~~~~---~~~~~~~Gt~~YmAPEvl~g 508 (511)
|+++...... .......++..|+|||++.+
T Consensus 166 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 198 (320)
T 2i6l_A 166 GLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLS 198 (320)
T ss_dssp TTCBCC--------CCCGGGSCCTTCCHHHHHC
T ss_pred ccccccCCCcccccccccccccccccCcHHhcC
Confidence 9998764321 12334567889999998854
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=99.95 E-value=4.6e-28 Score=244.60 Aligned_cols=169 Identities=15% Similarity=0.233 Sum_probs=145.4
Q ss_pred cCCCeEEEeeeecccceEEEEe----EEEEEEEEecCCCCch---------------HHHHHHHHHHHHHhCCCCceeeE
Q 010401 338 NSDNLEFIDQIGPNSFKGVYKG----KRVGIEKLKGCDKGNA---------------YEFELRKDLLELMTCGHKNILQF 398 (511)
Q Consensus 338 ~~~~y~l~~~LG~GsFG~VYkg----k~VAVKkL~~~~~~~~---------------~~~~~~~Ei~iL~~l~HpNIV~l 398 (511)
..++|++.+.||+|+||.||++ +.||+|++........ ....+.+|+.++..++||||+++
T Consensus 29 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 29 YINDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp EETTEEEEEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred ccCceEEEEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 4578999999999999999996 5899999974321111 11668899999999999999999
Q ss_pred eeeEeeCCCcEEEEEeccCCCCHHHH------HHh--cCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCceEEcC
Q 010401 399 YCVCVDENHGLCVVTKLMEGGSVNDL------ILK--SRKLQTKEIIRIAIDVAEGIKFLND-HGVAYRDLNSQRILLDR 469 (511)
Q Consensus 399 ~g~~~~~~~~l~LVmEy~~gGsL~~l------L~~--~~~L~e~~~~~ia~qIa~gL~yLH~-~gIIHRDLKp~NILld~ 469 (511)
++++.+.+. +|+||||+++|+|.++ +.. ...+++..++.++.||+.||.|||+ +||+||||||+||+++.
T Consensus 109 ~~~~~~~~~-~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~~ 187 (348)
T 2pml_X 109 EGIITNYDE-VYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDK 187 (348)
T ss_dssp SEEEESSSE-EEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEECT
T ss_pred EEEEeeCCe-EEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEcC
Confidence 999998775 9999999999999998 654 5679999999999999999999999 99999999999999999
Q ss_pred CCcEEEEecCCceecccCCCccccccCCCccccHHhhccc
Q 010401 470 HGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEVCFLL 509 (511)
Q Consensus 470 ~g~vKL~DFGlS~~l~~~~~~~~~~~Gt~~YmAPEvl~gl 509 (511)
++.+||+|||++...... ......|++.|+|||++.+.
T Consensus 188 ~~~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~ 225 (348)
T 2pml_X 188 NGRVKLSDFGESEYMVDK--KIKGSRGTYEFMPPEFFSNE 225 (348)
T ss_dssp TSCEEECCCTTCEECBTT--EECSSCSCGGGCCGGGGSSC
T ss_pred CCcEEEeccccccccccc--cccCCCCCcCccCchhhcCC
Confidence 999999999999876443 34456789999999998753
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.3e-27 Score=262.43 Aligned_cols=172 Identities=19% Similarity=0.371 Sum_probs=142.1
Q ss_pred ceEecCCCeEEEeeeecccceEEEEeE---------EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEee
Q 010401 334 RWLLNSDNLEFIDQIGPNSFKGVYKGK---------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVD 404 (511)
Q Consensus 334 ~~~l~~~~y~l~~~LG~GsFG~VYkgk---------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~ 404 (511)
.+.+..++|++.+.||+|+||.||+|+ .||+|++... ........+.+|+.++..++||||+++++++.+
T Consensus 384 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 462 (656)
T 2j0j_A 384 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE 462 (656)
T ss_dssp GTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST-TCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred ccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence 556677889999999999999999974 4888888642 233445668999999999999999999999854
Q ss_pred CCCcEEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCcee
Q 010401 405 ENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTA 483 (511)
Q Consensus 405 ~~~~l~LVmEy~~gGsL~~lL~~~~-~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~ 483 (511)
+. +|+||||+.+|+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 463 -~~-~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~ 540 (656)
T 2j0j_A 463 -NP-VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 540 (656)
T ss_dssp -SS-CEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCS
T ss_pred -Cc-eEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCee
Confidence 43 899999999999999997543 799999999999999999999999999999999999999999999999999987
Q ss_pred cccCCC-ccccccCCCccccHHhhcc
Q 010401 484 CKSVGE-ATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 484 l~~~~~-~~~~~~Gt~~YmAPEvl~g 508 (511)
...... ......+++.|+|||++.+
T Consensus 541 ~~~~~~~~~~~~~~t~~y~aPE~~~~ 566 (656)
T 2j0j_A 541 MEDSTYYKASKGKLPIKWMAPESINF 566 (656)
T ss_dssp CCC----------CCGGGCCHHHHHH
T ss_pred cCCCcceeccCCCCCcceeCHHHhcC
Confidence 644322 1223456788999999864
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=99.95 E-value=2.6e-27 Score=236.57 Aligned_cols=169 Identities=21% Similarity=0.366 Sum_probs=136.3
Q ss_pred cCCCeEEEeeeecccceEEEEe-------EEEEEEEEecCCCCchHHHHHHHHHHHHHhC---CCCceeeEeeeEee---
Q 010401 338 NSDNLEFIDQIGPNSFKGVYKG-------KRVGIEKLKGCDKGNAYEFELRKDLLELMTC---GHKNILQFYCVCVD--- 404 (511)
Q Consensus 338 ~~~~y~l~~~LG~GsFG~VYkg-------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l---~HpNIV~l~g~~~~--- 404 (511)
..++|++.+.||+|+||.||++ +.||+|++............+.+|+.+++.+ +||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 3578999999999999999996 4689999874332222122345666666554 89999999999872
Q ss_pred -CCCcEEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCc
Q 010401 405 -ENHGLCVVTKLMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIV 481 (511)
Q Consensus 405 -~~~~l~LVmEy~~gGsL~~lL~~~--~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS 481 (511)
....+++||||+. |+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~ 167 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA 167 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCccc
Confidence 2234899999998 5999999764 35999999999999999999999999999999999999999999999999998
Q ss_pred eecccCCCccccccCCCccccHHhhcc
Q 010401 482 TACKSVGEATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 482 ~~l~~~~~~~~~~~Gt~~YmAPEvl~g 508 (511)
+..... .......|++.|+|||++.+
T Consensus 168 ~~~~~~-~~~~~~~~~~~y~aPE~~~~ 193 (326)
T 1blx_A 168 RIYSFQ-MALTSVVVTLWYRAPEVLLQ 193 (326)
T ss_dssp CCCCGG-GGGCCCCCCCTTCCHHHHTT
T ss_pred ccccCC-CCccccccccceeCHHHHhc
Confidence 765432 22345678999999999865
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.2e-27 Score=238.28 Aligned_cols=168 Identities=17% Similarity=0.179 Sum_probs=136.0
Q ss_pred cCCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCc----hHHHHHHHHHHHHHhC----CCCceeeEeeeEe
Q 010401 338 NSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGN----AYEFELRKDLLELMTC----GHKNILQFYCVCV 403 (511)
Q Consensus 338 ~~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~----~~~~~~~~Ei~iL~~l----~HpNIV~l~g~~~ 403 (511)
-.++|++.+.||+|+||.||++ +.||+|++....... .....+.+|+.++.++ +||||+++++++.
T Consensus 29 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~ 108 (312)
T 2iwi_A 29 FEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFE 108 (312)
T ss_dssp ----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-
T ss_pred hhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEe
Confidence 3578999999999999999996 479999997533222 1122356788888887 8999999999998
Q ss_pred eCCCcEEEEEec-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEc-CCCcEEEEecCCc
Q 010401 404 DENHGLCVVTKL-MEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLD-RHGNVCLGDMGIV 481 (511)
Q Consensus 404 ~~~~~l~LVmEy-~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld-~~g~vKL~DFGlS 481 (511)
+.+. .++|||| +.+++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++ .++.+||+|||++
T Consensus 109 ~~~~-~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~ 187 (312)
T 2iwi_A 109 TQEG-FMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSG 187 (312)
T ss_dssp -----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSSC
T ss_pred cCCe-EEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcchh
Confidence 7776 8999999 78999999998888899999999999999999999999999999999999999 8899999999999
Q ss_pred eecccCCCccccccCCCccccHHhhcc
Q 010401 482 TACKSVGEATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 482 ~~l~~~~~~~~~~~Gt~~YmAPEvl~g 508 (511)
+..... ......|++.|+|||++.+
T Consensus 188 ~~~~~~--~~~~~~~~~~y~aPE~~~~ 212 (312)
T 2iwi_A 188 ALLHDE--PYTDFDGTRVYSPPEWISR 212 (312)
T ss_dssp EECCSS--CBCCCCSCTTTSCHHHHHH
T ss_pred hhcccC--cccccCCcccccCceeeec
Confidence 876542 2345578999999998864
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=2.4e-27 Score=234.64 Aligned_cols=170 Identities=18% Similarity=0.291 Sum_probs=139.5
Q ss_pred CCCeEEEeeeecccceEEEEe------EEEEEEEEecCCC--CchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCC-CcE
Q 010401 339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDK--GNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN-HGL 409 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~--~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~-~~l 409 (511)
.++|++.+.||+|+||.||++ +.+|+|++..... .......+.+|+.++..++||||+++++++...+ ..+
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 367899999999999999996 4799999964221 1223466899999999999999999999985432 348
Q ss_pred EEEEeccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccC
Q 010401 410 CVVTKLMEGGSVNDLILK--SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV 487 (511)
Q Consensus 410 ~LVmEy~~gGsL~~lL~~--~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~ 487 (511)
|+||||+.++ |.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~ 162 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPF 162 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTT
T ss_pred EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCcc
Confidence 9999999885 7777754 457999999999999999999999999999999999999999999999999999876432
Q ss_pred C--CccccccCCCccccHHhhccc
Q 010401 488 G--EATEYETDGYRWLAPEVCFLL 509 (511)
Q Consensus 488 ~--~~~~~~~Gt~~YmAPEvl~gl 509 (511)
. .......|++.|+|||++.+.
T Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~~~ 186 (305)
T 2wtk_C 163 AADDTCRTSQGSPAFQPPEIANGL 186 (305)
T ss_dssp CSSCEECCCCSCGGGCCHHHHTCC
T ss_pred ccccccccCCCCCCCcChhhccCc
Confidence 2 223455689999999998753
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=5.1e-27 Score=239.98 Aligned_cols=164 Identities=18% Similarity=0.272 Sum_probs=136.3
Q ss_pred CCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCC--------CCceeeEeeeEee
Q 010401 339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCG--------HKNILQFYCVCVD 404 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~--------HpNIV~l~g~~~~ 404 (511)
.++|++.+.||+|+||.||++ +.||+|++.. .......+.+|+.++..++ |+||+++++++..
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~ 112 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKS---AEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKI 112 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS---CHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEec---CCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceee
Confidence 578999999999999999996 4799999963 3344566788999988874 8889999999873
Q ss_pred ---CCCcEEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCceEEcCCC-------
Q 010401 405 ---ENHGLCVVTKLMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDH-GVAYRDLNSQRILLDRHG------- 471 (511)
Q Consensus 405 ---~~~~l~LVmEy~~gGsL~~lL~~~--~~L~e~~~~~ia~qIa~gL~yLH~~-gIIHRDLKp~NILld~~g------- 471 (511)
....+|+||||+ +++|.+.+... ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++
T Consensus 113 ~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~ 191 (397)
T 1wak_A 113 SGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLA 191 (397)
T ss_dssp EETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHH
T ss_pred cCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhh
Confidence 222489999999 55777766543 5699999999999999999999998 999999999999999775
Q ss_pred ------------------------------------------cEEEEecCCceecccCCCccccccCCCccccHHhhccc
Q 010401 472 ------------------------------------------NVCLGDMGIVTACKSVGEATEYETDGYRWLAPEVCFLL 509 (511)
Q Consensus 472 ------------------------------------------~vKL~DFGlS~~l~~~~~~~~~~~Gt~~YmAPEvl~gl 509 (511)
.+||+|||+++..... .....||+.|+|||++.+.
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~---~~~~~gt~~y~aPE~~~~~ 268 (397)
T 1wak_A 192 AEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH---FTEDIQTRQYRSLEVLIGS 268 (397)
T ss_dssp HHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC---SCSCCSCGGGCCHHHHHTS
T ss_pred hhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc---CccCCCCCcccCChhhcCC
Confidence 7999999999876432 3455789999999998753
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3e-27 Score=240.62 Aligned_cols=170 Identities=20% Similarity=0.258 Sum_probs=133.7
Q ss_pred ecCCCeEEEeeeecccceEEEEe-----EEEEEEEEecCCCC---------chHHHHHHHHHHHHHhCCCCceeeEeeeE
Q 010401 337 LNSDNLEFIDQIGPNSFKGVYKG-----KRVGIEKLKGCDKG---------NAYEFELRKDLLELMTCGHKNILQFYCVC 402 (511)
Q Consensus 337 l~~~~y~l~~~LG~GsFG~VYkg-----k~VAVKkL~~~~~~---------~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~ 402 (511)
...++|++.+.||+|+||.||++ +.||+|++...... ......+.+|+.++..++||||+++++++
T Consensus 19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 98 (362)
T 3pg1_A 19 AMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIF 98 (362)
T ss_dssp HTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred HhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeE
Confidence 34678999999999999999996 47999998643221 11236689999999999999999999998
Q ss_pred eeCC----CcEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEe
Q 010401 403 VDEN----HGLCVVTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGD 477 (511)
Q Consensus 403 ~~~~----~~l~LVmEy~~gGsL~~lL~~~-~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~D 477 (511)
...+ ..+|+||||+. |+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|
T Consensus 99 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~D 177 (362)
T 3pg1_A 99 VHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICD 177 (362)
T ss_dssp EECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred EeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEe
Confidence 6533 23899999998 4888888644 4799999999999999999999999999999999999999999999999
Q ss_pred cCCceecccCCCccccccCCCccccHHhhcc
Q 010401 478 MGIVTACKSVGEATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 478 FGlS~~l~~~~~~~~~~~Gt~~YmAPEvl~g 508 (511)
||+++..... .......||+.|+|||++.+
T Consensus 178 fg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~ 207 (362)
T 3pg1_A 178 FNLAREDTAD-ANKTHYVTHRWYRAPELVMQ 207 (362)
T ss_dssp TTC----------------CGGGCCHHHHTT
T ss_pred cCcccccccc-cccceecccceecCcHHhcC
Confidence 9998755432 23445678899999999875
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=3.7e-27 Score=236.66 Aligned_cols=170 Identities=21% Similarity=0.345 Sum_probs=126.0
Q ss_pred ceEecCCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHH-HHHhCCCCceeeEeeeEeeCC
Q 010401 334 RWLLNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLL-ELMTCGHKNILQFYCVCVDEN 406 (511)
Q Consensus 334 ~~~l~~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~-iL~~l~HpNIV~l~g~~~~~~ 406 (511)
.|.+..++|++.+.||+|+||.||++ +.||+|++.... ......++.+|+. +++.++||||+++++++.+.+
T Consensus 16 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~ 94 (327)
T 3aln_A 16 HWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV-DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREG 94 (327)
T ss_dssp EECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC-CHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSS
T ss_pred hcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc-CchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCC
Confidence 67788899999999999999999995 579999997532 2333445566665 566789999999999999877
Q ss_pred CcEEEEEeccCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCceEEcCCCcEEEEecCC
Q 010401 407 HGLCVVTKLMEGGSVNDLILK-----SRKLQTKEIIRIAIDVAEGIKFLNDH-GVAYRDLNSQRILLDRHGNVCLGDMGI 480 (511)
Q Consensus 407 ~~l~LVmEy~~gGsL~~lL~~-----~~~L~e~~~~~ia~qIa~gL~yLH~~-gIIHRDLKp~NILld~~g~vKL~DFGl 480 (511)
. .|+||||+.+ +|.+++.. ...+++..+..++.|++.||.|||++ ||+||||||+|||++.++.+||+|||+
T Consensus 95 ~-~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~ 172 (327)
T 3aln_A 95 D-CWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGI 172 (327)
T ss_dssp E-EEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSS
T ss_pred c-eEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCC
Confidence 5 9999999986 88888753 46799999999999999999999998 999999999999999999999999999
Q ss_pred ceecccCCCccccccCCCccccHHhhc
Q 010401 481 VTACKSVGEATEYETDGYRWLAPEVCF 507 (511)
Q Consensus 481 S~~l~~~~~~~~~~~Gt~~YmAPEvl~ 507 (511)
++...... ......||+.|+|||++.
T Consensus 173 ~~~~~~~~-~~~~~~gt~~y~aPE~~~ 198 (327)
T 3aln_A 173 SGQLVDSI-AKTRDAGCRPYMAPERID 198 (327)
T ss_dssp SCC------------------------
T ss_pred ceeccccc-ccccCCCCccccCceeec
Confidence 97764322 233447899999999983
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=6.1e-27 Score=245.93 Aligned_cols=161 Identities=20% Similarity=0.221 Sum_probs=132.4
Q ss_pred CCeEEEeeeecccceEEEEeE------EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCC-----Cc
Q 010401 340 DNLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN-----HG 408 (511)
Q Consensus 340 ~~y~l~~~LG~GsFG~VYkgk------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~-----~~ 408 (511)
.+|++.+.||+|+||.||+++ .||||++..... ...+|+.+++.++||||++++++|.... ..
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~ 127 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 127 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch------hHHHHHHHHHHcCCCCccceeeEEeccCCCCccee
Confidence 368999999999999999964 699999974321 1246899999999999999999885422 12
Q ss_pred EEEEEeccCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCC-CcEEEEecCCcee
Q 010401 409 LCVVTKLMEGGSVNDLIL----KSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRH-GNVCLGDMGIVTA 483 (511)
Q Consensus 409 l~LVmEy~~gGsL~~lL~----~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~-g~vKL~DFGlS~~ 483 (511)
+++||||+++ +|.+++. ....+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+++.
T Consensus 128 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~ 206 (420)
T 1j1b_A 128 LNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 206 (420)
T ss_dssp EEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhh
Confidence 6799999986 7776664 24679999999999999999999999999999999999999955 6789999999987
Q ss_pred cccCCCccccccCCCccccHHhhcc
Q 010401 484 CKSVGEATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 484 l~~~~~~~~~~~Gt~~YmAPEvl~g 508 (511)
+.... ......||+.|+|||++.+
T Consensus 207 ~~~~~-~~~~~~~t~~y~aPE~~~~ 230 (420)
T 1j1b_A 207 LVRGE-PNVSYICSRYYRAPELIFG 230 (420)
T ss_dssp CCTTC-CCCSCCSCTTSCCHHHHTT
T ss_pred cccCC-CceeeeeCCCcCCHHHHcC
Confidence 65433 2344578999999999875
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=99.94 E-value=8.7e-27 Score=242.54 Aligned_cols=162 Identities=19% Similarity=0.213 Sum_probs=133.3
Q ss_pred CCCeEEEeeeecccceEEEEeE-----EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCC-----c
Q 010401 339 SDNLEFIDQIGPNSFKGVYKGK-----RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENH-----G 408 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkgk-----~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~-----~ 408 (511)
..+|++.+.||+|+||.||+++ .+|+|++...... ..+|+.+++.++||||+++++++...+. .
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~------~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~ 112 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF------KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVF 112 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS------CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch------HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceE
Confidence 3468999999999999999974 5899988643221 2368899999999999999999865432 2
Q ss_pred EEEEEeccCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEc-CCCcEEEEecCCcee
Q 010401 409 LCVVTKLMEGGSVNDLIL----KSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLD-RHGNVCLGDMGIVTA 483 (511)
Q Consensus 409 l~LVmEy~~gGsL~~lL~----~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld-~~g~vKL~DFGlS~~ 483 (511)
+|+||||+++ ++...+. ....+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++.
T Consensus 113 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 113 LNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EEEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 7899999987 4444432 246799999999999999999999999999999999999999 799999999999987
Q ss_pred cccCCCccccccCCCccccHHhhcc
Q 010401 484 CKSVGEATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 484 l~~~~~~~~~~~Gt~~YmAPEvl~g 508 (511)
..... ......||+.|+|||++.+
T Consensus 192 ~~~~~-~~~~~~~t~~y~aPE~~~~ 215 (394)
T 4e7w_A 192 LIAGE-PNVSYICSRYYRAPELIFG 215 (394)
T ss_dssp CCTTC-CCCSSCSCGGGCCHHHHTT
T ss_pred ccCCC-CCcccccCcCccCHHHHcC
Confidence 64433 2345578999999999865
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.1e-26 Score=244.96 Aligned_cols=164 Identities=19% Similarity=0.276 Sum_probs=138.9
Q ss_pred cCCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhC------CCCceeeEeeeEeeC
Q 010401 338 NSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTC------GHKNILQFYCVCVDE 405 (511)
Q Consensus 338 ~~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l------~HpNIV~l~g~~~~~ 405 (511)
...+|++++.||+|+||.||++ +.||+|++.. .......+.+|+.++..+ +|+||+++++++...
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~---~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 171 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRN---EKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR 171 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECS---CHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEET
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECC---ccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccC
Confidence 3567999999999999999996 5799999963 233445567787777765 678999999999988
Q ss_pred CCcEEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCc--EEEEecCCc
Q 010401 406 NHGLCVVTKLMEGGSVNDLILKSR--KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGN--VCLGDMGIV 481 (511)
Q Consensus 406 ~~~l~LVmEy~~gGsL~~lL~~~~--~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~--vKL~DFGlS 481 (511)
+. +|+||||+. ++|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++
T Consensus 172 ~~-~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a 249 (429)
T 3kvw_A 172 NH-ICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSS 249 (429)
T ss_dssp TE-EEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred Ce-EEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccc
Confidence 76 999999996 59999986543 5999999999999999999999999999999999999999887 999999998
Q ss_pred eecccCCCccccccCCCccccHHhhccc
Q 010401 482 TACKSVGEATEYETDGYRWLAPEVCFLL 509 (511)
Q Consensus 482 ~~l~~~~~~~~~~~Gt~~YmAPEvl~gl 509 (511)
..... ......||+.|+|||++.+.
T Consensus 250 ~~~~~---~~~~~~gt~~y~aPE~~~~~ 274 (429)
T 3kvw_A 250 CYEHQ---RVYTYIQSRFYRAPEVILGA 274 (429)
T ss_dssp EETTC---CCCSSCSCGGGCCHHHHHTB
T ss_pred eecCC---cccccCCCCCccChHHHhCC
Confidence 76533 23456889999999998763
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=3.6e-27 Score=239.92 Aligned_cols=164 Identities=18% Similarity=0.301 Sum_probs=137.6
Q ss_pred CCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCC-----
Q 010401 339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENH----- 407 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~----- 407 (511)
.++|.+.+.||+|+||.||++ +.||+|++...........++.+|+.+++.++||||+++++++...+.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 468999999999999999996 579999997644444456678999999999999999999999987653
Q ss_pred cEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccC
Q 010401 408 GLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV 487 (511)
Q Consensus 408 ~l~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~ 487 (511)
.+|+||||+. ++|.+++. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 103 ~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 179 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE 179 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC----
T ss_pred eEEEEecccc-CCHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCCCC
Confidence 2599999997 48887763 35999999999999999999999999999999999999999999999999998765432
Q ss_pred CCccccccCCCccccHHhhcc
Q 010401 488 GEATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 488 ~~~~~~~~Gt~~YmAPEvl~g 508 (511)
.....||+.|+|||++.+
T Consensus 180 ---~~~~~~t~~y~aPE~~~~ 197 (353)
T 3coi_A 180 ---MTGYVVTRWYRAPEVILS 197 (353)
T ss_dssp -------CCSBCCSCHHHHSC
T ss_pred ---ccccccCcCcCCHHHHhC
Confidence 344578999999999865
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=4.9e-27 Score=241.15 Aligned_cols=164 Identities=7% Similarity=0.035 Sum_probs=120.8
Q ss_pred CCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCc-hHHHHHHHHHH---HHHhCCCCceeeEe-------eeE
Q 010401 340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGN-AYEFELRKDLL---ELMTCGHKNILQFY-------CVC 402 (511)
Q Consensus 340 ~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~-~~~~~~~~Ei~---iL~~l~HpNIV~l~-------g~~ 402 (511)
.+|++.+.||+|+||.||++ +.||+|++....... .....+.+|+. .|.. +||||++++ +++
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehhe
Confidence 35899999999999999996 479999998644323 23445677744 4455 799988865 444
Q ss_pred eeCC----------------CcEEEEEeccCCCCHHHHHHhc-CCCCHHHH------HHHHHHHHHHHHHHHHCCccccC
Q 010401 403 VDEN----------------HGLCVVTKLMEGGSVNDLILKS-RKLQTKEI------IRIAIDVAEGIKFLNDHGVAYRD 459 (511)
Q Consensus 403 ~~~~----------------~~l~LVmEy~~gGsL~~lL~~~-~~L~e~~~------~~ia~qIa~gL~yLH~~gIIHRD 459 (511)
...+ ..+|+||||+. |+|.+++... ..+.+..+ ..++.||+.||+|||++||+|||
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrD 219 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGH 219 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCc
Confidence 3322 22799999998 7999999753 34555555 67779999999999999999999
Q ss_pred CCCCceEEcCCCcEEEEecCCceecccCCCccccccCCCccccHHhhcc
Q 010401 460 LNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 460 LKp~NILld~~g~vKL~DFGlS~~l~~~~~~~~~~~Gt~~YmAPEvl~g 508 (511)
|||+|||++.++.+||+|||+++.... ......+|+.|+|||++.+
T Consensus 220 ikp~NIll~~~~~~kL~DFG~a~~~~~---~~~~~~~t~~y~aPE~~~~ 265 (371)
T 3q60_A 220 FTPDNLFIMPDGRLMLGDVSALWKVGT---RGPASSVPVTYAPREFLNA 265 (371)
T ss_dssp CSGGGEEECTTSCEEECCGGGEEETTC---EEEGGGSCGGGCCHHHHTC
T ss_pred CCHHHEEECCCCCEEEEecceeeecCC---CccCccCCcCCcChhhccC
Confidence 999999999999999999999987643 2224567799999999865
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=3.9e-27 Score=237.17 Aligned_cols=169 Identities=17% Similarity=0.213 Sum_probs=143.2
Q ss_pred ecCCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCc----hHHHHHHHHHHHHHhCC--CCceeeEeeeEee
Q 010401 337 LNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGN----AYEFELRKDLLELMTCG--HKNILQFYCVCVD 404 (511)
Q Consensus 337 l~~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~----~~~~~~~~Ei~iL~~l~--HpNIV~l~g~~~~ 404 (511)
...++|++.+.||+|+||.||++ +.||+|++....... .....+.+|+.++..++ |+||+++++++.+
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~ 119 (320)
T 3a99_A 40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER 119 (320)
T ss_dssp CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec
Confidence 34678999999999999999996 469999997543222 11234567888888885 5999999999998
Q ss_pred CCCcEEEEEeccCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEc-CCCcEEEEecCCce
Q 010401 405 ENHGLCVVTKLMEG-GSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLD-RHGNVCLGDMGIVT 482 (511)
Q Consensus 405 ~~~~l~LVmEy~~g-GsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld-~~g~vKL~DFGlS~ 482 (511)
.+. +++||||+.+ ++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||+++
T Consensus 120 ~~~-~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~ 198 (320)
T 3a99_A 120 PDS-FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 198 (320)
T ss_dssp SSE-EEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred CCc-EEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCcccc
Confidence 775 9999999976 89999998888899999999999999999999999999999999999999 78999999999998
Q ss_pred ecccCCCccccccCCCccccHHhhcc
Q 010401 483 ACKSVGEATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 483 ~l~~~~~~~~~~~Gt~~YmAPEvl~g 508 (511)
..... ......||+.|+|||++.+
T Consensus 199 ~~~~~--~~~~~~gt~~y~aPE~~~~ 222 (320)
T 3a99_A 199 LLKDT--VYTDFDGTRVYSPPEWIRY 222 (320)
T ss_dssp ECCSS--CBCCCCSCGGGSCHHHHHH
T ss_pred ccccc--cccCCCCCccCCChHHhcc
Confidence 76542 2344578999999999864
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.94 E-value=7.3e-27 Score=259.76 Aligned_cols=162 Identities=20% Similarity=0.265 Sum_probs=137.2
Q ss_pred CCCeEEEeeeecccceEEEEe-------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCc---
Q 010401 339 SDNLEFIDQIGPNSFKGVYKG-------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHG--- 408 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkg-------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~--- 408 (511)
.++|++.+.||+|+||.||++ +.||+|++... ........+.+|+.++..++||||+++++++...+..
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 157 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS-GDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP 157 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSS-CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCcc-CCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence 578999999999999999996 56999988642 2233445688999999999999999999999876542
Q ss_pred -EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccC
Q 010401 409 -LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV 487 (511)
Q Consensus 409 -l~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~ 487 (511)
.||||||+++++|.+++.. .+++..++.++.||+.||.|||++|||||||||+|||++.+ .+||+|||+++.....
T Consensus 158 ~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~ 234 (681)
T 2pzi_A 158 VGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF 234 (681)
T ss_dssp EEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEETTCC
T ss_pred eeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhcccC
Confidence 6999999999999988744 79999999999999999999999999999999999999875 8999999999876542
Q ss_pred CCccccccCCCccccHHhhcc
Q 010401 488 GEATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 488 ~~~~~~~~Gt~~YmAPEvl~g 508 (511)
....||+.|+|||++.+
T Consensus 235 ----~~~~gt~~y~aPE~~~~ 251 (681)
T 2pzi_A 235 ----GYLYGTPGFQAPEIVRT 251 (681)
T ss_dssp ----SCCCCCTTTSCTTHHHH
T ss_pred ----CccCCCccccCHHHHcC
Confidence 45679999999999864
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.1e-26 Score=230.99 Aligned_cols=171 Identities=19% Similarity=0.328 Sum_probs=126.5
Q ss_pred ceEecCCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCC
Q 010401 334 RWLLNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENH 407 (511)
Q Consensus 334 ~~~l~~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~ 407 (511)
.|....++|++.+.||+|+||.||++ +.||+|++............+.++..++..++||||+++++++.+.+.
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~ 98 (318)
T 2dyl_A 19 RYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTD 98 (318)
T ss_dssp EEECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred hhhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCc
Confidence 57777889999999999999999996 479999997543222222333444456777899999999999988775
Q ss_pred cEEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCceEEcCCCcEEEEecCCceecc
Q 010401 408 GLCVVTKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDH-GVAYRDLNSQRILLDRHGNVCLGDMGIVTACK 485 (511)
Q Consensus 408 ~l~LVmEy~~gGsL~~lL~~-~~~L~e~~~~~ia~qIa~gL~yLH~~-gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~ 485 (511)
+|+||||+ ++.+..+... ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++....
T Consensus 99 -~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 176 (318)
T 2dyl_A 99 -VFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLV 176 (318)
T ss_dssp -EEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred -EEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhcc
Confidence 99999999 5566666543 46899999999999999999999995 99999999999999999999999999987664
Q ss_pred cCCCccccccCCCccccHHhhc
Q 010401 486 SVGEATEYETDGYRWLAPEVCF 507 (511)
Q Consensus 486 ~~~~~~~~~~Gt~~YmAPEvl~ 507 (511)
... ......|++.|+|||++.
T Consensus 177 ~~~-~~~~~~~~~~y~aPE~~~ 197 (318)
T 2dyl_A 177 DDK-AKDRSAGCAAYMAPERID 197 (318)
T ss_dssp -----------CCTTCCHHHHC
T ss_pred CCc-cccccCCCccccChhhcc
Confidence 422 234557899999999985
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2e-26 Score=231.66 Aligned_cols=162 Identities=16% Similarity=0.307 Sum_probs=137.1
Q ss_pred CCCeEEEeeeecccceEEEEe-------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCc------eeeEeeeEeeC
Q 010401 339 SDNLEFIDQIGPNSFKGVYKG-------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKN------ILQFYCVCVDE 405 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkg-------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpN------IV~l~g~~~~~ 405 (511)
.++|++.+.||+|+||.||++ +.||+|+++. .......+.+|+.++..++|++ ++.+++++...
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~---~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 94 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRN---VGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFH 94 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS---CHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEET
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcc---cccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeC
Confidence 578999999999999999986 4799999963 3344556788998888886655 89999999887
Q ss_pred CCcEEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEE----------------
Q 010401 406 NHGLCVVTKLMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILL---------------- 467 (511)
Q Consensus 406 ~~~l~LVmEy~~gGsL~~lL~~~--~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILl---------------- 467 (511)
+. +|+||||+ +++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 95 ~~-~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~ 172 (355)
T 2eu9_A 95 GH-MCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCE 172 (355)
T ss_dssp TE-EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCC
T ss_pred Ce-EEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccccccc
Confidence 76 99999999 55777777554 379999999999999999999999999999999999999
Q ss_pred ---cCCCcEEEEecCCceecccCCCccccccCCCccccHHhhcc
Q 010401 468 ---DRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 468 ---d~~g~vKL~DFGlS~~l~~~~~~~~~~~Gt~~YmAPEvl~g 508 (511)
+.++.+||+|||+++.... ......||+.|+|||++.+
T Consensus 173 ~~~~~~~~~kl~Dfg~~~~~~~---~~~~~~gt~~y~aPE~~~~ 213 (355)
T 2eu9_A 173 EKSVKNTSIRVADFGSATFDHE---HHTTIVATRHYRPPEVILE 213 (355)
T ss_dssp EEEESCCCEEECCCTTCEETTS---CCCSSCSCGGGCCHHHHTT
T ss_pred ccccCCCcEEEeecCccccccc---cccCCcCCCcccCCeeeec
Confidence 6688999999999986533 2345678999999999865
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.94 E-value=9.5e-27 Score=236.04 Aligned_cols=166 Identities=19% Similarity=0.189 Sum_probs=125.1
Q ss_pred cCCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCC----
Q 010401 338 NSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENH---- 407 (511)
Q Consensus 338 ~~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~---- 407 (511)
..++|++.+.||+|+||.||++ +.||+|++....... ....+++..+..++||||+++++++...+.
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~ 97 (360)
T 3e3p_A 21 EMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR---NRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRR 97 (360)
T ss_dssp HHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCC---CHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTT
T ss_pred hccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcccc---HHHHHHHHHHHhcCCCCcccHHHhhhcccccccc
Confidence 4578999999999999999996 479999986533222 234567777888899999999999965332
Q ss_pred --cEEEEEeccCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHH--HCCccccCCCCCceEEcC-CCcEEEEec
Q 010401 408 --GLCVVTKLMEGGSVNDLIL----KSRKLQTKEIIRIAIDVAEGIKFLN--DHGVAYRDLNSQRILLDR-HGNVCLGDM 478 (511)
Q Consensus 408 --~l~LVmEy~~gGsL~~lL~----~~~~L~e~~~~~ia~qIa~gL~yLH--~~gIIHRDLKp~NILld~-~g~vKL~DF 478 (511)
.+++||||+.+ +|.+.+. ....+++..+..++.||+.||.||| ++||+||||||+|||++. ++.+||+||
T Consensus 98 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Df 176 (360)
T 3e3p_A 98 DIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDF 176 (360)
T ss_dssp CEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCC
T ss_pred ceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeC
Confidence 27899999987 5555443 4567899999999999999999999 999999999999999996 899999999
Q ss_pred CCceecccCCCccccccCCCccccHHhhcc
Q 010401 479 GIVTACKSVGEATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 479 GlS~~l~~~~~~~~~~~Gt~~YmAPEvl~g 508 (511)
|+++...... ......||+.|+|||++.+
T Consensus 177 g~a~~~~~~~-~~~~~~gt~~y~aPE~~~~ 205 (360)
T 3e3p_A 177 GSAKKLSPSE-PNVAYICSRYYRAPELIFG 205 (360)
T ss_dssp TTCBCCCTTS-CCCSTTSCGGGCCHHHHTT
T ss_pred CCceecCCCC-CcccccCCcceeCHHHHcC
Confidence 9998765432 3445678999999999864
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=5.4e-27 Score=243.87 Aligned_cols=163 Identities=20% Similarity=0.316 Sum_probs=122.2
Q ss_pred CeEE-EeeeecccceEEEEeE--------EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeC-CCcEE
Q 010401 341 NLEF-IDQIGPNSFKGVYKGK--------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDE-NHGLC 410 (511)
Q Consensus 341 ~y~l-~~~LG~GsFG~VYkgk--------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~-~~~l~ 410 (511)
.|++ .++||+|+||.||+++ .||+|++..... ...+.+|+.+++.++||||+++++++... +..+|
T Consensus 21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 96 (405)
T 3rgf_A 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI----SMSACREIALLRELKHPNVISLQKVFLSHADRKVW 96 (405)
T ss_dssp HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC----CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEE
T ss_pred hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC----CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEE
Confidence 3555 4579999999999975 589999964322 23578899999999999999999999653 33489
Q ss_pred EEEeccCCCCHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEE----cCCCcEEEEe
Q 010401 411 VVTKLMEGGSVNDLILKS---------RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILL----DRHGNVCLGD 477 (511)
Q Consensus 411 LVmEy~~gGsL~~lL~~~---------~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILl----d~~g~vKL~D 477 (511)
+||||+.+ +|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|
T Consensus 97 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~D 175 (405)
T 3rgf_A 97 LLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIAD 175 (405)
T ss_dssp EEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECC
T ss_pred EEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEE
Confidence 99999975 888887521 249999999999999999999999999999999999999 6788999999
Q ss_pred cCCceecccCC---CccccccCCCccccHHhhcc
Q 010401 478 MGIVTACKSVG---EATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 478 FGlS~~l~~~~---~~~~~~~Gt~~YmAPEvl~g 508 (511)
||+++...... .......||+.|+|||++.+
T Consensus 176 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 209 (405)
T 3rgf_A 176 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLG 209 (405)
T ss_dssp TTCCC----------------CCCTTCCHHHHTT
T ss_pred CCCceecCCCCcccccCCCceecCcccCchhhcC
Confidence 99998764322 12344678999999999876
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.94 E-value=3.3e-26 Score=232.78 Aligned_cols=167 Identities=15% Similarity=0.274 Sum_probs=139.2
Q ss_pred EecCCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCC-----------CCceeeE
Q 010401 336 LLNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCG-----------HKNILQF 398 (511)
Q Consensus 336 ~l~~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~-----------HpNIV~l 398 (511)
.+..++|++.+.||+|+||.||++ +.||+|++.. .......+.+|+.++..+. ||||+++
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~ 91 (373)
T 1q8y_A 15 PYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG---DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKL 91 (373)
T ss_dssp EETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS---CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCC
T ss_pred cccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC---CccchhhhhHHHHHHHHhhcccccchhccccchHHHH
Confidence 356788999999999999999996 4799999963 3334456788888888775 8999999
Q ss_pred eeeEeeCC---CcEEEEEeccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCCCceEEc----
Q 010401 399 YCVCVDEN---HGLCVVTKLMEGGSVNDLILK--SRKLQTKEIIRIAIDVAEGIKFLNDH-GVAYRDLNSQRILLD---- 468 (511)
Q Consensus 399 ~g~~~~~~---~~l~LVmEy~~gGsL~~lL~~--~~~L~e~~~~~ia~qIa~gL~yLH~~-gIIHRDLKp~NILld---- 468 (511)
++++...+ ..+++||||+ +++|.+++.. ...+++..+..++.||+.||.|||++ ||+||||||+|||++
T Consensus 92 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~ 170 (373)
T 1q8y_A 92 LDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDS 170 (373)
T ss_dssp CEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEET
T ss_pred HHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCC
Confidence 99987643 1389999999 8899999965 34699999999999999999999998 999999999999995
Q ss_pred --CCCcEEEEecCCceecccCCCccccccCCCccccHHhhccc
Q 010401 469 --RHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEVCFLL 509 (511)
Q Consensus 469 --~~g~vKL~DFGlS~~l~~~~~~~~~~~Gt~~YmAPEvl~gl 509 (511)
..+.+||+|||+++..... .....||+.|+|||++.+.
T Consensus 171 ~~~~~~~kl~Dfg~a~~~~~~---~~~~~~t~~y~aPE~~~~~ 210 (373)
T 1q8y_A 171 PENLIQIKIADLGNACWYDEH---YTNSIQTREYRSPEVLLGA 210 (373)
T ss_dssp TTTEEEEEECCCTTCEETTBC---CCSCCSCGGGCCHHHHHTC
T ss_pred CcCcceEEEcccccccccCCC---CCCCCCCccccCcHHHhCC
Confidence 3448999999999876432 3455789999999998753
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=2e-26 Score=243.59 Aligned_cols=168 Identities=14% Similarity=0.227 Sum_probs=132.9
Q ss_pred ceEecCCCeEEEeeeecccceEEEE-----eEEEEEEEEecCCCCchHHHHHHHHHHHHHhC-CCCceeeEeeeEeeCCC
Q 010401 334 RWLLNSDNLEFIDQIGPNSFKGVYK-----GKRVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCVCVDENH 407 (511)
Q Consensus 334 ~~~l~~~~y~l~~~LG~GsFG~VYk-----gk~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l-~HpNIV~l~g~~~~~~~ 407 (511)
.+.+...+|.+.+.||+|+||.||. ++.||||++...... .+.+|+.+++.+ +||||+++++++.+.+.
T Consensus 18 ~~~i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~-----~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 92 (432)
T 3p23_A 18 VVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS-----FADREVQLLRESDEHPNVIRYFCTEKDRQF 92 (432)
T ss_dssp CEEETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE-----ECHHHHHHHHHSCCCTTBCCEEEEEEETTE
T ss_pred cEEEccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH-----HHHHHHHHHHhccCCCCcCeEEEEEecCCE
Confidence 4566777899999999999999554 468999999642221 246788999988 89999999999988775
Q ss_pred cEEEEEeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcC-----CCcEEEEecCCc
Q 010401 408 GLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDR-----HGNVCLGDMGIV 481 (511)
Q Consensus 408 ~l~LVmEy~~gGsL~~lL~~~~-~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~-----~g~vKL~DFGlS 481 (511)
+|+||||+.+ +|.+++.... .+.+..++.++.||+.||.|||++||+||||||+|||++. ...+||+|||++
T Consensus 93 -~~lv~E~~~g-~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a 170 (432)
T 3p23_A 93 -QYIAIELCAA-TLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLC 170 (432)
T ss_dssp -EEEEEECCSE-EHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEE
T ss_pred -EEEEEECCCC-CHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccce
Confidence 8999999964 9999996543 4566677899999999999999999999999999999953 236889999999
Q ss_pred eecccCC---CccccccCCCccccHHhhcc
Q 010401 482 TACKSVG---EATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 482 ~~l~~~~---~~~~~~~Gt~~YmAPEvl~g 508 (511)
+...... .......||+.|+|||++.+
T Consensus 171 ~~~~~~~~~~~~~~~~~gt~~y~APE~l~~ 200 (432)
T 3p23_A 171 KKLAVGRHSFSRRSGVPGTEGWIAPEMLSE 200 (432)
T ss_dssp ECC------------CCSCTTSCCGGGTSC
T ss_pred eeccCCCcceeeccccCCCcCccChhhhhc
Confidence 8765332 12344679999999999863
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.93 E-value=9.2e-26 Score=242.59 Aligned_cols=165 Identities=21% Similarity=0.275 Sum_probs=135.3
Q ss_pred CCCeEEEeeeecccceEEEEeE------EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCc-eeeEeeeEeeCCCcEEE
Q 010401 339 SDNLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKN-ILQFYCVCVDENHGLCV 411 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkgk------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpN-IV~l~g~~~~~~~~l~L 411 (511)
.++|++.++||+|+||.||+|+ .||||++...... .++.+|+.++..+.|++ |..+..++...+ ..||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~-~~~l 80 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKIYRILQGGTGIPNVRWFGVEGD-YNVL 80 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS----CCHHHHHHHHHHTTTSTTCCCEEEEEEETT-EEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCC-EEEE
Confidence 5789999999999999999964 6999988753332 23678889999997755 444544445444 4899
Q ss_pred EEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEE---cCCCcEEEEecCCceecccC
Q 010401 412 VTKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILL---DRHGNVCLGDMGIVTACKSV 487 (511)
Q Consensus 412 VmEy~~gGsL~~lL~~-~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILl---d~~g~vKL~DFGlS~~l~~~ 487 (511)
||||+ +++|.+++.. ...+++..++.|+.||+.||+|||++|||||||||+|||| +.++.+||+|||+++.....
T Consensus 81 vme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~ 159 (483)
T 3sv0_A 81 VMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT 159 (483)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred EEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCC
Confidence 99999 8899999964 5689999999999999999999999999999999999999 68899999999999877543
Q ss_pred CCc-------cccccCCCccccHHhhccc
Q 010401 488 GEA-------TEYETDGYRWLAPEVCFLL 509 (511)
Q Consensus 488 ~~~-------~~~~~Gt~~YmAPEvl~gl 509 (511)
... .....||+.|+|||++.+.
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~ 188 (483)
T 3sv0_A 160 STHQHIPYRENKNLTGTARYASVNTHLGI 188 (483)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTC
T ss_pred ccccccccccccccCCCccccCHHHhcCC
Confidence 321 2256789999999998753
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=4.9e-26 Score=239.98 Aligned_cols=161 Identities=19% Similarity=0.268 Sum_probs=124.4
Q ss_pred CeEEEeeeecccceEEEE-----eEEEEEEEEecCCCCchHHHHHHHHHHHHHhC-CCCceeeEeeeEeeCCCcEEEEEe
Q 010401 341 NLEFIDQIGPNSFKGVYK-----GKRVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCVCVDENHGLCVVTK 414 (511)
Q Consensus 341 ~y~l~~~LG~GsFG~VYk-----gk~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l-~HpNIV~l~g~~~~~~~~l~LVmE 414 (511)
.|...+.||+|+||+||. |+.||||++... ....+.+|+.++..+ +||||+++++++.+++. +|+|||
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~-----~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~-~~lv~E 89 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID-----FCDIALMEIKLLTESDDHPNVIRYYCSETTDRF-LYIALE 89 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG-----GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSE-EEEEEC
T ss_pred eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH-----HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCe-EEEEEe
Confidence 456678999999999975 468999998642 234567899999875 89999999999987765 999999
Q ss_pred ccCCCCHHHHHHhcCCC-------CHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCC-------------CcEE
Q 010401 415 LMEGGSVNDLILKSRKL-------QTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRH-------------GNVC 474 (511)
Q Consensus 415 y~~gGsL~~lL~~~~~L-------~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~-------------g~vK 474 (511)
|+. |+|.+++...... .+..++.++.||+.||+|||++||+||||||+|||++.+ +.+|
T Consensus 90 ~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k 168 (434)
T 2rio_A 90 LCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRIL 168 (434)
T ss_dssp CCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred cCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEE
Confidence 996 5999999754332 233457899999999999999999999999999999754 4899
Q ss_pred EEecCCceecccCCC----ccccccCCCccccHHhhcc
Q 010401 475 LGDMGIVTACKSVGE----ATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 475 L~DFGlS~~l~~~~~----~~~~~~Gt~~YmAPEvl~g 508 (511)
|+|||+++....... ......||+.|+|||++.+
T Consensus 169 L~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 206 (434)
T 2rio_A 169 ISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEE 206 (434)
T ss_dssp ECCCTTCEECCC--------------CCTTSCHHHHSC
T ss_pred EcccccceecCCCCccceeeecCCCCCCCccCHHHhcc
Confidence 999999987754322 1234579999999999865
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=8.8e-26 Score=229.35 Aligned_cols=162 Identities=20% Similarity=0.274 Sum_probs=114.9
Q ss_pred CCCeEEEe-eeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeC---CCc
Q 010401 339 SDNLEFID-QIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDE---NHG 408 (511)
Q Consensus 339 ~~~y~l~~-~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~---~~~ 408 (511)
.++|.+.+ .||+|+||.||++ +.||+|++... .. ...+....+..++||||+++++++... +..
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~---~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 100 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS---PK---ARQEVDHHWQASGGPHIVCILDVYENMHHGKRC 100 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS---HH---HHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc---HH---HHHHHHHHHHhcCCCChHHHHHHHhhccCCCce
Confidence 46788865 6999999999996 57999999631 11 112222335667999999999998752 223
Q ss_pred EEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcC---CCcEEEEecCCcee
Q 010401 409 LCVVTKLMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDR---HGNVCLGDMGIVTA 483 (511)
Q Consensus 409 l~LVmEy~~gGsL~~lL~~~--~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~---~g~vKL~DFGlS~~ 483 (511)
+|+||||+.+|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++.
T Consensus 101 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~ 180 (336)
T 3fhr_A 101 LLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE 180 (336)
T ss_dssp EEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEecccccee
Confidence 89999999999999999764 36999999999999999999999999999999999999986 45599999999986
Q ss_pred cccCCCccccccCCCccccHHhhcc
Q 010401 484 CKSVGEATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 484 l~~~~~~~~~~~Gt~~YmAPEvl~g 508 (511)
.... ......||+.|+|||++.+
T Consensus 181 ~~~~--~~~~~~~t~~y~aPE~~~~ 203 (336)
T 3fhr_A 181 TTQN--ALQTPCYTPYYVAPEVLGP 203 (336)
T ss_dssp C------------------------
T ss_pred cccc--ccccCCCCcCccChhhhCC
Confidence 5432 2345678999999999753
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.9e-25 Score=230.53 Aligned_cols=163 Identities=22% Similarity=0.291 Sum_probs=136.2
Q ss_pred CCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCC-CC-----ceeeEeeeEeeCC
Q 010401 339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCG-HK-----NILQFYCVCVDEN 406 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~-Hp-----NIV~l~g~~~~~~ 406 (511)
.++|++.+.||+|+||.||+| +.||+|+++. ......++..|+.++..++ |+ +|+++++++...+
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 129 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKN---KKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN 129 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECS---SHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEec---cHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC
Confidence 578999999999999999996 5799999963 2333455677887777663 44 5999999999877
Q ss_pred CcEEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HCCccccCCCCCceEEc--CCCcEEEEecCC
Q 010401 407 HGLCVVTKLMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLN--DHGVAYRDLNSQRILLD--RHGNVCLGDMGI 480 (511)
Q Consensus 407 ~~l~LVmEy~~gGsL~~lL~~~--~~L~e~~~~~ia~qIa~gL~yLH--~~gIIHRDLKp~NILld--~~g~vKL~DFGl 480 (511)
. +|+||||+.+ +|.+++... +.+++..++.++.||+.||.||| +.||+||||||+|||++ .++.+||+|||+
T Consensus 130 ~-~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~ 207 (382)
T 2vx3_A 130 H-LCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGS 207 (382)
T ss_dssp E-EEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTT
T ss_pred c-eEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccC
Confidence 6 9999999965 999999654 46999999999999999999999 57999999999999995 478899999999
Q ss_pred ceecccCCCccccccCCCccccHHhhccc
Q 010401 481 VTACKSVGEATEYETDGYRWLAPEVCFLL 509 (511)
Q Consensus 481 S~~l~~~~~~~~~~~Gt~~YmAPEvl~gl 509 (511)
++.... ......||+.|+|||++.+.
T Consensus 208 a~~~~~---~~~~~~~t~~y~aPE~~~~~ 233 (382)
T 2vx3_A 208 SCQLGQ---RIYQYIQSRFYRSPEVLLGM 233 (382)
T ss_dssp CEETTC---CCCSSCSCGGGCCHHHHTTC
T ss_pred ceeccc---ccccccCCccccChHHHcCC
Confidence 987643 23456789999999998763
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.1e-25 Score=244.94 Aligned_cols=153 Identities=15% Similarity=0.118 Sum_probs=119.3
Q ss_pred EeeeecccceEEEEe----EEEEEEEEecCCCCch------HHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEEe
Q 010401 345 IDQIGPNSFKGVYKG----KRVGIEKLKGCDKGNA------YEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTK 414 (511)
Q Consensus 345 ~~~LG~GsFG~VYkg----k~VAVKkL~~~~~~~~------~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVmE 414 (511)
.+.||+|+||.||++ +.+++|++........ ...++.+|+.++++++||||+++..++...+. .|||||
T Consensus 341 ~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~-~~lVmE 419 (540)
T 3en9_A 341 EHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDN-KRIMMS 419 (540)
T ss_dssp -------CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTT-TEEEEE
T ss_pred CCEEeeCCCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCc-cEEEEE
Confidence 578999999999964 5789998764322211 12347899999999999999966655656665 799999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCc----
Q 010401 415 LMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA---- 490 (511)
Q Consensus 415 y~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~---- 490 (511)
|+++++|.+++.. +..++.||+.||+|||++||+||||||+|||++. .+||+|||+++........
T Consensus 420 ~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~~ 489 (540)
T 3en9_A 420 YINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVDL 489 (540)
T ss_dssp CCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHHHH
T ss_pred CCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCccccccch
Confidence 9999999999854 5689999999999999999999999999999998 9999999999887543221
Q ss_pred ---cccccCCCccccHHhhcc
Q 010401 491 ---TEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 491 ---~~~~~Gt~~YmAPEvl~g 508 (511)
.....||+.|||||++.+
T Consensus 490 ~~~~~~~~GT~~y~APEv~~~ 510 (540)
T 3en9_A 490 IVFKKAVLSTHHEKFDEIWER 510 (540)
T ss_dssp HHHHHHHHHHCGGGHHHHHHH
T ss_pred hhhhhhhcCCCCcCCHHHHHH
Confidence 135678999999999875
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.91 E-value=4.1e-24 Score=213.08 Aligned_cols=142 Identities=15% Similarity=0.125 Sum_probs=123.5
Q ss_pred ecCCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCC-chHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcE
Q 010401 337 LNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKG-NAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGL 409 (511)
Q Consensus 337 l~~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~-~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l 409 (511)
+-.++|++.+.||+|+||.||++ +.||+|++...... ......+.+|+..+..++||||+++++++.+.+. +
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~-~ 106 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAG-G 106 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTE-E
T ss_pred EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCc-E
Confidence 34577999999999999999995 57999999754333 2344668899999999999999999999998776 9
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCc
Q 010401 410 CVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIV 481 (511)
Q Consensus 410 ~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS 481 (511)
|+||||+.+++|.+++.. + .....+..++.||+.||+|||++||+||||||+|||++.+|.+||+++|..
T Consensus 107 ~lv~e~~~g~~L~~~l~~-~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~~~ 176 (286)
T 3uqc_A 107 LVVAEWIRGGSLQEVADT-S-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPATM 176 (286)
T ss_dssp EEEEECCCEEEHHHHHTT-C-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCCCC
T ss_pred EEEEEecCCCCHHHHHhc-C-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecccc
Confidence 999999999999999844 3 456678899999999999999999999999999999999999999987763
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=2.4e-25 Score=248.08 Aligned_cols=167 Identities=17% Similarity=0.216 Sum_probs=139.4
Q ss_pred CCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEee-----CCCc
Q 010401 340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVD-----ENHG 408 (511)
Q Consensus 340 ~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~-----~~~~ 408 (511)
++|++.+.||+|+||.||++ +.||+|++... ........+.+|+.++..++||||+++++++.. .+..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~-~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC-CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 57899999999999999985 57999998742 334455668999999999999999999998755 1333
Q ss_pred EEEEEeccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCc---EEEEecCCce
Q 010401 409 LCVVTKLMEGGSVNDLILKSR---KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGN---VCLGDMGIVT 482 (511)
Q Consensus 409 l~LVmEy~~gGsL~~lL~~~~---~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~---vKL~DFGlS~ 482 (511)
.|+||||+++|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++.
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~ 172 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK 172 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccccccc
Confidence 899999999999999997543 6899999999999999999999999999999999999997664 9999999998
Q ss_pred ecccCCCccccccCCCccccHHhhcc
Q 010401 483 ACKSVGEATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 483 ~l~~~~~~~~~~~Gt~~YmAPEvl~g 508 (511)
...... ......|++.|+|||++.+
T Consensus 173 ~~~~~~-~~~~~~gt~~Y~APE~l~~ 197 (676)
T 3qa8_A 173 ELDQGE-LCTEFVGTLQYLAPELLEQ 197 (676)
T ss_dssp BTTSCC-CCCCCCSCCTTCSSCSSCC
T ss_pred cccccc-ccccccCCcccCChHHhcc
Confidence 765432 3445678999999999864
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.1e-23 Score=209.37 Aligned_cols=140 Identities=18% Similarity=0.310 Sum_probs=119.9
Q ss_pred CCeEEE-eeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHH-HhCCCCceeeEeeeEee---CCCc
Q 010401 340 DNLEFI-DQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLEL-MTCGHKNILQFYCVCVD---ENHG 408 (511)
Q Consensus 340 ~~y~l~-~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL-~~l~HpNIV~l~g~~~~---~~~~ 408 (511)
++|.+. +.||+|+||.||++ +.||+|++... ..+.+|+.++ +..+||||+++++++.. .+..
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 89 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 89 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCce
Confidence 456776 78999999999996 47999999631 3456777777 55699999999999876 2234
Q ss_pred EEEEEeccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcC---CCcEEEEecCCcee
Q 010401 409 LCVVTKLMEGGSVNDLILKSR--KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDR---HGNVCLGDMGIVTA 483 (511)
Q Consensus 409 l~LVmEy~~gGsL~~lL~~~~--~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~---~g~vKL~DFGlS~~ 483 (511)
+|+||||+++|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++..
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 169 (299)
T 3m2w_A 90 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 169 (299)
T ss_dssp EEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccccccc
Confidence 899999999999999997643 6999999999999999999999999999999999999998 78999999999977
Q ss_pred ccc
Q 010401 484 CKS 486 (511)
Q Consensus 484 l~~ 486 (511)
...
T Consensus 170 ~~~ 172 (299)
T 3m2w_A 170 TTG 172 (299)
T ss_dssp CTT
T ss_pred ccc
Confidence 643
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.89 E-value=8.6e-24 Score=221.47 Aligned_cols=164 Identities=14% Similarity=0.131 Sum_probs=121.5
Q ss_pred CCCeEEEeeeecccceEEEEeE------EEEEEEEecCCCC-chHHHHHHHHHHHHHhCCC-Cce----------e----
Q 010401 339 SDNLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDKG-NAYEFELRKDLLELMTCGH-KNI----------L---- 396 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkgk------~VAVKkL~~~~~~-~~~~~~~~~Ei~iL~~l~H-pNI----------V---- 396 (511)
..+|++.+.||+|+||.||+++ .||||++...... ......+.+|+.++..+.| +|+ +
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 3457889999999999999964 7999998743222 2234568899999988877 221 1
Q ss_pred -------eEeeeEeeCC----CcEEEEEeccCCCCHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Q 010401 397 -------QFYCVCVDEN----HGLCVVTKLMEGGSVNDLILK-------SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYR 458 (511)
Q Consensus 397 -------~l~g~~~~~~----~~l~LVmEy~~gGsL~~lL~~-------~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHR 458 (511)
.+..++.... ..++++|+++ +++|.+++.. ...+++..++.++.||+.||+|||++|||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHr 235 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT 235 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence 1111111111 1267888876 5699999841 2357788999999999999999999999999
Q ss_pred CCCCCceEEcCCCcEEEEecCCceecccCCCccccccCCCccccHHhhc
Q 010401 459 DLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEVCF 507 (511)
Q Consensus 459 DLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~~~~~Gt~~YmAPEvl~ 507 (511)
||||+|||++.++.+||+|||+++..... ....+| +.|+|||++.
T Consensus 236 DiKp~NILl~~~~~~kL~DFG~a~~~~~~---~~~~~g-~~y~aPE~~~ 280 (413)
T 3dzo_A 236 YLRPVDIVLDQRGGVFLTGFEHLVRDGAS---AVSPIG-RGFAPPETTA 280 (413)
T ss_dssp CCCGGGEEECTTCCEEECCGGGCEETTEE---ECCCCC-TTTCCHHHHH
T ss_pred CcccceEEEecCCeEEEEeccceeecCCc---cccCCC-CceeCchhhh
Confidence 99999999999999999999998865432 445567 9999999984
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=2.3e-22 Score=201.21 Aligned_cols=143 Identities=11% Similarity=0.024 Sum_probs=112.4
Q ss_pred CCCeEEEeeeecccceEEEEe-----EEEEEEEEecCCCCc----------------hHHHHHHHHHHHHHhCCCCceee
Q 010401 339 SDNLEFIDQIGPNSFKGVYKG-----KRVGIEKLKGCDKGN----------------AYEFELRKDLLELMTCGHKNILQ 397 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkg-----k~VAVKkL~~~~~~~----------------~~~~~~~~Ei~iL~~l~HpNIV~ 397 (511)
...|.+.+.||+|+||.||++ +.||+|+++...... .....+.+|+.++..++ | ++
T Consensus 89 ~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~ 165 (282)
T 1zar_A 89 GKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LA 165 (282)
T ss_dssp TSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SS
T ss_pred CeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CC
Confidence 445678899999999999996 579999996422111 12445889999999998 4 66
Q ss_pred EeeeEeeCCCcEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEe
Q 010401 398 FYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGD 477 (511)
Q Consensus 398 l~g~~~~~~~~l~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~D 477 (511)
+++++.. +. .|+||||++|++|.+ +. ......++.||+.||.|||++||+||||||+|||++ ++.+||+|
T Consensus 166 v~~~~~~-~~-~~lvmE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~D 235 (282)
T 1zar_A 166 VPKVYAW-EG-NAVLMELIDAKELYR-VR------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIID 235 (282)
T ss_dssp SCCEEEE-ET-TEEEEECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECC
T ss_pred cCeEEec-cc-eEEEEEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEE
Confidence 6665543 33 799999999999987 41 123457999999999999999999999999999999 99999999
Q ss_pred cCCceecccCCCccccccCCCccccHHhhc
Q 010401 478 MGIVTACKSVGEATEYETDGYRWLAPEVCF 507 (511)
Q Consensus 478 FGlS~~l~~~~~~~~~~~Gt~~YmAPEvl~ 507 (511)
||+++.. ..|+|||++.
T Consensus 236 FG~a~~~-------------~~~~a~e~l~ 252 (282)
T 1zar_A 236 FPQSVEV-------------GEEGWREILE 252 (282)
T ss_dssp CTTCEET-------------TSTTHHHHHH
T ss_pred CCCCeEC-------------CCCCHHHHHH
Confidence 9998743 2368888875
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=2.6e-19 Score=176.06 Aligned_cols=135 Identities=16% Similarity=0.137 Sum_probs=102.6
Q ss_pred eEEEeeeecccceEEEEeE------E--EEEEEEecCCCCc----------------------hHHHHHHHHHHHHHhCC
Q 010401 342 LEFIDQIGPNSFKGVYKGK------R--VGIEKLKGCDKGN----------------------AYEFELRKDLLELMTCG 391 (511)
Q Consensus 342 y~l~~~LG~GsFG~VYkgk------~--VAVKkL~~~~~~~----------------------~~~~~~~~Ei~iL~~l~ 391 (511)
|++.+.||+|+||.||+|+ . ||||+++...... .....+.+|+..+..+.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 6888999999999999964 5 9999875421110 11235788999999988
Q ss_pred CCce--eeEeeeEeeCCCcEEEEEeccCC-C----CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-HCCccccCCCCC
Q 010401 392 HKNI--LQFYCVCVDENHGLCVVTKLMEG-G----SVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN-DHGVAYRDLNSQ 463 (511)
Q Consensus 392 HpNI--V~l~g~~~~~~~~l~LVmEy~~g-G----sL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH-~~gIIHRDLKp~ 463 (511)
|++| ..+++. + ..+|||||+.+ | +|.++... .++..+..++.||+.||.||| ++||+||||||+
T Consensus 129 ~~~i~~p~~~~~----~-~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~ 200 (258)
T 1zth_A 129 EAGVSVPQPYTY----M-KNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLSEY 200 (258)
T ss_dssp HTTCCCCCEEEE----E-TTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTT
T ss_pred hCCCCCCeEEEc----C-CCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHH
Confidence 8764 333332 2 26899999942 3 67666432 235567889999999999999 999999999999
Q ss_pred ceEEcCCCcEEEEecCCceeccc
Q 010401 464 RILLDRHGNVCLGDMGIVTACKS 486 (511)
Q Consensus 464 NILld~~g~vKL~DFGlS~~l~~ 486 (511)
|||++. .++|+|||+|.....
T Consensus 201 NILl~~--~~~liDFG~a~~~~~ 221 (258)
T 1zth_A 201 NIMYID--KVYFIDMGQAVTLRH 221 (258)
T ss_dssp SEEESS--SEEECCCTTCEETTS
T ss_pred HEEEcC--cEEEEECcccccCCC
Confidence 999998 999999999987643
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.60 E-value=6.8e-16 Score=162.09 Aligned_cols=136 Identities=12% Similarity=0.065 Sum_probs=95.3
Q ss_pred eEEEeeeecccceEEEEe-----EEEEEEEEecCCCC------------chHH--------HHHHHHHHHHHhCCCCcee
Q 010401 342 LEFIDQIGPNSFKGVYKG-----KRVGIEKLKGCDKG------------NAYE--------FELRKDLLELMTCGHKNIL 396 (511)
Q Consensus 342 y~l~~~LG~GsFG~VYkg-----k~VAVKkL~~~~~~------------~~~~--------~~~~~Ei~iL~~l~HpNIV 396 (511)
|++...||.|+||.||+| +.||||+++..... .... ....+|...|.++.+.++.
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~ 176 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP 176 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 899999999999999995 58999987532100 0000 0123455566665444432
Q ss_pred eEeeeEeeCCCcEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCC-----
Q 010401 397 QFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG----- 471 (511)
Q Consensus 397 ~l~g~~~~~~~~l~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g----- 471 (511)
-..-+.. .. .+|||||+.|++|..+. .......++.||+.+|.|||++|||||||||.|||++++|
T Consensus 177 vp~p~~~-~~--~~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d~ 247 (397)
T 4gyi_A 177 VPEPIAQ-SR--HTIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAEDP 247 (397)
T ss_dssp CCCEEEE-ET--TEEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSCT
T ss_pred CCeeeec-cC--ceEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcccc
Confidence 2221212 12 47999999998886543 1223467889999999999999999999999999999877
Q ss_pred -----cEEEEecCCceeccc
Q 010401 472 -----NVCLGDMGIVTACKS 486 (511)
Q Consensus 472 -----~vKL~DFGlS~~l~~ 486 (511)
.+.|+||+-+.....
T Consensus 248 ~~~~~~~~iID~~Q~V~~~h 267 (397)
T 4gyi_A 248 SSITLTPIIIXFPQMVSMDH 267 (397)
T ss_dssp TSEEEEEEECCCTTCEETTS
T ss_pred cccccceEEEEeCCcccCCC
Confidence 389999998765443
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.22 E-value=4.5e-11 Score=115.92 Aligned_cols=136 Identities=13% Similarity=0.113 Sum_probs=104.7
Q ss_pred CCeEEEeeeecccceEEEEe----EEEEEEEEecCCCCchHHHHHHHHHHHHHhC-CCCceeeEeeeEeeCCCcEEEEEe
Q 010401 340 DNLEFIDQIGPNSFKGVYKG----KRVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCVCVDENHGLCVVTK 414 (511)
Q Consensus 340 ~~y~l~~~LG~GsFG~VYkg----k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l-~HpNIV~l~g~~~~~~~~l~LVmE 414 (511)
+.|++...++.|+++.||+. +.+++|......... ...+.+|+.++..+ .+..+.++++++.+.+. .|+|||
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~~~~~~vlK~~~~~~~~~--~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~-~~lv~e 90 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGT--TYDVEREKDMMLWLEGKLPVPKVLHFERHDGW-SNLLMS 90 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEECSSCEEEEEEECGGGTTS--TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTE-EEEEEE
T ss_pred ccceeEeeccCCCCCeEEEEECCCCcEEEEeCCcccCCC--HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCc-eEEEEE
Confidence 35788889999999999994 588999886421111 12467888888877 36778888988877654 899999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH------------------------------------------
Q 010401 415 LMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLND------------------------------------------ 452 (511)
Q Consensus 415 y~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~------------------------------------------ 452 (511)
|++|.+|.+.+. +......++.+++.+|..||+
T Consensus 91 ~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (263)
T 3tm0_A 91 EADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFK 165 (263)
T ss_dssp CCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSS
T ss_pred ecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCC
Confidence 999999877531 122334678899999999998
Q ss_pred -----------------CCccccCCCCCceEEcCCCcEEEEecCCcee
Q 010401 453 -----------------HGVAYRDLNSQRILLDRHGNVCLGDMGIVTA 483 (511)
Q Consensus 453 -----------------~gIIHRDLKp~NILld~~g~vKL~DFGlS~~ 483 (511)
..++|+|++|.|||+++++.+.|+||+.+..
T Consensus 166 ~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 166 DPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp SHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred CHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 4589999999999998766667999998754
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.04 E-value=5.1e-10 Score=106.94 Aligned_cols=130 Identities=12% Similarity=0.035 Sum_probs=90.4
Q ss_pred CeEEEeeeecccceEEEEe-----EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCc--eeeEeeeEeeCCCcEEEEE
Q 010401 341 NLEFIDQIGPNSFKGVYKG-----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKN--ILQFYCVCVDENHGLCVVT 413 (511)
Q Consensus 341 ~y~l~~~LG~GsFG~VYkg-----k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpN--IV~l~g~~~~~~~~l~LVm 413 (511)
.+.+....+.|..+.||+. +.+++|...... ...+.+|+.++..+.+.+ +.+++++...++. .|+||
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~-----~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~-~~~v~ 94 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA-----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGR-DWLLL 94 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSCT-----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSC-EEEEE
T ss_pred CCceEecccCCCCceEEEEecCCCCeEEEEeCCccc-----chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCC-CEEEE
Confidence 3444444456667999985 358888875421 123567888777774434 4568887776655 89999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---------------------------------------
Q 010401 414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHG--------------------------------------- 454 (511)
Q Consensus 414 Ey~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~g--------------------------------------- 454 (511)
||++|.+|. +. ... ...++.+++..|..||+..
T Consensus 95 e~i~G~~l~--~~---~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (264)
T 1nd4_A 95 GEVPGQDLL--SS---HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLA 166 (264)
T ss_dssp ECCSSEETT--TS---CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCC
T ss_pred EecCCcccC--cC---cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCcc
Confidence 999998884 21 111 2245667777777777643
Q ss_pred -------------------ccccCCCCCceEEcCCCcEEEEecCCceec
Q 010401 455 -------------------VAYRDLNSQRILLDRHGNVCLGDMGIVTAC 484 (511)
Q Consensus 455 -------------------IIHRDLKp~NILld~~g~vKL~DFGlS~~l 484 (511)
++|+|++|.|||+++++.+.|+|||.+...
T Consensus 167 ~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~g 215 (264)
T 1nd4_A 167 PAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVA 215 (264)
T ss_dssp HHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred HHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcccC
Confidence 999999999999987766779999997653
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.94 E-value=1.9e-09 Score=109.71 Aligned_cols=137 Identities=10% Similarity=0.132 Sum_probs=98.9
Q ss_pred EEeeeecccceEEEEe----EEEEEEEEe--cCCCCchHHHHHHHHHHHHHhCC--CCceeeEeeeEeeCC--CcEEEEE
Q 010401 344 FIDQIGPNSFKGVYKG----KRVGIEKLK--GCDKGNAYEFELRKDLLELMTCG--HKNILQFYCVCVDEN--HGLCVVT 413 (511)
Q Consensus 344 l~~~LG~GsFG~VYkg----k~VAVKkL~--~~~~~~~~~~~~~~Ei~iL~~l~--HpNIV~l~g~~~~~~--~~l~LVm 413 (511)
-++.|+.|.++.||+. ..+.+|+.. ... .......+.+|..++..+. +..+.++++++.+.+ ...|+||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~~~~~vlr~~~~p~~~-~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTPGQTYVMRAKPGPKSK-LLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECSSCEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEECCceEEEEeCCCCCCC-CCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 3577899999999984 356676654 211 1112335778888888876 455788888877653 2278999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-----------------------------------------
Q 010401 414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLND----------------------------------------- 452 (511)
Q Consensus 414 Ey~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~----------------------------------------- 452 (511)
||++|..+.+. ....++......++.+++..|..||.
T Consensus 121 e~v~G~~l~~~--~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (359)
T 3dxp_A 121 EFVSGRVLWDQ--SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMD 198 (359)
T ss_dssp ECCCCBCCCCT--TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHH
T ss_pred EecCCeecCCC--ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHH
Confidence 99999777432 12346788888999999999999997
Q ss_pred -----------------CCccccCCCCCceEEcCCCc--EEEEecCCcee
Q 010401 453 -----------------HGVAYRDLNSQRILLDRHGN--VCLGDMGIVTA 483 (511)
Q Consensus 453 -----------------~gIIHRDLKp~NILld~~g~--vKL~DFGlS~~ 483 (511)
.+++|+|+++.|||++.++. +.|+||+.+..
T Consensus 199 ~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 199 SLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 35899999999999997653 68999999764
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.41 E-value=6.1e-07 Score=89.18 Aligned_cols=133 Identities=16% Similarity=0.088 Sum_probs=94.0
Q ss_pred eeeecccceEEEEe-EEEEEEEEecCCCCchHHHHHHHHHHHHHhC-CCCc--eeeEeeeEeeCCC--cEEEEEeccCCC
Q 010401 346 DQIGPNSFKGVYKG-KRVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKN--ILQFYCVCVDENH--GLCVVTKLMEGG 419 (511)
Q Consensus 346 ~~LG~GsFG~VYkg-k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l-~HpN--IV~l~g~~~~~~~--~l~LVmEy~~gG 419 (511)
+.++.|....||+. ..+.+|+-.. ......+.+|..++..+ .+.. +...+......+. ..|+||++++|.
T Consensus 26 ~~~~~G~~n~v~~v~~~~vlR~~~~----~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G~ 101 (304)
T 3sg8_A 26 EISGEGNDCIAYEINRDFIFKFPKH----SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKGV 101 (304)
T ss_dssp CEEEECSSEEEEESTTSEEEEEESS----HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCCE
T ss_pred EecCCCCcceEEEECCEEEEEecCC----cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCCe
Confidence 45899999999984 4566776532 13345678899888776 3333 3344444333221 147899999998
Q ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-----------------------------------------------
Q 010401 420 SVNDLILKSRKLQTKEIIRIAIDVAEGIKFLND----------------------------------------------- 452 (511)
Q Consensus 420 sL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~----------------------------------------------- 452 (511)
.|.+... ..++..+...++.+++..|..||+
T Consensus 102 ~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 179 (304)
T 3sg8_A 102 PLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYRD 179 (304)
T ss_dssp ECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHHH
T ss_pred ECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHHH
Confidence 8875432 346777778888888888888885
Q ss_pred -----------CCccccCCCCCceEEcC--CCcEEEEecCCceec
Q 010401 453 -----------HGVAYRDLNSQRILLDR--HGNVCLGDMGIVTAC 484 (511)
Q Consensus 453 -----------~gIIHRDLKp~NILld~--~g~vKL~DFGlS~~l 484 (511)
..++|+|++|.||+++. .+.+.|+||+.+...
T Consensus 180 ~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~ 224 (304)
T 3sg8_A 180 ILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAIS 224 (304)
T ss_dssp HHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEE
T ss_pred HHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccC
Confidence 13699999999999998 456789999997653
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.28 E-value=7e-06 Score=82.15 Aligned_cols=133 Identities=17% Similarity=0.088 Sum_probs=87.3
Q ss_pred eeeecccceEEEE-eEEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCC---ceeeEeeeEeeCCCcEEEEEeccCCCCH
Q 010401 346 DQIGPNSFKGVYK-GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHK---NILQFYCVCVDENHGLCVVTKLMEGGSV 421 (511)
Q Consensus 346 ~~LG~GsFG~VYk-gk~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~Hp---NIV~l~g~~~~~~~~l~LVmEy~~gGsL 421 (511)
+.++.|....||+ |+.+.+|+-. .......+.+|..+|..+.+. .+.+.+.+........|+||||++|..+
T Consensus 25 ~~l~~G~~n~v~~vg~~~VlR~~~----~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~l 100 (306)
T 3tdw_A 25 ESLGEGFRNYAILVNGDWVFRFPK----SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQIL 100 (306)
T ss_dssp EEEEECSSEEEEEETTTEEEEEES----SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEEC
T ss_pred eecCCCcceeEEEECCEEEEEecC----CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeEC
Confidence 5578888888988 5567777642 123345688999999888642 2456666654333347899999999887
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-------------------------------------------------
Q 010401 422 NDLILKSRKLQTKEIIRIAIDVAEGIKFLND------------------------------------------------- 452 (511)
Q Consensus 422 ~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~------------------------------------------------- 452 (511)
.+... ..++......++.++...|..||+
T Consensus 101 ~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~ 178 (306)
T 3tdw_A 101 GEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRFQS 178 (306)
T ss_dssp HHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHHHHH
T ss_pred chhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHHHHH
Confidence 65321 123344444444444444444443
Q ss_pred -----------CCccccCCCCCceEEcC---CCc-EEEEecCCceec
Q 010401 453 -----------HGVAYRDLNSQRILLDR---HGN-VCLGDMGIVTAC 484 (511)
Q Consensus 453 -----------~gIIHRDLKp~NILld~---~g~-vKL~DFGlS~~l 484 (511)
..++|+|+++.|||++. ++. +.|+||+.+...
T Consensus 179 ~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 179 YMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 14699999999999997 455 489999987653
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=97.96 E-value=0.0001 Score=71.13 Aligned_cols=126 Identities=12% Similarity=0.097 Sum_probs=83.9
Q ss_pred eecccce-EEEE------eEEEEEEEEecCCCCchHHHHHHHHHHHHHhCC-CCceeeEeeeEeeCCCcEEEEEeccCCC
Q 010401 348 IGPNSFK-GVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCG-HKNILQFYCVCVDENHGLCVVTKLMEGG 419 (511)
Q Consensus 348 LG~GsFG-~VYk------gk~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~-HpNIV~l~g~~~~~~~~l~LVmEy~~gG 419 (511)
+..|..| .||+ +..+.+|.-... ....+.+|...|..+. +--+.++++++.+.+. .|+|||+++|.
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~-----~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~-~~lvme~l~G~ 105 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS-----VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDD-AWLLTTAIPGK 105 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEETH-----HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTE-EEEEEECCCSE
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCCC-----CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCe-EEEEEEeeCCc
Confidence 4445444 5786 235677765421 2345677888887663 2235677888877765 89999999998
Q ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC----------------------------------------------
Q 010401 420 SVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDH---------------------------------------------- 453 (511)
Q Consensus 420 sL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~---------------------------------------------- 453 (511)
++.+..... ......+..+++..|.-||..
T Consensus 106 ~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 181 (272)
T 4gkh_A 106 TAFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK 181 (272)
T ss_dssp EHHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred cccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence 887765321 112234455555556555531
Q ss_pred ------------CccccCCCCCceEEcCCCcEEEEecCCcee
Q 010401 454 ------------GVAYRDLNSQRILLDRHGNVCLGDMGIVTA 483 (511)
Q Consensus 454 ------------gIIHRDLKp~NILld~~g~vKL~DFGlS~~ 483 (511)
.++|+|+.+.|||+++++.+-|+||+.+..
T Consensus 182 ~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 182 EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 168999999999999877778999999764
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.71 E-value=5.4e-05 Score=76.43 Aligned_cols=31 Identities=16% Similarity=0.168 Sum_probs=26.2
Q ss_pred CCccccCCCCCceEEcCCCcEEEEecCCcee
Q 010401 453 HGVAYRDLNSQRILLDRHGNVCLGDMGIVTA 483 (511)
Q Consensus 453 ~gIIHRDLKp~NILld~~g~vKL~DFGlS~~ 483 (511)
..++|+|+.+.|||++++..+.|+||+.+..
T Consensus 222 ~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~~ 252 (357)
T 3ats_A 222 PVLLWGDARVGNVLYRDFQPVAVLDWEMVAL 252 (357)
T ss_dssp CEEECSSCSGGGEEEETTEEEEECCGGGCEE
T ss_pred ceEEeCCCCCCeEEEeCCcEEEEEccccccc
Confidence 4699999999999999644579999998754
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.64 E-value=0.00047 Score=68.20 Aligned_cols=31 Identities=16% Similarity=0.268 Sum_probs=27.9
Q ss_pred CCccccCCCCCceEEcCCCcEEEEecCCcee
Q 010401 453 HGVAYRDLNSQRILLDRHGNVCLGDMGIVTA 483 (511)
Q Consensus 453 ~gIIHRDLKp~NILld~~g~vKL~DFGlS~~ 483 (511)
.+++|+|+++.|||++.++.+.|+||+.+..
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 5799999999999998888999999998753
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.59 E-value=0.00019 Score=73.70 Aligned_cols=72 Identities=15% Similarity=0.138 Sum_probs=43.6
Q ss_pred EeeeecccceEEEEe------EEEEEEEEecCCC--C---chHHHHHHHHHHHHHhCCC--C-ceeeEeeeEeeCCCcEE
Q 010401 345 IDQIGPNSFKGVYKG------KRVGIEKLKGCDK--G---NAYEFELRKDLLELMTCGH--K-NILQFYCVCVDENHGLC 410 (511)
Q Consensus 345 ~~~LG~GsFG~VYkg------k~VAVKkL~~~~~--~---~~~~~~~~~Ei~iL~~l~H--p-NIV~l~g~~~~~~~~l~ 410 (511)
.+.||.|.++.||++ +.+++|....... . .....++..|..++..+.. + .+.+++.+ +.+. .+
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~-~~ 111 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEM-AV 111 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTT-TE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCc-cE
Confidence 468999999999986 3588887643111 0 0112335667777766522 3 34455543 3333 57
Q ss_pred EEEeccCCC
Q 010401 411 VVTKLMEGG 419 (511)
Q Consensus 411 LVmEy~~gG 419 (511)
+||||+.+.
T Consensus 112 lvmE~l~g~ 120 (397)
T 2olc_A 112 TVMEDLSHL 120 (397)
T ss_dssp EEECCCTTS
T ss_pred EEEEeCCCc
Confidence 999999763
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.21 E-value=0.0012 Score=68.50 Aligned_cols=33 Identities=9% Similarity=0.100 Sum_probs=28.2
Q ss_pred HHCCccccCCCCCceEEcCCCcEEEEecCCceec
Q 010401 451 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC 484 (511)
Q Consensus 451 H~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l 484 (511)
+...++|+|+++.|||++.++ ++|+||+.+...
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G 262 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYG 262 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC-EEECCCTTCEEE
T ss_pred CCCeEEecCCCCCcEEEeCCC-CEEEeCcccccC
Confidence 346799999999999999776 999999987643
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.98 E-value=0.0047 Score=60.89 Aligned_cols=29 Identities=14% Similarity=0.063 Sum_probs=24.7
Q ss_pred CccccCCCCCceEEcCCCcEEEEecCCcee
Q 010401 454 GVAYRDLNSQRILLDRHGNVCLGDMGIVTA 483 (511)
Q Consensus 454 gIIHRDLKp~NILld~~g~vKL~DFGlS~~ 483 (511)
.++|+|+.+.||+ ..++.+.|+||..+..
T Consensus 174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 174 AACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 3899999999999 5667789999998654
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=96.75 E-value=0.0087 Score=60.40 Aligned_cols=73 Identities=10% Similarity=0.132 Sum_probs=51.7
Q ss_pred EEEeeeecccceEEEEe----EEEEEEEEecCCCCchHHHHHHHHHHHHHhCC---CCceeeEeeeEeeCCCcEEEEEec
Q 010401 343 EFIDQIGPNSFKGVYKG----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCG---HKNILQFYCVCVDENHGLCVVTKL 415 (511)
Q Consensus 343 ~l~~~LG~GsFG~VYkg----k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~---HpNIV~l~g~~~~~~~~l~LVmEy 415 (511)
.-.+.|+.|.+..+|+. ..+.+|.-... ....+..|...|..+. ...+.+.+++....+. .|+||||
T Consensus 39 ~~~~~l~gG~~n~~y~v~~~~~~~vlK~~~~~-----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~-~~lvme~ 112 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLINDEVQTVFVKINERS-----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGH-SFLLLEA 112 (312)
T ss_dssp CEEEEECCSSSSEEEEEESSSCEEEEEEEEGG-----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSE-EEEEEEC
T ss_pred eeeEEeCCccceeeeEEEECCCeEEEEeCCcc-----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCc-eEEEEEe
Confidence 34577899999999984 46777776531 2345677877777662 3567788877766554 8999999
Q ss_pred cCCCCH
Q 010401 416 MEGGSV 421 (511)
Q Consensus 416 ~~gGsL 421 (511)
+++..+
T Consensus 113 l~G~~~ 118 (312)
T 3jr1_A 113 LNKSKN 118 (312)
T ss_dssp CCCCCC
T ss_pred ccCCCC
Confidence 998753
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=96.41 E-value=0.012 Score=57.46 Aligned_cols=75 Identities=13% Similarity=0.138 Sum_probs=48.1
Q ss_pred CCCeEEEeeeecccceEEEE-----eEEEEEEEEecCCCCchHHHHHHHHHHHHHhCCC---CceeeEeeeEeeCCCcEE
Q 010401 339 SDNLEFIDQIGPNSFKGVYK-----GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGH---KNILQFYCVCVDENHGLC 410 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYk-----gk~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~H---pNIV~l~g~~~~~~~~l~ 410 (511)
...+.-++.+|.|..+.||+ |+.+.+|+-....... ...+..|...|+.+.- --+.+.+++ +. -+
T Consensus 14 G~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~--~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~~---~~ 86 (288)
T 3f7w_A 14 GREVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPAL--DGLFRAEALGLDWLGRSFGSPVPQVAGW--DD---RT 86 (288)
T ss_dssp CCCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCC--TTHHHHHHHHHHHHTCSTTCCSCCEEEE--ET---TE
T ss_pred CCCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcch--hhHHHHHHHHHHHHHhhCCCCcceEEec--cC---ce
Confidence 34566778999999999999 5688888765322221 2235677777776632 123444443 22 36
Q ss_pred EEEeccCCCC
Q 010401 411 VVTKLMEGGS 420 (511)
Q Consensus 411 LVmEy~~gGs 420 (511)
+||||+.++.
T Consensus 87 lv~e~l~~~~ 96 (288)
T 3f7w_A 87 LAMEWVDERP 96 (288)
T ss_dssp EEEECCCCCC
T ss_pred EEEEeecccC
Confidence 8999998764
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.10 E-value=0.0069 Score=59.80 Aligned_cols=41 Identities=20% Similarity=0.202 Sum_probs=31.5
Q ss_pred HHHHHHHHHH-------CCccccCCCCCceEEcCCCcEEEEecCCcee
Q 010401 443 VAEGIKFLND-------HGVAYRDLNSQRILLDRHGNVCLGDMGIVTA 483 (511)
Q Consensus 443 Ia~gL~yLH~-------~gIIHRDLKp~NILld~~g~vKL~DFGlS~~ 483 (511)
+...+++++. .+++|+|+++.|||++.++.+.|+||+.+..
T Consensus 170 l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 170 IRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp HHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 3445556653 3699999999999999776668999998654
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=95.74 E-value=0.064 Score=53.24 Aligned_cols=32 Identities=19% Similarity=0.103 Sum_probs=27.5
Q ss_pred CCccccCCCCCceEEcCC----CcEEEEecCCceec
Q 010401 453 HGVAYRDLNSQRILLDRH----GNVCLGDMGIVTAC 484 (511)
Q Consensus 453 ~gIIHRDLKp~NILld~~----g~vKL~DFGlS~~l 484 (511)
..++|+|+.+.|||++.+ +.+.|+||+.+...
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 469999999999999874 68999999987653
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=95.61 E-value=0.066 Score=52.78 Aligned_cols=29 Identities=14% Similarity=-0.007 Sum_probs=25.1
Q ss_pred CCccccCCCCCceEEcCCCcEEEEecCCcee
Q 010401 453 HGVAYRDLNSQRILLDRHGNVCLGDMGIVTA 483 (511)
Q Consensus 453 ~gIIHRDLKp~NILld~~g~vKL~DFGlS~~ 483 (511)
..++|+|+++.|||++ + .+.|+||+.+..
T Consensus 195 ~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 195 VLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred eeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 4589999999999999 4 899999988654
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=95.05 E-value=0.07 Score=55.84 Aligned_cols=66 Identities=9% Similarity=0.083 Sum_probs=39.1
Q ss_pred EeeeecccceEEEEeE-------------EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCc-eeeEeeeEeeCCCcEE
Q 010401 345 IDQIGPNSFKGVYKGK-------------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKN-ILQFYCVCVDENHGLC 410 (511)
Q Consensus 345 ~~~LG~GsFG~VYkgk-------------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpN-IV~l~g~~~~~~~~l~ 410 (511)
++.|+.|-...||+.. .+.+|+... . .. ...+..|..++..+...+ ..++++.+. + .
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~-~-~~--~~~li~E~~~l~~L~~~g~~P~l~~~~~--~---g 148 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-P-ET--ESHLVAESVIFTLLSERHLGPKLYGIFS--G---G 148 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-C-CC--HHHHHHHHHHHHHHHHTTSSSCEEEEET--T---E
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCC-C-Cc--HHHHHHHHHHHHHHHhCCCCCcEEEEeC--C---C
Confidence 4667888888999853 455665532 1 11 123446777776663223 356666543 2 2
Q ss_pred EEEeccCCC
Q 010401 411 VVTKLMEGG 419 (511)
Q Consensus 411 LVmEy~~gG 419 (511)
+||||++|.
T Consensus 149 ~v~e~l~G~ 157 (429)
T 1nw1_A 149 RLEEYIPSR 157 (429)
T ss_dssp EEECCCCEE
T ss_pred EEEEEeCCc
Confidence 899999763
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=93.93 E-value=0.09 Score=54.44 Aligned_cols=30 Identities=20% Similarity=0.191 Sum_probs=26.7
Q ss_pred CccccCCCCCceEEcCC----CcEEEEecCCcee
Q 010401 454 GVAYRDLNSQRILLDRH----GNVCLGDMGIVTA 483 (511)
Q Consensus 454 gIIHRDLKp~NILld~~----g~vKL~DFGlS~~ 483 (511)
.++|+|+.+.|||++.+ +.+.|+||..+..
T Consensus 221 ~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 221 VFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp EEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred EEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 58999999999999876 7899999998754
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=93.46 E-value=0.28 Score=51.96 Aligned_cols=68 Identities=15% Similarity=0.098 Sum_probs=38.9
Q ss_pred EeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCce-eeEeeeEeeCCCcEEEEEeccC
Q 010401 345 IDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNI-LQFYCVCVDENHGLCVVTKLME 417 (511)
Q Consensus 345 ~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNI-V~l~g~~~~~~~~l~LVmEy~~ 417 (511)
++.|+.|-...+|+. +.+.+|+... ..... .....|..++..+...++ .++++.+ .+ .+||||++
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~-~~~~~--idR~~E~~vl~~L~~~gl~P~ll~~~--~~---G~v~e~I~ 184 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGP-KTDEI--INREREKKISCILYNKNIAKKIYVFF--TN---GRIEEFMD 184 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC--CCSC--SCHHHHHHHHHHHTTSSSBCCEEEEE--TT---EEEEECCC
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCC-Chhhh--cCHHHHHHHHHHHHhcCCCCCEEEEe--CC---eEEEEeeC
Confidence 456788888889984 4566665532 11111 112577777777754444 5677665 22 25999998
Q ss_pred CCC
Q 010401 418 GGS 420 (511)
Q Consensus 418 gGs 420 (511)
|..
T Consensus 185 G~~ 187 (458)
T 2qg7_A 185 GYA 187 (458)
T ss_dssp SEE
T ss_pred Ccc
Confidence 643
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=85.57 E-value=0.64 Score=46.75 Aligned_cols=29 Identities=17% Similarity=0.096 Sum_probs=24.2
Q ss_pred CccccCCCCCceEEcCCCcEEEEecCCcee
Q 010401 454 GVAYRDLNSQRILLDRHGNVCLGDMGIVTA 483 (511)
Q Consensus 454 gIIHRDLKp~NILld~~g~vKL~DFGlS~~ 483 (511)
.++|+|+++.|||++.++ +.|+||..+..
T Consensus 213 ~l~HgDl~~~Nil~~~~~-~~lID~e~a~~ 241 (369)
T 3c5i_A 213 VFCHNDLQENNIINTNKC-LRLIDFEYSGF 241 (369)
T ss_dssp EEECSCCCGGGEEECC-C-EEECCCTTCEE
T ss_pred EEEeCCCCcccEEecCCc-EEEEEecCCCC
Confidence 589999999999998655 89999987643
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=85.23 E-value=0.47 Score=47.65 Aligned_cols=32 Identities=9% Similarity=0.129 Sum_probs=27.9
Q ss_pred CCccccCCCCCceEEcCCCcEEEEecCCceec
Q 010401 453 HGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC 484 (511)
Q Consensus 453 ~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l 484 (511)
..++|+|+.+.||+++.++.+.|+||+.+...
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 36999999999999998888999999886543
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 511 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-28 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-27 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-26 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-26 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-26 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 9e-26 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-25 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-25 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-24 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 4e-24 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 6e-24 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-23 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-23 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 5e-23 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 6e-23 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-22 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-22 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-22 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-22 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 4e-22 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 5e-22 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 6e-21 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 7e-21 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-20 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-20 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-20 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-20 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 3e-20 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-20 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 5e-20 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 8e-20 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-19 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-19 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-19 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-19 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 4e-19 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 5e-19 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 7e-19 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 9e-19 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-18 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-18 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-18 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-18 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-18 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-18 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 5e-18 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-17 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-17 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 4e-17 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-16 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-16 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-15 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-15 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 9e-15 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-14 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 7e-14 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-13 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 7e-13 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-12 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-07 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 4e-06 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (278), Expect = 3e-28
Identities = 48/178 (26%), Positives = 75/178 (42%), Gaps = 8/178 (4%)
Query: 335 WLLNSDNLEFIDQIGPNSFKGVYKGKR---VGIEKLKGCDKGNAYEFELRKDLLELMTCG 391
W + + +IG SF VYKGK V ++ L + ++ L
Sbjct: 3 WEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR 62
Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFL 450
H NIL F L +VT+ EG S+ + K + ++I IA A+G+ +L
Sbjct: 63 HVNILLFMGYS--TAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYL 120
Query: 451 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG--YRWLAPEVC 506
+ + +RDL S I L V +GD G+ T + ++E W+APEV
Sbjct: 121 HAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (269), Expect = 4e-27
Identities = 44/178 (24%), Positives = 79/178 (44%), Gaps = 13/178 (7%)
Query: 335 WLLNSDNLEFIDQIGPNSF----KGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTC 390
W LN L+ + IG F G Y+G +V ++ +K A+ E +
Sbjct: 2 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASV----MTQL 57
Query: 391 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK--LQTKEIIRIAIDVAEGIK 448
H N++Q V V+E GL +VT+ M GS+ D + + L +++ ++DV E ++
Sbjct: 58 RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAME 117
Query: 449 FLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEVC 506
+L + +RDL ++ +L+ + D G+ K + +W APE
Sbjct: 118 YLEGNNFVHRDLAARNVLVSEDNVAKVSDFGL---TKEASSTQDTGKLPVKWTAPEAL 172
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (266), Expect = 1e-26
Identities = 42/176 (23%), Positives = 86/176 (48%), Gaps = 5/176 (2%)
Query: 336 LLNSDNLEFIDQIGPNSFKGVYKGKRVGIEK--LKGCDKGNAYEFELRKDLLELMTCGHK 393
+++ L F+ +IG F V+ G + +K +K +G E + ++ +M H
Sbjct: 1 VIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHP 60
Query: 394 NILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQT-KEIIRIAIDVAEGIKFLND 452
++Q Y VC+++ +C+V + ME G ++D + R L + ++ + +DV EG+ +L +
Sbjct: 61 KLVQLYGVCLEQAP-ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE 119
Query: 453 HGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG-YRWLAPEVCF 507
V +RDL ++ L+ + + + D G+ + T +W +PEV
Sbjct: 120 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFS 175
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (265), Expect = 2e-26
Identities = 37/179 (20%), Positives = 65/179 (36%), Gaps = 12/179 (6%)
Query: 334 RWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEK---LKGCDKGNAYEFELRKDLLE---- 386
+W L ++ E +G F VY + + LK K + + L
Sbjct: 2 QWAL--EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 59
Query: 387 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEG 446
H NIL+ Y D + ++ + G+V + K K + ++A
Sbjct: 60 QSHLRHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 118
Query: 447 IKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEV 505
+ + + V +RD+ + +LL G + + D G S T T Y L PE+
Sbjct: 119 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDY--LPPEM 175
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (264), Expect = 3e-26
Identities = 46/181 (25%), Positives = 82/181 (45%), Gaps = 6/181 (3%)
Query: 330 EEIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEK---LKGCDKGNAYEFE-LRKDLL 385
E + R L D E I ++G +F VYK + K D + E E ++
Sbjct: 2 EHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEID 61
Query: 386 ELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVA 444
L +C H NI++ EN+ L ++ + GG+V+ ++L+ R L +I +
Sbjct: 62 ILASCDHPNIVKLLDAFYYENN-LWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTL 120
Query: 445 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPE 504
+ + +L+D+ + +RDL + IL G++ L D G+ + + W+APE
Sbjct: 121 DALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPE 180
Query: 505 V 505
V
Sbjct: 181 V 181
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (263), Expect = 9e-26
Identities = 37/178 (20%), Positives = 84/178 (47%), Gaps = 13/178 (7%)
Query: 337 LNSDNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTC 390
L D+ E I ++G + V+K G + + + + A ++ ++L L C
Sbjct: 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIH-LEIKPAIRNQIIRELQVLHEC 61
Query: 391 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFL 450
I+ FY + + + + M+GGS++ ++ K+ ++ + + +++I V +G+ +L
Sbjct: 62 NSPYIVGFYGAFYSDGE-ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYL 120
Query: 451 -NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR-WLAPEVC 506
H + +RD+ IL++ G + L D G+ + ++ G R +++PE
Sbjct: 121 REKHKIMHRDVKPSNILVNSRGEIKLCDFGV---SGQLIDSMANSFVGTRSYMSPERL 175
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (258), Expect = 1e-25
Identities = 40/174 (22%), Positives = 81/174 (46%), Gaps = 5/174 (2%)
Query: 337 LNSDNLEFIDQIGPNSFKGVYKGKRVGIEK--LKGCDKGNAYEFELRKDLLELMTCGHKN 394
++ +L F+ ++G F V GK G +K +G+ E E ++ +M H+
Sbjct: 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEK 60
Query: 395 ILQFYCVCVDENHGLCVVTKLMEGGSVNDLI-LKSRKLQTKEIIRIAIDVAEGIKFLNDH 453
++Q Y VC + + ++T+ M G + + + + QT++++ + DV E +++L
Sbjct: 61 LVQLYGVCTKQRP-IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK 119
Query: 454 GVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG-YRWLAPEVC 506
+RDL ++ L++ G V + D G+ + + RW PEV
Sbjct: 120 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVL 173
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (259), Expect = 1e-25
Identities = 38/178 (21%), Positives = 77/178 (43%), Gaps = 7/178 (3%)
Query: 334 RWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEK--LKGCDKGNAYEFELRKDLLELMTCG 391
W + + L+ ++++G F V+ G G K +K +G+ + +
Sbjct: 7 EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQ 66
Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR--KLQTKEIIRIAIDVAEGIKF 449
H+ +++ Y V E + ++T+ ME GS+ D + KL +++ +A +AEG+ F
Sbjct: 67 HQRLVRLYAVVTQEP--IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAF 124
Query: 450 LNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG-YRWLAPEVC 506
+ + +RDL + IL+ + + D G+ + +W APE
Sbjct: 125 IEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI 182
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (250), Expect = 2e-24
Identities = 45/183 (24%), Positives = 76/183 (41%), Gaps = 16/183 (8%)
Query: 340 DNLEFIDQIGPNSFKGVYKGKRVGIEK---LKGCDKGNAYEFELRKDLLE---LMTCGHK 393
++ E + IG S+ K +R K K D G+ E E + + E L H
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 394 NILQFYCVCVDENHG-LCVVTKLMEGGSVNDLILKSRK----LQTKEIIRIAIDVAEGIK 448
NI+++Y +D + L +V + EGG + +I K K L + ++R+ + +K
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 449 FLND-----HGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAP 503
+ H V +RDL + LD NV LGD G+ + +++P
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSP 183
Query: 504 EVC 506
E
Sbjct: 184 EQM 186
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (249), Expect = 4e-24
Identities = 26/176 (14%), Positives = 64/176 (36%), Gaps = 10/176 (5%)
Query: 340 DNLEFIDQIGPNSFKGVYKGKRVGIEK---LKGCDKGNAYEFELRKDLLE----LMTCGH 392
++ +F +G SF V + + + +K +K + + + + H
Sbjct: 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 393 KNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLND 452
++ Y D+ L + G + I K ++ +++L+
Sbjct: 68 PFFVKLYFTFQDDEK-LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 126
Query: 453 HGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYET--DGYRWLAPEVC 506
G+ +RDL + ILL+ ++ + D G + + ++++PE+
Sbjct: 127 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL 182
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.9 bits (246), Expect = 6e-24
Identities = 32/173 (18%), Positives = 72/173 (41%), Gaps = 8/173 (4%)
Query: 340 DNLEFIDQIGPNSFKGVYKGKRVGIEK---LKGCDKGNAYEF--ELRKDLLELMTCGHKN 394
++ + + +G ++ V E+ +K D A + ++K++ H+N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 395 ILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHG 454
+++FY + N + + GG + D I + + R + G+ +L+ G
Sbjct: 65 VVKFYGHRREGNI-QYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 123
Query: 455 VAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG--YRWLAPEV 505
+ +RD+ + +LLD N+ + D G+ T + ++APE+
Sbjct: 124 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 176
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.5 bits (247), Expect = 1e-23
Identities = 38/211 (18%), Positives = 72/211 (34%), Gaps = 39/211 (18%)
Query: 334 RWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKL------------KGCDKGNAYEFELR 381
+W +NLEF +G +F V GI K + D
Sbjct: 31 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSE 90
Query: 382 KDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK----------- 430
++ + H+NI+ C + ++ + G + + + R+
Sbjct: 91 LKMMTQLG-SHENIVNLLGACTLSGP-IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYEN 148
Query: 431 ------------LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDM 478
L ++++ A VA+G++FL +RDL ++ +L+ V + D
Sbjct: 149 QKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDF 208
Query: 479 GIVTACKSVGEATEYETDG--YRWLAPEVCF 507
G+ S +W+APE F
Sbjct: 209 GLARDIMSDSNYVVRGNARLPVKWMAPESLF 239
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 98.1 bits (244), Expect = 2e-23
Identities = 42/172 (24%), Positives = 73/172 (42%), Gaps = 12/172 (6%)
Query: 343 EFIDQIGPNSFKGVYKGKRVGIEK---LKGCDKGNAYEFELRKDLLE----LMTCGHKNI 395
+ +IG SF VY + V + +K E +D+++ L H N
Sbjct: 18 SDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNT 77
Query: 396 LQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGV 455
+Q+ + E+ +V + G + + L + + LQ EI + +G+ +L+ H +
Sbjct: 78 IQYRGCYLREHT-AWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNM 136
Query: 456 AYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEVCF 507
+RD+ + ILL G V LGD G + A + W+APEV
Sbjct: 137 IHRDVKAGNILLSEPGLVKLGDFGS---ASIMAPANSFVGT-PYWMAPEVIL 184
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 98.2 bits (244), Expect = 5e-23
Identities = 30/176 (17%), Positives = 74/176 (42%), Gaps = 13/176 (7%)
Query: 340 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHK 393
D + ++++G +F V++ G+ + + + Y + ++ H
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMN--QLHHP 86
Query: 394 NILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLND 452
++ + D+ + ++ + + GG + D I K+ E+I EG+K +++
Sbjct: 87 KLINLHDAFEDKYE-MVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE 145
Query: 453 HGVAYRDLNSQRILLD--RHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEVC 506
H + + D+ + I+ + + +V + D G+ T E + T + APE+
Sbjct: 146 HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP-DEIVKVTTATAEFAAPEIV 200
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.3 bits (239), Expect = 6e-23
Identities = 41/187 (21%), Positives = 79/187 (42%), Gaps = 18/187 (9%)
Query: 334 RWLLNSDNLEFID-QIGPNSFKGVYKGK--------RVGIEKLK-GCDKGNAYEFELRKD 383
+ L DNL D ++G +F V +G V I+ LK G +K + E
Sbjct: 2 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ 61
Query: 384 LLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK-LQTKEIIRIAID 442
++ + I++ VC + L +V ++ GG ++ ++ R+ + + +
Sbjct: 62 IM--HQLDNPYIVRLIGVC--QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQ 117
Query: 443 VAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG---YR 499
V+ G+K+L + +RDL ++ +LL + D G+ A + + G +
Sbjct: 118 VSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK 177
Query: 500 WLAPEVC 506
W APE
Sbjct: 178 WYAPECI 184
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.8 bits (235), Expect = 2e-22
Identities = 45/186 (24%), Positives = 85/186 (45%), Gaps = 17/186 (9%)
Query: 332 IGRWLLNSDNLEFIDQIGPNSFKGVYKG--------KRVGIEKLKGCDKGNAYEFELRKD 383
+ R LL ++ E +G +F V KG K V ++ LK A + EL +
Sbjct: 3 LDRKLLTLEDKE----LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAE 58
Query: 384 LLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDV 443
+ + I++ +C E+ +V ++ E G +N + ++R ++ K II + V
Sbjct: 59 ANVMQQLDNPYIVRMIGICEAES--WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQV 116
Query: 444 AEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG---YRW 500
+ G+K+L + +RDL ++ +LL + D G+ A ++ + +T G +W
Sbjct: 117 SMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKW 176
Query: 501 LAPEVC 506
APE
Sbjct: 177 YAPECI 182
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.6 bits (237), Expect = 2e-22
Identities = 36/174 (20%), Positives = 68/174 (39%), Gaps = 9/174 (5%)
Query: 340 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLK--GCDKGNAYEFELRKDLLELMTCG 391
++ +G SF V+ + I+ LK + E + + + +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 392 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN 451
H + +C + + L V + + GG + I K A ++ G++FL+
Sbjct: 62 HPFLTHMFCTFQTKEN-LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLH 120
Query: 452 DHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEV 505
G+ YRDL ILLD+ G++ + D G+ T ++APE+
Sbjct: 121 SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEI 174
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 95.9 bits (238), Expect = 3e-22
Identities = 28/177 (15%), Positives = 70/177 (39%), Gaps = 17/177 (9%)
Query: 340 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHK 393
D+ + +++G +F V++ G + + + + RK++ + H
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETV--RKEIQTMSVLRHP 83
Query: 394 NILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLND 452
++ + D+N + ++ + M GG + + + K+ E + V +G+ +++
Sbjct: 84 TLVNLHDAFEDDNE-MVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE 142
Query: 453 HGVAYRDLNSQRILL--DRHGNVCLGDMGIVTACKSVGEATEYETDGY--RWLAPEV 505
+ + DL + I+ R + L D G+ + + + APEV
Sbjct: 143 NNYVHLDLKPENIMFTTKRSNELKLIDFGL---TAHLDPKQSVKVTTGTAEFAAPEV 196
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.9 bits (235), Expect = 3e-22
Identities = 44/183 (24%), Positives = 81/183 (44%), Gaps = 17/183 (9%)
Query: 339 SDNLEFIDQIGPNSFKGVYKGKRVGIE-KLKGCDKGNAYEFELRKDLLELMTCGHKNILQ 397
+ + + IG F V++GK G E +K + ++ + + H+NIL
Sbjct: 2 ARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILG 61
Query: 398 FYCVCVDENHG---LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFL---- 450
F +N L +V+ E GS+ D L + + +I++A+ A G+ L
Sbjct: 62 FIAADNKDNGTWTQLWLVSDYHEHGSLFDY-LNRYTVTVEGMIKLALSTASGLAHLHMEI 120
Query: 451 ----NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY----RWLA 502
+A+RDL S+ IL+ ++G C+ D+G+ S + + + R++A
Sbjct: 121 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 180
Query: 503 PEV 505
PEV
Sbjct: 181 PEV 183
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 94.0 bits (233), Expect = 4e-22
Identities = 40/181 (22%), Positives = 68/181 (37%), Gaps = 16/181 (8%)
Query: 340 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMT---- 389
+N E + +G V + K ++ + G+ E+++ +
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 390 ----CGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAE 445
GH NI+Q +V LM+ G + D + + L KE +I + E
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTF-FFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLE 121
Query: 446 GIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEV 505
I L+ + +RDL + ILLD N+ L D G + E +LAPE+
Sbjct: 122 VICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREV-CGTPSYLAPEI 180
Query: 506 C 506
Sbjct: 181 I 181
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.6 bits (232), Expect = 5e-22
Identities = 33/177 (18%), Positives = 68/177 (38%), Gaps = 7/177 (3%)
Query: 335 WLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEK--LKGCDKGNAYEFELRKDLLELMTCGH 392
W + ++L ++G F V+ G G + +K G ++ + H
Sbjct: 12 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRH 71
Query: 393 KNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQT--KEIIRIAIDVAEGIKFL 450
+ ++Q Y V + +VT+ M GS+ D + +++ +A +A G+ ++
Sbjct: 72 EKLVQLYAVV--SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV 129
Query: 451 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG-YRWLAPEVC 506
+RDL + IL+ + + D G+ + +W APE
Sbjct: 130 ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 186
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 90.6 bits (224), Expect = 6e-21
Identities = 31/181 (17%), Positives = 65/181 (35%), Gaps = 13/181 (7%)
Query: 339 SDNLEFIDQIGPNSFKGVYKGKRVGIEK---LKGCDKGNAYEFELRKDLLE----LMTCG 391
SD E + +G V+ + + + + +K A +
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 392 HKNILQFYCVCVDENHG---LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIK 448
H I+ Y E +V + ++G ++ D++ + K I + D + +
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALN 125
Query: 449 FLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG---YRWLAPEV 505
F + +G+ +RD+ I++ V + D GI A G + ++L+PE
Sbjct: 126 FSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 185
Query: 506 C 506
Sbjct: 186 A 186
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 90.6 bits (224), Expect = 7e-21
Identities = 31/179 (17%), Positives = 70/179 (39%), Gaps = 7/179 (3%)
Query: 334 RWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEK---LKGCDKGNAYEFELRKDLLELMTC 390
+W + ++ ++G + VY+G +K + E K+ +
Sbjct: 11 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI 70
Query: 391 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK--LQTKEIIRIAIDVAEGIK 448
H N++Q VC E ++T+ M G++ D + + + + ++ +A ++ ++
Sbjct: 71 KHPNLVQLLGVCTREPP-FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAME 129
Query: 449 FLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG-YRWLAPEVC 506
+L +RDL ++ L+ + V + D G+ +W APE
Sbjct: 130 YLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL 188
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.1 bits (223), Expect = 1e-20
Identities = 37/172 (21%), Positives = 72/172 (41%), Gaps = 6/172 (3%)
Query: 339 SDNLEFIDQIGPNSFKGVYKGKRVGIEK---LKGCDKGNAYEFELRKDLLELM-TCGHKN 394
++IG + VY V + ++ + + EL + + +M + N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 395 ILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHG 454
I+ + + + L VV + + GGS+ D++ ++ +I + + + ++FL+ +
Sbjct: 79 IVNYLDSYLVGDE-LWVVMEYLAGGSLTDVVTETCM-DEGQIAAVCRECLQALEFLHSNQ 136
Query: 455 VAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEVC 506
V +RD+ S ILL G+V L D G W+APEV
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV 188
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.3 bits (223), Expect = 1e-20
Identities = 40/205 (19%), Positives = 69/205 (33%), Gaps = 32/205 (15%)
Query: 334 RWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGC----------DKGNAYEFELRKD 383
+W + L F +G +F V + G+ K L +
Sbjct: 17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSE 76
Query: 384 LLELMTCG-HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR------------- 429
L L G H NI+ C V+T+ G + + + + R
Sbjct: 77 LKVLSYLGNHMNIVNLLGACTIGGP-TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIM 135
Query: 430 -----KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC 484
L ++++ + VA+G+ FL +RDL ++ ILL + D G+
Sbjct: 136 EDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDI 195
Query: 485 KSVGEATEYETDGY--RWLAPEVCF 507
K+ +W+APE F
Sbjct: 196 KNDSNYVVKGNARLPVKWMAPESIF 220
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 90.6 bits (224), Expect = 2e-20
Identities = 38/177 (21%), Positives = 72/177 (40%), Gaps = 13/177 (7%)
Query: 340 DNLEFIDQIGPNSFKGVYKGKRVG---------IEKLKGCDKGNAYEFELRKDLLELM-T 389
++ IG F VY ++ ++K + K + +L L+ T
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 390 CGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKF 449
I+ + L + LM GG ++ + + ++ A ++ G++
Sbjct: 64 GDCPFIVCMSYAFHTPDK-LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEH 122
Query: 450 LNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEVC 506
+++ V YRDL ILLD HG+V + D+G+ AC + + ++APEV
Sbjct: 123 MHNRFVVYRDLKPANILLDEHGHVRISDLGL--ACDFSKKKPHASVGTHGYMAPEVL 177
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 88.3 bits (218), Expect = 3e-20
Identities = 42/185 (22%), Positives = 81/185 (43%), Gaps = 16/185 (8%)
Query: 336 LLNSDNLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDKGNAYEFELRKDLLE--- 386
L+ +L ++++G SF V +G+ + +K + E D +
Sbjct: 4 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVN 63
Query: 387 -LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVA 444
+ + H+N+++ Y V + + +VT+L GS+ D + K + + R A+ VA
Sbjct: 64 AMHSLDHRNLIRLYGVVLTPP--MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVA 121
Query: 445 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG---YRWL 501
EG+ +L +RDL ++ +LL V +GD G++ A + + + W
Sbjct: 122 EGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181
Query: 502 APEVC 506
APE
Sbjct: 182 APESL 186
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 88.8 bits (219), Expect = 3e-20
Identities = 35/199 (17%), Positives = 72/199 (36%), Gaps = 29/199 (14%)
Query: 334 RWLLNSDNLEFIDQIGPNSFKGVYK-----------GKRVGIEKLKGCDKGNAYEFELRK 382
+W D L+ +G +F V + + V ++ LK + + + +
Sbjct: 7 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSE 66
Query: 383 DLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK------------ 430
+ + H N++ C L V+ + + G+++ + R
Sbjct: 67 LKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDL 126
Query: 431 ----LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS 486
L + +I + VA+G++FL +RDL ++ ILL V + D G+
Sbjct: 127 YKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYK 186
Query: 487 VGEATEYETDG--YRWLAP 503
+ +W+AP
Sbjct: 187 DPDYVRKGDARLPLKWMAP 205
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 88.8 bits (219), Expect = 3e-20
Identities = 44/174 (25%), Positives = 75/174 (43%), Gaps = 10/174 (5%)
Query: 343 EFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLE---LMTCGHK 393
E +D +G F VYK + V I+K+K + A + R L E L H
Sbjct: 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 60
Query: 394 NILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDH 453
NI+ +++ + +V ME + S L I + +G+++L+ H
Sbjct: 61 NIIGLLDAFGHKSN-ISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH 119
Query: 454 GVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEVCF 507
+ +RDL +LLD +G + L D G+ + S A ++ + APE+ F
Sbjct: 120 WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLF 173
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 88.3 bits (218), Expect = 5e-20
Identities = 38/185 (20%), Positives = 84/185 (45%), Gaps = 20/185 (10%)
Query: 336 LLNSDNLEFIDQIGPNSFKGVYKGKR----------VGIEKLKGCDKGNAYEFELRKDLL 385
+L + I +G +F VYKG V I++L+ A + E+ +
Sbjct: 5 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EILDEAY 63
Query: 386 ELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQT-KEIIRIAIDVA 444
+ + + ++ + +C+ + ++T+LM G + D + + + + ++ + +A
Sbjct: 64 VMASVDNPHVCRLLGICLTST--VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 121
Query: 445 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRW 500
+G+ +L D + +RDL ++ +L+ +V + D G+ A E EY +G +W
Sbjct: 122 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGL--AKLLGAEEKEYHAEGGKVPIKW 179
Query: 501 LAPEV 505
+A E
Sbjct: 180 MALES 184
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 87.8 bits (217), Expect = 8e-20
Identities = 37/175 (21%), Positives = 74/175 (42%), Gaps = 11/175 (6%)
Query: 340 DNLEFIDQIGPNSFKGVYKGKRVGIEK---LKGCDKGNAYEFELRKDLLE----LMTCGH 392
+ + + +G SF V+ + + +K K + + + L H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 393 KNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLND 452
I++ + D + ++ +EGG + L+ KS++ A +V +++L+
Sbjct: 64 PFIIRMWGTFQDAQQ-IFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS 122
Query: 453 HGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEVCF 507
+ YRDL + ILLD++G++ + D G K V + T ++APEV
Sbjct: 123 KDIIYRDLKPENILLDKNGHIKITDFGF---AKYVPDVTYTLCGTPDYIAPEVVS 174
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 87.4 bits (216), Expect = 1e-19
Identities = 29/171 (16%), Positives = 63/171 (36%), Gaps = 7/171 (4%)
Query: 340 DNLEFIDQIGPNSFKGVYKGKRVGIEK---LKGCDKGNAYEFELRKDLLELMTCGHKNIL 396
+ + +G F V++ +K K + ++K++ L H+NIL
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNIL 64
Query: 397 QFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLNDHGV 455
+ L ++ + + G + + I S +L +EI+ V E ++FL+ H +
Sbjct: 65 HLHESFESMEE-LVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNI 123
Query: 456 AYRDLNSQRILLD--RHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPE 504
+ D+ + I+ R + + + G K T +
Sbjct: 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEV 174
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 87.2 bits (215), Expect = 2e-19
Identities = 41/193 (21%), Positives = 81/193 (41%), Gaps = 28/193 (14%)
Query: 337 LNSDNLEFIDQIGPNSFKGVYKGKR--------VGIEKLK-GCDKGNAYEFELRKDLLEL 387
L+ ++++F D IG +F V K + I+++K K + +F ++L
Sbjct: 7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCK 66
Query: 388 MTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKS----------------RKL 431
+ H NI+ C + L + + G++ D + KS L
Sbjct: 67 L-GHHPNIINLLGACEHRGY-LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 124
Query: 432 QTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT 491
+++++ A DVA G+ +L+ +RDL ++ IL+ + + D G+ + + T
Sbjct: 125 SSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKT 184
Query: 492 EYETDGYRWLAPE 504
RW+A E
Sbjct: 185 MGRL-PVRWMAIE 196
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 86.4 bits (213), Expect = 2e-19
Identities = 33/183 (18%), Positives = 73/183 (39%), Gaps = 14/183 (7%)
Query: 335 WLLNSDNLEFIDQIGPNSFKGVYKGKR---------VGIEKLKGCDKGNAYEFELRKDLL 385
+ + + +E IG F V++G V I+ K C + E + ++ L
Sbjct: 2 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVRE-KFLQEAL 60
Query: 386 ELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVA 444
+ H +I++ V + + + ++ +L G + + L +I A ++
Sbjct: 61 TMRQFDHPHIVKLIGVITE--NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLS 118
Query: 445 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG-YRWLAP 503
+ +L +RD+ ++ +L+ + V LGD G+ + + +W+AP
Sbjct: 119 TALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 178
Query: 504 EVC 506
E
Sbjct: 179 ESI 181
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 86.2 bits (213), Expect = 3e-19
Identities = 39/177 (22%), Positives = 72/177 (40%), Gaps = 12/177 (6%)
Query: 339 SDNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGH 392
D +F D +G +F V K V I+ + E + ++ L H
Sbjct: 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAK-KALEGKEGSMENEIAVLHKIKH 66
Query: 393 KNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLND 452
NI+ + H L ++ +L+ GG + D I++ ++ R+ V + +K+L+D
Sbjct: 67 PNIVALDDIYESGGH-LYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHD 125
Query: 453 HGVAYRDLNSQRILL---DRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEVC 506
G+ +RDL + +L D + + D G+ G ++APEV
Sbjct: 126 LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP-GSVLSTACGTPGYVAPEVL 181
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 85.7 bits (211), Expect = 4e-19
Identities = 34/194 (17%), Positives = 72/194 (37%), Gaps = 25/194 (12%)
Query: 335 WLLNSDNLEFIDQIGPNSFKGVYKG-----------KRVGIEKLKGCDKGNAYEFELRKD 383
W + + + ++G SF VY+G RV I+ + E +
Sbjct: 15 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNE-AASMRERIEFLNE 73
Query: 384 LLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK----------LQT 433
+ ++++ V V+ +LM G + + R
Sbjct: 74 ASVMKEFNCHHVVRLLGVVSQGQP-TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSL 132
Query: 434 KEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY 493
++I++A ++A+G+ +LN + +RDL ++ ++ V +GD G+ +
Sbjct: 133 SKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 192
Query: 494 ETD--GYRWLAPEV 505
RW++PE
Sbjct: 193 GKGLLPVRWMSPES 206
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 85.6 bits (211), Expect = 5e-19
Identities = 38/193 (19%), Positives = 73/193 (37%), Gaps = 17/193 (8%)
Query: 330 EEIGRWLLNSDNLE--FIDQIGPNSFKGVYKGK---------RVGIEKLKGCDKGNAYEF 378
+ + ++ +L F + IG F VY G ++ L
Sbjct: 15 QAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS- 73
Query: 379 ELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL-KSRKLQTKEII 437
+ + + + H N+L +C+ VV M+ G + + I ++ K++I
Sbjct: 74 QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI 133
Query: 438 RIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG 497
+ VA+G+KFL +RDL ++ +LD V + D G+ + + G
Sbjct: 134 GFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTG 193
Query: 498 YR----WLAPEVC 506
+ W+A E
Sbjct: 194 AKLPVKWMALESL 206
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 84.9 bits (209), Expect = 7e-19
Identities = 37/175 (21%), Positives = 74/175 (42%), Gaps = 8/175 (4%)
Query: 340 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHK 393
+N + +++IG ++ VYK G+ V ++K++ + +++ L H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 394 NILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK-LQTKEIIRIAIDVAEGIKFLND 452
NI++ V EN L +V + + + + + I + +G+ F +
Sbjct: 62 NIVKLLDVIHTENK-LYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 453 HGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEVCF 507
H V +RDL Q +L++ G + L D G+ A +E + APE+
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 175
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 84.0 bits (207), Expect = 9e-19
Identities = 32/177 (18%), Positives = 63/177 (35%), Gaps = 15/177 (8%)
Query: 343 EFIDQIGPNSFKGVYK------GKRVGIEKLK------GCDKGNAYEFELRKDLLELMTC 390
+ +G F VY V I+ ++ + N + LL+ ++
Sbjct: 7 QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 66
Query: 391 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFL 450
G +++ + + ++ + + D I + LQ + V E ++
Sbjct: 67 GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC 126
Query: 451 NDHGVAYRDLNSQRILLDRH-GNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEVC 506
++ GV +RD+ + IL+D + G + L D G K T Y PE
Sbjct: 127 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVY--SPPEWI 181
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 83.9 bits (207), Expect = 1e-18
Identities = 43/176 (24%), Positives = 81/176 (46%), Gaps = 14/176 (7%)
Query: 342 LEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNI 395
L+F +IG SFK VYKG V +L+ + +++ L H NI
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70
Query: 396 LQFYCVCVDENHG---LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLND 452
++FY G + +VT+LM G++ + + + ++ K + + +G++FL+
Sbjct: 71 VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHT 130
Query: 453 HG--VAYRDLNSQRILL-DRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEV 505
+ +RDL I + G+V +GD+G+ T ++ T ++APE+
Sbjct: 131 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGT--PEFMAPEM 184
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 84.0 bits (207), Expect = 1e-18
Identities = 36/185 (19%), Positives = 72/185 (38%), Gaps = 17/185 (9%)
Query: 337 LNSDNLEFIDQIGPNSFKGVYKGKR---------VGIEKLKGCDKGNAYEFELRKDLLEL 387
++ ++ IG F V G V I+ LK + + +
Sbjct: 23 IDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRR-DFLSEASIM 81
Query: 388 MTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQT-KEIIRIAIDVAEG 446
H N++ V + ++T+ ME GS++ + ++ T +++ + +A G
Sbjct: 82 GQFDHPNVIHLEGVVTKSTP-VMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAG 140
Query: 447 IKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG-----YRWL 501
+K+L D +RDL ++ IL++ + + D G+ + Y + RW
Sbjct: 141 MKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWT 200
Query: 502 APEVC 506
APE
Sbjct: 201 APEAI 205
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 83.8 bits (206), Expect = 1e-18
Identities = 35/173 (20%), Positives = 74/173 (42%), Gaps = 6/173 (3%)
Query: 340 DNLEFIDQIGPNSFKGVYK-----GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKN 394
+ +++IG ++ VYK G+ ++K++ + +++ L H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 395 ILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHG 454
I++ Y V + L +V + ++ L + L++ + + GI + +D
Sbjct: 62 IVKLYDVIHTKKR-LVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR 120
Query: 455 VAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEVCF 507
V +RDL Q +L++R G + + D G+ A +E + AP+V
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLM 173
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 83.3 bits (205), Expect = 2e-18
Identities = 32/182 (17%), Positives = 72/182 (39%), Gaps = 16/182 (8%)
Query: 339 SDNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLE----LM 388
D + +++G F V K G + + +K ++ R+D+ L
Sbjct: 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 68
Query: 389 TCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIK 448
H N++ + V ++ + ++ +L+ GG + D + + L +E + G+
Sbjct: 69 EIQHPNVITLHEVYENKTD-VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVY 127
Query: 449 FLNDHGVAYRDLNSQRILLDRHG----NVCLGDMGIVTACKSVGEATEYETDGYRWLAPE 504
+L+ +A+ DL + I+L + + D G+ G + ++APE
Sbjct: 128 YLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF-GNEFKNIFGTPEFVAPE 186
Query: 505 VC 506
+
Sbjct: 187 IV 188
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 83.4 bits (205), Expect = 3e-18
Identities = 30/163 (18%), Positives = 70/163 (42%), Gaps = 20/163 (12%)
Query: 331 EIGRWLLNSDNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDL 384
E+ ++ E + +IG +F V+K G++V ++K+ ++ + +++
Sbjct: 8 EVSKY-------EKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREI 60
Query: 385 LELMTCGHKNILQFYCVCVDENHG-------LCVVTKLMEGGSVNDLILKSRKLQTKEII 437
L H+N++ +C + + +V E L K EI
Sbjct: 61 KILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIK 120
Query: 438 RIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGI 480
R+ + G+ +++ + + +RD+ + +L+ R G + L D G+
Sbjct: 121 RVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGL 163
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 83.6 bits (206), Expect = 3e-18
Identities = 33/181 (18%), Positives = 67/181 (37%), Gaps = 20/181 (11%)
Query: 340 DNLEFIDQ-IGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGH 392
D+ + Q +G V + ++ ++ L+ C K E EL +
Sbjct: 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR-EVELHWRASQ-----C 64
Query: 393 KNILQFYCVCVD---ENHGLCVVTKLMEGGSVNDLILK--SRKLQTKEIIRIAIDVAEGI 447
+I++ V + L +V + ++GG + I + +E I + E I
Sbjct: 65 PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAI 124
Query: 448 KFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY--RWLAPEV 505
++L+ +A+RD+ + +L + + K T Y ++APEV
Sbjct: 125 QYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEV 184
Query: 506 C 506
Sbjct: 185 L 185
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 82.6 bits (203), Expect = 5e-18
Identities = 37/209 (17%), Positives = 77/209 (36%), Gaps = 37/209 (17%)
Query: 335 WLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGC----------DKGNAYEFELRKDL 384
+N+E++ IG +F V++ + G+ + + + + +++
Sbjct: 8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREA 67
Query: 385 LELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK-------------- 430
+ + NI++ VC +C++ + M G +N+ +
Sbjct: 68 ALMAEFDNPNIVKLLGVCAVGKP-MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTR 126
Query: 431 ----------LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGI 480
L E + IA VA G+ +L++ +RDL ++ L+ + V + D G+
Sbjct: 127 ARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGL 186
Query: 481 VTACKSVGEATEYETDG--YRWLAPEVCF 507
S D RW+ PE F
Sbjct: 187 SRNIYSADYYKADGNDAIPIRWMPPESIF 215
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.1 bits (202), Expect = 1e-17
Identities = 30/174 (17%), Positives = 66/174 (37%), Gaps = 8/174 (4%)
Query: 340 DNLEFIDQIGPNSFKGVYKGKRVGIEK---LKGCDKGNAYEFELRKDLLE----LMTCGH 392
++ +++ +G +F V + + +K K + + L H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 393 KNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLND 452
+ + LC V + GG + + + R + ++ +++L+
Sbjct: 65 PFLTALKYAFQTHDR-LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS 123
Query: 453 HGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEVC 506
V YRD+ + ++LD+ G++ + D G+ S G + +LAPEV
Sbjct: 124 RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVL 177
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 80.6 bits (198), Expect = 3e-17
Identities = 32/176 (18%), Positives = 68/176 (38%), Gaps = 12/176 (6%)
Query: 343 EFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNIL 396
+ IG ++ V RV I+K+ + + +++ L+ H+NI+
Sbjct: 11 TNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQ-RTLREIKILLRFRHENII 69
Query: 397 QFYCVCVDENHGLCVVTKLMEG--GSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHG 454
+ L+ G+ +LK++ L I + G+K+++
Sbjct: 70 GINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 129
Query: 455 VAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETD---GYRWLAPEVCF 507
V +RDL +LL+ ++ + D G+ + T + T+ + APE+
Sbjct: 130 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 185
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 79.5 bits (195), Expect = 4e-17
Identities = 39/184 (21%), Positives = 75/184 (40%), Gaps = 16/184 (8%)
Query: 337 LNSDNLEFIDQIGPNSFKGVYKGKR----------VGIEKLKGCDKGNAYEFELRKDLLE 386
++ + IG F VYKG V I+ LK + +
Sbjct: 4 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKA-GYTEKQRVDFLGEAGI 62
Query: 387 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK-LQTKEIIRIAIDVAE 445
+ H NI++ V + ++T+ ME G+++ + + +++ + +A
Sbjct: 63 MGQFSHHNIIRLEGVISKYKP-MMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAA 121
Query: 446 GIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG---YRWLA 502
G+K+L + +RDL ++ IL++ + + D G+ + EAT + G RW A
Sbjct: 122 GMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA 181
Query: 503 PEVC 506
PE
Sbjct: 182 PEAI 185
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 79.1 bits (194), Expect = 1e-16
Identities = 25/175 (14%), Positives = 64/175 (36%), Gaps = 10/175 (5%)
Query: 338 NSDNLEFIDQIGPNSFKGVYKGKRVGIEK---LKGCDKGNAYEFELRKDLLELMTCGHKN 394
N D+ + + ++G + V++ + + +K + + +LE + N
Sbjct: 33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRG-GPN 91
Query: 395 ILQFYCVCVDENHG-LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDH 453
I+ + D +V + + L + L +I ++ + + + +
Sbjct: 92 IITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSM 148
Query: 454 GVAYRDLNSQRILLDR-HGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEVCF 507
G+ +RD+ +++D H + L D G+ G+ + PE+
Sbjct: 149 GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP-GQEYNVRVASRYFKGPELLV 202
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 78.0 bits (191), Expect = 1e-16
Identities = 45/205 (21%), Positives = 82/205 (40%), Gaps = 32/205 (15%)
Query: 334 RWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCD---------KGNAYEFELRKDL 384
RW L D L +G +F V + +G++K K K +A E +L +
Sbjct: 7 RWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLI 66
Query: 385 LEL----MTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR----------- 429
E+ M HKNI+ C + L V+ + G++ + + R
Sbjct: 67 SEMEMMKMIGKHKNIINLLGACTQDGP-LYVIVEYASKGNLREYLQARRPPGLEYSYNPS 125
Query: 430 -----KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC 484
+L +K+++ A VA G+++L +RDL ++ +L+ + + D G+
Sbjct: 126 HNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI 185
Query: 485 KSVGE--ATEYETDGYRWLAPEVCF 507
+ T +W+APE F
Sbjct: 186 HHIDYYKKTTNGRLPVKWMAPEALF 210
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 75.6 bits (185), Expect = 1e-15
Identities = 33/174 (18%), Positives = 63/174 (36%), Gaps = 11/174 (6%)
Query: 340 DNLEFIDQIGPNSFKGVYKGKRVGIEK---LKGCDKGNAYEFELRKDLLE----LMTCGH 392
D + I +G SF V K +K DK + + + L L
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 393 KNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLND 452
+++ D ++ L +V + + GG + + + + A + ++L+
Sbjct: 101 PFLVKLEFSFKDNSN-LYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 453 HGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEVC 506
+ YRDL + +L+D+ G + + D G K LAPE+
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTP---EALAPEII 210
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 74.6 bits (182), Expect = 2e-15
Identities = 32/174 (18%), Positives = 71/174 (40%), Gaps = 7/174 (4%)
Query: 340 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHK 393
E +++IG ++ V+K + V +++++ D +++ L HK
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 394 NILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDH 453
NI++ + V + +V + + + L + + + +G+ F +
Sbjct: 62 NIVRLHDVLHSDKKL-TLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR 120
Query: 454 GVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEVCF 507
V +RDL Q +L++R+G + L + G+ A E + P+V F
Sbjct: 121 NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLF 174
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 73.0 bits (178), Expect = 9e-15
Identities = 28/173 (16%), Positives = 65/173 (37%), Gaps = 13/173 (7%)
Query: 340 DNLEFIDQIGPNSFKGVYKGKRVG------------IEKLKGCDKGNAYEFELRKDLLEL 387
+N E + +G ++ V+ +++ ++K K E + +
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 388 MTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGI 447
++ + E L ++ + GG + + + + E+ ++ +
Sbjct: 84 HIRQSPFLVTLHYAFQTETK-LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLAL 142
Query: 448 KFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRW 500
+ L+ G+ YRD+ + ILLD +G+V L D G+ + Y+ G
Sbjct: 143 EHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIE 195
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 71.4 bits (174), Expect = 3e-14
Identities = 25/181 (13%), Positives = 55/181 (30%), Gaps = 14/181 (7%)
Query: 340 DNLEFIDQIGPNSFKGVYKGKRVGIEK---LKGCDKGNAYEFELRKDLLELMTCGHKNIL 396
+ +IG SF +Y G + + +K + +L + +
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP-QLHIESKIYKMMQGGVGI 65
Query: 397 QFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVA 456
C E +V +L+ + SRK K ++ +A + I++++
Sbjct: 66 PTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFI 125
Query: 457 YRDLNSQRIL---LDRHGNVCLGDMGIVTACKSVGEATEYETDG-------YRWLAPEVC 506
+RD+ L + V + D G+ + R+ +
Sbjct: 126 HRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTH 185
Query: 507 F 507
Sbjct: 186 L 186
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 69.9 bits (170), Expect = 7e-14
Identities = 39/177 (22%), Positives = 71/177 (40%), Gaps = 16/177 (9%)
Query: 340 DNLEFIDQIGPNSFKGVYK-------GKRVGIEKLKGCDKGNAYEFELRKD---LLELMT 389
E + +IG ++ V+K G+ V +++++ ++ L L T
Sbjct: 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 66
Query: 390 CGHKNILQFYCVCV----DENHGLCVVTKLMEGGSVNDL-ILKSRKLQTKEIIRIAIDVA 444
H N+++ + VC D L +V + ++ L + + T+ I + +
Sbjct: 67 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 126
Query: 445 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYE-TDGYRW 500
G+ FL+ H V +RDL Q IL+ G + L D G+ T T YR
Sbjct: 127 RGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRA 183
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 69.1 bits (168), Expect = 1e-13
Identities = 26/178 (14%), Positives = 59/178 (33%), Gaps = 16/178 (8%)
Query: 343 EFIDQIGPNSFKGVYKGKRVGIEK---LKGCDKGNAYEFELRKDLLELMTCGHKNILQFY 399
+ +IG SF +++G + + +K + + +LR + +
Sbjct: 8 KVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAP-QLRDEYRTYKLLAGCTGIPNV 66
Query: 400 CVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRD 459
E +V L+ + L L RK K + A + ++ +++ + YRD
Sbjct: 67 YYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRD 126
Query: 460 LNSQRILLDR-----HGNVCLGDMGIVTACKSVGEATEYETDGY-------RWLAPEV 505
+ L+ R + + D G+V + R+++
Sbjct: 127 IKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINT 184
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 67.5 bits (164), Expect = 7e-13
Identities = 36/180 (20%), Positives = 60/180 (33%), Gaps = 22/180 (12%)
Query: 343 EFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNIL 396
IG SF VY+ G+ V I+K+ + E ++ + H NI+
Sbjct: 23 TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQI------MRKLDHCNIV 76
Query: 397 QFYCVCVDENHG-----LCVVTKLMEGGSVNDLILKSRK---LQTKEIIRIAIDVAEGIK 448
+ L +V + SR L + + +
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 449 FLNDHGVAYRDLNSQRILLDRHGNVC-LGDMGIVTACKSVGEATEYETDGYRWLAPEVCF 507
+++ G+ +RD+ Q +LLD V L D G GE + APE+ F
Sbjct: 137 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR-GEPNVSYICSRYYRAPELIF 195
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 65.7 bits (159), Expect = 3e-12
Identities = 27/179 (15%), Positives = 68/179 (37%), Gaps = 14/179 (7%)
Query: 339 SDNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGH 392
+ + + +G ++ V G RV ++KL + + ++L L H
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 393 KNILQFYCVCVDENH----GLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIK 448
+N++ V + + G +N+++ K +KL + + + G+K
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-KCQKLTDDHVQFLIYQILRGLK 135
Query: 449 FLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEVCF 507
+++ + +RDL + ++ + + D G+ + + + APE+
Sbjct: 136 YIHSADIIHRDLKPSNLAVNEDCELKILDFGL---ARHTDDEMTGYVATRWYRAPEIML 191
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 50.8 bits (120), Expect = 2e-07
Identities = 29/188 (15%), Positives = 64/188 (34%), Gaps = 24/188 (12%)
Query: 343 EFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLE---------L 387
+ ++G F V+ V ++ ++G DK E LL+
Sbjct: 16 ILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTKE 74
Query: 388 MTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQT----KEIIRIAIDV 443
+ G +IL+ + V + E N L L + + +I+ +
Sbjct: 75 DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQL 134
Query: 444 AEGIKFLN-DHGVAYRDLNSQRILLDRHGNVC-LGDMGIVTACKSVGEATEYETD--GYR 499
G+ +++ G+ + D+ + +L++ + L + I + Y
Sbjct: 135 LLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTRE 194
Query: 500 WLAPEVCF 507
+ +PEV
Sbjct: 195 YRSPEVLL 202
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 45.2 bits (106), Expect = 4e-06
Identities = 15/148 (10%), Positives = 44/148 (29%), Gaps = 18/148 (12%)
Query: 346 DQIGPNSFKGVYK-----GKRVGIEKLK--------GCDKGNAYEFELRKDLLELMTCGH 392
+G V+ ++ K +K + + +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 393 KNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLND 452
+ + + + V + + LME + +++ + + + E +
Sbjct: 66 RALQKLQGLAVPKVYAWEGNAVLMELIDAKE----LYRVRVENPDEVLDMILEEVAKFYH 121
Query: 453 HGVAYRDLNSQRILLDRHGNVCLGDMGI 480
G+ + DL+ +L+ G + + D
Sbjct: 122 RGIVHGDLSQYNVLVSEEG-IWIIDFPQ 148
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 511 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 99.98 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 99.97 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 99.97 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 99.97 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 99.97 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 99.97 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 99.97 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 99.97 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 99.97 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 99.97 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 99.97 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 99.97 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 99.96 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 99.96 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 99.96 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 99.96 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.92 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.85 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.07 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.33 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.19 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 95.43 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 93.63 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 91.44 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-37 Score=308.97 Aligned_cols=174 Identities=28% Similarity=0.417 Sum_probs=148.6
Q ss_pred cceEecCCCeEEEeeeecccceEEEEeE---EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcE
Q 010401 333 GRWLLNSDNLEFIDQIGPNSFKGVYKGK---RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGL 409 (511)
Q Consensus 333 ~~~~l~~~~y~l~~~LG~GsFG~VYkgk---~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l 409 (511)
++|+++.++|++.+.||+|+||.||+|+ .||||+++...........+.+|+.++.+++|||||+++|++.+ +. +
T Consensus 1 ddwei~~~~~~~~~~lG~G~fg~Vy~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~-~ 78 (276)
T d1uwha_ 1 DDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQ-L 78 (276)
T ss_dssp CCCBCCTTCCCCCSEEEECSSCEEEEEESSSEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SS-C
T ss_pred CCcccccccEEEEEEEeeCCCcEEEEEEECCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cE-E
Confidence 3688999999999999999999999986 69999997655555566778999999999999999999998764 33 8
Q ss_pred EEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCC
Q 010401 410 CVVTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG 488 (511)
Q Consensus 410 ~LVmEy~~gGsL~~lL~~~-~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~ 488 (511)
|+||||+++|+|.+++... ..+++..+..++.||+.||+|||+++||||||||+|||++.++.+||+|||+|+......
T Consensus 79 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~ 158 (276)
T d1uwha_ 79 AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS 158 (276)
T ss_dssp EEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred EEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence 9999999999999999654 579999999999999999999999999999999999999999999999999998764322
Q ss_pred C--ccccccCCCccccHHhhcc
Q 010401 489 E--ATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 489 ~--~~~~~~Gt~~YmAPEvl~g 508 (511)
. ......||+.|||||++.+
T Consensus 159 ~~~~~~~~~gt~~y~APE~l~~ 180 (276)
T d1uwha_ 159 GSHQFEQLSGSILWMAPEVIRM 180 (276)
T ss_dssp -------CCCCGGGCCHHHHTT
T ss_pred CcccccccccCcccCCHHHHhc
Confidence 2 2345679999999999864
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-37 Score=307.76 Aligned_cols=168 Identities=17% Similarity=0.308 Sum_probs=145.6
Q ss_pred CCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEE
Q 010401 339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV 412 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LV 412 (511)
.++|++++.||+|+||.||++ +.||+|++..... .....++.+|+.++++++||||+++++++.+++. +|||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~-~~iv 81 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNI-QYLF 81 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEETTE-EEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHhCCCCCEeeEeeeeccCce-eEEE
Confidence 467899999999999999996 4799999975332 2233458899999999999999999999998876 9999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCC--c
Q 010401 413 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE--A 490 (511)
Q Consensus 413 mEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~--~ 490 (511)
|||+++|+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+....... .
T Consensus 82 mEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~ 161 (271)
T d1nvra_ 82 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 161 (271)
T ss_dssp EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred EeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCcccc
Confidence 99999999999998778899999999999999999999999999999999999999999999999999987654332 2
Q ss_pred cccccCCCccccHHhhcc
Q 010401 491 TEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 491 ~~~~~Gt~~YmAPEvl~g 508 (511)
....+||+.|||||++.+
T Consensus 162 ~~~~~GT~~Y~APE~~~~ 179 (271)
T d1nvra_ 162 LNKMCGTLPYVAPELLKR 179 (271)
T ss_dssp BCCCCSCGGGSCTHHHHC
T ss_pred ccceeeCcCccCHhHhcC
Confidence 445689999999999875
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-36 Score=305.34 Aligned_cols=166 Identities=22% Similarity=0.354 Sum_probs=148.0
Q ss_pred CCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEE
Q 010401 340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT 413 (511)
Q Consensus 340 ~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVm 413 (511)
++|++++.||+|+||.||++ +.||+|++...... ....+.+|+.+++.++||||+++++++.+++. +||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~-~~ivm 96 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGDE-LWVVM 96 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE-EEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh--HHHHHHHHHHHHHhCCCCCEeeEeEEEEECCE-EEEEE
Confidence 46899999999999999996 57999999753322 24568999999999999999999999998886 99999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCcccc
Q 010401 414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY 493 (511)
Q Consensus 414 Ey~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~~~ 493 (511)
||+++|+|.+++.. +.+++..++.++.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+.+.........
T Consensus 97 Ey~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~ 175 (293)
T d1yhwa1 97 EYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST 175 (293)
T ss_dssp ECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCC
T ss_pred EecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeeccccccccc
Confidence 99999999998754 57999999999999999999999999999999999999999999999999999987665555667
Q ss_pred ccCCCccccHHhhccc
Q 010401 494 ETDGYRWLAPEVCFLL 509 (511)
Q Consensus 494 ~~Gt~~YmAPEvl~gl 509 (511)
.+||+.|||||++.+.
T Consensus 176 ~~gt~~Y~aPE~~~~~ 191 (293)
T d1yhwa1 176 MVGTPYWMAPEVVTRK 191 (293)
T ss_dssp CCSCGGGCCHHHHSSS
T ss_pred cccCCCccChhhhcCC
Confidence 7899999999999763
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-37 Score=310.57 Aligned_cols=169 Identities=20% Similarity=0.359 Sum_probs=148.5
Q ss_pred ecCCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEE
Q 010401 337 LNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLC 410 (511)
Q Consensus 337 l~~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~ 410 (511)
+..++|++++.||+|+||.||+| +.||+|+++.. .......++.+|+.+|+.++|||||+++++|.+++. +|
T Consensus 3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~-~~ 80 (322)
T d1s9ja_ 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE-IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGE-IS 80 (322)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECC-CCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSE-EE
T ss_pred CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChh-hCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE-EE
Confidence 45678999999999999999995 57999999753 233445678999999999999999999999998876 99
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCceEEcCCCcEEEEecCCceecccCCC
Q 010401 411 VVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLND-HGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE 489 (511)
Q Consensus 411 LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~-~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~ 489 (511)
|||||+++|+|.+++.+.+.+++..++.++.||+.||.|||+ +||+||||||+|||++.+|.+||+|||+|+.....
T Consensus 81 iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~-- 158 (322)
T d1s9ja_ 81 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 158 (322)
T ss_dssp EEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--
T ss_pred EEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC--
Confidence 999999999999999888899999999999999999999997 59999999999999999999999999999876432
Q ss_pred ccccccCCCccccHHhhccc
Q 010401 490 ATEYETDGYRWLAPEVCFLL 509 (511)
Q Consensus 490 ~~~~~~Gt~~YmAPEvl~gl 509 (511)
.....+||+.|||||++.+.
T Consensus 159 ~~~~~~GT~~Y~APEvl~~~ 178 (322)
T d1s9ja_ 159 MANSFVGTRSYMSPERLQGT 178 (322)
T ss_dssp TC---CCSSCCCCHHHHHCS
T ss_pred ccccccCCccccCchHHcCC
Confidence 23456899999999999864
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=9.1e-37 Score=304.36 Aligned_cols=172 Identities=19% Similarity=0.363 Sum_probs=150.0
Q ss_pred cceEecCCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCC
Q 010401 333 GRWLLNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN 406 (511)
Q Consensus 333 ~~~~l~~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~ 406 (511)
++|+++.++|++.+.||+|+||.||+| +.||||+++... ....++.+|+.+|++++|||||+++|+|.+++
T Consensus 10 ~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~---~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 86 (287)
T d1opja_ 10 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP 86 (287)
T ss_dssp CTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC---SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred cccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc---chHHHHHHHHHHHHhCCCCCEecCCccEeeCC
Confidence 478899999999999999999999996 469999996432 23456899999999999999999999999877
Q ss_pred CcEEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceec
Q 010401 407 HGLCVVTKLMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC 484 (511)
Q Consensus 407 ~~l~LVmEy~~gGsL~~lL~~~--~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l 484 (511)
. +|+||||+++|+|.+++... ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+|+..
T Consensus 87 ~-~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~ 165 (287)
T d1opja_ 87 P-FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM 165 (287)
T ss_dssp S-CEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTC
T ss_pred e-eEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeec
Confidence 6 99999999999999999653 57899999999999999999999999999999999999999999999999999876
Q ss_pred ccCCCc-cccccCCCccccHHhhcc
Q 010401 485 KSVGEA-TEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 485 ~~~~~~-~~~~~Gt~~YmAPEvl~g 508 (511)
...... .....|++.|||||++.+
T Consensus 166 ~~~~~~~~~~~~g~~~y~aPE~~~~ 190 (287)
T d1opja_ 166 TGDTYTAHAGAKFPIKWTAPESLAY 190 (287)
T ss_dssp CSSSSEEETTEEECGGGCCHHHHHH
T ss_pred CCCCceeeccccccccccChHHHcC
Confidence 543322 233457889999999864
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-36 Score=300.53 Aligned_cols=168 Identities=19% Similarity=0.283 Sum_probs=148.0
Q ss_pred CCCeEEEeeeecccceEEEEe------EEEEEEEEecCCC-CchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEE
Q 010401 339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDK-GNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCV 411 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~-~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~L 411 (511)
.++|++++.||+|+||.||++ +.||+|++..... .......+.+|+.+++.++||||+++++++.+++. +|+
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~-~~i 83 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATR-VYL 83 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE-EEE
T ss_pred hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCE-EEE
Confidence 468999999999999999996 4799999964221 12234568899999999999999999999998876 999
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCcc
Q 010401 412 VTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT 491 (511)
Q Consensus 412 VmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~ 491 (511)
||||+++|+|.+++...+.+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+..... ..
T Consensus 84 vmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~--~~ 161 (263)
T d2j4za1 84 ILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RR 161 (263)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC--CC
T ss_pred EEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCC--cc
Confidence 9999999999999988889999999999999999999999999999999999999999999999999999876542 24
Q ss_pred ccccCCCccccHHhhccc
Q 010401 492 EYETDGYRWLAPEVCFLL 509 (511)
Q Consensus 492 ~~~~Gt~~YmAPEvl~gl 509 (511)
....||+.|||||++.+.
T Consensus 162 ~~~~Gt~~Y~APE~~~~~ 179 (263)
T d2j4za1 162 TTLCGTLDYLPPEMIEGR 179 (263)
T ss_dssp EETTEEGGGCCHHHHTTC
T ss_pred cccCCCCcccCHHHHcCC
Confidence 556899999999999864
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-36 Score=303.18 Aligned_cols=166 Identities=23% Similarity=0.418 Sum_probs=145.8
Q ss_pred CCeEEEeeeecccceEEEEeE------EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEE
Q 010401 340 DNLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT 413 (511)
Q Consensus 340 ~~y~l~~~LG~GsFG~VYkgk------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVm 413 (511)
+.|++++.||+|+||.||+|+ .||+|++... .......+.+|+.+|+.++|||||++++++.+++. +||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~-~~lvm 88 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENN-LWILI 88 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--SSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTE-EEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCe-EEEEE
Confidence 468999999999999999974 7999999743 23334567899999999999999999999998886 99999
Q ss_pred eccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCccc
Q 010401 414 KLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE 492 (511)
Q Consensus 414 Ey~~gGsL~~lL~~-~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~~ 492 (511)
||+++|+|.+++.+ .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+..........
T Consensus 89 Ey~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~~ 168 (288)
T d2jfla1 89 EFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRD 168 (288)
T ss_dssp ECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHHT
T ss_pred ecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCccccc
Confidence 99999999999765 46799999999999999999999999999999999999999999999999999987654333345
Q ss_pred cccCCCccccHHhhcc
Q 010401 493 YETDGYRWLAPEVCFL 508 (511)
Q Consensus 493 ~~~Gt~~YmAPEvl~g 508 (511)
...||+.|||||++.+
T Consensus 169 ~~~Gt~~y~APE~l~~ 184 (288)
T d2jfla1 169 SFIGTPYWMAPEVVMC 184 (288)
T ss_dssp CCCSCCTTCCHHHHTT
T ss_pred ccccccccCCHHHHhh
Confidence 6789999999999853
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-36 Score=299.65 Aligned_cols=170 Identities=24% Similarity=0.307 Sum_probs=136.0
Q ss_pred CCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeC-CCcEEE
Q 010401 339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDE-NHGLCV 411 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~-~~~l~L 411 (511)
.++|++++.||+|+||.||++ +.||+|++............+.+|+.++++++|||||++++++.+. +..+||
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 367999999999999999996 4799999986555555566789999999999999999999999754 334899
Q ss_pred EEeccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC-----ccccCCCCCceEEcCCCcEEEEecCCce
Q 010401 412 VTKLMEGGSVNDLILK----SRKLQTKEIIRIAIDVAEGIKFLNDHG-----VAYRDLNSQRILLDRHGNVCLGDMGIVT 482 (511)
Q Consensus 412 VmEy~~gGsL~~lL~~----~~~L~e~~~~~ia~qIa~gL~yLH~~g-----IIHRDLKp~NILld~~g~vKL~DFGlS~ 482 (511)
||||+++|+|.+++.+ .+.+++..++.++.||+.||+|||++| ||||||||+|||++.++.+||+|||+|+
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence 9999999999999853 357999999999999999999999976 9999999999999999999999999998
Q ss_pred ecccCCCccccccCCCccccHHhhcc
Q 010401 483 ACKSVGEATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 483 ~l~~~~~~~~~~~Gt~~YmAPEvl~g 508 (511)
.+...........||+.|||||++.+
T Consensus 163 ~~~~~~~~~~~~~gt~~Y~APE~l~~ 188 (269)
T d2java1 163 ILNHDTSFAKAFVGTPYYMSPEQMNR 188 (269)
T ss_dssp HC-----------CCCSCCCHHHHTT
T ss_pred ecccCCCccccCCCCcccCCHHHHcC
Confidence 87655444556789999999999865
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-36 Score=308.42 Aligned_cols=172 Identities=17% Similarity=0.285 Sum_probs=152.3
Q ss_pred ecCCCeEEEeeeecccceEEEEe------EEEEEEEEecCCC-CchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcE
Q 010401 337 LNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDK-GNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGL 409 (511)
Q Consensus 337 l~~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~-~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l 409 (511)
+..++|++++.||+|+||.||++ +.||+|++.+... .......+.+|+.+|+.++||||+++++++.+++. +
T Consensus 2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~-~ 80 (337)
T d1o6la_ 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDR-L 80 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSE-E
T ss_pred CchHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccc-c
Confidence 34578999999999999999996 4799999974221 12234567899999999999999999999998876 9
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCC
Q 010401 410 CVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE 489 (511)
Q Consensus 410 ~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~ 489 (511)
|+||||++||+|.+++...+.+++..++.++.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+.......
T Consensus 81 ~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~ 160 (337)
T d1o6la_ 81 CFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA 160 (337)
T ss_dssp EEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred ccceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCCc
Confidence 99999999999999998888999999999999999999999999999999999999999999999999999997766555
Q ss_pred ccccccCCCccccHHhhccc
Q 010401 490 ATEYETDGYRWLAPEVCFLL 509 (511)
Q Consensus 490 ~~~~~~Gt~~YmAPEvl~gl 509 (511)
.....+||+.|||||++.+.
T Consensus 161 ~~~~~~GT~~Y~aPE~~~~~ 180 (337)
T d1o6la_ 161 TMKTFCGTPEYLAPEVLEDN 180 (337)
T ss_dssp CBCCCEECGGGCCGGGGSSS
T ss_pred ccccceeCHHHhhhhhccCC
Confidence 56678899999999998753
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-36 Score=293.73 Aligned_cols=168 Identities=23% Similarity=0.463 Sum_probs=137.1
Q ss_pred ecCCCeEEEeeeecccceEEEEe-----EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEE
Q 010401 337 LNSDNLEFIDQIGPNSFKGVYKG-----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCV 411 (511)
Q Consensus 337 l~~~~y~l~~~LG~GsFG~VYkg-----k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~L 411 (511)
++.++|++++.||+|+||.||+| +.||||++... .....++.+|+.++++++||||++++|+|.+++. +|+
T Consensus 2 idp~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~---~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~-~~l 77 (263)
T d1sm2a_ 2 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG---AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAP-ICL 77 (263)
T ss_dssp BCCSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS---SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS-CEE
T ss_pred CChHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC---cCcHHHHHHHHHHHHhcCCCCcccccceeccCCc-eEE
Confidence 46788999999999999999997 46999999642 2234568999999999999999999999998776 999
Q ss_pred EEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCC-
Q 010401 412 VTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE- 489 (511)
Q Consensus 412 VmEy~~gGsL~~lL~~~-~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~- 489 (511)
||||+++|+|.+++... ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++.......
T Consensus 78 v~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~ 157 (263)
T d1sm2a_ 78 VFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 157 (263)
T ss_dssp EEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC-----------
T ss_pred EEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCce
Confidence 99999999999998654 5789999999999999999999999999999999999999999999999999987654332
Q ss_pred ccccccCCCccccHHhhcc
Q 010401 490 ATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 490 ~~~~~~Gt~~YmAPEvl~g 508 (511)
......||+.|||||++.+
T Consensus 158 ~~~~~~gt~~y~aPE~l~~ 176 (263)
T d1sm2a_ 158 SSTGTKFPVKWASPEVFSF 176 (263)
T ss_dssp -------CTTSCCHHHHTT
T ss_pred eecceecCcccCChHHhcC
Confidence 2334578999999999875
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-36 Score=295.56 Aligned_cols=171 Identities=22% Similarity=0.433 Sum_probs=147.7
Q ss_pred cceEecCCCeEEEeeeecccceEEEEe-----EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCC
Q 010401 333 GRWLLNSDNLEFIDQIGPNSFKGVYKG-----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENH 407 (511)
Q Consensus 333 ~~~~l~~~~y~l~~~LG~GsFG~VYkg-----k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~ 407 (511)
++|+++.++|++.+.||+|+||.||+| +.||||+++... .....+.+|+.++.+++|||||+++|++.+ +.
T Consensus 6 ~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~ 81 (272)
T d1qpca_ 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS---MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EP 81 (272)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred CCeecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc---CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CC
Confidence 378889999999999999999999996 479999996432 234568999999999999999999998864 33
Q ss_pred cEEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecc
Q 010401 408 GLCVVTKLMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK 485 (511)
Q Consensus 408 ~l~LVmEy~~gGsL~~lL~~~--~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~ 485 (511)
+|+||||+++|+|.+++... ..+++..+..++.||+.||.|||+++|+||||||+||||+.++.+||+|||+|+.+.
T Consensus 82 -~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~ 160 (272)
T d1qpca_ 82 -IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIE 160 (272)
T ss_dssp -CEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred -eEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEcc
Confidence 79999999999999987432 369999999999999999999999999999999999999999999999999999875
Q ss_pred cCCC-ccccccCCCccccHHhhcc
Q 010401 486 SVGE-ATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 486 ~~~~-~~~~~~Gt~~YmAPEvl~g 508 (511)
.... ......||+.|||||++.+
T Consensus 161 ~~~~~~~~~~~gt~~y~APE~~~~ 184 (272)
T d1qpca_ 161 DNEYTAREGAKFPIKWTAPEAINY 184 (272)
T ss_dssp SSCEECCTTCCCCTTTSCHHHHHH
T ss_pred CCccccccccCCcccccChHHHhC
Confidence 4332 2344578899999999864
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9.8e-36 Score=300.39 Aligned_cols=163 Identities=26% Similarity=0.368 Sum_probs=144.8
Q ss_pred CeEEEeeeecccceEEEEe------EEEEEEEEecCCCCc-hHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEE
Q 010401 341 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGN-AYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT 413 (511)
Q Consensus 341 ~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~-~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVm 413 (511)
.|+.++.||+|+||.||+| +.||||++....... .....+.+|+.+|++++|||||++++++.+++. +|+||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~-~~iv~ 94 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHT-AWLVM 94 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTE-EEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCE-EEEEE
Confidence 4899999999999999996 479999997544333 234568999999999999999999999998876 99999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCcccc
Q 010401 414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY 493 (511)
Q Consensus 414 Ey~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~~~ 493 (511)
|||.+|+|..++...+.+++..++.++.||+.||.|||++|||||||||+|||++.++.+||+|||+|+.... ...
T Consensus 95 E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~----~~~ 170 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----ANS 170 (309)
T ss_dssp ECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS----BCC
T ss_pred EecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC----CCc
Confidence 9999999988777778899999999999999999999999999999999999999999999999999986543 345
Q ss_pred ccCCCccccHHhhcc
Q 010401 494 ETDGYRWLAPEVCFL 508 (511)
Q Consensus 494 ~~Gt~~YmAPEvl~g 508 (511)
..||+.|||||++.+
T Consensus 171 ~~GT~~Y~APE~~~~ 185 (309)
T d1u5ra_ 171 FVGTPYWMAPEVILA 185 (309)
T ss_dssp CCSCGGGCCHHHHTT
T ss_pred cccCccccCHHHHhc
Confidence 689999999999875
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-36 Score=303.35 Aligned_cols=173 Identities=22% Similarity=0.369 Sum_probs=146.4
Q ss_pred ceEecCCCeEEEeeeecccceEEEEeE-----------EEEEEEEecCCCCchHHHHHHHHHHHHHhC-CCCceeeEeee
Q 010401 334 RWLLNSDNLEFIDQIGPNSFKGVYKGK-----------RVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCV 401 (511)
Q Consensus 334 ~~~l~~~~y~l~~~LG~GsFG~VYkgk-----------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l-~HpNIV~l~g~ 401 (511)
+|+++.++|++.+.||+|+||.||+|+ .||+|++.... .......+.+|+.+++++ +|||||+++++
T Consensus 31 kwei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~ 109 (325)
T d1rjba_ 31 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGA 109 (325)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc-CHHHHHHHHHHHHHHHHhcCCCcEeEEEEE
Confidence 688899999999999999999999975 48999886432 223345688999999988 89999999999
Q ss_pred EeeCCCcEEEEEeccCCCCHHHHHHhc-----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Q 010401 402 CVDENHGLCVVTKLMEGGSVNDLILKS-----------------------RKLQTKEIIRIAIDVAEGIKFLNDHGVAYR 458 (511)
Q Consensus 402 ~~~~~~~l~LVmEy~~gGsL~~lL~~~-----------------------~~L~e~~~~~ia~qIa~gL~yLH~~gIIHR 458 (511)
|.+.+. +|+||||+++|+|.++|... ..+++..++.|+.||+.||+|||+++||||
T Consensus 110 ~~~~~~-~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHR 188 (325)
T d1rjba_ 110 CTLSGP-IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHR 188 (325)
T ss_dssp ECSSSS-CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEET
T ss_pred EeeCCe-EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeec
Confidence 998876 99999999999999999653 248899999999999999999999999999
Q ss_pred CCCCCceEEcCCCcEEEEecCCceecccCCCc--cccccCCCccccHHhhcc
Q 010401 459 DLNSQRILLDRHGNVCLGDMGIVTACKSVGEA--TEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 459 DLKp~NILld~~g~vKL~DFGlS~~l~~~~~~--~~~~~Gt~~YmAPEvl~g 508 (511)
||||+|||++.++.+||+|||+|+........ .....||+.|||||++.+
T Consensus 189 DlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~ 240 (325)
T d1rjba_ 189 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE 240 (325)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH
T ss_pred cCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcC
Confidence 99999999999999999999999876554332 234567999999999864
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-36 Score=300.43 Aligned_cols=170 Identities=15% Similarity=0.239 Sum_probs=145.2
Q ss_pred CCCeEEEeeeecccceEEEEe------EEEEEEEEecCCC-CchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEE
Q 010401 339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDK-GNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCV 411 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~-~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~L 411 (511)
.++|++++.||+|+||+||++ +.||||++..... .......+.+|+.++++++||||+++++++.+++. +||
T Consensus 7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~-~~i 85 (288)
T d1uu3a_ 7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEK-LYF 85 (288)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSE-EEE
T ss_pred CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCE-EEE
Confidence 467999999999999999996 4799999974221 12233568899999999999999999999998776 999
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCC--
Q 010401 412 VTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE-- 489 (511)
Q Consensus 412 VmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~-- 489 (511)
||||+++|+|.+++...+.+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+.+.....
T Consensus 86 vmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~ 165 (288)
T d1uu3a_ 86 GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 165 (288)
T ss_dssp EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred EEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCccc
Confidence 999999999999998888999999999999999999999999999999999999999999999999999987754332
Q ss_pred ccccccCCCccccHHhhccc
Q 010401 490 ATEYETDGYRWLAPEVCFLL 509 (511)
Q Consensus 490 ~~~~~~Gt~~YmAPEvl~gl 509 (511)
.....+||+.|||||++.+.
T Consensus 166 ~~~~~~GT~~Y~APE~~~~~ 185 (288)
T d1uu3a_ 166 RANSFVGTAQYVSPELLTEK 185 (288)
T ss_dssp ----CCCCGGGCCHHHHHTC
T ss_pred ccccccCCccccCceeeccC
Confidence 23456799999999998753
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-35 Score=292.55 Aligned_cols=165 Identities=25% Similarity=0.400 Sum_probs=143.4
Q ss_pred eEEEeeeecccceEEEEeE------EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeC---CCcEEEE
Q 010401 342 LEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDE---NHGLCVV 412 (511)
Q Consensus 342 y~l~~~LG~GsFG~VYkgk------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~---~~~l~LV 412 (511)
|++.++||+|+||.||+|+ .||+|++............+.+|+.+|++++|||||+++++|.+. +..+|||
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence 5788899999999999963 799999986544555556789999999999999999999998752 3348999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCCCceEEc-CCCcEEEEecCCceecccCCC
Q 010401 413 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHG--VAYRDLNSQRILLD-RHGNVCLGDMGIVTACKSVGE 489 (511)
Q Consensus 413 mEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~g--IIHRDLKp~NILld-~~g~vKL~DFGlS~~l~~~~~ 489 (511)
|||+++|+|.+++.+...+++..++.++.||+.||+|||+++ |+||||||+|||++ .++.+||+|||+|+.... .
T Consensus 91 mE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~--~ 168 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA--S 168 (270)
T ss_dssp EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT--T
T ss_pred EeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC--C
Confidence 999999999999988889999999999999999999999998 99999999999997 578999999999976433 2
Q ss_pred ccccccCCCccccHHhhcc
Q 010401 490 ATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 490 ~~~~~~Gt~~YmAPEvl~g 508 (511)
......||+.|||||++.+
T Consensus 169 ~~~~~~GT~~Y~aPE~~~~ 187 (270)
T d1t4ha_ 169 FAKAVIGTPEFMAPEMYEE 187 (270)
T ss_dssp SBEESCSSCCCCCGGGGGT
T ss_pred ccCCcccCccccCHHHhCC
Confidence 3456689999999999864
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.2e-35 Score=297.77 Aligned_cols=170 Identities=20% Similarity=0.331 Sum_probs=136.1
Q ss_pred ecCCCeEEEeeeecccceEEEEeE---------EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCC
Q 010401 337 LNSDNLEFIDQIGPNSFKGVYKGK---------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENH 407 (511)
Q Consensus 337 l~~~~y~l~~~LG~GsFG~VYkgk---------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~ 407 (511)
++.++|++.+.||+|+||.||+|+ .||||++.. ........++.+|+.+|++++|||||+++|+|.+++.
T Consensus 23 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~-~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~ 101 (299)
T d1jpaa_ 23 IDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKS-GYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTP 101 (299)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCS-SCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred hChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECc-ccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCE
Confidence 556789999999999999999985 378888864 2333445678999999999999999999999988776
Q ss_pred cEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceeccc
Q 010401 408 GLCVVTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS 486 (511)
Q Consensus 408 ~l~LVmEy~~gGsL~~lL~~~-~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~ 486 (511)
+|+||||+++|+|.+++... +.+++..+..++.||+.||+|||+++||||||||+||||+.++++||+|||+++.+..
T Consensus 102 -~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 102 -VMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180 (299)
T ss_dssp -CEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred -EEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccC
Confidence 99999999999999988764 5799999999999999999999999999999999999999999999999999987654
Q ss_pred CCCc-----cccccCCCccccHHhhcc
Q 010401 487 VGEA-----TEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 487 ~~~~-----~~~~~Gt~~YmAPEvl~g 508 (511)
.... .....||+.|||||++.+
T Consensus 181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~ 207 (299)
T d1jpaa_ 181 DTSDPTYTSALGGKIPIRWTAPEAIQY 207 (299)
T ss_dssp ---------------CGGGSCHHHHHS
T ss_pred CCCcceeeecccccCCccccCHHHHhc
Confidence 3221 122357889999999864
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-35 Score=290.83 Aligned_cols=167 Identities=24% Similarity=0.379 Sum_probs=139.1
Q ss_pred CCeEEE-eeeecccceEEEEe--------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEE
Q 010401 340 DNLEFI-DQIGPNSFKGVYKG--------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLC 410 (511)
Q Consensus 340 ~~y~l~-~~LG~GsFG~VYkg--------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~ 410 (511)
+.+.+. ++||+|+||.||+| +.||||+++..........++.+|+.+|++++|||||+++|+|.++ . +|
T Consensus 6 ~~~~le~k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~-~~ 83 (277)
T d1xbba_ 6 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-S-WM 83 (277)
T ss_dssp GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-S-EE
T ss_pred hhCeecCCCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-C-EE
Confidence 334544 47999999999997 3699999975444445566799999999999999999999998654 3 89
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCc
Q 010401 411 VVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA 490 (511)
Q Consensus 411 LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~ 490 (511)
|||||+++|+|.+++.....+++..+..++.||+.||+|||+++||||||||+|||++.++.+||+|||+++.+......
T Consensus 84 lvmE~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~ 163 (277)
T d1xbba_ 84 LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 163 (277)
T ss_dssp EEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE
T ss_pred EEEEcCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhccccccc
Confidence 99999999999999988889999999999999999999999999999999999999999999999999999876543321
Q ss_pred ---cccccCCCccccHHhhcc
Q 010401 491 ---TEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 491 ---~~~~~Gt~~YmAPEvl~g 508 (511)
.....||+.|||||++.+
T Consensus 164 ~~~~~~~~gt~~y~APE~l~~ 184 (277)
T d1xbba_ 164 YKAQTHGKWPVKWYAPECINY 184 (277)
T ss_dssp EEC----CCCGGGCCHHHHHH
T ss_pred cccccccCCCceecCchhhcC
Confidence 233568899999999864
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-35 Score=292.21 Aligned_cols=172 Identities=23% Similarity=0.390 Sum_probs=147.1
Q ss_pred ceEecCCCeEEEee-eecccceEEEEeE--------EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEee
Q 010401 334 RWLLNSDNLEFIDQ-IGPNSFKGVYKGK--------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVD 404 (511)
Q Consensus 334 ~~~l~~~~y~l~~~-LG~GsFG~VYkgk--------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~ 404 (511)
++.+..++|.+.+. ||+|+||.||+|. .||||+++.. .......++.+|+.+|++++|||||+++|++.+
T Consensus 2 ~l~l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~ 80 (285)
T d1u59a_ 2 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA 80 (285)
T ss_dssp CCBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred ceeecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChh-cCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc
Confidence 45677788999985 9999999999973 5999999743 333445678999999999999999999999875
Q ss_pred CCCcEEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCcee
Q 010401 405 ENHGLCVVTKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTA 483 (511)
Q Consensus 405 ~~~~l~LVmEy~~gGsL~~lL~~-~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~ 483 (511)
+ . +||||||+++|+|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.
T Consensus 81 ~-~-~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~ 158 (285)
T d1u59a_ 81 E-A-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKA 158 (285)
T ss_dssp S-S-EEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred C-e-EEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhc
Confidence 4 3 8999999999999999854 45799999999999999999999999999999999999999999999999999988
Q ss_pred cccCCC---ccccccCCCccccHHhhcc
Q 010401 484 CKSVGE---ATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 484 l~~~~~---~~~~~~Gt~~YmAPEvl~g 508 (511)
+..... ......||+.|||||++.+
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 186 (285)
T d1u59a_ 159 LGADDSYYTARSAGKWPLKWYAPECINF 186 (285)
T ss_dssp CTTCSCEECCCCSSCCCGGGCCHHHHHH
T ss_pred ccccccccccccccccCccccChHHHhC
Confidence 754332 2234568899999999864
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-35 Score=290.21 Aligned_cols=170 Identities=22% Similarity=0.356 Sum_probs=140.1
Q ss_pred ecCCCeEEEeeeecccceEEEEeE----------EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCC
Q 010401 337 LNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN 406 (511)
Q Consensus 337 l~~~~y~l~~~LG~GsFG~VYkgk----------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~ 406 (511)
+..+.|++.++||+|+||.||+|+ .||||++.. ........++.+|+.++.+++|||||+++|++.+.+
T Consensus 4 i~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~-~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~ 82 (283)
T d1mqba_ 4 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKA-GYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK 82 (283)
T ss_dssp CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECT-TCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred CCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECc-ccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCC
Confidence 456789999999999999999974 589999964 333444556899999999999999999999999877
Q ss_pred CcEEEEEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecc
Q 010401 407 HGLCVVTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK 485 (511)
Q Consensus 407 ~~l~LVmEy~~gGsL~~lL~~~-~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~ 485 (511)
. +++||||+.+|++.+++... ..+++..+..++.||+.||+|||+++|+||||||+||||+.++.+||+|||+++.+.
T Consensus 83 ~-~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 161 (283)
T d1mqba_ 83 P-MMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 161 (283)
T ss_dssp S-EEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred c-eEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhccc
Confidence 6 99999999999999988654 579999999999999999999999999999999999999999999999999998765
Q ss_pred cCCCc---cccccCCCccccHHhhcc
Q 010401 486 SVGEA---TEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 486 ~~~~~---~~~~~Gt~~YmAPEvl~g 508 (511)
..... .....||+.|||||++.+
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~APE~l~~ 187 (283)
T d1mqba_ 162 DDPEATYTTSGGKIPIRWTAPEAISY 187 (283)
T ss_dssp ------------CCCGGGSCHHHHHS
T ss_pred CCCccceEeccCCCCccccCHHHHcc
Confidence 43322 233467899999999865
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.8e-35 Score=297.96 Aligned_cols=167 Identities=22% Similarity=0.351 Sum_probs=130.2
Q ss_pred CCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEE
Q 010401 340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT 413 (511)
Q Consensus 340 ~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVm 413 (511)
+.|++.+.||+|+||+||++ +.||+|++...... .....+.+|+.+|+.++||||+++++++.+++. +||||
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~-~~lvm 86 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE-GKEGSMENEIAVLHKIKHPNIVALDDIYESGGH-LYLIM 86 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEECSSE-EEEEE
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh-hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE-EEEEE
Confidence 56999999999999999996 47999999753322 234557899999999999999999999998876 99999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEc---CCCcEEEEecCCceecccCCCc
Q 010401 414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLD---RHGNVCLGDMGIVTACKSVGEA 490 (511)
Q Consensus 414 Ey~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld---~~g~vKL~DFGlS~~l~~~~~~ 490 (511)
||++||+|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||+. .++.+||+|||+|+..... ..
T Consensus 87 E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~-~~ 165 (307)
T d1a06a_ 87 QLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG-SV 165 (307)
T ss_dssp CCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC------------
T ss_pred eccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCC-Ce
Confidence 9999999999998888999999999999999999999999999999999999995 5789999999999866433 23
Q ss_pred cccccCCCccccHHhhccc
Q 010401 491 TEYETDGYRWLAPEVCFLL 509 (511)
Q Consensus 491 ~~~~~Gt~~YmAPEvl~gl 509 (511)
....+||+.|||||++.+.
T Consensus 166 ~~~~~GT~~y~APE~~~~~ 184 (307)
T d1a06a_ 166 LSTACGTPGYVAPEVLAQK 184 (307)
T ss_dssp -------CTTSCHHHHTTC
T ss_pred eeeeeeCccccCcHHHcCC
Confidence 4456899999999998763
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=7e-35 Score=299.03 Aligned_cols=166 Identities=16% Similarity=0.296 Sum_probs=145.5
Q ss_pred CCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEE
Q 010401 340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT 413 (511)
Q Consensus 340 ~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVm 413 (511)
++|++++.||+|+||.||++ +.||||++.. ........+.+|+.+|+.++|||||++++++.+++. +||||
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~--~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~-~~ivm 102 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMT--PHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNE-MVMIY 102 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECC--CSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTE-EEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcc--cchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE-EEEEE
Confidence 57899999999999999995 5799999963 233445668999999999999999999999998876 99999
Q ss_pred eccCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcC--CCcEEEEecCCceecccCCCc
Q 010401 414 KLMEGGSVNDLIL-KSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDR--HGNVCLGDMGIVTACKSVGEA 490 (511)
Q Consensus 414 Ey~~gGsL~~lL~-~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~--~g~vKL~DFGlS~~l~~~~~~ 490 (511)
|||+||+|.+++. ..+.+++..++.|+.||+.||+|||++|||||||||+|||++. ++.+||+|||+|+.+... ..
T Consensus 103 E~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~-~~ 181 (350)
T d1koaa2 103 EFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK-QS 181 (350)
T ss_dssp CCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT-SC
T ss_pred EcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecccc-cc
Confidence 9999999999985 4467999999999999999999999999999999999999964 678999999999877543 33
Q ss_pred cccccCCCccccHHhhccc
Q 010401 491 TEYETDGYRWLAPEVCFLL 509 (511)
Q Consensus 491 ~~~~~Gt~~YmAPEvl~gl 509 (511)
.....||+.|||||++.+.
T Consensus 182 ~~~~~gT~~Y~aPEv~~~~ 200 (350)
T d1koaa2 182 VKVTTGTAEFAAPEVAEGK 200 (350)
T ss_dssp EEEECSCTTTCCHHHHHTC
T ss_pred cceecCcccccCHHHHcCC
Confidence 4567899999999998763
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.4e-35 Score=297.13 Aligned_cols=167 Identities=22% Similarity=0.328 Sum_probs=147.2
Q ss_pred CCCeEEEeeeecccceEEEEe------EEEEEEEEecCCC-CchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEE
Q 010401 339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDK-GNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCV 411 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~-~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~L 411 (511)
.++|++++.||+|+||.||++ +.||+|+++.... .......+.+|+.+++.++||||+++++++.+++. +|+
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~-~~i 81 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQ-IFM 81 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSE-EEE
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCe-eee
Confidence 357999999999999999996 4799999974221 11234568899999999999999999999998776 999
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCcc
Q 010401 412 VTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT 491 (511)
Q Consensus 412 VmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~ 491 (511)
||||+.||+|..++.....+++..++.++.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+..... .
T Consensus 82 vmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~---~ 158 (316)
T d1fota_ 82 IMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV---T 158 (316)
T ss_dssp EECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC---B
T ss_pred EeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEeccc---c
Confidence 9999999999999988889999999999999999999999999999999999999999999999999999876542 4
Q ss_pred ccccCCCccccHHhhccc
Q 010401 492 EYETDGYRWLAPEVCFLL 509 (511)
Q Consensus 492 ~~~~Gt~~YmAPEvl~gl 509 (511)
...+||+.|||||++.+.
T Consensus 159 ~~~~Gt~~Y~APE~l~~~ 176 (316)
T d1fota_ 159 YTLCGTPDYIAPEVVSTK 176 (316)
T ss_dssp CCCCSCTTTCCHHHHTTC
T ss_pred ccccCcccccCHHHHcCC
Confidence 457899999999998763
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-34 Score=288.73 Aligned_cols=167 Identities=17% Similarity=0.264 Sum_probs=146.7
Q ss_pred CCeEEEeeeecccceEEEEe------EEEEEEEEecCCCC----chHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcE
Q 010401 340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKG----NAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGL 409 (511)
Q Consensus 340 ~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~----~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l 409 (511)
++|++++.||+|+||+||+| +.||||++...... ......+.+|+.+|+.++|||||+++++|.+++. +
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~-~ 88 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD-V 88 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE-E
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE-E
Confidence 56999999999999999996 47999999753322 2235678999999999999999999999998876 9
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCC----cEEEEecCCceecc
Q 010401 410 CVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG----NVCLGDMGIVTACK 485 (511)
Q Consensus 410 ~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g----~vKL~DFGlS~~l~ 485 (511)
||||||+++|+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+...
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~ 168 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 168 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECT
T ss_pred EEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcC
Confidence 99999999999999998888999999999999999999999999999999999999999776 59999999998775
Q ss_pred cCCCccccccCCCccccHHhhcc
Q 010401 486 SVGEATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 486 ~~~~~~~~~~Gt~~YmAPEvl~g 508 (511)
... ......||+.|+|||++.+
T Consensus 169 ~~~-~~~~~~~t~~y~APE~~~~ 190 (293)
T d1jksa_ 169 FGN-EFKNIFGTPEFVAPEIVNY 190 (293)
T ss_dssp TSC-BCSCCCCCGGGCCHHHHTT
T ss_pred CCc-cccccCCCCcccCHHHHcC
Confidence 433 3445678999999999875
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-35 Score=292.00 Aligned_cols=176 Identities=22% Similarity=0.371 Sum_probs=140.9
Q ss_pred ccceEecCCCeEEEeeeecccceEEEEeE-----------EEEEEEEecCCCCchHHHHHHHHHHHHHhC-CCCceeeEe
Q 010401 332 IGRWLLNSDNLEFIDQIGPNSFKGVYKGK-----------RVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFY 399 (511)
Q Consensus 332 i~~~~l~~~~y~l~~~LG~GsFG~VYkgk-----------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l-~HpNIV~l~ 399 (511)
..+|+++.++|++.++||+|+||.||+|+ .||||+++.. ........+.+|+..+.++ +|+||+.++
T Consensus 5 ~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~~e~~~l~~~~~h~~iv~~~ 83 (299)
T d1ywna1 5 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVVNLL 83 (299)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-----CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccc-cCcHHHHHHHHHHHHHHhhcCCCeEEEee
Confidence 34788899999999999999999999963 6999999742 2333445577777777765 789999999
Q ss_pred eeEeeCCCcEEEEEeccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCC
Q 010401 400 CVCVDENHGLCVVTKLMEGGSVNDLILKS----------------RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQ 463 (511)
Q Consensus 400 g~~~~~~~~l~LVmEy~~gGsL~~lL~~~----------------~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~ 463 (511)
+++...+..+++||||+++|+|.+++... ..+++..+..++.||+.||+|||+++||||||||+
T Consensus 84 ~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~ 163 (299)
T d1ywna1 84 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAAR 163 (299)
T ss_dssp EEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred eeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCcc
Confidence 99887766689999999999999999643 24889999999999999999999999999999999
Q ss_pred ceEEcCCCcEEEEecCCceecccCCC--ccccccCCCccccHHhhcc
Q 010401 464 RILLDRHGNVCLGDMGIVTACKSVGE--ATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 464 NILld~~g~vKL~DFGlS~~l~~~~~--~~~~~~Gt~~YmAPEvl~g 508 (511)
||||+.++++||+|||+|+....... ......||+.|||||++.+
T Consensus 164 NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~ 210 (299)
T d1ywna1 164 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD 210 (299)
T ss_dssp GEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHH
T ss_pred ceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhc
Confidence 99999999999999999987654332 2334578999999999865
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.7e-34 Score=296.46 Aligned_cols=166 Identities=17% Similarity=0.311 Sum_probs=145.2
Q ss_pred CCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEE
Q 010401 340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT 413 (511)
Q Consensus 340 ~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVm 413 (511)
++|++++.||+|+||.||++ +.||+|++... .......+.+|+.+|+.++|||||+++++|.+++. +||||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~--~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~-~~ivm 105 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP--YPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYE-MVLIL 105 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSE-EEEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCc--chhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE-EEEEE
Confidence 56899999999999999996 47999999742 33345568899999999999999999999998776 99999
Q ss_pred eccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEc--CCCcEEEEecCCceecccCCCc
Q 010401 414 KLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLD--RHGNVCLGDMGIVTACKSVGEA 490 (511)
Q Consensus 414 Ey~~gGsL~~lL~~~-~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld--~~g~vKL~DFGlS~~l~~~~~~ 490 (511)
||++||+|.+++... .++++.+++.|+.||+.||+|||++|||||||||+|||++ .++.+||+|||+|+.+... ..
T Consensus 106 E~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~-~~ 184 (352)
T d1koba_ 106 EFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD-EI 184 (352)
T ss_dssp ECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT-SC
T ss_pred EcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCC-Cc
Confidence 999999999987554 4799999999999999999999999999999999999998 6789999999999887543 33
Q ss_pred cccccCCCccccHHhhccc
Q 010401 491 TEYETDGYRWLAPEVCFLL 509 (511)
Q Consensus 491 ~~~~~Gt~~YmAPEvl~gl 509 (511)
.....||+.|||||++.+.
T Consensus 185 ~~~~~gt~~y~aPE~~~~~ 203 (352)
T d1koba_ 185 VKVTTATAEFAAPEIVDRE 203 (352)
T ss_dssp EEEECSSGGGCCHHHHTTC
T ss_pred eeeccCcccccCHHHHcCC
Confidence 5567899999999998753
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=4.6e-34 Score=283.69 Aligned_cols=168 Identities=23% Similarity=0.239 Sum_probs=148.2
Q ss_pred CCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCch-------HHHHHHHHHHHHHhCC-CCceeeEeeeEee
Q 010401 339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNA-------YEFELRKDLLELMTCG-HKNILQFYCVCVD 404 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~-------~~~~~~~Ei~iL~~l~-HpNIV~l~g~~~~ 404 (511)
.++|++++.||+|+||+||++ +.+|||++........ ....+.+|+.++++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 478999999999999999996 5799999976443221 2235789999999996 9999999999998
Q ss_pred CCCcEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceec
Q 010401 405 ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC 484 (511)
Q Consensus 405 ~~~~l~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l 484 (511)
++. +||||||+++|+|.++|...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 82 ~~~-~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~ 160 (277)
T d1phka_ 82 NTF-FFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL 160 (277)
T ss_dssp SSE-EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred Ccc-eEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEc
Confidence 776 9999999999999999988889999999999999999999999999999999999999999999999999999877
Q ss_pred ccCCCccccccCCCccccHHhhcc
Q 010401 485 KSVGEATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 485 ~~~~~~~~~~~Gt~~YmAPEvl~g 508 (511)
.... ......||+.|+|||++.+
T Consensus 161 ~~~~-~~~~~~gt~~y~~PE~~~~ 183 (277)
T d1phka_ 161 DPGE-KLREVCGTPSYLAPEIIEC 183 (277)
T ss_dssp CTTC-CBCCCCSCGGGCCHHHHHH
T ss_pred cCCC-ceeeeeccCCCCCHHHhhc
Confidence 5433 3455689999999999874
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-34 Score=288.16 Aligned_cols=172 Identities=22% Similarity=0.397 Sum_probs=142.5
Q ss_pred ccceEecCCCeEEEeeeecccceEEEEeE-----EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCC
Q 010401 332 IGRWLLNSDNLEFIDQIGPNSFKGVYKGK-----RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN 406 (511)
Q Consensus 332 i~~~~l~~~~y~l~~~LG~GsFG~VYkgk-----~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~ 406 (511)
.+.|+++.++|++.+.||+|+||+||+|+ .||||+++... .....+.+|+.++++++|||||+++|+|.+ +
T Consensus 9 ~~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~---~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~ 84 (285)
T d1fmka3 9 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT---MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-E 84 (285)
T ss_dssp TTCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred CcceEcCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc---CCHHHHHHHHHHHHhcccCCEeEEEEEEec-C
Confidence 35788889999999999999999999974 79999996432 224568999999999999999999999864 4
Q ss_pred CcEEEEEeccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceec
Q 010401 407 HGLCVVTKLMEGGSVNDLILK--SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC 484 (511)
Q Consensus 407 ~~l~LVmEy~~gGsL~~lL~~--~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l 484 (511)
. +|+||||+++|+|..++.. ...+++..++.++.||+.||+|||++||+||||||+||||+.++++||+|||+++..
T Consensus 85 ~-~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~ 163 (285)
T d1fmka3 85 P-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLI 163 (285)
T ss_dssp S-CEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC--
T ss_pred C-eEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhc
Confidence 3 7999999999999998853 357999999999999999999999999999999999999999999999999999876
Q ss_pred ccCC-CccccccCCCccccHHhhcc
Q 010401 485 KSVG-EATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 485 ~~~~-~~~~~~~Gt~~YmAPEvl~g 508 (511)
.... .......||+.|+|||++..
T Consensus 164 ~~~~~~~~~~~~gt~~y~aPE~~~~ 188 (285)
T d1fmka3 164 EDNEYTARQGAKFPIKWTAPEAALY 188 (285)
T ss_dssp ------------CCGGGSCHHHHHH
T ss_pred cCCCceeeccccccccccChHHHhC
Confidence 4332 22344678999999999864
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-34 Score=285.25 Aligned_cols=172 Identities=19% Similarity=0.363 Sum_probs=136.5
Q ss_pred ceEecCCCeEEEeeeecccceEEEEeE---------EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEee
Q 010401 334 RWLLNSDNLEFIDQIGPNSFKGVYKGK---------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVD 404 (511)
Q Consensus 334 ~~~l~~~~y~l~~~LG~GsFG~VYkgk---------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~ 404 (511)
+|+++.++|++.+.||+|+||.||+|+ .||||+++.. ........+.+|+.++++++||||++++|++.+
T Consensus 1 ~~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 79 (273)
T d1mp8a_ 1 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE 79 (273)
T ss_dssp CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred CCCcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 478888999999999999999999974 3788888542 333445668999999999999999999999864
Q ss_pred CCCcEEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCcee
Q 010401 405 ENHGLCVVTKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTA 483 (511)
Q Consensus 405 ~~~~l~LVmEy~~gGsL~~lL~~-~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~ 483 (511)
+. +|+||||+++|+|.+++.. ...+++..++.++.||+.||.|||+++||||||||+|||++.++.+||+|||+|+.
T Consensus 80 -~~-~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~ 157 (273)
T d1mp8a_ 80 -NP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 157 (273)
T ss_dssp -SS-CEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC------
T ss_pred -Ce-EEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhhee
Confidence 33 8999999999999998754 45799999999999999999999999999999999999999999999999999987
Q ss_pred cccCCC-ccccccCCCccccHHhhcc
Q 010401 484 CKSVGE-ATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 484 l~~~~~-~~~~~~Gt~~YmAPEvl~g 508 (511)
...... ......||+.|+|||++.+
T Consensus 158 ~~~~~~~~~~~~~gt~~y~apE~l~~ 183 (273)
T d1mp8a_ 158 MEDSTYYKASKGKLPIKWMAPESINF 183 (273)
T ss_dssp -------------CCGGGCCHHHHHH
T ss_pred ccCCcceeccceecCcccchhhHhcc
Confidence 654322 2344567899999999864
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-34 Score=283.50 Aligned_cols=167 Identities=24% Similarity=0.449 Sum_probs=146.0
Q ss_pred cCCCeEEEeeeecccceEEEEeE-----EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEE
Q 010401 338 NSDNLEFIDQIGPNSFKGVYKGK-----RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV 412 (511)
Q Consensus 338 ~~~~y~l~~~LG~GsFG~VYkgk-----~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LV 412 (511)
+.++|+++++||+|+||.||+|+ .||||+++.... ...++.+|+.++.+++||||++++|+|.+++. +++|
T Consensus 2 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~---~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~-~~iv 77 (258)
T d1k2pa_ 2 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM---SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRP-IFII 77 (258)
T ss_dssp CCCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS---CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSS-EEEE
T ss_pred ChHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC---CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCc-eEEE
Confidence 56789999999999999999974 799999985332 24568999999999999999999999998776 9999
Q ss_pred EeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCC-c
Q 010401 413 TKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE-A 490 (511)
Q Consensus 413 mEy~~gGsL~~lL~~-~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~-~ 490 (511)
|||+.+|+|..++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....... .
T Consensus 78 ~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 157 (258)
T d1k2pa_ 78 TEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS 157 (258)
T ss_dssp EECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCC
T ss_pred EEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCcee
Confidence 999999999999754 45799999999999999999999999999999999999999999999999999987654333 2
Q ss_pred cccccCCCccccHHhhcc
Q 010401 491 TEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 491 ~~~~~Gt~~YmAPEvl~g 508 (511)
.....||+.|+|||++.+
T Consensus 158 ~~~~~~t~~y~aPE~~~~ 175 (258)
T d1k2pa_ 158 SVGSKFPVRWSPPEVLMY 175 (258)
T ss_dssp CCCSCCCGGGCCHHHHHH
T ss_pred ecccCCCCCcCCcHHhcC
Confidence 334568899999999864
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-34 Score=289.69 Aligned_cols=169 Identities=21% Similarity=0.323 Sum_probs=146.3
Q ss_pred CCeEEEeeeecccceEEEEe------EEEEEEEEecCCC-CchHHHHHHHHHHHHH-hCCCCceeeEeeeEeeCCCcEEE
Q 010401 340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDK-GNAYEFELRKDLLELM-TCGHKNILQFYCVCVDENHGLCV 411 (511)
Q Consensus 340 ~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~-~~~~~~~~~~Ei~iL~-~l~HpNIV~l~g~~~~~~~~l~L 411 (511)
++|++++.||+|+||+||+| +.||||+++.... .......+..|+.++. .++||||+++++++.+++. +||
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~-~yi 80 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN-LFF 80 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE-EEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCc-eeE
Confidence 68999999999999999996 5799999974211 1112234556666554 6899999999999998876 999
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCcc
Q 010401 412 VTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT 491 (511)
Q Consensus 412 VmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~ 491 (511)
||||+++|+|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.........
T Consensus 81 vmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~~~ 160 (320)
T d1xjda_ 81 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT 160 (320)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCB
T ss_pred EEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccccccc
Confidence 99999999999999888899999999999999999999999999999999999999999999999999998776655556
Q ss_pred ccccCCCccccHHhhccc
Q 010401 492 EYETDGYRWLAPEVCFLL 509 (511)
Q Consensus 492 ~~~~Gt~~YmAPEvl~gl 509 (511)
....||+.|+|||++.+.
T Consensus 161 ~~~~gt~~y~aPE~~~~~ 178 (320)
T d1xjda_ 161 NTFCGTPDYIAPEILLGQ 178 (320)
T ss_dssp CCCCSCGGGCCHHHHTTC
T ss_pred cccCCCCCcCCHHHHcCC
Confidence 677899999999999764
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.5e-34 Score=296.36 Aligned_cols=167 Identities=18% Similarity=0.232 Sum_probs=146.9
Q ss_pred CCCeEEEeeeecccceEEEEe------EEEEEEEEecCCC-CchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEE
Q 010401 339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDK-GNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCV 411 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~-~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~L 411 (511)
.++|++++.||+|+||.||++ +.||+|++..... .......+.+|+.+|+.++||||+++++++.+.+. +|+
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~-~~~ 118 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSN-LYM 118 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE-EEE
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccc-ccc
Confidence 357899999999999999996 4799999964221 11223557899999999999999999999998776 999
Q ss_pred EEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCcc
Q 010401 412 VTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT 491 (511)
Q Consensus 412 VmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~ 491 (511)
||||+.+|+|..++...+.+++..++.|+.||+.||.|||++|||||||||+|||++.+|.+||+|||+|+.+... .
T Consensus 119 v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~---~ 195 (350)
T d1rdqe_ 119 VMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR---T 195 (350)
T ss_dssp EEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC---B
T ss_pred ccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc---c
Confidence 9999999999999988889999999999999999999999999999999999999999999999999999887542 3
Q ss_pred ccccCCCccccHHhhccc
Q 010401 492 EYETDGYRWLAPEVCFLL 509 (511)
Q Consensus 492 ~~~~Gt~~YmAPEvl~gl 509 (511)
....||+.|||||++.+.
T Consensus 196 ~~~~Gt~~Y~APE~~~~~ 213 (350)
T d1rdqe_ 196 WTLCGTPEALAPEIILSK 213 (350)
T ss_dssp CCCEECGGGCCHHHHTTC
T ss_pred ccccCccccCCHHHHcCC
Confidence 456899999999999763
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=3.7e-34 Score=294.93 Aligned_cols=168 Identities=22% Similarity=0.284 Sum_probs=142.5
Q ss_pred cCCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCc-hHHHHH---HHHHHHHHhCCCCceeeEeeeEeeCCC
Q 010401 338 NSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGN-AYEFEL---RKDLLELMTCGHKNILQFYCVCVDENH 407 (511)
Q Consensus 338 ~~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~-~~~~~~---~~Ei~iL~~l~HpNIV~l~g~~~~~~~ 407 (511)
..++|++++.||+|+||.||+| +.||+|++....... .....+ .+++.+++.++|||||+++++|.+++.
T Consensus 2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~ 81 (364)
T d1omwa3 2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 81 (364)
T ss_dssp CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred CHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCE
Confidence 4578999999999999999996 479999996422111 111223 344666777899999999999998876
Q ss_pred cEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccC
Q 010401 408 GLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV 487 (511)
Q Consensus 408 ~l~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~ 487 (511)
+||||||+++|+|.+++.....+++..++.|+.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+.+...
T Consensus 82 -~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~ 160 (364)
T d1omwa3 82 -LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK 160 (364)
T ss_dssp -EEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSS
T ss_pred -EEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCC
Confidence 9999999999999999988889999999999999999999999999999999999999999999999999999876543
Q ss_pred CCccccccCCCccccHHhhcc
Q 010401 488 GEATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 488 ~~~~~~~~Gt~~YmAPEvl~g 508 (511)
......||+.|||||++..
T Consensus 161 --~~~~~~GT~~y~APE~~~~ 179 (364)
T d1omwa3 161 --KPHASVGTHGYMAPEVLQK 179 (364)
T ss_dssp --CCCSCCSCGGGCCHHHHST
T ss_pred --cccccccccccchhHHhhc
Confidence 2455689999999999864
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-33 Score=285.30 Aligned_cols=169 Identities=20% Similarity=0.402 Sum_probs=140.7
Q ss_pred ecCCCeEEEeeeecccceEEEEeE----------EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCC
Q 010401 337 LNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN 406 (511)
Q Consensus 337 l~~~~y~l~~~LG~GsFG~VYkgk----------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~ 406 (511)
+..++|++++.||+|+||.||+|+ .||+|+++.. .......++.+|+.++++++|||||+++|+|.+++
T Consensus 6 ~k~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~ 84 (317)
T d1xkka_ 6 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTST 84 (317)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred CCHHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 455789999999999999999974 4889988643 22334567899999999999999999999998653
Q ss_pred CcEEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecc
Q 010401 407 HGLCVVTKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK 485 (511)
Q Consensus 407 ~~l~LVmEy~~gGsL~~lL~~-~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~ 485 (511)
.+++|||+.+|+|.+++.. ...+++..++.++.||+.||+|||+++||||||||+|||++.++.+||+|||+|+...
T Consensus 85 --~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 85 --VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 162 (317)
T ss_dssp --EEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred --eeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceecc
Confidence 7899999999999998865 4589999999999999999999999999999999999999999999999999998765
Q ss_pred cCCCc--cccccCCCccccHHhhcc
Q 010401 486 SVGEA--TEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 486 ~~~~~--~~~~~Gt~~YmAPEvl~g 508 (511)
..... .....||+.|||||++.+
T Consensus 163 ~~~~~~~~~~~~gt~~y~APE~l~~ 187 (317)
T d1xkka_ 163 AEEKEYHAEGGKVPIKWMALESILH 187 (317)
T ss_dssp TTCC--------CCTTTSCHHHHHH
T ss_pred cccccccccccccCccccChHHHhc
Confidence 43322 233468999999999865
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.3e-34 Score=285.80 Aligned_cols=175 Identities=22% Similarity=0.415 Sum_probs=148.7
Q ss_pred cceEecCCCeEEEeeeecccceEEEEeE-----------EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeee
Q 010401 333 GRWLLNSDNLEFIDQIGPNSFKGVYKGK-----------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV 401 (511)
Q Consensus 333 ~~~~l~~~~y~l~~~LG~GsFG~VYkgk-----------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~ 401 (511)
..|+++.++|++++.||+|+||.||+|+ .||||+++. ........++.+|+.+++.++||||++++++
T Consensus 6 ~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~-~~~~~~~~~~~~E~~il~~l~h~niv~~~~~ 84 (301)
T d1lufa_ 6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKE-EASADMQADFQREAALMAEFDNPNIVKLLGV 84 (301)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCT-TCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred hhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEECh-hcChHHHHHHHHHHHHHHhcCCCCcccceee
Confidence 3567788899999999999999999984 689999874 2334445678999999999999999999999
Q ss_pred EeeCCCcEEEEEeccCCCCHHHHHHhcC------------------------CCCHHHHHHHHHHHHHHHHHHHHCCccc
Q 010401 402 CVDENHGLCVVTKLMEGGSVNDLILKSR------------------------KLQTKEIIRIAIDVAEGIKFLNDHGVAY 457 (511)
Q Consensus 402 ~~~~~~~l~LVmEy~~gGsL~~lL~~~~------------------------~L~e~~~~~ia~qIa~gL~yLH~~gIIH 457 (511)
|.+.+. ++++|||+.+|+|.+++.... .+++..++.++.||+.||+|||+++|||
T Consensus 85 ~~~~~~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivH 163 (301)
T d1lufa_ 85 CAVGKP-MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVH 163 (301)
T ss_dssp ECSSSS-CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred eccCCc-eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEe
Confidence 998776 999999999999999996422 3788999999999999999999999999
Q ss_pred cCCCCCceEEcCCCcEEEEecCCceecccCCC--ccccccCCCccccHHhhccc
Q 010401 458 RDLNSQRILLDRHGNVCLGDMGIVTACKSVGE--ATEYETDGYRWLAPEVCFLL 509 (511)
Q Consensus 458 RDLKp~NILld~~g~vKL~DFGlS~~l~~~~~--~~~~~~Gt~~YmAPEvl~gl 509 (511)
|||||+|||++.++++||+|||+|+.+..... ......|++.|+|||++.+.
T Consensus 164 rDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 217 (301)
T d1lufa_ 164 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN 217 (301)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHC
T ss_pred eEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccC
Confidence 99999999999999999999999987644332 22345688999999998753
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-34 Score=285.12 Aligned_cols=165 Identities=24% Similarity=0.319 Sum_probs=139.4
Q ss_pred EEeeeecccceEEEEe------EEEEEEEEecCCCCch---HHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEEe
Q 010401 344 FIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNA---YEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTK 414 (511)
Q Consensus 344 l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~---~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVmE 414 (511)
.+++||+|+||+||+| +.||||+++....... ....+.+|+.+++.++|||||++++++.+++. +|||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~-~~ivmE 80 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN-ISLVFD 80 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC-CEEEEE
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCc-eeehhh
Confidence 4689999999999996 4799999965332221 22458899999999999999999999998887 999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCccccc
Q 010401 415 LMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYE 494 (511)
Q Consensus 415 y~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~~~~ 494 (511)
|+.++++..++.....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++............
T Consensus 81 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~~~ 160 (299)
T d1ua2a_ 81 FMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQ 160 (299)
T ss_dssp CCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCCS
T ss_pred hhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCcccccce
Confidence 99998777776666789999999999999999999999999999999999999999999999999998776655555567
Q ss_pred cCCCccccHHhhccc
Q 010401 495 TDGYRWLAPEVCFLL 509 (511)
Q Consensus 495 ~Gt~~YmAPEvl~gl 509 (511)
+||+.|+|||++.+.
T Consensus 161 ~gt~~y~aPE~~~~~ 175 (299)
T d1ua2a_ 161 VVTRWYRAPELLFGA 175 (299)
T ss_dssp CCCCTTCCHHHHTTC
T ss_pred ecChhhccHHHHccC
Confidence 899999999998643
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-34 Score=283.83 Aligned_cols=167 Identities=22% Similarity=0.336 Sum_probs=142.1
Q ss_pred CCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEE
Q 010401 340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT 413 (511)
Q Consensus 340 ~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVm 413 (511)
++|++++.||+|+||+||+| +.||+|+++..........++.+|+.++++++|||||++++++.+++. +|+||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~-~~iv~ 80 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENK-LYLVF 80 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTE-EEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccc-eeEEE
Confidence 68999999999999999996 479999997543333334568899999999999999999999998876 99999
Q ss_pred eccCCCCHHHHHH-h-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCcc
Q 010401 414 KLMEGGSVNDLIL-K-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT 491 (511)
Q Consensus 414 Ey~~gGsL~~lL~-~-~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~ 491 (511)
||+.+ ++.+++. . ...+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+|+.........
T Consensus 81 e~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~~ 159 (298)
T d1gz8a_ 81 EFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY 159 (298)
T ss_dssp ECCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBCT
T ss_pred eecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCcccc
Confidence 99976 5544443 2 4579999999999999999999999999999999999999999999999999998876655566
Q ss_pred ccccCCCccccHHhhcc
Q 010401 492 EYETDGYRWLAPEVCFL 508 (511)
Q Consensus 492 ~~~~Gt~~YmAPEvl~g 508 (511)
....||+.|+|||++..
T Consensus 160 ~~~~gt~~y~apE~~~~ 176 (298)
T d1gz8a_ 160 THEVVTLWYRAPEILLG 176 (298)
T ss_dssp TCCBCCCTTCCHHHHTT
T ss_pred eeecccceeeehhhhcc
Confidence 67789999999999765
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.4e-33 Score=276.55 Aligned_cols=171 Identities=19% Similarity=0.309 Sum_probs=140.8
Q ss_pred CCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCc-hHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCC---c
Q 010401 339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGN-AYEFELRKDLLELMTCGHKNILQFYCVCVDENH---G 408 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~-~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~---~ 408 (511)
.++|++.+.||+|+||.||++ +.||+|+++...... ....++.+|+.+++.++||||+++++++...+. .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 467999999999999999996 579999997644333 345568999999999999999999999976542 3
Q ss_pred EEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCC
Q 010401 409 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG 488 (511)
Q Consensus 409 l~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~ 488 (511)
+||||||++||+|.+++...+.+++.+++.++.||+.||+|||++|||||||||+|||++.++..+|+|||+++......
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~ 165 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSG 165 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC---
T ss_pred EEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhcccc
Confidence 79999999999999999888899999999999999999999999999999999999999999999999999987654322
Q ss_pred ---CccccccCCCccccHHhhccc
Q 010401 489 ---EATEYETDGYRWLAPEVCFLL 509 (511)
Q Consensus 489 ---~~~~~~~Gt~~YmAPEvl~gl 509 (511)
.......||+.|||||++.+.
T Consensus 166 ~~~~~~~~~~Gt~~Y~aPE~~~~~ 189 (277)
T d1o6ya_ 166 NSVTQTAAVIGTAQYLSPEQARGD 189 (277)
T ss_dssp -------------TTCCHHHHTTC
T ss_pred ccccccccccCcccccCHHHHcCC
Confidence 233455799999999998753
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-33 Score=282.89 Aligned_cols=165 Identities=19% Similarity=0.268 Sum_probs=144.0
Q ss_pred CCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEE
Q 010401 339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV 412 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LV 412 (511)
.++|++++.||+|+||.||+| +.||+|+++. .......+.+|+.+|+.++||||+++++++.+++. +|||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~---~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~-~~lv 79 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV---KGTDQVLVKKEISILNIARHRNILHLHESFESMEE-LVMI 79 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---CTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTE-EEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcC---CcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE-EEEE
Confidence 467999999999999999996 4799999963 23334568899999999999999999999998876 9999
Q ss_pred EeccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCC--CcEEEEecCCceecccCCC
Q 010401 413 TKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRH--GNVCLGDMGIVTACKSVGE 489 (511)
Q Consensus 413 mEy~~gGsL~~lL~~~~-~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~--g~vKL~DFGlS~~l~~~~~ 489 (511)
||||+||+|.+++...+ .+++.+++.|+.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++..... .
T Consensus 80 mE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~-~ 158 (321)
T d1tkia_ 80 FEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG-D 158 (321)
T ss_dssp ECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT-C
T ss_pred EecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccC-C
Confidence 99999999999997654 79999999999999999999999999999999999999854 58999999999876543 2
Q ss_pred ccccccCCCccccHHhhcc
Q 010401 490 ATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 490 ~~~~~~Gt~~YmAPEvl~g 508 (511)
......||+.|+|||++.+
T Consensus 159 ~~~~~~~t~~y~ape~~~~ 177 (321)
T d1tkia_ 159 NFRLLFTAPEYYAPEVHQH 177 (321)
T ss_dssp EEEEEESCGGGSCHHHHTT
T ss_pred cccccccccccccchhccC
Confidence 3455678999999999865
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-33 Score=281.01 Aligned_cols=174 Identities=23% Similarity=0.432 Sum_probs=145.1
Q ss_pred cceEecCCCeEEEeeeecccceEEEEeE-------------EEEEEEEecCCCCchHHHHHHHHHHHHHhC-CCCceeeE
Q 010401 333 GRWLLNSDNLEFIDQIGPNSFKGVYKGK-------------RVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQF 398 (511)
Q Consensus 333 ~~~~l~~~~y~l~~~LG~GsFG~VYkgk-------------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l-~HpNIV~l 398 (511)
.+|.++.++|++++.||+|+||.||+|+ .||||+++. ........++.+|...+.++ +|||||++
T Consensus 6 ~~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~-~~~~~~~~~~~~e~~~l~~~~~HpnIv~~ 84 (299)
T d1fgka_ 6 PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKS-DATEKDLSDLISEMEMMKMIGKHKNIINL 84 (299)
T ss_dssp TTTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCT-TCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CcCcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECc-ccChHHHHHHHHHHHHHHHhcCCCeEEec
Confidence 4688999999999999999999999975 589999974 33334456688888888887 89999999
Q ss_pred eeeEeeCCCcEEEEEeccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCC
Q 010401 399 YCVCVDENHGLCVVTKLMEGGSVNDLILKS----------------RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNS 462 (511)
Q Consensus 399 ~g~~~~~~~~l~LVmEy~~gGsL~~lL~~~----------------~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp 462 (511)
+++|.+++. +|+||||+.+|+|.++|... ..+++..++.++.||+.||+|||+++||||||||
T Consensus 85 ~~~~~~~~~-~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp 163 (299)
T d1fgka_ 85 LGACTQDGP-LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAA 163 (299)
T ss_dssp EEEECSSSS-CEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred ccccccCCe-EEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecc
Confidence 999998776 99999999999999999643 3589999999999999999999999999999999
Q ss_pred CceEEcCCCcEEEEecCCceecccCCC--ccccccCCCccccHHhhcc
Q 010401 463 QRILLDRHGNVCLGDMGIVTACKSVGE--ATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 463 ~NILld~~g~vKL~DFGlS~~l~~~~~--~~~~~~Gt~~YmAPEvl~g 508 (511)
+|||++.++.+||+|||+++....... ......|++.|+|||++.+
T Consensus 164 ~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~ 211 (299)
T d1fgka_ 164 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD 211 (299)
T ss_dssp GGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHH
T ss_pred cceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcC
Confidence 999999999999999999987654332 2344578899999999865
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-33 Score=281.53 Aligned_cols=173 Identities=23% Similarity=0.376 Sum_probs=150.6
Q ss_pred ceEecCCCeEEEeeeecccceEEEEeE-----------EEEEEEEecCCCCchHHHHHHHHHHHHHhC-CCCceeeEeee
Q 010401 334 RWLLNSDNLEFIDQIGPNSFKGVYKGK-----------RVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCV 401 (511)
Q Consensus 334 ~~~l~~~~y~l~~~LG~GsFG~VYkgk-----------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l-~HpNIV~l~g~ 401 (511)
.|+++.++|++.+.||+|+||.||+|+ .||||+++.. ........+.+|+.+++++ +|||||+++|+
T Consensus 17 ~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~-~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~ 95 (311)
T d1t46a_ 17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS-AHLTEREALMSELKVLSYLGNHMNIVNLLGA 95 (311)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcc-cCHHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence 688899999999999999999999974 6999999753 3334455688999999998 79999999999
Q ss_pred EeeCCCcEEEEEeccCCCCHHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCC
Q 010401 402 CVDENHGLCVVTKLMEGGSVNDLILKSR------------------KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQ 463 (511)
Q Consensus 402 ~~~~~~~l~LVmEy~~gGsL~~lL~~~~------------------~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~ 463 (511)
|.+.+. +|+||||+++|+|.+++.... .+++..+..++.||+.||+|||+++||||||||+
T Consensus 96 ~~~~~~-~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~ 174 (311)
T d1t46a_ 96 CTIGGP-TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAAR 174 (311)
T ss_dssp ECSSSS-CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred EeeCCE-EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccc
Confidence 998776 999999999999999996532 5899999999999999999999999999999999
Q ss_pred ceEEcCCCcEEEEecCCceecccCCC--ccccccCCCccccHHhhcc
Q 010401 464 RILLDRHGNVCLGDMGIVTACKSVGE--ATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 464 NILld~~g~vKL~DFGlS~~l~~~~~--~~~~~~Gt~~YmAPEvl~g 508 (511)
|||++.++.+||+|||+++....... ......||+.|+|||++.+
T Consensus 175 NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 221 (311)
T d1t46a_ 175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN 221 (311)
T ss_dssp GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH
T ss_pred cccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcC
Confidence 99999999999999999987754332 2234578899999999874
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-33 Score=278.32 Aligned_cols=168 Identities=24% Similarity=0.436 Sum_probs=138.8
Q ss_pred ceEecCCCeEEEeeeecccceEEEEe----EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcE
Q 010401 334 RWLLNSDNLEFIDQIGPNSFKGVYKG----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGL 409 (511)
Q Consensus 334 ~~~l~~~~y~l~~~LG~GsFG~VYkg----k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l 409 (511)
.|+++.++|++++.||+|+||.||+| +.||||+++... ....+.+|+.++++++||||++++|+|.+.+..+
T Consensus 1 ~w~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~ 76 (262)
T d1byga_ 1 GWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL 76 (262)
T ss_dssp CCBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CC
T ss_pred CCccCHHHeEEeEEEecCCCeEEEEEEECCeEEEEEEECcHH----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcE
Confidence 48889999999999999999999996 579999996422 2356889999999999999999999997655458
Q ss_pred EEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccC
Q 010401 410 CVVTKLMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV 487 (511)
Q Consensus 410 ~LVmEy~~gGsL~~lL~~~--~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~ 487 (511)
|+||||+++|+|.+++... ..+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++.....
T Consensus 77 ~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~ 156 (262)
T d1byga_ 77 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 156 (262)
T ss_dssp EEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCCC
Confidence 9999999999999999653 35899999999999999999999999999999999999999999999999999865432
Q ss_pred CCccccccCCCccccHHhhcc
Q 010401 488 GEATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 488 ~~~~~~~~Gt~~YmAPEvl~g 508 (511)
.....+++.|+|||++.+
T Consensus 157 ---~~~~~~~~~y~aPE~l~~ 174 (262)
T d1byga_ 157 ---QDTGKLPVKWTAPEALRE 174 (262)
T ss_dssp --------CCTTTSCHHHHHH
T ss_pred ---CccccccccCCChHHHhC
Confidence 344577889999999865
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.7e-33 Score=278.32 Aligned_cols=169 Identities=20% Similarity=0.301 Sum_probs=143.6
Q ss_pred CCeEEEeeeecccceEEEEe-----EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEEe
Q 010401 340 DNLEFIDQIGPNSFKGVYKG-----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTK 414 (511)
Q Consensus 340 ~~y~l~~~LG~GsFG~VYkg-----k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVmE 414 (511)
++|+++++||+|+||.||+| +.||||++...........++.+|+.+|++++||||+++++++.+++. +|++||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~-~~i~~e 80 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKR-LVLVFE 80 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSC-EEEEEE
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCc-eeEEEE
Confidence 68999999999999999996 469999997544333345678999999999999999999999998887 999999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCccccc
Q 010401 415 LMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYE 494 (511)
Q Consensus 415 y~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~~~~ 494 (511)
|+.++.+..+....+.+++..+..++.||+.||+|||++|||||||||+|||++.++.+||+|||++.............
T Consensus 81 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~ 160 (286)
T d1ob3a_ 81 HLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHE 160 (286)
T ss_dssp CCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--------
T ss_pred eehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCcccccee
Confidence 99887777776667889999999999999999999999999999999999999999999999999998776555555666
Q ss_pred cCCCccccHHhhccc
Q 010401 495 TDGYRWLAPEVCFLL 509 (511)
Q Consensus 495 ~Gt~~YmAPEvl~gl 509 (511)
.|++.|+|||++.+.
T Consensus 161 ~~~~~y~~pE~~~~~ 175 (286)
T d1ob3a_ 161 IVTLWYRAPDVLMGS 175 (286)
T ss_dssp -CCCTTCCHHHHTTC
T ss_pred cccchhhhHHHHhCC
Confidence 789999999998753
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-33 Score=279.12 Aligned_cols=175 Identities=19% Similarity=0.327 Sum_probs=149.7
Q ss_pred cceEecCCCeEEEeeeecccceEEEEeE-----------EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeee
Q 010401 333 GRWLLNSDNLEFIDQIGPNSFKGVYKGK-----------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV 401 (511)
Q Consensus 333 ~~~~l~~~~y~l~~~LG~GsFG~VYkgk-----------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~ 401 (511)
++|+++.++|++.+.||+|+||.||+|. .||||+++.. ........+.+|+.++++++||||++++|+
T Consensus 13 ~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~-~~~~~~~~~~~E~~il~~l~h~nIv~~~~~ 91 (308)
T d1p4oa_ 13 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFNCHHVVRLLGV 91 (308)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT-SCHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred cceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcc-cChHHHHHHHHHHHHHHHcCCCCEeeeeeE
Confidence 4788999999999999999999999863 5899999743 333444568999999999999999999999
Q ss_pred EeeCCCcEEEEEeccCCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCC
Q 010401 402 CVDENHGLCVVTKLMEGGSVNDLILKS----------RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG 471 (511)
Q Consensus 402 ~~~~~~~l~LVmEy~~gGsL~~lL~~~----------~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g 471 (511)
|..++. +++||||+.+|+|.+++... ..+++..+..++.||+.||.|||+++|+||||||+|||++.++
T Consensus 92 ~~~~~~-~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~ 170 (308)
T d1p4oa_ 92 VSQGQP-TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF 170 (308)
T ss_dssp ECSSSS-CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTC
T ss_pred EecCCc-eeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCc
Confidence 987776 99999999999999998532 2468899999999999999999999999999999999999999
Q ss_pred cEEEEecCCceecccCCCc--cccccCCCccccHHhhccc
Q 010401 472 NVCLGDMGIVTACKSVGEA--TEYETDGYRWLAPEVCFLL 509 (511)
Q Consensus 472 ~vKL~DFGlS~~l~~~~~~--~~~~~Gt~~YmAPEvl~gl 509 (511)
++||+|||+++.+...... .....||+.|+|||.+.+.
T Consensus 171 ~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~ 210 (308)
T d1p4oa_ 171 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG 210 (308)
T ss_dssp CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHC
T ss_pred eEEEeecccceeccCCcceeeccceecccccCCHHHHccC
Confidence 9999999999876543322 2334678999999998653
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-33 Score=276.03 Aligned_cols=170 Identities=25% Similarity=0.401 Sum_probs=135.3
Q ss_pred ecCCCeEEEeeeecccceEEEEeE---------EEEEEEEecCCC-CchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCC
Q 010401 337 LNSDNLEFIDQIGPNSFKGVYKGK---------RVGIEKLKGCDK-GNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN 406 (511)
Q Consensus 337 l~~~~y~l~~~LG~GsFG~VYkgk---------~VAVKkL~~~~~-~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~ 406 (511)
++.++|++.+.||+|+||.||+|+ .||||++..... ......++.+|+.+|++++||||++++|+|.++
T Consensus 5 i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~- 83 (273)
T d1u46a_ 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP- 83 (273)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-
T ss_pred EchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-
Confidence 556789999999999999999985 589999875433 233456789999999999999999999999764
Q ss_pred CcEEEEEeccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecc
Q 010401 407 HGLCVVTKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK 485 (511)
Q Consensus 407 ~~l~LVmEy~~gGsL~~lL~~-~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~ 485 (511)
. +++||||+.+|++.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~-~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 84 P-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP 162 (273)
T ss_dssp S-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred c-hheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcc
Confidence 3 7899999999999998754 4579999999999999999999999999999999999999999999999999999875
Q ss_pred cCCC---ccccccCCCccccHHhhcc
Q 010401 486 SVGE---ATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 486 ~~~~---~~~~~~Gt~~YmAPEvl~g 508 (511)
.... ......|++.|+|||++.+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~ 188 (273)
T d1u46a_ 163 QNDDHYVMQEHRKVPFAWCAPESLKT 188 (273)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHH
T ss_pred cCCCcceecCccccCcccCCHHHHhC
Confidence 4332 2234467889999999875
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-33 Score=278.65 Aligned_cols=169 Identities=23% Similarity=0.386 Sum_probs=140.7
Q ss_pred ecCCCeEEEeeeecccceEEEEeE--------EEEEEEEecCCCCchHHHHHHHHHHHHHhC-CCCceeeEeeeEeeCCC
Q 010401 337 LNSDNLEFIDQIGPNSFKGVYKGK--------RVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCVCVDENH 407 (511)
Q Consensus 337 l~~~~y~l~~~LG~GsFG~VYkgk--------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l-~HpNIV~l~g~~~~~~~ 407 (511)
++.++|++.++||+|+||.||+|+ .||||++.... .......+.+|+.+|+++ +|||||+++|+|.+++.
T Consensus 7 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~ 85 (309)
T d1fvra_ 7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY 85 (309)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTE
T ss_pred cCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc-ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCe
Confidence 466899999999999999999974 47888886422 222345689999999998 79999999999998876
Q ss_pred cEEEEEeccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCC
Q 010401 408 GLCVVTKLMEGGSVNDLILKS----------------RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG 471 (511)
Q Consensus 408 ~l~LVmEy~~gGsL~~lL~~~----------------~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g 471 (511)
+|+||||+++|+|.++|... ..+++..+..++.||+.||.|||+++|+||||||+|||++.++
T Consensus 86 -~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~ 164 (309)
T d1fvra_ 86 -LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 164 (309)
T ss_dssp -EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred -eEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCC
Confidence 99999999999999999643 5699999999999999999999999999999999999999999
Q ss_pred cEEEEecCCceecccCCCccccccCCCccccHHhhcc
Q 010401 472 NVCLGDMGIVTACKSVGEATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 472 ~vKL~DFGlS~~l~~~~~~~~~~~Gt~~YmAPEvl~g 508 (511)
.+||+|||+++..... .......||+.|+|||.+.+
T Consensus 165 ~~kl~DfG~a~~~~~~-~~~~~~~gt~~y~aPE~l~~ 200 (309)
T d1fvra_ 165 VAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNY 200 (309)
T ss_dssp CEEECCTTCEESSCEE-CCC----CCTTTCCHHHHHH
T ss_pred ceEEcccccccccccc-ccccceecCCcccchHHhcc
Confidence 9999999999765432 22345578999999999864
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=6e-33 Score=274.00 Aligned_cols=166 Identities=17% Similarity=0.214 Sum_probs=141.1
Q ss_pred CCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCch----HHHHHHHHHHHHHhCC--CCceeeEeeeEeeCCC
Q 010401 340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNA----YEFELRKDLLELMTCG--HKNILQFYCVCVDENH 407 (511)
Q Consensus 340 ~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~----~~~~~~~Ei~iL~~l~--HpNIV~l~g~~~~~~~ 407 (511)
++|++.+.||+|+||.||+| +.||||++........ ...++.+|+.++++++ ||||+++++++.+++.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 57999999999999999996 4799999975332211 1233678999998885 8999999999998876
Q ss_pred cEEEEEeccCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcC-CCcEEEEecCCceecc
Q 010401 408 GLCVVTKLMEG-GSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDR-HGNVCLGDMGIVTACK 485 (511)
Q Consensus 408 ~l~LVmEy~~g-GsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~-~g~vKL~DFGlS~~l~ 485 (511)
+|+||||+.+ +++.+++.....+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+|+...
T Consensus 84 -~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~ 162 (273)
T d1xwsa_ 84 -FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK 162 (273)
T ss_dssp -EEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred -EEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceecc
Confidence 9999999975 688888888889999999999999999999999999999999999999985 5799999999998754
Q ss_pred cCCCccccccCCCccccHHhhcc
Q 010401 486 SVGEATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 486 ~~~~~~~~~~Gt~~YmAPEvl~g 508 (511)
.. ......||+.|||||++.+
T Consensus 163 ~~--~~~~~~GT~~y~aPE~~~~ 183 (273)
T d1xwsa_ 163 DT--VYTDFDGTRVYSPPEWIRY 183 (273)
T ss_dssp SS--CBCCCCSCGGGSCHHHHHH
T ss_pred cc--cccccccCCCcCCHHHHcC
Confidence 32 2445689999999999875
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=3.2e-32 Score=273.07 Aligned_cols=165 Identities=25% Similarity=0.451 Sum_probs=136.6
Q ss_pred CCeEEEeeeecccceEEEEeE----EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCC---cEEEE
Q 010401 340 DNLEFIDQIGPNSFKGVYKGK----RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENH---GLCVV 412 (511)
Q Consensus 340 ~~y~l~~~LG~GsFG~VYkgk----~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~---~l~LV 412 (511)
++|.+.+.||+|+||.||+|+ .||||++... .......+.|+..+..++||||++++|++.+++. .+|+|
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~---~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv 79 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEETTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECcc---chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence 568999999999999999964 8999999532 2223334556666677899999999999987652 38999
Q ss_pred EeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH--------CCccccCCCCCceEEcCCCcEEEEecCCceec
Q 010401 413 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLND--------HGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC 484 (511)
Q Consensus 413 mEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~--------~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l 484 (511)
|||+++|+|.++|++ ..+++..++.++.|++.||.|||. +|||||||||+||||+.++.+||+|||+++..
T Consensus 80 ~Ey~~~g~L~~~l~~-~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~ 158 (303)
T d1vjya_ 80 SDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH 158 (303)
T ss_dssp EECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred EecccCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccc
Confidence 999999999999965 468999999999999999999996 59999999999999999999999999999877
Q ss_pred ccCCC----ccccccCCCccccHHhhcc
Q 010401 485 KSVGE----ATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 485 ~~~~~----~~~~~~Gt~~YmAPEvl~g 508 (511)
..... ......||+.|||||++.+
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 186 (303)
T d1vjya_ 159 DSATDTIDIAPNHRVGTKRYMAPEVLDD 186 (303)
T ss_dssp ETTTTEECC----CCSCGGGCCHHHHTT
T ss_pred cCCCcceeccccceecccCcCChhhccc
Confidence 54332 2234579999999999864
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.7e-32 Score=279.21 Aligned_cols=162 Identities=19% Similarity=0.270 Sum_probs=137.1
Q ss_pred CCCeEEEe-eeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHh-CCCCceeeEeeeEeeC---CC
Q 010401 339 SDNLEFID-QIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMT-CGHKNILQFYCVCVDE---NH 407 (511)
Q Consensus 339 ~~~y~l~~-~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~-l~HpNIV~l~g~~~~~---~~ 407 (511)
.++|+++. .||+|+||+||++ +.||||+++.. ..+.+|+.++.+ ++|||||+++++|.+. +.
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~ 82 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK 82 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCC
Confidence 35788875 5999999999996 47999999631 346788888665 5899999999998752 23
Q ss_pred cEEEEEeccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcC---CCcEEEEecCCce
Q 010401 408 GLCVVTKLMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDR---HGNVCLGDMGIVT 482 (511)
Q Consensus 408 ~l~LVmEy~~gGsL~~lL~~~--~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~---~g~vKL~DFGlS~ 482 (511)
.+|||||||+||+|.++|... ..+++.+++.|+.||+.||+|||++||+||||||+|||++. .+.+||+|||+|+
T Consensus 83 ~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~ 162 (335)
T d2ozaa1 83 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 162 (335)
T ss_dssp EEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceee
Confidence 489999999999999999754 47999999999999999999999999999999999999985 5679999999998
Q ss_pred ecccCCCccccccCCCccccHHhhcc
Q 010401 483 ACKSVGEATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 483 ~l~~~~~~~~~~~Gt~~YmAPEvl~g 508 (511)
..... .......||+.|||||++.+
T Consensus 163 ~~~~~-~~~~~~~gt~~y~aPE~~~~ 187 (335)
T d2ozaa1 163 ETTSH-NSLTTPCYTPYYVAPEVLGP 187 (335)
T ss_dssp ECCCC-CCCCCCSCCCSSCCCCCCCG
T ss_pred eccCC-CccccccCCcccCCcHHHcC
Confidence 76543 33556789999999999865
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=7.6e-32 Score=265.47 Aligned_cols=169 Identities=20% Similarity=0.308 Sum_probs=151.7
Q ss_pred CCeEEEeeeecccceEEEEeE------EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEE
Q 010401 340 DNLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT 413 (511)
Q Consensus 340 ~~y~l~~~LG~GsFG~VYkgk------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVm 413 (511)
++|+++++||+|+||+||+|+ .||||+++..........++.+|+.+++.++||||+++++++.+.+. ++++|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~-~~iv~ 80 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKK-LTLVF 80 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE-EEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccc-eeEEe
Confidence 579999999999999999964 69999998655555566778999999999999999999999998876 99999
Q ss_pred eccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCcccc
Q 010401 414 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY 493 (511)
Q Consensus 414 Ey~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~~~~ 493 (511)
+++.+++|..++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++...........
T Consensus 81 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~~~ 160 (292)
T d1unla_ 81 EFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA 160 (292)
T ss_dssp ECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCCCS
T ss_pred eeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCcccee
Confidence 99999999998888889999999999999999999999999999999999999999999999999999987665555556
Q ss_pred ccCCCccccHHhhccc
Q 010401 494 ETDGYRWLAPEVCFLL 509 (511)
Q Consensus 494 ~~Gt~~YmAPEvl~gl 509 (511)
..+++.|+|||++.+.
T Consensus 161 ~~~~~~~~~pe~~~~~ 176 (292)
T d1unla_ 161 EVVTLWYRPPDVLFGA 176 (292)
T ss_dssp CCSCGGGCCHHHHTTC
T ss_pred eccccchhhhhHhccC
Confidence 6778889999998753
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=9.7e-32 Score=270.83 Aligned_cols=165 Identities=22% Similarity=0.347 Sum_probs=140.3
Q ss_pred EEEeeeecccceEEEEeE---------EEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEE
Q 010401 343 EFIDQIGPNSFKGVYKGK---------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT 413 (511)
Q Consensus 343 ~l~~~LG~GsFG~VYkgk---------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVm 413 (511)
.+.++||+|+||+||+|+ .||||+++. ........++.+|+.+|++++||||++++|++.+.+..+++||
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~-~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ 108 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR-ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 108 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECC-CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECc-ccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEE
Confidence 446889999999999975 489999964 2344455679999999999999999999999987665589999
Q ss_pred eccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCCc--
Q 010401 414 KLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA-- 490 (511)
Q Consensus 414 Ey~~gGsL~~lL~~~-~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~~-- 490 (511)
||+.+|+|.+++... ..+++..++.++.|++.||.|||+.+|+||||||+|||+++++.+||+|||+++........
T Consensus 109 E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~ 188 (311)
T d1r0pa_ 109 PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV 188 (311)
T ss_dssp ECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCT
T ss_pred EEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccccccc
Confidence 999999999998654 46788899999999999999999999999999999999999999999999999876543221
Q ss_pred --cccccCCCccccHHhhcc
Q 010401 491 --TEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 491 --~~~~~Gt~~YmAPEvl~g 508 (511)
.....||+.|+|||++..
T Consensus 189 ~~~~~~~gt~~y~aPE~~~~ 208 (311)
T d1r0pa_ 189 HNKTGAKLPVKWMALESLQT 208 (311)
T ss_dssp TCTTCSSCCGGGSCHHHHHH
T ss_pred eecccccccccccChHHHhc
Confidence 223467899999999864
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=9.4e-32 Score=272.91 Aligned_cols=168 Identities=19% Similarity=0.331 Sum_probs=139.3
Q ss_pred eEecCCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCC-
Q 010401 335 WLLNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENH- 407 (511)
Q Consensus 335 ~~l~~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~- 407 (511)
|.+ .++|++++.||+|+||+||+| +.||||+++...........+.+|+.+|+.++|||||+++++|...+.
T Consensus 14 ~~~-~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~ 92 (346)
T d1cm8a_ 14 WEV-RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETL 92 (346)
T ss_dssp ECC-BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSST
T ss_pred eec-CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccc
Confidence 444 578999999999999999996 579999997654455556678999999999999999999999976542
Q ss_pred ----cEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCcee
Q 010401 408 ----GLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTA 483 (511)
Q Consensus 408 ----~l~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~ 483 (511)
.+|+||||+ +++|..++ ....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.
T Consensus 93 ~~~~~~~lv~e~~-~~~l~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~ 170 (346)
T d1cm8a_ 93 DDFTDFYLVMPFM-GTDLGKLM-KHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQ 170 (346)
T ss_dssp TTCCCCEEEEECC-SEEHHHHH-HHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred cccceEEEEEecc-cccHHHHH-HhccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceec
Confidence 279999999 55787776 456799999999999999999999999999999999999999999999999999987
Q ss_pred cccCCCccccccCCCccccHHhhcc
Q 010401 484 CKSVGEATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 484 l~~~~~~~~~~~Gt~~YmAPEvl~g 508 (511)
.... .....||+.|+|||++.+
T Consensus 171 ~~~~---~~~~~~t~~y~aPE~~~~ 192 (346)
T d1cm8a_ 171 ADSE---MTGYVVTRWYRAPEVILN 192 (346)
T ss_dssp CCSS---CCSSCSCGGGCCTHHHHT
T ss_pred cCCc---cccccccccccCHHHHcC
Confidence 6432 456689999999999875
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=9.1e-32 Score=267.54 Aligned_cols=170 Identities=21% Similarity=0.341 Sum_probs=136.5
Q ss_pred CCCeEEEeeeecccceEEEEe-------EEEEEEEEecCCCCchHHHHHHHHHHHHHh---CCCCceeeEeeeEeeC---
Q 010401 339 SDNLEFIDQIGPNSFKGVYKG-------KRVGIEKLKGCDKGNAYEFELRKDLLELMT---CGHKNILQFYCVCVDE--- 405 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkg-------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~---l~HpNIV~l~g~~~~~--- 405 (511)
.++|+++++||+|+||.||++ +.||||+++...........+.+|+.+++. ++||||++++++|...
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 468999999999999999996 368999997533322222334566666554 4899999999998632
Q ss_pred -CCcEEEEEeccCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCcee
Q 010401 406 -NHGLCVVTKLMEGGSVNDLIL-KSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTA 483 (511)
Q Consensus 406 -~~~l~LVmEy~~gGsL~~lL~-~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~ 483 (511)
+..+|++|||+.++.+..... ....+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+++.
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~ 165 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI 165 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCC
T ss_pred cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhhh
Confidence 234899999999877655543 345799999999999999999999999999999999999999999999999999876
Q ss_pred cccCCCccccccCCCccccHHhhccc
Q 010401 484 CKSVGEATEYETDGYRWLAPEVCFLL 509 (511)
Q Consensus 484 l~~~~~~~~~~~Gt~~YmAPEvl~gl 509 (511)
.... .......||+.|||||++.+.
T Consensus 166 ~~~~-~~~~~~~gT~~Y~APE~~~~~ 190 (305)
T d1blxa_ 166 YSFQ-MALTSVVVTLWYRAPEVLLQS 190 (305)
T ss_dssp CCGG-GGGCCCCCCCTTCCHHHHTTC
T ss_pred hccc-ccCCCcccChhhcCcchhcCC
Confidence 5432 334567899999999998764
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.6e-31 Score=266.05 Aligned_cols=171 Identities=18% Similarity=0.306 Sum_probs=139.2
Q ss_pred CCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCC------
Q 010401 339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN------ 406 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~------ 406 (511)
.++|+++++||+|+||+||+| +.||||++...........++.+|+.+|+.++||||+++++++....
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 367899999999999999996 47999998754444445566889999999999999999999986532
Q ss_pred -CcEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecc
Q 010401 407 -HGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK 485 (511)
Q Consensus 407 -~~l~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~ 485 (511)
..+|+||||+.++.+.........+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~ 168 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFS 168 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred CceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeecc
Confidence 2389999999887666555556789999999999999999999999999999999999999999999999999997664
Q ss_pred cCC----CccccccCCCccccHHhhccc
Q 010401 486 SVG----EATEYETDGYRWLAPEVCFLL 509 (511)
Q Consensus 486 ~~~----~~~~~~~Gt~~YmAPEvl~gl 509 (511)
... ......+||+.|+|||++.+.
T Consensus 169 ~~~~~~~~~~~~~~gT~~Y~aPE~~~~~ 196 (318)
T d3blha1 169 LAKNSQPNRYTNRVVTLWYRPPELLLGE 196 (318)
T ss_dssp C-----CCCCCSCCSCGGGCCHHHHTTC
T ss_pred cccccccccccceecCHHHhhHHHHcCC
Confidence 322 122335789999999998754
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=99.97 E-value=4.9e-31 Score=265.40 Aligned_cols=162 Identities=15% Similarity=0.297 Sum_probs=138.0
Q ss_pred CCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhC-CCCceeeEeeeEeeCC-CcEE
Q 010401 339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCVCVDEN-HGLC 410 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l-~HpNIV~l~g~~~~~~-~~l~ 410 (511)
.++|+++++||+|+||+||+| +.||+|+++... ..++.+|+.+|+.+ +||||++++++|.... ..++
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-----~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~ 108 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA 108 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEE
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH-----HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCcee
Confidence 467999999999999999996 579999996321 35678999999998 4999999999997543 3489
Q ss_pred EEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCC-cEEEEecCCceecccCCC
Q 010401 411 VVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG-NVCLGDMGIVTACKSVGE 489 (511)
Q Consensus 411 LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g-~vKL~DFGlS~~l~~~~~ 489 (511)
+||||+.+++|..+. +.+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+......
T Consensus 109 ~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~- 184 (328)
T d3bqca1 109 LVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ- 184 (328)
T ss_dssp EEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC-
T ss_pred EEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCCC-
Confidence 999999999997653 5699999999999999999999999999999999999999655 69999999998765433
Q ss_pred ccccccCCCccccHHhhccc
Q 010401 490 ATEYETDGYRWLAPEVCFLL 509 (511)
Q Consensus 490 ~~~~~~Gt~~YmAPEvl~gl 509 (511)
......||+.|+|||++.+.
T Consensus 185 ~~~~~~~t~~y~aPE~~~~~ 204 (328)
T d3bqca1 185 EYNVRVASRYFKGPELLVDY 204 (328)
T ss_dssp CCCSCCSCGGGCCHHHHTTC
T ss_pred cccccccCccccCcccccCC
Confidence 34556789999999998753
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=4.6e-31 Score=268.44 Aligned_cols=168 Identities=17% Similarity=0.274 Sum_probs=136.9
Q ss_pred CCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCC---cE
Q 010401 339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENH---GL 409 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~---~l 409 (511)
.++|++++.||+|+||+||+| +.||||++.... ......++.+|+.+|+.++||||+++++++..... ..
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc-ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 356999999999999999996 479999997432 34445678999999999999999999999976532 13
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccCCC
Q 010401 410 CVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE 489 (511)
Q Consensus 410 ~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~~~ 489 (511)
+++++|+.+|+|.+++.. +.+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+++.......
T Consensus 86 ~~l~~~~~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~ 164 (345)
T d1pmea_ 86 VYLVTHLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 164 (345)
T ss_dssp EEEEEECCCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGC
T ss_pred EEEEEeecCCchhhhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCCc
Confidence 455566778999999954 5799999999999999999999999999999999999999999999999999987643322
Q ss_pred ---ccccccCCCccccHHhhcc
Q 010401 490 ---ATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 490 ---~~~~~~Gt~~YmAPEvl~g 508 (511)
.....+||+.|+|||++..
T Consensus 165 ~~~~~~~~~gt~~y~aPE~l~~ 186 (345)
T d1pmea_ 165 HTGFLTEYVATRWYRAPEIMLN 186 (345)
T ss_dssp BCCTTCCCCSCGGGCCGGGTTT
T ss_pred cceeeccccccceechHHHhhc
Confidence 2345578999999999854
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.5e-30 Score=265.21 Aligned_cols=162 Identities=19% Similarity=0.185 Sum_probs=132.8
Q ss_pred CeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCC-----CcE
Q 010401 341 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN-----HGL 409 (511)
Q Consensus 341 ~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~-----~~l 409 (511)
+|+.+++||+|+||+||++ +.||||++...... ..+|+.+|++++||||++++++|.... ..+
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~ 94 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 94 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH------HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEE
Confidence 5889999999999999996 47999999753322 247899999999999999999986432 237
Q ss_pred EEEEeccCCCCHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCC-cEEEEecCCceecc
Q 010401 410 CVVTKLMEGGSVNDLI---LKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG-NVCLGDMGIVTACK 485 (511)
Q Consensus 410 ~LVmEy~~gGsL~~lL---~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g-~vKL~DFGlS~~l~ 485 (511)
||||||++++.+..+. .....+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++...
T Consensus 95 ~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~ 174 (350)
T d1q5ka_ 95 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 174 (350)
T ss_dssp EEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECC
T ss_pred EEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhcc
Confidence 8999999875433333 2345799999999999999999999999999999999999999775 89999999998765
Q ss_pred cCCCccccccCCCccccHHhhccc
Q 010401 486 SVGEATEYETDGYRWLAPEVCFLL 509 (511)
Q Consensus 486 ~~~~~~~~~~Gt~~YmAPEvl~gl 509 (511)
... ......||+.|+|||++.+.
T Consensus 175 ~~~-~~~~~~gt~~y~aPE~~~~~ 197 (350)
T d1q5ka_ 175 RGE-PNVSYICSRYYRAPELIFGA 197 (350)
T ss_dssp TTS-CCCSCCSCTTSCCHHHHTTC
T ss_pred CCc-ccccccccccccChHHhhcc
Confidence 433 34456789999999998753
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=6.1e-31 Score=266.17 Aligned_cols=170 Identities=18% Similarity=0.296 Sum_probs=146.0
Q ss_pred cCCCeEEEeeeecccceEEEEe---------EEEEEEEEecCCC--CchHHHHHHHHHHHHHhCCC-CceeeEeeeEeeC
Q 010401 338 NSDNLEFIDQIGPNSFKGVYKG---------KRVGIEKLKGCDK--GNAYEFELRKDLLELMTCGH-KNILQFYCVCVDE 405 (511)
Q Consensus 338 ~~~~y~l~~~LG~GsFG~VYkg---------k~VAVKkL~~~~~--~~~~~~~~~~Ei~iL~~l~H-pNIV~l~g~~~~~ 405 (511)
..++|++++.||+|+||+||++ +.||+|+++.... .......+.+|+.++++++| |||+++++++.+.
T Consensus 22 ~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~ 101 (322)
T d1vzoa_ 22 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE 101 (322)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET
T ss_pred chhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccC
Confidence 3578999999999999999996 3699999864221 11223457899999999966 8999999999988
Q ss_pred CCcEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecc
Q 010401 406 NHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK 485 (511)
Q Consensus 406 ~~~l~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~ 485 (511)
+. ++++|||+.+|+|.+++...+.+++..+..++.||+.||+|||+++|+||||||+|||++.+|.+||+|||+++.+.
T Consensus 102 ~~-~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~ 180 (322)
T d1vzoa_ 102 TK-LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV 180 (322)
T ss_dssp TE-EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred Cc-eeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhhc
Confidence 76 99999999999999999888889999999999999999999999999999999999999999999999999998764
Q ss_pred cCC-CccccccCCCccccHHhhcc
Q 010401 486 SVG-EATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 486 ~~~-~~~~~~~Gt~~YmAPEvl~g 508 (511)
... .......|++.|+|||++.+
T Consensus 181 ~~~~~~~~~~~g~~~~~~pe~~~~ 204 (322)
T d1vzoa_ 181 ADETERAYDFCGTIEYMAPDIVRG 204 (322)
T ss_dssp GGGGGGGCGGGSCCTTCCHHHHTT
T ss_pred ccccccccccccccccchhHHhhc
Confidence 332 23445678999999999865
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1.5e-30 Score=263.41 Aligned_cols=169 Identities=15% Similarity=0.288 Sum_probs=140.0
Q ss_pred eEecCCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCC--
Q 010401 335 WLLNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN-- 406 (511)
Q Consensus 335 ~~l~~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~-- 406 (511)
|.+ .++|++++.||+|+||+||+| +.||||++...........++.+|+.+|+.++||||+++++++....
T Consensus 14 ~~~-~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~ 92 (348)
T d2gfsa1 14 WEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSL 92 (348)
T ss_dssp EEE-ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSST
T ss_pred ccC-CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeecccc
Confidence 544 578999999999999999996 57999999865555555667899999999999999999999986432
Q ss_pred --CcEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceec
Q 010401 407 --HGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC 484 (511)
Q Consensus 407 --~~l~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l 484 (511)
...+++|+|+.+|+|.+++. .+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+|++|||++...
T Consensus 93 ~~~~~~~i~~~~~gg~L~~~~~-~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~ 171 (348)
T d2gfsa1 93 EEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT 171 (348)
T ss_dssp TTCCCCEEEEECCSEEHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CC
T ss_pred ccCceEEEEEeecCCchhhhcc-cccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhccc
Confidence 12466677788999999984 457999999999999999999999999999999999999999999999999998765
Q ss_pred ccCCCccccccCCCccccHHhhcc
Q 010401 485 KSVGEATEYETDGYRWLAPEVCFL 508 (511)
Q Consensus 485 ~~~~~~~~~~~Gt~~YmAPEvl~g 508 (511)
.. ......|++.|+|||++.+
T Consensus 172 ~~---~~~~~~g~~~y~apE~~~~ 192 (348)
T d2gfsa1 172 DD---EMTGYVATRWYRAPEIMLN 192 (348)
T ss_dssp TG---GGSSSCHHHHTSCHHHHTT
T ss_pred Cc---ccccccccccccCchhhcC
Confidence 33 2445678899999999765
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.96 E-value=7.5e-30 Score=253.50 Aligned_cols=165 Identities=19% Similarity=0.228 Sum_probs=133.1
Q ss_pred CCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCCCcEEEEE
Q 010401 340 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT 413 (511)
Q Consensus 340 ~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~~~l~LVm 413 (511)
++|++++.||+|+||.||+| +.||||++...... .++..|+.+++.++|+|++.+++.+...+...++||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivm 82 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 82 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC----HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEE
Confidence 57999999999999999996 47999998753222 236789999999988876666655555555589999
Q ss_pred eccCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEc---CCCcEEEEecCCceecccCCC
Q 010401 414 KLMEGGSVNDLIL-KSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLD---RHGNVCLGDMGIVTACKSVGE 489 (511)
Q Consensus 414 Ey~~gGsL~~lL~-~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld---~~g~vKL~DFGlS~~l~~~~~ 489 (511)
||+. ++|.+.+. ..+.+++..+..++.||+.||+|||++|||||||||+|||++ .+..+||+|||+|+.+.....
T Consensus 83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~ 161 (299)
T d1ckia_ 83 ELLG-PSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 161 (299)
T ss_dssp ECCC-CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTT
T ss_pred EEcC-CchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceecccccc
Confidence 9995 47766664 456899999999999999999999999999999999999986 355799999999998754332
Q ss_pred -------ccccccCCCccccHHhhccc
Q 010401 490 -------ATEYETDGYRWLAPEVCFLL 509 (511)
Q Consensus 490 -------~~~~~~Gt~~YmAPEvl~gl 509 (511)
......||+.|||||++.+.
T Consensus 162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~ 188 (299)
T d1ckia_ 162 HQHIPYRENKNLTGTARYASINTHLGI 188 (299)
T ss_dssp CCBCCCCBCCSCCCCSSSCCHHHHTTB
T ss_pred ccceeccccCCcCCCccccCHHHHhCC
Confidence 12345799999999998764
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=5.1e-30 Score=261.66 Aligned_cols=167 Identities=20% Similarity=0.279 Sum_probs=131.3
Q ss_pred CCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCCCceeeEeeeEeeCC-----C
Q 010401 339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN-----H 407 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~HpNIV~l~g~~~~~~-----~ 407 (511)
.++|+++++||+|+||+||+| +.||||++...........++.+|+.+++.++||||++++++|...+ .
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 467999999999999999995 57999999865555555667899999999999999999999996432 3
Q ss_pred cEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCceecccC
Q 010401 408 GLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV 487 (511)
Q Consensus 408 ~l~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS~~l~~~ 487 (511)
.+|+||||+.++ +.+.+ ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+|++|||+++.....
T Consensus 96 ~~~iv~Ey~~~~-l~~~~--~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~ 172 (355)
T d2b1pa1 96 DVYLVMELMDAN-LCQVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 172 (355)
T ss_dssp EEEEEEECCSEE-HHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred eeEEEEeccchH-HHHhh--hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhccccc
Confidence 489999999764 44444 356899999999999999999999999999999999999999999999999998766443
Q ss_pred CCccccccCCCccccHHhhccc
Q 010401 488 GEATEYETDGYRWLAPEVCFLL 509 (511)
Q Consensus 488 ~~~~~~~~Gt~~YmAPEvl~gl 509 (511)
.......||+.|+|||++++.
T Consensus 173 -~~~~~~~~t~~y~aPE~l~~~ 193 (355)
T d2b1pa1 173 -FMMTPYVVTRYYRAPEVILGM 193 (355)
T ss_dssp ---------CCTTCCHHHHTTC
T ss_pred -cccccccccccccChhhhcCC
Confidence 334556789999999999764
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.96 E-value=1.8e-29 Score=251.38 Aligned_cols=165 Identities=19% Similarity=0.291 Sum_probs=137.5
Q ss_pred CCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCCC-CceeeEeeeEeeCCCcEEE
Q 010401 339 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGH-KNILQFYCVCVDENHGLCV 411 (511)
Q Consensus 339 ~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~H-pNIV~l~g~~~~~~~~l~L 411 (511)
.++|++++.||+|+||.||+| +.||||++...... ..+.+|+.++..+.| +||+.+++++..+.. .|+
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~-~~~ 78 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLH-NVL 78 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTE-EEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc----HHHHHHHHHHHHhcCCCCCCEEEEEeecCCc-cEE
Confidence 578999999999999999996 57999998643222 235677888888855 899999999887775 899
Q ss_pred EEeccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcC-----CCcEEEEecCCceecc
Q 010401 412 VTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDR-----HGNVCLGDMGIVTACK 485 (511)
Q Consensus 412 VmEy~~gGsL~~lL~~~-~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~-----~g~vKL~DFGlS~~l~ 485 (511)
||||+ +++|.+++... ..+++..+..++.|++.||+|||++|||||||||+|||++. ++.+||+|||+|+...
T Consensus 79 vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~ 157 (293)
T d1csna_ 79 VIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 157 (293)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred EEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence 99999 67999998654 47999999999999999999999999999999999999974 5789999999998764
Q ss_pred cCCC-------ccccccCCCccccHHhhccc
Q 010401 486 SVGE-------ATEYETDGYRWLAPEVCFLL 509 (511)
Q Consensus 486 ~~~~-------~~~~~~Gt~~YmAPEvl~gl 509 (511)
.... ......||+.|||||++.+.
T Consensus 158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~ 188 (293)
T d1csna_ 158 DPVTKQHIPYREKKNLSGTARYMSINTHLGR 188 (293)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC
T ss_pred cCccccceeecccCceEEchhhcCHHHhcCC
Confidence 3221 12345799999999998764
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.92 E-value=6.3e-25 Score=221.98 Aligned_cols=166 Identities=15% Similarity=0.252 Sum_probs=129.1
Q ss_pred cCCCeEEEeeeecccceEEEEe------EEEEEEEEecCCCCchHHHHHHHHHHHHHhCC-----------CCceeeEee
Q 010401 338 NSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCG-----------HKNILQFYC 400 (511)
Q Consensus 338 ~~~~y~l~~~LG~GsFG~VYkg------k~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~-----------HpNIV~l~g 400 (511)
..++|+++++||+|+||+||+| +.||||+++. .......+.+|+.+++.++ |+||+++++
T Consensus 11 ~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~---~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~ 87 (362)
T d1q8ya_ 11 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG---DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLD 87 (362)
T ss_dssp TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS---CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCE
T ss_pred cCCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEec---cccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEE
Confidence 3456999999999999999996 5799999963 2333455678888777654 588999999
Q ss_pred eEeeCC-CcEEEEEeccCCCCHHHH-HH--hcCCCCHHHHHHHHHHHHHHHHHHHH-CCccccCCCCCceEEcCCCc---
Q 010401 401 VCVDEN-HGLCVVTKLMEGGSVNDL-IL--KSRKLQTKEIIRIAIDVAEGIKFLND-HGVAYRDLNSQRILLDRHGN--- 472 (511)
Q Consensus 401 ~~~~~~-~~l~LVmEy~~gGsL~~l-L~--~~~~L~e~~~~~ia~qIa~gL~yLH~-~gIIHRDLKp~NILld~~g~--- 472 (511)
++.... ...+++|+++..+..... .. ....+++..+..++.||+.||+|||+ +||+||||||+|||++.++.
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~ 167 (362)
T d1q8ya_ 88 HFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPEN 167 (362)
T ss_dssp EEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTT
T ss_pred EeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccc
Confidence 886533 236677777655443332 22 34578999999999999999999998 89999999999999986653
Q ss_pred ---EEEEecCCceecccCCCccccccCCCccccHHhhccc
Q 010401 473 ---VCLGDMGIVTACKSVGEATEYETDGYRWLAPEVCFLL 509 (511)
Q Consensus 473 ---vKL~DFGlS~~l~~~~~~~~~~~Gt~~YmAPEvl~gl 509 (511)
++++|||.+..... ......||+.|+|||++.+.
T Consensus 168 ~~~~kl~dfg~s~~~~~---~~~~~~gt~~y~aPE~~~~~ 204 (362)
T d1q8ya_ 168 LIQIKIADLGNACWYDE---HYTNSIQTREYRSPEVLLGA 204 (362)
T ss_dssp EEEEEECCCTTCEETTB---CCCSCCSCGGGCCHHHHHTC
T ss_pred cceeeEeeccccccccc---ccccccccccccChhhcccc
Confidence 99999999876543 24566899999999998753
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.85 E-value=1.9e-21 Score=180.61 Aligned_cols=132 Identities=11% Similarity=0.105 Sum_probs=102.3
Q ss_pred EEEeeeecccceEEEEe-----EEEEEEEEecCCCC----------------chHHHHHHHHHHHHHhCCCCceeeEeee
Q 010401 343 EFIDQIGPNSFKGVYKG-----KRVGIEKLKGCDKG----------------NAYEFELRKDLLELMTCGHKNILQFYCV 401 (511)
Q Consensus 343 ~l~~~LG~GsFG~VYkg-----k~VAVKkL~~~~~~----------------~~~~~~~~~Ei~iL~~l~HpNIV~l~g~ 401 (511)
.+.+.||+|+||.||+| +.||||+++..... ........+|...+.++.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 57899999999999995 58999987632110 0011234567888889999999988865
Q ss_pred EeeCCCcEEEEEeccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCCCceEEcCCCcEEEEecCCc
Q 010401 402 CVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIV 481 (511)
Q Consensus 402 ~~~~~~~l~LVmEy~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~gIIHRDLKp~NILld~~g~vKL~DFGlS 481 (511)
. . .+++|||+++..+. .++...+..++.|++.+|.|||++||+||||||+|||++++ .++|+|||+|
T Consensus 83 ~---~--~~lvme~~~~~~~~-------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDFG~a 149 (191)
T d1zara2 83 E---G--NAVLMELIDAKELY-------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFPQS 149 (191)
T ss_dssp E---T--TEEEEECCCCEEGG-------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCCTTC
T ss_pred c---C--CEEEEEeecccccc-------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEECCCc
Confidence 3 1 36999999885543 24555667899999999999999999999999999999865 5899999999
Q ss_pred eecccC
Q 010401 482 TACKSV 487 (511)
Q Consensus 482 ~~l~~~ 487 (511)
+....+
T Consensus 150 ~~~~~~ 155 (191)
T d1zara2 150 VEVGEE 155 (191)
T ss_dssp EETTST
T ss_pred ccCCCC
Confidence 876543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.07 E-value=5.9e-06 Score=77.15 Aligned_cols=136 Identities=12% Similarity=0.108 Sum_probs=83.7
Q ss_pred CCeEEEeeeecccceEEEE----eEEEEEEEEecCCCCchHHHHHHHHHHHHHhCC-CCceeeEeeeEeeCCCcEEEEEe
Q 010401 340 DNLEFIDQIGPNSFKGVYK----GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCG-HKNILQFYCVCVDENHGLCVVTK 414 (511)
Q Consensus 340 ~~y~l~~~LG~GsFG~VYk----gk~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~-HpNIV~l~g~~~~~~~~l~LVmE 414 (511)
+.|++.+..+-++...||+ ++.+.+|+......... ..+.+|...+..+. +--+.+++.+..+++. .|+||+
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~~~~~~~vlk~~~~~~~~~~--~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~-~~lv~~ 90 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTT--YDVEREKDMMLWLEGKLPVPKVLHFERHDGW-SNLLMS 90 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEECSSCEEEEEEECGGGTTST--TCHHHHHHHHHHHTTTSCCCCEEEEEEETTE-EEEEEE
T ss_pred hceEEEEcCCCCCCCcEEEEEeCCCeEEEEEcCCCcccch--hhHHHHHHHHHHHhccCCCCcEEEEEecCCc-eEEEEE
Confidence 3556666655555678887 34677787754322221 23456666665542 3234566766666654 789999
Q ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-----------------------------------------
Q 010401 415 LMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDH----------------------------------------- 453 (511)
Q Consensus 415 y~~gGsL~~lL~~~~~L~e~~~~~ia~qIa~gL~yLH~~----------------------------------------- 453 (511)
+++|..+.+..... .....++.+++..+..||+.
T Consensus 91 ~l~G~~~~~~~~~~-----~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (263)
T d1j7la_ 91 EADGVLCSEEYEDE-----QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFK 165 (263)
T ss_dssp CCSSEEHHHHTTTC-----SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCS
T ss_pred eccccccccccccc-----ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccch
Confidence 99998775543111 11122333444444444421
Q ss_pred ------------------CccccCCCCCceEEcCCCcEEEEecCCcee
Q 010401 454 ------------------GVAYRDLNSQRILLDRHGNVCLGDMGIVTA 483 (511)
Q Consensus 454 ------------------gIIHRDLKp~NILld~~g~vKL~DFGlS~~ 483 (511)
.++|+|+.|.|||+++++.+-|+||+.+..
T Consensus 166 ~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 166 DPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp SHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 268999999999999776677999998765
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.33 E-value=0.00062 Score=62.56 Aligned_cols=29 Identities=17% Similarity=0.116 Sum_probs=25.7
Q ss_pred ccccCCCCCceEEcCCCcEEEEecCCcee
Q 010401 455 VAYRDLNSQRILLDRHGNVCLGDMGIVTA 483 (511)
Q Consensus 455 IIHRDLKp~NILld~~g~vKL~DFGlS~~ 483 (511)
++|+|+.|.|||++.+..+-|+||+.+..
T Consensus 177 liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 177 VTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp EECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred EEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 79999999999999876678999998754
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.19 E-value=0.0006 Score=68.26 Aligned_cols=29 Identities=17% Similarity=0.123 Sum_probs=25.2
Q ss_pred CccccCCCCCceEEcCCCcEEEEecCCcee
Q 010401 454 GVAYRDLNSQRILLDRHGNVCLGDMGIVTA 483 (511)
Q Consensus 454 gIIHRDLKp~NILld~~g~vKL~DFGlS~~ 483 (511)
.++|+|+.+.|||++.++ ++|+||.++..
T Consensus 224 ~LiHGDl~~gNIlv~~~~-~~vID~E~a~~ 252 (392)
T d2pula1 224 TLIHGDLHTGSIFASEHE-TKVIDPEFAFY 252 (392)
T ss_dssp EEECSCCCGGGEEECSSC-EEECCCTTCEE
T ss_pred ceeccCCcCCceeEcCCc-eEEechhhccc
Confidence 589999999999998665 89999988754
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=95.43 E-value=0.017 Score=55.43 Aligned_cols=28 Identities=18% Similarity=0.082 Sum_probs=23.3
Q ss_pred CccccCCCCCceEEcCCCcEEEEecCCcee
Q 010401 454 GVAYRDLNSQRILLDRHGNVCLGDMGIVTA 483 (511)
Q Consensus 454 gIIHRDLKp~NILld~~g~vKL~DFGlS~~ 483 (511)
++||+|+.+.|||+++ + ..++||+-+..
T Consensus 193 ~liHgDlh~~NvL~~~-~-~~~IDFdd~~~ 220 (325)
T d1zyla1 193 LRLHGDCHAGNILWRD-G-PMFVDLDDARN 220 (325)
T ss_dssp EECCSSCSGGGEEESS-S-EEECCCTTCCE
T ss_pred eeecCCCCcccEEEeC-C-ceEEechhccc
Confidence 6899999999999974 3 45899998754
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=93.63 E-value=0.096 Score=51.29 Aligned_cols=71 Identities=8% Similarity=0.047 Sum_probs=40.7
Q ss_pred CCeEEEeeeecccceEEEEeE-------------EEEEEEEecCCCCchHHHHHHHHHHHHHhCC-CCceeeEeeeEeeC
Q 010401 340 DNLEFIDQIGPNSFKGVYKGK-------------RVGIEKLKGCDKGNAYEFELRKDLLELMTCG-HKNILQFYCVCVDE 405 (511)
Q Consensus 340 ~~y~l~~~LG~GsFG~VYkgk-------------~VAVKkL~~~~~~~~~~~~~~~Ei~iL~~l~-HpNIV~l~g~~~~~ 405 (511)
+++++ +.|+-|--=.+|+.. .|.+++ ... ... .....+|..+++.+. +.-..++++++.
T Consensus 43 ~~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi-~g~-~~~--~idr~~E~~i~~~ls~~gl~Pkll~~~~-- 115 (395)
T d1nw1a_ 43 EHLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRV-YFN-PET--ESHLVAESVIFTLLSERHLGPKLYGIFS-- 115 (395)
T ss_dssp GGEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEE-ECS-CCC--HHHHHHHHHHHHHHHHTTSSSCEEEEET--
T ss_pred cceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEe-cCC-cch--hhHHHHHHHHHHHHHhCCCCCeEEEEcC--
Confidence 34444 567777777888743 233433 332 222 233567777777663 333457777663
Q ss_pred CCcEEEEEeccCCCC
Q 010401 406 NHGLCVVTKLMEGGS 420 (511)
Q Consensus 406 ~~~l~LVmEy~~gGs 420 (511)
+ ++||||++|..
T Consensus 116 ~---g~I~efi~g~~ 127 (395)
T d1nw1a_ 116 G---GRLEEYIPSRP 127 (395)
T ss_dssp T---EEEECCCCEEE
T ss_pred C---ceEEEEecccc
Confidence 2 48999998643
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=91.44 E-value=0.024 Score=53.63 Aligned_cols=31 Identities=19% Similarity=0.114 Sum_probs=27.3
Q ss_pred CCccccCCCCCceEEcCCCcEEEEecCCcee
Q 010401 453 HGVAYRDLNSQRILLDRHGNVCLGDMGIVTA 483 (511)
Q Consensus 453 ~gIIHRDLKp~NILld~~g~vKL~DFGlS~~ 483 (511)
.|+||+|+.++||+++.+...-|+||+.+..
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cccccCCcchhhhhcccccceeEeccccccc
Confidence 4799999999999999887778999998643
|